PheCode,Phenotype,Category,OMICSPRED ID,Internal R2,Platform,Description,Hazard Ratio,FDR adjusted P-value
8.52,Intestinal infection due to C. difficile,infectious diseases,OPGS000538,0.109,SomaScan,Cyclic AMP-responsive element-binding protein 3-like protein 4,1.13 (1.07 1.20),4.04E-02
8.52,Intestinal infection due to C. difficile,infectious diseases,OPGS005167,0.269,RNAseq,TCF19,1.13 (1.07 1.19),4.04E-02
8.6,Viral Enteritis,infectious diseases,OPGS012118,0.040,RNAseq,KIAA0753,0.89 (0.84 0.93),4.54E-02
38,Septicemia,infectious diseases,OPGS005704,0.221,RNAseq,AF131215.5,1.05 (1.03 1.07),4.28E-02
38,Septicemia,infectious diseases,OPGS009970,0.070,RNAseq,CLDN23,1.05 (1.03 1.07),4.28E-02
70.2,Viral hepatitis B,infectious diseases,OPGS014979,0.016,RNAseq,SUCNR1,1.43 (1.24 1.66),1.17E-02
70.3,Viral hepatitis C,infectious diseases,OPGS003023,0.027,Metabolon,5alpha-androstan-3beta.17alpha-diol disulfate,0.78 (0.71 0.86),2.25E-02
70.4,Chronic hepatitis,infectious diseases,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.73 (0.67 0.80),9.73E-09
70.4,Chronic hepatitis,infectious diseases,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.37 (1.24 1.50),8.36E-08
70.4,Chronic hepatitis,infectious diseases,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.74 (0.67 0.81),3.42E-07
70.4,Chronic hepatitis,infectious diseases,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.73 (0.67 0.81),4.02E-07
70.4,Chronic hepatitis,infectious diseases,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.75 (0.69 0.82),5.56E-07
70.4,Chronic hepatitis,infectious diseases,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.76 (0.69 0.83),5.74E-07
70.4,Chronic hepatitis,infectious diseases,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.36 (1.23 1.50),8.08E-07
70.4,Chronic hepatitis,infectious diseases,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.76 (0.70 0.83),2.47E-06
70.4,Chronic hepatitis,infectious diseases,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.75 (0.69 0.83),2.63E-06
70.4,Chronic hepatitis,infectious diseases,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.73 (0.66 0.81),4.44E-06
70.4,Chronic hepatitis,infectious diseases,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.27 (1.16 1.40),2.50E-04
70.4,Chronic hepatitis,infectious diseases,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.79 (0.72 0.87),3.34E-04
70.4,Chronic hepatitis,infectious diseases,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,1.27 (1.15 1.40),9.04E-04
70.4,Chronic hepatitis,infectious diseases,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.24 (1.13 1.37),1.37E-03
70.4,Chronic hepatitis,infectious diseases,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.78 (0.70 0.87),2.26E-03
70.4,Chronic hepatitis,infectious diseases,OPGS000984,0.055,SomaScan,Complement C2,1.26 (1.14 1.40),3.87E-03
70.4,Chronic hepatitis,infectious diseases,OPGS000290,0.171,SomaScan,Complement C4,0.81 (0.73 0.89),7.89E-03
70.4,Chronic hepatitis,infectious diseases,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,1.23 (1.11 1.36),1.42E-02
70.4,Chronic hepatitis,infectious diseases,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.82 (0.74 0.90),1.56E-02
70.4,Chronic hepatitis,infectious diseases,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,0.83 (0.76 0.92),3.11E-02
70.4,Chronic hepatitis,infectious diseases,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.75 (0.69 0.83),2.63E-06
70.4,Chronic hepatitis,infectious diseases,OPGS002568,0.043,Olink,Granzyme A,0.81 (0.74 0.89),3.08E-03
70.4,Chronic hepatitis,infectious diseases,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.81 (0.73 0.89),5.56E-03
70.4,Chronic hepatitis,infectious diseases,OPGS013243,0.029,RNAseq,TRAV3,0.69 (0.63 0.76),5.42E-11
70.4,Chronic hepatitis,infectious diseases,OPGS006499,0.176,RNAseq,C4A,0.72 (0.66 0.79),6.88E-10
70.4,Chronic hepatitis,infectious diseases,OPGS014496,0.019,RNAseq,VARS1,1.38 (1.26 1.50),6.88E-10
70.4,Chronic hepatitis,infectious diseases,OPGS007675,0.126,RNAseq,TRAV12-2,1.41 (1.29 1.54),7.94E-10
70.4,Chronic hepatitis,infectious diseases,OPGS006845,0.158,RNAseq,FLOT1,1.40 (1.28 1.53),1.77E-09
70.4,Chronic hepatitis,infectious diseases,OPGS005230,0.263,RNAseq,LINC00243,1.40 (1.27 1.55),2.40E-08
70.4,Chronic hepatitis,infectious diseases,OPGS010826,0.056,RNAseq,TRIM10,0.75 (0.68 0.81),6.35E-08
70.4,Chronic hepatitis,infectious diseases,OPGS006716,0.164,RNAseq,IER3,1.37 (1.25 1.51),7.24E-08
70.4,Chronic hepatitis,infectious diseases,OPGS009865,0.072,RNAseq,TRAV17,0.74 (0.68 0.81),1.68E-07
70.4,Chronic hepatitis,infectious diseases,OPGS011784,0.044,RNAseq,TUBB,1.39 (1.25 1.54),5.08E-07
70.4,Chronic hepatitis,infectious diseases,OPGS009198,0.085,RNAseq,TRAV12-1,1.37 (1.24 1.51),5.56E-07
70.4,Chronic hepatitis,infectious diseases,OPGS006866,0.157,RNAseq,AL662795.2,1.39 (1.25 1.54),5.56E-07
70.4,Chronic hepatitis,infectious diseases,OPGS010693,0.058,RNAseq,TRBV5-1,1.34 (1.22 1.47),6.36E-07
70.4,Chronic hepatitis,infectious diseases,OPGS012006,0.041,RNAseq,VARS2,0.75 (0.68 0.82),1.31E-06
70.4,Chronic hepatitis,infectious diseases,OPGS003680,0.611,RNAseq,,1.30 (1.19 1.42),2.32E-06
70.4,Chronic hepatitis,infectious diseases,OPGS013225,0.029,RNAseq,REG4,0.76 (0.69 0.84),8.09E-06
70.4,Chronic hepatitis,infectious diseases,OPGS013045,0.030,RNAseq,NEU1,0.77 (0.70 0.84),9.82E-06
70.4,Chronic hepatitis,infectious diseases,OPGS009371,0.082,RNAseq,TRBV19,0.75 (0.68 0.83),1.95E-05
70.4,Chronic hepatitis,infectious diseases,OPGS004334,0.383,RNAseq,HLA-G,0.75 (0.68 0.83),2.80E-05
70.4,Chronic hepatitis,infectious diseases,OPGS005334,0.253,RNAseq,AL645933.4,0.77 (0.70 0.85),1.05E-04
70.4,Chronic hepatitis,infectious diseases,OPGS014283,0.021,RNAseq,MXRA8,0.76 (0.69 0.85),1.62E-04
70.4,Chronic hepatitis,infectious diseases,OPGS013013,0.031,RNAseq,FOXJ1,0.80 (0.73 0.87),1.63E-04
70.4,Chronic hepatitis,infectious diseases,OPGS009222,0.085,RNAseq,,0.79 (0.72 0.86),1.72E-04
70.4,Chronic hepatitis,infectious diseases,OPGS003843,0.532,RNAseq,BTN3A2,0.80 (0.73 0.87),2.67E-04
70.4,Chronic hepatitis,infectious diseases,OPGS011073,0.053,RNAseq,TRBV7-3,1.35 (1.20 1.51),2.73E-04
70.4,Chronic hepatitis,infectious diseases,OPGS010142,0.067,RNAseq,PRSS16,1.23 (1.13 1.33),5.92E-04
70.4,Chronic hepatitis,infectious diseases,OPGS010561,0.060,RNAseq,IL2RA,1.26 (1.14 1.38),7.12E-04
70.4,Chronic hepatitis,infectious diseases,OPGS004406,0.369,RNAseq,,0.79 (0.71 0.87),7.29E-04
70.4,Chronic hepatitis,infectious diseases,OPGS010607,0.059,RNAseq,TRAV8-1,1.26 (1.14 1.38),8.24E-04
70.4,Chronic hepatitis,infectious diseases,OPGS009241,0.084,RNAseq,ZKSCAN4,1.24 (1.13 1.35),1.14E-03
70.4,Chronic hepatitis,infectious diseases,OPGS006942,0.154,RNAseq,SKIV2L,0.78 (0.70 0.87),1.54E-03
70.4,Chronic hepatitis,infectious diseases,OPGS012093,0.040,RNAseq,TRIM26,1.25 (1.14 1.38),1.65E-03
70.4,Chronic hepatitis,infectious diseases,OPGS015052,0.015,RNAseq,CISH,1.25 (1.13 1.39),3.25E-03
70.4,Chronic hepatitis,infectious diseases,OPGS010624,0.059,RNAseq,TRBV18,1.25 (1.13 1.38),3.25E-03
70.4,Chronic hepatitis,infectious diseases,OPGS014580,0.018,RNAseq,DACT1,1.26 (1.13 1.40),7.03E-03
70.4,Chronic hepatitis,infectious diseases,OPGS011283,0.050,RNAseq,CD248,0.81 (0.74 0.89),7.03E-03
70.4,Chronic hepatitis,infectious diseases,OPGS007248,0.141,RNAseq,,0.78 (0.70 0.88),7.89E-03
70.4,Chronic hepatitis,infectious diseases,OPGS013406,0.027,RNAseq,AL353759.1,1.25 (1.12 1.39),9.56E-03
70.4,Chronic hepatitis,infectious diseases,OPGS012358,0.037,RNAseq,SFRP5,0.81 (0.73 0.90),1.12E-02
70.4,Chronic hepatitis,infectious diseases,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.30 (1.14 1.47),1.42E-02
70.4,Chronic hepatitis,infectious diseases,OPGS009920,0.071,RNAseq,LINC02446,0.82 (0.74 0.90),1.47E-02
70.4,Chronic hepatitis,infectious diseases,OPGS007604,0.128,RNAseq,U91328.1,1.22 (1.10 1.34),1.56E-02
70.4,Chronic hepatitis,infectious diseases,OPGS005674,0.223,RNAseq,ACTR5,1.23 (1.11 1.36),1.79E-02
70.4,Chronic hepatitis,infectious diseases,OPGS006248,0.189,RNAseq,MCCD1,0.82 (0.75 0.91),2.11E-02
70.4,Chronic hepatitis,infectious diseases,OPGS006854,0.158,RNAseq,,0.83 (0.76 0.91),2.17E-02
70.4,Chronic hepatitis,infectious diseases,OPGS011249,0.050,RNAseq,AC009113.1,0.86 (0.80 0.93),2.21E-02
70.4,Chronic hepatitis,infectious diseases,OPGS011787,0.044,RNAseq,C2,1.21 (1.10 1.33),2.26E-02
70.4,Chronic hepatitis,infectious diseases,OPGS010850,0.056,RNAseq,LTA,0.82 (0.75 0.91),2.46E-02
70.4,Chronic hepatitis,infectious diseases,OPGS013780,0.024,RNAseq,ZSCAN16,1.20 (1.09 1.31),2.73E-02
70.4,Chronic hepatitis,infectious diseases,OPGS013896,0.023,RNAseq,ATF6B,1.21 (1.10 1.33),2.73E-02
70.4,Chronic hepatitis,infectious diseases,OPGS007407,0.135,RNAseq,TRBV2,1.20 (1.09 1.32),2.73E-02
70.4,Chronic hepatitis,infectious diseases,OPGS005129,0.274,RNAseq,MKRN2,0.80 (0.71 0.90),2.80E-02
70.4,Chronic hepatitis,infectious diseases,OPGS007297,0.140,RNAseq,GPANK1,0.81 (0.72 0.90),3.13E-02
70.4,Chronic hepatitis,infectious diseases,OPGS013298,0.028,RNAseq,IL7R,0.83 (0.74 0.91),4.34E-02
70.4,Chronic hepatitis,infectious diseases,OPGS014311,0.020,RNAseq,MBNL2,0.86 (0.79 0.93),4.58E-02
70.9,Hepatitis NOS,infectious diseases,OPGS013632,0.025,RNAseq,PIP4K2C,1.19 (1.11 1.27),1.13E-02
78,Viral warts & HPV,infectious diseases,OPGS006248,0.189,RNAseq,MCCD1,0.87 (0.83 0.92),9.28E-03
112,Candidiasis,infectious diseases,OPGS001550,0.024,SomaScan,Trefoil factor 3,0.93 (0.90 0.96),1.45E-02
112,Candidiasis,infectious diseases,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.94 (0.91 0.96),1.45E-02
112,Candidiasis,infectious diseases,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.94 (0.91 0.97),2.71E-02
112,Candidiasis,infectious diseases,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.94 (0.91 0.97),3.14E-02
112,Candidiasis,infectious diseases,OPGS012358,0.037,RNAseq,SFRP5,0.92 (0.89 0.95),3.27E-04
112,Candidiasis,infectious diseases,OPGS014283,0.021,RNAseq,MXRA8,0.92 (0.89 0.95),7.40E-04
112,Candidiasis,infectious diseases,OPGS013225,0.029,RNAseq,REG4,0.93 (0.91 0.96),1.45E-02
112,Candidiasis,infectious diseases,OPGS011283,0.050,RNAseq,CD248,0.93 (0.91 0.96),1.45E-02
112,Candidiasis,infectious diseases,OPGS009920,0.071,RNAseq,LINC02446,0.93 (0.91 0.96),1.45E-02
112,Candidiasis,infectious diseases,OPGS004065,0.446,RNAseq,,0.93 (0.90 0.96),2.01E-02
112,Candidiasis,infectious diseases,OPGS006866,0.157,RNAseq,AL662795.2,1.07 (1.04 1.10),2.41E-02
112,Candidiasis,infectious diseases,OPGS014232,0.021,RNAseq,TRAV1-2,0.94 (0.91 0.97),2.76E-02
112,Candidiasis,infectious diseases,OPGS006634,0.169,RNAseq,,0.94 (0.91 0.97),3.90E-02
112,Candidiasis,infectious diseases,OPGS010693,0.058,RNAseq,TRBV5-1,1.06 (1.03 1.09),3.90E-02
112,Candidiasis,infectious diseases,OPGS010826,0.056,RNAseq,TRIM10,0.94 (0.92 0.97),4.41E-02
112,Candidiasis,infectious diseases,OPGS012006,0.041,RNAseq,VARS2,0.94 (0.91 0.97),4.91E-02
112,Candidiasis,infectious diseases,OPGS006942,0.154,RNAseq,SKIV2L,0.94 (0.91 0.97),4.91E-02
133,Arthropod-borne diseases,infectious diseases,OPGS011126,0.052,RNAseq,C22orf39,228.98 (23.21 2258.86),4.86E-02
153.2,Colon cancer,neoplasms,OPGS010163,0.066,RNAseq,AL121832.2,1.07 (1.04 1.10),1.86E-02
153.3,Malignant neoplasm of rectum. rectosigmoid junction. and anus,neoplasms,OPGS010163,0.066,RNAseq,AL121832.2,1.08 (1.05 1.12),3.70E-02
153.3,Malignant neoplasm of rectum. rectosigmoid junction. and anus,neoplasms,OPGS010624,0.059,RNAseq,TRBV18,1.08 (1.04 1.11),4.21E-02
155.1,Malignant neoplasm of liver. primary,neoplasms,OPGS002665,0.011,Olink,Neurocan core protein,0.77 (0.71 0.84),1.42E-05
155.1,Malignant neoplasm of liver. primary,neoplasms,OPGS006705,0.165,RNAseq,MAU2,0.79 (0.72 0.86),1.84E-03
155.1,Malignant neoplasm of liver. primary,neoplasms,OPGS014323,0.020,RNAseq,MEF2B,0.90 (0.86 0.94),9.16E-03
157,Pancreatic cancer,neoplasms,OPGS001840,0.016,SomaScan,Inactive pancreatic lipase-related protein 1,0.87 (0.83 0.91),9.53E-05
157,Pancreatic cancer,neoplasms,OPGS000101,0.374,SomaScan,CD209 antigen,1.14 (1.08 1.20),5.47E-03
157,Pancreatic cancer,neoplasms,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.13 (1.08 1.19),5.47E-03
157,Pancreatic cancer,neoplasms,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.89 (0.85 0.94),1.10E-02
157,Pancreatic cancer,neoplasms,OPGS001954,0.014,SomaScan,Tuftelin,0.89 (0.85 0.94),1.10E-02
157,Pancreatic cancer,neoplasms,OPGS001658,0.020,SomaScan,Endoglin,0.89 (0.85 0.94),1.13E-02
157,Pancreatic cancer,neoplasms,OPGS000088,0.392,SomaScan,E-selectin,0.89 (0.85 0.94),1.13E-02
157,Pancreatic cancer,neoplasms,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,1.12 (1.07 1.18),1.42E-02
157,Pancreatic cancer,neoplasms,OPGS002645,0.017,Olink,Carboxypeptidase A1,0.87 (0.83 0.91),1.98E-05
157,Pancreatic cancer,neoplasms,OPGS002408,0.270,Olink,E-selectin,0.88 (0.84 0.93),5.47E-03
157,Pancreatic cancer,neoplasms,OPGS002651,0.015,Olink,von Willebrand factor,1.13 (1.08 1.19),5.47E-03
157,Pancreatic cancer,neoplasms,OPGS002500,0.098,Olink,Galectin-4,0.88 (0.84 0.93),5.93E-03
157,Pancreatic cancer,neoplasms,OPGS003149,0.015,Metabolon,sphingosine,1.11 (1.06 1.17),3.51E-02
157,Pancreatic cancer,neoplasms,OPGS015054,0.015,RNAseq,H19,1.12 (1.07 1.18),1.10E-02
165.1,Cancer of bronchus; lung,neoplasms,OPGS002175,0.011,SomaScan,Chymase,0.99 (0.98 0.99),3.13E-02
165.1,Cancer of bronchus; lung,neoplasms,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,0.94 (0.91 0.96),3.22E-02
165.1,Cancer of bronchus; lung,neoplasms,OPGS003190,0.012,Metabolon,3-methylxanthine,1.08 (1.05 1.11),8.94E-03
165.1,Cancer of bronchus; lung,neoplasms,OPGS003226,0.010,Metabolon,indolin-2-one,0.93 (0.90 0.96),1.12E-02
165.1,Cancer of bronchus; lung,neoplasms,OPGS003106,0.018,Metabolon,X - 12126,1.07 (1.04 1.10),3.13E-02
165.1,Cancer of bronchus; lung,neoplasms,OPGS003097,0.019,Metabolon,X - 12216,1.07 (1.04 1.10),4.86E-02
165.1,Cancer of bronchus; lung,neoplasms,OPGS003834,0.535,RNAseq,AC026748.3,1.10 (1.07 1.13),2.55E-05
165.1,Cancer of bronchus; lung,neoplasms,OPGS004694,0.324,RNAseq,IREB2,0.93 (0.90 0.96),6.93E-03
165.1,Cancer of bronchus; lung,neoplasms,OPGS009150,0.086,RNAseq,UQCC1,0.94 (0.91 0.96),3.22E-02
172,Skin cancer,neoplasms,OPGS001634,0.021,SomaScan,Melanocyte protein PMEL,0.85 (0.82 0.89),1.01E-07
172.1,Melanomas of skin. dx or hx,neoplasms,OPGS001634,0.021,SomaScan,Melanocyte protein PMEL,0.77 (0.71 0.84),1.95E-05
172.11,Melanomas of skin,neoplasms,OPGS001634,0.021,SomaScan,Melanocyte protein PMEL,0.86 (0.84 0.88),6.13E-31
172.11,Melanomas of skin,neoplasms,OPGS000400,0.139,SomaScan,Agouti-signaling protein,1.13 (1.10 1.15),3.67E-20
172.11,Melanomas of skin,neoplasms,OPGS000734,0.080,SomaScan,KDEL motif-containing protein 2,0.95 (0.93 0.97),1.96E-02
172.11,Melanomas of skin,neoplasms,OPGS003096,0.019,Metabolon,pyroglutamylglutamine,1.08 (1.05 1.11),6.05E-06
172.11,Melanomas of skin,neoplasms,OPGS003007,0.030,Metabolon,trans-urocanate,0.94 (0.92 0.97),5.02E-03
172.11,Melanomas of skin,neoplasms,OPGS004322,0.386,RNAseq,CDK10,0.86 (0.84 0.88),6.13E-31
172.11,Melanomas of skin,neoplasms,OPGS010527,0.060,RNAseq,SPG7,0.87 (0.85 0.89),1.67E-24
172.11,Melanomas of skin,neoplasms,OPGS008718,0.096,RNAseq,,1.11 (1.08 1.14),1.89E-13
172.11,Melanomas of skin,neoplasms,OPGS008702,0.097,RNAseq,,1.10 (1.07 1.13),1.07E-10
172.11,Melanomas of skin,neoplasms,OPGS007969,0.116,RNAseq,SPATA2L,1.10 (1.07 1.12),1.38E-09
172.11,Melanomas of skin,neoplasms,OPGS003834,0.535,RNAseq,AC026748.3,0.92 (0.89 0.94),1.02E-08
172.11,Melanomas of skin,neoplasms,OPGS007528,0.131,RNAseq,SPIRE2,0.93 (0.90 0.95),3.79E-05
172.11,Melanomas of skin,neoplasms,OPGS005895,0.209,RNAseq,MAP1LC3A,0.93 (0.91 0.96),3.79E-05
172.11,Melanomas of skin,neoplasms,OPGS010512,0.061,RNAseq,ITCH,0.93 (0.91 0.96),3.79E-05
172.11,Melanomas of skin,neoplasms,OPGS006251,0.189,RNAseq,MX1,0.94 (0.92 0.97),3.56E-03
172.11,Melanomas of skin,neoplasms,OPGS012279,0.038,RNAseq,CDKN2A,0.94 (0.92 0.97),3.93E-03
172.11,Melanomas of skin,neoplasms,OPGS014277,0.021,RNAseq,DEF8,0.94 (0.91 0.96),5.02E-03
172.11,Melanomas of skin,neoplasms,OPGS013309,0.028,RNAseq,LINC00304,1.06 (1.03 1.08),5.27E-03
172.11,Melanomas of skin,neoplasms,OPGS006115,0.197,RNAseq,LINC01001,1.06 (1.03 1.09),7.48E-03
172.11,Melanomas of skin,neoplasms,OPGS006117,0.196,RNAseq,AL627309.1,1.05 (1.03 1.08),3.77E-02
172.11,Melanomas of skin,neoplasms,OPGS013409,0.027,RNAseq,MTAP,1.05 (1.03 1.08),3.77E-02
172.11,Melanomas of skin,neoplasms,OPGS006874,0.157,RNAseq,CENPBD1,0.95 (0.93 0.98),3.77E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000400,0.139,SomaScan,Agouti-signaling protein,1.10 (1.09 1.11),4.18E-54
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001634,0.021,SomaScan,Melanocyte protein PMEL,0.91 (0.90 0.92),4.21E-54
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001025,0.051,SomaScan,Transmembrane glycoprotein NMB,0.92 (0.91 0.93),1.17E-29
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001011,0.052,SomaScan,Transmembrane glycoprotein NMB,0.93 (0.92 0.94),1.95E-22
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000896,0.063,SomaScan,Interleukin-23,1.05 (1.03 1.06),1.19E-10
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000582,0.101,SomaScan,Cathepsin S,0.96 (0.95 0.97),5.77E-08
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.96 (0.95 0.98),2.24E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002103,0.012,SomaScan,Trefoil factor 3,0.97 (0.96 0.98),5.82E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001550,0.024,SomaScan,Trefoil factor 3,0.97 (0.96 0.98),5.82E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.97 (0.96 0.98),5.10E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.97 (0.96 0.98),1.00E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001812,0.017,SomaScan,Fibroblast growth factor 19,1.03 (1.01 1.04),4.13E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000145,0.292,SomaScan,Cathepsin H,0.98 (0.96 0.99),5.25E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000261,0.188,SomaScan,alpha-2-macroglobulin receptor-associated protein,1.02 (1.01 1.04),5.29E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001553,0.024,SomaScan,Protein G6b,1.03 (1.01 1.04),5.81E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000156,0.272,SomaScan,alpha-2-macroglobulin receptor-associated protein,1.02 (1.01 1.04),7.00E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000158,0.272,SomaScan,Copine-1,1.02 (1.01 1.04),8.31E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001937,0.014,SomaScan,Protocadherin gamma-B1,1.02 (1.01 1.04),1.06E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000887,0.064,SomaScan,Protein O-linked-mannose beta-1.4-N-acetylglucosaminyltransferase 2,1.02 (1.01 1.04),1.34E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000970,0.056,SomaScan,Extracellular matrix protein 1,1.02 (1.01 1.04),1.64E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,1.02 (1.01 1.04),1.64E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,0.98 (0.97 0.99),1.81E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000913,0.061,SomaScan,Fibroblast growth factor 7,1.02 (1.01 1.04),1.91E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000734,0.080,SomaScan,KDEL motif-containing protein 2,0.98 (0.97 0.99),1.96E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000632,0.093,SomaScan,Erythrocyte band 7 integral membrane protein,0.98 (0.97 0.99),2.19E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001671,0.020,SomaScan,Tumor necrosis factor ligand superfamily member 6. soluble form,1.02 (1.01 1.03),2.26E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001883,0.015,SomaScan,UMP-CMP kinase,0.98 (0.97 0.99),2.44E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001985,0.013,SomaScan,Isochorismatase domain-containing protein 1,1.02 (1.01 1.03),2.65E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000244,0.195,SomaScan,C-C motif chemokine 25,1.02 (1.01 1.03),2.65E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001828,0.016,SomaScan,Splicing factor 1,1.02 (1.01 1.03),3.08E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000649,0.091,SomaScan,Transcobalamin-1,0.98 (0.97 0.99),3.12E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001673,0.020,SomaScan,Procollagen C-endopeptidase enhancer 1,1.02 (1.01 1.03),3.12E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000832,0.069,SomaScan,Complement C1q tumor necrosis factor-related protein 5,0.98 (0.97 0.99),3.13E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000664,0.088,SomaScan,BPI fold-containing family A member 2,0.98 (0.97 0.99),3.24E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001238,0.037,SomaScan,Dedicator of cytokinesis protein 9,0.98 (0.97 0.99),3.40E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001352,0.031,SomaScan,Sterol-4-alpha-carboxylate 3-dehydrogenase. decarboxylating,1.02 (1.01 1.03),3.42E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001769,0.018,SomaScan,Peptidyl-prolyl cis-trans isomerase FKBP14,1.02 (1.01 1.03),3.53E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS000566,0.103,SomaScan,CD109 antigen,0.98 (0.97 0.99),3.73E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001928,0.014,SomaScan,Sorting nexin-1,0.98 (0.97 0.99),4.18E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS001319,0.032,SomaScan,Rieske domain-containing protein,1.02 (1.01 1.03),4.71E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002530,0.067,Olink,Trefoil factor 3,0.95 (0.94 0.96),8.38E-13
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002643,0.018,Olink,Neuroblastoma suppressor of tumorigenicity 1,0.96 (0.94 0.97),7.81E-11
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002598,0.031,Olink,Interleukin-10,1.05 (1.03 1.06),1.22E-10
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002420,0.225,Olink,Interleukin-12 subunit beta,1.04 (1.03 1.06),6.39E-09
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002433,0.194,Olink,Interleukin-12 subunit alpha;beta,1.04 (1.03 1.06),1.22E-08
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.97 (0.96 0.98),4.02E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002427,0.216,Olink,Alpha-2-macroglobulin receptor-associated protein,1.03 (1.01 1.04),2.07E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002568,0.043,Olink,Granzyme A,0.97 (0.96 0.99),2.88E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002437,0.187,Olink,Serine protease 27,0.97 (0.96 0.99),3.34E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002657,0.013,Olink,Fibroblast growth factor 19,1.02 (1.01 1.04),1.33E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.98 (0.97 0.99),3.41E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003038,0.025,Metabolon,1-margaroyl-2-linoleoyl-GPC (17:0/18:2)*,0.96 (0.95 0.97),4.06E-07
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003096,0.019,Metabolon,pyroglutamylglutamine,1.04 (1.02 1.05),5.65E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003120,0.017,Metabolon,2-docosahexaenoyl-GPC (22:6)*,1.04 (1.02 1.05),6.89E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002936,0.044,Metabolon,1-dihomo-linoleoyl-GPC (20:2)*,0.97 (0.96 0.98),1.26E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002954,0.040,Metabolon,1-oleoyl-2-linoleoyl-GPC (18:1/18:2)*,0.97 (0.96 0.98),1.58E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002977,0.035,Metabolon,1.2-dilinoleoyl-GPC (18:2/18:2),0.97 (0.96 0.98),3.66E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003086,0.020,Metabolon,1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)*,0.97 (0.96 0.98),3.90E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003073,0.021,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*,1.03 (1.02 1.05),4.55E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003125,0.017,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6),1.03 (1.02 1.04),7.28E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003074,0.021,Metabolon,1-stearoyl-2-linoleoyl-GPC (18:0/18:2)*,0.97 (0.96 0.98),7.28E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003011,0.030,Metabolon,1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)*,0.97 (0.96 0.98),7.49E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003109,0.018,Metabolon,1-linoleoyl-GPE (18:2)*,0.97 (0.96 0.98),9.17E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003168,0.014,Metabolon,X - 24054,0.97 (0.96 0.98),1.29E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003042,0.024,Metabolon,1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6),1.03 (1.02 1.04),1.71E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002829,0.079,Metabolon,arachidonate (20:4n6),1.03 (1.02 1.04),1.71E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002941,0.043,Metabolon,1-palmitoyl-2-linolenoyl-GPC (16:0/18:3)*,0.97 (0.96 0.98),1.71E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002855,0.069,Metabolon,1-palmityl-2-arachidonoyl-GPC (O-16:0/20:4)*,1.03 (1.02 1.04),2.04E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002997,0.032,Metabolon,1-palmitoyl-2-linoleoyl-GPC (16:0/18:2),0.97 (0.96 0.98),2.23E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003007,0.030,Metabolon,trans-urocanate,0.97 (0.96 0.98),2.67E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002791,0.100,Metabolon,2-arachidonoyl-GPC (20:4)*,1.03 (1.02 1.04),5.44E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002747,0.146,Metabolon,1-arachidonoyl-GPC (20:4n6)*,1.03 (1.02 1.04),5.76E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003152,0.014,Metabolon,1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2)*,0.97 (0.96 0.98),8.15E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002890,0.056,Metabolon,X - 23705,1.03 (1.02 1.04),9.27E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003159,0.014,Metabolon,docosapentaenoate (n3 DPA; 22:5n3),1.03 (1.02 1.04),1.00E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003014,0.029,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6)*,1.03 (1.02 1.04),1.00E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003060,0.022,Metabolon,stearidonate (18:4n3),1.03 (1.02 1.04),1.01E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003043,0.024,Metabolon,1-docosahexaenoyl-GPC (22:6)*,1.03 (1.02 1.04),1.10E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002734,0.178,Metabolon,1-stearoyl-2-arachidonoyl-GPC (18:0/20:4),1.03 (1.02 1.04),1.10E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003075,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*,1.03 (1.02 1.04),1.22E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002764,0.129,Metabolon,1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4),1.03 (1.01 1.04),1.68E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003113,0.018,Metabolon,1-docosapentaenoyl-GPC (22:5n6)*,1.03 (1.01 1.04),2.01E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002843,0.073,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4),1.03 (1.01 1.04),2.08E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003189,0.012,Metabolon,2-linoleoyl-GPE (18:2)*,0.97 (0.96 0.99),2.27E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002931,0.045,Metabolon,eicosapentaenoate (EPA; 20:5n3),1.03 (1.01 1.04),3.54E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002949,0.041,Metabolon,1-stearoyl-2-meadoyl-GPC (18:0/20:3n9)*,1.03 (1.01 1.04),4.55E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002972,0.036,Metabolon,1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9)*,1.03 (1.01 1.04),4.74E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003057,0.022,Metabolon,1-adrenoyl-GPC (22:4)*,1.03 (1.01 1.04),5.81E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003019,0.028,Metabolon,1-oleoyl-2-linoleoyl-GPI (18:1/18:2)*,0.98 (0.96 0.99),7.00E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002899,0.053,Metabolon,1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5)*,1.02 (1.01 1.04),7.99E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002834,0.075,Metabolon,phosphatidylcholine (18:0/20:5. 16:0/22:5n6)*,1.02 (1.01 1.04),9.11E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003016,0.029,Metabolon,1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)*,1.02 (1.01 1.04),9.91E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003100,0.019,Metabolon,1-arachidonylglycerol (20:4),1.02 (1.01 1.04),1.17E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002938,0.044,Metabolon,2-arachidonoyl-GPE (20:4)*,1.02 (1.01 1.04),1.17E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003121,0.017,Metabolon,1.2-dipalmitoyl-GPC (16:0/16:0),1.02 (1.01 1.04),1.26E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003114,0.018,Metabolon,1-myristoyl-2-linoleoyl-GPC (14:0/18:2)*,0.98 (0.97 0.99),1.34E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002980,0.034,Metabolon,1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2)*,0.98 (0.97 0.99),1.68E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002819,0.083,Metabolon,phosphatidylcholine (16:0/22:5n3. 18:1/20:4)*,1.02 (1.01 1.03),2.13E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002959,0.039,Metabolon,sphingomyelin (d18:1/18:1. d18:2/18:0),1.02 (1.01 1.03),4.08E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002785,0.103,Metabolon,flavin adenine dinucleotide (FAD),0.98 (0.97 0.99),4.44E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003228,0.010,Metabolon,adenine,0.98 (0.97 0.99),4.54E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS002872,0.061,Metabolon,1-eicosapentaenoyl-GPC (20:5)*,1.02 (1.01 1.03),4.79E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003522,0.062,Nightingale,Degree of unsaturation,1.03 (1.01 1.04),1.99E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010527,0.060,RNAseq,SPG7,0.93 (0.91 0.94),2.61E-32
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003834,0.535,RNAseq,AC026748.3,1.08 (1.06 1.09),1.27E-28
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004322,0.386,RNAseq,CDK10,0.93 (0.92 0.95),1.62E-25
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010348,0.063,RNAseq,TRBV6-5,0.94 (0.92 0.95),8.69E-24
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009992,0.069,RNAseq,CASP8,0.94 (0.93 0.95),5.42E-21
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011431,0.048,RNAseq,VWA7,0.94 (0.93 0.95),5.42E-21
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004736,0.319,RNAseq,,0.94 (0.93 0.95),1.28E-19
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009808,0.073,RNAseq,BZW1,1.06 (1.05 1.07),1.23E-18
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012654,0.034,RNAseq,CLPTM1L,0.94 (0.93 0.95),2.78E-18
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005895,0.209,RNAseq,MAP1LC3A,0.95 (0.93 0.96),1.40E-17
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004883,0.301,RNAseq,KRT5,0.95 (0.93 0.96),8.05E-17
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014758,0.017,RNAseq,TRAV10,0.95 (0.94 0.96),2.93E-16
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS007969,0.116,RNAseq,SPATA2L,1.06 (1.04 1.07),2.34E-15
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014283,0.021,RNAseq,MXRA8,0.95 (0.94 0.96),7.61E-15
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008702,0.097,RNAseq,,1.05 (1.04 1.06),3.73E-13
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008718,0.096,RNAseq,,1.05 (1.04 1.06),6.50E-13
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS007528,0.131,RNAseq,SPIRE2,0.95 (0.94 0.96),6.50E-13
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003928,0.495,RNAseq,RNASET2,1.05 (1.04 1.06),4.31E-12
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010624,0.059,RNAseq,TRBV18,0.95 (0.94 0.96),5.07E-12
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003797,0.549,RNAseq,PADI6,0.96 (0.94 0.97),1.19E-10
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS015030,0.016,RNAseq,PRRC2A,0.96 (0.94 0.97),2.65E-10
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005389,0.248,RNAseq,TRAV23DV6,1.05 (1.03 1.06),4.19E-10
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014277,0.021,RNAseq,DEF8,0.95 (0.94 0.97),4.47E-10
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013073,0.030,RNAseq,BACH2,1.05 (1.03 1.06),6.24E-10
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011296,0.050,RNAseq,AC021066.1,0.96 (0.95 0.97),2.76E-09
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003950,0.485,RNAseq,CHMP4B,1.04 (1.03 1.06),8.91E-09
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009464,0.080,RNAseq,CTLA4,1.04 (1.03 1.05),4.13E-08
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010691,0.058,RNAseq,RPRD2,1.04 (1.03 1.05),5.33E-08
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013225,0.029,RNAseq,REG4,0.96 (0.95 0.97),1.38E-07
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010420,0.062,RNAseq,ATP1B2,1.04 (1.03 1.05),2.47E-07
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013309,0.028,RNAseq,LINC00304,1.04 (1.03 1.05),2.96E-07
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004064,0.446,RNAseq,EXOC2,0.96 (0.95 0.97),3.38E-07
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004144,0.424,RNAseq,PSORS1C3,0.96 (0.95 0.97),6.53E-07
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008867,0.093,RNAseq,TSBP1-AS1,0.97 (0.95 0.98),1.95E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013797,0.024,RNAseq,LMTK3,0.97 (0.95 0.98),1.95E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004213,0.410,RNAseq,,0.96 (0.95 0.98),1.95E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011853,0.043,RNAseq,TRBV6-1,1.04 (1.02 1.05),2.72E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS007638,0.128,RNAseq,CTSS,0.97 (0.96 0.98),3.54E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014375,0.020,RNAseq,MUS81,0.97 (0.95 0.98),3.60E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012952,0.031,RNAseq,PPP1R14B,0.97 (0.95 0.98),4.04E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005613,0.228,RNAseq,CDKN2B,0.97 (0.96 0.98),4.04E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011854,0.043,RNAseq,FLACC1,1.04 (1.02 1.05),4.30E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009371,0.082,RNAseq,TRBV19,0.97 (0.95 0.98),4.30E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010512,0.061,RNAseq,ITCH,0.97 (0.95 0.98),4.30E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010561,0.060,RNAseq,IL2RA,1.04 (1.02 1.05),5.15E-06
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS007018,0.151,RNAseq,TRBV10-3,1.03 (1.02 1.05),1.16E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006038,0.201,RNAseq,HLA-DQA2,0.97 (0.95 0.98),1.48E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005518,0.236,RNAseq,POLR2E,0.97 (0.96 0.98),1.71E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006807,0.160,RNAseq,BNC2,1.03 (1.02 1.05),1.81E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012337,0.037,RNAseq,SMC2,1.03 (1.02 1.05),3.37E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013956,0.023,RNAseq,CASP10,0.97 (0.96 0.98),3.61E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010799,0.057,RNAseq,SAPCD1-AS1,0.97 (0.96 0.98),3.90E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014622,0.018,RNAseq,CACNA1I,1.03 (1.02 1.05),4.02E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011283,0.050,RNAseq,CD248,0.97 (0.96 0.98),4.58E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010632,0.059,RNAseq,LRRN3,0.97 (0.96 0.98),4.95E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008000,0.116,RNAseq,AL009179.2,1.03 (1.02 1.04),5.00E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008566,0.100,RNAseq,DBNDD1,1.03 (1.02 1.04),5.27E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008555,0.100,RNAseq,CALCRL,0.97 (0.96 0.98),6.22E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010700,0.058,RNAseq,DCLRE1B,1.03 (1.02 1.05),6.55E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010661,0.059,RNAseq,PTPN22,0.97 (0.96 0.98),7.28E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013254,0.029,RNAseq,UBAC2-AS1,0.97 (0.96 0.98),9.30E-05
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014878,0.016,RNAseq,ZNF618,0.97 (0.96 0.98),1.51E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009176,0.086,RNAseq,,0.97 (0.96 0.98),1.68E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003643,0.644,RNAseq,SEPTIN2,1.03 (1.02 1.04),1.71E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006273,0.188,RNAseq,AC137932.2,0.97 (0.96 0.98),1.81E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005603,0.230,RNAseq,FANCA,1.03 (1.02 1.04),2.38E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006942,0.154,RNAseq,SKIV2L,0.97 (0.96 0.98),2.41E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010893,0.055,RNAseq,PROB1,0.97 (0.96 0.98),2.89E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011988,0.041,RNAseq,ZBTB10,0.97 (0.96 0.98),3.20E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013423,0.027,RNAseq,TANGO6,0.97 (0.96 0.98),3.56E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012171,0.039,RNAseq,TRBV15,1.03 (1.02 1.04),3.58E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004345,0.381,RNAseq,SENP7,1.03 (1.02 1.04),3.73E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012358,0.037,RNAseq,SFRP5,0.97 (0.96 0.98),3.78E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003996,0.464,RNAseq,SPAG1,0.97 (0.96 0.98),3.80E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004498,0.354,RNAseq,TEF,1.03 (1.02 1.04),4.07E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010278,0.065,RNAseq,DHX35,0.97 (0.96 0.98),4.16E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009920,0.071,RNAseq,LINC02446,0.97 (0.96 0.98),5.33E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013958,0.023,RNAseq,CSNK2B,0.97 (0.96 0.98),5.33E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006911,0.155,RNAseq,RPS6KA2,1.03 (1.02 1.04),5.70E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012096,0.040,RNAseq,CCR7,0.97 (0.96 0.98),7.47E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006874,0.157,RNAseq,CENPBD1,0.97 (0.96 0.98),7.53E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS007376,0.137,RNAseq,ZBTB7B,0.97 (0.96 0.98),7.65E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011092,0.052,RNAseq,IFIT1,0.97 (0.96 0.98),7.76E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014380,0.020,RNAseq,BAG3,1.03 (1.02 1.04),7.95E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012287,0.038,RNAseq,DRD4,0.97 (0.96 0.98),8.15E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004084,0.442,RNAseq,CPNE1,1.03 (1.02 1.04),8.15E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008615,0.098,RNAseq,CNPY4,0.97 (0.96 0.98),8.54E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004389,0.372,RNAseq,AP003774.2,1.03 (1.02 1.04),8.54E-04
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013854,0.024,RNAseq,CFL1,0.97 (0.96 0.98),1.00E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009794,0.073,RNAseq,RN7SL473P,0.97 (0.96 0.98),1.06E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009592,0.077,RNAseq,APOBR,0.97 (0.96 0.99),1.09E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011585,0.046,RNAseq,CD8B,0.97 (0.96 0.99),1.32E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005736,0.219,RNAseq,,1.03 (1.01 1.04),1.47E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006317,0.185,RNAseq,ULBP3,0.97 (0.96 0.99),1.54E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011787,0.044,RNAseq,C2,1.03 (1.01 1.04),1.59E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008928,0.091,RNAseq,N4BP2L1,0.97 (0.96 0.99),1.63E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010531,0.060,RNAseq,TICAM1,0.97 (0.96 0.99),1.84E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS007867,0.119,RNAseq,MOSPD3,1.03 (1.01 1.04),1.94E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013953,0.023,RNAseq,OBSCN,0.97 (0.96 0.99),1.99E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012521,0.035,RNAseq,HERC5,0.97 (0.96 0.99),1.99E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013782,0.024,RNAseq,GFOD2,0.97 (0.96 0.99),1.99E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003936,0.490,RNAseq,CTSH,0.97 (0.96 0.99),2.71E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005706,0.221,RNAseq,OXLD1,0.97 (0.96 0.99),2.88E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010987,0.054,RNAseq,AC242988.2,1.03 (1.01 1.04),2.92E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013383,0.027,RNAseq,PPP1R11,0.97 (0.96 0.99),3.99E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013699,0.025,RNAseq,TRAV5,0.98 (0.96 0.99),4.29E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS015131,0.015,RNAseq,PTBP1,1.03 (1.01 1.04),4.61E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014937,0.016,RNAseq,EIF3M,0.97 (0.96 0.99),4.68E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005230,0.263,RNAseq,LINC00243,1.03 (1.01 1.04),4.74E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004460,0.361,RNAseq,RMI2,1.03 (1.01 1.04),4.74E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014459,0.019,RNAseq,ARID2,1.02 (1.01 1.04),4.76E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011517,0.047,RNAseq,MAP3K8,0.98 (0.96 0.99),4.79E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011257,0.050,RNAseq,CBFA2T3,0.98 (0.96 0.99),4.80E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014957,0.016,RNAseq,TCF25,0.97 (0.96 0.99),5.29E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009025,0.089,RNAseq,AC079209.1,1.02 (1.01 1.04),5.29E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009375,0.082,RNAseq,OPLAH,0.98 (0.96 0.99),5.67E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013935,0.023,RNAseq,EFCAB8,1.03 (1.01 1.04),5.77E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004098,0.438,RNAseq,PCGF3,1.02 (1.01 1.04),5.77E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS007532,0.131,RNAseq,GIGYF1,1.02 (1.01 1.04),6.06E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014210,0.021,RNAseq,MYC,0.98 (0.96 0.99),6.15E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009479,0.080,RNAseq,AL121753.2,1.02 (1.01 1.04),7.00E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004076,0.443,RNAseq,SMCO4,0.98 (0.96 0.99),7.00E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004956,0.291,RNAseq,,1.02 (1.01 1.04),7.06E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011482,0.047,RNAseq,TRAV8-4,0.98 (0.96 0.99),7.17E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009279,0.084,RNAseq,PKN2-AS1,0.98 (0.96 0.99),7.28E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014489,0.019,RNAseq,AP002381.2,0.98 (0.96 0.99),7.53E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013058,0.030,RNAseq,PREP,1.02 (1.01 1.04),8.17E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009893,0.071,RNAseq,HORMAD1,0.98 (0.96 0.99),8.19E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009244,0.084,RNAseq,H2AW,0.98 (0.96 0.99),8.31E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004548,0.346,RNAseq,,0.98 (0.96 0.99),8.31E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006235,0.190,RNAseq,CHMP1A,0.98 (0.96 0.99),8.31E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012438,0.036,RNAseq,DNAJC16,0.98 (0.96 0.99),8.42E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014685,0.018,RNAseq,IMPG2,1.02 (1.01 1.04),8.54E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011445,0.048,RNAseq,ATG13,1.02 (1.01 1.04),9.91E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012483,0.036,RNAseq,FRMD6,1.02 (1.01 1.04),9.96E-03
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014163,0.021,RNAseq,AFF1,1.02 (1.01 1.04),1.06E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014501,0.019,RNAseq,GCN1,1.02 (1.01 1.04),1.09E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011959,0.042,RNAseq,SRC,1.02 (1.01 1.04),1.12E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006207,0.191,RNAseq,USP49,0.98 (0.96 0.99),1.12E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010543,0.060,RNAseq,CARS2,0.98 (0.97 0.99),1.16E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008989,0.090,RNAseq,IGKV1-17,1.02 (1.01 1.04),1.17E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011010,0.054,RNAseq,TRBV5-4,1.02 (1.01 1.04),1.20E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004839,0.305,RNAseq,KRT73-AS1,1.02 (1.01 1.04),1.20E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014948,0.016,RNAseq,HBEGF,1.02 (1.01 1.04),1.21E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005636,0.226,RNAseq,,1.02 (1.01 1.04),1.24E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012433,0.036,RNAseq,AL513314.2,1.02 (1.01 1.04),1.26E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014880,0.016,RNAseq,EHBP1L1,0.98 (0.97 0.99),1.28E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011732,0.044,RNAseq,LRRC43,0.98 (0.97 0.99),1.30E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009401,0.081,RNAseq,EPHX1,1.02 (1.01 1.04),1.32E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011906,0.042,RNAseq,ICOS,1.02 (1.01 1.04),1.33E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010822,0.056,RNAseq,SAMD1,0.98 (0.97 0.99),1.33E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013059,0.030,RNAseq,NPM3,1.02 (1.01 1.04),1.34E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006999,0.152,RNAseq,ADAMTSL4,1.02 (1.01 1.04),1.44E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS007090,0.148,RNAseq,AP3M2,0.98 (0.97 0.99),1.47E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006908,0.155,RNAseq,SLC29A3,1.02 (1.01 1.04),1.57E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013289,0.028,RNAseq,IGKV1-5,0.98 (0.97 0.99),1.57E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005597,0.230,RNAseq,ATP8B4,1.02 (1.01 1.04),1.57E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS007823,0.121,RNAseq,IL27RA,0.98 (0.97 0.99),1.64E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006269,0.188,RNAseq,RALY-AS1,1.02 (1.01 1.04),1.64E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012957,0.031,RNAseq,CD209,0.98 (0.97 0.99),1.70E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014315,0.020,RNAseq,MRPL9,0.98 (0.97 0.99),1.70E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004515,0.352,RNAseq,RAC1,1.02 (1.01 1.04),1.71E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006124,0.196,RNAseq,ZC3H12C,0.98 (0.97 0.99),1.77E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003861,0.524,RNAseq,NRG1,1.02 (1.01 1.04),1.85E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010615,0.059,RNAseq,SIGLEC1,0.98 (0.97 0.99),1.91E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013643,0.025,RNAseq,HLA-DQB2,0.98 (0.97 0.99),1.92E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010209,0.066,RNAseq,TDRKH,0.98 (0.97 0.99),1.95E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010727,0.058,RNAseq,ZNF439,1.02 (1.01 1.03),2.10E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011907,0.042,RNAseq,ITPKB,0.98 (0.97 0.99),2.10E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010736,0.057,RNAseq,PCNT,0.98 (0.97 0.99),2.13E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009529,0.078,RNAseq,CMPK1,0.98 (0.97 0.99),2.19E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014428,0.019,RNAseq,ERGIC3,1.02 (1.01 1.04),2.19E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006871,0.157,RNAseq,HDGFL3,0.98 (0.97 0.99),2.26E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013808,0.024,RNAseq,CASZ1,0.98 (0.97 0.99),2.26E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008236,0.108,RNAseq,SF3A3,0.98 (0.97 0.99),2.35E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014443,0.019,RNAseq,ABCB1,0.98 (0.97 0.99),2.35E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS007452,0.134,RNAseq,TMEM258,0.98 (0.97 0.99),2.35E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014331,0.020,RNAseq,KLHL25,0.98 (0.97 0.99),2.40E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009315,0.083,RNAseq,,0.98 (0.97 0.99),2.47E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004363,0.378,RNAseq,LINC01806,1.02 (1.01 1.03),2.56E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009711,0.075,RNAseq,TRAV21,0.98 (0.97 0.99),2.85E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012086,0.040,RNAseq,FAM83D,0.98 (0.97 0.99),2.88E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006115,0.197,RNAseq,LINC01001,1.02 (1.01 1.03),2.90E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005226,0.263,RNAseq,AC107959.1,0.98 (0.97 0.99),2.96E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005018,0.284,RNAseq,CDCA7L,1.02 (1.01 1.03),3.02E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013047,0.030,RNAseq,SMARCA2,0.98 (0.97 0.99),3.10E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006143,0.195,RNAseq,DOCK7,0.98 (0.97 0.99),3.12E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009729,0.074,RNAseq,LINC01259,1.02 (1.01 1.03),3.20E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009281,0.084,RNAseq,ZNF814,1.02 (1.01 1.03),3.37E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012607,0.035,RNAseq,AC090004.1,0.98 (0.97 0.99),3.41E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003804,0.547,RNAseq,FGFR1,0.98 (0.97 0.99),3.41E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005289,0.258,RNAseq,UBA7,1.02 (1.01 1.03),3.42E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009409,0.081,RNAseq,PRPF6,0.98 (0.97 0.99),3.44E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014801,0.017,RNAseq,TP63,1.02 (1.01 1.03),3.45E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010332,0.064,RNAseq,NCOA1,0.98 (0.97 0.99),3.48E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS014723,0.017,RNAseq,,1.02 (1.01 1.03),3.58E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008404,0.104,RNAseq,APRT,1.02 (1.01 1.03),3.58E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010277,0.065,RNAseq,CXCR6,0.98 (0.97 0.99),3.69E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS007489,0.133,RNAseq,RRM2B,1.02 (1.01 1.03),3.86E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005657,0.224,RNAseq,RNH1,0.98 (0.97 0.99),4.01E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004479,0.358,RNAseq,ST3GAL6-AS1,0.98 (0.97 0.99),4.07E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS009810,0.073,RNAseq,,1.02 (1.01 1.03),4.07E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010101,0.068,RNAseq,PLEKHM2,0.98 (0.97 0.99),4.08E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008699,0.097,RNAseq,DUSP4,1.02 (1.01 1.03),4.26E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012786,0.033,RNAseq,PLAGL2,0.98 (0.97 0.99),4.33E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012012,0.041,RNAseq,STK19,1.02 (1.01 1.03),4.44E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008463,0.103,RNAseq,FAM157C,1.02 (1.01 1.03),4.44E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS005057,0.281,RNAseq,COPG2,1.02 (1.01 1.03),4.61E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012080,0.040,RNAseq,CD70,0.98 (0.97 0.99),4.67E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS012531,0.035,RNAseq,ATG9A,1.02 (1.01 1.03),4.68E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS011321,0.049,RNAseq,GDF11,1.02 (1.01 1.03),4.71E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS013932,0.023,RNAseq,VEGFC,0.98 (0.97 0.99),4.76E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS008481,0.102,RNAseq,FOXO6,1.02 (1.01 1.03),4.84E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS003968,0.476,RNAseq,AC093495.1,1.02 (1.01 1.03),4.84E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004130,0.428,RNAseq,F5,0.98 (0.97 0.99),4.91E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS010772,0.057,RNAseq,COASY,0.98 (0.97 0.99),4.93E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS004920,0.296,RNAseq,L3MBTL3,0.98 (0.97 0.99),4.99E-02
172.2,Other non-epithelial cancer of skin,neoplasms,OPGS006798,0.161,RNAseq,ANXA2,0.98 (0.97 0.99),5.00E-02
172.3,Carcinoma in situ of skin,neoplasms,OPGS000400,0.139,SomaScan,Agouti-signaling protein,1.14 (1.10 1.18),3.67E-08
172.3,Carcinoma in situ of skin,neoplasms,OPGS001634,0.021,SomaScan,Melanocyte protein PMEL,0.87 (0.84 0.91),5.92E-08
172.3,Carcinoma in situ of skin,neoplasms,OPGS001025,0.051,SomaScan,Transmembrane glycoprotein NMB,0.87 (0.83 0.91),1.95E-05
172.3,Carcinoma in situ of skin,neoplasms,OPGS001011,0.052,SomaScan,Transmembrane glycoprotein NMB,0.88 (0.84 0.92),1.60E-04
172.3,Carcinoma in situ of skin,neoplasms,OPGS003950,0.485,RNAseq,CHMP4B,1.10 (1.06 1.15),1.19E-02
174.1,Breast cancer [female],neoplasms,OPGS000135,0.315,SomaScan,Glutathione S-transferase Mu 3,0.93 (0.91 0.96),1.62E-02
174.1,Breast cancer [female],neoplasms,OPGS008523,0.101,RNAseq,AC008937.3,1.07 (1.04 1.10),5.35E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS001490,0.026,SomaScan,Intercellular adhesion molecule 2,0.96 (0.95 0.98),4.08E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS001658,0.020,SomaScan,Endoglin,0.96 (0.95 0.98),4.08E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS000088,0.392,SomaScan,E-selectin,0.96 (0.95 0.98),4.08E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,0.96 (0.95 0.98),4.37E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS000155,0.275,SomaScan,Interleukin-3 receptor subunit alpha,0.97 (0.95 0.98),5.21E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS000889,0.064,SomaScan,Hepatocyte growth factor receptor,0.97 (0.95 0.98),6.76E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS001915,0.014,SomaScan,N-acetylglucosamine-6-sulfatase,0.97 (0.95 0.98),9.31E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS001016,0.052,SomaScan,Protein jagged-1,0.97 (0.95 0.98),9.31E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.97 (0.95 0.98),9.31E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS000600,0.099,SomaScan,Insulin receptor,0.97 (0.95 0.98),9.35E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS000838,0.069,SomaScan,DNA/RNA-binding protein KIN17,0.97 (0.95 0.98),9.76E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS000121,0.341,SomaScan,D-glucuronyl C5-epimerase,1.03 (1.02 1.05),1.03E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,1.03 (1.02 1.05),1.17E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS000067,0.438,SomaScan,Adhesion G protein-coupled receptor F5,0.97 (0.95 0.98),1.38E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS001045,0.050,SomaScan,Carbohydrate sulfotransferase 15,0.97 (0.95 0.98),1.81E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS001301,0.034,SomaScan,Glycosaminoglycan xylosylkinase,1.03 (1.02 1.05),1.86E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,0.97 (0.95 0.98),1.86E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS001464,0.027,SomaScan,Platelet glycoprotein Ib alpha chain,0.97 (0.95 0.98),1.87E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS000362,0.147,SomaScan,Golgi membrane protein 1,1.03 (1.02 1.05),2.26E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS001377,0.030,SomaScan,Vascular cell adhesion protein 1,0.97 (0.96 0.99),3.51E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS001127,0.044,SomaScan,Carbohydrate sulfotransferase 15,0.97 (0.96 0.99),4.38E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.97 (0.96 0.99),4.38E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS000135,0.315,SomaScan,Glutathione S-transferase Mu 3,0.97 (0.96 0.99),4.46E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS002408,0.270,Olink,E-selectin,0.97 (0.95 0.98),6.43E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS002590,0.035,Olink,Platelet endothelial cell adhesion molecule,0.97 (0.95 0.98),9.76E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS002578,0.039,Olink,Leukemia inhibitory factor receptor,0.97 (0.95 0.98),1.17E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS002638,0.019,Olink,Ephrin type-B receptor 4,0.97 (0.96 0.99),3.38E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS002500,0.098,Olink,Galectin-4,0.97 (0.96 0.99),3.73E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS003137,0.016,Metabolon,ergothioneine,1.03 (1.01 1.05),4.88E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS008523,0.101,RNAseq,AC008937.3,1.06 (1.05 1.08),5.47E-13
174.11,Malignant neoplasm of female breast,neoplasms,OPGS008996,0.090,RNAseq,CCND1,0.96 (0.95 0.98),1.37E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS005772,0.217,RNAseq,CMSS1,1.04 (1.02 1.06),1.37E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS006083,0.199,RNAseq,CCDC170,1.04 (1.02 1.05),2.36E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS004788,0.311,RNAseq,APOBEC3A,0.96 (0.95 0.98),4.08E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS015054,0.015,RNAseq,H19,1.03 (1.02 1.05),6.76E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS003651,0.639,RNAseq,ABO,0.97 (0.95 0.98),9.31E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS007187,0.144,RNAseq,SLC35E3,1.03 (1.02 1.05),9.35E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS005063,0.280,RNAseq,TNNT3,1.03 (1.02 1.05),9.76E-03
174.11,Malignant neoplasm of female breast,neoplasms,OPGS005788,0.216,RNAseq,XPNPEP3,0.97 (0.95 0.98),1.05E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS010174,0.066,RNAseq,H2BC9,0.97 (0.95 0.98),1.05E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS005580,0.232,RNAseq,ZBTB38,1.03 (1.02 1.05),1.86E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS008575,0.099,RNAseq,NIT2,1.03 (1.02 1.05),1.87E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS012381,0.037,RNAseq,ATF7IP,0.97 (0.95 0.98),1.87E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS014163,0.021,RNAseq,AFF1,1.03 (1.02 1.05),1.87E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS009625,0.076,RNAseq,TRMT1L,1.03 (1.02 1.05),2.16E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS004965,0.291,RNAseq,CBX6,0.97 (0.96 0.98),2.26E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS013201,0.029,RNAseq,NRCAM,1.03 (1.02 1.05),3.23E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS014059,0.022,RNAseq,BCL2,0.97 (0.96 0.99),3.73E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS009212,0.085,RNAseq,AL158212.2,0.97 (0.96 0.99),3.73E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS003625,0.664,RNAseq,,1.03 (1.01 1.05),3.83E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS005685,0.222,RNAseq,TLR1,0.97 (0.96 0.99),3.83E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS015035,0.016,RNAseq,PLAAT4,0.97 (0.96 0.99),4.22E-02
174.11,Malignant neoplasm of female breast,neoplasms,OPGS012382,0.037,RNAseq,FBXO11,0.97 (0.96 0.99),4.38E-02
175,Acquired absence of breast,neoplasms,OPGS008523,0.101,RNAseq,AC008937.3,1.04 (1.02 1.06),7.82E-03
180,Cervical cancer and dysplasia,neoplasms,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,1.13 (1.09 1.17),8.38E-09
180,Cervical cancer and dysplasia,neoplasms,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,1.11 (1.07 1.14),1.10E-05
180,Cervical cancer and dysplasia,neoplasms,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,1.10 (1.06 1.13),3.51E-05
180,Cervical cancer and dysplasia,neoplasms,OPGS002070,0.012,SomaScan,Gro-beta/gamma,1.08 (1.04 1.11),3.26E-03
180,Cervical cancer and dysplasia,neoplasms,OPGS000538,0.109,SomaScan,Cyclic AMP-responsive element-binding protein 3-like protein 4,0.93 (0.90 0.96),2.76E-02
180,Cervical cancer and dysplasia,neoplasms,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,1.07 (1.04 1.11),3.31E-02
180,Cervical cancer and dysplasia,neoplasms,OPGS001670,0.020,SomaScan,Carboxypeptidase Z,1.07 (1.03 1.11),3.94E-02
180,Cervical cancer and dysplasia,neoplasms,OPGS002643,0.018,Olink,Neuroblastoma suppressor of tumorigenicity 1,1.16 (1.12 1.20),6.24E-14
180,Cervical cancer and dysplasia,neoplasms,OPGS002658,0.013,Olink,C-C motif chemokine 22,1.14 (1.10 1.18),1.10E-10
180,Cervical cancer and dysplasia,neoplasms,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,1.10 (1.06 1.14),3.51E-05
180,Cervical cancer and dysplasia,neoplasms,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,1.07 (1.04 1.11),1.98E-02
180,Cervical cancer and dysplasia,neoplasms,OPGS002559,0.048,Olink,C-C motif chemokine 19,1.07 (1.03 1.10),3.58E-02
180,Cervical cancer and dysplasia,neoplasms,OPGS005519,0.236,RNAseq,AL645933.3,1.15 (1.11 1.19),1.10E-10
180,Cervical cancer and dysplasia,neoplasms,OPGS006038,0.201,RNAseq,HLA-DQA2,1.12 (1.09 1.16),3.08E-09
180,Cervical cancer and dysplasia,neoplasms,OPGS013045,0.030,RNAseq,NEU1,1.11 (1.08 1.15),1.50E-06
180,Cervical cancer and dysplasia,neoplasms,OPGS011431,0.048,RNAseq,VWA7,1.11 (1.07 1.15),1.10E-05
180,Cervical cancer and dysplasia,neoplasms,OPGS009077,0.088,RNAseq,DDAH2,1.10 (1.06 1.13),3.37E-05
180,Cervical cancer and dysplasia,neoplasms,OPGS012271,0.038,RNAseq,TRBV5-6,0.93 (0.90 0.95),3.57E-04
180,Cervical cancer and dysplasia,neoplasms,OPGS007675,0.126,RNAseq,TRAV12-2,0.92 (0.88 0.95),3.57E-04
180,Cervical cancer and dysplasia,neoplasms,OPGS005334,0.253,RNAseq,AL645933.4,1.09 (1.05 1.13),6.02E-04
180,Cervical cancer and dysplasia,neoplasms,OPGS014059,0.022,RNAseq,BCL2,1.09 (1.05 1.13),6.30E-04
180,Cervical cancer and dysplasia,neoplasms,OPGS010348,0.063,RNAseq,TRBV6-5,1.09 (1.05 1.12),6.30E-04
180,Cervical cancer and dysplasia,neoplasms,OPGS014758,0.017,RNAseq,TRAV10,1.09 (1.05 1.13),7.82E-04
180,Cervical cancer and dysplasia,neoplasms,OPGS004122,0.430,RNAseq,HLA-DRB5,1.08 (1.05 1.12),8.98E-04
180,Cervical cancer and dysplasia,neoplasms,OPGS011626,0.046,RNAseq,ABCF1,0.92 (0.89 0.95),1.16E-03
180,Cervical cancer and dysplasia,neoplasms,OPGS007407,0.135,RNAseq,TRBV2,0.92 (0.89 0.95),1.58E-03
180,Cervical cancer and dysplasia,neoplasms,OPGS012964,0.031,RNAseq,SLC33A1,0.93 (0.90 0.96),1.19E-02
180,Cervical cancer and dysplasia,neoplasms,OPGS006942,0.154,RNAseq,SKIV2L,0.93 (0.90 0.96),1.49E-02
180,Cervical cancer and dysplasia,neoplasms,OPGS013243,0.029,RNAseq,TRAV3,1.07 (1.04 1.11),1.94E-02
180,Cervical cancer and dysplasia,neoplasms,OPGS011086,0.053,RNAseq,HSPA1B,1.07 (1.04 1.11),2.06E-02
180,Cervical cancer and dysplasia,neoplasms,OPGS011674,0.045,RNAseq,PRSS23,1.07 (1.04 1.11),2.50E-02
180,Cervical cancer and dysplasia,neoplasms,OPGS007138,0.146,RNAseq,HCG27,0.93 (0.90 0.96),2.65E-02
180,Cervical cancer and dysplasia,neoplasms,OPGS006716,0.164,RNAseq,IER3,0.93 (0.90 0.97),3.31E-02
180,Cervical cancer and dysplasia,neoplasms,OPGS007136,0.146,RNAseq,HS3ST3B1,0.93 (0.90 0.97),4.37E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,1.10 (1.07 1.12),9.77E-10
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,1.08 (1.06 1.11),9.01E-08
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS002070,0.012,SomaScan,Gro-beta/gamma,1.07 (1.05 1.10),1.13E-05
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,1.07 (1.04 1.09),1.03E-04
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS001670,0.020,SomaScan,Carboxypeptidase Z,1.06 (1.03 1.09),2.28E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,1.06 (1.03 1.08),3.68E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS000984,0.055,SomaScan,Complement C2,0.95 (0.93 0.97),6.23E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS000645,0.091,SomaScan,Trypsin-3,0.95 (0.93 0.97),1.69E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,1.05 (1.02 1.07),2.39E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS001755,0.018,SomaScan,N-acetyllactosaminide beta-1.6-N-acetylglucosaminyl-transferase. isoform C,1.05 (1.02 1.07),2.47E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS000538,0.109,SomaScan,Cyclic AMP-responsive element-binding protein 3-like protein 4,0.95 (0.93 0.97),2.49E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,0.95 (0.93 0.98),2.61E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS000579,0.102,SomaScan,SUN domain-containing protein 5,1.04 (1.02 1.06),4.37E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS001231,0.037,SomaScan,Osteocalcin,0.95 (0.93 0.98),4.60E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS002643,0.018,Olink,Neuroblastoma suppressor of tumorigenicity 1,1.14 (1.11 1.16),4.70E-20
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS002658,0.013,Olink,C-C motif chemokine 22,1.10 (1.07 1.12),9.50E-10
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS002559,0.048,Olink,C-C motif chemokine 19,1.06 (1.03 1.08),2.16E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,1.05 (1.03 1.08),9.43E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS002522,0.073,Olink,CUB domain-containing protein 1,1.05 (1.02 1.07),3.58E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS002892,0.054,Metabolon,propionylcarnitine,1.06 (1.03 1.08),6.01E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS002946,0.043,Metabolon,isovalerylcarnitine,1.05 (1.02 1.07),4.83E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS011431,0.048,RNAseq,VWA7,1.11 (1.08 1.13),3.31E-11
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS006038,0.201,RNAseq,HLA-DQA2,1.09 (1.07 1.12),1.08E-10
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS005519,0.236,RNAseq,AL645933.3,1.10 (1.07 1.13),2.05E-10
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS009077,0.088,RNAseq,DDAH2,1.09 (1.07 1.12),1.11E-09
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS004122,0.430,RNAseq,HLA-DRB5,1.09 (1.06 1.12),1.90E-09
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS013045,0.030,RNAseq,NEU1,1.09 (1.06 1.11),9.49E-08
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS010348,0.063,RNAseq,TRBV6-5,1.08 (1.06 1.11),2.08E-07
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS006942,0.154,RNAseq,SKIV2L,0.93 (0.90 0.95),2.23E-06
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS011626,0.046,RNAseq,ABCF1,0.93 (0.90 0.95),3.41E-06
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS011716,0.045,RNAseq,FBLN7,1.07 (1.05 1.10),1.09E-05
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS009300,0.083,RNAseq,TRAV26-1,1.07 (1.05 1.10),1.86E-05
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS014758,0.017,RNAseq,TRAV10,1.07 (1.05 1.10),2.52E-05
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS012808,0.033,RNAseq,TRBV20-1,0.93 (0.91 0.96),2.76E-05
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS014059,0.022,RNAseq,BCL2,1.07 (1.04 1.10),3.29E-05
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS008402,0.104,RNAseq,TNXB,1.07 (1.04 1.09),1.12E-04
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS005334,0.253,RNAseq,AL645933.4,1.07 (1.04 1.09),1.27E-04
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS007691,0.126,RNAseq,HLA-DRB1,0.94 (0.92 0.96),4.11E-04
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS012271,0.038,RNAseq,TRBV5-6,0.95 (0.93 0.97),6.12E-04
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS010255,0.065,RNAseq,HLA-DPA1,1.06 (1.04 1.09),1.18E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS012093,0.040,RNAseq,TRIM26,0.95 (0.92 0.97),4.11E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS006001,0.203,RNAseq,HLA-DQA1,0.95 (0.92 0.97),4.96E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS007407,0.135,RNAseq,TRBV2,0.95 (0.92 0.97),4.96E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS006716,0.164,RNAseq,IER3,0.95 (0.92 0.97),6.43E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS007675,0.126,RNAseq,TRAV12-2,0.95 (0.92 0.97),7.92E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS004100,0.438,RNAseq,GSDMB,0.95 (0.93 0.97),7.94E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS007297,0.140,RNAseq,GPANK1,0.95 (0.92 0.97),8.74E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS007138,0.146,RNAseq,HCG27,0.95 (0.93 0.97),9.43E-03
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS011901,0.042,RNAseq,DTHD1,1.05 (1.03 1.08),1.05E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS012964,0.031,RNAseq,SLC33A1,0.95 (0.93 0.97),1.05E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS011674,0.045,RNAseq,PRSS23,1.05 (1.03 1.08),1.63E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS004438,0.366,RNAseq,PAX8-AS1,1.05 (1.03 1.08),1.66E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS005481,0.240,RNAseq,AC018521.5,0.95 (0.93 0.97),1.69E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.05 (1.03 1.08),1.75E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS010624,0.059,RNAseq,TRBV18,1.05 (1.03 1.08),2.19E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS011086,0.053,RNAseq,HSPA1B,1.05 (1.02 1.07),2.61E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS005389,0.248,RNAseq,TRAV23DV6,0.95 (0.93 0.98),2.88E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS011585,0.046,RNAseq,CD8B,0.95 (0.93 0.98),3.58E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS009865,0.072,RNAseq,TRAV17,1.05 (1.02 1.07),4.37E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS006940,0.154,RNAseq,,0.95 (0.93 0.98),4.60E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS013243,0.029,RNAseq,TRAV3,1.05 (1.02 1.07),4.60E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS011288,0.050,RNAseq,AC104809.2,1.05 (1.02 1.07),4.60E-02
180.3,Cervical intraepithelial neoplasia [CIN] [Cervical dysplasia],neoplasms,OPGS010393,0.063,RNAseq,GPR153,1.05 (1.02 1.07),4.83E-02
182,Malignant neoplasm of uterus,neoplasms,OPGS010624,0.059,RNAseq,TRBV18,0.90 (0.87 0.94),2.27E-02
182,Malignant neoplasm of uterus,neoplasms,OPGS006858,0.157,RNAseq,ATF7IP2,1.10 (1.06 1.15),2.27E-02
184.2,Cancer of other female genital organs (excluding uterus and ovary),neoplasms,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,1.21 (1.13 1.31),1.48E-03
184.2,Cancer of other female genital organs (excluding uterus and ovary),neoplasms,OPGS001883,0.015,SomaScan,UMP-CMP kinase,1.20 (1.12 1.28),1.48E-03
184.2,Cancer of other female genital organs (excluding uterus and ovary),neoplasms,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,1.16 (1.09 1.24),1.55E-02
184.2,Cancer of other female genital organs (excluding uterus and ovary),neoplasms,OPGS002658,0.013,Olink,C-C motif chemokine 22,1.33 (1.23 1.44),1.83E-08
184.2,Cancer of other female genital organs (excluding uterus and ovary),neoplasms,OPGS013045,0.030,RNAseq,NEU1,1.24 (1.15 1.35),7.37E-04
184.2,Cancer of other female genital organs (excluding uterus and ovary),neoplasms,OPGS010624,0.059,RNAseq,TRBV18,1.23 (1.14 1.33),9.45E-04
184.2,Cancer of other female genital organs (excluding uterus and ovary),neoplasms,OPGS010348,0.063,RNAseq,TRBV6-5,1.21 (1.12 1.30),2.08E-03
184.2,Cancer of other female genital organs (excluding uterus and ovary),neoplasms,OPGS008402,0.104,RNAseq,TNXB,1.19 (1.11 1.28),3.57E-03
184.2,Cancer of other female genital organs (excluding uterus and ovary),neoplasms,OPGS012761,0.033,RNAseq,TRAV12-3,0.85 (0.79 0.91),6.92E-03
184.2,Cancer of other female genital organs (excluding uterus and ovary),neoplasms,OPGS013896,0.023,RNAseq,ATF6B,0.85 (0.79 0.91),1.47E-02
184.2,Cancer of other female genital organs (excluding uterus and ovary),neoplasms,OPGS010561,0.060,RNAseq,IL2RA,0.85 (0.78 0.91),3.19E-02
185,Cancer of prostate,neoplasms,OPGS000062,0.455,SomaScan,Beta-microseminoprotein,0.87 (0.86 0.89),3.34E-49
185,Cancer of prostate,neoplasms,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.94 (0.92 0.96),6.94E-09
185,Cancer of prostate,neoplasms,OPGS002027,0.012,SomaScan,Retroviral-like aspartic protease 1,1.05 (1.03 1.07),8.22E-05
185,Cancer of prostate,neoplasms,OPGS000099,0.376,SomaScan,Kunitz-type protease inhibitor 2,1.05 (1.03 1.07),3.45E-04
185,Cancer of prostate,neoplasms,OPGS000413,0.136,SomaScan,Angiostatin,0.96 (0.95 0.98),3.52E-03
185,Cancer of prostate,neoplasms,OPGS000726,0.081,SomaScan,Plasminogen,0.96 (0.95 0.98),4.07E-03
185,Cancer of prostate,neoplasms,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.04 (1.02 1.06),5.25E-03
185,Cancer of prostate,neoplasms,OPGS000734,0.080,SomaScan,KDEL motif-containing protein 2,0.97 (0.95 0.98),1.11E-02
185,Cancer of prostate,neoplasms,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,0.96 (0.95 0.98),1.35E-02
185,Cancer of prostate,neoplasms,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,1.04 (1.02 1.06),1.40E-02
185,Cancer of prostate,neoplasms,OPGS000331,0.157,SomaScan,Tapasin,0.96 (0.95 0.98),1.55E-02
185,Cancer of prostate,neoplasms,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,1.04 (1.02 1.05),1.98E-02
185,Cancer of prostate,neoplasms,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.04 (1.02 1.05),2.24E-02
185,Cancer of prostate,neoplasms,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.97 (0.95 0.98),3.86E-02
185,Cancer of prostate,neoplasms,OPGS002658,0.013,Olink,C-C motif chemokine 22,1.04 (1.02 1.06),4.07E-03
185,Cancer of prostate,neoplasms,OPGS002993,0.032,Metabolon,vanillylmandelate (VMA),1.03 (1.02 1.05),3.05E-02
185,Cancer of prostate,neoplasms,OPGS003897,0.508,RNAseq,CASC8,1.08 (1.06 1.10),3.37E-15
185,Cancer of prostate,neoplasms,OPGS010849,0.056,RNAseq,AGAP6,0.93 (0.92 0.95),2.09E-11
185,Cancer of prostate,neoplasms,OPGS011540,0.047,RNAseq,TMEM17,1.06 (1.04 1.08),5.18E-07
185,Cancer of prostate,neoplasms,OPGS010693,0.058,RNAseq,TRBV5-1,0.95 (0.93 0.96),7.87E-06
185,Cancer of prostate,neoplasms,OPGS005858,0.211,RNAseq,GGCX,0.95 (0.93 0.97),8.60E-06
185,Cancer of prostate,neoplasms,OPGS009198,0.085,RNAseq,TRAV12-1,0.95 (0.93 0.97),8.60E-06
185,Cancer of prostate,neoplasms,OPGS006735,0.164,RNAseq,TPCN2,0.95 (0.93 0.97),8.60E-06
185,Cancer of prostate,neoplasms,OPGS005618,0.227,RNAseq,PPP1R14A,1.05 (1.04 1.07),8.60E-06
185,Cancer of prostate,neoplasms,OPGS005580,0.232,RNAseq,ZBTB38,1.05 (1.03 1.07),2.67E-05
185,Cancer of prostate,neoplasms,OPGS004144,0.424,RNAseq,PSORS1C3,1.05 (1.03 1.07),2.67E-05
185,Cancer of prostate,neoplasms,OPGS013045,0.030,RNAseq,NEU1,1.05 (1.03 1.07),8.31E-05
185,Cancer of prostate,neoplasms,OPGS012246,0.039,RNAseq,ZFP36L2,0.95 (0.94 0.97),1.09E-04
185,Cancer of prostate,neoplasms,OPGS006427,0.179,RNAseq,PDK1,1.05 (1.03 1.07),1.85E-04
185,Cancer of prostate,neoplasms,OPGS009132,0.087,RNAseq,ZNF217,1.04 (1.03 1.06),1.85E-04
185,Cancer of prostate,neoplasms,OPGS009371,0.082,RNAseq,TRBV19,1.05 (1.03 1.06),2.25E-04
185,Cancer of prostate,neoplasms,OPGS014455,0.019,RNAseq,AL121845.1,0.96 (0.94 0.97),2.25E-04
185,Cancer of prostate,neoplasms,OPGS005065,0.280,RNAseq,SLC25A37,1.05 (1.03 1.07),2.69E-04
185,Cancer of prostate,neoplasms,OPGS011972,0.041,RNAseq,BIK,1.05 (1.03 1.07),3.09E-04
185,Cancer of prostate,neoplasms,OPGS003834,0.535,RNAseq,AC026748.3,1.05 (1.03 1.06),3.45E-04
185,Cancer of prostate,neoplasms,OPGS007764,0.123,RNAseq,HLA-E,0.96 (0.94 0.97),5.00E-04
185,Cancer of prostate,neoplasms,OPGS007373,0.137,RNAseq,HIBADH,0.96 (0.94 0.97),5.70E-04
185,Cancer of prostate,neoplasms,OPGS004107,0.435,RNAseq,TMEM204,0.96 (0.94 0.97),6.11E-04
185,Cancer of prostate,neoplasms,OPGS014319,0.020,RNAseq,RUVBL1,1.04 (1.02 1.06),2.33E-03
185,Cancer of prostate,neoplasms,OPGS007407,0.135,RNAseq,TRBV2,0.96 (0.94 0.98),2.41E-03
185,Cancer of prostate,neoplasms,OPGS015092,0.015,RNAseq,XRN2,1.04 (1.02 1.06),2.41E-03
185,Cancer of prostate,neoplasms,OPGS010402,0.062,RNAseq,,1.04 (1.02 1.06),3.01E-03
185,Cancer of prostate,neoplasms,OPGS007604,0.128,RNAseq,U91328.1,0.96 (0.94 0.98),3.37E-03
185,Cancer of prostate,neoplasms,OPGS010904,0.055,RNAseq,EEFSEC,0.96 (0.95 0.98),3.56E-03
185,Cancer of prostate,neoplasms,OPGS014496,0.019,RNAseq,VARS1,0.96 (0.94 0.98),3.56E-03
185,Cancer of prostate,neoplasms,OPGS006742,0.163,RNAseq,,1.04 (1.02 1.06),3.92E-03
185,Cancer of prostate,neoplasms,OPGS008010,0.115,RNAseq,CHMP2B,1.04 (1.02 1.06),4.07E-03
185,Cancer of prostate,neoplasms,OPGS012654,0.034,RNAseq,CLPTM1L,0.96 (0.94 0.98),4.07E-03
185,Cancer of prostate,neoplasms,OPGS004179,0.416,RNAseq,NKX3-1,1.04 (1.02 1.06),4.92E-03
185,Cancer of prostate,neoplasms,OPGS010475,0.061,RNAseq,ZNRD1,1.04 (1.02 1.06),4.94E-03
185,Cancer of prostate,neoplasms,OPGS004445,0.364,RNAseq,CEACAM21,1.04 (1.02 1.06),6.68E-03
185,Cancer of prostate,neoplasms,OPGS004929,0.295,RNAseq,OTX1,0.96 (0.95 0.98),6.76E-03
185,Cancer of prostate,neoplasms,OPGS013314,0.028,RNAseq,SMAD2,1.04 (1.02 1.06),6.93E-03
185,Cancer of prostate,neoplasms,OPGS012210,0.039,RNAseq,FOXP4,0.96 (0.95 0.98),7.76E-03
185,Cancer of prostate,neoplasms,OPGS006630,0.169,RNAseq,NUCKS1,1.04 (1.02 1.06),7.76E-03
185,Cancer of prostate,neoplasms,OPGS007876,0.119,RNAseq,MDM4,0.96 (0.95 0.98),7.76E-03
185,Cancer of prostate,neoplasms,OPGS010607,0.059,RNAseq,TRAV8-1,0.96 (0.95 0.98),7.89E-03
185,Cancer of prostate,neoplasms,OPGS011367,0.049,RNAseq,SLK,1.04 (1.02 1.06),8.60E-03
185,Cancer of prostate,neoplasms,OPGS006517,0.174,RNAseq,,0.96 (0.95 0.98),9.70E-03
185,Cancer of prostate,neoplasms,OPGS014738,0.017,RNAseq,KCNAB3,0.96 (0.95 0.98),1.01E-02
185,Cancer of prostate,neoplasms,OPGS004488,0.357,RNAseq,,0.96 (0.95 0.98),1.09E-02
185,Cancer of prostate,neoplasms,OPGS007903,0.118,RNAseq,PACSIN2,1.04 (1.02 1.05),1.35E-02
185,Cancer of prostate,neoplasms,OPGS003643,0.644,RNAseq,SEPTIN2,0.96 (0.95 0.98),1.35E-02
185,Cancer of prostate,neoplasms,OPGS013780,0.024,RNAseq,ZSCAN16,0.96 (0.95 0.98),1.35E-02
185,Cancer of prostate,neoplasms,OPGS005960,0.206,RNAseq,ALOX5,0.97 (0.95 0.98),1.53E-02
185,Cancer of prostate,neoplasms,OPGS005918,0.208,RNAseq,DDR1,1.04 (1.02 1.05),1.59E-02
185,Cancer of prostate,neoplasms,OPGS008873,0.093,RNAseq,VMAC,0.97 (0.95 0.98),1.85E-02
185,Cancer of prostate,neoplasms,OPGS008551,0.100,RNAseq,LY86-AS1,1.04 (1.02 1.05),2.13E-02
185,Cancer of prostate,neoplasms,OPGS012393,0.037,RNAseq,TUBA1B,1.03 (1.02 1.05),2.15E-02
185,Cancer of prostate,neoplasms,OPGS007984,0.116,RNAseq,,1.04 (1.02 1.05),2.15E-02
185,Cancer of prostate,neoplasms,OPGS011283,0.050,RNAseq,CD248,1.04 (1.02 1.05),2.21E-02
185,Cancer of prostate,neoplasms,OPGS007924,0.118,RNAseq,FAHD2B,0.97 (0.95 0.98),2.21E-02
185,Cancer of prostate,neoplasms,OPGS011591,0.046,RNAseq,H2AJ,1.03 (1.02 1.05),2.27E-02
185,Cancer of prostate,neoplasms,OPGS005374,0.249,RNAseq,ROGDI,0.97 (0.95 0.98),2.27E-02
185,Cancer of prostate,neoplasms,OPGS011110,0.052,RNAseq,CMTM2,0.97 (0.95 0.98),2.35E-02
185,Cancer of prostate,neoplasms,OPGS007663,0.127,RNAseq,NFE4,0.97 (0.95 0.98),2.41E-02
185,Cancer of prostate,neoplasms,OPGS005236,0.262,RNAseq,SFXN4,1.03 (1.02 1.05),2.81E-02
185,Cancer of prostate,neoplasms,OPGS009497,0.079,RNAseq,BAALC,1.03 (1.02 1.05),2.87E-02
185,Cancer of prostate,neoplasms,OPGS013872,0.023,RNAseq,NADK,0.97 (0.95 0.98),2.88E-02
185,Cancer of prostate,neoplasms,OPGS014988,0.016,RNAseq,KDM1A,0.97 (0.95 0.98),3.04E-02
185,Cancer of prostate,neoplasms,OPGS012504,0.036,RNAseq,ASB8,1.03 (1.02 1.05),3.79E-02
185,Cancer of prostate,neoplasms,OPGS004137,0.427,RNAseq,AC006001.2,1.03 (1.02 1.05),3.79E-02
185,Cancer of prostate,neoplasms,OPGS004949,0.293,RNAseq,ILRUN,1.03 (1.02 1.05),3.86E-02
185,Cancer of prostate,neoplasms,OPGS003843,0.532,RNAseq,BTN3A2,1.03 (1.02 1.05),3.86E-02
185,Cancer of prostate,neoplasms,OPGS011488,0.047,RNAseq,KLK1,0.97 (0.95 0.98),4.02E-02
185,Cancer of prostate,neoplasms,OPGS009993,0.069,RNAseq,SNX21,1.03 (1.02 1.05),4.02E-02
185,Cancer of prostate,neoplasms,OPGS008023,0.115,RNAseq,ARNT,0.97 (0.95 0.98),4.02E-02
185,Cancer of prostate,neoplasms,OPGS012803,0.033,RNAseq,PRRT2,1.03 (1.02 1.05),4.02E-02
185,Cancer of prostate,neoplasms,OPGS004184,0.415,RNAseq,TECPR1,1.03 (1.02 1.05),4.30E-02
185,Cancer of prostate,neoplasms,OPGS013745,0.024,RNAseq,PRTFDC1,0.97 (0.95 0.99),4.90E-02
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS000062,0.455,SomaScan,Beta-microseminoprotein,0.87 (0.85 0.90),9.44E-21
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.93 (0.91 0.96),1.02E-03
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.94 (0.91 0.96),3.74E-03
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.07 (1.04 1.10),4.51E-03
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS001598,0.022,SomaScan,SPARC,0.95 (0.92 0.97),3.68E-02
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,1.06 (1.03 1.09),3.68E-02
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.06 (1.03 1.08),3.90E-02
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,1.06 (1.03 1.08),4.09E-02
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS003897,0.508,RNAseq,CASC8,1.07 (1.04 1.10),1.02E-03
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS010693,0.058,RNAseq,TRBV5-1,0.93 (0.91 0.96),1.02E-03
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS010849,0.056,RNAseq,AGAP6,0.94 (0.91 0.96),4.95E-03
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS005858,0.211,RNAseq,GGCX,0.94 (0.91 0.96),6.14E-03
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS004107,0.435,RNAseq,TMEM204,0.94 (0.91 0.96),7.06E-03
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS004144,0.424,RNAseq,PSORS1C3,1.06 (1.03 1.09),8.74E-03
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS011540,0.047,RNAseq,TMEM17,1.06 (1.03 1.09),9.70E-03
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS005618,0.227,RNAseq,PPP1R14A,1.06 (1.04 1.09),9.77E-03
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS006735,0.164,RNAseq,TPCN2,0.94 (0.92 0.97),1.05E-02
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS012246,0.039,RNAseq,ZFP36L2,0.94 (0.92 0.97),1.80E-02
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS009497,0.079,RNAseq,BAALC,1.06 (1.03 1.08),2.24E-02
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS005580,0.232,RNAseq,ZBTB38,1.06 (1.03 1.09),2.26E-02
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS011367,0.049,RNAseq,SLK,1.06 (1.03 1.08),2.33E-02
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS009198,0.085,RNAseq,TRAV12-1,0.95 (0.92 0.97),2.69E-02
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS009720,0.075,RNAseq,ZCCHC2,1.06 (1.03 1.08),3.36E-02
187.1,Malignant neoplasm of unspecified male genital organ,neoplasms,OPGS013045,0.030,RNAseq,NEU1,1.06 (1.03 1.09),3.68E-02
187.2,Malignant neoplasm of testis,neoplasms,OPGS000062,0.455,SomaScan,Beta-microseminoprotein,0.88 (0.86 0.90),5.44E-20
187.2,Malignant neoplasm of testis,neoplasms,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.93 (0.91 0.96),4.77E-04
187.2,Malignant neoplasm of testis,neoplasms,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.07 (1.04 1.10),2.04E-03
187.2,Malignant neoplasm of testis,neoplasms,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.94 (0.91 0.96),2.69E-03
187.2,Malignant neoplasm of testis,neoplasms,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.06 (1.03 1.09),2.24E-02
187.2,Malignant neoplasm of testis,neoplasms,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,1.06 (1.03 1.08),4.46E-02
187.2,Malignant neoplasm of testis,neoplasms,OPGS003897,0.508,RNAseq,CASC8,1.07 (1.04 1.10),4.77E-04
187.2,Malignant neoplasm of testis,neoplasms,OPGS010693,0.058,RNAseq,TRBV5-1,0.93 (0.91 0.96),4.77E-04
187.2,Malignant neoplasm of testis,neoplasms,OPGS010849,0.056,RNAseq,AGAP6,0.94 (0.92 0.96),4.18E-03
187.2,Malignant neoplasm of testis,neoplasms,OPGS005858,0.211,RNAseq,GGCX,0.94 (0.92 0.97),7.12E-03
187.2,Malignant neoplasm of testis,neoplasms,OPGS004107,0.435,RNAseq,TMEM204,0.94 (0.91 0.96),7.12E-03
187.2,Malignant neoplasm of testis,neoplasms,OPGS006735,0.164,RNAseq,TPCN2,0.94 (0.92 0.97),1.02E-02
187.2,Malignant neoplasm of testis,neoplasms,OPGS004144,0.424,RNAseq,PSORS1C3,1.06 (1.03 1.08),1.67E-02
187.2,Malignant neoplasm of testis,neoplasms,OPGS012246,0.039,RNAseq,ZFP36L2,0.94 (0.92 0.97),1.67E-02
187.2,Malignant neoplasm of testis,neoplasms,OPGS005618,0.227,RNAseq,PPP1R14A,1.06 (1.03 1.09),2.24E-02
187.2,Malignant neoplasm of testis,neoplasms,OPGS009497,0.079,RNAseq,BAALC,1.06 (1.03 1.08),2.24E-02
187.2,Malignant neoplasm of testis,neoplasms,OPGS011540,0.047,RNAseq,TMEM17,1.06 (1.03 1.08),2.45E-02
187.2,Malignant neoplasm of testis,neoplasms,OPGS012210,0.039,RNAseq,FOXP4,0.95 (0.92 0.97),3.38E-02
187.2,Malignant neoplasm of testis,neoplasms,OPGS013045,0.030,RNAseq,NEU1,1.06 (1.03 1.08),3.38E-02
187.2,Malignant neoplasm of testis,neoplasms,OPGS009198,0.085,RNAseq,TRAV12-1,0.95 (0.92 0.97),3.38E-02
187.2,Malignant neoplasm of testis,neoplasms,OPGS009720,0.075,RNAseq,ZCCHC2,1.05 (1.03 1.08),4.72E-02
189,Cancer of urinary organs (incl. kidney and bladder),neoplasms,OPGS000135,0.315,SomaScan,Glutathione S-transferase Mu 3,0.93 (0.90 0.96),1.72E-02
189.11,Malignant neoplasm of kidney. except pelvis,neoplasms,OPGS005150,0.271,RNAseq,RERE,0.90 (0.86 0.94),1.86E-02
189.2,Cancer of bladder,neoplasms,OPGS000135,0.315,SomaScan,Glutathione S-transferase Mu 3,0.89 (0.85 0.93),5.95E-04
189.2,Cancer of bladder,neoplasms,OPGS003834,0.535,RNAseq,AC026748.3,1.13 (1.09 1.18),2.18E-04
189.2,Cancer of bladder,neoplasms,OPGS005763,0.217,RNAseq,FAM53A,1.10 (1.05 1.14),4.83E-02
189.21,Malignant neoplasm of bladder,neoplasms,OPGS000135,0.315,SomaScan,Glutathione S-transferase Mu 3,0.89 (0.86 0.92),2.51E-07
189.21,Malignant neoplasm of bladder,neoplasms,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,0.93 (0.89 0.96),2.72E-02
189.21,Malignant neoplasm of bladder,neoplasms,OPGS003896,0.508,RNAseq,GSTM4,0.92 (0.89 0.95),4.56E-03
189.21,Malignant neoplasm of bladder,neoplasms,OPGS003834,0.535,RNAseq,AC026748.3,1.08 (1.05 1.12),1.28E-02
189.21,Malignant neoplasm of bladder,neoplasms,OPGS007802,0.122,RNAseq,LYNX1,0.92 (0.89 0.95),1.28E-02
189.21,Malignant neoplasm of bladder,neoplasms,OPGS006849,0.158,RNAseq,LYPD2,0.93 (0.90 0.96),2.72E-02
189.21,Malignant neoplasm of bladder,neoplasms,OPGS006171,0.193,RNAseq,NOP10,1.07 (1.04 1.11),4.60E-02
189.4,Malignant neoplasm of other urinary organs,neoplasms,OPGS015130,0.015,RNAseq,ATF7,1.17 (1.09 1.25),4.24E-02
193,Thyroid cancer,neoplasms,OPGS010108,0.067,RNAseq,TRMO,0.74 (0.69 0.80),1.84E-11
195.1,Malignant neoplasm. other,neoplasms,OPGS000400,0.139,SomaScan,Agouti-signaling protein,1.04 (1.03 1.05),8.13E-09
195.1,Malignant neoplasm. other,neoplasms,OPGS001634,0.021,SomaScan,Melanocyte protein PMEL,0.97 (0.96 0.98),1.00E-04
195.1,Malignant neoplasm. other,neoplasms,OPGS001025,0.051,SomaScan,Transmembrane glycoprotein NMB,0.97 (0.96 0.99),6.31E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS000734,0.080,SomaScan,KDEL motif-containing protein 2,0.98 (0.97 0.99),1.07E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS000582,0.101,SomaScan,Cathepsin S,0.98 (0.97 0.99),1.88E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS001011,0.052,SomaScan,Transmembrane glycoprotein NMB,0.98 (0.97 0.99),3.11E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS000062,0.455,SomaScan,Beta-microseminoprotein,0.98 (0.97 0.99),3.49E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS002432,0.195,Olink,Cathepsin S,1.02 (1.01 1.04),1.10E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS003168,0.014,Metabolon,X - 24054,0.97 (0.96 0.98),1.45E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003073,0.021,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*,1.03 (1.02 1.04),1.61E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002977,0.035,Metabolon,1.2-dilinoleoyl-GPC (18:2/18:2),0.97 (0.96 0.98),1.61E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003074,0.021,Metabolon,1-stearoyl-2-linoleoyl-GPC (18:0/18:2)*,0.97 (0.96 0.98),1.61E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002829,0.079,Metabolon,arachidonate (20:4n6),1.03 (1.02 1.04),1.61E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003109,0.018,Metabolon,1-linoleoyl-GPE (18:2)*,0.97 (0.96 0.98),1.61E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002997,0.032,Metabolon,1-palmitoyl-2-linoleoyl-GPC (16:0/18:2),0.97 (0.96 0.98),1.61E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002791,0.100,Metabolon,2-arachidonoyl-GPC (20:4)*,1.03 (1.02 1.04),1.61E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002941,0.043,Metabolon,1-palmitoyl-2-linolenoyl-GPC (16:0/18:3)*,0.97 (0.96 0.98),1.72E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003152,0.014,Metabolon,1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2)*,0.97 (0.96 0.98),1.72E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002933,0.044,Metabolon,1-palmitoyl-2-linoleoyl-GPI (16:0/18:2),0.97 (0.96 0.98),1.72E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002954,0.040,Metabolon,1-oleoyl-2-linoleoyl-GPC (18:1/18:2)*,0.97 (0.96 0.98),1.83E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002936,0.044,Metabolon,1-dihomo-linoleoyl-GPC (20:2)*,0.97 (0.96 0.98),1.93E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003086,0.020,Metabolon,1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)*,0.97 (0.96 0.98),1.94E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002734,0.178,Metabolon,1-stearoyl-2-arachidonoyl-GPC (18:0/20:4),1.03 (1.02 1.04),2.15E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002855,0.069,Metabolon,1-palmityl-2-arachidonoyl-GPC (O-16:0/20:4)*,1.03 (1.02 1.04),2.15E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003011,0.030,Metabolon,1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)*,0.97 (0.96 0.98),3.15E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002890,0.056,Metabolon,X - 23705,1.03 (1.02 1.04),3.15E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003075,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*,1.03 (1.02 1.04),4.65E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002747,0.146,Metabolon,1-arachidonoyl-GPC (20:4n6)*,1.03 (1.02 1.04),4.65E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003057,0.022,Metabolon,1-adrenoyl-GPC (22:4)*,1.03 (1.02 1.04),4.65E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003159,0.014,Metabolon,docosapentaenoate (n3 DPA; 22:5n3),1.03 (1.01 1.04),4.65E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003035,0.025,Metabolon,1-linoleoyl-GPI (18:2)*,0.97 (0.96 0.99),4.93E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002764,0.129,Metabolon,1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4),1.03 (1.01 1.04),4.93E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002843,0.073,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4),1.03 (1.01 1.04),5.19E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003121,0.017,Metabolon,1.2-dipalmitoyl-GPC (16:0/16:0),1.03 (1.01 1.04),6.57E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002872,0.061,Metabolon,1-eicosapentaenoyl-GPC (20:5)*,1.03 (1.01 1.04),6.57E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003100,0.019,Metabolon,1-arachidonylglycerol (20:4),1.03 (1.01 1.04),6.57E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002931,0.045,Metabolon,eicosapentaenoate (EPA; 20:5n3),1.03 (1.01 1.04),6.66E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003189,0.012,Metabolon,2-linoleoyl-GPE (18:2)*,0.97 (0.96 0.99),7.50E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002949,0.041,Metabolon,1-stearoyl-2-meadoyl-GPC (18:0/20:3n9)*,1.03 (1.01 1.04),7.50E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002972,0.036,Metabolon,1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9)*,1.03 (1.01 1.04),7.53E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003120,0.017,Metabolon,2-docosahexaenoyl-GPC (22:6)*,1.03 (1.01 1.04),7.58E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003038,0.025,Metabolon,1-margaroyl-2-linoleoyl-GPC (17:0/18:2)*,0.98 (0.96 0.99),7.74E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS003114,0.018,Metabolon,1-myristoyl-2-linoleoyl-GPC (14:0/18:2)*,0.98 (0.96 0.99),8.04E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002899,0.053,Metabolon,1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5)*,1.03 (1.01 1.04),8.04E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002980,0.034,Metabolon,1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2)*,0.98 (0.96 0.99),9.25E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS002819,0.083,Metabolon,phosphatidylcholine (16:0/22:5n3. 18:1/20:4)*,1.02 (1.01 1.04),1.17E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS003016,0.029,Metabolon,1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)*,1.02 (1.01 1.04),1.23E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS003019,0.028,Metabolon,1-oleoyl-2-linoleoyl-GPI (18:1/18:2)*,0.98 (0.96 0.99),1.24E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS003043,0.024,Metabolon,1-docosahexaenoyl-GPC (22:6)*,1.02 (1.01 1.04),1.27E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS002863,0.066,Metabolon,1-stearoyl-2-linoleoyl-GPI (18:0/18:2),0.98 (0.96 0.99),1.29E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS003125,0.017,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6),1.02 (1.01 1.04),1.35E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS003042,0.024,Metabolon,1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6),1.02 (1.01 1.04),1.37E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS002981,0.034,Metabolon,1-docosapentaenoyl-GPC (22:5n3)*,1.02 (1.01 1.04),1.88E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS002834,0.075,Metabolon,phosphatidylcholine (18:0/20:5. 16:0/22:5n6)*,1.02 (1.01 1.04),1.93E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS002971,0.036,Metabolon,1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4)*,1.02 (1.01 1.04),2.50E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS003060,0.022,Metabolon,stearidonate (18:4n3),1.02 (1.01 1.04),2.53E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS002837,0.075,Metabolon,1-stearoyl-2-arachidonoyl-GPI (18:0/20:4),1.02 (1.01 1.03),2.89E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS002963,0.038,Metabolon,1-palmitoyl-2-oleoyl-GPI (16:0/18:1)*,0.98 (0.97 0.99),3.77E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS003522,0.062,Nightingale,Degree of unsaturation,1.03 (1.01 1.04),9.49E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS011367,0.049,RNAseq,SLK,1.03 (1.02 1.05),1.00E-04
195.1,Malignant neoplasm. other,neoplasms,OPGS005895,0.209,RNAseq,MAP1LC3A,0.97 (0.96 0.98),3.33E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS014960,0.016,RNAseq,MYNN,0.97 (0.96 0.99),4.65E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS010527,0.060,RNAseq,SPG7,0.97 (0.96 0.99),4.65E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS006999,0.152,RNAseq,ADAMTSL4,1.03 (1.02 1.04),5.10E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS007528,0.131,RNAseq,SPIRE2,0.97 (0.96 0.99),6.57E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS007452,0.134,RNAseq,TMEM258,0.98 (0.96 0.99),7.74E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS008821,0.094,RNAseq,AC243772.2,0.97 (0.96 0.99),9.77E-03
195.1,Malignant neoplasm. other,neoplasms,OPGS010691,0.058,RNAseq,RPRD2,1.02 (1.01 1.04),1.10E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS004345,0.381,RNAseq,SENP7,1.02 (1.01 1.04),1.12E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS010420,0.062,RNAseq,ATP1B2,1.02 (1.01 1.04),1.29E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS009794,0.073,RNAseq,RN7SL473P,0.98 (0.97 0.99),1.72E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS005317,0.255,RNAseq,PTGDR,1.02 (1.01 1.04),1.86E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS010888,0.055,RNAseq,AC107068.1,1.02 (1.01 1.04),1.92E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS003897,0.508,RNAseq,CASC8,1.02 (1.01 1.04),2.15E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS012654,0.034,RNAseq,CLPTM1L,0.98 (0.97 0.99),2.33E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS013958,0.023,RNAseq,CSNK2B,0.98 (0.97 0.99),2.53E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS009519,0.079,RNAseq,GGT1,0.98 (0.96 0.99),2.61E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS008401,0.104,RNAseq,MCM4,1.02 (1.01 1.04),2.74E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS010512,0.061,RNAseq,ITCH,0.98 (0.97 0.99),2.76E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS007489,0.133,RNAseq,RRM2B,1.02 (1.01 1.04),2.86E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS011819,0.043,RNAseq,IL1RN,0.98 (0.97 0.99),2.91E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS011693,0.045,RNAseq,CABLES1,1.02 (1.01 1.03),3.02E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS008569,0.100,RNAseq,RAD23B,1.02 (1.01 1.03),3.02E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS006621,0.169,RNAseq,NME7,0.98 (0.97 0.99),3.77E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS011598,0.046,RNAseq,FPGS,1.02 (1.01 1.04),4.67E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS011137,0.052,RNAseq,USP28,0.98 (0.97 0.99),4.67E-02
195.1,Malignant neoplasm. other,neoplasms,OPGS004322,0.386,RNAseq,CDK10,0.98 (0.97 0.99),4.80E-02
197,Chemotherapy,neoplasms,OPGS012039,0.041,RNAseq,SGO2,0.97 (0.96 0.98),1.26E-02
198.1,Secondary malignancy of lymph nodes,neoplasms,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,0.94 (0.92 0.96),9.49E-05
198.4,Secondary malignant neoplasm of liver,neoplasms,OPGS005334,0.253,RNAseq,AL645933.4,0.93 (0.91 0.96),3.53E-03
200,Myeloproliferative disease,neoplasms,OPGS011698,0.045,RNAseq,JAK2,1.22 (1.16 1.28),1.82E-09
200.1,Polycythemia vera,neoplasms,OPGS011698,0.045,RNAseq,JAK2,1.53 (1.41 1.65),1.20E-20
201,Hodgkin's disease,neoplasms,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.79 (0.72 0.87),3.62E-03
201,Hodgkin's disease,neoplasms,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.82 (0.75 0.89),9.74E-03
201,Hodgkin's disease,neoplasms,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,0.83 (0.76 0.90),2.87E-02
201,Hodgkin's disease,neoplasms,OPGS010693,0.058,RNAseq,TRBV5-1,1.23 (1.14 1.34),3.62E-03
201,Hodgkin's disease,neoplasms,OPGS012358,0.037,RNAseq,SFRP5,0.81 (0.74 0.88),7.70E-03
201,Hodgkin's disease,neoplasms,OPGS013256,0.029,RNAseq,SLC27A2,1.23 (1.13 1.34),7.70E-03
201,Hodgkin's disease,neoplasms,OPGS011283,0.050,RNAseq,CD248,0.82 (0.76 0.89),1.35E-02
201,Hodgkin's disease,neoplasms,OPGS013225,0.029,RNAseq,REG4,0.83 (0.76 0.90),1.39E-02
201,Hodgkin's disease,neoplasms,OPGS006248,0.189,RNAseq,MCCD1,0.83 (0.76 0.90),2.87E-02
201,Hodgkin's disease,neoplasms,OPGS013699,0.025,RNAseq,TRAV5,0.83 (0.76 0.90),2.95E-02
201,Hodgkin's disease,neoplasms,OPGS007855,0.120,RNAseq,ZNF367,0.83 (0.76 0.91),4.63E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.90 (0.87 0.94),7.68E-04
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.10 (1.06 1.15),8.11E-04
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.91 (0.88 0.95),3.23E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,1.10 (1.05 1.14),3.68E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.91 (0.88 0.95),3.68E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.92 (0.88 0.95),4.84E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.91 (0.88 0.95),4.92E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.92 (0.88 0.95),6.05E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.92 (0.89 0.96),1.22E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.92 (0.89 0.96),1.68E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.93 (0.89 0.96),2.31E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,1.08 (1.04 1.12),3.92E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.93 (0.89 0.96),4.97E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.90 (0.87 0.94),7.68E-04
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS002517,0.079,Olink,Tumor necrosis factor receptor superfamily member 5,0.92 (0.89 0.96),1.51E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS009198,0.085,RNAseq,TRAV12-1,1.14 (1.10 1.19),3.60E-07
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS006845,0.158,RNAseq,FLOT1,1.11 (1.07 1.16),1.56E-04
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS013225,0.029,RNAseq,REG4,0.90 (0.87 0.94),7.68E-04
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS009865,0.072,RNAseq,TRAV17,0.91 (0.88 0.95),2.09E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS003680,0.611,RNAseq,,1.09 (1.06 1.14),2.59E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS011283,0.050,RNAseq,CD248,0.91 (0.88 0.95),2.59E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS010826,0.056,RNAseq,TRIM10,0.92 (0.88 0.95),4.75E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS010348,0.063,RNAseq,TRBV6-5,0.91 (0.88 0.95),4.75E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS010693,0.058,RNAseq,TRBV5-1,1.09 (1.05 1.13),4.84E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS014283,0.021,RNAseq,MXRA8,0.91 (0.88 0.95),5.44E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS004406,0.369,RNAseq,,0.92 (0.88 0.95),6.05E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS004567,0.343,RNAseq,HLA-C,1.09 (1.05 1.13),6.05E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS013243,0.029,RNAseq,TRAV3,0.92 (0.88 0.95),6.05E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS006615,0.170,RNAseq,TNFRSF14,0.92 (0.88 0.95),7.03E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS011784,0.044,RNAseq,TUBB,1.09 (1.05 1.14),7.03E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS013045,0.030,RNAseq,NEU1,0.92 (0.89 0.96),9.36E-03
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS007675,0.126,RNAseq,TRAV12-2,1.09 (1.05 1.13),1.02E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS005005,0.286,RNAseq,HLA-DOA,1.09 (1.05 1.13),1.02E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS014496,0.019,RNAseq,VARS1,1.08 (1.04 1.12),1.19E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS005230,0.263,RNAseq,LINC00243,1.09 (1.04 1.13),1.34E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS013155,0.029,RNAseq,MDS2,1.09 (1.05 1.13),1.36E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS008402,0.104,RNAseq,TNXB,0.92 (0.89 0.96),1.68E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS015030,0.016,RNAseq,PRRC2A,0.92 (0.89 0.96),2.31E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS006942,0.154,RNAseq,SKIV2L,0.92 (0.89 0.96),2.52E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS013648,0.025,RNAseq,RN7SL491P,1.07 (1.04 1.11),3.92E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS009371,0.082,RNAseq,TRBV19,0.93 (0.89 0.96),4.30E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS013699,0.025,RNAseq,TRAV5,0.93 (0.89 0.96),4.77E-02
202.2,Non-Hodgkins lymphoma,neoplasms,OPGS006716,0.164,RNAseq,IER3,1.08 (1.04 1.12),4.97E-02
202.21,Nodular lymphoma,neoplasms,OPGS000538,0.109,SomaScan,Cyclic AMP-responsive element-binding protein 3-like protein 4,1.24 (1.16 1.33),9.54E-07
202.21,Nodular lymphoma,neoplasms,OPGS000681,0.087,SomaScan,Protein-glutamine gamma-glutamyltransferase E,0.82 (0.75 0.88),1.55E-03
202.21,Nodular lymphoma,neoplasms,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,1.21 (1.11 1.31),7.46E-03
202.21,Nodular lymphoma,neoplasms,OPGS000984,0.055,SomaScan,Complement C2,1.21 (1.11 1.31),2.24E-02
202.21,Nodular lymphoma,neoplasms,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.19 (1.10 1.30),2.98E-02
202.21,Nodular lymphoma,neoplasms,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.18 (1.09 1.28),3.18E-02
202.21,Nodular lymphoma,neoplasms,OPGS002598,0.031,Olink,Interleukin-10,1.26 (1.18 1.35),7.40E-07
202.21,Nodular lymphoma,neoplasms,OPGS009198,0.085,RNAseq,TRAV12-1,1.31 (1.21 1.42),8.23E-07
202.21,Nodular lymphoma,neoplasms,OPGS005167,0.269,RNAseq,TCF19,1.24 (1.16 1.32),8.23E-07
202.21,Nodular lymphoma,neoplasms,OPGS011536,0.047,RNAseq,TRAV2,1.24 (1.15 1.35),1.24E-04
202.21,Nodular lymphoma,neoplasms,OPGS004567,0.343,RNAseq,HLA-C,1.23 (1.14 1.33),4.59E-04
202.21,Nodular lymphoma,neoplasms,OPGS014232,0.021,RNAseq,TRAV1-2,1.23 (1.14 1.33),6.00E-04
202.21,Nodular lymphoma,neoplasms,OPGS011431,0.048,RNAseq,VWA7,0.83 (0.77 0.89),1.73E-03
202.21,Nodular lymphoma,neoplasms,OPGS008889,0.092,RNAseq,TRAV20,1.21 (1.12 1.31),3.32E-03
202.21,Nodular lymphoma,neoplasms,OPGS014580,0.018,RNAseq,DACT1,0.84 (0.77 0.90),3.57E-03
202.21,Nodular lymphoma,neoplasms,OPGS006976,0.153,RNAseq,UTS2,1.14 (1.08 1.21),5.00E-03
202.21,Nodular lymphoma,neoplasms,OPGS015052,0.015,RNAseq,CISH,0.84 (0.77 0.91),1.03E-02
202.21,Nodular lymphoma,neoplasms,OPGS013514,0.026,RNAseq,GZMK,1.20 (1.11 1.30),1.04E-02
202.21,Nodular lymphoma,neoplasms,OPGS008988,0.090,RNAseq,MRPL55,0.85 (0.78 0.92),3.16E-02
202.21,Nodular lymphoma,neoplasms,OPGS010607,0.059,RNAseq,TRAV8-1,0.85 (0.78 0.92),4.90E-02
202.24,Large cell lymphoma,neoplasms,OPGS000984,0.055,SomaScan,Complement C2,1.20 (1.12 1.27),2.31E-04
202.24,Large cell lymphoma,neoplasms,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.13 (1.07 1.20),2.88E-02
202.24,Large cell lymphoma,neoplasms,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.14 (1.07 1.21),2.88E-02
202.24,Large cell lymphoma,neoplasms,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.89 (0.84 0.94),4.81E-02
202.24,Large cell lymphoma,neoplasms,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.89 (0.83 0.94),4.81E-02
202.24,Large cell lymphoma,neoplasms,OPGS011431,0.048,RNAseq,VWA7,0.85 (0.80 0.89),7.17E-05
202.24,Large cell lymphoma,neoplasms,OPGS009198,0.085,RNAseq,TRAV12-1,1.18 (1.11 1.25),2.38E-04
202.24,Large cell lymphoma,neoplasms,OPGS013243,0.029,RNAseq,TRAV3,0.87 (0.82 0.92),3.34E-03
202.24,Large cell lymphoma,neoplasms,OPGS003680,0.611,RNAseq,,1.15 (1.08 1.21),4.22E-03
202.24,Large cell lymphoma,neoplasms,OPGS006845,0.158,RNAseq,FLOT1,1.14 (1.08 1.21),1.91E-02
202.24,Large cell lymphoma,neoplasms,OPGS014496,0.019,RNAseq,VARS1,1.13 (1.07 1.20),2.23E-02
202.24,Large cell lymphoma,neoplasms,OPGS005334,0.253,RNAseq,AL645933.4,0.88 (0.83 0.93),2.46E-02
202.24,Large cell lymphoma,neoplasms,OPGS013045,0.030,RNAseq,NEU1,0.88 (0.83 0.93),2.46E-02
202.24,Large cell lymphoma,neoplasms,OPGS007675,0.126,RNAseq,TRAV12-2,1.14 (1.07 1.20),2.46E-02
202.24,Large cell lymphoma,neoplasms,OPGS006499,0.176,RNAseq,C4A,0.89 (0.84 0.94),3.90E-02
202.24,Large cell lymphoma,neoplasms,OPGS010826,0.056,RNAseq,TRIM10,0.89 (0.84 0.94),4.81E-02
204.12,Lymphoid leukemia. chronic,neoplasms,OPGS005846,0.212,RNAseq,SP140,0.80 (0.75 0.86),4.64E-07
204.12,Lymphoid leukemia. chronic,neoplasms,OPGS005759,0.217,RNAseq,GRAMD1B,1.17 (1.10 1.25),3.45E-03
204.12,Lymphoid leukemia. chronic,neoplasms,OPGS010490,0.061,RNAseq,ZNF655,0.89 (0.85 0.93),4.51E-03
204.12,Lymphoid leukemia. chronic,neoplasms,OPGS012273,0.038,RNAseq,ACTA2-AS1,1.17 (1.09 1.24),1.27E-02
204.12,Lymphoid leukemia. chronic,neoplasms,OPGS005366,0.250,RNAseq,FAS,1.16 (1.09 1.24),1.27E-02
204.12,Lymphoid leukemia. chronic,neoplasms,OPGS005389,0.248,RNAseq,TRAV23DV6,0.88 (0.83 0.93),1.47E-02
204.12,Lymphoid leukemia. chronic,neoplasms,OPGS012214,0.039,RNAseq,GORASP1,0.87 (0.82 0.93),2.82E-02
208,Benign neoplasm of colon,neoplasms,OPGS001130,0.044,SomaScan,Chordin-like protein 2,1.04 (1.03 1.05),2.10E-10
208,Benign neoplasm of colon,neoplasms,OPGS001965,0.013,SomaScan,Bone morphogenetic protein 6,1.04 (1.02 1.05),4.46E-07
208,Benign neoplasm of colon,neoplasms,OPGS000578,0.102,SomaScan,Nidogen-2,1.03 (1.02 1.04),8.53E-05
208,Benign neoplasm of colon,neoplasms,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,0.97 (0.96 0.98),1.28E-04
208,Benign neoplasm of colon,neoplasms,OPGS000117,0.345,SomaScan,Galactoside 3(4)-L-fucosyltransferase,0.97 (0.96 0.98),3.47E-04
208,Benign neoplasm of colon,neoplasms,OPGS000101,0.374,SomaScan,CD209 antigen,0.97 (0.96 0.98),3.69E-04
208,Benign neoplasm of colon,neoplasms,OPGS000198,0.236,SomaScan,Peptidyl-glycine alpha-amidating monooxygenase,1.03 (1.02 1.04),4.03E-04
208,Benign neoplasm of colon,neoplasms,OPGS000734,0.080,SomaScan,KDEL motif-containing protein 2,0.98 (0.97 0.99),1.48E-03
208,Benign neoplasm of colon,neoplasms,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,0.98 (0.97 0.99),2.06E-03
208,Benign neoplasm of colon,neoplasms,OPGS000346,0.151,SomaScan,N-acetyllactosaminide beta-1.3-N-acetylglucosaminyltransferase 2,0.98 (0.97 0.99),4.61E-03
208,Benign neoplasm of colon,neoplasms,OPGS001832,0.016,SomaScan,Neurogenic locus notch homolog protein 1,0.98 (0.97 0.99),4.66E-03
208,Benign neoplasm of colon,neoplasms,OPGS001700,0.019,SomaScan,Semaphorin-6B,0.98 (0.97 0.99),5.67E-03
208,Benign neoplasm of colon,neoplasms,OPGS000362,0.147,SomaScan,Golgi membrane protein 1,0.98 (0.97 0.99),5.74E-03
208,Benign neoplasm of colon,neoplasms,OPGS001327,0.032,SomaScan,Basal Cell Adhesion Molecule,0.98 (0.97 0.99),6.58E-03
208,Benign neoplasm of colon,neoplasms,OPGS000321,0.161,SomaScan,von Willebrand factor,0.98 (0.97 0.99),7.31E-03
208,Benign neoplasm of colon,neoplasms,OPGS000106,0.366,SomaScan,Protein FAM3D,0.98 (0.97 0.99),7.59E-03
208,Benign neoplasm of colon,neoplasms,OPGS000212,0.222,SomaScan,Tyrosine-protein kinase receptor Tie-1. soluble,0.98 (0.97 0.99),8.28E-03
208,Benign neoplasm of colon,neoplasms,OPGS001083,0.047,SomaScan,Desmoglein-2,0.98 (0.97 0.99),9.14E-03
208,Benign neoplasm of colon,neoplasms,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.98 (0.97 0.99),9.14E-03
208,Benign neoplasm of colon,neoplasms,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,0.98 (0.97 0.99),1.09E-02
208,Benign neoplasm of colon,neoplasms,OPGS000630,0.094,SomaScan,Glutaminyl-peptide cyclotransferase-like protein,0.98 (0.97 0.99),1.68E-02
208,Benign neoplasm of colon,neoplasms,OPGS000220,0.213,SomaScan,Vascular endothelial growth factor receptor 2,1.02 (1.01 1.03),1.92E-02
208,Benign neoplasm of colon,neoplasms,OPGS000095,0.381,SomaScan,Sulfhydryl oxidase 2,0.98 (0.97 0.99),1.93E-02
208,Benign neoplasm of colon,neoplasms,OPGS000322,0.161,SomaScan,SPARC-like protein 1,1.02 (1.01 1.03),2.23E-02
208,Benign neoplasm of colon,neoplasms,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,1.02 (1.01 1.03),2.62E-02
208,Benign neoplasm of colon,neoplasms,OPGS001485,0.026,SomaScan,Tolloid-like protein 1,0.98 (0.97 0.99),2.66E-02
208,Benign neoplasm of colon,neoplasms,OPGS001174,0.040,SomaScan,Platelet glycoprotein 4,0.98 (0.97 0.99),2.66E-02
208,Benign neoplasm of colon,neoplasms,OPGS001377,0.030,SomaScan,Vascular cell adhesion protein 1,0.98 (0.97 0.99),3.58E-02
208,Benign neoplasm of colon,neoplasms,OPGS002629,0.023,Olink,Interleukin-18-binding protein,0.97 (0.96 0.98),5.76E-06
208,Benign neoplasm of colon,neoplasms,OPGS002651,0.015,Olink,von Willebrand factor,0.98 (0.97 0.99),1.42E-03
208,Benign neoplasm of colon,neoplasms,OPGS002500,0.098,Olink,Galectin-4,1.02 (1.01 1.04),2.20E-03
208,Benign neoplasm of colon,neoplasms,OPGS002637,0.020,Olink,Bone morphogenetic protein 4,1.02 (1.01 1.03),1.10E-02
208,Benign neoplasm of colon,neoplasms,OPGS002628,0.023,Olink,Pro-adrenomedullin,1.02 (1.01 1.03),1.94E-02
208,Benign neoplasm of colon,neoplasms,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.98 (0.97 0.99),2.19E-02
208,Benign neoplasm of colon,neoplasms,OPGS002602,0.030,Olink,Fatty acid-binding protein. intestinal,1.02 (1.01 1.03),3.53E-02
208,Benign neoplasm of colon,neoplasms,OPGS002482,0.125,Olink,Tumor necrosis factor ligand superfamily member 10,0.98 (0.97 0.99),4.05E-02
208,Benign neoplasm of colon,neoplasms,OPGS002872,0.061,Metabolon,1-eicosapentaenoyl-GPC (20:5)*,1.04 (1.03 1.05),2.11E-08
208,Benign neoplasm of colon,neoplasms,OPGS002977,0.035,Metabolon,1.2-dilinoleoyl-GPC (18:2/18:2),0.96 (0.95 0.97),2.11E-08
208,Benign neoplasm of colon,neoplasms,OPGS002954,0.040,Metabolon,1-oleoyl-2-linoleoyl-GPC (18:1/18:2)*,0.96 (0.95 0.97),2.11E-08
208,Benign neoplasm of colon,neoplasms,OPGS002899,0.053,Metabolon,1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5)*,1.04 (1.03 1.05),4.37E-08
208,Benign neoplasm of colon,neoplasms,OPGS003038,0.025,Metabolon,1-margaroyl-2-linoleoyl-GPC (17:0/18:2)*,0.97 (0.96 0.98),1.15E-07
208,Benign neoplasm of colon,neoplasms,OPGS002734,0.178,Metabolon,1-stearoyl-2-arachidonoyl-GPC (18:0/20:4),1.04 (1.02 1.05),1.45E-07
208,Benign neoplasm of colon,neoplasms,OPGS002949,0.041,Metabolon,1-stearoyl-2-meadoyl-GPC (18:0/20:3n9)*,1.04 (1.02 1.05),1.57E-07
208,Benign neoplasm of colon,neoplasms,OPGS002819,0.083,Metabolon,phosphatidylcholine (16:0/22:5n3. 18:1/20:4)*,1.04 (1.02 1.05),1.72E-07
208,Benign neoplasm of colon,neoplasms,OPGS003109,0.018,Metabolon,1-linoleoyl-GPE (18:2)*,0.97 (0.96 0.98),4.04E-07
208,Benign neoplasm of colon,neoplasms,OPGS003074,0.021,Metabolon,1-stearoyl-2-linoleoyl-GPC (18:0/18:2)*,0.97 (0.96 0.98),4.04E-07
208,Benign neoplasm of colon,neoplasms,OPGS003159,0.014,Metabolon,docosapentaenoate (n3 DPA; 22:5n3),1.03 (1.02 1.05),4.45E-07
208,Benign neoplasm of colon,neoplasms,OPGS002972,0.036,Metabolon,1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9)*,1.03 (1.02 1.05),4.46E-07
208,Benign neoplasm of colon,neoplasms,OPGS002931,0.045,Metabolon,eicosapentaenoate (EPA; 20:5n3),1.03 (1.02 1.05),4.85E-07
208,Benign neoplasm of colon,neoplasms,OPGS003073,0.021,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*,1.03 (1.02 1.05),4.85E-07
208,Benign neoplasm of colon,neoplasms,OPGS003152,0.014,Metabolon,1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2)*,0.97 (0.96 0.98),4.85E-07
208,Benign neoplasm of colon,neoplasms,OPGS003057,0.022,Metabolon,1-adrenoyl-GPC (22:4)*,1.03 (1.02 1.05),4.96E-07
208,Benign neoplasm of colon,neoplasms,OPGS002764,0.129,Metabolon,1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4),1.03 (1.02 1.04),6.19E-07
208,Benign neoplasm of colon,neoplasms,OPGS003075,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*,1.03 (1.02 1.04),6.57E-07
208,Benign neoplasm of colon,neoplasms,OPGS002791,0.100,Metabolon,2-arachidonoyl-GPC (20:4)*,1.03 (1.02 1.04),7.25E-07
208,Benign neoplasm of colon,neoplasms,OPGS003189,0.012,Metabolon,2-linoleoyl-GPE (18:2)*,0.97 (0.96 0.98),9.00E-07
208,Benign neoplasm of colon,neoplasms,OPGS003100,0.019,Metabolon,1-arachidonylglycerol (20:4),1.03 (1.02 1.04),9.00E-07
208,Benign neoplasm of colon,neoplasms,OPGS002893,0.054,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3)*,1.03 (1.02 1.04),9.23E-07
208,Benign neoplasm of colon,neoplasms,OPGS003168,0.014,Metabolon,X - 24054,0.97 (0.96 0.98),9.23E-07
208,Benign neoplasm of colon,neoplasms,OPGS002829,0.079,Metabolon,arachidonate (20:4n6),1.03 (1.02 1.04),1.09E-06
208,Benign neoplasm of colon,neoplasms,OPGS002941,0.043,Metabolon,1-palmitoyl-2-linolenoyl-GPC (16:0/18:3)*,0.97 (0.96 0.98),1.23E-06
208,Benign neoplasm of colon,neoplasms,OPGS002890,0.056,Metabolon,X - 23705,1.03 (1.02 1.04),1.23E-06
208,Benign neoplasm of colon,neoplasms,OPGS002747,0.146,Metabolon,1-arachidonoyl-GPC (20:4n6)*,1.03 (1.02 1.04),1.34E-06
208,Benign neoplasm of colon,neoplasms,OPGS002909,0.049,Metabolon,X - 24439,0.97 (0.96 0.98),1.60E-06
208,Benign neoplasm of colon,neoplasms,OPGS002981,0.034,Metabolon,1-docosapentaenoyl-GPC (22:5n3)*,1.03 (1.02 1.04),1.98E-06
208,Benign neoplasm of colon,neoplasms,OPGS003121,0.017,Metabolon,1.2-dipalmitoyl-GPC (16:0/16:0),1.03 (1.02 1.04),4.17E-06
208,Benign neoplasm of colon,neoplasms,OPGS003016,0.029,Metabolon,1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)*,1.03 (1.02 1.04),4.94E-06
208,Benign neoplasm of colon,neoplasms,OPGS002980,0.034,Metabolon,1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2)*,0.97 (0.96 0.98),7.08E-06
208,Benign neoplasm of colon,neoplasms,OPGS002834,0.075,Metabolon,phosphatidylcholine (18:0/20:5. 16:0/22:5n6)*,1.03 (1.02 1.04),7.42E-06
208,Benign neoplasm of colon,neoplasms,OPGS003029,0.026,Metabolon,docosatrienoate (22:3n3),0.97 (0.96 0.98),1.19E-05
208,Benign neoplasm of colon,neoplasms,OPGS002855,0.069,Metabolon,1-palmityl-2-arachidonoyl-GPC (O-16:0/20:4)*,1.03 (1.02 1.04),1.41E-05
208,Benign neoplasm of colon,neoplasms,OPGS002843,0.073,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4),1.03 (1.02 1.04),1.50E-05
208,Benign neoplasm of colon,neoplasms,OPGS002936,0.044,Metabolon,1-dihomo-linoleoyl-GPC (20:2)*,0.97 (0.96 0.98),1.63E-05
208,Benign neoplasm of colon,neoplasms,OPGS003086,0.020,Metabolon,1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)*,0.97 (0.96 0.98),1.85E-05
208,Benign neoplasm of colon,neoplasms,OPGS002857,0.067,Metabolon,1-arachidonoyl-GPA (20:4),1.03 (1.02 1.04),2.61E-05
208,Benign neoplasm of colon,neoplasms,OPGS002997,0.032,Metabolon,1-palmitoyl-2-linoleoyl-GPC (16:0/18:2),0.97 (0.96 0.98),2.65E-05
208,Benign neoplasm of colon,neoplasms,OPGS002807,0.089,Metabolon,1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3)*,0.97 (0.96 0.98),4.36E-05
208,Benign neoplasm of colon,neoplasms,OPGS002948,0.042,Metabolon,1-dihomo-linolenoyl-GPE (20:3n3 or 6)*,0.97 (0.96 0.98),7.24E-05
208,Benign neoplasm of colon,neoplasms,OPGS003011,0.030,Metabolon,1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)*,0.97 (0.96 0.98),7.73E-05
208,Benign neoplasm of colon,neoplasms,OPGS002695,0.405,Metabolon,X - 11491,0.97 (0.96 0.98),8.33E-05
208,Benign neoplasm of colon,neoplasms,OPGS003060,0.022,Metabolon,stearidonate (18:4n3),1.03 (1.02 1.04),9.36E-05
208,Benign neoplasm of colon,neoplasms,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.03 (1.02 1.04),9.71E-05
208,Benign neoplasm of colon,neoplasms,OPGS002971,0.036,Metabolon,1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4)*,1.03 (1.02 1.04),2.41E-04
208,Benign neoplasm of colon,neoplasms,OPGS002921,0.047,Metabolon,1-oleoyl-2-linoleoyl-GPE (18:1/18:2)*,0.98 (0.97 0.99),9.73E-04
208,Benign neoplasm of colon,neoplasms,OPGS003042,0.024,Metabolon,1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6),1.02 (1.01 1.04),1.42E-03
208,Benign neoplasm of colon,neoplasms,OPGS002789,0.102,Metabolon,1-palmitoyl-2-linoleoyl-GPE (16:0/18:2),0.98 (0.97 0.99),1.48E-03
208,Benign neoplasm of colon,neoplasms,OPGS003019,0.028,Metabolon,1-oleoyl-2-linoleoyl-GPI (18:1/18:2)*,0.98 (0.97 0.99),1.70E-03
208,Benign neoplasm of colon,neoplasms,OPGS003136,0.016,Metabolon,1-eicosapentaenoyl-GPE (20:5)*,1.02 (1.01 1.04),1.82E-03
208,Benign neoplasm of colon,neoplasms,OPGS003125,0.017,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6),1.02 (1.01 1.03),2.18E-03
208,Benign neoplasm of colon,neoplasms,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.02 (1.01 1.04),2.39E-03
208,Benign neoplasm of colon,neoplasms,OPGS002820,0.082,Metabolon,5alpha-androstan-3alpha. 17beta-diol-17-glucosiduronate,0.98 (0.97 0.99),2.49E-03
208,Benign neoplasm of colon,neoplasms,OPGS002850,0.070,Metabolon,1-stearoyl-2-linoleoyl-GPE (18:0/18:2)*,0.98 (0.97 0.99),3.41E-03
208,Benign neoplasm of colon,neoplasms,OPGS003114,0.018,Metabolon,1-myristoyl-2-linoleoyl-GPC (14:0/18:2)*,0.98 (0.97 0.99),3.60E-03
208,Benign neoplasm of colon,neoplasms,OPGS003149,0.015,Metabolon,sphingosine,0.98 (0.97 0.99),3.86E-03
208,Benign neoplasm of colon,neoplasms,OPGS002933,0.044,Metabolon,1-palmitoyl-2-linoleoyl-GPI (16:0/18:2),0.98 (0.97 0.99),4.54E-03
208,Benign neoplasm of colon,neoplasms,OPGS002798,0.095,Metabolon,X - 18921,1.02 (1.01 1.03),5.04E-03
208,Benign neoplasm of colon,neoplasms,OPGS002837,0.075,Metabolon,1-stearoyl-2-arachidonoyl-GPI (18:0/20:4),1.02 (1.01 1.03),6.75E-03
208,Benign neoplasm of colon,neoplasms,OPGS003035,0.025,Metabolon,1-linoleoyl-GPI (18:2)*,0.98 (0.97 0.99),9.14E-03
208,Benign neoplasm of colon,neoplasms,OPGS003008,0.030,Metabolon,quinolinate,0.98 (0.97 0.99),1.42E-02
208,Benign neoplasm of colon,neoplasms,OPGS002698,0.378,Metabolon,X - 19141,0.98 (0.97 0.99),1.66E-02
208,Benign neoplasm of colon,neoplasms,OPGS002780,0.113,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)*,1.02 (1.01 1.03),1.74E-02
208,Benign neoplasm of colon,neoplasms,OPGS002771,0.124,Metabolon,glutarylcarnitine (C5),0.98 (0.97 0.99),2.19E-02
208,Benign neoplasm of colon,neoplasms,OPGS002832,0.078,Metabolon,X - 24438,0.98 (0.97 0.99),2.33E-02
208,Benign neoplasm of colon,neoplasms,OPGS002774,0.119,Metabolon,X - 21467,0.98 (0.97 0.99),2.51E-02
208,Benign neoplasm of colon,neoplasms,OPGS003120,0.017,Metabolon,2-docosahexaenoyl-GPC (22:6)*,1.02 (1.01 1.03),3.13E-02
208,Benign neoplasm of colon,neoplasms,OPGS003014,0.029,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6)*,1.02 (1.01 1.03),3.23E-02
208,Benign neoplasm of colon,neoplasms,OPGS003043,0.024,Metabolon,1-docosahexaenoyl-GPC (22:6)*,1.02 (1.01 1.03),4.05E-02
208,Benign neoplasm of colon,neoplasms,OPGS003118,0.017,Metabolon,1-(1-enyl-palmitoyl)-GPC (P-16:0)*,1.02 (1.01 1.03),4.14E-02
208,Benign neoplasm of colon,neoplasms,OPGS002817,0.085,Metabolon,X - 23293,1.02 (1.01 1.03),4.42E-02
208,Benign neoplasm of colon,neoplasms,OPGS003117,0.018,Metabolon,3-hydroxydecanoate,1.02 (1.01 1.03),4.68E-02
208,Benign neoplasm of colon,neoplasms,OPGS003113,0.018,Metabolon,1-docosapentaenoyl-GPC (22:5n6)*,1.02 (1.01 1.03),4.84E-02
208,Benign neoplasm of colon,neoplasms,OPGS003522,0.062,Nightingale,Degree of unsaturation,1.03 (1.02 1.04),5.36E-05
208,Benign neoplasm of colon,neoplasms,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.02 (1.01 1.04),1.72E-03
208,Benign neoplasm of colon,neoplasms,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.02 (1.01 1.03),3.33E-02
208,Benign neoplasm of colon,neoplasms,OPGS010163,0.066,RNAseq,AL121832.2,1.07 (1.06 1.08),2.64E-32
208,Benign neoplasm of colon,neoplasms,OPGS010719,0.058,RNAseq,LAMA5,1.04 (1.03 1.06),3.13E-11
208,Benign neoplasm of colon,neoplasms,OPGS007876,0.119,RNAseq,MDM4,0.97 (0.96 0.98),4.08E-07
208,Benign neoplasm of colon,neoplasms,OPGS011917,0.042,RNAseq,PIK3C2B,0.97 (0.96 0.98),4.85E-07
208,Benign neoplasm of colon,neoplasms,OPGS004301,0.389,RNAseq,LAMC1,1.03 (1.02 1.04),6.57E-07
208,Benign neoplasm of colon,neoplasms,OPGS004012,0.460,RNAseq,ZFP90,1.03 (1.02 1.05),6.72E-07
208,Benign neoplasm of colon,neoplasms,OPGS014960,0.016,RNAseq,MYNN,0.97 (0.96 0.98),1.17E-05
208,Benign neoplasm of colon,neoplasms,OPGS005899,0.209,RNAseq,MSLN,0.97 (0.96 0.98),1.90E-04
208,Benign neoplasm of colon,neoplasms,OPGS012729,0.033,RNAseq,SREBF2,0.97 (0.96 0.98),4.04E-04
208,Benign neoplasm of colon,neoplasms,OPGS011800,0.044,RNAseq,SMAD6,1.03 (1.02 1.04),4.04E-04
208,Benign neoplasm of colon,neoplasms,OPGS004215,0.409,RNAseq,UGT2B17,0.98 (0.97 0.99),8.16E-04
208,Benign neoplasm of colon,neoplasms,OPGS011358,0.049,RNAseq,UTP23,0.98 (0.97 0.99),9.14E-04
208,Benign neoplasm of colon,neoplasms,OPGS009379,0.082,RNAseq,AC016876.2,0.98 (0.96 0.99),1.00E-03
208,Benign neoplasm of colon,neoplasms,OPGS003897,0.508,RNAseq,CASC8,1.02 (1.01 1.04),1.13E-03
208,Benign neoplasm of colon,neoplasms,OPGS007493,0.132,RNAseq,TXN2,1.02 (1.01 1.04),1.20E-03
208,Benign neoplasm of colon,neoplasms,OPGS007286,0.140,RNAseq,COX14,1.02 (1.01 1.04),1.83E-03
208,Benign neoplasm of colon,neoplasms,OPGS004449,0.363,RNAseq,CDC14A,0.98 (0.97 0.99),1.83E-03
208,Benign neoplasm of colon,neoplasms,OPGS007612,0.128,RNAseq,AC074032.1,0.98 (0.97 0.99),2.22E-03
208,Benign neoplasm of colon,neoplasms,OPGS009958,0.070,RNAseq,NID2,1.02 (1.01 1.03),2.39E-03
208,Benign neoplasm of colon,neoplasms,OPGS007359,0.137,RNAseq,ARPIN,0.98 (0.97 0.99),2.46E-03
208,Benign neoplasm of colon,neoplasms,OPGS011638,0.045,RNAseq,BRD3OS,1.02 (1.01 1.03),3.88E-03
208,Benign neoplasm of colon,neoplasms,OPGS014695,0.017,RNAseq,QPCTL,0.98 (0.97 0.99),4.17E-03
208,Benign neoplasm of colon,neoplasms,OPGS004458,0.361,RNAseq,ISG20,0.98 (0.97 0.99),5.04E-03
208,Benign neoplasm of colon,neoplasms,OPGS007682,0.126,RNAseq,AC016831.4,0.98 (0.97 0.99),5.67E-03
208,Benign neoplasm of colon,neoplasms,OPGS006131,0.196,RNAseq,MAPK3,0.98 (0.97 0.99),7.03E-03
208,Benign neoplasm of colon,neoplasms,OPGS013164,0.029,RNAseq,FSIP1,1.02 (1.01 1.03),8.80E-03
208,Benign neoplasm of colon,neoplasms,OPGS010420,0.062,RNAseq,ATP1B2,1.02 (1.01 1.03),9.14E-03
208,Benign neoplasm of colon,neoplasms,OPGS008423,0.103,RNAseq,MED6,1.02 (1.01 1.03),1.01E-02
208,Benign neoplasm of colon,neoplasms,OPGS013472,0.027,RNAseq,STAT1,0.98 (0.97 0.99),1.05E-02
208,Benign neoplasm of colon,neoplasms,OPGS012791,0.033,RNAseq,DLGAP1-AS2,1.02 (1.01 1.03),1.19E-02
208,Benign neoplasm of colon,neoplasms,OPGS007376,0.137,RNAseq,ZBTB7B,0.98 (0.97 0.99),1.27E-02
208,Benign neoplasm of colon,neoplasms,OPGS007838,0.120,RNAseq,KCNH3,1.02 (1.01 1.03),1.27E-02
208,Benign neoplasm of colon,neoplasms,OPGS011419,0.048,RNAseq,GOLGB1,0.98 (0.97 0.99),1.27E-02
208,Benign neoplasm of colon,neoplasms,OPGS009746,0.074,RNAseq,SPAST,1.02 (1.01 1.03),1.28E-02
208,Benign neoplasm of colon,neoplasms,OPGS011156,0.051,RNAseq,TMEM163,0.98 (0.97 0.99),1.30E-02
208,Benign neoplasm of colon,neoplasms,OPGS014419,0.020,RNAseq,SF3A1,0.98 (0.97 0.99),1.30E-02
208,Benign neoplasm of colon,neoplasms,OPGS004092,0.440,RNAseq,PLCH2,0.98 (0.97 0.99),1.49E-02
208,Benign neoplasm of colon,neoplasms,OPGS007636,0.128,RNAseq,LINC01409,0.98 (0.97 0.99),1.66E-02
208,Benign neoplasm of colon,neoplasms,OPGS006384,0.182,RNAseq,RCSD1,1.02 (1.01 1.03),1.82E-02
208,Benign neoplasm of colon,neoplasms,OPGS008192,0.109,RNAseq,PHF10,1.02 (1.01 1.03),2.16E-02
208,Benign neoplasm of colon,neoplasms,OPGS015069,0.015,RNAseq,GLUD1,1.02 (1.01 1.03),2.17E-02
208,Benign neoplasm of colon,neoplasms,OPGS010946,0.055,RNAseq,HELZ2,0.98 (0.97 0.99),2.17E-02
208,Benign neoplasm of colon,neoplasms,OPGS014684,0.018,RNAseq,TYMS,1.02 (1.01 1.03),2.33E-02
208,Benign neoplasm of colon,neoplasms,OPGS014093,0.022,RNAseq,MYBL1,0.98 (0.97 0.99),2.34E-02
208,Benign neoplasm of colon,neoplasms,OPGS010624,0.059,RNAseq,TRBV18,1.02 (1.01 1.03),2.43E-02
208,Benign neoplasm of colon,neoplasms,OPGS005929,0.207,RNAseq,MYRF,0.98 (0.97 0.99),2.45E-02
208,Benign neoplasm of colon,neoplasms,OPGS006990,0.152,RNAseq,NCALD,1.02 (1.01 1.03),2.55E-02
208,Benign neoplasm of colon,neoplasms,OPGS011137,0.052,RNAseq,USP28,0.98 (0.97 0.99),2.66E-02
208,Benign neoplasm of colon,neoplasms,OPGS008832,0.093,RNAseq,PFKFB2,1.02 (1.01 1.03),2.66E-02
208,Benign neoplasm of colon,neoplasms,OPGS008884,0.092,RNAseq,PLXNB2,1.02 (1.01 1.03),2.88E-02
208,Benign neoplasm of colon,neoplasms,OPGS012928,0.032,RNAseq,ATP1A1,0.98 (0.97 0.99),2.88E-02
208,Benign neoplasm of colon,neoplasms,OPGS004590,0.341,RNAseq,AGAP9,0.98 (0.97 0.99),3.15E-02
208,Benign neoplasm of colon,neoplasms,OPGS014023,0.022,RNAseq,LEFTY1,0.98 (0.97 0.99),3.19E-02
208,Benign neoplasm of colon,neoplasms,OPGS006695,0.166,RNAseq,DLL1,1.02 (1.01 1.03),3.69E-02
208,Benign neoplasm of colon,neoplasms,OPGS008738,0.095,RNAseq,STBD1,0.98 (0.97 0.99),4.01E-02
208,Benign neoplasm of colon,neoplasms,OPGS004955,0.291,RNAseq,DAP,0.98 (0.97 0.99),4.09E-02
208,Benign neoplasm of colon,neoplasms,OPGS007736,0.124,RNAseq,AEN,0.98 (0.97 0.99),4.44E-02
208,Benign neoplasm of colon,neoplasms,OPGS007026,0.151,RNAseq,,0.98 (0.97 0.99),4.55E-02
208,Benign neoplasm of colon,neoplasms,OPGS007466,0.133,RNAseq,GNAO1,1.02 (1.01 1.03),4.55E-02
208,Benign neoplasm of colon,neoplasms,OPGS006031,0.201,RNAseq,CCR1,1.02 (1.01 1.03),4.76E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS000252,0.192,SomaScan,Gastrokine-2,0.95 (0.93 0.96),3.19E-05
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS001102,0.046,SomaScan,Granzyme A,1.06 (1.04 1.08),9.83E-05
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS001137,0.043,SomaScan,Trefoil factor 1,0.95 (0.93 0.97),2.61E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,1.05 (1.03 1.07),4.64E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,0.96 (0.94 0.97),5.60E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS000572,0.102,SomaScan,Glutamate receptor 4,1.05 (1.03 1.07),6.45E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS001286,0.034,SomaScan,Granzyme K,1.05 (1.03 1.07),6.45E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,1.04 (1.02 1.07),1.38E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.04 (1.02 1.06),1.64E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,0.96 (0.94 0.98),1.76E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.04 (1.02 1.06),2.69E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,1.04 (1.02 1.06),2.72E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS002568,0.043,Olink,Granzyme A,1.06 (1.04 1.08),2.29E-05
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS006500,0.176,RNAseq,THBS3,1.07 (1.04 1.09),3.47E-06
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS007995,0.116,RNAseq,PPARG,0.94 (0.92 0.96),2.29E-05
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS009371,0.082,RNAseq,TRBV19,1.05 (1.03 1.07),3.76E-04
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS012171,0.039,RNAseq,TRBV15,0.95 (0.93 0.97),1.01E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS012093,0.040,RNAseq,TRIM26,0.95 (0.93 0.97),1.43E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS013514,0.026,RNAseq,GZMK,1.05 (1.03 1.07),2.13E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS013225,0.029,RNAseq,REG4,1.05 (1.03 1.07),4.64E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS015052,0.015,RNAseq,CISH,0.96 (0.94 0.97),4.98E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS003621,0.665,RNAseq,,1.05 (1.03 1.07),6.45E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS014443,0.019,RNAseq,ABCB1,1.05 (1.03 1.07),6.45E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS006565,0.172,RNAseq,ANKRA2,0.96 (0.94 0.98),6.45E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS007739,0.124,RNAseq,CAPS2,0.96 (0.94 0.98),8.81E-03
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS012587,0.035,RNAseq,COL5A1,1.05 (1.02 1.07),1.02E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS014232,0.021,RNAseq,TRAV1-2,1.04 (1.02 1.06),1.09E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS012006,0.041,RNAseq,VARS2,1.04 (1.02 1.07),1.09E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS006048,0.200,RNAseq,,1.04 (1.02 1.06),1.38E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS011338,0.049,RNAseq,MUC1,1.04 (1.02 1.06),1.38E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS005918,0.208,RNAseq,DDR1,1.04 (1.02 1.06),1.48E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS006974,0.153,RNAseq,MAP3K10,0.96 (0.94 0.98),1.64E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS013305,0.028,RNAseq,TRBV14,0.96 (0.94 0.98),1.98E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS007089,0.148,RNAseq,HLA-A,1.04 (1.02 1.06),2.03E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS011948,0.042,RNAseq,ADGRG1,0.96 (0.94 0.98),2.03E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS011420,0.048,RNAseq,MTX1,1.04 (1.02 1.06),2.04E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS012079,0.040,RNAseq,LANCL1,1.04 (1.02 1.06),3.43E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS010356,0.063,RNAseq,COPZ2,0.96 (0.94 0.98),4.31E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS007691,0.126,RNAseq,HLA-DRB1,0.96 (0.94 0.98),4.35E-02
211,Benign neoplasm of other parts of digestive system,neoplasms,OPGS014527,0.019,RNAseq,TAF6,0.96 (0.95 0.98),4.49E-02
216,Benign neoplasm of skin,neoplasms,OPGS001025,0.051,SomaScan,Transmembrane glycoprotein NMB,1.06 (1.04 1.07),3.90E-06
216,Benign neoplasm of skin,neoplasms,OPGS001634,0.021,SomaScan,Melanocyte protein PMEL,0.95 (0.93 0.97),5.01E-04
216,Benign neoplasm of skin,neoplasms,OPGS001011,0.052,SomaScan,Transmembrane glycoprotein NMB,1.04 (1.03 1.06),4.57E-03
216,Benign neoplasm of skin,neoplasms,OPGS014960,0.016,RNAseq,MYNN,0.94 (0.92 0.96),3.24E-06
216,Benign neoplasm of skin,neoplasms,OPGS006807,0.160,RNAseq,BNC2,0.94 (0.93 0.96),3.90E-06
216,Benign neoplasm of skin,neoplasms,OPGS010527,0.060,RNAseq,SPG7,0.95 (0.93 0.97),5.25E-05
216,Benign neoplasm of skin,neoplasms,OPGS007969,0.116,RNAseq,SPATA2L,1.05 (1.03 1.07),5.03E-03
218.1,Uterine leiomyoma,neoplasms,OPGS000734,0.080,SomaScan,KDEL motif-containing protein 2,0.94 (0.93 0.96),1.29E-09
218.1,Uterine leiomyoma,neoplasms,OPGS003114,0.018,Metabolon,1-myristoyl-2-linoleoyl-GPC (14:0/18:2)*,1.04 (1.02 1.06),1.37E-02
218.1,Uterine leiomyoma,neoplasms,OPGS003147,0.015,Metabolon,X - 24452,0.96 (0.95 0.98),4.70E-02
218.1,Uterine leiomyoma,neoplasms,OPGS010420,0.062,RNAseq,ATP1B2,1.06 (1.05 1.08),4.51E-09
218.1,Uterine leiomyoma,neoplasms,OPGS013276,0.028,RNAseq,ZNF346,1.05 (1.03 1.07),2.28E-05
218.1,Uterine leiomyoma,neoplasms,OPGS014960,0.016,RNAseq,MYNN,0.95 (0.93 0.97),2.96E-04
218.1,Uterine leiomyoma,neoplasms,OPGS004705,0.323,RNAseq,HEATR3,1.05 (1.03 1.07),1.86E-03
218.1,Uterine leiomyoma,neoplasms,OPGS012876,0.032,RNAseq,MRPS31,0.96 (0.94 0.97),2.96E-03
218.1,Uterine leiomyoma,neoplasms,OPGS015055,0.015,RNAseq,ZNF726,0.96 (0.94 0.98),7.15E-03
218.1,Uterine leiomyoma,neoplasms,OPGS009772,0.074,RNAseq,,1.04 (1.02 1.06),7.23E-03
218.1,Uterine leiomyoma,neoplasms,OPGS012484,0.036,RNAseq,ABCB9,0.96 (0.94 0.98),1.03E-02
218.1,Uterine leiomyoma,neoplasms,OPGS009289,0.084,RNAseq,AC010883.1,0.96 (0.94 0.98),1.37E-02
218.1,Uterine leiomyoma,neoplasms,OPGS005225,0.263,RNAseq,CDC42,1.04 (1.02 1.06),1.37E-02
218.1,Uterine leiomyoma,neoplasms,OPGS013762,0.024,RNAseq,CFH,1.04 (1.02 1.06),1.37E-02
218.1,Uterine leiomyoma,neoplasms,OPGS009214,0.085,RNAseq,FGFR4,1.04 (1.02 1.06),1.37E-02
218.1,Uterine leiomyoma,neoplasms,OPGS014482,0.019,RNAseq,SLC25A15,0.96 (0.94 0.98),1.64E-02
218.1,Uterine leiomyoma,neoplasms,OPGS007651,0.127,RNAseq,KMT5A,0.96 (0.94 0.98),1.64E-02
218.1,Uterine leiomyoma,neoplasms,OPGS015031,0.016,RNAseq,DDA1,0.96 (0.94 0.98),2.88E-02
220,Benign neoplasm of ovary,neoplasms,OPGS012665,0.034,RNAseq,DRG1,0.89 (0.85 0.93),1.62E-03
220,Benign neoplasm of ovary,neoplasms,OPGS004071,0.444,RNAseq,MTRF1L,1.13 (1.08 1.18),1.62E-03
223,Benign neoplasm of kidney and other urinary organs,neoplasms,OPGS009278,0.084,RNAseq,,0.75 (0.67 0.84),1.01E-02
227.2,Benign neoplasm of parathyroid gland,neoplasms,OPGS014614,0.018,RNAseq,HLX,1.25 (1.15 1.35),5.23E-04
227.3,Benign neoplasm of pituitary gland and craniopharyngeal duct (pouch),neoplasms,OPGS002140,0.011,SomaScan,Prolyl 4-hydroxylase subunit alpha-1,0.89 (0.86 0.94),2.00E-02
229,Benign neoplasm of unspecified sites,neoplasms,OPGS006807,0.160,RNAseq,BNC2,0.90 (0.86 0.93),9.14E-05
240,Simple and unspecified goiter,endocrine/metabolic,OPGS000913,0.061,SomaScan,Fibroblast growth factor 7,1.18 (1.10 1.26),4.50E-02
240,Simple and unspecified goiter,endocrine/metabolic,OPGS010108,0.067,RNAseq,TRMO,1.18 (1.11 1.27),2.13E-02
241.2,Nontoxic multinodular goiter,endocrine/metabolic,OPGS010108,0.067,RNAseq,TRMO,1.34 (1.26 1.43),3.70E-15
241.2,Nontoxic multinodular goiter,endocrine/metabolic,OPGS011966,0.042,RNAseq,FAM227B,0.74 (0.68 0.80),2.16E-09
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.81 (0.78 0.84),4.46E-21
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.80 (0.76 0.83),4.61E-21
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.82 (0.79 0.85),9.20E-21
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.82 (0.78 0.85),1.81E-20
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.82 (0.79 0.85),2.01E-20
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.83 (0.80 0.86),1.24E-18
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.83 (0.80 0.86),6.03E-18
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,1.20 (1.16 1.25),4.84E-16
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.84 (0.81 0.87),2.71E-15
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.18 (1.14 1.23),3.24E-14
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000576,0.102,SomaScan,Interleukin-21,0.85 (0.82 0.88),1.17E-13
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.17 (1.13 1.22),7.83E-13
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.85 (0.82 0.89),8.55E-13
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.18 (1.13 1.23),2.35E-12
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000290,0.171,SomaScan,Complement C4,0.86 (0.82 0.89),4.16E-11
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,0.87 (0.83 0.91),2.83E-09
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.87 (0.84 0.91),1.52E-08
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.15 (1.10 1.20),2.58E-08
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.88 (0.84 0.91),4.78E-08
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.87 (0.83 0.91),2.10E-07
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.13 (1.09 1.18),4.34E-07
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.13 (1.08 1.17),1.09E-06
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000390,0.141,SomaScan,Palmitoyl-protein thioesterase 1,1.13 (1.09 1.18),1.09E-06
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.89 (0.85 0.92),2.64E-06
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,0.89 (0.86 0.93),5.36E-06
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001883,0.015,SomaScan,UMP-CMP kinase,0.89 (0.85 0.93),2.34E-05
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,1.12 (1.07 1.16),2.81E-05
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001102,0.046,SomaScan,Granzyme A,0.90 (0.87 0.94),5.73E-05
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.11 (1.06 1.16),1.66E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000645,0.091,SomaScan,Trypsin-3,1.11 (1.06 1.15),4.32E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000391,0.141,SomaScan,T-cell surface glycoprotein CD3 epsilon chain,1.10 (1.05 1.14),1.59E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,0.91 (0.87 0.95),2.12E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,1.09 (1.05 1.14),2.50E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,0.92 (0.88 0.96),3.45E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.09 (1.05 1.13),3.61E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001553,0.024,SomaScan,Protein G6b,1.09 (1.04 1.14),7.18E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000531,0.111,SomaScan,Cadherin-7,1.09 (1.04 1.13),7.18E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001054,0.049,SomaScan,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,0.92 (0.89 0.96),1.52E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001022,0.052,SomaScan,Carbohydrate sulfotransferase 9,1.08 (1.04 1.12),2.19E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,1.08 (1.04 1.12),2.28E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,1.08 (1.04 1.12),2.30E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS000986,0.054,SomaScan,Solute carrier family 22 member 16,1.08 (1.04 1.13),2.35E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS001552,0.024,SomaScan,C-C motif chemokine 5,1.08 (1.03 1.12),3.77E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS002568,0.043,Olink,Granzyme A,0.85 (0.82 0.88),2.37E-13
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.87 (0.84 0.91),2.45E-09
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.88 (0.84 0.91),8.42E-08
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.91 (0.87 0.94),2.00E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS002581,0.038,Olink,Fractalkine,1.09 (1.05 1.13),2.91E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,0.92 (0.88 0.95),3.78E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS002428,0.212,Olink,Secreted frizzled-related protein 3,0.92 (0.89 0.96),1.54E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS002897,0.053,Metabolon,6-oxopiperidine-2-carboxylic acid,1.08 (1.04 1.12),5.28E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.25 (1.20 1.30),1.12E-25
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.81 (0.78 0.84),4.31E-23
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.23 (1.19 1.28),6.41E-23
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013225,0.029,RNAseq,REG4,0.83 (0.79 0.86),4.44E-18
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.83 (0.80 0.86),4.44E-18
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010693,0.058,RNAseq,TRBV5-1,1.21 (1.16 1.25),7.31E-18
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS004406,0.369,RNAseq,,0.83 (0.79 0.86),1.38E-16
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.20 (1.15 1.25),1.38E-16
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010826,0.056,RNAseq,TRIM10,0.84 (0.81 0.87),1.38E-16
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS005230,0.263,RNAseq,LINC00243,1.20 (1.16 1.25),2.97E-16
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS011784,0.044,RNAseq,TUBB,1.22 (1.16 1.27),2.97E-16
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS009371,0.082,RNAseq,TRBV19,0.83 (0.80 0.86),9.25E-16
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS014496,0.019,RNAseq,VARS1,1.18 (1.14 1.23),9.65E-16
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013045,0.030,RNAseq,NEU1,0.84 (0.81 0.87),1.50E-15
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS011283,0.050,RNAseq,CD248,0.84 (0.81 0.88),3.04E-14
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS012006,0.041,RNAseq,VARS2,0.84 (0.81 0.88),3.07E-14
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS014283,0.021,RNAseq,MXRA8,0.84 (0.80 0.87),3.37E-14
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS003680,0.611,RNAseq,,1.17 (1.13 1.22),7.45E-14
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS009865,0.072,RNAseq,TRAV17,0.85 (0.82 0.88),7.57E-14
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013013,0.031,RNAseq,FOXJ1,0.86 (0.83 0.89),7.50E-13
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS006866,0.157,RNAseq,AL662795.2,1.19 (1.14 1.24),7.50E-13
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS006248,0.189,RNAseq,MCCD1,0.85 (0.82 0.89),8.42E-12
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS012093,0.040,RNAseq,TRIM26,1.17 (1.12 1.22),3.63E-11
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS012358,0.037,RNAseq,SFRP5,0.86 (0.82 0.89),7.62E-11
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS005334,0.253,RNAseq,AL645933.4,0.86 (0.83 0.89),7.88E-11
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS007018,0.151,RNAseq,TRBV10-3,1.17 (1.12 1.22),1.15E-10
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS009198,0.085,RNAseq,TRAV12-1,1.16 (1.11 1.21),2.34E-10
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS007407,0.135,RNAseq,TRBV2,1.15 (1.11 1.20),1.59E-09
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS011787,0.044,RNAseq,C2,1.15 (1.11 1.20),2.47E-09
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS003843,0.532,RNAseq,BTN3A2,0.88 (0.84 0.91),2.69E-09
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS004334,0.383,RNAseq,HLA-G,0.87 (0.83 0.90),2.83E-09
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS015030,0.016,RNAseq,PRRC2A,0.87 (0.83 0.90),2.83E-09
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS006942,0.154,RNAseq,SKIV2L,0.86 (0.83 0.90),4.34E-09
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS004489,0.357,RNAseq,,0.87 (0.83 0.90),4.68E-09
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010607,0.059,RNAseq,TRAV8-1,1.14 (1.10 1.19),1.21E-08
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS007248,0.141,RNAseq,,0.86 (0.82 0.90),1.52E-08
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS007297,0.140,RNAseq,GPANK1,0.86 (0.82 0.90),2.16E-08
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS009222,0.085,RNAseq,,0.88 (0.85 0.92),1.54E-07
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013699,0.025,RNAseq,TRAV5,0.88 (0.84 0.92),2.43E-07
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS009920,0.071,RNAseq,LINC02446,0.88 (0.85 0.92),4.61E-07
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010564,0.060,RNAseq,CEACAM6,0.89 (0.85 0.92),1.22E-06
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS007089,0.148,RNAseq,HLA-A,0.88 (0.84 0.92),1.28E-06
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS003621,0.665,RNAseq,,0.89 (0.85 0.93),4.76E-06
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS014443,0.019,RNAseq,ABCB1,0.89 (0.85 0.93),5.97E-06
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013201,0.029,RNAseq,NRCAM,0.89 (0.85 0.93),1.28E-05
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS006048,0.200,RNAseq,,0.89 (0.85 0.93),2.23E-05
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013514,0.026,RNAseq,GZMK,0.90 (0.86 0.93),2.34E-05
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013780,0.024,RNAseq,ZSCAN16,1.11 (1.07 1.15),3.34E-05
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013896,0.023,RNAseq,ATF6B,1.11 (1.07 1.16),1.13E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS014232,0.021,RNAseq,TRAV1-2,0.90 (0.87 0.94),1.66E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS012271,0.038,RNAseq,TRBV5-6,0.92 (0.89 0.95),1.73E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010348,0.063,RNAseq,TRBV6-5,0.90 (0.87 0.94),1.79E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS007063,0.150,RNAseq,CEP170,1.10 (1.06 1.15),1.79E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS015052,0.015,RNAseq,CISH,1.11 (1.06 1.15),2.27E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS007145,0.146,RNAseq,BAG6,1.10 (1.06 1.15),2.27E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS011536,0.047,RNAseq,TRAV2,0.90 (0.87 0.94),2.86E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013406,0.027,RNAseq,AL353759.1,1.11 (1.06 1.16),2.95E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS009464,0.080,RNAseq,CTLA4,0.91 (0.87 0.94),3.28E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS005918,0.208,RNAseq,DDR1,0.90 (0.87 0.94),5.01E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS011472,0.047,RNAseq,FEZ1,0.91 (0.87 0.95),5.17E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS007604,0.128,RNAseq,U91328.1,1.10 (1.06 1.15),5.19E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010561,0.060,RNAseq,IL2RA,1.10 (1.06 1.14),5.70E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS008383,0.104,RNAseq,CD160,0.91 (0.87 0.95),6.08E-04
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS012855,0.032,RNAseq,TRBV9,1.10 (1.05 1.14),1.02E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS011010,0.054,RNAseq,TRBV5-4,1.10 (1.06 1.15),1.02E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010929,0.055,RNAseq,EOMES,0.91 (0.87 0.95),1.16E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013068,0.030,RNAseq,AL021807.1,1.09 (1.05 1.14),1.21E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010142,0.067,RNAseq,PRSS16,1.09 (1.05 1.13),1.63E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS014680,0.018,RNAseq,GALE,0.92 (0.88 0.95),1.85E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS014758,0.017,RNAseq,TRAV10,0.92 (0.89 0.95),1.90E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013958,0.023,RNAseq,CSNK2B,1.10 (1.05 1.14),1.96E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS008073,0.114,RNAseq,,1.10 (1.05 1.15),2.91E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS011073,0.053,RNAseq,TRBV7-3,1.10 (1.05 1.14),3.97E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010965,0.054,RNAseq,H4C12,0.91 (0.87 0.95),4.60E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS011853,0.043,RNAseq,TRBV6-1,0.92 (0.88 0.96),5.45E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS003928,0.495,RNAseq,RNASET2,0.92 (0.88 0.96),6.69E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013241,0.029,RNAseq,SYTL3,0.94 (0.91 0.97),7.00E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS006457,0.178,RNAseq,MAF1,0.93 (0.89 0.96),7.43E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010779,0.057,RNAseq,ACE,1.09 (1.04 1.13),7.89E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS007764,0.123,RNAseq,HLA-E,1.09 (1.04 1.13),7.93E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS011108,0.052,RNAseq,LDLR,0.92 (0.88 0.96),8.47E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS011005,0.054,RNAseq,SLC1A5,1.08 (1.04 1.12),8.48E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS011674,0.045,RNAseq,PRSS23,0.92 (0.89 0.96),9.56E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS006861,0.157,RNAseq,ANXA1,1.08 (1.04 1.13),9.91E-03
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS008520,0.101,RNAseq,GNA15,0.92 (0.88 0.96),1.26E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS015004,0.016,RNAseq,MRPL15,0.94 (0.91 0.97),1.58E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS006911,0.155,RNAseq,RPS6KA2,0.92 (0.89 0.96),1.76E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS009144,0.087,RNAseq,ZFP64,1.08 (1.04 1.13),1.86E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS009241,0.084,RNAseq,ZKSCAN4,1.08 (1.03 1.12),2.59E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS012636,0.034,RNAseq,KIR2DL3,1.08 (1.03 1.12),2.61E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS007691,0.126,RNAseq,HLA-DRB1,1.08 (1.04 1.12),2.73E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS003620,0.668,RNAseq,ZFP57,1.08 (1.03 1.12),2.76E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS006986,0.152,RNAseq,H4C8,1.08 (1.03 1.12),3.04E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010475,0.061,RNAseq,ZNRD1,0.93 (0.89 0.97),3.47E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010212,0.066,RNAseq,PSMB9,1.07 (1.03 1.12),3.51E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS013826,0.024,RNAseq,MLLT10,1.06 (1.03 1.10),3.51E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010802,0.057,RNAseq,TMBIM6,0.93 (0.89 0.97),3.75E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS010492,0.061,RNAseq,HCG18,0.93 (0.89 0.97),3.75E-02
242,Thyrotoxicosis with or without goiter,endocrine/metabolic,OPGS003873,0.519,RNAseq,IQCB1,0.93 (0.89 0.97),3.93E-02
242.1,Graves' disease,endocrine/metabolic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.65 (0.60 0.71),1.12E-20
242.1,Graves' disease,endocrine/metabolic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.69 (0.64 0.74),6.31E-20
242.1,Graves' disease,endocrine/metabolic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.42 (1.32 1.52),2.76E-19
242.1,Graves' disease,endocrine/metabolic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.72 (0.67 0.77),2.76E-17
242.1,Graves' disease,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.72 (0.68 0.78),3.36E-17
242.1,Graves' disease,endocrine/metabolic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.72 (0.68 0.78),3.36E-17
242.1,Graves' disease,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.73 (0.68 0.78),4.22E-17
242.1,Graves' disease,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.72 (0.67 0.78),1.45E-15
242.1,Graves' disease,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.37 (1.27 1.47),1.45E-14
242.1,Graves' disease,endocrine/metabolic,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,0.75 (0.69 0.80),1.22E-11
242.1,Graves' disease,endocrine/metabolic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.76 (0.71 0.82),3.97E-11
242.1,Graves' disease,endocrine/metabolic,OPGS000576,0.102,SomaScan,Interleukin-21,0.77 (0.72 0.83),7.97E-11
242.1,Graves' disease,endocrine/metabolic,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,0.77 (0.71 0.82),1.14E-10
242.1,Graves' disease,endocrine/metabolic,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.31 (1.21 1.40),1.91E-10
242.1,Graves' disease,endocrine/metabolic,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,1.32 (1.22 1.42),6.46E-10
242.1,Graves' disease,endocrine/metabolic,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.77 (0.71 0.82),1.00E-09
242.1,Graves' disease,endocrine/metabolic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.29 (1.20 1.39),4.87E-09
242.1,Graves' disease,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.33 (1.22 1.44),5.54E-09
242.1,Graves' disease,endocrine/metabolic,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.78 (0.72 0.84),7.50E-09
242.1,Graves' disease,endocrine/metabolic,OPGS000290,0.171,SomaScan,Complement C4,0.77 (0.72 0.83),1.57E-08
242.1,Graves' disease,endocrine/metabolic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.28 (1.19 1.38),2.75E-08
242.1,Graves' disease,endocrine/metabolic,OPGS001883,0.015,SomaScan,UMP-CMP kinase,0.75 (0.69 0.82),4.61E-08
242.1,Graves' disease,endocrine/metabolic,OPGS001102,0.046,SomaScan,Granzyme A,0.79 (0.74 0.85),1.08E-07
242.1,Graves' disease,endocrine/metabolic,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.78 (0.72 0.84),1.12E-07
242.1,Graves' disease,endocrine/metabolic,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.26 (1.16 1.36),3.01E-06
242.1,Graves' disease,endocrine/metabolic,OPGS000645,0.091,SomaScan,Trypsin-3,1.24 (1.15 1.35),2.45E-05
242.1,Graves' disease,endocrine/metabolic,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,1.22 (1.13 1.31),2.69E-05
242.1,Graves' disease,endocrine/metabolic,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,0.78 (0.71 0.86),6.43E-05
242.1,Graves' disease,endocrine/metabolic,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,1.22 (1.13 1.32),1.16E-04
242.1,Graves' disease,endocrine/metabolic,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.83 (0.77 0.89),2.18E-04
242.1,Graves' disease,endocrine/metabolic,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,1.20 (1.11 1.29),5.50E-04
242.1,Graves' disease,endocrine/metabolic,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.82 (0.75 0.89),1.02E-03
242.1,Graves' disease,endocrine/metabolic,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,0.85 (0.79 0.91),1.85E-03
242.1,Graves' disease,endocrine/metabolic,OPGS001236,0.037,SomaScan,Calcipressin-1,0.88 (0.81 0.94),3.74E-02
242.1,Graves' disease,endocrine/metabolic,OPGS002568,0.043,Olink,Granzyme A,0.74 (0.69 0.79),9.47E-14
242.1,Graves' disease,endocrine/metabolic,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.78 (0.73 0.85),5.80E-08
242.1,Graves' disease,endocrine/metabolic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.81 (0.75 0.87),2.88E-06
242.1,Graves' disease,endocrine/metabolic,OPGS002428,0.212,Olink,Secreted frizzled-related protein 3,0.84 (0.78 0.91),2.34E-03
242.1,Graves' disease,endocrine/metabolic,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.87 (0.80 0.93),1.66E-02
242.1,Graves' disease,endocrine/metabolic,OPGS002439,0.184,Olink,Interleukin-5 receptor subunit alpha,0.86 (0.80 0.93),1.99E-02
242.1,Graves' disease,endocrine/metabolic,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,0.87 (0.80 0.94),4.60E-02
242.1,Graves' disease,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.70 (0.66 0.75),1.60E-21
242.1,Graves' disease,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.44 (1.35 1.55),8.72E-21
242.1,Graves' disease,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.43 (1.33 1.53),2.61E-20
242.1,Graves' disease,endocrine/metabolic,OPGS013045,0.030,RNAseq,NEU1,0.71 (0.66 0.76),3.31E-19
242.1,Graves' disease,endocrine/metabolic,OPGS014496,0.019,RNAseq,VARS1,1.38 (1.29 1.47),5.37E-19
242.1,Graves' disease,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.39 (1.29 1.49),8.40E-16
242.1,Graves' disease,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.73 (0.68 0.79),9.39E-15
242.1,Graves' disease,endocrine/metabolic,OPGS004406,0.369,RNAseq,,0.71 (0.66 0.77),1.07E-14
242.1,Graves' disease,endocrine/metabolic,OPGS010693,0.058,RNAseq,TRBV5-1,1.36 (1.27 1.47),1.29E-14
242.1,Graves' disease,endocrine/metabolic,OPGS005230,0.263,RNAseq,LINC00243,1.39 (1.29 1.49),1.45E-14
242.1,Graves' disease,endocrine/metabolic,OPGS010826,0.056,RNAseq,TRIM10,0.75 (0.70 0.81),8.84E-14
242.1,Graves' disease,endocrine/metabolic,OPGS015030,0.016,RNAseq,PRRC2A,0.73 (0.67 0.79),4.24E-13
242.1,Graves' disease,endocrine/metabolic,OPGS012006,0.041,RNAseq,VARS2,0.75 (0.70 0.80),9.02E-13
242.1,Graves' disease,endocrine/metabolic,OPGS007297,0.140,RNAseq,GPANK1,0.69 (0.63 0.76),2.42E-12
242.1,Graves' disease,endocrine/metabolic,OPGS013225,0.029,RNAseq,REG4,0.75 (0.70 0.81),8.65E-12
242.1,Graves' disease,endocrine/metabolic,OPGS013699,0.025,RNAseq,TRAV5,0.74 (0.68 0.80),1.25E-11
242.1,Graves' disease,endocrine/metabolic,OPGS006248,0.189,RNAseq,MCCD1,0.75 (0.70 0.81),2.55E-11
242.1,Graves' disease,endocrine/metabolic,OPGS003680,0.611,RNAseq,,1.28 (1.20 1.37),2.01E-10
242.1,Graves' disease,endocrine/metabolic,OPGS011787,0.044,RNAseq,C2,1.30 (1.21 1.40),4.98E-10
242.1,Graves' disease,endocrine/metabolic,OPGS012093,0.040,RNAseq,TRIM26,1.31 (1.22 1.41),5.16E-10
242.1,Graves' disease,endocrine/metabolic,OPGS011784,0.044,RNAseq,TUBB,1.33 (1.23 1.44),6.42E-10
242.1,Graves' disease,endocrine/metabolic,OPGS003621,0.665,RNAseq,,0.76 (0.71 0.82),2.04E-09
242.1,Graves' disease,endocrine/metabolic,OPGS009371,0.082,RNAseq,TRBV19,0.76 (0.71 0.83),5.54E-09
242.1,Graves' disease,endocrine/metabolic,OPGS011283,0.050,RNAseq,CD248,0.77 (0.72 0.83),5.97E-09
242.1,Graves' disease,endocrine/metabolic,OPGS014283,0.021,RNAseq,MXRA8,0.76 (0.70 0.83),7.36E-09
242.1,Graves' disease,endocrine/metabolic,OPGS005334,0.253,RNAseq,AL645933.4,0.78 (0.72 0.84),8.83E-09
242.1,Graves' disease,endocrine/metabolic,OPGS006866,0.157,RNAseq,AL662795.2,1.31 (1.21 1.41),9.75E-09
242.1,Graves' disease,endocrine/metabolic,OPGS007407,0.135,RNAseq,TRBV2,1.28 (1.19 1.37),9.93E-09
242.1,Graves' disease,endocrine/metabolic,OPGS009865,0.072,RNAseq,TRAV17,0.79 (0.73 0.84),1.01E-08
242.1,Graves' disease,endocrine/metabolic,OPGS012358,0.037,RNAseq,SFRP5,0.77 (0.71 0.83),1.83E-08
242.1,Graves' disease,endocrine/metabolic,OPGS006048,0.200,RNAseq,,0.77 (0.71 0.84),1.67E-07
242.1,Graves' disease,endocrine/metabolic,OPGS007248,0.141,RNAseq,,0.76 (0.69 0.83),2.43E-07
242.1,Graves' disease,endocrine/metabolic,OPGS013514,0.026,RNAseq,GZMK,0.79 (0.73 0.85),3.86E-07
242.1,Graves' disease,endocrine/metabolic,OPGS004489,0.357,RNAseq,,0.78 (0.72 0.85),3.86E-07
242.1,Graves' disease,endocrine/metabolic,OPGS015052,0.015,RNAseq,CISH,1.27 (1.17 1.37),7.65E-07
242.1,Graves' disease,endocrine/metabolic,OPGS013201,0.029,RNAseq,NRCAM,0.78 (0.72 0.85),1.36E-06
242.1,Graves' disease,endocrine/metabolic,OPGS007018,0.151,RNAseq,TRBV10-3,1.27 (1.17 1.38),1.50E-06
242.1,Graves' disease,endocrine/metabolic,OPGS014232,0.021,RNAseq,TRAV1-2,0.80 (0.74 0.86),2.20E-06
242.1,Graves' disease,endocrine/metabolic,OPGS013013,0.031,RNAseq,FOXJ1,0.82 (0.77 0.88),2.20E-06
242.1,Graves' disease,endocrine/metabolic,OPGS010607,0.059,RNAseq,TRAV8-1,1.23 (1.14 1.32),9.13E-06
242.1,Graves' disease,endocrine/metabolic,OPGS010348,0.063,RNAseq,TRBV6-5,0.81 (0.75 0.88),1.82E-05
242.1,Graves' disease,endocrine/metabolic,OPGS013896,0.023,RNAseq,ATF6B,1.22 (1.13 1.32),3.54E-05
242.1,Graves' disease,endocrine/metabolic,OPGS012271,0.038,RNAseq,TRBV5-6,0.87 (0.82 0.91),4.49E-05
242.1,Graves' disease,endocrine/metabolic,OPGS013958,0.023,RNAseq,CSNK2B,1.24 (1.14 1.34),4.64E-05
242.1,Graves' disease,endocrine/metabolic,OPGS006942,0.154,RNAseq,SKIV2L,0.81 (0.75 0.88),7.08E-05
242.1,Graves' disease,endocrine/metabolic,OPGS009222,0.085,RNAseq,,0.84 (0.78 0.90),2.20E-04
242.1,Graves' disease,endocrine/metabolic,OPGS008402,0.104,RNAseq,TNXB,0.83 (0.76 0.90),5.50E-04
242.1,Graves' disease,endocrine/metabolic,OPGS003620,0.668,RNAseq,ZFP57,1.18 (1.10 1.27),8.13E-04
242.1,Graves' disease,endocrine/metabolic,OPGS014758,0.017,RNAseq,TRAV10,0.86 (0.81 0.92),1.02E-03
242.1,Graves' disease,endocrine/metabolic,OPGS004956,0.291,RNAseq,,1.20 (1.11 1.30),1.02E-03
242.1,Graves' disease,endocrine/metabolic,OPGS010475,0.061,RNAseq,ZNRD1,0.84 (0.78 0.91),1.29E-03
242.1,Graves' disease,endocrine/metabolic,OPGS007691,0.126,RNAseq,HLA-DRB1,1.18 (1.10 1.28),1.31E-03
242.1,Graves' disease,endocrine/metabolic,OPGS006370,0.183,RNAseq,NELL2,0.86 (0.80 0.92),1.96E-03
242.1,Graves' disease,endocrine/metabolic,OPGS009198,0.085,RNAseq,TRAV12-1,1.18 (1.10 1.28),2.28E-03
242.1,Graves' disease,endocrine/metabolic,OPGS014443,0.019,RNAseq,ABCB1,0.84 (0.78 0.91),2.30E-03
242.1,Graves' disease,endocrine/metabolic,OPGS011010,0.054,RNAseq,TRBV5-4,1.19 (1.10 1.28),2.93E-03
242.1,Graves' disease,endocrine/metabolic,OPGS013298,0.028,RNAseq,IL7R,0.84 (0.78 0.91),3.00E-03
242.1,Graves' disease,endocrine/metabolic,OPGS010277,0.065,RNAseq,CXCR6,0.85 (0.79 0.92),3.83E-03
242.1,Graves' disease,endocrine/metabolic,OPGS010564,0.060,RNAseq,CEACAM6,0.85 (0.79 0.92),4.95E-03
242.1,Graves' disease,endocrine/metabolic,OPGS004334,0.383,RNAseq,HLA-G,0.85 (0.79 0.92),5.76E-03
242.1,Graves' disease,endocrine/metabolic,OPGS010929,0.055,RNAseq,EOMES,0.85 (0.79 0.92),5.76E-03
242.1,Graves' disease,endocrine/metabolic,OPGS011005,0.054,RNAseq,SLC1A5,1.15 (1.08 1.24),6.69E-03
242.1,Graves' disease,endocrine/metabolic,OPGS005918,0.208,RNAseq,DDR1,0.85 (0.78 0.92),7.28E-03
242.1,Graves' disease,endocrine/metabolic,OPGS009015,0.090,RNAseq,SMIM10L1,0.87 (0.81 0.93),8.73E-03
242.1,Graves' disease,endocrine/metabolic,OPGS011265,0.050,RNAseq,HSPA5,0.87 (0.81 0.93),1.35E-02
242.1,Graves' disease,endocrine/metabolic,OPGS004122,0.430,RNAseq,HLA-DRB5,0.86 (0.79 0.93),1.76E-02
242.1,Graves' disease,endocrine/metabolic,OPGS005433,0.244,RNAseq,MICB,1.17 (1.08 1.27),1.77E-02
242.1,Graves' disease,endocrine/metabolic,OPGS004705,0.323,RNAseq,HEATR3,0.87 (0.81 0.93),1.89E-02
242.1,Graves' disease,endocrine/metabolic,OPGS007145,0.146,RNAseq,BAG6,1.15 (1.07 1.24),2.08E-02
242.1,Graves' disease,endocrine/metabolic,OPGS014580,0.018,RNAseq,DACT1,1.17 (1.08 1.26),2.26E-02
242.1,Graves' disease,endocrine/metabolic,OPGS007089,0.148,RNAseq,HLA-A,0.86 (0.79 0.93),2.35E-02
242.1,Graves' disease,endocrine/metabolic,OPGS012855,0.032,RNAseq,TRBV9,1.15 (1.07 1.24),2.38E-02
242.1,Graves' disease,endocrine/metabolic,OPGS009626,0.076,RNAseq,APBA2,0.86 (0.79 0.93),2.75E-02
242.1,Graves' disease,endocrine/metabolic,OPGS013437,0.027,RNAseq,TRAV29DV5,1.14 (1.06 1.23),3.03E-02
242.1,Graves' disease,endocrine/metabolic,OPGS009920,0.071,RNAseq,LINC02446,0.87 (0.81 0.94),3.20E-02
242.1,Graves' disease,endocrine/metabolic,OPGS006320,0.185,RNAseq,CEP128,0.87 (0.81 0.94),3.29E-02
242.1,Graves' disease,endocrine/metabolic,OPGS003643,0.644,RNAseq,SEPTIN2,0.86 (0.80 0.94),3.78E-02
242.1,Graves' disease,endocrine/metabolic,OPGS010561,0.060,RNAseq,IL2RA,1.15 (1.06 1.23),3.80E-02
242.1,Graves' disease,endocrine/metabolic,OPGS011472,0.047,RNAseq,FEZ1,0.87 (0.81 0.94),4.04E-02
242.1,Graves' disease,endocrine/metabolic,OPGS003650,0.639,RNAseq,CHST13,0.88 (0.81 0.94),4.60E-02
242.3,Exophthalmos,endocrine/metabolic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.45 (1.26 1.66),5.21E-04
242.3,Exophthalmos,endocrine/metabolic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.66 (0.56 0.78),1.70E-03
242.3,Exophthalmos,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.72 (0.63 0.83),3.29E-03
242.3,Exophthalmos,endocrine/metabolic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.70 (0.61 0.81),3.38E-03
242.3,Exophthalmos,endocrine/metabolic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.73 (0.64 0.84),8.46E-03
242.3,Exophthalmos,endocrine/metabolic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.73 (0.64 0.84),1.01E-02
242.3,Exophthalmos,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.73 (0.63 0.84),1.72E-02
242.3,Exophthalmos,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.74 (0.65 0.85),1.87E-02
242.3,Exophthalmos,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.36 (1.18 1.57),2.14E-02
242.3,Exophthalmos,endocrine/metabolic,OPGS000290,0.171,SomaScan,Complement C4,0.72 (0.62 0.84),2.57E-02
242.3,Exophthalmos,endocrine/metabolic,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,0.73 (0.63 0.85),2.57E-02
242.3,Exophthalmos,endocrine/metabolic,OPGS002568,0.043,Olink,Granzyme A,0.74 (0.64 0.85),2.42E-02
242.3,Exophthalmos,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.54 (1.34 1.77),1.28E-05
242.3,Exophthalmos,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.69 (0.60 0.78),1.28E-04
242.3,Exophthalmos,endocrine/metabolic,OPGS013045,0.030,RNAseq,NEU1,0.68 (0.60 0.78),2.82E-04
242.3,Exophthalmos,endocrine/metabolic,OPGS013201,0.029,RNAseq,NRCAM,0.62 (0.52 0.74),6.76E-04
242.3,Exophthalmos,endocrine/metabolic,OPGS010693,0.058,RNAseq,TRBV5-1,1.43 (1.24 1.65),1.45E-03
242.3,Exophthalmos,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.41 (1.23 1.62),1.90E-03
242.3,Exophthalmos,endocrine/metabolic,OPGS014496,0.019,RNAseq,VARS1,1.37 (1.20 1.56),3.38E-03
242.3,Exophthalmos,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.41 (1.22 1.63),3.38E-03
242.3,Exophthalmos,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.73 (0.64 0.84),1.55E-02
242.3,Exophthalmos,endocrine/metabolic,OPGS004406,0.369,RNAseq,,0.71 (0.61 0.83),1.72E-02
242.3,Exophthalmos,endocrine/metabolic,OPGS007407,0.135,RNAseq,TRBV2,1.35 (1.17 1.56),2.25E-02
242.3,Exophthalmos,endocrine/metabolic,OPGS007297,0.140,RNAseq,GPANK1,0.69 (0.57 0.83),3.88E-02
242.3,Exophthalmos,endocrine/metabolic,OPGS015030,0.016,RNAseq,PRRC2A,0.73 (0.63 0.85),3.88E-02
242.3,Exophthalmos,endocrine/metabolic,OPGS007691,0.126,RNAseq,HLA-DRB1,1.33 (1.15 1.54),4.95E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.88 (0.84 0.92),3.68E-05
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.88 (0.84 0.92),4.28E-05
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.87 (0.83 0.92),4.28E-05
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.89 (0.85 0.93),1.36E-04
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,1.13 (1.08 1.18),2.06E-04
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.89 (0.85 0.93),2.55E-04
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.90 (0.86 0.94),5.70E-04
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.90 (0.86 0.94),1.25E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.90 (0.86 0.94),1.64E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.89 (0.85 0.94),2.47E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.91 (0.87 0.95),1.13E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.10 (1.05 1.16),1.40E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.09 (1.05 1.14),2.13E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.92 (0.88 0.96),2.35E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS000576,0.102,SomaScan,Interleukin-21,0.92 (0.88 0.96),3.50E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.92 (0.88 0.96),4.02E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS000290,0.171,SomaScan,Complement C4,0.92 (0.88 0.96),4.15E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS002568,0.043,Olink,Granzyme A,0.90 (0.86 0.94),2.44E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.91 (0.87 0.95),6.53E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS014283,0.021,RNAseq,MXRA8,0.87 (0.83 0.91),8.27E-06
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.14 (1.09 1.19),4.15E-05
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS010693,0.058,RNAseq,TRBV5-1,1.13 (1.08 1.18),4.78E-05
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.88 (0.85 0.92),7.70E-05
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS013225,0.029,RNAseq,REG4,0.89 (0.85 0.93),2.59E-04
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS007018,0.151,RNAseq,TRBV10-3,1.13 (1.08 1.19),2.59E-04
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS005230,0.263,RNAseq,LINC00243,1.13 (1.08 1.18),2.69E-04
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.12 (1.07 1.17),4.35E-04
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.90 (0.86 0.94),7.14E-04
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS012358,0.037,RNAseq,SFRP5,0.89 (0.85 0.94),9.05E-04
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS011283,0.050,RNAseq,CD248,0.90 (0.86 0.94),9.05E-04
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS009371,0.082,RNAseq,TRBV19,0.90 (0.86 0.94),1.83E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS005334,0.253,RNAseq,AL645933.4,0.90 (0.86 0.94),1.94E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS006866,0.157,RNAseq,AL662795.2,1.11 (1.06 1.17),2.12E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS010348,0.063,RNAseq,TRBV6-5,0.90 (0.86 0.94),2.27E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS013045,0.030,RNAseq,NEU1,0.90 (0.86 0.94),2.47E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS011010,0.054,RNAseq,TRBV5-4,1.11 (1.06 1.16),3.42E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS011787,0.044,RNAseq,C2,1.10 (1.06 1.15),5.54E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS006942,0.154,RNAseq,SKIV2L,0.90 (0.86 0.94),5.97E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS013201,0.029,RNAseq,NRCAM,0.90 (0.86 0.95),9.97E-03
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS007407,0.135,RNAseq,TRBV2,1.10 (1.05 1.15),1.03E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS012006,0.041,RNAseq,VARS2,0.91 (0.87 0.95),1.08E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS009367,0.082,RNAseq,AC021016.3,0.91 (0.87 0.95),1.13E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.10 (1.05 1.15),1.23E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS011784,0.044,RNAseq,TUBB,1.10 (1.05 1.15),1.42E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS014953,0.016,RNAseq,AC010680.4,0.91 (0.87 0.95),1.75E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS004489,0.357,RNAseq,,0.91 (0.87 0.95),1.90E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS013699,0.025,RNAseq,TRAV5,0.91 (0.87 0.95),2.15E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS006248,0.189,RNAseq,MCCD1,0.91 (0.87 0.96),2.35E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS004406,0.369,RNAseq,,0.91 (0.87 0.95),2.35E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS012855,0.032,RNAseq,TRBV9,1.09 (1.05 1.14),2.38E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS014496,0.019,RNAseq,VARS1,1.09 (1.04 1.14),3.63E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS003680,0.611,RNAseq,,1.09 (1.04 1.13),4.15E-02
244.1,Secondary hypothyroidism,endocrine/metabolic,OPGS010724,0.058,RNAseq,TIPRL,1.10 (1.04 1.15),4.15E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,1.13 (1.12 1.15),3.92E-68
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.12 (1.11 1.14),1.17E-62
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.90 (0.89 0.92),2.84E-43
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001464,0.027,SomaScan,Platelet glycoprotein Ib alpha chain,1.09 (1.08 1.11),5.75E-38
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.92 (0.90 0.93),8.51E-37
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.09 (1.08 1.11),7.53E-35
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.92 (0.91 0.94),3.30E-28
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.08 (1.07 1.09),1.23E-27
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.08 (1.07 1.09),3.28E-27
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.93 (0.92 0.94),5.42E-24
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001377,0.030,SomaScan,Vascular cell adhesion protein 1,1.07 (1.06 1.09),3.80E-23
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000517,0.114,SomaScan,Advanced glycosylation end product-specific receptor. soluble,0.93 (0.92 0.95),3.07E-22
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.07 (1.06 1.09),5.21E-22
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000576,0.102,SomaScan,Interleukin-21,0.93 (0.92 0.95),9.65E-22
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000846,0.068,SomaScan,2-phosphoxylose phosphatase 1,1.07 (1.06 1.08),8.06E-21
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.94 (0.92 0.95),1.03E-20
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,0.93 (0.92 0.95),5.67E-20
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000137,0.312,SomaScan,Complement C4b,0.94 (0.92 0.95),1.84E-19
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000290,0.171,SomaScan,Complement C4,0.94 (0.93 0.95),2.39E-17
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.06 (1.05 1.08),1.22E-15
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001231,0.037,SomaScan,Osteocalcin,1.06 (1.04 1.07),1.03E-14
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000645,0.091,SomaScan,Trypsin-3,0.95 (0.94 0.96),4.66E-13
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000538,0.109,SomaScan,Cyclic AMP-responsive element-binding protein 3-like protein 4,1.05 (1.04 1.07),1.06E-12
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000069,0.437,SomaScan,Leukocyte immunoglobulin-like receptor subfamily B member 1,1.06 (1.04 1.07),3.12E-12
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.05 (1.04 1.07),5.41E-12
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.95 (0.94 0.96),4.27E-11
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002246,0.010,SomaScan,Sperm-associated antigen 11B,0.95 (0.94 0.97),5.40E-11
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000896,0.063,SomaScan,Interleukin-23,0.95 (0.94 0.97),2.38E-10
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,1.05 (1.04 1.06),2.38E-10
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.95 (0.94 0.97),2.61E-10
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.95 (0.94 0.97),3.95E-10
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.96 (0.94 0.97),3.69E-09
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,0.96 (0.94 0.97),4.20E-09
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.96 (0.94 0.97),7.61E-08
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,0.96 (0.95 0.97),2.77E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.96 (0.95 0.97),2.80E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001913,0.014,SomaScan,Thyroid Stimulating Hormone,1.04 (1.03 1.05),2.92E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001755,0.018,SomaScan,N-acetyllactosaminide beta-1.6-N-acetylglucosaminyl-transferase. isoform C,0.96 (0.95 0.97),1.17E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000681,0.087,SomaScan,Protein-glutamine gamma-glutamyltransferase E,0.96 (0.95 0.98),5.11E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002103,0.012,SomaScan,Trefoil factor 3,0.96 (0.95 0.98),8.63E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.97 (0.95 0.98),9.08E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000469,0.125,SomaScan,Complement factor B,1.04 (1.02 1.05),1.68E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000713,0.082,SomaScan,Metalloproteinase inhibitor 4,0.97 (0.96 0.98),1.30E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001278,0.035,SomaScan,Immunoglobulin G,0.97 (0.96 0.98),1.32E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000081,0.402,SomaScan,Axin-2,1.03 (1.02 1.05),2.14E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001553,0.024,SomaScan,Protein G6b,1.03 (1.02 1.05),2.54E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001958,0.014,SomaScan,Immunoglobulin G,0.97 (0.96 0.98),3.08E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001241,0.037,SomaScan,Desmoglein-2,0.97 (0.96 0.98),9.60E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,0.97 (0.96 0.98),9.66E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000331,0.157,SomaScan,Tapasin,0.97 (0.96 0.98),1.40E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000301,0.166,SomaScan,Hepatitis A virus cellular receptor 2,1.03 (1.01 1.04),1.55E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000184,0.253,SomaScan,Granulysin,0.97 (0.96 0.99),1.61E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001598,0.022,SomaScan,SPARC,0.97 (0.96 0.99),1.80E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001286,0.034,SomaScan,Granzyme K,1.03 (1.01 1.04),1.98E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,0.97 (0.96 0.99),2.03E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000836,0.069,SomaScan,Lymphotactin,1.03 (1.01 1.04),2.08E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000899,0.063,SomaScan,Collagen alpha-2(XI) chain,0.97 (0.96 0.99),2.37E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.97 (0.96 0.99),3.57E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000123,0.339,SomaScan,GDH/6PGL endoplasmic bifunctional protein,0.97 (0.96 0.99),4.93E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.03 (1.01 1.04),6.56E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000275,0.182,SomaScan,PH and SEC7 domain-containing protein 2,1.03 (1.01 1.04),6.59E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001668,0.020,SomaScan,Histone H2B type 2-E,0.98 (0.96 0.99),6.94E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.98 (0.96 0.99),7.28E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001826,0.016,SomaScan,Stromal cell-derived factor 1,1.02 (1.01 1.04),8.71E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000879,0.065,SomaScan,Natural cytotoxicity triggering receptor 3,1.02 (1.01 1.04),1.16E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001338,0.032,SomaScan,Immunoglobulin A,0.98 (0.97 0.99),1.23E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000261,0.188,SomaScan,alpha-2-macroglobulin receptor-associated protein,1.02 (1.01 1.04),1.25E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001757,0.018,SomaScan,Stromal cell-derived factor 1,1.02 (1.01 1.04),1.32E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000749,0.078,SomaScan,Protein TMEPAI,1.02 (1.01 1.04),1.59E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001251,0.036,SomaScan,Immunoglobulin A,0.98 (0.97 0.99),1.64E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,0.98 (0.96 0.99),1.72E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000390,0.141,SomaScan,Palmitoyl-protein thioesterase 1,1.02 (1.01 1.04),1.74E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000967,0.056,SomaScan,Interleukin-7 receptor subunit alpha,1.02 (1.01 1.04),1.75E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002054,0.012,SomaScan,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,1.02 (1.01 1.03),2.09E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000582,0.101,SomaScan,Cathepsin S,1.02 (1.01 1.04),2.71E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000191,0.247,SomaScan,Tenascin-X,1.02 (1.01 1.04),3.40E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000007,0.709,SomaScan,Paired immunoglobulin-like type 2 receptor alpha isoform FDF03-deltaTM,0.98 (0.97 0.99),3.56E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001677,0.020,SomaScan,Complement component 1 Q subcomponent-binding protein. mitochondrial,1.02 (1.01 1.04),3.63E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000009,0.694,SomaScan,Paired immunoglobulin-like type 2 receptor alpha isoform FDF03-M14,0.98 (0.97 0.99),3.77E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001729,0.019,SomaScan,Tubulin polymerization-promoting protein family member 2,0.98 (0.97 0.99),3.84E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001637,0.021,SomaScan,Calcineurin subunit B type 1,0.98 (0.97 0.99),3.99E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001912,0.014,SomaScan,Centromere protein V,1.02 (1.01 1.04),4.32E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001511,0.025,SomaScan,Complement C3d fragment,1.02 (1.01 1.04),4.55E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS000935,0.059,SomaScan,Vitronectin,0.98 (0.97 0.99),4.57E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS001331,0.032,SomaScan,DnaJ homolog subfamily C member 30,0.98 (0.97 0.99),4.77E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002585,0.037,Olink,T-cell surface glycoprotein CD5,1.09 (1.07 1.10),8.80E-32
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002608,0.028,Olink,Integrin beta-2,1.09 (1.07 1.10),9.28E-32
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002584,0.037,Olink,Fms-related tyrosine kinase 3 ligand,1.06 (1.05 1.07),1.01E-18
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002629,0.023,Olink,Interleukin-18-binding protein,1.06 (1.05 1.08),8.05E-18
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.94 (0.93 0.95),2.58E-16
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,0.95 (0.94 0.96),2.66E-11
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002633,0.021,Olink,C-X-C motif chemokine 11,1.05 (1.04 1.06),3.88E-11
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002446,0.174,Olink,Lymphotactin,1.05 (1.03 1.06),1.91E-09
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002530,0.067,Olink,Trefoil factor 3,0.96 (0.95 0.97),1.11E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002422,0.223,Olink,Lymphotoxin-alpha,0.96 (0.95 0.98),1.19E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.96 (0.95 0.98),1.60E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002542,0.061,Olink,C-X-C motif chemokine 10,1.03 (1.02 1.05),1.85E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002516,0.081,Olink,Metalloproteinase inhibitor 4,0.97 (0.95 0.98),2.27E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002527,0.069,Olink,Natural killer cell receptor 2B4,1.03 (1.02 1.05),1.25E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002581,0.038,Olink,Fractalkine,1.03 (1.02 1.05),2.07E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002522,0.073,Olink,CUB domain-containing protein 1,0.97 (0.96 0.98),5.36E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002643,0.018,Olink,Neuroblastoma suppressor of tumorigenicity 1,0.97 (0.96 0.98),5.77E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.97 (0.96 0.98),6.11E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002423,0.221,Olink,Fc receptor-like protein 2,1.03 (1.02 1.04),8.39E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002492,0.105,Olink,Trem-like transcript 2 protein,1.03 (1.02 1.04),1.51E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002598,0.031,Olink,Interleukin-10,0.97 (0.96 0.99),3.69E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002439,0.184,Olink,Interleukin-5 receptor subunit alpha,0.98 (0.96 0.99),1.05E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002568,0.043,Olink,Granzyme A,0.98 (0.96 0.99),1.37E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003121,0.017,Metabolon,1.2-dipalmitoyl-GPC (16:0/16:0),1.07 (1.05 1.08),5.04E-19
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003008,0.030,Metabolon,quinolinate,1.05 (1.04 1.06),3.18E-10
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002958,0.040,Metabolon,1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6)*,0.96 (0.94 0.97),1.92E-08
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002832,0.078,Metabolon,X - 24438,0.96 (0.94 0.97),2.48E-08
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002934,0.044,Metabolon,1-oleoyl-2-dihomo-linolenoyl-GPC (18:1/20:3)*,0.96 (0.95 0.97),2.97E-08
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003065,0.022,Metabolon,X - 12100,1.04 (1.03 1.06),7.28E-08
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003189,0.012,Metabolon,2-linoleoyl-GPE (18:2)*,0.96 (0.95 0.97),2.07E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002909,0.049,Metabolon,X - 24439,0.96 (0.95 0.97),2.67E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002948,0.042,Metabolon,1-dihomo-linolenoyl-GPE (20:3n3 or 6)*,0.96 (0.95 0.97),3.21E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003029,0.026,Metabolon,docosatrienoate (22:3n3),0.96 (0.95 0.97),3.91E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003159,0.014,Metabolon,docosapentaenoate (n3 DPA; 22:5n3),1.04 (1.03 1.05),4.66E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002942,0.043,Metabolon,kynurenine,1.04 (1.03 1.05),5.17E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003057,0.022,Metabolon,1-adrenoyl-GPC (22:4)*,1.04 (1.03 1.05),5.30E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002949,0.041,Metabolon,1-stearoyl-2-meadoyl-GPC (18:0/20:3n9)*,1.04 (1.03 1.05),5.53E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003150,0.015,Metabolon,dihomo-linolenate (20:3n3 or n6),0.96 (0.95 0.97),6.01E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003152,0.014,Metabolon,1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2)*,0.96 (0.95 0.97),7.88E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003100,0.019,Metabolon,1-arachidonylglycerol (20:4),1.04 (1.03 1.05),1.28E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002972,0.036,Metabolon,1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9)*,1.04 (1.03 1.05),1.50E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002834,0.075,Metabolon,phosphatidylcholine (18:0/20:5. 16:0/22:5n6)*,1.04 (1.03 1.05),1.98E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003109,0.018,Metabolon,1-linoleoyl-GPE (18:2)*,0.96 (0.95 0.98),2.24E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002890,0.056,Metabolon,X - 23705,1.04 (1.02 1.05),2.81E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002829,0.079,Metabolon,arachidonate (20:4n6),1.04 (1.02 1.05),6.11E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003016,0.029,Metabolon,1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)*,1.04 (1.02 1.05),6.11E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002734,0.178,Metabolon,1-stearoyl-2-arachidonoyl-GPC (18:0/20:4),1.04 (1.02 1.05),7.12E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002899,0.053,Metabolon,1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5)*,1.04 (1.02 1.05),7.27E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002764,0.129,Metabolon,1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4),1.04 (1.02 1.05),8.63E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002952,0.040,Metabolon,1-dihomo-linolenoyl-GPC (20:3n3 or 6)*,0.96 (0.95 0.98),9.08E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003168,0.014,Metabolon,X - 24054,0.96 (0.95 0.98),1.05E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002791,0.100,Metabolon,2-arachidonoyl-GPC (20:4)*,1.04 (1.02 1.05),1.07E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003042,0.024,Metabolon,1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6),1.04 (1.02 1.05),1.10E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002747,0.146,Metabolon,1-arachidonoyl-GPC (20:4n6)*,1.04 (1.02 1.05),1.11E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002843,0.073,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4),1.04 (1.02 1.05),1.52E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002931,0.045,Metabolon,eicosapentaenoate (EPA; 20:5n3),1.04 (1.02 1.05),1.59E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002961,0.039,Metabolon,1-stearoyl-2-dihomo-linolenoyl-GPC (18:0/20:3n3 or 6)*,0.97 (0.95 0.98),1.88E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002859,0.067,Metabolon,1-arachidonoyl-GPE (20:4n6)*,1.04 (1.02 1.05),1.96E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002855,0.069,Metabolon,1-palmityl-2-arachidonoyl-GPC (O-16:0/20:4)*,1.04 (1.02 1.05),2.19E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002819,0.083,Metabolon,phosphatidylcholine (16:0/22:5n3. 18:1/20:4)*,1.04 (1.02 1.05),2.46E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002857,0.067,Metabolon,1-arachidonoyl-GPA (20:4),1.04 (1.02 1.05),3.31E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003125,0.017,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6),1.03 (1.02 1.05),6.00E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003136,0.016,Metabolon,1-eicosapentaenoyl-GPE (20:5)*,1.03 (1.02 1.05),6.08E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002980,0.034,Metabolon,1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2)*,0.97 (0.95 0.98),7.25E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002872,0.061,Metabolon,1-eicosapentaenoyl-GPC (20:5)*,1.03 (1.02 1.05),7.79E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003077,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPC (P-16:0/22:6)*,1.03 (1.02 1.05),1.05E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002886,0.057,Metabolon,X - 12822,1.03 (1.02 1.05),1.23E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002997,0.032,Metabolon,1-palmitoyl-2-linoleoyl-GPC (16:0/18:2),0.97 (0.96 0.98),1.33E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003118,0.017,Metabolon,1-(1-enyl-palmitoyl)-GPC (P-16:0)*,1.03 (1.02 1.05),1.68E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002938,0.044,Metabolon,2-arachidonoyl-GPE (20:4)*,1.03 (1.02 1.05),1.80E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002780,0.113,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)*,1.03 (1.02 1.05),2.15E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002981,0.034,Metabolon,1-docosapentaenoyl-GPC (22:5n3)*,1.03 (1.02 1.05),2.97E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003073,0.021,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*,1.03 (1.02 1.05),3.35E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003043,0.024,Metabolon,1-docosahexaenoyl-GPC (22:6)*,1.03 (1.02 1.05),3.54E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002977,0.035,Metabolon,1.2-dilinoleoyl-GPC (18:2/18:2),0.97 (0.96 0.98),4.69E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003014,0.029,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6)*,1.03 (1.02 1.04),5.77E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003060,0.022,Metabolon,stearidonate (18:4n3),1.03 (1.02 1.04),5.93E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003019,0.028,Metabolon,1-oleoyl-2-linoleoyl-GPI (18:1/18:2)*,0.97 (0.96 0.98),8.42E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003113,0.018,Metabolon,1-docosapentaenoyl-GPC (22:5n6)*,1.03 (1.02 1.04),1.16E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003120,0.017,Metabolon,2-docosahexaenoyl-GPC (22:6)*,1.03 (1.01 1.04),1.86E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003170,0.014,Metabolon,X - 13846,1.03 (1.01 1.04),2.31E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002901,0.052,Metabolon,X - 23369,1.03 (1.01 1.04),2.34E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002971,0.036,Metabolon,1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4)*,1.03 (1.01 1.04),2.60E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002941,0.043,Metabolon,1-palmitoyl-2-linolenoyl-GPC (16:0/18:3)*,0.97 (0.96 0.99),2.75E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002854,0.069,Metabolon,oleoyl ethanolamide,0.97 (0.96 0.99),3.11E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003011,0.030,Metabolon,1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)*,0.97 (0.96 0.99),3.53E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003090,0.020,Metabolon,X - 12714,1.03 (1.01 1.04),4.07E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002810,0.088,Metabolon,X - 12707,0.97 (0.96 0.99),6.05E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002893,0.054,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3)*,1.03 (1.01 1.04),6.78E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002964,0.037,Metabolon,1-docosahexaenoyl-GPE (22:6)*,1.03 (1.01 1.04),7.05E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.03 (1.01 1.04),8.20E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002904,0.051,Metabolon,1-arachidonoyl-GPI (20:4)*,1.03 (1.01 1.04),8.89E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003031,0.026,Metabolon,X - 21312,1.02 (1.01 1.04),9.53E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002936,0.044,Metabolon,1-dihomo-linoleoyl-GPC (20:2)*,0.98 (0.96 0.99),9.98E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003114,0.018,Metabolon,1-myristoyl-2-linoleoyl-GPC (14:0/18:2)*,0.98 (0.96 0.99),1.04E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003038,0.025,Metabolon,1-margaroyl-2-linoleoyl-GPC (17:0/18:2)*,0.98 (0.96 0.99),1.53E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002967,0.037,Metabolon,X - 11381,0.98 (0.96 0.99),1.96E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003075,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*,1.02 (1.01 1.04),2.31E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002837,0.075,Metabolon,1-stearoyl-2-arachidonoyl-GPI (18:0/20:4),1.02 (1.01 1.04),2.98E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002807,0.089,Metabolon,1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3)*,0.98 (0.97 0.99),3.55E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003108,0.018,Metabolon,1-(1-enyl-oleoyl)-GPC (P-18:1)*,1.02 (1.01 1.03),4.43E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003074,0.021,Metabolon,1-stearoyl-2-linoleoyl-GPC (18:0/18:2)*,0.98 (0.97 0.99),4.77E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS002789,0.102,Metabolon,1-palmitoyl-2-linoleoyl-GPE (16:0/18:2),0.98 (0.97 0.99),4.80E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003497,0.072,Nightingale,Linoleic acid,0.97 (0.95 0.98),5.49E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003522,0.062,Nightingale,Degree of unsaturation,1.02 (1.01 1.04),1.48E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.89 (0.88 0.90),5.54E-63
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.11 (1.10 1.13),3.15E-54
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009371,0.082,RNAseq,TRBV19,0.90 (0.89 0.91),5.09E-48
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010700,0.058,RNAseq,DCLRE1B,0.91 (0.90 0.92),5.92E-48
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012171,0.039,RNAseq,TRBV15,0.91 (0.89 0.92),2.31E-45
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007018,0.151,RNAseq,TRBV10-3,1.11 (1.09 1.12),2.48E-45
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.91 (0.90 0.93),2.52E-40
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.10 (1.08 1.11),9.03E-40
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010108,0.067,RNAseq,TRMO,1.10 (1.08 1.11),2.90E-38
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013305,0.028,RNAseq,TRBV14,0.92 (0.90 0.93),2.58E-37
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011108,0.052,RNAseq,LDLR,0.91 (0.90 0.93),2.74E-37
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013939,0.023,RNAseq,BATF2,1.09 (1.08 1.10),3.37E-36
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009198,0.085,RNAseq,TRAV12-1,1.09 (1.08 1.11),3.66E-36
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010661,0.059,RNAseq,PTPN22,1.09 (1.07 1.10),4.86E-34
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.09 (1.07 1.10),2.87E-33
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011536,0.047,RNAseq,TRAV2,0.92 (0.91 0.93),8.27E-30
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014283,0.021,RNAseq,MXRA8,0.92 (0.91 0.94),4.25E-28
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009464,0.080,RNAseq,CTLA4,0.93 (0.91 0.94),8.78E-28
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013472,0.027,RNAseq,STAT1,1.08 (1.07 1.09),5.78E-27
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006038,0.201,RNAseq,HLA-DQA2,1.08 (1.06 1.09),7.15E-27
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010624,0.059,RNAseq,TRBV18,1.08 (1.07 1.09),9.57E-27
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013073,0.030,RNAseq,BACH2,0.93 (0.92 0.94),1.05E-26
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012698,0.034,RNAseq,SNHG32,1.07 (1.06 1.08),1.70E-22
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007764,0.123,RNAseq,HLA-E,1.07 (1.06 1.09),8.75E-22
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014093,0.022,RNAseq,MYBL1,1.08 (1.06 1.09),9.43E-22
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008889,0.092,RNAseq,TRAV20,1.07 (1.06 1.08),3.72E-21
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005230,0.263,RNAseq,LINC00243,1.07 (1.06 1.08),5.56E-21
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011784,0.044,RNAseq,TUBB,1.07 (1.06 1.09),2.82E-20
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008402,0.104,RNAseq,TNXB,1.07 (1.05 1.08),3.40E-20
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004144,0.424,RNAseq,PSORS1C3,0.94 (0.93 0.95),2.70E-17
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003928,0.495,RNAseq,RNASET2,0.94 (0.93 0.95),2.28E-16
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014380,0.020,RNAseq,BAG3,0.94 (0.93 0.96),1.03E-15
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013201,0.029,RNAseq,NRCAM,0.94 (0.93 0.95),1.32E-15
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007145,0.146,RNAseq,BAG6,1.06 (1.05 1.07),1.34E-15
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010561,0.060,RNAseq,IL2RA,1.06 (1.05 1.07),2.46E-15
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004939,0.294,RNAseq,,0.94 (0.93 0.96),6.60E-15
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007407,0.135,RNAseq,TRBV2,1.06 (1.04 1.07),8.47E-15
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009077,0.088,RNAseq,DDAH2,0.95 (0.93 0.96),5.05E-14
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006942,0.154,RNAseq,SKIV2L,0.95 (0.93 0.96),1.11E-13
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004406,0.369,RNAseq,,0.95 (0.93 0.96),2.30E-13
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010826,0.056,RNAseq,TRIM10,0.95 (0.94 0.96),3.46E-13
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012271,0.038,RNAseq,TRBV5-6,0.95 (0.94 0.96),8.13E-13
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005167,0.269,RNAseq,TCF19,1.05 (1.04 1.07),8.51E-13
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009865,0.072,RNAseq,TRAV17,0.95 (0.94 0.96),2.97E-12
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS015052,0.015,RNAseq,CISH,0.95 (0.94 0.96),3.24E-12
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013013,0.031,RNAseq,FOXJ1,0.95 (0.94 0.96),3.24E-12
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009672,0.076,RNAseq,CALR,1.05 (1.04 1.07),4.52E-12
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004489,0.357,RNAseq,,0.95 (0.94 0.96),6.19E-12
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014622,0.018,RNAseq,CACNA1I,0.95 (0.94 0.97),1.11E-11
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007956,0.117,RNAseq,PHTF1,0.95 (0.94 0.96),1.42E-11
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013817,0.024,RNAseq,MYADM,0.95 (0.94 0.96),1.46E-11
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005334,0.253,RNAseq,AL645933.4,0.95 (0.94 0.96),2.08E-11
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010417,0.062,RNAseq,PHETA1,0.95 (0.94 0.96),2.86E-11
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009423,0.081,RNAseq,PSTPIP2,1.05 (1.04 1.07),3.66E-11
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007508,0.132,RNAseq,ALDH2,0.95 (0.94 0.96),4.27E-11
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011787,0.044,RNAseq,C2,1.05 (1.03 1.06),3.09E-10
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014550,0.019,RNAseq,ACAD10,0.95 (0.94 0.97),3.89E-10
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011283,0.050,RNAseq,CD248,0.95 (0.94 0.97),3.93E-10
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014496,0.019,RNAseq,VARS1,1.05 (1.03 1.06),8.93E-10
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007384,0.137,RNAseq,HLA-B,0.96 (0.94 0.97),9.42E-10
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010632,0.059,RNAseq,LRRN3,1.05 (1.03 1.06),1.63E-09
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010564,0.060,RNAseq,CEACAM6,0.96 (0.94 0.97),2.32E-09
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008383,0.104,RNAseq,CD160,0.96 (0.94 0.97),2.38E-09
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013324,0.028,RNAseq,PRF1,0.96 (0.95 0.97),4.17E-09
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012717,0.033,RNAseq,GBP4,1.05 (1.03 1.06),5.52E-09
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011288,0.050,RNAseq,AC104809.2,1.05 (1.03 1.06),7.81E-09
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008841,0.093,RNAseq,HSD17B8,1.05 (1.03 1.06),9.81E-09
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008572,0.099,RNAseq,GGT5,1.04 (1.03 1.06),1.77E-08
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008349,0.105,RNAseq,TANK,0.96 (0.95 0.97),1.88E-08
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008601,0.099,RNAseq,COLQ,1.04 (1.03 1.06),2.20E-08
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006866,0.157,RNAseq,AL662795.2,1.04 (1.03 1.06),2.20E-08
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006911,0.155,RNAseq,RPS6KA2,0.96 (0.94 0.97),2.38E-08
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009072,0.088,RNAseq,HLA-DQB1,0.96 (0.95 0.97),1.24E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012639,0.034,RNAseq,GBP5,1.04 (1.03 1.06),2.08E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011853,0.043,RNAseq,TRBV6-1,0.96 (0.95 0.97),2.20E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009626,0.076,RNAseq,APBA2,0.96 (0.95 0.97),3.47E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009920,0.071,RNAseq,LINC02446,0.96 (0.95 0.97),3.96E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004122,0.430,RNAseq,HLA-DRB5,0.96 (0.95 0.97),4.49E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011010,0.054,RNAseq,TRBV5-4,1.04 (1.03 1.05),5.89E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012855,0.032,RNAseq,TRBV9,1.04 (1.03 1.05),6.16E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011674,0.045,RNAseq,PRSS23,0.96 (0.95 0.97),6.67E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010492,0.061,RNAseq,HCG18,0.96 (0.95 0.97),9.85E-07
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012761,0.033,RNAseq,TRAV12-3,1.04 (1.03 1.05),1.01E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009711,0.075,RNAseq,TRAV21,0.96 (0.95 0.97),1.05E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011948,0.042,RNAseq,ADGRG1,0.96 (0.95 0.97),1.19E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009168,0.086,RNAseq,CD44,0.96 (0.95 0.98),1.46E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011820,0.043,RNAseq,LINC02033,1.04 (1.02 1.05),1.67E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007711,0.125,RNAseq,HMOX1,1.04 (1.03 1.05),2.14E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013225,0.029,RNAseq,REG4,0.96 (0.95 0.98),2.56E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009228,0.085,RNAseq,SNRPC,0.96 (0.95 0.98),2.81E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004294,0.390,RNAseq,INPP5B,1.04 (1.02 1.05),3.04E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006919,0.155,RNAseq,AC105233.5,1.04 (1.02 1.05),3.30E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007089,0.148,RNAseq,HLA-A,0.96 (0.95 0.98),3.77E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007730,0.124,RNAseq,CKB,1.04 (1.02 1.05),4.67E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003680,0.611,RNAseq,,1.04 (1.02 1.05),4.78E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006201,0.192,RNAseq,MAPKAPK5-AS1,0.96 (0.95 0.98),4.78E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005796,0.215,RNAseq,,0.96 (0.95 0.98),5.01E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010693,0.058,RNAseq,TRBV5-1,1.04 (1.02 1.05),5.86E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013383,0.027,RNAseq,PPP1R11,0.96 (0.95 0.98),5.94E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008807,0.094,RNAseq,ARHGEF40,0.96 (0.95 0.98),6.83E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010132,0.067,RNAseq,FAM216A,1.04 (1.02 1.05),6.98E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003711,0.593,RNAseq,,1.04 (1.02 1.05),7.47E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012242,0.039,RNAseq,,1.04 (1.02 1.05),9.08E-06
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012366,0.037,RNAseq,STMN1,0.97 (0.95 0.98),1.01E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011671,0.045,RNAseq,MICA,1.04 (1.02 1.05),1.38E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010874,0.056,RNAseq,ALS2CL,0.97 (0.95 0.98),1.82E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012946,0.031,RNAseq,PHC2,0.97 (0.95 0.98),1.88E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004727,0.320,RNAseq,CD226,0.97 (0.95 0.98),2.11E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010531,0.060,RNAseq,TICAM1,1.04 (1.02 1.05),2.18E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011308,0.049,RNAseq,PI4K2B,0.97 (0.95 0.98),2.26E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.04 (1.02 1.05),2.32E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008073,0.114,RNAseq,,1.04 (1.02 1.05),2.34E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005676,0.222,RNAseq,FOXK1,1.04 (1.02 1.05),2.45E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013959,0.023,RNAseq,TMEM131,0.97 (0.95 0.98),2.61E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.97 (0.95 0.98),2.61E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009935,0.070,RNAseq,TENT4B,0.97 (0.95 0.98),2.63E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007532,0.131,RNAseq,GIGYF1,0.97 (0.95 0.98),3.31E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003805,0.546,RNAseq,NFE2L3,1.04 (1.02 1.05),3.66E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008094,0.113,RNAseq,SCART1,1.03 (1.02 1.05),3.97E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007240,0.142,RNAseq,,1.03 (1.02 1.05),4.06E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013660,0.025,RNAseq,CD8A,1.03 (1.02 1.05),5.53E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014419,0.020,RNAseq,SF3A1,0.97 (0.95 0.98),5.65E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003812,0.544,RNAseq,AP002954.1,1.03 (1.02 1.05),6.81E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011585,0.046,RNAseq,CD8B,0.97 (0.96 0.98),8.11E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005918,0.208,RNAseq,DDR1,0.97 (0.95 0.98),8.45E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014236,0.021,RNAseq,NPEPPS,1.03 (1.02 1.05),9.48E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008835,0.093,RNAseq,NIPSNAP1,1.03 (1.02 1.05),9.67E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006930,0.154,RNAseq,,0.97 (0.96 0.98),9.72E-05
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009962,0.070,RNAseq,CCHCR1,0.97 (0.96 0.98),1.15E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009841,0.072,RNAseq,PDGFRB,0.97 (0.96 0.98),1.17E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007248,0.141,RNAseq,,0.97 (0.95 0.98),1.17E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003964,0.478,RNAseq,FCHO2,1.03 (1.02 1.05),1.20E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007170,0.145,RNAseq,AC105749.1,1.03 (1.02 1.05),1.32E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010205,0.066,RNAseq,KLF12,1.03 (1.02 1.05),1.53E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004669,0.328,RNAseq,RTKN2,1.03 (1.02 1.05),1.61E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012729,0.033,RNAseq,SREBF2,0.97 (0.96 0.98),1.70E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010274,0.065,RNAseq,ARPC3,1.03 (1.02 1.05),2.03E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005890,0.210,RNAseq,CIP2A,0.97 (0.96 0.98),2.15E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003625,0.664,RNAseq,,0.97 (0.96 0.98),2.15E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007057,0.150,RNAseq,RPL3L,1.03 (1.02 1.05),2.21E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012659,0.034,RNAseq,REV1,0.97 (0.96 0.98),2.84E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011005,0.054,RNAseq,SLC1A5,1.03 (1.02 1.04),2.89E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010965,0.054,RNAseq,H4C12,0.97 (0.95 0.98),2.98E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014443,0.019,RNAseq,ABCB1,0.97 (0.96 0.98),3.02E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012358,0.037,RNAseq,SFRP5,0.97 (0.96 0.98),3.05E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004053,0.449,RNAseq,ELOA,0.97 (0.96 0.98),3.08E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007485,0.133,RNAseq,NUDCD3,1.03 (1.02 1.04),3.35E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009222,0.085,RNAseq,,0.97 (0.96 0.98),4.18E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006596,0.171,RNAseq,SESN1,1.03 (1.02 1.04),4.21E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008268,0.107,RNAseq,CD4,1.03 (1.02 1.05),4.34E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011906,0.042,RNAseq,ICOS,0.97 (0.96 0.98),4.34E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004444,0.364,RNAseq,FADS2,0.97 (0.96 0.98),4.57E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011919,0.042,RNAseq,SOS2,0.97 (0.96 0.98),4.69E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004836,0.306,RNAseq,RAB2A,1.03 (1.02 1.04),5.24E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005158,0.271,RNAseq,DEF6,1.03 (1.02 1.05),5.55E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007376,0.137,RNAseq,ZBTB7B,0.97 (0.96 0.98),5.67E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004553,0.345,RNAseq,IQCN,0.97 (0.96 0.98),6.00E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010373,0.063,RNAseq,AC007262.2,1.03 (1.02 1.04),6.00E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010903,0.055,RNAseq,AL359962.1,1.03 (1.02 1.04),6.33E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009664,0.076,RNAseq,DOCK2,0.97 (0.96 0.98),6.33E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004125,0.429,RNAseq,UHRF1BP1,1.03 (1.02 1.04),6.60E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013298,0.028,RNAseq,IL7R,1.03 (1.02 1.04),6.67E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004498,0.354,RNAseq,TEF,0.97 (0.96 0.98),6.68E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006865,0.157,RNAseq,SOD2,1.03 (1.02 1.04),6.81E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008000,0.116,RNAseq,AL009179.2,1.03 (1.02 1.04),7.17E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007701,0.125,RNAseq,DHCR24,0.97 (0.96 0.98),8.67E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004291,0.390,RNAseq,PTPN12,0.97 (0.96 0.98),9.25E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003689,0.605,RNAseq,LRRC6,0.97 (0.96 0.98),9.36E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005519,0.236,RNAseq,AL645933.3,0.97 (0.96 0.98),9.36E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004918,0.297,RNAseq,PPM1F,1.03 (1.02 1.04),9.67E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014812,0.017,RNAseq,ERG,0.97 (0.96 0.98),9.68E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008456,0.103,RNAseq,GALK1,0.97 (0.96 0.98),9.72E-04
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007695,0.126,RNAseq,ICAM4,1.03 (1.02 1.04),1.03E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012699,0.034,RNAseq,BUD13,0.97 (0.96 0.98),1.03E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005433,0.244,RNAseq,MICB,1.03 (1.02 1.04),1.05E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012876,0.032,RNAseq,MRPS31,1.03 (1.02 1.04),1.07E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003641,0.645,RNAseq,EIF5AL1,1.03 (1.02 1.04),1.14E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012984,0.031,RNAseq,POU5F1,1.03 (1.02 1.04),1.24E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013932,0.023,RNAseq,VEGFC,1.03 (1.02 1.04),1.25E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007196,0.144,RNAseq,CLECL1,1.03 (1.02 1.04),1.25E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003843,0.532,RNAseq,BTN3A2,0.97 (0.96 0.99),1.27E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011419,0.048,RNAseq,GOLGB1,1.03 (1.02 1.04),1.34E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013293,0.028,RNAseq,LINC01232,0.97 (0.96 0.99),1.36E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003643,0.644,RNAseq,SEPTIN2,0.97 (0.96 0.99),1.49E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013820,0.024,RNAseq,TCF7,0.97 (0.96 0.99),1.51E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012952,0.031,RNAseq,PPP1R14B,1.03 (1.01 1.04),1.51E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013165,0.029,RNAseq,B3GALT2,1.03 (1.02 1.04),1.55E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012786,0.033,RNAseq,PLAGL2,1.03 (1.01 1.04),1.56E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004501,0.354,RNAseq,TBKBP1,1.03 (1.01 1.04),1.72E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014232,0.021,RNAseq,TRAV1-2,1.03 (1.01 1.04),1.73E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008500,0.102,RNAseq,FGFBP2,0.97 (0.96 0.99),1.83E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003644,0.643,RNAseq,KANSL1-AS1,1.03 (1.01 1.04),1.86E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012497,0.036,RNAseq,AC092295.2,0.97 (0.96 0.99),1.87E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012266,0.038,RNAseq,RASGRP1,1.03 (1.01 1.04),1.92E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005535,0.235,RNAseq,VMO1,1.03 (1.01 1.04),1.95E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012521,0.035,RNAseq,HERC5,1.03 (1.01 1.04),2.01E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007604,0.128,RNAseq,U91328.1,1.03 (1.01 1.04),2.09E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004765,0.314,RNAseq,LINC01184,1.03 (1.01 1.04),2.13E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010981,0.054,RNAseq,TM4SF19,0.97 (0.96 0.99),2.16E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010155,0.066,RNAseq,FSCN1,1.03 (1.01 1.04),2.26E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004297,0.390,RNAseq,HACD4,0.97 (0.96 0.99),2.45E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011344,0.049,RNAseq,,1.03 (1.01 1.04),2.49E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012162,0.040,RNAseq,RSAD2,1.03 (1.01 1.04),2.53E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008999,0.090,RNAseq,,0.97 (0.96 0.99),2.97E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006618,0.169,RNAseq,DCAKD,1.03 (1.01 1.04),2.98E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012904,0.032,RNAseq,ZMIZ1,1.03 (1.01 1.04),3.14E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011847,0.043,RNAseq,AC020928.1,0.97 (0.96 0.99),3.14E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010116,0.067,RNAseq,GPBP1,0.97 (0.96 0.99),3.24E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004853,0.304,RNAseq,C1QTNF6,1.03 (1.01 1.04),3.31E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009191,0.085,RNAseq,PACS1,0.97 (0.96 0.99),3.54E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008977,0.090,RNAseq,CLOCK,0.97 (0.96 0.99),3.54E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007538,0.131,RNAseq,AC245452.1,1.03 (1.01 1.04),3.64E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009225,0.085,RNAseq,CD5,0.97 (0.96 0.99),3.64E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003988,0.468,RNAseq,SIRT1,1.03 (1.01 1.04),3.70E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004307,0.388,RNAseq,ITGA4,0.97 (0.96 0.99),3.73E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008041,0.115,RNAseq,FCGR1A,0.97 (0.96 0.99),3.81E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009320,0.083,RNAseq,ARG2,0.97 (0.96 0.99),4.04E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011809,0.043,RNAseq,CD1C,1.03 (1.01 1.04),4.04E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003996,0.464,RNAseq,SPAG1,1.03 (1.01 1.04),4.13E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004363,0.378,RNAseq,LINC01806,0.97 (0.96 0.99),4.16E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003621,0.665,RNAseq,,0.97 (0.96 0.99),4.27E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010552,0.060,RNAseq,,0.97 (0.96 0.99),4.48E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011546,0.047,RNAseq,SLC66A1,0.97 (0.96 0.99),4.49E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005567,0.233,RNAseq,PLEKHA1,0.97 (0.96 0.99),4.49E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007515,0.132,RNAseq,INSL3,0.97 (0.96 0.99),4.55E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009461,0.080,RNAseq,TG,1.03 (1.01 1.04),4.58E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006065,0.200,RNAseq,RRP15,1.03 (1.01 1.04),4.59E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005150,0.271,RNAseq,RERE,0.97 (0.96 0.99),4.60E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009401,0.081,RNAseq,EPHX1,0.97 (0.96 0.99),4.61E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013485,0.027,RNAseq,,1.03 (1.01 1.04),4.62E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004596,0.340,RNAseq,AP000560.1,1.03 (1.01 1.04),4.74E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008898,0.092,RNAseq,TMEM121,1.03 (1.01 1.04),4.83E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003564,0.785,RNAseq,,1.03 (1.01 1.04),4.87E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012851,0.032,RNAseq,SUDS3,1.03 (1.01 1.04),5.17E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005685,0.222,RNAseq,TLR1,0.97 (0.96 0.99),5.31E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014525,0.019,RNAseq,AL590666.1,0.98 (0.96 0.99),5.31E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006034,0.201,RNAseq,,1.03 (1.01 1.04),5.34E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008645,0.098,RNAseq,INPP5D,0.97 (0.96 0.99),5.53E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004070,0.445,RNAseq,AC092683.1,1.03 (1.01 1.04),5.56E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010770,0.057,RNAseq,RALGAPA1,0.97 (0.96 0.99),5.56E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012929,0.031,RNAseq,RANGAP1,1.03 (1.01 1.04),5.56E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006336,0.184,RNAseq,PDE4A,1.03 (1.01 1.04),5.57E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004774,0.313,RNAseq,PRKD2,0.97 (0.96 0.99),5.67E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010105,0.068,RNAseq,SH2D2A,0.98 (0.96 0.99),5.68E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006202,0.192,RNAseq,ZNF281,1.03 (1.01 1.04),5.68E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012028,0.041,RNAseq,HLA-DQB1-AS1,0.97 (0.96 0.99),5.87E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007410,0.135,RNAseq,IFITM2,0.97 (0.96 0.99),5.90E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013958,0.023,RNAseq,CSNK2B,0.97 (0.96 0.99),5.99E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014751,0.017,RNAseq,PTPN13,0.97 (0.96 0.99),6.05E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012792,0.033,RNAseq,Z94721.1,0.97 (0.96 0.99),6.29E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005600,0.230,RNAseq,AC022784.1,0.97 (0.96 0.99),6.56E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014249,0.021,RNAseq,IFI6,1.03 (1.01 1.04),6.86E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004213,0.410,RNAseq,,1.03 (1.01 1.04),6.91E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011776,0.044,RNAseq,LST1,0.98 (0.96 0.99),6.94E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007205,0.143,RNAseq,AP1M1,0.98 (0.96 0.99),7.05E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008129,0.111,RNAseq,VIM,0.98 (0.96 0.99),7.05E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008210,0.109,RNAseq,FLVCR1,1.03 (1.01 1.04),7.11E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008629,0.098,RNAseq,SMC4,1.03 (1.01 1.04),7.28E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004334,0.383,RNAseq,HLA-G,0.98 (0.96 0.99),7.40E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003699,0.599,RNAseq,AC009506.2,1.03 (1.01 1.04),7.41E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011123,0.052,RNAseq,HAVCR2,1.03 (1.01 1.04),7.44E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006562,0.172,RNAseq,PLGRKT,0.98 (0.96 0.99),7.45E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008647,0.098,RNAseq,RN7SL32P,1.03 (1.01 1.04),7.49E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005640,0.226,RNAseq,MSRA,1.03 (1.01 1.04),7.60E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003856,0.526,RNAseq,RPS26,1.03 (1.01 1.04),7.97E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008274,0.107,RNAseq,NCR3,1.03 (1.01 1.04),7.97E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011073,0.053,RNAseq,TRBV7-3,1.03 (1.01 1.04),8.00E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005929,0.207,RNAseq,MYRF,0.98 (0.96 0.99),8.04E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009514,0.079,RNAseq,ATP1B3,0.98 (0.96 0.99),8.15E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013734,0.024,RNAseq,OAS2,1.03 (1.01 1.04),8.15E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011141,0.052,RNAseq,PPHLN1,1.03 (1.01 1.04),8.66E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007414,0.135,RNAseq,ARID5B,1.02 (1.01 1.04),8.74E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006924,0.154,RNAseq,DSC1,0.98 (0.96 0.99),8.80E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006024,0.202,RNAseq,TNFRSF18,1.03 (1.01 1.04),8.80E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013366,0.027,RNAseq,TMEM19,1.02 (1.01 1.04),8.89E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012484,0.036,RNAseq,ABCB9,1.02 (1.01 1.04),9.03E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005366,0.250,RNAseq,FAS,0.98 (0.96 0.99),9.12E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004389,0.372,RNAseq,AP003774.2,0.98 (0.96 0.99),9.20E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004280,0.392,RNAseq,SYNGR1,1.02 (1.01 1.04),9.25E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011095,0.052,RNAseq,CEBPA,1.02 (1.01 1.04),9.40E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013788,0.024,RNAseq,SUMO1,1.02 (1.01 1.04),9.41E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005781,0.217,RNAseq,CAMK4,0.98 (0.96 0.99),9.56E-03
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004992,0.288,RNAseq,MAPK8IP1,1.02 (1.01 1.04),1.02E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008418,0.103,RNAseq,SESN3,0.98 (0.96 0.99),1.02E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011583,0.046,RNAseq,BAG1,1.02 (1.01 1.04),1.02E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011184,0.051,RNAseq,AL162724.1,0.98 (0.96 0.99),1.02E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012373,0.037,RNAseq,UBR5,0.98 (0.96 0.99),1.03E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012220,0.039,RNAseq,UPK3B,1.02 (1.01 1.04),1.06E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009688,0.075,RNAseq,H2BC12,0.98 (0.96 0.99),1.08E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010348,0.063,RNAseq,TRBV6-5,0.98 (0.96 0.99),1.10E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012061,0.041,RNAseq,CSGALNACT2,0.98 (0.96 0.99),1.11E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014960,0.016,RNAseq,MYNN,1.02 (1.01 1.04),1.11E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010142,0.067,RNAseq,PRSS16,1.02 (1.01 1.04),1.12E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011482,0.047,RNAseq,TRAV8-4,1.02 (1.01 1.04),1.12E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010212,0.066,RNAseq,PSMB9,1.02 (1.01 1.04),1.12E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009393,0.082,RNAseq,TRAPPC6B,0.98 (0.96 0.99),1.12E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014116,0.022,RNAseq,BEND3,0.98 (0.96 0.99),1.16E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013406,0.027,RNAseq,AL353759.1,1.02 (1.01 1.04),1.16E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010846,0.056,RNAseq,CYB5B,0.98 (0.96 0.99),1.16E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005999,0.203,RNAseq,ACAP1,0.98 (0.96 0.99),1.16E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007109,0.147,RNAseq,BTN3A1,0.98 (0.96 0.99),1.17E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009882,0.071,RNAseq,WBP2,0.98 (0.96 0.99),1.18E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003569,0.762,RNAseq,,0.98 (0.96 0.99),1.18E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004188,0.414,RNAseq,ALDH16A1,1.02 (1.01 1.04),1.19E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012527,0.035,RNAseq,DDB2,1.02 (1.01 1.04),1.19E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004220,0.407,RNAseq,TRBV4-1,1.02 (1.01 1.04),1.19E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007634,0.128,RNAseq,AL359644.1,0.98 (0.96 0.99),1.19E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012587,0.035,RNAseq,COL5A1,1.02 (1.01 1.04),1.19E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006247,0.189,RNAseq,TMEM254,1.02 (1.01 1.04),1.19E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010642,0.059,RNAseq,HCK,0.98 (0.96 0.99),1.19E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013844,0.024,RNAseq,BAHCC1,1.02 (1.01 1.04),1.20E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005815,0.214,RNAseq,LINC01089,0.98 (0.96 0.99),1.22E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012278,0.038,RNAseq,SS18,1.02 (1.01 1.04),1.23E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012702,0.034,RNAseq,AC092803.1,0.98 (0.96 0.99),1.23E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004390,0.372,RNAseq,FZD1,1.02 (1.01 1.04),1.24E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005025,0.284,RNAseq,NCKIPSD,0.98 (0.96 0.99),1.30E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012894,0.032,RNAseq,CADM1,0.98 (0.96 0.99),1.32E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010447,0.062,RNAseq,NOTCH2NLC,1.02 (1.01 1.04),1.37E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004579,0.342,RNAseq,PKN3,0.98 (0.96 0.99),1.37E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004639,0.335,RNAseq,GPN3,1.02 (1.01 1.04),1.38E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013503,0.026,RNAseq,NOTCH4,1.02 (1.01 1.04),1.47E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005558,0.234,RNAseq,OMA1,1.02 (1.01 1.04),1.48E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013208,0.029,RNAseq,SNX27,1.02 (1.01 1.04),1.48E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010701,0.058,RNAseq,AC139019.1,1.02 (1.01 1.04),1.50E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004030,0.456,RNAseq,YWHAB,1.02 (1.01 1.04),1.53E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011794,0.044,RNAseq,PRKCQ,1.02 (1.01 1.04),1.56E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014163,0.021,RNAseq,AFF1,1.02 (1.01 1.04),1.56E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005440,0.243,RNAseq,TES,0.98 (0.96 0.99),1.64E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008820,0.094,RNAseq,TP53I13,1.02 (1.01 1.04),1.64E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013446,0.027,RNAseq,STX11,0.98 (0.96 0.99),1.64E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006338,0.184,RNAseq,ENO1,1.02 (1.01 1.04),1.64E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011959,0.042,RNAseq,SRC,0.98 (0.96 0.99),1.64E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004598,0.340,RNAseq,RPAP1,0.98 (0.96 0.99),1.64E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012273,0.038,RNAseq,ACTA2-AS1,0.98 (0.96 0.99),1.64E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS015007,0.016,RNAseq,RMDN3,1.02 (1.01 1.04),1.64E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011321,0.049,RNAseq,GDF11,0.98 (0.96 0.99),1.66E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003628,0.662,RNAseq,,1.02 (1.01 1.04),1.71E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013798,0.024,RNAseq,RNF5,1.02 (1.01 1.04),1.71E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010671,0.058,RNAseq,LINC02649,0.98 (0.96 0.99),1.71E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004266,0.397,RNAseq,LINC00211,1.02 (1.01 1.04),1.72E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011576,0.046,RNAseq,AC026356.1,1.02 (1.01 1.04),1.72E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010475,0.061,RNAseq,ZNRD1,0.98 (0.96 0.99),1.75E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008281,0.107,RNAseq,HLA-F-AS1,0.98 (0.96 0.99),1.75E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006227,0.190,RNAseq,UNC119B,1.02 (1.01 1.04),1.84E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011471,0.047,RNAseq,IRF3,0.98 (0.96 0.99),1.87E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004275,0.393,RNAseq,TACSTD2,1.02 (1.01 1.04),1.92E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009133,0.087,RNAseq,PRDX2,0.98 (0.96 0.99),1.98E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004604,0.339,RNAseq,ELMO1,0.98 (0.96 0.99),1.99E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006814,0.160,RNAseq,TMEM65,1.02 (1.01 1.04),1.99E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010580,0.060,RNAseq,RHOF,0.98 (0.96 0.99),2.00E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003742,0.573,RNAseq,AHI1,0.98 (0.96 0.99),2.03E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009118,0.087,RNAseq,LY6G5C,0.98 (0.97 0.99),2.08E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005704,0.221,RNAseq,AF131215.5,0.98 (0.96 0.99),2.08E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007681,0.126,RNAseq,FAM50B,1.02 (1.01 1.04),2.10E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006959,0.153,RNAseq,AC253576.2,1.02 (1.01 1.04),2.16E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010615,0.059,RNAseq,SIGLEC1,1.02 (1.01 1.04),2.16E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004856,0.303,RNAseq,TMPRSS3,1.02 (1.01 1.04),2.16E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009069,0.089,RNAseq,LMBRD2,1.02 (1.01 1.04),2.17E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005300,0.257,RNAseq,AF131215.6,0.98 (0.96 0.99),2.18E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009803,0.073,RNAseq,UBE2E2,0.98 (0.96 0.99),2.18E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004611,0.338,RNAseq,GFPT1,0.98 (0.96 0.99),2.20E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009810,0.073,RNAseq,,1.02 (1.01 1.04),2.20E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007088,0.148,RNAseq,SMARCE1,1.02 (1.01 1.04),2.20E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010583,0.060,RNAseq,HSPH1,1.02 (1.01 1.04),2.21E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014221,0.021,RNAseq,HIC1,0.98 (0.96 0.99),2.21E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012537,0.035,RNAseq,PLAG1,1.02 (1.01 1.04),2.21E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006501,0.175,RNAseq,ADGRD1,1.02 (1.01 1.04),2.26E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012689,0.034,RNAseq,AC026341.1,1.02 (1.01 1.04),2.32E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009176,0.086,RNAseq,,0.98 (0.96 0.99),2.35E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012080,0.040,RNAseq,CD70,1.02 (1.01 1.04),2.35E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005800,0.215,RNAseq,ACTR2,1.02 (1.01 1.04),2.39E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006553,0.173,RNAseq,BATF3,1.02 (1.01 1.04),2.40E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004081,0.443,RNAseq,,1.02 (1.01 1.04),2.40E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013501,0.026,RNAseq,HLA-DMA,1.02 (1.01 1.04),2.56E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011970,0.041,RNAseq,IL31RA,0.98 (0.96 0.99),2.61E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004083,0.442,RNAseq,WDR6,1.02 (1.01 1.04),2.68E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006371,0.183,RNAseq,ADCY7,0.98 (0.96 0.99),2.77E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011811,0.043,RNAseq,ZBTB46,0.98 (0.97 0.99),2.78E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012975,0.031,RNAseq,JCAD,0.98 (0.96 0.99),2.87E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014034,0.022,RNAseq,NAB2,1.02 (1.01 1.04),2.92E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006136,0.195,RNAseq,IL12RB2,1.02 (1.01 1.04),2.98E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004476,0.359,RNAseq,TMEM156,1.02 (1.01 1.04),2.99E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005964,0.205,RNAseq,CD96,1.02 (1.01 1.04),3.00E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005738,0.219,RNAseq,DENND3,1.02 (1.01 1.04),3.08E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004943,0.293,RNAseq,,1.02 (1.01 1.04),3.08E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014282,0.021,RNAseq,VCPIP1,1.02 (1.01 1.04),3.10E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009105,0.087,RNAseq,ZNF589,0.98 (0.97 0.99),3.11E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005926,0.207,RNAseq,NCSTN,1.02 (1.01 1.04),3.15E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003592,0.698,RNAseq,SH3YL1,1.02 (1.01 1.04),3.24E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009622,0.077,RNAseq,TMEM252,0.98 (0.96 0.99),3.25E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013816,0.024,RNAseq,C5AR2,1.02 (1.01 1.04),3.27E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012458,0.036,RNAseq,PRAG1,0.98 (0.97 0.99),3.28E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS015056,0.015,RNAseq,TIMMDC1,1.02 (1.01 1.04),3.28E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010605,0.059,RNAseq,PPP1CC,0.98 (0.96 0.99),3.30E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS005069,0.279,RNAseq,COG6,0.98 (0.97 0.99),3.32E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008950,0.091,RNAseq,UBE2L3,1.02 (1.01 1.03),3.42E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014375,0.020,RNAseq,MUS81,1.02 (1.01 1.04),3.43E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004316,0.386,RNAseq,,0.98 (0.97 0.99),3.47E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011092,0.052,RNAseq,IFIT1,1.02 (1.01 1.04),3.48E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011744,0.044,RNAseq,C12orf76,1.02 (1.01 1.04),3.52E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006320,0.185,RNAseq,CEP128,0.98 (0.97 0.99),3.56E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013141,0.029,RNAseq,RPS10,1.02 (1.01 1.03),3.58E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014940,0.016,RNAseq,NAPA-AS1,1.02 (1.01 1.04),3.64E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008955,0.091,RNAseq,MRNIP,1.02 (1.01 1.04),3.65E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013377,0.027,RNAseq,TXK,1.02 (1.01 1.03),3.67E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013292,0.028,RNAseq,AL121985.1,1.02 (1.01 1.04),3.67E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010652,0.059,RNAseq,CAND1,1.02 (1.01 1.03),3.71E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007138,0.146,RNAseq,HCG27,0.98 (0.97 0.99),3.72E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014893,0.016,RNAseq,ZWINT,0.98 (0.97 0.99),3.81E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006001,0.203,RNAseq,HLA-DQA1,0.98 (0.97 0.99),3.94E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004525,0.350,RNAseq,PARP1,0.98 (0.97 0.99),4.01E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010779,0.057,RNAseq,ACE,1.02 (1.01 1.04),4.01E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006209,0.191,RNAseq,CA8,0.98 (0.97 0.99),4.04E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013521,0.026,RNAseq,AL355001.2,1.02 (1.01 1.03),4.05E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009973,0.070,RNAseq,DDX17,1.02 (1.01 1.03),4.18E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012043,0.041,RNAseq,RPS6KB1,1.02 (1.01 1.03),4.24E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007856,0.120,RNAseq,CAMKK2,1.02 (1.01 1.04),4.24E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011716,0.045,RNAseq,FBLN7,0.98 (0.97 0.99),4.25E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011472,0.047,RNAseq,FEZ1,0.98 (0.97 0.99),4.28E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007962,0.117,RNAseq,RAPGEFL1,0.98 (0.96 0.99),4.34E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011039,0.053,RNAseq,,1.02 (1.01 1.03),4.37E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008624,0.098,RNAseq,DNAJC8,1.02 (1.01 1.04),4.43E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009970,0.070,RNAseq,CLDN23,0.98 (0.97 0.99),4.44E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006441,0.178,RNAseq,AC048382.6,1.02 (1.01 1.03),4.48E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS007421,0.135,RNAseq,ARMH1,1.02 (1.01 1.04),4.48E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS012934,0.031,RNAseq,TRAFD1,1.02 (1.01 1.04),4.49E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010202,0.066,RNAseq,SIVA1,1.02 (1.01 1.03),4.55E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004089,0.441,RNAseq,NNT,1.02 (1.01 1.03),4.55E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013254,0.029,RNAseq,UBAC2-AS1,0.98 (0.97 0.99),4.58E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004323,0.386,RNAseq,BOK,0.98 (0.97 0.99),4.58E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008916,0.091,RNAseq,LINC00672,0.98 (0.97 0.99),4.58E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014276,0.021,RNAseq,DCTN3,1.02 (1.01 1.04),4.64E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS008869,0.093,RNAseq,,0.98 (0.97 0.99),4.64E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS011965,0.042,RNAseq,CEACAM1,1.02 (1.01 1.03),4.66E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009193,0.085,RNAseq,DNAI2,0.98 (0.97 0.99),4.66E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS003583,0.713,RNAseq,NAAA,0.98 (0.97 0.99),4.68E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS014176,0.021,RNAseq,TRAV27,0.98 (0.97 0.99),4.76E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS010787,0.057,RNAseq,PARP2,1.02 (1.01 1.03),4.77E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006020,0.202,RNAseq,AC002091.2,1.02 (1.01 1.03),4.79E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004339,0.382,RNAseq,PPP2R3C,1.02 (1.01 1.04),4.86E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS009786,0.073,RNAseq,IMPA2,0.98 (0.97 0.99),4.92E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS006097,0.198,RNAseq,GNAZ,1.02 (1.01 1.03),4.93E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS013056,0.030,RNAseq,DCST1-AS1,1.02 (1.01 1.04),4.96E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004517,0.352,RNAseq,GPR137B,0.98 (0.97 0.99),4.98E-02
244.4,Hypothyroidism NOS,endocrine/metabolic,OPGS004634,0.335,RNAseq,DDX59,0.98 (0.97 0.99),4.98E-02
245.21,Chronic lymphocytic thyroiditis,endocrine/metabolic,OPGS007018,0.151,RNAseq,TRBV10-3,1.38 (1.21 1.57),1.14E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.92 (0.89 0.95),1.28E-05
250,Diabetes mellitus,endocrine/metabolic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.92 (0.89 0.95),2.25E-05
250,Diabetes mellitus,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.08 (1.05 1.11),6.48E-05
250,Diabetes mellitus,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.08 (1.05 1.11),2.11E-04
250,Diabetes mellitus,endocrine/metabolic,OPGS000198,0.236,SomaScan,Peptidyl-glycine alpha-amidating monooxygenase,0.93 (0.91 0.96),1.10E-03
250,Diabetes mellitus,endocrine/metabolic,OPGS001231,0.037,SomaScan,Osteocalcin,1.07 (1.04 1.10),1.16E-03
250,Diabetes mellitus,endocrine/metabolic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.06 (1.03 1.09),1.40E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.06 (1.03 1.09),2.37E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS000576,0.102,SomaScan,Interleukin-21,0.94 (0.92 0.97),2.82E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.95 (0.92 0.97),3.54E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.93 (0.91 0.96),5.19E-04
250,Diabetes mellitus,endocrine/metabolic,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.94 (0.92 0.97),3.73E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS003180,0.013,Metabolon,1-palmitoyl-GPA (16:0),1.06 (1.03 1.10),4.04E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS002771,0.124,Metabolon,glutarylcarnitine (C5),1.06 (1.03 1.09),4.43E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.89 (0.87 0.91),3.73E-15
250,Diabetes mellitus,endocrine/metabolic,OPGS010624,0.059,RNAseq,TRBV18,1.12 (1.09 1.15),1.98E-10
250,Diabetes mellitus,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.91 (0.89 0.94),1.39E-07
250,Diabetes mellitus,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.10 (1.07 1.13),2.44E-07
250,Diabetes mellitus,endocrine/metabolic,OPGS011853,0.043,RNAseq,TRBV6-1,0.91 (0.89 0.94),1.30E-06
250,Diabetes mellitus,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.09 (1.06 1.12),5.82E-06
250,Diabetes mellitus,endocrine/metabolic,OPGS009865,0.072,RNAseq,TRAV17,0.92 (0.90 0.95),2.58E-05
250,Diabetes mellitus,endocrine/metabolic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.09 (1.06 1.13),2.72E-05
250,Diabetes mellitus,endocrine/metabolic,OPGS012171,0.039,RNAseq,TRBV15,0.92 (0.90 0.95),3.80E-05
250,Diabetes mellitus,endocrine/metabolic,OPGS006038,0.201,RNAseq,HLA-DQA2,1.08 (1.05 1.11),5.68E-05
250,Diabetes mellitus,endocrine/metabolic,OPGS005334,0.253,RNAseq,AL645933.4,0.93 (0.90 0.95),8.72E-05
250,Diabetes mellitus,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.93 (0.90 0.95),1.28E-04
250,Diabetes mellitus,endocrine/metabolic,OPGS010348,0.063,RNAseq,TRBV6-5,1.08 (1.05 1.11),2.69E-04
250,Diabetes mellitus,endocrine/metabolic,OPGS003680,0.611,RNAseq,,1.07 (1.04 1.10),3.35E-04
250,Diabetes mellitus,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.07 (1.04 1.10),9.35E-04
250,Diabetes mellitus,endocrine/metabolic,OPGS010449,0.062,RNAseq,PARVA,0.94 (0.91 0.96),3.05E-03
250,Diabetes mellitus,endocrine/metabolic,OPGS015077,0.015,RNAseq,ACTN1,1.07 (1.04 1.10),3.37E-03
250,Diabetes mellitus,endocrine/metabolic,OPGS013660,0.025,RNAseq,CD8A,1.07 (1.04 1.10),3.37E-03
250,Diabetes mellitus,endocrine/metabolic,OPGS012954,0.031,RNAseq,FBXL22,0.94 (0.91 0.97),4.50E-03
250,Diabetes mellitus,endocrine/metabolic,OPGS006541,0.173,RNAseq,ZFYVE28,0.94 (0.91 0.97),7.29E-03
250,Diabetes mellitus,endocrine/metabolic,OPGS010826,0.056,RNAseq,TRIM10,0.94 (0.92 0.97),1.26E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS010856,0.056,RNAseq,RIOK3,0.94 (0.92 0.97),1.40E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS008867,0.093,RNAseq,TSBP1-AS1,1.06 (1.03 1.09),2.25E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS012271,0.038,RNAseq,TRBV5-6,0.95 (0.92 0.97),2.50E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS014341,0.020,RNAseq,NFAT5,1.06 (1.03 1.09),2.80E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS009962,0.070,RNAseq,CCHCR1,1.06 (1.03 1.09),3.37E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS005375,0.249,RNAseq,,0.94 (0.92 0.97),3.37E-02
250,Diabetes mellitus,endocrine/metabolic,OPGS004144,0.424,RNAseq,PSORS1C3,1.06 (1.03 1.09),3.73E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.76 (0.73 0.78),3.46E-59
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.29 (1.25 1.34),6.05E-51
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.74 (0.71 0.77),4.54E-47
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000576,0.102,SomaScan,Interleukin-21,0.79 (0.77 0.82),4.24E-43
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.27 (1.22 1.31),8.99E-34
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.82 (0.80 0.85),6.50E-31
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.22 (1.18 1.26),4.04E-30
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.22 (1.18 1.26),3.46E-28
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.83 (0.80 0.85),1.15E-27
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000290,0.171,SomaScan,Complement C4,0.82 (0.79 0.85),1.99E-27
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.83 (0.81 0.86),1.18E-26
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.84 (0.81 0.87),1.37E-24
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.82 (0.80 0.85),2.28E-23
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.19 (1.15 1.23),3.94E-23
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001231,0.037,SomaScan,Osteocalcin,1.18 (1.14 1.22),2.20E-19
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.86 (0.83 0.88),6.09E-19
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.85 (0.82 0.88),5.21E-18
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.84 (0.81 0.87),2.34E-17
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.85 (0.81 0.88),1.72E-15
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001911,0.014,SomaScan,Ectodysplasin-A. secreted form,0.85 (0.82 0.88),1.15E-14
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001893,0.015,SomaScan,Interleukin-17F,0.86 (0.83 0.89),2.28E-14
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.14 (1.10 1.18),5.83E-12
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.88 (0.85 0.91),2.99E-11
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,0.87 (0.84 0.91),8.99E-10
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000137,0.312,SomaScan,Complement C4b,0.89 (0.86 0.92),1.22E-09
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.89 (0.86 0.92),4.51E-09
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000390,0.141,SomaScan,Palmitoyl-protein thioesterase 1,1.11 (1.08 1.15),8.82E-08
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000517,0.114,SomaScan,Advanced glycosylation end product-specific receptor. soluble,0.90 (0.87 0.93),1.35E-07
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.90 (0.87 0.93),2.33E-07
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,0.90 (0.87 0.93),1.26E-06
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.91 (0.88 0.94),4.39E-06
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,1.09 (1.05 1.13),8.70E-05
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000123,0.339,SomaScan,GDH/6PGL endoplasmic bifunctional protein,0.92 (0.89 0.95),8.86E-05
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001553,0.024,SomaScan,Protein G6b,1.09 (1.05 1.13),1.23E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,0.93 (0.90 0.96),4.70E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002012,0.013,SomaScan,Apolipoprotein M,1.09 (1.05 1.14),1.57E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000846,0.068,SomaScan,2-phosphoxylose phosphatase 1,1.07 (1.04 1.11),2.80E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.08 (1.04 1.11),3.09E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001207,0.038,SomaScan,Apolipoprotein M,1.07 (1.04 1.11),3.68E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000681,0.087,SomaScan,Protein-glutamine gamma-glutamyltransferase E,0.93 (0.90 0.96),5.19E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000156,0.272,SomaScan,alpha-2-macroglobulin receptor-associated protein,0.93 (0.89 0.96),9.07E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001550,0.024,SomaScan,Trefoil factor 3,0.93 (0.90 0.97),1.66E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,1.07 (1.03 1.10),1.88E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000331,0.157,SomaScan,Tapasin,0.93 (0.90 0.97),2.01E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.94 (0.91 0.97),2.05E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000879,0.065,SomaScan,Natural cytotoxicity triggering receptor 3,1.07 (1.03 1.11),2.16E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000129,0.329,SomaScan,Neutrophil collagenase,0.94 (0.91 0.97),3.11E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.06 (1.03 1.10),3.45E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000935,0.059,SomaScan,Vitronectin,0.94 (0.91 0.97),3.48E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001761,0.018,SomaScan,Sulfatase-modifying factor 2,1.06 (1.03 1.10),3.79E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS001390,0.030,SomaScan,Non-secretory ribonuclease,1.06 (1.03 1.10),3.79E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS000899,0.063,SomaScan,Collagen alpha-2(XI) chain,0.94 (0.91 0.97),3.94E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.78 (0.76 0.81),1.82E-42
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.83 (0.80 0.86),6.14E-22
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.85 (0.82 0.87),1.01E-20
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.86 (0.83 0.88),7.05E-18
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,0.89 (0.86 0.92),2.11E-08
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002427,0.216,Olink,Alpha-2-macroglobulin receptor-associated protein,0.89 (0.85 0.92),1.42E-06
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002551,0.054,Olink,Gastrotropin,0.91 (0.88 0.94),4.17E-06
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002522,0.073,Olink,CUB domain-containing protein 1,0.92 (0.89 0.95),3.95E-05
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002428,0.212,Olink,Secreted frizzled-related protein 3,0.94 (0.91 0.97),4.07E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002439,0.184,Olink,Interleukin-5 receptor subunit alpha,0.94 (0.91 0.98),4.68E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002886,0.057,Metabolon,X - 12822,1.10 (1.06 1.13),8.30E-06
250.1,Type 1 diabetes,endocrine/metabolic,OPGS003220,0.011,Metabolon,3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF),0.93 (0.90 0.96),1.66E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS003180,0.013,Metabolon,1-palmitoyl-GPA (16:0),1.08 (1.04 1.13),3.28E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002813,0.087,Metabolon,histidylalanine,0.93 (0.90 0.97),6.75E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002771,0.124,Metabolon,glutarylcarnitine (C5),1.07 (1.03 1.10),1.62E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002942,0.043,Metabolon,kynurenine,1.06 (1.03 1.10),2.13E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS002816,0.086,Metabolon,X - 11470,0.94 (0.91 0.97),3.54E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS003497,0.072,Nightingale,Linoleic acid,0.93 (0.90 0.97),6.49E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.76 (0.74 0.78),2.65E-87
250.1,Type 1 diabetes,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.73 (0.71 0.76),4.86E-76
250.1,Type 1 diabetes,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.36 (1.31 1.40),8.00E-75
250.1,Type 1 diabetes,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.32 (1.27 1.36),1.43E-57
250.1,Type 1 diabetes,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.80 (0.77 0.82),5.21E-44
250.1,Type 1 diabetes,endocrine/metabolic,OPGS012171,0.039,RNAseq,TRBV15,0.79 (0.76 0.81),7.13E-43
250.1,Type 1 diabetes,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.26 (1.22 1.30),8.92E-42
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010624,0.059,RNAseq,TRBV18,1.28 (1.23 1.32),2.76E-41
250.1,Type 1 diabetes,endocrine/metabolic,OPGS006038,0.201,RNAseq,HLA-DQA2,1.23 (1.20 1.27),7.04E-41
250.1,Type 1 diabetes,endocrine/metabolic,OPGS005334,0.253,RNAseq,AL645933.4,0.80 (0.77 0.83),8.27E-35
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009865,0.072,RNAseq,TRAV17,0.82 (0.79 0.84),8.68E-32
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009198,0.085,RNAseq,TRAV12-1,1.24 (1.20 1.28),1.28E-31
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011536,0.047,RNAseq,TRAV2,0.81 (0.78 0.84),2.78E-28
250.1,Type 1 diabetes,endocrine/metabolic,OPGS005230,0.263,RNAseq,LINC00243,1.21 (1.17 1.26),1.57E-26
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011853,0.043,RNAseq,TRBV6-1,0.82 (0.79 0.85),8.51E-26
250.1,Type 1 diabetes,endocrine/metabolic,OPGS004122,0.430,RNAseq,HLA-DRB5,0.83 (0.80 0.86),3.74E-22
250.1,Type 1 diabetes,endocrine/metabolic,OPGS003680,0.611,RNAseq,,1.17 (1.14 1.21),1.29E-20
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010348,0.063,RNAseq,TRBV6-5,1.18 (1.14 1.22),1.97E-20
250.1,Type 1 diabetes,endocrine/metabolic,OPGS014496,0.019,RNAseq,VARS1,1.17 (1.13 1.20),2.87E-19
250.1,Type 1 diabetes,endocrine/metabolic,OPGS012006,0.041,RNAseq,VARS2,0.86 (0.83 0.88),5.51E-18
250.1,Type 1 diabetes,endocrine/metabolic,OPGS004213,0.410,RNAseq,,1.16 (1.13 1.20),6.32E-18
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011787,0.044,RNAseq,C2,1.17 (1.13 1.21),3.88E-17
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011784,0.044,RNAseq,TUBB,1.18 (1.13 1.22),1.06E-16
250.1,Type 1 diabetes,endocrine/metabolic,OPGS007145,0.146,RNAseq,BAG6,1.16 (1.12 1.20),1.07E-16
250.1,Type 1 diabetes,endocrine/metabolic,OPGS007407,0.135,RNAseq,TRBV2,1.16 (1.12 1.20),3.33E-16
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010826,0.056,RNAseq,TRIM10,0.87 (0.84 0.90),7.14E-16
250.1,Type 1 diabetes,endocrine/metabolic,OPGS013660,0.025,RNAseq,CD8A,1.16 (1.12 1.20),3.01E-15
250.1,Type 1 diabetes,endocrine/metabolic,OPGS007018,0.151,RNAseq,TRBV10-3,1.17 (1.13 1.21),3.40E-15
250.1,Type 1 diabetes,endocrine/metabolic,OPGS013305,0.028,RNAseq,TRBV14,0.87 (0.84 0.90),4.38E-15
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.19 (1.14 1.24),4.44E-15
250.1,Type 1 diabetes,endocrine/metabolic,OPGS008867,0.093,RNAseq,TSBP1-AS1,1.17 (1.13 1.21),7.57E-15
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009278,0.084,RNAseq,,0.87 (0.84 0.90),6.15E-14
250.1,Type 1 diabetes,endocrine/metabolic,OPGS004406,0.369,RNAseq,,0.87 (0.84 0.90),2.36E-13
250.1,Type 1 diabetes,endocrine/metabolic,OPGS013201,0.029,RNAseq,NRCAM,0.87 (0.84 0.90),1.02E-12
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011086,0.053,RNAseq,HSPA1B,0.87 (0.84 0.90),1.90E-12
250.1,Type 1 diabetes,endocrine/metabolic,OPGS006866,0.157,RNAseq,AL662795.2,1.15 (1.11 1.19),3.18E-12
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009072,0.088,RNAseq,HLA-DQB1,0.88 (0.85 0.91),3.65E-12
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009118,0.087,RNAseq,LY6G5C,0.89 (0.87 0.92),8.17E-11
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011494,0.047,RNAseq,RNF26,1.13 (1.09 1.17),1.61E-10
250.1,Type 1 diabetes,endocrine/metabolic,OPGS008889,0.092,RNAseq,TRAV20,1.13 (1.09 1.17),2.31E-10
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011265,0.050,RNAseq,HSPA5,0.89 (0.86 0.92),2.63E-10
250.1,Type 1 diabetes,endocrine/metabolic,OPGS005005,0.286,RNAseq,HLA-DOA,0.89 (0.86 0.92),4.45E-09
250.1,Type 1 diabetes,endocrine/metabolic,OPGS004144,0.424,RNAseq,PSORS1C3,1.11 (1.08 1.15),4.88E-09
250.1,Type 1 diabetes,endocrine/metabolic,OPGS008786,0.094,RNAseq,GABBR1,1.13 (1.09 1.17),6.75E-09
250.1,Type 1 diabetes,endocrine/metabolic,OPGS007297,0.140,RNAseq,GPANK1,0.88 (0.85 0.92),1.19E-08
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010700,0.058,RNAseq,DCLRE1B,0.90 (0.87 0.93),1.39E-08
250.1,Type 1 diabetes,endocrine/metabolic,OPGS008402,0.104,RNAseq,TNXB,1.11 (1.08 1.15),3.07E-08
250.1,Type 1 diabetes,endocrine/metabolic,OPGS014758,0.017,RNAseq,TRAV10,1.12 (1.08 1.16),3.13E-08
250.1,Type 1 diabetes,endocrine/metabolic,OPGS014985,0.016,RNAseq,PDLIM7,0.90 (0.87 0.93),6.72E-08
250.1,Type 1 diabetes,endocrine/metabolic,OPGS012028,0.041,RNAseq,HLA-DQB1-AS1,0.90 (0.87 0.93),1.06E-07
250.1,Type 1 diabetes,endocrine/metabolic,OPGS014176,0.021,RNAseq,TRAV27,1.11 (1.07 1.14),1.33E-07
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010874,0.056,RNAseq,ALS2CL,0.90 (0.87 0.93),1.47E-07
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011948,0.042,RNAseq,ADGRG1,0.90 (0.87 0.93),1.85E-07
250.1,Type 1 diabetes,endocrine/metabolic,OPGS015052,0.015,RNAseq,CISH,1.11 (1.07 1.15),4.53E-07
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011716,0.045,RNAseq,FBLN7,0.90 (0.87 0.93),4.53E-07
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011025,0.053,RNAseq,MDC1,1.09 (1.06 1.12),7.34E-07
250.1,Type 1 diabetes,endocrine/metabolic,OPGS012271,0.038,RNAseq,TRBV5-6,0.92 (0.89 0.95),9.91E-07
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010693,0.058,RNAseq,TRBV5-1,1.10 (1.07 1.14),1.35E-06
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009404,0.081,RNAseq,GCSAM,0.91 (0.88 0.94),1.76E-06
250.1,Type 1 diabetes,endocrine/metabolic,OPGS013013,0.031,RNAseq,FOXJ1,0.91 (0.88 0.94),3.62E-06
250.1,Type 1 diabetes,endocrine/metabolic,OPGS013225,0.029,RNAseq,REG4,0.91 (0.88 0.94),4.49E-06
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010779,0.057,RNAseq,ACE,1.10 (1.06 1.14),4.49E-06
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011626,0.046,RNAseq,ABCF1,1.09 (1.06 1.13),7.12E-06
250.1,Type 1 diabetes,endocrine/metabolic,OPGS013639,0.025,RNAseq,H2BC15,0.93 (0.90 0.95),1.25E-05
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009626,0.076,RNAseq,APBA2,0.91 (0.88 0.94),1.65E-05
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009672,0.076,RNAseq,CALR,0.91 (0.88 0.94),1.81E-05
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010607,0.059,RNAseq,TRAV8-1,1.09 (1.06 1.13),3.48E-05
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009077,0.088,RNAseq,DDAH2,0.91 (0.88 0.95),4.60E-05
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009241,0.084,RNAseq,ZKSCAN4,1.09 (1.05 1.12),8.03E-05
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010142,0.067,RNAseq,PRSS16,1.08 (1.05 1.12),8.80E-05
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011431,0.048,RNAseq,VWA7,1.09 (1.05 1.13),9.43E-05
250.1,Type 1 diabetes,endocrine/metabolic,OPGS014075,0.022,RNAseq,AGER,0.92 (0.89 0.95),1.23E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS008841,0.093,RNAseq,HSD17B8,1.09 (1.05 1.13),1.64E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS007237,0.142,RNAseq,COL11A2,0.91 (0.88 0.95),1.98E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010661,0.059,RNAseq,PTPN22,1.08 (1.05 1.12),2.06E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS007240,0.142,RNAseq,,0.92 (0.88 0.95),2.30E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS006048,0.200,RNAseq,,0.92 (0.89 0.95),2.78E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS013595,0.026,RNAseq,NINJ2,1.09 (1.05 1.13),3.00E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010564,0.060,RNAseq,CEACAM6,0.92 (0.89 0.95),3.14E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS007384,0.137,RNAseq,HLA-B,0.93 (0.90 0.96),3.58E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011472,0.047,RNAseq,FEZ1,0.92 (0.89 0.96),3.80E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS003843,0.532,RNAseq,BTN3A2,0.93 (0.90 0.96),4.00E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS003621,0.665,RNAseq,,0.92 (0.89 0.96),6.37E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS013472,0.027,RNAseq,STAT1,1.08 (1.04 1.12),9.21E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS015030,0.016,RNAseq,PRRC2A,1.08 (1.04 1.12),9.66E-04
250.1,Type 1 diabetes,endocrine/metabolic,OPGS012093,0.040,RNAseq,TRIM26,1.08 (1.04 1.12),1.13E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS004567,0.343,RNAseq,HLA-C,0.93 (0.90 0.96),1.69E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS008281,0.107,RNAseq,HLA-F-AS1,0.93 (0.90 0.96),1.72E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS006942,0.154,RNAseq,SKIV2L,0.93 (0.90 0.96),1.81E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS012761,0.033,RNAseq,TRAV12-3,1.08 (1.04 1.12),1.81E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS008019,0.115,RNAseq,HLA-DOB,1.08 (1.04 1.11),1.92E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS004112,0.433,RNAseq,HLA-F,0.93 (0.90 0.96),2.08E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011585,0.046,RNAseq,CD8B,1.07 (1.04 1.11),3.48E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS013045,0.030,RNAseq,NEU1,0.93 (0.90 0.96),4.16E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS005519,0.236,RNAseq,AL645933.3,0.93 (0.90 0.97),4.71E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS006001,0.203,RNAseq,HLA-DQA1,0.93 (0.90 0.96),5.47E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS006408,0.180,RNAseq,SCAP,1.07 (1.04 1.11),6.42E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009225,0.085,RNAseq,CD5,0.93 (0.90 0.97),6.90E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS013068,0.030,RNAseq,AL021807.1,1.07 (1.03 1.11),7.92E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS005489,0.239,RNAseq,TRAPPC5,0.94 (0.90 0.97),9.98E-03
250.1,Type 1 diabetes,endocrine/metabolic,OPGS014680,0.018,RNAseq,GALE,0.94 (0.91 0.97),1.24E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS004489,0.357,RNAseq,,0.94 (0.90 0.97),1.25E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS004334,0.383,RNAseq,HLA-G,0.94 (0.90 0.97),1.34E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS008699,0.097,RNAseq,DUSP4,1.07 (1.03 1.11),1.43E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS014580,0.018,RNAseq,DACT1,1.07 (1.03 1.11),1.46E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009962,0.070,RNAseq,CCHCR1,1.07 (1.03 1.10),1.57E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS004759,0.315,RNAseq,BCL2L13,1.07 (1.03 1.11),1.66E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS014375,0.020,RNAseq,MUS81,1.07 (1.03 1.10),1.93E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010014,0.069,RNAseq,LINC02245,1.07 (1.03 1.10),2.06E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS013324,0.028,RNAseq,PRF1,0.95 (0.92 0.97),2.44E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS012070,0.040,RNAseq,P4HTM,1.06 (1.03 1.10),2.44E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011157,0.051,RNAseq,DCP1A,1.06 (1.03 1.10),2.49E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS005280,0.258,RNAseq,DEXI,0.94 (0.91 0.97),2.49E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS013699,0.025,RNAseq,TRAV5,1.06 (1.03 1.10),2.49E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS011812,0.043,RNAseq,KLHDC8A,1.06 (1.03 1.10),3.02E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS012123,0.040,RNAseq,SLFN13,0.94 (0.92 0.97),3.12E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS008635,0.098,RNAseq,KIRREL3,1.06 (1.03 1.10),3.37E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS014283,0.021,RNAseq,MXRA8,0.94 (0.91 0.97),3.39E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS010917,0.055,RNAseq,LSM2,1.07 (1.03 1.11),3.39E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS004077,0.443,RNAseq,HDHD3,0.94 (0.91 0.98),3.79E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS004897,0.299,RNAseq,AC018647.2,0.94 (0.91 0.97),4.10E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS006705,0.165,RNAseq,MAU2,0.94 (0.91 0.98),4.39E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS003620,0.668,RNAseq,ZFP57,1.06 (1.03 1.10),4.72E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS008059,0.114,RNAseq,PCSK5,1.06 (1.03 1.10),4.73E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS006148,0.194,RNAseq,SDHC,0.95 (0.92 0.98),4.75E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009171,0.086,RNAseq,NTN5,1.06 (1.03 1.10),4.78E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS009083,0.088,RNAseq,ZBTB11-AS1,1.06 (1.03 1.10),4.84E-02
250.1,Type 1 diabetes,endocrine/metabolic,OPGS012562,0.035,RNAseq,H2BC17,1.06 (1.03 1.10),4.97E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.57 (0.51 0.63),1.13E-24
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.63 (1.47 1.80),2.03E-18
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.43 (0.36 0.52),1.88E-17
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000576,0.102,SomaScan,Interleukin-21,0.66 (0.60 0.73),8.88E-15
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.68 (0.62 0.75),1.07E-12
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.52 (1.37 1.69),5.32E-12
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001231,0.037,SomaScan,Osteocalcin,1.51 (1.36 1.68),1.04E-11
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.68 (0.62 0.75),2.32E-11
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.64 (0.57 0.72),3.36E-11
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.57 (1.40 1.77),6.02E-11
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.69 (0.63 0.76),6.02E-11
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.71 (0.64 0.78),1.05E-09
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.44 (1.30 1.59),1.58E-09
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.39 (1.26 1.53),3.18E-08
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.71 (0.64 0.79),9.00E-08
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.74 (0.67 0.81),1.63E-07
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000290,0.171,SomaScan,Complement C4,0.71 (0.64 0.79),3.40E-07
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001911,0.014,SomaScan,Ectodysplasin-A. secreted form,0.62 (0.54 0.73),3.82E-07
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.68 (0.60 0.77),4.28E-07
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001893,0.015,SomaScan,Interleukin-17F,0.66 (0.57 0.75),4.39E-07
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.75 (0.68 0.83),1.51E-05
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.72 (0.63 0.82),2.70E-04
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.77 (0.69 0.86),2.87E-04
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000191,0.247,SomaScan,Tenascin-X,0.81 (0.73 0.89),4.89E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,1.25 (1.12 1.40),1.20E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000390,0.141,SomaScan,Palmitoyl-protein thioesterase 1,1.24 (1.11 1.38),1.93E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.82 (0.73 0.91),2.49E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001553,0.024,SomaScan,Protein G6b,1.25 (1.11 1.40),2.49E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,1.23 (1.10 1.37),2.65E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,0.77 (0.68 0.89),2.78E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.82 (0.73 0.91),3.84E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.23 (1.10 1.37),4.53E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.54 (0.48 0.60),5.56E-25
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.64 (0.58 0.71),8.88E-15
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.68 (0.60 0.76),5.32E-09
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.72 (0.65 0.80),9.67E-08
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS002551,0.054,Olink,Gastrotropin,0.77 (0.69 0.86),3.29E-04
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,0.79 (0.70 0.88),6.93E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.65 (0.60 0.70),7.77E-29
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.56 (0.51 0.61),1.36E-28
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.75 (1.59 1.93),6.71E-26
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.67 (1.51 1.85),7.17E-20
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.64 (0.58 0.70),3.27E-19
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS005334,0.253,RNAseq,AL645933.4,0.61 (0.55 0.68),1.84E-16
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.55 (1.41 1.71),9.07E-16
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS009865,0.072,RNAseq,TRAV17,0.67 (0.61 0.74),3.92E-13
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS011853,0.043,RNAseq,TRBV6-1,0.64 (0.57 0.72),4.09E-12
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS010624,0.059,RNAseq,TRBV18,1.55 (1.39 1.72),4.58E-12
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS014496,0.019,RNAseq,VARS1,1.43 (1.31 1.57),6.93E-12
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS004122,0.430,RNAseq,HLA-DRB5,0.63 (0.56 0.70),6.93E-12
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS009198,0.085,RNAseq,TRAV12-1,1.52 (1.36 1.70),3.14E-11
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS006038,0.201,RNAseq,HLA-DQA2,1.39 (1.27 1.51),6.14E-11
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS005230,0.263,RNAseq,LINC00243,1.48 (1.33 1.65),1.93E-10
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS011536,0.047,RNAseq,TRAV2,0.65 (0.58 0.73),2.36E-10
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS011086,0.053,RNAseq,HSPA1B,0.68 (0.61 0.76),2.67E-10
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS003680,0.611,RNAseq,,1.40 (1.28 1.54),5.75E-10
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS012006,0.041,RNAseq,VARS2,0.70 (0.63 0.77),9.24E-10
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS011787,0.044,RNAseq,C2,1.44 (1.30 1.59),1.58E-09
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS007407,0.135,RNAseq,TRBV2,1.42 (1.28 1.57),4.33E-09
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS010826,0.056,RNAseq,TRIM10,0.73 (0.67 0.80),2.54E-08
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS012171,0.039,RNAseq,TRBV15,0.71 (0.64 0.79),3.65E-08
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS009072,0.088,RNAseq,HLA-DQB1,0.75 (0.68 0.82),2.45E-07
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS009118,0.087,RNAseq,LY6G5C,0.77 (0.71 0.84),5.72E-07
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS011784,0.044,RNAseq,TUBB,1.41 (1.26 1.58),6.67E-07
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS004213,0.410,RNAseq,,1.33 (1.21 1.46),7.32E-07
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS004406,0.369,RNAseq,,0.72 (0.65 0.80),1.15E-06
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS013660,0.025,RNAseq,CD8A,1.38 (1.23 1.53),2.15E-06
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS011265,0.050,RNAseq,HSPA5,0.76 (0.69 0.84),3.54E-06
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS008786,0.094,RNAseq,GABBR1,1.39 (1.23 1.56),1.49E-05
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS010607,0.059,RNAseq,TRAV8-1,1.33 (1.20 1.47),1.77E-05
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.53 (1.30 1.80),5.14E-05
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS008867,0.093,RNAseq,TSBP1-AS1,1.38 (1.22 1.56),6.19E-05
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS013045,0.030,RNAseq,NEU1,0.77 (0.70 0.85),8.86E-05
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS013201,0.029,RNAseq,NRCAM,0.74 (0.66 0.83),1.90E-04
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS006048,0.200,RNAseq,,0.74 (0.66 0.84),1.99E-04
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS012093,0.040,RNAseq,TRIM26,1.30 (1.17 1.45),2.70E-04
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS010700,0.058,RNAseq,DCLRE1B,0.80 (0.73 0.88),2.75E-04
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS015052,0.015,RNAseq,CISH,1.31 (1.18 1.47),3.29E-04
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS009672,0.076,RNAseq,CALR,0.77 (0.69 0.86),3.39E-04
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS010348,0.063,RNAseq,TRBV6-5,1.29 (1.16 1.43),3.53E-04
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS010693,0.058,RNAseq,TRBV5-1,1.28 (1.15 1.41),5.23E-04
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS013225,0.029,RNAseq,REG4,0.78 (0.71 0.87),6.21E-04
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS010874,0.056,RNAseq,ALS2CL,0.76 (0.68 0.85),7.64E-04
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS009404,0.081,RNAseq,GCSAM,0.80 (0.72 0.88),1.51E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS013013,0.031,RNAseq,FOXJ1,0.81 (0.73 0.89),1.52E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS006866,0.157,RNAseq,AL662795.2,1.28 (1.14 1.43),2.79E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS012028,0.041,RNAseq,HLA-DQB1-AS1,0.79 (0.72 0.88),2.94E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS007297,0.140,RNAseq,GPANK1,0.76 (0.67 0.86),3.70E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS007956,0.117,RNAseq,PHTF1,0.80 (0.72 0.89),4.52E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS014985,0.016,RNAseq,PDLIM7,0.80 (0.72 0.89),4.97E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS007018,0.151,RNAseq,TRBV10-3,1.28 (1.14 1.44),5.93E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS010661,0.059,RNAseq,PTPN22,1.24 (1.12 1.38),6.71E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS008889,0.092,RNAseq,TRAV20,1.24 (1.12 1.37),8.65E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS014176,0.021,RNAseq,TRAV27,1.23 (1.11 1.35),8.95E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS007145,0.146,RNAseq,BAG6,1.23 (1.11 1.36),9.86E-03
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS005257,0.260,RNAseq,ITGB7,1.20 (1.10 1.32),1.52E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS004144,0.424,RNAseq,PSORS1C3,1.21 (1.10 1.33),1.52E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS010564,0.060,RNAseq,CEACAM6,0.81 (0.73 0.90),1.56E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS009464,0.080,RNAseq,CTLA4,0.81 (0.73 0.90),1.56E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS009626,0.076,RNAseq,APBA2,0.79 (0.70 0.90),2.78E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS010142,0.067,RNAseq,PRSS16,1.19 (1.09 1.31),2.78E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS004138,0.426,RNAseq,HEBP1,0.82 (0.74 0.91),2.78E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS014758,0.017,RNAseq,TRAV10,1.25 (1.11 1.40),2.78E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS013305,0.028,RNAseq,TRBV14,0.83 (0.75 0.91),2.79E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS008075,0.113,RNAseq,AKAP12,1.20 (1.09 1.33),3.59E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS013227,0.029,RNAseq,ZEB1-AS1,1.17 (1.07 1.27),4.11E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS009278,0.084,RNAseq,,0.82 (0.74 0.91),4.63E-02
250.11,Type 1 diabetes with ketoacidosis,endocrine/metabolic,OPGS014075,0.022,RNAseq,AGER,0.82 (0.73 0.91),4.91E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.61 (0.57 0.65),1.08E-36
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.58 (1.47 1.70),5.95E-32
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.49 (0.44 0.55),1.93E-29
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000576,0.102,SomaScan,Interleukin-21,0.67 (0.63 0.72),4.70E-27
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.68 (0.63 0.73),1.15E-25
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.69 (0.64 0.74),6.38E-23
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.49 (1.38 1.61),6.71E-22
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.69 (0.65 0.74),6.72E-22
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.66 (0.61 0.72),3.26E-19
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000290,0.171,SomaScan,Complement C4,0.69 (0.63 0.74),3.04E-18
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.72 (0.67 0.77),4.54E-18
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001231,0.037,SomaScan,Osteocalcin,1.43 (1.32 1.54),2.04E-17
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.71 (0.66 0.76),9.48E-17
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.40 (1.30 1.51),1.90E-16
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.37 (1.27 1.47),4.02E-15
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.74 (0.69 0.79),5.01E-15
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.44 (1.33 1.57),9.74E-15
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.71 (0.65 0.78),1.14E-11
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.71 (0.64 0.78),1.37E-09
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001893,0.015,SomaScan,Interleukin-17F,0.73 (0.66 0.80),1.62E-09
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001911,0.014,SomaScan,Ectodysplasin-A. secreted form,0.71 (0.65 0.79),2.87E-09
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.79 (0.73 0.85),4.97E-08
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000390,0.141,SomaScan,Palmitoyl-protein thioesterase 1,1.28 (1.18 1.38),1.12E-07
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.80 (0.74 0.86),1.26E-06
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,0.77 (0.70 0.84),1.35E-05
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.23 (1.14 1.33),2.10E-05
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,1.21 (1.12 1.31),2.27E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,0.82 (0.76 0.89),2.63E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,1.21 (1.12 1.31),3.87E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.83 (0.77 0.90),4.40E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.21 (1.12 1.31),5.43E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.84 (0.78 0.91),1.41E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000137,0.312,SomaScan,Complement C4b,0.84 (0.78 0.91),1.55E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000191,0.247,SomaScan,Tenascin-X,0.85 (0.79 0.92),2.50E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,0.86 (0.79 0.92),3.73E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001553,0.024,SomaScan,Protein G6b,1.18 (1.09 1.28),7.26E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000123,0.339,SomaScan,GDH/6PGL endoplasmic bifunctional protein,0.86 (0.79 0.93),1.03E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000899,0.063,SomaScan,Collagen alpha-2(XI) chain,0.85 (0.79 0.92),1.11E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,0.85 (0.78 0.92),1.24E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000517,0.114,SomaScan,Advanced glycosylation end product-specific receptor. soluble,0.86 (0.80 0.93),1.32E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000645,0.091,SomaScan,Trypsin-3,1.17 (1.08 1.27),1.34E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001400,0.029,SomaScan,Plexin-A1,1.16 (1.07 1.26),3.87E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001885,0.015,SomaScan,Cathepsin L2,0.86 (0.79 0.94),5.00E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.60 (0.56 0.65),9.11E-35
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.63 (0.58 0.68),4.11E-25
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.72 (0.67 0.77),1.30E-16
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.75 (0.70 0.81),8.70E-12
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002428,0.212,Olink,Secreted frizzled-related protein 3,0.82 (0.76 0.89),1.84E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002427,0.216,Olink,Alpha-2-macroglobulin receptor-associated protein,0.78 (0.70 0.87),1.33E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002568,0.043,Olink,Granzyme A,0.85 (0.79 0.92),2.86E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,0.84 (0.78 0.91),2.88E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002551,0.054,Olink,Gastrotropin,0.85 (0.79 0.92),5.18E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002643,0.018,Olink,Neuroblastoma suppressor of tumorigenicity 1,0.87 (0.81 0.94),3.49E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002813,0.087,Metabolon,histidylalanine,0.82 (0.76 0.89),3.01E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS003180,0.013,Metabolon,1-palmitoyl-GPA (16:0),1.19 (1.08 1.32),4.75E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS003497,0.072,Nightingale,Linoleic acid,0.85 (0.79 0.92),4.50E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.56 (0.52 0.60),4.44E-56
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.65 (0.62 0.69),5.40E-56
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.71 (1.59 1.83),3.18E-47
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.67 (1.55 1.79),3.82E-39
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.66 (0.62 0.70),5.95E-32
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.51 (1.41 1.62),1.08E-27
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS005334,0.253,RNAseq,AL645933.4,0.66 (0.61 0.71),5.98E-24
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010624,0.059,RNAseq,TRBV18,1.54 (1.42 1.66),6.74E-24
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009865,0.072,RNAseq,TRAV17,0.69 (0.64 0.74),8.88E-23
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS006038,0.201,RNAseq,HLA-DQA2,1.38 (1.29 1.47),4.70E-21
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011787,0.044,RNAseq,C2,1.46 (1.35 1.57),9.42E-21
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS012171,0.039,RNAseq,TRBV15,0.70 (0.65 0.75),2.54E-19
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011853,0.043,RNAseq,TRBV6-1,0.68 (0.63 0.74),2.34E-18
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009198,0.085,RNAseq,TRAV12-1,1.44 (1.33 1.56),1.65E-17
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS005230,0.263,RNAseq,LINC00243,1.43 (1.33 1.55),1.71E-17
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS014496,0.019,RNAseq,VARS1,1.36 (1.28 1.46),2.06E-17
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011784,0.044,RNAseq,TUBB,1.43 (1.31 1.55),4.02E-15
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS012006,0.041,RNAseq,VARS2,0.73 (0.68 0.78),5.83E-15
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011536,0.047,RNAseq,TRAV2,0.71 (0.65 0.77),1.75E-14
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS004122,0.430,RNAseq,HLA-DRB5,0.70 (0.64 0.76),2.13E-14
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010826,0.056,RNAseq,TRIM10,0.75 (0.70 0.81),1.01E-13
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS007018,0.151,RNAseq,TRBV10-3,1.43 (1.31 1.56),1.38E-13
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS003680,0.611,RNAseq,,1.33 (1.24 1.42),1.41E-13
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS004406,0.369,RNAseq,,0.73 (0.68 0.79),3.50E-12
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS013660,0.025,RNAseq,CD8A,1.33 (1.23 1.44),9.19E-11
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS007407,0.135,RNAseq,TRBV2,1.30 (1.21 1.40),5.08E-10
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011086,0.053,RNAseq,HSPA1B,0.76 (0.70 0.82),5.47E-10
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009072,0.088,RNAseq,HLA-DQB1,0.78 (0.73 0.84),7.33E-10
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS007145,0.146,RNAseq,BAG6,1.29 (1.20 1.38),1.42E-09
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS013225,0.029,RNAseq,REG4,0.78 (0.72 0.84),5.66E-09
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.44 (1.30 1.61),7.80E-09
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010348,0.063,RNAseq,TRBV6-5,1.29 (1.19 1.39),8.65E-09
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009118,0.087,RNAseq,LY6G5C,0.81 (0.76 0.86),9.43E-09
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011494,0.047,RNAseq,RNF26,1.29 (1.20 1.40),9.60E-09
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS004213,0.410,RNAseq,,1.26 (1.18 1.35),1.14E-08
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS013201,0.029,RNAseq,NRCAM,0.76 (0.69 0.82),3.73E-08
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS006866,0.157,RNAseq,AL662795.2,1.30 (1.20 1.40),5.89E-08
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS014176,0.021,RNAseq,TRAV27,1.25 (1.17 1.34),8.75E-08
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009278,0.084,RNAseq,,0.78 (0.73 0.85),8.98E-08
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS008889,0.092,RNAseq,TRAV20,1.26 (1.17 1.36),1.98E-07
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010564,0.060,RNAseq,CEACAM6,0.79 (0.73 0.85),2.27E-07
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010693,0.058,RNAseq,TRBV5-1,1.25 (1.17 1.35),2.96E-07
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS012028,0.041,RNAseq,HLA-DQB1-AS1,0.80 (0.74 0.86),5.35E-07
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010607,0.059,RNAseq,TRAV8-1,1.25 (1.16 1.34),9.25E-07
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS013045,0.030,RNAseq,NEU1,0.81 (0.75 0.87),1.33E-06
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS012093,0.040,RNAseq,TRIM26,1.25 (1.16 1.35),1.60E-06
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011025,0.053,RNAseq,MDC1,1.17 (1.11 1.23),6.07E-06
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS015052,0.015,RNAseq,CISH,1.24 (1.14 1.34),1.98E-05
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009222,0.085,RNAseq,,0.82 (0.76 0.88),2.84E-05
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010874,0.056,RNAseq,ALS2CL,0.81 (0.75 0.88),7.07E-05
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS008867,0.093,RNAseq,TSBP1-AS1,1.24 (1.14 1.35),7.49E-05
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS007297,0.140,RNAseq,GPANK1,0.80 (0.73 0.87),7.89E-05
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS013013,0.031,RNAseq,FOXJ1,0.84 (0.78 0.90),1.28E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS008786,0.094,RNAseq,GABBR1,1.23 (1.13 1.33),1.72E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS012698,0.034,RNAseq,SNHG32,0.81 (0.75 0.89),2.72E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS013305,0.028,RNAseq,TRBV14,0.84 (0.78 0.90),3.82E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009404,0.081,RNAseq,GCSAM,0.84 (0.78 0.90),4.06E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009077,0.088,RNAseq,DDAH2,0.83 (0.76 0.90),4.37E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010212,0.066,RNAseq,PSMB9,1.19 (1.10 1.27),5.40E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS005005,0.286,RNAseq,HLA-DOA,0.84 (0.78 0.90),5.68E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS003843,0.532,RNAseq,BTN3A2,0.85 (0.79 0.91),6.96E-04
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009241,0.084,RNAseq,ZKSCAN4,1.18 (1.09 1.26),1.23E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010779,0.057,RNAseq,ACE,1.19 (1.10 1.28),1.26E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS012761,0.033,RNAseq,TRAV12-3,1.20 (1.11 1.30),1.55E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011716,0.045,RNAseq,FBLN7,0.84 (0.78 0.91),1.94E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS008841,0.093,RNAseq,HSD17B8,1.20 (1.11 1.31),2.01E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010930,0.055,RNAseq,RET,0.85 (0.79 0.92),2.06E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009626,0.076,RNAseq,APBA2,0.83 (0.76 0.90),2.15E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011948,0.042,RNAseq,ADGRG1,0.84 (0.78 0.91),2.23E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS013639,0.025,RNAseq,H2BC15,0.89 (0.84 0.94),2.55E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS003621,0.665,RNAseq,,0.85 (0.78 0.92),3.42E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS008402,0.104,RNAseq,TNXB,1.17 (1.08 1.25),4.05E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS014283,0.021,RNAseq,MXRA8,0.85 (0.78 0.92),4.23E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010926,0.055,RNAseq,CACNA2D4,0.86 (0.80 0.93),5.38E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010700,0.058,RNAseq,DCLRE1B,0.87 (0.81 0.93),5.80E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS004144,0.424,RNAseq,PSORS1C3,1.15 (1.07 1.23),9.34E-03
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010142,0.067,RNAseq,PRSS16,1.15 (1.07 1.23),1.12E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010929,0.055,RNAseq,EOMES,0.86 (0.79 0.93),1.15E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS013595,0.026,RNAseq,NINJ2,1.18 (1.09 1.28),1.18E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS014758,0.017,RNAseq,TRAV10,1.18 (1.08 1.28),1.18E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS006048,0.200,RNAseq,,0.85 (0.79 0.92),1.21E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS005104,0.276,RNAseq,APBB2,1.15 (1.07 1.23),1.47E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011472,0.047,RNAseq,FEZ1,0.86 (0.80 0.93),1.49E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS014443,0.019,RNAseq,ABCB1,0.86 (0.79 0.93),1.61E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS013068,0.030,RNAseq,AL021807.1,1.15 (1.07 1.24),2.13E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS007384,0.137,RNAseq,HLA-B,0.87 (0.81 0.94),2.20E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS013780,0.024,RNAseq,ZSCAN16,1.15 (1.07 1.23),2.26E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS008015,0.115,RNAseq,HNRNPLL,0.87 (0.81 0.94),2.76E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS004334,0.383,RNAseq,HLA-G,0.87 (0.80 0.94),2.89E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS014075,0.022,RNAseq,AGER,0.86 (0.80 0.93),2.89E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011591,0.046,RNAseq,H2AJ,1.14 (1.06 1.22),2.89E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS003620,0.668,RNAseq,ZFP57,1.14 (1.06 1.23),3.49E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010739,0.057,RNAseq,CUTA,0.85 (0.77 0.93),4.22E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS007248,0.141,RNAseq,,0.86 (0.79 0.93),4.28E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011265,0.050,RNAseq,HSPA5,0.88 (0.82 0.94),4.41E-02
250.13,Type 1 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS007866,0.119,RNAseq,TSHZ2,0.87 (0.81 0.94),4.82E-02
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.63 (0.56 0.71),3.50E-10
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.55 (1.37 1.75),2.24E-09
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.51 (0.42 0.61),4.10E-09
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS000576,0.102,SomaScan,Interleukin-21,0.68 (0.61 0.76),6.53E-08
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS001231,0.037,SomaScan,Osteocalcin,1.49 (1.31 1.69),6.99E-07
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.49 (1.31 1.69),7.64E-07
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.69 (0.62 0.78),8.63E-07
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.54 (1.33 1.77),2.63E-06
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.66 (0.58 0.76),4.82E-06
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.71 (0.63 0.80),8.28E-06
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS000290,0.171,SomaScan,Complement C4,0.68 (0.60 0.78),9.66E-06
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.72 (0.64 0.81),2.14E-05
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.73 (0.65 0.82),8.47E-05
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.39 (1.23 1.57),9.27E-05
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.69 (0.59 0.80),3.92E-04
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.34 (1.19 1.50),7.95E-04
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS000390,0.141,SomaScan,Palmitoyl-protein thioesterase 1,1.37 (1.20 1.56),9.52E-04
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.77 (0.69 0.87),4.10E-03
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.77 (0.68 0.88),1.67E-02
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.61 (0.53 0.69),8.44E-11
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.71 (0.63 0.80),1.32E-05
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.72 (0.63 0.81),4.42E-05
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.73 (0.64 0.84),1.80E-03
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS002551,0.054,Olink,Gastrotropin,0.74 (0.65 0.85),2.28E-03
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.74 (1.55 1.96),1.17E-16
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.61 (0.54 0.68),2.99E-13
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.63 (0.56 0.70),2.99E-13
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.68 (0.63 0.75),3.29E-13
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.61 (1.43 1.82),4.95E-11
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS004122,0.430,RNAseq,HLA-DRB5,0.60 (0.52 0.69),2.88E-09
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS010624,0.059,RNAseq,TRBV18,1.55 (1.36 1.76),9.44E-08
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS014496,0.019,RNAseq,VARS1,1.43 (1.28 1.59),1.61E-07
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS005334,0.253,RNAseq,AL645933.4,0.67 (0.59 0.76),3.87E-07
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS013660,0.025,RNAseq,CD8A,1.52 (1.33 1.73),4.47E-07
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.44 (1.28 1.62),9.91E-07
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS011853,0.043,RNAseq,TRBV6-1,0.66 (0.58 0.76),1.33E-06
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS009865,0.072,RNAseq,TRAV17,0.70 (0.63 0.79),3.50E-06
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS006038,0.201,RNAseq,HLA-DQA2,1.34 (1.21 1.49),3.07E-05
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS009118,0.087,RNAseq,LY6G5C,0.76 (0.68 0.84),3.23E-05
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS009198,0.085,RNAseq,TRAV12-1,1.41 (1.24 1.61),8.47E-05
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS011787,0.044,RNAseq,C2,1.38 (1.22 1.56),1.32E-04
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS007145,0.146,RNAseq,BAG6,1.34 (1.19 1.50),6.60E-04
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS013045,0.030,RNAseq,NEU1,0.75 (0.67 0.85),1.06E-03
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS012006,0.041,RNAseq,VARS2,0.75 (0.67 0.85),1.48E-03
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS011025,0.053,RNAseq,MDC1,1.21 (1.12 1.32),2.28E-03
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS003680,0.611,RNAseq,,1.30 (1.16 1.45),2.46E-03
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.56 (1.28 1.89),2.79E-03
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS005230,0.263,RNAseq,LINC00243,1.34 (1.18 1.52),2.82E-03
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS004406,0.369,RNAseq,,0.74 (0.65 0.85),2.84E-03
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS011536,0.047,RNAseq,TRAV2,0.75 (0.65 0.85),6.29E-03
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS012171,0.039,RNAseq,TRBV15,0.77 (0.68 0.87),7.14E-03
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS007407,0.135,RNAseq,TRBV2,1.29 (1.14 1.46),1.48E-02
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS011086,0.053,RNAseq,HSPA1B,0.76 (0.67 0.87),1.48E-02
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS009530,0.078,RNAseq,AC243829.4,1.22 (1.10 1.34),1.66E-02
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS012761,0.033,RNAseq,TRAV12-3,1.32 (1.15 1.51),1.67E-02
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS008053,0.114,RNAseq,EDEM2,1.34 (1.16 1.56),2.57E-02
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS009278,0.084,RNAseq,,0.78 (0.68 0.88),2.69E-02
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS011716,0.045,RNAseq,FBLN7,0.78 (0.69 0.88),2.89E-02
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS010607,0.059,RNAseq,TRAV8-1,1.28 (1.13 1.44),2.94E-02
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS010826,0.056,RNAseq,TRIM10,0.80 (0.71 0.90),3.60E-02
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS010693,0.058,RNAseq,TRBV5-1,1.27 (1.12 1.43),3.71E-02
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS004142,0.426,RNAseq,ARL6IP1,0.79 (0.69 0.89),3.84E-02
250.14,Type 1 diabetes with neurological manifestations,endocrine/metabolic,OPGS008786,0.094,RNAseq,GABBR1,1.31 (1.14 1.50),4.22E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,0.96 (0.95 0.97),2.90E-08
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,0.96 (0.95 0.97),3.55E-08
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,0.96 (0.95 0.97),3.55E-08
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001587,0.023,SomaScan,Carboxypeptidase E,0.96 (0.95 0.97),5.19E-08
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.96 (0.95 0.97),1.37E-07
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000911,0.062,SomaScan,Protein MENT,0.96 (0.95 0.97),1.37E-07
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.04 (1.03 1.05),1.64E-07
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000198,0.236,SomaScan,Peptidyl-glycine alpha-amidating monooxygenase,0.96 (0.95 0.98),6.31E-07
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,0.96 (0.95 0.98),9.24E-07
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,1.04 (1.02 1.05),1.31E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000362,0.147,SomaScan,Golgi membrane protein 1,1.04 (1.02 1.05),1.33E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,0.97 (0.96 0.98),2.55E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000106,0.366,SomaScan,Protein FAM3D,1.03 (1.02 1.05),4.04E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000857,0.067,SomaScan,Moesin,0.97 (0.96 0.98),6.40E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,0.97 (0.96 0.98),6.51E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001661,0.020,SomaScan,Stromal cell-derived factor 2-like protein 1,1.03 (1.02 1.05),1.05E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,1.03 (1.02 1.05),1.06E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,0.97 (0.96 0.98),1.15E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.03 (1.02 1.04),1.22E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,0.97 (0.96 0.98),1.29E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,1.03 (1.02 1.05),1.41E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,1.03 (1.02 1.04),2.07E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000032,0.570,SomaScan,Protein S100-A13,1.03 (1.02 1.04),2.43E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,0.97 (0.96 0.98),2.72E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000447,0.129,SomaScan,MANSC domain-containing protein 4,0.97 (0.96 0.98),2.74E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,0.97 (0.96 0.98),3.47E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,0.97 (0.96 0.98),3.58E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,1.03 (1.02 1.04),4.81E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001915,0.014,SomaScan,N-acetylglucosamine-6-sulfatase,0.97 (0.96 0.98),6.66E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001231,0.037,SomaScan,Osteocalcin,1.03 (1.02 1.04),7.04E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000179,0.254,SomaScan,Cardiotrophin-1,0.97 (0.96 0.98),7.15E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.03 (1.02 1.04),8.03E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.97 (0.96 0.98),1.04E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001883,0.015,SomaScan,UMP-CMP kinase,1.03 (1.02 1.04),1.07E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001155,0.042,SomaScan,Zinc finger protein 276,0.97 (0.96 0.98),1.11E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001658,0.020,SomaScan,Endoglin,0.97 (0.96 0.98),1.12E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001840,0.016,SomaScan,Inactive pancreatic lipase-related protein 1,1.03 (1.02 1.04),1.15E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,0.97 (0.96 0.98),1.17E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.97 (0.96 0.98),2.01E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000351,0.151,SomaScan,C1GALT1-specific chaperone 1,1.03 (1.02 1.04),3.30E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000101,0.374,SomaScan,CD209 antigen,1.03 (1.02 1.04),4.95E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002008,0.013,SomaScan,Signal peptide. CUB and EGF-like domain-containing protein 1,0.97 (0.96 0.99),6.03E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,0.97 (0.96 0.98),6.21E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000088,0.392,SomaScan,E-selectin,0.97 (0.96 0.99),6.59E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,0.97 (0.96 0.99),7.37E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000646,0.091,SomaScan,Protein-tyrosine sulfotransferase 2,1.03 (1.01 1.04),7.58E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,1.03 (1.01 1.04),8.08E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000671,0.088,SomaScan,Carbohydrate sulfotransferase 11,1.03 (1.01 1.04),8.46E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.03 (1.01 1.04),9.70E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000773,0.076,SomaScan,ERO1-like protein beta,1.03 (1.01 1.04),1.24E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001440,0.028,SomaScan,Pancreatic hormone,0.97 (0.96 0.99),1.33E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001286,0.034,SomaScan,Granzyme K,1.03 (1.01 1.04),1.40E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,0.98 (0.96 0.99),1.65E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001323,0.032,SomaScan,Sorting nexin-7,0.98 (0.96 0.99),1.67E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000137,0.312,SomaScan,Complement C4b,0.98 (0.96 0.99),1.87E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,0.98 (0.96 0.99),1.96E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001343,0.031,SomaScan,Beta-1.3-N-acetylglucosaminyltransferase radical fringe,1.03 (1.01 1.04),2.04E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000155,0.275,SomaScan,Interleukin-3 receptor subunit alpha,0.98 (0.96 0.99),2.20E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.98 (0.96 0.99),2.97E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001127,0.044,SomaScan,Carbohydrate sulfotransferase 15,0.98 (0.97 0.99),3.35E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000812,0.071,SomaScan,Cathepsin F,0.98 (0.97 0.99),3.80E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000115,0.347,SomaScan,Protein CEI,0.98 (0.97 0.99),4.37E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000600,0.099,SomaScan,Insulin receptor,0.98 (0.97 0.99),4.85E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001045,0.050,SomaScan,Carbohydrate sulfotransferase 15,0.98 (0.97 0.99),5.22E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000912,0.061,SomaScan,Ras-related protein Rab-14,1.02 (1.01 1.04),5.65E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.98 (0.97 0.99),5.67E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001102,0.046,SomaScan,Granzyme A,1.02 (1.01 1.04),6.53E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000699,0.085,SomaScan,Myeloperoxidase,1.02 (1.01 1.04),6.62E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001954,0.014,SomaScan,Tuftelin,0.98 (0.97 0.99),6.88E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000319,0.161,SomaScan,Beta-mannosidase,0.98 (0.97 0.99),6.88E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.02 (1.01 1.03),7.65E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000970,0.056,SomaScan,Extracellular matrix protein 1,1.02 (1.01 1.03),7.88E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001301,0.034,SomaScan,Glycosaminoglycan xylosylkinase,1.02 (1.01 1.03),8.24E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001092,0.046,SomaScan,TOM1-like protein 1,1.02 (1.01 1.03),8.88E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000366,0.146,SomaScan,Protein delta homolog 1,0.98 (0.97 0.99),9.50E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001490,0.026,SomaScan,Intercellular adhesion molecule 2,0.98 (0.97 0.99),9.88E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001354,0.031,SomaScan,M-phase inducer phosphatase 2,0.98 (0.97 0.99),9.92E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,0.98 (0.97 0.99),1.14E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000095,0.381,SomaScan,Sulfhydryl oxidase 2,1.02 (1.01 1.03),1.17E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000889,0.064,SomaScan,Hepatocyte growth factor receptor,0.98 (0.97 0.99),1.31E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,1.02 (1.01 1.03),1.32E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000427,0.132,SomaScan,Adhesion G-protein coupled receptor F1,0.98 (0.97 0.99),1.33E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,1.02 (1.01 1.03),1.61E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000415,0.136,SomaScan,Protein delta homolog 1,0.98 (0.97 0.99),1.82E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000044,0.517,SomaScan,Chymotrypsinogen B2,1.02 (1.01 1.03),1.83E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001157,0.041,SomaScan,Transmembrane protein 106A,0.98 (0.97 0.99),2.37E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.98 (0.97 0.99),2.54E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001369,0.030,SomaScan,Importin subunit alpha-1,1.02 (1.01 1.03),2.86E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002138,0.011,SomaScan,Pterin-4-alpha-carbinolamine dehydratase 2,0.98 (0.97 0.99),2.87E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000426,0.133,SomaScan,Sushi. von Willebrand factor type A. EGF and pentraxin domain-containing protein 1,1.02 (1.01 1.03),2.87E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002142,0.011,SomaScan,Titin,0.98 (0.97 0.99),2.87E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000763,0.077,SomaScan,Trypsin-2,1.02 (1.01 1.03),2.88E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000170,0.265,SomaScan,Lactase-phlorizin hydrolase,0.98 (0.97 0.99),2.91E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001541,0.024,SomaScan,Transmembrane protein 106B,0.98 (0.97 0.99),3.03E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001468,0.027,SomaScan,Complement C5,0.98 (0.97 0.99),3.07E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002043,0.012,SomaScan,Matrix-remodeling-associated protein 8,1.02 (1.01 1.03),3.07E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001081,0.047,SomaScan,Sex hormone-binding globulin,0.98 (0.97 0.99),3.18E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001626,0.021,SomaScan,Neural cell adhesion molecule L1,0.98 (0.97 0.99),3.52E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.02 (1.01 1.03),3.52E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000502,0.117,SomaScan,Neutrophil collagenase,0.98 (0.97 0.99),3.69E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000782,0.075,SomaScan,Beta-1.4-galactosyltransferase 2,1.02 (1.01 1.03),3.83E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000312,0.163,SomaScan,Selenoprotein S,0.98 (0.97 0.99),4.14E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000121,0.341,SomaScan,D-glucuronyl C5-epimerase,1.02 (1.01 1.03),4.29E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000576,0.102,SomaScan,Interleukin-21,0.98 (0.97 0.99),4.37E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS001977,0.013,SomaScan,C-C motif chemokine 4-like,1.02 (1.01 1.03),4.57E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000274,0.182,SomaScan,NAD(P)H dehydrogenase [quinone] 1,0.98 (0.97 0.99),4.59E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000212,0.222,SomaScan,Tyrosine-protein kinase receptor Tie-1. soluble,1.02 (1.01 1.03),4.91E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS000220,0.213,SomaScan,Vascular endothelial growth factor receptor 2,0.98 (0.97 0.99),4.91E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002626,0.023,Olink,Fibroblast growth factor 21,0.97 (0.96 0.98),2.45E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.97 (0.96 0.98),1.07E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002500,0.098,Olink,Galectin-4,0.97 (0.96 0.98),2.72E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002422,0.223,Olink,Lymphotoxin-alpha,0.97 (0.96 0.98),1.99E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002651,0.015,Olink,von Willebrand factor,1.03 (1.02 1.04),3.92E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002645,0.017,Olink,Carboxypeptidase A1,1.03 (1.02 1.04),5.44E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002408,0.270,Olink,E-selectin,0.97 (0.96 0.99),7.73E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002656,0.013,Olink,Angiotensin-converting enzyme 2,0.98 (0.96 0.99),1.70E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002665,0.011,Olink,Neurocan core protein,0.98 (0.97 0.99),2.09E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.98 (0.97 0.99),4.19E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002483,0.125,Olink,Protein delta homolog 1,0.98 (0.97 0.99),6.60E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002590,0.035,Olink,Platelet endothelial cell adhesion molecule,0.98 (0.97 0.99),8.17E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002395,0.362,Olink,Intercellular adhesion molecule 2,0.98 (0.97 0.99),1.72E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002437,0.187,Olink,Serine protease 27,0.98 (0.97 0.99),3.46E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002543,0.061,Olink,Netrin receptor UNC5C,1.02 (1.01 1.03),3.96E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003188,0.012,Metabolon,2-palmitoleoyl-GPC (16:1)*,0.96 (0.95 0.98),3.04E-07
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003034,0.025,Metabolon,1-palmitoleoyl-GPC (16:1)*,0.96 (0.95 0.98),6.26E-07
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003012,0.030,Metabolon,arginine,1.03 (1.02 1.04),8.08E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003196,0.012,Metabolon,1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)*,0.97 (0.96 0.98),1.75E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003114,0.018,Metabolon,1-myristoyl-2-linoleoyl-GPC (14:0/18:2)*,0.97 (0.96 0.98),1.79E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003006,0.030,Metabolon,cholesterol,0.97 (0.96 0.98),2.23E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003200,0.012,Metabolon,threonine,1.03 (1.01 1.04),9.70E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003149,0.015,Metabolon,sphingosine,1.03 (1.01 1.04),1.04E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003198,0.012,Metabolon,gamma-glutamylthreonine*,1.03 (1.01 1.04),1.84E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002731,0.186,Metabolon,X - 11593,0.98 (0.96 0.99),2.68E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),0.98 (0.96 0.99),2.97E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003216,0.011,Metabolon,1-linolenoyl-GPC (18:3)*,0.98 (0.97 0.99),7.21E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003007,0.030,Metabolon,trans-urocanate,1.02 (1.01 1.03),8.30E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002943,0.043,Metabolon,2-palmitoyl-GPE (16:0)*,0.98 (0.97 0.99),8.33E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002771,0.124,Metabolon,glutarylcarnitine (C5),1.02 (1.01 1.03),9.50E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003197,0.012,Metabolon,1-stearoyl-GPC (18:0),0.98 (0.97 0.99),1.33E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003153,0.014,Metabolon,retinol (Vitamin A),0.98 (0.97 0.99),1.72E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003133,0.016,Metabolon,X - 21659,0.98 (0.97 0.99),1.77E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003087,0.020,Metabolon,X - 01911,0.98 (0.97 0.99),1.84E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002952,0.040,Metabolon,1-dihomo-linolenoyl-GPC (20:3n3 or 6)*,0.98 (0.97 0.99),1.84E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003162,0.014,Metabolon,2-hydroxybutyrate/2-hydroxyisobutyrate,0.98 (0.97 0.99),1.90E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003225,0.010,Metabolon,pyruvate,0.98 (0.97 0.99),2.03E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS002878,0.060,Metabolon,1-stearoyl-GPE (18:0),0.98 (0.97 0.99),2.54E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003113,0.018,Metabolon,1-docosapentaenoyl-GPC (22:5n6)*,0.98 (0.97 0.99),2.87E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003092,0.019,Metabolon,X - 21474,0.98 (0.97 0.99),3.41E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003217,0.011,Metabolon,X - 24024,0.98 (0.97 0.99),3.41E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003116,0.018,Metabolon,1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1)*,0.98 (0.97 0.99),3.96E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003497,0.072,Nightingale,Linoleic acid,0.97 (0.95 0.98),1.17E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003452,0.087,Nightingale,Total cholesterol,0.97 (0.96 0.98),7.01E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,0.97 (0.96 0.98),2.72E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,0.97 (0.96 0.98),2.98E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,0.97 (0.96 0.98),3.96E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,0.97 (0.96 0.98),7.15E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003454,0.087,Nightingale,Total esterified cholesterol,0.97 (0.96 0.98),7.62E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,0.97 (0.96 0.98),9.55E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003439,0.107,Nightingale,Concentration of IDL particles,0.97 (0.96 0.98),1.04E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,0.97 (0.96 0.98),1.11E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003523,0.062,Nightingale,Total fatty acids,0.97 (0.96 0.98),1.11E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,0.97 (0.96 0.98),1.17E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003431,0.118,Nightingale,Total lipids in large LDL,0.97 (0.96 0.98),1.61E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003525,0.052,Nightingale,Saturated fatty acids,0.97 (0.96 0.98),1.79E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,0.97 (0.96 0.98),2.21E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003526,0.050,Nightingale,Phosphatidylcholines,0.97 (0.96 0.98),2.23E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,0.97 (0.96 0.98),3.10E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,0.97 (0.96 0.98),4.95E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,0.97 (0.96 0.98),4.95E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,0.97 (0.96 0.98),5.38E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,0.97 (0.96 0.98),5.61E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,0.97 (0.96 0.98),5.86E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003434,0.113,Nightingale,Phospholipids in IDL,0.97 (0.96 0.99),7.54E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003438,0.109,Nightingale,Total lipids in IDL,0.97 (0.96 0.99),7.61E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003455,0.087,Nightingale,Total free cholesterol,0.97 (0.96 0.99),7.61E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,0.97 (0.96 0.99),8.20E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003530,0.047,Nightingale,Phosphoglycerides,0.97 (0.96 0.99),8.29E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,0.97 (0.96 0.99),8.44E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003428,0.121,Nightingale,Total lipids in small LDL,0.97 (0.96 0.99),8.60E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.97 (0.96 0.99),8.87E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,0.97 (0.96 0.99),1.31E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,0.98 (0.96 0.99),1.32E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,0.98 (0.96 0.99),1.47E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003528,0.050,Nightingale,Total cholines,0.98 (0.96 0.99),1.60E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,0.98 (0.96 0.99),1.62E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003444,0.101,Nightingale,Apolipoprotein B,0.98 (0.96 0.99),1.65E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003423,0.126,Nightingale,LDL cholesterol,0.98 (0.96 0.99),1.73E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.98 (0.96 0.99),1.98E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,0.98 (0.96 0.99),2.04E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003440,0.106,Nightingale,Cholesterol in IDL,0.98 (0.96 0.99),2.04E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,0.98 (0.96 0.99),2.49E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,0.98 (0.96 0.99),2.62E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.98 (0.96 0.99),2.81E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.98 (0.96 0.99),2.84E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.98 (0.97 0.99),3.41E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003457,0.086,Nightingale,Concentration of very large HDL particles,0.98 (0.97 0.99),4.23E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.98 (0.97 0.99),4.59E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003488,0.074,Nightingale,VLDL cholesterol,0.98 (0.97 0.99),5.51E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,0.98 (0.97 0.99),6.29E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,0.98 (0.97 0.99),6.40E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.98 (0.97 0.99),6.91E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003461,0.084,Nightingale,Total lipids in very large HDL,0.98 (0.97 0.99),7.43E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003549,0.015,Nightingale,Tyrosine,0.98 (0.97 0.99),9.04E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,0.98 (0.97 0.99),1.05E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,0.98 (0.97 0.99),1.27E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,0.98 (0.97 0.99),1.31E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003520,0.062,Nightingale,HDL cholesterol,0.98 (0.97 0.99),1.32E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003448,0.093,Nightingale,Phospholipids in very large HDL,0.98 (0.97 0.99),1.32E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003450,0.092,Nightingale,Triglycerides in IDL,0.98 (0.97 0.99),1.45E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,0.98 (0.97 0.99),1.93E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,0.98 (0.97 0.99),2.29E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,0.98 (0.97 0.99),2.65E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,0.98 (0.97 0.99),2.83E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,0.98 (0.97 0.99),2.98E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003464,0.082,Nightingale,Triglycerides in LDL,0.98 (0.97 0.99),3.62E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003532,0.045,Nightingale,Apolipoprotein A1,0.98 (0.97 0.99),3.87E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,0.98 (0.97 0.99),4.91E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010624,0.059,RNAseq,TRBV18,1.05 (1.04 1.06),9.60E-14
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.95 (0.94 0.96),4.43E-13
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005375,0.249,RNAseq,,0.95 (0.94 0.96),1.99E-12
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013693,0.025,RNAseq,,0.96 (0.94 0.97),2.44E-11
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.96 (0.95 0.97),4.85E-11
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010591,0.060,RNAseq,ZZEF1,1.05 (1.03 1.06),1.96E-10
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012867,0.032,RNAseq,CCND2,0.96 (0.95 0.97),2.75E-09
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.04 (1.03 1.05),2.75E-09
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012171,0.039,RNAseq,TRBV15,0.96 (0.95 0.97),5.70E-09
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011585,0.046,RNAseq,CD8B,1.04 (1.03 1.05),7.19E-09
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007041,0.151,RNAseq,SYT11,1.04 (1.03 1.05),2.62E-08
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011901,0.042,RNAseq,DTHD1,1.04 (1.03 1.05),2.90E-08
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013660,0.025,RNAseq,CD8A,1.04 (1.03 1.05),3.55E-08
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010737,0.057,RNAseq,PEAK1,1.04 (1.03 1.05),5.63E-08
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010779,0.057,RNAseq,ACE,1.04 (1.03 1.05),5.81E-08
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011853,0.043,RNAseq,TRBV6-1,0.96 (0.95 0.98),5.78E-07
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010348,0.063,RNAseq,TRBV6-5,1.04 (1.02 1.05),5.97E-07
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009865,0.072,RNAseq,TRAV17,0.97 (0.95 0.98),1.06E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010263,0.065,RNAseq,CBX7,1.04 (1.02 1.05),1.89E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006038,0.201,RNAseq,HLA-DQA2,1.03 (1.02 1.05),2.15E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014341,0.020,RNAseq,NFAT5,1.03 (1.02 1.05),4.56E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012380,0.037,RNAseq,AC007381.1,0.97 (0.96 0.98),7.14E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009289,0.084,RNAseq,AC010883.1,0.97 (0.96 0.98),7.36E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010663,0.059,RNAseq,SPRED2,1.03 (1.02 1.05),7.41E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS015030,0.016,RNAseq,PRRC2A,1.03 (1.02 1.05),9.06E-06
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003680,0.611,RNAseq,,1.03 (1.02 1.04),1.02E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009198,0.085,RNAseq,TRAV12-1,1.03 (1.02 1.04),1.78E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014758,0.017,RNAseq,TRAV10,1.03 (1.02 1.05),1.88E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010014,0.069,RNAseq,LINC02245,1.03 (1.02 1.04),2.43E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS015031,0.016,RNAseq,DDA1,0.97 (0.96 0.98),3.98E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.03 (1.02 1.04),4.51E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005300,0.257,RNAseq,AF131215.6,1.03 (1.02 1.04),6.95E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS015102,0.015,RNAseq,BOP1,1.03 (1.02 1.04),6.95E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012329,0.038,RNAseq,CPEB3,1.03 (1.02 1.04),6.95E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014718,0.017,RNAseq,MRC2,1.03 (1.02 1.04),7.15E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.03 (1.02 1.04),7.15E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004104,0.436,RNAseq,ESPN,1.03 (1.02 1.04),7.62E-05
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008814,0.094,RNAseq,UBE3C,0.97 (0.96 0.98),1.06E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS015054,0.015,RNAseq,H19,1.03 (1.02 1.04),1.14E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.97 (0.96 0.98),1.28E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011494,0.047,RNAseq,RNF26,1.03 (1.02 1.04),1.41E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006766,0.162,RNAseq,FAM234A,1.03 (1.02 1.04),1.54E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005334,0.253,RNAseq,AL645933.4,0.97 (0.96 0.98),1.55E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005944,0.207,RNAseq,SSR1,0.97 (0.96 0.98),1.63E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010657,0.059,RNAseq,HMG20A,1.03 (1.02 1.04),1.88E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008577,0.099,RNAseq,CDC123,1.03 (1.02 1.04),1.99E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008383,0.104,RNAseq,CD160,1.03 (1.02 1.04),1.99E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008033,0.115,RNAseq,SGCB,0.97 (0.96 0.98),2.01E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009188,0.085,RNAseq,DCAF5,0.97 (0.96 0.98),2.07E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005353,0.251,RNAseq,WWP2,1.03 (1.02 1.04),2.21E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009278,0.084,RNAseq,,0.97 (0.96 0.98),2.49E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004598,0.340,RNAseq,RPAP1,0.97 (0.96 0.98),2.66E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012855,0.032,RNAseq,TRBV9,0.97 (0.96 0.98),2.90E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006215,0.191,RNAseq,PGAP3,1.03 (1.02 1.04),3.25E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011716,0.045,RNAseq,FBLN7,0.97 (0.96 0.98),3.42E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008889,0.092,RNAseq,TRAV20,1.03 (1.02 1.04),3.45E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010856,0.056,RNAseq,RIOK3,0.97 (0.96 0.98),4.37E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010826,0.056,RNAseq,TRIM10,0.97 (0.96 0.98),4.46E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005796,0.215,RNAseq,,1.03 (1.02 1.04),5.38E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007148,0.146,RNAseq,AC022400.8,1.03 (1.02 1.04),5.38E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012455,0.036,RNAseq,EIF5A2,1.03 (1.02 1.04),5.61E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003660,0.627,RNAseq,SENP6,1.03 (1.02 1.04),5.61E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006705,0.165,RNAseq,MAU2,0.97 (0.96 0.98),5.61E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006541,0.173,RNAseq,ZFYVE28,0.97 (0.96 0.99),7.15E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004213,0.410,RNAseq,,1.03 (1.01 1.04),7.37E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012741,0.033,RNAseq,GIPR,0.97 (0.96 0.99),7.54E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012628,0.034,RNAseq,RMC1,0.97 (0.96 0.99),7.75E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008270,0.107,RNAseq,ERO1B,1.03 (1.01 1.04),7.75E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012859,0.032,RNAseq,NBEAL2,1.03 (1.01 1.04),8.20E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007544,0.131,RNAseq,ANK1,1.03 (1.01 1.04),8.31E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012474,0.036,RNAseq,HNRNPH1,0.97 (0.96 0.99),8.33E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011272,0.050,RNAseq,AC007780.1,1.03 (1.01 1.04),8.46E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011618,0.046,RNAseq,MED27,1.03 (1.01 1.04),8.46E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003950,0.485,RNAseq,CHMP4B,0.97 (0.96 0.99),8.46E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007846,0.120,RNAseq,SLC39A10,0.97 (0.96 0.99),9.55E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008513,0.101,RNAseq,CEP68,1.03 (1.01 1.04),9.70E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006265,0.188,RNAseq,RBM6,0.97 (0.96 0.99),9.97E-04
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013990,0.023,RNAseq,UQCR10,1.03 (1.01 1.04),1.02E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008273,0.107,RNAseq,GRK4,1.03 (1.01 1.04),1.02E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006391,0.181,RNAseq,GTF2I,1.03 (1.01 1.04),1.02E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004743,0.317,RNAseq,ARG1,0.97 (0.96 0.99),1.02E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008402,0.104,RNAseq,TNXB,1.03 (1.01 1.04),1.02E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014726,0.017,RNAseq,PIK3C2A,0.97 (0.96 0.99),1.03E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007781,0.123,RNAseq,MAP3K13,0.97 (0.96 0.99),1.04E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009970,0.070,RNAseq,CLDN23,1.03 (1.01 1.04),1.08E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003699,0.599,RNAseq,AC009506.2,1.03 (1.01 1.04),1.24E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004994,0.287,RNAseq,TIGAR,0.97 (0.96 0.99),1.24E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009850,0.072,RNAseq,ACTG1,1.03 (1.01 1.04),1.32E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007363,0.137,RNAseq,UCKL1,0.97 (0.96 0.99),1.33E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013514,0.026,RNAseq,GZMK,1.03 (1.01 1.04),1.34E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006619,0.169,RNAseq,,1.03 (1.01 1.04),1.37E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009077,0.088,RNAseq,DDAH2,0.97 (0.96 0.99),1.47E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009758,0.074,RNAseq,ADARB1,1.03 (1.01 1.04),1.47E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003943,0.486,RNAseq,CLEC18A,0.98 (0.96 0.99),1.52E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS015100,0.015,RNAseq,NDUFAF3,1.03 (1.01 1.04),1.74E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS015116,0.015,RNAseq,,0.98 (0.96 0.99),1.78E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007829,0.121,RNAseq,,1.03 (1.01 1.04),2.04E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005153,0.271,RNAseq,LMF1,1.02 (1.01 1.04),2.04E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009606,0.077,RNAseq,SAE1,0.98 (0.96 0.99),2.17E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005254,0.260,RNAseq,MAN2C1,0.98 (0.96 0.99),2.19E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003708,0.594,RNAseq,HSD17B12,0.98 (0.96 0.99),2.19E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009938,0.070,RNAseq,ZBTB6,1.02 (1.01 1.04),2.52E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011283,0.050,RNAseq,CD248,1.02 (1.01 1.04),2.55E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS015028,0.016,RNAseq,JUNB,0.98 (0.97 0.99),2.57E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014232,0.021,RNAseq,TRAV1-2,1.02 (1.01 1.04),2.62E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012510,0.036,RNAseq,KLRF1,1.02 (1.01 1.04),2.62E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012475,0.036,RNAseq,SCRN3,0.98 (0.96 0.99),2.62E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011086,0.053,RNAseq,HSPA1B,0.98 (0.96 0.99),2.62E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003651,0.639,RNAseq,ABO,0.98 (0.96 0.99),2.65E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009697,0.075,RNAseq,SEC22A,0.98 (0.96 0.99),2.67E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009574,0.078,RNAseq,CDKN1C,1.02 (1.01 1.04),2.67E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008188,0.109,RNAseq,DMPK,0.98 (0.96 0.99),2.82E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012951,0.031,RNAseq,MRPL4,1.02 (1.01 1.04),2.92E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009078,0.088,RNAseq,MAPRE3,0.98 (0.97 0.99),2.95E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012714,0.033,RNAseq,RABGAP1,0.98 (0.96 0.99),3.03E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011434,0.048,RNAseq,ZNF483,1.02 (1.01 1.04),3.17E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007852,0.120,RNAseq,NOS3,1.02 (1.01 1.04),4.18E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004897,0.299,RNAseq,AC018647.2,0.98 (0.97 0.99),4.23E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005071,0.279,RNAseq,GIT1,1.02 (1.01 1.04),4.83E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008517,0.101,RNAseq,BAZ2B,1.02 (1.01 1.04),4.85E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003864,0.522,RNAseq,STARD10,1.02 (1.01 1.04),4.95E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005829,0.213,RNAseq,MACF1,1.02 (1.01 1.04),5.17E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS015077,0.015,RNAseq,ACTN1,1.02 (1.01 1.04),5.31E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010725,0.058,RNAseq,RBM20,1.02 (1.01 1.04),5.42E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012768,0.033,RNAseq,HMGA1,1.02 (1.01 1.03),5.51E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010935,0.055,RNAseq,TMEM191B,1.02 (1.01 1.03),5.51E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013330,0.028,RNAseq,AP1G1,0.98 (0.97 0.99),5.67E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009706,0.075,RNAseq,DIDO1,1.02 (1.01 1.04),6.14E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006284,0.187,RNAseq,MPPED2,0.98 (0.97 0.99),6.34E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004091,0.440,RNAseq,LINC00565,0.98 (0.97 0.99),6.48E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012605,0.035,RNAseq,HSPA1A,0.98 (0.97 0.99),6.62E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008524,0.101,RNAseq,KLHL42,1.02 (1.01 1.04),6.62E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011902,0.042,RNAseq,LONRF1,0.98 (0.97 0.99),6.62E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011291,0.050,RNAseq,GMPPB,1.02 (1.01 1.03),7.33E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011784,0.044,RNAseq,TUBB,1.02 (1.01 1.04),7.33E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007486,0.133,RNAseq,EHHADH,0.98 (0.97 0.99),7.51E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010929,0.055,RNAseq,EOMES,1.02 (1.01 1.03),7.52E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013607,0.026,RNAseq,AC026347.1,0.98 (0.97 0.99),7.58E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009293,0.083,RNAseq,SLBP,0.98 (0.97 0.99),7.66E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008650,0.098,RNAseq,ATP5MC1,0.98 (0.97 0.99),7.69E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010305,0.064,RNAseq,KCNH2,0.98 (0.97 0.99),8.24E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005504,0.238,RNAseq,MRTO4,1.02 (1.01 1.03),8.52E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014393,0.020,RNAseq,FIG4,1.02 (1.01 1.03),8.61E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004293,0.390,RNAseq,CWF19L1,0.98 (0.97 0.99),8.69E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012496,0.036,RNAseq,NT5DC4,1.02 (1.01 1.03),8.78E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010972,0.054,RNAseq,FBXL20,1.02 (1.01 1.03),9.00E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011948,0.042,RNAseq,ADGRG1,0.98 (0.97 0.99),9.47E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009241,0.084,RNAseq,ZKSCAN4,1.02 (1.01 1.03),9.50E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012546,0.035,RNAseq,ABHD14A,0.98 (0.97 0.99),9.52E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004144,0.424,RNAseq,PSORS1C3,1.02 (1.01 1.03),9.78E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006941,0.154,RNAseq,RBMS1,1.02 (1.01 1.03),9.92E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013658,0.025,RNAseq,CXXC5,1.02 (1.01 1.03),9.92E-03
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011265,0.050,RNAseq,HSPA5,0.98 (0.97 0.99),1.00E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008698,0.097,RNAseq,FUZ,1.02 (1.01 1.03),1.08E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012804,0.033,RNAseq,CARS1,1.02 (1.01 1.03),1.09E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006034,0.201,RNAseq,,0.98 (0.97 0.99),1.14E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010692,0.058,RNAseq,IPO9,0.98 (0.97 0.99),1.14E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007893,0.119,RNAseq,INTS8,0.98 (0.97 0.99),1.14E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010883,0.055,RNAseq,ZNF664,1.02 (1.01 1.03),1.14E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005363,0.250,RNAseq,FAM177A1,0.98 (0.97 0.99),1.14E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007869,0.119,RNAseq,MEG3,0.98 (0.97 0.99),1.17E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005489,0.239,RNAseq,TRAPPC5,0.98 (0.97 0.99),1.17E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012484,0.036,RNAseq,ABCB9,0.98 (0.97 0.99),1.27E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014533,0.019,RNAseq,ZDHHC24,1.02 (1.01 1.03),1.27E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003685,0.608,RNAseq,ANPEP,1.02 (1.01 1.03),1.27E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013529,0.026,RNAseq,PRPF40A,0.98 (0.97 0.99),1.27E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005469,0.241,RNAseq,SPX,1.02 (1.01 1.03),1.27E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005610,0.228,RNAseq,LINC02193,1.02 (1.01 1.03),1.28E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007651,0.127,RNAseq,KMT5A,0.98 (0.97 0.99),1.29E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010665,0.059,RNAseq,CNEP1R1,1.02 (1.01 1.03),1.30E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004210,0.410,RNAseq,DNAJB6,1.02 (1.01 1.03),1.31E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014598,0.018,RNAseq,HMGXB4,0.98 (0.97 0.99),1.32E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004163,0.418,RNAseq,LGSN,1.02 (1.01 1.03),1.33E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014974,0.016,RNAseq,ZNF865,0.98 (0.97 0.99),1.36E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006608,0.170,RNAseq,MFHAS1,1.02 (1.01 1.03),1.37E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008082,0.113,RNAseq,NUDT5,1.02 (1.01 1.03),1.37E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011350,0.049,RNAseq,BHLHE40,0.98 (0.97 0.99),1.40E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011636,0.045,RNAseq,LIN7C,1.02 (1.01 1.03),1.40E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012837,0.032,RNAseq,INKA2,0.98 (0.97 0.99),1.40E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011366,0.049,RNAseq,DOCK4,0.98 (0.97 0.99),1.50E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008253,0.108,RNAseq,SPON2,1.02 (1.01 1.03),1.54E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007792,0.122,RNAseq,ZKSCAN5,1.02 (1.01 1.03),1.61E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011010,0.054,RNAseq,TRBV5-4,0.98 (0.97 0.99),1.61E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008970,0.090,RNAseq,JMY,0.98 (0.97 0.99),1.61E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009320,0.083,RNAseq,ARG2,1.02 (1.01 1.03),1.61E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010993,0.054,RNAseq,SNAP47,1.02 (1.01 1.03),1.66E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006277,0.188,RNAseq,PDIA6,0.98 (0.97 0.99),1.66E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014715,0.017,RNAseq,LAMTOR2,1.02 (1.01 1.03),1.66E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013640,0.025,RNAseq,FBXW7,0.98 (0.97 0.99),1.71E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013324,0.028,RNAseq,PRF1,0.98 (0.97 0.99),1.72E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003928,0.495,RNAseq,RNASET2,0.98 (0.97 0.99),1.72E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013277,0.028,RNAseq,TFAM,0.98 (0.97 0.99),1.73E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003980,0.470,RNAseq,BAK1,1.02 (1.01 1.03),1.77E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014949,0.016,RNAseq,ZNF436,1.02 (1.01 1.03),1.81E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009180,0.086,RNAseq,CNKSR1,1.02 (1.01 1.03),1.84E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007086,0.148,RNAseq,SRP14-AS1,0.98 (0.97 0.99),1.86E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004943,0.293,RNAseq,,1.02 (1.01 1.03),1.89E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014695,0.017,RNAseq,QPCTL,0.98 (0.97 0.99),1.94E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014434,0.019,RNAseq,CRB2,0.98 (0.97 0.99),1.94E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007784,0.123,RNAseq,CCDC9,0.98 (0.97 0.99),1.94E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009597,0.077,RNAseq,CLTB,0.98 (0.97 0.99),1.97E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005943,0.207,RNAseq,ERN1,0.98 (0.97 0.99),1.99E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014489,0.019,RNAseq,AP002381.2,1.02 (1.01 1.03),2.00E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008607,0.099,RNAseq,ZNF518B,0.98 (0.97 0.99),2.01E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011528,0.047,RNAseq,TRBC1,0.98 (0.97 0.99),2.04E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008761,0.095,RNAseq,CCDC134,1.02 (1.01 1.03),2.08E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007286,0.140,RNAseq,COX14,1.02 (1.01 1.03),2.09E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012279,0.038,RNAseq,CDKN2A,0.98 (0.97 0.99),2.20E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004657,0.330,RNAseq,LPP,0.98 (0.97 0.99),2.21E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010449,0.062,RNAseq,PARVA,0.98 (0.97 0.99),2.28E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004014,0.460,RNAseq,PRMT6,0.98 (0.97 0.99),2.31E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012609,0.035,RNAseq,RAD21,0.98 (0.97 0.99),2.32E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005122,0.274,RNAseq,OBI1,0.98 (0.97 0.99),2.33E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011752,0.044,RNAseq,AL359532.1,0.98 (0.97 0.99),2.33E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010949,0.055,RNAseq,AC008897.3,1.02 (1.01 1.03),2.37E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006112,0.197,RNAseq,CCDC127,0.98 (0.97 0.99),2.40E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014703,0.017,RNAseq,TCF4,0.98 (0.97 0.99),2.43E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013230,0.029,RNAseq,EP300,1.02 (1.01 1.03),2.45E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010937,0.055,RNAseq,H4C3,0.98 (0.97 0.99),2.46E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006323,0.185,RNAseq,REEP5,1.02 (1.01 1.03),2.51E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010906,0.055,RNAseq,HMGN2,0.98 (0.97 0.99),2.54E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006269,0.188,RNAseq,RALY-AS1,0.98 (0.97 0.99),2.54E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013578,0.026,RNAseq,METTL2A,0.98 (0.97 0.99),2.69E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005907,0.208,RNAseq,TNFAIP8,1.02 (1.01 1.03),2.70E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007532,0.131,RNAseq,GIGYF1,0.98 (0.97 0.99),2.83E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005215,0.264,RNAseq,SREBF1,0.98 (0.97 0.99),2.83E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009551,0.078,RNAseq,PCED1B-AS1,0.98 (0.97 0.99),2.83E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008024,0.115,RNAseq,FMNL3,1.02 (1.01 1.03),2.87E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004406,0.369,RNAseq,,0.98 (0.97 0.99),2.87E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011713,0.045,RNAseq,PPP2R3A,1.02 (1.01 1.03),2.87E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007764,0.123,RNAseq,HLA-E,1.02 (1.01 1.03),3.05E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006271,0.188,RNAseq,MCC,1.02 (1.01 1.03),3.05E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014108,0.022,RNAseq,RCN2,1.02 (1.01 1.03),3.08E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004783,0.312,RNAseq,SLIT1,1.02 (1.01 1.03),3.08E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009703,0.075,RNAseq,HBP1,1.02 (1.01 1.03),3.11E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009839,0.072,RNAseq,MPIG6B,1.02 (1.01 1.03),3.14E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014405,0.020,RNAseq,AC018761.2,1.02 (1.01 1.03),3.20E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014803,0.017,RNAseq,TLE1,1.02 (1.01 1.03),3.20E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007094,0.148,RNAseq,UTP25,0.98 (0.97 0.99),3.20E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011082,0.053,RNAseq,AL138824.1,0.98 (0.97 0.99),3.26E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012005,0.041,RNAseq,EML2,0.98 (0.97 0.99),3.40E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008558,0.100,RNAseq,TSPAN32,0.98 (0.97 0.99),3.40E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006833,0.159,RNAseq,DESI1,1.02 (1.01 1.03),3.41E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010437,0.062,RNAseq,LINC01133,1.02 (1.01 1.03),3.41E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012669,0.034,RNAseq,SMARCAL1,0.98 (0.97 0.99),3.41E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011395,0.048,RNAseq,TIE1,1.02 (1.01 1.03),3.41E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008529,0.101,RNAseq,CRIP3,1.02 (1.01 1.03),3.41E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013825,0.024,RNAseq,EFNB2,1.02 (1.01 1.03),3.51E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011183,0.051,RNAseq,DLK1,0.98 (0.97 0.99),3.51E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010281,0.065,RNAseq,MED1,1.02 (1.01 1.03),3.52E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005793,0.216,RNAseq,,0.98 (0.97 0.99),3.52E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013198,0.029,RNAseq,PDIA3,0.98 (0.97 0.99),3.56E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008331,0.106,RNAseq,ANGEL1,1.02 (1.01 1.03),3.69E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005613,0.228,RNAseq,CDKN2B,0.98 (0.97 0.99),3.69E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006348,0.184,RNAseq,PTPRJ,1.02 (1.01 1.03),3.79E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010927,0.055,RNAseq,NUTF2,0.98 (0.97 0.99),3.82E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010700,0.058,RNAseq,DCLRE1B,0.98 (0.97 0.99),3.83E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014214,0.021,RNAseq,PRSS22,0.98 (0.97 0.99),3.87E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006091,0.198,RNAseq,RNF157,1.02 (1.01 1.03),3.87E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011029,0.053,RNAseq,DRAIC,1.02 (1.01 1.03),3.91E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005567,0.233,RNAseq,PLEKHA1,1.02 (1.01 1.03),3.91E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.02 (1.01 1.03),3.96E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011885,0.043,RNAseq,CLTA,1.02 (1.01 1.03),3.96E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013305,0.028,RNAseq,TRBV14,0.98 (0.97 0.99),3.96E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008560,0.100,RNAseq,FAM76B,1.02 (1.01 1.03),3.96E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010326,0.064,RNAseq,KCNK7,1.02 (1.01 1.03),3.96E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS006408,0.180,RNAseq,SCAP,1.02 (1.01 1.03),4.06E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009672,0.076,RNAseq,CALR,0.98 (0.97 0.99),4.07E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011331,0.049,RNAseq,MAEA,1.02 (1.01 1.03),4.08E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014850,0.017,RNAseq,KCNK10,0.98 (0.97 0.99),4.09E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013199,0.029,RNAseq,ACP1,0.98 (0.97 0.99),4.09E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011915,0.042,RNAseq,RNF19B,1.02 (1.01 1.03),4.14E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008417,0.103,RNAseq,GPR19,1.02 (1.01 1.03),4.14E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003664,0.625,RNAseq,,1.02 (1.01 1.03),4.24E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012061,0.041,RNAseq,CSGALNACT2,0.98 (0.97 0.99),4.28E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012334,0.037,RNAseq,SPRY2,1.02 (1.01 1.03),4.31E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009783,0.073,RNAseq,CRK,0.98 (0.97 0.99),4.31E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005696,0.222,RNAseq,ST6GAL1,1.02 (1.01 1.03),4.34E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008074,0.113,RNAseq,JAZF1,1.02 (1.01 1.03),4.34E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014875,0.017,RNAseq,AC008738.5,0.98 (0.97 0.99),4.35E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS011407,0.048,RNAseq,KPNA2,0.98 (0.97 0.99),4.37E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010627,0.059,RNAseq,TPD52L2,1.02 (1.01 1.03),4.39E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS005289,0.258,RNAseq,UBA7,0.98 (0.97 0.99),4.39E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008164,0.110,RNAseq,ITPKB-IT1,1.02 (1.01 1.03),4.43E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012084,0.040,RNAseq,DCP1B,0.98 (0.97 0.99),4.50E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009925,0.071,RNAseq,ATP2A3,0.98 (0.97 0.99),4.58E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS013535,0.026,RNAseq,AC005534.1,1.02 (1.01 1.03),4.62E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS004389,0.372,RNAseq,AP003774.2,0.98 (0.97 0.99),4.62E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012047,0.041,RNAseq,TREML1,1.02 (1.01 1.03),4.62E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012482,0.036,RNAseq,POLDIP3,1.02 (1.01 1.03),4.72E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS003625,0.664,RNAseq,,0.98 (0.97 0.99),4.73E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS012137,0.040,RNAseq,TIMM17A,1.02 (1.01 1.03),4.77E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS014563,0.018,RNAseq,HSPA13,0.98 (0.97 0.99),4.80E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS010992,0.054,RNAseq,LCMT1,1.02 (1.01 1.03),4.83E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS008237,0.108,RNAseq,IL17RA,1.02 (1.01 1.03),4.83E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007306,0.139,RNAseq,RBL2,1.02 (1.01 1.03),4.90E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS007692,0.126,RNAseq,NAA38,0.98 (0.97 0.99),4.93E-02
250.2,Type 2 diabetes,endocrine/metabolic,OPGS009151,0.086,RNAseq,AC064836.3,1.02 (1.01 1.03),5.00E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.88 (0.84 0.91),4.26E-08
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.14 (1.09 1.18),6.46E-08
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.13 (1.09 1.18),3.71E-07
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.88 (0.84 0.92),8.76E-07
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001231,0.037,SomaScan,Osteocalcin,1.11 (1.07 1.16),4.50E-05
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.90 (0.87 0.94),7.73E-05
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.11 (1.07 1.16),2.52E-04
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000576,0.102,SomaScan,Interleukin-21,0.91 (0.88 0.95),9.69E-04
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000290,0.171,SomaScan,Complement C4,0.91 (0.87 0.95),1.10E-03
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.92 (0.88 0.95),3.25E-03
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.09 (1.05 1.13),4.28E-03
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.09 (1.05 1.13),6.24E-03
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.92 (0.89 0.96),9.87E-03
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.92 (0.89 0.96),1.59E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.93 (0.89 0.96),1.76E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000198,0.236,SomaScan,Peptidyl-glycine alpha-amidating monooxygenase,0.92 (0.89 0.96),1.76E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.93 (0.89 0.96),2.95E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS000390,0.141,SomaScan,Palmitoyl-protein thioesterase 1,1.08 (1.04 1.12),3.31E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.93 (0.89 0.96),4.98E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.90 (0.86 0.93),3.32E-05
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.90 (0.87 0.94),2.52E-04
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.91 (0.87 0.94),2.59E-04
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS003012,0.030,Metabolon,arginine,1.09 (1.04 1.13),1.47E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.84 (0.82 0.87),1.28E-18
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.85 (0.82 0.88),2.04E-13
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.16 (1.11 1.20),3.67E-10
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS012171,0.039,RNAseq,TRBV15,0.87 (0.84 0.90),1.54E-09
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.87 (0.84 0.91),1.81E-09
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010624,0.059,RNAseq,TRBV18,1.15 (1.11 1.20),1.81E-09
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.15 (1.10 1.19),2.90E-09
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS006038,0.201,RNAseq,HLA-DQA2,1.13 (1.09 1.17),4.74E-08
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.13 (1.09 1.18),1.23E-07
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009865,0.072,RNAseq,TRAV17,0.89 (0.85 0.92),3.32E-07
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS005334,0.253,RNAseq,AL645933.4,0.89 (0.86 0.93),4.75E-06
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS004122,0.430,RNAseq,HLA-DRB5,0.89 (0.86 0.93),2.95E-05
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011787,0.044,RNAseq,C2,1.11 (1.07 1.16),3.54E-05
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011948,0.042,RNAseq,ADGRG1,0.90 (0.87 0.94),7.50E-05
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS003680,0.611,RNAseq,,1.10 (1.06 1.15),1.05E-04
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS005230,0.263,RNAseq,LINC00243,1.11 (1.07 1.15),1.08E-04
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011853,0.043,RNAseq,TRBV6-1,0.90 (0.87 0.94),2.52E-04
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009198,0.085,RNAseq,TRAV12-1,1.10 (1.06 1.15),4.06E-04
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS013660,0.025,RNAseq,CD8A,1.10 (1.06 1.15),4.98E-04
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010826,0.056,RNAseq,TRIM10,0.91 (0.88 0.95),1.47E-03
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011536,0.047,RNAseq,TRAV2,0.91 (0.88 0.95),1.65E-03
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.11 (1.06 1.15),1.70E-03
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010700,0.058,RNAseq,DCLRE1B,0.92 (0.89 0.95),2.82E-03
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS012006,0.041,RNAseq,VARS2,0.92 (0.88 0.95),2.82E-03
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS008889,0.092,RNAseq,TRAV20,1.09 (1.05 1.13),8.24E-03
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS007018,0.151,RNAseq,TRBV10-3,1.09 (1.05 1.13),9.55E-03
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS011086,0.053,RNAseq,HSPA1B,0.92 (0.88 0.96),1.19E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS015028,0.016,RNAseq,JUNB,0.93 (0.89 0.96),1.25E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009278,0.084,RNAseq,,0.92 (0.89 0.96),1.32E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS007145,0.146,RNAseq,BAG6,1.08 (1.04 1.12),1.90E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS014393,0.020,RNAseq,FIG4,1.08 (1.04 1.12),2.54E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010779,0.057,RNAseq,ACE,1.08 (1.04 1.12),2.63E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS008784,0.094,RNAseq,,0.93 (0.89 0.96),2.84E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS014496,0.019,RNAseq,VARS1,1.08 (1.04 1.12),2.95E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS004678,0.327,RNAseq,ZNF772,0.93 (0.89 0.96),3.16E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS007297,0.140,RNAseq,GPANK1,0.92 (0.88 0.96),3.16E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS006244,0.189,RNAseq,RCCD1,1.07 (1.04 1.11),3.31E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS008507,0.101,RNAseq,PSMB1,0.93 (0.89 0.96),3.45E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS014176,0.021,RNAseq,TRAV27,1.08 (1.04 1.12),3.48E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS008402,0.104,RNAseq,TNXB,1.08 (1.04 1.12),3.48E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS004406,0.369,RNAseq,,0.93 (0.89 0.96),3.59E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS006069,0.199,RNAseq,ZFP1,0.93 (0.90 0.97),3.99E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS005375,0.249,RNAseq,,0.93 (0.89 0.97),4.01E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS009803,0.073,RNAseq,UBE2E2,1.08 (1.04 1.12),4.14E-02
250.23,Type 2 diabetes with ophthalmic manifestations,endocrine/metabolic,OPGS010856,0.056,RNAseq,RIOK3,0.93 (0.89 0.97),4.35E-02
250.24,Type 2 diabetes with neurological manifestations,endocrine/metabolic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.87 (0.83 0.92),1.13E-02
250.42,Other abnormal glucose,endocrine/metabolic,OPGS013333,0.028,RNAseq,MNT,0.85 (0.80 0.91),4.03E-02
250.6,Polyneuropathy in diabetes,endocrine/metabolic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.86 (0.81 0.91),1.85E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.86 (0.83 0.90),3.11E-10
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.15 (1.11 1.20),9.69E-10
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.15 (1.10 1.19),1.92E-08
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.87 (0.84 0.91),2.56E-07
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.89 (0.85 0.92),4.79E-07
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS000576,0.102,SomaScan,Interleukin-21,0.90 (0.86 0.93),1.27E-05
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.90 (0.86 0.93),2.61E-05
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.11 (1.07 1.16),2.78E-05
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS000290,0.171,SomaScan,Complement C4,0.90 (0.86 0.93),3.51E-05
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.12 (1.08 1.17),3.51E-05
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.90 (0.87 0.94),4.37E-05
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.90 (0.87 0.94),1.57E-04
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS001231,0.037,SomaScan,Osteocalcin,1.11 (1.06 1.15),1.66E-04
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.91 (0.87 0.94),3.31E-04
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.10 (1.06 1.15),3.45E-04
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS000390,0.141,SomaScan,Palmitoyl-protein thioesterase 1,1.09 (1.05 1.14),5.67E-03
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.92 (0.88 0.96),7.80E-03
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.92 (0.88 0.96),9.53E-03
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.92 (0.88 0.96),1.20E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.92 (0.89 0.96),3.40E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.88 (0.85 0.91),1.72E-07
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.89 (0.86 0.93),2.37E-05
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.90 (0.87 0.94),7.44E-05
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS002923,0.047,Metabolon,gluconate,1.09 (1.04 1.14),3.92E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.84 (0.81 0.86),5.45E-21
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.84 (0.81 0.88),3.98E-14
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.17 (1.13 1.22),2.38E-12
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.16 (1.12 1.21),5.62E-11
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.86 (0.83 0.90),7.92E-11
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS010624,0.059,RNAseq,TRBV18,1.16 (1.11 1.20),2.30E-09
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS012171,0.039,RNAseq,TRBV15,0.87 (0.84 0.91),7.39E-09
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.15 (1.10 1.19),7.39E-09
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS006038,0.201,RNAseq,HLA-DQA2,1.13 (1.09 1.18),1.94E-08
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS009865,0.072,RNAseq,TRAV17,0.88 (0.84 0.91),3.78E-08
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS005334,0.253,RNAseq,AL645933.4,0.88 (0.85 0.92),2.70E-07
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS004122,0.430,RNAseq,HLA-DRB5,0.89 (0.85 0.93),9.86E-06
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS011787,0.044,RNAseq,C2,1.12 (1.08 1.17),9.86E-06
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS003680,0.611,RNAseq,,1.12 (1.07 1.16),1.08E-05
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS005230,0.263,RNAseq,LINC00243,1.12 (1.07 1.16),3.39E-05
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS012006,0.041,RNAseq,VARS2,0.90 (0.87 0.94),7.09E-05
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.12 (1.07 1.17),1.53E-04
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS013660,0.025,RNAseq,CD8A,1.11 (1.07 1.15),1.66E-04
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS011536,0.047,RNAseq,TRAV2,0.90 (0.87 0.94),1.66E-04
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS011853,0.043,RNAseq,TRBV6-1,0.90 (0.87 0.94),2.28E-04
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS009198,0.085,RNAseq,TRAV12-1,1.11 (1.06 1.15),3.05E-04
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS011948,0.042,RNAseq,ADGRG1,0.91 (0.87 0.94),7.28E-04
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS010826,0.056,RNAseq,TRIM10,0.92 (0.88 0.95),1.92E-03
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS007018,0.151,RNAseq,TRBV10-3,1.10 (1.06 1.15),1.92E-03
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS011086,0.053,RNAseq,HSPA1B,0.91 (0.87 0.95),2.08E-03
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS010700,0.058,RNAseq,DCLRE1B,0.92 (0.89 0.95),2.81E-03
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS004406,0.369,RNAseq,,0.92 (0.88 0.95),4.40E-03
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS014496,0.019,RNAseq,VARS1,1.09 (1.05 1.13),5.78E-03
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS007297,0.140,RNAseq,GPANK1,0.91 (0.87 0.95),5.98E-03
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS014176,0.021,RNAseq,TRAV27,1.09 (1.05 1.13),5.98E-03
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS015028,0.016,RNAseq,JUNB,0.92 (0.89 0.96),7.25E-03
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS007407,0.135,RNAseq,TRBV2,1.09 (1.04 1.13),1.15E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS006069,0.199,RNAseq,ZFP1,0.92 (0.89 0.96),1.65E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS010607,0.059,RNAseq,TRAV8-1,1.08 (1.04 1.13),1.75E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS008889,0.092,RNAseq,TRAV20,1.08 (1.04 1.12),2.58E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS010856,0.056,RNAseq,RIOK3,0.93 (0.89 0.96),2.90E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS009278,0.084,RNAseq,,0.92 (0.89 0.96),3.02E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS006866,0.157,RNAseq,AL662795.2,1.08 (1.04 1.13),3.02E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS014075,0.022,RNAseq,AGER,0.92 (0.89 0.96),3.21E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS007145,0.146,RNAseq,BAG6,1.08 (1.04 1.12),3.75E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS012028,0.041,RNAseq,HLA-DQB1-AS1,0.93 (0.89 0.96),4.26E-02
250.7,Diabetic retinopathy,endocrine/metabolic,OPGS008402,0.104,RNAseq,TNXB,1.08 (1.03 1.12),4.79E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.85 (0.82 0.89),2.75E-10
251.1,Hypoglycemia,endocrine/metabolic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.17 (1.12 1.22),2.06E-09
251.1,Hypoglycemia,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.17 (1.12 1.23),2.95E-08
251.1,Hypoglycemia,endocrine/metabolic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.86 (0.82 0.90),1.56E-07
251.1,Hypoglycemia,endocrine/metabolic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.15 (1.10 1.20),4.62E-07
251.1,Hypoglycemia,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.89 (0.85 0.93),2.37E-05
251.1,Hypoglycemia,endocrine/metabolic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.89 (0.85 0.93),2.66E-05
251.1,Hypoglycemia,endocrine/metabolic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.89 (0.86 0.93),3.01E-04
251.1,Hypoglycemia,endocrine/metabolic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.90 (0.86 0.94),3.39E-04
251.1,Hypoglycemia,endocrine/metabolic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.89 (0.85 0.93),4.35E-04
251.1,Hypoglycemia,endocrine/metabolic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.90 (0.86 0.94),5.67E-04
251.1,Hypoglycemia,endocrine/metabolic,OPGS000576,0.102,SomaScan,Interleukin-21,0.90 (0.86 0.94),5.81E-04
251.1,Hypoglycemia,endocrine/metabolic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.11 (1.06 1.16),6.12E-04
251.1,Hypoglycemia,endocrine/metabolic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.90 (0.86 0.94),6.41E-04
251.1,Hypoglycemia,endocrine/metabolic,OPGS001231,0.037,SomaScan,Osteocalcin,1.11 (1.06 1.15),2.11E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.10 (1.06 1.15),2.44E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.90 (0.86 0.94),3.94E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS000879,0.065,SomaScan,Natural cytotoxicity triggering receptor 3,1.11 (1.06 1.16),7.35E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS002197,0.011,SomaScan,Pleckstrin homology domain-containing family A member 7,1.08 (1.04 1.13),2.25E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS001911,0.014,SomaScan,Ectodysplasin-A. secreted form,0.92 (0.88 0.96),4.62E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.86 (0.83 0.90),4.06E-08
251.1,Hypoglycemia,endocrine/metabolic,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.90 (0.86 0.94),1.10E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.90 (0.87 0.94),1.16E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.91 (0.87 0.95),8.40E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.84 (0.81 0.88),9.20E-15
251.1,Hypoglycemia,endocrine/metabolic,OPGS013243,0.029,RNAseq,TRAV3,0.84 (0.80 0.87),5.41E-13
251.1,Hypoglycemia,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.19 (1.14 1.24),2.11E-12
251.1,Hypoglycemia,endocrine/metabolic,OPGS006716,0.164,RNAseq,IER3,1.19 (1.14 1.24),3.61E-12
251.1,Hypoglycemia,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.86 (0.83 0.90),1.79E-09
251.1,Hypoglycemia,endocrine/metabolic,OPGS009865,0.072,RNAseq,TRAV17,0.86 (0.82 0.90),3.47E-09
251.1,Hypoglycemia,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.14 (1.09 1.19),1.54E-06
251.1,Hypoglycemia,endocrine/metabolic,OPGS005334,0.253,RNAseq,AL645933.4,0.88 (0.84 0.91),2.07E-06
251.1,Hypoglycemia,endocrine/metabolic,OPGS014496,0.019,RNAseq,VARS1,1.13 (1.08 1.17),9.99E-06
251.1,Hypoglycemia,endocrine/metabolic,OPGS005230,0.263,RNAseq,LINC00243,1.13 (1.08 1.18),2.37E-05
251.1,Hypoglycemia,endocrine/metabolic,OPGS011536,0.047,RNAseq,TRAV2,0.88 (0.85 0.92),4.15E-05
251.1,Hypoglycemia,endocrine/metabolic,OPGS010826,0.056,RNAseq,TRIM10,0.89 (0.86 0.93),4.84E-05
251.1,Hypoglycemia,endocrine/metabolic,OPGS010624,0.059,RNAseq,TRBV18,1.13 (1.08 1.18),5.00E-05
251.1,Hypoglycemia,endocrine/metabolic,OPGS011494,0.047,RNAseq,RNF26,1.12 (1.07 1.17),3.55E-04
251.1,Hypoglycemia,endocrine/metabolic,OPGS010700,0.058,RNAseq,DCLRE1B,0.91 (0.87 0.94),5.67E-04
251.1,Hypoglycemia,endocrine/metabolic,OPGS007407,0.135,RNAseq,TRBV2,1.11 (1.06 1.16),6.95E-04
251.1,Hypoglycemia,endocrine/metabolic,OPGS009198,0.085,RNAseq,TRAV12-1,1.11 (1.07 1.16),6.95E-04
251.1,Hypoglycemia,endocrine/metabolic,OPGS004122,0.430,RNAseq,HLA-DRB5,0.90 (0.86 0.94),9.68E-04
251.1,Hypoglycemia,endocrine/metabolic,OPGS004406,0.369,RNAseq,,0.90 (0.86 0.94),9.93E-04
251.1,Hypoglycemia,endocrine/metabolic,OPGS003680,0.611,RNAseq,,1.10 (1.06 1.15),1.11E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS011787,0.044,RNAseq,C2,1.11 (1.06 1.15),1.63E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS011853,0.043,RNAseq,TRBV6-1,0.90 (0.86 0.94),1.81E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS009072,0.088,RNAseq,HLA-DQB1,0.91 (0.87 0.95),2.15E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.12 (1.07 1.17),2.15E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS006038,0.201,RNAseq,HLA-DQA2,1.10 (1.05 1.14),2.65E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS005489,0.239,RNAseq,TRAPPC5,0.91 (0.87 0.95),5.45E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS007145,0.146,RNAseq,BAG6,1.10 (1.05 1.14),6.26E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS012006,0.041,RNAseq,VARS2,0.91 (0.87 0.95),7.05E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS012171,0.039,RNAseq,TRBV15,0.91 (0.87 0.95),7.70E-03
251.1,Hypoglycemia,endocrine/metabolic,OPGS009225,0.085,RNAseq,CD5,0.91 (0.87 0.95),1.17E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS010661,0.059,RNAseq,PTPN22,1.09 (1.05 1.14),1.39E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS012268,0.038,RNAseq,AC087501.4,0.92 (0.88 0.96),1.39E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS005005,0.286,RNAseq,HLA-DOA,0.92 (0.88 0.96),1.46E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS014680,0.018,RNAseq,GALE,0.92 (0.88 0.96),1.51E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS008513,0.101,RNAseq,CEP68,1.10 (1.05 1.15),1.51E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS011265,0.050,RNAseq,HSPA5,0.92 (0.88 0.96),2.00E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS010874,0.056,RNAseq,ALS2CL,0.91 (0.87 0.96),2.11E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS011948,0.042,RNAseq,ADGRG1,0.92 (0.88 0.96),2.28E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS006001,0.203,RNAseq,HLA-DQA1,0.91 (0.87 0.96),2.28E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS011784,0.044,RNAseq,TUBB,1.09 (1.04 1.14),2.66E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS007237,0.142,RNAseq,COL11A2,0.91 (0.86 0.95),2.79E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS013597,0.026,RNAseq,KEL,1.08 (1.04 1.13),3.86E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS006048,0.200,RNAseq,,0.92 (0.88 0.96),3.91E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS013780,0.024,RNAseq,ZSCAN16,1.08 (1.04 1.13),4.19E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS012028,0.041,RNAseq,HLA-DQB1-AS1,0.92 (0.88 0.96),4.26E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS011152,0.052,RNAseq,CLIP2,1.08 (1.04 1.13),4.29E-02
251.1,Hypoglycemia,endocrine/metabolic,OPGS006081,0.199,RNAseq,BRK1,0.93 (0.89 0.96),4.80E-02
253,Disorders of the pituitary gland and its hypothalamic control,endocrine/metabolic,OPGS008939,0.091,RNAseq,,1.32 (1.18 1.48),2.87E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.82 (0.77 0.89),7.86E-03
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.84 (0.78 0.91),1.43E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS006942,0.154,RNAseq,SKIV2L,0.82 (0.75 0.89),1.10E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS006499,0.176,RNAseq,C4A,0.84 (0.78 0.91),1.43E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS012271,0.038,RNAseq,TRBV5-6,0.87 (0.82 0.93),1.43E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS004081,0.443,RNAseq,,1.18 (1.10 1.27),1.66E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS012358,0.037,RNAseq,SFRP5,0.84 (0.78 0.91),3.07E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS007022,0.151,RNAseq,SLC35A1,0.85 (0.78 0.91),3.85E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS013225,0.029,RNAseq,REG4,0.85 (0.79 0.92),4.34E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS006248,0.189,RNAseq,MCCD1,0.85 (0.79 0.92),4.34E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.17 (1.08 1.26),4.34E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS009865,0.072,RNAseq,TRAV17,0.85 (0.79 0.92),4.34E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS005230,0.263,RNAseq,LINC00243,1.18 (1.09 1.27),4.34E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS007297,0.140,RNAseq,GPANK1,0.83 (0.76 0.91),4.34E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS011787,0.044,RNAseq,C2,1.17 (1.09 1.26),4.58E-02
255.21,Glucocorticoid deficiency,endocrine/metabolic,OPGS010693,0.058,RNAseq,TRBV5-1,1.17 (1.08 1.26),4.60E-02
261.2,Vitamin B-complex deficiencies,endocrine/metabolic,OPGS000649,0.091,SomaScan,Transcobalamin-1,0.84 (0.81 0.88),2.91E-13
261.2,Vitamin B-complex deficiencies,endocrine/metabolic,OPGS000664,0.088,SomaScan,BPI fold-containing family A member 2,0.90 (0.86 0.94),1.19E-02
261.2,Vitamin B-complex deficiencies,endocrine/metabolic,OPGS001812,0.017,SomaScan,Fibroblast growth factor 19,1.10 (1.05 1.14),4.81E-02
261.2,Vitamin B-complex deficiencies,endocrine/metabolic,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,1.10 (1.05 1.15),4.81E-02
261.2,Vitamin B-complex deficiencies,endocrine/metabolic,OPGS002657,0.013,Olink,Fibroblast growth factor 19,1.10 (1.06 1.15),2.18E-02
261.2,Vitamin B-complex deficiencies,endocrine/metabolic,OPGS005329,0.254,RNAseq,CLYBL,0.91 (0.87 0.95),1.19E-02
261.2,Vitamin B-complex deficiencies,endocrine/metabolic,OPGS006496,0.176,RNAseq,TCN1,0.91 (0.87 0.95),2.40E-02
261.2,Vitamin B-complex deficiencies,endocrine/metabolic,OPGS006944,0.154,RNAseq,,0.91 (0.87 0.95),3.53E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.14 (1.11 1.16),1.55E-31
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000115,0.347,SomaScan,Protein CEI,1.14 (1.12 1.17),9.02E-31
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.14 (1.12 1.16),1.11E-30
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.14 (1.12 1.16),2.98E-30
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000613,0.096,SomaScan,Stromelysin-1,1.14 (1.12 1.17),6.31E-28
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000857,0.067,SomaScan,Moesin,1.12 (1.10 1.14),1.44E-27
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000312,0.163,SomaScan,Selenoprotein S,1.14 (1.11 1.16),2.06E-27
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.12 (1.10 1.14),1.24E-26
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.13 (1.11 1.16),1.99E-26
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.14 (1.11 1.16),2.74E-26
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.13 (1.11 1.16),4.89E-25
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.11 (1.09 1.13),3.25E-23
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.11 (1.09 1.13),2.68E-22
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.11 (1.08 1.13),8.58E-21
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.11 (1.09 1.14),5.41E-19
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.10 (1.08 1.12),8.12E-19
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.90 (0.88 0.92),1.43E-17
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.10 (1.08 1.13),2.83E-17
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.11 (1.09 1.14),3.36E-17
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.10 (1.08 1.12),5.49E-17
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.09 (1.07 1.12),6.60E-17
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.10 (1.08 1.12),1.84E-16
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002108,0.012,SomaScan,Neuralized-like protein 4,1.11 (1.08 1.13),5.98E-16
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000883,0.064,SomaScan,Group XIIB secretory phospholipase A2-like protein,1.10 (1.08 1.12),9.74E-16
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.10 (1.07 1.12),1.10E-15
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,0.91 (0.88 0.93),6.77E-15
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000285,0.176,SomaScan,Complement C1q tumor necrosis factor-related protein 1,1.10 (1.07 1.12),8.42E-15
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001058,0.049,SomaScan,Protocadherin beta-10,1.10 (1.08 1.13),1.97E-14
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001392,0.029,SomaScan,Cadherin-related family member 5,1.10 (1.08 1.13),3.81E-14
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000577,0.102,SomaScan,Platelet-activating factor acetylhydrolase,1.09 (1.07 1.11),6.27E-14
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.09 (1.07 1.11),1.13E-13
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000860,0.066,SomaScan,Cell surface glycoprotein CD200 receptor 2,0.91 (0.89 0.93),1.18E-13
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000348,0.151,SomaScan,Quinone oxidoreductase-like protein 1,1.10 (1.07 1.12),1.52E-13
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.09 (1.07 1.12),1.77E-13
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000154,0.277,SomaScan,Granulins,1.09 (1.07 1.11),1.83E-13
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.08 (1.06 1.10),3.05E-13
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.09 (1.06 1.11),3.14E-13
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.09 (1.07 1.11),9.81E-13
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.92 (0.90 0.94),9.93E-13
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001144,0.043,SomaScan,Proprotein convertase subtilisin/kexin type 9,1.10 (1.08 1.13),1.37E-12
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000838,0.069,SomaScan,DNA/RNA-binding protein KIN17,0.92 (0.90 0.94),3.36E-12
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001437,0.028,SomaScan,Steroidogenic acute regulatory protein. mitochondrial,1.09 (1.06 1.11),4.42E-12
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,0.92 (0.90 0.94),5.10E-12
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000492,0.119,SomaScan,Inactive gamma-glutamyltranspeptidase 2,1.09 (1.06 1.11),9.25E-12
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001279,0.035,SomaScan,Four-jointed box protein 1,1.08 (1.06 1.11),9.52E-12
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000445,0.129,SomaScan,Collectin-10,0.92 (0.90 0.94),1.13E-11
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000172,0.257,SomaScan,Dermokine,0.92 (0.90 0.94),1.69E-11
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001002,0.053,SomaScan,Tumor protein p53-inducible protein 11,1.08 (1.06 1.11),6.79E-11
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.93 (0.91 0.95),2.03E-10
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001297,0.034,SomaScan,Neogenin,0.93 (0.91 0.95),2.09E-10
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.08 (1.06 1.10),2.24E-10
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,0.92 (0.90 0.94),2.71E-10
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001963,0.013,SomaScan,Annexin A9,1.08 (1.06 1.11),5.09E-10
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001093,0.046,SomaScan,C-reactive protein,0.93 (0.91 0.95),7.80E-09
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001252,0.036,SomaScan,Neuronal pentraxin-2,1.07 (1.05 1.09),7.94E-09
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.07 (1.05 1.09),8.19E-09
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000510,0.115,SomaScan,Guanine nucleotide-binding protein G(k) subunit alpha,0.93 (0.91 0.95),1.41E-08
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001041,0.050,SomaScan,RING finger protein 122,1.07 (1.05 1.09),2.53E-08
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.06 (1.04 1.09),2.26E-07
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000401,0.139,SomaScan,Hemoglobin subunit theta-1,1.07 (1.04 1.09),3.33E-07
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.06 (1.04 1.08),1.26E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001124,0.044,SomaScan,Tumor necrosis factor receptor type 1-associated DEATH domain protein,1.06 (1.04 1.08),1.76E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.06 (1.04 1.08),2.63E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001112,0.045,SomaScan,Hemojuvelin,1.06 (1.04 1.08),2.71E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000874,0.065,SomaScan,Carbonic anhydrase-related protein 10,1.06 (1.04 1.08),3.93E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.06 (1.04 1.08),8.61E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000715,0.082,SomaScan,Surfeit locus protein 1,1.06 (1.04 1.08),9.03E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001715,0.019,SomaScan,Histone deacetylase 8,1.06 (1.04 1.08),1.07E-05
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000901,0.063,SomaScan,Ski-like protein,1.05 (1.03 1.08),6.37E-05
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000951,0.057,SomaScan,Pseudokinase FAM20A,0.95 (0.93 0.97),1.13E-04
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.05 (1.03 1.08),1.28E-04
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001354,0.031,SomaScan,M-phase inducer phosphatase 2,1.05 (1.03 1.07),1.42E-04
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.95 (0.93 0.97),1.89E-04
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000911,0.062,SomaScan,Protein MENT,1.05 (1.03 1.07),2.53E-04
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000215,0.218,SomaScan,Immunoglobulin superfamily containing leucine-rich repeat protein 2,0.95 (0.93 0.97),9.16E-04
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000155,0.275,SomaScan,Interleukin-3 receptor subunit alpha,0.95 (0.94 0.98),1.08E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000378,0.143,SomaScan,Immunoglobulin superfamily containing leucine-rich repeat protein 2,0.96 (0.94 0.98),1.59E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001106,0.046,SomaScan,Disintegrin and metalloproteinase domain-containing protein 11,1.05 (1.02 1.07),2.31E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000632,0.093,SomaScan,Erythrocyte band 7 integral membrane protein,1.05 (1.02 1.07),2.88E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000736,0.080,SomaScan,Semaphorin-6A,0.96 (0.94 0.98),4.41E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000427,0.132,SomaScan,Adhesion G-protein coupled receptor F1,1.04 (1.02 1.07),5.20E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001238,0.037,SomaScan,Dedicator of cytokinesis protein 9,1.04 (1.02 1.07),5.79E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001016,0.052,SomaScan,Protein jagged-1,0.96 (0.94 0.98),6.82E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001928,0.014,SomaScan,Sorting nexin-1,1.04 (1.02 1.06),9.18E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002046,0.012,SomaScan,Set1/Ash2 histone methyltransferase complex subunit ASH2,1.04 (1.02 1.06),1.13E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000642,0.092,SomaScan,Heparin cofactor 2,0.96 (0.94 0.98),1.60E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001518,0.025,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,1.04 (1.02 1.06),1.60E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001110,0.045,SomaScan,15-hydroxyprostaglandin dehydrogenase [NAD(+)],1.04 (1.02 1.06),1.87E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000117,0.345,SomaScan,Galactoside 3(4)-L-fucosyltransferase,0.96 (0.94 0.98),1.99E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.96 (0.94 0.98),2.02E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000011,0.683,SomaScan,Hepatocyte growth factor-like protein,1.04 (1.02 1.06),2.12E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001700,0.019,SomaScan,Semaphorin-6B,0.96 (0.94 0.98),2.12E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001832,0.016,SomaScan,Neurogenic locus notch homolog protein 1,0.96 (0.94 0.98),2.54E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000521,0.113,SomaScan,Transmembrane protease serine 11D,1.04 (1.02 1.06),2.54E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002219,0.011,SomaScan,Zinc finger protein 843,1.04 (1.02 1.06),2.65E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000351,0.151,SomaScan,C1GALT1-specific chaperone 1,1.04 (1.02 1.06),3.07E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000278,0.180,SomaScan,Cadherin-5,0.96 (0.94 0.98),3.28E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001485,0.026,SomaScan,Tolloid-like protein 1,0.96 (0.94 0.98),3.28E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000600,0.099,SomaScan,Insulin receptor,0.97 (0.95 0.99),3.93E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS000196,0.236,SomaScan,Protein FAM3B,1.04 (1.02 1.06),3.97E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001641,0.021,SomaScan,Killer cell lectin-like receptor subfamily F member 1,1.04 (1.02 1.06),4.00E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS001042,0.050,SomaScan,Cadherin-related family member 1,1.04 (1.01 1.06),4.19E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002436,0.191,Olink,Progranulin,1.08 (1.06 1.11),1.07E-11
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002558,0.048,Olink,Proprotein convertase subtilisin/kexin type 9,1.08 (1.06 1.10),4.80E-10
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002638,0.019,Olink,Ephrin type-B receptor 4,0.95 (0.93 0.97),1.05E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002600,0.030,Olink,Heme oxygenase 1,0.96 (0.94 0.98),2.50E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002552,0.053,Olink,Low-density lipoprotein receptor,0.96 (0.94 0.98),5.31E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002590,0.035,Olink,Platelet endothelial cell adhesion molecule,0.96 (0.94 0.98),6.23E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002605,0.030,Olink,Sortilin,0.96 (0.94 0.98),9.25E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002578,0.039,Olink,Leukemia inhibitory factor receptor,0.96 (0.94 0.98),1.01E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002454,0.157,Olink,Galectin-9,0.96 (0.94 0.98),1.41E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002440,0.183,Olink,Cadherin-5,0.96 (0.94 0.98),1.41E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002430,0.205,Olink,Chitinase-3-like protein 1,1.04 (1.02 1.06),1.52E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002589,0.035,Olink,Lysosome membrane protein 2,1.04 (1.02 1.06),2.20E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002656,0.013,Olink,Angiotensin-converting enzyme 2,0.96 (0.94 0.98),2.94E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003006,0.030,Metabolon,cholesterol,1.20 (1.17 1.22),4.31E-56
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.18 (1.15 1.20),1.03E-44
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.14 (1.12 1.16),8.75E-35
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003058,0.022,Metabolon,sphingomyelin (d18:1/17:0. d17:1/18:0. d19:1/16:0),1.13 (1.11 1.16),1.28E-28
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.13 (1.11 1.16),1.97E-26
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.11 (1.08 1.13),6.40E-20
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.10 (1.08 1.12),5.58E-18
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002951,0.041,Metabolon,stearoyl sphingomyelin (d18:1/18:0),1.10 (1.08 1.12),1.28E-16
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.10 (1.07 1.12),3.68E-16
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.10 (1.08 1.13),1.17E-13
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002915,0.048,Metabolon,sphingomyelin (d18:1/20:0. d16:1/22:0)*,1.08 (1.06 1.10),5.07E-11
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003203,0.012,Metabolon,sphingomyelin (d18:2/23:0. d18:1/23:1. d17:1/24:1)*,1.08 (1.06 1.10),1.99E-10
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002874,0.060,Metabolon,campesterol,1.07 (1.05 1.10),1.39E-09
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002837,0.075,Metabolon,1-stearoyl-2-arachidonoyl-GPI (18:0/20:4),1.07 (1.05 1.09),6.16E-08
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003127,0.017,Metabolon,sphingomyelin (d18:1/22:1. d18:2/22:0. d16:1/24:1)*,1.07 (1.04 1.09),7.78E-08
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002940,0.044,Metabolon,lactosyl-N-palmitoyl-sphingosine,1.06 (1.04 1.08),1.86E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003217,0.011,Metabolon,X - 24024,1.05 (1.03 1.07),8.46E-05
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002770,0.124,Metabolon,1-stearoyl-2-arachidonoyl-GPE (18:0/20:4),1.05 (1.03 1.07),2.34E-04
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003151,0.014,Metabolon,1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2)*,1.05 (1.03 1.07),3.71E-04
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002956,0.040,Metabolon,sphingomyelin (d18:1/15:0. d16:1/17:0)*,1.05 (1.03 1.07),4.37E-04
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003000,0.031,Metabolon,1-stearoyl-2-oleoyl-GPE (18:0/18:1),1.05 (1.03 1.07),7.99E-04
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002893,0.054,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3)*,1.05 (1.02 1.07),2.05E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002873,0.061,Metabolon,X - 14658,1.05 (1.02 1.07),2.50E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003119,0.017,Metabolon,1-palmitoyl-GPC (16:0),1.04 (1.02 1.07),4.52E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002802,0.092,Metabolon,1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6)*,1.04 (1.02 1.06),8.15E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002888,0.057,Metabolon,sphingomyelin (d18:1/14:0. d16:1/16:0)*,1.04 (1.02 1.06),1.58E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003183,0.013,Metabolon,X - 16944,0.96 (0.94 0.98),1.60E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002896,0.053,Metabolon,X - 11261,0.96 (0.94 0.98),2.16E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002917,0.048,Metabolon,sphingomyelin (d18:1/21:0. d17:1/22:0. d16:1/23:0)*,1.04 (1.02 1.06),2.26E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003067,0.022,Metabolon,X - 12339,0.96 (0.94 0.98),2.26E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002891,0.056,Metabolon,1-palmitoyl-2-oleoyl-GPE (16:0/18:1),1.04 (1.02 1.06),2.26E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS002982,0.033,Metabolon,X - 12681,0.96 (0.94 0.98),2.46E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.30 (1.27 1.33),2.90E-115
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.29 (1.26 1.32),7.08E-113
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.29 (1.26 1.32),1.53E-110
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.29 (1.27 1.32),9.73E-109
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.29 (1.26 1.32),4.19E-107
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.27 (1.25 1.30),5.32E-107
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.27 (1.24 1.30),1.53E-106
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.27 (1.24 1.30),6.73E-106
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.29 (1.26 1.32),6.73E-106
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.29 (1.26 1.32),6.86E-106
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.29 (1.26 1.32),7.66E-106
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.29 (1.26 1.32),1.26E-104
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.29 (1.26 1.31),1.38E-104
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.28 (1.25 1.31),1.38E-104
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.29 (1.26 1.31),1.58E-104
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.29 (1.26 1.32),4.75E-104
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.28 (1.25 1.31),5.27E-104
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003423,0.126,Nightingale,LDL cholesterol,1.29 (1.26 1.32),2.99E-103
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.28 (1.26 1.31),2.50E-102
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.28 (1.26 1.31),2.71E-102
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.28 (1.25 1.31),3.36E-102
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.28 (1.25 1.31),1.19E-101
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.28 (1.26 1.31),1.07E-100
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.29 (1.26 1.31),1.07E-100
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.28 (1.25 1.31),4.53E-100
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.27 (1.25 1.30),5.96E-100
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.28 (1.25 1.31),2.44E-99
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.27 (1.25 1.30),4.98E-99
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.28 (1.25 1.31),3.70E-98
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.28 (1.25 1.31),8.27E-98
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003452,0.087,Nightingale,Total cholesterol,1.27 (1.24 1.29),7.98E-96
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.27 (1.24 1.30),1.81E-93
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.25 (1.23 1.28),3.90E-93
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.25 (1.22 1.28),2.21E-91
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003455,0.087,Nightingale,Total free cholesterol,1.25 (1.23 1.28),2.33E-91
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.25 (1.22 1.27),3.76E-90
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.24 (1.22 1.27),5.59E-89
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.25 (1.22 1.28),8.78E-89
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.24 (1.21 1.26),2.20E-81
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.21 (1.19 1.24),2.09E-70
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003497,0.072,Nightingale,Linoleic acid,1.21 (1.19 1.24),8.34E-69
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.20 (1.18 1.23),5.56E-67
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.20 (1.18 1.23),2.71E-66
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003523,0.062,Nightingale,Total fatty acids,1.20 (1.18 1.23),1.17E-65
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.21 (1.18 1.23),1.45E-65
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.20 (1.18 1.23),2.74E-64
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.20 (1.17 1.22),6.85E-63
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.20 (1.17 1.22),2.04E-61
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003527,0.050,Nightingale,Sphingomyelins,1.20 (1.18 1.23),3.65E-60
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.19 (1.17 1.22),2.72E-59
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.19 (1.17 1.22),8.43E-59
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.19 (1.17 1.22),1.39E-58
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.19 (1.16 1.21),6.73E-56
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.20 (1.17 1.22),9.91E-56
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003528,0.050,Nightingale,Total cholines,1.18 (1.15 1.20),4.92E-50
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.17 (1.15 1.20),3.30E-49
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.17 (1.15 1.20),1.07E-47
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.17 (1.15 1.20),1.83E-47
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.17 (1.15 1.19),6.12E-47
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,1.16 (1.13 1.18),5.29E-41
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.15 (1.13 1.18),5.29E-37
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,1.15 (1.12 1.17),2.01E-35
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003526,0.050,Nightingale,Phosphatidylcholines,1.15 (1.12 1.17),2.80E-35
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.14 (1.11 1.16),1.32E-30
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003476,0.076,Nightingale,Phospholipids in medium VLDL,1.12 (1.09 1.14),9.85E-23
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.11 (1.09 1.14),8.37E-22
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003486,0.074,Nightingale,Total triglycerides,1.11 (1.09 1.14),2.39E-21
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.90 (0.89 0.92),4.27E-18
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003518,0.065,Nightingale,Triglycerides in medium HDL,1.10 (1.08 1.12),1.48E-17
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003475,0.076,Nightingale,Total lipids in medium VLDL,1.10 (1.08 1.12),4.86E-17
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.91 (0.89 0.93),9.46E-16
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003490,0.073,Nightingale,Free cholesterol in medium VLDL,1.10 (1.07 1.12),1.18E-15
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003477,0.076,Nightingale,Concentration of medium VLDL particles,1.09 (1.07 1.12),6.89E-15
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.09 (1.07 1.11),4.16E-14
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003479,0.075,Nightingale,Triglycerides in VLDL,1.09 (1.07 1.11),3.27E-13
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003484,0.075,Nightingale,Triglycerides in HDL,1.09 (1.06 1.11),1.22E-12
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003481,0.075,Nightingale,Triglycerides in medium VLDL,1.09 (1.06 1.11),2.53E-12
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003499,0.071,Nightingale,Phospholipids in large VLDL,1.07 (1.05 1.10),4.71E-09
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.93 (0.91 0.95),4.79E-09
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.93 (0.91 0.95),7.03E-09
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003471,0.077,Nightingale,Cholesteryl esters in large VLDL,1.07 (1.05 1.09),1.04E-07
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,1.06 (1.04 1.09),9.76E-07
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003494,0.072,Nightingale,Concentration of large VLDL particles,1.06 (1.04 1.09),1.37E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003493,0.073,Nightingale,Total lipids in large VLDL,1.06 (1.04 1.09),1.46E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003498,0.071,Nightingale,Triglycerides in large VLDL,1.06 (1.04 1.08),5.00E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003507,0.070,Nightingale,Free cholesterol in large VLDL,1.06 (1.04 1.08),7.76E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.94 (0.92 0.96),7.88E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.95 (0.93 0.97),1.17E-05
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.95 (0.93 0.97),1.29E-05
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.95 (0.93 0.97),1.34E-05
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003540,0.029,Nightingale,Free cholesterol in small HDL,0.95 (0.93 0.97),2.87E-05
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003483,0.075,Nightingale,Cholesterol in large VLDL,1.06 (1.03 1.08),3.03E-05
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.95 (0.93 0.97),4.29E-05
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.95 (0.93 0.97),8.59E-05
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.95 (0.93 0.97),1.17E-04
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.95 (0.93 0.97),4.54E-04
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003495,0.072,Nightingale,Triglycerides in very large HDL,1.05 (1.02 1.07),1.51E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.96 (0.94 0.98),6.22E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003520,0.062,Nightingale,HDL cholesterol,0.96 (0.94 0.98),7.22E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.96 (0.94 0.98),2.02E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003516,0.066,Nightingale,Phospholipids in very large VLDL,1.04 (1.02 1.06),3.38E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003448,0.093,Nightingale,Phospholipids in very large HDL,0.97 (0.95 0.99),4.98E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS006535,0.174,RNAseq,PSRC1,0.92 (0.90 0.94),2.03E-11
272.1,Hyperlipidemia,endocrine/metabolic,OPGS010653,0.059,RNAseq,CELSR2,1.06 (1.04 1.09),1.14E-06
272.1,Hyperlipidemia,endocrine/metabolic,OPGS006143,0.195,RNAseq,DOCK7,1.05 (1.03 1.08),8.99E-05
272.1,Hyperlipidemia,endocrine/metabolic,OPGS010657,0.059,RNAseq,HMG20A,1.05 (1.03 1.07),1.88E-04
272.1,Hyperlipidemia,endocrine/metabolic,OPGS004717,0.321,RNAseq,ARNTL,0.96 (0.94 0.98),2.71E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS013879,0.023,RNAseq,DDX54,0.96 (0.94 0.98),5.87E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS006497,0.176,RNAseq,SNX18,1.04 (1.02 1.06),7.17E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS004861,0.303,RNAseq,GRB14,1.04 (1.02 1.07),7.30E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS006403,0.180,RNAseq,AL356599.1,1.04 (1.02 1.06),7.86E-03
272.1,Hyperlipidemia,endocrine/metabolic,OPGS012551,0.035,RNAseq,LYRM7,1.04 (1.02 1.06),1.02E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS009606,0.077,RNAseq,SAE1,0.96 (0.94 0.98),1.15E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS006029,0.201,RNAseq,FLVCR2,1.04 (1.02 1.06),1.24E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS004485,0.357,RNAseq,LPL,0.96 (0.94 0.98),1.38E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS010025,0.069,RNAseq,UNC93B1,0.96 (0.94 0.98),1.38E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS008693,0.097,RNAseq,SEPTIN11,1.04 (1.02 1.06),1.41E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS011256,0.050,RNAseq,USP1,1.04 (1.02 1.06),1.47E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS013430,0.027,RNAseq,NFAM1,1.04 (1.02 1.06),1.99E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS012824,0.032,RNAseq,USP34,1.04 (1.02 1.06),2.06E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS013466,0.027,RNAseq,AC100786.1,1.04 (1.02 1.06),2.39E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS004919,0.296,RNAseq,WDR25,1.04 (1.02 1.06),2.41E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS004013,0.460,RNAseq,ANK3,0.96 (0.94 0.98),2.50E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003668,0.621,RNAseq,LGALS9,0.96 (0.94 0.98),2.54E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS013894,0.023,RNAseq,,1.04 (1.02 1.06),2.57E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS013199,0.029,RNAseq,ACP1,0.96 (0.94 0.98),2.80E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS013792,0.024,RNAseq,YIPF2,1.04 (1.02 1.06),2.85E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS010747,0.057,RNAseq,TIPIN,1.04 (1.02 1.06),2.85E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS004382,0.374,RNAseq,FES,0.96 (0.94 0.98),2.94E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS004917,0.297,RNAseq,PSMB3,1.04 (1.02 1.06),3.19E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS008075,0.113,RNAseq,AKAP12,0.96 (0.94 0.98),3.28E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS008893,0.092,RNAseq,APEH,0.96 (0.94 0.98),3.52E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS007282,0.140,RNAseq,CERCAM,1.04 (1.02 1.06),3.63E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS014141,0.022,RNAseq,NAGS,1.04 (1.02 1.06),3.82E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS011316,0.049,RNAseq,MYOSLID,1.04 (1.02 1.06),3.96E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS003802,0.547,RNAseq,IQSEC3,0.96 (0.94 0.99),4.35E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS013767,0.024,RNAseq,REL,1.04 (1.01 1.06),4.50E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS011775,0.044,RNAseq,GMEB2,0.97 (0.95 0.99),4.53E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS008678,0.097,RNAseq,DHODH,1.04 (1.01 1.06),4.59E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS005180,0.268,RNAseq,ISL2,0.97 (0.95 0.99),4.59E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS006958,0.153,RNAseq,TSC22D1,0.97 (0.95 0.99),4.59E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS013688,0.025,RNAseq,AC004825.2,0.96 (0.94 0.99),4.59E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS005591,0.231,RNAseq,SPHK1,0.96 (0.94 0.99),4.92E-02
272.1,Hyperlipidemia,endocrine/metabolic,OPGS009323,0.083,RNAseq,NAIP,1.04 (1.01 1.06),4.98E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000312,0.163,SomaScan,Selenoprotein S,1.14 (1.13 1.15),6.53E-171
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000115,0.347,SomaScan,Protein CEI,1.14 (1.13 1.15),6.93E-171
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.13 (1.12 1.14),5.53E-167
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.13 (1.12 1.14),3.06E-166
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000613,0.096,SomaScan,Stromelysin-1,1.14 (1.13 1.15),3.09E-164
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.13 (1.12 1.14),1.82E-162
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.14 (1.13 1.15),1.18E-156
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.14 (1.12 1.15),8.42E-152
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000857,0.067,SomaScan,Moesin,1.11 (1.10 1.12),3.03E-135
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.12 (1.11 1.13),1.94E-131
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.11 (1.10 1.12),8.66E-130
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.12 (1.11 1.13),2.78E-119
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.10 (1.09 1.11),1.39E-117
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.89 (0.88 0.90),8.79E-117
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.11 (1.10 1.12),5.24E-114
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.12 (1.10 1.13),1.94E-106
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002108,0.012,SomaScan,Neuralized-like protein 4,1.11 (1.10 1.13),9.72E-105
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.10 (1.09 1.11),4.10E-104
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.10 (1.09 1.11),5.77E-104
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.09 (1.09 1.10),1.37E-99
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,0.90 (0.89 0.91),2.29E-99
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000348,0.151,SomaScan,Quinone oxidoreductase-like protein 1,1.11 (1.10 1.12),8.24E-98
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001392,0.029,SomaScan,Cadherin-related family member 5,1.11 (1.10 1.12),6.14E-96
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001058,0.049,SomaScan,Protocadherin beta-10,1.11 (1.10 1.12),7.21E-95
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000860,0.066,SomaScan,Cell surface glycoprotein CD200 receptor 2,0.90 (0.89 0.91),6.53E-94
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.10 (1.09 1.11),3.22E-89
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,0.91 (0.90 0.92),2.19E-88
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000492,0.119,SomaScan,Inactive gamma-glutamyltranspeptidase 2,1.10 (1.09 1.11),1.60E-86
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.09 (1.08 1.10),2.89E-84
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.09 (1.08 1.10),3.61E-78
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.08 (1.07 1.09),2.84E-76
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,0.92 (0.91 0.92),3.09E-76
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001002,0.053,SomaScan,Tumor protein p53-inducible protein 11,1.09 (1.08 1.10),7.62E-76
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000445,0.129,SomaScan,Collectin-10,0.92 (0.91 0.93),1.14E-75
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001963,0.013,SomaScan,Annexin A9,1.09 (1.08 1.10),3.09E-74
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000172,0.257,SomaScan,Dermokine,0.92 (0.91 0.93),9.43E-74
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.92 (0.91 0.93),4.29E-73
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000510,0.115,SomaScan,Guanine nucleotide-binding protein G(k) subunit alpha,0.92 (0.91 0.93),1.22E-72
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000838,0.069,SomaScan,DNA/RNA-binding protein KIN17,0.92 (0.91 0.93),1.84E-72
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.08 (1.07 1.09),3.55E-65
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001715,0.019,SomaScan,Histone deacetylase 8,1.08 (1.07 1.09),2.47E-64
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.08 (1.07 1.09),4.12E-62
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.07 (1.06 1.08),1.44E-60
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000401,0.139,SomaScan,Hemoglobin subunit theta-1,1.08 (1.07 1.09),1.49E-59
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.07 (1.06 1.08),1.76E-58
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.93 (0.92 0.94),1.81E-57
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001437,0.028,SomaScan,Steroidogenic acute regulatory protein. mitochondrial,1.08 (1.07 1.09),1.48E-55
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.07 (1.06 1.08),1.67E-53
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000577,0.102,SomaScan,Platelet-activating factor acetylhydrolase,1.07 (1.06 1.08),1.41E-47
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000883,0.064,SomaScan,Group XIIB secretory phospholipase A2-like protein,1.07 (1.06 1.08),1.41E-46
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000715,0.082,SomaScan,Surfeit locus protein 1,1.06 (1.05 1.07),5.41E-45
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.07 (1.06 1.08),1.35E-44
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001252,0.036,SomaScan,Neuronal pentraxin-2,1.06 (1.05 1.07),2.44E-42
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000285,0.176,SomaScan,Complement C1q tumor necrosis factor-related protein 1,1.06 (1.05 1.07),2.77E-41
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.06 (1.05 1.07),4.81E-41
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000154,0.277,SomaScan,Granulins,1.06 (1.05 1.07),3.15E-39
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001093,0.046,SomaScan,C-reactive protein,0.94 (0.93 0.95),1.99E-38
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001144,0.043,SomaScan,Proprotein convertase subtilisin/kexin type 9,1.07 (1.06 1.08),1.96E-36
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001279,0.035,SomaScan,Four-jointed box protein 1,1.06 (1.05 1.07),1.35E-35
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001041,0.050,SomaScan,RING finger protein 122,1.06 (1.05 1.07),1.23E-34
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001106,0.046,SomaScan,Disintegrin and metalloproteinase domain-containing protein 11,1.06 (1.05 1.07),1.69E-33
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001297,0.034,SomaScan,Neogenin,0.95 (0.94 0.96),2.20E-30
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.05 (1.04 1.06),1.94E-29
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000951,0.057,SomaScan,Pseudokinase FAM20A,0.95 (0.94 0.96),2.21E-27
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.05 (1.04 1.06),3.31E-25
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.05 (1.04 1.06),2.03E-24
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000642,0.092,SomaScan,Heparin cofactor 2,0.96 (0.95 0.96),2.51E-23
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001124,0.044,SomaScan,Tumor necrosis factor receptor type 1-associated DEATH domain protein,1.05 (1.04 1.06),4.90E-23
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.05 (1.04 1.06),5.29E-23
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001112,0.045,SomaScan,Hemojuvelin,1.05 (1.04 1.06),1.39E-22
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000061,0.457,SomaScan,Haptoglobin,0.96 (0.95 0.96),2.38E-22
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001121,0.044,SomaScan,Growth factor receptor-bound protein 7,0.96 (0.95 0.96),2.74E-22
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000040,0.535,SomaScan,Haptoglobin,0.96 (0.95 0.97),7.92E-21
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000155,0.275,SomaScan,Interleukin-3 receptor subunit alpha,0.96 (0.95 0.97),8.92E-19
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,1.04 (1.03 1.05),1.23E-18
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.04 (1.03 1.05),8.87E-18
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001092,0.046,SomaScan,TOM1-like protein 1,1.04 (1.03 1.05),1.78E-17
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000911,0.062,SomaScan,Protein MENT,1.04 (1.03 1.05),3.86E-17
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001501,0.025,SomaScan,Hemoglobin,1.04 (1.03 1.05),1.26E-16
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.96 (0.95 0.97),2.03E-16
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000255,0.191,SomaScan,Ferritin,0.96 (0.95 0.97),2.90E-16
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.96 (0.95 0.97),3.47E-16
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001950,0.014,SomaScan,Apolipoprotein A-V,0.96 (0.96 0.97),8.73E-16
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001354,0.031,SomaScan,M-phase inducer phosphatase 2,1.04 (1.03 1.05),2.23E-15
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000874,0.065,SomaScan,Carbonic anhydrase-related protein 10,1.04 (1.03 1.05),7.51E-15
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000600,0.099,SomaScan,Insulin receptor,0.97 (0.96 0.97),2.30E-14
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000351,0.151,SomaScan,C1GALT1-specific chaperone 1,1.04 (1.03 1.05),4.08E-14
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,0.97 (0.96 0.97),1.99E-13
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000901,0.063,SomaScan,Ski-like protein,1.04 (1.03 1.04),2.07E-13
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.97 (0.96 0.97),2.43E-13
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001658,0.020,SomaScan,Endoglin,0.97 (0.96 0.98),8.82E-13
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000215,0.218,SomaScan,Immunoglobulin superfamily containing leucine-rich repeat protein 2,0.97 (0.96 0.98),4.63E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000427,0.132,SomaScan,Adhesion G-protein coupled receptor F1,1.03 (1.02 1.04),8.56E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001954,0.014,SomaScan,Tuftelin,0.97 (0.96 0.98),1.58E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000088,0.392,SomaScan,E-selectin,0.97 (0.96 0.98),1.94E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000095,0.381,SomaScan,Sulfhydryl oxidase 2,1.03 (1.02 1.04),3.83E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001915,0.014,SomaScan,N-acetylglucosamine-6-sulfatase,0.97 (0.96 0.98),5.89E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000378,0.143,SomaScan,Immunoglobulin superfamily containing leucine-rich repeat protein 2,0.97 (0.96 0.98),6.27E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.97 (0.96 0.98),6.29E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000736,0.080,SomaScan,Semaphorin-6A,0.97 (0.96 0.98),7.94E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000527,0.112,SomaScan,Scavenger receptor cysteine-rich type 1 protein M130,0.97 (0.96 0.98),2.77E-10
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001045,0.050,SomaScan,Carbohydrate sulfotransferase 15,0.97 (0.96 0.98),3.15E-10
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001102,0.046,SomaScan,Granzyme A,1.03 (1.02 1.04),5.23E-10
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000889,0.064,SomaScan,Hepatocyte growth factor receptor,0.97 (0.96 0.98),1.04E-09
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001127,0.044,SomaScan,Carbohydrate sulfotransferase 15,0.97 (0.96 0.98),4.50E-09
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000422,0.134,SomaScan,Ubiquitin carboxyl-terminal hydrolase 21,1.03 (1.02 1.04),5.90E-09
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002043,0.012,SomaScan,Matrix-remodeling-associated protein 8,1.03 (1.02 1.04),1.46E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001826,0.016,SomaScan,Stromal cell-derived factor 1,1.03 (1.02 1.03),3.46E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001757,0.018,SomaScan,Stromal cell-derived factor 1,1.03 (1.02 1.03),4.58E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,1.03 (1.02 1.04),5.61E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000221,0.213,SomaScan,Protein FAM177A1,0.97 (0.96 0.98),6.50E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001129,0.044,SomaScan,Sodium-coupled monocarboxylate transporter 1,1.03 (1.02 1.04),7.76E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000917,0.061,SomaScan,Interleukin-6 receptor subunit beta,0.97 (0.97 0.98),8.13E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001626,0.021,SomaScan,Neural cell adhesion molecule L1,0.97 (0.97 0.98),8.18E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000502,0.117,SomaScan,Neutrophil collagenase,1.03 (1.02 1.04),1.06E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000955,0.057,SomaScan,Repulsive guidance molecule A,1.03 (1.02 1.04),1.82E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001490,0.026,SomaScan,Intercellular adhesion molecule 2,0.97 (0.97 0.98),2.26E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.97 (0.97 0.98),2.36E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002275,0.010,SomaScan,Interferon-induced protein with tetratricopeptide repeats 2,1.03 (1.02 1.03),2.69E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000663,0.089,SomaScan,Secreted and transmembrane protein 1,0.98 (0.97 0.98),7.34E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000220,0.213,SomaScan,Vascular endothelial growth factor receptor 2,0.98 (0.97 0.98),7.91E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001286,0.034,SomaScan,Granzyme K,1.02 (1.02 1.03),1.54E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002270,0.010,SomaScan,Tumor necrosis factor receptor superfamily member 21,0.97 (0.96 0.98),2.52E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002292,0.010,SomaScan,Interleukin-18-binding protein,0.97 (0.96 0.98),2.52E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001661,0.020,SomaScan,Stromal cell-derived factor 2-like protein 1,0.98 (0.97 0.98),2.55E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000246,0.195,SomaScan,Apolipoprotein L1,0.98 (0.97 0.99),3.56E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000909,0.062,SomaScan,Leukocyte immunoglobulin-like receptor subfamily A member 4,1.02 (1.02 1.03),4.14E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.02 (1.01 1.03),5.39E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000278,0.180,SomaScan,Cadherin-5,0.98 (0.97 0.99),6.33E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001016,0.052,SomaScan,Protein jagged-1,0.98 (0.97 0.99),7.17E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000170,0.265,SomaScan,Lactase-phlorizin hydrolase,0.98 (0.97 0.99),1.03E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001812,0.017,SomaScan,Fibroblast growth factor 19,0.98 (0.97 0.99),1.29E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000923,0.060,SomaScan,Thrombospondin type-1 domain-containing protein 1,0.98 (0.97 0.99),1.62E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001216,0.038,SomaScan,C-type mannose receptor 2,0.98 (0.97 0.99),3.03E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000646,0.091,SomaScan,Protein-tyrosine sulfotransferase 2,1.02 (1.01 1.03),3.86E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.02 (1.01 1.03),4.18E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000108,0.360,SomaScan,Intercellular adhesion molecule 5,0.98 (0.97 0.99),5.39E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,0.98 (0.97 0.99),6.68E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001209,0.038,SomaScan,Stromal cell-derived factor 1,1.02 (1.01 1.03),7.47E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000200,0.234,SomaScan,Apolipoprotein L1,0.98 (0.97 0.99),7.66E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000749,0.078,SomaScan,Protein TMEPAI,1.02 (1.01 1.03),7.98E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000463,0.125,SomaScan,Toll-like receptor 4:Lymphocyte antigen 96 complex,0.98 (0.97 0.99),1.23E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001123,0.044,SomaScan,Semaphorin-3G,0.98 (0.97 0.99),1.98E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000250,0.192,SomaScan,Complement C1r subcomponent,1.02 (1.01 1.03),2.09E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000664,0.088,SomaScan,BPI fold-containing family A member 2,1.02 (1.01 1.03),2.43E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000067,0.438,SomaScan,Adhesion G protein-coupled receptor F5,0.98 (0.97 0.99),3.29E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,1.02 (1.01 1.03),3.31E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000166,0.267,SomaScan,P-selectin,0.98 (0.97 0.99),4.12E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000671,0.088,SomaScan,Carbohydrate sulfotransferase 11,1.02 (1.01 1.03),4.18E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001518,0.025,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,1.02 (1.01 1.03),4.51E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000213,0.222,SomaScan,ER membrane protein complex subunit 4,0.98 (0.97 0.99),4.51E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000927,0.059,SomaScan,Neuropilin-1,0.98 (0.97 0.99),6.82E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.02 (1.01 1.03),7.83E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000743,0.079,SomaScan,Furin,1.02 (1.01 1.03),8.47E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001208,0.038,SomaScan,Macrophage colony-stimulating factor 1 receptor,0.98 (0.97 0.99),8.56E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001301,0.034,SomaScan,Glycosaminoglycan xylosylkinase,1.02 (1.01 1.03),9.62E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000214,0.221,SomaScan,Intercellular adhesion molecule 5,0.98 (0.97 0.99),1.05E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001618,0.022,SomaScan,Neurexin-3-beta,0.98 (0.97 0.99),1.09E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000101,0.374,SomaScan,CD209 antigen,1.02 (1.01 1.03),1.21E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001157,0.041,SomaScan,Transmembrane protein 106A,0.98 (0.97 0.99),1.42E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000196,0.236,SomaScan,Protein FAM3B,1.02 (1.01 1.03),1.44E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000725,0.081,SomaScan,Glycolipid transfer protein domain-containing protein 2,1.02 (1.01 1.03),1.56E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001516,0.025,SomaScan,Tumor necrosis factor ligand superfamily member 8,0.98 (0.97 0.99),1.74E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002220,0.011,SomaScan,ATP-citrate synthase,0.98 (0.97 0.99),2.22E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000141,0.306,SomaScan,Complement C1s subcomponent,1.02 (1.01 1.03),2.67E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001342,0.031,SomaScan,Proprotein convertase subtilisin/kexin type 7,0.98 (0.97 0.99),2.82E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000969,0.056,SomaScan,Transferrin receptor protein 1,1.02 (1.01 1.03),3.01E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000283,0.177,SomaScan,Cathelicidin antimicrobial peptide,1.02 (1.01 1.03),3.39E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000383,0.142,SomaScan,Protein FAM3B,1.02 (1.01 1.03),3.40E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000645,0.091,SomaScan,Trypsin-3,0.98 (0.97 0.99),3.42E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000117,0.345,SomaScan,Galactoside 3(4)-L-fucosyltransferase,0.98 (0.97 0.99),3.97E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001306,0.033,SomaScan,Macrophage colony-stimulating factor 1 receptor,0.98 (0.98 0.99),4.15E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000112,0.352,SomaScan,Valine--tRNA ligase,1.02 (1.01 1.03),4.34E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000544,0.108,SomaScan,Segment polarity protein dishevelled homolog DVL-2,1.02 (1.01 1.03),4.69E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001460,0.027,SomaScan,Gap junction alpha-1 protein,1.02 (1.01 1.03),4.73E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001007,0.053,SomaScan,Neuropilin-1,0.98 (0.98 0.99),5.08E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001290,0.034,SomaScan,Glypican-3,1.02 (1.01 1.03),5.26E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001883,0.015,SomaScan,UMP-CMP kinase,1.02 (1.01 1.03),5.50E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000679,0.087,SomaScan,Mannosyl-oligosaccharide 1.2-alpha-mannosidase IB,1.02 (1.01 1.03),5.59E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001578,0.023,SomaScan,Serpin A9,1.02 (1.01 1.03),5.73E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000073,0.428,SomaScan,Interleukin-1 receptor-like 1,1.02 (1.01 1.03),5.73E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002246,0.010,SomaScan,Sperm-associated antigen 11B,0.98 (0.98 0.99),5.75E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001070,0.048,SomaScan,Vascular endothelial growth factor C,1.02 (1.01 1.02),6.39E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001831,0.016,SomaScan,SUN domain-containing protein 3,1.02 (1.01 1.02),7.72E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001238,0.037,SomaScan,Dedicator of cytokinesis protein 9,1.02 (1.01 1.03),7.82E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,0.98 (0.98 0.99),7.84E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001724,0.019,SomaScan,T-lymphocyte surface antigen Ly-9,1.02 (1.01 1.02),7.97E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.02 (1.01 1.02),8.77E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002148,0.011,SomaScan,Pescadillo homolog,0.98 (0.98 0.99),8.92E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000538,0.109,SomaScan,Cyclic AMP-responsive element-binding protein 3-like protein 4,1.02 (1.01 1.02),9.38E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000163,0.269,SomaScan,Single Ig IL-1-related receptor,1.02 (1.01 1.02),9.98E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000356,0.149,SomaScan,Promotilin,1.02 (1.01 1.02),1.02E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000173,0.257,SomaScan,Janus kinase and microtubule-interacting protein 3,1.02 (1.01 1.02),1.06E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001042,0.050,SomaScan,Cadherin-related family member 1,1.02 (1.01 1.02),1.08E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001832,0.016,SomaScan,Neurogenic locus notch homolog protein 1,0.98 (0.98 0.99),1.18E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000126,0.332,SomaScan,Vascular endothelial growth factor receptor 3,0.98 (0.98 0.99),1.20E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001485,0.026,SomaScan,Tolloid-like protein 1,0.98 (0.98 0.99),1.26E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000632,0.093,SomaScan,Erythrocyte band 7 integral membrane protein,1.02 (1.01 1.02),1.28E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000421,0.134,SomaScan,Lysozyme C,1.02 (1.01 1.02),1.34E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001246,0.036,SomaScan,Endothelial cell-selective adhesion molecule,0.98 (0.98 0.99),1.39E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001700,0.019,SomaScan,Semaphorin-6B,0.98 (0.98 0.99),1.42E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,1.02 (1.01 1.02),1.49E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001818,0.017,SomaScan,Dynactin subunit 2,1.02 (1.01 1.02),1.50E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000362,0.147,SomaScan,Golgi membrane protein 1,1.02 (1.01 1.02),1.51E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000252,0.192,SomaScan,Gastrokine-2,0.99 (0.98 0.99),1.58E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001049,0.049,SomaScan,Chloride intracellular channel protein 5,1.02 (1.01 1.02),1.60E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001395,0.029,SomaScan,CMRF35-like molecule 2,0.99 (0.98 0.99),1.63E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000807,0.072,SomaScan,C-C motif chemokine 22,1.02 (1.01 1.02),1.74E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000698,0.085,SomaScan,Alcohol dehydrogenase 1B,1.02 (1.01 1.02),1.77E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001937,0.014,SomaScan,Protocadherin gamma-B1,1.01 (1.01 1.02),1.79E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,1.01 (1.01 1.02),2.10E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002186,0.011,SomaScan,Suprabasin,0.99 (0.98 0.99),2.20E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001879,0.015,SomaScan,Arfaptin-2,1.02 (1.01 1.02),2.20E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000394,0.140,SomaScan,Superoxide dismutase [Mn]. mitochondrial,1.01 (1.01 1.02),2.21E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000479,0.122,SomaScan,C-C motif chemokine 25,0.99 (0.98 0.99),2.35E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,1.01 (1.01 1.02),2.43E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001860,0.016,SomaScan,Immunoglobulin E,0.99 (0.98 0.99),2.48E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000384,0.142,SomaScan,Ectonucleoside triphosphate diphosphohydrolase 5,0.99 (0.98 0.99),2.48E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000879,0.065,SomaScan,Natural cytotoxicity triggering receptor 3,0.99 (0.98 0.99),2.48E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001174,0.040,SomaScan,Platelet glycoprotein 4,0.99 (0.98 0.99),2.54E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001985,0.013,SomaScan,Isochorismatase domain-containing protein 1,1.01 (1.01 1.02),2.95E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,1.01 (1.01 1.02),2.95E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000765,0.077,SomaScan,Angiopoietin-1 receptor. soluble,0.99 (0.98 0.99),3.04E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000229,0.207,SomaScan,Interleukin-19,1.01 (1.01 1.02),3.17E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000070,0.436,SomaScan,Secretory phospholipase A2 receptor,1.01 (1.01 1.02),3.19E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001828,0.016,SomaScan,Splicing factor 1,1.01 (1.01 1.02),3.26E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000998,0.053,SomaScan,Tyrosine-protein phosphatase non-receptor type 4,1.01 (1.01 1.02),3.45E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,0.99 (0.98 0.99),3.54E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000521,0.113,SomaScan,Transmembrane protease serine 11D,1.01 (1.01 1.02),3.56E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000321,0.161,SomaScan,von Willebrand factor,1.01 (1.01 1.02),3.60E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.99 (0.98 0.99),3.62E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001769,0.018,SomaScan,Peptidyl-prolyl cis-trans isomerase FKBP14,1.01 (1.01 1.02),3.65E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000992,0.054,SomaScan,Arylamine N-acetyltransferase 1,0.99 (0.98 1.00),3.83E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000137,0.312,SomaScan,Complement C4b,0.99 (0.98 1.00),4.17E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001352,0.031,SomaScan,Sterol-4-alpha-carboxylate 3-dehydrogenase. decarboxylating,1.01 (1.00 1.02),4.17E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000011,0.683,SomaScan,Hepatocyte growth factor-like protein,1.01 (1.00 1.02),4.18E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS000717,0.082,SomaScan,Zinc finger protein 175,0.99 (0.98 1.00),4.75E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS001744,0.018,SomaScan,DnaJ homolog subfamily C member 15,0.99 (0.98 1.00),4.90E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002558,0.048,Olink,Proprotein convertase subtilisin/kexin type 9,1.06 (1.05 1.07),2.92E-36
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002436,0.191,Olink,Progranulin,1.06 (1.05 1.07),2.58E-35
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002552,0.053,Olink,Low-density lipoprotein receptor,0.95 (0.94 0.95),3.13E-32
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002600,0.030,Olink,Heme oxygenase 1,0.95 (0.94 0.96),1.39E-28
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002578,0.039,Olink,Leukemia inhibitory factor receptor,0.96 (0.95 0.97),1.59E-17
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002590,0.035,Olink,Platelet endothelial cell adhesion molecule,0.96 (0.96 0.97),7.12E-15
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002408,0.270,Olink,E-selectin,0.97 (0.96 0.98),1.26E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002638,0.019,Olink,Ephrin type-B receptor 4,0.97 (0.96 0.98),4.61E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002656,0.013,Olink,Angiotensin-converting enzyme 2,0.97 (0.96 0.98),3.89E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002568,0.043,Olink,Granzyme A,1.03 (1.02 1.04),2.38E-10
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002531,0.066,Olink,Tissue factor,0.97 (0.96 0.98),2.67E-10
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002557,0.050,Olink,Epithelial cell adhesion molecule,0.97 (0.96 0.98),3.30E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002500,0.098,Olink,Galectin-4,0.97 (0.97 0.98),4.13E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002497,0.100,Olink,Scavenger receptor cysteine-rich type 1 protein M130,0.97 (0.96 0.98),6.15E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002665,0.011,Olink,Neurocan core protein,1.03 (1.02 1.04),7.26E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002395,0.362,Olink,Intercellular adhesion molecule 2,0.97 (0.97 0.98),2.11E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002605,0.030,Olink,Sortilin,0.97 (0.97 0.98),2.78E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002440,0.183,Olink,Cadherin-5,0.98 (0.97 0.98),3.20E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002422,0.223,Olink,Lymphotoxin-alpha,0.98 (0.97 0.99),4.14E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002554,0.053,Olink,P-selectin,0.98 (0.97 0.99),2.24E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002657,0.013,Olink,Fibroblast growth factor 19,0.98 (0.97 0.99),3.53E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002462,0.144,Olink,Sialoadhesin,0.98 (0.97 0.99),4.76E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002637,0.020,Olink,Bone morphogenetic protein 4,0.98 (0.97 0.99),8.21E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002651,0.015,Olink,von Willebrand factor,1.02 (1.01 1.03),1.24E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002626,0.023,Olink,Fibroblast growth factor 21,1.02 (1.01 1.03),1.79E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002430,0.205,Olink,Chitinase-3-like protein 1,1.02 (1.01 1.03),2.47E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002640,0.019,Olink,NT-3 growth factor receptor,0.98 (0.97 0.99),2.78E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002437,0.187,Olink,Serine protease 27,1.02 (1.01 1.03),2.89E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002579,0.039,Olink,Macrophage receptor MARCO,0.98 (0.97 0.99),4.11E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002435,0.193,Olink,Fibroblast growth factor 5,1.02 (1.01 1.03),2.40E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002499,0.098,Olink,Transferrin receptor protein 1,1.02 (1.01 1.03),2.61E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002629,0.023,Olink,Interleukin-18-binding protein,0.98 (0.97 0.99),4.52E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002588,0.036,Olink,Urokinase-type plasminogen activator,0.98 (0.98 0.99),6.46E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002487,0.120,Olink,Interleukin-1 receptor type 2,1.01 (1.01 1.02),2.15E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002529,0.068,Olink,Tumor necrosis factor receptor superfamily member 3,0.99 (0.98 1.00),3.90E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002466,0.143,Olink,SLAM family member 7,1.01 (1.00 1.02),4.12E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002617,0.026,Olink,C-X-C motif chemokine 9,1.01 (1.00 1.02),4.25E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002589,0.035,Olink,Lysosome membrane protein 2,1.01 (1.00 1.02),4.90E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002480,0.127,Olink,Neprilysin,1.01 (1.00 1.02),4.96E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003006,0.030,Metabolon,cholesterol,1.18 (1.17 1.19),5.38E-290
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.16 (1.15 1.17),8.68E-221
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.13 (1.12 1.14),2.99E-173
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.12 (1.11 1.13),1.51E-139
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003058,0.022,Metabolon,sphingomyelin (d18:1/17:0. d17:1/18:0. d19:1/16:0),1.12 (1.11 1.13),1.74E-132
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.10 (1.09 1.11),4.28E-78
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.08 (1.07 1.09),2.84E-73
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.08 (1.07 1.09),4.31E-73
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002951,0.041,Metabolon,stearoyl sphingomyelin (d18:1/18:0),1.08 (1.07 1.09),5.24E-70
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.08 (1.07 1.09),3.47E-67
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003203,0.012,Metabolon,sphingomyelin (d18:2/23:0. d18:1/23:1. d17:1/24:1)*,1.07 (1.06 1.08),8.82E-55
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002915,0.048,Metabolon,sphingomyelin (d18:1/20:0. d16:1/22:0)*,1.06 (1.06 1.07),2.61E-44
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003127,0.017,Metabolon,sphingomyelin (d18:1/22:1. d18:2/22:0. d16:1/24:1)*,1.06 (1.05 1.07),2.01E-36
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002874,0.060,Metabolon,campesterol,1.06 (1.05 1.06),5.91E-32
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003217,0.011,Metabolon,X - 24024,1.05 (1.04 1.06),3.08E-30
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002940,0.044,Metabolon,lactosyl-N-palmitoyl-sphingosine,1.05 (1.04 1.06),9.30E-29
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003151,0.014,Metabolon,1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2)*,1.05 (1.04 1.06),1.22E-27
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002802,0.092,Metabolon,1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6)*,1.05 (1.04 1.06),1.70E-26
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002770,0.124,Metabolon,1-stearoyl-2-arachidonoyl-GPE (18:0/20:4),1.05 (1.04 1.06),6.67E-26
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002837,0.075,Metabolon,1-stearoyl-2-arachidonoyl-GPI (18:0/20:4),1.05 (1.04 1.06),3.43E-25
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003119,0.017,Metabolon,1-palmitoyl-GPC (16:0),1.05 (1.04 1.06),5.88E-23
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003000,0.031,Metabolon,1-stearoyl-2-oleoyl-GPE (18:0/18:1),1.04 (1.04 1.05),2.35E-21
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002943,0.043,Metabolon,2-palmitoyl-GPE (16:0)*,1.04 (1.04 1.05),3.29E-21
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002860,0.066,Metabolon,1-palmitoyl-GPE (16:0),1.04 (1.03 1.05),1.98E-19
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002878,0.060,Metabolon,1-stearoyl-GPE (18:0),1.04 (1.03 1.05),2.67E-19
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002893,0.054,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3)*,1.04 (1.03 1.05),1.99E-17
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002756,0.139,Metabolon,1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)*,1.04 (1.03 1.05),9.89E-17
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002751,0.145,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)*,1.04 (1.03 1.05),7.04E-16
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002891,0.056,Metabolon,1-palmitoyl-2-oleoyl-GPE (16:0/18:1),1.04 (1.03 1.05),9.94E-16
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003200,0.012,Metabolon,threonine,0.96 (0.96 0.97),7.88E-15
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002988,0.033,Metabolon,2-stearoyl-GPE (18:0)*,1.04 (1.03 1.05),1.00E-14
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003198,0.012,Metabolon,gamma-glutamylthreonine*,0.97 (0.96 0.97),6.88E-14
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002910,0.049,Metabolon,X - 24422,0.97 (0.96 0.97),1.95E-13
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002842,0.073,Metabolon,glycosyl-N-palmitoyl-sphingosine,1.03 (1.03 1.04),1.76E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002819,0.083,Metabolon,phosphatidylcholine (16:0/22:5n3. 18:1/20:4)*,1.03 (1.02 1.04),4.36E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002917,0.048,Metabolon,sphingomyelin (d18:1/21:0. d17:1/22:0. d16:1/23:0)*,1.03 (1.02 1.04),4.50E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002956,0.040,Metabolon,sphingomyelin (d18:1/15:0. d16:1/17:0)*,1.03 (1.02 1.04),1.43E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003113,0.018,Metabolon,1-docosapentaenoyl-GPC (22:5n6)*,1.03 (1.02 1.04),1.60E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002964,0.037,Metabolon,1-docosahexaenoyl-GPE (22:6)*,1.03 (1.02 1.04),2.62E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003196,0.012,Metabolon,1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)*,1.03 (1.02 1.04),3.70E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002982,0.033,Metabolon,X - 12681,0.97 (0.96 0.98),5.85E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003034,0.025,Metabolon,1-palmitoleoyl-GPC (16:1)*,1.03 (1.02 1.04),1.92E-10
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003060,0.022,Metabolon,stearidonate (18:4n3),1.03 (1.02 1.04),1.95E-10
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003067,0.022,Metabolon,X - 12339,0.97 (0.96 0.98),3.06E-10
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002745,0.154,Metabolon,isobutyrylcarnitine,0.97 (0.96 0.98),3.01E-09
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003153,0.014,Metabolon,retinol (Vitamin A),1.03 (1.02 1.04),1.29E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002850,0.070,Metabolon,1-stearoyl-2-linoleoyl-GPE (18:0/18:2)*,1.03 (1.02 1.04),1.74E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003197,0.012,Metabolon,1-stearoyl-GPC (18:0),1.03 (1.02 1.04),1.75E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003183,0.013,Metabolon,X - 16944,0.97 (0.96 0.98),1.76E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002896,0.053,Metabolon,X - 11261,0.97 (0.96 0.98),2.82E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003216,0.011,Metabolon,1-linolenoyl-GPC (18:3)*,1.03 (1.02 1.04),6.79E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002981,0.034,Metabolon,1-docosapentaenoyl-GPC (22:5n3)*,1.03 (1.02 1.03),3.46E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003014,0.029,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6)*,1.03 (1.02 1.03),5.00E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003201,0.012,Metabolon,glycerophosphorylcholine (GPC),1.03 (1.02 1.03),9.60E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002888,0.057,Metabolon,sphingomyelin (d18:1/14:0. d16:1/16:0)*,1.02 (1.02 1.03),1.37E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003172,0.013,Metabolon,deoxycholate,0.98 (0.97 0.99),5.56E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002734,0.178,Metabolon,1-stearoyl-2-arachidonoyl-GPC (18:0/20:4),1.02 (1.01 1.03),6.47E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002834,0.075,Metabolon,phosphatidylcholine (18:0/20:5. 16:0/22:5n6)*,1.02 (1.01 1.03),1.07E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002967,0.037,Metabolon,X - 11381,0.98 (0.97 0.99),1.81E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002980,0.034,Metabolon,1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2)*,0.98 (0.97 0.99),1.96E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002841,0.073,Metabolon,sphingomyelin (d18:1/20:1. d18:2/20:0)*,1.02 (1.01 1.03),1.99E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003162,0.014,Metabolon,2-hydroxybutyrate/2-hydroxyisobutyrate,1.02 (1.01 1.03),4.17E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002704,0.312,Metabolon,5-acetylamino-6-formylamino-3-methyluracil,1.02 (1.01 1.03),4.76E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002824,0.081,Metabolon,4-acetamidobutanoate,1.02 (1.01 1.03),6.35E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002948,0.042,Metabolon,1-dihomo-linolenoyl-GPE (20:3n3 or 6)*,0.98 (0.97 0.99),7.12E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002859,0.067,Metabolon,1-arachidonoyl-GPE (20:4n6)*,1.02 (1.01 1.03),7.50E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002873,0.061,Metabolon,X - 14658,1.02 (1.01 1.03),1.84E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002827,0.080,Metabolon,5-acetylamino-6-amino-3-methyluracil,1.02 (1.01 1.03),2.42E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003100,0.019,Metabolon,1-arachidonylglycerol (20:4),1.02 (1.01 1.03),2.45E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002958,0.040,Metabolon,1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6)*,0.98 (0.97 0.99),3.31E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003057,0.022,Metabolon,1-adrenoyl-GPC (22:4)*,1.02 (1.01 1.03),3.73E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002832,0.078,Metabolon,X - 24438,0.98 (0.97 0.99),4.94E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003152,0.014,Metabolon,1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2)*,0.98 (0.97 0.99),5.68E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002821,0.082,Metabolon,N-acetylputrescine,1.02 (1.01 1.03),5.79E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003116,0.018,Metabolon,1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1)*,0.98 (0.97 0.99),5.82E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002843,0.073,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4),1.02 (1.01 1.03),7.12E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002829,0.079,Metabolon,arachidonate (20:4n6),1.02 (1.01 1.03),7.28E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002816,0.086,Metabolon,X - 11470,0.98 (0.97 0.99),7.31E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003166,0.014,Metabolon,thyroxine,1.02 (1.01 1.03),7.31E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003159,0.014,Metabolon,docosapentaenoate (n3 DPA; 22:5n3),1.02 (1.01 1.03),8.38E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002972,0.036,Metabolon,1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9)*,1.02 (1.01 1.03),1.04E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003168,0.014,Metabolon,X - 24054,0.98 (0.97 0.99),1.14E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003189,0.012,Metabolon,2-linoleoyl-GPE (18:2)*,0.98 (0.97 0.99),1.17E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003109,0.018,Metabolon,1-linoleoyl-GPE (18:2)*,0.98 (0.97 0.99),1.26E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002961,0.039,Metabolon,1-stearoyl-2-dihomo-linolenoyl-GPC (18:0/20:3n3 or 6)*,0.98 (0.97 0.99),1.28E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002934,0.044,Metabolon,1-oleoyl-2-dihomo-linolenoyl-GPC (18:1/20:3)*,0.98 (0.97 0.99),1.40E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002882,0.058,Metabolon,1-methylxanthine,0.98 (0.97 0.99),1.42E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002890,0.056,Metabolon,X - 23705,1.02 (1.01 1.03),1.56E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003016,0.029,Metabolon,1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)*,1.02 (1.01 1.03),1.87E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002791,0.100,Metabolon,2-arachidonoyl-GPC (20:4)*,1.02 (1.01 1.03),2.27E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002949,0.041,Metabolon,1-stearoyl-2-meadoyl-GPC (18:0/20:3n9)*,1.02 (1.01 1.03),2.52E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002847,0.071,Metabolon,acisoga,0.98 (0.97 0.99),2.72E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002789,0.102,Metabolon,1-palmitoyl-2-linoleoyl-GPE (16:0/18:2),1.02 (1.01 1.03),2.82E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003073,0.021,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*,1.02 (1.01 1.03),3.39E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002909,0.049,Metabolon,X - 24439,0.98 (0.97 0.99),3.63E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002921,0.047,Metabolon,1-oleoyl-2-linoleoyl-GPE (18:1/18:2)*,1.02 (1.01 1.03),3.63E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003150,0.015,Metabolon,dihomo-linolenate (20:3n3 or n6),0.98 (0.97 0.99),3.76E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003121,0.017,Metabolon,1.2-dipalmitoyl-GPC (16:0/16:0),1.02 (1.01 1.03),3.78E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003024,0.027,Metabolon,X - 13529,1.02 (1.01 1.03),3.93E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002855,0.069,Metabolon,1-palmityl-2-arachidonoyl-GPC (O-16:0/20:4)*,1.02 (1.01 1.03),4.01E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003118,0.017,Metabolon,1-(1-enyl-palmitoyl)-GPC (P-16:0)*,1.02 (1.01 1.03),4.45E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003029,0.026,Metabolon,docosatrienoate (22:3n3),0.98 (0.97 0.99),5.02E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002754,0.142,Metabolon,X - 12688,1.02 (1.01 1.03),5.12E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002750,0.146,Metabolon,5alpha-androstan-3alpha.17alpha-diol monosulfate,0.98 (0.98 0.99),6.03E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002911,0.049,Metabolon,1-methylurate,0.98 (0.98 0.99),6.30E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003149,0.015,Metabolon,sphingosine,1.02 (1.01 1.02),6.94E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002785,0.103,Metabolon,flavin adenine dinucleotide (FAD),1.02 (1.01 1.03),7.84E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002764,0.129,Metabolon,1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4),1.02 (1.01 1.02),8.06E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003132,0.016,Metabolon,2-methylmalonyl carnitine,1.02 (1.01 1.03),8.17E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002931,0.045,Metabolon,eicosapentaenoate (EPA; 20:5n3),1.02 (1.01 1.02),9.23E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002899,0.053,Metabolon,1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5)*,1.02 (1.01 1.02),9.91E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002807,0.089,Metabolon,1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3)*,1.02 (1.01 1.02),1.30E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002941,0.043,Metabolon,1-palmitoyl-2-linolenoyl-GPC (16:0/18:3)*,0.98 (0.98 0.99),1.31E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002977,0.035,Metabolon,1.2-dilinoleoyl-GPC (18:2/18:2),0.98 (0.98 0.99),1.36E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002820,0.082,Metabolon,5alpha-androstan-3alpha. 17beta-diol-17-glucosiduronate,1.02 (1.01 1.02),1.37E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003042,0.024,Metabolon,1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6),1.02 (1.01 1.02),1.42E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002922,0.047,Metabolon,stearoylcarnitine,1.02 (1.01 1.02),1.49E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002747,0.146,Metabolon,1-arachidonoyl-GPC (20:4n6)*,1.01 (1.01 1.02),1.79E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002811,0.088,Metabolon,hexanoylcarnitine,0.99 (0.98 0.99),1.83E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003077,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPC (P-16:0/22:6)*,1.01 (1.01 1.02),1.88E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003054,0.023,Metabolon,X - 21286,0.99 (0.98 0.99),2.09E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003125,0.017,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6),1.01 (1.01 1.02),2.27E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002780,0.113,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)*,1.01 (1.01 1.02),2.27E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002833,0.077,Metabolon,taurocholenate sulfate,0.99 (0.98 0.99),2.68E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003179,0.013,Metabolon,4-methyl-2-oxopentanoate,1.01 (1.01 1.02),3.49E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002971,0.036,Metabolon,1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4)*,1.01 (1.00 1.02),3.87E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003075,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*,1.01 (1.00 1.02),4.27E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS002872,0.061,Metabolon,1-eicosapentaenoyl-GPC (20:5)*,1.01 (1.00 1.02),4.88E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003455,0.087,Nightingale,Total free cholesterol,1.24 (1.23 1.25),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.19 (1.18 1.20),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.26 (1.25 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.26 (1.25 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.27 (1.26 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.26 (1.25 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.19 (1.18 1.20),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.27 (1.26 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.25 (1.24 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.24 (1.23 1.25),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.22 (1.21 1.23),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.24 (1.23 1.25),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.25 (1.24 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.27 (1.26 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.27 (1.26 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.27 (1.25 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003523,0.062,Nightingale,Total fatty acids,1.19 (1.18 1.20),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.23 (1.22 1.24),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.23 (1.21 1.24),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003497,0.072,Nightingale,Linoleic acid,1.20 (1.19 1.21),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.27 (1.26 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.26 (1.25 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.27 (1.26 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.27 (1.26 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.20 (1.19 1.21),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.26 (1.25 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.19 (1.18 1.20),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003452,0.087,Nightingale,Total cholesterol,1.25 (1.24 1.26),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.19 (1.18 1.20),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.26 (1.25 1.27),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.25 (1.24 1.26),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.19 (1.18 1.20),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003423,0.126,Nightingale,LDL cholesterol,1.26 (1.25 1.28),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.18 (1.17 1.20),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.22 (1.21 1.23),0.00E+00
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.18 (1.17 1.19),5.91E-308
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.18 (1.17 1.19),5.10E-296
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003527,0.050,Nightingale,Sphingomyelins,1.18 (1.17 1.19),5.35E-295
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.18 (1.17 1.19),3.31E-291
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.17 (1.16 1.18),1.17E-284
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.18 (1.17 1.19),9.42E-282
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.16 (1.15 1.17),1.31E-256
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.16 (1.15 1.17),3.00E-253
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003528,0.050,Nightingale,Total cholines,1.16 (1.15 1.17),2.22E-252
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.16 (1.15 1.17),6.07E-250
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.16 (1.15 1.17),2.87E-238
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,1.15 (1.14 1.16),3.20E-217
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003526,0.050,Nightingale,Phosphatidylcholines,1.14 (1.13 1.15),8.58E-199
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.14 (1.13 1.15),2.39E-184
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,1.13 (1.12 1.14),5.19E-175
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.13 (1.12 1.14),6.96E-165
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003476,0.076,Nightingale,Phospholipids in medium VLDL,1.11 (1.10 1.12),4.86E-128
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003486,0.074,Nightingale,Total triglycerides,1.11 (1.10 1.12),3.89E-123
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.11 (1.10 1.12),2.14E-118
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003518,0.065,Nightingale,Triglycerides in medium HDL,1.10 (1.09 1.11),6.53E-98
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003475,0.076,Nightingale,Total lipids in medium VLDL,1.10 (1.09 1.11),2.44E-94
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003490,0.073,Nightingale,Free cholesterol in medium VLDL,1.09 (1.08 1.10),8.15E-87
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003477,0.076,Nightingale,Concentration of medium VLDL particles,1.09 (1.08 1.10),8.42E-84
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.92 (0.91 0.93),1.41E-80
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.09 (1.08 1.10),3.17E-78
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003479,0.075,Nightingale,Triglycerides in VLDL,1.08 (1.07 1.09),4.77E-72
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003484,0.075,Nightingale,Triglycerides in HDL,1.08 (1.07 1.09),8.91E-69
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003481,0.075,Nightingale,Triglycerides in medium VLDL,1.08 (1.07 1.09),2.61E-66
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.93 (0.92 0.93),3.03E-62
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003499,0.071,Nightingale,Phospholipids in large VLDL,1.07 (1.06 1.08),9.90E-55
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003471,0.077,Nightingale,Cholesteryl esters in large VLDL,1.07 (1.06 1.08),1.91E-46
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.94 (0.93 0.95),5.67E-46
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.94 (0.93 0.95),1.24E-45
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,1.07 (1.06 1.07),2.36E-43
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003494,0.072,Nightingale,Concentration of large VLDL particles,1.06 (1.05 1.07),1.55E-38
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003493,0.073,Nightingale,Total lipids in large VLDL,1.06 (1.05 1.07),2.02E-38
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003507,0.070,Nightingale,Free cholesterol in large VLDL,1.06 (1.05 1.07),2.28E-37
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003483,0.075,Nightingale,Cholesterol in large VLDL,1.06 (1.05 1.07),7.51E-37
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003498,0.071,Nightingale,Triglycerides in large VLDL,1.06 (1.05 1.07),1.10E-35
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.95 (0.94 0.96),1.76E-28
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.95 (0.94 0.96),1.84E-28
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.95 (0.94 0.96),3.60E-27
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.95 (0.94 0.96),1.90E-26
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.96 (0.95 0.96),1.98E-23
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.95 (0.95 0.96),2.23E-23
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003540,0.029,Nightingale,Free cholesterol in small HDL,0.96 (0.95 0.96),2.24E-22
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.96 (0.95 0.97),6.02E-21
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003495,0.072,Nightingale,Triglycerides in very large HDL,1.04 (1.03 1.05),2.93E-19
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003516,0.066,Nightingale,Phospholipids in very large VLDL,1.04 (1.03 1.05),4.96E-18
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003520,0.062,Nightingale,HDL cholesterol,0.96 (0.95 0.97),1.11E-16
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003510,0.068,Nightingale,Cholesterol in chylomicrons and extremely large VLDL,1.04 (1.03 1.05),1.10E-15
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003500,0.071,Nightingale,Total lipids in very large VLDL,1.04 (1.03 1.05),2.32E-14
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.96 (0.96 0.97),3.53E-14
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003506,0.070,Nightingale,Cholesterol in very large VLDL,1.03 (1.03 1.04),1.88E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003513,0.067,Nightingale,Free cholesterol in very large VLDL,1.03 (1.03 1.04),1.88E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003504,0.070,Nightingale,Triglycerides in very large VLDL,1.03 (1.03 1.04),2.56E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003496,0.072,Nightingale,Cholesteryl esters in very large VLDL,1.03 (1.03 1.04),3.44E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003448,0.093,Nightingale,Phospholipids in very large HDL,0.97 (0.96 0.98),4.82E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003502,0.070,Nightingale,Concentration of very large VLDL particles,1.03 (1.02 1.04),7.24E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.97 (0.96 0.98),8.56E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003491,0.073,Nightingale,Total lipids in chylomicrons and extremely large VLDL,1.03 (1.02 1.04),6.41E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,1.03 (1.02 1.04),1.68E-09
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,1.03 (1.02 1.04),2.63E-09
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003478,0.075,Nightingale,Triglycerides in large HDL,1.03 (1.02 1.04),4.36E-09
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003487,0.074,Nightingale,Phospholipids in chylomicrons and extremely large VLDL,1.03 (1.02 1.04),7.06E-09
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.97 (0.96 0.98),4.54E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003547,0.022,Nightingale,Concentration of small HDL particles,1.03 (1.02 1.03),5.99E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003548,0.022,Nightingale,Total lipids in small HDL,1.02 (1.02 1.03),2.30E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003542,0.028,Nightingale,Phospholipids in medium HDL,0.98 (0.98 0.99),6.43E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003509,0.069,Nightingale,Free cholesterol in chylomicrons and extremely large VLDL,1.01 (1.00 1.02),4.42E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006535,0.174,RNAseq,PSRC1,0.95 (0.94 0.96),4.30E-29
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010653,0.059,RNAseq,CELSR2,1.05 (1.04 1.06),1.31E-26
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013792,0.024,RNAseq,YIPF2,1.05 (1.04 1.06),7.57E-25
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012730,0.033,RNAseq,CARM1,0.96 (0.96 0.97),1.99E-14
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011108,0.052,RNAseq,LDLR,0.97 (0.96 0.98),1.13E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010949,0.055,RNAseq,AC008897.3,0.97 (0.96 0.98),1.63E-12
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003651,0.639,RNAseq,ABO,0.97 (0.96 0.98),3.07E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006705,0.165,RNAseq,MAU2,1.03 (1.02 1.04),3.95E-11
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013514,0.026,RNAseq,GZMK,1.03 (1.02 1.04),5.34E-10
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS015052,0.015,RNAseq,CISH,0.97 (0.96 0.98),1.58E-09
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014232,0.021,RNAseq,TRAV1-2,1.03 (1.02 1.04),2.76E-09
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013651,0.025,RNAseq,SMARCA4,1.03 (1.02 1.04),4.32E-09
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS015054,0.015,RNAseq,H19,1.03 (1.02 1.04),9.24E-09
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004382,0.374,RNAseq,FES,0.97 (0.96 0.98),1.42E-08
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005167,0.269,RNAseq,TCF19,1.03 (1.02 1.03),2.26E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008705,0.096,RNAseq,RPS6KA1,0.97 (0.97 0.98),4.07E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008889,0.092,RNAseq,TRAV20,1.03 (1.02 1.03),4.59E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004485,0.357,RNAseq,LPL,0.97 (0.97 0.98),5.50E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011637,0.045,RNAseq,DHDDS,1.03 (1.02 1.03),7.36E-07
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011712,0.045,RNAseq,DNAJC3,0.98 (0.97 0.98),1.43E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011936,0.042,RNAseq,INTS10,0.98 (0.97 0.98),2.12E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003621,0.665,RNAseq,,1.02 (1.02 1.03),2.15E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014580,0.018,RNAseq,DACT1,0.98 (0.97 0.98),2.21E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007943,0.117,RNAseq,SLC22A1,0.98 (0.97 0.99),3.12E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005918,0.208,RNAseq,DDR1,1.02 (1.01 1.03),6.12E-06
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006940,0.154,RNAseq,,1.02 (1.01 1.03),1.34E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014443,0.019,RNAseq,ABCB1,1.02 (1.01 1.03),1.61E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009171,0.086,RNAseq,NTN5,1.02 (1.01 1.03),3.35E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006143,0.195,RNAseq,DOCK7,1.02 (1.01 1.03),3.65E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013958,0.023,RNAseq,CSNK2B,0.98 (0.97 0.99),6.16E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012496,0.036,RNAseq,NT5DC4,1.02 (1.01 1.03),6.17E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011256,0.050,RNAseq,USP1,1.02 (1.01 1.03),6.23E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014440,0.019,RNAseq,C19orf38,1.02 (1.01 1.03),9.87E-05
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008309,0.106,RNAseq,SP1,1.02 (1.01 1.03),1.15E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008273,0.107,RNAseq,GRK4,1.02 (1.01 1.03),1.69E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011884,0.043,RNAseq,PRKCE,1.02 (1.01 1.03),1.82E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009077,0.088,RNAseq,DDAH2,0.98 (0.97 0.99),2.06E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009151,0.086,RNAseq,AC064836.3,1.02 (1.01 1.03),2.06E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013199,0.029,RNAseq,ACP1,0.98 (0.97 0.99),2.34E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006804,0.160,RNAseq,TRIM5,0.98 (0.97 0.99),2.49E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010779,0.057,RNAseq,ACE,1.02 (1.01 1.03),2.50E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004935,0.295,RNAseq,GATAD2A,0.98 (0.97 0.99),3.00E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007365,0.137,RNAseq,MCM6,1.02 (1.01 1.03),3.11E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010207,0.066,RNAseq,RAF1,0.98 (0.97 0.99),3.31E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003769,0.565,RNAseq,WAC-AS1,1.02 (1.01 1.03),3.87E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008678,0.097,RNAseq,DHODH,1.02 (1.01 1.03),4.01E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007717,0.125,RNAseq,GUCY1A1,0.98 (0.97 0.99),4.12E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013298,0.028,RNAseq,IL7R,1.02 (1.01 1.03),4.49E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003943,0.486,RNAseq,CLEC18A,0.98 (0.97 0.99),5.74E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014163,0.021,RNAseq,AFF1,1.02 (1.01 1.03),5.79E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011303,0.050,RNAseq,,1.02 (1.01 1.03),5.90E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011805,0.043,RNAseq,CDKN2D,0.98 (0.97 0.99),5.91E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014060,0.022,RNAseq,AC074117.1,1.02 (1.01 1.03),5.96E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012729,0.033,RNAseq,SREBF2,0.98 (0.97 0.99),6.23E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013770,0.024,RNAseq,UBN1,0.98 (0.97 0.99),6.98E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004311,0.387,RNAseq,ZNF429,0.98 (0.97 0.99),7.31E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014688,0.018,RNAseq,CERT1,0.98 (0.97 0.99),7.63E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012006,0.041,RNAseq,VARS2,1.02 (1.01 1.03),8.06E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003784,0.554,RNAseq,KCNK17,0.98 (0.97 0.99),8.14E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005346,0.252,RNAseq,,1.02 (1.01 1.03),9.09E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010277,0.065,RNAseq,CXCR6,1.02 (1.01 1.03),9.30E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013942,0.023,RNAseq,ZHX3,1.02 (1.01 1.03),9.62E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014323,0.020,RNAseq,MEF2B,1.02 (1.01 1.03),9.84E-04
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010337,0.064,RNAseq,GEN1,0.98 (0.97 0.99),1.04E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003664,0.625,RNAseq,,1.02 (1.01 1.03),1.06E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010693,0.058,RNAseq,TRBV5-1,0.98 (0.97 0.99),1.06E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013130,0.030,RNAseq,QPCT,0.98 (0.97 0.99),1.08E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006048,0.200,RNAseq,,1.02 (1.01 1.03),1.09E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011716,0.045,RNAseq,FBLN7,0.98 (0.97 0.99),1.16E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014341,0.020,RNAseq,NFAT5,1.02 (1.01 1.03),1.17E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010263,0.065,RNAseq,CBX7,1.02 (1.01 1.03),1.25E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013045,0.030,RNAseq,NEU1,1.02 (1.01 1.03),1.30E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004943,0.293,RNAseq,,1.02 (1.01 1.03),1.35E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003969,0.476,RNAseq,WDR41,0.98 (0.97 0.99),1.40E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009746,0.074,RNAseq,SPAST,1.02 (1.01 1.03),1.43E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012171,0.039,RNAseq,TRBV15,0.98 (0.97 0.99),1.43E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004593,0.340,RNAseq,AMIGO1,0.98 (0.97 0.99),1.74E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008178,0.110,RNAseq,MMD,0.98 (0.97 0.99),1.75E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006248,0.189,RNAseq,MCCD1,1.02 (1.01 1.03),1.86E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS015029,0.016,RNAseq,SHE,0.98 (0.97 0.99),1.89E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006446,0.178,RNAseq,,1.02 (1.01 1.03),1.90E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008216,0.109,RNAseq,NSMAF,1.02 (1.01 1.03),1.90E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010041,0.069,RNAseq,GPRC5B,0.98 (0.97 0.99),2.11E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011948,0.042,RNAseq,ADGRG1,0.98 (0.97 0.99),2.16E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012824,0.032,RNAseq,USP34,1.02 (1.01 1.03),2.22E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006807,0.160,RNAseq,BNC2,0.98 (0.97 0.99),2.22E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012904,0.032,RNAseq,ZMIZ1,1.02 (1.01 1.03),2.30E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004468,0.360,RNAseq,AC020656.2,1.02 (1.01 1.03),2.49E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005353,0.251,RNAseq,WWP2,1.02 (1.01 1.03),2.53E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010014,0.069,RNAseq,LINC02245,1.02 (1.01 1.03),2.57E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008054,0.114,RNAseq,PRKG1,0.98 (0.97 0.99),2.60E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003699,0.599,RNAseq,AC009506.2,1.02 (1.01 1.03),2.61E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010211,0.066,RNAseq,TRBV27,0.98 (0.97 0.99),2.88E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012061,0.041,RNAseq,CSGALNACT2,0.98 (0.97 0.99),2.90E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008137,0.111,RNAseq,,0.98 (0.97 0.99),2.91E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006648,0.168,RNAseq,TRBV11-3,1.02 (1.01 1.03),2.92E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003978,0.470,RNAseq,COG5,1.02 (1.01 1.03),2.94E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010032,0.069,RNAseq,ABCA5,1.02 (1.01 1.03),3.31E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004717,0.321,RNAseq,ARNTL,0.98 (0.97 0.99),3.35E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011282,0.050,RNAseq,SMAD7,1.02 (1.01 1.03),3.46E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011283,0.050,RNAseq,CD248,1.02 (1.01 1.03),3.54E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010938,0.055,RNAseq,KIF3C,1.02 (1.01 1.03),3.61E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008402,0.104,RNAseq,TNXB,1.02 (1.01 1.03),3.64E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005494,0.239,RNAseq,,1.02 (1.01 1.03),3.70E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003715,0.590,RNAseq,FAM117B,1.02 (1.01 1.03),3.73E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010929,0.055,RNAseq,EOMES,1.02 (1.01 1.03),3.73E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012136,0.040,RNAseq,NFIL3,0.98 (0.97 0.99),3.93E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007764,0.123,RNAseq,HLA-E,1.02 (1.01 1.03),3.98E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006064,0.200,RNAseq,DNTTIP1,0.98 (0.97 0.99),4.11E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011585,0.046,RNAseq,CD8B,1.02 (1.01 1.03),4.32E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013558,0.026,RNAseq,FGFR1OP2,0.98 (0.97 0.99),4.39E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012700,0.034,RNAseq,NFATC2,1.02 (1.01 1.03),4.39E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011003,0.054,RNAseq,RNF114,1.02 (1.01 1.03),4.40E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009179,0.086,RNAseq,PLEC,0.98 (0.98 0.99),4.41E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010798,0.057,RNAseq,SCD,0.98 (0.97 0.99),4.41E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012146,0.040,RNAseq,SMARCAD1,1.02 (1.01 1.03),4.42E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013705,0.025,RNAseq,AL512408.1,0.98 (0.98 0.99),5.06E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008033,0.115,RNAseq,SGCB,0.98 (0.98 0.99),5.10E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013330,0.028,RNAseq,AP1G1,0.98 (0.97 0.99),5.15E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009769,0.074,RNAseq,NLRC4,0.98 (0.98 0.99),5.20E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013875,0.023,RNAseq,TTC39C,0.98 (0.97 0.99),5.21E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011441,0.048,RNAseq,PLEKHO1,1.02 (1.01 1.03),5.36E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007584,0.129,RNAseq,HSD3B7,0.98 (0.98 0.99),5.38E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014524,0.019,RNAseq,PSME3,1.02 (1.01 1.03),5.59E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004334,0.383,RNAseq,HLA-G,1.02 (1.01 1.03),6.02E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003889,0.511,RNAseq,ARL14EP,0.98 (0.98 0.99),6.20E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007635,0.128,RNAseq,PKD1L3,0.98 (0.98 0.99),6.39E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013328,0.028,RNAseq,ZNF490,1.02 (1.01 1.03),6.55E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007337,0.138,RNAseq,MED21,1.02 (1.01 1.03),7.07E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005217,0.264,RNAseq,CENPQ,0.98 (0.98 0.99),7.57E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007014,0.151,RNAseq,C10orf88,0.98 (0.98 0.99),7.76E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013008,0.031,RNAseq,ABHD1,0.98 (0.98 0.99),7.82E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004740,0.318,RNAseq,SCARB1,0.98 (0.98 0.99),7.96E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011142,0.052,RNAseq,JAK3,1.02 (1.01 1.02),8.17E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009703,0.075,RNAseq,HBP1,0.98 (0.98 0.99),8.46E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005430,0.244,RNAseq,NCF1,1.02 (1.01 1.02),8.54E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011287,0.050,RNAseq,,1.02 (1.01 1.02),8.74E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007546,0.131,RNAseq,ZBP1,1.02 (1.01 1.02),8.82E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014214,0.021,RNAseq,PRSS22,0.98 (0.98 0.99),9.06E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011132,0.052,RNAseq,HEATR5B,1.02 (1.01 1.02),9.14E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011811,0.043,RNAseq,ZBTB46,0.98 (0.98 0.99),9.27E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004125,0.429,RNAseq,UHRF1BP1,1.02 (1.01 1.02),9.38E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009221,0.085,RNAseq,ARL15,1.02 (1.01 1.02),9.40E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008444,0.103,RNAseq,CSF1R,0.98 (0.98 0.99),9.91E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007010,0.151,RNAseq,MMAB,0.98 (0.98 0.99),9.98E-03
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014990,0.016,RNAseq,AC004151.1,1.02 (1.01 1.02),1.04E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013170,0.029,RNAseq,N4BP2L2,0.98 (0.98 0.99),1.06E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011919,0.042,RNAseq,SOS2,0.98 (0.98 0.99),1.06E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011449,0.048,RNAseq,ACAT2,0.98 (0.98 0.99),1.07E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006637,0.169,RNAseq,PCCB,1.02 (1.01 1.02),1.07E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007619,0.128,RNAseq,KCNG2,1.02 (1.01 1.02),1.08E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010821,0.056,RNAseq,PAFAH1B2,1.02 (1.01 1.02),1.11E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014344,0.020,RNAseq,AC022167.3,1.02 (1.01 1.02),1.14E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008005,0.115,RNAseq,GNGT2,1.02 (1.01 1.02),1.18E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012010,0.041,RNAseq,AC092111.1,1.02 (1.01 1.02),1.18E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008629,0.098,RNAseq,SMC4,1.02 (1.01 1.02),1.26E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012237,0.039,RNAseq,DNAJC13,1.02 (1.01 1.02),1.26E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014499,0.019,RNAseq,BAZ1A,0.98 (0.98 0.99),1.26E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013734,0.024,RNAseq,OAS2,1.02 (1.01 1.02),1.27E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011713,0.045,RNAseq,PPP2R3A,1.02 (1.01 1.02),1.29E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010092,0.068,RNAseq,STAC3,0.98 (0.98 0.99),1.30E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004489,0.357,RNAseq,,1.02 (1.01 1.02),1.30E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011692,0.045,RNAseq,CA1,0.98 (0.98 0.99),1.32E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004501,0.354,RNAseq,TBKBP1,0.98 (0.98 0.99),1.34E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009794,0.073,RNAseq,RN7SL473P,0.98 (0.98 0.99),1.34E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012094,0.040,RNAseq,ENTPD5,0.99 (0.98 0.99),1.36E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007641,0.127,RNAseq,CACNA1H,1.02 (1.01 1.02),1.39E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004340,0.382,RNAseq,SAYSD1,0.98 (0.98 0.99),1.40E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012984,0.031,RNAseq,POU5F1,0.99 (0.98 0.99),1.41E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014331,0.020,RNAseq,KLHL25,1.02 (1.01 1.02),1.44E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011037,0.053,RNAseq,TMEM170A,0.98 (0.98 0.99),1.48E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009210,0.085,RNAseq,EHD1,1.02 (1.01 1.02),1.49E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014506,0.019,RNAseq,ZNF781,1.01 (1.01 1.02),1.49E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006760,0.162,RNAseq,ZMYND12,1.02 (1.01 1.02),1.49E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004968,0.290,RNAseq,FCHO1,0.99 (0.98 0.99),1.52E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009483,0.080,RNAseq,DNAJC5,0.99 (0.98 0.99),1.54E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003717,0.589,RNAseq,AC006205.2,1.02 (1.01 1.02),1.56E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011583,0.046,RNAseq,BAG1,1.02 (1.01 1.02),1.57E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011659,0.045,RNAseq,KHDRBS2,0.99 (0.98 0.99),1.59E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011392,0.048,RNAseq,PRKDC,0.99 (0.98 0.99),1.60E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013097,0.030,RNAseq,TMUB1,1.01 (1.01 1.02),1.61E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008148,0.111,RNAseq,C1QB,1.02 (1.01 1.02),1.63E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006152,0.194,RNAseq,ITGB3,1.02 (1.01 1.02),1.63E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004706,0.323,RNAseq,AC011462.5,1.02 (1.01 1.02),1.67E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014117,0.022,RNAseq,PIGS,0.99 (0.98 0.99),1.70E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008871,0.093,RNAseq,GOLGA3,1.01 (1.01 1.02),1.71E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013459,0.027,RNAseq,PRR11,1.01 (1.01 1.02),1.72E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004195,0.413,RNAseq,TRIM27,1.01 (1.01 1.02),1.76E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003804,0.547,RNAseq,FGFR1,1.01 (1.01 1.02),1.77E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003701,0.597,RNAseq,AC040970.1,1.02 (1.01 1.02),1.78E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014553,0.019,RNAseq,DISP1,0.99 (0.98 0.99),1.78E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004814,0.309,RNAseq,DHX58,0.99 (0.98 0.99),1.78E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005907,0.208,RNAseq,TNFAIP8,1.01 (1.01 1.02),1.79E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004859,0.303,RNAseq,AC119673.3,1.01 (1.01 1.02),1.81E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013679,0.025,RNAseq,TRBV13,1.01 (1.01 1.02),1.85E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007500,0.132,RNAseq,ITGB1BP1,0.99 (0.98 0.99),1.90E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS015030,0.016,RNAseq,PRRC2A,1.01 (1.01 1.02),1.91E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004370,0.376,RNAseq,LINC01825,0.99 (0.98 0.99),1.91E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013208,0.029,RNAseq,SNX27,1.01 (1.01 1.02),1.91E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009190,0.085,RNAseq,COL13A1,1.01 (1.01 1.02),1.91E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005248,0.261,RNAseq,RPL17,1.01 (1.01 1.02),1.95E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006038,0.201,RNAseq,HLA-DQA2,1.01 (1.01 1.02),1.96E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008601,0.099,RNAseq,COLQ,1.01 (1.01 1.02),1.97E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007394,0.136,RNAseq,AL662844.4,0.99 (0.98 0.99),1.99E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010181,0.066,RNAseq,KCTD21,1.01 (1.01 1.02),2.03E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005955,0.206,RNAseq,USP3,1.01 (1.01 1.02),2.05E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011568,0.046,RNAseq,ID2,1.01 (1.01 1.02),2.05E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013169,0.029,RNAseq,MAPKAP1,0.99 (0.98 0.99),2.06E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009264,0.084,RNAseq,RAB21,0.99 (0.98 0.99),2.07E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007065,0.149,RNAseq,TRAF3IP3,1.01 (1.01 1.02),2.08E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008260,0.107,RNAseq,WDR86,1.01 (1.01 1.02),2.09E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004478,0.358,RNAseq,TPRA1,0.99 (0.98 0.99),2.10E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009758,0.074,RNAseq,ADARB1,1.01 (1.01 1.02),2.11E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007220,0.143,RNAseq,TAF1A,1.01 (1.01 1.02),2.21E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012162,0.040,RNAseq,RSAD2,1.01 (1.01 1.02),2.24E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012524,0.035,RNAseq,AL357079.1,0.99 (0.98 0.99),2.24E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013825,0.024,RNAseq,EFNB2,1.01 (1.01 1.02),2.25E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004559,0.344,RNAseq,AC083798.2,0.99 (0.98 0.99),2.28E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005289,0.258,RNAseq,UBA7,0.99 (0.98 0.99),2.31E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006829,0.159,RNAseq,GINS2,0.99 (0.98 0.99),2.35E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012768,0.033,RNAseq,HMGA1,1.01 (1.01 1.02),2.38E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013933,0.023,RNAseq,R3HCC1L,0.99 (0.98 0.99),2.38E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010210,0.066,RNAseq,DCAF16,0.99 (0.98 0.99),2.43E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006055,0.200,RNAseq,EXO5,0.99 (0.98 0.99),2.48E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006862,0.157,RNAseq,AL391834.1,1.01 (1.01 1.02),2.48E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007485,0.133,RNAseq,NUDCD3,1.01 (1.01 1.02),2.49E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007452,0.134,RNAseq,TMEM258,0.99 (0.98 0.99),2.61E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009687,0.075,RNAseq,ADO,1.01 (1.01 1.02),2.64E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010426,0.062,RNAseq,FAM168A,0.99 (0.98 0.99),2.66E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007364,0.137,RNAseq,NT5C2,0.99 (0.98 0.99),2.68E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014790,0.017,RNAseq,SYNJ1,1.01 (1.01 1.02),2.68E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005919,0.208,RNAseq,COX6B1,1.01 (1.01 1.02),2.69E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010035,0.069,RNAseq,UTP4,1.01 (1.01 1.02),2.74E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007797,0.122,RNAseq,SLC44A2,1.01 (1.01 1.02),2.74E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004215,0.409,RNAseq,UGT2B17,1.01 (1.01 1.02),2.76E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004406,0.369,RNAseq,,1.01 (1.01 1.02),2.78E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014434,0.019,RNAseq,CRB2,0.99 (0.98 0.99),2.81E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014489,0.019,RNAseq,AP002381.2,1.01 (1.01 1.02),2.84E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009549,0.078,RNAseq,GCNT1,0.99 (0.98 0.99),2.87E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014496,0.019,RNAseq,VARS1,0.99 (0.98 0.99),2.88E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013324,0.028,RNAseq,PRF1,0.99 (0.98 0.99),2.89E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005363,0.250,RNAseq,FAM177A1,0.99 (0.98 0.99),2.95E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004044,0.451,RNAseq,PPDPF,0.99 (0.98 0.99),3.02E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012186,0.039,RNAseq,CDPF1,1.01 (1.01 1.02),3.07E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014183,0.021,RNAseq,PAXBP1-AS1,1.01 (1.01 1.02),3.09E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010728,0.058,RNAseq,GBE1,0.99 (0.98 0.99),3.09E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007953,0.117,RNAseq,OASL,1.01 (1.01 1.02),3.11E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014718,0.017,RNAseq,MRC2,1.01 (1.01 1.02),3.16E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009666,0.076,RNAseq,AC104964.4,0.99 (0.98 0.99),3.16E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006119,0.196,RNAseq,LCMT2,0.99 (0.98 0.99),3.18E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012605,0.035,RNAseq,HSPA1A,0.99 (0.98 0.99),3.23E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010700,0.058,RNAseq,DCLRE1B,0.99 (0.98 0.99),3.24E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008338,0.106,RNAseq,C1orf50,1.01 (1.01 1.02),3.26E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005168,0.269,RNAseq,,0.99 (0.98 0.99),3.30E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004379,0.374,RNAseq,LYZ,1.01 (1.01 1.02),3.30E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012093,0.040,RNAseq,TRIM26,0.99 (0.98 0.99),3.31E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005052,0.281,RNAseq,TRIM37,1.01 (1.01 1.02),3.40E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010615,0.059,RNAseq,SIGLEC1,1.01 (1.01 1.02),3.42E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008244,0.108,RNAseq,ICA1L,0.99 (0.98 0.99),3.52E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011273,0.050,RNAseq,SLC25A4,1.01 (1.01 1.02),3.52E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005857,0.211,RNAseq,MANSC1,0.99 (0.98 0.99),3.53E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007559,0.130,RNAseq,RPS6KA4,0.99 (0.98 0.99),3.54E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005551,0.234,RNAseq,P2RX4,1.01 (1.01 1.02),3.57E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010284,0.064,RNAseq,AFG1L,1.01 (1.01 1.02),3.61E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011930,0.042,RNAseq,AC135782.3,0.99 (0.98 0.99),3.66E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008500,0.102,RNAseq,FGFBP2,0.99 (0.98 0.99),3.70E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006240,0.189,RNAseq,KCNQ5,0.99 (0.98 0.99),3.70E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009473,0.080,RNAseq,CDC34,1.01 (1.01 1.02),3.70E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005473,0.241,RNAseq,LY75,0.99 (0.98 0.99),3.71E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009800,0.073,RNAseq,CD180,1.01 (1.00 1.02),3.72E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011093,0.052,RNAseq,FAIM,0.99 (0.98 0.99),3.73E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS010206,0.066,RNAseq,RELB,1.01 (1.01 1.02),3.78E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012601,0.035,RNAseq,RN7SL1,1.01 (1.01 1.02),3.79E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009513,0.079,RNAseq,C18orf32,0.99 (0.98 0.99),3.80E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013421,0.027,RNAseq,CARF,0.99 (0.98 0.99),3.80E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009596,0.077,RNAseq,PNMA1,0.99 (0.98 1.00),3.80E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011043,0.053,RNAseq,AC104653.2,0.99 (0.98 0.99),3.87E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006341,0.184,RNAseq,AL034550.2,0.99 (0.98 1.00),3.89E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004598,0.340,RNAseq,RPAP1,0.99 (0.98 1.00),3.93E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014641,0.018,RNAseq,DDX19A,0.99 (0.98 0.99),3.96E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007873,0.119,RNAseq,PAFAH1B1,0.99 (0.98 1.00),3.98E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011442,0.048,RNAseq,FYTTD1,1.01 (1.00 1.02),4.07E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005676,0.222,RNAseq,FOXK1,1.01 (1.00 1.02),4.09E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS008650,0.098,RNAseq,ATP5MC1,0.99 (0.98 1.00),4.09E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012380,0.037,RNAseq,AC007381.1,0.99 (0.98 1.00),4.18E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009180,0.086,RNAseq,CNKSR1,1.01 (1.00 1.02),4.21E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009188,0.085,RNAseq,DCAF5,0.99 (0.98 1.00),4.22E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005492,0.239,RNAseq,AC022413.2,1.01 (1.00 1.02),4.22E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014707,0.017,RNAseq,NEDD9,1.01 (1.00 1.02),4.24E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014081,0.022,RNAseq,TSPAN13,0.99 (0.98 1.00),4.25E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013445,0.027,RNAseq,AC131212.2,0.99 (0.98 1.00),4.25E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003633,0.652,RNAseq,KIAA1324,1.01 (1.00 1.02),4.39E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006071,0.199,RNAseq,UGDH,0.99 (0.98 1.00),4.39E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009589,0.077,RNAseq,WDR73,0.99 (0.98 1.00),4.40E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003708,0.594,RNAseq,HSD17B12,0.99 (0.98 1.00),4.46E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS007240,0.142,RNAseq,,1.01 (1.00 1.02),4.55E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS003921,0.497,RNAseq,SLC35F3,1.01 (1.00 1.02),4.56E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009161,0.086,RNAseq,MRPS6,0.99 (0.98 1.00),4.59E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS014144,0.021,RNAseq,AC118549.1,1.01 (1.00 1.02),4.59E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004678,0.327,RNAseq,ZNF772,0.99 (0.98 1.00),4.65E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011915,0.042,RNAseq,RNF19B,1.01 (1.00 1.02),4.75E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004393,0.372,RNAseq,SAMM50,0.99 (0.98 1.00),4.75E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005753,0.218,RNAseq,VPS13C,0.99 (0.98 1.00),4.78E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS005196,0.266,RNAseq,AASS,1.01 (1.00 1.02),4.79E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS009103,0.088,RNAseq,NUDT3,1.01 (1.00 1.02),4.82E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS013033,0.030,RNAseq,AP000977.1,0.99 (0.98 1.00),4.82E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS006169,0.193,RNAseq,TMEM128,1.01 (1.00 1.02),4.83E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS012901,0.032,RNAseq,RANGRF,1.01 (1.00 1.02),4.85E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS011969,0.042,RNAseq,SIPA1,1.01 (1.00 1.02),4.90E-02
272.11,Hypercholesterolemia,endocrine/metabolic,OPGS004636,0.335,RNAseq,PTPA,1.01 (1.00 1.02),4.98E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.27 (1.15 1.41),6.40E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.27 (1.14 1.40),1.16E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.78 (0.70 0.87),1.20E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.26 (1.13 1.39),2.15E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS001343,0.031,SomaScan,Beta-1.3-N-acetylglucosaminyltransferase radical fringe,0.79 (0.71 0.88),2.89E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.79 (0.71 0.88),3.19E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.28 (1.14 1.43),3.52E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.26 (1.13 1.41),3.68E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS000032,0.570,SomaScan,Protein S100-A13,0.79 (0.71 0.89),4.59E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.24 (1.12 1.38),6.03E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.28 (1.14 1.44),6.67E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.24 (1.12 1.38),7.39E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS000857,0.067,SomaScan,Moesin,1.24 (1.11 1.38),1.16E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.21 (1.09 1.33),1.82E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.81 (0.73 0.91),2.17E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.81 (0.73 0.91),2.22E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS001342,0.031,SomaScan,Proprotein convertase subtilisin/kexin type 7,0.82 (0.73 0.91),2.92E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.26 (1.11 1.43),3.51E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.22 (1.09 1.36),3.85E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.25 (1.10 1.41),4.73E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS000984,0.055,SomaScan,Complement C2,1.25 (1.10 1.42),4.91E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS002182,0.011,SomaScan,Integrin beta-7,1.03 (1.01 1.05),4.91E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.53 (1.38 1.69),1.65E-12
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.50 (1.35 1.66),2.86E-11
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.45 (1.30 1.61),3.37E-09
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.33 (1.19 1.49),1.73E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003217,0.011,Metabolon,X - 24024,1.30 (1.17 1.45),4.10E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003151,0.014,Metabolon,1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2)*,1.25 (1.12 1.39),8.05E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS002874,0.060,Metabolon,campesterol,1.25 (1.12 1.41),1.69E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003119,0.017,Metabolon,1-palmitoyl-GPC (16:0),1.26 (1.11 1.42),2.82E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003088,0.020,Metabolon,1-palmitoyl-2-linoleoyl-glycerol (16:0/18:2)*,1.22 (1.10 1.37),3.80E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.70 (1.51 1.92),1.85E-14
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.65 (1.47 1.86),1.56E-13
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.63 (1.45 1.84),6.53E-13
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.66 (1.47 1.87),6.53E-13
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.63 (1.45 1.83),7.09E-13
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.62 (1.45 1.83),8.71E-13
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.63 (1.45 1.84),1.65E-12
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.60 (1.43 1.80),2.63E-12
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.60 (1.42 1.80),1.10E-11
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,1.59 (1.41 1.78),1.68E-11
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,1.58 (1.40 1.78),3.13E-11
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.62 (1.43 1.84),3.80E-11
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.57 (1.39 1.76),3.80E-11
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003486,0.074,Nightingale,Total triglycerides,1.57 (1.40 1.76),3.80E-11
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.59 (1.41 1.79),5.16E-11
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003476,0.076,Nightingale,Phospholipids in medium VLDL,1.55 (1.38 1.74),2.12E-10
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003523,0.062,Nightingale,Total fatty acids,1.54 (1.37 1.74),4.15E-10
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003475,0.076,Nightingale,Total lipids in medium VLDL,1.53 (1.36 1.73),7.18E-10
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003490,0.073,Nightingale,Free cholesterol in medium VLDL,1.53 (1.36 1.72),1.12E-09
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.52 (1.35 1.71),1.20E-09
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.51 (1.35 1.70),1.28E-09
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.52 (1.35 1.71),1.63E-09
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.52 (1.35 1.72),5.69E-09
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003477,0.076,Nightingale,Concentration of medium VLDL particles,1.50 (1.33 1.68),1.08E-08
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.49 (1.32 1.67),1.10E-08
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.51 (1.34 1.71),1.22E-08
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003479,0.075,Nightingale,Triglycerides in VLDL,1.49 (1.33 1.68),1.22E-08
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.48 (1.32 1.66),1.32E-08
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.47 (1.31 1.65),3.71E-08
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.49 (1.32 1.68),4.44E-08
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.53 (1.34 1.74),7.68E-08
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003497,0.072,Nightingale,Linoleic acid,1.48 (1.31 1.66),8.10E-08
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003481,0.075,Nightingale,Triglycerides in medium VLDL,1.46 (1.30 1.65),8.93E-08
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003493,0.073,Nightingale,Total lipids in large VLDL,1.47 (1.30 1.65),1.21E-07
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003499,0.071,Nightingale,Phospholipids in large VLDL,1.46 (1.30 1.65),1.43E-07
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.45 (1.29 1.63),1.43E-07
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003507,0.070,Nightingale,Free cholesterol in large VLDL,1.46 (1.29 1.64),2.34E-07
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003518,0.065,Nightingale,Triglycerides in medium HDL,1.44 (1.28 1.61),3.76E-07
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003471,0.077,Nightingale,Cholesteryl esters in large VLDL,1.45 (1.28 1.63),4.58E-07
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.49 (1.31 1.69),4.60E-07
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003494,0.072,Nightingale,Concentration of large VLDL particles,1.44 (1.28 1.62),5.62E-07
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003498,0.071,Nightingale,Triglycerides in large VLDL,1.42 (1.26 1.60),2.31E-06
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,1.43 (1.27 1.61),2.86E-06
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003483,0.075,Nightingale,Cholesterol in large VLDL,1.42 (1.26 1.59),3.58E-06
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.46 (1.28 1.66),4.27E-06
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.46 (1.28 1.66),4.91E-06
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.46 (1.28 1.66),5.40E-06
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.41 (1.25 1.59),6.19E-06
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.45 (1.27 1.65),7.03E-06
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.44 (1.27 1.64),1.07E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.43 (1.26 1.64),1.72E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.41 (1.24 1.60),2.54E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003516,0.066,Nightingale,Phospholipids in very large VLDL,1.39 (1.23 1.57),3.49E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.41 (1.24 1.61),3.93E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.41 (1.24 1.61),4.02E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003452,0.087,Nightingale,Total cholesterol,1.40 (1.23 1.58),4.46E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003504,0.070,Nightingale,Triglycerides in very large VLDL,1.38 (1.22 1.56),4.75E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.38 (1.22 1.56),4.77E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.40 (1.24 1.60),5.05E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.39 (1.23 1.57),5.55E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.41 (1.24 1.61),7.30E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003423,0.126,Nightingale,LDL cholesterol,1.40 (1.23 1.60),7.30E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003513,0.067,Nightingale,Free cholesterol in very large VLDL,1.37 (1.22 1.55),7.30E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003496,0.072,Nightingale,Cholesteryl esters in very large VLDL,1.37 (1.21 1.55),7.30E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.39 (1.22 1.58),8.26E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003502,0.070,Nightingale,Concentration of very large VLDL particles,1.37 (1.21 1.54),9.14E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.37 (1.21 1.55),9.27E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.40 (1.23 1.60),9.27E-05
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.38 (1.22 1.56),1.19E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.39 (1.22 1.58),1.22E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003506,0.070,Nightingale,Cholesterol in very large VLDL,1.36 (1.21 1.54),1.31E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.39 (1.22 1.59),1.48E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.38 (1.21 1.57),1.48E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003500,0.071,Nightingale,Total lipids in very large VLDL,1.36 (1.20 1.53),1.48E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.38 (1.22 1.58),1.54E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.38 (1.21 1.56),1.54E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.38 (1.21 1.56),1.69E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003510,0.068,Nightingale,Cholesterol in chylomicrons and extremely large VLDL,1.35 (1.20 1.53),2.29E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.35 (1.19 1.52),2.31E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.38 (1.21 1.57),2.33E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.75 (0.67 0.84),3.44E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.37 (1.20 1.56),3.62E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,1.34 (1.19 1.52),3.72E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.75 (0.67 0.85),3.89E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003455,0.087,Nightingale,Total free cholesterol,1.34 (1.19 1.52),4.31E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.75 (0.67 0.85),4.52E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.75 (0.67 0.85),4.78E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003484,0.075,Nightingale,Triglycerides in HDL,1.32 (1.17 1.48),5.00E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003509,0.069,Nightingale,Free cholesterol in chylomicrons and extremely large VLDL,1.34 (1.18 1.51),5.15E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,1.34 (1.18 1.51),5.62E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.76 (0.67 0.85),7.11E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.76 (0.67 0.85),7.57E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.76 (0.68 0.86),7.68E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.34 (1.18 1.53),7.93E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003491,0.073,Nightingale,Total lipids in chylomicrons and extremely large VLDL,1.33 (1.17 1.50),9.63E-04
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003487,0.074,Nightingale,Phospholipids in chylomicrons and extremely large VLDL,1.32 (1.17 1.50),1.06E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003520,0.062,Nightingale,HDL cholesterol,0.77 (0.68 0.86),1.22E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.78 (0.69 0.87),3.48E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.78 (0.69 0.88),4.43E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.78 (0.69 0.88),6.04E-03
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003448,0.093,Nightingale,Phospholipids in very large HDL,0.79 (0.71 0.89),1.23E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003527,0.050,Nightingale,Sphingomyelins,1.27 (1.13 1.44),1.35E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.25 (1.11 1.41),2.19E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003462,0.083,Nightingale,Average diameter for VLDL particles,1.25 (1.11 1.41),2.82E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.24 (1.10 1.39),4.10E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS003528,0.050,Nightingale,Total cholines,1.24 (1.10 1.39),4.55E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS005489,0.239,RNAseq,TRAPPC5,1.24 (1.11 1.39),1.76E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS007664,0.127,RNAseq,MMP1,1.26 (1.12 1.42),2.17E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS009195,0.085,RNAseq,POLR1B,1.19 (1.08 1.31),3.88E-02
272.13,Mixed hyperlipidemia,endocrine/metabolic,OPGS007034,0.151,RNAseq,LGR4,0.81 (0.73 0.91),3.96E-02
274.1,Gout,endocrine/metabolic,OPGS000812,0.071,SomaScan,Cathepsin F,1.07 (1.04 1.10),5.45E-04
274.1,Gout,endocrine/metabolic,OPGS002008,0.013,SomaScan,Signal peptide. CUB and EGF-like domain-containing protein 1,1.06 (1.03 1.10),6.10E-03
274.1,Gout,endocrine/metabolic,OPGS001753,0.018,SomaScan,Apolipoprotein A-I,1.05 (1.02 1.08),3.57E-02
274.1,Gout,endocrine/metabolic,OPGS002905,0.051,Metabolon,urate,1.50 (1.45 1.55),9.02E-127
274.1,Gout,endocrine/metabolic,OPGS002788,0.102,Metabolon,4-hydroxychlorothalonil,1.34 (1.31 1.37),3.51E-113
274.1,Gout,endocrine/metabolic,OPGS002840,0.074,Metabolon,X - 18914,1.33 (1.30 1.36),1.95E-110
274.1,Gout,endocrine/metabolic,OPGS002944,0.043,Metabolon,X - 18249,1.33 (1.30 1.37),5.81E-110
274.1,Gout,endocrine/metabolic,OPGS003173,0.013,Metabolon,X - 18901,1.21 (1.19 1.24),3.76E-51
274.1,Gout,endocrine/metabolic,OPGS003162,0.014,Metabolon,2-hydroxybutyrate/2-hydroxyisobutyrate,1.14 (1.10 1.17),3.84E-15
274.1,Gout,endocrine/metabolic,OPGS003145,0.015,Metabolon,adenosine 3'.5'-cyclic monophosphate (cAMP),0.88 (0.86 0.91),1.95E-14
274.1,Gout,endocrine/metabolic,OPGS002884,0.058,Metabolon,ferulic acid 4-sulfate,1.11 (1.08 1.14),5.67E-10
274.1,Gout,endocrine/metabolic,OPGS003196,0.012,Metabolon,1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)*,1.11 (1.08 1.14),8.34E-10
274.1,Gout,endocrine/metabolic,OPGS002930,0.046,Metabolon,X - 13866,1.11 (1.08 1.14),1.69E-09
274.1,Gout,endocrine/metabolic,OPGS003220,0.011,Metabolon,3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF),0.90 (0.88 0.93),7.56E-09
274.1,Gout,endocrine/metabolic,OPGS002801,0.093,Metabolon,X - 12824,1.10 (1.07 1.13),2.01E-08
274.1,Gout,endocrine/metabolic,OPGS003114,0.018,Metabolon,1-myristoyl-2-linoleoyl-GPC (14:0/18:2)*,1.10 (1.07 1.13),3.16E-08
274.1,Gout,endocrine/metabolic,OPGS003217,0.011,Metabolon,X - 24024,1.10 (1.07 1.13),3.37E-08
274.1,Gout,endocrine/metabolic,OPGS003135,0.016,Metabolon,X - 15486,1.10 (1.07 1.13),1.13E-07
274.1,Gout,endocrine/metabolic,OPGS002818,0.083,Metabolon,X - 24241,1.10 (1.07 1.13),1.56E-07
274.1,Gout,endocrine/metabolic,OPGS002886,0.057,Metabolon,X - 12822,1.09 (1.06 1.12),3.51E-07
274.1,Gout,endocrine/metabolic,OPGS003119,0.017,Metabolon,1-palmitoyl-GPC (16:0),1.09 (1.06 1.13),7.17E-07
274.1,Gout,endocrine/metabolic,OPGS003198,0.012,Metabolon,gamma-glutamylthreonine*,0.92 (0.89 0.94),1.06E-06
274.1,Gout,endocrine/metabolic,OPGS003200,0.012,Metabolon,threonine,0.92 (0.89 0.95),3.17E-06
274.1,Gout,endocrine/metabolic,OPGS003089,0.020,Metabolon,X - 17690,1.09 (1.06 1.12),5.70E-06
274.1,Gout,endocrine/metabolic,OPGS003197,0.012,Metabolon,1-stearoyl-GPC (18:0),1.09 (1.06 1.12),1.21E-05
274.1,Gout,endocrine/metabolic,OPGS003063,0.022,Metabolon,2-aminobutyrate,1.08 (1.05 1.11),1.24E-04
274.1,Gout,endocrine/metabolic,OPGS003031,0.026,Metabolon,X - 21312,1.07 (1.04 1.10),3.42E-04
274.1,Gout,endocrine/metabolic,OPGS003153,0.014,Metabolon,retinol (Vitamin A),1.07 (1.04 1.10),5.02E-04
274.1,Gout,endocrine/metabolic,OPGS003216,0.011,Metabolon,1-linolenoyl-GPC (18:3)*,1.07 (1.04 1.10),8.46E-04
274.1,Gout,endocrine/metabolic,OPGS003126,0.017,Metabolon,X - 21829,1.07 (1.04 1.10),9.08E-04
274.1,Gout,endocrine/metabolic,OPGS003177,0.013,Metabolon,X - 02269,0.94 (0.91 0.96),1.88E-03
274.1,Gout,endocrine/metabolic,OPGS002983,0.033,Metabolon,4-androsten-3beta.17beta-diol disulfate (2),0.94 (0.91 0.96),2.14E-03
274.1,Gout,endocrine/metabolic,OPGS002892,0.054,Metabolon,propionylcarnitine,1.07 (1.04 1.10),3.14E-03
274.1,Gout,endocrine/metabolic,OPGS002864,0.066,Metabolon,21-hydroxypregnenolone disulfate,0.94 (0.91 0.97),3.41E-03
274.1,Gout,endocrine/metabolic,OPGS002711,0.257,Metabolon,X - 21792,0.94 (0.91 0.97),3.57E-03
274.1,Gout,endocrine/metabolic,OPGS002833,0.077,Metabolon,taurocholenate sulfate,0.94 (0.91 0.97),4.27E-03
274.1,Gout,endocrine/metabolic,OPGS002880,0.059,Metabolon,X - 17337,1.06 (1.03 1.09),5.20E-03
274.1,Gout,endocrine/metabolic,OPGS002962,0.038,Metabolon,acetylcarnitine,1.06 (1.03 1.09),6.10E-03
274.1,Gout,endocrine/metabolic,OPGS003201,0.012,Metabolon,glycerophosphorylcholine (GPC),1.06 (1.03 1.09),1.22E-02
274.1,Gout,endocrine/metabolic,OPGS002904,0.051,Metabolon,1-arachidonoyl-GPI (20:4)*,0.94 (0.92 0.97),1.58E-02
274.1,Gout,endocrine/metabolic,OPGS003136,0.016,Metabolon,1-eicosapentaenoyl-GPE (20:5)*,0.95 (0.92 0.97),2.36E-02
274.1,Gout,endocrine/metabolic,OPGS002938,0.044,Metabolon,2-arachidonoyl-GPE (20:4)*,0.95 (0.92 0.97),3.27E-02
274.1,Gout,endocrine/metabolic,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.05 (1.02 1.08),4.91E-02
274.1,Gout,endocrine/metabolic,OPGS003481,0.075,Nightingale,Triglycerides in medium VLDL,1.09 (1.06 1.12),7.04E-06
274.1,Gout,endocrine/metabolic,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.09 (1.06 1.12),7.98E-06
274.1,Gout,endocrine/metabolic,OPGS003477,0.076,Nightingale,Concentration of medium VLDL particles,1.08 (1.05 1.11),2.71E-05
274.1,Gout,endocrine/metabolic,OPGS003479,0.075,Nightingale,Triglycerides in VLDL,1.08 (1.05 1.11),5.22E-05
274.1,Gout,endocrine/metabolic,OPGS003490,0.073,Nightingale,Free cholesterol in medium VLDL,1.08 (1.05 1.11),5.64E-05
274.1,Gout,endocrine/metabolic,OPGS003486,0.074,Nightingale,Total triglycerides,1.08 (1.05 1.11),8.71E-05
274.1,Gout,endocrine/metabolic,OPGS003537,0.031,Nightingale,Glycoprotein acetyls,1.08 (1.05 1.11),1.28E-04
274.1,Gout,endocrine/metabolic,OPGS003475,0.076,Nightingale,Total lipids in medium VLDL,1.08 (1.05 1.11),1.77E-04
274.1,Gout,endocrine/metabolic,OPGS003540,0.029,Nightingale,Free cholesterol in small HDL,1.07 (1.04 1.10),2.61E-04
274.1,Gout,endocrine/metabolic,OPGS003494,0.072,Nightingale,Concentration of large VLDL particles,1.08 (1.04 1.11),2.74E-04
274.1,Gout,endocrine/metabolic,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.07 (1.04 1.10),6.18E-04
274.1,Gout,endocrine/metabolic,OPGS003498,0.071,Nightingale,Triglycerides in large VLDL,1.07 (1.04 1.10),6.33E-04
274.1,Gout,endocrine/metabolic,OPGS003493,0.073,Nightingale,Total lipids in large VLDL,1.07 (1.04 1.10),9.63E-04
274.1,Gout,endocrine/metabolic,OPGS003476,0.076,Nightingale,Phospholipids in medium VLDL,1.07 (1.04 1.10),9.99E-04
274.1,Gout,endocrine/metabolic,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.07 (1.04 1.10),9.99E-04
274.1,Gout,endocrine/metabolic,OPGS003499,0.071,Nightingale,Phospholipids in large VLDL,1.07 (1.04 1.10),1.05E-03
274.1,Gout,endocrine/metabolic,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,1.07 (1.04 1.10),1.05E-03
274.1,Gout,endocrine/metabolic,OPGS003462,0.083,Nightingale,Average diameter for VLDL particles,1.07 (1.04 1.10),1.18E-03
274.1,Gout,endocrine/metabolic,OPGS003507,0.070,Nightingale,Free cholesterol in large VLDL,1.07 (1.04 1.10),1.88E-03
274.1,Gout,endocrine/metabolic,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.07 (1.04 1.10),1.88E-03
274.1,Gout,endocrine/metabolic,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.07 (1.04 1.10),1.88E-03
274.1,Gout,endocrine/metabolic,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.07 (1.04 1.10),2.98E-03
274.1,Gout,endocrine/metabolic,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,1.06 (1.03 1.09),3.79E-03
274.1,Gout,endocrine/metabolic,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.06 (1.03 1.09),4.32E-03
274.1,Gout,endocrine/metabolic,OPGS003522,0.062,Nightingale,Degree of unsaturation,0.94 (0.92 0.97),5.04E-03
274.1,Gout,endocrine/metabolic,OPGS003500,0.071,Nightingale,Total lipids in very large VLDL,1.06 (1.03 1.09),8.31E-03
274.1,Gout,endocrine/metabolic,OPGS003483,0.075,Nightingale,Cholesterol in large VLDL,1.06 (1.03 1.09),9.86E-03
274.1,Gout,endocrine/metabolic,OPGS003502,0.070,Nightingale,Concentration of very large VLDL particles,1.06 (1.03 1.09),1.37E-02
274.1,Gout,endocrine/metabolic,OPGS003504,0.070,Nightingale,Triglycerides in very large VLDL,1.06 (1.03 1.09),1.76E-02
274.1,Gout,endocrine/metabolic,OPGS003518,0.065,Nightingale,Triglycerides in medium HDL,1.06 (1.03 1.09),2.05E-02
274.1,Gout,endocrine/metabolic,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,1.06 (1.03 1.09),2.28E-02
274.1,Gout,endocrine/metabolic,OPGS007426,0.135,RNAseq,SLC2A9,1.19 (1.16 1.23),8.12E-31
274.1,Gout,endocrine/metabolic,OPGS005681,0.222,RNAseq,ABCG2,1.07 (1.04 1.10),4.75E-04
274.1,Gout,endocrine/metabolic,OPGS007559,0.130,RNAseq,RPS6KA4,0.94 (0.91 0.97),4.45E-03
274.1,Gout,endocrine/metabolic,OPGS012036,0.041,RNAseq,GSE1,0.94 (0.91 0.97),5.04E-03
274.1,Gout,endocrine/metabolic,OPGS005352,0.252,RNAseq,BARD1,1.06 (1.03 1.10),6.10E-03
274.1,Gout,endocrine/metabolic,OPGS014341,0.020,RNAseq,NFAT5,1.06 (1.03 1.09),8.26E-03
274.1,Gout,endocrine/metabolic,OPGS013798,0.024,RNAseq,RNF5,1.06 (1.03 1.09),1.01E-02
274.1,Gout,endocrine/metabolic,OPGS005246,0.261,RNAseq,Z97989.1,0.95 (0.92 0.97),1.58E-02
274.1,Gout,endocrine/metabolic,OPGS013595,0.026,RNAseq,NINJ2,1.06 (1.03 1.09),2.17E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS000969,0.056,SomaScan,Transferrin receptor protein 1,0.33 (0.31 0.34),0.00E+00
275.1,Disorders of iron metabolism,hematopoietic,OPGS000798,0.073,SomaScan,N-acetylated-alpha-linked acidic dipeptidase 2,0.31 (0.30 0.33),0.00E+00
275.1,Disorders of iron metabolism,hematopoietic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,1.30 (1.22 1.39),1.83E-14
275.1,Disorders of iron metabolism,hematopoietic,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,1.27 (1.20 1.34),3.40E-14
275.1,Disorders of iron metabolism,hematopoietic,OPGS000261,0.188,SomaScan,alpha-2-macroglobulin receptor-associated protein,1.20 (1.15 1.25),1.95E-13
275.1,Disorders of iron metabolism,hematopoietic,OPGS001679,0.020,SomaScan,Metalloproteinase inhibitor 1,1.29 (1.21 1.37),3.93E-13
275.1,Disorders of iron metabolism,hematopoietic,OPGS000156,0.272,SomaScan,alpha-2-macroglobulin receptor-associated protein,1.20 (1.15 1.25),7.76E-13
275.1,Disorders of iron metabolism,hematopoietic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,0.80 (0.75 0.85),4.05E-10
275.1,Disorders of iron metabolism,hematopoietic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,1.22 (1.15 1.28),4.58E-10
275.1,Disorders of iron metabolism,hematopoietic,OPGS000290,0.171,SomaScan,Complement C4,1.21 (1.15 1.29),1.82E-08
275.1,Disorders of iron metabolism,hematopoietic,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,0.83 (0.78 0.88),2.13E-07
275.1,Disorders of iron metabolism,hematopoietic,OPGS000137,0.312,SomaScan,Complement C4b,1.19 (1.12 1.26),6.23E-06
275.1,Disorders of iron metabolism,hematopoietic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,1.18 (1.11 1.25),1.10E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,0.85 (0.80 0.90),1.19E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,1.19 (1.12 1.27),1.35E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,1.19 (1.12 1.27),1.38E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS000576,0.102,SomaScan,Interleukin-21,1.18 (1.11 1.26),2.78E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,0.85 (0.80 0.90),3.04E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,1.17 (1.10 1.25),9.76E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS001286,0.034,SomaScan,Granzyme K,0.86 (0.81 0.91),1.27E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS000123,0.339,SomaScan,GDH/6PGL endoplasmic bifunctional protein,1.15 (1.09 1.22),3.43E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,1.15 (1.08 1.22),6.40E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS001200,0.039,SomaScan,DnaJ homolog subfamily B member 11,1.13 (1.07 1.20),7.75E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS002246,0.010,SomaScan,Sperm-associated antigen 11B,1.15 (1.08 1.22),1.67E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS000984,0.055,SomaScan,Complement C2,0.89 (0.84 0.94),2.47E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,0.88 (0.83 0.94),4.85E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS000517,0.114,SomaScan,Advanced glycosylation end product-specific receptor. soluble,1.13 (1.07 1.20),6.19E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS001598,0.022,SomaScan,SPARC,1.13 (1.06 1.20),1.36E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS000846,0.068,SomaScan,2-phosphoxylose phosphatase 1,0.90 (0.85 0.95),4.76E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS002499,0.098,Olink,Transferrin receptor protein 1,0.52 (0.49 0.56),2.20E-80
275.1,Disorders of iron metabolism,hematopoietic,OPGS002427,0.216,Olink,Alpha-2-macroglobulin receptor-associated protein,1.21 (1.16 1.27),1.09E-15
275.1,Disorders of iron metabolism,hematopoietic,OPGS002643,0.018,Olink,Neuroblastoma suppressor of tumorigenicity 1,1.17 (1.11 1.25),3.50E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,1.18 (1.11 1.25),3.50E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,1.15 (1.08 1.22),5.39E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS002422,0.223,Olink,Lymphotoxin-alpha,1.14 (1.07 1.22),7.73E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS002559,0.048,Olink,C-C motif chemokine 19,1.11 (1.05 1.18),4.32E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS002913,0.049,Metabolon,X - 21285,0.39 (0.37 0.42),6.10E-166
275.1,Disorders of iron metabolism,hematopoietic,OPGS002884,0.058,Metabolon,ferulic acid 4-sulfate,2.11 (1.97 2.25),1.05E-101
275.1,Disorders of iron metabolism,hematopoietic,OPGS002866,0.064,Metabolon,N-acetyltryptophan,2.13 (1.98 2.28),3.28E-94
275.1,Disorders of iron metabolism,hematopoietic,OPGS002983,0.033,Metabolon,4-androsten-3beta.17beta-diol disulfate (2),0.52 (0.49 0.55),2.19E-93
275.1,Disorders of iron metabolism,hematopoietic,OPGS002932,0.045,Metabolon,4-androsten-3beta.17beta-diol monosulfate (2),0.62 (0.59 0.66),4.22E-68
275.1,Disorders of iron metabolism,hematopoietic,OPGS002775,0.116,Metabolon,X - 21410,0.53 (0.49 0.57),1.66E-65
275.1,Disorders of iron metabolism,hematopoietic,OPGS003177,0.013,Metabolon,X - 02269,0.67 (0.63 0.70),5.14E-60
275.1,Disorders of iron metabolism,hematopoietic,OPGS002930,0.046,Metabolon,X - 13866,1.66 (1.56 1.76),2.01E-55
275.1,Disorders of iron metabolism,hematopoietic,OPGS002876,0.060,Metabolon,3-methoxytyrosine,0.61 (0.58 0.65),9.23E-55
275.1,Disorders of iron metabolism,hematopoietic,OPGS003031,0.026,Metabolon,X - 21312,0.58 (0.54 0.62),9.90E-45
275.1,Disorders of iron metabolism,hematopoietic,OPGS002730,0.193,Metabolon,N-acetylkynurenine (2),1.47 (1.39 1.55),6.05E-39
275.1,Disorders of iron metabolism,hematopoietic,OPGS003135,0.016,Metabolon,X - 15486,1.47 (1.38 1.56),3.28E-32
275.1,Disorders of iron metabolism,hematopoietic,OPGS003018,0.028,Metabolon,X - 18899,0.74 (0.71 0.78),3.22E-31
275.1,Disorders of iron metabolism,hematopoietic,OPGS002729,0.194,Metabolon,16a-hydroxy DHEA 3-sulfate,0.59 (0.54 0.65),1.98E-28
275.1,Disorders of iron metabolism,hematopoietic,OPGS002787,0.102,Metabolon,X - 24544,0.66 (0.62 0.71),6.03E-27
275.1,Disorders of iron metabolism,hematopoietic,OPGS002753,0.142,Metabolon,andro steroid monosulfate (1)*,0.66 (0.62 0.71),1.21E-25
275.1,Disorders of iron metabolism,hematopoietic,OPGS002864,0.066,Metabolon,21-hydroxypregnenolone disulfate,0.72 (0.68 0.77),2.87E-24
275.1,Disorders of iron metabolism,hematopoietic,OPGS002801,0.093,Metabolon,X - 12824,1.38 (1.30 1.47),1.59E-23
275.1,Disorders of iron metabolism,hematopoietic,OPGS002759,0.134,Metabolon,2-aminooctanoate,0.75 (0.71 0.79),3.34E-23
275.1,Disorders of iron metabolism,hematopoietic,OPGS003220,0.011,Metabolon,3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF),0.71 (0.67 0.76),2.26E-22
275.1,Disorders of iron metabolism,hematopoietic,OPGS002886,0.057,Metabolon,X - 12822,1.35 (1.27 1.43),3.58E-22
275.1,Disorders of iron metabolism,hematopoietic,OPGS002779,0.113,Metabolon,X - 21470,0.74 (0.70 0.79),6.28E-21
275.1,Disorders of iron metabolism,hematopoietic,OPGS002721,0.209,Metabolon,N-acetylphenylalanine,1.26 (1.20 1.34),8.22E-14
275.1,Disorders of iron metabolism,hematopoietic,OPGS002782,0.110,Metabolon,4-androsten-3beta.17beta-diol disulfate (1),0.82 (0.77 0.87),4.48E-10
275.1,Disorders of iron metabolism,hematopoietic,OPGS003027,0.026,Metabolon,xanthurenate,1.20 (1.14 1.27),3.71E-08
275.1,Disorders of iron metabolism,hematopoietic,OPGS002849,0.070,Metabolon,X - 16071,1.22 (1.15 1.30),4.61E-08
275.1,Disorders of iron metabolism,hematopoietic,OPGS002698,0.378,Metabolon,X - 19141,0.84 (0.79 0.89),5.19E-07
275.1,Disorders of iron metabolism,hematopoietic,OPGS003126,0.017,Metabolon,X - 21829,1.17 (1.10 1.24),3.32E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS002711,0.257,Metabolon,X - 21792,0.86 (0.81 0.91),5.55E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS002757,0.135,Metabolon,5alpha-androstan-3beta.17beta-diol disulfate,0.87 (0.82 0.92),6.97E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS003059,0.022,Metabolon,X - 09789,0.86 (0.81 0.92),2.30E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS002740,0.162,Metabolon,N-acetylhistidine,1.13 (1.06 1.20),1.18E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS003145,0.015,Metabolon,adenosine 3'.5'-cyclic monophosphate (cAMP),1.12 (1.06 1.19),1.57E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS012562,0.035,RNAseq,H2BC17,0.42 (0.40 0.44),0.00E+00
275.1,Disorders of iron metabolism,hematopoietic,OPGS007604,0.128,RNAseq,U91328.1,0.30 (0.28 0.32),1.96E-280
275.1,Disorders of iron metabolism,hematopoietic,OPGS010937,0.055,RNAseq,H4C3,0.25 (0.23 0.27),2.56E-236
275.1,Disorders of iron metabolism,hematopoietic,OPGS008119,0.112,RNAseq,TRIM38,0.70 (0.68 0.72),2.22E-120
275.1,Disorders of iron metabolism,hematopoietic,OPGS004720,0.321,RNAseq,AL590705.3,2.30 (2.14 2.47),3.87E-111
275.1,Disorders of iron metabolism,hematopoietic,OPGS012452,0.036,RNAseq,H2AC6,2.44 (2.22 2.68),1.10E-74
275.1,Disorders of iron metabolism,hematopoietic,OPGS009672,0.076,RNAseq,CALR,1.71 (1.62 1.81),1.73E-74
275.1,Disorders of iron metabolism,hematopoietic,OPGS004134,0.427,RNAseq,H2BC5,1.60 (1.51 1.69),3.93E-58
275.1,Disorders of iron metabolism,hematopoietic,OPGS012855,0.032,RNAseq,TRBV9,1.62 (1.53 1.72),4.27E-55
275.1,Disorders of iron metabolism,hematopoietic,OPGS007446,0.134,RNAseq,AL645939.6,0.69 (0.66 0.72),9.21E-50
275.1,Disorders of iron metabolism,hematopoietic,OPGS006509,0.175,RNAseq,ZNF322,0.62 (0.58 0.66),1.26E-44
275.1,Disorders of iron metabolism,hematopoietic,OPGS008786,0.094,RNAseq,GABBR1,0.71 (0.68 0.75),7.13E-34
275.1,Disorders of iron metabolism,hematopoietic,OPGS013595,0.026,RNAseq,NINJ2,0.73 (0.69 0.77),3.17E-31
275.1,Disorders of iron metabolism,hematopoietic,OPGS013068,0.030,RNAseq,AL021807.1,0.67 (0.63 0.72),1.41E-29
275.1,Disorders of iron metabolism,hematopoietic,OPGS009865,0.072,RNAseq,TRAV17,1.42 (1.34 1.52),2.48E-24
275.1,Disorders of iron metabolism,hematopoietic,OPGS006940,0.154,RNAseq,,0.70 (0.66 0.75),1.03E-23
275.1,Disorders of iron metabolism,hematopoietic,OPGS009241,0.084,RNAseq,ZKSCAN4,0.69 (0.64 0.74),4.14E-21
275.1,Disorders of iron metabolism,hematopoietic,OPGS014270,0.021,RNAseq,AL121944.2,0.61 (0.55 0.67),7.74E-21
275.1,Disorders of iron metabolism,hematopoietic,OPGS006986,0.152,RNAseq,H4C8,1.32 (1.25 1.39),1.64E-20
275.1,Disorders of iron metabolism,hematopoietic,OPGS011626,0.046,RNAseq,ABCF1,0.72 (0.67 0.77),1.99E-20
275.1,Disorders of iron metabolism,hematopoietic,OPGS004112,0.433,RNAseq,HLA-F,1.31 (1.24 1.39),1.34E-16
275.1,Disorders of iron metabolism,hematopoietic,OPGS011784,0.044,RNAseq,TUBB,0.80 (0.76 0.84),2.76E-16
275.1,Disorders of iron metabolism,hematopoietic,OPGS013243,0.029,RNAseq,TRAV3,1.32 (1.24 1.41),8.91E-16
275.1,Disorders of iron metabolism,hematopoietic,OPGS004081,0.443,RNAseq,,0.75 (0.70 0.80),1.82E-15
275.1,Disorders of iron metabolism,hematopoietic,OPGS006434,0.179,RNAseq,BTN2A1,0.73 (0.68 0.78),5.76E-15
275.1,Disorders of iron metabolism,hematopoietic,OPGS007167,0.145,RNAseq,ABT1,1.67 (1.49 1.89),5.87E-15
275.1,Disorders of iron metabolism,hematopoietic,OPGS003620,0.668,RNAseq,ZFP57,0.76 (0.71 0.81),1.62E-13
275.1,Disorders of iron metabolism,hematopoietic,OPGS013437,0.027,RNAseq,TRAV29DV5,0.77 (0.72 0.82),2.03E-13
275.1,Disorders of iron metabolism,hematopoietic,OPGS010142,0.067,RNAseq,PRSS16,0.73 (0.67 0.79),2.65E-13
275.1,Disorders of iron metabolism,hematopoietic,OPGS012171,0.039,RNAseq,TRBV15,1.29 (1.21 1.37),4.40E-13
275.1,Disorders of iron metabolism,hematopoietic,OPGS004852,0.304,RNAseq,KIAA0319,1.27 (1.20 1.35),5.08E-13
275.1,Disorders of iron metabolism,hematopoietic,OPGS007675,0.126,RNAseq,TRAV12-2,0.78 (0.73 0.83),1.47E-12
275.1,Disorders of iron metabolism,hematopoietic,OPGS006499,0.176,RNAseq,C4A,1.29 (1.21 1.38),3.39E-12
275.1,Disorders of iron metabolism,hematopoietic,OPGS004195,0.413,RNAseq,TRIM27,0.77 (0.73 0.83),3.60E-12
275.1,Disorders of iron metabolism,hematopoietic,OPGS004334,0.383,RNAseq,HLA-G,0.78 (0.74 0.83),5.02E-12
275.1,Disorders of iron metabolism,hematopoietic,OPGS007387,0.136,RNAseq,C6orf62,1.24 (1.18 1.32),1.17E-11
275.1,Disorders of iron metabolism,hematopoietic,OPGS010926,0.055,RNAseq,CACNA2D4,1.28 (1.20 1.37),5.28E-11
275.1,Disorders of iron metabolism,hematopoietic,OPGS008158,0.110,RNAseq,,1.33 (1.23 1.44),1.13E-10
275.1,Disorders of iron metabolism,hematopoietic,OPGS005245,0.261,RNAseq,ZNF391,1.27 (1.19 1.35),5.82E-10
275.1,Disorders of iron metabolism,hematopoietic,OPGS006845,0.158,RNAseq,FLOT1,0.80 (0.75 0.86),2.53E-09
275.1,Disorders of iron metabolism,hematopoietic,OPGS010624,0.059,RNAseq,TRBV18,0.82 (0.77 0.87),1.92E-08
275.1,Disorders of iron metabolism,hematopoietic,OPGS011344,0.049,RNAseq,,0.82 (0.77 0.87),3.71E-08
275.1,Disorders of iron metabolism,hematopoietic,OPGS013305,0.028,RNAseq,TRBV14,1.23 (1.15 1.31),4.34E-08
275.1,Disorders of iron metabolism,hematopoietic,OPGS009077,0.088,RNAseq,DDAH2,1.20 (1.13 1.27),1.17E-07
275.1,Disorders of iron metabolism,hematopoietic,OPGS005334,0.253,RNAseq,AL645933.4,1.20 (1.13 1.28),2.30E-07
275.1,Disorders of iron metabolism,hematopoietic,OPGS009688,0.075,RNAseq,H2BC12,0.79 (0.73 0.85),2.78E-07
275.1,Disorders of iron metabolism,hematopoietic,OPGS013406,0.027,RNAseq,AL353759.1,1.22 (1.14 1.30),4.11E-07
275.1,Disorders of iron metabolism,hematopoietic,OPGS006716,0.164,RNAseq,IER3,0.84 (0.79 0.89),1.66E-06
275.1,Disorders of iron metabolism,hematopoietic,OPGS007764,0.123,RNAseq,HLA-E,0.84 (0.79 0.90),3.89E-06
275.1,Disorders of iron metabolism,hematopoietic,OPGS009163,0.086,RNAseq,HCG11,0.84 (0.79 0.89),4.54E-06
275.1,Disorders of iron metabolism,hematopoietic,OPGS013526,0.026,RNAseq,H2BC11,0.84 (0.79 0.89),5.10E-06
275.1,Disorders of iron metabolism,hematopoietic,OPGS010607,0.059,RNAseq,TRAV8-1,0.85 (0.80 0.90),2.08E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS007685,0.126,RNAseq,H1-2,0.85 (0.80 0.90),2.43E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS006253,0.189,RNAseq,CABP5,1.17 (1.10 1.24),2.43E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS007172,0.144,RNAseq,ALDH5A1,0.86 (0.81 0.91),3.50E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS014680,0.018,RNAseq,GALE,1.19 (1.11 1.27),4.06E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS005167,0.269,RNAseq,TCF19,0.83 (0.77 0.89),6.65E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS015052,0.015,RNAseq,CISH,1.17 (1.10 1.24),8.15E-05
275.1,Disorders of iron metabolism,hematopoietic,OPGS004956,0.291,RNAseq,,1.17 (1.10 1.25),1.25E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS013699,0.025,RNAseq,TRAV5,0.86 (0.81 0.91),1.26E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS006048,0.200,RNAseq,,0.85 (0.80 0.91),1.31E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS011948,0.042,RNAseq,ADGRG1,1.16 (1.09 1.23),2.60E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS010532,0.060,RNAseq,AL031777.2,0.85 (0.79 0.91),4.46E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS011853,0.043,RNAseq,TRBV6-1,1.15 (1.08 1.22),5.58E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS014580,0.018,RNAseq,DACT1,1.16 (1.09 1.24),6.40E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS007321,0.139,RNAseq,BTN2A2,1.15 (1.08 1.23),8.30E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS014496,0.019,RNAseq,VARS1,0.86 (0.81 0.92),8.60E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS010017,0.069,RNAseq,,0.86 (0.80 0.92),8.89E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS005918,0.208,RNAseq,DDR1,0.86 (0.81 0.92),9.86E-04
275.1,Disorders of iron metabolism,hematopoietic,OPGS008852,0.093,RNAseq,H2AC8,1.15 (1.08 1.23),1.52E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS009198,0.085,RNAseq,TRAV12-1,0.87 (0.82 0.93),1.55E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS005230,0.263,RNAseq,LINC00243,0.88 (0.83 0.93),1.56E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS009669,0.076,RNAseq,CRTAM,0.87 (0.82 0.93),1.76E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS014326,0.020,RNAseq,,1.17 (1.09 1.26),3.85E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS005459,0.242,RNAseq,HMGN4,1.15 (1.08 1.24),3.85E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS010922,0.055,RNAseq,WDR3,1.11 (1.06 1.17),4.98E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS004065,0.446,RNAseq,,0.87 (0.81 0.93),5.29E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS013324,0.028,RNAseq,PRF1,1.17 (1.08 1.27),7.98E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS012657,0.034,RNAseq,EMC3,1.13 (1.06 1.20),9.84E-03
275.1,Disorders of iron metabolism,hematopoietic,OPGS004122,0.430,RNAseq,HLA-DRB5,1.12 (1.06 1.19),1.11E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS008352,0.105,RNAseq,THUMPD1,1.12 (1.06 1.19),1.42E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS008871,0.093,RNAseq,GOLGA3,1.12 (1.05 1.18),1.43E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS009067,0.089,RNAseq,AC130456.3,1.13 (1.06 1.20),1.70E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS015135,0.015,RNAseq,FBXL19-AS1,0.90 (0.85 0.95),1.82E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS010099,0.068,RNAseq,FERMT3,0.89 (0.84 0.95),1.84E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS011005,0.054,RNAseq,SLC1A5,0.89 (0.83 0.94),2.00E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS003680,0.611,RNAseq,,0.89 (0.83 0.95),2.06E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS010829,0.056,RNAseq,GPLD1,1.12 (1.05 1.18),2.52E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS003621,0.665,RNAseq,,0.89 (0.84 0.95),2.52E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS008613,0.098,RNAseq,MFF,0.90 (0.85 0.95),2.64E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS008643,0.098,RNAseq,TRIM40,0.86 (0.79 0.93),2.65E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS004489,0.357,RNAseq,,0.89 (0.84 0.95),2.70E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS006417,0.180,RNAseq,ZNF575,0.89 (0.84 0.95),2.78E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS012332,0.037,RNAseq,IBTK,0.90 (0.85 0.95),2.80E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS004220,0.407,RNAseq,TRBV4-1,0.90 (0.84 0.95),3.06E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS007865,0.119,RNAseq,MAL,1.11 (1.05 1.18),3.55E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS009222,0.085,RNAseq,,1.12 (1.05 1.19),3.86E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS007496,0.132,RNAseq,EIF5A,0.89 (0.84 0.95),3.98E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS011073,0.053,RNAseq,TRBV7-3,0.91 (0.86 0.96),4.77E-02
275.1,Disorders of iron metabolism,hematopoietic,OPGS003642,0.644,RNAseq,ERAP1,1.11 (1.05 1.18),4.97E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000857,0.067,SomaScan,Moesin,1.23 (1.15 1.31),3.07E-06
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.22 (1.15 1.30),3.30E-06
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.22 (1.14 1.30),3.30E-06
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.25 (1.16 1.34),5.40E-06
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.22 (1.14 1.31),6.12E-06
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.23 (1.15 1.32),6.12E-06
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000115,0.347,SomaScan,Protein CEI,1.25 (1.16 1.34),9.51E-06
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.21 (1.13 1.29),1.02E-05
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.20 (1.13 1.28),1.02E-05
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.20 (1.13 1.28),1.02E-05
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000312,0.163,SomaScan,Selenoprotein S,1.26 (1.17 1.37),1.02E-05
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.24 (1.15 1.33),1.02E-05
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.20 (1.12 1.27),1.97E-05
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.24 (1.15 1.33),3.39E-05
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.24 (1.14 1.34),2.10E-04
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.23 (1.14 1.34),2.36E-04
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.20 (1.12 1.29),4.60E-04
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.85 (0.80 0.91),5.12E-04
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000613,0.096,SomaScan,Stromelysin-1,1.22 (1.13 1.32),5.12E-04
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.19 (1.11 1.28),1.15E-03
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.15 (1.09 1.23),1.85E-03
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.17 (1.09 1.26),1.25E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000911,0.062,SomaScan,Protein MENT,1.15 (1.08 1.23),1.67E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.17 (1.08 1.26),2.48E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.16 (1.08 1.24),2.48E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.88 (0.82 0.94),2.76E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.15 (1.07 1.23),3.03E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS000172,0.257,SomaScan,Dermokine,0.87 (0.81 0.93),3.53E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS001093,0.046,SomaScan,C-reactive protein,0.88 (0.82 0.94),4.00E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003006,0.030,Metabolon,cholesterol,1.19 (1.11 1.28),1.85E-03
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.14 (1.07 1.22),2.90E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.17 (1.09 1.26),4.49E-03
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.17 (1.09 1.25),1.01E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.17 (1.09 1.25),1.01E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.17 (1.09 1.26),1.21E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.16 (1.08 1.25),1.45E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.17 (1.09 1.26),1.60E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.16 (1.08 1.25),1.60E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.17 (1.08 1.25),1.60E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.16 (1.08 1.25),1.80E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.16 (1.08 1.25),1.83E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.16 (1.08 1.24),1.86E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.16 (1.08 1.24),2.48E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.15 (1.07 1.24),2.48E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.16 (1.08 1.24),2.48E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.16 (1.08 1.24),2.48E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.16 (1.08 1.25),2.48E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.16 (1.08 1.24),2.48E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.16 (1.08 1.24),2.48E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.16 (1.08 1.25),2.48E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.15 (1.08 1.24),2.48E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.16 (1.08 1.25),2.48E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.16 (1.07 1.24),2.83E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.15 (1.07 1.23),2.90E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.16 (1.07 1.24),2.90E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003423,0.126,Nightingale,LDL cholesterol,1.15 (1.07 1.24),3.03E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.15 (1.07 1.24),3.36E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.15 (1.07 1.24),3.53E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.15 (1.07 1.24),3.69E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.14 (1.07 1.23),4.00E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.14 (1.07 1.23),4.01E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.15 (1.07 1.23),4.03E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.14 (1.07 1.23),4.99E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS014782,0.017,RNAseq,DNAJB11,0.88 (0.83 0.94),2.83E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS012608,0.035,RNAseq,SEC11C,0.87 (0.82 0.94),2.95E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS008884,0.092,RNAseq,PLXNB2,1.14 (1.06 1.22),4.15E-02
276.11,Hyperosmolality and/or hypernatremia,endocrine/metabolic,OPGS012787,0.033,RNAseq,FURIN,0.88 (0.82 0.94),4.44E-02
276.12,Hyposmolality and/or hyponatremia,endocrine/metabolic,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.06 (1.04 1.09),4.24E-02
276.12,Hyposmolality and/or hyponatremia,endocrine/metabolic,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.06 (1.03 1.09),4.24E-02
276.12,Hyposmolality and/or hyponatremia,endocrine/metabolic,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.06 (1.03 1.09),4.24E-02
276.12,Hyposmolality and/or hyponatremia,endocrine/metabolic,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.06 (1.03 1.09),4.24E-02
276.12,Hyposmolality and/or hyponatremia,endocrine/metabolic,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.06 (1.03 1.09),4.24E-02
276.12,Hyposmolality and/or hyponatremia,endocrine/metabolic,OPGS000857,0.067,SomaScan,Moesin,1.06 (1.03 1.09),4.24E-02
276.12,Hyposmolality and/or hyponatremia,endocrine/metabolic,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.06 (1.03 1.09),4.24E-02
276.12,Hyposmolality and/or hyponatremia,endocrine/metabolic,OPGS000115,0.347,SomaScan,Protein CEI,1.06 (1.03 1.09),4.24E-02
276.12,Hyposmolality and/or hyponatremia,endocrine/metabolic,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.06 (1.03 1.09),4.24E-02
276.12,Hyposmolality and/or hyponatremia,endocrine/metabolic,OPGS000312,0.163,SomaScan,Selenoprotein S,1.06 (1.03 1.09),4.24E-02
276.12,Hyposmolality and/or hyponatremia,endocrine/metabolic,OPGS006403,0.180,RNAseq,AL356599.1,1.06 (1.03 1.09),4.24E-02
276.12,Hyposmolality and/or hyponatremia,endocrine/metabolic,OPGS014610,0.018,RNAseq,PPAN,1.06 (1.03 1.09),4.24E-02
276.5,Hypovolemia,endocrine/metabolic,OPGS010059,0.068,RNAseq,FCGR3A,0.94 (0.92 0.97),3.51E-02
276.6,Fluid overload,endocrine/metabolic,OPGS002010,0.013,SomaScan,Myc proto-oncogene protein,1.02 (1.01 1.02),2.82E-02
276.8,Polydipsia,endocrine/metabolic,OPGS001003,0.053,SomaScan,Alkaline phosphatase. tissue-nonspecific isozyme,0.76 (0.68 0.84),1.84E-03
277,Other disorders of metabolism,endocrine/metabolic,OPGS000717,0.082,SomaScan,Zinc finger protein 175,1.18 (1.14 1.22),7.28E-22
277,Other disorders of metabolism,endocrine/metabolic,OPGS002186,0.011,SomaScan,Suprabasin,1.17 (1.14 1.21),1.02E-21
277,Other disorders of metabolism,endocrine/metabolic,OPGS001879,0.015,SomaScan,Arfaptin-2,0.85 (0.83 0.88),1.02E-21
277,Other disorders of metabolism,endocrine/metabolic,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,1.16 (1.12 1.20),5.90E-17
277,Other disorders of metabolism,endocrine/metabolic,OPGS001546,0.024,SomaScan,Glypican-6,1.17 (1.13 1.21),1.32E-15
277,Other disorders of metabolism,endocrine/metabolic,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,1.15 (1.11 1.19),7.90E-12
277,Other disorders of metabolism,endocrine/metabolic,OPGS000793,0.074,SomaScan,Lysosomal acid phosphatase,1.14 (1.09 1.18),2.10E-07
277,Other disorders of metabolism,endocrine/metabolic,OPGS000272,0.183,SomaScan,Alpha-1-antitrypsin,0.89 (0.85 0.92),2.37E-06
277,Other disorders of metabolism,endocrine/metabolic,OPGS000159,0.271,SomaScan,39S ribosomal protein L33. mitochondrial,1.13 (1.08 1.17),3.79E-06
277,Other disorders of metabolism,endocrine/metabolic,OPGS000500,0.118,SomaScan,Synaptosomal-associated protein 25,1.11 (1.07 1.16),7.11E-05
277,Other disorders of metabolism,endocrine/metabolic,OPGS000658,0.089,SomaScan,Ubiquitin carboxyl-terminal hydrolase isozyme L1,1.10 (1.06 1.14),2.33E-03
277,Other disorders of metabolism,endocrine/metabolic,OPGS000217,0.216,SomaScan,Neutrophil cytosol factor 2,1.10 (1.06 1.15),5.61E-03
277,Other disorders of metabolism,endocrine/metabolic,OPGS002654,0.015,Olink,Thrombopoietin,1.16 (1.13 1.21),1.51E-14
277,Other disorders of metabolism,endocrine/metabolic,OPGS002529,0.068,Olink,Tumor necrosis factor receptor superfamily member 3,1.12 (1.08 1.16),1.37E-05
277,Other disorders of metabolism,endocrine/metabolic,OPGS010518,0.061,RNAseq,ELF2,1.10 (1.05 1.15),1.43E-02
277,Other disorders of metabolism,endocrine/metabolic,OPGS009928,0.070,RNAseq,PRCP,1.10 (1.05 1.14),2.28E-02
277,Other disorders of metabolism,endocrine/metabolic,OPGS006404,0.180,RNAseq,SNX30,1.09 (1.05 1.14),4.81E-02
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS001707,0.019,SomaScan,Serine/threonine-protein kinase VRK1,1.80 (1.75 1.85),0.00E+00
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS001903,0.015,SomaScan,Tissue Factor,5.02 (4.60 5.48),2.77E-278
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS001953,0.014,SomaScan,Nuclear receptor subfamily 1 group D member 2,4.96 (4.55 5.42),3.15E-276
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS001837,0.016,SomaScan,Testis-specific chromodomain protein Y 1,5.81 (5.27 6.41),2.42E-269
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002003,0.013,SomaScan,Ectonucleoside triphosphate diphosphohydrolase 6,4.26 (3.93 4.62),1.29E-268
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS001556,0.023,SomaScan,Retinol dehydrogenase 16,1.89 (1.83 1.96),4.84E-264
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS001683,0.020,SomaScan,Protein-tyrosine kinase 6,6.44 (5.79 7.16),1.08E-257
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS000499,0.118,SomaScan,Angiopoietin-related protein 1,6.53 (5.87 7.27),2.10E-254
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002216,0.011,SomaScan,Interferon gamma,7.97 (7.02 9.04),1.50E-225
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS000864,0.066,SomaScan,UDP-glucuronosyltransferase 1-6,0.11 (0.10 0.13),7.39E-223
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS003157,0.014,Metabolon,X - 10458,0.20 (0.18 0.22),6.06E-295
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002716,0.242,Metabolon,bilirubin (E.E)*,6.47 (5.84 7.17),2.55E-274
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002737,0.169,Metabolon,succinimide,6.49 (5.85 7.20),2.40E-270
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002719,0.216,Metabolon,X - 21448,6.68 (6.00 7.43),2.21E-264
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002725,0.200,Metabolon,X - 11530,6.51 (5.86 7.23),1.48E-263
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002790,0.100,Metabolon,X - 11442,6.74 (6.06 7.50),2.10E-263
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002718,0.234,Metabolon,bilirubin (Z.Z),6.64 (5.97 7.39),5.55E-263
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002808,0.089,Metabolon,X - 11441,6.75 (6.06 7.51),6.20E-263
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS003169,0.014,Metabolon,X - 21796,6.67 (5.99 7.42),6.92E-263
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002722,0.209,Metabolon,X - 16946,6.73 (6.05 7.50),6.81E-262
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002727,0.198,Metabolon,X - 11522,6.54 (5.88 7.27),2.65E-259
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002717,0.241,Metabolon,biliverdin,6.91 (6.19 7.72),1.96E-257
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002723,0.204,Metabolon,X - 21458,6.84 (6.13 7.63),5.22E-255
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS003166,0.014,Metabolon,thyroxine,0.25 (0.23 0.27),4.26E-250
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS003027,0.026,Metabolon,xanthurenate,1.93 (1.82 2.05),3.20E-104
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS003052,0.023,Metabolon,X - 11880,0.55 (0.51 0.58),6.75E-61
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS003131,0.017,Metabolon,X - 21339,1.23 (1.15 1.33),6.79E-06
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002749,0.146,Metabolon,X - 21441,0.84 (0.78 0.90),1.43E-03
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS002736,0.172,Metabolon,glycocholenate sulfate*,1.17 (1.08 1.26),1.83E-02
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS004972,0.290,RNAseq,USP40,1.34 (1.22 1.46),2.23E-07
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS013759,0.024,RNAseq,ATG16L1,0.83 (0.76 0.91),2.72E-02
277.4,Disorders of bilirubin excretion,endocrine/metabolic,OPGS006278,0.187,RNAseq,ZNF506,1.16 (1.08 1.25),3.09E-02
278.1,Obesity,endocrine/metabolic,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,0.95 (0.94 0.96),2.14E-09
278.1,Obesity,endocrine/metabolic,OPGS000179,0.254,SomaScan,Cardiotrophin-1,0.95 (0.94 0.97),2.74E-09
278.1,Obesity,endocrine/metabolic,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,0.96 (0.94 0.97),6.02E-09
278.1,Obesity,endocrine/metabolic,OPGS000115,0.347,SomaScan,Protein CEI,0.96 (0.94 0.97),6.02E-09
278.1,Obesity,endocrine/metabolic,OPGS000172,0.257,SomaScan,Dermokine,1.04 (1.03 1.06),8.30E-09
278.1,Obesity,endocrine/metabolic,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,0.96 (0.94 0.97),8.36E-09
278.1,Obesity,endocrine/metabolic,OPGS000857,0.067,SomaScan,Moesin,0.96 (0.94 0.97),1.06E-08
278.1,Obesity,endocrine/metabolic,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,0.96 (0.95 0.97),5.67E-08
278.1,Obesity,endocrine/metabolic,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,0.96 (0.94 0.97),6.02E-08
278.1,Obesity,endocrine/metabolic,OPGS002139,0.011,SomaScan,Interleukin-27,0.96 (0.95 0.97),7.55E-08
278.1,Obesity,endocrine/metabolic,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,0.96 (0.95 0.97),1.37E-07
278.1,Obesity,endocrine/metabolic,OPGS001587,0.023,SomaScan,Carboxypeptidase E,0.96 (0.95 0.97),1.38E-07
278.1,Obesity,endocrine/metabolic,OPGS001172,0.040,SomaScan,Apolipoprotein B,0.96 (0.95 0.97),1.44E-07
278.1,Obesity,endocrine/metabolic,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,0.96 (0.95 0.97),2.42E-07
278.1,Obesity,endocrine/metabolic,OPGS000312,0.163,SomaScan,Selenoprotein S,0.96 (0.95 0.97),3.36E-07
278.1,Obesity,endocrine/metabolic,OPGS001162,0.041,SomaScan,Beta-defensin 119,0.96 (0.95 0.97),7.92E-07
278.1,Obesity,endocrine/metabolic,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,1.04 (1.03 1.05),4.02E-06
278.1,Obesity,endocrine/metabolic,OPGS000307,0.164,SomaScan,Apolipoprotein E,0.96 (0.95 0.98),4.08E-06
278.1,Obesity,endocrine/metabolic,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,0.96 (0.95 0.98),1.40E-05
278.1,Obesity,endocrine/metabolic,OPGS000613,0.096,SomaScan,Stromelysin-1,0.97 (0.95 0.98),1.48E-05
278.1,Obesity,endocrine/metabolic,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,1.04 (1.02 1.05),2.13E-05
278.1,Obesity,endocrine/metabolic,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,1.03 (1.02 1.05),2.22E-05
278.1,Obesity,endocrine/metabolic,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,0.97 (0.95 0.98),2.47E-05
278.1,Obesity,endocrine/metabolic,OPGS000632,0.093,SomaScan,Erythrocyte band 7 integral membrane protein,1.04 (1.02 1.05),3.69E-05
278.1,Obesity,endocrine/metabolic,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,0.97 (0.96 0.98),7.52E-05
278.1,Obesity,endocrine/metabolic,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,1.03 (1.02 1.04),9.67E-05
278.1,Obesity,endocrine/metabolic,OPGS000698,0.085,SomaScan,Alcohol dehydrogenase 1B,1.03 (1.02 1.05),1.19E-04
278.1,Obesity,endocrine/metabolic,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,0.97 (0.96 0.98),2.23E-04
278.1,Obesity,endocrine/metabolic,OPGS001238,0.037,SomaScan,Dedicator of cytokinesis protein 9,1.03 (1.02 1.05),2.23E-04
278.1,Obesity,endocrine/metabolic,OPGS001392,0.029,SomaScan,Cadherin-related family member 5,0.97 (0.96 0.98),2.99E-04
278.1,Obesity,endocrine/metabolic,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,0.97 (0.96 0.98),3.57E-04
278.1,Obesity,endocrine/metabolic,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,1.03 (1.02 1.04),3.69E-04
278.1,Obesity,endocrine/metabolic,OPGS002046,0.012,SomaScan,Set1/Ash2 histone methyltransferase complex subunit ASH2,1.03 (1.02 1.04),4.00E-04
278.1,Obesity,endocrine/metabolic,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,1.03 (1.02 1.04),4.34E-04
278.1,Obesity,endocrine/metabolic,OPGS000521,0.113,SomaScan,Transmembrane protease serine 11D,1.03 (1.02 1.04),4.64E-04
278.1,Obesity,endocrine/metabolic,OPGS002108,0.012,SomaScan,Neuralized-like protein 4,0.97 (0.96 0.98),4.64E-04
278.1,Obesity,endocrine/metabolic,OPGS000510,0.115,SomaScan,Guanine nucleotide-binding protein G(k) subunit alpha,1.03 (1.02 1.04),5.85E-04
278.1,Obesity,endocrine/metabolic,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,1.03 (1.02 1.04),6.76E-04
278.1,Obesity,endocrine/metabolic,OPGS001671,0.020,SomaScan,Tumor necrosis factor ligand superfamily member 6. soluble form,0.97 (0.96 0.98),9.26E-04
278.1,Obesity,endocrine/metabolic,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,1.03 (1.02 1.04),1.23E-03
278.1,Obesity,endocrine/metabolic,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,0.97 (0.96 0.98),1.59E-03
278.1,Obesity,endocrine/metabolic,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,0.97 (0.96 0.98),1.76E-03
278.1,Obesity,endocrine/metabolic,OPGS001928,0.014,SomaScan,Sorting nexin-1,1.03 (1.02 1.04),1.82E-03
278.1,Obesity,endocrine/metabolic,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,0.97 (0.96 0.99),2.89E-03
278.1,Obesity,endocrine/metabolic,OPGS000860,0.066,SomaScan,Cell surface glycoprotein CD200 receptor 2,1.03 (1.01 1.04),3.82E-03
278.1,Obesity,endocrine/metabolic,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,1.03 (1.01 1.04),4.07E-03
278.1,Obesity,endocrine/metabolic,OPGS000911,0.062,SomaScan,Protein MENT,0.97 (0.96 0.99),4.42E-03
278.1,Obesity,endocrine/metabolic,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,0.97 (0.96 0.99),5.04E-03
278.1,Obesity,endocrine/metabolic,OPGS001715,0.019,SomaScan,Histone deacetylase 8,0.97 (0.96 0.99),5.54E-03
278.1,Obesity,endocrine/metabolic,OPGS002219,0.011,SomaScan,Zinc finger protein 843,1.03 (1.01 1.04),5.71E-03
278.1,Obesity,endocrine/metabolic,OPGS001058,0.049,SomaScan,Protocadherin beta-10,0.98 (0.96 0.99),7.23E-03
278.1,Obesity,endocrine/metabolic,OPGS000348,0.151,SomaScan,Quinone oxidoreductase-like protein 1,0.98 (0.96 0.99),8.29E-03
278.1,Obesity,endocrine/metabolic,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,0.98 (0.96 0.99),8.71E-03
278.1,Obesity,endocrine/metabolic,OPGS000047,0.511,SomaScan,Cysteine-rich with EGF-like domain protein 1,0.98 (0.96 0.99),8.71E-03
278.1,Obesity,endocrine/metabolic,OPGS000011,0.683,SomaScan,Hepatocyte growth factor-like protein,1.02 (1.01 1.04),1.24E-02
278.1,Obesity,endocrine/metabolic,OPGS001035,0.051,SomaScan,Kallikrein-8,1.02 (1.01 1.04),1.43E-02
278.1,Obesity,endocrine/metabolic,OPGS000553,0.106,SomaScan,Kallikrein-8,1.02 (1.01 1.04),1.59E-02
278.1,Obesity,endocrine/metabolic,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,0.98 (0.96 0.99),1.64E-02
278.1,Obesity,endocrine/metabolic,OPGS000204,0.233,SomaScan,PR domain zinc finger protein 1,1.02 (1.01 1.04),2.14E-02
278.1,Obesity,endocrine/metabolic,OPGS000760,0.077,SomaScan,Inositol monophosphatase 3,0.98 (0.97 0.99),2.14E-02
278.1,Obesity,endocrine/metabolic,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,0.98 (0.96 0.99),2.49E-02
278.1,Obesity,endocrine/metabolic,OPGS000160,0.271,SomaScan,Glypican-5,0.98 (0.97 0.99),2.49E-02
278.1,Obesity,endocrine/metabolic,OPGS000290,0.171,SomaScan,Complement C4,0.98 (0.96 0.99),2.49E-02
278.1,Obesity,endocrine/metabolic,OPGS000356,0.149,SomaScan,Promotilin,1.02 (1.01 1.04),2.49E-02
278.1,Obesity,endocrine/metabolic,OPGS000873,0.065,SomaScan,Tensin-2,1.02 (1.01 1.04),2.85E-02
278.1,Obesity,endocrine/metabolic,OPGS001365,0.030,SomaScan,Leukocyte cell-derived chemotaxin 1,0.98 (0.97 0.99),3.20E-02
278.1,Obesity,endocrine/metabolic,OPGS001121,0.044,SomaScan,Growth factor receptor-bound protein 7,1.02 (1.01 1.04),3.61E-02
278.1,Obesity,endocrine/metabolic,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,0.98 (0.97 0.99),3.83E-02
278.1,Obesity,endocrine/metabolic,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,0.98 (0.97 0.99),3.85E-02
278.1,Obesity,endocrine/metabolic,OPGS000935,0.059,SomaScan,Vitronectin,0.98 (0.97 0.99),4.04E-02
278.1,Obesity,endocrine/metabolic,OPGS000445,0.129,SomaScan,Collectin-10,1.02 (1.01 1.03),4.12E-02
278.1,Obesity,endocrine/metabolic,OPGS001641,0.021,SomaScan,Killer cell lectin-like receptor subfamily F member 1,1.02 (1.01 1.04),4.14E-02
278.1,Obesity,endocrine/metabolic,OPGS000319,0.161,SomaScan,Beta-mannosidase,0.98 (0.97 0.99),4.34E-02
278.1,Obesity,endocrine/metabolic,OPGS002409,0.270,Olink,Glypican-5,0.98 (0.96 0.99),1.80E-02
278.1,Obesity,endocrine/metabolic,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),0.96 (0.95 0.97),4.02E-06
278.1,Obesity,endocrine/metabolic,OPGS003090,0.020,Metabolon,X - 12714,1.03 (1.02 1.05),4.74E-05
278.1,Obesity,endocrine/metabolic,OPGS003170,0.014,Metabolon,X - 13846,1.03 (1.02 1.04),8.10E-04
278.1,Obesity,endocrine/metabolic,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,0.97 (0.96 0.98),1.23E-03
278.1,Obesity,endocrine/metabolic,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),0.97 (0.96 0.99),5.20E-03
278.1,Obesity,endocrine/metabolic,OPGS003006,0.030,Metabolon,cholesterol,0.97 (0.96 0.99),5.54E-03
278.1,Obesity,endocrine/metabolic,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,0.98 (0.96 0.99),7.19E-03
278.1,Obesity,endocrine/metabolic,OPGS003054,0.023,Metabolon,X - 21286,0.98 (0.96 0.99),9.27E-03
278.1,Obesity,endocrine/metabolic,OPGS003204,0.012,Metabolon,X - 18886,1.03 (1.01 1.04),1.03E-02
278.1,Obesity,endocrine/metabolic,OPGS002735,0.174,Metabolon,etiocholanolone glucuronide,1.02 (1.01 1.04),2.78E-02
278.1,Obesity,endocrine/metabolic,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),0.98 (0.97 0.99),3.16E-02
278.1,Obesity,endocrine/metabolic,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,0.96 (0.95 0.98),4.08E-06
278.1,Obesity,endocrine/metabolic,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,0.96 (0.95 0.98),6.42E-06
278.1,Obesity,endocrine/metabolic,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,0.97 (0.95 0.98),1.60E-05
278.1,Obesity,endocrine/metabolic,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,0.97 (0.95 0.98),1.60E-05
278.1,Obesity,endocrine/metabolic,OPGS003423,0.126,Nightingale,LDL cholesterol,0.97 (0.95 0.98),1.62E-05
278.1,Obesity,endocrine/metabolic,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,0.97 (0.95 0.98),2.15E-05
278.1,Obesity,endocrine/metabolic,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,0.97 (0.95 0.98),2.35E-05
278.1,Obesity,endocrine/metabolic,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,0.97 (0.95 0.98),2.68E-05
278.1,Obesity,endocrine/metabolic,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,0.97 (0.95 0.98),2.75E-05
278.1,Obesity,endocrine/metabolic,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,0.97 (0.95 0.98),2.75E-05
278.1,Obesity,endocrine/metabolic,OPGS003428,0.121,Nightingale,Total lipids in small LDL,0.97 (0.95 0.98),2.75E-05
278.1,Obesity,endocrine/metabolic,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,0.97 (0.95 0.98),3.69E-05
278.1,Obesity,endocrine/metabolic,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,0.97 (0.96 0.98),4.62E-05
278.1,Obesity,endocrine/metabolic,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,0.97 (0.96 0.98),4.74E-05
278.1,Obesity,endocrine/metabolic,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,0.97 (0.96 0.98),5.86E-05
278.1,Obesity,endocrine/metabolic,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,0.97 (0.96 0.98),6.46E-05
278.1,Obesity,endocrine/metabolic,OPGS003431,0.118,Nightingale,Total lipids in large LDL,0.97 (0.96 0.98),7.87E-05
278.1,Obesity,endocrine/metabolic,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,0.97 (0.96 0.98),9.08E-05
278.1,Obesity,endocrine/metabolic,OPGS003440,0.106,Nightingale,Cholesterol in IDL,0.97 (0.96 0.98),1.07E-04
278.1,Obesity,endocrine/metabolic,OPGS003439,0.107,Nightingale,Concentration of IDL particles,0.97 (0.96 0.98),1.19E-04
278.1,Obesity,endocrine/metabolic,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,0.97 (0.96 0.98),1.52E-04
278.1,Obesity,endocrine/metabolic,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,0.97 (0.96 0.98),1.80E-04
278.1,Obesity,endocrine/metabolic,OPGS003438,0.109,Nightingale,Total lipids in IDL,0.97 (0.96 0.98),1.96E-04
278.1,Obesity,endocrine/metabolic,OPGS003454,0.087,Nightingale,Total esterified cholesterol,0.97 (0.96 0.98),2.71E-04
278.1,Obesity,endocrine/metabolic,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,0.97 (0.96 0.98),3.27E-04
278.1,Obesity,endocrine/metabolic,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,0.97 (0.96 0.98),3.57E-04
278.1,Obesity,endocrine/metabolic,OPGS003434,0.113,Nightingale,Phospholipids in IDL,0.97 (0.96 0.98),5.85E-04
278.1,Obesity,endocrine/metabolic,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,0.97 (0.96 0.98),7.39E-04
278.1,Obesity,endocrine/metabolic,OPGS003444,0.101,Nightingale,Apolipoprotein B,0.97 (0.96 0.98),8.88E-04
278.1,Obesity,endocrine/metabolic,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,0.97 (0.96 0.98),1.20E-03
278.1,Obesity,endocrine/metabolic,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,0.97 (0.96 0.98),1.23E-03
278.1,Obesity,endocrine/metabolic,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,0.97 (0.96 0.98),1.31E-03
278.1,Obesity,endocrine/metabolic,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,0.97 (0.96 0.98),1.53E-03
278.1,Obesity,endocrine/metabolic,OPGS003452,0.087,Nightingale,Total cholesterol,0.97 (0.96 0.98),1.55E-03
278.1,Obesity,endocrine/metabolic,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,0.97 (0.96 0.99),2.56E-03
278.1,Obesity,endocrine/metabolic,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,0.97 (0.96 0.99),3.13E-03
278.1,Obesity,endocrine/metabolic,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,0.97 (0.96 0.99),3.13E-03
278.1,Obesity,endocrine/metabolic,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,0.97 (0.96 0.99),5.54E-03
278.1,Obesity,endocrine/metabolic,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,0.97 (0.96 0.99),6.63E-03
278.1,Obesity,endocrine/metabolic,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,0.97 (0.96 0.99),7.59E-03
278.1,Obesity,endocrine/metabolic,OPGS003523,0.062,Nightingale,Total fatty acids,0.98 (0.96 0.99),9.57E-03
278.1,Obesity,endocrine/metabolic,OPGS003497,0.072,Nightingale,Linoleic acid,0.98 (0.96 0.99),1.57E-02
278.1,Obesity,endocrine/metabolic,OPGS003488,0.074,Nightingale,VLDL cholesterol,0.98 (0.96 0.99),1.67E-02
278.1,Obesity,endocrine/metabolic,OPGS003455,0.087,Nightingale,Total free cholesterol,0.98 (0.96 0.99),1.99E-02
278.1,Obesity,endocrine/metabolic,OPGS003525,0.052,Nightingale,Saturated fatty acids,0.98 (0.97 0.99),3.16E-02
278.1,Obesity,endocrine/metabolic,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,1.02 (1.01 1.04),3.97E-02
278.1,Obesity,endocrine/metabolic,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,0.98 (0.97 0.99),4.67E-02
278.1,Obesity,endocrine/metabolic,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,0.98 (0.97 0.99),4.91E-02
278.1,Obesity,endocrine/metabolic,OPGS004125,0.429,RNAseq,UHRF1BP1,1.04 (1.03 1.05),4.07E-07
278.1,Obesity,endocrine/metabolic,OPGS014859,0.017,RNAseq,AC104452.1,0.96 (0.95 0.98),4.08E-06
278.1,Obesity,endocrine/metabolic,OPGS011291,0.050,RNAseq,GMPPB,1.04 (1.02 1.05),6.37E-06
278.1,Obesity,endocrine/metabolic,OPGS005289,0.258,RNAseq,UBA7,0.96 (0.95 0.98),8.74E-06
278.1,Obesity,endocrine/metabolic,OPGS012717,0.033,RNAseq,GBP4,0.97 (0.95 0.98),1.60E-05
278.1,Obesity,endocrine/metabolic,OPGS003625,0.664,RNAseq,,0.97 (0.95 0.98),2.22E-05
278.1,Obesity,endocrine/metabolic,OPGS013425,0.027,RNAseq,SLC25A44,0.97 (0.96 0.98),3.91E-05
278.1,Obesity,endocrine/metabolic,OPGS004949,0.293,RNAseq,ILRUN,1.03 (1.02 1.05),4.62E-05
278.1,Obesity,endocrine/metabolic,OPGS003644,0.643,RNAseq,KANSL1-AS1,1.03 (1.02 1.05),6.35E-05
278.1,Obesity,endocrine/metabolic,OPGS014489,0.019,RNAseq,AP002381.2,1.03 (1.02 1.05),1.80E-04
278.1,Obesity,endocrine/metabolic,OPGS005353,0.251,RNAseq,WWP2,1.03 (1.02 1.04),2.25E-04
278.1,Obesity,endocrine/metabolic,OPGS013630,0.025,RNAseq,AC134407.2,1.03 (1.02 1.04),3.78E-04
278.1,Obesity,endocrine/metabolic,OPGS014954,0.016,RNAseq,MRTFB,0.97 (0.96 0.98),6.86E-04
278.1,Obesity,endocrine/metabolic,OPGS007588,0.129,RNAseq,FANCL,1.03 (1.02 1.04),8.19E-04
278.1,Obesity,endocrine/metabolic,OPGS012628,0.034,RNAseq,RMC1,0.97 (0.96 0.98),8.80E-04
278.1,Obesity,endocrine/metabolic,OPGS004224,0.407,RNAseq,SVBP,1.03 (1.02 1.04),1.22E-03
278.1,Obesity,endocrine/metabolic,OPGS003943,0.486,RNAseq,CLEC18A,0.97 (0.96 0.98),1.23E-03
278.1,Obesity,endocrine/metabolic,OPGS005595,0.230,RNAseq,SGF29,0.97 (0.96 0.98),1.42E-03
278.1,Obesity,endocrine/metabolic,OPGS009228,0.085,RNAseq,SNRPC,0.97 (0.96 0.98),1.59E-03
278.1,Obesity,endocrine/metabolic,OPGS005059,0.281,RNAseq,STIM2,1.03 (1.02 1.04),1.76E-03
278.1,Obesity,endocrine/metabolic,OPGS009320,0.083,RNAseq,ARG2,1.03 (1.02 1.04),2.20E-03
278.1,Obesity,endocrine/metabolic,OPGS013141,0.029,RNAseq,RPS10,1.03 (1.01 1.04),2.24E-03
278.1,Obesity,endocrine/metabolic,OPGS008177,0.110,RNAseq,Z95118.2,1.03 (1.02 1.04),2.24E-03
278.1,Obesity,endocrine/metabolic,OPGS006391,0.181,RNAseq,GTF2I,1.03 (1.02 1.04),2.27E-03
278.1,Obesity,endocrine/metabolic,OPGS005211,0.265,RNAseq,SULT1A2,1.03 (1.01 1.04),2.41E-03
278.1,Obesity,endocrine/metabolic,OPGS009426,0.081,RNAseq,SLC4A2,1.03 (1.01 1.04),3.13E-03
278.1,Obesity,endocrine/metabolic,OPGS006265,0.188,RNAseq,RBM6,0.97 (0.96 0.99),3.13E-03
278.1,Obesity,endocrine/metabolic,OPGS012137,0.040,RNAseq,TIMM17A,1.03 (1.01 1.04),4.07E-03
278.1,Obesity,endocrine/metabolic,OPGS012251,0.039,RNAseq,BHLHE40-AS1,0.97 (0.96 0.99),4.72E-03
278.1,Obesity,endocrine/metabolic,OPGS007376,0.137,RNAseq,ZBTB7B,0.97 (0.96 0.99),4.76E-03
278.1,Obesity,endocrine/metabolic,OPGS012683,0.034,RNAseq,RPL22L1,1.03 (1.01 1.04),5.09E-03
278.1,Obesity,endocrine/metabolic,OPGS009758,0.074,RNAseq,ADARB1,1.03 (1.01 1.04),5.16E-03
278.1,Obesity,endocrine/metabolic,OPGS005184,0.268,RNAseq,TUFM,1.03 (1.01 1.04),5.23E-03
278.1,Obesity,endocrine/metabolic,OPGS009606,0.077,RNAseq,SAE1,0.97 (0.96 0.99),5.72E-03
278.1,Obesity,endocrine/metabolic,OPGS012732,0.033,RNAseq,AF165147.1,0.97 (0.96 0.99),5.72E-03
278.1,Obesity,endocrine/metabolic,OPGS004864,0.303,RNAseq,TMEM80,1.03 (1.01 1.04),6.50E-03
278.1,Obesity,endocrine/metabolic,OPGS005300,0.257,RNAseq,AF131215.6,1.03 (1.01 1.04),6.59E-03
278.1,Obesity,endocrine/metabolic,OPGS006039,0.201,RNAseq,TRIP12,0.97 (0.96 0.99),7.91E-03
278.1,Obesity,endocrine/metabolic,OPGS007829,0.121,RNAseq,,1.03 (1.01 1.04),7.93E-03
278.1,Obesity,endocrine/metabolic,OPGS010782,0.057,RNAseq,PRUNE1,1.02 (1.01 1.04),8.00E-03
278.1,Obesity,endocrine/metabolic,OPGS012786,0.033,RNAseq,PLAGL2,0.98 (0.96 0.99),8.71E-03
278.1,Obesity,endocrine/metabolic,OPGS013868,0.023,RNAseq,CRELD1,1.03 (1.01 1.04),9.58E-03
278.1,Obesity,endocrine/metabolic,OPGS009303,0.083,RNAseq,EBLN3P,1.03 (1.01 1.04),9.63E-03
278.1,Obesity,endocrine/metabolic,OPGS012455,0.036,RNAseq,EIF5A2,0.98 (0.96 0.99),1.02E-02
278.1,Obesity,endocrine/metabolic,OPGS005037,0.283,RNAseq,RWDD2B,0.98 (0.96 0.99),1.02E-02
278.1,Obesity,endocrine/metabolic,OPGS005704,0.221,RNAseq,AF131215.5,1.03 (1.01 1.04),1.03E-02
278.1,Obesity,endocrine/metabolic,OPGS009970,0.070,RNAseq,CLDN23,1.03 (1.01 1.04),1.04E-02
278.1,Obesity,endocrine/metabolic,OPGS004300,0.389,RNAseq,PLCL1,0.98 (0.96 0.99),1.08E-02
278.1,Obesity,endocrine/metabolic,OPGS008033,0.115,RNAseq,SGCB,0.98 (0.96 0.99),1.20E-02
278.1,Obesity,endocrine/metabolic,OPGS013966,0.023,RNAseq,PLA2G12A,1.02 (1.01 1.04),1.25E-02
278.1,Obesity,endocrine/metabolic,OPGS012496,0.036,RNAseq,NT5DC4,1.02 (1.01 1.04),1.28E-02
278.1,Obesity,endocrine/metabolic,OPGS010692,0.058,RNAseq,IPO9,0.98 (0.96 0.99),1.35E-02
278.1,Obesity,endocrine/metabolic,OPGS012458,0.036,RNAseq,PRAG1,1.02 (1.01 1.04),1.57E-02
278.1,Obesity,endocrine/metabolic,OPGS011739,0.044,RNAseq,DHX36,0.98 (0.96 0.99),1.67E-02
278.1,Obesity,endocrine/metabolic,OPGS009978,0.070,RNAseq,C3orf38,1.02 (1.01 1.04),1.74E-02
278.1,Obesity,endocrine/metabolic,OPGS008559,0.100,RNAseq,AC125232.2,1.02 (1.01 1.04),1.74E-02
278.1,Obesity,endocrine/metabolic,OPGS006081,0.199,RNAseq,BRK1,0.98 (0.96 0.99),1.78E-02
278.1,Obesity,endocrine/metabolic,OPGS012898,0.032,RNAseq,COA8,1.02 (1.01 1.04),1.79E-02
278.1,Obesity,endocrine/metabolic,OPGS011636,0.045,RNAseq,LIN7C,1.02 (1.01 1.04),1.79E-02
278.1,Obesity,endocrine/metabolic,OPGS010434,0.062,RNAseq,RAPGEF6,0.98 (0.96 0.99),1.88E-02
278.1,Obesity,endocrine/metabolic,OPGS008888,0.092,RNAseq,AC016355.1,1.02 (1.01 1.04),1.95E-02
278.1,Obesity,endocrine/metabolic,OPGS007915,0.118,RNAseq,IGSF9B,1.02 (1.01 1.04),2.02E-02
278.1,Obesity,endocrine/metabolic,OPGS004110,0.434,RNAseq,TBC1D9B,0.98 (0.96 0.99),2.04E-02
278.1,Obesity,endocrine/metabolic,OPGS008960,0.091,RNAseq,KLHDC8B,0.98 (0.97 0.99),2.17E-02
278.1,Obesity,endocrine/metabolic,OPGS013170,0.029,RNAseq,N4BP2L2,0.98 (0.96 0.99),2.19E-02
278.1,Obesity,endocrine/metabolic,OPGS010657,0.059,RNAseq,HMG20A,1.02 (1.01 1.04),2.51E-02
278.1,Obesity,endocrine/metabolic,OPGS013049,0.030,RNAseq,,0.98 (0.96 0.99),2.55E-02
278.1,Obesity,endocrine/metabolic,OPGS011683,0.045,RNAseq,ZCCHC7,1.02 (1.01 1.04),2.60E-02
278.1,Obesity,endocrine/metabolic,OPGS012794,0.033,RNAseq,PRR14,0.98 (0.97 0.99),2.68E-02
278.1,Obesity,endocrine/metabolic,OPGS009220,0.085,RNAseq,SH2D4A,0.98 (0.96 0.99),2.69E-02
278.1,Obesity,endocrine/metabolic,OPGS004583,0.342,RNAseq,VCL,0.98 (0.97 0.99),2.85E-02
278.1,Obesity,endocrine/metabolic,OPGS011007,0.054,RNAseq,,0.98 (0.97 0.99),2.97E-02
278.1,Obesity,endocrine/metabolic,OPGS006610,0.170,RNAseq,,1.02 (1.01 1.04),2.98E-02
278.1,Obesity,endocrine/metabolic,OPGS007881,0.119,RNAseq,TEX261,1.02 (1.01 1.04),2.98E-02
278.1,Obesity,endocrine/metabolic,OPGS005414,0.245,RNAseq,MAP2K5,1.02 (1.01 1.04),2.98E-02
278.1,Obesity,endocrine/metabolic,OPGS004779,0.312,RNAseq,FSBP,0.98 (0.97 0.99),2.98E-02
278.1,Obesity,endocrine/metabolic,OPGS004717,0.321,RNAseq,ARNTL,0.98 (0.97 0.99),2.98E-02
278.1,Obesity,endocrine/metabolic,OPGS005796,0.215,RNAseq,,1.02 (1.01 1.04),3.10E-02
278.1,Obesity,endocrine/metabolic,OPGS006209,0.191,RNAseq,CA8,1.02 (1.01 1.04),3.10E-02
278.1,Obesity,endocrine/metabolic,OPGS011185,0.051,RNAseq,GTF2F1,1.02 (1.01 1.04),3.35E-02
278.1,Obesity,endocrine/metabolic,OPGS008278,0.107,RNAseq,DPEP3,1.02 (1.01 1.04),3.72E-02
278.1,Obesity,endocrine/metabolic,OPGS012738,0.033,RNAseq,TAF4B,0.98 (0.97 0.99),3.83E-02
278.1,Obesity,endocrine/metabolic,OPGS008919,0.091,RNAseq,ARL1,1.02 (1.01 1.04),3.83E-02
278.1,Obesity,endocrine/metabolic,OPGS013542,0.026,RNAseq,SMILR,0.98 (0.97 0.99),4.02E-02
278.1,Obesity,endocrine/metabolic,OPGS011229,0.051,RNAseq,PLCB3,0.98 (0.96 0.99),4.03E-02
278.1,Obesity,endocrine/metabolic,OPGS003900,0.507,RNAseq,NEGR1,1.02 (1.01 1.04),4.04E-02
278.1,Obesity,endocrine/metabolic,OPGS011494,0.047,RNAseq,RNF26,1.02 (1.01 1.04),4.04E-02
278.1,Obesity,endocrine/metabolic,OPGS008599,0.099,RNAseq,UBE2Q2,1.02 (1.01 1.04),4.15E-02
278.1,Obesity,endocrine/metabolic,OPGS007326,0.138,RNAseq,HECW2,0.98 (0.97 0.99),4.27E-02
278.1,Obesity,endocrine/metabolic,OPGS009218,0.085,RNAseq,EIF3CL,1.02 (1.01 1.04),4.50E-02
278.1,Obesity,endocrine/metabolic,OPGS009760,0.074,RNAseq,DNAJC27,0.98 (0.97 0.99),4.63E-02
278.1,Obesity,endocrine/metabolic,OPGS006608,0.170,RNAseq,MFHAS1,1.02 (1.01 1.03),4.69E-02
278.1,Obesity,endocrine/metabolic,OPGS008500,0.102,RNAseq,FGFBP2,0.98 (0.97 0.99),4.74E-02
278.1,Obesity,endocrine/metabolic,OPGS008431,0.103,RNAseq,DANCR,1.02 (1.01 1.03),4.80E-02
278.1,Obesity,endocrine/metabolic,OPGS009285,0.084,RNAseq,AC022916.2,1.02 (1.01 1.03),4.91E-02
278.1,Obesity,endocrine/metabolic,OPGS005387,0.248,RNAseq,CCNL1,1.02 (1.01 1.03),4.93E-02
278.1,Obesity,endocrine/metabolic,OPGS012753,0.033,RNAseq,BNIP3,1.02 (1.01 1.04),4.95E-02
279.7,Other immunological findings,endocrine/metabolic,OPGS000290,0.171,SomaScan,Complement C4,0.79 (0.71 0.88),4.22E-02
279.7,Other immunological findings,endocrine/metabolic,OPGS007675,0.126,RNAseq,TRAV12-2,1.29 (1.17 1.43),5.90E-03
279.7,Other immunological findings,endocrine/metabolic,OPGS012005,0.041,RNAseq,EML2,1.45 (1.25 1.68),1.08E-02
279.7,Other immunological findings,endocrine/metabolic,OPGS013045,0.030,RNAseq,NEU1,0.79 (0.72 0.88),2.77E-02
279.7,Other immunological findings,endocrine/metabolic,OPGS006845,0.158,RNAseq,FLOT1,1.25 (1.13 1.38),3.54E-02
279.7,Other immunological findings,endocrine/metabolic,OPGS010693,0.058,RNAseq,TRBV5-1,1.25 (1.13 1.38),3.59E-02
279.7,Other immunological findings,endocrine/metabolic,OPGS008911,0.092,RNAseq,C5orf63,0.79 (0.71 0.88),4.22E-02
279.7,Other immunological findings,endocrine/metabolic,OPGS010607,0.059,RNAseq,TRAV8-1,1.25 (1.13 1.38),4.23E-02
279.7,Other immunological findings,endocrine/metabolic,OPGS005230,0.263,RNAseq,LINC00243,1.25 (1.13 1.39),4.38E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS000969,0.056,SomaScan,Transferrin receptor protein 1,1.05 (1.03 1.07),1.45E-04
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.04 (1.02 1.06),2.43E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.96 (0.94 0.98),2.63E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.04 (1.02 1.06),5.11E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS001812,0.017,SomaScan,Fibroblast growth factor 19,0.96 (0.95 0.98),9.49E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.04 (1.02 1.05),9.55E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.04 (1.02 1.05),1.01E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.97 (0.95 0.98),1.21E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS000984,0.055,SomaScan,Complement C2,1.04 (1.02 1.05),1.21E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS001550,0.024,SomaScan,Trefoil factor 3,0.96 (0.95 0.98),1.40E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS001955,0.014,SomaScan,Protein delta homolog 2,1.03 (1.02 1.04),1.98E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS002270,0.010,SomaScan,Tumor necrosis factor receptor superfamily member 21,0.96 (0.94 0.98),1.98E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS002292,0.010,SomaScan,Interleukin-18-binding protein,0.96 (0.94 0.98),1.98E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.97 (0.95 0.98),1.98E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS000517,0.114,SomaScan,Advanced glycosylation end product-specific receptor. soluble,0.97 (0.95 0.98),2.16E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.97 (0.95 0.98),2.75E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS001095,0.046,SomaScan,tRNA (guanine-N(7)-)-methyltransferase,0.97 (0.95 0.98),3.12E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.97 (0.95 0.98),3.47E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.97 (0.95 0.98),3.99E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.97 (0.95 0.98),4.18E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS000908,0.062,SomaScan,Bone sialoprotein 2,1.03 (1.02 1.05),4.34E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS002557,0.050,Olink,Epithelial cell adhesion molecule,0.97 (0.95 0.98),1.98E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS002657,0.013,Olink,Fibroblast growth factor 19,0.97 (0.95 0.99),4.34E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS003054,0.023,Metabolon,X - 21286,0.96 (0.95 0.98),9.55E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS003190,0.012,Metabolon,3-methylxanthine,1.03 (1.02 1.05),4.34E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.03 (1.02 1.05),2.11E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS013243,0.029,RNAseq,TRAV3,0.95 (0.93 0.96),4.60E-06
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS006499,0.176,RNAseq,C4A,0.95 (0.94 0.97),1.23E-04
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.05 (1.03 1.07),1.45E-04
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS007675,0.126,RNAseq,TRAV12-2,1.05 (1.03 1.06),2.57E-04
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS006038,0.201,RNAseq,HLA-DQA2,1.04 (1.03 1.06),4.45E-04
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS009865,0.072,RNAseq,TRAV17,0.96 (0.95 0.98),3.86E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS004940,0.294,RNAseq,CNOT2-DT,1.04 (1.02 1.06),4.64E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS011536,0.047,RNAseq,TRAV2,0.96 (0.95 0.98),4.64E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.96 (0.95 0.98),4.92E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS010624,0.059,RNAseq,TRBV18,1.04 (1.02 1.06),5.31E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS009225,0.085,RNAseq,CD5,0.96 (0.95 0.98),5.45E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS012171,0.039,RNAseq,TRBV15,0.96 (0.95 0.98),5.83E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS013990,0.023,RNAseq,UQCR10,1.04 (1.02 1.06),9.55E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS006845,0.158,RNAseq,FLOT1,1.04 (1.02 1.05),9.55E-03
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS012043,0.041,RNAseq,RPS6KB1,1.04 (1.02 1.05),1.01E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS009268,0.084,RNAseq,OAZ1,1.04 (1.02 1.05),1.53E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS006716,0.164,RNAseq,IER3,1.04 (1.02 1.05),1.62E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS006866,0.157,RNAseq,AL662795.2,1.03 (1.02 1.05),1.98E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS014283,0.021,RNAseq,MXRA8,0.97 (0.95 0.98),2.11E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS004712,0.322,RNAseq,CFAP410,0.97 (0.95 0.98),2.80E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS006942,0.154,RNAseq,SKIV2L,0.97 (0.95 0.98),2.83E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS006048,0.200,RNAseq,,0.97 (0.95 0.98),3.12E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS007002,0.152,RNAseq,,1.03 (1.02 1.05),3.29E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS007550,0.130,RNAseq,SORD,0.97 (0.95 0.98),3.33E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS004448,0.364,RNAseq,,1.03 (1.02 1.05),3.40E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS006478,0.176,RNAseq,RNFT1,0.97 (0.95 0.98),3.47E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS014496,0.019,RNAseq,VARS1,1.03 (1.02 1.05),3.48E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS013298,0.028,RNAseq,IL7R,0.97 (0.95 0.98),3.78E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS008976,0.090,RNAseq,EDEM3,0.97 (0.95 0.98),3.78E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS008947,0.091,RNAseq,LBH,1.03 (1.02 1.05),3.88E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS007858,0.120,RNAseq,DRC1,0.97 (0.95 0.99),4.19E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS014580,0.018,RNAseq,DACT1,1.03 (1.02 1.05),4.34E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS003680,0.611,RNAseq,,1.03 (1.01 1.05),4.61E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS005230,0.263,RNAseq,LINC00243,1.03 (1.01 1.05),4.69E-02
280.1,Iron deficiency anemias. unspecified or not due to blood loss,hematopoietic,OPGS007145,0.146,RNAseq,BAG6,1.03 (1.01 1.05),4.87E-02
280.2,Iron deficiency anemia secondary to blood loss (chronic),hematopoietic,OPGS009341,0.083,RNAseq,TMEM161A,0.87 (0.82 0.92),3.28E-02
281.11,Pernicious anemia,hematopoietic,OPGS000649,0.091,SomaScan,Transcobalamin-1,0.87 (0.83 0.92),6.55E-03
281.11,Pernicious anemia,hematopoietic,OPGS002568,0.043,Olink,Granzyme A,0.89 (0.84 0.94),4.87E-02
281.11,Pernicious anemia,hematopoietic,OPGS012006,0.041,RNAseq,VARS2,0.87 (0.82 0.91),4.56E-03
281.11,Pernicious anemia,hematopoietic,OPGS013958,0.023,RNAseq,CSNK2B,1.15 (1.09 1.22),1.26E-02
281.11,Pernicious anemia,hematopoietic,OPGS015052,0.015,RNAseq,CISH,1.15 (1.08 1.21),1.53E-02
281.11,Pernicious anemia,hematopoietic,OPGS010293,0.064,RNAseq,,1.11 (1.06 1.16),1.59E-02
281.11,Pernicious anemia,hematopoietic,OPGS011431,0.048,RNAseq,VWA7,1.14 (1.08 1.21),2.39E-02
281.11,Pernicious anemia,hematopoietic,OPGS007297,0.140,RNAseq,GPANK1,0.87 (0.82 0.93),2.68E-02
281.11,Pernicious anemia,hematopoietic,OPGS013514,0.026,RNAseq,GZMK,0.89 (0.84 0.94),4.87E-02
282.5,Sickle cell anemia,hematopoietic,OPGS002250,0.010,SomaScan,Tyrosine-protein kinase ZAP-70,0.47 (0.35 0.64),1.71E-02
285,Other anemias,hematopoietic,OPGS000969,0.056,SomaScan,Transferrin receptor protein 1,1.05 (1.04 1.07),7.96E-09
285,Other anemias,hematopoietic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.05 (1.03 1.06),3.69E-07
285,Other anemias,hematopoietic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.04 (1.03 1.06),4.97E-06
285,Other anemias,hematopoietic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.96 (0.95 0.97),3.93E-05
285,Other anemias,hematopoietic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.96 (0.95 0.98),8.75E-05
285,Other anemias,hematopoietic,OPGS000984,0.055,SomaScan,Complement C2,1.04 (1.02 1.05),1.24E-04
285,Other anemias,hematopoietic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.96 (0.95 0.98),1.73E-04
285,Other anemias,hematopoietic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.96 (0.95 0.98),2.12E-04
285,Other anemias,hematopoietic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.97 (0.95 0.98),3.83E-04
285,Other anemias,hematopoietic,OPGS000885,0.064,SomaScan,Dipeptidase 2,1.04 (1.02 1.05),4.45E-04
285,Other anemias,hematopoietic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.03 (1.02 1.05),9.36E-04
285,Other anemias,hematopoietic,OPGS001337,0.032,SomaScan,Cholecystokinin,1.03 (1.02 1.05),1.77E-03
285,Other anemias,hematopoietic,OPGS000150,0.284,SomaScan,Plasma kallikrein,0.97 (0.95 0.98),2.73E-03
285,Other anemias,hematopoietic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.97 (0.95 0.98),2.96E-03
285,Other anemias,hematopoietic,OPGS000670,0.088,SomaScan,Glutathione S-transferase A1,0.97 (0.96 0.98),3.98E-03
285,Other anemias,hematopoietic,OPGS000790,0.074,SomaScan,Laminin subunit alpha-4,1.03 (1.02 1.05),4.05E-03
285,Other anemias,hematopoietic,OPGS000237,0.200,SomaScan,Transmembrane protein 87B,1.03 (1.02 1.05),4.60E-03
285,Other anemias,hematopoietic,OPGS000563,0.104,SomaScan,Liver-expressed antimicrobial peptide 2,1.03 (1.02 1.05),5.09E-03
285,Other anemias,hematopoietic,OPGS001257,0.036,SomaScan,Glucagon,1.03 (1.02 1.05),5.35E-03
285,Other anemias,hematopoietic,OPGS000795,0.074,SomaScan,Plasma serine protease inhibitor,1.03 (1.02 1.05),7.09E-03
285,Other anemias,hematopoietic,OPGS000910,0.062,SomaScan,Neurexin-1,1.03 (1.02 1.05),8.30E-03
285,Other anemias,hematopoietic,OPGS001231,0.037,SomaScan,Osteocalcin,1.03 (1.02 1.05),8.30E-03
285,Other anemias,hematopoietic,OPGS000925,0.060,SomaScan,Plexin domain-containing protein 1,1.03 (1.02 1.04),8.79E-03
285,Other anemias,hematopoietic,OPGS000290,0.171,SomaScan,Complement C4,0.97 (0.96 0.98),1.02E-02
285,Other anemias,hematopoietic,OPGS000960,0.057,SomaScan,Cadherin-15,1.03 (1.02 1.04),1.06E-02
285,Other anemias,hematopoietic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.03 (1.02 1.04),1.09E-02
285,Other anemias,hematopoietic,OPGS000710,0.082,SomaScan,Thrombin,0.97 (0.96 0.98),1.14E-02
285,Other anemias,hematopoietic,OPGS001574,0.023,SomaScan,Keratin-associated protein 2-4,1.03 (1.02 1.04),1.15E-02
285,Other anemias,hematopoietic,OPGS001059,0.049,SomaScan,Inter-alpha-trypsin inhibitor heavy chain H4,1.03 (1.02 1.04),1.32E-02
285,Other anemias,hematopoietic,OPGS000844,0.068,SomaScan,Growth/differentiation factor 2,0.97 (0.96 0.99),1.47E-02
285,Other anemias,hematopoietic,OPGS001798,0.017,SomaScan,Bone sialoprotein 2,1.03 (1.01 1.04),1.49E-02
285,Other anemias,hematopoietic,OPGS001294,0.034,SomaScan,Peroxidasin homolog,1.03 (1.01 1.04),1.98E-02
285,Other anemias,hematopoietic,OPGS000879,0.065,SomaScan,Natural cytotoxicity triggering receptor 3,1.03 (1.01 1.04),2.05E-02
285,Other anemias,hematopoietic,OPGS000123,0.339,SomaScan,GDH/6PGL endoplasmic bifunctional protein,0.97 (0.96 0.99),2.09E-02
285,Other anemias,hematopoietic,OPGS001191,0.039,SomaScan,Progonadoliberin-1,1.03 (1.01 1.04),2.41E-02
285,Other anemias,hematopoietic,OPGS001721,0.019,SomaScan,Chromogranin-A,1.03 (1.01 1.04),2.67E-02
285,Other anemias,hematopoietic,OPGS000888,0.064,SomaScan,Glucosidase 2 subunit beta,0.97 (0.96 0.99),2.71E-02
285,Other anemias,hematopoietic,OPGS001427,0.028,SomaScan,Alpha-2-macroglobulin,0.97 (0.96 0.99),2.96E-02
285,Other anemias,hematopoietic,OPGS001487,0.026,SomaScan,Interleukin-2,0.97 (0.96 0.99),3.03E-02
285,Other anemias,hematopoietic,OPGS001824,0.016,SomaScan,ADM2,1.03 (1.01 1.04),3.16E-02
285,Other anemias,hematopoietic,OPGS001084,0.047,SomaScan,Activating signal cointegrator 1 complex subunit 1,0.97 (0.96 0.99),3.25E-02
285,Other anemias,hematopoietic,OPGS000570,0.103,SomaScan,Complement decay-accelerating factor,1.03 (1.01 1.04),3.77E-02
285,Other anemias,hematopoietic,OPGS000719,0.081,SomaScan,Parathyroid hormone-related protein,1.03 (1.01 1.04),4.04E-02
285,Other anemias,hematopoietic,OPGS001779,0.018,SomaScan,Histatin-3,1.03 (1.01 1.04),4.05E-02
285,Other anemias,hematopoietic,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.96 (0.95 0.98),2.09E-04
285,Other anemias,hematopoietic,OPGS002510,0.085,Olink,Bone morphogenetic protein 6,1.03 (1.02 1.05),1.48E-03
285,Other anemias,hematopoietic,OPGS002592,0.035,Olink,Vascular endothelial growth factor D,0.97 (0.96 0.98),6.58E-03
285,Other anemias,hematopoietic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.97 (0.96 0.99),1.66E-02
285,Other anemias,hematopoietic,OPGS002479,0.127,Olink,Growth/differentiation factor 2,0.97 (0.96 0.99),1.98E-02
285,Other anemias,hematopoietic,OPGS002540,0.062,Olink,Plexin-B1,0.97 (0.96 0.99),3.03E-02
285,Other anemias,hematopoietic,OPGS003054,0.023,Metabolon,X - 21286,0.97 (0.95 0.98),9.58E-04
285,Other anemias,hematopoietic,OPGS002742,0.161,Metabolon,bradykinin,0.97 (0.96 0.98),4.25E-03
285,Other anemias,hematopoietic,OPGS002726,0.198,Metabolon,methionylalanine,0.97 (0.96 0.98),6.58E-03
285,Other anemias,hematopoietic,OPGS002794,0.099,Metabolon,X - 14095,0.97 (0.96 0.99),1.66E-02
285,Other anemias,hematopoietic,OPGS003029,0.026,Metabolon,docosatrienoate (22:3n3),0.97 (0.96 0.99),3.54E-02
285,Other anemias,hematopoietic,OPGS002767,0.127,Metabolon,phenylalanylarginine,0.97 (0.96 0.99),4.38E-02
285,Other anemias,hematopoietic,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.03 (1.01 1.04),4.57E-02
285,Other anemias,hematopoietic,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.03 (1.02 1.04),1.44E-02
285,Other anemias,hematopoietic,OPGS003550,0.015,Nightingale,Phenylalanine,0.97 (0.96 0.99),1.57E-02
285,Other anemias,hematopoietic,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.03 (1.01 1.04),2.17E-02
285,Other anemias,hematopoietic,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.03 (1.01 1.04),3.57E-02
285,Other anemias,hematopoietic,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.03 (1.01 1.04),3.57E-02
285,Other anemias,hematopoietic,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.03 (1.01 1.04),3.86E-02
285,Other anemias,hematopoietic,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.03 (1.01 1.04),4.87E-02
285,Other anemias,hematopoietic,OPGS013243,0.029,RNAseq,TRAV3,0.95 (0.93 0.96),2.94E-10
285,Other anemias,hematopoietic,OPGS009865,0.072,RNAseq,TRAV17,0.95 (0.94 0.97),2.18E-07
285,Other anemias,hematopoietic,OPGS006499,0.176,RNAseq,C4A,0.96 (0.94 0.97),1.89E-06
285,Other anemias,hematopoietic,OPGS007675,0.126,RNAseq,TRAV12-2,1.04 (1.03 1.06),2.34E-06
285,Other anemias,hematopoietic,OPGS003680,0.611,RNAseq,,1.04 (1.03 1.05),4.96E-05
285,Other anemias,hematopoietic,OPGS006845,0.158,RNAseq,FLOT1,1.04 (1.02 1.05),8.37E-05
285,Other anemias,hematopoietic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.96 (0.95 0.98),8.64E-05
285,Other anemias,hematopoietic,OPGS014496,0.019,RNAseq,VARS1,1.04 (1.02 1.05),1.56E-04
285,Other anemias,hematopoietic,OPGS010624,0.059,RNAseq,TRBV18,1.04 (1.02 1.05),1.56E-04
285,Other anemias,hematopoietic,OPGS005230,0.263,RNAseq,LINC00243,1.04 (1.02 1.05),2.12E-04
285,Other anemias,hematopoietic,OPGS012171,0.039,RNAseq,TRBV15,0.97 (0.95 0.98),9.00E-04
285,Other anemias,hematopoietic,OPGS005334,0.253,RNAseq,AL645933.4,0.97 (0.95 0.98),2.04E-03
285,Other anemias,hematopoietic,OPGS006716,0.164,RNAseq,IER3,1.03 (1.02 1.05),2.28E-03
285,Other anemias,hematopoietic,OPGS007604,0.128,RNAseq,U91328.1,1.03 (1.02 1.05),2.28E-03
285,Other anemias,hematopoietic,OPGS010826,0.056,RNAseq,TRIM10,0.97 (0.96 0.98),2.73E-03
285,Other anemias,hematopoietic,OPGS012006,0.041,RNAseq,VARS2,0.97 (0.96 0.98),6.57E-03
285,Other anemias,hematopoietic,OPGS006048,0.200,RNAseq,,0.97 (0.96 0.98),1.02E-02
285,Other anemias,hematopoietic,OPGS006866,0.157,RNAseq,AL662795.2,1.03 (1.02 1.04),1.41E-02
285,Other anemias,hematopoietic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.03 (1.02 1.05),1.49E-02
285,Other anemias,hematopoietic,OPGS009198,0.085,RNAseq,TRAV12-1,1.03 (1.01 1.04),1.57E-02
285,Other anemias,hematopoietic,OPGS014208,0.021,RNAseq,TM4SF1,0.97 (0.96 0.99),1.66E-02
285,Other anemias,hematopoietic,OPGS003843,0.532,RNAseq,BTN3A2,0.97 (0.96 0.99),1.90E-02
285,Other anemias,hematopoietic,OPGS012358,0.037,RNAseq,SFRP5,0.97 (0.96 0.99),2.29E-02
285,Other anemias,hematopoietic,OPGS007407,0.135,RNAseq,TRBV2,1.03 (1.01 1.04),2.67E-02
285,Other anemias,hematopoietic,OPGS006942,0.154,RNAseq,SKIV2L,0.97 (0.96 0.99),3.57E-02
285,Other anemias,hematopoietic,OPGS009191,0.085,RNAseq,PACS1,0.97 (0.96 0.99),3.89E-02
285,Other anemias,hematopoietic,OPGS003944,0.486,RNAseq,GSTA1,1.03 (1.01 1.04),3.90E-02
285,Other anemias,hematopoietic,OPGS014283,0.021,RNAseq,MXRA8,0.97 (0.96 0.99),4.30E-02
285,Other anemias,hematopoietic,OPGS007297,0.140,RNAseq,GPANK1,0.97 (0.96 0.99),4.39E-02
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS001139,0.043,SomaScan,Protein SEC13 homolog,1.73 (1.56 1.92),6.64E-21
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS000064,0.442,SomaScan,Calcium/calmodulin-dependent protein kinase type 1,1.85 (1.64 2.09),9.03E-20
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS000531,0.111,SomaScan,Cadherin-7,1.46 (1.32 1.63),4.76E-09
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS000682,0.087,SomaScan,Sulfotransferase family cytosolic 1B member 1,1.35 (1.22 1.49),1.89E-06
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS000180,0.254,SomaScan,Sialic acid-binding Ig-like lectin 11,0.72 (0.64 0.80),1.89E-06
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS000545,0.107,SomaScan,Torsin-1A-interacting protein 1,1.34 (1.21 1.48),2.29E-05
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS000468,0.125,SomaScan,Dermatopontin,0.77 (0.70 0.85),4.43E-05
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS001365,0.030,SomaScan,Leukocyte cell-derived chemotaxin 1,1.24 (1.15 1.34),6.63E-05
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS001252,0.036,SomaScan,Neuronal pentraxin-2,0.77 (0.70 0.85),1.58E-04
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS001089,0.047,SomaScan,Tissue factor pathway inhibitor,0.77 (0.70 0.85),2.53E-04
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.25 (1.14 1.37),1.96E-03
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS000986,0.054,SomaScan,Solute carrier family 22 member 16,1.23 (1.11 1.36),4.57E-02
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS002651,0.015,Olink,von Willebrand factor,1.23 (1.12 1.36),9.90E-03
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS002408,0.270,Olink,E-selectin,0.83 (0.76 0.90),2.26E-02
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS012642,0.034,RNAseq,SLC19A2,2.70 (2.55 2.87),1.66E-235
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS005386,0.248,RNAseq,METTL18,0.69 (0.64 0.73),2.26E-25
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS004332,0.383,RNAseq,ATP1B1,0.53 (0.47 0.60),2.82E-21
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS006611,0.170,RNAseq,C1orf112,1.51 (1.40 1.64),4.53E-21
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS004130,0.428,RNAseq,F5,1.44 (1.30 1.61),3.80E-08
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS006621,0.169,RNAseq,NME7,0.78 (0.71 0.85),6.63E-05
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS004058,0.447,RNAseq,XCL2,0.82 (0.75 0.89),6.00E-03
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS014885,0.016,RNAseq,DAZAP1,0.82 (0.75 0.90),2.66E-02
286.12,Congenital deficiency of other clotting factors (including factor VII),hematopoietic,OPGS013941,0.023,RNAseq,ZNF34,0.85 (0.78 0.92),3.99E-02
286.7,Other and unspecified coagulation defects,hematopoietic,OPGS015122,0.015,RNAseq,RANBP1,0.87 (0.82 0.92),4.50E-02
287.3,Thrombocytopenia,hematopoietic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.91 (0.88 0.95),2.84E-02
287.3,Thrombocytopenia,hematopoietic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.91 (0.88 0.95),2.84E-02
287.3,Thrombocytopenia,hematopoietic,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,1.09 (1.05 1.14),4.69E-02
287.3,Thrombocytopenia,hematopoietic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.92 (0.88 0.96),4.69E-02
287.3,Thrombocytopenia,hematopoietic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.92 (0.88 0.95),4.69E-02
287.3,Thrombocytopenia,hematopoietic,OPGS002510,0.085,Olink,Bone morphogenetic protein 6,1.09 (1.05 1.13),4.69E-02
289.8,Polycythemia. secondary,hematopoietic,OPGS002010,0.013,SomaScan,Myc proto-oncogene protein,1.02 (1.02 1.03),1.34E-12
289.8,Polycythemia. secondary,hematopoietic,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.23 (1.13 1.34),5.26E-03
289.8,Polycythemia. secondary,hematopoietic,OPGS011698,0.045,RNAseq,JAK2,1.34 (1.23 1.45),1.59E-08
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.20 (1.14 1.25),4.95E-10
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000857,0.067,SomaScan,Moesin,1.20 (1.14 1.25),4.95E-10
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.19 (1.13 1.24),1.35E-09
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.19 (1.13 1.25),2.79E-09
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.18 (1.13 1.24),4.57E-09
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.18 (1.13 1.24),6.23E-09
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.18 (1.12 1.23),2.13E-08
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.19 (1.13 1.25),7.08E-08
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.86 (0.82 0.90),2.86E-07
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.86 (0.82 0.91),2.58E-06
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.18 (1.11 1.24),2.58E-06
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.17 (1.11 1.23),3.35E-06
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000911,0.062,SomaScan,Protein MENT,1.16 (1.10 1.21),3.99E-06
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000115,0.347,SomaScan,Protein CEI,1.16 (1.10 1.23),1.88E-05
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.87 (0.83 0.91),2.10E-05
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.15 (1.09 1.21),2.45E-05
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.14 (1.09 1.20),3.14E-05
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.15 (1.10 1.21),4.24E-05
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.14 (1.09 1.20),4.24E-05
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.16 (1.10 1.22),4.40E-05
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.13 (1.08 1.18),8.12E-05
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000032,0.570,SomaScan,Protein S100-A13,0.88 (0.84 0.92),8.38E-05
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.15 (1.09 1.22),8.38E-05
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.88 (0.84 0.93),2.17E-04
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.13 (1.08 1.18),4.55E-04
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.14 (1.08 1.20),4.88E-04
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.88 (0.84 0.93),5.45E-04
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.14 (1.08 1.20),1.26E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.12 (1.06 1.17),5.77E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000312,0.163,SomaScan,Selenoprotein S,1.12 (1.06 1.19),7.38E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000502,0.117,SomaScan,Neutrophil collagenase,1.11 (1.05 1.17),1.66E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001093,0.046,SomaScan,C-reactive protein,0.90 (0.86 0.95),1.70E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000613,0.096,SomaScan,Stromelysin-1,1.11 (1.05 1.17),2.60E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.11 (1.05 1.16),2.81E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.11 (1.05 1.17),2.81E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000172,0.257,SomaScan,Dermokine,0.90 (0.86 0.95),3.33E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS000901,0.063,SomaScan,Ski-like protein,1.10 (1.04 1.15),4.75E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.16 (1.10 1.22),2.60E-06
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003006,0.030,Metabolon,cholesterol,1.14 (1.08 1.20),3.93E-04
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.12 (1.06 1.18),4.42E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.13 (1.08 1.19),1.21E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.13 (1.07 1.19),1.45E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.13 (1.07 1.19),1.59E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.13 (1.07 1.19),1.82E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.13 (1.07 1.19),2.16E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.13 (1.07 1.19),2.49E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.89 (0.85 0.94),3.06E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003455,0.087,Nightingale,Total free cholesterol,1.12 (1.07 1.18),4.52E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.12 (1.07 1.18),4.88E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.12 (1.06 1.18),5.77E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.12 (1.06 1.18),5.77E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.12 (1.06 1.18),6.40E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.12 (1.06 1.18),6.71E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.12 (1.06 1.18),6.84E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.12 (1.06 1.18),7.38E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.12 (1.06 1.18),7.65E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.12 (1.06 1.18),8.45E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.12 (1.06 1.18),8.45E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003423,0.126,Nightingale,LDL cholesterol,1.12 (1.06 1.18),8.57E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.12 (1.06 1.18),8.74E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.12 (1.06 1.18),9.08E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.12 (1.06 1.18),9.11E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.12 (1.06 1.18),9.47E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.12 (1.06 1.18),9.47E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003523,0.062,Nightingale,Total fatty acids,1.11 (1.06 1.17),9.47E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.11 (1.06 1.17),1.20E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.11 (1.06 1.17),1.55E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.11 (1.06 1.17),1.57E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.11 (1.05 1.16),2.28E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003497,0.072,Nightingale,Linoleic acid,1.10 (1.05 1.16),2.79E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.10 (1.05 1.16),4.70E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS012380,0.037,RNAseq,AC007381.1,0.90 (0.86 0.95),7.74E-03
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS004811,0.309,RNAseq,LINC01003,0.91 (0.87 0.96),3.70E-02
290,Delirium dementia and amnestic and other cognitive disorders,mental disorders,OPGS006963,0.153,RNAseq,CLEC2L,0.90 (0.85 0.95),3.90E-02
290.1,Dementias,mental disorders,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.74 (1.69 1.79),0.00E+00
290.1,Dementias,mental disorders,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.73 (1.68 1.78),0.00E+00
290.1,Dementias,mental disorders,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.77 (1.72 1.82),0.00E+00
290.1,Dementias,mental disorders,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.71 (1.66 1.76),0.00E+00
290.1,Dementias,mental disorders,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.74 (1.70 1.79),0.00E+00
290.1,Dementias,mental disorders,OPGS000857,0.067,SomaScan,Moesin,1.75 (1.70 1.80),0.00E+00
290.1,Dementias,mental disorders,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.74 (1.69 1.79),0.00E+00
290.1,Dementias,mental disorders,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.59 (0.57 0.60),2.44E-281
290.1,Dementias,mental disorders,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.84 (1.78 1.90),7.88E-276
290.1,Dementias,mental disorders,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.61 (0.59 0.63),3.29E-247
290.1,Dementias,mental disorders,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.93 (1.86 2.00),1.57E-246
290.1,Dementias,mental disorders,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.69 (1.64 1.75),2.95E-245
290.1,Dementias,mental disorders,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.88 (1.81 1.95),4.30E-244
290.1,Dementias,mental disorders,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.47 (1.44 1.51),7.50E-243
290.1,Dementias,mental disorders,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.79 (1.73 1.85),1.22E-240
290.1,Dementias,mental disorders,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.65 (1.60 1.70),2.49E-234
290.1,Dementias,mental disorders,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.83 (1.77 1.90),4.24E-225
290.1,Dementias,mental disorders,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.60 (0.58 0.62),1.11E-223
290.1,Dementias,mental disorders,OPGS000911,0.062,SomaScan,Protein MENT,1.65 (1.60 1.70),1.59E-220
290.1,Dementias,mental disorders,OPGS000115,0.347,SomaScan,Protein CEI,1.89 (1.82 1.96),3.65E-219
290.1,Dementias,mental disorders,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.79 (1.73 1.86),2.49E-214
290.1,Dementias,mental disorders,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.59 (1.54 1.64),1.09E-205
290.1,Dementias,mental disorders,OPGS000032,0.570,SomaScan,Protein S100-A13,0.62 (0.60 0.64),5.74E-202
290.1,Dementias,mental disorders,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.64 (0.62 0.66),1.89E-180
290.1,Dementias,mental disorders,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.83 (1.76 1.91),3.15E-180
290.1,Dementias,mental disorders,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.52 (1.47 1.57),5.87E-155
290.1,Dementias,mental disorders,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.62 (0.60 0.64),3.30E-143
290.1,Dementias,mental disorders,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.58 (1.53 1.64),3.05E-139
290.1,Dementias,mental disorders,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.79 (1.71 1.87),3.96E-134
290.1,Dementias,mental disorders,OPGS001343,0.031,SomaScan,Beta-1.3-N-acetylglucosaminyltransferase radical fringe,0.69 (0.67 0.71),7.58E-134
290.1,Dementias,mental disorders,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.60 (1.54 1.66),1.05E-128
290.1,Dementias,mental disorders,OPGS000312,0.163,SomaScan,Selenoprotein S,1.79 (1.70 1.87),1.06E-128
290.1,Dementias,mental disorders,OPGS001354,0.031,SomaScan,M-phase inducer phosphatase 2,1.50 (1.45 1.55),4.73E-121
290.1,Dementias,mental disorders,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.48 (1.43 1.53),1.86E-113
290.1,Dementias,mental disorders,OPGS000613,0.096,SomaScan,Stromelysin-1,1.71 (1.63 1.80),4.26E-104
290.1,Dementias,mental disorders,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.49 (1.44 1.55),1.12E-103
290.1,Dementias,mental disorders,OPGS001093,0.046,SomaScan,C-reactive protein,0.70 (0.67 0.72),4.48E-94
290.1,Dementias,mental disorders,OPGS000502,0.117,SomaScan,Neutrophil collagenase,1.44 (1.39 1.49),8.07E-91
290.1,Dementias,mental disorders,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.64 (1.56 1.72),1.64E-88
290.1,Dementias,mental disorders,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.61 (1.53 1.69),1.84E-84
290.1,Dementias,mental disorders,OPGS000427,0.132,SomaScan,Adhesion G-protein coupled receptor F1,1.41 (1.37 1.46),2.33E-83
290.1,Dementias,mental disorders,OPGS000172,0.257,SomaScan,Dermokine,0.68 (0.65 0.71),1.03E-76
290.1,Dementias,mental disorders,OPGS000912,0.061,SomaScan,Ras-related protein Rab-14,0.72 (0.70 0.75),1.39E-73
290.1,Dementias,mental disorders,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.34 (1.29 1.39),3.60E-60
290.1,Dementias,mental disorders,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,0.77 (0.75 0.80),4.05E-60
290.1,Dementias,mental disorders,OPGS000901,0.063,SomaScan,Ski-like protein,1.29 (1.25 1.34),5.81E-50
290.1,Dementias,mental disorders,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.69 (0.65 0.72),1.56E-45
290.1,Dementias,mental disorders,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.76 (0.73 0.79),4.35E-44
290.1,Dementias,mental disorders,OPGS002275,0.010,SomaScan,Interferon-induced protein with tetratricopeptide repeats 2,0.77 (0.74 0.80),1.66E-43
290.1,Dementias,mental disorders,OPGS001092,0.046,SomaScan,TOM1-like protein 1,0.80 (0.77 0.83),8.25E-38
290.1,Dementias,mental disorders,OPGS000577,0.102,SomaScan,Platelet-activating factor acetylhydrolase,1.26 (1.22 1.30),9.49E-38
290.1,Dementias,mental disorders,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.29 (1.23 1.35),4.71E-26
290.1,Dementias,mental disorders,OPGS000112,0.352,SomaScan,Valine--tRNA ligase,1.20 (1.16 1.24),1.36E-25
290.1,Dementias,mental disorders,OPGS000422,0.134,SomaScan,Ubiquitin carboxyl-terminal hydrolase 21,1.20 (1.16 1.24),2.70E-24
290.1,Dementias,mental disorders,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.24 (1.19 1.29),2.14E-23
290.1,Dementias,mental disorders,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,0.83 (0.79 0.86),6.27E-18
290.1,Dementias,mental disorders,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,0.82 (0.78 0.86),2.34E-17
290.1,Dementias,mental disorders,OPGS002108,0.012,SomaScan,Neuralized-like protein 4,1.22 (1.17 1.27),2.91E-17
290.1,Dementias,mental disorders,OPGS000743,0.079,SomaScan,Furin,1.16 (1.13 1.20),3.19E-17
290.1,Dementias,mental disorders,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.18 (1.13 1.22),1.27E-15
290.1,Dementias,mental disorders,OPGS000510,0.115,SomaScan,Guanine nucleotide-binding protein G(k) subunit alpha,0.85 (0.81 0.88),1.72E-14
290.1,Dementias,mental disorders,OPGS001392,0.029,SomaScan,Cadherin-related family member 5,1.19 (1.14 1.24),9.47E-14
290.1,Dementias,mental disorders,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,0.85 (0.82 0.89),5.44E-12
290.1,Dementias,mental disorders,OPGS000715,0.082,SomaScan,Surfeit locus protein 1,1.13 (1.09 1.17),1.42E-11
290.1,Dementias,mental disorders,OPGS000445,0.129,SomaScan,Collectin-10,0.87 (0.84 0.90),2.20E-11
290.1,Dementias,mental disorders,OPGS000938,0.059,SomaScan,Endothelial monocyte-activating polypeptide 2,1.13 (1.09 1.17),6.56E-11
290.1,Dementias,mental disorders,OPGS000021,0.605,SomaScan,COP9 signalosome complex subunit 7b,1.13 (1.09 1.17),2.08E-10
290.1,Dementias,mental disorders,OPGS001715,0.019,SomaScan,Histone deacetylase 8,1.12 (1.09 1.16),3.56E-10
290.1,Dementias,mental disorders,OPGS000802,0.073,SomaScan,Mediator of RNA polymerase II transcription subunit 4,1.13 (1.09 1.16),5.17E-10
290.1,Dementias,mental disorders,OPGS001357,0.031,SomaScan,Tumor necrosis factor receptor superfamily member 13C,1.12 (1.09 1.16),9.96E-10
290.1,Dementias,mental disorders,OPGS000860,0.066,SomaScan,Cell surface glycoprotein CD200 receptor 2,0.87 (0.84 0.91),2.80E-09
290.1,Dementias,mental disorders,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.12 (1.08 1.16),4.61E-08
290.1,Dementias,mental disorders,OPGS000764,0.077,SomaScan,Carboxypeptidase A2,1.11 (1.07 1.15),3.97E-07
290.1,Dementias,mental disorders,OPGS001106,0.046,SomaScan,Disintegrin and metalloproteinase domain-containing protein 11,0.90 (0.87 0.93),5.94E-07
290.1,Dementias,mental disorders,OPGS000348,0.151,SomaScan,Quinone oxidoreductase-like protein 1,1.12 (1.07 1.16),1.20E-06
290.1,Dementias,mental disorders,OPGS000165,0.267,SomaScan,Granulocyte colony-stimulating factor,1.10 (1.07 1.14),1.47E-06
290.1,Dementias,mental disorders,OPGS001138,0.043,SomaScan,Transmembrane protein 59-like,1.10 (1.06 1.14),2.10E-06
290.1,Dementias,mental disorders,OPGS001437,0.028,SomaScan,Steroidogenic acute regulatory protein. mitochondrial,1.11 (1.07 1.15),3.42E-06
290.1,Dementias,mental disorders,OPGS001087,0.047,SomaScan,Deformed epidermal autoregulatory factor 1 homolog,1.10 (1.06 1.14),6.14E-06
290.1,Dementias,mental disorders,OPGS000401,0.139,SomaScan,Hemoglobin subunit theta-1,0.92 (0.89 0.95),1.54E-05
290.1,Dementias,mental disorders,OPGS001085,0.047,SomaScan,Melanoma-associated antigen 3,1.09 (1.06 1.13),1.96E-05
290.1,Dementias,mental disorders,OPGS001121,0.044,SomaScan,Growth factor receptor-bound protein 7,0.92 (0.88 0.95),4.96E-05
290.1,Dementias,mental disorders,OPGS001041,0.050,SomaScan,RING finger protein 122,1.09 (1.06 1.13),7.22E-05
290.1,Dementias,mental disorders,OPGS000951,0.057,SomaScan,Pseudokinase FAM20A,0.92 (0.89 0.95),1.62E-04
290.1,Dementias,mental disorders,OPGS000473,0.123,SomaScan,Cofilin-1,1.08 (1.05 1.12),2.32E-04
290.1,Dementias,mental disorders,OPGS000955,0.057,SomaScan,Repulsive guidance molecule A,0.92 (0.89 0.95),2.91E-04
290.1,Dementias,mental disorders,OPGS001058,0.049,SomaScan,Protocadherin beta-10,1.09 (1.05 1.13),7.36E-04
290.1,Dementias,mental disorders,OPGS000049,0.490,SomaScan,MAP kinase-activated protein kinase 5,1.07 (1.04 1.11),4.13E-03
290.1,Dementias,mental disorders,OPGS002028,0.012,SomaScan,Myc box-dependent-interacting protein 1,1.07 (1.04 1.11),4.31E-03
290.1,Dementias,mental disorders,OPGS001240,0.037,SomaScan,Galanin-like peptide,0.93 (0.90 0.97),9.61E-03
290.1,Dementias,mental disorders,OPGS001019,0.052,SomaScan,DNA repair protein XRCC4,1.07 (1.03 1.11),1.51E-02
290.1,Dementias,mental disorders,OPGS000007,0.709,SomaScan,Paired immunoglobulin-like type 2 receptor alpha isoform FDF03-deltaTM,0.94 (0.91 0.97),2.92E-02
290.1,Dementias,mental disorders,OPGS000009,0.694,SomaScan,Paired immunoglobulin-like type 2 receptor alpha isoform FDF03-M14,0.94 (0.91 0.97),4.71E-02
290.1,Dementias,mental disorders,OPGS002600,0.030,Olink,Heme oxygenase 1,0.91 (0.88 0.94),1.78E-05
290.1,Dementias,mental disorders,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.60 (1.56 1.65),2.70E-201
290.1,Dementias,mental disorders,OPGS003006,0.030,Metabolon,cholesterol,1.55 (1.49 1.62),2.28E-107
290.1,Dementias,mental disorders,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.45 (1.40 1.50),5.37E-102
290.1,Dementias,mental disorders,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.28 (1.24 1.32),8.00E-49
290.1,Dementias,mental disorders,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.25 (1.21 1.29),2.85E-38
290.1,Dementias,mental disorders,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.26 (1.20 1.32),1.05E-20
290.1,Dementias,mental disorders,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.12 (1.08 1.16),4.44E-08
290.1,Dementias,mental disorders,OPGS003203,0.012,Metabolon,sphingomyelin (d18:2/23:0. d18:1/23:1. d17:1/24:1)*,1.11 (1.07 1.15),2.84E-07
290.1,Dementias,mental disorders,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.09 (1.05 1.13),2.50E-04
290.1,Dementias,mental disorders,OPGS003127,0.017,Metabolon,sphingomyelin (d18:1/22:1. d18:2/22:0. d16:1/24:1)*,1.08 (1.04 1.12),9.37E-04
290.1,Dementias,mental disorders,OPGS003058,0.022,Metabolon,sphingomyelin (d18:1/17:0. d17:1/18:0. d19:1/16:0),1.08 (1.04 1.12),1.43E-03
290.1,Dementias,mental disorders,OPGS002837,0.075,Metabolon,1-stearoyl-2-arachidonoyl-GPI (18:0/20:4),1.07 (1.04 1.11),3.74E-03
290.1,Dementias,mental disorders,OPGS002915,0.048,Metabolon,sphingomyelin (d18:1/20:0. d16:1/22:0)*,1.07 (1.04 1.11),5.09E-03
290.1,Dementias,mental disorders,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.43 (1.38 1.49),2.26E-71
290.1,Dementias,mental disorders,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.41 (1.36 1.47),6.18E-68
290.1,Dementias,mental disorders,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.41 (1.36 1.47),2.47E-66
290.1,Dementias,mental disorders,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.42 (1.36 1.48),2.57E-66
290.1,Dementias,mental disorders,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.40 (1.35 1.46),2.94E-65
290.1,Dementias,mental disorders,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.40 (1.34 1.45),1.48E-63
290.1,Dementias,mental disorders,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.41 (1.35 1.46),2.27E-63
290.1,Dementias,mental disorders,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.40 (1.35 1.46),5.46E-63
290.1,Dementias,mental disorders,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.40 (1.34 1.45),1.83E-62
290.1,Dementias,mental disorders,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.38 (1.33 1.43),1.47E-61
290.1,Dementias,mental disorders,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.39 (1.34 1.44),1.59E-61
290.1,Dementias,mental disorders,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.39 (1.34 1.45),2.18E-61
290.1,Dementias,mental disorders,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.40 (1.34 1.45),5.09E-61
290.1,Dementias,mental disorders,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.39 (1.34 1.44),4.06E-60
290.1,Dementias,mental disorders,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.37 (1.32 1.42),6.07E-59
290.1,Dementias,mental disorders,OPGS003423,0.126,Nightingale,LDL cholesterol,1.38 (1.33 1.44),8.86E-59
290.1,Dementias,mental disorders,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.37 (1.32 1.42),4.90E-58
290.1,Dementias,mental disorders,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.36 (1.31 1.41),3.97E-56
290.1,Dementias,mental disorders,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.36 (1.31 1.42),7.57E-56
290.1,Dementias,mental disorders,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.36 (1.31 1.41),1.51E-55
290.1,Dementias,mental disorders,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.35 (1.31 1.41),2.33E-55
290.1,Dementias,mental disorders,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.37 (1.31 1.42),2.64E-55
290.1,Dementias,mental disorders,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.34 (1.29 1.39),2.37E-51
290.1,Dementias,mental disorders,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.34 (1.29 1.40),7.43E-51
290.1,Dementias,mental disorders,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.33 (1.28 1.38),1.88E-50
290.1,Dementias,mental disorders,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.75 (0.73 0.78),3.45E-50
290.1,Dementias,mental disorders,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.33 (1.28 1.38),1.21E-49
290.1,Dementias,mental disorders,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.33 (1.28 1.38),4.08E-49
290.1,Dementias,mental disorders,OPGS003452,0.087,Nightingale,Total cholesterol,1.32 (1.28 1.37),3.00E-48
290.1,Dementias,mental disorders,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.32 (1.27 1.37),4.98E-47
290.1,Dementias,mental disorders,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.30 (1.25 1.35),4.79E-44
290.1,Dementias,mental disorders,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.29 (1.25 1.34),3.24E-43
290.1,Dementias,mental disorders,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.30 (1.26 1.35),1.48E-42
290.1,Dementias,mental disorders,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.28 (1.24 1.33),4.72E-41
290.1,Dementias,mental disorders,OPGS003497,0.072,Nightingale,Linoleic acid,1.28 (1.24 1.33),5.21E-41
290.1,Dementias,mental disorders,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.29 (1.24 1.33),5.58E-41
290.1,Dementias,mental disorders,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.28 (1.24 1.33),5.93E-41
290.1,Dementias,mental disorders,OPGS003455,0.087,Nightingale,Total free cholesterol,1.28 (1.24 1.33),9.25E-40
290.1,Dementias,mental disorders,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.27 (1.23 1.32),4.49E-39
290.1,Dementias,mental disorders,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.27 (1.22 1.31),2.61E-38
290.1,Dementias,mental disorders,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.27 (1.23 1.32),2.62E-38
290.1,Dementias,mental disorders,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.26 (1.22 1.31),5.16E-38
290.1,Dementias,mental disorders,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.27 (1.23 1.32),6.86E-38
290.1,Dementias,mental disorders,OPGS003523,0.062,Nightingale,Total fatty acids,1.26 (1.21 1.30),1.16E-35
290.1,Dementias,mental disorders,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.25 (1.21 1.29),9.60E-34
290.1,Dementias,mental disorders,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.24 (1.20 1.29),7.19E-32
290.1,Dementias,mental disorders,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.25 (1.20 1.29),2.58E-31
290.1,Dementias,mental disorders,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.23 (1.19 1.28),1.98E-30
290.1,Dementias,mental disorders,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.23 (1.19 1.28),2.43E-30
290.1,Dementias,mental disorders,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.23 (1.19 1.28),5.40E-30
290.1,Dementias,mental disorders,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.81 (0.78 0.84),7.25E-29
290.1,Dementias,mental disorders,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.23 (1.19 1.27),2.47E-28
290.1,Dementias,mental disorders,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,1.22 (1.18 1.26),5.45E-27
290.1,Dementias,mental disorders,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.22 (1.18 1.26),7.55E-26
290.1,Dementias,mental disorders,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.83 (0.80 0.86),2.83E-22
290.1,Dementias,mental disorders,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.20 (1.16 1.24),4.15E-22
290.1,Dementias,mental disorders,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.83 (0.81 0.86),8.38E-22
290.1,Dementias,mental disorders,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.84 (0.81 0.87),1.89E-20
290.1,Dementias,mental disorders,OPGS003527,0.050,Nightingale,Sphingomyelins,1.19 (1.15 1.24),3.83E-20
290.1,Dementias,mental disorders,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.84 (0.81 0.87),9.97E-20
290.1,Dementias,mental disorders,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.18 (1.14 1.23),1.99E-19
290.1,Dementias,mental disorders,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.18 (1.14 1.22),9.02E-19
290.1,Dementias,mental disorders,OPGS003486,0.074,Nightingale,Total triglycerides,1.18 (1.14 1.22),2.85E-18
290.1,Dementias,mental disorders,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.18 (1.14 1.22),3.38E-18
290.1,Dementias,mental disorders,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.17 (1.13 1.22),1.70E-17
290.1,Dementias,mental disorders,OPGS003476,0.076,Nightingale,Phospholipids in medium VLDL,1.17 (1.13 1.22),1.76E-17
290.1,Dementias,mental disorders,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.85 (0.82 0.88),2.90E-17
290.1,Dementias,mental disorders,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,1.17 (1.13 1.21),9.63E-17
290.1,Dementias,mental disorders,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.17 (1.13 1.21),1.73E-16
290.1,Dementias,mental disorders,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.85 (0.82 0.88),1.96E-16
290.1,Dementias,mental disorders,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.17 (1.13 1.21),7.18E-16
290.1,Dementias,mental disorders,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.86 (0.83 0.89),2.00E-15
290.1,Dementias,mental disorders,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.86 (0.83 0.89),3.14E-15
290.1,Dementias,mental disorders,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.86 (0.83 0.89),4.50E-15
290.1,Dementias,mental disorders,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.86 (0.83 0.89),5.15E-15
290.1,Dementias,mental disorders,OPGS003475,0.076,Nightingale,Total lipids in medium VLDL,1.16 (1.12 1.20),5.31E-15
290.1,Dementias,mental disorders,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.86 (0.83 0.89),1.39E-14
290.1,Dementias,mental disorders,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.15 (1.11 1.19),8.14E-14
290.1,Dementias,mental disorders,OPGS003528,0.050,Nightingale,Total cholines,1.15 (1.11 1.19),1.67E-12
290.1,Dementias,mental disorders,OPGS003526,0.050,Nightingale,Phosphatidylcholines,1.14 (1.10 1.18),1.34E-11
290.1,Dementias,mental disorders,OPGS003540,0.029,Nightingale,Free cholesterol in small HDL,0.87 (0.84 0.91),1.36E-11
290.1,Dementias,mental disorders,OPGS003542,0.028,Nightingale,Phospholipids in medium HDL,0.88 (0.85 0.91),9.15E-11
290.1,Dementias,mental disorders,OPGS003490,0.073,Nightingale,Free cholesterol in medium VLDL,1.13 (1.09 1.17),2.19E-10
290.1,Dementias,mental disorders,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,1.13 (1.10 1.18),2.34E-10
290.1,Dementias,mental disorders,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.13 (1.09 1.17),4.57E-10
290.1,Dementias,mental disorders,OPGS003477,0.076,Nightingale,Concentration of medium VLDL particles,1.13 (1.09 1.17),9.06E-10
290.1,Dementias,mental disorders,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,1.13 (1.09 1.17),1.20E-09
290.1,Dementias,mental disorders,OPGS003507,0.070,Nightingale,Free cholesterol in large VLDL,1.12 (1.09 1.16),4.30E-09
290.1,Dementias,mental disorders,OPGS003499,0.071,Nightingale,Phospholipids in large VLDL,1.12 (1.08 1.16),6.73E-09
290.1,Dementias,mental disorders,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,1.12 (1.08 1.16),9.19E-09
290.1,Dementias,mental disorders,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.89 (0.86 0.93),3.37E-08
290.1,Dementias,mental disorders,OPGS003479,0.075,Nightingale,Triglycerides in VLDL,1.11 (1.08 1.15),8.09E-08
290.1,Dementias,mental disorders,OPGS003491,0.073,Nightingale,Total lipids in chylomicrons and extremely large VLDL,1.12 (1.08 1.16),1.00E-07
290.1,Dementias,mental disorders,OPGS003481,0.075,Nightingale,Triglycerides in medium VLDL,1.11 (1.08 1.15),1.06E-07
290.1,Dementias,mental disorders,OPGS003471,0.077,Nightingale,Cholesteryl esters in large VLDL,1.11 (1.08 1.15),1.49E-07
290.1,Dementias,mental disorders,OPGS003516,0.066,Nightingale,Phospholipids in very large VLDL,1.11 (1.07 1.15),2.76E-07
290.1,Dementias,mental disorders,OPGS003510,0.068,Nightingale,Cholesterol in chylomicrons and extremely large VLDL,1.11 (1.07 1.15),1.28E-06
290.1,Dementias,mental disorders,OPGS003506,0.070,Nightingale,Cholesterol in very large VLDL,1.11 (1.07 1.15),1.39E-06
290.1,Dementias,mental disorders,OPGS003513,0.067,Nightingale,Free cholesterol in very large VLDL,1.10 (1.07 1.14),3.03E-06
290.1,Dementias,mental disorders,OPGS003520,0.062,Nightingale,HDL cholesterol,0.91 (0.88 0.94),3.56E-06
290.1,Dementias,mental disorders,OPGS003487,0.074,Nightingale,Phospholipids in chylomicrons and extremely large VLDL,1.10 (1.06 1.14),4.76E-06
290.1,Dementias,mental disorders,OPGS003537,0.031,Nightingale,Glycoprotein acetyls,1.10 (1.06 1.14),5.44E-06
290.1,Dementias,mental disorders,OPGS003493,0.073,Nightingale,Total lipids in large VLDL,1.10 (1.06 1.14),6.80E-06
290.1,Dementias,mental disorders,OPGS003483,0.075,Nightingale,Cholesterol in large VLDL,1.10 (1.06 1.14),7.23E-06
290.1,Dementias,mental disorders,OPGS003494,0.072,Nightingale,Concentration of large VLDL particles,1.10 (1.06 1.14),8.33E-06
290.1,Dementias,mental disorders,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.10 (1.06 1.14),1.21E-05
290.1,Dementias,mental disorders,OPGS003498,0.071,Nightingale,Triglycerides in large VLDL,1.10 (1.06 1.14),1.25E-05
290.1,Dementias,mental disorders,OPGS003496,0.072,Nightingale,Cholesteryl esters in very large VLDL,1.09 (1.06 1.13),3.93E-05
290.1,Dementias,mental disorders,OPGS003502,0.070,Nightingale,Concentration of very large VLDL particles,1.09 (1.06 1.13),4.06E-05
290.1,Dementias,mental disorders,OPGS003500,0.071,Nightingale,Total lipids in very large VLDL,1.09 (1.05 1.13),1.57E-04
290.1,Dementias,mental disorders,OPGS003504,0.070,Nightingale,Triglycerides in very large VLDL,1.09 (1.05 1.13),1.64E-04
290.1,Dementias,mental disorders,OPGS003448,0.093,Nightingale,Phospholipids in very large HDL,0.93 (0.90 0.96),3.14E-03
290.1,Dementias,mental disorders,OPGS003509,0.069,Nightingale,Free cholesterol in chylomicrons and extremely large VLDL,1.07 (1.04 1.11),5.21E-03
290.1,Dementias,mental disorders,OPGS014287,0.020,RNAseq,TOMM40,1.26 (1.21 1.30),1.14E-33
290.1,Dementias,mental disorders,OPGS009175,0.086,RNAseq,CEACAM19,1.10 (1.06 1.14),3.17E-05
290.1,Dementias,mental disorders,OPGS013849,0.024,RNAseq,AL627171.4,0.93 (0.90 0.96),8.90E-04
290.1,Dementias,mental disorders,OPGS006106,0.197,RNAseq,TBCB,1.07 (1.03 1.10),2.92E-03
290.1,Dementias,mental disorders,OPGS015114,0.015,RNAseq,GBA,1.06 (1.03 1.09),5.84E-03
290.1,Dementias,mental disorders,OPGS003821,0.540,RNAseq,ADAM15,1.07 (1.03 1.11),1.52E-02
290.1,Dementias,mental disorders,OPGS012353,0.037,RNAseq,IFT57,1.07 (1.03 1.10),1.69E-02
290.1,Dementias,mental disorders,OPGS007338,0.138,RNAseq,CFAP97D2,0.94 (0.90 0.97),1.74E-02
290.1,Dementias,mental disorders,OPGS013283,0.028,RNAseq,AC108704.2,1.07 (1.03 1.10),1.89E-02
290.1,Dementias,mental disorders,OPGS009905,0.071,RNAseq,SEC14L2,0.94 (0.90 0.97),2.16E-02
290.1,Dementias,mental disorders,OPGS008906,0.092,RNAseq,ABCA7,0.94 (0.91 0.97),2.18E-02
290.1,Dementias,mental disorders,OPGS011245,0.050,RNAseq,ARHGAP18,0.94 (0.91 0.97),2.35E-02
290.1,Dementias,mental disorders,OPGS009146,0.087,RNAseq,FBXL3,1.07 (1.03 1.11),2.47E-02
290.1,Dementias,mental disorders,OPGS006526,0.174,RNAseq,AP1B1,0.94 (0.91 0.97),3.00E-02
290.1,Dementias,mental disorders,OPGS008830,0.093,RNAseq,AP006621.5,0.94 (0.91 0.97),3.13E-02
290.1,Dementias,mental disorders,OPGS010100,0.068,RNAseq,SEMA6B,1.06 (1.02 1.09),3.96E-02
290.11,Alzheimer's disease,mental disorders,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,2.00 (1.93 2.07),0.00E+00
290.11,Alzheimer's disease,mental disorders,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,2.04 (1.97 2.12),0.00E+00
290.11,Alzheimer's disease,mental disorders,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.99 (1.92 2.06),0.00E+00
290.11,Alzheimer's disease,mental disorders,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.94 (1.87 2.00),0.00E+00
290.11,Alzheimer's disease,mental disorders,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.99 (1.92 2.06),0.00E+00
290.11,Alzheimer's disease,mental disorders,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.97 (1.90 2.04),0.00E+00
290.11,Alzheimer's disease,mental disorders,OPGS000857,0.067,SomaScan,Moesin,2.01 (1.94 2.08),0.00E+00
290.11,Alzheimer's disease,mental disorders,OPGS000179,0.254,SomaScan,Cardiotrophin-1,2.23 (2.14 2.33),5.13E-294
290.11,Alzheimer's disease,mental disorders,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,2.46 (2.34 2.59),1.71E-271
290.11,Alzheimer's disease,mental disorders,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.51 (0.49 0.53),4.01E-271
290.11,Alzheimer's disease,mental disorders,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,2.35 (2.24 2.46),1.25E-264
290.11,Alzheimer's disease,mental disorders,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,2.14 (2.04 2.23),8.48E-253
290.11,Alzheimer's disease,mental disorders,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.97 (1.89 2.05),1.06E-252
290.11,Alzheimer's disease,mental disorders,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.54 (0.52 0.56),2.92E-245
290.11,Alzheimer's disease,mental disorders,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.58 (1.54 1.63),2.29E-242
290.11,Alzheimer's disease,mental disorders,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,2.22 (2.12 2.33),2.41E-241
290.11,Alzheimer's disease,mental disorders,OPGS000115,0.347,SomaScan,Protein CEI,2.39 (2.27 2.52),2.84E-239
290.11,Alzheimer's disease,mental disorders,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.88 (1.81 1.95),3.81E-239
290.11,Alzheimer's disease,mental disorders,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,2.16 (2.06 2.26),2.44E-232
290.11,Alzheimer's disease,mental disorders,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.52 (0.50 0.55),6.05E-220
290.11,Alzheimer's disease,mental disorders,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.81 (1.74 1.88),6.10E-213
290.11,Alzheimer's disease,mental disorders,OPGS001172,0.040,SomaScan,Apolipoprotein B,2.37 (2.24 2.50),7.74E-207
290.11,Alzheimer's disease,mental disorders,OPGS000911,0.062,SomaScan,Protein MENT,1.85 (1.78 1.93),8.94E-207
290.11,Alzheimer's disease,mental disorders,OPGS000032,0.570,SomaScan,Protein S100-A13,0.55 (0.53 0.58),3.61E-188
290.11,Alzheimer's disease,mental disorders,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.57 (0.55 0.60),1.61E-169
290.11,Alzheimer's disease,mental disorders,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.71 (1.65 1.78),1.35E-160
290.11,Alzheimer's disease,mental disorders,OPGS001323,0.032,SomaScan,Sorting nexin-7,2.28 (2.14 2.42),5.43E-154
290.11,Alzheimer's disease,mental disorders,OPGS000312,0.163,SomaScan,Selenoprotein S,2.43 (2.27 2.59),3.25E-148
290.11,Alzheimer's disease,mental disorders,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.94 (1.85 2.04),1.32E-145
290.11,Alzheimer's disease,mental disorders,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.82 (1.74 1.90),1.43E-143
290.11,Alzheimer's disease,mental disorders,OPGS001343,0.031,SomaScan,Beta-1.3-N-acetylglucosaminyltransferase radical fringe,0.63 (0.60 0.65),9.13E-133
290.11,Alzheimer's disease,mental disorders,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.56 (0.53 0.58),6.63E-128
290.11,Alzheimer's disease,mental disorders,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.78 (1.70 1.87),1.27E-125
290.11,Alzheimer's disease,mental disorders,OPGS000613,0.096,SomaScan,Stromelysin-1,2.40 (2.23 2.57),4.90E-123
290.11,Alzheimer's disease,mental disorders,OPGS001354,0.031,SomaScan,M-phase inducer phosphatase 2,1.68 (1.61 1.75),5.93E-118
290.11,Alzheimer's disease,mental disorders,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.66 (1.59 1.73),4.80E-114
290.11,Alzheimer's disease,mental disorders,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,2.22 (2.07 2.39),5.71E-102
290.11,Alzheimer's disease,mental disorders,OPGS000307,0.164,SomaScan,Apolipoprotein E,2.13 (1.99 2.29),3.25E-96
290.11,Alzheimer's disease,mental disorders,OPGS000502,0.117,SomaScan,Neutrophil collagenase,1.61 (1.54 1.69),6.04E-92
290.11,Alzheimer's disease,mental disorders,OPGS001093,0.046,SomaScan,C-reactive protein,0.64 (0.61 0.67),3.69E-85
290.11,Alzheimer's disease,mental disorders,OPGS000427,0.132,SomaScan,Adhesion G-protein coupled receptor F1,1.55 (1.48 1.62),7.86E-80
290.11,Alzheimer's disease,mental disorders,OPGS000172,0.257,SomaScan,Dermokine,0.59 (0.56 0.62),1.08E-79
290.11,Alzheimer's disease,mental disorders,OPGS000901,0.063,SomaScan,Ski-like protein,1.44 (1.38 1.50),2.56E-63
290.11,Alzheimer's disease,mental disorders,OPGS000912,0.061,SomaScan,Ras-related protein Rab-14,0.68 (0.65 0.72),9.15E-61
290.11,Alzheimer's disease,mental disorders,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.45 (1.38 1.51),2.54E-57
290.11,Alzheimer's disease,mental disorders,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,0.74 (0.71 0.77),1.21E-51
290.11,Alzheimer's disease,mental disorders,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.51 (0.46 0.55),2.90E-50
290.11,Alzheimer's disease,mental disorders,OPGS000577,0.102,SomaScan,Platelet-activating factor acetylhydrolase,1.39 (1.33 1.46),1.42E-47
290.11,Alzheimer's disease,mental disorders,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.70 (0.67 0.74),1.44E-42
290.11,Alzheimer's disease,mental disorders,OPGS002275,0.010,SomaScan,Interferon-induced protein with tetratricopeptide repeats 2,0.72 (0.68 0.75),2.94E-39
290.11,Alzheimer's disease,mental disorders,OPGS001092,0.046,SomaScan,TOM1-like protein 1,0.77 (0.73 0.80),3.87E-33
290.11,Alzheimer's disease,mental disorders,OPGS000112,0.352,SomaScan,Valine--tRNA ligase,1.30 (1.25 1.36),9.67E-32
290.11,Alzheimer's disease,mental disorders,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.56 (1.45 1.68),4.51E-31
290.11,Alzheimer's disease,mental disorders,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.40 (1.33 1.49),9.81E-30
290.11,Alzheimer's disease,mental disorders,OPGS000422,0.134,SomaScan,Ubiquitin carboxyl-terminal hydrolase 21,1.28 (1.23 1.34),4.15E-29
290.11,Alzheimer's disease,mental disorders,OPGS000743,0.079,SomaScan,Furin,1.26 (1.21 1.32),3.66E-25
290.11,Alzheimer's disease,mental disorders,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,0.71 (0.66 0.76),3.54E-22
290.11,Alzheimer's disease,mental disorders,OPGS002108,0.012,SomaScan,Neuralized-like protein 4,1.41 (1.32 1.51),7.88E-22
290.11,Alzheimer's disease,mental disorders,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,0.75 (0.71 0.79),5.63E-21
290.11,Alzheimer's disease,mental disorders,OPGS001392,0.029,SomaScan,Cadherin-related family member 5,1.36 (1.28 1.45),1.57E-18
290.11,Alzheimer's disease,mental disorders,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.26 (1.20 1.32),3.34E-18
290.11,Alzheimer's disease,mental disorders,OPGS000715,0.082,SomaScan,Surfeit locus protein 1,1.20 (1.16 1.25),1.37E-17
290.11,Alzheimer's disease,mental disorders,OPGS001715,0.019,SomaScan,Histone deacetylase 8,1.20 (1.16 1.25),4.29E-17
290.11,Alzheimer's disease,mental disorders,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,0.76 (0.72 0.81),8.51E-17
290.11,Alzheimer's disease,mental disorders,OPGS000510,0.115,SomaScan,Guanine nucleotide-binding protein G(k) subunit alpha,0.78 (0.74 0.83),2.30E-16
290.11,Alzheimer's disease,mental disorders,OPGS000021,0.605,SomaScan,COP9 signalosome complex subunit 7b,1.21 (1.16 1.26),1.68E-15
290.11,Alzheimer's disease,mental disorders,OPGS001357,0.031,SomaScan,Tumor necrosis factor receptor superfamily member 13C,1.20 (1.15 1.25),2.08E-14
290.11,Alzheimer's disease,mental disorders,OPGS000445,0.129,SomaScan,Collectin-10,0.81 (0.77 0.85),2.32E-14
290.11,Alzheimer's disease,mental disorders,OPGS000802,0.073,SomaScan,Mediator of RNA polymerase II transcription subunit 4,1.20 (1.15 1.25),3.86E-14
290.11,Alzheimer's disease,mental disorders,OPGS000860,0.066,SomaScan,Cell surface glycoprotein CD200 receptor 2,0.79 (0.74 0.84),2.30E-13
290.11,Alzheimer's disease,mental disorders,OPGS000938,0.059,SomaScan,Endothelial monocyte-activating polypeptide 2,1.18 (1.13 1.23),3.08E-12
290.11,Alzheimer's disease,mental disorders,OPGS001087,0.047,SomaScan,Deformed epidermal autoregulatory factor 1 homolog,1.19 (1.13 1.24),7.04E-12
290.11,Alzheimer's disease,mental disorders,OPGS000165,0.267,SomaScan,Granulocyte colony-stimulating factor,1.17 (1.12 1.22),8.35E-11
290.11,Alzheimer's disease,mental disorders,OPGS000348,0.151,SomaScan,Quinone oxidoreductase-like protein 1,1.20 (1.14 1.27),3.62E-10
290.11,Alzheimer's disease,mental disorders,OPGS001437,0.028,SomaScan,Steroidogenic acute regulatory protein. mitochondrial,1.19 (1.13 1.25),6.26E-10
290.11,Alzheimer's disease,mental disorders,OPGS001138,0.043,SomaScan,Transmembrane protein 59-like,1.16 (1.11 1.21),9.39E-10
290.11,Alzheimer's disease,mental disorders,OPGS001019,0.052,SomaScan,DNA repair protein XRCC4,1.16 (1.11 1.21),1.08E-08
290.11,Alzheimer's disease,mental disorders,OPGS000473,0.123,SomaScan,Cofilin-1,1.15 (1.10 1.20),1.14E-08
290.11,Alzheimer's disease,mental disorders,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.16 (1.11 1.21),5.64E-08
290.11,Alzheimer's disease,mental disorders,OPGS001041,0.050,SomaScan,RING finger protein 122,1.16 (1.10 1.21),1.39E-07
290.11,Alzheimer's disease,mental disorders,OPGS001058,0.049,SomaScan,Protocadherin beta-10,1.17 (1.11 1.23),5.05E-07
290.11,Alzheimer's disease,mental disorders,OPGS000764,0.077,SomaScan,Carboxypeptidase A2,1.14 (1.09 1.19),5.05E-07
290.11,Alzheimer's disease,mental disorders,OPGS000951,0.057,SomaScan,Pseudokinase FAM20A,0.88 (0.84 0.92),8.96E-07
290.11,Alzheimer's disease,mental disorders,OPGS001106,0.046,SomaScan,Disintegrin and metalloproteinase domain-containing protein 11,0.88 (0.84 0.92),1.21E-06
290.11,Alzheimer's disease,mental disorders,OPGS001085,0.047,SomaScan,Melanoma-associated antigen 3,1.13 (1.08 1.18),3.07E-06
290.11,Alzheimer's disease,mental disorders,OPGS001121,0.044,SomaScan,Growth factor receptor-bound protein 7,0.89 (0.85 0.93),2.38E-05
290.11,Alzheimer's disease,mental disorders,OPGS001124,0.044,SomaScan,Tumor necrosis factor receptor type 1-associated DEATH domain protein,1.12 (1.07 1.17),1.13E-04
290.11,Alzheimer's disease,mental disorders,OPGS000049,0.490,SomaScan,MAP kinase-activated protein kinase 5,1.11 (1.07 1.17),1.35E-04
290.11,Alzheimer's disease,mental disorders,OPGS000955,0.057,SomaScan,Repulsive guidance molecule A,0.90 (0.86 0.94),3.24E-04
290.11,Alzheimer's disease,mental disorders,OPGS001129,0.044,SomaScan,Sodium-coupled monocarboxylate transporter 1,1.11 (1.06 1.16),5.14E-04
290.11,Alzheimer's disease,mental disorders,OPGS001259,0.035,SomaScan,Leucine-rich repeat and transmembrane domain-containing protein 2,1.11 (1.06 1.16),8.23E-04
290.11,Alzheimer's disease,mental disorders,OPGS000401,0.139,SomaScan,Hemoglobin subunit theta-1,0.92 (0.88 0.96),4.53E-03
290.11,Alzheimer's disease,mental disorders,OPGS002229,0.011,SomaScan,Uncharacterized protein C17orf89,1.07 (1.04 1.11),4.69E-03
290.11,Alzheimer's disease,mental disorders,OPGS001963,0.013,SomaScan,Annexin A9,1.11 (1.05 1.16),4.75E-03
290.11,Alzheimer's disease,mental disorders,OPGS000053,0.480,SomaScan,Myeloid cell surface antigen CD33,1.09 (1.05 1.15),8.02E-03
290.11,Alzheimer's disease,mental disorders,OPGS001256,0.036,SomaScan,Testican-1,1.09 (1.04 1.14),1.07E-02
290.11,Alzheimer's disease,mental disorders,OPGS001240,0.037,SomaScan,Galanin-like peptide,0.92 (0.87 0.96),1.23E-02
290.11,Alzheimer's disease,mental disorders,OPGS002028,0.012,SomaScan,Myc box-dependent-interacting protein 1,1.09 (1.04 1.13),1.93E-02
290.11,Alzheimer's disease,mental disorders,OPGS002132,0.011,SomaScan,Down syndrome cell adhesion molecule,1.07 (1.03 1.12),4.62E-02
290.11,Alzheimer's disease,mental disorders,OPGS002600,0.030,Olink,Heme oxygenase 1,0.86 (0.83 0.90),2.93E-08
290.11,Alzheimer's disease,mental disorders,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.81 (1.74 1.88),9.30E-200
290.11,Alzheimer's disease,mental disorders,OPGS003006,0.030,Metabolon,cholesterol,1.83 (1.74 1.93),9.88E-112
290.11,Alzheimer's disease,mental disorders,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.60 (1.53 1.67),2.02E-99
290.11,Alzheimer's disease,mental disorders,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.37 (1.32 1.43),9.14E-49
290.11,Alzheimer's disease,mental disorders,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.32 (1.27 1.38),1.13E-37
290.11,Alzheimer's disease,mental disorders,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.49 (1.38 1.60),5.69E-25
290.11,Alzheimer's disease,mental disorders,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.17 (1.12 1.23),1.39E-08
290.11,Alzheimer's disease,mental disorders,OPGS003203,0.012,Metabolon,sphingomyelin (d18:2/23:0. d18:1/23:1. d17:1/24:1)*,1.15 (1.10 1.21),2.58E-08
290.11,Alzheimer's disease,mental disorders,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.13 (1.08 1.19),1.63E-05
290.11,Alzheimer's disease,mental disorders,OPGS003058,0.022,Metabolon,sphingomyelin (d18:1/17:0. d17:1/18:0. d19:1/16:0),1.12 (1.07 1.17),1.43E-04
290.11,Alzheimer's disease,mental disorders,OPGS003127,0.017,Metabolon,sphingomyelin (d18:1/22:1. d18:2/22:0. d16:1/24:1)*,1.11 (1.06 1.16),2.97E-04
290.11,Alzheimer's disease,mental disorders,OPGS002837,0.075,Metabolon,1-stearoyl-2-arachidonoyl-GPI (18:0/20:4),1.08 (1.03 1.13),3.57E-02
290.11,Alzheimer's disease,mental disorders,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.66 (1.58 1.75),7.97E-79
290.11,Alzheimer's disease,mental disorders,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.67 (1.58 1.76),2.24E-77
290.11,Alzheimer's disease,mental disorders,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.64 (1.56 1.73),1.44E-75
290.11,Alzheimer's disease,mental disorders,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.65 (1.57 1.74),1.94E-74
290.11,Alzheimer's disease,mental disorders,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.62 (1.54 1.71),5.36E-74
290.11,Alzheimer's disease,mental disorders,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.65 (1.56 1.73),1.19E-73
290.11,Alzheimer's disease,mental disorders,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.63 (1.55 1.72),5.09E-71
290.11,Alzheimer's disease,mental disorders,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.60 (1.52 1.68),3.12E-70
290.11,Alzheimer's disease,mental disorders,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.59 (1.52 1.68),2.24E-69
290.11,Alzheimer's disease,mental disorders,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.60 (1.52 1.69),2.44E-69
290.11,Alzheimer's disease,mental disorders,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.60 (1.52 1.68),3.02E-69
290.11,Alzheimer's disease,mental disorders,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.60 (1.52 1.69),3.18E-68
290.11,Alzheimer's disease,mental disorders,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.59 (1.51 1.68),2.52E-67
290.11,Alzheimer's disease,mental disorders,OPGS003423,0.126,Nightingale,LDL cholesterol,1.59 (1.51 1.67),1.62E-66
290.11,Alzheimer's disease,mental disorders,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.56 (1.48 1.64),1.36E-65
290.11,Alzheimer's disease,mental disorders,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.56 (1.48 1.64),2.27E-65
290.11,Alzheimer's disease,mental disorders,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.56 (1.48 1.64),3.43E-64
290.11,Alzheimer's disease,mental disorders,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.55 (1.48 1.63),7.28E-63
290.11,Alzheimer's disease,mental disorders,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.54 (1.46 1.61),8.09E-63
290.11,Alzheimer's disease,mental disorders,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.53 (1.46 1.61),3.56E-62
290.11,Alzheimer's disease,mental disorders,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.56 (1.48 1.64),4.38E-62
290.11,Alzheimer's disease,mental disorders,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.54 (1.47 1.62),3.73E-61
290.11,Alzheimer's disease,mental disorders,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.53 (1.45 1.61),7.58E-58
290.11,Alzheimer's disease,mental disorders,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.49 (1.42 1.56),7.64E-58
290.11,Alzheimer's disease,mental disorders,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.51 (1.44 1.59),4.27E-57
290.11,Alzheimer's disease,mental disorders,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.67 (0.64 0.70),9.42E-57
290.11,Alzheimer's disease,mental disorders,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.51 (1.44 1.59),2.82E-56
290.11,Alzheimer's disease,mental disorders,OPGS003452,0.087,Nightingale,Total cholesterol,1.49 (1.42 1.57),7.45E-56
290.11,Alzheimer's disease,mental disorders,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.50 (1.43 1.58),1.03E-55
290.11,Alzheimer's disease,mental disorders,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.46 (1.40 1.53),2.06E-54
290.11,Alzheimer's disease,mental disorders,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.47 (1.40 1.55),1.21E-53
290.11,Alzheimer's disease,mental disorders,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.44 (1.38 1.51),4.39E-51
290.11,Alzheimer's disease,mental disorders,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.46 (1.39 1.53),1.79E-49
290.11,Alzheimer's disease,mental disorders,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.41 (1.34 1.47),7.53E-46
290.11,Alzheimer's disease,mental disorders,OPGS003497,0.072,Nightingale,Linoleic acid,1.41 (1.34 1.47),7.53E-46
290.11,Alzheimer's disease,mental disorders,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.42 (1.35 1.49),1.15E-45
290.11,Alzheimer's disease,mental disorders,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.40 (1.34 1.46),4.52E-44
290.11,Alzheimer's disease,mental disorders,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.40 (1.34 1.46),1.52E-43
290.11,Alzheimer's disease,mental disorders,OPGS003455,0.087,Nightingale,Total free cholesterol,1.41 (1.34 1.48),1.59E-43
290.11,Alzheimer's disease,mental disorders,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.39 (1.33 1.46),3.22E-42
290.11,Alzheimer's disease,mental disorders,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.39 (1.33 1.46),7.46E-42
290.11,Alzheimer's disease,mental disorders,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.35 (1.30 1.42),6.25E-38
290.11,Alzheimer's disease,mental disorders,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.35 (1.29 1.41),1.08E-37
290.11,Alzheimer's disease,mental disorders,OPGS003523,0.062,Nightingale,Total fatty acids,1.34 (1.29 1.41),2.41E-35
290.11,Alzheimer's disease,mental disorders,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.34 (1.28 1.41),5.13E-35
290.11,Alzheimer's disease,mental disorders,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.35 (1.29 1.42),2.58E-34
290.11,Alzheimer's disease,mental disorders,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.33 (1.27 1.39),1.11E-32
290.11,Alzheimer's disease,mental disorders,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.74 (0.71 0.78),1.64E-31
290.11,Alzheimer's disease,mental disorders,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.31 (1.26 1.37),1.40E-30
290.11,Alzheimer's disease,mental disorders,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.31 (1.25 1.37),3.45E-29
290.11,Alzheimer's disease,mental disorders,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.30 (1.24 1.36),9.73E-29
290.11,Alzheimer's disease,mental disorders,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.30 (1.24 1.36),9.27E-28
290.11,Alzheimer's disease,mental disorders,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.77 (0.74 0.81),8.14E-26
290.11,Alzheimer's disease,mental disorders,OPGS003527,0.050,Nightingale,Sphingomyelins,1.30 (1.24 1.36),1.64E-25
290.11,Alzheimer's disease,mental disorders,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.78 (0.74 0.81),6.82E-25
290.11,Alzheimer's disease,mental disorders,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,1.28 (1.22 1.34),9.86E-25
290.11,Alzheimer's disease,mental disorders,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.28 (1.23 1.34),1.13E-24
290.11,Alzheimer's disease,mental disorders,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.78 (0.74 0.82),3.92E-24
290.11,Alzheimer's disease,mental disorders,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.25 (1.20 1.31),3.08E-20
290.11,Alzheimer's disease,mental disorders,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.80 (0.76 0.84),4.10E-20
290.11,Alzheimer's disease,mental disorders,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.25 (1.19 1.30),1.91E-19
290.11,Alzheimer's disease,mental disorders,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.24 (1.19 1.30),4.96E-19
290.11,Alzheimer's disease,mental disorders,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.24 (1.18 1.30),1.84E-18
290.11,Alzheimer's disease,mental disorders,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.81 (0.77 0.84),4.40E-18
290.11,Alzheimer's disease,mental disorders,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.81 (0.77 0.85),4.84E-18
290.11,Alzheimer's disease,mental disorders,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.81 (0.77 0.85),1.22E-17
290.11,Alzheimer's disease,mental disorders,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,1.23 (1.17 1.29),4.75E-17
290.11,Alzheimer's disease,mental disorders,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.82 (0.78 0.86),6.55E-16
290.11,Alzheimer's disease,mental disorders,OPGS003476,0.076,Nightingale,Phospholipids in medium VLDL,1.22 (1.16 1.27),1.86E-15
290.11,Alzheimer's disease,mental disorders,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.82 (0.79 0.86),2.68E-15
290.11,Alzheimer's disease,mental disorders,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.21 (1.16 1.27),2.92E-15
290.11,Alzheimer's disease,mental disorders,OPGS003486,0.074,Nightingale,Total triglycerides,1.21 (1.16 1.27),3.07E-15
290.11,Alzheimer's disease,mental disorders,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.82 (0.79 0.86),3.54E-15
290.11,Alzheimer's disease,mental disorders,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.82 (0.79 0.86),5.82E-15
290.11,Alzheimer's disease,mental disorders,OPGS003540,0.029,Nightingale,Free cholesterol in small HDL,0.82 (0.78 0.86),8.78E-15
290.11,Alzheimer's disease,mental disorders,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.21 (1.16 1.27),8.78E-15
290.11,Alzheimer's disease,mental disorders,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.21 (1.16 1.27),1.34E-14
290.11,Alzheimer's disease,mental disorders,OPGS003542,0.028,Nightingale,Phospholipids in medium HDL,0.83 (0.79 0.87),1.12E-13
290.11,Alzheimer's disease,mental disorders,OPGS003528,0.050,Nightingale,Total cholines,1.20 (1.15 1.26),1.23E-13
290.11,Alzheimer's disease,mental disorders,OPGS003475,0.076,Nightingale,Total lipids in medium VLDL,1.20 (1.14 1.25),7.99E-13
290.11,Alzheimer's disease,mental disorders,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,1.19 (1.13 1.24),3.03E-11
290.11,Alzheimer's disease,mental disorders,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.18 (1.13 1.24),3.86E-11
290.11,Alzheimer's disease,mental disorders,OPGS003526,0.050,Nightingale,Phosphatidylcholines,1.18 (1.12 1.23),1.75E-10
290.11,Alzheimer's disease,mental disorders,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,1.18 (1.13 1.24),2.64E-10
290.11,Alzheimer's disease,mental disorders,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.17 (1.12 1.22),8.85E-10
290.11,Alzheimer's disease,mental disorders,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,1.17 (1.12 1.22),3.49E-09
290.11,Alzheimer's disease,mental disorders,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.86 (0.82 0.90),1.21E-08
290.11,Alzheimer's disease,mental disorders,OPGS003490,0.073,Nightingale,Free cholesterol in medium VLDL,1.16 (1.11 1.21),1.93E-08
290.11,Alzheimer's disease,mental disorders,OPGS003477,0.076,Nightingale,Concentration of medium VLDL particles,1.15 (1.10 1.21),5.42E-08
290.11,Alzheimer's disease,mental disorders,OPGS003491,0.073,Nightingale,Total lipids in chylomicrons and extremely large VLDL,1.15 (1.10 1.21),1.28E-07
290.11,Alzheimer's disease,mental disorders,OPGS003499,0.071,Nightingale,Phospholipids in large VLDL,1.15 (1.10 1.20),1.64E-07
290.11,Alzheimer's disease,mental disorders,OPGS003507,0.070,Nightingale,Free cholesterol in large VLDL,1.15 (1.10 1.20),1.76E-07
290.11,Alzheimer's disease,mental disorders,OPGS003516,0.066,Nightingale,Phospholipids in very large VLDL,1.15 (1.10 1.20),3.44E-07
290.11,Alzheimer's disease,mental disorders,OPGS003510,0.068,Nightingale,Cholesterol in chylomicrons and extremely large VLDL,1.14 (1.09 1.19),2.20E-06
290.11,Alzheimer's disease,mental disorders,OPGS003471,0.077,Nightingale,Cholesteryl esters in large VLDL,1.13 (1.08 1.19),3.73E-06
290.11,Alzheimer's disease,mental disorders,OPGS003506,0.070,Nightingale,Cholesterol in very large VLDL,1.14 (1.09 1.19),3.90E-06
290.11,Alzheimer's disease,mental disorders,OPGS003513,0.067,Nightingale,Free cholesterol in very large VLDL,1.13 (1.08 1.19),5.02E-06
290.11,Alzheimer's disease,mental disorders,OPGS003479,0.075,Nightingale,Triglycerides in VLDL,1.13 (1.08 1.18),9.62E-06
290.11,Alzheimer's disease,mental disorders,OPGS003481,0.075,Nightingale,Triglycerides in medium VLDL,1.13 (1.08 1.18),1.10E-05
290.11,Alzheimer's disease,mental disorders,OPGS003487,0.074,Nightingale,Phospholipids in chylomicrons and extremely large VLDL,1.13 (1.08 1.18),1.22E-05
290.11,Alzheimer's disease,mental disorders,OPGS003483,0.075,Nightingale,Cholesterol in large VLDL,1.12 (1.07 1.17),1.52E-04
290.11,Alzheimer's disease,mental disorders,OPGS003520,0.062,Nightingale,HDL cholesterol,0.90 (0.86 0.94),1.81E-04
290.11,Alzheimer's disease,mental disorders,OPGS003502,0.070,Nightingale,Concentration of very large VLDL particles,1.11 (1.07 1.17),2.22E-04
290.11,Alzheimer's disease,mental disorders,OPGS003537,0.031,Nightingale,Glycoprotein acetyls,1.11 (1.06 1.17),2.34E-04
290.11,Alzheimer's disease,mental disorders,OPGS003494,0.072,Nightingale,Concentration of large VLDL particles,1.11 (1.06 1.16),3.08E-04
290.11,Alzheimer's disease,mental disorders,OPGS003496,0.072,Nightingale,Cholesteryl esters in very large VLDL,1.11 (1.06 1.16),4.18E-04
290.11,Alzheimer's disease,mental disorders,OPGS003498,0.071,Nightingale,Triglycerides in large VLDL,1.11 (1.06 1.16),4.62E-04
290.11,Alzheimer's disease,mental disorders,OPGS003493,0.073,Nightingale,Total lipids in large VLDL,1.11 (1.06 1.16),6.74E-04
290.11,Alzheimer's disease,mental disorders,OPGS003504,0.070,Nightingale,Triglycerides in very large VLDL,1.11 (1.06 1.16),8.64E-04
290.11,Alzheimer's disease,mental disorders,OPGS003500,0.071,Nightingale,Total lipids in very large VLDL,1.11 (1.06 1.16),1.02E-03
290.11,Alzheimer's disease,mental disorders,OPGS003448,0.093,Nightingale,Phospholipids in very large HDL,0.91 (0.87 0.95),1.43E-03
290.11,Alzheimer's disease,mental disorders,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.10 (1.05 1.15),3.99E-03
290.11,Alzheimer's disease,mental disorders,OPGS003509,0.069,Nightingale,Free cholesterol in chylomicrons and extremely large VLDL,1.09 (1.04 1.14),1.20E-02
290.11,Alzheimer's disease,mental disorders,OPGS014287,0.020,RNAseq,TOMM40,1.32 (1.26 1.39),3.86E-29
290.11,Alzheimer's disease,mental disorders,OPGS010779,0.057,RNAseq,ACE,0.91 (0.87 0.95),1.60E-03
290.11,Alzheimer's disease,mental disorders,OPGS009175,0.086,RNAseq,CEACAM19,1.10 (1.05 1.15),3.32E-03
290.11,Alzheimer's disease,mental disorders,OPGS006772,0.162,RNAseq,GABRR2,0.91 (0.87 0.95),4.02E-03
290.11,Alzheimer's disease,mental disorders,OPGS012563,0.035,RNAseq,AL355388.1,1.09 (1.04 1.13),5.50E-03
290.11,Alzheimer's disease,mental disorders,OPGS008460,0.103,RNAseq,YEATS4,0.92 (0.88 0.96),6.89E-03
290.11,Alzheimer's disease,mental disorders,OPGS009180,0.086,RNAseq,CNKSR1,1.09 (1.04 1.14),8.29E-03
290.11,Alzheimer's disease,mental disorders,OPGS009721,0.075,RNAseq,UBE2J1,1.09 (1.04 1.14),1.09E-02
290.11,Alzheimer's disease,mental disorders,OPGS010348,0.063,RNAseq,TRBV6-5,0.92 (0.88 0.96),1.30E-02
290.11,Alzheimer's disease,mental disorders,OPGS009905,0.071,RNAseq,SEC14L2,0.92 (0.88 0.96),1.58E-02
290.11,Alzheimer's disease,mental disorders,OPGS003821,0.540,RNAseq,ADAM15,1.09 (1.04 1.14),1.78E-02
290.11,Alzheimer's disease,mental disorders,OPGS011681,0.045,RNAseq,YDJC,0.92 (0.88 0.96),2.27E-02
290.11,Alzheimer's disease,mental disorders,OPGS004213,0.410,RNAseq,,0.92 (0.88 0.96),2.70E-02
290.11,Alzheimer's disease,mental disorders,OPGS008753,0.095,RNAseq,PVR,0.92 (0.88 0.97),2.79E-02
290.11,Alzheimer's disease,mental disorders,OPGS010115,0.067,RNAseq,SZT2,1.10 (1.04 1.15),2.96E-02
290.11,Alzheimer's disease,mental disorders,OPGS013879,0.023,RNAseq,DDX54,1.09 (1.04 1.15),3.27E-02
290.11,Alzheimer's disease,mental disorders,OPGS007179,0.144,RNAseq,SMG5,0.92 (0.88 0.97),3.42E-02
290.11,Alzheimer's disease,mental disorders,OPGS013948,0.023,RNAseq,C9orf139,0.93 (0.89 0.97),3.54E-02
290.11,Alzheimer's disease,mental disorders,OPGS009670,0.076,RNAseq,ERCC2,1.08 (1.03 1.13),3.68E-02
290.11,Alzheimer's disease,mental disorders,OPGS013323,0.028,RNAseq,ERCC5,0.92 (0.88 0.97),3.77E-02
290.11,Alzheimer's disease,mental disorders,OPGS005971,0.205,RNAseq,NSUN4,1.08 (1.03 1.13),4.22E-02
290.11,Alzheimer's disease,mental disorders,OPGS005421,0.245,RNAseq,MUC20,0.92 (0.88 0.97),4.77E-02
290.11,Alzheimer's disease,mental disorders,OPGS008577,0.099,RNAseq,CDC123,1.08 (1.03 1.13),4.85E-02
290.11,Alzheimer's disease,mental disorders,OPGS003927,0.495,RNAseq,JAKMIP2,0.92 (0.88 0.97),4.85E-02
290.11,Alzheimer's disease,mental disorders,OPGS009158,0.086,RNAseq,OTULIN,1.07 (1.03 1.12),4.94E-02
290.12,Dementia with cerebral degenerations,mental disorders,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.39 (1.24 1.55),4.66E-05
290.12,Dementia with cerebral degenerations,mental disorders,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.38 (1.24 1.54),4.66E-05
290.12,Dementia with cerebral degenerations,mental disorders,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.39 (1.24 1.55),4.66E-05
290.12,Dementia with cerebral degenerations,mental disorders,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.73 (0.65 0.82),3.05E-04
290.12,Dementia with cerebral degenerations,mental disorders,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.36 (1.21 1.52),3.05E-04
290.12,Dementia with cerebral degenerations,mental disorders,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.37 (1.22 1.53),3.05E-04
290.12,Dementia with cerebral degenerations,mental disorders,OPGS000857,0.067,SomaScan,Moesin,1.37 (1.22 1.53),3.05E-04
290.12,Dementia with cerebral degenerations,mental disorders,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.35 (1.20 1.52),7.11E-04
290.12,Dementia with cerebral degenerations,mental disorders,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.73 (0.65 0.83),8.82E-04
290.12,Dementia with cerebral degenerations,mental disorders,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.29 (1.17 1.43),1.11E-03
290.12,Dementia with cerebral degenerations,mental disorders,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.38 (1.21 1.57),1.37E-03
290.12,Dementia with cerebral degenerations,mental disorders,OPGS000911,0.062,SomaScan,Protein MENT,1.34 (1.19 1.52),2.52E-03
290.12,Dementia with cerebral degenerations,mental disorders,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.76 (0.67 0.85),4.39E-03
290.12,Dementia with cerebral degenerations,mental disorders,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.38 (1.20 1.58),4.39E-03
290.12,Dementia with cerebral degenerations,mental disorders,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.33 (1.18 1.50),4.39E-03
290.12,Dementia with cerebral degenerations,mental disorders,OPGS000032,0.570,SomaScan,Protein S100-A13,0.76 (0.67 0.85),4.39E-03
290.12,Dementia with cerebral degenerations,mental disorders,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.38 (1.20 1.59),5.34E-03
290.12,Dementia with cerebral degenerations,mental disorders,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.33 (1.17 1.52),1.08E-02
290.12,Dementia with cerebral degenerations,mental disorders,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.30 (1.15 1.47),1.16E-02
290.12,Dementia with cerebral degenerations,mental disorders,OPGS000115,0.347,SomaScan,Protein CEI,1.36 (1.18 1.57),1.76E-02
290.12,Dementia with cerebral degenerations,mental disorders,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.34 (1.17 1.53),1.82E-02
290.12,Dementia with cerebral degenerations,mental disorders,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.77 (0.69 0.87),1.83E-02
290.12,Dementia with cerebral degenerations,mental disorders,OPGS001343,0.031,SomaScan,Beta-1.3-N-acetylglucosaminyltransferase radical fringe,0.78 (0.69 0.88),2.12E-02
290.12,Dementia with cerebral degenerations,mental disorders,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.28 (1.13 1.44),4.72E-02
290.12,Dementia with cerebral degenerations,mental disorders,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.31 (1.16 1.48),8.77E-03
290.16,Vascular dementia,mental disorders,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.63 (1.55 1.71),7.05E-79
290.16,Vascular dementia,mental disorders,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.64 (1.56 1.73),3.26E-76
290.16,Vascular dementia,mental disorders,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.60 (1.53 1.69),1.02E-74
290.16,Vascular dementia,mental disorders,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.59 (1.52 1.67),2.52E-74
290.16,Vascular dementia,mental disorders,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.60 (1.52 1.69),2.49E-72
290.16,Vascular dementia,mental disorders,OPGS000857,0.067,SomaScan,Moesin,1.63 (1.54 1.71),2.94E-72
290.16,Vascular dementia,mental disorders,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.61 (1.53 1.70),3.53E-70
290.16,Vascular dementia,mental disorders,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.63 (0.59 0.66),3.81E-64
290.16,Vascular dementia,mental disorders,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.68 (1.58 1.78),2.45E-60
290.16,Vascular dementia,mental disorders,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.70 (1.60 1.82),1.30E-53
290.16,Vascular dementia,mental disorders,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.74 (1.62 1.86),2.58E-53
290.16,Vascular dementia,mental disorders,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.40 (1.35 1.47),4.27E-51
290.16,Vascular dementia,mental disorders,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.53 (1.45 1.62),1.28E-50
290.16,Vascular dementia,mental disorders,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.66 (0.63 0.70),2.13E-50
290.16,Vascular dementia,mental disorders,OPGS000911,0.062,SomaScan,Protein MENT,1.55 (1.46 1.63),4.13E-50
290.16,Vascular dementia,mental disorders,OPGS000115,0.347,SomaScan,Protein CEI,1.72 (1.61 1.85),1.55E-49
290.16,Vascular dementia,mental disorders,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.61 (1.52 1.72),2.54E-48
290.16,Vascular dementia,mental disorders,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.65 (0.62 0.69),7.91E-47
290.16,Vascular dementia,mental disorders,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.65 (1.54 1.76),3.39E-45
290.16,Vascular dementia,mental disorders,OPGS000032,0.570,SomaScan,Protein S100-A13,0.66 (0.63 0.70),8.51E-45
290.16,Vascular dementia,mental disorders,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.51 (1.43 1.60),3.21E-44
290.16,Vascular dementia,mental disorders,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.61 (1.51 1.72),3.50E-42
290.16,Vascular dementia,mental disorders,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.68 (0.65 0.72),2.15E-39
290.16,Vascular dementia,mental disorders,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.45 (1.38 1.53),1.67E-38
290.16,Vascular dementia,mental disorders,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.65 (1.53 1.77),1.88E-38
290.16,Vascular dementia,mental disorders,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.53 (1.43 1.63),1.29E-35
290.16,Vascular dementia,mental disorders,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.67 (0.63 0.72),1.91E-30
290.16,Vascular dementia,mental disorders,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.40 (1.32 1.48),1.09E-28
290.16,Vascular dementia,mental disorders,OPGS001343,0.031,SomaScan,Beta-1.3-N-acetylglucosaminyltransferase radical fringe,0.73 (0.69 0.77),8.28E-28
290.16,Vascular dementia,mental disorders,OPGS000312,0.163,SomaScan,Selenoprotein S,1.58 (1.46 1.72),4.15E-27
290.16,Vascular dementia,mental disorders,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.47 (1.38 1.58),4.50E-27
290.16,Vascular dementia,mental disorders,OPGS001354,0.031,SomaScan,M-phase inducer phosphatase 2,1.41 (1.33 1.50),4.24E-26
290.16,Vascular dementia,mental disorders,OPGS000613,0.096,SomaScan,Stromelysin-1,1.57 (1.45 1.71),1.31E-24
290.16,Vascular dementia,mental disorders,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.50 (1.39 1.63),1.40E-21
290.16,Vascular dementia,mental disorders,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.39 (1.31 1.48),2.35E-21
290.16,Vascular dementia,mental disorders,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.37 (1.29 1.45),2.59E-21
290.16,Vascular dementia,mental disorders,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.52 (1.40 1.65),3.23E-21
290.16,Vascular dementia,mental disorders,OPGS001093,0.046,SomaScan,C-reactive protein,0.74 (0.70 0.79),2.17E-19
290.16,Vascular dementia,mental disorders,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.48 (1.37 1.61),3.05E-19
290.16,Vascular dementia,mental disorders,OPGS000427,0.132,SomaScan,Adhesion G-protein coupled receptor F1,1.34 (1.26 1.43),5.67E-18
290.16,Vascular dementia,mental disorders,OPGS000912,0.061,SomaScan,Ras-related protein Rab-14,0.76 (0.72 0.81),2.61E-15
290.16,Vascular dementia,mental disorders,OPGS000172,0.257,SomaScan,Dermokine,0.74 (0.69 0.80),1.29E-14
290.16,Vascular dementia,mental disorders,OPGS000502,0.117,SomaScan,Neutrophil collagenase,1.30 (1.22 1.38),1.12E-13
290.16,Vascular dementia,mental disorders,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,0.80 (0.76 0.85),2.41E-12
290.16,Vascular dementia,mental disorders,OPGS000901,0.063,SomaScan,Ski-like protein,1.25 (1.17 1.32),8.39E-11
290.16,Vascular dementia,mental disorders,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.79 (0.74 0.84),6.28E-10
290.16,Vascular dementia,mental disorders,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.75 (0.69 0.82),1.99E-09
290.16,Vascular dementia,mental disorders,OPGS001092,0.046,SomaScan,TOM1-like protein 1,0.82 (0.77 0.87),2.47E-09
290.16,Vascular dementia,mental disorders,OPGS000577,0.102,SomaScan,Platelet-activating factor acetylhydrolase,1.22 (1.15 1.30),1.90E-08
290.16,Vascular dementia,mental disorders,OPGS002275,0.010,SomaScan,Interferon-induced protein with tetratricopeptide repeats 2,0.81 (0.76 0.87),4.67E-08
290.16,Vascular dementia,mental disorders,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.21 (1.14 1.29),1.47E-07
290.16,Vascular dementia,mental disorders,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.22 (1.13 1.31),7.45E-06
290.16,Vascular dementia,mental disorders,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.24 (1.15 1.34),1.05E-05
290.16,Vascular dementia,mental disorders,OPGS000422,0.134,SomaScan,Ubiquitin carboxyl-terminal hydrolase 21,1.17 (1.10 1.24),2.28E-05
290.16,Vascular dementia,mental disorders,OPGS000112,0.352,SomaScan,Valine--tRNA ligase,1.16 (1.10 1.24),8.67E-05
290.16,Vascular dementia,mental disorders,OPGS000743,0.079,SomaScan,Furin,1.15 (1.09 1.23),3.15E-04
290.16,Vascular dementia,mental disorders,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,0.84 (0.78 0.90),5.44E-04
290.16,Vascular dementia,mental disorders,OPGS002108,0.012,SomaScan,Neuralized-like protein 4,1.18 (1.10 1.27),1.42E-03
290.16,Vascular dementia,mental disorders,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,0.86 (0.81 0.93),5.45E-03
290.16,Vascular dementia,mental disorders,OPGS001392,0.029,SomaScan,Cadherin-related family member 5,1.16 (1.08 1.25),6.12E-03
290.16,Vascular dementia,mental disorders,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.14 (1.07 1.22),1.01E-02
290.16,Vascular dementia,mental disorders,OPGS000510,0.115,SomaScan,Guanine nucleotide-binding protein G(k) subunit alpha,0.87 (0.81 0.94),1.23E-02
290.16,Vascular dementia,mental disorders,OPGS000021,0.605,SomaScan,COP9 signalosome complex subunit 7b,1.12 (1.05 1.19),2.17E-02
290.16,Vascular dementia,mental disorders,OPGS000715,0.082,SomaScan,Surfeit locus protein 1,1.12 (1.05 1.18),2.29E-02
290.16,Vascular dementia,mental disorders,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,0.88 (0.81 0.94),2.41E-02
290.16,Vascular dementia,mental disorders,OPGS000445,0.129,SomaScan,Collectin-10,0.89 (0.83 0.95),2.99E-02
290.16,Vascular dementia,mental disorders,OPGS000802,0.073,SomaScan,Mediator of RNA polymerase II transcription subunit 4,1.11 (1.05 1.18),3.86E-02
290.16,Vascular dementia,mental disorders,OPGS000860,0.066,SomaScan,Cell surface glycoprotein CD200 receptor 2,0.88 (0.82 0.95),4.60E-02
290.16,Vascular dementia,mental disorders,OPGS002498,0.099,Olink,Tartrate-resistant acid phosphatase type 5,0.89 (0.84 0.95),2.02E-02
290.16,Vascular dementia,mental disorders,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.49 (1.41 1.57),1.17E-41
290.16,Vascular dementia,mental disorders,OPGS003006,0.030,Metabolon,cholesterol,1.47 (1.37 1.57),2.57E-25
290.16,Vascular dementia,mental disorders,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.37 (1.29 1.45),1.11E-21
290.16,Vascular dementia,mental disorders,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.23 (1.16 1.31),4.65E-10
290.16,Vascular dementia,mental disorders,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.20 (1.13 1.27),2.54E-07
290.16,Vascular dementia,mental disorders,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.24 (1.14 1.34),3.33E-05
290.16,Vascular dementia,mental disorders,OPGS003184,0.013,Metabolon,2-hydroxyglutarate,1.12 (1.05 1.19),2.17E-02
290.16,Vascular dementia,mental disorders,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.35 (1.26 1.45),5.14E-15
290.16,Vascular dementia,mental disorders,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.34 (1.25 1.43),1.77E-14
290.16,Vascular dementia,mental disorders,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.34 (1.25 1.43),2.93E-14
290.16,Vascular dementia,mental disorders,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.33 (1.25 1.43),5.47E-14
290.16,Vascular dementia,mental disorders,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.33 (1.24 1.43),5.89E-14
290.16,Vascular dementia,mental disorders,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.33 (1.24 1.42),6.12E-14
290.16,Vascular dementia,mental disorders,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.32 (1.24 1.42),8.28E-14
290.16,Vascular dementia,mental disorders,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.31 (1.23 1.40),3.80E-13
290.16,Vascular dementia,mental disorders,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.32 (1.23 1.41),4.94E-13
290.16,Vascular dementia,mental disorders,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.31 (1.22 1.40),1.02E-12
290.16,Vascular dementia,mental disorders,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.30 (1.22 1.39),2.90E-12
290.16,Vascular dementia,mental disorders,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.77 (0.73 0.83),3.35E-12
290.16,Vascular dementia,mental disorders,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.30 (1.22 1.39),5.37E-12
290.16,Vascular dementia,mental disorders,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.29 (1.21 1.38),6.23E-12
290.16,Vascular dementia,mental disorders,OPGS003423,0.126,Nightingale,LDL cholesterol,1.30 (1.21 1.39),6.23E-12
290.16,Vascular dementia,mental disorders,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.29 (1.21 1.38),9.33E-12
290.16,Vascular dementia,mental disorders,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.29 (1.21 1.38),1.68E-11
290.16,Vascular dementia,mental disorders,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.28 (1.20 1.37),4.43E-11
290.16,Vascular dementia,mental disorders,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.28 (1.20 1.37),4.58E-11
290.16,Vascular dementia,mental disorders,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.29 (1.20 1.37),4.96E-11
290.16,Vascular dementia,mental disorders,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.28 (1.20 1.36),4.96E-11
290.16,Vascular dementia,mental disorders,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.27 (1.19 1.36),1.60E-10
290.16,Vascular dementia,mental disorders,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.27 (1.19 1.35),3.07E-10
290.16,Vascular dementia,mental disorders,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.27 (1.19 1.36),3.07E-10
290.16,Vascular dementia,mental disorders,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.26 (1.18 1.34),3.98E-10
290.16,Vascular dementia,mental disorders,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.26 (1.18 1.35),6.63E-10
290.16,Vascular dementia,mental disorders,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.25 (1.17 1.33),1.62E-09
290.16,Vascular dementia,mental disorders,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.25 (1.17 1.34),2.30E-09
290.16,Vascular dementia,mental disorders,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.25 (1.17 1.34),2.96E-09
290.16,Vascular dementia,mental disorders,OPGS003452,0.087,Nightingale,Total cholesterol,1.25 (1.17 1.33),3.44E-09
290.16,Vascular dementia,mental disorders,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.25 (1.17 1.33),4.43E-09
290.16,Vascular dementia,mental disorders,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.24 (1.16 1.32),5.29E-09
290.16,Vascular dementia,mental disorders,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.25 (1.17 1.33),8.37E-09
290.16,Vascular dementia,mental disorders,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.23 (1.16 1.31),1.10E-08
290.16,Vascular dementia,mental disorders,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.23 (1.15 1.31),2.33E-08
290.16,Vascular dementia,mental disorders,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.22 (1.15 1.30),9.52E-08
290.16,Vascular dementia,mental disorders,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.22 (1.14 1.30),1.62E-07
290.16,Vascular dementia,mental disorders,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.21 (1.14 1.29),2.65E-07
290.16,Vascular dementia,mental disorders,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.82 (0.77 0.87),2.72E-07
290.16,Vascular dementia,mental disorders,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.21 (1.14 1.29),3.39E-07
290.16,Vascular dementia,mental disorders,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.21 (1.14 1.29),4.15E-07
290.16,Vascular dementia,mental disorders,OPGS003497,0.072,Nightingale,Linoleic acid,1.20 (1.13 1.28),1.71E-06
290.16,Vascular dementia,mental disorders,OPGS003455,0.087,Nightingale,Total free cholesterol,1.20 (1.13 1.28),2.25E-06
290.16,Vascular dementia,mental disorders,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.19 (1.12 1.27),2.86E-06
290.16,Vascular dementia,mental disorders,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.19 (1.12 1.27),3.44E-06
290.16,Vascular dementia,mental disorders,OPGS003523,0.062,Nightingale,Total fatty acids,1.19 (1.12 1.27),3.44E-06
290.16,Vascular dementia,mental disorders,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.19 (1.12 1.27),5.27E-06
290.16,Vascular dementia,mental disorders,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.19 (1.12 1.27),1.43E-05
290.16,Vascular dementia,mental disorders,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.18 (1.11 1.26),2.28E-05
290.16,Vascular dementia,mental disorders,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.85 (0.80 0.90),2.87E-05
290.16,Vascular dementia,mental disorders,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.17 (1.10 1.25),5.55E-05
290.16,Vascular dementia,mental disorders,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.17 (1.10 1.25),6.11E-05
290.16,Vascular dementia,mental disorders,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.86 (0.80 0.91),1.38E-04
290.16,Vascular dementia,mental disorders,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,1.17 (1.10 1.24),1.45E-04
290.16,Vascular dementia,mental disorders,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.16 (1.09 1.24),2.19E-04
290.16,Vascular dementia,mental disorders,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.16 (1.09 1.23),3.86E-04
290.16,Vascular dementia,mental disorders,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.86 (0.81 0.92),4.79E-04
290.16,Vascular dementia,mental disorders,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.86 (0.81 0.92),5.73E-04
290.16,Vascular dementia,mental disorders,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.16 (1.09 1.23),7.37E-04
290.16,Vascular dementia,mental disorders,OPGS003540,0.029,Nightingale,Free cholesterol in small HDL,0.86 (0.81 0.92),7.98E-04
290.16,Vascular dementia,mental disorders,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.87 (0.81 0.92),9.05E-04
290.16,Vascular dementia,mental disorders,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.87 (0.82 0.92),9.27E-04
290.16,Vascular dementia,mental disorders,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.87 (0.82 0.92),1.18E-03
290.16,Vascular dementia,mental disorders,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.87 (0.82 0.93),1.18E-03
290.16,Vascular dementia,mental disorders,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,1.15 (1.08 1.22),1.23E-03
290.16,Vascular dementia,mental disorders,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.15 (1.08 1.22),1.33E-03
290.16,Vascular dementia,mental disorders,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.87 (0.82 0.93),1.46E-03
290.16,Vascular dementia,mental disorders,OPGS003476,0.076,Nightingale,Phospholipids in medium VLDL,1.15 (1.08 1.22),1.49E-03
290.16,Vascular dementia,mental disorders,OPGS003486,0.074,Nightingale,Total triglycerides,1.15 (1.08 1.22),1.60E-03
290.16,Vascular dementia,mental disorders,OPGS003475,0.076,Nightingale,Total lipids in medium VLDL,1.14 (1.07 1.22),2.66E-03
290.16,Vascular dementia,mental disorders,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.14 (1.07 1.21),3.47E-03
290.16,Vascular dementia,mental disorders,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.14 (1.07 1.21),6.78E-03
290.16,Vascular dementia,mental disorders,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.13 (1.07 1.21),7.09E-03
290.16,Vascular dementia,mental disorders,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.13 (1.06 1.20),9.80E-03
290.16,Vascular dementia,mental disorders,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.13 (1.06 1.20),1.51E-02
290.16,Vascular dementia,mental disorders,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.89 (0.83 0.94),1.54E-02
290.16,Vascular dementia,mental disorders,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.13 (1.06 1.20),1.62E-02
290.16,Vascular dementia,mental disorders,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.89 (0.83 0.94),1.64E-02
290.16,Vascular dementia,mental disorders,OPGS003527,0.050,Nightingale,Sphingomyelins,1.13 (1.06 1.20),2.05E-02
290.16,Vascular dementia,mental disorders,OPGS003490,0.073,Nightingale,Free cholesterol in medium VLDL,1.12 (1.06 1.20),2.13E-02
290.16,Vascular dementia,mental disorders,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,1.13 (1.06 1.20),2.14E-02
290.16,Vascular dementia,mental disorders,OPGS003542,0.028,Nightingale,Phospholipids in medium HDL,0.89 (0.84 0.95),2.48E-02
290.16,Vascular dementia,mental disorders,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,1.12 (1.06 1.20),2.64E-02
290.16,Vascular dementia,mental disorders,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,1.12 (1.05 1.19),4.02E-02
290.16,Vascular dementia,mental disorders,OPGS014287,0.020,RNAseq,TOMM40,1.20 (1.12 1.27),5.45E-06
290.16,Vascular dementia,mental disorders,OPGS005171,0.269,RNAseq,DARS1,0.85 (0.79 0.92),2.09E-03
290.16,Vascular dementia,mental disorders,OPGS013770,0.024,RNAseq,UBN1,0.89 (0.83 0.94),1.09E-02
290.16,Vascular dementia,mental disorders,OPGS013255,0.029,RNAseq,CROCC2,1.13 (1.06 1.20),1.48E-02
290.16,Vascular dementia,mental disorders,OPGS004598,0.340,RNAseq,RPAP1,0.89 (0.84 0.95),2.03E-02
290.16,Vascular dementia,mental disorders,OPGS007832,0.121,RNAseq,MICU3,1.12 (1.05 1.19),2.41E-02
290.16,Vascular dementia,mental disorders,OPGS012405,0.037,RNAseq,PTOV1,1.17 (1.07 1.27),4.03E-02
290.16,Vascular dementia,mental disorders,OPGS005218,0.264,RNAseq,THEMIS2,0.89 (0.84 0.95),4.50E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.36 (1.32 1.40),7.51E-95
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.35 (1.32 1.39),3.94E-92
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.35 (1.31 1.38),4.14E-91
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.35 (1.31 1.39),5.01E-91
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.36 (1.32 1.40),6.42E-89
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000857,0.067,SomaScan,Moesin,1.36 (1.32 1.40),8.70E-88
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.35 (1.31 1.39),8.13E-84
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.36 (1.32 1.41),2.16E-73
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.76 (0.74 0.78),1.01E-67
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.32 (1.28 1.36),1.15E-65
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.26 (1.23 1.29),2.75E-63
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.77 (0.75 0.79),3.59E-63
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.35 (1.31 1.40),5.75E-62
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.34 (1.30 1.39),2.16E-61
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.30 (1.26 1.34),2.33E-61
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.36 (1.31 1.41),1.23E-60
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000115,0.347,SomaScan,Protein CEI,1.35 (1.30 1.40),5.65E-57
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.29 (1.25 1.33),1.03E-56
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.34 (1.29 1.39),4.95E-54
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.33 (1.29 1.38),4.95E-54
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000911,0.062,SomaScan,Protein MENT,1.28 (1.24 1.32),2.15E-52
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.78 (0.76 0.81),6.23E-50
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000032,0.570,SomaScan,Protein S100-A13,0.79 (0.77 0.82),2.06E-47
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.32 (1.27 1.37),3.87E-46
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.80 (0.77 0.82),1.80E-45
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.24 (1.21 1.28),2.14E-40
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.27 (1.23 1.31),1.09E-39
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000312,0.163,SomaScan,Selenoprotein S,1.29 (1.24 1.34),5.05E-36
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.26 (1.22 1.30),1.14E-35
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001354,0.031,SomaScan,M-phase inducer phosphatase 2,1.22 (1.18 1.26),4.45E-31
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.22 (1.18 1.26),1.17E-30
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000613,0.096,SomaScan,Stromelysin-1,1.27 (1.22 1.32),1.26E-30
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.27 (1.22 1.32),2.15E-30
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.82 (0.79 0.84),5.74E-29
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.26 (1.21 1.31),1.35E-28
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001343,0.031,SomaScan,Beta-1.3-N-acetylglucosaminyltransferase radical fringe,0.84 (0.81 0.86),1.21E-27
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001093,0.046,SomaScan,C-reactive protein,0.83 (0.80 0.86),1.42E-26
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.24 (1.20 1.29),8.72E-26
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000502,0.117,SomaScan,Neutrophil collagenase,1.20 (1.16 1.25),5.22E-25
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.20 (1.16 1.24),4.43E-24
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000427,0.132,SomaScan,Adhesion G-protein coupled receptor F1,1.19 (1.15 1.23),5.36E-23
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000912,0.061,SomaScan,Ras-related protein Rab-14,0.86 (0.83 0.89),2.00E-16
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000172,0.257,SomaScan,Dermokine,0.86 (0.83 0.89),7.25E-15
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.15 (1.11 1.19),3.70E-14
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,0.88 (0.86 0.91),1.49E-12
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.86 (0.83 0.89),1.55E-12
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000577,0.102,SomaScan,Platelet-activating factor acetylhydrolase,1.14 (1.10 1.17),5.04E-12
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000901,0.063,SomaScan,Ski-like protein,1.13 (1.09 1.17),3.62E-11
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.14 (1.10 1.19),8.08E-11
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.88 (0.85 0.91),1.69E-10
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.13 (1.09 1.17),4.28E-08
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000422,0.134,SomaScan,Ubiquitin carboxyl-terminal hydrolase 21,1.10 (1.07 1.14),2.88E-07
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.11 (1.07 1.15),5.47E-07
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000112,0.352,SomaScan,Valine--tRNA ligase,1.09 (1.06 1.13),8.09E-06
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001092,0.046,SomaScan,TOM1-like protein 1,0.91 (0.89 0.94),8.31E-06
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000743,0.079,SomaScan,Furin,1.09 (1.05 1.12),4.81E-05
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,0.91 (0.88 0.94),7.43E-05
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS002108,0.012,SomaScan,Neuralized-like protein 4,1.10 (1.06 1.14),1.33E-04
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS002275,0.010,SomaScan,Interferon-induced protein with tetratricopeptide repeats 2,0.92 (0.89 0.95),1.52E-04
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001392,0.029,SomaScan,Cadherin-related family member 5,1.08 (1.05 1.13),1.35E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,0.92 (0.89 0.96),1.40E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001715,0.019,SomaScan,Histone deacetylase 8,1.07 (1.04 1.11),4.51E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000510,0.115,SomaScan,Guanine nucleotide-binding protein G(k) subunit alpha,0.93 (0.90 0.96),4.63E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000445,0.129,SomaScan,Collectin-10,0.93 (0.90 0.96),6.50E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,0.93 (0.90 0.96),6.64E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000715,0.082,SomaScan,Surfeit locus protein 1,1.07 (1.03 1.10),1.00E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000802,0.073,SomaScan,Mediator of RNA polymerase II transcription subunit 4,1.07 (1.03 1.10),1.01E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000348,0.151,SomaScan,Quinone oxidoreductase-like protein 1,1.07 (1.03 1.11),1.33E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000860,0.066,SomaScan,Cell surface glycoprotein CD200 receptor 2,0.93 (0.90 0.97),1.53E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS000021,0.605,SomaScan,COP9 signalosome complex subunit 7b,1.06 (1.03 1.10),2.32E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS001357,0.031,SomaScan,Tumor necrosis factor receptor superfamily member 13C,1.06 (1.03 1.10),3.57E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.28 (1.24 1.32),2.18E-52
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003006,0.030,Metabolon,cholesterol,1.23 (1.19 1.27),4.14E-28
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.20 (1.16 1.24),1.43E-25
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.15 (1.11 1.18),9.31E-15
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.13 (1.09 1.17),2.50E-11
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.10 (1.06 1.14),7.37E-05
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.07 (1.03 1.11),8.54E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.06 (1.03 1.10),4.17E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.19 (1.15 1.23),1.24E-19
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.19 (1.15 1.23),2.51E-19
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.18 (1.14 1.23),8.63E-19
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.18 (1.14 1.23),1.61E-18
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.18 (1.14 1.22),1.80E-18
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.18 (1.14 1.23),2.27E-18
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.18 (1.14 1.22),4.32E-18
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.18 (1.14 1.22),5.68E-18
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.18 (1.14 1.22),6.27E-18
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.18 (1.14 1.22),1.66E-17
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.18 (1.14 1.22),1.72E-17
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003423,0.126,Nightingale,LDL cholesterol,1.18 (1.14 1.22),2.08E-17
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.17 (1.13 1.22),3.25E-17
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.17 (1.13 1.21),5.02E-17
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.17 (1.13 1.21),7.23E-17
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.17 (1.13 1.21),9.37E-17
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.17 (1.13 1.22),1.40E-16
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.17 (1.13 1.21),2.50E-16
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.17 (1.13 1.21),2.63E-16
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.17 (1.13 1.21),2.65E-16
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.17 (1.13 1.21),3.20E-16
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.16 (1.12 1.21),1.28E-15
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.86 (0.83 0.89),1.28E-15
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.16 (1.12 1.20),7.86E-15
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.16 (1.12 1.20),2.11E-14
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.16 (1.12 1.20),3.70E-14
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.16 (1.12 1.20),4.84E-14
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.15 (1.11 1.19),8.56E-14
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.15 (1.11 1.19),3.88E-13
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.15 (1.11 1.19),1.49E-12
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.14 (1.10 1.18),7.90E-12
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.14 (1.10 1.18),9.71E-12
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003452,0.087,Nightingale,Total cholesterol,1.14 (1.10 1.18),2.63E-11
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.13 (1.10 1.17),5.73E-11
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.13 (1.09 1.17),1.01E-10
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.13 (1.09 1.17),3.06E-10
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.13 (1.09 1.17),3.57E-10
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.13 (1.09 1.17),3.85E-10
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003455,0.087,Nightingale,Total free cholesterol,1.13 (1.09 1.17),7.68E-10
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.13 (1.09 1.16),7.68E-10
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.13 (1.09 1.16),8.53E-10
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003497,0.072,Nightingale,Linoleic acid,1.12 (1.08 1.16),5.62E-09
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.12 (1.08 1.16),5.97E-09
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003523,0.062,Nightingale,Total fatty acids,1.12 (1.08 1.15),1.27E-08
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.11 (1.08 1.15),1.93E-08
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.11 (1.08 1.15),3.46E-08
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.11 (1.08 1.15),5.24E-08
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.11 (1.08 1.15),6.82E-08
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,1.11 (1.07 1.14),5.23E-07
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.10 (1.07 1.14),6.13E-07
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.10 (1.07 1.14),1.34E-06
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.10 (1.07 1.14),1.69E-06
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.10 (1.06 1.14),1.92E-06
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.91 (0.88 0.94),2.80E-06
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.91 (0.88 0.94),3.67E-06
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.10 (1.06 1.13),6.84E-06
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.10 (1.06 1.13),8.09E-06
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003476,0.076,Nightingale,Phospholipids in medium VLDL,1.09 (1.06 1.13),1.38E-05
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,1.09 (1.06 1.13),1.53E-05
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003475,0.076,Nightingale,Total lipids in medium VLDL,1.09 (1.05 1.13),6.56E-05
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.09 (1.05 1.13),7.32E-05
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.92 (0.89 0.95),8.26E-05
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.09 (1.05 1.12),1.06E-04
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.09 (1.05 1.12),1.24E-04
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003486,0.074,Nightingale,Total triglycerides,1.09 (1.05 1.12),1.46E-04
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.92 (0.89 0.95),2.24E-04
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.92 (0.89 0.95),2.51E-04
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.92 (0.89 0.95),2.68E-04
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.08 (1.05 1.12),3.71E-04
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.92 (0.89 0.96),3.87E-04
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.08 (1.05 1.12),4.83E-04
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.92 (0.89 0.96),4.83E-04
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.93 (0.90 0.96),4.97E-04
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003526,0.050,Nightingale,Phosphatidylcholines,1.08 (1.04 1.11),1.42E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.93 (0.90 0.96),1.46E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003477,0.076,Nightingale,Concentration of medium VLDL particles,1.07 (1.04 1.11),2.12E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,1.08 (1.04 1.11),2.26E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003490,0.073,Nightingale,Free cholesterol in medium VLDL,1.07 (1.04 1.11),2.32E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.07 (1.04 1.11),3.35E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003527,0.050,Nightingale,Sphingomyelins,1.07 (1.04 1.11),6.77E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003499,0.071,Nightingale,Phospholipids in large VLDL,1.07 (1.03 1.11),6.96E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,1.07 (1.03 1.10),1.51E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.94 (0.91 0.97),1.63E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003507,0.070,Nightingale,Free cholesterol in large VLDL,1.07 (1.03 1.10),1.81E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003481,0.075,Nightingale,Triglycerides in medium VLDL,1.06 (1.03 1.10),1.91E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003479,0.075,Nightingale,Triglycerides in VLDL,1.06 (1.03 1.10),2.19E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003528,0.050,Nightingale,Total cholines,1.06 (1.03 1.10),2.80E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,1.06 (1.03 1.10),2.94E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003540,0.029,Nightingale,Free cholesterol in small HDL,0.94 (0.91 0.97),2.95E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003471,0.077,Nightingale,Cholesteryl esters in large VLDL,1.06 (1.03 1.10),3.43E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.94 (0.91 0.97),3.57E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.94 (0.91 0.97),4.12E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003498,0.071,Nightingale,Triglycerides in large VLDL,1.06 (1.03 1.10),4.25E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.06 (1.03 1.10),4.27E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS014287,0.020,RNAseq,TOMM40,1.10 (1.06 1.13),9.76E-06
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS007536,0.131,RNAseq,LDLRAP1,0.93 (0.90 0.96),1.37E-03
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS006339,0.184,RNAseq,COCH,1.06 (1.03 1.10),1.63E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS012031,0.041,RNAseq,SIRT6,0.94 (0.91 0.97),1.65E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS013770,0.024,RNAseq,UBN1,0.94 (0.91 0.97),2.23E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS012540,0.035,RNAseq,RPL27A,1.06 (1.03 1.09),3.12E-02
290.2,Delirium due to conditions classified elsewhere,mental disorders,OPGS008031,0.115,RNAseq,LINC00909,1.06 (1.03 1.10),3.72E-02
291.1,Transient mental disorders due to conditions classified elsewhere,mental disorders,OPGS013184,0.029,RNAseq,SRRD,1.33 (1.18 1.50),3.94E-02
292,Neurological disorders,mental disorders,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.32 (1.27 1.39),7.17E-31
292,Neurological disorders,mental disorders,OPGS000857,0.067,SomaScan,Moesin,1.33 (1.27 1.39),4.45E-30
292,Neurological disorders,mental disorders,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.32 (1.26 1.38),4.45E-30
292,Neurological disorders,mental disorders,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.32 (1.27 1.39),8.25E-30
292,Neurological disorders,mental disorders,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.31 (1.26 1.37),8.25E-30
292,Neurological disorders,mental disorders,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.31 (1.25 1.37),4.74E-29
292,Neurological disorders,mental disorders,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.32 (1.26 1.38),2.44E-28
292,Neurological disorders,mental disorders,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.33 (1.26 1.40),1.68E-24
292,Neurological disorders,mental disorders,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.78 (0.74 0.81),7.86E-23
292,Neurological disorders,mental disorders,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.33 (1.26 1.40),2.81E-22
292,Neurological disorders,mental disorders,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.24 (1.19 1.29),2.69E-21
292,Neurological disorders,mental disorders,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.79 (0.75 0.82),5.26E-21
292,Neurological disorders,mental disorders,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.32 (1.25 1.40),1.51E-20
292,Neurological disorders,mental disorders,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.31 (1.24 1.38),2.00E-20
292,Neurological disorders,mental disorders,OPGS000115,0.347,SomaScan,Protein CEI,1.32 (1.25 1.40),7.78E-20
292,Neurological disorders,mental disorders,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.27 (1.21 1.34),8.40E-20
292,Neurological disorders,mental disorders,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.27 (1.21 1.33),1.59E-19
292,Neurological disorders,mental disorders,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.27 (1.21 1.33),1.59E-19
292,Neurological disorders,mental disorders,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.30 (1.23 1.37),3.23E-18
292,Neurological disorders,mental disorders,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.30 (1.23 1.38),6.67E-18
292,Neurological disorders,mental disorders,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.30 (1.23 1.37),1.39E-16
292,Neurological disorders,mental disorders,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.80 (0.76 0.84),3.01E-16
292,Neurological disorders,mental disorders,OPGS000032,0.570,SomaScan,Protein S100-A13,0.81 (0.77 0.85),7.37E-16
292,Neurological disorders,mental disorders,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.28 (1.21 1.35),7.77E-16
292,Neurological disorders,mental disorders,OPGS000911,0.062,SomaScan,Protein MENT,1.24 (1.18 1.30),2.73E-15
292,Neurological disorders,mental disorders,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.82 (0.78 0.86),1.02E-13
292,Neurological disorders,mental disorders,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.25 (1.18 1.32),1.73E-13
292,Neurological disorders,mental disorders,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.21 (1.16 1.27),2.15E-12
292,Neurological disorders,mental disorders,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.81 (0.77 0.86),1.23E-11
292,Neurological disorders,mental disorders,OPGS000312,0.163,SomaScan,Selenoprotein S,1.26 (1.18 1.33),1.42E-11
292,Neurological disorders,mental disorders,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.26 (1.18 1.34),3.88E-11
292,Neurological disorders,mental disorders,OPGS000613,0.096,SomaScan,Stromelysin-1,1.25 (1.17 1.32),1.84E-10
292,Neurological disorders,mental disorders,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.23 (1.16 1.31),1.70E-09
292,Neurological disorders,mental disorders,OPGS000502,0.117,SomaScan,Neutrophil collagenase,1.20 (1.14 1.26),2.38E-09
292,Neurological disorders,mental disorders,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.23 (1.16 1.30),5.12E-09
292,Neurological disorders,mental disorders,OPGS001093,0.046,SomaScan,C-reactive protein,0.84 (0.80 0.89),1.02E-08
292,Neurological disorders,mental disorders,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.19 (1.13 1.26),1.42E-08
292,Neurological disorders,mental disorders,OPGS001354,0.031,SomaScan,M-phase inducer phosphatase 2,1.18 (1.12 1.24),3.33E-08
292,Neurological disorders,mental disorders,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.18 (1.12 1.24),5.31E-08
292,Neurological disorders,mental disorders,OPGS001343,0.031,SomaScan,Beta-1.3-N-acetylglucosaminyltransferase radical fringe,0.85 (0.81 0.90),5.51E-08
292,Neurological disorders,mental disorders,OPGS000172,0.257,SomaScan,Dermokine,0.85 (0.80 0.90),9.00E-07
292,Neurological disorders,mental disorders,OPGS000427,0.132,SomaScan,Adhesion G-protein coupled receptor F1,1.15 (1.09 1.21),1.12E-05
292,Neurological disorders,mental disorders,OPGS000912,0.061,SomaScan,Ras-related protein Rab-14,0.87 (0.83 0.92),3.10E-05
292,Neurological disorders,mental disorders,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.14 (1.08 1.20),1.29E-04
292,Neurological disorders,mental disorders,OPGS000901,0.063,SomaScan,Ski-like protein,1.13 (1.07 1.19),3.30E-04
292,Neurological disorders,mental disorders,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.87 (0.82 0.92),4.06E-04
292,Neurological disorders,mental disorders,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,0.90 (0.86 0.95),3.44E-03
292,Neurological disorders,mental disorders,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.12 (1.06 1.18),9.26E-03
292,Neurological disorders,mental disorders,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.90 (0.85 0.95),9.59E-03
292,Neurological disorders,mental disorders,OPGS000577,0.102,SomaScan,Platelet-activating factor acetylhydrolase,1.11 (1.05 1.17),1.26E-02
292,Neurological disorders,mental disorders,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.12 (1.05 1.18),2.26E-02
292,Neurological disorders,mental disorders,OPGS002292,0.010,SomaScan,Interleukin-18-binding protein,1.07 (1.03 1.11),3.74E-02
292,Neurological disorders,mental disorders,OPGS002270,0.010,SomaScan,Tumor necrosis factor receptor superfamily member 21,1.07 (1.03 1.11),3.74E-02
292,Neurological disorders,mental disorders,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.10 (1.04 1.16),4.33E-02
292,Neurological disorders,mental disorders,OPGS001092,0.046,SomaScan,TOM1-like protein 1,0.91 (0.87 0.96),4.55E-02
292,Neurological disorders,mental disorders,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.27 (1.21 1.33),1.67E-19
292,Neurological disorders,mental disorders,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.22 (1.16 1.28),4.17E-12
292,Neurological disorders,mental disorders,OPGS003006,0.030,Metabolon,cholesterol,1.22 (1.16 1.29),1.69E-10
292,Neurological disorders,mental disorders,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.15 (1.10 1.21),4.40E-06
292,Neurological disorders,mental disorders,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.15 (1.09 1.20),1.15E-05
292,Neurological disorders,mental disorders,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.13 (1.07 1.20),6.42E-03
292,Neurological disorders,mental disorders,OPGS002916,0.048,Metabolon,betaine,0.90 (0.86 0.95),1.40E-02
292,Neurological disorders,mental disorders,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.20 (1.13 1.26),3.12E-08
292,Neurological disorders,mental disorders,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.19 (1.13 1.26),7.73E-08
292,Neurological disorders,mental disorders,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.19 (1.13 1.25),1.53E-07
292,Neurological disorders,mental disorders,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.19 (1.12 1.25),1.79E-07
292,Neurological disorders,mental disorders,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.19 (1.12 1.25),2.61E-07
292,Neurological disorders,mental disorders,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.18 (1.12 1.25),3.25E-07
292,Neurological disorders,mental disorders,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.18 (1.12 1.24),5.29E-07
292,Neurological disorders,mental disorders,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.18 (1.12 1.25),5.41E-07
292,Neurological disorders,mental disorders,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.18 (1.12 1.25),5.60E-07
292,Neurological disorders,mental disorders,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.18 (1.12 1.24),6.85E-07
292,Neurological disorders,mental disorders,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.17 (1.11 1.24),7.97E-07
292,Neurological disorders,mental disorders,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.17 (1.11 1.24),8.94E-07
292,Neurological disorders,mental disorders,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.18 (1.12 1.24),9.30E-07
292,Neurological disorders,mental disorders,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.18 (1.11 1.24),9.87E-07
292,Neurological disorders,mental disorders,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.17 (1.11 1.24),1.03E-06
292,Neurological disorders,mental disorders,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.17 (1.11 1.24),1.59E-06
292,Neurological disorders,mental disorders,OPGS003423,0.126,Nightingale,LDL cholesterol,1.17 (1.11 1.24),1.60E-06
292,Neurological disorders,mental disorders,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.17 (1.11 1.24),1.86E-06
292,Neurological disorders,mental disorders,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.17 (1.11 1.23),1.87E-06
292,Neurological disorders,mental disorders,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.17 (1.11 1.23),2.51E-06
292,Neurological disorders,mental disorders,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.17 (1.11 1.24),3.43E-06
292,Neurological disorders,mental disorders,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.17 (1.11 1.23),3.68E-06
292,Neurological disorders,mental disorders,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.17 (1.11 1.23),3.86E-06
292,Neurological disorders,mental disorders,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.17 (1.11 1.23),4.40E-06
292,Neurological disorders,mental disorders,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.16 (1.10 1.23),5.84E-06
292,Neurological disorders,mental disorders,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.16 (1.10 1.23),6.33E-06
292,Neurological disorders,mental disorders,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.16 (1.10 1.22),7.34E-06
292,Neurological disorders,mental disorders,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.16 (1.10 1.22),7.38E-06
292,Neurological disorders,mental disorders,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.16 (1.10 1.22),8.36E-06
292,Neurological disorders,mental disorders,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.16 (1.10 1.22),8.47E-06
292,Neurological disorders,mental disorders,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.16 (1.10 1.22),8.59E-06
292,Neurological disorders,mental disorders,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.16 (1.10 1.22),1.00E-05
292,Neurological disorders,mental disorders,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.16 (1.10 1.22),1.26E-05
292,Neurological disorders,mental disorders,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.15 (1.09 1.21),1.80E-05
292,Neurological disorders,mental disorders,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.15 (1.09 1.21),2.52E-05
292,Neurological disorders,mental disorders,OPGS003452,0.087,Nightingale,Total cholesterol,1.14 (1.08 1.20),2.45E-04
292,Neurological disorders,mental disorders,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.13 (1.07 1.19),8.46E-04
292,Neurological disorders,mental disorders,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.13 (1.07 1.19),9.79E-04
292,Neurological disorders,mental disorders,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.13 (1.07 1.18),9.88E-04
292,Neurological disorders,mental disorders,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.13 (1.07 1.19),1.02E-03
292,Neurological disorders,mental disorders,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.12 (1.07 1.18),1.09E-03
292,Neurological disorders,mental disorders,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.12 (1.07 1.18),1.10E-03
292,Neurological disorders,mental disorders,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.13 (1.07 1.19),1.36E-03
292,Neurological disorders,mental disorders,OPGS003455,0.087,Nightingale,Total free cholesterol,1.13 (1.07 1.19),1.56E-03
292,Neurological disorders,mental disorders,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.12 (1.07 1.18),1.88E-03
292,Neurological disorders,mental disorders,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.12 (1.06 1.18),3.87E-03
292,Neurological disorders,mental disorders,OPGS003523,0.062,Nightingale,Total fatty acids,1.12 (1.06 1.18),3.94E-03
292,Neurological disorders,mental disorders,OPGS003497,0.072,Nightingale,Linoleic acid,1.12 (1.06 1.18),4.30E-03
292,Neurological disorders,mental disorders,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.90 (0.85 0.94),5.70E-03
292,Neurological disorders,mental disorders,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.11 (1.06 1.17),5.78E-03
292,Neurological disorders,mental disorders,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.11 (1.06 1.17),9.11E-03
292,Neurological disorders,mental disorders,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.90 (0.86 0.95),9.11E-03
292,Neurological disorders,mental disorders,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.90 (0.85 0.95),9.38E-03
292,Neurological disorders,mental disorders,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.11 (1.05 1.17),1.19E-02
292,Neurological disorders,mental disorders,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.11 (1.05 1.17),1.49E-02
292,Neurological disorders,mental disorders,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.11 (1.05 1.16),1.70E-02
292,Neurological disorders,mental disorders,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.11 (1.05 1.16),1.80E-02
292,Neurological disorders,mental disorders,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.90 (0.86 0.95),1.96E-02
292,Neurological disorders,mental disorders,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.10 (1.04 1.16),4.73E-02
292,Neurological disorders,mental disorders,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.91 (0.87 0.96),4.76E-02
292,Neurological disorders,mental disorders,OPGS006678,0.166,RNAseq,SERINC3,0.91 (0.87 0.96),1.36E-02
292,Neurological disorders,mental disorders,OPGS003966,0.477,RNAseq,RNASE6,1.10 (1.05 1.16),2.13E-02
292,Neurological disorders,mental disorders,OPGS012385,0.037,RNAseq,AL356273.6,0.90 (0.85 0.95),2.13E-02
292,Neurological disorders,mental disorders,OPGS010509,0.061,RNAseq,TRPV3,0.91 (0.87 0.96),2.85E-02
292,Neurological disorders,mental disorders,OPGS013845,0.024,RNAseq,NIN,1.10 (1.04 1.16),3.34E-02
292.2,Mild cognitive impairment,mental disorders,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.36 (1.27 1.45),6.28E-15
292.2,Mild cognitive impairment,mental disorders,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.34 (1.26 1.43),2.59E-14
292.2,Mild cognitive impairment,mental disorders,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.34 (1.25 1.43),7.55E-14
292.2,Mild cognitive impairment,mental disorders,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.74 (0.69 0.80),2.25E-13
292.2,Mild cognitive impairment,mental disorders,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.33 (1.24 1.42),4.22E-13
292.2,Mild cognitive impairment,mental disorders,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.34 (1.25 1.43),6.06E-13
292.2,Mild cognitive impairment,mental disorders,OPGS000857,0.067,SomaScan,Moesin,1.32 (1.23 1.42),8.60E-12
292.2,Mild cognitive impairment,mental disorders,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.31 (1.22 1.41),5.16E-11
292.2,Mild cognitive impairment,mental disorders,OPGS000032,0.570,SomaScan,Protein S100-A13,0.77 (0.71 0.82),6.78E-10
292.2,Mild cognitive impairment,mental disorders,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.30 (1.21 1.40),9.70E-10
292.2,Mild cognitive impairment,mental disorders,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.77 (0.71 0.83),1.46E-09
292.2,Mild cognitive impairment,mental disorders,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.77 (0.72 0.83),1.96E-09
292.2,Mild cognitive impairment,mental disorders,OPGS000911,0.062,SomaScan,Protein MENT,1.30 (1.21 1.40),1.96E-09
292.2,Mild cognitive impairment,mental disorders,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.29 (1.20 1.38),2.01E-09
292.2,Mild cognitive impairment,mental disorders,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.32 (1.22 1.43),5.59E-09
292.2,Mild cognitive impairment,mental disorders,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.31 (1.21 1.41),7.96E-09
292.2,Mild cognitive impairment,mental disorders,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.24 (1.16 1.32),1.72E-08
292.2,Mild cognitive impairment,mental disorders,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.76 (0.71 0.83),3.02E-08
292.2,Mild cognitive impairment,mental disorders,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.32 (1.22 1.44),3.74E-08
292.2,Mild cognitive impairment,mental disorders,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.29 (1.19 1.40),3.85E-07
292.2,Mild cognitive impairment,mental disorders,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.30 (1.19 1.41),5.72E-07
292.2,Mild cognitive impairment,mental disorders,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.30 (1.19 1.41),6.71E-07
292.2,Mild cognitive impairment,mental disorders,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.80 (0.75 0.86),7.82E-07
292.2,Mild cognitive impairment,mental disorders,OPGS000115,0.347,SomaScan,Protein CEI,1.29 (1.18 1.40),2.16E-06
292.2,Mild cognitive impairment,mental disorders,OPGS000502,0.117,SomaScan,Neutrophil collagenase,1.26 (1.17 1.37),2.45E-06
292.2,Mild cognitive impairment,mental disorders,OPGS000912,0.061,SomaScan,Ras-related protein Rab-14,0.80 (0.74 0.87),1.45E-05
292.2,Mild cognitive impairment,mental disorders,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.27 (1.17 1.39),1.98E-05
292.2,Mild cognitive impairment,mental disorders,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.23 (1.14 1.32),3.63E-05
292.2,Mild cognitive impairment,mental disorders,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.23 (1.14 1.33),5.20E-05
292.2,Mild cognitive impairment,mental disorders,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.24 (1.15 1.35),5.22E-05
292.2,Mild cognitive impairment,mental disorders,OPGS001343,0.031,SomaScan,Beta-1.3-N-acetylglucosaminyltransferase radical fringe,0.84 (0.78 0.90),5.91E-04
292.2,Mild cognitive impairment,mental disorders,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.19 (1.11 1.28),1.32E-03
292.2,Mild cognitive impairment,mental disorders,OPGS001354,0.031,SomaScan,M-phase inducer phosphatase 2,1.20 (1.11 1.29),1.32E-03
292.2,Mild cognitive impairment,mental disorders,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,0.85 (0.79 0.91),1.99E-03
292.2,Mild cognitive impairment,mental disorders,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.21 (1.11 1.31),1.99E-03
292.2,Mild cognitive impairment,mental disorders,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.22 (1.11 1.33),4.92E-03
292.2,Mild cognitive impairment,mental disorders,OPGS000312,0.163,SomaScan,Selenoprotein S,1.21 (1.11 1.32),7.70E-03
292.2,Mild cognitive impairment,mental disorders,OPGS000613,0.096,SomaScan,Stromelysin-1,1.21 (1.10 1.32),1.03E-02
292.2,Mild cognitive impairment,mental disorders,OPGS000427,0.132,SomaScan,Adhesion G-protein coupled receptor F1,1.17 (1.08 1.26),2.41E-02
292.2,Mild cognitive impairment,mental disorders,OPGS000172,0.257,SomaScan,Dermokine,0.85 (0.78 0.92),2.41E-02
292.2,Mild cognitive impairment,mental disorders,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.19 (1.09 1.30),2.80E-02
292.2,Mild cognitive impairment,mental disorders,OPGS001200,0.039,SomaScan,DnaJ homolog subfamily B member 11,1.14 (1.06 1.22),4.67E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.32 (1.23 1.42),7.07E-11
292.2,Mild cognitive impairment,mental disorders,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.30 (1.21 1.40),8.84E-09
292.2,Mild cognitive impairment,mental disorders,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.21 (1.13 1.30),1.39E-04
292.2,Mild cognitive impairment,mental disorders,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.20 (1.11 1.29),8.76E-04
292.2,Mild cognitive impairment,mental disorders,OPGS003006,0.030,Metabolon,cholesterol,1.18 (1.09 1.29),1.34E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.19 (1.10 1.29),2.96E-03
292.2,Mild cognitive impairment,mental disorders,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.19 (1.10 1.29),4.89E-03
292.2,Mild cognitive impairment,mental disorders,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.19 (1.10 1.28),8.16E-03
292.2,Mild cognitive impairment,mental disorders,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.18 (1.09 1.28),1.17E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.18 (1.09 1.28),1.22E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.18 (1.09 1.28),1.22E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.18 (1.09 1.27),1.23E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.18 (1.09 1.27),1.30E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.18 (1.09 1.27),1.36E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.18 (1.09 1.28),1.40E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.18 (1.08 1.28),2.41E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.18 (1.08 1.28),2.41E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.17 (1.08 1.27),2.41E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.17 (1.08 1.26),2.44E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.16 (1.08 1.26),2.70E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.17 (1.08 1.26),2.70E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.17 (1.08 1.27),2.80E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.17 (1.08 1.27),2.81E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.16 (1.08 1.26),3.20E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.16 (1.08 1.26),3.30E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.17 (1.08 1.26),4.39E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.16 (1.07 1.26),4.67E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.17 (1.07 1.27),4.67E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.17 (1.07 1.26),4.67E-02
292.2,Mild cognitive impairment,mental disorders,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.16 (1.07 1.26),4.91E-02
292.2,Mild cognitive impairment,mental disorders,OPGS012525,0.035,RNAseq,AK9,0.89 (0.84 0.94),7.70E-03
292.2,Mild cognitive impairment,mental disorders,OPGS005073,0.279,RNAseq,PTCH1,1.16 (1.08 1.24),1.22E-02
292.2,Mild cognitive impairment,mental disorders,OPGS004544,0.347,RNAseq,AL450384.2,0.86 (0.80 0.93),4.87E-02
292.2,Mild cognitive impairment,mental disorders,OPGS004530,0.349,RNAseq,PAQR8,1.16 (1.07 1.25),4.91E-02
292.3,Memory loss,mental disorders,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.17 (1.12 1.23),5.93E-06
292.3,Memory loss,mental disorders,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.85 (0.81 0.90),6.81E-06
292.3,Memory loss,mental disorders,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.17 (1.11 1.23),6.81E-06
292.3,Memory loss,mental disorders,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.17 (1.11 1.23),1.04E-05
292.3,Memory loss,mental disorders,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.85 (0.81 0.90),1.56E-05
292.3,Memory loss,mental disorders,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.16 (1.10 1.22),2.85E-05
292.3,Memory loss,mental disorders,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.16 (1.10 1.22),5.63E-05
292.3,Memory loss,mental disorders,OPGS000032,0.570,SomaScan,Protein S100-A13,0.86 (0.82 0.91),9.56E-05
292.3,Memory loss,mental disorders,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.15 (1.09 1.21),1.22E-04
292.3,Memory loss,mental disorders,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.87 (0.83 0.92),1.99E-04
292.3,Memory loss,mental disorders,OPGS000911,0.062,SomaScan,Protein MENT,1.15 (1.09 1.21),2.62E-04
292.3,Memory loss,mental disorders,OPGS000857,0.067,SomaScan,Moesin,1.15 (1.09 1.21),2.62E-04
292.3,Memory loss,mental disorders,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.88 (0.83 0.92),6.87E-04
292.3,Memory loss,mental disorders,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.14 (1.08 1.20),1.27E-03
292.3,Memory loss,mental disorders,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.12 (1.07 1.18),5.96E-03
292.3,Memory loss,mental disorders,OPGS001343,0.031,SomaScan,Beta-1.3-N-acetylglucosaminyltransferase radical fringe,0.89 (0.84 0.94),8.89E-03
292.3,Memory loss,mental disorders,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.13 (1.07 1.19),9.14E-03
292.3,Memory loss,mental disorders,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.12 (1.06 1.18),1.54E-02
292.3,Memory loss,mental disorders,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.12 (1.06 1.18),1.61E-02
292.3,Memory loss,mental disorders,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.12 (1.06 1.19),2.51E-02
292.3,Memory loss,mental disorders,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.12 (1.06 1.19),3.49E-02
292.3,Memory loss,mental disorders,OPGS001093,0.046,SomaScan,C-reactive protein,0.89 (0.85 0.94),3.49E-02
292.3,Memory loss,mental disorders,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.11 (1.06 1.17),4.90E-02
292.4,Altered mental status,mental disorders,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.20 (1.17 1.23),1.83E-39
292.4,Altered mental status,mental disorders,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.20 (1.16 1.23),7.30E-39
292.4,Altered mental status,mental disorders,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.19 (1.16 1.22),9.66E-39
292.4,Altered mental status,mental disorders,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.20 (1.17 1.23),3.03E-38
292.4,Altered mental status,mental disorders,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.19 (1.16 1.22),7.81E-38
292.4,Altered mental status,mental disorders,OPGS000857,0.067,SomaScan,Moesin,1.20 (1.16 1.23),8.01E-38
292.4,Altered mental status,mental disorders,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.19 (1.16 1.22),2.09E-36
292.4,Altered mental status,mental disorders,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.85 (0.83 0.87),1.22E-31
292.4,Altered mental status,mental disorders,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.19 (1.15 1.22),3.98E-30
292.4,Altered mental status,mental disorders,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.85 (0.83 0.88),5.68E-29
292.4,Altered mental status,mental disorders,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.18 (1.14 1.21),6.99E-26
292.4,Altered mental status,mental disorders,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.16 (1.13 1.19),1.11E-25
292.4,Altered mental status,mental disorders,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.18 (1.15 1.21),1.57E-25
292.4,Altered mental status,mental disorders,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.15 (1.12 1.17),8.24E-25
292.4,Altered mental status,mental disorders,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.17 (1.14 1.21),1.20E-24
292.4,Altered mental status,mental disorders,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.86 (0.84 0.89),5.35E-24
292.4,Altered mental status,mental disorders,OPGS000911,0.062,SomaScan,Protein MENT,1.16 (1.13 1.19),2.45E-23
292.4,Altered mental status,mental disorders,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.16 (1.13 1.19),2.45E-23
292.4,Altered mental status,mental disorders,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.17 (1.14 1.21),1.30E-22
292.4,Altered mental status,mental disorders,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.17 (1.13 1.20),2.30E-22
292.4,Altered mental status,mental disorders,OPGS000032,0.570,SomaScan,Protein S100-A13,0.87 (0.85 0.89),3.50E-22
292.4,Altered mental status,mental disorders,OPGS000115,0.347,SomaScan,Protein CEI,1.16 (1.13 1.20),7.48E-22
292.4,Altered mental status,mental disorders,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.15 (1.12 1.18),1.50E-20
292.4,Altered mental status,mental disorders,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.14 (1.11 1.18),2.90E-20
292.4,Altered mental status,mental disorders,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.88 (0.86 0.90),1.02E-18
292.4,Altered mental status,mental disorders,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.15 (1.12 1.19),3.17E-18
292.4,Altered mental status,mental disorders,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.15 (1.12 1.19),2.18E-16
292.4,Altered mental status,mental disorders,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.13 (1.10 1.17),3.08E-16
292.4,Altered mental status,mental disorders,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.14 (1.11 1.17),3.82E-16
292.4,Altered mental status,mental disorders,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.88 (0.86 0.91),1.14E-14
292.4,Altered mental status,mental disorders,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.13 (1.09 1.16),3.20E-13
292.4,Altered mental status,mental disorders,OPGS000312,0.163,SomaScan,Selenoprotein S,1.13 (1.10 1.16),9.52E-13
292.4,Altered mental status,mental disorders,OPGS001354,0.031,SomaScan,M-phase inducer phosphatase 2,1.12 (1.09 1.15),1.45E-12
292.4,Altered mental status,mental disorders,OPGS001343,0.031,SomaScan,Beta-1.3-N-acetylglucosaminyltransferase radical fringe,0.90 (0.88 0.93),1.19E-11
292.4,Altered mental status,mental disorders,OPGS001093,0.046,SomaScan,C-reactive protein,0.90 (0.88 0.93),3.36E-11
292.4,Altered mental status,mental disorders,OPGS000613,0.096,SomaScan,Stromelysin-1,1.12 (1.09 1.16),3.56E-11
292.4,Altered mental status,mental disorders,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.11 (1.08 1.15),1.10E-09
292.4,Altered mental status,mental disorders,OPGS000427,0.132,SomaScan,Adhesion G-protein coupled receptor F1,1.10 (1.07 1.13),1.26E-09
292.4,Altered mental status,mental disorders,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.11 (1.07 1.14),1.12E-08
292.4,Altered mental status,mental disorders,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.09 (1.06 1.13),9.29E-08
292.4,Altered mental status,mental disorders,OPGS000912,0.061,SomaScan,Ras-related protein Rab-14,0.92 (0.89 0.94),1.14E-07
292.4,Altered mental status,mental disorders,OPGS000502,0.117,SomaScan,Neutrophil collagenase,1.09 (1.06 1.12),6.54E-07
292.4,Altered mental status,mental disorders,OPGS000172,0.257,SomaScan,Dermokine,0.92 (0.89 0.94),1.00E-06
292.4,Altered mental status,mental disorders,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,0.93 (0.90 0.95),3.32E-06
292.4,Altered mental status,mental disorders,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.93 (0.90 0.96),1.01E-04
292.4,Altered mental status,mental disorders,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.93 (0.90 0.96),1.25E-04
292.4,Altered mental status,mental disorders,OPGS000901,0.063,SomaScan,Ski-like protein,1.07 (1.04 1.10),3.44E-04
292.4,Altered mental status,mental disorders,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.07 (1.04 1.10),8.75E-04
292.4,Altered mental status,mental disorders,OPGS002275,0.010,SomaScan,Interferon-induced protein with tetratricopeptide repeats 2,0.94 (0.91 0.96),1.10E-03
292.4,Altered mental status,mental disorders,OPGS001092,0.046,SomaScan,TOM1-like protein 1,0.94 (0.92 0.97),2.64E-03
292.4,Altered mental status,mental disorders,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.07 (1.04 1.10),2.72E-03
292.4,Altered mental status,mental disorders,OPGS000577,0.102,SomaScan,Platelet-activating factor acetylhydrolase,1.06 (1.03 1.09),2.79E-03
292.4,Altered mental status,mental disorders,OPGS000112,0.352,SomaScan,Valine--tRNA ligase,1.06 (1.03 1.09),4.21E-03
292.4,Altered mental status,mental disorders,OPGS002296,0.010,SomaScan,Keratin. type II cytoskeletal 72,1.06 (1.03 1.10),1.29E-02
292.4,Altered mental status,mental disorders,OPGS000810,0.072,SomaScan,Cystatin-C,0.95 (0.92 0.97),1.52E-02
292.4,Altered mental status,mental disorders,OPGS000422,0.134,SomaScan,Ubiquitin carboxyl-terminal hydrolase 21,1.05 (1.03 1.08),2.05E-02
292.4,Altered mental status,mental disorders,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,0.95 (0.92 0.98),3.12E-02
292.4,Altered mental status,mental disorders,OPGS000263,0.187,SomaScan,Plexin-B2,1.05 (1.02 1.08),3.73E-02
292.4,Altered mental status,mental disorders,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.16 (1.13 1.19),3.35E-23
292.4,Altered mental status,mental disorders,OPGS003006,0.030,Metabolon,cholesterol,1.12 (1.09 1.16),5.68E-13
292.4,Altered mental status,mental disorders,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.11 (1.08 1.14),1.94E-11
292.4,Altered mental status,mental disorders,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.06 (1.03 1.09),5.06E-03
292.4,Altered mental status,mental disorders,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.06 (1.03 1.08),1.44E-02
292.4,Altered mental status,mental disorders,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.12 (1.08 1.15),4.64E-11
292.4,Altered mental status,mental disorders,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.11 (1.08 1.14),4.81E-10
292.4,Altered mental status,mental disorders,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.11 (1.08 1.14),6.26E-10
292.4,Altered mental status,mental disorders,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.11 (1.08 1.14),6.83E-10
292.4,Altered mental status,mental disorders,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.11 (1.08 1.14),1.05E-09
292.4,Altered mental status,mental disorders,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.11 (1.08 1.14),1.54E-09
292.4,Altered mental status,mental disorders,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.11 (1.07 1.14),1.74E-09
292.4,Altered mental status,mental disorders,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.11 (1.07 1.14),2.97E-09
292.4,Altered mental status,mental disorders,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.10 (1.07 1.14),3.45E-09
292.4,Altered mental status,mental disorders,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.10 (1.07 1.14),5.14E-09
292.4,Altered mental status,mental disorders,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.10 (1.07 1.14),6.74E-09
292.4,Altered mental status,mental disorders,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.10 (1.07 1.13),6.83E-09
292.4,Altered mental status,mental disorders,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.10 (1.07 1.14),6.83E-09
292.4,Altered mental status,mental disorders,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.10 (1.07 1.14),6.83E-09
292.4,Altered mental status,mental disorders,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.10 (1.07 1.14),7.21E-09
292.4,Altered mental status,mental disorders,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.10 (1.07 1.13),7.75E-09
292.4,Altered mental status,mental disorders,OPGS003423,0.126,Nightingale,LDL cholesterol,1.10 (1.07 1.13),9.92E-09
292.4,Altered mental status,mental disorders,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.10 (1.07 1.13),1.08E-08
292.4,Altered mental status,mental disorders,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.10 (1.07 1.13),1.09E-08
292.4,Altered mental status,mental disorders,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.10 (1.07 1.13),1.70E-08
292.4,Altered mental status,mental disorders,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.10 (1.07 1.13),2.47E-08
292.4,Altered mental status,mental disorders,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.10 (1.06 1.13),5.33E-08
292.4,Altered mental status,mental disorders,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.10 (1.07 1.13),6.18E-08
292.4,Altered mental status,mental disorders,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.10 (1.06 1.13),6.52E-08
292.4,Altered mental status,mental disorders,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.09 (1.06 1.13),6.93E-08
292.4,Altered mental status,mental disorders,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.09 (1.06 1.13),1.10E-07
292.4,Altered mental status,mental disorders,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.09 (1.06 1.13),1.31E-07
292.4,Altered mental status,mental disorders,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.09 (1.06 1.13),1.43E-07
292.4,Altered mental status,mental disorders,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.09 (1.06 1.12),1.77E-07
292.4,Altered mental status,mental disorders,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.09 (1.06 1.12),6.58E-07
292.4,Altered mental status,mental disorders,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.09 (1.06 1.12),9.93E-07
292.4,Altered mental status,mental disorders,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.08 (1.05 1.12),3.21E-06
292.4,Altered mental status,mental disorders,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.08 (1.05 1.11),5.53E-06
292.4,Altered mental status,mental disorders,OPGS003452,0.087,Nightingale,Total cholesterol,1.08 (1.05 1.11),1.35E-05
292.4,Altered mental status,mental disorders,OPGS003455,0.087,Nightingale,Total free cholesterol,1.08 (1.05 1.11),1.60E-05
292.4,Altered mental status,mental disorders,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.08 (1.05 1.11),2.09E-05
292.4,Altered mental status,mental disorders,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.08 (1.05 1.11),3.39E-05
292.4,Altered mental status,mental disorders,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.93 (0.90 0.95),3.46E-05
292.4,Altered mental status,mental disorders,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.07 (1.05 1.11),7.20E-05
292.4,Altered mental status,mental disorders,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.07 (1.04 1.10),1.95E-04
292.4,Altered mental status,mental disorders,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.93 (0.91 0.96),3.47E-04
292.4,Altered mental status,mental disorders,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.94 (0.91 0.96),3.98E-04
292.4,Altered mental status,mental disorders,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.94 (0.91 0.96),7.08E-04
292.4,Altered mental status,mental disorders,OPGS003497,0.072,Nightingale,Linoleic acid,1.07 (1.04 1.10),1.05E-03
292.4,Altered mental status,mental disorders,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.94 (0.91 0.96),1.14E-03
292.4,Altered mental status,mental disorders,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.07 (1.04 1.10),1.20E-03
292.4,Altered mental status,mental disorders,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.94 (0.91 0.97),1.81E-03
292.4,Altered mental status,mental disorders,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.06 (1.04 1.09),1.93E-03
292.4,Altered mental status,mental disorders,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.94 (0.91 0.97),2.08E-03
292.4,Altered mental status,mental disorders,OPGS003523,0.062,Nightingale,Total fatty acids,1.06 (1.03 1.09),2.72E-03
292.4,Altered mental status,mental disorders,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.06 (1.03 1.09),2.79E-03
292.4,Altered mental status,mental disorders,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.94 (0.92 0.97),3.10E-03
292.4,Altered mental status,mental disorders,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.94 (0.92 0.97),3.29E-03
292.4,Altered mental status,mental disorders,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.94 (0.92 0.97),3.30E-03
292.4,Altered mental status,mental disorders,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.06 (1.03 1.09),4.21E-03
292.4,Altered mental status,mental disorders,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.06 (1.03 1.09),5.61E-03
292.4,Altered mental status,mental disorders,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.06 (1.03 1.09),6.54E-03
292.4,Altered mental status,mental disorders,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.94 (0.92 0.97),6.74E-03
292.4,Altered mental status,mental disorders,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.06 (1.03 1.09),1.02E-02
292.4,Altered mental status,mental disorders,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.06 (1.03 1.09),1.40E-02
292.4,Altered mental status,mental disorders,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.06 (1.03 1.09),1.52E-02
292.4,Altered mental status,mental disorders,OPGS003520,0.062,Nightingale,HDL cholesterol,0.95 (0.92 0.97),1.52E-02
292.4,Altered mental status,mental disorders,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.06 (1.03 1.09),1.74E-02
292.4,Altered mental status,mental disorders,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.95 (0.92 0.98),2.99E-02
292.4,Altered mental status,mental disorders,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.05 (1.02 1.08),3.73E-02
292.4,Altered mental status,mental disorders,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.95 (0.92 0.98),3.73E-02
292.4,Altered mental status,mental disorders,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.05 (1.02 1.08),3.80E-02
292.4,Altered mental status,mental disorders,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,1.05 (1.02 1.08),4.09E-02
292.4,Altered mental status,mental disorders,OPGS003540,0.029,Nightingale,Free cholesterol in small HDL,0.95 (0.92 0.98),4.20E-02
292.4,Altered mental status,mental disorders,OPGS010027,0.069,RNAseq,RTCA,0.94 (0.92 0.97),5.11E-03
292.4,Altered mental status,mental disorders,OPGS006422,0.179,RNAseq,TMEM255B,0.95 (0.92 0.97),9.88E-03
292.4,Altered mental status,mental disorders,OPGS012784,0.033,RNAseq,GRAMD2B,0.95 (0.92 0.97),1.24E-02
292.4,Altered mental status,mental disorders,OPGS011006,0.054,RNAseq,AL353194.1,1.05 (1.03 1.08),1.52E-02
292.4,Altered mental status,mental disorders,OPGS006176,0.193,RNAseq,ZBED4,1.05 (1.02 1.08),2.73E-02
292.4,Altered mental status,mental disorders,OPGS004603,0.339,RNAseq,CST3,0.95 (0.93 0.98),3.73E-02
292.4,Altered mental status,mental disorders,OPGS011796,0.044,RNAseq,AKAP13,1.05 (1.02 1.08),4.20E-02
295.2,Paranoid disorders,mental disorders,OPGS010056,0.068,RNAseq,EDEM1,0.78 (0.70 0.86),3.03E-02
296.2,Depression,mental disorders,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,1.03 (1.02 1.05),1.98E-02
296.2,Depression,mental disorders,OPGS000384,0.142,SomaScan,Ectonucleoside triphosphate diphosphohydrolase 5,0.97 (0.96 0.98),3.61E-02
296.2,Depression,mental disorders,OPGS010648,0.059,RNAseq,UQCRC2,0.97 (0.96 0.98),2.43E-02
296.2,Depression,mental disorders,OPGS007619,0.128,RNAseq,KCNG2,1.03 (1.02 1.05),2.60E-02
296.2,Depression,mental disorders,OPGS012242,0.039,RNAseq,,0.97 (0.96 0.98),3.61E-02
296.2,Depression,mental disorders,OPGS014419,0.020,RNAseq,SF3A1,0.97 (0.96 0.98),3.61E-02
296.2,Depression,mental disorders,OPGS007594,0.129,RNAseq,METTL9,0.97 (0.96 0.98),3.61E-02
296.2,Depression,mental disorders,OPGS004007,0.461,RNAseq,TSTD3,0.97 (0.96 0.98),3.61E-02
296.2,Depression,mental disorders,OPGS011321,0.049,RNAseq,GDF11,1.03 (1.02 1.04),3.61E-02
296.2,Depression,mental disorders,OPGS013219,0.029,RNAseq,CCNC,1.03 (1.02 1.04),3.61E-02
296.2,Depression,mental disorders,OPGS005815,0.214,RNAseq,LINC01089,0.97 (0.96 0.99),3.92E-02
300.1,Anxiety disorder,mental disorders,OPGS000384,0.142,SomaScan,Ectonucleoside triphosphate diphosphohydrolase 5,0.96 (0.95 0.98),3.07E-02
303.3,Psychogenic disorder,mental disorders,OPGS008659,0.097,RNAseq,PGLS,0.80 (0.73 0.88),2.98E-02
306,Other mental disorder,mental disorders,OPGS000698,0.085,SomaScan,Alcohol dehydrogenase 1B,1.02 (1.01 1.03),4.50E-02
306,Other mental disorder,mental disorders,OPGS002585,0.037,Olink,T-cell surface glycoprotein CD5,1.02 (1.01 1.03),6.26E-03
306,Other mental disorder,mental disorders,OPGS002490,0.107,Olink,Cadherin-6,1.02 (1.01 1.03),1.48E-02
306,Other mental disorder,mental disorders,OPGS002468,0.142,Olink,Galectin-8,1.02 (1.01 1.03),3.08E-02
306,Other mental disorder,mental disorders,OPGS003225,0.010,Metabolon,pyruvate,0.98 (0.97 0.99),3.31E-02
306,Other mental disorder,mental disorders,OPGS012605,0.035,RNAseq,HSPA1A,0.98 (0.97 0.99),5.87E-03
306,Other mental disorder,mental disorders,OPGS006842,0.158,RNAseq,AC093583.1,1.02 (1.01 1.03),1.20E-02
306,Other mental disorder,mental disorders,OPGS004804,0.309,RNAseq,WFIKKN1,0.98 (0.97 0.99),1.48E-02
306,Other mental disorder,mental disorders,OPGS004940,0.294,RNAseq,CNOT2-DT,1.02 (1.01 1.03),1.56E-02
306,Other mental disorder,mental disorders,OPGS013964,0.023,RNAseq,LMO4,1.02 (1.01 1.03),1.76E-02
306,Other mental disorder,mental disorders,OPGS008031,0.115,RNAseq,LINC00909,1.02 (1.01 1.03),1.76E-02
306,Other mental disorder,mental disorders,OPGS011988,0.041,RNAseq,ZBTB10,1.02 (1.01 1.03),2.01E-02
306,Other mental disorder,mental disorders,OPGS010019,0.069,RNAseq,STMN3,1.02 (1.01 1.03),2.01E-02
306,Other mental disorder,mental disorders,OPGS004548,0.346,RNAseq,,0.98 (0.97 0.99),2.01E-02
306,Other mental disorder,mental disorders,OPGS009970,0.070,RNAseq,CLDN23,1.02 (1.01 1.03),2.83E-02
306,Other mental disorder,mental disorders,OPGS012552,0.035,RNAseq,REV3L,1.02 (1.01 1.03),3.31E-02
306,Other mental disorder,mental disorders,OPGS014221,0.021,RNAseq,HIC1,0.98 (0.97 0.99),3.82E-02
306,Other mental disorder,mental disorders,OPGS007619,0.128,RNAseq,KCNG2,1.02 (1.01 1.03),3.83E-02
306,Other mental disorder,mental disorders,OPGS009447,0.081,RNAseq,PROK2,0.98 (0.97 0.99),3.83E-02
306,Other mental disorder,mental disorders,OPGS012593,0.035,RNAseq,BMP2K,1.02 (1.01 1.03),4.74E-02
306,Other mental disorder,mental disorders,OPGS007546,0.131,RNAseq,ZBP1,1.02 (1.01 1.03),4.74E-02
306,Other mental disorder,mental disorders,OPGS005704,0.221,RNAseq,AF131215.5,1.02 (1.01 1.03),4.74E-02
306,Other mental disorder,mental disorders,OPGS014341,0.020,RNAseq,NFAT5,1.02 (1.01 1.03),4.74E-02
306,Other mental disorder,mental disorders,OPGS012264,0.038,RNAseq,RNF40,0.98 (0.98 0.99),4.74E-02
306,Other mental disorder,mental disorders,OPGS008529,0.101,RNAseq,CRIP3,1.02 (1.01 1.03),4.74E-02
306,Other mental disorder,mental disorders,OPGS003988,0.468,RNAseq,SIRT1,1.02 (1.01 1.03),4.74E-02
306,Other mental disorder,mental disorders,OPGS013059,0.030,RNAseq,NPM3,1.02 (1.01 1.03),4.74E-02
315,Develomental delays and disorders,mental disorders,OPGS000857,0.067,SomaScan,Moesin,1.23 (1.14 1.32),2.56E-04
315,Develomental delays and disorders,mental disorders,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.22 (1.14 1.31),2.57E-04
315,Develomental delays and disorders,mental disorders,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.22 (1.13 1.31),3.74E-04
315,Develomental delays and disorders,mental disorders,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.21 (1.13 1.30),3.74E-04
315,Develomental delays and disorders,mental disorders,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.22 (1.13 1.31),3.74E-04
315,Develomental delays and disorders,mental disorders,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.21 (1.12 1.29),3.74E-04
315,Develomental delays and disorders,mental disorders,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.21 (1.13 1.30),3.74E-04
315,Develomental delays and disorders,mental disorders,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.21 (1.13 1.30),3.74E-04
315,Develomental delays and disorders,mental disorders,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.22 (1.13 1.32),1.28E-03
315,Develomental delays and disorders,mental disorders,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.23 (1.13 1.34),1.28E-03
315,Develomental delays and disorders,mental disorders,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.23 (1.13 1.34),1.81E-03
315,Develomental delays and disorders,mental disorders,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.21 (1.12 1.31),2.54E-03
315,Develomental delays and disorders,mental disorders,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.22 (1.12 1.32),2.77E-03
315,Develomental delays and disorders,mental disorders,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.21 (1.12 1.32),4.02E-03
315,Develomental delays and disorders,mental disorders,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.84 (0.78 0.91),4.76E-03
315,Develomental delays and disorders,mental disorders,OPGS000115,0.347,SomaScan,Protein CEI,1.21 (1.11 1.31),6.80E-03
315,Develomental delays and disorders,mental disorders,OPGS001093,0.046,SomaScan,C-reactive protein,0.85 (0.78 0.91),2.19E-02
315,Develomental delays and disorders,mental disorders,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.17 (1.09 1.27),2.52E-02
315,Develomental delays and disorders,mental disorders,OPGS000911,0.062,SomaScan,Protein MENT,1.17 (1.09 1.26),2.81E-02
315,Develomental delays and disorders,mental disorders,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.17 (1.08 1.25),3.93E-02
315,Develomental delays and disorders,mental disorders,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.86 (0.80 0.93),4.07E-02
315,Develomental delays and disorders,mental disorders,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.20 (1.10 1.31),4.99E-02
315,Develomental delays and disorders,mental disorders,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.18 (1.09 1.27),1.47E-02
316,Substance addiction and disorders,mental disorders,OPGS007241,0.142,RNAseq,SIGLEC9,0.79 (0.72 0.87),1.20E-02
316.1,Polyneuropathy due to drugs,mental disorders,OPGS004362,0.378,RNAseq,NIPAL2,0.76 (0.68 0.85),1.41E-02
317,Alcohol-related disorders,mental disorders,OPGS002010,0.013,SomaScan,Myc proto-oncogene protein,1.01 (1.01 1.02),2.32E-02
317,Alcohol-related disorders,mental disorders,OPGS002910,0.049,Metabolon,X - 24422,0.95 (0.93 0.97),2.32E-02
318,Tobacco use disorder,mental disorders,OPGS002010,0.013,SomaScan,Myc proto-oncogene protein,1.01 (1.01 1.02),1.34E-02
318,Tobacco use disorder,mental disorders,OPGS003190,0.012,Metabolon,3-methylxanthine,0.97 (0.95 0.98),2.45E-04
318,Tobacco use disorder,mental disorders,OPGS003106,0.018,Metabolon,X - 12126,0.97 (0.96 0.98),2.45E-04
318,Tobacco use disorder,mental disorders,OPGS003097,0.019,Metabolon,X - 12216,0.97 (0.96 0.98),1.17E-03
318,Tobacco use disorder,mental disorders,OPGS003226,0.010,Metabolon,indolin-2-one,1.03 (1.02 1.04),2.36E-03
318,Tobacco use disorder,mental disorders,OPGS004556,0.345,RNAseq,KIF26A,1.03 (1.02 1.04),2.92E-03
318,Tobacco use disorder,mental disorders,OPGS011717,0.044,RNAseq,ZC3H7A,1.03 (1.02 1.04),9.25E-03
318,Tobacco use disorder,mental disorders,OPGS006230,0.190,RNAseq,CHRNB1,0.97 (0.96 0.98),1.30E-02
318,Tobacco use disorder,mental disorders,OPGS013262,0.028,RNAseq,AP005432.1,0.97 (0.96 0.98),1.32E-02
318,Tobacco use disorder,mental disorders,OPGS008621,0.098,RNAseq,DBN1,0.97 (0.96 0.99),1.70E-02
318,Tobacco use disorder,mental disorders,OPGS004134,0.427,RNAseq,H2BC5,1.03 (1.02 1.04),1.70E-02
318,Tobacco use disorder,mental disorders,OPGS010468,0.062,RNAseq,SCAI,1.03 (1.01 1.04),3.29E-02
318,Tobacco use disorder,mental disorders,OPGS005918,0.208,RNAseq,DDR1,1.03 (1.01 1.04),4.94E-02
318,Tobacco use disorder,mental disorders,OPGS013276,0.028,RNAseq,ZNF346,1.02 (1.01 1.04),4.94E-02
324,Other CNS infection and poliomyelitis,neurological,OPGS008244,0.108,RNAseq,ICA1L,0.96 (0.94 0.98),9.46E-03
331,Other cerebral degenerations,neurological,OPGS000857,0.067,SomaScan,Moesin,1.30 (1.22 1.40),1.24E-09
331,Other cerebral degenerations,neurological,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.30 (1.21 1.39),1.24E-09
331,Other cerebral degenerations,neurological,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.30 (1.21 1.39),1.24E-09
331,Other cerebral degenerations,neurological,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.29 (1.20 1.38),1.45E-09
331,Other cerebral degenerations,neurological,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.28 (1.20 1.37),1.80E-09
331,Other cerebral degenerations,neurological,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.28 (1.19 1.37),8.54E-09
331,Other cerebral degenerations,neurological,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.27 (1.19 1.36),1.26E-08
331,Other cerebral degenerations,neurological,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.31 (1.21 1.42),1.37E-08
331,Other cerebral degenerations,neurological,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.31 (1.21 1.42),1.09E-07
331,Other cerebral degenerations,neurological,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.23 (1.16 1.31),1.09E-07
331,Other cerebral degenerations,neurological,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.31 (1.21 1.43),1.56E-07
331,Other cerebral degenerations,neurological,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.80 (0.74 0.86),8.22E-07
331,Other cerebral degenerations,neurological,OPGS000115,0.347,SomaScan,Protein CEI,1.30 (1.19 1.41),1.67E-06
331,Other cerebral degenerations,neurological,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.80 (0.75 0.86),1.71E-06
331,Other cerebral degenerations,neurological,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.24 (1.15 1.34),9.19E-06
331,Other cerebral degenerations,neurological,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.26 (1.16 1.36),1.27E-05
331,Other cerebral degenerations,neurological,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.27 (1.17 1.38),1.80E-05
331,Other cerebral degenerations,neurological,OPGS000911,0.062,SomaScan,Protein MENT,1.23 (1.14 1.32),3.40E-05
331,Other cerebral degenerations,neurological,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.26 (1.16 1.36),4.38E-05
331,Other cerebral degenerations,neurological,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.82 (0.76 0.88),9.26E-05
331,Other cerebral degenerations,neurological,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.22 (1.13 1.31),9.26E-05
331,Other cerebral degenerations,neurological,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.24 (1.14 1.34),1.09E-04
331,Other cerebral degenerations,neurological,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.25 (1.15 1.36),1.62E-04
331,Other cerebral degenerations,neurological,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.20 (1.12 1.29),4.20E-04
331,Other cerebral degenerations,neurological,OPGS000032,0.570,SomaScan,Protein S100-A13,0.83 (0.77 0.89),4.55E-04
331,Other cerebral degenerations,neurological,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.25 (1.14 1.37),8.23E-04
331,Other cerebral degenerations,neurological,OPGS001093,0.046,SomaScan,C-reactive protein,0.83 (0.77 0.89),8.57E-04
331,Other cerebral degenerations,neurological,OPGS000312,0.163,SomaScan,Selenoprotein S,1.24 (1.13 1.35),1.08E-03
331,Other cerebral degenerations,neurological,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.20 (1.11 1.30),1.84E-03
331,Other cerebral degenerations,neurological,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.84 (0.78 0.91),3.02E-03
331,Other cerebral degenerations,neurological,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.20 (1.10 1.30),7.55E-03
331,Other cerebral degenerations,neurological,OPGS000613,0.096,SomaScan,Stromelysin-1,1.21 (1.11 1.33),8.81E-03
331,Other cerebral degenerations,neurological,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.21 (1.10 1.32),1.57E-02
331,Other cerebral degenerations,neurological,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.20 (1.10 1.32),1.68E-02
331,Other cerebral degenerations,neurological,OPGS000502,0.117,SomaScan,Neutrophil collagenase,1.17 (1.08 1.27),3.81E-02
331,Other cerebral degenerations,neurological,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.16 (1.08 1.26),3.90E-02
331,Other cerebral degenerations,neurological,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.86 (0.79 0.93),4.85E-02
331,Other cerebral degenerations,neurological,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.23 (1.14 1.32),4.14E-05
331,Other cerebral degenerations,neurological,OPGS003006,0.030,Metabolon,cholesterol,1.25 (1.15 1.36),1.09E-04
331,Other cerebral degenerations,neurological,OPGS011654,0.045,RNAseq,APBB3,0.83 (0.76 0.91),3.84E-02
331,Other cerebral degenerations,neurological,OPGS005578,0.232,RNAseq,STK39,0.86 (0.80 0.93),3.99E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.22 (1.15 1.28),3.03E-08
331.9,Cerebral degeneration. unspecified,neurological,OPGS000857,0.067,SomaScan,Moesin,1.20 (1.14 1.27),1.80E-07
331.9,Cerebral degeneration. unspecified,neurological,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.20 (1.14 1.27),2.54E-07
331.9,Cerebral degeneration. unspecified,neurological,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.19 (1.13 1.26),3.40E-07
331.9,Cerebral degeneration. unspecified,neurological,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.19 (1.13 1.26),4.54E-07
331.9,Cerebral degeneration. unspecified,neurological,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.19 (1.13 1.26),4.82E-07
331.9,Cerebral degeneration. unspecified,neurological,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.20 (1.13 1.27),8.89E-07
331.9,Cerebral degeneration. unspecified,neurological,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.20 (1.14 1.28),8.89E-07
331.9,Cerebral degeneration. unspecified,neurological,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.18 (1.12 1.25),1.57E-06
331.9,Cerebral degeneration. unspecified,neurological,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.21 (1.14 1.29),2.37E-06
331.9,Cerebral degeneration. unspecified,neurological,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.20 (1.13 1.27),7.04E-06
331.9,Cerebral degeneration. unspecified,neurological,OPGS000115,0.347,SomaScan,Protein CEI,1.20 (1.13 1.28),7.04E-06
331.9,Cerebral degeneration. unspecified,neurological,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.85 (0.81 0.90),1.98E-05
331.9,Cerebral degeneration. unspecified,neurological,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.85 (0.81 0.90),1.98E-05
331.9,Cerebral degeneration. unspecified,neurological,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.85 (0.81 0.90),3.49E-05
331.9,Cerebral degeneration. unspecified,neurological,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.17 (1.11 1.24),3.49E-05
331.9,Cerebral degeneration. unspecified,neurological,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.16 (1.10 1.23),9.50E-05
331.9,Cerebral degeneration. unspecified,neurological,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.18 (1.11 1.26),1.11E-04
331.9,Cerebral degeneration. unspecified,neurological,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.17 (1.10 1.24),3.33E-04
331.9,Cerebral degeneration. unspecified,neurological,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.17 (1.10 1.25),5.16E-04
331.9,Cerebral degeneration. unspecified,neurological,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.16 (1.10 1.24),5.59E-04
331.9,Cerebral degeneration. unspecified,neurological,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.86 (0.81 0.92),9.31E-04
331.9,Cerebral degeneration. unspecified,neurological,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.16 (1.09 1.24),1.99E-03
331.9,Cerebral degeneration. unspecified,neurological,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.13 (1.07 1.19),3.01E-03
331.9,Cerebral degeneration. unspecified,neurological,OPGS000312,0.163,SomaScan,Selenoprotein S,1.16 (1.09 1.24),3.03E-03
331.9,Cerebral degeneration. unspecified,neurological,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.13 (1.07 1.20),7.78E-03
331.9,Cerebral degeneration. unspecified,neurological,OPGS000613,0.096,SomaScan,Stromelysin-1,1.15 (1.08 1.23),7.78E-03
331.9,Cerebral degeneration. unspecified,neurological,OPGS000032,0.570,SomaScan,Protein S100-A13,0.88 (0.83 0.93),7.78E-03
331.9,Cerebral degeneration. unspecified,neurological,OPGS000911,0.062,SomaScan,Protein MENT,1.13 (1.07 1.20),7.78E-03
331.9,Cerebral degeneration. unspecified,neurological,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.15 (1.08 1.23),1.11E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.13 (1.07 1.20),1.52E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.12 (1.06 1.19),1.97E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS000172,0.257,SomaScan,Dermokine,0.89 (0.84 0.95),4.02E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS002600,0.030,Olink,Heme oxygenase 1,0.88 (0.83 0.93),1.06E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.20 (1.13 1.26),8.89E-07
331.9,Cerebral degeneration. unspecified,neurological,OPGS003006,0.030,Metabolon,cholesterol,1.18 (1.11 1.25),1.53E-04
331.9,Cerebral degeneration. unspecified,neurological,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.13 (1.06 1.20),1.55E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.15 (1.08 1.22),6.59E-03
331.9,Cerebral degeneration. unspecified,neurological,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.15 (1.08 1.22),6.59E-03
331.9,Cerebral degeneration. unspecified,neurological,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.14 (1.08 1.22),8.92E-03
331.9,Cerebral degeneration. unspecified,neurological,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.14 (1.07 1.21),1.06E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.14 (1.07 1.21),1.06E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.14 (1.07 1.21),1.06E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.14 (1.07 1.21),1.08E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.14 (1.07 1.21),1.13E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.14 (1.07 1.21),1.28E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.14 (1.07 1.21),1.28E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.14 (1.07 1.21),1.29E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.14 (1.07 1.21),1.38E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.14 (1.07 1.21),1.44E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.14 (1.07 1.21),1.44E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.13 (1.07 1.21),1.60E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003423,0.126,Nightingale,LDL cholesterol,1.13 (1.07 1.21),1.60E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.13 (1.07 1.21),1.60E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.13 (1.07 1.20),1.70E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.13 (1.07 1.21),1.70E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.13 (1.06 1.20),1.74E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.13 (1.07 1.20),1.74E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.13 (1.06 1.20),1.91E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.13 (1.06 1.20),2.03E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.13 (1.06 1.20),2.37E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.13 (1.06 1.20),2.89E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.13 (1.06 1.20),3.22E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003452,0.087,Nightingale,Total cholesterol,1.12 (1.06 1.19),3.22E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.12 (1.06 1.19),4.39E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS005356,0.251,RNAseq,TTC37,1.14 (1.08 1.20),1.14E-03
331.9,Cerebral degeneration. unspecified,neurological,OPGS011409,0.048,RNAseq,NTMT1,1.11 (1.06 1.16),8.94E-03
331.9,Cerebral degeneration. unspecified,neurological,OPGS009582,0.077,RNAseq,GLMP,1.14 (1.07 1.21),1.74E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS004535,0.349,RNAseq,GFRA2,0.89 (0.84 0.95),3.11E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS014652,0.018,RNAseq,FOSL2,0.89 (0.84 0.95),3.22E-02
331.9,Cerebral degeneration. unspecified,neurological,OPGS011920,0.042,RNAseq,TTLL7,1.08 (1.04 1.13),4.56E-02
332,Parkinson's disease,neurological,OPGS003625,0.664,RNAseq,,1.11 (1.07 1.16),1.49E-03
332,Parkinson's disease,neurological,OPGS003644,0.643,RNAseq,KANSL1-AS1,0.90 (0.86 0.93),1.49E-03
332,Parkinson's disease,neurological,OPGS012851,0.032,RNAseq,SUDS3,0.90 (0.86 0.94),3.90E-03
333,Extrapyramidal disease and abnormal movement disorders,neurological,OPGS003162,0.014,Metabolon,2-hydroxybutyrate/2-hydroxyisobutyrate,1.18 (1.10 1.27),2.81E-02
333,Extrapyramidal disease and abnormal movement disorders,neurological,OPGS010356,0.063,RNAseq,COPZ2,1.16 (1.09 1.23),2.81E-02
334.1,Spinocerebellar disease,neurological,OPGS001865,0.015,SomaScan,Alpha-2-antiplasmin,0.79 (0.72 0.87),1.55E-02
335,Multiple sclerosis,neurological,OPGS002070,0.012,SomaScan,Gro-beta/gamma,1.53 (1.47 1.60),3.55E-91
335,Multiple sclerosis,neurological,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,0.63 (0.60 0.66),8.01E-76
335,Multiple sclerosis,neurological,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.67 (0.64 0.70),1.67E-56
335,Multiple sclerosis,neurological,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,1.49 (1.41 1.57),1.17E-42
335,Multiple sclerosis,neurological,OPGS000137,0.312,SomaScan,Complement C4b,1.35 (1.28 1.41),1.25E-29
335,Multiple sclerosis,neurological,OPGS001231,0.037,SomaScan,Osteocalcin,0.75 (0.72 0.79),1.74E-27
335,Multiple sclerosis,neurological,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.75 (0.71 0.79),8.19E-27
335,Multiple sclerosis,neurological,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,0.77 (0.74 0.81),1.08E-23
335,Multiple sclerosis,neurological,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.79 (0.75 0.83),1.98E-20
335,Multiple sclerosis,neurological,OPGS000984,0.055,SomaScan,Complement C2,0.81 (0.78 0.85),2.32E-19
335,Multiple sclerosis,neurological,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,0.80 (0.76 0.84),6.81E-16
335,Multiple sclerosis,neurological,OPGS002246,0.010,SomaScan,Sperm-associated antigen 11B,1.26 (1.20 1.32),8.25E-16
335,Multiple sclerosis,neurological,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,1.24 (1.18 1.31),2.04E-15
335,Multiple sclerosis,neurological,OPGS001883,0.015,SomaScan,UMP-CMP kinase,0.79 (0.75 0.83),6.00E-15
335,Multiple sclerosis,neurological,OPGS000681,0.087,SomaScan,Protein-glutamine gamma-glutamyltransferase E,1.23 (1.17 1.29),3.39E-14
335,Multiple sclerosis,neurological,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.83 (0.79 0.87),6.59E-14
335,Multiple sclerosis,neurological,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.83 (0.79 0.87),4.36E-13
335,Multiple sclerosis,neurological,OPGS001598,0.022,SomaScan,SPARC,1.23 (1.17 1.29),5.99E-13
335,Multiple sclerosis,neurological,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,1.18 (1.13 1.23),6.46E-12
335,Multiple sclerosis,neurological,OPGS000123,0.339,SomaScan,GDH/6PGL endoplasmic bifunctional protein,1.20 (1.14 1.25),2.98E-11
335,Multiple sclerosis,neurological,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,0.85 (0.81 0.88),1.57E-10
335,Multiple sclerosis,neurological,OPGS001102,0.046,SomaScan,Granzyme A,0.84 (0.81 0.88),2.48E-10
335,Multiple sclerosis,neurological,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.85 (0.81 0.89),6.66E-10
335,Multiple sclerosis,neurological,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,1.17 (1.12 1.22),5.22E-09
335,Multiple sclerosis,neurological,OPGS000469,0.125,SomaScan,Complement factor B,0.86 (0.82 0.90),8.91E-09
335,Multiple sclerosis,neurological,OPGS001679,0.020,SomaScan,Metalloproteinase inhibitor 1,1.18 (1.12 1.24),1.02E-08
335,Multiple sclerosis,neurological,OPGS001286,0.034,SomaScan,Granzyme K,0.86 (0.82 0.90),3.81E-08
335,Multiple sclerosis,neurological,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.86 (0.82 0.90),4.79E-08
335,Multiple sclerosis,neurological,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,1.16 (1.11 1.22),1.94E-07
335,Multiple sclerosis,neurological,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.87 (0.83 0.91),2.54E-07
335,Multiple sclerosis,neurological,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.87 (0.83 0.91),1.06E-06
335,Multiple sclerosis,neurological,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.86 (0.81 0.90),2.36E-06
335,Multiple sclerosis,neurological,OPGS001893,0.015,SomaScan,Interleukin-17F,0.86 (0.82 0.91),4.20E-06
335,Multiple sclerosis,neurological,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,1.14 (1.09 1.20),1.91E-05
335,Multiple sclerosis,neurological,OPGS001911,0.014,SomaScan,Ectodysplasin-A. secreted form,0.88 (0.83 0.92),1.13E-04
335,Multiple sclerosis,neurological,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,1.12 (1.07 1.18),2.69E-04
335,Multiple sclerosis,neurological,OPGS001755,0.018,SomaScan,N-acetyllactosaminide beta-1.6-N-acetylglucosaminyl-transferase. isoform C,1.10 (1.06 1.15),8.36E-04
335,Multiple sclerosis,neurological,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.11 (1.06 1.17),1.09E-03
335,Multiple sclerosis,neurological,OPGS000846,0.068,SomaScan,2-phosphoxylose phosphatase 1,0.90 (0.86 0.95),3.41E-03
335,Multiple sclerosis,neurological,OPGS000290,0.171,SomaScan,Complement C4,0.90 (0.86 0.95),4.18E-03
335,Multiple sclerosis,neurological,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,0.91 (0.87 0.95),7.87E-03
335,Multiple sclerosis,neurological,OPGS000798,0.073,SomaScan,N-acetylated-alpha-linked acidic dipeptidase 2,0.91 (0.87 0.96),1.11E-02
335,Multiple sclerosis,neurological,OPGS000517,0.114,SomaScan,Advanced glycosylation end product-specific receptor. soluble,1.09 (1.04 1.15),3.23E-02
335,Multiple sclerosis,neurological,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,0.92 (0.87 0.96),3.71E-02
335,Multiple sclerosis,neurological,OPGS000665,0.088,SomaScan,Glutamate receptor ionotropic. delta-2,0.92 (0.87 0.96),3.81E-02
335,Multiple sclerosis,neurological,OPGS002643,0.018,Olink,Neuroblastoma suppressor of tumorigenicity 1,1.41 (1.34 1.48),2.02E-38
335,Multiple sclerosis,neurological,OPGS002568,0.043,Olink,Granzyme A,0.80 (0.77 0.84),1.16E-17
335,Multiple sclerosis,neurological,OPGS002559,0.048,Olink,C-C motif chemokine 19,1.21 (1.16 1.27),1.60E-14
335,Multiple sclerosis,neurological,OPGS002551,0.054,Olink,Gastrotropin,1.20 (1.15 1.26),8.72E-12
335,Multiple sclerosis,neurological,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,1.12 (1.07 1.18),5.10E-04
335,Multiple sclerosis,neurological,OPGS002530,0.067,Olink,Trefoil factor 3,0.89 (0.85 0.94),2.15E-03
335,Multiple sclerosis,neurological,OPGS003121,0.017,Metabolon,1.2-dipalmitoyl-GPC (16:0/16:0),0.89 (0.85 0.93),8.06E-05
335,Multiple sclerosis,neurological,OPGS003174,0.013,Metabolon,X - 16649,0.92 (0.87 0.96),3.63E-02
335,Multiple sclerosis,neurological,OPGS009077,0.088,RNAseq,DDAH2,1.52 (1.45 1.58),6.96E-79
335,Multiple sclerosis,neurological,OPGS006248,0.189,RNAseq,MCCD1,0.66 (0.63 0.69),4.81E-61
335,Multiple sclerosis,neurological,OPGS013958,0.023,RNAseq,CSNK2B,1.53 (1.45 1.61),1.99E-49
335,Multiple sclerosis,neurological,OPGS015030,0.016,RNAseq,PRRC2A,0.68 (0.65 0.71),5.95E-49
335,Multiple sclerosis,neurological,OPGS011283,0.050,RNAseq,CD248,0.70 (0.67 0.73),3.77E-45
335,Multiple sclerosis,neurological,OPGS013699,0.025,RNAseq,TRAV5,0.70 (0.66 0.73),5.29E-43
335,Multiple sclerosis,neurological,OPGS010693,0.058,RNAseq,TRBV5-1,1.39 (1.33 1.45),1.09E-42
335,Multiple sclerosis,neurological,OPGS012358,0.037,RNAseq,SFRP5,0.70 (0.66 0.73),2.01E-41
335,Multiple sclerosis,neurological,OPGS012171,0.039,RNAseq,TRBV15,1.39 (1.32 1.46),4.40E-35
335,Multiple sclerosis,neurological,OPGS006942,0.154,RNAseq,SKIV2L,0.71 (0.67 0.75),1.42E-33
335,Multiple sclerosis,neurological,OPGS008889,0.092,RNAseq,TRAV20,0.73 (0.70 0.77),8.60E-31
335,Multiple sclerosis,neurological,OPGS004956,0.291,RNAseq,,1.39 (1.32 1.47),1.99E-30
335,Multiple sclerosis,neurological,OPGS007384,0.137,RNAseq,HLA-B,1.39 (1.32 1.47),1.44E-29
335,Multiple sclerosis,neurological,OPGS011086,0.053,RNAseq,HSPA1B,1.27 (1.22 1.32),9.33E-29
335,Multiple sclerosis,neurological,OPGS013225,0.029,RNAseq,REG4,0.76 (0.73 0.80),4.81E-28
335,Multiple sclerosis,neurological,OPGS008402,0.104,RNAseq,TNXB,0.74 (0.70 0.78),5.79E-27
335,Multiple sclerosis,neurological,OPGS011585,0.046,RNAseq,CD8B,0.77 (0.74 0.81),1.13E-24
335,Multiple sclerosis,neurological,OPGS005334,0.253,RNAseq,AL645933.4,1.30 (1.24 1.37),1.24E-24
335,Multiple sclerosis,neurological,OPGS012855,0.032,RNAseq,TRBV9,1.30 (1.24 1.36),2.50E-24
335,Multiple sclerosis,neurological,OPGS007394,0.136,RNAseq,AL662844.4,1.31 (1.25 1.38),1.78E-23
335,Multiple sclerosis,neurological,OPGS004122,0.430,RNAseq,HLA-DRB5,1.27 (1.21 1.33),2.66E-23
335,Multiple sclerosis,neurological,OPGS013514,0.026,RNAseq,GZMK,0.77 (0.74 0.81),1.06E-22
335,Multiple sclerosis,neurological,OPGS014283,0.021,RNAseq,MXRA8,0.79 (0.75 0.83),3.01E-18
335,Multiple sclerosis,neurological,OPGS010874,0.056,RNAseq,ALS2CL,1.23 (1.17 1.28),8.59E-17
335,Multiple sclerosis,neurological,OPGS011716,0.045,RNAseq,FBLN7,1.24 (1.19 1.30),1.17E-16
335,Multiple sclerosis,neurological,OPGS011626,0.046,RNAseq,ABCF1,0.80 (0.76 0.85),2.51E-14
335,Multiple sclerosis,neurological,OPGS010624,0.059,RNAseq,TRBV18,0.82 (0.78 0.86),1.63E-13
335,Multiple sclerosis,neurological,OPGS015052,0.015,RNAseq,CISH,1.23 (1.17 1.29),2.03E-13
335,Multiple sclerosis,neurological,OPGS010348,0.063,RNAseq,TRBV6-5,0.82 (0.78 0.86),3.99E-13
335,Multiple sclerosis,neurological,OPGS005519,0.236,RNAseq,AL645933.3,1.22 (1.16 1.29),2.82E-12
335,Multiple sclerosis,neurological,OPGS010929,0.055,RNAseq,EOMES,0.82 (0.78 0.87),7.17E-12
335,Multiple sclerosis,neurological,OPGS014232,0.021,RNAseq,TRAV1-2,0.83 (0.79 0.87),1.28E-11
335,Multiple sclerosis,neurological,OPGS013305,0.028,RNAseq,TRBV14,1.21 (1.15 1.27),2.50E-11
335,Multiple sclerosis,neurological,OPGS011025,0.053,RNAseq,MDC1,1.15 (1.11 1.19),4.08E-11
335,Multiple sclerosis,neurological,OPGS010561,0.060,RNAseq,IL2RA,1.18 (1.13 1.24),2.87E-10
335,Multiple sclerosis,neurological,OPGS011853,0.043,RNAseq,TRBV6-1,1.18 (1.13 1.24),3.51E-10
335,Multiple sclerosis,neurological,OPGS011010,0.054,RNAseq,TRBV5-4,1.20 (1.14 1.26),6.07E-10
335,Multiple sclerosis,neurological,OPGS009711,0.075,RNAseq,TRAV21,1.18 (1.12 1.23),1.10E-09
335,Multiple sclerosis,neurological,OPGS013045,0.030,RNAseq,NEU1,0.85 (0.81 0.89),1.13E-09
335,Multiple sclerosis,neurological,OPGS006038,0.201,RNAseq,HLA-DQA2,0.83 (0.78 0.87),1.19E-09
335,Multiple sclerosis,neurological,OPGS004213,0.410,RNAseq,,0.84 (0.79 0.88),1.19E-09
335,Multiple sclerosis,neurological,OPGS009176,0.086,RNAseq,,0.85 (0.81 0.89),1.60E-09
335,Multiple sclerosis,neurological,OPGS012636,0.034,RNAseq,KIR2DL3,1.17 (1.12 1.22),2.28E-09
335,Multiple sclerosis,neurological,OPGS013243,0.029,RNAseq,TRAV3,1.18 (1.12 1.24),1.04E-08
335,Multiple sclerosis,neurological,OPGS004567,0.343,RNAseq,HLA-C,1.17 (1.11 1.22),1.30E-08
335,Multiple sclerosis,neurological,OPGS011431,0.048,RNAseq,VWA7,1.18 (1.12 1.24),2.31E-08
335,Multiple sclerosis,neurological,OPGS014443,0.019,RNAseq,ABCB1,0.85 (0.81 0.89),3.44E-08
335,Multiple sclerosis,neurological,OPGS012698,0.034,RNAseq,SNHG32,0.85 (0.80 0.89),4.83E-08
335,Multiple sclerosis,neurological,OPGS003621,0.665,RNAseq,,0.86 (0.82 0.90),7.70E-08
335,Multiple sclerosis,neurological,OPGS013155,0.029,RNAseq,MDS2,1.17 (1.11 1.22),1.58E-07
335,Multiple sclerosis,neurological,OPGS004489,0.357,RNAseq,,0.86 (0.82 0.90),4.65E-07
335,Multiple sclerosis,neurological,OPGS006940,0.154,RNAseq,,0.86 (0.82 0.91),9.54E-07
335,Multiple sclerosis,neurological,OPGS012006,0.041,RNAseq,VARS2,0.87 (0.83 0.91),1.06E-06
335,Multiple sclerosis,neurological,OPGS010277,0.065,RNAseq,CXCR6,0.87 (0.83 0.91),1.79E-06
335,Multiple sclerosis,neurological,OPGS009300,0.083,RNAseq,TRAV26-1,1.15 (1.10 1.21),2.44E-06
335,Multiple sclerosis,neurological,OPGS004334,0.383,RNAseq,HLA-G,0.87 (0.83 0.91),2.44E-06
335,Multiple sclerosis,neurological,OPGS009672,0.076,RNAseq,CALR,1.15 (1.09 1.20),2.90E-06
335,Multiple sclerosis,neurological,OPGS013660,0.025,RNAseq,CD8A,0.87 (0.83 0.92),4.67E-06
335,Multiple sclerosis,neurological,OPGS004112,0.433,RNAseq,HLA-F,1.14 (1.09 1.20),6.41E-06
335,Multiple sclerosis,neurological,OPGS006499,0.176,RNAseq,C4A,1.15 (1.09 1.21),9.82E-06
335,Multiple sclerosis,neurological,OPGS005918,0.208,RNAseq,DDR1,0.87 (0.83 0.91),1.07E-05
335,Multiple sclerosis,neurological,OPGS014176,0.021,RNAseq,TRAV27,1.13 (1.08 1.18),2.06E-05
335,Multiple sclerosis,neurological,OPGS012271,0.038,RNAseq,TRBV5-6,0.90 (0.87 0.94),2.20E-05
335,Multiple sclerosis,neurological,OPGS011948,0.042,RNAseq,ADGRG1,1.14 (1.08 1.19),2.22E-05
335,Multiple sclerosis,neurological,OPGS005389,0.248,RNAseq,TRAV23DV6,1.15 (1.09 1.21),3.65E-05
335,Multiple sclerosis,neurological,OPGS008869,0.093,RNAseq,,1.17 (1.10 1.24),5.40E-05
335,Multiple sclerosis,neurological,OPGS010475,0.061,RNAseq,ZNRD1,0.88 (0.84 0.93),7.13E-05
335,Multiple sclerosis,neurological,OPGS007089,0.148,RNAseq,HLA-A,0.88 (0.84 0.93),1.76E-04
335,Multiple sclerosis,neurological,OPGS004144,0.424,RNAseq,PSORS1C3,0.88 (0.84 0.93),4.15E-04
335,Multiple sclerosis,neurological,OPGS009920,0.071,RNAseq,LINC02446,0.89 (0.85 0.94),4.42E-04
335,Multiple sclerosis,neurological,OPGS007297,0.140,RNAseq,GPANK1,0.89 (0.84 0.94),1.09E-03
335,Multiple sclerosis,neurological,OPGS013780,0.024,RNAseq,ZSCAN16,1.11 (1.06 1.16),1.21E-03
335,Multiple sclerosis,neurological,OPGS013383,0.027,RNAseq,PPP1R11,0.88 (0.84 0.93),1.34E-03
335,Multiple sclerosis,neurological,OPGS011674,0.045,RNAseq,PRSS23,1.11 (1.06 1.17),1.37E-03
335,Multiple sclerosis,neurological,OPGS012093,0.040,RNAseq,TRIM26,1.11 (1.06 1.17),1.92E-03
335,Multiple sclerosis,neurological,OPGS014758,0.017,RNAseq,TRAV10,0.91 (0.87 0.95),2.71E-03
335,Multiple sclerosis,neurological,OPGS007865,0.119,RNAseq,MAL,1.11 (1.05 1.16),3.15E-03
335,Multiple sclerosis,neurological,OPGS009404,0.081,RNAseq,GCSAM,1.11 (1.06 1.17),3.58E-03
335,Multiple sclerosis,neurological,OPGS014478,0.019,RNAseq,,1.12 (1.06 1.18),4.30E-03
335,Multiple sclerosis,neurological,OPGS007675,0.126,RNAseq,TRAV12-2,0.90 (0.86 0.95),4.66E-03
335,Multiple sclerosis,neurological,OPGS011671,0.045,RNAseq,MICA,0.90 (0.85 0.95),5.86E-03
335,Multiple sclerosis,neurological,OPGS009225,0.085,RNAseq,CD5,1.10 (1.05 1.15),6.52E-03
335,Multiple sclerosis,neurological,OPGS009118,0.087,RNAseq,LY6G5C,1.11 (1.06 1.17),6.61E-03
335,Multiple sclerosis,neurological,OPGS011762,0.044,RNAseq,AL110114.1,1.10 (1.05 1.15),6.90E-03
335,Multiple sclerosis,neurological,OPGS012808,0.033,RNAseq,TRBV20-1,0.91 (0.86 0.95),7.12E-03
335,Multiple sclerosis,neurological,OPGS003620,0.668,RNAseq,ZFP57,1.10 (1.05 1.15),7.96E-03
335,Multiple sclerosis,neurological,OPGS009841,0.072,RNAseq,PDGFRB,1.10 (1.05 1.16),8.26E-03
335,Multiple sclerosis,neurological,OPGS014278,0.021,RNAseq,PPIB,0.91 (0.87 0.96),8.44E-03
335,Multiple sclerosis,neurological,OPGS004406,0.369,RNAseq,,0.91 (0.86 0.95),8.91E-03
335,Multiple sclerosis,neurological,OPGS010850,0.056,RNAseq,LTA,0.91 (0.87 0.95),9.18E-03
335,Multiple sclerosis,neurological,OPGS014406,0.020,RNAseq,LINC01023,0.91 (0.87 0.95),9.62E-03
335,Multiple sclerosis,neurological,OPGS006306,0.186,RNAseq,CLN8,1.10 (1.05 1.16),9.95E-03
335,Multiple sclerosis,neurological,OPGS008701,0.097,RNAseq,LIMD2,1.10 (1.05 1.16),1.00E-02
335,Multiple sclerosis,neurological,OPGS010492,0.061,RNAseq,HCG18,0.91 (0.86 0.95),1.26E-02
335,Multiple sclerosis,neurological,OPGS008500,0.102,RNAseq,FGFBP2,1.10 (1.05 1.15),1.34E-02
335,Multiple sclerosis,neurological,OPGS013501,0.026,RNAseq,HLA-DMA,1.09 (1.04 1.14),1.50E-02
335,Multiple sclerosis,neurological,OPGS006367,0.183,RNAseq,GALC,0.92 (0.87 0.96),1.71E-02
335,Multiple sclerosis,neurological,OPGS003742,0.573,RNAseq,AHI1,0.91 (0.87 0.96),1.77E-02
335,Multiple sclerosis,neurological,OPGS003873,0.519,RNAseq,IQCB1,1.09 (1.04 1.15),2.16E-02
335,Multiple sclerosis,neurological,OPGS010255,0.065,RNAseq,HLA-DPA1,1.10 (1.04 1.15),2.80E-02
335,Multiple sclerosis,neurological,OPGS014580,0.018,RNAseq,DACT1,1.10 (1.04 1.15),2.81E-02
335,Multiple sclerosis,neurological,OPGS013798,0.024,RNAseq,RNF5,1.09 (1.04 1.14),3.78E-02
335,Multiple sclerosis,neurological,OPGS005715,0.220,RNAseq,LINC00539,1.09 (1.04 1.14),4.09E-02
335,Multiple sclerosis,neurological,OPGS013406,0.027,RNAseq,AL353759.1,1.09 (1.04 1.15),4.10E-02
335,Multiple sclerosis,neurological,OPGS013201,0.029,RNAseq,NRCAM,0.92 (0.87 0.96),4.71E-02
335,Multiple sclerosis,neurological,OPGS012043,0.041,RNAseq,RPS6KB1,1.09 (1.04 1.14),4.96E-02
335,Multiple sclerosis,neurological,OPGS011067,0.053,RNAseq,POLR2J2,0.92 (0.88 0.97),5.00E-02
339,Other headache syndromes,neurological,OPGS003114,0.018,Metabolon,1-myristoyl-2-linoleoyl-GPC (14:0/18:2)*,1.04 (1.03 1.06),3.32E-02
339,Other headache syndromes,neurological,OPGS004967,0.291,RNAseq,RAB38,0.96 (0.94 0.97),3.32E-02
341,Other demyelinating diseases of central nervous system,neurological,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.73 (0.66 0.82),6.78E-04
341,Other demyelinating diseases of central nervous system,neurological,OPGS002070,0.012,SomaScan,Gro-beta/gamma,1.31 (1.19 1.45),6.78E-04
341,Other demyelinating diseases of central nervous system,neurological,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,0.74 (0.66 0.83),9.24E-04
341,Other demyelinating diseases of central nervous system,neurological,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,1.39 (1.22 1.58),1.18E-03
341,Other demyelinating diseases of central nervous system,neurological,OPGS002643,0.018,Olink,Neuroblastoma suppressor of tumorigenicity 1,1.36 (1.21 1.53),9.24E-04
341,Other demyelinating diseases of central nervous system,neurological,OPGS009077,0.088,RNAseq,DDAH2,1.30 (1.17 1.45),1.67E-03
341,Other demyelinating diseases of central nervous system,neurological,OPGS013958,0.023,RNAseq,CSNK2B,1.31 (1.16 1.48),4.02E-02
346.1,Nonspecific abnormal findings on radiological and other examination of skull and head,neurological,OPGS002519,0.079,Olink,Resistin,1.30 (1.17 1.45),8.40E-03
346.1,Nonspecific abnormal findings on radiological and other examination of skull and head,neurological,OPGS010860,0.056,RNAseq,RLN2,0.77 (0.70 0.86),7.73E-03
346.1,Nonspecific abnormal findings on radiological and other examination of skull and head,neurological,OPGS009586,0.077,RNAseq,RETN,1.21 (1.12 1.32),2.20E-02
351,Other peripheral nerve disorders,neurological,OPGS001879,0.015,SomaScan,Arfaptin-2,1.05 (1.03 1.06),1.87E-03
351,Other peripheral nerve disorders,neurological,OPGS002186,0.011,SomaScan,Suprabasin,0.96 (0.94 0.97),1.87E-03
351,Other peripheral nerve disorders,neurological,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,1.04 (1.02 1.06),2.17E-03
351,Other peripheral nerve disorders,neurological,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,0.96 (0.95 0.98),1.63E-02
351,Other peripheral nerve disorders,neurological,OPGS000717,0.082,SomaScan,Zinc finger protein 175,0.96 (0.95 0.98),1.69E-02
351,Other peripheral nerve disorders,neurological,OPGS002030,0.012,SomaScan,BAG family molecular chaperone regulator 3,1.03 (1.02 1.05),2.65E-02
351,Other peripheral nerve disorders,neurological,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,0.97 (0.95 0.98),2.65E-02
351,Other peripheral nerve disorders,neurological,OPGS000159,0.271,SomaScan,39S ribosomal protein L33. mitochondrial,0.97 (0.95 0.98),2.65E-02
351,Other peripheral nerve disorders,neurological,OPGS000204,0.233,SomaScan,PR domain zinc finger protein 1,1.03 (1.02 1.05),4.01E-02
351,Other peripheral nerve disorders,neurological,OPGS002654,0.015,Olink,Thrombopoietin,0.96 (0.95 0.98),1.90E-02
351,Other peripheral nerve disorders,neurological,OPGS002529,0.068,Olink,Tumor necrosis factor receptor superfamily member 3,0.97 (0.95 0.98),3.49E-02
351,Other peripheral nerve disorders,neurological,OPGS003096,0.019,Metabolon,pyroglutamylglutamine,0.97 (0.95 0.98),2.34E-02
351,Other peripheral nerve disorders,neurological,OPGS013933,0.023,RNAseq,R3HCC1L,0.96 (0.94 0.97),7.13E-04
351,Other peripheral nerve disorders,neurological,OPGS005580,0.232,RNAseq,ZBTB38,0.96 (0.95 0.98),4.55E-03
351,Other peripheral nerve disorders,neurological,OPGS005111,0.275,RNAseq,,1.04 (1.02 1.05),1.63E-02
351,Other peripheral nerve disorders,neurological,OPGS014889,0.016,RNAseq,BX537318.1,0.97 (0.95 0.98),1.90E-02
351,Other peripheral nerve disorders,neurological,OPGS013243,0.029,RNAseq,TRAV3,0.97 (0.95 0.98),2.65E-02
351,Other peripheral nerve disorders,neurological,OPGS006334,0.185,RNAseq,MRPL39,0.97 (0.95 0.98),2.65E-02
351,Other peripheral nerve disorders,neurological,OPGS009211,0.085,RNAseq,DNA2,1.03 (1.02 1.05),2.65E-02
351,Other peripheral nerve disorders,neurological,OPGS003680,0.611,RNAseq,,1.03 (1.02 1.05),2.65E-02
351,Other peripheral nerve disorders,neurological,OPGS004498,0.354,RNAseq,TEF,0.97 (0.95 0.98),2.65E-02
351,Other peripheral nerve disorders,neurological,OPGS005027,0.284,RNAseq,EEF1AKMT2,0.97 (0.95 0.98),2.65E-02
351,Other peripheral nerve disorders,neurological,OPGS011837,0.043,RNAseq,SKP2,1.03 (1.02 1.05),2.65E-02
351,Other peripheral nerve disorders,neurological,OPGS005398,0.247,RNAseq,RALGPS1,0.97 (0.95 0.98),3.07E-02
351,Other peripheral nerve disorders,neurological,OPGS007301,0.139,RNAseq,ITGB5,1.03 (1.02 1.05),3.49E-02
351,Other peripheral nerve disorders,neurological,OPGS005162,0.270,RNAseq,SPTLC2,1.03 (1.02 1.05),4.27E-02
351,Other peripheral nerve disorders,neurological,OPGS007171,0.145,RNAseq,EI24,0.97 (0.95 0.98),4.97E-02
358.1,Myasthenia gravis,neurological,OPGS014933,0.016,RNAseq,FAM83H,0.80 (0.73 0.88),3.85E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000120,0.344,SomaScan,Anaphase-promoting complex subunit 7,0.82 (0.80 0.84),1.50E-49
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000231,0.202,SomaScan,Glycosyltransferase 8 domain-containing protein 1,1.22 (1.19 1.25),1.91E-48
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000185,0.252,SomaScan,Histone-lysine N-methyltransferase 2D,0.82 (0.80 0.84),2.69E-48
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001571,0.023,SomaScan,Basic leucine zipper transcriptional factor ATF-like 3,1.22 (1.19 1.25),1.98E-47
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000113,0.350,SomaScan,NADH dehydrogenase [ubiquinone] iron-sulfur protein 4. mitochondrial,0.82 (0.80 0.85),8.41E-47
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000705,0.084,SomaScan,Growth arrest and DNA damage-inducible proteins-interacting protein 1,1.21 (1.18 1.24),1.97E-46
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001609,0.022,SomaScan,Small integral membrane protein 24,1.21 (1.18 1.25),2.38E-45
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS002232,0.011,SomaScan,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16,1.21 (1.18 1.24),7.71E-44
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000940,0.058,SomaScan,Endoplasmic reticulum mannosyl-oligosaccharide 1.2-alpha-mannosidase,0.83 (0.80 0.85),4.35E-43
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000893,0.064,SomaScan,t-SNARE domain-containing protein 1,1.20 (1.17 1.23),8.03E-42
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001680,0.020,SomaScan,Spectrin alpha chain. non-erythrocytic 1,1.20 (1.17 1.23),1.28E-39
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000727,0.080,SomaScan,Replication initiator 1,1.20 (1.17 1.23),1.63E-39
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000936,0.059,SomaScan,Membrane-associated progesterone receptor component 2,0.84 (0.82 0.86),5.51E-38
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000136,0.314,SomaScan,Thiosulfate sulfurtransferase,0.84 (0.82 0.86),6.50E-38
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001573,0.023,SomaScan,Properdin,0.84 (0.82 0.87),3.95E-32
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001591,0.022,SomaScan,Baculoviral IAP repeat-containing protein 5,1.18 (1.15 1.21),2.41E-30
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001567,0.023,SomaScan,RecQ-mediated genome instability protein 1,1.17 (1.14 1.20),2.99E-28
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001900,0.015,SomaScan,Glucokinase,1.17 (1.14 1.20),2.46E-27
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001420,0.029,SomaScan,Apolipoprotein D,1.17 (1.14 1.20),1.78E-26
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001541,0.024,SomaScan,Transmembrane protein 106B,1.16 (1.13 1.19),3.12E-25
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001811,0.017,SomaScan,Endogenous retrovirus group V member 1 Env polyprotein,1.16 (1.13 1.19),3.57E-25
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001382,0.030,SomaScan,Leucine-rich repeat-containing protein 74A,1.16 (1.13 1.20),2.68E-24
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001341,0.031,SomaScan,Augurin,1.16 (1.13 1.19),1.10E-23
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000799,0.073,SomaScan,Tyrosine-protein kinase Fyn,0.87 (0.84 0.89),9.77E-22
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001330,0.032,SomaScan,Cytochrome c oxidase subunit 4 isoform 2. mitochondrial,1.16 (1.13 1.19),3.73E-21
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001406,0.029,SomaScan,Kallikrein-14,1.15 (1.12 1.18),6.25E-20
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001268,0.035,SomaScan,Serine/threonine-protein kinase 16,1.14 (1.11 1.17),9.47E-20
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001122,0.044,SomaScan,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha,1.13 (1.10 1.16),1.41E-17
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001370,0.030,SomaScan,Retinal rod rhodopsin-sensitive cGMP 3'.5'-cyclic phosphodiesterase subunit delta,1.12 (1.10 1.15),3.20E-16
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001277,0.035,SomaScan,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha,1.13 (1.10 1.16),3.61E-16
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001720,0.019,SomaScan,Calnexin,1.13 (1.10 1.16),8.43E-16
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001276,0.035,SomaScan,Mast cell-expressed membrane protein 1,1.13 (1.10 1.16),2.29E-15
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001243,0.036,SomaScan,Complement C1q and tumor necrosis factor-related protein 9A,1.14 (1.10 1.17),9.85E-15
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001150,0.042,SomaScan,Annexin A5,0.87 (0.84 0.90),3.44E-14
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS002181,0.011,SomaScan,DNA-binding protein inhibitor ID-1,1.12 (1.09 1.15),3.65E-14
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001674,0.020,SomaScan,C-type lectin domain family 4 member M,1.12 (1.09 1.15),3.74E-14
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000597,0.099,SomaScan,Complement factor H,0.90 (0.88 0.93),6.44E-13
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001056,0.049,SomaScan,Insulin growth factor-like family member 3,1.11 (1.08 1.14),3.00E-12
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000907,0.062,SomaScan,Glycerol-3-phosphate dehydrogenase 1-like protein,1.11 (1.08 1.14),1.14E-11
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001772,0.018,SomaScan,Serine/threonine-protein kinase PAK 3,1.11 (1.08 1.14),2.75E-11
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001465,0.027,SomaScan,DNA polymerase epsilon subunit 2,1.10 (1.07 1.13),1.68E-10
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.10 (1.07 1.13),4.83E-10
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000308,0.164,SomaScan,Complement factor H-related protein 5,1.10 (1.07 1.14),1.81E-09
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001397,0.029,SomaScan,Regulator of G-protein signaling 8,1.10 (1.07 1.13),3.40E-09
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001424,0.029,SomaScan,Phosphatidylinositol 4.5-bisphosphate 3-kinase catalytic subunit gamma isoform,1.10 (1.07 1.13),1.59E-08
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000695,0.085,SomaScan,SLAM family member 7,1.09 (1.06 1.12),2.66E-08
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000916,0.061,SomaScan,CD63 antigen,1.09 (1.06 1.12),2.71E-08
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001443,0.028,SomaScan,Zona pellucida sperm-binding protein 4,1.09 (1.06 1.12),3.61E-08
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000973,0.056,SomaScan,DCN1-like protein 5,1.09 (1.06 1.12),8.90E-08
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001412,0.029,SomaScan,Tyrosine-protein phosphatase non-receptor type 1,1.09 (1.06 1.12),1.76E-07
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000633,0.093,SomaScan,Interleukin-10 receptor subunit alpha,1.08 (1.06 1.11),1.78E-07
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001202,0.039,SomaScan,Zinc-alpha-2-glycoprotein,1.09 (1.06 1.12),5.12E-07
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000397,0.139,SomaScan,TLR4 interactor with leucine rich repeats,1.08 (1.05 1.11),2.88E-06
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001511,0.025,SomaScan,Complement C3d fragment,0.93 (0.91 0.95),2.97E-06
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001421,0.029,SomaScan,Alpha-N-acetylgalactosaminide alpha-2.6-sialyltransferase 2,1.09 (1.06 1.12),3.06E-06
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS002174,0.011,SomaScan,Phospholipase B-like 1,0.93 (0.91 0.95),3.41E-06
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS002231,0.011,SomaScan,Vesicle transport through interaction with t-SNAREs homolog 1A,0.93 (0.91 0.95),3.41E-06
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001912,0.014,SomaScan,Centromere protein V,0.93 (0.91 0.95),3.69E-06
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001636,0.021,SomaScan,Complement C3b,0.92 (0.90 0.95),4.38E-06
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001471,0.027,SomaScan,Bcl-2-like protein 1,1.08 (1.05 1.11),5.74E-06
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000012,0.679,SomaScan,Hemopexin,1.08 (1.05 1.10),8.73E-06
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000935,0.059,SomaScan,Vitronectin,1.07 (1.05 1.10),1.58E-05
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001019,0.052,SomaScan,DNA repair protein XRCC4,1.07 (1.05 1.10),1.97E-05
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001212,0.038,SomaScan,Regulator of G-protein signaling 19,1.07 (1.04 1.10),2.99E-05
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001292,0.034,SomaScan,Kallikrein-6,1.07 (1.05 1.10),3.64E-05
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000469,0.125,SomaScan,Complement factor B,0.94 (0.91 0.96),3.80E-05
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000170,0.265,SomaScan,Lactase-phlorizin hydrolase,0.94 (0.92 0.96),2.04E-04
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000482,0.121,SomaScan,Complement factor H-related protein 5,1.07 (1.04 1.10),2.71E-04
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001259,0.035,SomaScan,Leucine-rich repeat and transmembrane domain-containing protein 2,1.06 (1.04 1.09),4.40E-04
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,0.94 (0.92 0.97),1.69E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,0.94 (0.92 0.97),2.06E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,0.94 (0.92 0.97),2.36E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001154,0.042,SomaScan,Kinetochore protein NDC80 homolog,1.06 (1.03 1.09),3.52E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001433,0.028,SomaScan,Rho guanine nucleotide exchange factor 10,0.94 (0.92 0.97),3.52E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,0.94 (0.92 0.97),3.88E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000688,0.086,SomaScan,Dual specificity protein kinase CLK2,1.06 (1.03 1.08),4.81E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,1.06 (1.03 1.08),5.21E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,0.94 (0.92 0.97),5.62E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000511,0.115,SomaScan,Pulmonary surfactant-associated protein B,0.95 (0.93 0.97),1.05E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,0.95 (0.92 0.97),1.10E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001587,0.023,SomaScan,Carboxypeptidase E,0.95 (0.92 0.97),1.13E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000857,0.067,SomaScan,Moesin,0.95 (0.92 0.97),1.23E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000121,0.341,SomaScan,D-glucuronyl C5-epimerase,1.05 (1.03 1.08),1.76E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,0.95 (0.92 0.97),1.84E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,1.05 (1.03 1.08),2.01E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,1.05 (1.02 1.08),2.17E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.95 (0.93 0.98),2.29E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,1.05 (1.03 1.08),2.29E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,1.05 (1.02 1.08),2.47E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000260,0.190,SomaScan,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,1.05 (1.02 1.08),3.15E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,0.95 (0.93 0.98),3.90E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001080,0.047,SomaScan,Complement factor I,0.95 (0.93 0.98),3.96E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,0.95 (0.93 0.98),4.02E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS003518,0.065,Nightingale,Triglycerides in medium HDL,0.95 (0.92 0.97),5.94E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,0.95 (0.93 0.98),2.90E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS005567,0.233,RNAseq,PLEKHA1,0.89 (0.87 0.92),2.70E-14
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS013762,0.024,RNAseq,CFH,0.93 (0.90 0.95),2.75E-06
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS004567,0.343,RNAseq,HLA-C,1.06 (1.04 1.09),5.73E-04
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS006942,0.154,RNAseq,SKIV2L,0.94 (0.92 0.96),6.81E-04
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS011714,0.045,RNAseq,AFMID,1.06 (1.03 1.08),1.15E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS007365,0.137,RNAseq,MCM6,1.06 (1.03 1.08),2.06E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS014912,0.016,RNAseq,KCNA5,0.95 (0.92 0.97),2.06E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS010078,0.068,RNAseq,SLC12A3,0.95 (0.92 0.97),5.21E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS014485,0.019,RNAseq,AC008764.9,0.95 (0.92 0.97),5.72E-03
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS015068,0.015,RNAseq,ZBTB41,1.06 (1.03 1.08),1.56E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS014410,0.020,RNAseq,AL359220.1,1.05 (1.02 1.07),2.76E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS011787,0.044,RNAseq,C2,1.05 (1.02 1.08),2.92E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS005171,0.269,RNAseq,DARS1,1.05 (1.02 1.07),3.64E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS014903,0.016,RNAseq,PACSIN1,0.95 (0.93 0.98),3.90E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS010512,0.061,RNAseq,ITCH,0.95 (0.93 0.98),3.96E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS004877,0.301,RNAseq,SELENOM,0.95 (0.93 0.98),4.36E-02
362.2,Degeneration of macula and posterior pole of retina,sense organs,OPGS012684,0.034,RNAseq,ZFP91,0.95 (0.93 0.98),4.91E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000120,0.344,SomaScan,Anaphase-promoting complex subunit 7,0.82 (0.80 0.84),2.10E-49
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000231,0.202,SomaScan,Glycosyltransferase 8 domain-containing protein 1,1.22 (1.19 1.25),2.73E-48
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000185,0.252,SomaScan,Histone-lysine N-methyltransferase 2D,0.82 (0.80 0.84),3.48E-48
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001571,0.023,SomaScan,Basic leucine zipper transcriptional factor ATF-like 3,1.22 (1.19 1.25),2.67E-47
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000113,0.350,SomaScan,NADH dehydrogenase [ubiquinone] iron-sulfur protein 4. mitochondrial,0.82 (0.80 0.85),1.04E-46
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000705,0.084,SomaScan,Growth arrest and DNA damage-inducible proteins-interacting protein 1,1.21 (1.18 1.24),2.31E-46
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001609,0.022,SomaScan,Small integral membrane protein 24,1.21 (1.18 1.25),3.01E-45
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS002232,0.011,SomaScan,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16,1.21 (1.18 1.24),9.89E-44
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000940,0.058,SomaScan,Endoplasmic reticulum mannosyl-oligosaccharide 1.2-alpha-mannosidase,0.83 (0.80 0.85),7.14E-43
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000893,0.064,SomaScan,t-SNARE domain-containing protein 1,1.20 (1.17 1.23),8.88E-42
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001680,0.020,SomaScan,Spectrin alpha chain. non-erythrocytic 1,1.20 (1.17 1.23),1.58E-39
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000727,0.080,SomaScan,Replication initiator 1,1.20 (1.17 1.23),1.90E-39
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000936,0.059,SomaScan,Membrane-associated progesterone receptor component 2,0.84 (0.82 0.86),6.74E-38
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000136,0.314,SomaScan,Thiosulfate sulfurtransferase,0.84 (0.82 0.86),6.94E-38
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001573,0.023,SomaScan,Properdin,0.85 (0.82 0.87),6.71E-32
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001591,0.022,SomaScan,Baculoviral IAP repeat-containing protein 5,1.18 (1.15 1.21),2.87E-30
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001567,0.023,SomaScan,RecQ-mediated genome instability protein 1,1.17 (1.14 1.20),3.55E-28
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001900,0.015,SomaScan,Glucokinase,1.17 (1.14 1.20),2.23E-27
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001420,0.029,SomaScan,Apolipoprotein D,1.17 (1.14 1.20),1.79E-26
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001541,0.024,SomaScan,Transmembrane protein 106B,1.16 (1.13 1.19),2.94E-25
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001811,0.017,SomaScan,Endogenous retrovirus group V member 1 Env polyprotein,1.16 (1.13 1.19),3.09E-25
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001382,0.030,SomaScan,Leucine-rich repeat-containing protein 74A,1.16 (1.13 1.20),3.02E-24
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001341,0.031,SomaScan,Augurin,1.16 (1.13 1.19),1.28E-23
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000799,0.073,SomaScan,Tyrosine-protein kinase Fyn,0.87 (0.84 0.89),1.38E-21
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001330,0.032,SomaScan,Cytochrome c oxidase subunit 4 isoform 2. mitochondrial,1.16 (1.13 1.19),4.39E-21
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001406,0.029,SomaScan,Kallikrein-14,1.15 (1.12 1.18),6.56E-20
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001268,0.035,SomaScan,Serine/threonine-protein kinase 16,1.14 (1.11 1.17),1.09E-19
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001122,0.044,SomaScan,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha,1.13 (1.10 1.16),2.07E-17
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001277,0.035,SomaScan,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha,1.13 (1.10 1.16),3.44E-16
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001370,0.030,SomaScan,Retinal rod rhodopsin-sensitive cGMP 3'.5'-cyclic phosphodiesterase subunit delta,1.12 (1.10 1.15),4.45E-16
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001720,0.019,SomaScan,Calnexin,1.13 (1.10 1.16),9.40E-16
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001276,0.035,SomaScan,Mast cell-expressed membrane protein 1,1.13 (1.10 1.16),2.57E-15
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001243,0.036,SomaScan,Complement C1q and tumor necrosis factor-related protein 9A,1.14 (1.10 1.17),1.13E-14
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS002181,0.011,SomaScan,DNA-binding protein inhibitor ID-1,1.12 (1.09 1.15),3.18E-14
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001150,0.042,SomaScan,Annexin A5,0.87 (0.84 0.90),3.66E-14
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001674,0.020,SomaScan,C-type lectin domain family 4 member M,1.12 (1.09 1.15),3.83E-14
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000597,0.099,SomaScan,Complement factor H,0.90 (0.88 0.93),8.98E-13
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001056,0.049,SomaScan,Insulin growth factor-like family member 3,1.11 (1.08 1.14),3.22E-12
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000907,0.062,SomaScan,Glycerol-3-phosphate dehydrogenase 1-like protein,1.11 (1.08 1.14),1.18E-11
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001772,0.018,SomaScan,Serine/threonine-protein kinase PAK 3,1.11 (1.08 1.14),2.78E-11
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001465,0.027,SomaScan,DNA polymerase epsilon subunit 2,1.10 (1.07 1.13),1.74E-10
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.10 (1.07 1.13),5.36E-10
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000308,0.164,SomaScan,Complement factor H-related protein 5,1.10 (1.07 1.13),2.14E-09
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001397,0.029,SomaScan,Regulator of G-protein signaling 8,1.10 (1.07 1.13),3.40E-09
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001424,0.029,SomaScan,Phosphatidylinositol 4.5-bisphosphate 3-kinase catalytic subunit gamma isoform,1.10 (1.07 1.13),1.62E-08
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000916,0.061,SomaScan,CD63 antigen,1.09 (1.06 1.12),2.07E-08
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000695,0.085,SomaScan,SLAM family member 7,1.09 (1.06 1.12),2.64E-08
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001443,0.028,SomaScan,Zona pellucida sperm-binding protein 4,1.09 (1.06 1.12),3.45E-08
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000973,0.056,SomaScan,DCN1-like protein 5,1.09 (1.06 1.11),1.03E-07
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001412,0.029,SomaScan,Tyrosine-protein phosphatase non-receptor type 1,1.09 (1.06 1.12),1.79E-07
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000633,0.093,SomaScan,Interleukin-10 receptor subunit alpha,1.08 (1.06 1.11),1.85E-07
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001202,0.039,SomaScan,Zinc-alpha-2-glycoprotein,1.09 (1.06 1.12),5.37E-07
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001511,0.025,SomaScan,Complement C3d fragment,0.93 (0.91 0.95),2.55E-06
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS002174,0.011,SomaScan,Phospholipase B-like 1,0.93 (0.91 0.95),2.89E-06
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS002231,0.011,SomaScan,Vesicle transport through interaction with t-SNAREs homolog 1A,0.93 (0.91 0.95),2.89E-06
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000397,0.139,SomaScan,TLR4 interactor with leucine rich repeats,1.08 (1.05 1.11),2.89E-06
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001421,0.029,SomaScan,Alpha-N-acetylgalactosaminide alpha-2.6-sialyltransferase 2,1.09 (1.06 1.12),3.03E-06
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001912,0.014,SomaScan,Centromere protein V,0.93 (0.91 0.95),3.07E-06
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001636,0.021,SomaScan,Complement C3b,0.92 (0.90 0.95),3.86E-06
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001471,0.027,SomaScan,Bcl-2-like protein 1,1.08 (1.05 1.11),5.64E-06
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000012,0.679,SomaScan,Hemopexin,1.08 (1.05 1.10),7.04E-06
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000935,0.059,SomaScan,Vitronectin,1.07 (1.05 1.10),1.63E-05
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001019,0.052,SomaScan,DNA repair protein XRCC4,1.07 (1.05 1.10),1.96E-05
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001212,0.038,SomaScan,Regulator of G-protein signaling 19,1.07 (1.04 1.10),3.13E-05
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001292,0.034,SomaScan,Kallikrein-6,1.07 (1.05 1.10),3.26E-05
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000469,0.125,SomaScan,Complement factor B,0.94 (0.91 0.96),4.17E-05
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000170,0.265,SomaScan,Lactase-phlorizin hydrolase,0.94 (0.92 0.96),1.88E-04
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000482,0.121,SomaScan,Complement factor H-related protein 5,1.07 (1.04 1.10),2.77E-04
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001259,0.035,SomaScan,Leucine-rich repeat and transmembrane domain-containing protein 2,1.06 (1.04 1.09),4.24E-04
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,0.94 (0.92 0.97),1.52E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,0.94 (0.92 0.97),1.80E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,0.94 (0.92 0.97),2.03E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001433,0.028,SomaScan,Rho guanine nucleotide exchange factor 10,0.94 (0.92 0.97),3.21E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,0.94 (0.92 0.97),3.36E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001154,0.042,SomaScan,Kinetochore protein NDC80 homolog,1.06 (1.03 1.09),3.74E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,0.94 (0.92 0.97),4.81E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000688,0.086,SomaScan,Dual specificity protein kinase CLK2,1.06 (1.03 1.08),4.81E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,1.06 (1.03 1.08),5.81E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000511,0.115,SomaScan,Pulmonary surfactant-associated protein B,0.95 (0.92 0.97),9.46E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,0.95 (0.92 0.97),9.86E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001587,0.023,SomaScan,Carboxypeptidase E,0.95 (0.92 0.97),9.87E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000857,0.067,SomaScan,Moesin,0.95 (0.92 0.97),1.08E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,0.95 (0.92 0.97),1.72E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000121,0.341,SomaScan,D-glucuronyl C5-epimerase,1.05 (1.03 1.08),1.76E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,1.05 (1.03 1.08),1.90E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,1.05 (1.02 1.08),2.03E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,1.05 (1.03 1.08),2.11E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,1.05 (1.02 1.08),2.35E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.95 (0.93 0.98),2.42E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000260,0.190,SomaScan,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,1.05 (1.02 1.08),3.21E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,0.95 (0.93 0.98),3.44E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,0.95 (0.93 0.98),3.59E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS001080,0.047,SomaScan,Complement factor I,0.95 (0.93 0.98),4.60E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS003518,0.065,Nightingale,Triglycerides in medium HDL,0.95 (0.92 0.97),5.40E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,0.95 (0.93 0.98),2.57E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS005567,0.233,RNAseq,PLEKHA1,0.89 (0.87 0.92),2.74E-14
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS013762,0.024,RNAseq,CFH,0.93 (0.90 0.95),2.89E-06
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS004567,0.343,RNAseq,HLA-C,1.06 (1.04 1.09),6.32E-04
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS006942,0.154,RNAseq,SKIV2L,0.94 (0.92 0.96),6.32E-04
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS011714,0.045,RNAseq,AFMID,1.06 (1.03 1.08),1.09E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS007365,0.137,RNAseq,MCM6,1.06 (1.03 1.08),1.80E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS014912,0.016,RNAseq,KCNA5,0.94 (0.92 0.97),1.86E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS010078,0.068,RNAseq,SLC12A3,0.95 (0.92 0.97),4.81E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS014485,0.019,RNAseq,AC008764.9,0.94 (0.92 0.97),5.28E-03
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS015068,0.015,RNAseq,ZBTB41,1.06 (1.03 1.08),1.67E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS014410,0.020,RNAseq,AL359220.1,1.05 (1.02 1.07),2.61E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS011787,0.044,RNAseq,C2,1.05 (1.02 1.08),2.90E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS005171,0.269,RNAseq,DARS1,1.05 (1.02 1.07),3.28E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS014903,0.016,RNAseq,PACSIN1,0.95 (0.93 0.98),3.70E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS012684,0.034,RNAseq,ZFP91,0.95 (0.93 0.98),3.81E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS010512,0.061,RNAseq,ITCH,0.95 (0.93 0.98),3.97E-02
362.29,Macular degeneration (senile) of retina NOS,sense organs,OPGS004877,0.301,RNAseq,SELENOM,0.95 (0.93 0.98),4.31E-02
362.6,Peripheral retinal degenerations,sense organs,OPGS012663,0.034,RNAseq,C5orf34,1.23 (1.13 1.34),4.67E-02
362.7,Hereditary retinal dystrophies,sense organs,OPGS011784,0.044,RNAseq,TUBB,0.72 (0.65 0.81),3.31E-04
363,Chorioretinal inflammations. scars. and other disorders of choroid,sense organs,OPGS012930,0.031,RNAseq,HMCES,0.75 (0.67 0.83),3.30E-03
364.2,Corneal edema,sense organs,OPGS008083,0.113,RNAseq,AC012291.3,1.36 (1.23 1.51),3.89E-05
364.5,Corneal dystrophy,sense organs,OPGS006429,0.179,RNAseq,AP006621.3,1.22 (1.12 1.33),4.34E-02
365,Glaucoma,sense organs,OPGS009511,0.079,RNAseq,AFAP1-AS1,0.92 (0.90 0.95),1.87E-07
365,Glaucoma,sense organs,OPGS012279,0.038,RNAseq,CDKN2A,0.94 (0.92 0.96),3.33E-04
365,Glaucoma,sense organs,OPGS003656,0.631,RNAseq,AFAP1,0.94 (0.92 0.97),3.59E-03
365,Glaucoma,sense organs,OPGS008530,0.101,RNAseq,LTBP2,0.95 (0.92 0.97),5.16E-03
365,Glaucoma,sense organs,OPGS005232,0.263,RNAseq,ALDH9A1,0.95 (0.93 0.97),8.34E-03
365,Glaucoma,sense organs,OPGS008334,0.106,RNAseq,UBXN2B,0.95 (0.93 0.97),1.67E-02
365,Glaucoma,sense organs,OPGS004410,0.369,RNAseq,G3BP2,1.05 (1.03 1.08),1.69E-02
365,Glaucoma,sense organs,OPGS014645,0.018,RNAseq,ARHGEF12,1.05 (1.03 1.08),1.92E-02
365,Glaucoma,sense organs,OPGS005568,0.233,RNAseq,SRP72,0.95 (0.93 0.98),4.16E-02
365.11,Primary open angle glaucoma,sense organs,OPGS012279,0.038,RNAseq,CDKN2A,0.90 (0.86 0.93),6.14E-03
366,Cataract,sense organs,OPGS000135,0.315,SomaScan,Glutathione S-transferase Mu 3,0.97 (0.96 0.98),4.13E-04
366,Cataract,sense organs,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,0.98 (0.96 0.99),6.84E-03
366,Cataract,sense organs,OPGS000984,0.055,SomaScan,Complement C2,1.02 (1.01 1.04),9.64E-03
366,Cataract,sense organs,OPGS000197,0.236,SomaScan,Inter-alpha-trypsin inhibitor heavy chain H1,1.02 (1.01 1.04),9.64E-03
366,Cataract,sense organs,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.02 (1.01 1.03),1.52E-02
366,Cataract,sense organs,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.02 (1.01 1.03),1.74E-02
366,Cataract,sense organs,OPGS000161,0.270,SomaScan,Vascular endothelial growth factor A. isoform 121,1.02 (1.01 1.03),2.72E-02
366,Cataract,sense organs,OPGS000170,0.265,SomaScan,Lactase-phlorizin hydrolase,0.98 (0.97 0.99),3.59E-02
366,Cataract,sense organs,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.02 (1.01 1.03),4.08E-02
366,Cataract,sense organs,OPGS000403,0.138,SomaScan,Vascular endothelial growth factor receptor 1,0.98 (0.97 0.99),4.10E-02
366,Cataract,sense organs,OPGS001831,0.016,SomaScan,SUN domain-containing protein 3,0.98 (0.97 0.99),4.64E-02
366,Cataract,sense organs,OPGS002484,0.124,Olink,Vascular endothelial growth factor A,1.02 (1.01 1.04),1.43E-02
366,Cataract,sense organs,OPGS002651,0.015,Olink,von Willebrand factor,1.02 (1.01 1.03),4.08E-02
366,Cataract,sense organs,OPGS002754,0.142,Metabolon,X - 12688,1.02 (1.01 1.03),2.22E-02
366,Cataract,sense organs,OPGS012800,0.033,RNAseq,SMIM38,1.03 (1.02 1.05),4.95E-06
366,Cataract,sense organs,OPGS003713,0.590,RNAseq,COQ8A,1.03 (1.02 1.05),6.74E-06
366,Cataract,sense organs,OPGS005549,0.234,RNAseq,LINC02701,0.97 (0.96 0.98),9.42E-06
366,Cataract,sense organs,OPGS007410,0.135,RNAseq,IFITM2,1.03 (1.02 1.04),4.97E-05
366,Cataract,sense organs,OPGS007509,0.132,RNAseq,THOC7,0.97 (0.96 0.98),7.93E-05
366,Cataract,sense organs,OPGS015027,0.016,RNAseq,AC104162.2,1.03 (1.02 1.04),7.93E-05
366,Cataract,sense organs,OPGS011535,0.047,RNAseq,PSEN2,1.03 (1.02 1.04),1.69E-04
366,Cataract,sense organs,OPGS004718,0.321,RNAseq,FAM118B,1.03 (1.02 1.04),1.76E-04
366,Cataract,sense organs,OPGS011233,0.050,RNAseq,CLIC6,1.03 (1.02 1.04),3.07E-04
366,Cataract,sense organs,OPGS010446,0.062,RNAseq,STK17A,1.03 (1.02 1.04),4.13E-04
366,Cataract,sense organs,OPGS009865,0.072,RNAseq,TRAV17,0.97 (0.96 0.99),3.88E-03
366,Cataract,sense organs,OPGS014584,0.018,RNAseq,TLCD3A,1.03 (1.02 1.04),3.88E-03
366,Cataract,sense organs,OPGS004405,0.369,RNAseq,SCGB1C1,0.97 (0.96 0.99),3.88E-03
366,Cataract,sense organs,OPGS013235,0.029,RNAseq,PDE6G,0.97 (0.96 0.99),4.06E-03
366,Cataract,sense organs,OPGS003896,0.508,RNAseq,GSTM4,0.97 (0.96 0.99),4.06E-03
366,Cataract,sense organs,OPGS014341,0.020,RNAseq,NFAT5,1.03 (1.01 1.04),4.24E-03
366,Cataract,sense organs,OPGS006716,0.164,RNAseq,IER3,1.03 (1.01 1.04),5.91E-03
366,Cataract,sense organs,OPGS013305,0.028,RNAseq,TRBV14,0.98 (0.97 0.99),6.84E-03
366,Cataract,sense organs,OPGS008012,0.115,RNAseq,GNL3,1.03 (1.01 1.04),7.83E-03
366,Cataract,sense organs,OPGS005087,0.277,RNAseq,AC009779.4,1.02 (1.01 1.04),9.64E-03
366,Cataract,sense organs,OPGS013622,0.025,RNAseq,AC009022.1,1.02 (1.01 1.03),1.41E-02
366,Cataract,sense organs,OPGS006452,0.178,RNAseq,AC069307.1,1.02 (1.01 1.04),1.50E-02
366,Cataract,sense organs,OPGS004873,0.302,RNAseq,PCMTD2,1.02 (1.01 1.04),1.57E-02
366,Cataract,sense organs,OPGS012057,0.041,RNAseq,POLG2,0.98 (0.97 0.99),1.83E-02
366,Cataract,sense organs,OPGS006845,0.158,RNAseq,FLOT1,1.02 (1.01 1.03),1.93E-02
366,Cataract,sense organs,OPGS008368,0.105,RNAseq,FNDC10,1.02 (1.01 1.03),2.19E-02
366,Cataract,sense organs,OPGS005406,0.246,RNAseq,COA1,1.02 (1.01 1.03),2.72E-02
366,Cataract,sense organs,OPGS012920,0.032,RNAseq,AC000123.2,1.02 (1.01 1.03),2.72E-02
366,Cataract,sense organs,OPGS012397,0.037,RNAseq,SIRT3,0.98 (0.97 0.99),2.72E-02
366,Cataract,sense organs,OPGS010369,0.063,RNAseq,PRPF19,0.98 (0.97 0.99),2.98E-02
366,Cataract,sense organs,OPGS008652,0.097,RNAseq,AC006252.1,1.02 (1.01 1.03),3.05E-02
366,Cataract,sense organs,OPGS007675,0.126,RNAseq,TRAV12-2,1.02 (1.01 1.03),3.05E-02
366,Cataract,sense organs,OPGS007365,0.137,RNAseq,MCM6,1.02 (1.01 1.03),3.05E-02
366,Cataract,sense organs,OPGS004787,0.311,RNAseq,ZNF793,0.98 (0.97 0.99),3.15E-02
366,Cataract,sense organs,OPGS005567,0.233,RNAseq,PLEKHA1,0.98 (0.97 0.99),3.36E-02
366,Cataract,sense organs,OPGS006499,0.176,RNAseq,C4A,0.98 (0.97 0.99),3.51E-02
366,Cataract,sense organs,OPGS011965,0.042,RNAseq,CEACAM1,0.98 (0.97 0.99),4.08E-02
366,Cataract,sense organs,OPGS012171,0.039,RNAseq,TRBV15,0.98 (0.97 0.99),4.08E-02
366,Cataract,sense organs,OPGS005136,0.273,RNAseq,MRPL21,0.98 (0.97 0.99),4.08E-02
366,Cataract,sense organs,OPGS014491,0.019,RNAseq,FZD8,1.02 (1.01 1.03),4.10E-02
366,Cataract,sense organs,OPGS008759,0.095,RNAseq,RFT1,0.98 (0.97 0.99),4.10E-02
366,Cataract,sense organs,OPGS006859,0.157,RNAseq,PDGFB,0.98 (0.97 0.99),4.10E-02
366,Cataract,sense organs,OPGS011639,0.045,RNAseq,ST6GALNAC4,0.98 (0.97 0.99),4.10E-02
366,Cataract,sense organs,OPGS011389,0.048,RNAseq,FSD1L,0.98 (0.97 0.99),4.10E-02
366,Cataract,sense organs,OPGS013897,0.023,RNAseq,GPR137,1.02 (1.01 1.03),4.51E-02
366,Cataract,sense organs,OPGS009477,0.080,RNAseq,ADORA2B,0.98 (0.97 0.99),4.51E-02
366,Cataract,sense organs,OPGS005117,0.275,RNAseq,NPIPB12,0.98 (0.97 0.99),4.51E-02
366,Cataract,sense organs,OPGS003755,0.569,RNAseq,CASP7,0.98 (0.97 0.99),4.94E-02
366.2,Senile cataract,sense organs,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.03 (1.02 1.04),2.35E-02
366.2,Senile cataract,sense organs,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.03 (1.02 1.04),2.35E-02
366.2,Senile cataract,sense organs,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.97 (0.96 0.99),4.14E-02
366.2,Senile cataract,sense organs,OPGS002557,0.050,Olink,Epithelial cell adhesion molecule,0.97 (0.96 0.99),3.42E-02
366.2,Senile cataract,sense organs,OPGS002408,0.270,Olink,E-selectin,0.97 (0.96 0.99),4.14E-02
366.2,Senile cataract,sense organs,OPGS002500,0.098,Olink,Galectin-4,0.97 (0.96 0.99),4.77E-02
366.2,Senile cataract,sense organs,OPGS003713,0.590,RNAseq,COQ8A,1.04 (1.02 1.05),5.41E-03
366.2,Senile cataract,sense organs,OPGS005549,0.234,RNAseq,LINC02701,0.97 (0.95 0.98),5.41E-03
366.2,Senile cataract,sense organs,OPGS014584,0.018,RNAseq,TLCD3A,1.03 (1.02 1.05),6.99E-03
366.2,Senile cataract,sense organs,OPGS003821,0.540,RNAseq,ADAM15,0.97 (0.96 0.98),8.31E-03
366.2,Senile cataract,sense organs,OPGS011535,0.047,RNAseq,PSEN2,1.03 (1.02 1.05),8.35E-03
366.2,Senile cataract,sense organs,OPGS012800,0.033,RNAseq,SMIM38,1.03 (1.02 1.05),1.01E-02
366.2,Senile cataract,sense organs,OPGS011044,0.053,RNAseq,AL359922.3,1.03 (1.02 1.05),1.73E-02
366.2,Senile cataract,sense organs,OPGS005641,0.225,RNAseq,RHOT1,1.03 (1.02 1.05),1.94E-02
366.2,Senile cataract,sense organs,OPGS007410,0.135,RNAseq,IFITM2,1.03 (1.02 1.04),2.09E-02
366.2,Senile cataract,sense organs,OPGS010446,0.062,RNAseq,STK17A,1.03 (1.02 1.04),2.35E-02
366.2,Senile cataract,sense organs,OPGS006554,0.173,RNAseq,EXOSC6,1.03 (1.02 1.04),2.93E-02
366.2,Senile cataract,sense organs,OPGS011389,0.048,RNAseq,FSD1L,0.97 (0.96 0.98),2.93E-02
366.2,Senile cataract,sense organs,OPGS005567,0.233,RNAseq,PLEKHA1,0.97 (0.96 0.98),2.93E-02
366.2,Senile cataract,sense organs,OPGS008912,0.091,RNAseq,MAPK8,0.97 (0.96 0.98),2.93E-02
366.2,Senile cataract,sense organs,OPGS013305,0.028,RNAseq,TRBV14,0.97 (0.96 0.99),3.05E-02
366.2,Senile cataract,sense organs,OPGS004479,0.358,RNAseq,ST3GAL6-AS1,1.03 (1.02 1.04),3.05E-02
366.2,Senile cataract,sense organs,OPGS006859,0.157,RNAseq,PDGFB,0.97 (0.96 0.99),3.56E-02
366.2,Senile cataract,sense organs,OPGS009865,0.072,RNAseq,TRAV17,0.97 (0.96 0.99),3.56E-02
366.2,Senile cataract,sense organs,OPGS010835,0.056,RNAseq,AL031590.1,0.97 (0.96 0.99),3.56E-02
366.2,Senile cataract,sense organs,OPGS005087,0.277,RNAseq,AC009779.4,1.03 (1.01 1.04),4.92E-02
366.2,Senile cataract,sense organs,OPGS014491,0.019,RNAseq,FZD8,1.03 (1.01 1.04),4.92E-02
366.2,Senile cataract,sense organs,OPGS013942,0.023,RNAseq,ZHX3,1.03 (1.01 1.04),4.97E-02
367.1,Myopia,sense organs,OPGS005087,0.277,RNAseq,AC009779.4,1.12 (1.08 1.16),2.42E-04
368.2,Diplopia and disorders of binocular vision,sense organs,OPGS003167,0.014,Metabolon,X - 22475,1.13 (1.07 1.19),4.44E-02
370.1,Corneal ulcer,sense organs,OPGS006958,0.153,RNAseq,TSC22D1,0.73 (0.64 0.83),1.68E-02
371.1,Uveitis. noninfectious or NOS,sense organs,OPGS007394,0.136,RNAseq,AL662844.4,0.84 (0.78 0.89),2.07E-03
371.3,Inflammation of eyelids,sense organs,OPGS002175,0.011,SomaScan,Chymase,0.98 (0.98 0.99),2.27E-04
371.3,Inflammation of eyelids,sense organs,OPGS001860,0.016,SomaScan,Immunoglobulin E,0.93 (0.89 0.96),3.68E-02
371.3,Inflammation of eyelids,sense organs,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,1.08 (1.04 1.12),3.68E-02
371.3,Inflammation of eyelids,sense organs,OPGS005685,0.222,RNAseq,TLR1,1.10 (1.06 1.14),9.02E-03
371.3,Inflammation of eyelids,sense organs,OPGS005334,0.253,RNAseq,AL645933.4,1.09 (1.05 1.13),1.11E-02
371.3,Inflammation of eyelids,sense organs,OPGS008402,0.104,RNAseq,TNXB,1.08 (1.04 1.12),3.02E-02
371.3,Inflammation of eyelids,sense organs,OPGS006499,0.176,RNAseq,C4A,1.08 (1.05 1.12),3.35E-02
371.3,Inflammation of eyelids,sense organs,OPGS013045,0.030,RNAseq,NEU1,1.08 (1.04 1.12),3.35E-02
371.3,Inflammation of eyelids,sense organs,OPGS014496,0.019,RNAseq,VARS1,0.92 (0.89 0.96),3.68E-02
371.3,Inflammation of eyelids,sense organs,OPGS003680,0.611,RNAseq,,0.92 (0.89 0.96),3.68E-02
371.3,Inflammation of eyelids,sense organs,OPGS007675,0.126,RNAseq,TRAV12-2,0.93 (0.90 0.96),4.05E-02
371.3,Inflammation of eyelids,sense organs,OPGS012656,0.034,RNAseq,NR1D1,1.07 (1.04 1.11),4.33E-02
375.2,Epiphora,sense organs,OPGS001019,0.052,SomaScan,DNA repair protein XRCC4,0.88 (0.83 0.92),2.92E-02
379.4,Anomalies of pupillary function,sense organs,OPGS006936,0.154,RNAseq,CEBPZ,1.44 (1.24 1.67),3.30E-02
380.4,Impacted cerumen,sense organs,OPGS001523,0.025,SomaScan,Pregnancy-specific beta-1-glycoprotein 9,0.81 (0.74 0.89),4.77E-02
380.4,Impacted cerumen,sense organs,OPGS010961,0.054,RNAseq,EMC10,0.80 (0.74 0.88),9.71E-03
381.1,Otitis media,sense organs,OPGS010310,0.064,RNAseq,AC092384.1,1.13 (1.07 1.19),3.24E-02
381.1,Otitis media,sense organs,OPGS009562,0.078,RNAseq,AC027307.2,1.13 (1.07 1.19),4.63E-02
382,Otalgia,sense organs,OPGS005710,0.221,RNAseq,GPX4,0.81 (0.74 0.88),3.54E-02
383,Otosclerosis,sense organs,OPGS008491,0.102,RNAseq,ANKRD13D,1.25 (1.16 1.35),2.56E-04
383,Otosclerosis,sense organs,OPGS009450,0.080,RNAseq,AP003068.2,1.22 (1.12 1.32),4.97E-02
383,Otosclerosis,sense organs,OPGS008320,0.106,RNAseq,PELI3,0.80 (0.73 0.89),4.97E-02
385,Other disorders of middle ear and mastoid,sense organs,OPGS000300,0.166,SomaScan,Triggering receptor expressed on myeloid cells 1,0.73 (0.65 0.83),2.90E-02
389.1,Sensorineural hearing loss,sense organs,OPGS000129,0.329,SomaScan,Neutrophil collagenase,0.86 (0.81 0.91),2.83E-02
401.1,Essential hypertension,circulatory system,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.03 (1.02 1.03),1.07E-16
401.1,Essential hypertension,circulatory system,OPGS001132,0.044,SomaScan,N-terminal pro-BNP,0.98 (0.97 0.98),5.68E-10
401.1,Essential hypertension,circulatory system,OPGS001377,0.030,SomaScan,Vascular cell adhesion protein 1,1.02 (1.01 1.03),3.01E-08
401.1,Essential hypertension,circulatory system,OPGS001464,0.027,SomaScan,Platelet glycoprotein Ib alpha chain,1.02 (1.01 1.02),8.53E-08
401.1,Essential hypertension,circulatory system,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.02 (1.01 1.02),1.74E-07
401.1,Essential hypertension,circulatory system,OPGS000521,0.113,SomaScan,Transmembrane protease serine 11D,1.02 (1.01 1.02),2.57E-07
401.1,Essential hypertension,circulatory system,OPGS001472,0.027,SomaScan,Angiotensinogen,1.02 (1.01 1.02),3.00E-07
401.1,Essential hypertension,circulatory system,OPGS001238,0.037,SomaScan,Dedicator of cytokinesis protein 9,1.02 (1.01 1.02),3.00E-07
401.1,Essential hypertension,circulatory system,OPGS000826,0.070,SomaScan,Tumor necrosis factor ligand superfamily member 12,1.02 (1.01 1.02),5.15E-07
401.1,Essential hypertension,circulatory system,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.98 (0.98 0.99),8.13E-07
401.1,Essential hypertension,circulatory system,OPGS000698,0.085,SomaScan,Alcohol dehydrogenase 1B,1.02 (1.01 1.02),1.02E-06
401.1,Essential hypertension,circulatory system,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.02 (1.01 1.02),1.34E-06
401.1,Essential hypertension,circulatory system,OPGS001102,0.046,SomaScan,Granzyme A,1.02 (1.01 1.02),1.54E-06
401.1,Essential hypertension,circulatory system,OPGS001157,0.041,SomaScan,Transmembrane protein 106A,0.98 (0.98 0.99),1.66E-06
401.1,Essential hypertension,circulatory system,OPGS000319,0.161,SomaScan,Beta-mannosidase,0.98 (0.98 0.99),2.11E-06
401.1,Essential hypertension,circulatory system,OPGS001831,0.016,SomaScan,SUN domain-containing protein 3,1.02 (1.01 1.02),6.12E-06
401.1,Essential hypertension,circulatory system,OPGS000632,0.093,SomaScan,Erythrocyte band 7 integral membrane protein,1.02 (1.01 1.02),6.25E-06
401.1,Essential hypertension,circulatory system,OPGS001812,0.017,SomaScan,Fibroblast growth factor 19,0.98 (0.98 0.99),1.06E-05
401.1,Essential hypertension,circulatory system,OPGS002046,0.012,SomaScan,Set1/Ash2 histone methyltransferase complex subunit ASH2,1.02 (1.01 1.02),1.12E-05
401.1,Essential hypertension,circulatory system,OPGS001928,0.014,SomaScan,Sorting nexin-1,1.02 (1.01 1.02),1.25E-05
401.1,Essential hypertension,circulatory system,OPGS000137,0.312,SomaScan,Complement C4b,0.98 (0.98 0.99),1.25E-05
401.1,Essential hypertension,circulatory system,OPGS000664,0.088,SomaScan,BPI fold-containing family A member 2,1.02 (1.01 1.02),1.28E-05
401.1,Essential hypertension,circulatory system,OPGS000163,0.269,SomaScan,Single Ig IL-1-related receptor,1.02 (1.01 1.02),1.41E-05
401.1,Essential hypertension,circulatory system,OPGS000992,0.054,SomaScan,Arylamine N-acetyltransferase 1,0.98 (0.98 0.99),2.35E-05
401.1,Essential hypertension,circulatory system,OPGS001328,0.032,SomaScan,CXADR-like membrane protein,1.02 (1.01 1.02),4.13E-05
401.1,Essential hypertension,circulatory system,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.99 (0.98 0.99),4.43E-05
401.1,Essential hypertension,circulatory system,OPGS001242,0.037,SomaScan,Sex hormone-binding globulin,1.01 (1.01 1.02),7.57E-05
401.1,Essential hypertension,circulatory system,OPGS000173,0.257,SomaScan,Janus kinase and microtubule-interacting protein 3,1.01 (1.01 1.02),8.57E-05
401.1,Essential hypertension,circulatory system,OPGS001615,0.022,SomaScan,Cerebral cavernous malformations 2 protein,0.99 (0.98 0.99),1.36E-04
401.1,Essential hypertension,circulatory system,OPGS001598,0.022,SomaScan,SPARC,0.99 (0.98 0.99),1.87E-04
401.1,Essential hypertension,circulatory system,OPGS001252,0.036,SomaScan,Neuronal pentraxin-2,1.01 (1.01 1.02),2.46E-04
401.1,Essential hypertension,circulatory system,OPGS000492,0.119,SomaScan,Inactive gamma-glutamyltranspeptidase 2,1.01 (1.01 1.02),2.57E-04
401.1,Essential hypertension,circulatory system,OPGS001440,0.028,SomaScan,Pancreatic hormone,0.99 (0.98 0.99),2.67E-04
401.1,Essential hypertension,circulatory system,OPGS001058,0.049,SomaScan,Protocadherin beta-10,1.01 (1.01 1.02),3.02E-04
401.1,Essential hypertension,circulatory system,OPGS001365,0.030,SomaScan,Leukocyte cell-derived chemotaxin 1,0.99 (0.98 0.99),3.07E-04
401.1,Essential hypertension,circulatory system,OPGS001460,0.027,SomaScan,Gap junction alpha-1 protein,1.01 (1.01 1.02),3.09E-04
401.1,Essential hypertension,circulatory system,OPGS001462,0.027,SomaScan,Beta-crystallin B2,1.01 (1.01 1.02),3.28E-04
401.1,Essential hypertension,circulatory system,OPGS000204,0.233,SomaScan,PR domain zinc finger protein 1,1.01 (1.01 1.02),3.36E-04
401.1,Essential hypertension,circulatory system,OPGS002246,0.010,SomaScan,Sperm-associated antigen 11B,0.99 (0.98 0.99),3.36E-04
401.1,Essential hypertension,circulatory system,OPGS001392,0.029,SomaScan,Cadherin-related family member 5,1.01 (1.01 1.02),3.61E-04
401.1,Essential hypertension,circulatory system,OPGS000401,0.139,SomaScan,Hemoglobin subunit theta-1,1.01 (1.01 1.02),3.65E-04
401.1,Essential hypertension,circulatory system,OPGS000011,0.683,SomaScan,Hepatocyte growth factor-like protein,1.01 (1.01 1.02),4.40E-04
401.1,Essential hypertension,circulatory system,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,0.99 (0.98 0.99),4.55E-04
401.1,Essential hypertension,circulatory system,OPGS000106,0.366,SomaScan,Protein FAM3D,0.99 (0.98 0.99),4.83E-04
401.1,Essential hypertension,circulatory system,OPGS002108,0.012,SomaScan,Neuralized-like protein 4,1.01 (1.01 1.02),4.97E-04
401.1,Essential hypertension,circulatory system,OPGS000969,0.056,SomaScan,Transferrin receptor protein 1,0.99 (0.98 0.99),5.32E-04
401.1,Essential hypertension,circulatory system,OPGS000860,0.066,SomaScan,Cell surface glycoprotein CD200 receptor 2,0.99 (0.98 0.99),5.32E-04
401.1,Essential hypertension,circulatory system,OPGS001963,0.013,SomaScan,Annexin A9,1.01 (1.01 1.02),5.93E-04
401.1,Essential hypertension,circulatory system,OPGS002219,0.011,SomaScan,Zinc finger protein 843,1.01 (1.01 1.02),6.85E-04
401.1,Essential hypertension,circulatory system,OPGS001070,0.048,SomaScan,Vascular endothelial growth factor C,1.01 (1.01 1.02),6.86E-04
401.1,Essential hypertension,circulatory system,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.99 (0.98 0.99),6.96E-04
401.1,Essential hypertension,circulatory system,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,1.01 (1.01 1.02),7.77E-04
401.1,Essential hypertension,circulatory system,OPGS001671,0.020,SomaScan,Tumor necrosis factor ligand superfamily member 6. soluble form,0.99 (0.98 0.99),7.79E-04
401.1,Essential hypertension,circulatory system,OPGS000766,0.077,SomaScan,Peptidyl-tRNA hydrolase ICT1. mitochondrial,0.99 (0.98 0.99),7.79E-04
401.1,Essential hypertension,circulatory system,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.01 (1.01 1.02),7.91E-04
401.1,Essential hypertension,circulatory system,OPGS000421,0.134,SomaScan,Lysozyme C,1.01 (1.01 1.02),8.85E-04
401.1,Essential hypertension,circulatory system,OPGS000434,0.132,SomaScan,DNA repair protein RAD51 homolog 4,1.01 (1.01 1.02),1.00E-03
401.1,Essential hypertension,circulatory system,OPGS000582,0.101,SomaScan,Cathepsin S,0.99 (0.98 0.99),1.03E-03
401.1,Essential hypertension,circulatory system,OPGS001369,0.030,SomaScan,Importin subunit alpha-1,1.01 (1.01 1.02),1.07E-03
401.1,Essential hypertension,circulatory system,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.01 (1.01 1.02),1.08E-03
401.1,Essential hypertension,circulatory system,OPGS000014,0.645,SomaScan,Carboxypeptidase A4,1.01 (1.01 1.02),1.11E-03
401.1,Essential hypertension,circulatory system,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.01 (1.01 1.02),1.15E-03
401.1,Essential hypertension,circulatory system,OPGS001342,0.031,SomaScan,Proprotein convertase subtilisin/kexin type 7,0.99 (0.98 0.99),1.15E-03
401.1,Essential hypertension,circulatory system,OPGS001121,0.044,SomaScan,Growth factor receptor-bound protein 7,0.99 (0.98 0.99),1.15E-03
401.1,Essential hypertension,circulatory system,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.01 (1.01 1.02),2.12E-03
401.1,Essential hypertension,circulatory system,OPGS000855,0.067,SomaScan,Cathepsin B,0.99 (0.98 0.99),2.16E-03
401.1,Essential hypertension,circulatory system,OPGS000613,0.096,SomaScan,Stromelysin-1,1.01 (1.01 1.02),2.32E-03
401.1,Essential hypertension,circulatory system,OPGS000873,0.065,SomaScan,Tensin-2,1.01 (1.01 1.02),2.42E-03
401.1,Essential hypertension,circulatory system,OPGS002043,0.012,SomaScan,Matrix-remodeling-associated protein 8,1.01 (1.01 1.02),2.49E-03
401.1,Essential hypertension,circulatory system,OPGS001267,0.035,SomaScan,Heparin-binding EGF-like growth factor,0.99 (0.98 0.99),2.77E-03
401.1,Essential hypertension,circulatory system,OPGS001883,0.015,SomaScan,UMP-CMP kinase,1.01 (1.01 1.02),2.79E-03
401.1,Essential hypertension,circulatory system,OPGS000348,0.151,SomaScan,Quinone oxidoreductase-like protein 1,1.01 (1.01 1.02),2.99E-03
401.1,Essential hypertension,circulatory system,OPGS000212,0.222,SomaScan,Tyrosine-protein kinase receptor Tie-1. soluble,0.99 (0.98 0.99),3.00E-03
401.1,Essential hypertension,circulatory system,OPGS000510,0.115,SomaScan,Guanine nucleotide-binding protein G(k) subunit alpha,0.99 (0.98 0.99),3.17E-03
401.1,Essential hypertension,circulatory system,OPGS000426,0.133,SomaScan,Sushi. von Willebrand factor type A. EGF and pentraxin domain-containing protein 1,1.01 (1.01 1.02),3.33E-03
401.1,Essential hypertension,circulatory system,OPGS001002,0.053,SomaScan,Tumor protein p53-inducible protein 11,1.01 (1.01 1.02),3.50E-03
401.1,Essential hypertension,circulatory system,OPGS000285,0.176,SomaScan,Complement C1q tumor necrosis factor-related protein 1,1.01 (1.01 1.02),3.77E-03
401.1,Essential hypertension,circulatory system,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,1.01 (1.01 1.02),3.86E-03
401.1,Essential hypertension,circulatory system,OPGS002321,0.010,SomaScan,Fibronectin Fragment 3,0.99 (0.98 0.99),3.92E-03
401.1,Essential hypertension,circulatory system,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,0.99 (0.98 0.99),3.94E-03
401.1,Essential hypertension,circulatory system,OPGS001541,0.024,SomaScan,Transmembrane protein 106B,0.99 (0.98 0.99),4.08E-03
401.1,Essential hypertension,circulatory system,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.01 (1.01 1.02),4.63E-03
401.1,Essential hypertension,circulatory system,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.01 (1.01 1.02),4.71E-03
401.1,Essential hypertension,circulatory system,OPGS000312,0.163,SomaScan,Selenoprotein S,1.01 (1.01 1.02),4.74E-03
401.1,Essential hypertension,circulatory system,OPGS000394,0.140,SomaScan,Superoxide dismutase [Mn]. mitochondrial,1.01 (1.01 1.02),4.74E-03
401.1,Essential hypertension,circulatory system,OPGS000883,0.064,SomaScan,Group XIIB secretory phospholipase A2-like protein,1.01 (1.01 1.02),4.93E-03
401.1,Essential hypertension,circulatory system,OPGS000833,0.069,SomaScan,Protein LEG1 homolog,1.01 (1.01 1.02),4.98E-03
401.1,Essential hypertension,circulatory system,OPGS000653,0.090,SomaScan,Neuropeptide W,0.99 (0.98 0.99),5.05E-03
401.1,Essential hypertension,circulatory system,OPGS001715,0.019,SomaScan,Histone deacetylase 8,1.01 (1.01 1.02),5.61E-03
401.1,Essential hypertension,circulatory system,OPGS000362,0.147,SomaScan,Golgi membrane protein 1,0.99 (0.98 0.99),5.61E-03
401.1,Essential hypertension,circulatory system,OPGS000008,0.699,SomaScan,Intercellular adhesion molecule 1,1.01 (1.01 1.02),5.97E-03
401.1,Essential hypertension,circulatory system,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,0.99 (0.98 0.99),6.11E-03
401.1,Essential hypertension,circulatory system,OPGS001719,0.019,SomaScan,Urotensin-2B,1.01 (1.01 1.02),6.15E-03
401.1,Essential hypertension,circulatory system,OPGS000838,0.069,SomaScan,DNA/RNA-binding protein KIN17,0.99 (0.98 0.99),6.15E-03
401.1,Essential hypertension,circulatory system,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,0.99 (0.98 0.99),6.39E-03
401.1,Essential hypertension,circulatory system,OPGS000563,0.104,SomaScan,Liver-expressed antimicrobial peptide 2,0.99 (0.98 0.99),6.46E-03
401.1,Essential hypertension,circulatory system,OPGS001547,0.024,SomaScan,Cytokine receptor-like factor 1,0.99 (0.98 0.99),6.49E-03
401.1,Essential hypertension,circulatory system,OPGS000197,0.236,SomaScan,Inter-alpha-trypsin inhibitor heavy chain H1,0.99 (0.98 0.99),6.65E-03
401.1,Essential hypertension,circulatory system,OPGS002093,0.012,SomaScan,Fibronectin,0.99 (0.98 0.99),6.67E-03
401.1,Essential hypertension,circulatory system,OPGS001327,0.032,SomaScan,Basal Cell Adhesion Molecule,0.99 (0.98 0.99),6.71E-03
401.1,Essential hypertension,circulatory system,OPGS000538,0.109,SomaScan,Cyclic AMP-responsive element-binding protein 3-like protein 4,0.99 (0.98 1.00),7.83E-03
401.1,Essential hypertension,circulatory system,OPGS000357,0.149,SomaScan,Inter-alpha-trypsin inhibitor heavy chain H3,1.01 (1.00 1.02),8.72E-03
401.1,Essential hypertension,circulatory system,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,0.99 (0.98 1.00),8.76E-03
401.1,Essential hypertension,circulatory system,OPGS000073,0.428,SomaScan,Interleukin-1 receptor-like 1,1.01 (1.00 1.02),8.81E-03
401.1,Essential hypertension,circulatory system,OPGS001404,0.029,SomaScan,Interferon gamma receptor 1,1.01 (1.00 1.02),8.95E-03
401.1,Essential hypertension,circulatory system,OPGS001112,0.045,SomaScan,Hemojuvelin,1.01 (1.00 1.02),9.26E-03
401.1,Essential hypertension,circulatory system,OPGS001115,0.045,SomaScan,Small integral membrane protein 9,1.01 (1.00 1.02),9.37E-03
401.1,Essential hypertension,circulatory system,OPGS002089,0.012,SomaScan,Protein FAM19A4,0.99 (0.98 1.00),9.53E-03
401.1,Essential hypertension,circulatory system,OPGS001967,0.013,SomaScan,Sprouty-related. EVH1 domain-containing protein 1,0.99 (0.98 1.00),9.53E-03
401.1,Essential hypertension,circulatory system,OPGS000655,0.090,SomaScan,Lysosomal Pro-X carboxypeptidase,1.01 (1.00 1.02),9.71E-03
401.1,Essential hypertension,circulatory system,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,1.01 (1.00 1.02),1.06E-02
401.1,Essential hypertension,circulatory system,OPGS000955,0.057,SomaScan,Repulsive guidance molecule A,1.01 (1.00 1.02),1.06E-02
401.1,Essential hypertension,circulatory system,OPGS000872,0.065,SomaScan,Ras-related protein Rab-26,1.01 (1.00 1.02),1.07E-02
401.1,Essential hypertension,circulatory system,OPGS000853,0.067,SomaScan,Tumor necrosis factor receptor superfamily member 19L,0.99 (0.98 1.00),1.07E-02
401.1,Essential hypertension,circulatory system,OPGS001092,0.046,SomaScan,TOM1-like protein 1,1.01 (1.00 1.02),1.15E-02
401.1,Essential hypertension,circulatory system,OPGS000768,0.076,SomaScan,Multiple inositol polyphosphate phosphatase 1,0.99 (0.98 1.00),1.17E-02
401.1,Essential hypertension,circulatory system,OPGS001560,0.023,SomaScan,Pleiotrophin,0.99 (0.98 1.00),1.18E-02
401.1,Essential hypertension,circulatory system,OPGS002197,0.011,SomaScan,Pleckstrin homology domain-containing family A member 7,1.01 (1.00 1.02),1.21E-02
401.1,Essential hypertension,circulatory system,OPGS000517,0.114,SomaScan,Advanced glycosylation end product-specific receptor. soluble,0.99 (0.98 1.00),1.28E-02
401.1,Essential hypertension,circulatory system,OPGS001286,0.034,SomaScan,Granzyme K,1.01 (1.00 1.02),1.31E-02
401.1,Essential hypertension,circulatory system,OPGS001297,0.034,SomaScan,Neogenin,0.99 (0.98 1.00),1.41E-02
401.1,Essential hypertension,circulatory system,OPGS001174,0.040,SomaScan,Platelet glycoprotein 4,0.99 (0.98 1.00),1.42E-02
401.1,Essential hypertension,circulatory system,OPGS000925,0.060,SomaScan,Plexin domain-containing protein 1,0.99 (0.98 1.00),1.44E-02
401.1,Essential hypertension,circulatory system,OPGS000221,0.213,SomaScan,Protein FAM177A1,0.99 (0.98 1.00),1.51E-02
401.1,Essential hypertension,circulatory system,OPGS000445,0.129,SomaScan,Collectin-10,0.99 (0.98 1.00),1.52E-02
401.1,Essential hypertension,circulatory system,OPGS001501,0.025,SomaScan,Hemoglobin,1.01 (1.00 1.02),1.56E-02
401.1,Essential hypertension,circulatory system,OPGS001832,0.016,SomaScan,Neurogenic locus notch homolog protein 1,0.99 (0.98 1.00),1.69E-02
401.1,Essential hypertension,circulatory system,OPGS001437,0.028,SomaScan,Steroidogenic acute regulatory protein. mitochondrial,1.01 (1.00 1.02),1.71E-02
401.1,Essential hypertension,circulatory system,OPGS000844,0.068,SomaScan,Growth/differentiation factor 2,1.01 (1.00 1.02),1.71E-02
401.1,Essential hypertension,circulatory system,OPGS000334,0.156,SomaScan,Sushi. von Willebrand factor type A. EGF and pentraxin domain-containing protein 1,1.01 (1.00 1.02),1.72E-02
401.1,Essential hypertension,circulatory system,OPGS001427,0.028,SomaScan,Alpha-2-macroglobulin,1.01 (1.00 1.02),1.76E-02
401.1,Essential hypertension,circulatory system,OPGS000699,0.085,SomaScan,Myeloperoxidase,1.01 (1.00 1.02),1.83E-02
401.1,Essential hypertension,circulatory system,OPGS002117,0.012,SomaScan,Rho guanine nucleotide exchange factor 25,1.01 (1.00 1.02),1.85E-02
401.1,Essential hypertension,circulatory system,OPGS001700,0.019,SomaScan,Semaphorin-6B,0.99 (0.98 1.00),1.90E-02
401.1,Essential hypertension,circulatory system,OPGS000935,0.059,SomaScan,Vitronectin,0.99 (0.98 1.00),1.92E-02
401.1,Essential hypertension,circulatory system,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.01 (1.00 1.02),2.03E-02
401.1,Essential hypertension,circulatory system,OPGS000154,0.277,SomaScan,Granulins,1.01 (1.00 1.02),2.04E-02
401.1,Essential hypertension,circulatory system,OPGS001528,0.025,SomaScan,Histone H1.2,0.99 (0.98 1.00),2.17E-02
401.1,Essential hypertension,circulatory system,OPGS002124,0.011,SomaScan,6-pyruvoyl tetrahydrobiopterin synthase,0.99 (0.98 1.00),2.28E-02
401.1,Essential hypertension,circulatory system,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.99 (0.98 1.00),2.28E-02
401.1,Essential hypertension,circulatory system,OPGS000284,0.177,SomaScan,Protein eva-1 homolog C,1.01 (1.00 1.02),2.44E-02
401.1,Essential hypertension,circulatory system,OPGS002179,0.011,SomaScan,Ciliary neurotrophic factor,1.01 (1.00 1.02),2.57E-02
401.1,Essential hypertension,circulatory system,OPGS001912,0.014,SomaScan,Centromere protein V,0.99 (0.98 1.00),2.63E-02
401.1,Essential hypertension,circulatory system,OPGS000115,0.347,SomaScan,Protein CEI,1.01 (1.00 1.02),2.64E-02
401.1,Essential hypertension,circulatory system,OPGS002139,0.011,SomaScan,Interleukin-27,0.99 (0.98 1.00),2.66E-02
401.1,Essential hypertension,circulatory system,OPGS001129,0.044,SomaScan,Sodium-coupled monocarboxylate transporter 1,1.01 (1.00 1.02),2.71E-02
401.1,Essential hypertension,circulatory system,OPGS001574,0.023,SomaScan,Keratin-associated protein 2-4,0.99 (0.98 1.00),2.77E-02
401.1,Essential hypertension,circulatory system,OPGS001347,0.031,SomaScan,Tumor necrosis factor receptor superfamily member 19L,0.99 (0.98 1.00),2.83E-02
401.1,Essential hypertension,circulatory system,OPGS001257,0.036,SomaScan,Glucagon,0.99 (0.98 1.00),2.90E-02
401.1,Essential hypertension,circulatory system,OPGS000349,0.151,SomaScan,Gamma-glutamyl hydrolase,1.01 (1.00 1.02),2.97E-02
401.1,Essential hypertension,circulatory system,OPGS002329,0.010,SomaScan,Transmembrane protein 154,0.99 (0.98 1.00),3.02E-02
401.1,Essential hypertension,circulatory system,OPGS000172,0.257,SomaScan,Dermokine,0.99 (0.98 1.00),3.04E-02
401.1,Essential hypertension,circulatory system,OPGS001809,0.017,SomaScan,PILR alpha-associated neural protein,1.01 (1.00 1.02),3.05E-02
401.1,Essential hypertension,circulatory system,OPGS000311,0.164,SomaScan,Tyrosine-protein kinase JAK2,0.99 (0.99 1.00),3.21E-02
401.1,Essential hypertension,circulatory system,OPGS001817,0.017,SomaScan,PILR alpha-associated neural protein,1.01 (1.00 1.02),3.22E-02
401.1,Essential hypertension,circulatory system,OPGS001230,0.037,SomaScan,Kynurenine--oxoglutarate transaminase 3,0.99 (0.99 1.00),3.29E-02
401.1,Essential hypertension,circulatory system,OPGS001511,0.025,SomaScan,Complement C3d fragment,0.99 (0.99 1.00),3.29E-02
401.1,Essential hypertension,circulatory system,OPGS001490,0.026,SomaScan,Intercellular adhesion molecule 2,1.01 (1.00 1.02),3.34E-02
401.1,Essential hypertension,circulatory system,OPGS001294,0.034,SomaScan,Peroxidasin homolog,0.99 (0.99 1.00),3.35E-02
401.1,Essential hypertension,circulatory system,OPGS001084,0.047,SomaScan,Activating signal cointegrator 1 complex subunit 1,1.01 (1.00 1.02),3.40E-02
401.1,Essential hypertension,circulatory system,OPGS001759,0.018,SomaScan,Hyaluronidase-1,1.01 (1.00 1.02),3.43E-02
401.1,Essential hypertension,circulatory system,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,1.01 (1.00 1.02),3.47E-02
401.1,Essential hypertension,circulatory system,OPGS001246,0.036,SomaScan,Endothelial cell-selective adhesion molecule,0.99 (0.99 1.00),3.51E-02
401.1,Essential hypertension,circulatory system,OPGS001605,0.022,SomaScan,Peptidyl-prolyl cis-trans isomerase FKBP1B,0.99 (0.99 1.00),3.54E-02
401.1,Essential hypertension,circulatory system,OPGS001913,0.014,SomaScan,Thyroid Stimulating Hormone,0.99 (0.99 1.00),3.54E-02
401.1,Essential hypertension,circulatory system,OPGS001223,0.037,SomaScan,Interleukin-11 receptor subunit alpha,0.99 (0.99 1.00),3.54E-02
401.1,Essential hypertension,circulatory system,OPGS000951,0.057,SomaScan,Pseudokinase FAM20A,0.99 (0.99 1.00),3.59E-02
401.1,Essential hypertension,circulatory system,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.01 (1.00 1.02),3.59E-02
401.1,Essential hypertension,circulatory system,OPGS000993,0.054,SomaScan,Protachykinin-1,0.99 (0.99 1.00),3.74E-02
401.1,Essential hypertension,circulatory system,OPGS001177,0.040,SomaScan,Gastrin-releasing peptide,0.99 (0.99 1.00),3.79E-02
401.1,Essential hypertension,circulatory system,OPGS000250,0.192,SomaScan,Complement C1r subcomponent,1.01 (1.00 1.01),3.97E-02
401.1,Essential hypertension,circulatory system,OPGS001641,0.021,SomaScan,Killer cell lectin-like receptor subfamily F member 1,1.01 (1.00 1.01),3.99E-02
401.1,Essential hypertension,circulatory system,OPGS001130,0.044,SomaScan,Chordin-like protein 2,1.01 (1.00 1.01),3.99E-02
401.1,Essential hypertension,circulatory system,OPGS000798,0.073,SomaScan,N-acetylated-alpha-linked acidic dipeptidase 2,0.99 (0.99 1.00),4.06E-02
401.1,Essential hypertension,circulatory system,OPGS000695,0.085,SomaScan,SLAM family member 7,0.99 (0.99 1.00),4.08E-02
401.1,Essential hypertension,circulatory system,OPGS000765,0.077,SomaScan,Angiopoietin-1 receptor. soluble,0.99 (0.99 1.00),4.09E-02
401.1,Essential hypertension,circulatory system,OPGS000603,0.098,SomaScan,Cell adhesion molecule-related/down-regulated by oncogenes,0.99 (0.99 1.00),4.10E-02
401.1,Essential hypertension,circulatory system,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,0.99 (0.99 1.00),4.14E-02
401.1,Essential hypertension,circulatory system,OPGS001485,0.026,SomaScan,Tolloid-like protein 1,0.99 (0.99 1.00),4.18E-02
401.1,Essential hypertension,circulatory system,OPGS000278,0.180,SomaScan,Cadherin-5,0.99 (0.99 1.00),4.33E-02
401.1,Essential hypertension,circulatory system,OPGS002174,0.011,SomaScan,Phospholipase B-like 1,0.99 (0.99 1.00),4.38E-02
401.1,Essential hypertension,circulatory system,OPGS002231,0.011,SomaScan,Vesicle transport through interaction with t-SNAREs homolog 1A,0.99 (0.99 1.00),4.38E-02
401.1,Essential hypertension,circulatory system,OPGS000356,0.149,SomaScan,Promotilin,1.01 (1.00 1.01),4.40E-02
401.1,Essential hypertension,circulatory system,OPGS001400,0.029,SomaScan,Plexin-A1,1.01 (1.00 1.01),4.43E-02
401.1,Essential hypertension,circulatory system,OPGS001288,0.034,SomaScan,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,0.99 (0.99 1.00),4.45E-02
401.1,Essential hypertension,circulatory system,OPGS000726,0.081,SomaScan,Plasminogen,1.01 (1.00 1.01),4.46E-02
401.1,Essential hypertension,circulatory system,OPGS001210,0.038,SomaScan,Neurensin-1,0.99 (0.99 1.00),4.49E-02
401.1,Essential hypertension,circulatory system,OPGS000710,0.082,SomaScan,Thrombin,1.01 (1.00 1.01),4.55E-02
401.1,Essential hypertension,circulatory system,OPGS000907,0.062,SomaScan,Glycerol-3-phosphate dehydrogenase 1-like protein,0.99 (0.99 1.00),4.56E-02
401.1,Essential hypertension,circulatory system,OPGS001336,0.032,SomaScan,Poly(U)-specific endoribonuclease,1.01 (1.00 1.01),4.66E-02
401.1,Essential hypertension,circulatory system,OPGS001089,0.047,SomaScan,Tissue factor pathway inhibitor,1.01 (1.00 1.01),4.73E-02
401.1,Essential hypertension,circulatory system,OPGS001081,0.047,SomaScan,Sex hormone-binding globulin,1.01 (1.00 1.01),4.79E-02
401.1,Essential hypertension,circulatory system,OPGS001301,0.034,SomaScan,Glycosaminoglycan xylosylkinase,0.99 (0.99 1.00),4.86E-02
401.1,Essential hypertension,circulatory system,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.01 (1.00 1.01),4.93E-02
401.1,Essential hypertension,circulatory system,OPGS000818,0.071,SomaScan,Normal mucosa of esophagus-specific gene 1 protein,1.01 (1.00 1.01),4.98E-02
401.1,Essential hypertension,circulatory system,OPGS002435,0.193,Olink,Fibroblast growth factor 5,1.04 (1.04 1.05),6.06E-44
401.1,Essential hypertension,circulatory system,OPGS002585,0.037,Olink,T-cell surface glycoprotein CD5,1.02 (1.02 1.03),3.24E-11
401.1,Essential hypertension,circulatory system,OPGS002575,0.041,Olink,Natriuretic peptides B,0.98 (0.97 0.98),1.27E-09
401.1,Essential hypertension,circulatory system,OPGS002633,0.021,Olink,C-X-C motif chemokine 11,1.02 (1.02 1.03),1.66E-09
401.1,Essential hypertension,circulatory system,OPGS002575,0.041,Olink,Natriuretic peptides B,0.98 (0.98 0.99),9.87E-08
401.1,Essential hypertension,circulatory system,OPGS002615,0.026,Olink,Tumor necrosis factor ligand superfamily member 12,1.02 (1.01 1.02),1.61E-07
401.1,Essential hypertension,circulatory system,OPGS002531,0.066,Olink,Tissue factor,0.98 (0.98 0.99),1.16E-06
401.1,Essential hypertension,circulatory system,OPGS002657,0.013,Olink,Fibroblast growth factor 19,0.98 (0.98 0.99),5.08E-06
401.1,Essential hypertension,circulatory system,OPGS002568,0.043,Olink,Granzyme A,1.02 (1.01 1.02),4.26E-05
401.1,Essential hypertension,circulatory system,OPGS002608,0.028,Olink,Integrin beta-2,1.01 (1.01 1.02),7.51E-05
401.1,Essential hypertension,circulatory system,OPGS002437,0.187,Olink,Serine protease 27,1.01 (1.01 1.02),1.15E-04
401.1,Essential hypertension,circulatory system,OPGS002614,0.027,Olink,Carboxypeptidase B,0.99 (0.98 0.99),1.20E-04
401.1,Essential hypertension,circulatory system,OPGS002480,0.127,Olink,Neprilysin,1.01 (1.01 1.02),7.65E-04
401.1,Essential hypertension,circulatory system,OPGS002586,0.036,Olink,Delta and Notch-like epidermal growth factor-related receptor,0.99 (0.98 0.99),8.25E-04
401.1,Essential hypertension,circulatory system,OPGS002468,0.142,Olink,Galectin-8,1.01 (1.01 1.02),2.00E-03
401.1,Essential hypertension,circulatory system,OPGS002665,0.011,Olink,Neurocan core protein,0.99 (0.98 0.99),2.86E-03
401.1,Essential hypertension,circulatory system,OPGS002640,0.019,Olink,NT-3 growth factor receptor,0.99 (0.98 1.00),7.81E-03
401.1,Essential hypertension,circulatory system,OPGS002525,0.071,Olink,Layilin,0.99 (0.98 1.00),1.18E-02
401.1,Essential hypertension,circulatory system,OPGS002646,0.017,Olink,Proheparin-binding EGF-like growth factor,0.99 (0.98 1.00),1.27E-02
401.1,Essential hypertension,circulatory system,OPGS002436,0.191,Olink,Progranulin,1.01 (1.00 1.02),1.90E-02
401.1,Essential hypertension,circulatory system,OPGS002527,0.069,Olink,Natural killer cell receptor 2B4,1.01 (1.00 1.02),2.00E-02
401.1,Essential hypertension,circulatory system,OPGS002474,0.135,Olink,C-C motif chemokine 4,1.01 (1.00 1.02),2.48E-02
401.1,Essential hypertension,circulatory system,OPGS002417,0.237,Olink,Hepatitis A virus cellular receptor 1,1.01 (1.00 1.02),2.81E-02
401.1,Essential hypertension,circulatory system,OPGS002401,0.336,Olink,Interleukin-1 receptor-like 1,1.01 (1.00 1.02),3.12E-02
401.1,Essential hypertension,circulatory system,OPGS002552,0.053,Olink,Low-density lipoprotein receptor,0.99 (0.98 1.00),3.18E-02
401.1,Essential hypertension,circulatory system,OPGS002440,0.183,Olink,Cadherin-5,0.99 (0.99 1.00),3.45E-02
401.1,Essential hypertension,circulatory system,OPGS002494,0.103,Olink,Carboxypeptidase A2,0.99 (0.99 1.00),3.67E-02
401.1,Essential hypertension,circulatory system,OPGS002544,0.061,Olink,Cell adhesion molecule 3,1.01 (1.00 1.02),3.67E-02
401.1,Essential hypertension,circulatory system,OPGS002658,0.013,Olink,C-C motif chemokine 22,1.01 (1.00 1.02),3.71E-02
401.1,Essential hypertension,circulatory system,OPGS002629,0.023,Olink,Interleukin-18-binding protein,1.01 (1.00 1.01),3.76E-02
401.1,Essential hypertension,circulatory system,OPGS002935,0.044,Metabolon,dehydroisoandrosterone sulfate (DHEA-S),1.02 (1.01 1.02),5.71E-07
401.1,Essential hypertension,circulatory system,OPGS003151,0.014,Metabolon,1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2)*,1.02 (1.01 1.02),1.07E-06
401.1,Essential hypertension,circulatory system,OPGS003008,0.030,Metabolon,quinolinate,1.02 (1.01 1.02),1.82E-06
401.1,Essential hypertension,circulatory system,OPGS002922,0.047,Metabolon,stearoylcarnitine,1.02 (1.01 1.02),2.20E-06
401.1,Essential hypertension,circulatory system,OPGS002978,0.034,Metabolon,myristoylcarnitine,1.02 (1.01 1.02),4.54E-06
401.1,Essential hypertension,circulatory system,OPGS002886,0.057,Metabolon,X - 12822,1.02 (1.01 1.02),1.34E-05
401.1,Essential hypertension,circulatory system,OPGS003137,0.016,Metabolon,ergothioneine,0.98 (0.98 0.99),3.64E-05
401.1,Essential hypertension,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.02 (1.01 1.02),3.67E-05
401.1,Essential hypertension,circulatory system,OPGS002900,0.053,Metabolon,X - 17357,0.99 (0.98 0.99),5.42E-05
401.1,Essential hypertension,circulatory system,OPGS002912,0.049,Metabolon,oleoylcarnitine,1.01 (1.01 1.02),6.05E-05
401.1,Essential hypertension,circulatory system,OPGS002783,0.104,Metabolon,X - 21668,0.99 (0.98 0.99),8.57E-05
401.1,Essential hypertension,circulatory system,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.01 (1.01 1.02),8.97E-05
401.1,Essential hypertension,circulatory system,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.01 (1.01 1.02),2.12E-04
401.1,Essential hypertension,circulatory system,OPGS002918,0.048,Metabolon,palmitoylcarnitine,1.01 (1.01 1.02),2.18E-04
401.1,Essential hypertension,circulatory system,OPGS002946,0.043,Metabolon,isovalerylcarnitine,1.01 (1.01 1.02),2.67E-04
401.1,Essential hypertension,circulatory system,OPGS002885,0.057,Metabolon,linoleoylcarnitine*,1.01 (1.01 1.02),4.61E-04
401.1,Essential hypertension,circulatory system,OPGS002697,0.394,Metabolon,androsterone sulfate,1.01 (1.01 1.02),4.61E-04
401.1,Essential hypertension,circulatory system,OPGS002706,0.291,Metabolon,epiandrosterone sulfate,1.01 (1.01 1.02),5.07E-04
401.1,Essential hypertension,circulatory system,OPGS003089,0.020,Metabolon,X - 17690,1.01 (1.01 1.02),7.91E-04
401.1,Essential hypertension,circulatory system,OPGS003221,0.011,Metabolon,3-methyl-2-oxobutyrate,1.01 (1.01 1.02),1.13E-03
401.1,Essential hypertension,circulatory system,OPGS002757,0.135,Metabolon,5alpha-androstan-3beta.17beta-diol disulfate,1.01 (1.01 1.02),1.19E-03
401.1,Essential hypertension,circulatory system,OPGS002765,0.128,Metabolon,tauro-beta-muricholate,0.99 (0.98 0.99),1.32E-03
401.1,Essential hypertension,circulatory system,OPGS002873,0.061,Metabolon,X - 14658,1.01 (1.01 1.02),2.90E-03
401.1,Essential hypertension,circulatory system,OPGS003204,0.012,Metabolon,X - 18886,1.01 (1.01 1.02),2.90E-03
401.1,Essential hypertension,circulatory system,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.01 (1.01 1.02),2.98E-03
401.1,Essential hypertension,circulatory system,OPGS002838,0.075,Metabolon,adipoylcarnitine,0.99 (0.98 0.99),3.08E-03
401.1,Essential hypertension,circulatory system,OPGS002884,0.058,Metabolon,ferulic acid 4-sulfate,1.01 (1.01 1.02),3.12E-03
401.1,Essential hypertension,circulatory system,OPGS003009,0.030,Metabolon,4-androsten-3beta.17beta-diol monosulfate (1),1.01 (1.01 1.02),3.63E-03
401.1,Essential hypertension,circulatory system,OPGS003180,0.013,Metabolon,1-palmitoyl-GPA (16:0),0.99 (0.98 0.99),4.30E-03
401.1,Essential hypertension,circulatory system,OPGS002746,0.149,Metabolon,5alpha-androstan-3beta.17beta-diol monosulfate (1),1.01 (1.01 1.02),5.15E-03
401.1,Essential hypertension,circulatory system,OPGS003004,0.030,Metabolon,octadecanedioate,0.99 (0.98 0.99),5.27E-03
401.1,Essential hypertension,circulatory system,OPGS002712,0.257,Metabolon,5alpha-androstan-3alpha.17beta-diol monosulfate (1),1.01 (1.01 1.02),5.42E-03
401.1,Essential hypertension,circulatory system,OPGS002782,0.110,Metabolon,4-androsten-3beta.17beta-diol disulfate (1),1.01 (1.01 1.02),6.13E-03
401.1,Essential hypertension,circulatory system,OPGS002770,0.124,Metabolon,1-stearoyl-2-arachidonoyl-GPE (18:0/20:4),1.01 (1.00 1.02),7.84E-03
401.1,Essential hypertension,circulatory system,OPGS002803,0.092,Metabolon,X - 11538,0.99 (0.98 1.00),8.43E-03
401.1,Essential hypertension,circulatory system,OPGS002769,0.124,Metabolon,hexadecanedioate,0.99 (0.98 1.00),8.99E-03
401.1,Essential hypertension,circulatory system,OPGS003087,0.020,Metabolon,X - 01911,0.99 (0.98 1.00),9.26E-03
401.1,Essential hypertension,circulatory system,OPGS003031,0.026,Metabolon,X - 21312,1.01 (1.00 1.02),1.07E-02
401.1,Essential hypertension,circulatory system,OPGS002930,0.046,Metabolon,X - 13866,1.01 (1.00 1.02),1.07E-02
401.1,Essential hypertension,circulatory system,OPGS003012,0.030,Metabolon,arginine,1.01 (1.00 1.02),1.14E-02
401.1,Essential hypertension,circulatory system,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.01 (1.00 1.02),1.17E-02
401.1,Essential hypertension,circulatory system,OPGS002801,0.093,Metabolon,X - 12824,1.01 (1.00 1.02),1.17E-02
401.1,Essential hypertension,circulatory system,OPGS003000,0.031,Metabolon,1-stearoyl-2-oleoyl-GPE (18:0/18:1),1.01 (1.00 1.02),1.20E-02
401.1,Essential hypertension,circulatory system,OPGS002795,0.098,Metabolon,glycine,0.99 (0.98 1.00),1.26E-02
401.1,Essential hypertension,circulatory system,OPGS003141,0.016,Metabolon,cinnamoylglycine,0.99 (0.98 1.00),1.27E-02
401.1,Essential hypertension,circulatory system,OPGS003172,0.013,Metabolon,deoxycholate,0.99 (0.98 1.00),1.61E-02
401.1,Essential hypertension,circulatory system,OPGS002802,0.092,Metabolon,1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6)*,1.01 (1.00 1.02),1.65E-02
401.1,Essential hypertension,circulatory system,OPGS002925,0.046,Metabolon,gamma-CEHC,0.99 (0.98 1.00),1.80E-02
401.1,Essential hypertension,circulatory system,OPGS003126,0.017,Metabolon,X - 21829,1.01 (1.00 1.02),2.00E-02
401.1,Essential hypertension,circulatory system,OPGS003185,0.013,Metabolon,X - 12715,1.01 (1.00 1.02),2.18E-02
401.1,Essential hypertension,circulatory system,OPGS003132,0.016,Metabolon,2-methylmalonyl carnitine,1.01 (1.00 1.02),2.20E-02
401.1,Essential hypertension,circulatory system,OPGS003070,0.021,Metabolon,isovalerylglycine,0.99 (0.98 1.00),2.28E-02
401.1,Essential hypertension,circulatory system,OPGS003163,0.014,Metabolon,X - 17325,0.99 (0.98 1.00),2.28E-02
401.1,Essential hypertension,circulatory system,OPGS003133,0.016,Metabolon,X - 21659,0.99 (0.98 1.00),2.37E-02
401.1,Essential hypertension,circulatory system,OPGS002751,0.145,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)*,1.01 (1.00 1.02),2.55E-02
401.1,Essential hypertension,circulatory system,OPGS002891,0.056,Metabolon,1-palmitoyl-2-oleoyl-GPE (16:0/18:1),1.01 (1.00 1.02),2.68E-02
401.1,Essential hypertension,circulatory system,OPGS003225,0.010,Metabolon,pyruvate,0.99 (0.98 1.00),2.86E-02
401.1,Essential hypertension,circulatory system,OPGS003088,0.020,Metabolon,1-palmitoyl-2-linoleoyl-glycerol (16:0/18:2)*,1.01 (1.00 1.02),2.89E-02
401.1,Essential hypertension,circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.01 (1.00 1.02),2.97E-02
401.1,Essential hypertension,circulatory system,OPGS002966,0.037,Metabolon,tigloylglycine,0.99 (0.99 1.00),3.26E-02
401.1,Essential hypertension,circulatory system,OPGS002761,0.132,Metabolon,X - 11905,0.99 (0.99 1.00),3.32E-02
401.1,Essential hypertension,circulatory system,OPGS002786,0.103,Metabolon,tetradecanedioate,0.99 (0.99 1.00),3.48E-02
401.1,Essential hypertension,circulatory system,OPGS002906,0.051,Metabolon,X - 16570,0.99 (0.99 1.00),3.50E-02
401.1,Essential hypertension,circulatory system,OPGS003046,0.023,Metabolon,X - 17367,0.99 (0.99 1.00),3.59E-02
401.1,Essential hypertension,circulatory system,OPGS003111,0.018,Metabolon,X - 24542,0.99 (0.99 1.00),3.72E-02
401.1,Essential hypertension,circulatory system,OPGS002942,0.043,Metabolon,kynurenine,1.01 (1.00 1.01),3.74E-02
401.1,Essential hypertension,circulatory system,OPGS002932,0.045,Metabolon,4-androsten-3beta.17beta-diol monosulfate (2),1.01 (1.00 1.01),3.78E-02
401.1,Essential hypertension,circulatory system,OPGS003135,0.016,Metabolon,X - 15486,1.01 (1.00 1.01),3.83E-02
401.1,Essential hypertension,circulatory system,OPGS003092,0.019,Metabolon,X - 21474,0.99 (0.99 1.00),4.11E-02
401.1,Essential hypertension,circulatory system,OPGS002731,0.186,Metabolon,X - 11593,0.99 (0.99 1.00),4.11E-02
401.1,Essential hypertension,circulatory system,OPGS002984,0.033,Metabolon,gamma-glutamylglycine,0.99 (0.99 1.00),4.37E-02
401.1,Essential hypertension,circulatory system,OPGS002726,0.198,Metabolon,methionylalanine,1.01 (1.00 1.01),4.38E-02
401.1,Essential hypertension,circulatory system,OPGS003121,0.017,Metabolon,1.2-dipalmitoyl-GPC (16:0/16:0),1.01 (1.00 1.01),4.60E-02
401.1,Essential hypertension,circulatory system,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.01 (1.00 1.01),4.79E-02
401.1,Essential hypertension,circulatory system,OPGS002700,0.339,Metabolon,X - 24309,1.01 (1.00 1.01),4.89E-02
401.1,Essential hypertension,circulatory system,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.02 (1.02 1.03),9.59E-10
401.1,Essential hypertension,circulatory system,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.02 (1.01 1.03),2.61E-09
401.1,Essential hypertension,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.02 (1.01 1.03),3.17E-09
401.1,Essential hypertension,circulatory system,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.02 (1.01 1.03),7.15E-09
401.1,Essential hypertension,circulatory system,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.02 (1.01 1.03),1.01E-08
401.1,Essential hypertension,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.02 (1.01 1.03),1.05E-08
401.1,Essential hypertension,circulatory system,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.02 (1.01 1.03),1.15E-08
401.1,Essential hypertension,circulatory system,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.02 (1.01 1.03),1.91E-08
401.1,Essential hypertension,circulatory system,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.98 (0.98 0.99),5.70E-08
401.1,Essential hypertension,circulatory system,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.02 (1.01 1.03),6.01E-08
401.1,Essential hypertension,circulatory system,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.02 (1.01 1.02),1.34E-07
401.1,Essential hypertension,circulatory system,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.98 (0.98 0.99),2.98E-07
401.1,Essential hypertension,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.02 (1.01 1.02),5.15E-07
401.1,Essential hypertension,circulatory system,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.98 (0.98 0.99),5.70E-07
401.1,Essential hypertension,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.02 (1.01 1.02),9.56E-07
401.1,Essential hypertension,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.02 (1.01 1.02),9.76E-07
401.1,Essential hypertension,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.02 (1.01 1.02),9.76E-07
401.1,Essential hypertension,circulatory system,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.02 (1.01 1.02),1.24E-06
401.1,Essential hypertension,circulatory system,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.98 (0.98 0.99),1.49E-06
401.1,Essential hypertension,circulatory system,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.98 (0.98 0.99),4.24E-06
401.1,Essential hypertension,circulatory system,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.02 (1.01 1.02),9.00E-06
401.1,Essential hypertension,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.02 (1.01 1.02),9.45E-06
401.1,Essential hypertension,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.02 (1.01 1.02),1.10E-05
401.1,Essential hypertension,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.02 (1.01 1.02),1.25E-05
401.1,Essential hypertension,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.02 (1.01 1.02),1.32E-05
401.1,Essential hypertension,circulatory system,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.98 (0.98 0.99),1.39E-05
401.1,Essential hypertension,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.02 (1.01 1.02),1.52E-05
401.1,Essential hypertension,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.02 (1.01 1.02),1.54E-05
401.1,Essential hypertension,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.02 (1.01 1.02),1.78E-05
401.1,Essential hypertension,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.02 (1.01 1.02),1.94E-05
401.1,Essential hypertension,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.02 (1.01 1.02),2.35E-05
401.1,Essential hypertension,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.02 (1.01 1.02),2.35E-05
401.1,Essential hypertension,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.02 (1.01 1.02),2.75E-05
401.1,Essential hypertension,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.02 (1.01 1.02),2.90E-05
401.1,Essential hypertension,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.02 (1.01 1.02),3.33E-05
401.1,Essential hypertension,circulatory system,OPGS003520,0.062,Nightingale,HDL cholesterol,0.98 (0.98 0.99),3.51E-05
401.1,Essential hypertension,circulatory system,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.98 (0.98 0.99),3.67E-05
401.1,Essential hypertension,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.02 (1.01 1.02),4.20E-05
401.1,Essential hypertension,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.02 (1.01 1.02),4.44E-05
401.1,Essential hypertension,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.02 (1.01 1.02),4.44E-05
401.1,Essential hypertension,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.02 (1.01 1.02),5.42E-05
401.1,Essential hypertension,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.02 (1.01 1.02),5.43E-05
401.1,Essential hypertension,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.01 (1.01 1.02),5.70E-05
401.1,Essential hypertension,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.01 (1.01 1.02),7.32E-05
401.1,Essential hypertension,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.01 (1.01 1.02),9.33E-05
401.1,Essential hypertension,circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.01 (1.01 1.02),9.56E-05
401.1,Essential hypertension,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.01 (1.01 1.02),1.15E-04
401.1,Essential hypertension,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.01 (1.01 1.02),1.22E-04
401.1,Essential hypertension,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.01 (1.01 1.02),1.58E-04
401.1,Essential hypertension,circulatory system,OPGS003448,0.093,Nightingale,Phospholipids in very large HDL,0.99 (0.98 0.99),1.93E-04
401.1,Essential hypertension,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.01 (1.01 1.02),1.97E-04
401.1,Essential hypertension,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.01 (1.01 1.02),2.60E-04
401.1,Essential hypertension,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.01 (1.01 1.02),2.63E-04
401.1,Essential hypertension,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.01 (1.01 1.02),2.80E-04
401.1,Essential hypertension,circulatory system,OPGS003518,0.065,Nightingale,Triglycerides in medium HDL,1.01 (1.01 1.02),2.84E-04
401.1,Essential hypertension,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.01 (1.01 1.02),3.13E-04
401.1,Essential hypertension,circulatory system,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.01 (1.01 1.02),7.62E-04
401.1,Essential hypertension,circulatory system,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.99 (0.98 0.99),9.22E-04
401.1,Essential hypertension,circulatory system,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.99 (0.98 0.99),1.46E-03
401.1,Essential hypertension,circulatory system,OPGS003484,0.075,Nightingale,Triglycerides in HDL,1.01 (1.01 1.02),2.53E-03
401.1,Essential hypertension,circulatory system,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.01 (1.01 1.02),2.84E-03
401.1,Essential hypertension,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.01 (1.01 1.02),3.09E-03
401.1,Essential hypertension,circulatory system,OPGS003445,0.100,Nightingale,Glycine,0.99 (0.98 0.99),3.24E-03
401.1,Essential hypertension,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.01 (1.01 1.02),4.06E-03
401.1,Essential hypertension,circulatory system,OPGS003486,0.074,Nightingale,Total triglycerides,1.01 (1.01 1.02),5.66E-03
401.1,Essential hypertension,circulatory system,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.99 (0.98 0.99),5.97E-03
401.1,Essential hypertension,circulatory system,OPGS003523,0.062,Nightingale,Total fatty acids,1.01 (1.01 1.02),6.09E-03
401.1,Essential hypertension,circulatory system,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.99 (0.98 1.00),1.07E-02
401.1,Essential hypertension,circulatory system,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.01 (1.00 1.02),1.20E-02
401.1,Essential hypertension,circulatory system,OPGS003490,0.073,Nightingale,Free cholesterol in medium VLDL,1.01 (1.00 1.02),1.22E-02
401.1,Essential hypertension,circulatory system,OPGS003461,0.084,Nightingale,Total lipids in very large HDL,0.99 (0.98 1.00),1.50E-02
401.1,Essential hypertension,circulatory system,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.99 (0.98 1.00),1.90E-02
401.1,Essential hypertension,circulatory system,OPGS003457,0.086,Nightingale,Concentration of very large HDL particles,0.99 (0.98 1.00),2.21E-02
401.1,Essential hypertension,circulatory system,OPGS003476,0.076,Nightingale,Phospholipids in medium VLDL,1.01 (1.00 1.02),2.70E-02
401.1,Essential hypertension,circulatory system,OPGS003479,0.075,Nightingale,Triglycerides in VLDL,1.01 (1.00 1.02),2.73E-02
401.1,Essential hypertension,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.01 (1.00 1.02),2.96E-02
401.1,Essential hypertension,circulatory system,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.01 (1.00 1.02),3.26E-02
401.1,Essential hypertension,circulatory system,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.01 (1.00 1.01),3.79E-02
401.1,Essential hypertension,circulatory system,OPGS003542,0.028,Nightingale,Phospholipids in medium HDL,0.99 (0.99 1.00),4.30E-02
401.1,Essential hypertension,circulatory system,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.01 (1.00 1.01),4.58E-02
401.1,Essential hypertension,circulatory system,OPGS004382,0.374,RNAseq,FES,0.97 (0.96 0.97),6.17E-23
401.1,Essential hypertension,circulatory system,OPGS005063,0.280,RNAseq,TNNT3,0.97 (0.97 0.98),5.14E-17
401.1,Essential hypertension,circulatory system,OPGS007717,0.125,RNAseq,GUCY1A1,0.98 (0.97 0.98),1.79E-11
401.1,Essential hypertension,circulatory system,OPGS013939,0.023,RNAseq,BATF2,1.02 (1.02 1.03),1.19E-10
401.1,Essential hypertension,circulatory system,OPGS011811,0.043,RNAseq,ZBTB46,0.98 (0.97 0.98),2.43E-10
401.1,Essential hypertension,circulatory system,OPGS012171,0.039,RNAseq,TRBV15,0.98 (0.97 0.98),2.88E-10
401.1,Essential hypertension,circulatory system,OPGS009970,0.070,RNAseq,CLDN23,1.02 (1.02 1.03),4.44E-10
401.1,Essential hypertension,circulatory system,OPGS010779,0.057,RNAseq,ACE,1.02 (1.02 1.03),5.26E-10
401.1,Essential hypertension,circulatory system,OPGS005300,0.257,RNAseq,AF131215.6,1.02 (1.02 1.03),5.68E-10
401.1,Essential hypertension,circulatory system,OPGS013472,0.027,RNAseq,STAT1,1.02 (1.02 1.03),5.91E-10
401.1,Essential hypertension,circulatory system,OPGS014301,0.020,RNAseq,RRAS,0.98 (0.97 0.99),1.23E-09
401.1,Essential hypertension,circulatory system,OPGS010417,0.062,RNAseq,PHETA1,0.98 (0.97 0.98),1.60E-09
401.1,Essential hypertension,circulatory system,OPGS014992,0.016,RNAseq,KLF4,0.98 (0.97 0.99),3.78E-09
401.1,Essential hypertension,circulatory system,OPGS006034,0.201,RNAseq,,0.98 (0.97 0.99),1.15E-08
401.1,Essential hypertension,circulatory system,OPGS005704,0.221,RNAseq,AF131215.5,1.02 (1.01 1.03),1.43E-08
401.1,Essential hypertension,circulatory system,OPGS006637,0.169,RNAseq,PCCB,1.02 (1.01 1.03),1.54E-08
401.1,Essential hypertension,circulatory system,OPGS009801,0.073,RNAseq,NOC3L,0.98 (0.97 0.99),2.54E-08
401.1,Essential hypertension,circulatory system,OPGS011108,0.052,RNAseq,LDLR,0.98 (0.98 0.99),6.66E-08
401.1,Essential hypertension,circulatory system,OPGS014866,0.017,RNAseq,ARF1,0.98 (0.98 0.99),7.80E-08
401.1,Essential hypertension,circulatory system,OPGS006619,0.169,RNAseq,,1.02 (1.01 1.02),9.00E-08
401.1,Essential hypertension,circulatory system,OPGS011969,0.042,RNAseq,SIPA1,1.02 (1.01 1.03),9.66E-08
401.1,Essential hypertension,circulatory system,OPGS009320,0.083,RNAseq,ARG2,1.02 (1.01 1.02),1.16E-07
401.1,Essential hypertension,circulatory system,OPGS006712,0.165,RNAseq,SLC22A4,1.02 (1.01 1.02),2.09E-07
401.1,Essential hypertension,circulatory system,OPGS009762,0.074,RNAseq,AC025034.1,0.98 (0.98 0.99),2.52E-07
401.1,Essential hypertension,circulatory system,OPGS008024,0.115,RNAseq,FMNL3,1.02 (1.01 1.02),5.70E-07
401.1,Essential hypertension,circulatory system,OPGS007829,0.121,RNAseq,,1.02 (1.01 1.02),6.78E-07
401.1,Essential hypertension,circulatory system,OPGS010326,0.064,RNAseq,KCNK7,1.02 (1.01 1.02),8.46E-07
401.1,Essential hypertension,circulatory system,OPGS010210,0.066,RNAseq,DCAF16,0.98 (0.98 0.99),9.76E-07
401.1,Essential hypertension,circulatory system,OPGS008677,0.097,RNAseq,CDKN1B,1.02 (1.01 1.02),1.21E-06
401.1,Essential hypertension,circulatory system,OPGS009279,0.084,RNAseq,PKN2-AS1,1.02 (1.01 1.02),1.24E-06
401.1,Essential hypertension,circulatory system,OPGS009237,0.085,RNAseq,C11orf49,0.98 (0.98 0.99),1.24E-06
401.1,Essential hypertension,circulatory system,OPGS009483,0.080,RNAseq,DNAJC5,0.98 (0.98 0.99),1.24E-06
401.1,Essential hypertension,circulatory system,OPGS012787,0.033,RNAseq,FURIN,1.02 (1.01 1.02),1.70E-06
401.1,Essential hypertension,circulatory system,OPGS007394,0.136,RNAseq,AL662844.4,0.98 (0.98 0.99),1.70E-06
401.1,Essential hypertension,circulatory system,OPGS004949,0.293,RNAseq,ILRUN,1.02 (1.01 1.02),1.85E-06
401.1,Essential hypertension,circulatory system,OPGS008402,0.104,RNAseq,TNXB,1.02 (1.01 1.02),2.87E-06
401.1,Essential hypertension,circulatory system,OPGS006919,0.155,RNAseq,AC105233.5,0.98 (0.98 0.99),5.73E-06
401.1,Essential hypertension,circulatory system,OPGS006391,0.181,RNAseq,GTF2I,1.02 (1.01 1.02),5.73E-06
401.1,Essential hypertension,circulatory system,OPGS008033,0.115,RNAseq,SGCB,0.98 (0.98 0.99),9.32E-06
401.1,Essential hypertension,circulatory system,OPGS013344,0.028,RNAseq,NR4A1,0.98 (0.98 0.99),9.60E-06
401.1,Essential hypertension,circulatory system,OPGS008435,0.103,RNAseq,CWF19L2,1.02 (1.01 1.02),1.25E-05
401.1,Essential hypertension,circulatory system,OPGS004134,0.427,RNAseq,H2BC5,1.02 (1.01 1.02),1.25E-05
401.1,Essential hypertension,circulatory system,OPGS008479,0.102,RNAseq,NMT1,1.02 (1.01 1.02),1.39E-05
401.1,Essential hypertension,circulatory system,OPGS005951,0.206,RNAseq,CLCN6,0.98 (0.98 0.99),1.41E-05
401.1,Essential hypertension,circulatory system,OPGS010712,0.058,RNAseq,,0.98 (0.98 0.99),1.52E-05
401.1,Essential hypertension,circulatory system,OPGS008273,0.107,RNAseq,GRK4,1.02 (1.01 1.02),1.54E-05
401.1,Essential hypertension,circulatory system,OPGS009406,0.081,RNAseq,FAM215B,0.98 (0.98 0.99),1.77E-05
401.1,Essential hypertension,circulatory system,OPGS003708,0.594,RNAseq,HSD17B12,0.98 (0.98 0.99),1.77E-05
401.1,Essential hypertension,circulatory system,OPGS008529,0.101,RNAseq,CRIP3,1.02 (1.01 1.02),2.07E-05
401.1,Essential hypertension,circulatory system,OPGS012768,0.033,RNAseq,HMGA1,1.02 (1.01 1.02),2.35E-05
401.1,Essential hypertension,circulatory system,OPGS006306,0.186,RNAseq,CLN8,1.02 (1.01 1.02),2.35E-05
401.1,Essential hypertension,circulatory system,OPGS012841,0.032,RNAseq,ZNF738,0.98 (0.98 0.99),2.35E-05
401.1,Essential hypertension,circulatory system,OPGS007612,0.128,RNAseq,AC074032.1,1.02 (1.01 1.02),2.35E-05
401.1,Essential hypertension,circulatory system,OPGS006728,0.164,RNAseq,CHP1,0.98 (0.98 0.99),2.58E-05
401.1,Essential hypertension,circulatory system,OPGS010624,0.059,RNAseq,TRBV18,1.02 (1.01 1.02),2.59E-05
401.1,Essential hypertension,circulatory system,OPGS003711,0.593,RNAseq,,0.98 (0.98 0.99),3.09E-05
401.1,Essential hypertension,circulatory system,OPGS012793,0.033,RNAseq,ABCF3,1.02 (1.01 1.02),3.26E-05
401.1,Essential hypertension,circulatory system,OPGS008924,0.091,RNAseq,SWAP70,0.98 (0.98 0.99),3.27E-05
401.1,Essential hypertension,circulatory system,OPGS004303,0.388,RNAseq,,0.98 (0.98 0.99),3.51E-05
401.1,Essential hypertension,circulatory system,OPGS006271,0.188,RNAseq,MCC,1.02 (1.01 1.02),3.77E-05
401.1,Essential hypertension,circulatory system,OPGS005336,0.253,RNAseq,ANKRD36,1.02 (1.01 1.02),3.95E-05
401.1,Essential hypertension,circulatory system,OPGS015035,0.016,RNAseq,PLAAT4,1.02 (1.01 1.02),4.14E-05
401.1,Essential hypertension,circulatory system,OPGS004121,0.430,RNAseq,SLC22A5,1.02 (1.01 1.02),4.14E-05
401.1,Essential hypertension,circulatory system,OPGS007852,0.120,RNAseq,NOS3,1.02 (1.01 1.02),4.14E-05
401.1,Essential hypertension,circulatory system,OPGS008631,0.098,RNAseq,BLK,0.99 (0.98 0.99),4.34E-05
401.1,Essential hypertension,circulatory system,OPGS004986,0.288,RNAseq,H3C6,1.01 (1.01 1.02),4.39E-05
401.1,Essential hypertension,circulatory system,OPGS009810,0.073,RNAseq,,1.02 (1.01 1.02),4.39E-05
401.1,Essential hypertension,circulatory system,OPGS011614,0.046,RNAseq,H2BC7,1.02 (1.01 1.02),4.39E-05
401.1,Essential hypertension,circulatory system,OPGS005796,0.215,RNAseq,,1.02 (1.01 1.02),4.64E-05
401.1,Essential hypertension,circulatory system,OPGS012242,0.039,RNAseq,,0.99 (0.98 0.99),4.94E-05
401.1,Essential hypertension,circulatory system,OPGS010614,0.059,RNAseq,USP38,0.99 (0.98 0.99),5.41E-05
401.1,Essential hypertension,circulatory system,OPGS013692,0.025,RNAseq,CAPZA1,0.99 (0.98 0.99),7.14E-05
401.1,Essential hypertension,circulatory system,OPGS006064,0.200,RNAseq,DNTTIP1,0.99 (0.98 0.99),7.30E-05
401.1,Essential hypertension,circulatory system,OPGS013625,0.025,RNAseq,CCDC117,1.01 (1.01 1.02),7.57E-05
401.1,Essential hypertension,circulatory system,OPGS012458,0.036,RNAseq,PRAG1,1.01 (1.01 1.02),7.85E-05
401.1,Essential hypertension,circulatory system,OPGS009688,0.075,RNAseq,H2BC12,0.99 (0.98 0.99),8.33E-05
401.1,Essential hypertension,circulatory system,OPGS014539,0.019,RNAseq,NGFR,0.99 (0.98 0.99),8.57E-05
401.1,Essential hypertension,circulatory system,OPGS013045,0.030,RNAseq,NEU1,1.01 (1.01 1.02),9.56E-05
401.1,Essential hypertension,circulatory system,OPGS011537,0.047,RNAseq,ARFGEF2,1.01 (1.01 1.02),1.01E-04
401.1,Essential hypertension,circulatory system,OPGS012786,0.033,RNAseq,PLAGL2,0.99 (0.98 0.99),1.06E-04
401.1,Essential hypertension,circulatory system,OPGS007063,0.150,RNAseq,CEP170,1.01 (1.01 1.02),1.14E-04
401.1,Essential hypertension,circulatory system,OPGS005829,0.213,RNAseq,MACF1,1.01 (1.01 1.02),1.15E-04
401.1,Essential hypertension,circulatory system,OPGS010019,0.069,RNAseq,STMN3,1.01 (1.01 1.02),1.18E-04
401.1,Essential hypertension,circulatory system,OPGS006610,0.170,RNAseq,,1.01 (1.01 1.02),1.22E-04
401.1,Essential hypertension,circulatory system,OPGS007579,0.129,RNAseq,ACADVL,0.99 (0.98 0.99),1.27E-04
401.1,Essential hypertension,circulatory system,OPGS012628,0.034,RNAseq,RMC1,0.99 (0.98 0.99),1.38E-04
401.1,Essential hypertension,circulatory system,OPGS004311,0.387,RNAseq,ZNF429,0.99 (0.98 0.99),1.38E-04
401.1,Essential hypertension,circulatory system,OPGS007943,0.117,RNAseq,SLC22A1,0.99 (0.98 0.99),1.38E-04
401.1,Essential hypertension,circulatory system,OPGS006368,0.183,RNAseq,TBCK,1.01 (1.01 1.02),1.43E-04
401.1,Essential hypertension,circulatory system,OPGS006341,0.184,RNAseq,AL034550.2,0.99 (0.98 0.99),1.44E-04
401.1,Essential hypertension,circulatory system,OPGS005419,0.245,RNAseq,,1.01 (1.01 1.02),1.61E-04
401.1,Essential hypertension,circulatory system,OPGS006340,0.184,RNAseq,SIK2,1.01 (1.01 1.02),1.64E-04
401.1,Essential hypertension,circulatory system,OPGS005861,0.211,RNAseq,SMN2,0.99 (0.98 0.99),2.07E-04
401.1,Essential hypertension,circulatory system,OPGS009471,0.080,RNAseq,LIMA1,0.99 (0.98 0.99),2.12E-04
401.1,Essential hypertension,circulatory system,OPGS009303,0.083,RNAseq,EBLN3P,1.01 (1.01 1.02),2.15E-04
401.1,Essential hypertension,circulatory system,OPGS006132,0.196,RNAseq,EIF6,0.99 (0.98 0.99),2.18E-04
401.1,Essential hypertension,circulatory system,OPGS006323,0.185,RNAseq,REEP5,1.01 (1.01 1.02),2.27E-04
401.1,Essential hypertension,circulatory system,OPGS010591,0.060,RNAseq,ZZEF1,1.01 (1.01 1.02),2.27E-04
401.1,Essential hypertension,circulatory system,OPGS003889,0.511,RNAseq,ARL14EP,0.99 (0.98 0.99),2.27E-04
401.1,Essential hypertension,circulatory system,OPGS011476,0.047,RNAseq,AP000692.2,1.01 (1.01 1.02),2.38E-04
401.1,Essential hypertension,circulatory system,OPGS006193,0.192,RNAseq,AC091230.1,1.01 (1.01 1.02),2.38E-04
401.1,Essential hypertension,circulatory system,OPGS010014,0.069,RNAseq,LINC02245,1.01 (1.01 1.02),2.56E-04
401.1,Essential hypertension,circulatory system,OPGS005289,0.258,RNAseq,UBA7,0.99 (0.98 0.99),2.59E-04
401.1,Essential hypertension,circulatory system,OPGS004940,0.294,RNAseq,CNOT2-DT,1.01 (1.01 1.02),2.83E-04
401.1,Essential hypertension,circulatory system,OPGS003943,0.486,RNAseq,CLEC18A,0.99 (0.98 0.99),2.84E-04
401.1,Essential hypertension,circulatory system,OPGS006022,0.202,RNAseq,TNFSF12,1.01 (1.01 1.02),2.94E-04
401.1,Essential hypertension,circulatory system,OPGS013762,0.024,RNAseq,CFH,1.01 (1.01 1.02),3.00E-04
401.1,Essential hypertension,circulatory system,OPGS007337,0.138,RNAseq,MED21,1.01 (1.01 1.02),3.03E-04
401.1,Essential hypertension,circulatory system,OPGS005600,0.230,RNAseq,AC022784.1,1.01 (1.01 1.02),3.07E-04
401.1,Essential hypertension,circulatory system,OPGS011162,0.051,RNAseq,CACNA1D,0.99 (0.98 0.99),3.31E-04
401.1,Essential hypertension,circulatory system,OPGS012137,0.040,RNAseq,TIMM17A,1.01 (1.01 1.02),3.39E-04
401.1,Essential hypertension,circulatory system,OPGS014766,0.017,RNAseq,ARHGAP1,1.01 (1.01 1.02),3.47E-04
401.1,Essential hypertension,circulatory system,OPGS008555,0.100,RNAseq,CALCRL,1.01 (1.01 1.02),3.59E-04
401.1,Essential hypertension,circulatory system,OPGS011520,0.047,RNAseq,RRP1B,0.99 (0.98 0.99),3.78E-04
401.1,Essential hypertension,circulatory system,OPGS010337,0.064,RNAseq,GEN1,0.99 (0.98 0.99),3.91E-04
401.1,Essential hypertension,circulatory system,OPGS004630,0.336,RNAseq,RSRC1,0.99 (0.98 0.99),3.92E-04
401.1,Essential hypertension,circulatory system,OPGS009215,0.085,RNAseq,TNK1,0.99 (0.98 0.99),3.92E-04
401.1,Essential hypertension,circulatory system,OPGS003956,0.481,RNAseq,SLC5A11,0.99 (0.98 0.99),3.93E-04
401.1,Essential hypertension,circulatory system,OPGS013645,0.025,RNAseq,PIP4K2B,1.01 (1.01 1.02),3.93E-04
401.1,Essential hypertension,circulatory system,OPGS008807,0.094,RNAseq,ARHGEF40,0.99 (0.98 0.99),4.01E-04
401.1,Essential hypertension,circulatory system,OPGS009030,0.089,RNAseq,TRIB2,1.01 (1.01 1.02),4.02E-04
401.1,Essential hypertension,circulatory system,OPGS007584,0.129,RNAseq,HSD3B7,0.99 (0.98 0.99),4.07E-04
401.1,Essential hypertension,circulatory system,OPGS007641,0.127,RNAseq,CACNA1H,1.01 (1.01 1.02),4.15E-04
401.1,Essential hypertension,circulatory system,OPGS014087,0.022,RNAseq,C13orf46,1.01 (1.01 1.02),4.42E-04
401.1,Essential hypertension,circulatory system,OPGS010693,0.058,RNAseq,TRBV5-1,0.99 (0.98 0.99),4.44E-04
401.1,Essential hypertension,circulatory system,OPGS012056,0.041,RNAseq,DUSP8,1.01 (1.01 1.02),4.55E-04
401.1,Essential hypertension,circulatory system,OPGS011822,0.043,RNAseq,LINC01126,0.99 (0.98 0.99),4.56E-04
401.1,Essential hypertension,circulatory system,OPGS014370,0.020,RNAseq,NHLRC2,1.01 (1.01 1.02),4.61E-04
401.1,Essential hypertension,circulatory system,OPGS005687,0.222,RNAseq,CTSK,0.99 (0.98 0.99),4.61E-04
401.1,Essential hypertension,circulatory system,OPGS004956,0.291,RNAseq,,0.99 (0.98 0.99),4.90E-04
401.1,Essential hypertension,circulatory system,OPGS010700,0.058,RNAseq,DCLRE1B,0.99 (0.98 0.99),5.07E-04
401.1,Essential hypertension,circulatory system,OPGS003664,0.625,RNAseq,,1.01 (1.01 1.02),5.18E-04
401.1,Essential hypertension,circulatory system,OPGS005640,0.226,RNAseq,MSRA,0.99 (0.98 0.99),5.34E-04
401.1,Essential hypertension,circulatory system,OPGS013130,0.030,RNAseq,QPCT,0.99 (0.98 0.99),5.62E-04
401.1,Essential hypertension,circulatory system,OPGS011232,0.050,RNAseq,AL589765.4,1.01 (1.01 1.02),5.62E-04
401.1,Essential hypertension,circulatory system,OPGS011283,0.050,RNAseq,CD248,1.01 (1.01 1.02),5.62E-04
401.1,Essential hypertension,circulatory system,OPGS004677,0.327,RNAseq,SLC18B1,0.99 (0.98 0.99),5.62E-04
401.1,Essential hypertension,circulatory system,OPGS011884,0.043,RNAseq,PRKCE,1.01 (1.01 1.02),5.80E-04
401.1,Essential hypertension,circulatory system,OPGS010702,0.058,RNAseq,TASOR,1.01 (1.01 1.02),6.22E-04
401.1,Essential hypertension,circulatory system,OPGS013350,0.028,RNAseq,ACSS2,1.01 (1.01 1.02),6.26E-04
401.1,Essential hypertension,circulatory system,OPGS007364,0.137,RNAseq,NT5C2,0.99 (0.98 0.99),6.38E-04
401.1,Essential hypertension,circulatory system,OPGS013359,0.028,RNAseq,TM9SF4,1.01 (1.01 1.02),6.43E-04
401.1,Essential hypertension,circulatory system,OPGS014064,0.022,RNAseq,ZBTB34,1.01 (1.01 1.02),6.51E-04
401.1,Essential hypertension,circulatory system,OPGS003859,0.525,RNAseq,POLI,0.99 (0.98 0.99),6.70E-04
401.1,Essential hypertension,circulatory system,OPGS007701,0.125,RNAseq,DHCR24,0.99 (0.98 0.99),6.86E-04
401.1,Essential hypertension,circulatory system,OPGS012174,0.039,RNAseq,LINC01550,1.01 (1.01 1.02),6.87E-04
401.1,Essential hypertension,circulatory system,OPGS011332,0.049,RNAseq,AC010894.5,1.01 (1.01 1.02),6.95E-04
401.1,Essential hypertension,circulatory system,OPGS009727,0.074,RNAseq,GLRX2,0.99 (0.98 0.99),6.95E-04
401.1,Essential hypertension,circulatory system,OPGS011585,0.046,RNAseq,CD8B,1.01 (1.01 1.02),7.09E-04
401.1,Essential hypertension,circulatory system,OPGS003655,0.633,RNAseq,ZNF100,0.99 (0.98 0.99),7.11E-04
401.1,Essential hypertension,circulatory system,OPGS010993,0.054,RNAseq,SNAP47,1.01 (1.01 1.02),7.62E-04
401.1,Essential hypertension,circulatory system,OPGS013108,0.030,RNAseq,CHD6,1.01 (1.01 1.02),7.77E-04
401.1,Essential hypertension,circulatory system,OPGS007847,0.120,RNAseq,,0.99 (0.98 0.99),7.77E-04
401.1,Essential hypertension,circulatory system,OPGS013825,0.024,RNAseq,EFNB2,1.01 (1.01 1.02),7.79E-04
401.1,Essential hypertension,circulatory system,OPGS009563,0.078,RNAseq,CUL2,1.01 (1.01 1.02),7.82E-04
401.1,Essential hypertension,circulatory system,OPGS011020,0.053,RNAseq,HAUS5,1.01 (1.01 1.02),8.08E-04
401.1,Essential hypertension,circulatory system,OPGS007792,0.122,RNAseq,ZKSCAN5,1.01 (1.01 1.02),8.18E-04
401.1,Essential hypertension,circulatory system,OPGS005713,0.220,RNAseq,KANK2,0.99 (0.98 0.99),8.25E-04
401.1,Essential hypertension,circulatory system,OPGS006366,0.183,RNAseq,AC006254.1,1.01 (1.01 1.02),8.38E-04
401.1,Essential hypertension,circulatory system,OPGS011321,0.049,RNAseq,GDF11,1.01 (1.01 1.02),8.46E-04
401.1,Essential hypertension,circulatory system,OPGS006621,0.169,RNAseq,NME7,0.99 (0.98 0.99),8.53E-04
401.1,Essential hypertension,circulatory system,OPGS004468,0.360,RNAseq,AC020656.2,1.01 (1.01 1.02),8.78E-04
401.1,Essential hypertension,circulatory system,OPGS006608,0.170,RNAseq,MFHAS1,1.01 (1.01 1.02),8.84E-04
401.1,Essential hypertension,circulatory system,OPGS005150,0.271,RNAseq,RERE,1.01 (1.01 1.02),8.87E-04
401.1,Essential hypertension,circulatory system,OPGS012115,0.040,RNAseq,AC007566.1,0.99 (0.98 0.99),9.04E-04
401.1,Essential hypertension,circulatory system,OPGS008629,0.098,RNAseq,SMC4,1.01 (1.01 1.02),9.56E-04
401.1,Essential hypertension,circulatory system,OPGS007139,0.146,RNAseq,AC005532.1,0.99 (0.98 0.99),9.63E-04
401.1,Essential hypertension,circulatory system,OPGS007082,0.149,RNAseq,PHIP,1.01 (1.01 1.02),1.02E-03
401.1,Essential hypertension,circulatory system,OPGS004832,0.307,RNAseq,ARHGAP15,0.99 (0.98 0.99),1.02E-03
401.1,Essential hypertension,circulatory system,OPGS014774,0.017,RNAseq,SMARCD1,0.99 (0.98 0.99),1.04E-03
401.1,Essential hypertension,circulatory system,OPGS005089,0.277,RNAseq,ABHD17C,1.01 (1.01 1.02),1.04E-03
401.1,Essential hypertension,circulatory system,OPGS014051,0.022,RNAseq,CNOT2,0.99 (0.98 0.99),1.04E-03
401.1,Essential hypertension,circulatory system,OPGS011891,0.043,RNAseq,C1orf167,0.99 (0.98 0.99),1.07E-03
401.1,Essential hypertension,circulatory system,OPGS012204,0.039,RNAseq,MTRF1,1.01 (1.01 1.02),1.10E-03
401.1,Essential hypertension,circulatory system,OPGS011037,0.053,RNAseq,TMEM170A,0.99 (0.98 0.99),1.10E-03
401.1,Essential hypertension,circulatory system,OPGS007974,0.116,RNAseq,UBE2Z,0.99 (0.98 0.99),1.10E-03
401.1,Essential hypertension,circulatory system,OPGS008369,0.105,RNAseq,ADM,1.01 (1.01 1.02),1.13E-03
401.1,Essential hypertension,circulatory system,OPGS005346,0.252,RNAseq,,1.01 (1.01 1.02),1.13E-03
401.1,Essential hypertension,circulatory system,OPGS014438,0.019,RNAseq,ANP32A,1.01 (1.01 1.02),1.15E-03
401.1,Essential hypertension,circulatory system,OPGS009794,0.073,RNAseq,RN7SL473P,0.99 (0.98 0.99),1.15E-03
401.1,Essential hypertension,circulatory system,OPGS010929,0.055,RNAseq,EOMES,1.01 (1.01 1.02),1.15E-03
401.1,Essential hypertension,circulatory system,OPGS011948,0.042,RNAseq,ADGRG1,0.99 (0.98 0.99),1.15E-03
401.1,Essential hypertension,circulatory system,OPGS014606,0.018,RNAseq,KIF3B,0.99 (0.98 0.99),1.18E-03
401.1,Essential hypertension,circulatory system,OPGS014489,0.019,RNAseq,AP002381.2,1.01 (1.01 1.02),1.18E-03
401.1,Essential hypertension,circulatory system,OPGS004717,0.321,RNAseq,ARNTL,0.99 (0.98 0.99),1.18E-03
401.1,Essential hypertension,circulatory system,OPGS007680,0.126,RNAseq,AC110285.6,0.99 (0.98 0.99),1.21E-03
401.1,Essential hypertension,circulatory system,OPGS012287,0.038,RNAseq,DRD4,1.01 (1.01 1.02),1.26E-03
401.1,Essential hypertension,circulatory system,OPGS011532,0.047,RNAseq,GIT2,0.99 (0.98 0.99),1.30E-03
401.1,Essential hypertension,circulatory system,OPGS006466,0.177,RNAseq,NR1H3,1.01 (1.01 1.02),1.30E-03
401.1,Essential hypertension,circulatory system,OPGS007386,0.136,RNAseq,OCIAD1,0.99 (0.98 0.99),1.30E-03
401.1,Essential hypertension,circulatory system,OPGS011336,0.049,RNAseq,,1.01 (1.01 1.02),1.30E-03
401.1,Essential hypertension,circulatory system,OPGS004161,0.420,RNAseq,CDC16,1.01 (1.01 1.02),1.30E-03
401.1,Essential hypertension,circulatory system,OPGS012237,0.039,RNAseq,DNAJC13,1.01 (1.01 1.02),1.32E-03
401.1,Essential hypertension,circulatory system,OPGS013265,0.028,RNAseq,GATAD2B,0.99 (0.98 0.99),1.40E-03
401.1,Essential hypertension,circulatory system,OPGS010627,0.059,RNAseq,TPD52L2,1.01 (1.01 1.02),1.48E-03
401.1,Essential hypertension,circulatory system,OPGS008845,0.093,RNAseq,MLXIP,1.01 (1.01 1.02),1.53E-03
401.1,Essential hypertension,circulatory system,OPGS006075,0.199,RNAseq,RGS6,0.99 (0.98 0.99),1.54E-03
401.1,Essential hypertension,circulatory system,OPGS008628,0.098,RNAseq,DYM,0.99 (0.98 0.99),1.63E-03
401.1,Essential hypertension,circulatory system,OPGS012716,0.033,RNAseq,PSPC1-AS2,1.01 (1.01 1.02),1.66E-03
401.1,Essential hypertension,circulatory system,OPGS013817,0.024,RNAseq,MYADM,0.99 (0.98 0.99),1.77E-03
401.1,Essential hypertension,circulatory system,OPGS006713,0.165,RNAseq,TNS1,1.01 (1.01 1.02),1.80E-03
401.1,Essential hypertension,circulatory system,OPGS006265,0.188,RNAseq,RBM6,0.99 (0.98 0.99),1.80E-03
401.1,Essential hypertension,circulatory system,OPGS012496,0.036,RNAseq,NT5DC4,1.01 (1.01 1.02),1.82E-03
401.1,Essential hypertension,circulatory system,OPGS004845,0.305,RNAseq,PLEKHH2,1.01 (1.01 1.02),1.94E-03
401.1,Essential hypertension,circulatory system,OPGS014960,0.016,RNAseq,MYNN,0.99 (0.98 0.99),2.06E-03
401.1,Essential hypertension,circulatory system,OPGS008005,0.115,RNAseq,GNGT2,1.01 (1.01 1.02),2.12E-03
401.1,Essential hypertension,circulatory system,OPGS006941,0.154,RNAseq,RBMS1,1.01 (1.01 1.02),2.12E-03
401.1,Essential hypertension,circulatory system,OPGS005430,0.244,RNAseq,NCF1,1.01 (1.01 1.02),2.14E-03
401.1,Essential hypertension,circulatory system,OPGS011188,0.051,RNAseq,TRIM8,1.01 (1.01 1.02),2.22E-03
401.1,Essential hypertension,circulatory system,OPGS005186,0.267,RNAseq,NEIL2,1.01 (1.01 1.02),2.23E-03
401.1,Essential hypertension,circulatory system,OPGS014010,0.022,RNAseq,CYTH1,0.99 (0.98 0.99),2.51E-03
401.1,Essential hypertension,circulatory system,OPGS007065,0.149,RNAseq,TRAF3IP3,1.01 (1.01 1.02),2.51E-03
401.1,Essential hypertension,circulatory system,OPGS010454,0.062,RNAseq,GP1BA,1.01 (1.01 1.02),2.55E-03
401.1,Essential hypertension,circulatory system,OPGS013324,0.028,RNAseq,PRF1,0.99 (0.98 0.99),2.65E-03
401.1,Essential hypertension,circulatory system,OPGS013514,0.026,RNAseq,GZMK,1.01 (1.01 1.02),2.66E-03
401.1,Essential hypertension,circulatory system,OPGS006780,0.161,RNAseq,LY6E-DT,1.01 (1.01 1.02),2.70E-03
401.1,Essential hypertension,circulatory system,OPGS004688,0.325,RNAseq,MERTK,1.01 (1.01 1.02),2.77E-03
401.1,Essential hypertension,circulatory system,OPGS012118,0.040,RNAseq,KIAA0753,0.99 (0.98 0.99),2.84E-03
401.1,Essential hypertension,circulatory system,OPGS007625,0.128,RNAseq,AC091045.2,1.01 (1.01 1.02),2.84E-03
401.1,Essential hypertension,circulatory system,OPGS005918,0.208,RNAseq,DDR1,1.01 (1.01 1.02),2.87E-03
401.1,Essential hypertension,circulatory system,OPGS012547,0.035,RNAseq,AP002762.2,0.99 (0.98 0.99),2.90E-03
401.1,Essential hypertension,circulatory system,OPGS014344,0.020,RNAseq,AC022167.3,1.01 (1.01 1.02),2.90E-03
401.1,Essential hypertension,circulatory system,OPGS011367,0.049,RNAseq,SLK,1.01 (1.01 1.02),2.92E-03
401.1,Essential hypertension,circulatory system,OPGS005369,0.249,RNAseq,WFDC3,0.99 (0.98 0.99),2.98E-03
401.1,Essential hypertension,circulatory system,OPGS014082,0.022,RNAseq,ASXL1,1.01 (1.01 1.02),3.00E-03
401.1,Essential hypertension,circulatory system,OPGS007342,0.138,RNAseq,MAP3K7CL,0.99 (0.98 0.99),3.03E-03
401.1,Essential hypertension,circulatory system,OPGS007292,0.140,RNAseq,ZDHHC18,1.01 (1.01 1.02),3.05E-03
401.1,Essential hypertension,circulatory system,OPGS012899,0.032,RNAseq,AL590822.2,1.01 (1.01 1.02),3.08E-03
401.1,Essential hypertension,circulatory system,OPGS014325,0.020,RNAseq,RGS14,1.01 (1.01 1.02),3.08E-03
401.1,Essential hypertension,circulatory system,OPGS011308,0.049,RNAseq,PI4K2B,0.99 (0.98 0.99),3.08E-03
401.1,Essential hypertension,circulatory system,OPGS011776,0.044,RNAseq,LST1,1.01 (1.01 1.02),3.08E-03
401.1,Essential hypertension,circulatory system,OPGS011085,0.053,RNAseq,CHRAC1,0.99 (0.98 0.99),3.09E-03
401.1,Essential hypertension,circulatory system,OPGS009077,0.088,RNAseq,DDAH2,0.99 (0.98 0.99),3.11E-03
401.1,Essential hypertension,circulatory system,OPGS005108,0.275,RNAseq,IBA57,0.99 (0.98 0.99),3.13E-03
401.1,Essential hypertension,circulatory system,OPGS010023,0.069,RNAseq,SLC16A1,0.99 (0.98 0.99),3.14E-03
401.1,Essential hypertension,circulatory system,OPGS010035,0.069,RNAseq,UTP4,1.01 (1.01 1.02),3.17E-03
401.1,Essential hypertension,circulatory system,OPGS008661,0.097,RNAseq,ZNFX1,1.01 (1.01 1.02),3.21E-03
401.1,Essential hypertension,circulatory system,OPGS004598,0.340,RNAseq,RPAP1,0.99 (0.98 0.99),3.26E-03
401.1,Essential hypertension,circulatory system,OPGS012824,0.032,RNAseq,USP34,1.01 (1.01 1.02),3.26E-03
401.1,Essential hypertension,circulatory system,OPGS013899,0.023,RNAseq,AC025279.1,1.01 (1.01 1.02),3.33E-03
401.1,Essential hypertension,circulatory system,OPGS006324,0.185,RNAseq,RPS23,0.99 (0.98 0.99),3.36E-03
401.1,Essential hypertension,circulatory system,OPGS004707,0.323,RNAseq,,0.99 (0.98 0.99),3.45E-03
401.1,Essential hypertension,circulatory system,OPGS004490,0.357,RNAseq,BORCS7,0.99 (0.98 0.99),3.50E-03
401.1,Essential hypertension,circulatory system,OPGS014071,0.022,RNAseq,AC007342.9,0.99 (0.98 0.99),3.55E-03
401.1,Essential hypertension,circulatory system,OPGS012758,0.033,RNAseq,CMIP,1.01 (1.01 1.02),3.65E-03
401.1,Essential hypertension,circulatory system,OPGS014423,0.020,RNAseq,UCHL5,1.01 (1.01 1.02),3.68E-03
401.1,Essential hypertension,circulatory system,OPGS011856,0.043,RNAseq,E2F1,0.99 (0.98 0.99),3.78E-03
401.1,Essential hypertension,circulatory system,OPGS008784,0.094,RNAseq,,0.99 (0.98 0.99),3.80E-03
401.1,Essential hypertension,circulatory system,OPGS010853,0.056,RNAseq,STN1,0.99 (0.98 0.99),3.83E-03
401.1,Essential hypertension,circulatory system,OPGS007103,0.148,RNAseq,AC007384.1,1.01 (1.01 1.02),3.83E-03
401.1,Essential hypertension,circulatory system,OPGS009105,0.087,RNAseq,ZNF589,0.99 (0.98 0.99),3.85E-03
401.1,Essential hypertension,circulatory system,OPGS011360,0.049,RNAseq,PODXL,0.99 (0.98 0.99),3.87E-03
401.1,Essential hypertension,circulatory system,OPGS003856,0.526,RNAseq,RPS26,0.99 (0.98 0.99),3.92E-03
401.1,Essential hypertension,circulatory system,OPGS006725,0.164,RNAseq,ZNF160,0.99 (0.98 0.99),3.97E-03
401.1,Essential hypertension,circulatory system,OPGS011132,0.052,RNAseq,HEATR5B,1.01 (1.01 1.02),4.03E-03
401.1,Essential hypertension,circulatory system,OPGS006033,0.201,RNAseq,SFXN2,1.01 (1.01 1.02),4.12E-03
401.1,Essential hypertension,circulatory system,OPGS008157,0.110,RNAseq,WRN,1.01 (1.01 1.02),4.12E-03
401.1,Essential hypertension,circulatory system,OPGS004678,0.327,RNAseq,ZNF772,0.99 (0.98 0.99),4.21E-03
401.1,Essential hypertension,circulatory system,OPGS008650,0.098,RNAseq,ATP5MC1,0.99 (0.98 0.99),4.27E-03
401.1,Essential hypertension,circulatory system,OPGS006761,0.162,RNAseq,MGAT3,1.01 (1.01 1.02),4.29E-03
401.1,Essential hypertension,circulatory system,OPGS010348,0.063,RNAseq,TRBV6-5,1.01 (1.01 1.02),4.29E-03
401.1,Essential hypertension,circulatory system,OPGS003893,0.509,RNAseq,GRHL1,1.01 (1.01 1.02),4.32E-03
401.1,Essential hypertension,circulatory system,OPGS009729,0.074,RNAseq,LINC01259,1.01 (1.01 1.02),4.34E-03
401.1,Essential hypertension,circulatory system,OPGS008572,0.099,RNAseq,GGT5,1.01 (1.01 1.02),4.42E-03
401.1,Essential hypertension,circulatory system,OPGS004904,0.299,RNAseq,LAIR2,1.01 (1.01 1.02),4.42E-03
401.1,Essential hypertension,circulatory system,OPGS008352,0.105,RNAseq,THUMPD1,1.01 (1.01 1.02),4.60E-03
401.1,Essential hypertension,circulatory system,OPGS013822,0.024,RNAseq,SMC6,1.01 (1.01 1.02),4.63E-03
401.1,Essential hypertension,circulatory system,OPGS004193,0.413,RNAseq,CBWD1,0.99 (0.98 0.99),4.63E-03
401.1,Essential hypertension,circulatory system,OPGS010169,0.066,RNAseq,C1orf43,0.99 (0.98 0.99),4.63E-03
401.1,Essential hypertension,circulatory system,OPGS011919,0.042,RNAseq,SOS2,0.99 (0.98 0.99),4.63E-03
401.1,Essential hypertension,circulatory system,OPGS004171,0.417,RNAseq,AC097382.3,0.99 (0.98 0.99),4.65E-03
401.1,Essential hypertension,circulatory system,OPGS006230,0.190,RNAseq,CHRNB1,0.99 (0.98 0.99),4.74E-03
401.1,Essential hypertension,circulatory system,OPGS004480,0.358,RNAseq,FAM167A,1.01 (1.01 1.02),4.86E-03
401.1,Essential hypertension,circulatory system,OPGS010760,0.057,RNAseq,SNX2,1.01 (1.01 1.02),4.90E-03
401.1,Essential hypertension,circulatory system,OPGS007289,0.140,RNAseq,HYI,0.99 (0.98 0.99),4.90E-03
401.1,Essential hypertension,circulatory system,OPGS010880,0.056,RNAseq,ADIPOR1,1.01 (1.01 1.02),4.93E-03
401.1,Essential hypertension,circulatory system,OPGS004296,0.390,RNAseq,PRELID1,1.01 (1.01 1.02),4.98E-03
401.1,Essential hypertension,circulatory system,OPGS013705,0.025,RNAseq,AL512408.1,0.99 (0.98 0.99),5.24E-03
401.1,Essential hypertension,circulatory system,OPGS013459,0.027,RNAseq,PRR11,1.01 (1.01 1.02),5.42E-03
401.1,Essential hypertension,circulatory system,OPGS009260,0.084,RNAseq,CSK,1.01 (1.01 1.02),5.49E-03
401.1,Essential hypertension,circulatory system,OPGS006216,0.191,RNAseq,RRAGD,1.01 (1.01 1.02),5.53E-03
401.1,Essential hypertension,circulatory system,OPGS013543,0.026,RNAseq,C11orf58,1.01 (1.01 1.02),5.53E-03
401.1,Essential hypertension,circulatory system,OPGS003638,0.648,RNAseq,MGST3,0.99 (0.98 0.99),5.61E-03
401.1,Essential hypertension,circulatory system,OPGS014550,0.019,RNAseq,ACAD10,0.99 (0.98 0.99),5.62E-03
401.1,Essential hypertension,circulatory system,OPGS004315,0.386,RNAseq,AL391314.1,1.01 (1.01 1.02),5.66E-03
401.1,Essential hypertension,circulatory system,OPGS012904,0.032,RNAseq,ZMIZ1,1.01 (1.01 1.02),5.67E-03
401.1,Essential hypertension,circulatory system,OPGS004456,0.362,RNAseq,RIN1,1.01 (1.01 1.02),5.72E-03
401.1,Essential hypertension,circulatory system,OPGS010603,0.059,RNAseq,PTPRF,1.01 (1.01 1.02),5.82E-03
401.1,Essential hypertension,circulatory system,OPGS010370,0.063,RNAseq,TP53INP1,1.01 (1.01 1.02),5.97E-03
401.1,Essential hypertension,circulatory system,OPGS008169,0.110,RNAseq,AC104695.3,1.01 (1.01 1.02),6.09E-03
401.1,Essential hypertension,circulatory system,OPGS009171,0.086,RNAseq,NTN5,1.01 (1.01 1.02),6.09E-03
401.1,Essential hypertension,circulatory system,OPGS011260,0.050,RNAseq,AL121845.4,0.99 (0.98 0.99),6.13E-03
401.1,Essential hypertension,circulatory system,OPGS009783,0.073,RNAseq,CRK,0.99 (0.98 0.99),6.20E-03
401.1,Essential hypertension,circulatory system,OPGS008601,0.099,RNAseq,COLQ,1.01 (1.01 1.02),6.23E-03
401.1,Essential hypertension,circulatory system,OPGS009294,0.083,RNAseq,MANBA,0.99 (0.98 0.99),6.26E-03
401.1,Essential hypertension,circulatory system,OPGS014924,0.016,RNAseq,ZNF341,1.01 (1.01 1.02),6.36E-03
401.1,Essential hypertension,circulatory system,OPGS015007,0.016,RNAseq,RMDN3,1.01 (1.01 1.02),6.36E-03
401.1,Essential hypertension,circulatory system,OPGS008652,0.097,RNAseq,AC006252.1,0.99 (0.98 0.99),6.39E-03
401.1,Essential hypertension,circulatory system,OPGS014027,0.022,RNAseq,PPP2R2A,0.99 (0.98 0.99),6.39E-03
401.1,Essential hypertension,circulatory system,OPGS008226,0.108,RNAseq,DPH1,1.01 (1.01 1.02),6.49E-03
401.1,Essential hypertension,circulatory system,OPGS013225,0.029,RNAseq,REG4,1.01 (1.01 1.02),6.57E-03
401.1,Essential hypertension,circulatory system,OPGS014093,0.022,RNAseq,MYBL1,1.01 (1.01 1.02),6.57E-03
401.1,Essential hypertension,circulatory system,OPGS011979,0.041,RNAseq,AC104083.1,0.99 (0.98 0.99),6.57E-03
401.1,Essential hypertension,circulatory system,OPGS012405,0.037,RNAseq,PTOV1,0.99 (0.98 0.99),6.62E-03
401.1,Essential hypertension,circulatory system,OPGS008023,0.115,RNAseq,ARNT,0.99 (0.98 0.99),6.64E-03
401.1,Essential hypertension,circulatory system,OPGS006065,0.200,RNAseq,RRP15,1.01 (1.01 1.02),6.65E-03
401.1,Essential hypertension,circulatory system,OPGS012475,0.036,RNAseq,SCRN3,0.99 (0.98 0.99),6.65E-03
401.1,Essential hypertension,circulatory system,OPGS004733,0.319,RNAseq,LRPPRC,0.99 (0.98 0.99),6.65E-03
401.1,Essential hypertension,circulatory system,OPGS009423,0.081,RNAseq,PSTPIP2,1.01 (1.01 1.02),6.65E-03
401.1,Essential hypertension,circulatory system,OPGS010939,0.055,RNAseq,TM7SF2,0.99 (0.98 0.99),6.71E-03
401.1,Essential hypertension,circulatory system,OPGS004485,0.357,RNAseq,LPL,0.99 (0.98 0.99),6.72E-03
401.1,Essential hypertension,circulatory system,OPGS013688,0.025,RNAseq,AC004825.2,0.99 (0.98 0.99),6.82E-03
401.1,Essential hypertension,circulatory system,OPGS012847,0.032,RNAseq,PARTICL,1.01 (1.01 1.02),6.82E-03
401.1,Essential hypertension,circulatory system,OPGS010691,0.058,RNAseq,RPRD2,1.01 (1.01 1.02),6.83E-03
401.1,Essential hypertension,circulatory system,OPGS008908,0.092,RNAseq,LRCH1,0.99 (0.98 0.99),6.83E-03
401.1,Essential hypertension,circulatory system,OPGS005117,0.275,RNAseq,NPIPB12,1.01 (1.01 1.02),7.07E-03
401.1,Essential hypertension,circulatory system,OPGS005271,0.259,RNAseq,KLHL5,1.01 (1.01 1.02),7.21E-03
401.1,Essential hypertension,circulatory system,OPGS009390,0.082,RNAseq,ZFAND1,1.01 (1.01 1.02),7.21E-03
401.1,Essential hypertension,circulatory system,OPGS012928,0.032,RNAseq,ATP1A1,1.01 (1.01 1.02),7.34E-03
401.1,Essential hypertension,circulatory system,OPGS006435,0.179,RNAseq,OSGIN2,0.99 (0.98 0.99),7.40E-03
401.1,Essential hypertension,circulatory system,OPGS004980,0.289,RNAseq,BDH2,0.99 (0.98 1.00),7.49E-03
401.1,Essential hypertension,circulatory system,OPGS013396,0.027,RNAseq,AC004241.2,1.01 (1.00 1.02),7.64E-03
401.1,Essential hypertension,circulatory system,OPGS012160,0.040,RNAseq,ARHGAP42,1.01 (1.00 1.02),7.65E-03
401.1,Essential hypertension,circulatory system,OPGS008537,0.101,RNAseq,CERS6,1.01 (1.00 1.02),7.67E-03
401.1,Essential hypertension,circulatory system,OPGS014420,0.020,RNAseq,SGO1,1.01 (1.00 1.02),7.67E-03
401.1,Essential hypertension,circulatory system,OPGS005411,0.245,RNAseq,REEP1,1.01 (1.00 1.02),7.68E-03
401.1,Essential hypertension,circulatory system,OPGS008012,0.115,RNAseq,GNL3,0.99 (0.98 1.00),7.68E-03
401.1,Essential hypertension,circulatory system,OPGS003817,0.542,RNAseq,NPIPB2,1.01 (1.00 1.02),7.81E-03
401.1,Essential hypertension,circulatory system,OPGS005036,0.283,RNAseq,NAA60,0.99 (0.98 1.00),7.92E-03
401.1,Essential hypertension,circulatory system,OPGS010521,0.061,RNAseq,BICRAL,1.01 (1.00 1.02),8.27E-03
401.1,Essential hypertension,circulatory system,OPGS008681,0.097,RNAseq,POLR2C,1.01 (1.00 1.02),8.39E-03
401.1,Essential hypertension,circulatory system,OPGS008503,0.102,RNAseq,ANKIB1,0.99 (0.98 1.00),8.43E-03
401.1,Essential hypertension,circulatory system,OPGS005236,0.262,RNAseq,SFXN4,0.99 (0.98 1.00),8.65E-03
401.1,Essential hypertension,circulatory system,OPGS006535,0.174,RNAseq,PSRC1,0.99 (0.98 1.00),8.65E-03
401.1,Essential hypertension,circulatory system,OPGS011291,0.050,RNAseq,GMPPB,1.01 (1.00 1.02),8.91E-03
401.1,Essential hypertension,circulatory system,OPGS006806,0.160,RNAseq,KLHL9,1.01 (1.00 1.02),8.91E-03
401.1,Essential hypertension,circulatory system,OPGS013199,0.029,RNAseq,ACP1,0.99 (0.98 1.00),9.07E-03
401.1,Essential hypertension,circulatory system,OPGS004201,0.411,RNAseq,IPO8,0.99 (0.98 1.00),9.36E-03
401.1,Essential hypertension,circulatory system,OPGS014148,0.021,RNAseq,DDI2,0.99 (0.98 1.00),9.44E-03
401.1,Essential hypertension,circulatory system,OPGS006754,0.163,RNAseq,SDCCAG8,1.01 (1.00 1.02),9.44E-03
401.1,Essential hypertension,circulatory system,OPGS004370,0.376,RNAseq,LINC01825,0.99 (0.98 1.00),9.44E-03
401.1,Essential hypertension,circulatory system,OPGS006943,0.154,RNAseq,EVI5,1.01 (1.00 1.02),9.59E-03
401.1,Essential hypertension,circulatory system,OPGS011460,0.047,RNAseq,RGCC,0.99 (0.98 1.00),9.62E-03
401.1,Essential hypertension,circulatory system,OPGS012870,0.032,RNAseq,OAZ2,0.99 (0.98 1.00),9.81E-03
401.1,Essential hypertension,circulatory system,OPGS004234,0.404,RNAseq,FBN2,1.01 (1.00 1.02),9.82E-03
401.1,Essential hypertension,circulatory system,OPGS006235,0.190,RNAseq,CHMP1A,1.01 (1.00 1.02),9.82E-03
401.1,Essential hypertension,circulatory system,OPGS004207,0.410,RNAseq,KCTD21-AS1,1.01 (1.00 1.02),9.87E-03
401.1,Essential hypertension,circulatory system,OPGS004925,0.295,RNAseq,ELOVL7,0.99 (0.98 1.00),9.87E-03
401.1,Essential hypertension,circulatory system,OPGS013958,0.023,RNAseq,CSNK2B,0.99 (0.98 1.00),9.87E-03
401.1,Essential hypertension,circulatory system,OPGS013797,0.024,RNAseq,LMTK3,0.99 (0.98 1.00),1.01E-02
401.1,Essential hypertension,circulatory system,OPGS008450,0.103,RNAseq,MPO,1.01 (1.00 1.02),1.07E-02
401.1,Essential hypertension,circulatory system,OPGS004291,0.390,RNAseq,PTPN12,1.01 (1.00 1.02),1.07E-02
401.1,Essential hypertension,circulatory system,OPGS007207,0.143,RNAseq,PPP1R37,1.01 (1.00 1.02),1.07E-02
401.1,Essential hypertension,circulatory system,OPGS004893,0.300,RNAseq,UBE2E3,0.99 (0.98 1.00),1.09E-02
401.1,Essential hypertension,circulatory system,OPGS011963,0.042,RNAseq,GPAT4,1.01 (1.00 1.02),1.11E-02
401.1,Essential hypertension,circulatory system,OPGS013068,0.030,RNAseq,AL021807.1,0.99 (0.98 1.00),1.14E-02
401.1,Essential hypertension,circulatory system,OPGS007993,0.116,RNAseq,FRRS1,1.01 (1.00 1.02),1.15E-02
401.1,Essential hypertension,circulatory system,OPGS012842,0.032,RNAseq,PFKM,1.01 (1.00 1.02),1.17E-02
401.1,Essential hypertension,circulatory system,OPGS007730,0.124,RNAseq,CKB,0.99 (0.98 1.00),1.18E-02
401.1,Essential hypertension,circulatory system,OPGS006403,0.180,RNAseq,AL356599.1,1.01 (1.00 1.02),1.19E-02
401.1,Essential hypertension,circulatory system,OPGS009008,0.090,RNAseq,USP46,1.01 (1.00 1.02),1.19E-02
401.1,Essential hypertension,circulatory system,OPGS008934,0.091,RNAseq,CFDP1,0.99 (0.98 1.00),1.21E-02
401.1,Essential hypertension,circulatory system,OPGS012009,0.041,RNAseq,MAFF,0.99 (0.98 1.00),1.21E-02
401.1,Essential hypertension,circulatory system,OPGS012770,0.033,RNAseq,HSPA8,1.01 (1.00 1.02),1.21E-02
401.1,Essential hypertension,circulatory system,OPGS003566,0.779,RNAseq,,1.01 (1.00 1.02),1.21E-02
401.1,Essential hypertension,circulatory system,OPGS014443,0.019,RNAseq,ABCB1,1.01 (1.00 1.02),1.22E-02
401.1,Essential hypertension,circulatory system,OPGS012220,0.039,RNAseq,UPK3B,0.99 (0.98 1.00),1.23E-02
401.1,Essential hypertension,circulatory system,OPGS008975,0.090,RNAseq,LIME1,0.99 (0.98 1.00),1.23E-02
401.1,Essential hypertension,circulatory system,OPGS006248,0.189,RNAseq,MCCD1,1.01 (1.00 1.02),1.24E-02
401.1,Essential hypertension,circulatory system,OPGS004089,0.441,RNAseq,NNT,0.99 (0.98 1.00),1.25E-02
401.1,Essential hypertension,circulatory system,OPGS004849,0.305,RNAseq,,1.01 (1.00 1.02),1.26E-02
401.1,Essential hypertension,circulatory system,OPGS009368,0.082,RNAseq,PPP2R2D,0.99 (0.98 1.00),1.26E-02
401.1,Essential hypertension,circulatory system,OPGS015028,0.016,RNAseq,JUNB,0.99 (0.98 1.00),1.26E-02
401.1,Essential hypertension,circulatory system,OPGS011097,0.052,RNAseq,LINC01841,0.99 (0.98 1.00),1.27E-02
401.1,Essential hypertension,circulatory system,OPGS004353,0.380,RNAseq,KYAT3,0.99 (0.98 1.00),1.30E-02
401.1,Essential hypertension,circulatory system,OPGS011568,0.046,RNAseq,ID2,1.01 (1.00 1.02),1.30E-02
401.1,Essential hypertension,circulatory system,OPGS008892,0.092,RNAseq,PLSCR1,1.01 (1.00 1.02),1.30E-02
401.1,Essential hypertension,circulatory system,OPGS008616,0.098,RNAseq,AC069185.1,0.99 (0.98 1.00),1.31E-02
401.1,Essential hypertension,circulatory system,OPGS012960,0.031,RNAseq,CASD1,1.01 (1.00 1.02),1.33E-02
401.1,Essential hypertension,circulatory system,OPGS007983,0.116,RNAseq,CPEB2,0.99 (0.98 1.00),1.34E-02
401.1,Essential hypertension,circulatory system,OPGS011229,0.051,RNAseq,PLCB3,1.01 (1.00 1.02),1.35E-02
401.1,Essential hypertension,circulatory system,OPGS006200,0.192,RNAseq,AL157895.2,0.99 (0.98 1.00),1.35E-02
401.1,Essential hypertension,circulatory system,OPGS004611,0.338,RNAseq,GFPT1,1.01 (1.00 1.02),1.41E-02
401.1,Essential hypertension,circulatory system,OPGS004466,0.360,RNAseq,ADRB1,1.01 (1.00 1.02),1.42E-02
401.1,Essential hypertension,circulatory system,OPGS012007,0.041,RNAseq,LINC00239,1.01 (1.00 1.02),1.43E-02
401.1,Essential hypertension,circulatory system,OPGS005723,0.220,RNAseq,ZMAT3,0.99 (0.98 1.00),1.45E-02
401.1,Essential hypertension,circulatory system,OPGS010381,0.063,RNAseq,LINC01819,0.99 (0.98 1.00),1.45E-02
401.1,Essential hypertension,circulatory system,OPGS010296,0.064,RNAseq,DDX5,1.01 (1.00 1.02),1.48E-02
401.1,Essential hypertension,circulatory system,OPGS004548,0.346,RNAseq,,0.99 (0.98 1.00),1.50E-02
401.1,Essential hypertension,circulatory system,OPGS006640,0.168,RNAseq,AKR1B1,0.99 (0.98 1.00),1.52E-02
401.1,Essential hypertension,circulatory system,OPGS010609,0.059,RNAseq,OXNAD1,1.01 (1.00 1.02),1.52E-02
401.1,Essential hypertension,circulatory system,OPGS014778,0.017,RNAseq,ATP2B4,0.99 (0.98 1.00),1.52E-02
401.1,Essential hypertension,circulatory system,OPGS010002,0.069,RNAseq,PRADC1,0.99 (0.98 1.00),1.53E-02
401.1,Essential hypertension,circulatory system,OPGS007266,0.141,RNAseq,RGS5,1.01 (1.00 1.02),1.54E-02
401.1,Essential hypertension,circulatory system,OPGS006131,0.196,RNAseq,MAPK3,0.99 (0.98 1.00),1.56E-02
401.1,Essential hypertension,circulatory system,OPGS011934,0.042,RNAseq,RNF115,0.99 (0.98 1.00),1.56E-02
401.1,Essential hypertension,circulatory system,OPGS005702,0.221,RNAseq,NT5DC2,0.99 (0.98 1.00),1.56E-02
401.1,Essential hypertension,circulatory system,OPGS010692,0.058,RNAseq,IPO9,0.99 (0.98 1.00),1.56E-02
401.1,Essential hypertension,circulatory system,OPGS005913,0.208,RNAseq,DELE1,0.99 (0.98 1.00),1.57E-02
401.1,Essential hypertension,circulatory system,OPGS003985,0.468,RNAseq,SUMF1,1.01 (1.00 1.02),1.61E-02
401.1,Essential hypertension,circulatory system,OPGS011916,0.042,RNAseq,VTI1A,0.99 (0.98 1.00),1.63E-02
401.1,Essential hypertension,circulatory system,OPGS004275,0.393,RNAseq,TACSTD2,1.01 (1.00 1.02),1.66E-02
401.1,Essential hypertension,circulatory system,OPGS011883,0.043,RNAseq,RGL3,1.01 (1.00 1.02),1.66E-02
401.1,Essential hypertension,circulatory system,OPGS009087,0.088,RNAseq,THSD7A,1.01 (1.00 1.02),1.66E-02
401.1,Essential hypertension,circulatory system,OPGS014928,0.016,RNAseq,,0.99 (0.98 1.00),1.67E-02
401.1,Essential hypertension,circulatory system,OPGS005363,0.250,RNAseq,FAM177A1,0.99 (0.98 1.00),1.68E-02
401.1,Essential hypertension,circulatory system,OPGS012984,0.031,RNAseq,POU5F1,0.99 (0.98 1.00),1.68E-02
401.1,Essential hypertension,circulatory system,OPGS010856,0.056,RNAseq,RIOK3,0.99 (0.98 1.00),1.72E-02
401.1,Essential hypertension,circulatory system,OPGS007588,0.129,RNAseq,FANCL,1.01 (1.00 1.02),1.72E-02
401.1,Essential hypertension,circulatory system,OPGS007578,0.129,RNAseq,HAUS8,0.99 (0.98 1.00),1.73E-02
401.1,Essential hypertension,circulatory system,OPGS006717,0.164,RNAseq,AC144652.1,1.01 (1.00 1.02),1.76E-02
401.1,Essential hypertension,circulatory system,OPGS011137,0.052,RNAseq,USP28,0.99 (0.98 1.00),1.77E-02
401.1,Essential hypertension,circulatory system,OPGS012704,0.034,RNAseq,AC093827.4,1.01 (1.00 1.02),1.80E-02
401.1,Essential hypertension,circulatory system,OPGS003809,0.546,RNAseq,SPDYC,0.99 (0.98 1.00),1.80E-02
401.1,Essential hypertension,circulatory system,OPGS005804,0.215,RNAseq,A3GALT2,0.99 (0.98 1.00),1.80E-02
401.1,Essential hypertension,circulatory system,OPGS007512,0.132,RNAseq,ST3GAL5,0.99 (0.98 1.00),1.85E-02
401.1,Essential hypertension,circulatory system,OPGS009980,0.070,RNAseq,UBXN11,1.01 (1.00 1.02),1.85E-02
401.1,Essential hypertension,circulatory system,OPGS012336,0.037,RNAseq,IDH2,0.99 (0.98 1.00),1.88E-02
401.1,Essential hypertension,circulatory system,OPGS003567,0.775,RNAseq,,0.99 (0.98 1.00),1.89E-02
401.1,Essential hypertension,circulatory system,OPGS011145,0.052,RNAseq,HOXC4,0.99 (0.98 1.00),1.90E-02
401.1,Essential hypertension,circulatory system,OPGS006618,0.169,RNAseq,DCAKD,0.99 (0.98 1.00),1.90E-02
401.1,Essential hypertension,circulatory system,OPGS013208,0.029,RNAseq,SNX27,1.01 (1.00 1.02),1.91E-02
401.1,Essential hypertension,circulatory system,OPGS007878,0.119,RNAseq,ZFP36L1,1.01 (1.00 1.02),1.91E-02
401.1,Essential hypertension,circulatory system,OPGS009489,0.079,RNAseq,POC1B,1.01 (1.00 1.02),1.92E-02
401.1,Essential hypertension,circulatory system,OPGS010735,0.057,RNAseq,NAA40,0.99 (0.98 1.00),1.95E-02
401.1,Essential hypertension,circulatory system,OPGS006452,0.178,RNAseq,AC069307.1,1.01 (1.00 1.02),1.95E-02
401.1,Essential hypertension,circulatory system,OPGS006668,0.167,RNAseq,PLEKHA7,1.01 (1.00 1.02),1.96E-02
401.1,Essential hypertension,circulatory system,OPGS004847,0.305,RNAseq,MXRA7,0.99 (0.98 1.00),1.96E-02
401.1,Essential hypertension,circulatory system,OPGS004943,0.293,RNAseq,,1.01 (1.00 1.02),1.96E-02
401.1,Essential hypertension,circulatory system,OPGS012509,0.036,RNAseq,KRAS,1.01 (1.00 1.02),1.97E-02
401.1,Essential hypertension,circulatory system,OPGS013526,0.026,RNAseq,H2BC11,0.99 (0.98 1.00),1.97E-02
401.1,Essential hypertension,circulatory system,OPGS013197,0.029,RNAseq,IWS1,0.99 (0.98 1.00),1.98E-02
401.1,Essential hypertension,circulatory system,OPGS011010,0.054,RNAseq,TRBV5-4,0.99 (0.98 1.00),2.00E-02
401.1,Essential hypertension,circulatory system,OPGS013252,0.029,RNAseq,CAVIN2,0.99 (0.98 1.00),2.00E-02
401.1,Essential hypertension,circulatory system,OPGS011564,0.046,RNAseq,ABHD16B,0.99 (0.98 1.00),2.00E-02
401.1,Essential hypertension,circulatory system,OPGS006675,0.166,RNAseq,,1.01 (1.00 1.02),2.01E-02
401.1,Essential hypertension,circulatory system,OPGS006038,0.201,RNAseq,HLA-DQA2,1.01 (1.00 1.02),2.02E-02
401.1,Essential hypertension,circulatory system,OPGS009146,0.087,RNAseq,FBXL3,1.01 (1.00 1.02),2.02E-02
401.1,Essential hypertension,circulatory system,OPGS005245,0.261,RNAseq,ZNF391,0.99 (0.98 1.00),2.03E-02
401.1,Essential hypertension,circulatory system,OPGS014571,0.018,RNAseq,MAML2,0.99 (0.98 1.00),2.04E-02
401.1,Essential hypertension,circulatory system,OPGS012103,0.040,RNAseq,AC019254.1,1.01 (1.00 1.02),2.07E-02
401.1,Essential hypertension,circulatory system,OPGS012057,0.041,RNAseq,POLG2,0.99 (0.98 1.00),2.07E-02
401.1,Essential hypertension,circulatory system,OPGS011925,0.042,RNAseq,LINC02680,1.01 (1.00 1.02),2.07E-02
401.1,Essential hypertension,circulatory system,OPGS005398,0.247,RNAseq,RALGPS1,1.01 (1.00 1.02),2.09E-02
401.1,Essential hypertension,circulatory system,OPGS003660,0.627,RNAseq,SENP6,1.01 (1.00 1.02),2.09E-02
401.1,Essential hypertension,circulatory system,OPGS009103,0.088,RNAseq,NUDT3,1.01 (1.00 1.02),2.10E-02
401.1,Essential hypertension,circulatory system,OPGS009048,0.089,RNAseq,ANP32E,1.01 (1.00 1.02),2.11E-02
401.1,Essential hypertension,circulatory system,OPGS012918,0.032,RNAseq,STIMATE,1.01 (1.00 1.02),2.12E-02
401.1,Essential hypertension,circulatory system,OPGS005059,0.281,RNAseq,STIM2,1.01 (1.00 1.02),2.12E-02
401.1,Essential hypertension,circulatory system,OPGS008509,0.101,RNAseq,PABPC4,0.99 (0.98 1.00),2.12E-02
401.1,Essential hypertension,circulatory system,OPGS011421,0.048,RNAseq,ITGAL,1.01 (1.00 1.02),2.15E-02
401.1,Essential hypertension,circulatory system,OPGS007635,0.128,RNAseq,PKD1L3,0.99 (0.98 1.00),2.16E-02
401.1,Essential hypertension,circulatory system,OPGS004133,0.427,RNAseq,BLVRA,0.99 (0.98 1.00),2.17E-02
401.1,Essential hypertension,circulatory system,OPGS014818,0.017,RNAseq,SNORA77,0.99 (0.98 1.00),2.18E-02
401.1,Essential hypertension,circulatory system,OPGS011548,0.046,RNAseq,,0.99 (0.98 1.00),2.18E-02
401.1,Essential hypertension,circulatory system,OPGS011807,0.043,RNAseq,HIVEP2,0.99 (0.98 1.00),2.18E-02
401.1,Essential hypertension,circulatory system,OPGS011692,0.045,RNAseq,CA1,0.99 (0.98 1.00),2.21E-02
401.1,Essential hypertension,circulatory system,OPGS008303,0.107,RNAseq,TMEM116,0.99 (0.98 1.00),2.21E-02
401.1,Essential hypertension,circulatory system,OPGS009817,0.073,RNAseq,LRRC8D,1.01 (1.00 1.02),2.22E-02
401.1,Essential hypertension,circulatory system,OPGS012173,0.039,RNAseq,ZNF200,1.01 (1.00 1.02),2.22E-02
401.1,Essential hypertension,circulatory system,OPGS010823,0.056,RNAseq,RPS14,0.99 (0.98 1.00),2.24E-02
401.1,Essential hypertension,circulatory system,OPGS012862,0.032,RNAseq,USF3,1.01 (1.00 1.02),2.25E-02
401.1,Essential hypertension,circulatory system,OPGS012136,0.040,RNAseq,NFIL3,0.99 (0.98 1.00),2.27E-02
401.1,Essential hypertension,circulatory system,OPGS007691,0.126,RNAseq,HLA-DRB1,0.99 (0.98 1.00),2.27E-02
401.1,Essential hypertension,circulatory system,OPGS006589,0.171,RNAseq,TUBGCP2,0.99 (0.98 1.00),2.28E-02
401.1,Essential hypertension,circulatory system,OPGS007243,0.142,RNAseq,USF1,0.99 (0.98 1.00),2.28E-02
401.1,Essential hypertension,circulatory system,OPGS006565,0.172,RNAseq,ANKRA2,1.01 (1.00 1.02),2.28E-02
401.1,Essential hypertension,circulatory system,OPGS012035,0.041,RNAseq,ZMYND15,1.01 (1.00 1.02),2.28E-02
401.1,Essential hypertension,circulatory system,OPGS007619,0.128,RNAseq,KCNG2,1.01 (1.00 1.02),2.31E-02
401.1,Essential hypertension,circulatory system,OPGS003900,0.507,RNAseq,NEGR1,1.01 (1.00 1.02),2.31E-02
401.1,Essential hypertension,circulatory system,OPGS009906,0.071,RNAseq,CHST15,0.99 (0.98 1.00),2.31E-02
401.1,Essential hypertension,circulatory system,OPGS012732,0.033,RNAseq,AF165147.1,0.99 (0.98 1.00),2.32E-02
401.1,Essential hypertension,circulatory system,OPGS011197,0.051,RNAseq,APC,0.99 (0.98 1.00),2.33E-02
401.1,Essential hypertension,circulatory system,OPGS006736,0.164,RNAseq,ARL4C,0.99 (0.98 1.00),2.35E-02
401.1,Essential hypertension,circulatory system,OPGS004501,0.354,RNAseq,TBKBP1,0.99 (0.98 1.00),2.35E-02
401.1,Essential hypertension,circulatory system,OPGS008638,0.098,RNAseq,CRISP3,1.01 (1.00 1.02),2.37E-02
401.1,Essential hypertension,circulatory system,OPGS013755,0.024,RNAseq,LYG1,1.01 (1.00 1.02),2.37E-02
401.1,Essential hypertension,circulatory system,OPGS008513,0.101,RNAseq,CEP68,1.01 (1.00 1.02),2.38E-02
401.1,Essential hypertension,circulatory system,OPGS007216,0.143,RNAseq,CADM2,1.01 (1.00 1.02),2.39E-02
401.1,Essential hypertension,circulatory system,OPGS004945,0.293,RNAseq,EIF4B,1.01 (1.00 1.02),2.39E-02
401.1,Essential hypertension,circulatory system,OPGS003958,0.480,RNAseq,ERICH1,1.01 (1.00 1.02),2.40E-02
401.1,Essential hypertension,circulatory system,OPGS009205,0.085,RNAseq,C11orf68,1.01 (1.00 1.02),2.40E-02
401.1,Essential hypertension,circulatory system,OPGS009384,0.082,RNAseq,KLHL7,0.99 (0.98 1.00),2.41E-02
401.1,Essential hypertension,circulatory system,OPGS012026,0.041,RNAseq,SNHG15,1.01 (1.00 1.02),2.42E-02
401.1,Essential hypertension,circulatory system,OPGS003968,0.476,RNAseq,AC093495.1,1.01 (1.00 1.02),2.43E-02
401.1,Essential hypertension,circulatory system,OPGS007756,0.124,RNAseq,GRWD1,0.99 (0.98 1.00),2.43E-02
401.1,Essential hypertension,circulatory system,OPGS006049,0.200,RNAseq,CCDC115,1.01 (1.00 1.02),2.44E-02
401.1,Essential hypertension,circulatory system,OPGS007868,0.119,RNAseq,ING1,0.99 (0.98 1.00),2.45E-02
401.1,Essential hypertension,circulatory system,OPGS012729,0.033,RNAseq,SREBF2,0.99 (0.98 1.00),2.45E-02
401.1,Essential hypertension,circulatory system,OPGS011716,0.045,RNAseq,FBLN7,0.99 (0.98 1.00),2.46E-02
401.1,Essential hypertension,circulatory system,OPGS010181,0.066,RNAseq,KCTD21,1.01 (1.00 1.02),2.47E-02
401.1,Essential hypertension,circulatory system,OPGS011683,0.045,RNAseq,ZCCHC7,1.01 (1.00 1.02),2.48E-02
401.1,Essential hypertension,circulatory system,OPGS006066,0.199,RNAseq,WNT11,0.99 (0.98 1.00),2.48E-02
401.1,Essential hypertension,circulatory system,OPGS007259,0.141,RNAseq,BEND7,1.01 (1.00 1.02),2.48E-02
401.1,Essential hypertension,circulatory system,OPGS008984,0.090,RNAseq,ALOX15B,0.99 (0.98 1.00),2.50E-02
401.1,Essential hypertension,circulatory system,OPGS006201,0.192,RNAseq,MAPKAPK5-AS1,0.99 (0.98 1.00),2.50E-02
401.1,Essential hypertension,circulatory system,OPGS010935,0.055,RNAseq,TMEM191B,1.01 (1.00 1.02),2.50E-02
401.1,Essential hypertension,circulatory system,OPGS004936,0.294,RNAseq,,0.99 (0.98 1.00),2.52E-02
401.1,Essential hypertension,circulatory system,OPGS004665,0.329,RNAseq,AC022966.1,1.01 (1.00 1.02),2.52E-02
401.1,Essential hypertension,circulatory system,OPGS013221,0.029,RNAseq,ADAMTSL4-AS2,0.99 (0.98 1.00),2.52E-02
401.1,Essential hypertension,circulatory system,OPGS004331,0.383,RNAseq,AC004847.1,1.01 (1.00 1.02),2.53E-02
401.1,Essential hypertension,circulatory system,OPGS008523,0.101,RNAseq,AC008937.3,1.01 (1.00 1.02),2.56E-02
401.1,Essential hypertension,circulatory system,OPGS010274,0.065,RNAseq,ARPC3,1.01 (1.00 1.02),2.57E-02
401.1,Essential hypertension,circulatory system,OPGS004587,0.341,RNAseq,MYBPC3,1.01 (1.00 1.02),2.58E-02
401.1,Essential hypertension,circulatory system,OPGS008533,0.101,RNAseq,EXOSC7,0.99 (0.98 1.00),2.60E-02
401.1,Essential hypertension,circulatory system,OPGS006503,0.175,RNAseq,VPS8,1.01 (1.00 1.02),2.61E-02
401.1,Essential hypertension,circulatory system,OPGS010305,0.064,RNAseq,KCNH2,0.99 (0.98 1.00),2.63E-02
401.1,Essential hypertension,circulatory system,OPGS013770,0.024,RNAseq,UBN1,0.99 (0.98 1.00),2.63E-02
401.1,Essential hypertension,circulatory system,OPGS005449,0.243,RNAseq,ZNF708,0.99 (0.98 1.00),2.63E-02
401.1,Essential hypertension,circulatory system,OPGS005299,0.257,RNAseq,AC046134.2,0.99 (0.98 1.00),2.63E-02
401.1,Essential hypertension,circulatory system,OPGS012246,0.039,RNAseq,ZFP36L2,0.99 (0.98 1.00),2.64E-02
401.1,Essential hypertension,circulatory system,OPGS012946,0.031,RNAseq,PHC2,0.99 (0.98 1.00),2.70E-02
401.1,Essential hypertension,circulatory system,OPGS006945,0.154,RNAseq,AP2M1,0.99 (0.98 1.00),2.71E-02
401.1,Essential hypertension,circulatory system,OPGS011902,0.042,RNAseq,LONRF1,0.99 (0.98 1.00),2.73E-02
401.1,Essential hypertension,circulatory system,OPGS014397,0.020,RNAseq,TUT7,0.99 (0.98 1.00),2.81E-02
401.1,Essential hypertension,circulatory system,OPGS007349,0.138,RNAseq,AP4M1,0.99 (0.98 1.00),2.82E-02
401.1,Essential hypertension,circulatory system,OPGS012203,0.039,RNAseq,VTI1B,1.01 (1.00 1.02),2.83E-02
401.1,Essential hypertension,circulatory system,OPGS012601,0.035,RNAseq,RN7SL1,1.01 (1.00 1.02),2.85E-02
401.1,Essential hypertension,circulatory system,OPGS011385,0.048,RNAseq,SLC43A3,0.99 (0.98 1.00),2.86E-02
401.1,Essential hypertension,circulatory system,OPGS006878,0.156,RNAseq,ARID5A,1.01 (1.00 1.02),2.91E-02
401.1,Essential hypertension,circulatory system,OPGS008109,0.112,RNAseq,CIB2,0.99 (0.98 1.00),2.92E-02
401.1,Essential hypertension,circulatory system,OPGS014214,0.021,RNAseq,PRSS22,0.99 (0.99 1.00),2.97E-02
401.1,Essential hypertension,circulatory system,OPGS011680,0.045,RNAseq,ELK3,0.99 (0.98 1.00),2.97E-02
401.1,Essential hypertension,circulatory system,OPGS005726,0.220,RNAseq,TGOLN2,0.99 (0.98 1.00),2.97E-02
401.1,Essential hypertension,circulatory system,OPGS003646,0.643,RNAseq,CPA5,1.01 (1.00 1.02),2.97E-02
401.1,Essential hypertension,circulatory system,OPGS005871,0.211,RNAseq,FDFT1,1.01 (1.00 1.02),2.97E-02
401.1,Essential hypertension,circulatory system,OPGS013785,0.024,RNAseq,SLC39A14,1.01 (1.00 1.02),2.97E-02
401.1,Essential hypertension,circulatory system,OPGS008162,0.110,RNAseq,,0.99 (0.99 1.00),2.97E-02
401.1,Essential hypertension,circulatory system,OPGS003637,0.649,RNAseq,,0.99 (0.98 1.00),2.99E-02
401.1,Essential hypertension,circulatory system,OPGS012455,0.036,RNAseq,EIF5A2,0.99 (0.98 1.00),3.00E-02
401.1,Essential hypertension,circulatory system,OPGS011567,0.046,RNAseq,MIER2,1.01 (1.00 1.02),3.02E-02
401.1,Essential hypertension,circulatory system,OPGS004735,0.319,RNAseq,ADPRH,0.99 (0.99 1.00),3.02E-02
401.1,Essential hypertension,circulatory system,OPGS010854,0.056,RNAseq,UBE2H,0.99 (0.98 1.00),3.02E-02
401.1,Essential hypertension,circulatory system,OPGS004538,0.348,RNAseq,AC100810.1,1.01 (1.00 1.02),3.04E-02
401.1,Essential hypertension,circulatory system,OPGS007420,0.135,RNAseq,GLCE,0.99 (0.98 1.00),3.05E-02
401.1,Essential hypertension,circulatory system,OPGS006811,0.160,RNAseq,AC025569.1,1.01 (1.00 1.02),3.07E-02
401.1,Essential hypertension,circulatory system,OPGS006433,0.179,RNAseq,PECAM1,1.01 (1.00 1.02),3.08E-02
401.1,Essential hypertension,circulatory system,OPGS013064,0.030,RNAseq,ZNF22,1.01 (1.00 1.02),3.08E-02
401.1,Essential hypertension,circulatory system,OPGS014351,0.020,RNAseq,SMARCC1,0.99 (0.99 1.00),3.09E-02
401.1,Essential hypertension,circulatory system,OPGS014101,0.022,RNAseq,DES,0.99 (0.98 1.00),3.12E-02
401.1,Essential hypertension,circulatory system,OPGS007689,0.126,RNAseq,PLEKHA6,1.01 (1.00 1.02),3.12E-02
401.1,Essential hypertension,circulatory system,OPGS013494,0.026,RNAseq,TMEM88,1.01 (1.00 1.01),3.12E-02
401.1,Essential hypertension,circulatory system,OPGS009274,0.084,RNAseq,CCNG2,0.99 (0.98 1.00),3.13E-02
401.1,Essential hypertension,circulatory system,OPGS007876,0.119,RNAseq,MDM4,0.99 (0.99 1.00),3.13E-02
401.1,Essential hypertension,circulatory system,OPGS004504,0.354,RNAseq,ADH5,1.01 (1.00 1.02),3.15E-02
401.1,Essential hypertension,circulatory system,OPGS008437,0.103,RNAseq,TMEM222,0.99 (0.98 1.00),3.16E-02
401.1,Essential hypertension,circulatory system,OPGS007598,0.129,RNAseq,TGM1,1.01 (1.00 1.02),3.16E-02
401.1,Essential hypertension,circulatory system,OPGS004556,0.345,RNAseq,KIF26A,1.01 (1.00 1.02),3.18E-02
401.1,Essential hypertension,circulatory system,OPGS003980,0.470,RNAseq,BAK1,1.01 (1.00 1.02),3.18E-02
401.1,Essential hypertension,circulatory system,OPGS004288,0.391,RNAseq,,0.99 (0.99 1.00),3.18E-02
401.1,Essential hypertension,circulatory system,OPGS008114,0.112,RNAseq,FADD,0.99 (0.99 1.00),3.18E-02
401.1,Essential hypertension,circulatory system,OPGS012717,0.033,RNAseq,GBP4,1.01 (1.00 1.02),3.21E-02
401.1,Essential hypertension,circulatory system,OPGS011828,0.043,RNAseq,NEIL1,1.01 (1.00 1.02),3.21E-02
401.1,Essential hypertension,circulatory system,OPGS006225,0.191,RNAseq,NME8,1.01 (1.00 1.02),3.21E-02
401.1,Essential hypertension,circulatory system,OPGS012967,0.031,RNAseq,CCDC157,0.99 (0.99 1.00),3.22E-02
401.1,Essential hypertension,circulatory system,OPGS012799,0.033,RNAseq,ETV6,1.01 (1.00 1.02),3.23E-02
401.1,Essential hypertension,circulatory system,OPGS008223,0.108,RNAseq,TMEM106B,1.01 (1.00 1.02),3.23E-02
401.1,Essential hypertension,circulatory system,OPGS013146,0.029,RNAseq,AC068580.3,0.99 (0.99 1.00),3.25E-02
401.1,Essential hypertension,circulatory system,OPGS010932,0.055,RNAseq,GPR84,0.99 (0.99 1.00),3.26E-02
401.1,Essential hypertension,circulatory system,OPGS009988,0.070,RNAseq,WAPL,1.01 (1.00 1.02),3.29E-02
401.1,Essential hypertension,circulatory system,OPGS004982,0.289,RNAseq,BAIAP3,1.01 (1.00 1.02),3.29E-02
401.1,Essential hypertension,circulatory system,OPGS010792,0.057,RNAseq,,0.99 (0.99 1.00),3.29E-02
401.1,Essential hypertension,circulatory system,OPGS010987,0.054,RNAseq,AC242988.2,1.01 (1.00 1.02),3.29E-02
401.1,Essential hypertension,circulatory system,OPGS014132,0.022,RNAseq,SLC2A4RG,1.01 (1.00 1.02),3.30E-02
401.1,Essential hypertension,circulatory system,OPGS013390,0.027,RNAseq,STAU2,0.99 (0.99 1.00),3.32E-02
401.1,Essential hypertension,circulatory system,OPGS014565,0.018,RNAseq,PEG13,0.99 (0.99 1.00),3.32E-02
401.1,Essential hypertension,circulatory system,OPGS011427,0.048,RNAseq,SDC4,1.01 (1.00 1.02),3.34E-02
401.1,Essential hypertension,circulatory system,OPGS004297,0.390,RNAseq,HACD4,0.99 (0.99 1.00),3.35E-02
401.1,Essential hypertension,circulatory system,OPGS006635,0.169,RNAseq,MPRIP,0.99 (0.99 1.00),3.35E-02
401.1,Essential hypertension,circulatory system,OPGS010562,0.060,RNAseq,SRP19,1.01 (1.00 1.02),3.35E-02
401.1,Essential hypertension,circulatory system,OPGS011417,0.048,RNAseq,FLCN,0.99 (0.99 1.00),3.37E-02
401.1,Essential hypertension,circulatory system,OPGS010643,0.059,RNAseq,TOR1AIP1,1.01 (1.00 1.02),3.38E-02
401.1,Essential hypertension,circulatory system,OPGS012708,0.033,RNAseq,GRIN2D,0.99 (0.99 1.00),3.38E-02
401.1,Essential hypertension,circulatory system,OPGS004031,0.456,RNAseq,,1.01 (1.00 1.02),3.42E-02
401.1,Essential hypertension,circulatory system,OPGS004948,0.293,RNAseq,AC007686.4,0.99 (0.99 1.00),3.44E-02
401.1,Essential hypertension,circulatory system,OPGS010057,0.068,RNAseq,POMT1,0.99 (0.99 1.00),3.45E-02
401.1,Essential hypertension,circulatory system,OPGS003602,0.690,RNAseq,,0.99 (0.99 1.00),3.46E-02
401.1,Essential hypertension,circulatory system,OPGS010973,0.054,RNAseq,PLIN5,0.99 (0.99 1.00),3.49E-02
401.1,Essential hypertension,circulatory system,OPGS005223,0.263,RNAseq,NCLN,0.99 (0.99 1.00),3.49E-02
401.1,Essential hypertension,circulatory system,OPGS011894,0.043,RNAseq,HAUS6,0.99 (0.99 1.00),3.50E-02
401.1,Essential hypertension,circulatory system,OPGS003925,0.496,RNAseq,OSER1,0.99 (0.99 1.00),3.53E-02
401.1,Essential hypertension,circulatory system,OPGS012358,0.037,RNAseq,SFRP5,1.01 (1.00 1.02),3.54E-02
401.1,Essential hypertension,circulatory system,OPGS004389,0.372,RNAseq,AP003774.2,0.99 (0.99 1.00),3.54E-02
401.1,Essential hypertension,circulatory system,OPGS014669,0.018,RNAseq,CDKN3,1.01 (1.00 1.02),3.54E-02
401.1,Essential hypertension,circulatory system,OPGS007363,0.137,RNAseq,UCKL1,0.99 (0.99 1.00),3.57E-02
401.1,Essential hypertension,circulatory system,OPGS014937,0.016,RNAseq,EIF3M,0.99 (0.99 1.00),3.59E-02
401.1,Essential hypertension,circulatory system,OPGS009744,0.074,RNAseq,BRCA2,0.99 (0.99 1.00),3.60E-02
401.1,Essential hypertension,circulatory system,OPGS010260,0.065,RNAseq,AL354813.1,1.01 (1.00 1.02),3.61E-02
401.1,Essential hypertension,circulatory system,OPGS012700,0.034,RNAseq,NFATC2,1.01 (1.00 1.02),3.62E-02
401.1,Essential hypertension,circulatory system,OPGS007161,0.145,RNAseq,MAP3K6,1.01 (1.00 1.01),3.62E-02
401.1,Essential hypertension,circulatory system,OPGS003986,0.468,RNAseq,TMEM9B-AS1,0.99 (0.99 1.00),3.68E-02
401.1,Essential hypertension,circulatory system,OPGS005187,0.267,RNAseq,KLHDC7A,1.01 (1.00 1.01),3.70E-02
401.1,Essential hypertension,circulatory system,OPGS008818,0.094,RNAseq,RBP7,1.01 (1.00 1.02),3.71E-02
401.1,Essential hypertension,circulatory system,OPGS003613,0.673,RNAseq,THNSL2,0.99 (0.99 1.00),3.72E-02
401.1,Essential hypertension,circulatory system,OPGS014519,0.019,RNAseq,SENCR,0.99 (0.99 1.00),3.73E-02
401.1,Essential hypertension,circulatory system,OPGS010741,0.057,RNAseq,TNK2-AS1,0.99 (0.99 1.00),3.74E-02
401.1,Essential hypertension,circulatory system,OPGS014361,0.020,RNAseq,GORASP2,1.01 (1.00 1.01),3.74E-02
401.1,Essential hypertension,circulatory system,OPGS009276,0.084,RNAseq,FCER1A,0.99 (0.99 1.00),3.74E-02
401.1,Essential hypertension,circulatory system,OPGS009687,0.075,RNAseq,ADO,1.01 (1.00 1.01),3.74E-02
401.1,Essential hypertension,circulatory system,OPGS013445,0.027,RNAseq,AC131212.2,0.99 (0.99 1.00),3.74E-02
401.1,Essential hypertension,circulatory system,OPGS006773,0.162,RNAseq,SLC6A12,1.01 (1.00 1.02),3.74E-02
401.1,Essential hypertension,circulatory system,OPGS006632,0.169,RNAseq,SBF2-AS1,1.01 (1.00 1.01),3.78E-02
401.1,Essential hypertension,circulatory system,OPGS011570,0.046,RNAseq,ZNF888,1.01 (1.00 1.01),3.79E-02
401.1,Essential hypertension,circulatory system,OPGS011093,0.052,RNAseq,FAIM,0.99 (0.99 1.00),3.84E-02
401.1,Essential hypertension,circulatory system,OPGS007415,0.135,RNAseq,INO80C,1.01 (1.00 1.02),3.84E-02
401.1,Essential hypertension,circulatory system,OPGS004014,0.460,RNAseq,PRMT6,0.99 (0.99 1.00),3.88E-02
401.1,Essential hypertension,circulatory system,OPGS008231,0.108,RNAseq,PUS3,1.01 (1.00 1.01),3.88E-02
401.1,Essential hypertension,circulatory system,OPGS012436,0.036,RNAseq,TCEA1,1.01 (1.00 1.01),3.93E-02
401.1,Essential hypertension,circulatory system,OPGS009897,0.071,RNAseq,TNIP2,0.99 (0.99 1.00),3.93E-02
401.1,Essential hypertension,circulatory system,OPGS005891,0.209,RNAseq,KAT2B,0.99 (0.99 1.00),3.95E-02
401.1,Essential hypertension,circulatory system,OPGS012264,0.038,RNAseq,RNF40,0.99 (0.99 1.00),3.95E-02
401.1,Essential hypertension,circulatory system,OPGS009993,0.069,RNAseq,SNX21,1.01 (1.00 1.01),3.96E-02
401.1,Essential hypertension,circulatory system,OPGS007916,0.118,RNAseq,CHMP4A,1.01 (1.00 1.01),3.96E-02
401.1,Essential hypertension,circulatory system,OPGS003795,0.550,RNAseq,ABCC5,1.01 (1.00 1.01),3.97E-02
401.1,Essential hypertension,circulatory system,OPGS010163,0.066,RNAseq,AL121832.2,1.01 (1.00 1.01),3.97E-02
401.1,Essential hypertension,circulatory system,OPGS014684,0.018,RNAseq,TYMS,1.01 (1.00 1.01),3.99E-02
401.1,Essential hypertension,circulatory system,OPGS005353,0.251,RNAseq,WWP2,1.01 (1.00 1.01),3.99E-02
401.1,Essential hypertension,circulatory system,OPGS003699,0.599,RNAseq,AC009506.2,1.01 (1.00 1.01),4.01E-02
401.1,Essential hypertension,circulatory system,OPGS014623,0.018,RNAseq,XKR7,0.99 (0.99 1.00),4.08E-02
401.1,Essential hypertension,circulatory system,OPGS010754,0.057,RNAseq,SUCO,0.99 (0.99 1.00),4.08E-02
401.1,Essential hypertension,circulatory system,OPGS004726,0.320,RNAseq,FAAP20,0.99 (0.99 1.00),4.08E-02
401.1,Essential hypertension,circulatory system,OPGS010431,0.062,RNAseq,,0.99 (0.99 1.00),4.08E-02
401.1,Essential hypertension,circulatory system,OPGS008539,0.101,RNAseq,ITPR1,1.01 (1.00 1.01),4.09E-02
401.1,Essential hypertension,circulatory system,OPGS015030,0.016,RNAseq,PRRC2A,1.01 (1.00 1.01),4.09E-02
401.1,Essential hypertension,circulatory system,OPGS011616,0.046,RNAseq,RPP25L,0.99 (0.99 1.00),4.10E-02
401.1,Essential hypertension,circulatory system,OPGS006734,0.164,RNAseq,ATP6V0D1,1.01 (1.00 1.02),4.11E-02
401.1,Essential hypertension,circulatory system,OPGS012428,0.036,RNAseq,AMN,0.99 (0.99 1.00),4.11E-02
401.1,Essential hypertension,circulatory system,OPGS005944,0.207,RNAseq,SSR1,0.99 (0.99 1.00),4.11E-02
401.1,Essential hypertension,circulatory system,OPGS008460,0.103,RNAseq,YEATS4,1.01 (1.00 1.01),4.13E-02
401.1,Essential hypertension,circulatory system,OPGS008718,0.096,RNAseq,,1.01 (1.00 1.01),4.14E-02
401.1,Essential hypertension,circulatory system,OPGS003776,0.560,RNAseq,CARMIL1,0.99 (0.99 1.00),4.18E-02
401.1,Essential hypertension,circulatory system,OPGS010708,0.058,RNAseq,AC073115.1,1.01 (1.00 1.01),4.19E-02
401.1,Essential hypertension,circulatory system,OPGS014467,0.019,RNAseq,LINC02846,0.99 (0.99 1.00),4.21E-02
401.1,Essential hypertension,circulatory system,OPGS005720,0.220,RNAseq,GPR108,1.01 (1.00 1.01),4.25E-02
401.1,Essential hypertension,circulatory system,OPGS004209,0.410,RNAseq,SLC45A4,1.01 (1.00 1.01),4.25E-02
401.1,Essential hypertension,circulatory system,OPGS013243,0.029,RNAseq,TRAV3,0.99 (0.99 1.00),4.25E-02
401.1,Essential hypertension,circulatory system,OPGS003983,0.469,RNAseq,TMOD2,0.99 (0.99 1.00),4.27E-02
401.1,Essential hypertension,circulatory system,OPGS006932,0.154,RNAseq,HIVEP3,1.01 (1.00 1.01),4.30E-02
401.1,Essential hypertension,circulatory system,OPGS009176,0.086,RNAseq,,1.01 (1.00 1.01),4.32E-02
401.1,Essential hypertension,circulatory system,OPGS003784,0.554,RNAseq,KCNK17,0.99 (0.99 1.00),4.35E-02
401.1,Essential hypertension,circulatory system,OPGS013112,0.030,RNAseq,TFCP2,1.01 (1.00 1.01),4.37E-02
401.1,Essential hypertension,circulatory system,OPGS004861,0.303,RNAseq,GRB14,1.01 (1.00 1.01),4.38E-02
401.1,Essential hypertension,circulatory system,OPGS012415,0.037,RNAseq,BAG4,1.01 (1.00 1.01),4.38E-02
401.1,Essential hypertension,circulatory system,OPGS008976,0.090,RNAseq,EDEM3,0.99 (0.99 1.00),4.38E-02
401.1,Essential hypertension,circulatory system,OPGS014794,0.017,RNAseq,PDAP1,1.01 (1.00 1.01),4.38E-02
401.1,Essential hypertension,circulatory system,OPGS010195,0.066,RNAseq,GATAD1,1.01 (1.00 1.01),4.39E-02
401.1,Essential hypertension,circulatory system,OPGS006518,0.174,RNAseq,KDELR2,1.01 (1.00 1.01),4.39E-02
401.1,Essential hypertension,circulatory system,OPGS007158,0.145,RNAseq,LINC01176,0.99 (0.99 1.00),4.39E-02
401.1,Essential hypertension,circulatory system,OPGS012199,0.039,RNAseq,MPHOSPH8,1.01 (1.00 1.01),4.39E-02
401.1,Essential hypertension,circulatory system,OPGS007275,0.141,RNAseq,GJA4,0.99 (0.99 1.00),4.43E-02
401.1,Essential hypertension,circulatory system,OPGS007592,0.129,RNAseq,RUNX2,1.01 (1.00 1.01),4.43E-02
401.1,Essential hypertension,circulatory system,OPGS009661,0.076,RNAseq,ECI2,0.99 (0.99 1.00),4.44E-02
401.1,Essential hypertension,circulatory system,OPGS014152,0.021,RNAseq,HSD11B1-AS1,0.99 (0.99 1.00),4.44E-02
401.1,Essential hypertension,circulatory system,OPGS003933,0.491,RNAseq,KCNJ15,0.99 (0.99 1.00),4.46E-02
401.1,Essential hypertension,circulatory system,OPGS015085,0.015,RNAseq,UBE2E1,0.99 (0.99 1.00),4.47E-02
401.1,Essential hypertension,circulatory system,OPGS012474,0.036,RNAseq,HNRNPH1,0.99 (0.99 1.00),4.48E-02
401.1,Essential hypertension,circulatory system,OPGS005766,0.217,RNAseq,OCLN,1.01 (1.00 1.01),4.49E-02
401.1,Essential hypertension,circulatory system,OPGS009069,0.089,RNAseq,LMBRD2,0.99 (0.99 1.00),4.49E-02
401.1,Essential hypertension,circulatory system,OPGS009920,0.071,RNAseq,LINC02446,1.01 (1.00 1.01),4.50E-02
401.1,Essential hypertension,circulatory system,OPGS007969,0.116,RNAseq,SPATA2L,1.01 (1.00 1.01),4.51E-02
401.1,Essential hypertension,circulatory system,OPGS008084,0.113,RNAseq,SNED1,0.99 (0.99 1.00),4.55E-02
401.1,Essential hypertension,circulatory system,OPGS008723,0.096,RNAseq,PRMT2,1.01 (1.00 1.01),4.56E-02
401.1,Essential hypertension,circulatory system,OPGS009683,0.075,RNAseq,CYBC1,1.01 (1.00 1.01),4.57E-02
401.1,Essential hypertension,circulatory system,OPGS005222,0.263,RNAseq,PTK2B,0.99 (0.99 1.00),4.60E-02
401.1,Essential hypertension,circulatory system,OPGS010901,0.055,RNAseq,,1.01 (1.00 1.01),4.61E-02
401.1,Essential hypertension,circulatory system,OPGS011365,0.049,RNAseq,GGT7,1.01 (1.00 1.01),4.63E-02
401.1,Essential hypertension,circulatory system,OPGS011898,0.042,RNAseq,LINC02453,1.01 (1.00 1.01),4.63E-02
401.1,Essential hypertension,circulatory system,OPGS009509,0.079,RNAseq,AC004241.1,0.99 (0.99 1.00),4.63E-02
401.1,Essential hypertension,circulatory system,OPGS007729,0.124,RNAseq,SAV1,1.01 (1.00 1.01),4.63E-02
401.1,Essential hypertension,circulatory system,OPGS006538,0.173,RNAseq,TMEM170B,1.01 (1.00 1.01),4.64E-02
401.1,Essential hypertension,circulatory system,OPGS013631,0.025,RNAseq,AL135999.1,0.99 (0.99 1.00),4.66E-02
401.1,Essential hypertension,circulatory system,OPGS010079,0.068,RNAseq,DAB2IP,0.99 (0.99 1.00),4.67E-02
401.1,Essential hypertension,circulatory system,OPGS011721,0.044,RNAseq,RNF8,0.99 (0.99 1.00),4.68E-02
401.1,Essential hypertension,circulatory system,OPGS003658,0.628,RNAseq,SMIM1,0.99 (0.99 1.00),4.68E-02
401.1,Essential hypertension,circulatory system,OPGS011945,0.042,RNAseq,TIGD7,0.99 (0.99 1.00),4.71E-02
401.1,Essential hypertension,circulatory system,OPGS009532,0.078,RNAseq,MGST1,0.99 (0.99 1.00),4.72E-02
401.1,Essential hypertension,circulatory system,OPGS005665,0.224,RNAseq,TOR3A,1.01 (1.00 1.01),4.72E-02
401.1,Essential hypertension,circulatory system,OPGS013253,0.029,RNAseq,PITPNM1,1.01 (1.00 1.01),4.72E-02
401.1,Essential hypertension,circulatory system,OPGS009056,0.089,RNAseq,AC107959.3,1.01 (1.00 1.01),4.72E-02
401.1,Essential hypertension,circulatory system,OPGS003971,0.474,RNAseq,SPTBN1,0.99 (0.99 1.00),4.73E-02
401.1,Essential hypertension,circulatory system,OPGS012663,0.034,RNAseq,C5orf34,0.99 (0.99 1.00),4.76E-02
401.1,Essential hypertension,circulatory system,OPGS006199,0.192,RNAseq,SPSB2,0.99 (0.99 1.00),4.76E-02
401.1,Essential hypertension,circulatory system,OPGS014855,0.017,RNAseq,ALG5,0.99 (0.99 1.00),4.76E-02
401.1,Essential hypertension,circulatory system,OPGS014408,0.020,RNAseq,TRUB2,0.99 (0.99 1.00),4.80E-02
401.1,Essential hypertension,circulatory system,OPGS007313,0.139,RNAseq,MMP24OS,1.01 (1.00 1.01),4.82E-02
401.1,Essential hypertension,circulatory system,OPGS010021,0.069,RNAseq,RPRD1B,1.01 (1.00 1.01),4.86E-02
401.1,Essential hypertension,circulatory system,OPGS009590,0.077,RNAseq,AP002784.1,0.99 (0.99 1.00),4.88E-02
401.1,Essential hypertension,circulatory system,OPGS005052,0.281,RNAseq,TRIM37,1.01 (1.00 1.01),4.88E-02
401.1,Essential hypertension,circulatory system,OPGS003653,0.635,RNAseq,TRIM66,0.99 (0.99 1.00),4.88E-02
401.1,Essential hypertension,circulatory system,OPGS005389,0.248,RNAseq,TRAV23DV6,0.99 (0.99 1.00),4.93E-02
401.1,Essential hypertension,circulatory system,OPGS009348,0.082,RNAseq,NSUN6,1.01 (1.00 1.01),4.95E-02
401.1,Essential hypertension,circulatory system,OPGS003940,0.487,RNAseq,,0.99 (0.99 1.00),4.95E-02
401.1,Essential hypertension,circulatory system,OPGS011444,0.048,RNAseq,STEAP1B,1.01 (1.00 1.01),4.95E-02
401.1,Essential hypertension,circulatory system,OPGS004061,0.447,RNAseq,SNX16,1.01 (1.00 1.01),4.99E-02
401.1,Essential hypertension,circulatory system,OPGS008980,0.090,RNAseq,ZNF638,1.01 (1.00 1.01),4.99E-02
411,Ischemic Heart Disease,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.28 (1.14 1.44),1.61E-02
411,Ischemic Heart Disease,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.39 (1.25 1.54),2.21E-05
411,Ischemic Heart Disease,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.35 (1.21 1.52),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.35 (1.21 1.51),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.36 (1.21 1.52),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.34 (1.20 1.49),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.35 (1.21 1.51),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.36 (1.21 1.52),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.36 (1.21 1.53),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.36 (1.21 1.53),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.35 (1.21 1.52),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.34 (1.20 1.49),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.37 (1.22 1.54),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.34 (1.20 1.49),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.36 (1.21 1.52),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.37 (1.22 1.53),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.34 (1.20 1.50),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.37 (1.22 1.54),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.35 (1.21 1.51),1.97E-04
411,Ischemic Heart Disease,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.36 (1.21 1.52),2.06E-04
411,Ischemic Heart Disease,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.36 (1.21 1.53),2.12E-04
411,Ischemic Heart Disease,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.35 (1.20 1.52),2.17E-04
411,Ischemic Heart Disease,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.34 (1.20 1.50),2.55E-04
411,Ischemic Heart Disease,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.32 (1.18 1.46),2.65E-04
411,Ischemic Heart Disease,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.34 (1.20 1.50),2.67E-04
411,Ischemic Heart Disease,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.34 (1.20 1.51),2.67E-04
411,Ischemic Heart Disease,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.34 (1.20 1.50),2.67E-04
411,Ischemic Heart Disease,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.33 (1.19 1.49),3.01E-04
411,Ischemic Heart Disease,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.31 (1.18 1.46),3.23E-04
411,Ischemic Heart Disease,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.33 (1.19 1.49),3.64E-04
411,Ischemic Heart Disease,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.33 (1.19 1.49),3.94E-04
411,Ischemic Heart Disease,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.33 (1.18 1.49),4.51E-04
411,Ischemic Heart Disease,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.32 (1.18 1.48),5.56E-04
411,Ischemic Heart Disease,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.32 (1.18 1.47),8.47E-04
411,Ischemic Heart Disease,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.32 (1.18 1.48),8.60E-04
411,Ischemic Heart Disease,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.31 (1.17 1.46),1.03E-03
411,Ischemic Heart Disease,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.30 (1.16 1.45),1.41E-03
411,Ischemic Heart Disease,circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.28 (1.15 1.42),1.67E-03
411,Ischemic Heart Disease,circulatory system,OPGS003527,0.050,Nightingale,Sphingomyelins,1.29 (1.16 1.44),1.87E-03
411,Ischemic Heart Disease,circulatory system,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.79 (0.71 0.88),3.90E-03
411,Ischemic Heart Disease,circulatory system,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.79 (0.71 0.88),6.49E-03
411,Ischemic Heart Disease,circulatory system,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.80 (0.72 0.89),1.70E-02
411,Ischemic Heart Disease,circulatory system,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.80 (0.72 0.89),1.93E-02
411,Ischemic Heart Disease,circulatory system,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.80 (0.72 0.90),2.59E-02
411,Ischemic Heart Disease,circulatory system,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.81 (0.73 0.90),3.35E-02
411,Ischemic Heart Disease,circulatory system,OPGS014959,0.016,RNAseq,ADPRHL2,0.89 (0.85 0.94),2.29E-02
411,Ischemic Heart Disease,circulatory system,OPGS004337,0.382,RNAseq,TBC1D3L,0.83 (0.75 0.91),2.58E-02
411,Ischemic Heart Disease,circulatory system,OPGS012090,0.040,RNAseq,MAPK1,0.86 (0.80 0.93),4.12E-02
411,Ischemic Heart Disease,circulatory system,OPGS009138,0.087,RNAseq,RAD1,1.19 (1.09 1.30),4.12E-02
411,Ischemic Heart Disease,circulatory system,OPGS004832,0.307,RNAseq,ARHGAP15,1.24 (1.11 1.38),4.41E-02
411,Ischemic Heart Disease,circulatory system,OPGS006141,0.195,RNAseq,MED16,0.83 (0.76 0.92),4.56E-02
411,Ischemic Heart Disease,circulatory system,OPGS005394,0.247,RNAseq,TMX4,1.22 (1.10 1.36),4.87E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000115,0.347,SomaScan,Protein CEI,1.09 (1.06 1.12),4.17E-09
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.09 (1.06 1.11),2.39E-08
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000613,0.096,SomaScan,Stromelysin-1,1.09 (1.06 1.12),5.25E-08
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.09 (1.06 1.11),5.56E-08
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.08 (1.06 1.11),1.09E-07
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000857,0.067,SomaScan,Moesin,1.08 (1.05 1.11),1.30E-07
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.09 (1.06 1.12),2.26E-07
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000312,0.163,SomaScan,Selenoprotein S,1.08 (1.06 1.11),4.34E-07
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.08 (1.06 1.11),4.61E-07
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.08 (1.05 1.10),4.64E-07
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.08 (1.05 1.10),5.03E-07
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.08 (1.05 1.11),6.93E-07
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.07 (1.05 1.10),1.78E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.08 (1.05 1.11),2.47E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.07 (1.05 1.10),4.66E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.07 (1.04 1.10),5.97E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.07 (1.05 1.10),8.69E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.07 (1.04 1.09),1.12E-05
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.07 (1.04 1.09),2.51E-05
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.07 (1.04 1.10),1.12E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.94 (0.91 0.96),1.37E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.06 (1.04 1.09),1.89E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000445,0.129,SomaScan,Collectin-10,0.94 (0.91 0.96),2.44E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000577,0.102,SomaScan,Platelet-activating factor acetylhydrolase,1.06 (1.04 1.09),2.78E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000883,0.064,SomaScan,Group XIIB secretory phospholipase A2-like protein,1.06 (1.04 1.09),3.35E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001297,0.034,SomaScan,Neogenin,0.94 (0.92 0.96),3.41E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001093,0.046,SomaScan,C-reactive protein,0.94 (0.92 0.97),5.97E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.06 (1.03 1.09),8.80E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000348,0.151,SomaScan,Quinone oxidoreductase-like protein 1,1.06 (1.03 1.09),1.48E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001102,0.046,SomaScan,Granzyme A,1.06 (1.03 1.08),2.20E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,0.94 (0.92 0.97),3.41E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001106,0.046,SomaScan,Disintegrin and metalloproteinase domain-containing protein 11,1.05 (1.03 1.08),3.66E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001058,0.049,SomaScan,Protocadherin beta-10,1.06 (1.03 1.09),3.82E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.06 (1.03 1.08),5.60E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002108,0.012,SomaScan,Neuralized-like protein 4,1.06 (1.03 1.08),5.92E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000172,0.257,SomaScan,Dermokine,0.95 (0.93 0.97),6.41E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000154,0.277,SomaScan,Granulins,1.05 (1.03 1.08),7.53E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.05 (1.03 1.08),8.29E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001759,0.018,SomaScan,Hyaluronidase-1,1.05 (1.03 1.08),9.46E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.05 (1.03 1.08),1.00E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000838,0.069,SomaScan,DNA/RNA-binding protein KIN17,0.95 (0.93 0.98),1.20E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000860,0.066,SomaScan,Cell surface glycoprotein CD200 receptor 2,0.95 (0.93 0.98),1.35E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001715,0.019,SomaScan,Histone deacetylase 8,1.05 (1.02 1.08),1.43E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000492,0.119,SomaScan,Inactive gamma-glutamyltranspeptidase 2,1.05 (1.02 1.08),1.47E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.05 (1.02 1.08),1.51E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001279,0.035,SomaScan,Four-jointed box protein 1,1.05 (1.02 1.08),1.51E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001115,0.045,SomaScan,Small integral membrane protein 9,1.05 (1.02 1.08),1.51E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001392,0.029,SomaScan,Cadherin-related family member 5,1.05 (1.02 1.08),1.54E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001112,0.045,SomaScan,Hemojuvelin,1.05 (1.02 1.08),1.67E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.05 (1.02 1.08),1.74E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000285,0.176,SomaScan,Complement C1q tumor necrosis factor-related protein 1,1.05 (1.02 1.08),1.98E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001200,0.039,SomaScan,DnaJ homolog subfamily B member 11,1.05 (1.02 1.07),2.08E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001002,0.053,SomaScan,Tumor protein p53-inducible protein 11,1.05 (1.02 1.08),2.32E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.05 (1.02 1.07),2.33E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001985,0.013,SomaScan,Isochorismatase domain-containing protein 1,1.05 (1.02 1.07),2.36E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000510,0.115,SomaScan,Guanine nucleotide-binding protein G(k) subunit alpha,0.95 (0.93 0.98),2.38E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001828,0.016,SomaScan,Splicing factor 1,1.05 (1.02 1.07),2.43E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001769,0.018,SomaScan,Peptidyl-prolyl cis-trans isomerase FKBP14,1.05 (1.02 1.07),2.58E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001352,0.031,SomaScan,Sterol-4-alpha-carboxylate 3-dehydrogenase. decarboxylating,1.05 (1.02 1.07),3.07E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,0.95 (0.93 0.98),3.07E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,0.95 (0.93 0.98),3.12E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002204,0.011,SomaScan,Rho-related GTP-binding protein RhoG,1.05 (1.02 1.07),3.12E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001963,0.013,SomaScan,Annexin A9,1.05 (1.02 1.08),3.45E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,1.05 (1.02 1.07),3.45E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001937,0.014,SomaScan,Protocadherin gamma-B1,1.04 (1.02 1.07),4.22E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS001437,0.028,SomaScan,Steroidogenic acute regulatory protein. mitochondrial,1.05 (1.02 1.07),4.22E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.96 (0.93 0.98),4.22E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002656,0.013,Olink,Angiotensin-converting enzyme 2,0.94 (0.92 0.96),2.19E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002619,0.025,Olink,Transforming growth factor beta-1 proprotein,1.05 (1.02 1.08),1.83E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002568,0.043,Olink,Granzyme A,1.05 (1.02 1.07),4.14E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.12 (1.09 1.15),2.34E-15
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.10 (1.07 1.12),1.68E-09
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.09 (1.06 1.12),3.41E-09
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003058,0.022,Metabolon,sphingomyelin (d18:1/17:0. d17:1/18:0. d19:1/16:0),1.08 (1.05 1.10),2.09E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.08 (1.05 1.11),2.17E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.07 (1.04 1.09),4.15E-05
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.06 (1.04 1.09),2.23E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002878,0.060,Metabolon,1-stearoyl-GPE (18:0),1.06 (1.03 1.09),7.29E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002943,0.043,Metabolon,2-palmitoyl-GPE (16:0)*,1.06 (1.03 1.09),7.63E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002802,0.092,Metabolon,1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6)*,1.06 (1.03 1.09),7.63E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002891,0.056,Metabolon,1-palmitoyl-2-oleoyl-GPE (16:0/18:1),1.06 (1.03 1.08),2.07E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002874,0.060,Metabolon,campesterol,1.06 (1.03 1.08),2.25E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002860,0.066,Metabolon,1-palmitoyl-GPE (16:0),1.05 (1.03 1.08),6.91E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002751,0.145,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)*,1.05 (1.02 1.08),1.03E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002850,0.070,Metabolon,1-stearoyl-2-linoleoyl-GPE (18:0/18:2)*,1.05 (1.02 1.08),1.05E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.05 (1.02 1.08),1.74E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003000,0.031,Metabolon,1-stearoyl-2-oleoyl-GPE (18:0/18:1),1.05 (1.02 1.07),2.22E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002789,0.102,Metabolon,1-palmitoyl-2-linoleoyl-GPE (16:0/18:2),1.05 (1.02 1.07),2.97E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002988,0.033,Metabolon,2-stearoyl-GPE (18:0)*,1.05 (1.02 1.07),3.30E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS002921,0.047,Metabolon,1-oleoyl-2-linoleoyl-GPE (18:1/18:2)*,1.04 (1.02 1.07),4.22E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003217,0.011,Metabolon,X - 24024,1.04 (1.02 1.07),4.76E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.18 (1.15 1.21),6.25E-31
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.16 (1.13 1.19),4.30E-26
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.16 (1.13 1.19),7.62E-25
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.16 (1.13 1.19),1.46E-24
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.16 (1.13 1.19),1.46E-24
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.16 (1.13 1.19),1.76E-24
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.15 (1.12 1.18),2.43E-24
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.15 (1.12 1.18),2.61E-24
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.15 (1.12 1.18),3.11E-24
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.15 (1.12 1.18),5.68E-24
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.15 (1.12 1.18),6.45E-24
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.15 (1.12 1.18),7.86E-24
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.15 (1.12 1.18),7.86E-24
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.15 (1.12 1.18),8.64E-24
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.15 (1.12 1.18),9.69E-24
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.15 (1.12 1.18),9.69E-24
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.15 (1.12 1.18),1.18E-23
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.15 (1.12 1.18),1.28E-23
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.15 (1.12 1.18),2.13E-23
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.15 (1.12 1.18),3.28E-23
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.15 (1.12 1.18),3.48E-23
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.15 (1.12 1.18),3.92E-23
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.15 (1.12 1.18),5.04E-23
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.15 (1.12 1.18),8.70E-23
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.15 (1.12 1.18),8.70E-23
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.15 (1.12 1.18),1.05E-22
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.15 (1.12 1.18),1.10E-22
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.15 (1.12 1.18),1.93E-22
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.15 (1.12 1.18),1.98E-22
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.14 (1.11 1.17),2.64E-22
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.14 (1.11 1.17),3.55E-22
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.14 (1.11 1.17),3.59E-22
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.14 (1.11 1.17),1.98E-21
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.15 (1.12 1.18),1.99E-21
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.14 (1.11 1.17),3.75E-21
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.14 (1.11 1.16),5.27E-21
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.14 (1.11 1.17),4.48E-20
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.13 (1.10 1.16),3.59E-19
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.13 (1.10 1.16),3.59E-19
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.13 (1.10 1.16),5.27E-19
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.12 (1.09 1.15),1.26E-16
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.12 (1.09 1.14),1.26E-14
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.11 (1.08 1.14),1.70E-13
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.11 (1.08 1.14),1.95E-13
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.11 (1.08 1.13),1.43E-12
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.10 (1.07 1.12),1.40E-10
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.09 (1.07 1.12),4.54E-10
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003527,0.050,Nightingale,Sphingomyelins,1.10 (1.07 1.12),4.71E-10
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003497,0.072,Nightingale,Linoleic acid,1.09 (1.07 1.12),6.59E-10
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,0.92 (0.90 0.94),4.34E-09
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.09 (1.06 1.12),7.83E-09
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.09 (1.06 1.12),1.08E-08
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.09 (1.06 1.12),1.14E-08
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003487,0.074,Nightingale,Phospholipids in chylomicrons and extremely large VLDL,0.92 (0.90 0.94),1.71E-08
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003509,0.069,Nightingale,Free cholesterol in chylomicrons and extremely large VLDL,0.92 (0.90 0.94),1.71E-08
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.09 (1.06 1.11),1.96E-08
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,0.92 (0.90 0.94),2.04E-08
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003491,0.073,Nightingale,Total lipids in chylomicrons and extremely large VLDL,0.92 (0.90 0.94),2.98E-08
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003510,0.068,Nightingale,Cholesterol in chylomicrons and extremely large VLDL,0.93 (0.91 0.95),1.67E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003528,0.050,Nightingale,Total cholines,1.08 (1.05 1.10),2.30E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.93 (0.91 0.95),2.42E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003462,0.083,Nightingale,Average diameter for VLDL particles,0.93 (0.91 0.95),2.50E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003523,0.062,Nightingale,Total fatty acids,1.08 (1.05 1.10),2.56E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003516,0.066,Nightingale,Phospholipids in very large VLDL,0.93 (0.91 0.95),2.98E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.93 (0.91 0.95),3.47E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.93 (0.91 0.96),5.39E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003502,0.070,Nightingale,Concentration of very large VLDL particles,0.93 (0.91 0.96),5.57E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003513,0.067,Nightingale,Free cholesterol in very large VLDL,0.93 (0.91 0.96),5.60E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003496,0.072,Nightingale,Cholesteryl esters in very large VLDL,0.93 (0.91 0.96),7.64E-06
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003504,0.070,Nightingale,Triglycerides in very large VLDL,0.93 (0.91 0.96),1.24E-05
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003500,0.071,Nightingale,Total lipids in very large VLDL,0.93 (0.91 0.96),1.24E-05
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003506,0.070,Nightingale,Cholesterol in very large VLDL,0.93 (0.91 0.96),1.57E-05
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.93 (0.91 0.96),1.95E-05
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.07 (1.04 1.10),2.79E-05
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.07 (1.04 1.10),2.82E-05
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.07 (1.04 1.10),2.86E-05
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.94 (0.91 0.96),4.79E-05
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003520,0.062,Nightingale,HDL cholesterol,0.94 (0.91 0.96),6.10E-05
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.07 (1.04 1.09),6.74E-05
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.07 (1.04 1.09),1.04E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.94 (0.92 0.96),1.45E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.94 (0.92 0.96),1.46E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.94 (0.92 0.96),2.29E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.94 (0.92 0.97),2.70E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.94 (0.92 0.97),7.28E-04
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,0.95 (0.92 0.97),2.07E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.05 (1.03 1.08),4.62E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.95 (0.93 0.97),5.60E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003526,0.050,Nightingale,Phosphatidylcholines,1.05 (1.02 1.08),1.29E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003445,0.100,Nightingale,Glycine,0.95 (0.93 0.98),2.87E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003483,0.075,Nightingale,Cholesterol in large VLDL,0.96 (0.93 0.98),4.74E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003542,0.028,Nightingale,Phospholipids in medium HDL,0.96 (0.93 0.98),4.86E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS006535,0.174,RNAseq,PSRC1,0.95 (0.92 0.97),1.48E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS006621,0.169,RNAseq,NME7,0.95 (0.92 0.97),1.65E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS004382,0.374,RNAseq,FES,0.95 (0.93 0.97),3.38E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS005858,0.211,RNAseq,GGCX,1.05 (1.03 1.08),4.62E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS004862,0.303,RNAseq,SPOCD1,1.05 (1.03 1.08),6.54E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS012284,0.038,RNAseq,AC011446.1,1.05 (1.03 1.08),7.58E-03
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS011593,0.046,RNAseq,TUFT1,1.05 (1.02 1.08),1.08E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS005501,0.238,RNAseq,C2CD2L,1.05 (1.02 1.08),1.29E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS003660,0.627,RNAseq,SENP6,1.05 (1.02 1.08),1.29E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS013276,0.028,RNAseq,ZNF346,1.05 (1.02 1.07),1.33E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS010625,0.059,RNAseq,TBC1D22A,1.05 (1.02 1.08),1.74E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS004929,0.295,RNAseq,OTX1,1.05 (1.02 1.07),1.85E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS013409,0.027,RNAseq,MTAP,1.05 (1.02 1.07),2.16E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS012674,0.034,RNAseq,MYD88,0.95 (0.93 0.98),2.16E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS013199,0.029,RNAseq,ACP1,0.95 (0.93 0.98),2.20E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS007798,0.122,RNAseq,ARCN1,1.05 (1.02 1.08),2.21E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS014718,0.017,RNAseq,MRC2,1.05 (1.02 1.08),2.36E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS005687,0.222,RNAseq,CTSK,0.95 (0.93 0.98),2.67E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS014044,0.022,RNAseq,KCND3,0.95 (0.93 0.98),2.88E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS009375,0.082,RNAseq,OPLAH,1.05 (1.02 1.07),3.04E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS011739,0.044,RNAseq,DHX36,0.96 (0.93 0.98),3.38E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS012109,0.040,RNAseq,POLRMT,1.05 (1.02 1.07),3.39E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS011232,0.050,RNAseq,AL589765.4,1.05 (1.02 1.07),3.42E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS012772,0.033,RNAseq,GIGYF2,1.05 (1.02 1.07),3.45E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS015052,0.015,RNAseq,CISH,0.96 (0.93 0.98),3.45E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS004706,0.323,RNAseq,AC011462.5,1.05 (1.02 1.07),3.45E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS007508,0.132,RNAseq,ALDH2,0.96 (0.93 0.98),4.22E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS009164,0.086,RNAseq,SLC37A1,1.04 (1.02 1.07),4.22E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS013512,0.026,RNAseq,VPS26C,1.05 (1.02 1.08),4.22E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS010657,0.059,RNAseq,HMG20A,1.04 (1.02 1.07),4.34E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS013393,0.027,RNAseq,BTBD19,0.96 (0.94 0.98),4.69E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS008683,0.097,RNAseq,ARMT1,0.96 (0.93 0.98),4.76E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS009492,0.079,RNAseq,LINC00189,0.96 (0.93 0.98),4.80E-02
411.1,Unstable angina (intermediate coronary syndrome),circulatory system,OPGS007745,0.124,RNAseq,AMDHD2,1.04 (1.02 1.07),4.84E-02
411.2,Myocardial infarction,circulatory system,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.08 (1.07 1.10),2.19E-24
411.2,Myocardial infarction,circulatory system,OPGS000115,0.347,SomaScan,Protein CEI,1.08 (1.07 1.10),3.89E-24
411.2,Myocardial infarction,circulatory system,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.08 (1.06 1.10),7.27E-24
411.2,Myocardial infarction,circulatory system,OPGS000312,0.163,SomaScan,Selenoprotein S,1.08 (1.07 1.10),8.09E-23
411.2,Myocardial infarction,circulatory system,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.08 (1.06 1.09),9.82E-23
411.2,Myocardial infarction,circulatory system,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.07 (1.06 1.09),8.75E-21
411.2,Myocardial infarction,circulatory system,OPGS000857,0.067,SomaScan,Moesin,1.07 (1.06 1.09),2.03E-20
411.2,Myocardial infarction,circulatory system,OPGS000613,0.096,SomaScan,Stromelysin-1,1.08 (1.06 1.09),2.62E-20
411.2,Myocardial infarction,circulatory system,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.08 (1.06 1.09),3.77E-19
411.2,Myocardial infarction,circulatory system,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.07 (1.06 1.09),5.54E-19
411.2,Myocardial infarction,circulatory system,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.07 (1.05 1.08),8.19E-19
411.2,Myocardial infarction,circulatory system,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.07 (1.06 1.09),1.25E-18
411.2,Myocardial infarction,circulatory system,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.07 (1.05 1.08),1.35E-16
411.2,Myocardial infarction,circulatory system,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.06 (1.05 1.08),2.32E-16
411.2,Myocardial infarction,circulatory system,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.07 (1.05 1.08),9.22E-16
411.2,Myocardial infarction,circulatory system,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.94 (0.92 0.95),1.29E-15
411.2,Myocardial infarction,circulatory system,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.06 (1.05 1.08),3.15E-15
411.2,Myocardial infarction,circulatory system,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.06 (1.05 1.07),1.83E-14
411.2,Myocardial infarction,circulatory system,OPGS001297,0.034,SomaScan,Neogenin,0.94 (0.93 0.95),2.23E-14
411.2,Myocardial infarction,circulatory system,OPGS002108,0.012,SomaScan,Neuralized-like protein 4,1.06 (1.05 1.08),8.90E-14
411.2,Myocardial infarction,circulatory system,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.06 (1.05 1.08),1.26E-13
411.2,Myocardial infarction,circulatory system,OPGS000285,0.176,SomaScan,Complement C1q tumor necrosis factor-related protein 1,1.06 (1.05 1.08),1.62E-13
411.2,Myocardial infarction,circulatory system,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.06 (1.04 1.08),3.68E-13
411.2,Myocardial infarction,circulatory system,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.06 (1.04 1.07),3.92E-13
411.2,Myocardial infarction,circulatory system,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.06 (1.05 1.08),4.65E-13
411.2,Myocardial infarction,circulatory system,OPGS000172,0.257,SomaScan,Dermokine,0.94 (0.93 0.96),7.34E-13
411.2,Myocardial infarction,circulatory system,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,0.94 (0.93 0.96),7.42E-13
411.2,Myocardial infarction,circulatory system,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.06 (1.04 1.07),1.05E-12
411.2,Myocardial infarction,circulatory system,OPGS000883,0.064,SomaScan,Group XIIB secretory phospholipase A2-like protein,1.06 (1.04 1.07),4.43E-12
411.2,Myocardial infarction,circulatory system,OPGS000860,0.066,SomaScan,Cell surface glycoprotein CD200 receptor 2,0.94 (0.93 0.96),5.91E-12
411.2,Myocardial infarction,circulatory system,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.95 (0.93 0.96),8.27E-12
411.2,Myocardial infarction,circulatory system,OPGS001392,0.029,SomaScan,Cadherin-related family member 5,1.06 (1.04 1.08),9.90E-12
411.2,Myocardial infarction,circulatory system,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.05 (1.04 1.07),1.29E-11
411.2,Myocardial infarction,circulatory system,OPGS000445,0.129,SomaScan,Collectin-10,0.95 (0.93 0.96),3.23E-11
411.2,Myocardial infarction,circulatory system,OPGS000510,0.115,SomaScan,Guanine nucleotide-binding protein G(k) subunit alpha,0.95 (0.93 0.96),4.11E-11
411.2,Myocardial infarction,circulatory system,OPGS000154,0.277,SomaScan,Granulins,1.05 (1.04 1.07),5.19E-11
411.2,Myocardial infarction,circulatory system,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,0.95 (0.93 0.96),8.14E-11
411.2,Myocardial infarction,circulatory system,OPGS001715,0.019,SomaScan,Histone deacetylase 8,1.05 (1.04 1.07),1.46E-10
411.2,Myocardial infarction,circulatory system,OPGS001279,0.035,SomaScan,Four-jointed box protein 1,1.05 (1.04 1.07),1.70E-10
411.2,Myocardial infarction,circulatory system,OPGS000348,0.151,SomaScan,Quinone oxidoreductase-like protein 1,1.05 (1.04 1.07),2.16E-10
411.2,Myocardial infarction,circulatory system,OPGS000577,0.102,SomaScan,Platelet-activating factor acetylhydrolase,1.05 (1.04 1.07),4.27E-10
411.2,Myocardial infarction,circulatory system,OPGS001058,0.049,SomaScan,Protocadherin beta-10,1.05 (1.04 1.07),5.86E-10
411.2,Myocardial infarction,circulatory system,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,0.95 (0.94 0.96),5.97E-10
411.2,Myocardial infarction,circulatory system,OPGS001377,0.030,SomaScan,Vascular cell adhesion protein 1,1.05 (1.04 1.07),1.02E-09
411.2,Myocardial infarction,circulatory system,OPGS001963,0.013,SomaScan,Annexin A9,1.05 (1.04 1.07),1.47E-09
411.2,Myocardial infarction,circulatory system,OPGS001093,0.046,SomaScan,C-reactive protein,0.95 (0.94 0.97),3.61E-09
411.2,Myocardial infarction,circulatory system,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.05 (1.04 1.07),4.08E-09
411.2,Myocardial infarction,circulatory system,OPGS000492,0.119,SomaScan,Inactive gamma-glutamyltranspeptidase 2,1.05 (1.04 1.07),4.36E-09
411.2,Myocardial infarction,circulatory system,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.05 (1.03 1.07),4.42E-09
411.2,Myocardial infarction,circulatory system,OPGS000838,0.069,SomaScan,DNA/RNA-binding protein KIN17,0.95 (0.94 0.97),5.09E-09
411.2,Myocardial infarction,circulatory system,OPGS001464,0.027,SomaScan,Platelet glycoprotein Ib alpha chain,1.05 (1.03 1.06),7.32E-08
411.2,Myocardial infarction,circulatory system,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.05 (1.03 1.06),9.46E-08
411.2,Myocardial infarction,circulatory system,OPGS001144,0.043,SomaScan,Proprotein convertase subtilisin/kexin type 9,1.05 (1.03 1.06),1.94E-07
411.2,Myocardial infarction,circulatory system,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.96 (0.94 0.97),2.50E-07
411.2,Myocardial infarction,circulatory system,OPGS001437,0.028,SomaScan,Steroidogenic acute regulatory protein. mitochondrial,1.05 (1.03 1.06),2.50E-07
411.2,Myocardial infarction,circulatory system,OPGS001112,0.045,SomaScan,Hemojuvelin,1.04 (1.03 1.06),4.49E-07
411.2,Myocardial infarction,circulatory system,OPGS001002,0.053,SomaScan,Tumor protein p53-inducible protein 11,1.04 (1.03 1.06),5.15E-07
411.2,Myocardial infarction,circulatory system,OPGS000874,0.065,SomaScan,Carbonic anhydrase-related protein 10,1.04 (1.03 1.06),1.79E-06
411.2,Myocardial infarction,circulatory system,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.04 (1.03 1.06),1.94E-06
411.2,Myocardial infarction,circulatory system,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.04 (1.03 1.06),1.94E-06
411.2,Myocardial infarction,circulatory system,OPGS002321,0.010,SomaScan,Fibronectin Fragment 3,0.96 (0.95 0.97),2.70E-06
411.2,Myocardial infarction,circulatory system,OPGS002093,0.012,SomaScan,Fibronectin,0.96 (0.95 0.97),2.70E-06
411.2,Myocardial infarction,circulatory system,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.04 (1.03 1.05),3.81E-06
411.2,Myocardial infarction,circulatory system,OPGS000401,0.139,SomaScan,Hemoglobin subunit theta-1,1.04 (1.03 1.06),4.73E-06
411.2,Myocardial infarction,circulatory system,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.04 (1.03 1.06),6.20E-06
411.2,Myocardial infarction,circulatory system,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.04 (1.02 1.05),1.02E-05
411.2,Myocardial infarction,circulatory system,OPGS000715,0.082,SomaScan,Surfeit locus protein 1,1.04 (1.02 1.05),7.58E-05
411.2,Myocardial infarction,circulatory system,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.04 (1.02 1.05),8.63E-05
411.2,Myocardial infarction,circulatory system,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,0.96 (0.95 0.98),9.93E-05
411.2,Myocardial infarction,circulatory system,OPGS002186,0.011,SomaScan,Suprabasin,0.96 (0.95 0.98),1.11E-04
411.2,Myocardial infarction,circulatory system,OPGS001879,0.015,SomaScan,Arfaptin-2,1.04 (1.02 1.06),1.11E-04
411.2,Myocardial infarction,circulatory system,OPGS000717,0.082,SomaScan,Zinc finger protein 175,0.96 (0.95 0.98),1.20E-04
411.2,Myocardial infarction,circulatory system,OPGS001252,0.036,SomaScan,Neuronal pentraxin-2,1.03 (1.02 1.05),2.08E-04
411.2,Myocardial infarction,circulatory system,OPGS001977,0.013,SomaScan,C-C motif chemokine 4-like,1.03 (1.02 1.05),2.46E-04
411.2,Myocardial infarction,circulatory system,OPGS000159,0.271,SomaScan,39S ribosomal protein L33. mitochondrial,0.97 (0.95 0.98),2.54E-04
411.2,Myocardial infarction,circulatory system,OPGS000022,0.602,SomaScan,Interleukin-6 receptor subunit alpha,0.97 (0.95 0.98),3.51E-04
411.2,Myocardial infarction,circulatory system,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.03 (1.02 1.05),3.67E-04
411.2,Myocardial infarction,circulatory system,OPGS001121,0.044,SomaScan,Growth factor receptor-bound protein 7,0.97 (0.95 0.98),3.86E-04
411.2,Myocardial infarction,circulatory system,OPGS000020,0.609,SomaScan,Interleukin-6 receptor subunit alpha,0.97 (0.95 0.98),4.02E-04
411.2,Myocardial infarction,circulatory system,OPGS000911,0.062,SomaScan,Protein MENT,1.03 (1.02 1.05),4.45E-04
411.2,Myocardial infarction,circulatory system,OPGS000088,0.392,SomaScan,E-selectin,0.97 (0.96 0.98),6.12E-04
411.2,Myocardial infarction,circulatory system,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.97 (0.96 0.98),6.70E-04
411.2,Myocardial infarction,circulatory system,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,0.97 (0.95 0.98),7.18E-04
411.2,Myocardial infarction,circulatory system,OPGS000951,0.057,SomaScan,Pseudokinase FAM20A,0.97 (0.96 0.98),7.69E-04
411.2,Myocardial infarction,circulatory system,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,1.03 (1.02 1.05),1.06E-03
411.2,Myocardial infarction,circulatory system,OPGS000095,0.381,SomaScan,Sulfhydryl oxidase 2,1.03 (1.02 1.05),1.16E-03
411.2,Myocardial infarction,circulatory system,OPGS001041,0.050,SomaScan,RING finger protein 122,1.03 (1.02 1.05),2.03E-03
411.2,Myocardial infarction,circulatory system,OPGS001365,0.030,SomaScan,Leukocyte cell-derived chemotaxin 1,0.97 (0.96 0.98),2.07E-03
411.2,Myocardial infarction,circulatory system,OPGS001617,0.022,SomaScan,Nutritionally-regulated adipose and cardiac enriched protein homolog,1.03 (1.02 1.04),2.90E-03
411.2,Myocardial infarction,circulatory system,OPGS000101,0.374,SomaScan,CD209 antigen,1.03 (1.01 1.04),3.10E-03
411.2,Myocardial infarction,circulatory system,OPGS001102,0.046,SomaScan,Granzyme A,1.03 (1.01 1.04),3.64E-03
411.2,Myocardial infarction,circulatory system,OPGS000600,0.099,SomaScan,Insulin receptor,0.97 (0.96 0.99),3.68E-03
411.2,Myocardial infarction,circulatory system,OPGS001658,0.020,SomaScan,Endoglin,0.97 (0.96 0.99),3.68E-03
411.2,Myocardial infarction,circulatory system,OPGS001106,0.046,SomaScan,Disintegrin and metalloproteinase domain-containing protein 11,1.03 (1.01 1.04),3.98E-03
411.2,Myocardial infarction,circulatory system,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.03 (1.01 1.04),4.54E-03
411.2,Myocardial infarction,circulatory system,OPGS001238,0.037,SomaScan,Dedicator of cytokinesis protein 9,1.03 (1.01 1.04),4.75E-03
411.2,Myocardial infarction,circulatory system,OPGS000698,0.085,SomaScan,Alcohol dehydrogenase 1B,1.03 (1.01 1.04),4.75E-03
411.2,Myocardial infarction,circulatory system,OPGS001491,0.026,SomaScan,Platelet-derived growth factor subunit B,1.03 (1.01 1.04),4.75E-03
411.2,Myocardial infarction,circulatory system,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.97 (0.96 0.99),4.83E-03
411.2,Myocardial infarction,circulatory system,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,0.97 (0.96 0.99),5.98E-03
411.2,Myocardial infarction,circulatory system,OPGS000351,0.151,SomaScan,C1GALT1-specific chaperone 1,1.03 (1.01 1.04),6.43E-03
411.2,Myocardial infarction,circulatory system,OPGS001954,0.014,SomaScan,Tuftelin,0.97 (0.96 0.99),6.66E-03
411.2,Myocardial infarction,circulatory system,OPGS001045,0.050,SomaScan,Carbohydrate sulfotransferase 15,0.97 (0.96 0.99),7.62E-03
411.2,Myocardial infarction,circulatory system,OPGS001398,0.029,SomaScan,Nephronectin,0.97 (0.96 0.99),9.20E-03
411.2,Myocardial infarction,circulatory system,OPGS001127,0.044,SomaScan,Carbohydrate sulfotransferase 15,0.97 (0.96 0.99),9.68E-03
411.2,Myocardial infarction,circulatory system,OPGS000923,0.060,SomaScan,Thrombospondin type-1 domain-containing protein 1,0.97 (0.96 0.99),1.02E-02
411.2,Myocardial infarction,circulatory system,OPGS000521,0.113,SomaScan,Transmembrane protease serine 11D,1.03 (1.01 1.04),1.32E-02
411.2,Myocardial infarction,circulatory system,OPGS002046,0.012,SomaScan,Set1/Ash2 histone methyltransferase complex subunit ASH2,1.03 (1.01 1.04),1.34E-02
411.2,Myocardial infarction,circulatory system,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.97 (0.96 0.99),1.37E-02
411.2,Myocardial infarction,circulatory system,OPGS000346,0.151,SomaScan,N-acetyllactosaminide beta-1.3-N-acetylglucosaminyltransferase 2,1.03 (1.01 1.04),1.46E-02
411.2,Myocardial infarction,circulatory system,OPGS000632,0.093,SomaScan,Erythrocyte band 7 integral membrane protein,1.03 (1.01 1.04),1.54E-02
411.2,Myocardial infarction,circulatory system,OPGS000671,0.088,SomaScan,Carbohydrate sulfotransferase 11,1.03 (1.01 1.04),2.14E-02
411.2,Myocardial infarction,circulatory system,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,0.98 (0.96 0.99),2.37E-02
411.2,Myocardial infarction,circulatory system,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.03 (1.01 1.04),2.57E-02
411.2,Myocardial infarction,circulatory system,OPGS000626,0.094,SomaScan,CMRF35-like molecule 8,0.98 (0.96 0.99),2.91E-02
411.2,Myocardial infarction,circulatory system,OPGS000544,0.108,SomaScan,Segment polarity protein dishevelled homolog DVL-2,1.03 (1.01 1.04),2.94E-02
411.2,Myocardial infarction,circulatory system,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.98 (0.96 0.99),2.94E-02
411.2,Myocardial infarction,circulatory system,OPGS002270,0.010,SomaScan,Tumor necrosis factor receptor superfamily member 21,0.97 (0.96 0.99),2.96E-02
411.2,Myocardial infarction,circulatory system,OPGS002292,0.010,SomaScan,Interleukin-18-binding protein,0.97 (0.96 0.99),2.96E-02
411.2,Myocardial infarction,circulatory system,OPGS001809,0.017,SomaScan,PILR alpha-associated neural protein,1.02 (1.01 1.04),2.96E-02
411.2,Myocardial infarction,circulatory system,OPGS002204,0.011,SomaScan,Rho-related GTP-binding protein RhoG,1.02 (1.01 1.04),3.26E-02
411.2,Myocardial infarction,circulatory system,OPGS001915,0.014,SomaScan,N-acetylglucosamine-6-sulfatase,0.98 (0.96 0.99),3.31E-02
411.2,Myocardial infarction,circulatory system,OPGS000713,0.082,SomaScan,Metalloproteinase inhibitor 4,0.98 (0.96 0.99),3.39E-02
411.2,Myocardial infarction,circulatory system,OPGS001652,0.021,SomaScan,Galectin-7,1.02 (1.01 1.04),3.39E-02
411.2,Myocardial infarction,circulatory system,OPGS000155,0.275,SomaScan,Interleukin-3 receptor subunit alpha,0.98 (0.96 0.99),3.40E-02
411.2,Myocardial infarction,circulatory system,OPGS001671,0.020,SomaScan,Tumor necrosis factor ligand superfamily member 6. soluble form,0.98 (0.96 0.99),3.55E-02
411.2,Myocardial infarction,circulatory system,OPGS001817,0.017,SomaScan,PILR alpha-associated neural protein,1.02 (1.01 1.04),3.70E-02
411.2,Myocardial infarction,circulatory system,OPGS001928,0.014,SomaScan,Sorting nexin-1,1.02 (1.01 1.04),3.71E-02
411.2,Myocardial infarction,circulatory system,OPGS000417,0.135,SomaScan,UDP-GlcNAc:betaGal beta-1.3-N-acetylglucosaminyltransferase 8,0.98 (0.96 0.99),4.06E-02
411.2,Myocardial infarction,circulatory system,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.98 (0.96 0.99),4.06E-02
411.2,Myocardial infarction,circulatory system,OPGS000270,0.184,SomaScan,Suppressor of cytokine signaling 3,1.02 (1.01 1.04),4.41E-02
411.2,Myocardial infarction,circulatory system,OPGS002585,0.037,Olink,T-cell surface glycoprotein CD5,1.06 (1.04 1.07),1.70E-11
411.2,Myocardial infarction,circulatory system,OPGS002436,0.191,Olink,Progranulin,1.05 (1.04 1.07),1.51E-09
411.2,Myocardial infarction,circulatory system,OPGS002558,0.048,Olink,Proprotein convertase subtilisin/kexin type 9,1.04 (1.02 1.05),1.06E-05
411.2,Myocardial infarction,circulatory system,OPGS002629,0.023,Olink,Interleukin-18-binding protein,1.04 (1.02 1.05),2.43E-05
411.2,Myocardial infarction,circulatory system,OPGS002552,0.053,Olink,Low-density lipoprotein receptor,0.96 (0.95 0.98),6.12E-05
411.2,Myocardial infarction,circulatory system,OPGS002608,0.028,Olink,Integrin beta-2,1.04 (1.02 1.05),1.11E-04
411.2,Myocardial infarction,circulatory system,OPGS002656,0.013,Olink,Angiotensin-converting enzyme 2,0.97 (0.95 0.98),1.76E-04
411.2,Myocardial infarction,circulatory system,OPGS002387,0.541,Olink,Interleukin-6 receptor subunit alpha,0.97 (0.95 0.98),2.26E-04
411.2,Myocardial infarction,circulatory system,OPGS002396,0.361,Olink,Tumor necrosis factor receptor superfamily member 10C,0.97 (0.95 0.98),2.42E-04
411.2,Myocardial infarction,circulatory system,OPGS002391,0.469,Olink,CMRF35-like molecule 1,0.97 (0.95 0.98),3.75E-04
411.2,Myocardial infarction,circulatory system,OPGS002408,0.270,Olink,E-selectin,0.97 (0.95 0.98),3.88E-04
411.2,Myocardial infarction,circulatory system,OPGS002651,0.015,Olink,von Willebrand factor,1.03 (1.02 1.05),4.08E-04
411.2,Myocardial infarction,circulatory system,OPGS002613,0.027,Olink,Interleukin-6,0.97 (0.95 0.98),5.86E-04
411.2,Myocardial infarction,circulatory system,OPGS002482,0.125,Olink,Tumor necrosis factor ligand superfamily member 10,0.97 (0.95 0.98),7.12E-04
411.2,Myocardial infarction,circulatory system,OPGS002663,0.011,Olink,C-type lectin domain family 1 member B,1.03 (1.02 1.05),1.25E-03
411.2,Myocardial infarction,circulatory system,OPGS002617,0.026,Olink,C-X-C motif chemokine 9,1.03 (1.02 1.05),1.51E-03
411.2,Myocardial infarction,circulatory system,OPGS002653,0.015,Olink,CD40 ligand,1.03 (1.02 1.05),1.96E-03
411.2,Myocardial infarction,circulatory system,OPGS002435,0.193,Olink,Fibroblast growth factor 5,1.03 (1.02 1.04),2.52E-03
411.2,Myocardial infarction,circulatory system,OPGS002633,0.021,Olink,C-X-C motif chemokine 11,1.03 (1.02 1.04),3.22E-03
411.2,Myocardial infarction,circulatory system,OPGS002500,0.098,Olink,Galectin-4,0.97 (0.96 0.99),3.29E-03
411.2,Myocardial infarction,circulatory system,OPGS002660,0.012,Olink,Angiopoietin-1,1.03 (1.01 1.04),4.75E-03
411.2,Myocardial infarction,circulatory system,OPGS002661,0.011,Olink,Platelet-derived growth factor subunit A,1.03 (1.01 1.04),7.55E-03
411.2,Myocardial infarction,circulatory system,OPGS002649,0.016,Olink,Platelet-derived growth factor subunit B,1.03 (1.01 1.04),1.16E-02
411.2,Myocardial infarction,circulatory system,OPGS002458,0.151,Olink,Cobalamin binding intrinsic factor,0.97 (0.96 0.99),1.99E-02
411.2,Myocardial infarction,circulatory system,OPGS002474,0.135,Olink,C-C motif chemokine 4,1.03 (1.01 1.04),2.09E-02
411.2,Myocardial infarction,circulatory system,OPGS002420,0.225,Olink,Interleukin-12 subunit beta,1.03 (1.01 1.04),2.24E-02
411.2,Myocardial infarction,circulatory system,OPGS002542,0.061,Olink,C-X-C motif chemokine 10,1.02 (1.01 1.04),2.40E-02
411.2,Myocardial infarction,circulatory system,OPGS002446,0.174,Olink,Lymphotactin,1.03 (1.01 1.04),2.45E-02
411.2,Myocardial infarction,circulatory system,OPGS002602,0.030,Olink,Fatty acid-binding protein. intestinal,0.98 (0.96 0.99),2.89E-02
411.2,Myocardial infarction,circulatory system,OPGS002540,0.062,Olink,Plexin-B1,0.98 (0.96 0.99),3.43E-02
411.2,Myocardial infarction,circulatory system,OPGS002395,0.362,Olink,Intercellular adhesion molecule 2,0.98 (0.96 0.99),4.31E-02
411.2,Myocardial infarction,circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.11 (1.10 1.13),8.04E-45
411.2,Myocardial infarction,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.11 (1.09 1.12),4.00E-38
411.2,Myocardial infarction,circulatory system,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.09 (1.08 1.11),1.31E-28
411.2,Myocardial infarction,circulatory system,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.08 (1.06 1.09),4.81E-24
411.2,Myocardial infarction,circulatory system,OPGS003058,0.022,Metabolon,sphingomyelin (d18:1/17:0. d17:1/18:0. d19:1/16:0),1.07 (1.05 1.08),2.48E-16
411.2,Myocardial infarction,circulatory system,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.06 (1.04 1.07),1.87E-10
411.2,Myocardial infarction,circulatory system,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.05 (1.04 1.07),3.82E-10
411.2,Myocardial infarction,circulatory system,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.05 (1.03 1.06),2.00E-08
411.2,Myocardial infarction,circulatory system,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.05 (1.03 1.06),2.56E-08
411.2,Myocardial infarction,circulatory system,OPGS002951,0.041,Metabolon,stearoyl sphingomyelin (d18:1/18:0),1.05 (1.03 1.06),9.18E-08
411.2,Myocardial infarction,circulatory system,OPGS002802,0.092,Metabolon,1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6)*,1.04 (1.02 1.05),8.04E-06
411.2,Myocardial infarction,circulatory system,OPGS002874,0.060,Metabolon,campesterol,1.04 (1.02 1.05),1.10E-05
411.2,Myocardial infarction,circulatory system,OPGS002878,0.060,Metabolon,1-stearoyl-GPE (18:0),1.04 (1.02 1.05),1.56E-05
411.2,Myocardial infarction,circulatory system,OPGS002770,0.124,Metabolon,1-stearoyl-2-arachidonoyl-GPE (18:0/20:4),1.04 (1.02 1.05),2.72E-05
411.2,Myocardial infarction,circulatory system,OPGS003000,0.031,Metabolon,1-stearoyl-2-oleoyl-GPE (18:0/18:1),1.04 (1.02 1.05),3.27E-05
411.2,Myocardial infarction,circulatory system,OPGS002943,0.043,Metabolon,2-palmitoyl-GPE (16:0)*,1.04 (1.02 1.05),5.51E-05
411.2,Myocardial infarction,circulatory system,OPGS002860,0.066,Metabolon,1-palmitoyl-GPE (16:0),1.04 (1.02 1.05),5.95E-05
411.2,Myocardial infarction,circulatory system,OPGS002756,0.139,Metabolon,1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)*,1.04 (1.02 1.05),8.07E-05
411.2,Myocardial infarction,circulatory system,OPGS002751,0.145,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)*,1.04 (1.02 1.05),9.21E-05
411.2,Myocardial infarction,circulatory system,OPGS002891,0.056,Metabolon,1-palmitoyl-2-oleoyl-GPE (16:0/18:1),1.03 (1.02 1.05),2.09E-04
411.2,Myocardial infarction,circulatory system,OPGS002922,0.047,Metabolon,stearoylcarnitine,1.03 (1.02 1.05),3.27E-04
411.2,Myocardial infarction,circulatory system,OPGS003203,0.012,Metabolon,sphingomyelin (d18:2/23:0. d18:1/23:1. d17:1/24:1)*,1.03 (1.02 1.05),3.67E-04
411.2,Myocardial infarction,circulatory system,OPGS002988,0.033,Metabolon,2-stearoyl-GPE (18:0)*,1.03 (1.02 1.05),4.25E-04
411.2,Myocardial infarction,circulatory system,OPGS002842,0.073,Metabolon,glycosyl-N-palmitoyl-sphingosine,1.03 (1.02 1.05),1.03E-03
411.2,Myocardial infarction,circulatory system,OPGS002912,0.049,Metabolon,oleoylcarnitine,1.03 (1.02 1.05),1.51E-03
411.2,Myocardial infarction,circulatory system,OPGS002910,0.049,Metabolon,X - 24422,0.97 (0.96 0.98),1.90E-03
411.2,Myocardial infarction,circulatory system,OPGS002964,0.037,Metabolon,1-docosahexaenoyl-GPE (22:6)*,1.03 (1.02 1.05),2.14E-03
411.2,Myocardial infarction,circulatory system,OPGS002940,0.044,Metabolon,lactosyl-N-palmitoyl-sphingosine,1.03 (1.02 1.05),2.45E-03
411.2,Myocardial infarction,circulatory system,OPGS003008,0.030,Metabolon,quinolinate,1.03 (1.02 1.05),2.54E-03
411.2,Myocardial infarction,circulatory system,OPGS002978,0.034,Metabolon,myristoylcarnitine,1.03 (1.02 1.04),3.19E-03
411.2,Myocardial infarction,circulatory system,OPGS002918,0.048,Metabolon,palmitoylcarnitine,1.03 (1.01 1.04),4.42E-03
411.2,Myocardial infarction,circulatory system,OPGS002885,0.057,Metabolon,linoleoylcarnitine*,1.03 (1.01 1.04),4.81E-03
411.2,Myocardial infarction,circulatory system,OPGS003149,0.015,Metabolon,sphingosine,1.03 (1.01 1.04),8.88E-03
411.2,Myocardial infarction,circulatory system,OPGS002704,0.312,Metabolon,5-acetylamino-6-formylamino-3-methyluracil,1.03 (1.01 1.04),1.00E-02
411.2,Myocardial infarction,circulatory system,OPGS002850,0.070,Metabolon,1-stearoyl-2-linoleoyl-GPE (18:0/18:2)*,1.03 (1.01 1.04),1.03E-02
411.2,Myocardial infarction,circulatory system,OPGS003067,0.022,Metabolon,X - 12339,0.97 (0.96 0.99),1.21E-02
411.2,Myocardial infarction,circulatory system,OPGS003151,0.014,Metabolon,1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2)*,1.03 (1.01 1.04),1.54E-02
411.2,Myocardial infarction,circulatory system,OPGS003127,0.017,Metabolon,sphingomyelin (d18:1/22:1. d18:2/22:0. d16:1/24:1)*,1.03 (1.01 1.04),2.23E-02
411.2,Myocardial infarction,circulatory system,OPGS002824,0.081,Metabolon,4-acetamidobutanoate,1.02 (1.01 1.04),2.76E-02
411.2,Myocardial infarction,circulatory system,OPGS002915,0.048,Metabolon,sphingomyelin (d18:1/20:0. d16:1/22:0)*,1.02 (1.01 1.04),3.26E-02
411.2,Myocardial infarction,circulatory system,OPGS003200,0.012,Metabolon,threonine,0.98 (0.96 0.99),3.50E-02
411.2,Myocardial infarction,circulatory system,OPGS002982,0.033,Metabolon,X - 12681,0.98 (0.96 0.99),4.06E-02
411.2,Myocardial infarction,circulatory system,OPGS002911,0.049,Metabolon,1-methylurate,0.98 (0.96 0.99),4.95E-02
411.2,Myocardial infarction,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.16 (1.14 1.18),1.56E-81
411.2,Myocardial infarction,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.16 (1.14 1.18),1.56E-81
411.2,Myocardial infarction,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.16 (1.14 1.18),1.77E-81
411.2,Myocardial infarction,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.15 (1.14 1.17),1.77E-81
411.2,Myocardial infarction,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.16 (1.14 1.17),1.77E-81
411.2,Myocardial infarction,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.16 (1.14 1.18),4.28E-80
411.2,Myocardial infarction,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.16 (1.14 1.17),6.13E-80
411.2,Myocardial infarction,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.16 (1.14 1.17),1.02E-79
411.2,Myocardial infarction,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.16 (1.14 1.18),2.08E-79
411.2,Myocardial infarction,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.16 (1.14 1.17),3.32E-79
411.2,Myocardial infarction,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.16 (1.14 1.17),4.78E-79
411.2,Myocardial infarction,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.15 (1.14 1.17),4.78E-79
411.2,Myocardial infarction,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.15 (1.14 1.17),1.47E-78
411.2,Myocardial infarction,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.16 (1.14 1.17),1.71E-78
411.2,Myocardial infarction,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.16 (1.14 1.17),7.27E-78
411.2,Myocardial infarction,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.15 (1.14 1.17),9.58E-78
411.2,Myocardial infarction,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.15 (1.13 1.17),1.12E-77
411.2,Myocardial infarction,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.15 (1.14 1.17),1.74E-77
411.2,Myocardial infarction,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.16 (1.14 1.17),1.90E-77
411.2,Myocardial infarction,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.16 (1.14 1.17),3.11E-77
411.2,Myocardial infarction,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.15 (1.14 1.17),3.11E-77
411.2,Myocardial infarction,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.15 (1.13 1.17),5.60E-77
411.2,Myocardial infarction,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.15 (1.14 1.17),3.00E-76
411.2,Myocardial infarction,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.15 (1.14 1.17),3.60E-76
411.2,Myocardial infarction,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.15 (1.14 1.17),4.69E-76
411.2,Myocardial infarction,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.15 (1.14 1.17),5.04E-76
411.2,Myocardial infarction,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.15 (1.14 1.17),3.58E-75
411.2,Myocardial infarction,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.15 (1.13 1.17),5.44E-74
411.2,Myocardial infarction,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.15 (1.13 1.17),3.49E-73
411.2,Myocardial infarction,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.15 (1.13 1.16),3.58E-73
411.2,Myocardial infarction,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.14 (1.13 1.16),1.62E-72
411.2,Myocardial infarction,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.14 (1.13 1.16),2.50E-72
411.2,Myocardial infarction,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.15 (1.13 1.17),4.42E-71
411.2,Myocardial infarction,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.14 (1.13 1.16),4.56E-70
411.2,Myocardial infarction,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.13 (1.12 1.15),1.21E-61
411.2,Myocardial infarction,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.13 (1.12 1.15),7.14E-60
411.2,Myocardial infarction,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.13 (1.11 1.14),1.42E-56
411.2,Myocardial infarction,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.12 (1.11 1.14),2.55E-54
411.2,Myocardial infarction,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.12 (1.11 1.14),4.29E-54
411.2,Myocardial infarction,circulatory system,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.12 (1.10 1.13),3.91E-49
411.2,Myocardial infarction,circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.11 (1.10 1.13),7.21E-47
411.2,Myocardial infarction,circulatory system,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.11 (1.09 1.12),3.08E-43
411.2,Myocardial infarction,circulatory system,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.11 (1.09 1.13),3.69E-43
411.2,Myocardial infarction,circulatory system,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.11 (1.09 1.12),5.89E-42
411.2,Myocardial infarction,circulatory system,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.10 (1.09 1.12),5.90E-40
411.2,Myocardial infarction,circulatory system,OPGS003527,0.050,Nightingale,Sphingomyelins,1.10 (1.08 1.11),5.74E-33
411.2,Myocardial infarction,circulatory system,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.09 (1.08 1.11),3.35E-30
411.2,Myocardial infarction,circulatory system,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.09 (1.07 1.11),4.03E-30
411.2,Myocardial infarction,circulatory system,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.09 (1.07 1.10),5.83E-29
411.2,Myocardial infarction,circulatory system,OPGS003497,0.072,Nightingale,Linoleic acid,1.09 (1.07 1.10),2.26E-27
411.2,Myocardial infarction,circulatory system,OPGS003509,0.069,Nightingale,Free cholesterol in chylomicrons and extremely large VLDL,0.93 (0.91 0.94),3.81E-24
411.2,Myocardial infarction,circulatory system,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.08 (1.06 1.10),6.73E-24
411.2,Myocardial infarction,circulatory system,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.08 (1.06 1.09),9.39E-23
411.2,Myocardial infarction,circulatory system,OPGS003528,0.050,Nightingale,Total cholines,1.08 (1.06 1.09),8.36E-22
411.2,Myocardial infarction,circulatory system,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.08 (1.06 1.09),8.97E-22
411.2,Myocardial infarction,circulatory system,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.08 (1.06 1.09),1.60E-21
411.2,Myocardial infarction,circulatory system,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,0.93 (0.92 0.94),2.01E-21
411.2,Myocardial infarction,circulatory system,OPGS003487,0.074,Nightingale,Phospholipids in chylomicrons and extremely large VLDL,0.93 (0.92 0.94),3.84E-21
411.2,Myocardial infarction,circulatory system,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,0.93 (0.92 0.94),1.49E-20
411.2,Myocardial infarction,circulatory system,OPGS003523,0.062,Nightingale,Total fatty acids,1.07 (1.06 1.09),7.00E-20
411.2,Myocardial infarction,circulatory system,OPGS003491,0.073,Nightingale,Total lipids in chylomicrons and extremely large VLDL,0.93 (0.92 0.95),7.25E-20
411.2,Myocardial infarction,circulatory system,OPGS003462,0.083,Nightingale,Average diameter for VLDL particles,0.93 (0.92 0.95),5.02E-18
411.2,Myocardial infarction,circulatory system,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.07 (1.05 1.08),6.58E-18
411.2,Myocardial infarction,circulatory system,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.07 (1.05 1.08),2.80E-17
411.2,Myocardial infarction,circulatory system,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.07 (1.05 1.08),6.52E-17
411.2,Myocardial infarction,circulatory system,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.07 (1.05 1.08),6.51E-16
411.2,Myocardial infarction,circulatory system,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.94 (0.93 0.95),1.29E-15
411.2,Myocardial infarction,circulatory system,OPGS003513,0.067,Nightingale,Free cholesterol in very large VLDL,0.94 (0.93 0.95),2.23E-15
411.2,Myocardial infarction,circulatory system,OPGS003526,0.050,Nightingale,Phosphatidylcholines,1.06 (1.05 1.08),4.49E-15
411.2,Myocardial infarction,circulatory system,OPGS003500,0.071,Nightingale,Total lipids in very large VLDL,0.94 (0.93 0.95),1.05E-14
411.2,Myocardial infarction,circulatory system,OPGS003506,0.070,Nightingale,Cholesterol in very large VLDL,0.94 (0.93 0.95),1.09E-14
411.2,Myocardial infarction,circulatory system,OPGS003510,0.068,Nightingale,Cholesterol in chylomicrons and extremely large VLDL,0.94 (0.93 0.95),1.26E-14
411.2,Myocardial infarction,circulatory system,OPGS003504,0.070,Nightingale,Triglycerides in very large VLDL,0.94 (0.93 0.95),1.70E-14
411.2,Myocardial infarction,circulatory system,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.94 (0.93 0.96),1.97E-14
411.2,Myocardial infarction,circulatory system,OPGS003502,0.070,Nightingale,Concentration of very large VLDL particles,0.94 (0.93 0.96),3.57E-14
411.2,Myocardial infarction,circulatory system,OPGS003496,0.072,Nightingale,Cholesteryl esters in very large VLDL,0.94 (0.93 0.96),6.20E-14
411.2,Myocardial infarction,circulatory system,OPGS003516,0.066,Nightingale,Phospholipids in very large VLDL,0.94 (0.93 0.96),1.37E-13
411.2,Myocardial infarction,circulatory system,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.94 (0.93 0.96),2.59E-13
411.2,Myocardial infarction,circulatory system,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.94 (0.93 0.96),2.62E-13
411.2,Myocardial infarction,circulatory system,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.95 (0.93 0.96),2.12E-12
411.2,Myocardial infarction,circulatory system,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.95 (0.94 0.96),1.61E-10
411.2,Myocardial infarction,circulatory system,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.95 (0.94 0.97),8.72E-10
411.2,Myocardial infarction,circulatory system,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.95 (0.94 0.97),1.09E-09
411.2,Myocardial infarction,circulatory system,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.95 (0.94 0.97),2.93E-09
411.2,Myocardial infarction,circulatory system,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.05 (1.03 1.06),3.31E-09
411.2,Myocardial infarction,circulatory system,OPGS003520,0.062,Nightingale,HDL cholesterol,0.95 (0.94 0.97),3.36E-09
411.2,Myocardial infarction,circulatory system,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.96 (0.94 0.97),3.53E-08
411.2,Myocardial infarction,circulatory system,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.96 (0.94 0.97),9.35E-08
411.2,Myocardial infarction,circulatory system,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.96 (0.94 0.97),1.63E-07
411.2,Myocardial infarction,circulatory system,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,0.96 (0.95 0.98),4.98E-06
411.2,Myocardial infarction,circulatory system,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.96 (0.95 0.98),6.48E-06
411.2,Myocardial infarction,circulatory system,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,1.04 (1.02 1.05),1.82E-05
411.2,Myocardial infarction,circulatory system,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.04 (1.02 1.05),3.36E-05
411.2,Myocardial infarction,circulatory system,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.97 (0.95 0.98),1.84E-04
411.2,Myocardial infarction,circulatory system,OPGS003540,0.029,Nightingale,Free cholesterol in small HDL,0.97 (0.95 0.98),2.04E-04
411.2,Myocardial infarction,circulatory system,OPGS003542,0.028,Nightingale,Phospholipids in medium HDL,0.97 (0.95 0.98),3.44E-04
411.2,Myocardial infarction,circulatory system,OPGS003483,0.075,Nightingale,Cholesterol in large VLDL,0.97 (0.95 0.98),7.73E-04
411.2,Myocardial infarction,circulatory system,OPGS003507,0.070,Nightingale,Free cholesterol in large VLDL,0.97 (0.96 0.98),8.69E-04
411.2,Myocardial infarction,circulatory system,OPGS003494,0.072,Nightingale,Concentration of large VLDL particles,0.97 (0.96 0.98),1.04E-03
411.2,Myocardial infarction,circulatory system,OPGS003498,0.071,Nightingale,Triglycerides in large VLDL,0.97 (0.96 0.98),1.04E-03
411.2,Myocardial infarction,circulatory system,OPGS003537,0.031,Nightingale,Glycoprotein acetyls,0.97 (0.96 0.98),1.79E-03
411.2,Myocardial infarction,circulatory system,OPGS003448,0.093,Nightingale,Phospholipids in very large HDL,0.97 (0.96 0.99),3.06E-03
411.2,Myocardial infarction,circulatory system,OPGS003493,0.073,Nightingale,Total lipids in large VLDL,0.97 (0.96 0.99),5.23E-03
411.2,Myocardial infarction,circulatory system,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,1.03 (1.01 1.04),6.49E-03
411.2,Myocardial infarction,circulatory system,OPGS003445,0.100,Nightingale,Glycine,0.97 (0.96 0.99),2.16E-02
411.2,Myocardial infarction,circulatory system,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.03 (1.01 1.04),2.24E-02
411.2,Myocardial infarction,circulatory system,OPGS003471,0.077,Nightingale,Cholesteryl esters in large VLDL,0.98 (0.96 0.99),3.26E-02
411.2,Myocardial infarction,circulatory system,OPGS003518,0.065,Nightingale,Triglycerides in medium HDL,1.02 (1.01 1.04),3.31E-02
411.2,Myocardial infarction,circulatory system,OPGS013472,0.027,RNAseq,STAT1,1.06 (1.04 1.07),8.85E-13
411.2,Myocardial infarction,circulatory system,OPGS004382,0.374,RNAseq,FES,0.95 (0.94 0.96),7.13E-12
411.2,Myocardial infarction,circulatory system,OPGS013939,0.023,RNAseq,BATF2,1.05 (1.03 1.06),3.32E-09
411.2,Myocardial infarction,circulatory system,OPGS011108,0.052,RNAseq,LDLR,0.95 (0.94 0.97),1.36E-08
411.2,Myocardial infarction,circulatory system,OPGS011308,0.049,RNAseq,PI4K2B,0.96 (0.94 0.97),3.15E-07
411.2,Myocardial infarction,circulatory system,OPGS007943,0.117,RNAseq,SLC22A1,0.96 (0.95 0.97),3.49E-07
411.2,Myocardial infarction,circulatory system,OPGS006535,0.174,RNAseq,PSRC1,0.96 (0.94 0.97),4.02E-07
411.2,Myocardial infarction,circulatory system,OPGS005858,0.211,RNAseq,GGCX,1.04 (1.03 1.06),1.88E-06
411.2,Myocardial infarction,circulatory system,OPGS010653,0.059,RNAseq,CELSR2,1.04 (1.03 1.06),2.07E-06
411.2,Myocardial infarction,circulatory system,OPGS005687,0.222,RNAseq,CTSK,0.96 (0.95 0.97),3.74E-06
411.2,Myocardial infarction,circulatory system,OPGS010417,0.062,RNAseq,PHETA1,0.96 (0.95 0.97),4.57E-06
411.2,Myocardial infarction,circulatory system,OPGS004968,0.290,RNAseq,FCHO1,0.96 (0.95 0.98),1.82E-05
411.2,Myocardial infarction,circulatory system,OPGS011044,0.053,RNAseq,AL359922.3,1.04 (1.02 1.05),2.72E-05
411.2,Myocardial infarction,circulatory system,OPGS014093,0.022,RNAseq,MYBL1,1.04 (1.02 1.05),3.18E-05
411.2,Myocardial infarction,circulatory system,OPGS008273,0.107,RNAseq,GRK4,1.04 (1.02 1.05),3.80E-05
411.2,Myocardial infarction,circulatory system,OPGS011948,0.042,RNAseq,ADGRG1,0.96 (0.95 0.98),4.72E-05
411.2,Myocardial infarction,circulatory system,OPGS007873,0.119,RNAseq,PAFAH1B1,0.97 (0.95 0.98),4.84E-05
411.2,Myocardial infarction,circulatory system,OPGS008666,0.097,RNAseq,AL592148.3,0.96 (0.95 0.98),5.25E-05
411.2,Myocardial infarction,circulatory system,OPGS007456,0.134,RNAseq,TAF1A-AS1,1.04 (1.02 1.05),5.61E-05
411.2,Myocardial infarction,circulatory system,OPGS008807,0.094,RNAseq,ARHGEF40,0.96 (0.95 0.98),6.10E-05
411.2,Myocardial infarction,circulatory system,OPGS011936,0.042,RNAseq,INTS10,0.96 (0.95 0.98),6.64E-05
411.2,Myocardial infarction,circulatory system,OPGS003588,0.703,RNAseq,LIPA,1.04 (1.02 1.05),1.12E-04
411.2,Myocardial infarction,circulatory system,OPGS015077,0.015,RNAseq,ACTN1,1.03 (1.02 1.05),1.52E-04
411.2,Myocardial infarction,circulatory system,OPGS012279,0.038,RNAseq,CDKN2A,0.97 (0.95 0.98),1.59E-04
411.2,Myocardial infarction,circulatory system,OPGS006446,0.178,RNAseq,,1.03 (1.02 1.05),1.79E-04
411.2,Myocardial infarction,circulatory system,OPGS013817,0.024,RNAseq,MYADM,0.97 (0.95 0.98),2.04E-04
411.2,Myocardial infarction,circulatory system,OPGS013792,0.024,RNAseq,YIPF2,1.03 (1.02 1.05),2.96E-04
411.2,Myocardial infarction,circulatory system,OPGS004949,0.293,RNAseq,ILRUN,1.03 (1.02 1.05),3.12E-04
411.2,Myocardial infarction,circulatory system,OPGS003925,0.496,RNAseq,OSER1,0.97 (0.95 0.98),3.44E-04
411.2,Myocardial infarction,circulatory system,OPGS012787,0.033,RNAseq,FURIN,1.03 (1.02 1.05),5.18E-04
411.2,Myocardial infarction,circulatory system,OPGS012456,0.036,RNAseq,AC011944.2,0.97 (0.96 0.98),6.00E-04
411.2,Myocardial infarction,circulatory system,OPGS009659,0.076,RNAseq,NRXN2,1.03 (1.02 1.05),7.42E-04
411.2,Myocardial infarction,circulatory system,OPGS014550,0.019,RNAseq,ACAD10,0.97 (0.95 0.98),1.01E-03
411.2,Myocardial infarction,circulatory system,OPGS006621,0.169,RNAseq,NME7,0.97 (0.96 0.98),1.10E-03
411.2,Myocardial infarction,circulatory system,OPGS010700,0.058,RNAseq,DCLRE1B,0.97 (0.96 0.98),1.16E-03
411.2,Myocardial infarction,circulatory system,OPGS006433,0.179,RNAseq,PECAM1,1.03 (1.02 1.05),1.25E-03
411.2,Myocardial infarction,circulatory system,OPGS013409,0.027,RNAseq,MTAP,1.03 (1.02 1.05),1.37E-03
411.2,Myocardial infarction,circulatory system,OPGS014044,0.022,RNAseq,KCND3,0.97 (0.96 0.98),1.54E-03
411.2,Myocardial infarction,circulatory system,OPGS014718,0.017,RNAseq,MRC2,1.03 (1.02 1.05),1.95E-03
411.2,Myocardial infarction,circulatory system,OPGS006215,0.191,RNAseq,PGAP3,1.03 (1.02 1.05),2.15E-03
411.2,Myocardial infarction,circulatory system,OPGS011145,0.052,RNAseq,HOXC4,0.97 (0.96 0.98),2.36E-03
411.2,Myocardial infarction,circulatory system,OPGS012730,0.033,RNAseq,CARM1,0.97 (0.96 0.98),2.45E-03
411.2,Myocardial infarction,circulatory system,OPGS007953,0.117,RNAseq,OASL,1.03 (1.02 1.04),2.66E-03
411.2,Myocardial infarction,circulatory system,OPGS012717,0.033,RNAseq,GBP4,1.03 (1.02 1.05),2.90E-03
411.2,Myocardial infarction,circulatory system,OPGS014221,0.021,RNAseq,HIC1,0.97 (0.96 0.99),3.14E-03
411.2,Myocardial infarction,circulatory system,OPGS014745,0.017,RNAseq,KIF3A,0.97 (0.96 0.99),3.24E-03
411.2,Myocardial infarction,circulatory system,OPGS014246,0.021,RNAseq,COX18,0.97 (0.95 0.98),3.29E-03
411.2,Myocardial infarction,circulatory system,OPGS012162,0.040,RNAseq,RSAD2,1.03 (1.01 1.04),3.34E-03
411.2,Myocardial infarction,circulatory system,OPGS007508,0.132,RNAseq,ALDH2,0.97 (0.96 0.99),4.08E-03
411.2,Myocardial infarction,circulatory system,OPGS006671,0.167,RNAseq,GFM1,0.97 (0.96 0.99),4.44E-03
411.2,Myocardial infarction,circulatory system,OPGS008555,0.100,RNAseq,CALCRL,1.03 (1.01 1.04),5.51E-03
411.2,Myocardial infarction,circulatory system,OPGS010345,0.064,RNAseq,PLCG1,0.97 (0.96 0.99),5.91E-03
411.2,Myocardial infarction,circulatory system,OPGS009190,0.085,RNAseq,COL13A1,1.03 (1.01 1.04),5.97E-03
411.2,Myocardial infarction,circulatory system,OPGS011110,0.052,RNAseq,CMTM2,1.03 (1.01 1.04),6.40E-03
411.2,Myocardial infarction,circulatory system,OPGS012171,0.039,RNAseq,TRBV15,0.97 (0.96 0.99),6.40E-03
411.2,Myocardial infarction,circulatory system,OPGS010831,0.056,RNAseq,KLF2,1.03 (1.01 1.04),6.40E-03
411.2,Myocardial infarction,circulatory system,OPGS010972,0.054,RNAseq,FBXL20,1.03 (1.01 1.04),6.66E-03
411.2,Myocardial infarction,circulatory system,OPGS005689,0.222,RNAseq,SLC47A1,0.97 (0.96 0.99),6.72E-03
411.2,Myocardial infarction,circulatory system,OPGS011752,0.044,RNAseq,AL359532.1,0.97 (0.96 0.99),6.74E-03
411.2,Myocardial infarction,circulatory system,OPGS013411,0.027,RNAseq,GBP6,1.03 (1.01 1.04),7.24E-03
411.2,Myocardial infarction,circulatory system,OPGS012521,0.035,RNAseq,HERC5,1.03 (1.01 1.04),7.24E-03
411.2,Myocardial infarction,circulatory system,OPGS011387,0.048,RNAseq,ACVR1,0.97 (0.96 0.99),7.62E-03
411.2,Myocardial infarction,circulatory system,OPGS008932,0.091,RNAseq,IGF2BP2,0.97 (0.96 0.99),7.79E-03
411.2,Myocardial infarction,circulatory system,OPGS009289,0.084,RNAseq,AC010883.1,1.03 (1.01 1.04),7.79E-03
411.2,Myocardial infarction,circulatory system,OPGS008244,0.108,RNAseq,ICA1L,1.03 (1.01 1.04),7.84E-03
411.2,Myocardial infarction,circulatory system,OPGS012772,0.033,RNAseq,GIGYF2,1.03 (1.01 1.04),7.93E-03
411.2,Myocardial infarction,circulatory system,OPGS010370,0.063,RNAseq,TP53INP1,1.03 (1.01 1.04),8.62E-03
411.2,Myocardial infarction,circulatory system,OPGS012524,0.035,RNAseq,AL357079.1,0.97 (0.96 0.99),8.83E-03
411.2,Myocardial infarction,circulatory system,OPGS007717,0.125,RNAseq,GUCY1A1,0.97 (0.96 0.99),8.83E-03
411.2,Myocardial infarction,circulatory system,OPGS007509,0.132,RNAseq,THOC7,0.97 (0.96 0.99),8.83E-03
411.2,Myocardial infarction,circulatory system,OPGS004706,0.323,RNAseq,AC011462.5,1.03 (1.01 1.04),9.22E-03
411.2,Myocardial infarction,circulatory system,OPGS010472,0.061,RNAseq,XPO6,0.97 (0.96 0.99),9.76E-03
411.2,Myocardial infarction,circulatory system,OPGS006265,0.188,RNAseq,RBM6,0.97 (0.96 0.99),1.10E-02
411.2,Myocardial infarction,circulatory system,OPGS005346,0.252,RNAseq,,1.03 (1.01 1.04),1.16E-02
411.2,Myocardial infarction,circulatory system,OPGS012841,0.032,RNAseq,ZNF738,0.97 (0.96 0.99),1.20E-02
411.2,Myocardial infarction,circulatory system,OPGS010402,0.062,RNAseq,,1.03 (1.01 1.04),1.20E-02
411.2,Myocardial infarction,circulatory system,OPGS010993,0.054,RNAseq,SNAP47,1.03 (1.01 1.04),1.24E-02
411.2,Myocardial infarction,circulatory system,OPGS007764,0.123,RNAseq,HLA-E,1.03 (1.01 1.04),1.27E-02
411.2,Myocardial infarction,circulatory system,OPGS008303,0.107,RNAseq,TMEM116,0.97 (0.96 0.99),1.27E-02
411.2,Myocardial infarction,circulatory system,OPGS009423,0.081,RNAseq,PSTPIP2,1.03 (1.01 1.04),1.27E-02
411.2,Myocardial infarction,circulatory system,OPGS004598,0.340,RNAseq,RPAP1,0.97 (0.96 0.99),1.31E-02
411.2,Myocardial infarction,circulatory system,OPGS006860,0.157,RNAseq,,0.97 (0.96 0.99),1.39E-02
411.2,Myocardial infarction,circulatory system,OPGS007282,0.140,RNAseq,CERCAM,1.03 (1.01 1.04),1.40E-02
411.2,Myocardial infarction,circulatory system,OPGS012380,0.037,RNAseq,AC007381.1,0.97 (0.96 0.99),1.54E-02
411.2,Myocardial infarction,circulatory system,OPGS007742,0.124,RNAseq,CANT1,1.03 (1.01 1.04),1.57E-02
411.2,Myocardial infarction,circulatory system,OPGS014898,0.016,RNAseq,AC010245.2,1.03 (1.01 1.04),1.58E-02
411.2,Myocardial infarction,circulatory system,OPGS006940,0.154,RNAseq,,1.03 (1.01 1.04),1.58E-02
411.2,Myocardial infarction,circulatory system,OPGS014695,0.017,RNAseq,QPCTL,0.97 (0.96 0.99),1.73E-02
411.2,Myocardial infarction,circulatory system,OPGS009276,0.084,RNAseq,FCER1A,0.97 (0.96 0.99),1.84E-02
411.2,Myocardial infarction,circulatory system,OPGS005449,0.243,RNAseq,ZNF708,0.97 (0.96 0.99),1.88E-02
411.2,Myocardial infarction,circulatory system,OPGS005918,0.208,RNAseq,DDR1,1.03 (1.01 1.04),1.99E-02
411.2,Myocardial infarction,circulatory system,OPGS012732,0.033,RNAseq,AF165147.1,0.98 (0.96 0.99),2.08E-02
411.2,Myocardial infarction,circulatory system,OPGS010344,0.064,RNAseq,ZC3H13,0.98 (0.96 0.99),2.10E-02
411.2,Myocardial infarction,circulatory system,OPGS011979,0.041,RNAseq,AC104083.1,0.98 (0.96 0.99),2.34E-02
411.2,Myocardial infarction,circulatory system,OPGS014183,0.021,RNAseq,PAXBP1-AS1,1.02 (1.01 1.04),2.40E-02
411.2,Myocardial infarction,circulatory system,OPGS007220,0.143,RNAseq,TAF1A,1.03 (1.01 1.04),2.41E-02
411.2,Myocardial infarction,circulatory system,OPGS003655,0.633,RNAseq,ZNF100,0.98 (0.96 0.99),2.42E-02
411.2,Myocardial infarction,circulatory system,OPGS011266,0.050,RNAseq,AL137060.3,0.97 (0.96 0.99),2.46E-02
411.2,Myocardial infarction,circulatory system,OPGS015054,0.015,RNAseq,H19,1.02 (1.01 1.04),2.57E-02
411.2,Myocardial infarction,circulatory system,OPGS010507,0.061,RNAseq,EXTL3,0.98 (0.96 0.99),2.57E-02
411.2,Myocardial infarction,circulatory system,OPGS010929,0.055,RNAseq,EOMES,1.02 (1.01 1.04),2.59E-02
411.2,Myocardial infarction,circulatory system,OPGS008923,0.091,RNAseq,FAM3C,0.98 (0.96 0.99),2.68E-02
411.2,Myocardial infarction,circulatory system,OPGS004930,0.295,RNAseq,LINC00665,0.98 (0.96 0.99),2.70E-02
411.2,Myocardial infarction,circulatory system,OPGS004168,0.418,RNAseq,TMEM45B,0.98 (0.96 0.99),2.72E-02
411.2,Myocardial infarction,circulatory system,OPGS011721,0.044,RNAseq,RNF8,0.98 (0.96 0.99),2.72E-02
411.2,Myocardial infarction,circulatory system,OPGS004442,0.364,RNAseq,NEO1,0.98 (0.96 0.99),2.94E-02
411.2,Myocardial infarction,circulatory system,OPGS009559,0.078,RNAseq,ZNF365,1.02 (1.01 1.04),3.26E-02
411.2,Myocardial infarction,circulatory system,OPGS013774,0.024,RNAseq,AC027290.3,1.02 (1.01 1.04),3.26E-02
411.2,Myocardial infarction,circulatory system,OPGS012559,0.035,RNAseq,CORO1B,1.02 (1.01 1.04),3.26E-02
411.2,Myocardial infarction,circulatory system,OPGS009893,0.071,RNAseq,HORMAD1,0.98 (0.96 0.99),3.31E-02
411.2,Myocardial infarction,circulatory system,OPGS012967,0.031,RNAseq,CCDC157,0.98 (0.96 0.99),3.31E-02
411.2,Myocardial infarction,circulatory system,OPGS014319,0.020,RNAseq,RUVBL1,0.98 (0.96 0.99),3.35E-02
411.2,Myocardial infarction,circulatory system,OPGS015027,0.016,RNAseq,AC104162.2,1.02 (1.01 1.04),3.60E-02
411.2,Myocardial infarction,circulatory system,OPGS003576,0.728,RNAseq,DGKQ,0.98 (0.96 0.99),3.60E-02
411.2,Myocardial infarction,circulatory system,OPGS007440,0.134,RNAseq,RBM18,0.98 (0.96 0.99),3.62E-02
411.2,Myocardial infarction,circulatory system,OPGS007917,0.118,RNAseq,AL450998.2,1.02 (1.01 1.04),3.70E-02
411.2,Myocardial infarction,circulatory system,OPGS011567,0.046,RNAseq,MIER2,1.02 (1.01 1.04),3.70E-02
411.2,Myocardial infarction,circulatory system,OPGS013336,0.028,RNAseq,IL21R,1.02 (1.01 1.04),3.72E-02
411.2,Myocardial infarction,circulatory system,OPGS004501,0.354,RNAseq,TBKBP1,0.98 (0.96 0.99),3.73E-02
411.2,Myocardial infarction,circulatory system,OPGS013398,0.027,RNAseq,PREPL,1.02 (1.01 1.04),3.75E-02
411.2,Myocardial infarction,circulatory system,OPGS011806,0.043,RNAseq,NCF2,0.98 (0.96 0.99),4.10E-02
411.2,Myocardial infarction,circulatory system,OPGS005037,0.283,RNAseq,RWDD2B,0.98 (0.96 0.99),4.11E-02
411.2,Myocardial infarction,circulatory system,OPGS015092,0.015,RNAseq,XRN2,0.98 (0.96 0.99),4.17E-02
411.2,Myocardial infarction,circulatory system,OPGS009161,0.086,RNAseq,MRPS6,0.98 (0.96 0.99),4.18E-02
411.2,Myocardial infarction,circulatory system,OPGS004469,0.360,RNAseq,GDI2,1.02 (1.01 1.04),4.23E-02
411.2,Myocardial infarction,circulatory system,OPGS005469,0.241,RNAseq,SPX,1.02 (1.01 1.04),4.23E-02
411.2,Myocardial infarction,circulatory system,OPGS014232,0.021,RNAseq,TRAV1-2,1.02 (1.01 1.04),4.31E-02
411.2,Myocardial infarction,circulatory system,OPGS008601,0.099,RNAseq,COLQ,1.02 (1.01 1.04),4.33E-02
411.2,Myocardial infarction,circulatory system,OPGS005235,0.262,RNAseq,MED19,1.02 (1.01 1.04),4.38E-02
411.2,Myocardial infarction,circulatory system,OPGS014341,0.020,RNAseq,NFAT5,1.02 (1.01 1.04),4.41E-02
411.2,Myocardial infarction,circulatory system,OPGS013445,0.027,RNAseq,AC131212.2,0.98 (0.96 0.99),4.41E-02
411.2,Myocardial infarction,circulatory system,OPGS010692,0.058,RNAseq,IPO9,0.98 (0.96 0.99),4.53E-02
411.2,Myocardial infarction,circulatory system,OPGS014440,0.019,RNAseq,C19orf38,1.02 (1.01 1.04),4.58E-02
411.2,Myocardial infarction,circulatory system,OPGS011759,0.044,RNAseq,ZDHHC11,1.02 (1.01 1.04),4.58E-02
411.2,Myocardial infarction,circulatory system,OPGS004599,0.340,RNAseq,,0.98 (0.96 0.99),4.95E-02
411.3,Angina pectoris,circulatory system,OPGS000115,0.347,SomaScan,Protein CEI,1.08 (1.07 1.09),2.75E-27
411.3,Angina pectoris,circulatory system,OPGS000312,0.163,SomaScan,Selenoprotein S,1.08 (1.07 1.10),2.23E-26
411.3,Angina pectoris,circulatory system,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.08 (1.06 1.09),2.19E-25
411.3,Angina pectoris,circulatory system,OPGS000613,0.096,SomaScan,Stromelysin-1,1.08 (1.06 1.09),1.34E-24
411.3,Angina pectoris,circulatory system,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.08 (1.06 1.09),1.78E-24
411.3,Angina pectoris,circulatory system,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.08 (1.06 1.09),1.97E-24
411.3,Angina pectoris,circulatory system,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.07 (1.06 1.09),5.96E-23
411.3,Angina pectoris,circulatory system,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.07 (1.06 1.09),6.90E-22
411.3,Angina pectoris,circulatory system,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.93 (0.92 0.94),3.84E-21
411.3,Angina pectoris,circulatory system,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.06 (1.05 1.08),4.09E-19
411.3,Angina pectoris,circulatory system,OPGS002108,0.012,SomaScan,Neuralized-like protein 4,1.07 (1.06 1.09),5.41E-19
411.3,Angina pectoris,circulatory system,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.07 (1.05 1.08),5.62E-19
411.3,Angina pectoris,circulatory system,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.07 (1.05 1.08),6.31E-19
411.3,Angina pectoris,circulatory system,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.07 (1.05 1.08),3.36E-18
411.3,Angina pectoris,circulatory system,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,0.94 (0.92 0.95),3.71E-18
411.3,Angina pectoris,circulatory system,OPGS000857,0.067,SomaScan,Moesin,1.06 (1.05 1.08),7.60E-18
411.3,Angina pectoris,circulatory system,OPGS001392,0.029,SomaScan,Cadherin-related family member 5,1.07 (1.05 1.08),1.95E-17
411.3,Angina pectoris,circulatory system,OPGS000445,0.129,SomaScan,Collectin-10,0.94 (0.93 0.95),9.28E-17
411.3,Angina pectoris,circulatory system,OPGS000860,0.066,SomaScan,Cell surface glycoprotein CD200 receptor 2,0.94 (0.93 0.95),1.07E-16
411.3,Angina pectoris,circulatory system,OPGS000348,0.151,SomaScan,Quinone oxidoreductase-like protein 1,1.06 (1.05 1.08),1.41E-16
411.3,Angina pectoris,circulatory system,OPGS001058,0.049,SomaScan,Protocadherin beta-10,1.06 (1.05 1.08),1.41E-16
411.3,Angina pectoris,circulatory system,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.06 (1.04 1.07),5.95E-16
411.3,Angina pectoris,circulatory system,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,0.94 (0.93 0.95),3.23E-15
411.3,Angina pectoris,circulatory system,OPGS001963,0.013,SomaScan,Annexin A9,1.06 (1.05 1.08),6.35E-15
411.3,Angina pectoris,circulatory system,OPGS000492,0.119,SomaScan,Inactive gamma-glutamyltranspeptidase 2,1.06 (1.05 1.07),9.18E-15
411.3,Angina pectoris,circulatory system,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.06 (1.04 1.07),1.39E-14
411.3,Angina pectoris,circulatory system,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.06 (1.04 1.07),2.45E-14
411.3,Angina pectoris,circulatory system,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,0.95 (0.93 0.96),8.81E-14
411.3,Angina pectoris,circulatory system,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.95 (0.93 0.96),9.84E-14
411.3,Angina pectoris,circulatory system,OPGS000172,0.257,SomaScan,Dermokine,0.95 (0.93 0.96),1.99E-13
411.3,Angina pectoris,circulatory system,OPGS000510,0.115,SomaScan,Guanine nucleotide-binding protein G(k) subunit alpha,0.95 (0.93 0.96),3.40E-13
411.3,Angina pectoris,circulatory system,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.05 (1.04 1.07),1.02E-12
411.3,Angina pectoris,circulatory system,OPGS000154,0.277,SomaScan,Granulins,1.05 (1.04 1.07),1.27E-12
411.3,Angina pectoris,circulatory system,OPGS000285,0.176,SomaScan,Complement C1q tumor necrosis factor-related protein 1,1.05 (1.04 1.07),1.75E-12
411.3,Angina pectoris,circulatory system,OPGS000883,0.064,SomaScan,Group XIIB secretory phospholipase A2-like protein,1.05 (1.04 1.07),2.15E-12
411.3,Angina pectoris,circulatory system,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.05 (1.04 1.06),2.17E-12
411.3,Angina pectoris,circulatory system,OPGS001297,0.034,SomaScan,Neogenin,0.95 (0.94 0.96),6.55E-12
411.3,Angina pectoris,circulatory system,OPGS001144,0.043,SomaScan,Proprotein convertase subtilisin/kexin type 9,1.06 (1.04 1.07),1.16E-11
411.3,Angina pectoris,circulatory system,OPGS000401,0.139,SomaScan,Hemoglobin subunit theta-1,1.05 (1.04 1.07),1.68E-11
411.3,Angina pectoris,circulatory system,OPGS001279,0.035,SomaScan,Four-jointed box protein 1,1.05 (1.04 1.07),1.69E-11
411.3,Angina pectoris,circulatory system,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.05 (1.04 1.06),2.18E-11
411.3,Angina pectoris,circulatory system,OPGS001002,0.053,SomaScan,Tumor protein p53-inducible protein 11,1.05 (1.04 1.07),2.80E-11
411.3,Angina pectoris,circulatory system,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.05 (1.04 1.06),5.44E-11
411.3,Angina pectoris,circulatory system,OPGS001437,0.028,SomaScan,Steroidogenic acute regulatory protein. mitochondrial,1.05 (1.04 1.06),5.91E-11
411.3,Angina pectoris,circulatory system,OPGS001715,0.019,SomaScan,Histone deacetylase 8,1.05 (1.04 1.06),7.66E-11
411.3,Angina pectoris,circulatory system,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.05 (1.03 1.06),2.95E-10
411.3,Angina pectoris,circulatory system,OPGS001252,0.036,SomaScan,Neuronal pentraxin-2,1.05 (1.03 1.06),4.23E-10
411.3,Angina pectoris,circulatory system,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.05 (1.03 1.06),5.11E-10
411.3,Angina pectoris,circulatory system,OPGS000577,0.102,SomaScan,Platelet-activating factor acetylhydrolase,1.05 (1.03 1.06),9.28E-10
411.3,Angina pectoris,circulatory system,OPGS001041,0.050,SomaScan,RING finger protein 122,1.05 (1.03 1.06),3.25E-09
411.3,Angina pectoris,circulatory system,OPGS000838,0.069,SomaScan,DNA/RNA-binding protein KIN17,0.96 (0.94 0.97),3.87E-09
411.3,Angina pectoris,circulatory system,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.04 (1.03 1.06),1.75E-08
411.3,Angina pectoris,circulatory system,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.04 (1.03 1.06),3.66E-08
411.3,Angina pectoris,circulatory system,OPGS000715,0.082,SomaScan,Surfeit locus protein 1,1.04 (1.03 1.05),2.64E-07
411.3,Angina pectoris,circulatory system,OPGS001106,0.046,SomaScan,Disintegrin and metalloproteinase domain-containing protein 11,1.04 (1.03 1.05),5.13E-07
411.3,Angina pectoris,circulatory system,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.04 (1.03 1.05),5.86E-07
411.3,Angina pectoris,circulatory system,OPGS001112,0.045,SomaScan,Hemojuvelin,1.04 (1.02 1.05),2.05E-06
411.3,Angina pectoris,circulatory system,OPGS000022,0.602,SomaScan,Interleukin-6 receptor subunit alpha,0.96 (0.95 0.98),2.38E-06
411.3,Angina pectoris,circulatory system,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.96 (0.95 0.98),2.47E-06
411.3,Angina pectoris,circulatory system,OPGS000020,0.609,SomaScan,Interleukin-6 receptor subunit alpha,0.96 (0.95 0.98),3.21E-06
411.3,Angina pectoris,circulatory system,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.04 (1.02 1.05),4.31E-06
411.3,Angina pectoris,circulatory system,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.04 (1.02 1.05),4.65E-06
411.3,Angina pectoris,circulatory system,OPGS000951,0.057,SomaScan,Pseudokinase FAM20A,0.96 (0.95 0.98),6.13E-06
411.3,Angina pectoris,circulatory system,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.04 (1.02 1.05),8.32E-06
411.3,Angina pectoris,circulatory system,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.03 (1.02 1.05),1.12E-05
411.3,Angina pectoris,circulatory system,OPGS000544,0.108,SomaScan,Segment polarity protein dishevelled homolog DVL-2,1.04 (1.02 1.05),1.82E-05
411.3,Angina pectoris,circulatory system,OPGS001377,0.030,SomaScan,Vascular cell adhesion protein 1,1.04 (1.02 1.05),1.91E-05
411.3,Angina pectoris,circulatory system,OPGS001518,0.025,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,1.04 (1.02 1.05),2.38E-05
411.3,Angina pectoris,circulatory system,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,0.97 (0.95 0.98),5.36E-05
411.3,Angina pectoris,circulatory system,OPGS000874,0.065,SomaScan,Carbonic anhydrase-related protein 10,1.03 (1.02 1.05),6.18E-05
411.3,Angina pectoris,circulatory system,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.03 (1.02 1.05),6.33E-05
411.3,Angina pectoris,circulatory system,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.03 (1.02 1.05),6.65E-05
411.3,Angina pectoris,circulatory system,OPGS000717,0.082,SomaScan,Zinc finger protein 175,0.97 (0.95 0.98),6.87E-05
411.3,Angina pectoris,circulatory system,OPGS002186,0.011,SomaScan,Suprabasin,0.97 (0.95 0.98),7.03E-05
411.3,Angina pectoris,circulatory system,OPGS001879,0.015,SomaScan,Arfaptin-2,1.04 (1.02 1.05),7.03E-05
411.3,Angina pectoris,circulatory system,OPGS000141,0.306,SomaScan,Complement C1s subcomponent,1.03 (1.02 1.05),9.62E-05
411.3,Angina pectoris,circulatory system,OPGS001092,0.046,SomaScan,TOM1-like protein 1,1.03 (1.02 1.05),1.50E-04
411.3,Angina pectoris,circulatory system,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,1.03 (1.02 1.05),2.68E-04
411.3,Angina pectoris,circulatory system,OPGS000632,0.093,SomaScan,Erythrocyte band 7 integral membrane protein,1.03 (1.02 1.05),2.86E-04
411.3,Angina pectoris,circulatory system,OPGS001102,0.046,SomaScan,Granzyme A,1.03 (1.02 1.04),3.10E-04
411.3,Angina pectoris,circulatory system,OPGS002321,0.010,SomaScan,Fibronectin Fragment 3,0.97 (0.96 0.98),4.48E-04
411.3,Angina pectoris,circulatory system,OPGS001121,0.044,SomaScan,Growth factor receptor-bound protein 7,0.97 (0.96 0.98),4.65E-04
411.3,Angina pectoris,circulatory system,OPGS001238,0.037,SomaScan,Dedicator of cytokinesis protein 9,1.03 (1.02 1.04),4.71E-04
411.3,Angina pectoris,circulatory system,OPGS000250,0.192,SomaScan,Complement C1r subcomponent,1.03 (1.02 1.04),6.09E-04
411.3,Angina pectoris,circulatory system,OPGS001093,0.046,SomaScan,C-reactive protein,0.97 (0.96 0.98),7.04E-04
411.3,Angina pectoris,circulatory system,OPGS002046,0.012,SomaScan,Set1/Ash2 histone methyltransferase complex subunit ASH2,1.03 (1.02 1.04),8.39E-04
411.3,Angina pectoris,circulatory system,OPGS002093,0.012,SomaScan,Fibronectin,0.97 (0.96 0.98),9.09E-04
411.3,Angina pectoris,circulatory system,OPGS001365,0.030,SomaScan,Leukocyte cell-derived chemotaxin 1,0.97 (0.96 0.98),1.04E-03
411.3,Angina pectoris,circulatory system,OPGS000698,0.085,SomaScan,Alcohol dehydrogenase 1B,1.03 (1.02 1.04),1.36E-03
411.3,Angina pectoris,circulatory system,OPGS001124,0.044,SomaScan,Tumor necrosis factor receptor type 1-associated DEATH domain protein,1.03 (1.02 1.04),1.37E-03
411.3,Angina pectoris,circulatory system,OPGS001928,0.014,SomaScan,Sorting nexin-1,1.03 (1.02 1.04),1.53E-03
411.3,Angina pectoris,circulatory system,OPGS001464,0.027,SomaScan,Platelet glycoprotein Ib alpha chain,1.03 (1.01 1.04),1.63E-03
411.3,Angina pectoris,circulatory system,OPGS000927,0.059,SomaScan,Neuropilin-1,0.97 (0.96 0.99),2.00E-03
411.3,Angina pectoris,circulatory system,OPGS001671,0.020,SomaScan,Tumor necrosis factor ligand superfamily member 6. soluble form,0.97 (0.96 0.99),3.38E-03
411.3,Angina pectoris,circulatory system,OPGS001129,0.044,SomaScan,Sodium-coupled monocarboxylate transporter 1,1.03 (1.01 1.04),3.67E-03
411.3,Angina pectoris,circulatory system,OPGS000864,0.066,SomaScan,UDP-glucuronosyltransferase 1-6,0.97 (0.96 0.99),6.21E-03
411.3,Angina pectoris,circulatory system,OPGS002219,0.011,SomaScan,Zinc finger protein 843,1.03 (1.01 1.04),6.98E-03
411.3,Angina pectoris,circulatory system,OPGS001759,0.018,SomaScan,Hyaluronidase-1,1.03 (1.01 1.04),7.78E-03
411.3,Angina pectoris,circulatory system,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,0.97 (0.96 0.99),9.08E-03
411.3,Angina pectoris,circulatory system,OPGS001007,0.053,SomaScan,Neuropilin-1,0.98 (0.96 0.99),9.65E-03
411.3,Angina pectoris,circulatory system,OPGS001208,0.038,SomaScan,Macrophage colony-stimulating factor 1 receptor,0.98 (0.96 0.99),1.02E-02
411.3,Angina pectoris,circulatory system,OPGS000998,0.053,SomaScan,Tyrosine-protein phosphatase non-receptor type 4,1.03 (1.01 1.04),1.04E-02
411.3,Angina pectoris,circulatory system,OPGS001641,0.021,SomaScan,Killer cell lectin-like receptor subfamily F member 1,1.03 (1.01 1.04),1.05E-02
411.3,Angina pectoris,circulatory system,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.03 (1.01 1.04),1.05E-02
411.3,Angina pectoris,circulatory system,OPGS000521,0.113,SomaScan,Transmembrane protease serine 11D,1.03 (1.01 1.04),1.09E-02
411.3,Angina pectoris,circulatory system,OPGS001578,0.023,SomaScan,Serpin A9,1.02 (1.01 1.04),1.23E-02
411.3,Angina pectoris,circulatory system,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.02 (1.01 1.04),1.28E-02
411.3,Angina pectoris,circulatory system,OPGS002292,0.010,SomaScan,Interleukin-18-binding protein,0.97 (0.96 0.99),1.42E-02
411.3,Angina pectoris,circulatory system,OPGS002270,0.010,SomaScan,Tumor necrosis factor receptor superfamily member 21,0.97 (0.96 0.99),1.42E-02
411.3,Angina pectoris,circulatory system,OPGS001541,0.024,SomaScan,Transmembrane protein 106B,0.98 (0.96 0.99),1.47E-02
411.3,Angina pectoris,circulatory system,OPGS000283,0.177,SomaScan,Cathelicidin antimicrobial peptide,1.02 (1.01 1.04),1.59E-02
411.3,Angina pectoris,circulatory system,OPGS001611,0.022,SomaScan,Delta-like protein 3,1.02 (1.01 1.04),1.76E-02
411.3,Angina pectoris,circulatory system,OPGS001306,0.033,SomaScan,Macrophage colony-stimulating factor 1 receptor,0.98 (0.96 0.99),1.93E-02
411.3,Angina pectoris,circulatory system,OPGS000011,0.683,SomaScan,Hepatocyte growth factor-like protein,1.02 (1.01 1.04),2.07E-02
411.3,Angina pectoris,circulatory system,OPGS000159,0.271,SomaScan,39S ribosomal protein L33. mitochondrial,0.98 (0.96 0.99),2.53E-02
411.3,Angina pectoris,circulatory system,OPGS000099,0.376,SomaScan,Kunitz-type protease inhibitor 2,0.98 (0.97 0.99),2.79E-02
411.3,Angina pectoris,circulatory system,OPGS000092,0.387,SomaScan,Hepatocyte growth factor activator,0.98 (0.97 0.99),2.80E-02
411.3,Angina pectoris,circulatory system,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.02 (1.01 1.04),2.91E-02
411.3,Angina pectoris,circulatory system,OPGS000873,0.065,SomaScan,Tensin-2,1.02 (1.01 1.04),3.00E-02
411.3,Angina pectoris,circulatory system,OPGS001462,0.027,SomaScan,Beta-crystallin B2,1.02 (1.01 1.04),3.19E-02
411.3,Angina pectoris,circulatory system,OPGS000204,0.233,SomaScan,PR domain zinc finger protein 1,1.02 (1.01 1.04),3.50E-02
411.3,Angina pectoris,circulatory system,OPGS001924,0.014,SomaScan,Glycosyltransferase-like protein LARGE1,0.98 (0.96 0.99),3.67E-02
411.3,Angina pectoris,circulatory system,OPGS000068,0.438,SomaScan,Hepatocyte growth factor activator,0.98 (0.97 0.99),3.70E-02
411.3,Angina pectoris,circulatory system,OPGS001818,0.017,SomaScan,Dynactin subunit 2,1.02 (1.01 1.04),4.08E-02
411.3,Angina pectoris,circulatory system,OPGS000145,0.292,SomaScan,Cathepsin H,0.98 (0.97 0.99),4.90E-02
411.3,Angina pectoris,circulatory system,OPGS001115,0.045,SomaScan,Small integral membrane protein 9,1.02 (1.01 1.04),4.98E-02
411.3,Angina pectoris,circulatory system,OPGS002558,0.048,Olink,Proprotein convertase subtilisin/kexin type 9,1.05 (1.04 1.07),9.03E-12
411.3,Angina pectoris,circulatory system,OPGS002436,0.191,Olink,Progranulin,1.05 (1.04 1.06),4.15E-11
411.3,Angina pectoris,circulatory system,OPGS002552,0.053,Olink,Low-density lipoprotein receptor,0.95 (0.94 0.97),9.92E-10
411.3,Angina pectoris,circulatory system,OPGS002387,0.541,Olink,Interleukin-6 receptor subunit alpha,0.96 (0.95 0.98),1.65E-06
411.3,Angina pectoris,circulatory system,OPGS002585,0.037,Olink,T-cell surface glycoprotein CD5,1.04 (1.02 1.05),4.72E-06
411.3,Angina pectoris,circulatory system,OPGS002613,0.027,Olink,Interleukin-6,0.96 (0.95 0.98),5.74E-06
411.3,Angina pectoris,circulatory system,OPGS002617,0.026,Olink,C-X-C motif chemokine 9,1.03 (1.02 1.04),6.60E-04
411.3,Angina pectoris,circulatory system,OPGS002543,0.061,Olink,Netrin receptor UNC5C,1.03 (1.02 1.04),9.06E-04
411.3,Angina pectoris,circulatory system,OPGS002662,0.011,Olink,Protein-glutamine gamma-glutamyltransferase 2,0.97 (0.96 0.99),5.17E-03
411.3,Angina pectoris,circulatory system,OPGS002435,0.193,Olink,Fibroblast growth factor 5,1.03 (1.01 1.04),6.77E-03
411.3,Angina pectoris,circulatory system,OPGS002633,0.021,Olink,C-X-C motif chemokine 11,1.02 (1.01 1.04),1.38E-02
411.3,Angina pectoris,circulatory system,OPGS002568,0.043,Olink,Granzyme A,1.02 (1.01 1.04),2.18E-02
411.3,Angina pectoris,circulatory system,OPGS002432,0.195,Olink,Cathepsin S,1.02 (1.01 1.04),2.48E-02
411.3,Angina pectoris,circulatory system,OPGS002391,0.469,Olink,CMRF35-like molecule 1,0.98 (0.97 0.99),2.77E-02
411.3,Angina pectoris,circulatory system,OPGS002540,0.062,Olink,Plexin-B1,0.98 (0.96 0.99),2.96E-02
411.3,Angina pectoris,circulatory system,OPGS002656,0.013,Olink,Angiotensin-converting enzyme 2,0.98 (0.97 0.99),3.06E-02
411.3,Angina pectoris,circulatory system,OPGS002600,0.030,Olink,Heme oxygenase 1,0.98 (0.97 0.99),3.77E-02
411.3,Angina pectoris,circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.10 (1.09 1.12),5.20E-45
411.3,Angina pectoris,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.10 (1.09 1.12),3.57E-43
411.3,Angina pectoris,circulatory system,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.09 (1.07 1.10),6.00E-31
411.3,Angina pectoris,circulatory system,OPGS003058,0.022,Metabolon,sphingomyelin (d18:1/17:0. d17:1/18:0. d19:1/16:0),1.07 (1.06 1.08),6.77E-21
411.3,Angina pectoris,circulatory system,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.06 (1.05 1.08),1.34E-18
411.3,Angina pectoris,circulatory system,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.07 (1.05 1.08),1.68E-17
411.3,Angina pectoris,circulatory system,OPGS002951,0.041,Metabolon,stearoyl sphingomyelin (d18:1/18:0),1.04 (1.03 1.06),1.44E-08
411.3,Angina pectoris,circulatory system,OPGS003203,0.012,Metabolon,sphingomyelin (d18:2/23:0. d18:1/23:1. d17:1/24:1)*,1.04 (1.03 1.06),4.83E-08
411.3,Angina pectoris,circulatory system,OPGS002874,0.060,Metabolon,campesterol,1.04 (1.03 1.05),1.34E-07
411.3,Angina pectoris,circulatory system,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.04 (1.03 1.05),1.67E-07
411.3,Angina pectoris,circulatory system,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.04 (1.03 1.05),5.17E-07
411.3,Angina pectoris,circulatory system,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.04 (1.02 1.05),8.24E-06
411.3,Angina pectoris,circulatory system,OPGS002940,0.044,Metabolon,lactosyl-N-palmitoyl-sphingosine,1.04 (1.02 1.05),2.17E-05
411.3,Angina pectoris,circulatory system,OPGS002915,0.048,Metabolon,sphingomyelin (d18:1/20:0. d16:1/22:0)*,1.03 (1.02 1.05),2.35E-05
411.3,Angina pectoris,circulatory system,OPGS003151,0.014,Metabolon,1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2)*,1.03 (1.02 1.05),3.68E-05
411.3,Angina pectoris,circulatory system,OPGS003127,0.017,Metabolon,sphingomyelin (d18:1/22:1. d18:2/22:0. d16:1/24:1)*,1.03 (1.02 1.05),4.87E-05
411.3,Angina pectoris,circulatory system,OPGS003119,0.017,Metabolon,1-palmitoyl-GPC (16:0),1.03 (1.02 1.04),4.71E-04
411.3,Angina pectoris,circulatory system,OPGS002802,0.092,Metabolon,1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6)*,1.03 (1.02 1.04),1.02E-03
411.3,Angina pectoris,circulatory system,OPGS002943,0.043,Metabolon,2-palmitoyl-GPE (16:0)*,1.03 (1.02 1.04),1.33E-03
411.3,Angina pectoris,circulatory system,OPGS002860,0.066,Metabolon,1-palmitoyl-GPE (16:0),1.03 (1.01 1.04),1.89E-03
411.3,Angina pectoris,circulatory system,OPGS002770,0.124,Metabolon,1-stearoyl-2-arachidonoyl-GPE (18:0/20:4),1.03 (1.01 1.04),2.76E-03
411.3,Angina pectoris,circulatory system,OPGS002891,0.056,Metabolon,1-palmitoyl-2-oleoyl-GPE (16:0/18:1),1.03 (1.01 1.04),2.99E-03
411.3,Angina pectoris,circulatory system,OPGS002878,0.060,Metabolon,1-stearoyl-GPE (18:0),1.03 (1.01 1.04),3.79E-03
411.3,Angina pectoris,circulatory system,OPGS002982,0.033,Metabolon,X - 12681,0.97 (0.96 0.99),4.26E-03
411.3,Angina pectoris,circulatory system,OPGS002756,0.139,Metabolon,1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)*,1.03 (1.01 1.04),5.04E-03
411.3,Angina pectoris,circulatory system,OPGS002910,0.049,Metabolon,X - 24422,0.97 (0.96 0.99),5.43E-03
411.3,Angina pectoris,circulatory system,OPGS003200,0.012,Metabolon,threonine,0.98 (0.96 0.99),8.72E-03
411.3,Angina pectoris,circulatory system,OPGS002849,0.070,Metabolon,X - 16071,0.98 (0.96 0.99),8.72E-03
411.3,Angina pectoris,circulatory system,OPGS002988,0.033,Metabolon,2-stearoyl-GPE (18:0)*,1.03 (1.01 1.04),1.03E-02
411.3,Angina pectoris,circulatory system,OPGS003067,0.022,Metabolon,X - 12339,0.98 (0.96 0.99),1.05E-02
411.3,Angina pectoris,circulatory system,OPGS003197,0.012,Metabolon,1-stearoyl-GPC (18:0),1.03 (1.01 1.04),1.10E-02
411.3,Angina pectoris,circulatory system,OPGS003116,0.018,Metabolon,1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1)*,0.98 (0.96 0.99),1.14E-02
411.3,Angina pectoris,circulatory system,OPGS002842,0.073,Metabolon,glycosyl-N-palmitoyl-sphingosine,1.02 (1.01 1.04),1.28E-02
411.3,Angina pectoris,circulatory system,OPGS003217,0.011,Metabolon,X - 24024,1.02 (1.01 1.04),1.42E-02
411.3,Angina pectoris,circulatory system,OPGS003198,0.012,Metabolon,gamma-glutamylthreonine*,0.98 (0.96 0.99),1.45E-02
411.3,Angina pectoris,circulatory system,OPGS002745,0.154,Metabolon,isobutyrylcarnitine,0.98 (0.96 0.99),1.68E-02
411.3,Angina pectoris,circulatory system,OPGS002932,0.045,Metabolon,4-androsten-3beta.17beta-diol monosulfate (2),1.02 (1.01 1.04),1.96E-02
411.3,Angina pectoris,circulatory system,OPGS003000,0.031,Metabolon,1-stearoyl-2-oleoyl-GPE (18:0/18:1),1.02 (1.01 1.04),2.77E-02
411.3,Angina pectoris,circulatory system,OPGS002751,0.145,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)*,1.02 (1.01 1.04),2.78E-02
411.3,Angina pectoris,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.14 (1.13 1.16),4.25E-82
411.3,Angina pectoris,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.15 (1.13 1.16),1.83E-81
411.3,Angina pectoris,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.15 (1.13 1.16),1.87E-81
411.3,Angina pectoris,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.14 (1.13 1.16),1.87E-81
411.3,Angina pectoris,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.14 (1.13 1.16),3.91E-81
411.3,Angina pectoris,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.14 (1.13 1.16),3.91E-81
411.3,Angina pectoris,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.14 (1.13 1.16),3.91E-81
411.3,Angina pectoris,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.14 (1.12 1.15),1.18E-80
411.3,Angina pectoris,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.14 (1.13 1.16),1.18E-80
411.3,Angina pectoris,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.14 (1.13 1.16),1.28E-80
411.3,Angina pectoris,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.14 (1.13 1.16),1.78E-80
411.3,Angina pectoris,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.14 (1.13 1.16),1.99E-80
411.3,Angina pectoris,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.14 (1.13 1.16),2.67E-80
411.3,Angina pectoris,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.14 (1.13 1.16),4.20E-80
411.3,Angina pectoris,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.14 (1.13 1.16),1.16E-79
411.3,Angina pectoris,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.14 (1.13 1.16),1.27E-79
411.3,Angina pectoris,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.14 (1.13 1.16),1.26E-78
411.3,Angina pectoris,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.14 (1.13 1.16),5.54E-78
411.3,Angina pectoris,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.14 (1.13 1.16),6.01E-78
411.3,Angina pectoris,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.14 (1.13 1.16),8.23E-78
411.3,Angina pectoris,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.14 (1.13 1.16),9.14E-78
411.3,Angina pectoris,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.14 (1.13 1.16),1.17E-77
411.3,Angina pectoris,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.14 (1.12 1.16),1.20E-77
411.3,Angina pectoris,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.14 (1.12 1.16),1.47E-77
411.3,Angina pectoris,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.14 (1.12 1.15),7.73E-77
411.3,Angina pectoris,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.14 (1.12 1.15),1.89E-76
411.3,Angina pectoris,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.14 (1.12 1.15),2.94E-76
411.3,Angina pectoris,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.14 (1.13 1.16),3.17E-76
411.3,Angina pectoris,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.14 (1.12 1.15),4.70E-76
411.3,Angina pectoris,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.14 (1.12 1.15),1.59E-75
411.3,Angina pectoris,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.13 (1.12 1.15),1.00E-74
411.3,Angina pectoris,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.13 (1.12 1.15),2.56E-74
411.3,Angina pectoris,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.13 (1.12 1.15),9.32E-71
411.3,Angina pectoris,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.13 (1.11 1.14),3.02E-64
411.3,Angina pectoris,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.12 (1.11 1.14),1.62E-63
411.3,Angina pectoris,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.12 (1.11 1.14),2.75E-63
411.3,Angina pectoris,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.12 (1.10 1.13),1.46E-57
411.3,Angina pectoris,circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.11 (1.10 1.13),4.09E-53
411.3,Angina pectoris,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.11 (1.09 1.12),9.32E-49
411.3,Angina pectoris,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.11 (1.09 1.12),1.24E-48
411.3,Angina pectoris,circulatory system,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.10 (1.09 1.12),6.77E-45
411.3,Angina pectoris,circulatory system,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.10 (1.08 1.11),1.66E-41
411.3,Angina pectoris,circulatory system,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.10 (1.08 1.11),8.08E-40
411.3,Angina pectoris,circulatory system,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.09 (1.08 1.11),2.03E-39
411.3,Angina pectoris,circulatory system,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.09 (1.08 1.11),1.18E-38
411.3,Angina pectoris,circulatory system,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.09 (1.07 1.10),2.55E-32
411.3,Angina pectoris,circulatory system,OPGS003527,0.050,Nightingale,Sphingomyelins,1.09 (1.07 1.10),3.33E-32
411.3,Angina pectoris,circulatory system,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.08 (1.07 1.10),1.30E-29
411.3,Angina pectoris,circulatory system,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.08 (1.07 1.10),1.40E-29
411.3,Angina pectoris,circulatory system,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.08 (1.07 1.09),2.93E-28
411.3,Angina pectoris,circulatory system,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.08 (1.07 1.09),1.34E-27
411.3,Angina pectoris,circulatory system,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.08 (1.06 1.09),3.95E-27
411.3,Angina pectoris,circulatory system,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.07 (1.06 1.09),6.29E-25
411.3,Angina pectoris,circulatory system,OPGS003497,0.072,Nightingale,Linoleic acid,1.07 (1.06 1.09),1.50E-24
411.3,Angina pectoris,circulatory system,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.07 (1.06 1.08),1.88E-21
411.3,Angina pectoris,circulatory system,OPGS003523,0.062,Nightingale,Total fatty acids,1.07 (1.05 1.08),2.50E-20
411.3,Angina pectoris,circulatory system,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.94 (0.92 0.95),3.65E-20
411.3,Angina pectoris,circulatory system,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.94 (0.92 0.95),5.22E-20
411.3,Angina pectoris,circulatory system,OPGS003528,0.050,Nightingale,Total cholines,1.06 (1.05 1.08),1.96E-17
411.3,Angina pectoris,circulatory system,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.94 (0.93 0.95),9.28E-17
411.3,Angina pectoris,circulatory system,OPGS003520,0.062,Nightingale,HDL cholesterol,0.94 (0.93 0.96),3.96E-16
411.3,Angina pectoris,circulatory system,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.94 (0.93 0.96),6.15E-16
411.3,Angina pectoris,circulatory system,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.94 (0.93 0.96),9.26E-16
411.3,Angina pectoris,circulatory system,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.94 (0.93 0.96),1.97E-15
411.3,Angina pectoris,circulatory system,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.06 (1.04 1.07),3.40E-15
411.3,Angina pectoris,circulatory system,OPGS003509,0.069,Nightingale,Free cholesterol in chylomicrons and extremely large VLDL,0.95 (0.93 0.96),4.34E-15
411.3,Angina pectoris,circulatory system,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.95 (0.93 0.96),8.67E-15
411.3,Angina pectoris,circulatory system,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.06 (1.04 1.07),1.29E-14
411.3,Angina pectoris,circulatory system,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.06 (1.04 1.07),7.23E-14
411.3,Angina pectoris,circulatory system,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.95 (0.93 0.96),7.80E-14
411.3,Angina pectoris,circulatory system,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.06 (1.04 1.07),7.91E-14
411.3,Angina pectoris,circulatory system,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.95 (0.94 0.96),3.82E-13
411.3,Angina pectoris,circulatory system,OPGS003487,0.074,Nightingale,Phospholipids in chylomicrons and extremely large VLDL,0.95 (0.94 0.96),1.71E-12
411.3,Angina pectoris,circulatory system,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,0.95 (0.94 0.96),1.77E-12
411.3,Angina pectoris,circulatory system,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,0.95 (0.94 0.96),2.12E-12
411.3,Angina pectoris,circulatory system,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.95 (0.94 0.96),2.70E-12
411.3,Angina pectoris,circulatory system,OPGS003491,0.073,Nightingale,Total lipids in chylomicrons and extremely large VLDL,0.95 (0.94 0.96),2.95E-11
411.3,Angina pectoris,circulatory system,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.95 (0.94 0.96),3.06E-11
411.3,Angina pectoris,circulatory system,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.95 (0.94 0.97),1.60E-10
411.3,Angina pectoris,circulatory system,OPGS003526,0.050,Nightingale,Phosphatidylcholines,1.05 (1.03 1.06),4.23E-10
411.3,Angina pectoris,circulatory system,OPGS003462,0.083,Nightingale,Average diameter for VLDL particles,0.96 (0.94 0.97),6.60E-10
411.3,Angina pectoris,circulatory system,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.05 (1.03 1.06),8.13E-10
411.3,Angina pectoris,circulatory system,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.96 (0.94 0.97),2.19E-09
411.3,Angina pectoris,circulatory system,OPGS003542,0.028,Nightingale,Phospholipids in medium HDL,0.96 (0.95 0.97),1.17E-08
411.3,Angina pectoris,circulatory system,OPGS003504,0.070,Nightingale,Triglycerides in very large VLDL,0.96 (0.95 0.97),1.21E-08
411.3,Angina pectoris,circulatory system,OPGS003510,0.068,Nightingale,Cholesterol in chylomicrons and extremely large VLDL,0.96 (0.95 0.97),2.06E-08
411.3,Angina pectoris,circulatory system,OPGS003513,0.067,Nightingale,Free cholesterol in very large VLDL,0.96 (0.95 0.97),2.24E-08
411.3,Angina pectoris,circulatory system,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.96 (0.95 0.97),8.97E-08
411.3,Angina pectoris,circulatory system,OPGS003516,0.066,Nightingale,Phospholipids in very large VLDL,0.96 (0.95 0.97),9.94E-08
411.3,Angina pectoris,circulatory system,OPGS003500,0.071,Nightingale,Total lipids in very large VLDL,0.96 (0.95 0.97),1.16E-07
411.3,Angina pectoris,circulatory system,OPGS003506,0.070,Nightingale,Cholesterol in very large VLDL,0.96 (0.95 0.97),1.40E-07
411.3,Angina pectoris,circulatory system,OPGS003502,0.070,Nightingale,Concentration of very large VLDL particles,0.96 (0.95 0.97),1.51E-07
411.3,Angina pectoris,circulatory system,OPGS003496,0.072,Nightingale,Cholesteryl esters in very large VLDL,0.96 (0.95 0.97),5.02E-07
411.3,Angina pectoris,circulatory system,OPGS003448,0.093,Nightingale,Phospholipids in very large HDL,0.96 (0.95 0.97),5.07E-07
411.3,Angina pectoris,circulatory system,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,1.04 (1.03 1.05),1.22E-06
411.3,Angina pectoris,circulatory system,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,1.04 (1.02 1.05),6.82E-06
411.3,Angina pectoris,circulatory system,OPGS003540,0.029,Nightingale,Free cholesterol in small HDL,0.97 (0.95 0.98),1.00E-05
411.3,Angina pectoris,circulatory system,OPGS003518,0.065,Nightingale,Triglycerides in medium HDL,1.03 (1.02 1.05),3.07E-05
411.3,Angina pectoris,circulatory system,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.03 (1.02 1.05),6.25E-05
411.3,Angina pectoris,circulatory system,OPGS003476,0.076,Nightingale,Phospholipids in medium VLDL,1.03 (1.01 1.04),7.37E-03
411.3,Angina pectoris,circulatory system,OPGS003461,0.084,Nightingale,Total lipids in very large HDL,0.98 (0.96 0.99),9.11E-03
411.3,Angina pectoris,circulatory system,OPGS003457,0.086,Nightingale,Concentration of very large HDL particles,0.98 (0.96 0.99),1.00E-02
411.3,Angina pectoris,circulatory system,OPGS003486,0.074,Nightingale,Total triglycerides,1.03 (1.01 1.04),1.04E-02
411.3,Angina pectoris,circulatory system,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,0.98 (0.96 0.99),1.27E-02
411.3,Angina pectoris,circulatory system,OPGS003532,0.045,Nightingale,Apolipoprotein A1,0.98 (0.96 0.99),2.72E-02
411.3,Angina pectoris,circulatory system,OPGS005858,0.211,RNAseq,GGCX,1.04 (1.03 1.06),3.35E-08
411.3,Angina pectoris,circulatory system,OPGS004382,0.374,RNAseq,FES,0.96 (0.95 0.97),2.03E-07
411.3,Angina pectoris,circulatory system,OPGS006535,0.174,RNAseq,PSRC1,0.96 (0.95 0.97),2.98E-07
411.3,Angina pectoris,circulatory system,OPGS010653,0.059,RNAseq,CELSR2,1.04 (1.03 1.05),6.08E-07
411.3,Angina pectoris,circulatory system,OPGS007943,0.117,RNAseq,SLC22A1,0.97 (0.95 0.98),2.01E-05
411.3,Angina pectoris,circulatory system,OPGS012456,0.036,RNAseq,AC011944.2,0.97 (0.96 0.98),4.35E-05
411.3,Angina pectoris,circulatory system,OPGS011308,0.049,RNAseq,PI4K2B,0.97 (0.95 0.98),4.37E-05
411.3,Angina pectoris,circulatory system,OPGS010883,0.055,RNAseq,ZNF664,1.03 (1.02 1.05),7.69E-05
411.3,Angina pectoris,circulatory system,OPGS007717,0.125,RNAseq,GUCY1A1,0.97 (0.96 0.98),1.26E-04
411.3,Angina pectoris,circulatory system,OPGS011108,0.052,RNAseq,LDLR,0.97 (0.96 0.98),1.99E-04
411.3,Angina pectoris,circulatory system,OPGS009794,0.073,RNAseq,RN7SL473P,0.97 (0.96 0.98),4.19E-04
411.3,Angina pectoris,circulatory system,OPGS005687,0.222,RNAseq,CTSK,0.97 (0.96 0.98),4.50E-04
411.3,Angina pectoris,circulatory system,OPGS010700,0.058,RNAseq,DCLRE1B,0.97 (0.96 0.98),4.54E-04
411.3,Angina pectoris,circulatory system,OPGS013091,0.030,RNAseq,,0.97 (0.96 0.98),8.63E-04
411.3,Angina pectoris,circulatory system,OPGS013939,0.023,RNAseq,BATF2,1.03 (1.02 1.04),9.10E-04
411.3,Angina pectoris,circulatory system,OPGS011811,0.043,RNAseq,ZBTB46,0.97 (0.96 0.98),9.12E-04
411.3,Angina pectoris,circulatory system,OPGS008273,0.107,RNAseq,GRK4,1.03 (1.02 1.04),1.00E-03
411.3,Angina pectoris,circulatory system,OPGS013472,0.027,RNAseq,STAT1,1.03 (1.02 1.04),1.03E-03
411.3,Angina pectoris,circulatory system,OPGS006760,0.162,RNAseq,ZMYND12,1.03 (1.02 1.04),1.09E-03
411.3,Angina pectoris,circulatory system,OPGS011145,0.052,RNAseq,HOXC4,0.97 (0.96 0.98),1.37E-03
411.3,Angina pectoris,circulatory system,OPGS004949,0.293,RNAseq,ILRUN,1.03 (1.02 1.04),1.43E-03
411.3,Angina pectoris,circulatory system,OPGS010977,0.054,RNAseq,STPG1,0.97 (0.96 0.99),1.56E-03
411.3,Angina pectoris,circulatory system,OPGS004485,0.357,RNAseq,LPL,0.97 (0.96 0.99),1.83E-03
411.3,Angina pectoris,circulatory system,OPGS011044,0.053,RNAseq,AL359922.3,1.03 (1.02 1.04),1.89E-03
411.3,Angina pectoris,circulatory system,OPGS008628,0.098,RNAseq,DYM,0.97 (0.96 0.99),2.38E-03
411.3,Angina pectoris,circulatory system,OPGS013866,0.023,RNAseq,AC092755.2,1.03 (1.01 1.04),2.40E-03
411.3,Angina pectoris,circulatory system,OPGS012284,0.038,RNAseq,AC011446.1,1.03 (1.01 1.04),3.89E-03
411.3,Angina pectoris,circulatory system,OPGS011936,0.042,RNAseq,INTS10,0.97 (0.96 0.99),4.88E-03
411.3,Angina pectoris,circulatory system,OPGS011325,0.049,RNAseq,MLF2,1.03 (1.01 1.04),5.14E-03
411.3,Angina pectoris,circulatory system,OPGS015092,0.015,RNAseq,XRN2,0.97 (0.96 0.99),5.95E-03
411.3,Angina pectoris,circulatory system,OPGS009893,0.071,RNAseq,HORMAD1,0.97 (0.96 0.99),6.39E-03
411.3,Angina pectoris,circulatory system,OPGS006728,0.164,RNAseq,CHP1,0.97 (0.96 0.99),6.95E-03
411.3,Angina pectoris,circulatory system,OPGS011093,0.052,RNAseq,FAIM,0.97 (0.96 0.99),6.98E-03
411.3,Angina pectoris,circulatory system,OPGS008005,0.115,RNAseq,GNGT2,1.03 (1.01 1.04),7.18E-03
411.3,Angina pectoris,circulatory system,OPGS003708,0.594,RNAseq,HSD17B12,0.98 (0.96 0.99),8.52E-03
411.3,Angina pectoris,circulatory system,OPGS006621,0.169,RNAseq,NME7,0.98 (0.96 0.99),8.71E-03
411.3,Angina pectoris,circulatory system,OPGS006269,0.188,RNAseq,RALY-AS1,0.97 (0.96 0.99),8.72E-03
411.3,Angina pectoris,circulatory system,OPGS013409,0.027,RNAseq,MTAP,1.03 (1.01 1.04),9.03E-03
411.3,Angina pectoris,circulatory system,OPGS008562,0.100,RNAseq,SSR3,1.03 (1.01 1.04),9.11E-03
411.3,Angina pectoris,circulatory system,OPGS012732,0.033,RNAseq,AF165147.1,0.98 (0.96 0.99),9.31E-03
411.3,Angina pectoris,circulatory system,OPGS003660,0.627,RNAseq,SENP6,1.03 (1.01 1.04),9.31E-03
411.3,Angina pectoris,circulatory system,OPGS009408,0.081,RNAseq,,1.03 (1.01 1.04),9.47E-03
411.3,Angina pectoris,circulatory system,OPGS011003,0.054,RNAseq,RNF114,1.03 (1.01 1.04),1.04E-02
411.3,Angina pectoris,circulatory system,OPGS014221,0.021,RNAseq,HIC1,0.98 (0.96 0.99),1.04E-02
411.3,Angina pectoris,circulatory system,OPGS013276,0.028,RNAseq,ZNF346,1.02 (1.01 1.04),1.10E-02
411.3,Angina pectoris,circulatory system,OPGS003588,0.703,RNAseq,LIPA,1.02 (1.01 1.04),1.14E-02
411.3,Angina pectoris,circulatory system,OPGS011948,0.042,RNAseq,ADGRG1,0.98 (0.96 0.99),1.19E-02
411.3,Angina pectoris,circulatory system,OPGS007255,0.141,RNAseq,CD300A,1.03 (1.01 1.04),1.22E-02
411.3,Angina pectoris,circulatory system,OPGS011593,0.046,RNAseq,TUFT1,1.02 (1.01 1.04),1.22E-02
411.3,Angina pectoris,circulatory system,OPGS003925,0.496,RNAseq,OSER1,0.98 (0.96 0.99),1.31E-02
411.3,Angina pectoris,circulatory system,OPGS014341,0.020,RNAseq,NFAT5,1.02 (1.01 1.04),1.33E-02
411.3,Angina pectoris,circulatory system,OPGS014745,0.017,RNAseq,KIF3A,0.98 (0.96 0.99),1.33E-02
411.3,Angina pectoris,circulatory system,OPGS012730,0.033,RNAseq,CARM1,0.98 (0.96 0.99),1.34E-02
411.3,Angina pectoris,circulatory system,OPGS009105,0.087,RNAseq,ZNF589,0.98 (0.96 0.99),1.38E-02
411.3,Angina pectoris,circulatory system,OPGS008441,0.103,RNAseq,PTGS2,0.98 (0.96 0.99),1.43E-02
411.3,Angina pectoris,circulatory system,OPGS014814,0.017,RNAseq,DPY30,0.98 (0.96 0.99),1.53E-02
411.3,Angina pectoris,circulatory system,OPGS005141,0.273,RNAseq,TRAPPC4,1.02 (1.01 1.04),1.54E-02
411.3,Angina pectoris,circulatory system,OPGS004434,0.366,RNAseq,AC046185.3,1.02 (1.01 1.04),1.54E-02
411.3,Angina pectoris,circulatory system,OPGS014232,0.021,RNAseq,TRAV1-2,1.02 (1.01 1.04),1.54E-02
411.3,Angina pectoris,circulatory system,OPGS005829,0.213,RNAseq,MACF1,1.02 (1.01 1.04),1.54E-02
411.3,Angina pectoris,circulatory system,OPGS008235,0.108,RNAseq,AL109615.4,1.02 (1.01 1.04),1.59E-02
411.3,Angina pectoris,circulatory system,OPGS005747,0.218,RNAseq,AP000350.6,0.98 (0.96 0.99),1.59E-02
411.3,Angina pectoris,circulatory system,OPGS010780,0.057,RNAseq,GOLGA5,0.98 (0.96 0.99),1.59E-02
411.3,Angina pectoris,circulatory system,OPGS008661,0.097,RNAseq,ZNFX1,1.02 (1.01 1.04),1.67E-02
411.3,Angina pectoris,circulatory system,OPGS014645,0.018,RNAseq,ARHGEF12,1.02 (1.01 1.04),1.67E-02
411.3,Angina pectoris,circulatory system,OPGS013734,0.024,RNAseq,OAS2,1.02 (1.01 1.04),1.74E-02
411.3,Angina pectoris,circulatory system,OPGS014246,0.021,RNAseq,COX18,0.97 (0.96 0.99),1.74E-02
411.3,Angina pectoris,circulatory system,OPGS009087,0.088,RNAseq,THSD7A,1.02 (1.01 1.04),1.85E-02
411.3,Angina pectoris,circulatory system,OPGS010757,0.057,RNAseq,CACNG6,1.02 (1.01 1.04),1.95E-02
411.3,Angina pectoris,circulatory system,OPGS005161,0.270,RNAseq,GOT2,1.02 (1.01 1.04),1.98E-02
411.3,Angina pectoris,circulatory system,OPGS013792,0.024,RNAseq,YIPF2,1.02 (1.01 1.04),2.07E-02
411.3,Angina pectoris,circulatory system,OPGS010624,0.059,RNAseq,TRBV18,1.02 (1.01 1.04),2.08E-02
411.3,Angina pectoris,circulatory system,OPGS004943,0.293,RNAseq,,1.02 (1.01 1.04),2.14E-02
411.3,Angina pectoris,circulatory system,OPGS008865,0.093,RNAseq,AC240565.4,1.02 (1.01 1.04),2.18E-02
411.3,Angina pectoris,circulatory system,OPGS009862,0.072,RNAseq,Z69706.1,1.02 (1.01 1.04),2.28E-02
411.3,Angina pectoris,circulatory system,OPGS015027,0.016,RNAseq,AC104162.2,1.02 (1.01 1.04),2.28E-02
411.3,Angina pectoris,circulatory system,OPGS013170,0.029,RNAseq,N4BP2L2,0.98 (0.96 0.99),2.28E-02
411.3,Angina pectoris,circulatory system,OPGS009161,0.086,RNAseq,MRPS6,0.98 (0.97 0.99),2.30E-02
411.3,Angina pectoris,circulatory system,OPGS007122,0.147,RNAseq,FLT1,1.02 (1.01 1.04),2.31E-02
411.3,Angina pectoris,circulatory system,OPGS012674,0.034,RNAseq,MYD88,0.98 (0.96 0.99),2.32E-02
411.3,Angina pectoris,circulatory system,OPGS009077,0.088,RNAseq,DDAH2,0.98 (0.96 0.99),2.49E-02
411.3,Angina pectoris,circulatory system,OPGS013823,0.024,RNAseq,SERGEF,1.02 (1.01 1.04),2.50E-02
411.3,Angina pectoris,circulatory system,OPGS012171,0.039,RNAseq,TRBV15,0.98 (0.96 0.99),2.53E-02
411.3,Angina pectoris,circulatory system,OPGS014440,0.019,RNAseq,C19orf38,1.02 (1.01 1.04),2.70E-02
411.3,Angina pectoris,circulatory system,OPGS010520,0.061,RNAseq,AC009118.3,0.98 (0.96 0.99),2.71E-02
411.3,Angina pectoris,circulatory system,OPGS006152,0.194,RNAseq,ITGB3,1.02 (1.01 1.04),2.72E-02
411.3,Angina pectoris,circulatory system,OPGS011110,0.052,RNAseq,CMTM2,1.02 (1.01 1.04),2.72E-02
411.3,Angina pectoris,circulatory system,OPGS009146,0.087,RNAseq,FBXL3,1.02 (1.01 1.04),2.79E-02
411.3,Angina pectoris,circulatory system,OPGS007220,0.143,RNAseq,TAF1A,1.02 (1.01 1.04),2.79E-02
411.3,Angina pectoris,circulatory system,OPGS011037,0.053,RNAseq,TMEM170A,0.98 (0.96 0.99),2.79E-02
411.3,Angina pectoris,circulatory system,OPGS005124,0.274,RNAseq,CPQ,1.02 (1.01 1.04),2.79E-02
411.3,Angina pectoris,circulatory system,OPGS012628,0.034,RNAseq,RMC1,0.98 (0.96 0.99),2.79E-02
411.3,Angina pectoris,circulatory system,OPGS007082,0.149,RNAseq,PHIP,1.02 (1.01 1.04),2.87E-02
411.3,Angina pectoris,circulatory system,OPGS010012,0.069,RNAseq,UBC,0.98 (0.96 0.99),2.89E-02
411.3,Angina pectoris,circulatory system,OPGS010092,0.068,RNAseq,STAC3,0.98 (0.97 0.99),2.94E-02
411.3,Angina pectoris,circulatory system,OPGS010692,0.058,RNAseq,IPO9,0.98 (0.96 0.99),2.96E-02
411.3,Angina pectoris,circulatory system,OPGS009279,0.084,RNAseq,PKN2-AS1,1.02 (1.01 1.04),3.03E-02
411.3,Angina pectoris,circulatory system,OPGS013942,0.023,RNAseq,ZHX3,1.02 (1.01 1.04),3.04E-02
411.3,Angina pectoris,circulatory system,OPGS009578,0.077,RNAseq,PGAM5,0.98 (0.97 0.99),3.08E-02
411.3,Angina pectoris,circulatory system,OPGS010949,0.055,RNAseq,AC008897.3,0.98 (0.97 0.99),3.17E-02
411.3,Angina pectoris,circulatory system,OPGS008369,0.105,RNAseq,ADM,1.02 (1.01 1.04),3.19E-02
411.3,Angina pectoris,circulatory system,OPGS012787,0.033,RNAseq,FURIN,1.02 (1.01 1.04),3.31E-02
411.3,Angina pectoris,circulatory system,OPGS013817,0.024,RNAseq,MYADM,0.98 (0.97 0.99),3.31E-02
411.3,Angina pectoris,circulatory system,OPGS009089,0.088,RNAseq,TOB1,1.02 (1.01 1.04),3.32E-02
411.3,Angina pectoris,circulatory system,OPGS012400,0.037,RNAseq,LAMP3,0.98 (0.96 0.99),3.35E-02
411.3,Angina pectoris,circulatory system,OPGS009723,0.074,RNAseq,SGSM1,0.98 (0.96 0.99),3.40E-02
411.3,Angina pectoris,circulatory system,OPGS008141,0.111,RNAseq,CRYL1,0.98 (0.97 0.99),3.55E-02
411.3,Angina pectoris,circulatory system,OPGS009856,0.072,RNAseq,JADE1,0.98 (0.97 0.99),3.69E-02
411.3,Angina pectoris,circulatory system,OPGS008833,0.093,RNAseq,OBSL1,0.98 (0.96 0.99),3.74E-02
411.3,Angina pectoris,circulatory system,OPGS011619,0.046,RNAseq,AC104113.1,1.02 (1.01 1.04),3.75E-02
411.3,Angina pectoris,circulatory system,OPGS006717,0.164,RNAseq,AC144652.1,1.02 (1.01 1.04),3.91E-02
411.3,Angina pectoris,circulatory system,OPGS006344,0.184,RNAseq,ABITRAM,1.02 (1.01 1.04),3.91E-02
411.3,Angina pectoris,circulatory system,OPGS008678,0.097,RNAseq,DHODH,1.02 (1.01 1.04),3.91E-02
411.3,Angina pectoris,circulatory system,OPGS010661,0.059,RNAseq,PTPN22,1.02 (1.01 1.04),3.92E-02
411.3,Angina pectoris,circulatory system,OPGS010210,0.066,RNAseq,DCAF16,0.98 (0.97 0.99),3.95E-02
411.3,Angina pectoris,circulatory system,OPGS007014,0.151,RNAseq,C10orf88,0.98 (0.97 0.99),4.03E-02
411.3,Angina pectoris,circulatory system,OPGS014197,0.021,RNAseq,GOSR2,0.98 (0.96 0.99),4.03E-02
411.3,Angina pectoris,circulatory system,OPGS014986,0.016,RNAseq,AC124016.3,0.98 (0.97 0.99),4.10E-02
411.3,Angina pectoris,circulatory system,OPGS007873,0.119,RNAseq,PAFAH1B1,0.98 (0.97 0.99),4.10E-02
411.3,Angina pectoris,circulatory system,OPGS013571,0.026,RNAseq,ERMAP,0.98 (0.97 0.99),4.12E-02
411.3,Angina pectoris,circulatory system,OPGS014010,0.022,RNAseq,CYTH1,0.98 (0.97 0.99),4.12E-02
411.3,Angina pectoris,circulatory system,OPGS007475,0.133,RNAseq,RIDA,1.02 (1.01 1.04),4.20E-02
411.3,Angina pectoris,circulatory system,OPGS011785,0.044,RNAseq,FUT8-AS1,1.02 (1.01 1.04),4.21E-02
411.3,Angina pectoris,circulatory system,OPGS010078,0.068,RNAseq,SLC12A3,1.02 (1.01 1.04),4.22E-02
411.3,Angina pectoris,circulatory system,OPGS012347,0.037,RNAseq,RFC3,0.98 (0.97 0.99),4.41E-02
411.3,Angina pectoris,circulatory system,OPGS008555,0.100,RNAseq,CALCRL,1.02 (1.01 1.04),4.41E-02
411.3,Angina pectoris,circulatory system,OPGS012279,0.038,RNAseq,CDKN2A,0.98 (0.97 0.99),4.43E-02
411.3,Angina pectoris,circulatory system,OPGS010507,0.061,RNAseq,EXTL3,0.98 (0.97 0.99),4.45E-02
411.3,Angina pectoris,circulatory system,OPGS004112,0.433,RNAseq,HLA-F,1.02 (1.01 1.04),4.50E-02
411.3,Angina pectoris,circulatory system,OPGS008223,0.108,RNAseq,TMEM106B,1.02 (1.01 1.04),4.51E-02
411.3,Angina pectoris,circulatory system,OPGS010402,0.062,RNAseq,,1.02 (1.01 1.04),4.55E-02
411.3,Angina pectoris,circulatory system,OPGS004125,0.429,RNAseq,UHRF1BP1,1.02 (1.01 1.04),4.61E-02
411.3,Angina pectoris,circulatory system,OPGS014669,0.018,RNAseq,CDKN3,1.02 (1.01 1.04),4.61E-02
411.3,Angina pectoris,circulatory system,OPGS013485,0.027,RNAseq,,1.02 (1.01 1.04),4.61E-02
411.3,Angina pectoris,circulatory system,OPGS007123,0.147,RNAseq,LMF2,1.02 (1.01 1.04),4.80E-02
411.3,Angina pectoris,circulatory system,OPGS008102,0.112,RNAseq,TXNDC16,0.98 (0.97 0.99),4.81E-02
411.3,Angina pectoris,circulatory system,OPGS006024,0.202,RNAseq,TNFRSF18,1.02 (1.01 1.04),4.84E-02
411.3,Angina pectoris,circulatory system,OPGS013364,0.027,RNAseq,PHF19,1.02 (1.01 1.04),4.91E-02
411.3,Angina pectoris,circulatory system,OPGS014382,0.020,RNAseq,MIR3936HG,0.98 (0.96 0.99),4.98E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000115,0.347,SomaScan,Protein CEI,1.09 (1.07 1.10),8.63E-41
411.4,Coronary atherosclerosis,circulatory system,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.08 (1.07 1.10),2.65E-39
411.4,Coronary atherosclerosis,circulatory system,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.08 (1.07 1.10),3.43E-39
411.4,Coronary atherosclerosis,circulatory system,OPGS000312,0.163,SomaScan,Selenoprotein S,1.09 (1.07 1.10),2.73E-38
411.4,Coronary atherosclerosis,circulatory system,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.08 (1.07 1.09),6.72E-37
411.4,Coronary atherosclerosis,circulatory system,OPGS000613,0.096,SomaScan,Stromelysin-1,1.08 (1.07 1.10),1.96E-35
411.4,Coronary atherosclerosis,circulatory system,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.08 (1.07 1.09),3.20E-34
411.4,Coronary atherosclerosis,circulatory system,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.08 (1.07 1.09),1.82E-33
411.4,Coronary atherosclerosis,circulatory system,OPGS000857,0.067,SomaScan,Moesin,1.07 (1.06 1.09),3.44E-33
411.4,Coronary atherosclerosis,circulatory system,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.07 (1.06 1.09),4.75E-33
411.4,Coronary atherosclerosis,circulatory system,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.07 (1.06 1.09),1.40E-29
411.4,Coronary atherosclerosis,circulatory system,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.07 (1.06 1.08),1.79E-29
411.4,Coronary atherosclerosis,circulatory system,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.07 (1.06 1.08),3.40E-28
411.4,Coronary atherosclerosis,circulatory system,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.93 (0.92 0.94),4.37E-26
411.4,Coronary atherosclerosis,circulatory system,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.06 (1.05 1.08),5.34E-26
411.4,Coronary atherosclerosis,circulatory system,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.07 (1.06 1.08),1.97E-25
411.4,Coronary atherosclerosis,circulatory system,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.06 (1.05 1.08),2.15E-25
411.4,Coronary atherosclerosis,circulatory system,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.07 (1.05 1.08),5.28E-24
411.4,Coronary atherosclerosis,circulatory system,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.07 (1.05 1.08),2.34E-23
411.4,Coronary atherosclerosis,circulatory system,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.06 (1.05 1.07),2.81E-23
411.4,Coronary atherosclerosis,circulatory system,OPGS002108,0.012,SomaScan,Neuralized-like protein 4,1.07 (1.05 1.08),1.48E-22
411.4,Coronary atherosclerosis,circulatory system,OPGS000285,0.176,SomaScan,Complement C1q tumor necrosis factor-related protein 1,1.06 (1.05 1.08),1.59E-22
411.4,Coronary atherosclerosis,circulatory system,OPGS000154,0.277,SomaScan,Granulins,1.06 (1.05 1.08),3.06E-22
411.4,Coronary atherosclerosis,circulatory system,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.06 (1.05 1.07),8.02E-22
411.4,Coronary atherosclerosis,circulatory system,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,0.94 (0.93 0.95),4.00E-21
411.4,Coronary atherosclerosis,circulatory system,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.06 (1.05 1.07),4.00E-21
411.4,Coronary atherosclerosis,circulatory system,OPGS000445,0.129,SomaScan,Collectin-10,0.94 (0.93 0.95),1.61E-20
411.4,Coronary atherosclerosis,circulatory system,OPGS001392,0.029,SomaScan,Cadherin-related family member 5,1.06 (1.05 1.08),1.74E-20
411.4,Coronary atherosclerosis,circulatory system,OPGS000348,0.151,SomaScan,Quinone oxidoreductase-like protein 1,1.06 (1.05 1.07),1.06E-19
411.4,Coronary atherosclerosis,circulatory system,OPGS000860,0.066,SomaScan,Cell surface glycoprotein CD200 receptor 2,0.94 (0.93 0.95),1.66E-19
411.4,Coronary atherosclerosis,circulatory system,OPGS001058,0.049,SomaScan,Protocadherin beta-10,1.06 (1.05 1.07),1.98E-19
411.4,Coronary atherosclerosis,circulatory system,OPGS000172,0.257,SomaScan,Dermokine,0.95 (0.93 0.96),2.22E-18
411.4,Coronary atherosclerosis,circulatory system,OPGS000883,0.064,SomaScan,Group XIIB secretory phospholipase A2-like protein,1.06 (1.04 1.07),2.44E-18
411.4,Coronary atherosclerosis,circulatory system,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,0.94 (0.93 0.96),9.74E-18
411.4,Coronary atherosclerosis,circulatory system,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.06 (1.04 1.07),2.61E-17
411.4,Coronary atherosclerosis,circulatory system,OPGS000492,0.119,SomaScan,Inactive gamma-glutamyltranspeptidase 2,1.06 (1.04 1.07),5.52E-17
411.4,Coronary atherosclerosis,circulatory system,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.95 (0.94 0.96),8.60E-17
411.4,Coronary atherosclerosis,circulatory system,OPGS000577,0.102,SomaScan,Platelet-activating factor acetylhydrolase,1.05 (1.04 1.06),2.55E-16
411.4,Coronary atherosclerosis,circulatory system,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,0.95 (0.94 0.96),3.18E-16
411.4,Coronary atherosclerosis,circulatory system,OPGS001963,0.013,SomaScan,Annexin A9,1.05 (1.04 1.07),1.04E-15
411.4,Coronary atherosclerosis,circulatory system,OPGS001093,0.046,SomaScan,C-reactive protein,0.95 (0.94 0.96),1.90E-15
411.4,Coronary atherosclerosis,circulatory system,OPGS001297,0.034,SomaScan,Neogenin,0.95 (0.94 0.96),2.20E-15
411.4,Coronary atherosclerosis,circulatory system,OPGS001279,0.035,SomaScan,Four-jointed box protein 1,1.05 (1.04 1.06),2.43E-15
411.4,Coronary atherosclerosis,circulatory system,OPGS000510,0.115,SomaScan,Guanine nucleotide-binding protein G(k) subunit alpha,0.95 (0.94 0.96),2.48E-15
411.4,Coronary atherosclerosis,circulatory system,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.05 (1.04 1.06),3.77E-15
411.4,Coronary atherosclerosis,circulatory system,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.05 (1.04 1.06),5.83E-15
411.4,Coronary atherosclerosis,circulatory system,OPGS001437,0.028,SomaScan,Steroidogenic acute regulatory protein. mitochondrial,1.05 (1.04 1.06),8.49E-15
411.4,Coronary atherosclerosis,circulatory system,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.95 (0.94 0.96),1.95E-14
411.4,Coronary atherosclerosis,circulatory system,OPGS001002,0.053,SomaScan,Tumor protein p53-inducible protein 11,1.05 (1.04 1.06),1.44E-13
411.4,Coronary atherosclerosis,circulatory system,OPGS001715,0.019,SomaScan,Histone deacetylase 8,1.05 (1.04 1.06),2.71E-13
411.4,Coronary atherosclerosis,circulatory system,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.05 (1.04 1.06),3.21E-13
411.4,Coronary atherosclerosis,circulatory system,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.05 (1.04 1.06),6.13E-13
411.4,Coronary atherosclerosis,circulatory system,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.05 (1.03 1.06),2.20E-12
411.4,Coronary atherosclerosis,circulatory system,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.05 (1.03 1.06),2.44E-12
411.4,Coronary atherosclerosis,circulatory system,OPGS001112,0.045,SomaScan,Hemojuvelin,1.05 (1.03 1.06),3.06E-12
411.4,Coronary atherosclerosis,circulatory system,OPGS001144,0.043,SomaScan,Proprotein convertase subtilisin/kexin type 9,1.05 (1.04 1.06),5.77E-12
411.4,Coronary atherosclerosis,circulatory system,OPGS001252,0.036,SomaScan,Neuronal pentraxin-2,1.04 (1.03 1.06),1.17E-11
411.4,Coronary atherosclerosis,circulatory system,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.04 (1.03 1.06),1.54E-11
411.4,Coronary atherosclerosis,circulatory system,OPGS000401,0.139,SomaScan,Hemoglobin subunit theta-1,1.04 (1.03 1.06),6.01E-11
411.4,Coronary atherosclerosis,circulatory system,OPGS001377,0.030,SomaScan,Vascular cell adhesion protein 1,1.04 (1.03 1.05),4.82E-10
411.4,Coronary atherosclerosis,circulatory system,OPGS000838,0.069,SomaScan,DNA/RNA-binding protein KIN17,0.96 (0.95 0.97),5.88E-10
411.4,Coronary atherosclerosis,circulatory system,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.04 (1.03 1.05),1.21E-09
411.4,Coronary atherosclerosis,circulatory system,OPGS001041,0.050,SomaScan,RING finger protein 122,1.04 (1.03 1.05),2.93E-09
411.4,Coronary atherosclerosis,circulatory system,OPGS000874,0.065,SomaScan,Carbonic anhydrase-related protein 10,1.04 (1.03 1.05),4.45E-09
411.4,Coronary atherosclerosis,circulatory system,OPGS001464,0.027,SomaScan,Platelet glycoprotein Ib alpha chain,1.04 (1.03 1.05),1.68E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.04 (1.03 1.05),3.09E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.04 (1.02 1.05),4.64E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS001106,0.046,SomaScan,Disintegrin and metalloproteinase domain-containing protein 11,1.04 (1.02 1.05),1.17E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS002321,0.010,SomaScan,Fibronectin Fragment 3,0.97 (0.95 0.98),1.20E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS002093,0.012,SomaScan,Fibronectin,0.97 (0.96 0.98),2.49E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS000911,0.062,SomaScan,Protein MENT,1.03 (1.02 1.05),1.36E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS000715,0.082,SomaScan,Surfeit locus protein 1,1.03 (1.02 1.04),1.48E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS000022,0.602,SomaScan,Interleukin-6 receptor subunit alpha,0.97 (0.96 0.98),2.65E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS000020,0.609,SomaScan,Interleukin-6 receptor subunit alpha,0.97 (0.96 0.98),3.35E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS000951,0.057,SomaScan,Pseudokinase FAM20A,0.97 (0.96 0.98),4.46E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.97 (0.96 0.98),7.03E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS000141,0.306,SomaScan,Complement C1s subcomponent,1.03 (1.02 1.04),2.96E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS000927,0.059,SomaScan,Neuropilin-1,0.97 (0.96 0.98),3.17E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS001007,0.053,SomaScan,Neuropilin-1,0.97 (0.96 0.98),4.22E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS001121,0.044,SomaScan,Growth factor receptor-bound protein 7,0.97 (0.96 0.98),7.25E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS001518,0.025,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,1.03 (1.02 1.04),9.70E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS001354,0.031,SomaScan,M-phase inducer phosphatase 2,1.03 (1.02 1.04),1.03E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS000717,0.082,SomaScan,Zinc finger protein 175,0.97 (0.96 0.98),1.27E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,0.97 (0.96 0.98),1.58E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS001879,0.015,SomaScan,Arfaptin-2,1.03 (1.02 1.04),1.60E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS002186,0.011,SomaScan,Suprabasin,0.97 (0.96 0.98),1.60E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,0.97 (0.96 0.98),1.62E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS000417,0.135,SomaScan,UDP-GlcNAc:betaGal beta-1.3-N-acetylglucosaminyltransferase 8,0.97 (0.96 0.98),1.65E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS001365,0.030,SomaScan,Leukocyte cell-derived chemotaxin 1,0.97 (0.96 0.98),1.74E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS001129,0.044,SomaScan,Sodium-coupled monocarboxylate transporter 1,1.03 (1.02 1.04),1.96E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.03 (1.02 1.04),2.35E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS001124,0.044,SomaScan,Tumor necrosis factor receptor type 1-associated DEATH domain protein,1.03 (1.02 1.04),2.35E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS000092,0.387,SomaScan,Hepatocyte growth factor activator,0.97 (0.96 0.98),2.70E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS001977,0.013,SomaScan,C-C motif chemokine 4-like,1.03 (1.02 1.04),2.88E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS001092,0.046,SomaScan,TOM1-like protein 1,1.03 (1.02 1.04),4.08E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS001102,0.046,SomaScan,Granzyme A,1.03 (1.01 1.04),4.43E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS000068,0.438,SomaScan,Hepatocyte growth factor activator,0.97 (0.96 0.99),4.94E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS000544,0.108,SomaScan,Segment polarity protein dishevelled homolog DVL-2,1.03 (1.01 1.04),6.07E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS000250,0.192,SomaScan,Complement C1r subcomponent,1.03 (1.01 1.04),1.22E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.03 (1.01 1.04),1.32E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS000427,0.132,SomaScan,Adhesion G-protein coupled receptor F1,1.02 (1.01 1.04),1.53E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.02 (1.01 1.04),1.88E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS000998,0.053,SomaScan,Tyrosine-protein phosphatase non-receptor type 4,1.02 (1.01 1.04),2.41E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.02 (1.01 1.04),2.87E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS001578,0.023,SomaScan,Serpin A9,1.02 (1.01 1.04),3.52E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS000044,0.517,SomaScan,Chymotrypsinogen B2,1.02 (1.01 1.04),3.77E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.98 (0.97 0.99),3.77E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS002292,0.010,SomaScan,Interleukin-18-binding protein,0.98 (0.96 0.99),5.48E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS002270,0.010,SomaScan,Tumor necrosis factor receptor superfamily member 21,0.98 (0.96 0.99),5.48E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS001840,0.016,SomaScan,Inactive pancreatic lipase-related protein 1,1.02 (1.01 1.04),5.93E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.02 (1.01 1.03),8.00E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS000901,0.063,SomaScan,Ski-like protein,1.02 (1.01 1.03),8.92E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS001501,0.025,SomaScan,Hemoglobin,1.02 (1.01 1.03),9.49E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS000346,0.151,SomaScan,N-acetyllactosaminide beta-1.3-N-acetylglucosaminyltransferase 2,1.02 (1.01 1.03),9.49E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS001937,0.014,SomaScan,Protocadherin gamma-B1,1.02 (1.01 1.03),9.62E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS000159,0.271,SomaScan,39S ribosomal protein L33. mitochondrial,0.98 (0.97 0.99),9.97E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS000272,0.183,SomaScan,Alpha-1-antitrypsin,1.02 (1.01 1.03),1.01E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001208,0.038,SomaScan,Macrophage colony-stimulating factor 1 receptor,0.98 (0.97 0.99),1.03E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,0.98 (0.97 0.99),1.03E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000439,0.130,SomaScan,Vitamin K-dependent protein C,0.98 (0.97 0.99),1.04E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000500,0.118,SomaScan,Synaptosomal-associated protein 25,0.98 (0.97 0.99),1.17E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000145,0.292,SomaScan,Cathepsin H,0.98 (0.97 0.99),1.20E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001286,0.034,SomaScan,Granzyme K,1.02 (1.01 1.03),1.35E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001671,0.020,SomaScan,Tumor necrosis factor ligand superfamily member 6. soluble form,0.98 (0.97 0.99),1.35E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001238,0.037,SomaScan,Dedicator of cytokinesis protein 9,1.02 (1.01 1.03),1.37E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000935,0.059,SomaScan,Vitronectin,0.98 (0.97 0.99),1.47E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001818,0.017,SomaScan,Dynactin subunit 2,1.02 (1.01 1.03),1.47E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002046,0.012,SomaScan,Set1/Ash2 histone methyltransferase complex subunit ASH2,1.02 (1.01 1.03),1.57E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000632,0.093,SomaScan,Erythrocyte band 7 integral membrane protein,1.02 (1.01 1.03),1.58E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001553,0.024,SomaScan,Protein G6b,1.02 (1.01 1.03),1.67E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000283,0.177,SomaScan,Cathelicidin antimicrobial peptide,1.02 (1.01 1.03),1.72E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000173,0.257,SomaScan,Janus kinase and microtubule-interacting protein 3,1.02 (1.01 1.03),1.77E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000698,0.085,SomaScan,Alcohol dehydrogenase 1B,1.02 (1.01 1.03),1.92E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001803,0.017,SomaScan,Matrix Gla protein,0.98 (0.97 0.99),2.14E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.98 (0.97 0.99),2.16E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001615,0.022,SomaScan,Cerebral cavernous malformations 2 protein,0.98 (0.97 0.99),2.44E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,1.02 (1.01 1.03),2.44E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001516,0.025,SomaScan,Tumor necrosis factor ligand superfamily member 8,0.98 (0.97 0.99),2.52E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001306,0.033,SomaScan,Macrophage colony-stimulating factor 1 receptor,0.98 (0.97 0.99),2.74E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000111,0.357,SomaScan,Collectin-11,1.02 (1.01 1.03),2.75E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000825,0.070,SomaScan,Spondin-1,1.02 (1.01 1.03),2.79E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.98 (0.97 0.99),2.96E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001831,0.016,SomaScan,SUN domain-containing protein 3,1.02 (1.01 1.03),3.27E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002204,0.011,SomaScan,Rho-related GTP-binding protein RhoG,1.02 (1.01 1.03),3.35E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,0.98 (0.97 0.99),3.35E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000969,0.056,SomaScan,Transferrin receptor protein 1,1.02 (1.01 1.03),3.63E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,1.02 (1.01 1.03),3.63E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001950,0.014,SomaScan,Apolipoprotein A-V,0.98 (0.97 0.99),3.91E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000163,0.269,SomaScan,Single Ig IL-1-related receptor,1.02 (1.01 1.03),3.95E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001469,0.027,SomaScan,EH domain-binding protein 1,1.02 (1.01 1.03),4.05E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001928,0.014,SomaScan,Sorting nexin-1,1.02 (1.01 1.03),4.06E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001216,0.038,SomaScan,C-type mannose receptor 2,0.98 (0.97 0.99),4.16E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000658,0.089,SomaScan,Ubiquitin carboxyl-terminal hydrolase isozyme L1,0.98 (0.97 0.99),4.19E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001985,0.013,SomaScan,Isochorismatase domain-containing protein 1,1.02 (1.01 1.03),4.19E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001652,0.021,SomaScan,Galectin-7,1.02 (1.01 1.03),4.31E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001833,0.016,SomaScan,Interleukin-1 receptor antagonist protein,1.02 (1.01 1.03),4.56E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000452,0.127,SomaScan,C-C motif chemokine 17,1.02 (1.01 1.03),4.89E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001828,0.016,SomaScan,Splicing factor 1,1.02 (1.01 1.03),4.92E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS001617,0.022,SomaScan,Nutritionally-regulated adipose and cardiac enriched protein homolog,1.02 (1.01 1.03),4.97E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS000229,0.207,SomaScan,Interleukin-19,1.02 (1.01 1.03),4.97E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002436,0.191,Olink,Progranulin,1.06 (1.04 1.07),5.41E-18
411.4,Coronary atherosclerosis,circulatory system,OPGS002558,0.048,Olink,Proprotein convertase subtilisin/kexin type 9,1.04 (1.03 1.05),1.07E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS002585,0.037,Olink,T-cell surface glycoprotein CD5,1.04 (1.03 1.05),1.28E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS002656,0.013,Olink,Angiotensin-converting enzyme 2,0.96 (0.95 0.97),1.65E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS002552,0.053,Olink,Low-density lipoprotein receptor,0.96 (0.95 0.97),1.79E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS002435,0.193,Olink,Fibroblast growth factor 5,1.04 (1.02 1.05),1.20E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS002617,0.026,Olink,C-X-C motif chemokine 9,1.04 (1.02 1.05),2.95E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS002387,0.541,Olink,Interleukin-6 receptor subunit alpha,0.97 (0.96 0.98),4.50E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS002613,0.027,Olink,Interleukin-6,0.97 (0.96 0.98),6.49E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS002600,0.030,Olink,Heme oxygenase 1,0.97 (0.96 0.98),1.42E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS002633,0.021,Olink,C-X-C motif chemokine 11,1.03 (1.02 1.04),1.92E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS002608,0.028,Olink,Integrin beta-2,1.03 (1.02 1.04),2.51E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS002663,0.011,Olink,C-type lectin domain family 1 member B,1.03 (1.01 1.04),8.07E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS002645,0.017,Olink,Carboxypeptidase A1,1.03 (1.01 1.04),9.68E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS002662,0.011,Olink,Protein-glutamine gamma-glutamyltransferase 2,0.98 (0.97 0.99),2.49E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS002568,0.043,Olink,Granzyme A,1.02 (1.01 1.04),3.77E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS002661,0.011,Olink,Platelet-derived growth factor subunit A,1.02 (1.01 1.03),5.67E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS002660,0.012,Olink,Angiopoietin-1,1.02 (1.01 1.03),6.23E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS002649,0.016,Olink,Platelet-derived growth factor subunit B,1.02 (1.01 1.03),7.10E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS002653,0.015,Olink,CD40 ligand,1.02 (1.01 1.03),7.47E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS002432,0.195,Olink,Cathepsin S,1.02 (1.01 1.03),9.68E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS002602,0.030,Olink,Fatty acid-binding protein. intestinal,0.98 (0.97 0.99),1.10E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002580,0.039,Olink,Dickkopf-related protein 4,0.98 (0.97 0.99),1.52E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002543,0.061,Olink,Netrin receptor UNC5C,1.02 (1.01 1.03),1.81E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002540,0.062,Olink,Plexin-B1,0.98 (0.97 0.99),2.51E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002396,0.361,Olink,Tumor necrosis factor receptor superfamily member 10C,0.98 (0.97 0.99),2.85E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002482,0.125,Olink,Tumor necrosis factor ligand superfamily member 10,0.98 (0.97 0.99),3.23E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002637,0.020,Olink,Bone morphogenetic protein 4,0.98 (0.97 0.99),3.35E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002652,0.015,Olink,Dickkopf-related protein 1,1.02 (1.01 1.03),4.06E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002542,0.061,Olink,C-X-C motif chemokine 10,1.02 (1.01 1.03),4.19E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002629,0.023,Olink,Interleukin-18-binding protein,1.02 (1.01 1.03),4.85E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002474,0.135,Olink,C-C motif chemokine 4,1.02 (1.01 1.03),4.90E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.11 (1.10 1.13),4.63E-68
411.4,Coronary atherosclerosis,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.10 (1.09 1.12),1.15E-56
411.4,Coronary atherosclerosis,circulatory system,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.09 (1.08 1.11),1.87E-47
411.4,Coronary atherosclerosis,circulatory system,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.08 (1.07 1.09),1.05E-38
411.4,Coronary atherosclerosis,circulatory system,OPGS003058,0.022,Metabolon,sphingomyelin (d18:1/17:0. d17:1/18:0. d19:1/16:0),1.07 (1.06 1.08),1.63E-26
411.4,Coronary atherosclerosis,circulatory system,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.06 (1.04 1.07),2.74E-19
411.4,Coronary atherosclerosis,circulatory system,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.06 (1.05 1.07),2.36E-17
411.4,Coronary atherosclerosis,circulatory system,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.05 (1.04 1.07),2.97E-17
411.4,Coronary atherosclerosis,circulatory system,OPGS002874,0.060,Metabolon,campesterol,1.05 (1.03 1.06),3.00E-12
411.4,Coronary atherosclerosis,circulatory system,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.04 (1.03 1.06),7.33E-12
411.4,Coronary atherosclerosis,circulatory system,OPGS002951,0.041,Metabolon,stearoyl sphingomyelin (d18:1/18:0),1.04 (1.03 1.06),3.02E-11
411.4,Coronary atherosclerosis,circulatory system,OPGS002940,0.044,Metabolon,lactosyl-N-palmitoyl-sphingosine,1.04 (1.03 1.05),1.59E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS003203,0.012,Metabolon,sphingomyelin (d18:2/23:0. d18:1/23:1. d17:1/24:1)*,1.03 (1.02 1.05),3.71E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS002802,0.092,Metabolon,1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6)*,1.03 (1.02 1.05),6.90E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS003151,0.014,Metabolon,1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2)*,1.03 (1.02 1.05),1.06E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS002910,0.049,Metabolon,X - 24422,0.97 (0.96 0.98),8.09E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS002770,0.124,Metabolon,1-stearoyl-2-arachidonoyl-GPE (18:0/20:4),1.03 (1.02 1.04),8.72E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS002891,0.056,Metabolon,1-palmitoyl-2-oleoyl-GPE (16:0/18:1),1.03 (1.02 1.04),9.57E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS002878,0.060,Metabolon,1-stearoyl-GPE (18:0),1.03 (1.02 1.04),1.96E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS002756,0.139,Metabolon,1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)*,1.03 (1.02 1.04),1.96E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS002751,0.145,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)*,1.03 (1.02 1.04),2.31E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS002943,0.043,Metabolon,2-palmitoyl-GPE (16:0)*,1.03 (1.02 1.04),2.47E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS002860,0.066,Metabolon,1-palmitoyl-GPE (16:0),1.03 (1.02 1.04),2.87E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS003000,0.031,Metabolon,1-stearoyl-2-oleoyl-GPE (18:0/18:1),1.03 (1.02 1.04),3.44E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS002915,0.048,Metabolon,sphingomyelin (d18:1/20:0. d16:1/22:0)*,1.03 (1.02 1.04),5.26E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS003067,0.022,Metabolon,X - 12339,0.97 (0.96 0.98),1.23E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS002842,0.073,Metabolon,glycosyl-N-palmitoyl-sphingosine,1.03 (1.02 1.04),2.06E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS002982,0.033,Metabolon,X - 12681,0.97 (0.96 0.98),2.38E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS002988,0.033,Metabolon,2-stearoyl-GPE (18:0)*,1.03 (1.02 1.04),2.66E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS003127,0.017,Metabolon,sphingomyelin (d18:1/22:1. d18:2/22:0. d16:1/24:1)*,1.03 (1.01 1.04),4.59E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS002745,0.154,Metabolon,isobutyrylcarnitine,0.97 (0.96 0.99),6.34E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS002850,0.070,Metabolon,1-stearoyl-2-linoleoyl-GPE (18:0/18:2)*,1.03 (1.01 1.04),8.57E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS002704,0.312,Metabolon,5-acetylamino-6-formylamino-3-methyluracil,1.02 (1.01 1.04),1.39E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS003116,0.018,Metabolon,1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1)*,0.98 (0.97 0.99),2.23E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS002849,0.070,Metabolon,X - 16071,0.98 (0.97 0.99),3.06E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS003183,0.013,Metabolon,X - 16944,0.98 (0.97 0.99),3.58E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS003119,0.017,Metabolon,1-palmitoyl-GPC (16:0),1.02 (1.01 1.03),5.59E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS003217,0.011,Metabolon,X - 24024,1.02 (1.01 1.03),5.94E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS002824,0.081,Metabolon,4-acetamidobutanoate,1.02 (1.01 1.03),8.00E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS002736,0.172,Metabolon,glycocholenate sulfate*,0.98 (0.97 0.99),9.38E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS002827,0.080,Metabolon,5-acetylamino-6-amino-3-methyluracil,1.02 (1.01 1.03),1.06E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002921,0.047,Metabolon,1-oleoyl-2-linoleoyl-GPE (18:1/18:2)*,1.02 (1.01 1.03),1.27E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002882,0.058,Metabolon,1-methylxanthine,0.98 (0.97 0.99),1.55E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002911,0.049,Metabolon,1-methylurate,0.98 (0.97 0.99),1.71E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002789,0.102,Metabolon,1-palmitoyl-2-linoleoyl-GPE (16:0/18:2),1.02 (1.01 1.03),1.83E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002967,0.037,Metabolon,X - 11381,0.98 (0.97 0.99),1.92E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002754,0.142,Metabolon,X - 12688,1.02 (1.01 1.03),2.67E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002821,0.082,Metabolon,N-acetylputrescine,1.02 (1.01 1.03),2.79E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002774,0.119,Metabolon,X - 21467,0.98 (0.97 0.99),3.15E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS003200,0.012,Metabolon,threonine,0.98 (0.97 0.99),3.46E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002807,0.089,Metabolon,1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3)*,1.02 (1.01 1.03),3.50E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002893,0.054,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3)*,1.02 (1.01 1.03),3.63E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002901,0.052,Metabolon,X - 23369,0.98 (0.97 0.99),4.56E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS002986,0.033,Metabolon,isobutyrylglycine,0.98 (0.97 0.99),4.61E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.16 (1.14 1.17),9.31E-129
411.4,Coronary atherosclerosis,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.15 (1.14 1.17),4.49E-125
411.4,Coronary atherosclerosis,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.15 (1.14 1.17),4.38E-124
411.4,Coronary atherosclerosis,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.16 (1.14 1.17),1.04E-123
411.4,Coronary atherosclerosis,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.16 (1.14 1.17),1.20E-123
411.4,Coronary atherosclerosis,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.16 (1.14 1.17),1.62E-123
411.4,Coronary atherosclerosis,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.16 (1.14 1.17),6.43E-123
411.4,Coronary atherosclerosis,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.16 (1.14 1.17),6.43E-123
411.4,Coronary atherosclerosis,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.16 (1.14 1.17),9.63E-123
411.4,Coronary atherosclerosis,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.16 (1.14 1.17),1.63E-122
411.4,Coronary atherosclerosis,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.16 (1.14 1.17),1.68E-122
411.4,Coronary atherosclerosis,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.16 (1.14 1.17),4.61E-122
411.4,Coronary atherosclerosis,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.16 (1.14 1.17),1.88E-121
411.4,Coronary atherosclerosis,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.16 (1.14 1.17),1.88E-121
411.4,Coronary atherosclerosis,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.16 (1.14 1.17),2.15E-121
411.4,Coronary atherosclerosis,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.16 (1.14 1.17),3.10E-121
411.4,Coronary atherosclerosis,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.16 (1.14 1.17),3.30E-121
411.4,Coronary atherosclerosis,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.16 (1.14 1.17),5.49E-121
411.4,Coronary atherosclerosis,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.16 (1.14 1.17),9.56E-120
411.4,Coronary atherosclerosis,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.15 (1.14 1.17),3.21E-119
411.4,Coronary atherosclerosis,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.15 (1.14 1.16),9.34E-118
411.4,Coronary atherosclerosis,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.15 (1.14 1.17),3.73E-117
411.4,Coronary atherosclerosis,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.15 (1.14 1.17),4.11E-117
411.4,Coronary atherosclerosis,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.15 (1.14 1.17),1.18E-116
411.4,Coronary atherosclerosis,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.15 (1.14 1.17),2.22E-116
411.4,Coronary atherosclerosis,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.15 (1.14 1.17),2.41E-116
411.4,Coronary atherosclerosis,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.15 (1.14 1.17),3.73E-115
411.4,Coronary atherosclerosis,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.15 (1.14 1.17),4.36E-114
411.4,Coronary atherosclerosis,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.15 (1.14 1.16),1.18E-113
411.4,Coronary atherosclerosis,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.15 (1.14 1.17),9.06E-113
411.4,Coronary atherosclerosis,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.15 (1.14 1.16),1.02E-112
411.4,Coronary atherosclerosis,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.14 (1.13 1.16),2.90E-110
411.4,Coronary atherosclerosis,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.14 (1.13 1.16),5.95E-110
411.4,Coronary atherosclerosis,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.14 (1.13 1.15),7.13E-102
411.4,Coronary atherosclerosis,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.14 (1.12 1.15),7.25E-97
411.4,Coronary atherosclerosis,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.14 (1.12 1.15),5.68E-96
411.4,Coronary atherosclerosis,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.12 (1.11 1.14),9.08E-87
411.4,Coronary atherosclerosis,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.13 (1.11 1.14),2.85E-84
411.4,Coronary atherosclerosis,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.13 (1.11 1.14),4.38E-84
411.4,Coronary atherosclerosis,circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.12 (1.11 1.14),4.99E-82
411.4,Coronary atherosclerosis,circulatory system,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.12 (1.11 1.13),1.28E-80
411.4,Coronary atherosclerosis,circulatory system,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.11 (1.10 1.13),3.27E-72
411.4,Coronary atherosclerosis,circulatory system,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.11 (1.10 1.13),1.08E-70
411.4,Coronary atherosclerosis,circulatory system,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.11 (1.10 1.12),1.60E-69
411.4,Coronary atherosclerosis,circulatory system,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.11 (1.10 1.12),2.81E-69
411.4,Coronary atherosclerosis,circulatory system,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.10 (1.08 1.11),8.32E-54
411.4,Coronary atherosclerosis,circulatory system,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.10 (1.08 1.11),2.38E-52
411.4,Coronary atherosclerosis,circulatory system,OPGS003527,0.050,Nightingale,Sphingomyelins,1.09 (1.08 1.11),5.58E-49
411.4,Coronary atherosclerosis,circulatory system,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.09 (1.08 1.10),7.23E-48
411.4,Coronary atherosclerosis,circulatory system,OPGS003497,0.072,Nightingale,Linoleic acid,1.09 (1.08 1.10),1.11E-45
411.4,Coronary atherosclerosis,circulatory system,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.09 (1.08 1.10),1.27E-45
411.4,Coronary atherosclerosis,circulatory system,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.09 (1.08 1.10),7.68E-45
411.4,Coronary atherosclerosis,circulatory system,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.09 (1.08 1.10),8.65E-44
411.4,Coronary atherosclerosis,circulatory system,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.08 (1.07 1.10),5.84E-40
411.4,Coronary atherosclerosis,circulatory system,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.08 (1.06 1.09),4.49E-34
411.4,Coronary atherosclerosis,circulatory system,OPGS003523,0.062,Nightingale,Total fatty acids,1.08 (1.06 1.09),7.72E-34
411.4,Coronary atherosclerosis,circulatory system,OPGS003528,0.050,Nightingale,Total cholines,1.07 (1.06 1.09),4.87E-31
411.4,Coronary atherosclerosis,circulatory system,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.93 (0.92 0.95),1.18E-28
411.4,Coronary atherosclerosis,circulatory system,OPGS003509,0.069,Nightingale,Free cholesterol in chylomicrons and extremely large VLDL,0.93 (0.92 0.95),3.33E-28
411.4,Coronary atherosclerosis,circulatory system,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.93 (0.92 0.95),5.60E-28
411.4,Coronary atherosclerosis,circulatory system,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.07 (1.05 1.08),1.38E-25
411.4,Coronary atherosclerosis,circulatory system,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.07 (1.05 1.08),3.91E-25
411.4,Coronary atherosclerosis,circulatory system,OPGS003487,0.074,Nightingale,Phospholipids in chylomicrons and extremely large VLDL,0.94 (0.93 0.95),1.74E-24
411.4,Coronary atherosclerosis,circulatory system,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,0.94 (0.93 0.95),3.49E-24
411.4,Coronary atherosclerosis,circulatory system,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,0.94 (0.93 0.95),8.00E-24
411.4,Coronary atherosclerosis,circulatory system,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.06 (1.05 1.08),1.42E-23
411.4,Coronary atherosclerosis,circulatory system,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.94 (0.93 0.95),1.78E-23
411.4,Coronary atherosclerosis,circulatory system,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.06 (1.05 1.08),7.31E-23
411.4,Coronary atherosclerosis,circulatory system,OPGS003491,0.073,Nightingale,Total lipids in chylomicrons and extremely large VLDL,0.94 (0.93 0.95),2.12E-22
411.4,Coronary atherosclerosis,circulatory system,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.94 (0.93 0.95),2.17E-22
411.4,Coronary atherosclerosis,circulatory system,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.94 (0.93 0.95),5.77E-22
411.4,Coronary atherosclerosis,circulatory system,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.94 (0.93 0.95),2.69E-21
411.4,Coronary atherosclerosis,circulatory system,OPGS003520,0.062,Nightingale,HDL cholesterol,0.95 (0.93 0.96),1.13E-19
411.4,Coronary atherosclerosis,circulatory system,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.95 (0.93 0.96),1.37E-19
411.4,Coronary atherosclerosis,circulatory system,OPGS003462,0.083,Nightingale,Average diameter for VLDL particles,0.95 (0.93 0.96),3.18E-19
411.4,Coronary atherosclerosis,circulatory system,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.95 (0.93 0.96),5.94E-19
411.4,Coronary atherosclerosis,circulatory system,OPGS003526,0.050,Nightingale,Phosphatidylcholines,1.06 (1.04 1.07),6.29E-19
411.4,Coronary atherosclerosis,circulatory system,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.95 (0.94 0.96),4.35E-18
411.4,Coronary atherosclerosis,circulatory system,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.95 (0.94 0.96),2.25E-17
411.4,Coronary atherosclerosis,circulatory system,OPGS003513,0.067,Nightingale,Free cholesterol in very large VLDL,0.95 (0.94 0.96),2.00E-16
411.4,Coronary atherosclerosis,circulatory system,OPGS003504,0.070,Nightingale,Triglycerides in very large VLDL,0.95 (0.94 0.96),2.97E-16
411.4,Coronary atherosclerosis,circulatory system,OPGS003510,0.068,Nightingale,Cholesterol in chylomicrons and extremely large VLDL,0.95 (0.94 0.96),6.98E-16
411.4,Coronary atherosclerosis,circulatory system,OPGS003506,0.070,Nightingale,Cholesterol in very large VLDL,0.95 (0.94 0.96),1.09E-15
411.4,Coronary atherosclerosis,circulatory system,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.95 (0.94 0.96),2.89E-15
411.4,Coronary atherosclerosis,circulatory system,OPGS003502,0.070,Nightingale,Concentration of very large VLDL particles,0.95 (0.94 0.96),3.63E-15
411.4,Coronary atherosclerosis,circulatory system,OPGS003500,0.071,Nightingale,Total lipids in very large VLDL,0.95 (0.94 0.96),4.59E-15
411.4,Coronary atherosclerosis,circulatory system,OPGS003516,0.066,Nightingale,Phospholipids in very large VLDL,0.95 (0.94 0.96),1.74E-14
411.4,Coronary atherosclerosis,circulatory system,OPGS003496,0.072,Nightingale,Cholesteryl esters in very large VLDL,0.95 (0.94 0.96),2.56E-14
411.4,Coronary atherosclerosis,circulatory system,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.95 (0.94 0.97),2.01E-13
411.4,Coronary atherosclerosis,circulatory system,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.05 (1.04 1.06),3.33E-13
411.4,Coronary atherosclerosis,circulatory system,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,1.05 (1.03 1.06),6.74E-13
411.4,Coronary atherosclerosis,circulatory system,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.96 (0.95 0.97),7.45E-12
411.4,Coronary atherosclerosis,circulatory system,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.96 (0.95 0.97),4.74E-11
411.4,Coronary atherosclerosis,circulatory system,OPGS003542,0.028,Nightingale,Phospholipids in medium HDL,0.96 (0.95 0.97),3.58E-10
411.4,Coronary atherosclerosis,circulatory system,OPGS003448,0.093,Nightingale,Phospholipids in very large HDL,0.96 (0.95 0.97),1.15E-09
411.4,Coronary atherosclerosis,circulatory system,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,1.04 (1.03 1.05),4.14E-09
411.4,Coronary atherosclerosis,circulatory system,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.04 (1.02 1.05),8.61E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS003540,0.029,Nightingale,Free cholesterol in small HDL,0.96 (0.95 0.98),1.38E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS003518,0.065,Nightingale,Triglycerides in medium HDL,1.03 (1.02 1.05),1.45E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,0.97 (0.96 0.98),3.15E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS003486,0.074,Nightingale,Total triglycerides,1.03 (1.02 1.04),3.16E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS003476,0.076,Nightingale,Phospholipids in medium VLDL,1.03 (1.02 1.04),3.23E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS003445,0.100,Nightingale,Glycine,0.97 (0.96 0.99),6.75E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS003484,0.075,Nightingale,Triglycerides in HDL,1.03 (1.01 1.04),1.31E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS003461,0.084,Nightingale,Total lipids in very large HDL,0.98 (0.97 0.99),2.10E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS003457,0.086,Nightingale,Concentration of very large HDL particles,0.98 (0.97 0.99),2.42E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS003483,0.075,Nightingale,Cholesterol in large VLDL,0.98 (0.97 0.99),6.51E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS003507,0.070,Nightingale,Free cholesterol in large VLDL,0.98 (0.97 0.99),1.09E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS003537,0.031,Nightingale,Glycoprotein acetyls,0.98 (0.97 0.99),1.12E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS003498,0.071,Nightingale,Triglycerides in large VLDL,0.98 (0.97 0.99),1.17E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS003494,0.072,Nightingale,Concentration of large VLDL particles,0.98 (0.97 0.99),1.46E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS003512,0.067,Nightingale,Free cholesterol in very large HDL,0.98 (0.97 0.99),3.31E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS003493,0.073,Nightingale,Total lipids in large VLDL,0.98 (0.97 0.99),4.19E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS003532,0.045,Nightingale,Apolipoprotein A1,0.98 (0.97 0.99),4.58E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004382,0.374,RNAseq,FES,0.95 (0.94 0.96),3.88E-18
411.4,Coronary atherosclerosis,circulatory system,OPGS007943,0.117,RNAseq,SLC22A1,0.96 (0.94 0.97),2.59E-13
411.4,Coronary atherosclerosis,circulatory system,OPGS005858,0.211,RNAseq,GGCX,1.05 (1.03 1.06),8.23E-13
411.4,Coronary atherosclerosis,circulatory system,OPGS006535,0.174,RNAseq,PSRC1,0.96 (0.95 0.97),8.39E-12
411.4,Coronary atherosclerosis,circulatory system,OPGS010653,0.059,RNAseq,CELSR2,1.04 (1.03 1.05),1.32E-10
411.4,Coronary atherosclerosis,circulatory system,OPGS011308,0.049,RNAseq,PI4K2B,0.96 (0.95 0.97),1.81E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS013939,0.023,RNAseq,BATF2,1.04 (1.03 1.05),2.01E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS013472,0.027,RNAseq,STAT1,1.04 (1.03 1.05),2.82E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS012279,0.038,RNAseq,CDKN2A,0.96 (0.95 0.98),6.38E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS004949,0.293,RNAseq,ILRUN,1.04 (1.02 1.05),7.53E-08
411.4,Coronary atherosclerosis,circulatory system,OPGS008934,0.091,RNAseq,CFDP1,0.96 (0.95 0.98),1.04E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS012787,0.033,RNAseq,FURIN,1.04 (1.02 1.05),1.22E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS011108,0.052,RNAseq,LDLR,0.97 (0.95 0.98),2.84E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS011145,0.052,RNAseq,HOXC4,0.97 (0.96 0.98),3.18E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS012456,0.036,RNAseq,AC011944.2,0.97 (0.96 0.98),4.49E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS005687,0.222,RNAseq,CTSK,0.97 (0.95 0.98),5.44E-07
411.4,Coronary atherosclerosis,circulatory system,OPGS008244,0.108,RNAseq,ICA1L,1.03 (1.02 1.05),1.99E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS011948,0.042,RNAseq,ADGRG1,0.97 (0.96 0.98),6.00E-06
411.4,Coronary atherosclerosis,circulatory system,OPGS011044,0.053,RNAseq,AL359922.3,1.03 (1.02 1.04),1.02E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS014221,0.021,RNAseq,HIC1,0.97 (0.96 0.98),1.13E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS013792,0.024,RNAseq,YIPF2,1.03 (1.02 1.04),1.19E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS015092,0.015,RNAseq,XRN2,0.97 (0.96 0.98),1.40E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS014093,0.022,RNAseq,MYBL1,1.03 (1.02 1.04),2.37E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS013409,0.027,RNAseq,MTAP,1.03 (1.02 1.04),2.55E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS011936,0.042,RNAseq,INTS10,0.97 (0.96 0.98),2.96E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS012171,0.039,RNAseq,TRBV15,0.97 (0.96 0.98),3.01E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS003588,0.703,RNAseq,LIPA,1.03 (1.02 1.04),3.35E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS011037,0.053,RNAseq,TMEM170A,0.97 (0.96 0.98),7.74E-05
411.4,Coronary atherosclerosis,circulatory system,OPGS004968,0.290,RNAseq,FCHO1,0.97 (0.96 0.98),1.11E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS006728,0.164,RNAseq,CHP1,0.97 (0.96 0.98),1.24E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS003925,0.496,RNAseq,OSER1,0.97 (0.96 0.98),1.42E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS005235,0.262,RNAseq,MED19,1.03 (1.02 1.04),1.77E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS014232,0.021,RNAseq,TRAV1-2,1.03 (1.02 1.04),2.38E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS012730,0.033,RNAseq,CARM1,0.97 (0.96 0.98),2.47E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS011110,0.052,RNAseq,CMTM2,1.03 (1.02 1.04),2.55E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS011805,0.043,RNAseq,CDKN2D,0.97 (0.96 0.99),2.72E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS006621,0.169,RNAseq,NME7,0.97 (0.96 0.98),2.72E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS011441,0.048,RNAseq,PLEKHO1,1.03 (1.02 1.04),3.28E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS009161,0.086,RNAseq,MRPS6,0.97 (0.96 0.99),3.33E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS010700,0.058,RNAseq,DCLRE1B,0.97 (0.96 0.99),3.87E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS008577,0.099,RNAseq,CDC123,1.03 (1.01 1.04),4.13E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS004706,0.323,RNAseq,AC011462.5,1.03 (1.02 1.04),4.28E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS011593,0.046,RNAseq,TUFT1,1.03 (1.01 1.04),4.30E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS011739,0.044,RNAseq,DHX36,0.97 (0.96 0.99),4.94E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS007508,0.132,RNAseq,ALDH2,0.97 (0.96 0.99),5.00E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS008082,0.113,RNAseq,NUDT5,1.03 (1.01 1.04),5.14E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS013208,0.029,RNAseq,SNX27,1.03 (1.01 1.04),5.98E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS014697,0.017,RNAseq,TNFRSF12A,1.03 (1.01 1.04),7.97E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS007220,0.143,RNAseq,TAF1A,1.03 (1.01 1.04),8.05E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS004485,0.357,RNAseq,LPL,0.97 (0.96 0.99),9.34E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS014197,0.021,RNAseq,GOSR2,0.97 (0.96 0.99),9.59E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS011444,0.048,RNAseq,STEAP1B,1.03 (1.01 1.04),9.84E-04
411.4,Coronary atherosclerosis,circulatory system,OPGS004661,0.330,RNAseq,CYB5R2,1.02 (1.01 1.04),1.09E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS014164,0.021,RNAseq,SF3A2,0.98 (0.96 0.99),1.17E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS007798,0.122,RNAseq,ARCN1,1.03 (1.01 1.04),1.29E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS007873,0.119,RNAseq,PAFAH1B1,0.98 (0.97 0.99),1.34E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS013817,0.024,RNAseq,MYADM,0.98 (0.96 0.99),1.48E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS010402,0.062,RNAseq,,1.02 (1.01 1.04),1.71E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS014419,0.020,RNAseq,SF3A1,1.02 (1.01 1.04),1.72E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS012772,0.033,RNAseq,GIGYF2,1.02 (1.01 1.04),1.75E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS012162,0.040,RNAseq,RSAD2,1.02 (1.01 1.04),1.80E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS008273,0.107,RNAseq,GRK4,1.02 (1.01 1.04),1.83E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS008681,0.097,RNAseq,POLR2C,1.02 (1.01 1.04),2.08E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS006446,0.178,RNAseq,,1.02 (1.01 1.04),2.10E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS006760,0.162,RNAseq,ZMYND12,1.02 (1.01 1.04),2.22E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS008666,0.097,RNAseq,AL592148.3,0.98 (0.96 0.99),2.26E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS012521,0.035,RNAseq,HERC5,1.02 (1.01 1.04),2.26E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS010370,0.063,RNAseq,TP53INP1,1.02 (1.01 1.04),2.34E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS011093,0.052,RNAseq,FAIM,0.98 (0.97 0.99),2.44E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS006433,0.179,RNAseq,PECAM1,1.02 (1.01 1.04),2.47E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS012284,0.038,RNAseq,AC011446.1,1.02 (1.01 1.04),2.59E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS012467,0.036,RNAseq,ADPRHL1,0.98 (0.97 0.99),2.71E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS012988,0.031,RNAseq,PGBD4,1.02 (1.01 1.04),2.87E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS004923,0.296,RNAseq,FHL3,0.98 (0.97 0.99),3.21E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS012036,0.041,RNAseq,GSE1,1.02 (1.01 1.04),3.37E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS008601,0.099,RNAseq,COLQ,1.02 (1.01 1.04),3.39E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS004198,0.412,RNAseq,FAM107B,0.98 (0.97 0.99),3.50E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS005933,0.207,RNAseq,AC005332.7,1.02 (1.01 1.04),3.52E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS008807,0.094,RNAseq,ARHGEF40,0.98 (0.97 0.99),3.52E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS012380,0.037,RNAseq,AC007381.1,0.98 (0.97 0.99),4.37E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS013445,0.027,RNAseq,AC131212.2,0.98 (0.97 0.99),4.50E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS013364,0.027,RNAseq,PHF19,1.02 (1.01 1.04),5.17E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS004386,0.373,RNAseq,TMEM91,1.02 (1.01 1.04),5.38E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS007255,0.141,RNAseq,CD300A,1.02 (1.01 1.03),5.77E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS006132,0.196,RNAseq,EIF6,0.98 (0.97 0.99),5.81E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS010624,0.059,RNAseq,TRBV18,1.02 (1.01 1.03),6.07E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS010417,0.062,RNAseq,PHETA1,0.98 (0.97 0.99),6.23E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS004295,0.390,RNAseq,CTSF,0.98 (0.97 0.99),6.23E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS004943,0.293,RNAseq,,1.02 (1.01 1.03),6.71E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS005918,0.208,RNAseq,DDR1,1.02 (1.01 1.03),6.84E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS014645,0.018,RNAseq,ARHGEF12,1.02 (1.01 1.03),7.03E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS011167,0.051,RNAseq,RBM19,0.98 (0.97 0.99),7.06E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS013330,0.028,RNAseq,AP1G1,0.98 (0.97 0.99),7.45E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS013514,0.026,RNAseq,GZMK,1.02 (1.01 1.03),7.48E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS013958,0.023,RNAseq,CSNK2B,0.98 (0.97 0.99),7.82E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS007294,0.140,RNAseq,RPS6KL1,1.02 (1.01 1.03),8.00E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS004501,0.354,RNAseq,TBKBP1,0.98 (0.97 0.99),8.00E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS009659,0.076,RNAseq,NRXN2,1.02 (1.01 1.03),8.00E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS010692,0.058,RNAseq,IPO9,0.98 (0.97 0.99),8.00E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS012237,0.039,RNAseq,DNAJC13,1.02 (1.01 1.03),8.11E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS010567,0.060,RNAseq,PNPT1,0.98 (0.97 0.99),8.63E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS005346,0.252,RNAseq,,1.02 (1.01 1.03),8.77E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS009719,0.075,RNAseq,SEC61A2,1.02 (1.01 1.03),8.92E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS012510,0.036,RNAseq,KLRF1,1.02 (1.01 1.03),8.92E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS008555,0.100,RNAseq,CALCRL,1.02 (1.01 1.03),9.30E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS010757,0.057,RNAseq,CACNG6,1.02 (1.01 1.03),9.38E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS008102,0.112,RNAseq,TXNDC16,0.98 (0.97 0.99),9.52E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS012636,0.034,RNAseq,KIR2DL3,0.98 (0.97 0.99),9.52E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS012967,0.031,RNAseq,CCDC157,0.98 (0.97 0.99),9.55E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS014315,0.020,RNAseq,MRPL9,1.02 (1.01 1.03),9.93E-03
411.4,Coronary atherosclerosis,circulatory system,OPGS007282,0.140,RNAseq,CERCAM,1.02 (1.01 1.03),1.01E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS006927,0.154,RNAseq,TAF7,0.98 (0.97 0.99),1.04E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010929,0.055,RNAseq,EOMES,1.02 (1.01 1.03),1.06E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS011811,0.043,RNAseq,ZBTB46,0.98 (0.97 0.99),1.06E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS003621,0.665,RNAseq,,1.02 (1.01 1.03),1.06E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS005257,0.260,RNAseq,ITGB7,1.02 (1.01 1.03),1.07E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS011132,0.052,RNAseq,HEATR5B,1.02 (1.01 1.03),1.08E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS008021,0.115,RNAseq,PALM2AKAP2,0.98 (0.97 0.99),1.09E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS011752,0.044,RNAseq,AL359532.1,0.98 (0.97 0.99),1.12E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS013276,0.028,RNAseq,ZNF346,1.02 (1.01 1.03),1.17E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS013091,0.030,RNAseq,,0.98 (0.97 0.99),1.17E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012717,0.033,RNAseq,GBP4,1.02 (1.01 1.03),1.20E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS015052,0.015,RNAseq,CISH,0.98 (0.97 0.99),1.21E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010661,0.059,RNAseq,PTPN22,1.02 (1.01 1.03),1.24E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS007717,0.125,RNAseq,GUCY1A1,0.98 (0.97 0.99),1.27E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014044,0.022,RNAseq,KCND3,0.98 (0.97 0.99),1.27E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS008839,0.093,RNAseq,ALDOC,1.02 (1.01 1.03),1.27E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS007394,0.136,RNAseq,AL662844.4,0.98 (0.97 0.99),1.33E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009794,0.073,RNAseq,RN7SL473P,0.98 (0.97 0.99),1.34E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009190,0.085,RNAseq,COL13A1,1.02 (1.01 1.03),1.36E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012524,0.035,RNAseq,AL357079.1,0.98 (0.97 0.99),1.39E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012753,0.033,RNAseq,BNIP3,1.02 (1.01 1.03),1.41E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS006269,0.188,RNAseq,RALY-AS1,0.98 (0.97 0.99),1.43E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS003660,0.627,RNAseq,SENP6,1.02 (1.01 1.03),1.46E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS007456,0.134,RNAseq,TAF1A-AS1,1.02 (1.01 1.03),1.47E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014064,0.022,RNAseq,ZBTB34,1.02 (1.01 1.03),1.47E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009782,0.073,RNAseq,BMF,1.02 (1.01 1.03),1.51E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS013687,0.025,RNAseq,BCL10,1.02 (1.01 1.03),1.55E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014246,0.021,RNAseq,COX18,0.98 (0.97 0.99),1.57E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS003784,0.554,RNAseq,KCNK17,0.98 (0.97 0.99),1.68E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010883,0.055,RNAseq,ZNF664,1.02 (1.01 1.03),1.68E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS005914,0.208,RNAseq,SNW1,0.98 (0.97 0.99),1.72E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010345,0.064,RNAseq,PLCG1,0.98 (0.97 0.99),1.72E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS006822,0.160,RNAseq,TSHZ3,1.02 (1.01 1.03),1.73E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010715,0.058,RNAseq,AC041005.1,1.02 (1.01 1.03),1.76E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010594,0.060,RNAseq,ACVRL1,0.98 (0.97 0.99),1.79E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004599,0.340,RNAseq,,0.98 (0.97 0.99),1.80E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010014,0.069,RNAseq,LINC02245,1.02 (1.01 1.03),1.82E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS006275,0.188,RNAseq,ASAP2,0.98 (0.97 0.99),1.83E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS007656,0.127,RNAseq,JUN,0.98 (0.97 0.99),1.89E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014114,0.022,RNAseq,CCDC90B,1.02 (1.01 1.03),1.89E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS008408,0.104,RNAseq,ARVCF,1.02 (1.01 1.03),1.92E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS011092,0.052,RNAseq,IFIT1,1.02 (1.01 1.03),1.92E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012009,0.041,RNAseq,MAFF,1.02 (1.01 1.03),1.96E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS011321,0.049,RNAseq,GDF11,0.98 (0.97 0.99),1.97E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014550,0.019,RNAseq,ACAD10,0.98 (0.97 0.99),1.98E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004125,0.429,RNAseq,UHRF1BP1,1.02 (1.01 1.03),2.00E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004688,0.325,RNAseq,MERTK,1.02 (1.01 1.03),2.02E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012823,0.032,RNAseq,CEP83,0.98 (0.97 0.99),2.04E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS013170,0.029,RNAseq,N4BP2L2,0.98 (0.97 0.99),2.06E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009682,0.075,RNAseq,AL731557.1,1.02 (1.01 1.03),2.17E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009423,0.081,RNAseq,PSTPIP2,1.02 (1.01 1.03),2.23E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS013788,0.024,RNAseq,SUMO1,1.02 (1.01 1.03),2.23E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014813,0.017,RNAseq,ZNF141,0.98 (0.97 0.99),2.25E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS015030,0.016,RNAseq,PRRC2A,1.02 (1.01 1.03),2.25E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS011449,0.048,RNAseq,ACAT2,0.98 (0.97 0.99),2.25E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014331,0.020,RNAseq,KLHL25,1.02 (1.01 1.03),2.27E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004548,0.346,RNAseq,,0.98 (0.97 0.99),2.30E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS006152,0.194,RNAseq,ITGB3,1.02 (1.01 1.03),2.30E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS007082,0.149,RNAseq,PHIP,1.02 (1.01 1.03),2.37E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS006804,0.160,RNAseq,TRIM5,0.98 (0.97 0.99),2.44E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012535,0.035,RNAseq,,0.98 (0.97 0.99),2.44E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS007764,0.123,RNAseq,HLA-E,1.02 (1.01 1.03),2.48E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004906,0.299,RNAseq,C4orf3,0.98 (0.97 0.99),2.48E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS007056,0.150,RNAseq,LGALS8,1.02 (1.01 1.03),2.51E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014341,0.020,RNAseq,NFAT5,1.02 (1.01 1.03),2.52E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014440,0.019,RNAseq,C19orf38,1.02 (1.01 1.03),2.59E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS006873,0.157,RNAseq,FDX1,0.98 (0.97 0.99),2.64E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012732,0.033,RNAseq,AF165147.1,0.98 (0.97 0.99),2.75E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009077,0.088,RNAseq,DDAH2,0.98 (0.97 0.99),2.76E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012075,0.040,RNAseq,CENPF,1.02 (1.01 1.03),2.78E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010993,0.054,RNAseq,SNAP47,1.02 (1.01 1.03),2.79E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004774,0.313,RNAseq,PRKD2,1.02 (1.01 1.03),2.79E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS011432,0.048,RNAseq,TRAPPC11,1.02 (1.01 1.03),2.80E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009087,0.088,RNAseq,THSD7A,1.02 (1.01 1.03),2.81E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009893,0.071,RNAseq,HORMAD1,0.98 (0.97 0.99),3.00E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009103,0.088,RNAseq,NUDT3,1.02 (1.01 1.03),3.07E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012323,0.038,RNAseq,MIR320E,1.02 (1.01 1.03),3.09E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012812,0.033,RNAseq,LEMD3,1.02 (1.01 1.03),3.11E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010507,0.061,RNAseq,EXTL3,0.98 (0.97 0.99),3.24E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS011232,0.050,RNAseq,AL589765.4,1.02 (1.01 1.03),3.25E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010235,0.065,RNAseq,LRP3,1.02 (1.01 1.03),3.27E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010012,0.069,RNAseq,UBC,0.98 (0.97 0.99),3.34E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS008402,0.104,RNAseq,TNXB,1.02 (1.01 1.03),3.42E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012778,0.033,RNAseq,FAM135A,0.98 (0.97 0.99),3.42E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009746,0.074,RNAseq,SPAST,1.02 (1.01 1.03),3.42E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS006215,0.191,RNAseq,PGAP3,1.02 (1.01 1.03),3.42E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS003783,0.555,RNAseq,PPFIBP2,1.02 (1.01 1.03),3.43E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012674,0.034,RNAseq,MYD88,0.98 (0.97 0.99),3.52E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004678,0.327,RNAseq,ZNF772,0.98 (0.97 0.99),3.52E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010648,0.059,RNAseq,UQCRC2,0.98 (0.97 0.99),3.52E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004315,0.386,RNAseq,AL391314.1,1.02 (1.01 1.03),3.53E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS005248,0.261,RNAseq,RPL17,1.02 (1.01 1.03),3.58E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS005407,0.246,RNAseq,KLHL35,0.98 (0.97 0.99),3.63E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS011883,0.043,RNAseq,RGL3,1.02 (1.01 1.03),3.63E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004360,0.378,RNAseq,WASHC2C,1.02 (1.01 1.03),3.64E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014256,0.021,RNAseq,AL136441.1,1.02 (1.01 1.03),3.76E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS007953,0.117,RNAseq,OASL,1.02 (1.01 1.03),3.80E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS005674,0.223,RNAseq,ACTR5,0.98 (0.97 0.99),3.84E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009246,0.084,RNAseq,STXBP3,1.02 (1.01 1.03),3.87E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS007123,0.147,RNAseq,LMF2,1.02 (1.01 1.03),3.91E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014718,0.017,RNAseq,MRC2,1.02 (1.01 1.03),3.91E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009035,0.089,RNAseq,CD82,1.02 (1.01 1.03),3.91E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014375,0.020,RNAseq,MUS81,1.02 (1.01 1.03),3.94E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012019,0.041,RNAseq,SEMA7A,0.98 (0.97 0.99),3.95E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012400,0.037,RNAseq,LAMP3,0.98 (0.97 0.99),3.95E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012073,0.040,RNAseq,SGPP1,0.98 (0.97 0.99),3.95E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS006940,0.154,RNAseq,,1.02 (1.01 1.03),3.99E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS011567,0.046,RNAseq,MIER2,1.02 (1.01 1.03),4.02E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014183,0.021,RNAseq,PAXBP1-AS1,1.02 (1.01 1.03),4.03E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014081,0.022,RNAseq,TSPAN13,0.98 (0.97 0.99),4.11E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS007500,0.132,RNAseq,ITGB1BP1,0.98 (0.97 0.99),4.11E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010949,0.055,RNAseq,AC008897.3,0.98 (0.97 0.99),4.11E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS012819,0.033,RNAseq,DNAJC1,1.02 (1.01 1.03),4.15E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS007122,0.147,RNAseq,FLT1,1.02 (1.01 1.03),4.17E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009492,0.079,RNAseq,LINC00189,0.98 (0.97 0.99),4.19E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004228,0.406,RNAseq,ST6GALNAC1,1.02 (1.01 1.03),4.19E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS011387,0.048,RNAseq,ACVR1,0.98 (0.97 0.99),4.19E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004140,0.426,RNAseq,VPS53,0.98 (0.97 0.99),4.19E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009146,0.087,RNAseq,FBXL3,1.02 (1.01 1.03),4.22E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS006403,0.180,RNAseq,AL356599.1,1.02 (1.01 1.03),4.31E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004999,0.287,RNAseq,AL009031.1,0.98 (0.97 0.99),4.32E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS008881,0.092,RNAseq,PLXNC1,0.98 (0.97 0.99),4.37E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS004144,0.424,RNAseq,PSORS1C3,1.02 (1.01 1.03),4.40E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010966,0.054,RNAseq,CIAPIN1,1.02 (1.01 1.03),4.42E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010693,0.058,RNAseq,TRBV5-1,0.98 (0.97 0.99),4.53E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS013942,0.023,RNAseq,ZHX3,1.02 (1.01 1.03),4.77E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS014443,0.019,RNAseq,ABCB1,1.02 (1.01 1.03),4.77E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS013278,0.028,RNAseq,CEP120,1.02 (1.01 1.03),4.81E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS013485,0.027,RNAseq,,1.02 (1.01 1.03),4.83E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS010122,0.067,RNAseq,PAN3-AS1,1.02 (1.01 1.03),4.92E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS007248,0.141,RNAseq,,1.02 (1.01 1.03),4.92E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS011434,0.048,RNAseq,ZNF483,1.02 (1.01 1.03),4.92E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009898,0.071,RNAseq,MAP1S,0.98 (0.97 0.99),4.92E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009366,0.082,RNAseq,AL139289.1,0.98 (0.97 0.99),4.93E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS009008,0.090,RNAseq,USP46,1.02 (1.01 1.03),4.94E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS011979,0.041,RNAseq,AC104083.1,0.98 (0.97 0.99),4.97E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS013580,0.026,RNAseq,AC010327.7,1.02 (1.01 1.03),4.97E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS007147,0.146,RNAseq,EPAS1,1.02 (1.01 1.03),4.97E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS013633,0.025,RNAseq,MIA3,1.02 (1.01 1.03),4.97E-02
411.4,Coronary atherosclerosis,circulatory system,OPGS005549,0.234,RNAseq,LINC02701,0.98 (0.97 0.99),4.97E-02
411.41,Aneurysm and dissection of heart,circulatory system,OPGS007392,0.136,RNAseq,C21orf62-AS1,1.15 (1.09 1.22),3.52E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000115,0.347,SomaScan,Protein CEI,1.07 (1.06 1.09),1.88E-25
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000312,0.163,SomaScan,Selenoprotein S,1.08 (1.06 1.09),7.77E-25
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.07 (1.06 1.08),7.45E-24
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.07 (1.06 1.09),1.06E-23
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000613,0.096,SomaScan,Stromelysin-1,1.07 (1.06 1.09),2.17E-23
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.07 (1.06 1.08),4.09E-23
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.07 (1.06 1.09),3.92E-22
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.07 (1.06 1.09),3.92E-22
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000857,0.067,SomaScan,Moesin,1.06 (1.05 1.07),4.41E-18
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.06 (1.05 1.07),1.52E-17
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.06 (1.05 1.08),4.76E-17
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.06 (1.05 1.07),4.86E-17
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.94 (0.93 0.95),8.13E-17
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.06 (1.05 1.07),1.80E-16
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002108,0.012,SomaScan,Neuralized-like protein 4,1.06 (1.05 1.08),4.50E-16
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.06 (1.05 1.08),7.49E-16
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.06 (1.04 1.07),1.60E-15
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.06 (1.04 1.07),6.97E-15
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,0.94 (0.93 0.96),7.79E-15
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.06 (1.04 1.07),1.25E-14
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001392,0.029,SomaScan,Cadherin-related family member 5,1.06 (1.04 1.07),1.75E-14
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000860,0.066,SomaScan,Cell surface glycoprotein CD200 receptor 2,0.95 (0.93 0.96),3.41E-14
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000348,0.151,SomaScan,Quinone oxidoreductase-like protein 1,1.06 (1.04 1.07),3.74E-14
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001058,0.049,SomaScan,Protocadherin beta-10,1.06 (1.04 1.07),5.18E-14
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000445,0.129,SomaScan,Collectin-10,0.95 (0.94 0.96),1.34E-13
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,0.95 (0.94 0.96),5.18E-13
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.05 (1.04 1.06),7.50E-13
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.05 (1.04 1.06),7.87E-13
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.05 (1.04 1.06),1.58E-12
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000492,0.119,SomaScan,Inactive gamma-glutamyltranspeptidase 2,1.05 (1.04 1.07),2.24E-12
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001963,0.013,SomaScan,Annexin A9,1.05 (1.04 1.07),5.06E-12
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000154,0.277,SomaScan,Granulins,1.05 (1.04 1.06),5.81E-12
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000285,0.176,SomaScan,Complement C1q tumor necrosis factor-related protein 1,1.05 (1.04 1.06),9.31E-12
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000883,0.064,SomaScan,Group XIIB secretory phospholipase A2-like protein,1.05 (1.04 1.06),1.03E-11
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001377,0.030,SomaScan,Vascular cell adhesion protein 1,1.05 (1.04 1.06),1.45E-11
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001437,0.028,SomaScan,Steroidogenic acute regulatory protein. mitochondrial,1.05 (1.04 1.06),3.78E-11
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000577,0.102,SomaScan,Platelet-activating factor acetylhydrolase,1.05 (1.03 1.06),4.45E-11
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.95 (0.94 0.97),4.75E-11
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000172,0.257,SomaScan,Dermokine,0.95 (0.94 0.97),4.75E-11
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001002,0.053,SomaScan,Tumor protein p53-inducible protein 11,1.05 (1.03 1.06),1.24E-10
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.05 (1.03 1.06),1.63E-10
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001715,0.019,SomaScan,Histone deacetylase 8,1.05 (1.03 1.06),4.54E-10
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001279,0.035,SomaScan,Four-jointed box protein 1,1.05 (1.03 1.06),7.30E-10
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.05 (1.03 1.06),7.80E-10
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.05 (1.03 1.06),1.13E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000298,0.167,SomaScan,Proteasome activator complex subunit 1,0.96 (0.94 0.97),1.16E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.04 (1.03 1.06),1.30E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001144,0.043,SomaScan,Proprotein convertase subtilisin/kexin type 9,1.05 (1.03 1.06),1.42E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001297,0.034,SomaScan,Neogenin,0.96 (0.94 0.97),2.35E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001252,0.036,SomaScan,Neuronal pentraxin-2,1.04 (1.03 1.06),3.54E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000510,0.115,SomaScan,Guanine nucleotide-binding protein G(k) subunit alpha,0.96 (0.95 0.97),7.63E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000401,0.139,SomaScan,Hemoglobin subunit theta-1,1.04 (1.03 1.06),8.99E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.04 (1.03 1.06),1.37E-08
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001464,0.027,SomaScan,Platelet glycoprotein Ib alpha chain,1.04 (1.03 1.05),1.57E-08
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000838,0.069,SomaScan,DNA/RNA-binding protein KIN17,0.96 (0.95 0.97),4.38E-08
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000715,0.082,SomaScan,Surfeit locus protein 1,1.04 (1.03 1.05),1.26E-07
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.04 (1.03 1.05),4.30E-07
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001041,0.050,SomaScan,RING finger protein 122,1.04 (1.03 1.05),8.28E-07
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001112,0.045,SomaScan,Hemojuvelin,1.04 (1.02 1.05),2.02E-06
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002321,0.010,SomaScan,Fibronectin Fragment 3,0.97 (0.95 0.98),2.11E-06
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.04 (1.02 1.05),2.30E-06
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001093,0.046,SomaScan,C-reactive protein,0.96 (0.95 0.98),2.30E-06
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002093,0.012,SomaScan,Fibronectin,0.97 (0.95 0.98),4.11E-06
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.04 (1.02 1.05),7.43E-06
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.97 (0.95 0.98),1.15E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001106,0.046,SomaScan,Disintegrin and metalloproteinase domain-containing protein 11,1.03 (1.02 1.05),1.66E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001121,0.044,SomaScan,Growth factor receptor-bound protein 7,0.97 (0.96 0.98),3.50E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001102,0.046,SomaScan,Granzyme A,1.03 (1.02 1.05),3.69E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.03 (1.02 1.05),4.18E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000022,0.602,SomaScan,Interleukin-6 receptor subunit alpha,0.97 (0.96 0.98),4.29E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000874,0.065,SomaScan,Carbonic anhydrase-related protein 10,1.03 (1.02 1.05),5.85E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000020,0.609,SomaScan,Interleukin-6 receptor subunit alpha,0.97 (0.96 0.98),7.32E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.03 (1.02 1.04),7.39E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000951,0.057,SomaScan,Pseudokinase FAM20A,0.97 (0.96 0.98),8.44E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.03 (1.02 1.04),8.60E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.03 (1.02 1.05),9.02E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001092,0.046,SomaScan,TOM1-like protein 1,1.03 (1.02 1.04),2.07E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000250,0.192,SomaScan,Complement C1r subcomponent,1.03 (1.02 1.04),3.46E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000159,0.271,SomaScan,39S ribosomal protein L33. mitochondrial,0.97 (0.96 0.98),4.12E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001518,0.025,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,1.03 (1.02 1.04),4.38E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.03 (1.02 1.04),4.56E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,0.97 (0.96 0.98),6.56E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000901,0.063,SomaScan,Ski-like protein,1.03 (1.02 1.04),8.94E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000717,0.082,SomaScan,Zinc finger protein 175,0.97 (0.96 0.98),9.47E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001124,0.044,SomaScan,Tumor necrosis factor receptor type 1-associated DEATH domain protein,1.03 (1.02 1.04),9.73E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001879,0.015,SomaScan,Arfaptin-2,1.03 (1.02 1.04),1.27E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002186,0.011,SomaScan,Suprabasin,0.97 (0.96 0.98),1.27E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000927,0.059,SomaScan,Neuropilin-1,0.97 (0.96 0.99),1.82E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001129,0.044,SomaScan,Sodium-coupled monocarboxylate transporter 1,1.03 (1.01 1.04),2.16E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000145,0.292,SomaScan,Cathepsin H,0.97 (0.96 0.99),2.58E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000544,0.108,SomaScan,Segment polarity protein dishevelled homolog DVL-2,1.03 (1.01 1.04),3.09E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.03 (1.01 1.04),3.60E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001007,0.053,SomaScan,Neuropilin-1,0.97 (0.96 0.99),3.84E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000141,0.306,SomaScan,Complement C1s subcomponent,1.03 (1.01 1.04),4.84E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.98 (0.96 0.99),5.10E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000283,0.177,SomaScan,Cathelicidin antimicrobial peptide,1.02 (1.01 1.04),7.22E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001231,0.037,SomaScan,Osteocalcin,1.02 (1.01 1.04),7.74E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001365,0.030,SomaScan,Leukocyte cell-derived chemotaxin 1,0.98 (0.96 0.99),8.74E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001286,0.034,SomaScan,Granzyme K,1.02 (1.01 1.04),9.13E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.02 (1.01 1.04),1.04E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001598,0.022,SomaScan,SPARC,0.98 (0.96 0.99),1.14E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,1.02 (1.01 1.04),1.17E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001115,0.045,SomaScan,Small integral membrane protein 9,1.02 (1.01 1.04),1.58E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.98 (0.96 0.99),1.73E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002002,0.013,SomaScan,Fibroblast growth factor 18,0.98 (0.97 0.99),1.99E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001979,0.013,SomaScan,TATA-box-binding protein,0.98 (0.97 0.99),1.99E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000044,0.517,SomaScan,Chymotrypsinogen B2,1.02 (1.01 1.04),2.13E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001967,0.013,SomaScan,Sprouty-related. EVH1 domain-containing protein 1,0.98 (0.97 0.99),2.66E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002089,0.012,SomaScan,Protein FAM19A4,0.98 (0.97 0.99),2.66E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001553,0.024,SomaScan,Protein G6b,1.02 (1.01 1.04),2.67E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,0.98 (0.97 0.99),2.75E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001177,0.040,SomaScan,Gastrin-releasing peptide,0.98 (0.97 0.99),2.76E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002246,0.010,SomaScan,Sperm-associated antigen 11B,0.98 (0.97 0.99),2.77E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,0.98 (0.97 0.99),2.79E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001578,0.023,SomaScan,Serpin A9,1.02 (1.01 1.04),2.85E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001404,0.029,SomaScan,Interferon gamma receptor 1,1.02 (1.01 1.03),2.85E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002204,0.011,SomaScan,Rho-related GTP-binding protein RhoG,1.02 (1.01 1.04),3.23E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000998,0.053,SomaScan,Tyrosine-protein phosphatase non-receptor type 4,1.02 (1.01 1.03),3.23E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000099,0.376,SomaScan,Kunitz-type protease inhibitor 2,0.98 (0.97 0.99),3.64E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.02 (1.01 1.03),3.82E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002043,0.012,SomaScan,Matrix-remodeling-associated protein 8,1.02 (1.01 1.03),3.92E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000851,0.067,SomaScan,Epididymis-specific alpha-mannosidase,1.02 (1.01 1.03),3.98E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000517,0.114,SomaScan,Advanced glycosylation end product-specific receptor. soluble,0.98 (0.97 0.99),4.41E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001924,0.014,SomaScan,Glycosyltransferase-like protein LARGE1,0.98 (0.97 0.99),4.53E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,1.02 (1.01 1.03),4.54E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS000103,0.372,SomaScan,Lysophosphatidic acid phosphatase type 6,0.98 (0.97 0.99),4.73E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002585,0.037,Olink,T-cell surface glycoprotein CD5,1.05 (1.03 1.06),9.13E-10
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002436,0.191,Olink,Progranulin,1.05 (1.03 1.06),1.10E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002558,0.048,Olink,Proprotein convertase subtilisin/kexin type 9,1.04 (1.03 1.06),1.48E-08
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002435,0.193,Olink,Fibroblast growth factor 5,1.04 (1.02 1.05),3.56E-06
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002552,0.053,Olink,Low-density lipoprotein receptor,0.97 (0.95 0.98),1.15E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002387,0.541,Olink,Interleukin-6 receptor subunit alpha,0.97 (0.96 0.98),8.19E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002613,0.027,Olink,Interleukin-6,0.97 (0.96 0.98),1.53E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002608,0.028,Olink,Integrin beta-2,1.03 (1.02 1.04),6.84E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002568,0.043,Olink,Granzyme A,1.03 (1.02 1.04),9.47E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002653,0.015,Olink,CD40 ligand,1.03 (1.01 1.04),2.38E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002649,0.016,Olink,Platelet-derived growth factor subunit B,1.03 (1.01 1.04),2.49E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002629,0.023,Olink,Interleukin-18-binding protein,1.03 (1.01 1.04),3.47E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002663,0.011,Olink,C-type lectin domain family 1 member B,1.03 (1.01 1.04),6.04E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002660,0.012,Olink,Angiopoietin-1,1.03 (1.01 1.04),6.96E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002617,0.026,Olink,C-X-C motif chemokine 9,1.02 (1.01 1.04),8.15E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002656,0.013,Olink,Angiotensin-converting enzyme 2,0.98 (0.96 0.99),9.79E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002633,0.021,Olink,C-X-C motif chemokine 11,1.02 (1.01 1.04),1.02E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002543,0.061,Olink,Netrin receptor UNC5C,1.02 (1.01 1.04),1.27E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002661,0.011,Olink,Platelet-derived growth factor subunit A,1.02 (1.01 1.04),2.03E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002432,0.195,Olink,Cathepsin S,1.02 (1.01 1.04),2.95E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002600,0.030,Olink,Heme oxygenase 1,0.98 (0.97 0.99),3.14E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002391,0.469,Olink,CMRF35-like molecule 1,0.98 (0.97 0.99),4.34E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.10 (1.08 1.11),2.13E-43
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.10 (1.08 1.11),1.31E-40
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.08 (1.07 1.09),4.70E-28
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.07 (1.05 1.08),6.20E-22
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003058,0.022,Metabolon,sphingomyelin (d18:1/17:0. d17:1/18:0. d19:1/16:0),1.06 (1.05 1.07),1.90E-17
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.05 (1.04 1.07),8.51E-12
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.05 (1.03 1.06),3.40E-11
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.05 (1.03 1.06),1.90E-10
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.04 (1.03 1.06),8.38E-10
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002770,0.124,Metabolon,1-stearoyl-2-arachidonoyl-GPE (18:0/20:4),1.04 (1.02 1.05),9.61E-07
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002951,0.041,Metabolon,stearoyl sphingomyelin (d18:1/18:0),1.04 (1.02 1.05),1.41E-06
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002874,0.060,Metabolon,campesterol,1.04 (1.02 1.05),3.25E-06
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002802,0.092,Metabolon,1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6)*,1.03 (1.02 1.05),1.25E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002756,0.139,Metabolon,1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)*,1.03 (1.02 1.05),1.41E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002940,0.044,Metabolon,lactosyl-N-palmitoyl-sphingosine,1.03 (1.02 1.05),1.72E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003203,0.012,Metabolon,sphingomyelin (d18:2/23:0. d18:1/23:1. d17:1/24:1)*,1.03 (1.02 1.05),3.09E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002891,0.056,Metabolon,1-palmitoyl-2-oleoyl-GPE (16:0/18:1),1.03 (1.02 1.05),3.81E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002910,0.049,Metabolon,X - 24422,0.97 (0.96 0.98),1.10E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002751,0.145,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)*,1.03 (1.02 1.04),1.61E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002943,0.043,Metabolon,2-palmitoyl-GPE (16:0)*,1.03 (1.02 1.04),1.63E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002893,0.054,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3)*,1.03 (1.02 1.04),2.24E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002878,0.060,Metabolon,1-stearoyl-GPE (18:0),1.03 (1.02 1.04),2.93E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003000,0.031,Metabolon,1-stearoyl-2-oleoyl-GPE (18:0/18:1),1.03 (1.02 1.04),3.04E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002860,0.066,Metabolon,1-palmitoyl-GPE (16:0),1.03 (1.02 1.04),5.17E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003151,0.014,Metabolon,1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2)*,1.03 (1.02 1.04),5.60E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002819,0.083,Metabolon,phosphatidylcholine (16:0/22:5n3. 18:1/20:4)*,1.03 (1.02 1.04),5.67E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003008,0.030,Metabolon,quinolinate,1.03 (1.01 1.04),2.80E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003200,0.012,Metabolon,threonine,0.97 (0.96 0.99),2.80E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003198,0.012,Metabolon,gamma-glutamylthreonine*,0.97 (0.96 0.99),2.97E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002982,0.033,Metabolon,X - 12681,0.97 (0.96 0.99),3.62E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002704,0.312,Metabolon,5-acetylamino-6-formylamino-3-methyluracil,1.03 (1.01 1.04),4.46E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002915,0.048,Metabolon,sphingomyelin (d18:1/20:0. d16:1/22:0)*,1.03 (1.01 1.04),4.76E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003116,0.018,Metabolon,1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1)*,0.98 (0.96 0.99),5.05E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002745,0.154,Metabolon,isobutyrylcarnitine,0.98 (0.96 0.99),6.11E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003127,0.017,Metabolon,sphingomyelin (d18:1/22:1. d18:2/22:0. d16:1/24:1)*,1.02 (1.01 1.04),6.20E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003067,0.022,Metabolon,X - 12339,0.98 (0.96 0.99),9.47E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002988,0.033,Metabolon,2-stearoyl-GPE (18:0)*,1.02 (1.01 1.04),1.02E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002861,0.066,Metabolon,uracil,1.02 (1.01 1.04),1.08E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002981,0.034,Metabolon,1-docosapentaenoyl-GPC (22:5n3)*,1.02 (1.01 1.04),1.10E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003119,0.017,Metabolon,1-palmitoyl-GPC (16:0),1.02 (1.01 1.04),1.43E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003217,0.011,Metabolon,X - 24024,1.02 (1.01 1.04),1.59E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003183,0.013,Metabolon,X - 16944,0.98 (0.97 0.99),2.12E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002958,0.040,Metabolon,1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6)*,0.98 (0.97 0.99),2.31E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003194,0.012,Metabolon,O-sulfo-L-tyrosine,0.98 (0.97 0.99),2.31E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002824,0.081,Metabolon,4-acetamidobutanoate,1.02 (1.01 1.03),2.70E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002911,0.049,Metabolon,1-methylurate,0.98 (0.97 0.99),2.79E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002827,0.080,Metabolon,5-acetylamino-6-amino-3-methyluracil,1.02 (1.01 1.03),3.10E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003060,0.022,Metabolon,stearidonate (18:4n3),1.02 (1.01 1.03),3.20E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002961,0.039,Metabolon,1-stearoyl-2-dihomo-linolenoyl-GPC (18:0/20:3n3 or 6)*,0.98 (0.97 0.99),3.34E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003121,0.017,Metabolon,1.2-dipalmitoyl-GPC (16:0/16:0),1.02 (1.01 1.03),3.39E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002948,0.042,Metabolon,1-dihomo-linolenoyl-GPE (20:3n3 or 6)*,0.98 (0.97 0.99),3.67E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002850,0.070,Metabolon,1-stearoyl-2-linoleoyl-GPE (18:0/18:2)*,1.02 (1.01 1.03),3.94E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS002980,0.034,Metabolon,1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2)*,0.98 (0.97 0.99),4.13E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.14 (1.12 1.15),4.54E-82
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.13 (1.12 1.15),1.18E-78
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.14 (1.12 1.15),1.73E-78
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.13 (1.12 1.15),4.22E-78
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.14 (1.12 1.15),6.68E-78
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.14 (1.12 1.15),5.37E-77
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.14 (1.12 1.15),5.37E-77
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.14 (1.12 1.15),6.19E-77
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.13 (1.12 1.15),9.57E-77
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.13 (1.12 1.15),2.53E-76
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.14 (1.12 1.15),2.53E-76
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.14 (1.12 1.15),2.53E-76
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.13 (1.12 1.15),3.55E-76
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.14 (1.12 1.15),3.83E-76
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.13 (1.12 1.15),3.90E-76
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.13 (1.12 1.15),7.31E-76
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.13 (1.12 1.15),8.17E-76
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.13 (1.12 1.15),1.33E-75
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.13 (1.12 1.15),4.09E-75
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.13 (1.12 1.15),7.92E-75
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.13 (1.12 1.15),1.12E-74
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.13 (1.12 1.15),2.00E-74
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.13 (1.12 1.15),2.20E-74
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.13 (1.12 1.15),3.67E-74
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.13 (1.12 1.15),9.34E-74
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.13 (1.12 1.15),1.54E-73
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.13 (1.12 1.15),2.38E-73
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.13 (1.12 1.15),3.85E-73
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.13 (1.12 1.15),1.16E-72
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.13 (1.11 1.14),2.42E-71
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.13 (1.12 1.15),7.78E-71
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.13 (1.11 1.14),1.06E-70
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.13 (1.11 1.14),1.07E-70
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.12 (1.11 1.14),1.37E-64
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.12 (1.10 1.13),1.39E-59
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.12 (1.10 1.13),1.53E-58
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.11 (1.10 1.13),1.20E-57
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.11 (1.10 1.13),1.17E-55
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.11 (1.10 1.12),2.61E-54
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.10 (1.09 1.12),4.91E-51
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.10 (1.09 1.12),1.32E-48
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.10 (1.08 1.11),1.19E-45
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.10 (1.08 1.11),6.05E-43
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.09 (1.08 1.11),9.42E-41
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.09 (1.08 1.11),2.43E-40
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.09 (1.07 1.10),3.35E-35
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.08 (1.07 1.10),1.72E-33
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.08 (1.07 1.10),5.67E-33
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003527,0.050,Nightingale,Sphingomyelins,1.08 (1.07 1.10),1.25E-30
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.08 (1.07 1.09),3.71E-30
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.08 (1.06 1.09),2.38E-28
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.07 (1.06 1.09),2.20E-26
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.07 (1.06 1.09),1.60E-24
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003497,0.072,Nightingale,Linoleic acid,1.07 (1.06 1.08),3.42E-22
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.07 (1.05 1.08),7.29E-22
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003523,0.062,Nightingale,Total fatty acids,1.07 (1.05 1.08),2.22E-21
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003528,0.050,Nightingale,Total cholines,1.07 (1.05 1.08),8.76E-21
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.06 (1.05 1.08),2.27E-18
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.06 (1.05 1.08),4.22E-18
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.94 (0.93 0.96),3.59E-17
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.06 (1.05 1.07),3.92E-17
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003509,0.069,Nightingale,Free cholesterol in chylomicrons and extremely large VLDL,0.94 (0.93 0.96),4.57E-17
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.94 (0.93 0.96),2.07E-16
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,0.95 (0.93 0.96),3.20E-15
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003487,0.074,Nightingale,Phospholipids in chylomicrons and extremely large VLDL,0.95 (0.94 0.96),1.75E-14
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003526,0.050,Nightingale,Phosphatidylcholines,1.05 (1.04 1.07),1.76E-14
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,0.95 (0.94 0.96),2.20E-14
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.95 (0.94 0.96),3.63E-14
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003462,0.083,Nightingale,Average diameter for VLDL particles,0.95 (0.94 0.96),8.91E-14
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003491,0.073,Nightingale,Total lipids in chylomicrons and extremely large VLDL,0.95 (0.94 0.96),1.65E-13
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.95 (0.94 0.96),1.75E-13
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003520,0.062,Nightingale,HDL cholesterol,0.95 (0.94 0.96),1.83E-13
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.05 (1.04 1.07),3.72E-13
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.95 (0.94 0.96),4.97E-13
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.95 (0.94 0.96),7.76E-13
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.95 (0.94 0.96),5.06E-12
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.95 (0.94 0.97),1.85E-11
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.95 (0.94 0.97),8.82E-11
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003504,0.070,Nightingale,Triglycerides in very large VLDL,0.96 (0.94 0.97),1.35E-10
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003510,0.068,Nightingale,Cholesterol in chylomicrons and extremely large VLDL,0.96 (0.94 0.97),1.90E-10
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.96 (0.94 0.97),4.14E-10
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003513,0.067,Nightingale,Free cholesterol in very large VLDL,0.96 (0.94 0.97),7.36E-10
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003502,0.070,Nightingale,Concentration of very large VLDL particles,0.96 (0.95 0.97),1.57E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.04 (1.03 1.06),2.24E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003500,0.071,Nightingale,Total lipids in very large VLDL,0.96 (0.95 0.97),3.67E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.96 (0.95 0.97),4.63E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003506,0.070,Nightingale,Cholesterol in very large VLDL,0.96 (0.95 0.97),5.89E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003516,0.066,Nightingale,Phospholipids in very large VLDL,0.96 (0.95 0.97),8.66E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.96 (0.95 0.97),1.04E-08
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003496,0.072,Nightingale,Cholesteryl esters in very large VLDL,0.96 (0.95 0.97),2.08E-08
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,1.04 (1.03 1.05),5.13E-08
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.96 (0.95 0.97),2.47E-07
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.96 (0.95 0.97),3.25E-07
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003542,0.028,Nightingale,Phospholipids in medium HDL,0.96 (0.95 0.98),2.54E-06
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003518,0.065,Nightingale,Triglycerides in medium HDL,1.03 (1.02 1.05),1.66E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003448,0.093,Nightingale,Phospholipids in very large HDL,0.97 (0.95 0.98),1.66E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.03 (1.02 1.05),3.40E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,1.03 (1.02 1.05),3.73E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003540,0.029,Nightingale,Free cholesterol in small HDL,0.97 (0.96 0.98),7.80E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,0.97 (0.96 0.99),1.12E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003484,0.075,Nightingale,Triglycerides in HDL,1.02 (1.01 1.04),8.58E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003476,0.076,Nightingale,Phospholipids in medium VLDL,1.02 (1.01 1.04),1.39E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003486,0.074,Nightingale,Total triglycerides,1.02 (1.01 1.04),1.73E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003537,0.031,Nightingale,Glycoprotein acetyls,0.98 (0.97 0.99),2.99E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS013472,0.027,RNAseq,STAT1,1.05 (1.03 1.06),7.50E-11
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011108,0.052,RNAseq,LDLR,0.96 (0.94 0.97),3.05E-10
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS013939,0.023,RNAseq,BATF2,1.04 (1.03 1.06),6.38E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS006535,0.174,RNAseq,PSRC1,0.96 (0.95 0.97),7.97E-09
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004382,0.374,RNAseq,FES,0.96 (0.95 0.97),5.35E-08
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010653,0.059,RNAseq,CELSR2,1.04 (1.03 1.05),2.24E-07
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS007943,0.117,RNAseq,SLC22A1,0.96 (0.95 0.98),3.38E-07
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008273,0.107,RNAseq,GRK4,1.04 (1.02 1.05),8.86E-07
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS005858,0.211,RNAseq,GGCX,1.04 (1.02 1.05),1.47E-06
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011308,0.049,RNAseq,PI4K2B,0.96 (0.95 0.98),2.70E-06
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS005687,0.222,RNAseq,CTSK,0.97 (0.95 0.98),1.05E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011739,0.044,RNAseq,DHX36,0.97 (0.96 0.98),2.57E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012284,0.038,RNAseq,AC011446.1,1.03 (1.02 1.05),3.55E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS013817,0.024,RNAseq,MYADM,0.97 (0.96 0.98),5.20E-05
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS007873,0.119,RNAseq,PAFAH1B1,0.97 (0.96 0.98),1.36E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008807,0.094,RNAseq,ARHGEF40,0.97 (0.96 0.98),2.48E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011936,0.042,RNAseq,INTS10,0.97 (0.96 0.98),3.08E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014232,0.021,RNAseq,TRAV1-2,1.03 (1.02 1.04),3.71E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014093,0.022,RNAseq,MYBL1,1.03 (1.02 1.04),4.49E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012279,0.038,RNAseq,CDKN2A,0.97 (0.96 0.98),5.74E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS015052,0.015,RNAseq,CISH,0.97 (0.96 0.98),5.79E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS009659,0.076,RNAseq,NRXN2,1.03 (1.02 1.04),6.57E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012171,0.039,RNAseq,TRBV15,0.97 (0.96 0.98),7.62E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011145,0.052,RNAseq,HOXC4,0.97 (0.96 0.98),8.58E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004930,0.295,RNAseq,LINC00665,0.97 (0.96 0.98),9.57E-04
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008435,0.103,RNAseq,CWF19L2,1.03 (1.02 1.04),1.12E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008901,0.092,RNAseq,RFPL1S,1.03 (1.02 1.04),1.32E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010417,0.062,RNAseq,PHETA1,0.97 (0.96 0.99),1.44E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014164,0.021,RNAseq,SF3A2,0.97 (0.96 0.99),1.72E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011037,0.053,RNAseq,TMEM170A,0.97 (0.96 0.99),2.04E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008681,0.097,RNAseq,POLR2C,1.03 (1.01 1.04),2.07E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004125,0.429,RNAseq,UHRF1BP1,1.03 (1.01 1.04),2.16E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS009893,0.071,RNAseq,HORMAD1,0.97 (0.96 0.99),2.92E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS006403,0.180,RNAseq,AL356599.1,1.03 (1.01 1.04),3.06E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014089,0.022,RNAseq,HNRNPUL1,0.97 (0.96 0.99),3.09E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS009077,0.088,RNAseq,DDAH2,0.97 (0.96 0.99),3.09E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS007255,0.141,RNAseq,CD300A,1.03 (1.01 1.04),3.16E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010624,0.059,RNAseq,TRBV18,1.03 (1.01 1.04),3.35E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS006760,0.162,RNAseq,ZMYND12,1.03 (1.01 1.04),3.36E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS007082,0.149,RNAseq,PHIP,1.03 (1.01 1.04),3.43E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012732,0.033,RNAseq,AF165147.1,0.97 (0.96 0.99),3.43E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008666,0.097,RNAseq,AL592148.3,0.97 (0.96 0.99),3.67E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004014,0.460,RNAseq,PRMT6,0.97 (0.96 0.99),3.72E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004949,0.293,RNAseq,ILRUN,1.03 (1.01 1.04),3.82E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004694,0.324,RNAseq,IREB2,0.97 (0.96 0.99),4.17E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012787,0.033,RNAseq,FURIN,1.03 (1.01 1.04),4.23E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004706,0.323,RNAseq,AC011462.5,1.03 (1.01 1.04),4.39E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004677,0.327,RNAseq,SLC18B1,0.98 (0.96 0.99),4.41E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010657,0.059,RNAseq,HMG20A,1.03 (1.01 1.04),4.61E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS006621,0.169,RNAseq,NME7,0.98 (0.96 0.99),4.86E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011811,0.043,RNAseq,ZBTB46,0.98 (0.96 0.99),5.19E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012380,0.037,RNAseq,AC007381.1,0.98 (0.96 0.99),5.20E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS013276,0.028,RNAseq,ZNF346,1.02 (1.01 1.04),5.35E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS007717,0.125,RNAseq,GUCY1A1,0.98 (0.96 0.99),5.42E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014553,0.019,RNAseq,DISP1,0.98 (0.96 0.99),5.81E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008005,0.115,RNAseq,GNGT2,1.03 (1.01 1.04),5.96E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS005006,0.285,RNAseq,ARHGEF35-AS1,1.03 (1.01 1.04),6.59E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS005783,0.217,RNAseq,SNHG26,0.98 (0.96 0.99),6.59E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008555,0.100,RNAseq,CALCRL,1.03 (1.01 1.04),6.69E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011232,0.050,RNAseq,AL589765.4,1.03 (1.01 1.04),6.72E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS013208,0.029,RNAseq,SNX27,1.02 (1.01 1.04),6.77E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011948,0.042,RNAseq,ADGRG1,0.98 (0.96 0.99),6.81E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010977,0.054,RNAseq,STPG1,0.98 (0.96 0.99),6.82E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014126,0.022,RNAseq,RBFOX2,0.98 (0.96 0.99),7.24E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014221,0.021,RNAseq,HIC1,0.98 (0.96 0.99),7.56E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS009762,0.074,RNAseq,AC025034.1,1.02 (1.01 1.04),7.71E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004611,0.338,RNAseq,GFPT1,1.02 (1.01 1.04),7.95E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014256,0.021,RNAseq,AL136441.1,1.02 (1.01 1.04),8.37E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS006927,0.154,RNAseq,TAF7,0.98 (0.96 0.99),9.01E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS007220,0.143,RNAseq,TAF1A,1.02 (1.01 1.04),9.03E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003936,0.490,RNAseq,CTSH,0.98 (0.96 0.99),9.03E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014064,0.022,RNAseq,ZBTB34,1.02 (1.01 1.04),9.43E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014341,0.020,RNAseq,NFAT5,1.02 (1.01 1.04),9.43E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010929,0.055,RNAseq,EOMES,1.02 (1.01 1.04),9.72E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS007394,0.136,RNAseq,AL662844.4,0.98 (0.96 0.99),9.81E-03
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003588,0.703,RNAseq,LIPA,1.02 (1.01 1.04),1.04E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008054,0.114,RNAseq,PRKG1,0.98 (0.96 0.99),1.04E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS013514,0.026,RNAseq,GZMK,1.02 (1.01 1.04),1.08E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011637,0.045,RNAseq,DHDDS,1.02 (1.01 1.04),1.14E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008934,0.091,RNAseq,CFDP1,0.98 (0.96 0.99),1.14E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008832,0.093,RNAseq,PFKFB2,1.02 (1.01 1.04),1.15E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS009794,0.073,RNAseq,RN7SL473P,0.98 (0.96 0.99),1.17E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS009287,0.084,RNAseq,COPRS,1.02 (1.01 1.04),1.17E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010345,0.064,RNAseq,PLCG1,0.98 (0.96 0.99),1.18E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012700,0.034,RNAseq,NFATC2,1.02 (1.01 1.04),1.18E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012073,0.040,RNAseq,SGPP1,0.98 (0.96 0.99),1.38E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012717,0.033,RNAseq,GBP4,1.02 (1.01 1.04),1.38E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004357,0.379,RNAseq,ARSA,1.02 (1.01 1.04),1.43E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS009190,0.085,RNAseq,COL13A1,1.02 (1.01 1.04),1.52E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004485,0.357,RNAseq,LPL,0.98 (0.96 0.99),1.56E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS005829,0.213,RNAseq,MACF1,1.02 (1.01 1.04),1.57E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS006064,0.200,RNAseq,DNTTIP1,0.98 (0.97 0.99),1.58E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011752,0.044,RNAseq,AL359532.1,0.98 (0.96 0.99),1.65E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008359,0.105,RNAseq,FAM49A,1.02 (1.01 1.04),1.70E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014419,0.020,RNAseq,SF3A1,1.02 (1.01 1.04),1.71E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003621,0.665,RNAseq,,1.02 (1.01 1.04),1.82E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS007798,0.122,RNAseq,ARCN1,1.02 (1.01 1.04),1.94E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008628,0.098,RNAseq,DYM,0.98 (0.97 0.99),2.05E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS013445,0.027,RNAseq,AC131212.2,0.98 (0.97 0.99),2.08E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003660,0.627,RNAseq,SENP6,1.02 (1.01 1.04),2.09E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003708,0.594,RNAseq,HSD17B12,0.98 (0.97 0.99),2.09E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004816,0.308,RNAseq,ZNF595,0.98 (0.97 0.99),2.24E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012264,0.038,RNAseq,RNF40,0.98 (0.97 0.99),2.25E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS006433,0.179,RNAseq,PECAM1,1.02 (1.01 1.04),2.25E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010780,0.057,RNAseq,GOLGA5,0.98 (0.97 0.99),2.46E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008705,0.096,RNAseq,RPS6KA1,0.98 (0.97 0.99),2.49E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008375,0.105,RNAseq,IFI27,0.98 (0.97 0.99),2.57E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010729,0.058,RNAseq,TRIM32,0.98 (0.97 0.99),2.57E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS007508,0.132,RNAseq,ALDH2,0.98 (0.97 0.99),2.57E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS005735,0.219,RNAseq,REX1BD,1.02 (1.01 1.04),2.59E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004501,0.354,RNAseq,TBKBP1,0.98 (0.97 0.99),2.65E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014718,0.017,RNAseq,MRC2,1.02 (1.01 1.04),2.65E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS013798,0.024,RNAseq,RNF5,1.02 (1.01 1.03),2.67E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008309,0.106,RNAseq,SP1,1.02 (1.01 1.03),2.67E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014331,0.020,RNAseq,KLHL25,1.02 (1.01 1.03),2.67E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011449,0.048,RNAseq,ACAT2,0.98 (0.97 0.99),2.67E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011996,0.041,RNAseq,FBXO6,1.02 (1.01 1.03),2.72E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011132,0.052,RNAseq,HEATR5B,1.02 (1.01 1.04),2.79E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012006,0.041,RNAseq,VARS2,1.02 (1.01 1.04),2.88E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010668,0.058,RNAseq,ZNF418,0.98 (0.97 0.99),2.90E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS005369,0.249,RNAseq,WFDC3,0.98 (0.97 0.99),2.95E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014044,0.022,RNAseq,KCND3,0.98 (0.97 0.99),2.98E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS009489,0.079,RNAseq,POC1B,0.98 (0.97 0.99),3.04E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011044,0.053,RNAseq,AL359922.3,1.02 (1.01 1.04),3.23E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012730,0.033,RNAseq,CARM1,0.98 (0.97 0.99),3.23E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004968,0.290,RNAseq,FCHO1,0.98 (0.97 0.99),3.26E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS009682,0.075,RNAseq,AL731557.1,1.02 (1.01 1.03),3.36E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS013064,0.030,RNAseq,ZNF22,1.02 (1.01 1.03),3.36E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012111,0.040,RNAseq,AC022730.4,0.98 (0.97 0.99),3.38E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS005674,0.223,RNAseq,ACTR5,0.98 (0.97 0.99),3.39E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS009289,0.084,RNAseq,AC010883.1,1.02 (1.01 1.03),3.57E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003839,0.534,RNAseq,GATC,0.98 (0.97 0.99),3.66E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014423,0.020,RNAseq,UCHL5,1.02 (1.01 1.03),3.67E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010607,0.059,RNAseq,TRAV8-1,0.98 (0.97 0.99),3.67E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010700,0.058,RNAseq,DCLRE1B,0.98 (0.97 0.99),3.67E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS007701,0.125,RNAseq,DHCR24,0.98 (0.97 0.99),3.73E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014468,0.019,RNAseq,SLC19A1,1.02 (1.01 1.03),3.74E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012772,0.033,RNAseq,GIGYF2,1.02 (1.01 1.03),3.76E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014662,0.018,RNAseq,MXD1,0.98 (0.97 0.99),3.76E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008402,0.104,RNAseq,TNXB,1.02 (1.01 1.03),3.78E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012619,0.034,RNAseq,IFT122,0.98 (0.97 0.99),3.79E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012146,0.040,RNAseq,SMARCAD1,1.02 (1.01 1.03),3.79E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014475,0.019,RNAseq,TMEM181,1.02 (1.01 1.03),3.93E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004894,0.300,RNAseq,MPP7,1.02 (1.01 1.03),4.00E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS005259,0.260,RNAseq,RAB11FIP4,1.02 (1.01 1.03),4.00E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014506,0.019,RNAseq,ZNF781,1.02 (1.01 1.03),4.03E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS005346,0.252,RNAseq,,1.02 (1.01 1.03),4.03E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008095,0.113,RNAseq,FGGY,1.02 (1.01 1.03),4.14E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010402,0.062,RNAseq,,1.02 (1.01 1.03),4.22E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011442,0.048,RNAseq,FYTTD1,1.02 (1.01 1.03),4.22E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011779,0.044,RNAseq,,0.98 (0.97 0.99),4.22E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004108,0.434,RNAseq,GPD2,0.98 (0.97 0.99),4.25E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS007248,0.141,RNAseq,,1.02 (1.01 1.03),4.27E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS013305,0.028,RNAseq,TRBV14,0.98 (0.97 0.99),4.28E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008244,0.108,RNAseq,ICA1L,1.02 (1.01 1.03),4.32E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014580,0.018,RNAseq,DACT1,0.98 (0.97 0.99),4.32E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS009156,0.086,RNAseq,PROC,0.98 (0.97 0.99),4.34E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS009087,0.088,RNAseq,THSD7A,1.02 (1.01 1.03),4.39E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS009881,0.071,RNAseq,SMAGP,1.02 (1.01 1.03),4.42E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014147,0.021,RNAseq,BCDIN3D,1.02 (1.01 1.04),4.47E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS004999,0.287,RNAseq,AL009031.1,0.98 (0.97 0.99),4.53E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008082,0.113,RNAseq,NUDT5,1.02 (1.01 1.03),4.58E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS003968,0.476,RNAseq,AC093495.1,1.02 (1.01 1.03),4.62E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS011444,0.048,RNAseq,STEAP1B,1.02 (1.01 1.03),4.63E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS008129,0.111,RNAseq,VIM,0.98 (0.97 0.99),4.64E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS012456,0.036,RNAseq,AC011944.2,0.98 (0.97 0.99),4.73E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS014183,0.021,RNAseq,PAXBP1-AS1,1.02 (1.01 1.03),4.75E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS010931,0.055,RNAseq,ZNF550,1.02 (1.01 1.03),4.75E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS006024,0.202,RNAseq,TNFRSF18,1.02 (1.01 1.03),4.75E-02
411.8,Other chronic ischemic heart disease. unspecified,circulatory system,OPGS005167,0.269,RNAseq,TCF19,1.02 (1.01 1.03),4.78E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.08 (1.04 1.12),1.35E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.08 (1.04 1.12),2.55E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.08 (1.04 1.12),2.81E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS000115,0.347,SomaScan,Protein CEI,1.08 (1.04 1.12),2.96E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.08 (1.04 1.12),3.69E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS000312,0.163,SomaScan,Selenoprotein S,1.08 (1.04 1.12),3.87E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.07 (1.03 1.11),4.78E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.07 (1.03 1.11),4.94E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.10 (1.06 1.14),1.16E-03
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.09 (1.05 1.13),3.72E-03
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.08 (1.04 1.13),1.56E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.15 (1.10 1.19),5.67E-08
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.14 (1.10 1.19),1.54E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.14 (1.10 1.19),1.54E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.14 (1.10 1.19),1.61E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.14 (1.10 1.19),2.05E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.14 (1.10 1.19),2.05E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.14 (1.09 1.18),2.20E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.14 (1.09 1.18),2.44E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.14 (1.09 1.18),2.44E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.14 (1.09 1.18),2.44E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.14 (1.09 1.18),2.89E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.14 (1.09 1.18),2.89E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.14 (1.09 1.18),2.89E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.14 (1.09 1.18),3.21E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.14 (1.09 1.18),3.21E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.13 (1.09 1.18),3.58E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.13 (1.09 1.18),3.58E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.14 (1.09 1.18),3.58E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.13 (1.09 1.18),4.79E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.13 (1.09 1.18),4.79E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.13 (1.09 1.18),5.63E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.13 (1.09 1.17),5.71E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.13 (1.09 1.18),5.71E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.13 (1.08 1.17),7.63E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.13 (1.09 1.18),7.63E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.13 (1.09 1.18),7.63E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.13 (1.08 1.17),7.63E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.13 (1.09 1.17),7.63E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.13 (1.09 1.17),7.63E-07
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.13 (1.08 1.17),1.09E-06
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.13 (1.08 1.17),1.33E-06
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.13 (1.08 1.17),1.33E-06
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.13 (1.08 1.17),1.33E-06
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.12 (1.08 1.17),1.55E-06
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.12 (1.08 1.16),8.09E-06
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.12 (1.07 1.16),1.98E-05
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.11 (1.07 1.16),2.40E-05
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.11 (1.07 1.16),3.20E-05
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.11 (1.07 1.15),6.67E-05
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.10 (1.06 1.15),1.74E-04
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.10 (1.06 1.14),4.75E-04
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.10 (1.06 1.14),8.60E-04
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.10 (1.05 1.14),1.11E-03
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003497,0.072,Nightingale,Linoleic acid,1.09 (1.05 1.14),1.25E-03
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.09 (1.05 1.14),1.45E-03
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.09 (1.05 1.13),3.64E-03
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.08 (1.04 1.12),1.73E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.08 (1.04 1.12),2.81E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.93 (0.89 0.97),4.14E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.08 (1.04 1.12),4.29E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.07 (1.03 1.12),4.94E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.07 (1.03 1.12),4.94E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS004645,0.333,RNAseq,AC092117.1,0.93 (0.89 0.96),1.53E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS007134,0.146,RNAseq,TRAT1,0.92 (0.89 0.96),1.73E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS012109,0.040,RNAseq,POLRMT,1.08 (1.04 1.12),2.05E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS011145,0.052,RNAseq,HOXC4,0.93 (0.89 0.96),3.05E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS007417,0.135,RNAseq,,0.93 (0.89 0.96),4.14E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS005858,0.211,RNAseq,GGCX,1.08 (1.04 1.12),4.29E-02
411.9,Other acute and subacute forms of ischemic heart disease,circulatory system,OPGS011227,0.051,RNAseq,MCM3,0.93 (0.89 0.97),4.90E-02
414,Other forms of chronic heart disease,circulatory system,OPGS001900,0.015,SomaScan,Glucokinase,0.94 (0.92 0.97),4.55E-03
414,Other forms of chronic heart disease,circulatory system,OPGS002181,0.011,SomaScan,DNA-binding protein inhibitor ID-1,0.94 (0.92 0.97),4.76E-03
414,Other forms of chronic heart disease,circulatory system,OPGS001370,0.030,SomaScan,Retinal rod rhodopsin-sensitive cGMP 3'.5'-cyclic phosphodiesterase subunit delta,0.95 (0.92 0.97),2.58E-02
414,Other forms of chronic heart disease,circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.06 (1.03 1.09),3.35E-03
414,Other forms of chronic heart disease,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.06 (1.03 1.09),8.86E-03
414,Other forms of chronic heart disease,circulatory system,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.05 (1.03 1.08),2.03E-02
414,Other forms of chronic heart disease,circulatory system,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.06 (1.03 1.08),2.39E-02
414,Other forms of chronic heart disease,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.11 (1.08 1.14),2.06E-10
414,Other forms of chronic heart disease,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.11 (1.08 1.14),3.86E-10
414,Other forms of chronic heart disease,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.11 (1.08 1.14),7.47E-10
414,Other forms of chronic heart disease,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.10 (1.07 1.13),3.42E-08
414,Other forms of chronic heart disease,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.10 (1.07 1.13),3.64E-08
414,Other forms of chronic heart disease,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.10 (1.07 1.13),7.46E-08
414,Other forms of chronic heart disease,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.09 (1.07 1.12),1.19E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.09 (1.07 1.12),1.19E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.10 (1.07 1.13),1.42E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.09 (1.07 1.13),1.42E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.10 (1.07 1.13),1.42E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.09 (1.06 1.12),1.52E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.09 (1.06 1.12),1.65E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.09 (1.06 1.12),1.65E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.09 (1.06 1.12),1.65E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.09 (1.06 1.12),1.65E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.09 (1.06 1.12),1.66E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.09 (1.06 1.12),1.94E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.09 (1.06 1.12),1.94E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.09 (1.06 1.12),1.94E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.09 (1.06 1.12),2.75E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.09 (1.06 1.12),2.75E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.09 (1.06 1.12),2.75E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.09 (1.06 1.12),2.75E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.09 (1.06 1.12),3.41E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.09 (1.06 1.12),5.39E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.09 (1.06 1.12),6.40E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.09 (1.06 1.12),9.54E-07
414,Other forms of chronic heart disease,circulatory system,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.09 (1.06 1.11),1.07E-06
414,Other forms of chronic heart disease,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.09 (1.06 1.12),1.07E-06
414,Other forms of chronic heart disease,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.09 (1.06 1.12),1.36E-06
414,Other forms of chronic heart disease,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.09 (1.06 1.12),1.50E-06
414,Other forms of chronic heart disease,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.08 (1.06 1.11),2.03E-06
414,Other forms of chronic heart disease,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.08 (1.06 1.11),3.39E-06
414,Other forms of chronic heart disease,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.08 (1.06 1.11),3.46E-06
414,Other forms of chronic heart disease,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.08 (1.05 1.11),3.59E-06
414,Other forms of chronic heart disease,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.08 (1.05 1.11),5.03E-06
414,Other forms of chronic heart disease,circulatory system,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.08 (1.05 1.11),5.03E-06
414,Other forms of chronic heart disease,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.08 (1.05 1.11),5.61E-06
414,Other forms of chronic heart disease,circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.08 (1.05 1.11),7.92E-06
414,Other forms of chronic heart disease,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.08 (1.05 1.11),9.02E-06
414,Other forms of chronic heart disease,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.08 (1.05 1.11),1.03E-05
414,Other forms of chronic heart disease,circulatory system,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.08 (1.05 1.11),2.41E-05
414,Other forms of chronic heart disease,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.08 (1.05 1.11),2.60E-05
414,Other forms of chronic heart disease,circulatory system,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.07 (1.05 1.10),6.95E-05
414,Other forms of chronic heart disease,circulatory system,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.07 (1.04 1.10),1.25E-04
414,Other forms of chronic heart disease,circulatory system,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.07 (1.04 1.10),1.85E-04
414,Other forms of chronic heart disease,circulatory system,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.07 (1.04 1.10),4.17E-04
414,Other forms of chronic heart disease,circulatory system,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.07 (1.04 1.10),5.18E-04
414,Other forms of chronic heart disease,circulatory system,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.07 (1.04 1.10),5.66E-04
414,Other forms of chronic heart disease,circulatory system,OPGS003523,0.062,Nightingale,Total fatty acids,1.06 (1.04 1.09),1.57E-03
414,Other forms of chronic heart disease,circulatory system,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.06 (1.04 1.09),2.07E-03
414,Other forms of chronic heart disease,circulatory system,OPGS003526,0.050,Nightingale,Phosphatidylcholines,1.06 (1.03 1.09),2.16E-03
414,Other forms of chronic heart disease,circulatory system,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.06 (1.03 1.09),2.49E-03
414,Other forms of chronic heart disease,circulatory system,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.06 (1.03 1.09),2.86E-03
414,Other forms of chronic heart disease,circulatory system,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.06 (1.03 1.09),6.19E-03
414,Other forms of chronic heart disease,circulatory system,OPGS003528,0.050,Nightingale,Total cholines,1.06 (1.03 1.09),1.35E-02
414,Other forms of chronic heart disease,circulatory system,OPGS003497,0.072,Nightingale,Linoleic acid,1.06 (1.03 1.08),2.03E-02
414,Other forms of chronic heart disease,circulatory system,OPGS003518,0.065,Nightingale,Triglycerides in medium HDL,1.05 (1.03 1.08),2.69E-02
414,Other forms of chronic heart disease,circulatory system,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.05 (1.02 1.08),3.88E-02
414,Other forms of chronic heart disease,circulatory system,OPGS007082,0.149,RNAseq,PHIP,1.06 (1.03 1.09),5.46E-03
414,Other forms of chronic heart disease,circulatory system,OPGS008577,0.099,RNAseq,CDC123,1.06 (1.03 1.09),6.19E-03
414,Other forms of chronic heart disease,circulatory system,OPGS011591,0.046,RNAseq,H2AJ,1.06 (1.03 1.08),8.58E-03
414,Other forms of chronic heart disease,circulatory system,OPGS004961,0.291,RNAseq,TC2N,0.95 (0.92 0.97),2.03E-02
414,Other forms of chronic heart disease,circulatory system,OPGS012981,0.031,RNAseq,KCNJ2,1.06 (1.03 1.09),2.14E-02
414,Other forms of chronic heart disease,circulatory system,OPGS007680,0.126,RNAseq,AC110285.6,0.95 (0.93 0.98),2.14E-02
414,Other forms of chronic heart disease,circulatory system,OPGS009492,0.079,RNAseq,LINC00189,0.95 (0.92 0.97),2.31E-02
414,Other forms of chronic heart disease,circulatory system,OPGS007943,0.117,RNAseq,SLC22A1,0.95 (0.93 0.98),2.38E-02
414,Other forms of chronic heart disease,circulatory system,OPGS014898,0.016,RNAseq,AC010245.2,1.06 (1.03 1.09),2.68E-02
415,Pulmonary heart disease,circulatory system,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.21 (1.18 1.24),2.87E-56
415,Pulmonary heart disease,circulatory system,OPGS000088,0.392,SomaScan,E-selectin,0.84 (0.82 0.86),1.49E-51
415,Pulmonary heart disease,circulatory system,OPGS001658,0.020,SomaScan,Endoglin,0.85 (0.83 0.87),4.34E-44
415,Pulmonary heart disease,circulatory system,OPGS001954,0.014,SomaScan,Tuftelin,0.85 (0.83 0.87),8.44E-43
415,Pulmonary heart disease,circulatory system,OPGS000101,0.374,SomaScan,CD209 antigen,1.18 (1.16 1.21),8.44E-43
415,Pulmonary heart disease,circulatory system,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.85 (0.83 0.87),4.69E-42
415,Pulmonary heart disease,circulatory system,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,0.85 (0.83 0.87),1.23E-40
415,Pulmonary heart disease,circulatory system,OPGS000600,0.099,SomaScan,Insulin receptor,0.85 (0.84 0.87),3.78E-40
415,Pulmonary heart disease,circulatory system,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,1.18 (1.15 1.20),9.07E-40
415,Pulmonary heart disease,circulatory system,OPGS001490,0.026,SomaScan,Intercellular adhesion molecule 2,0.86 (0.84 0.88),2.56E-34
415,Pulmonary heart disease,circulatory system,OPGS000095,0.381,SomaScan,Sulfhydryl oxidase 2,1.16 (1.13 1.18),1.29E-31
415,Pulmonary heart disease,circulatory system,OPGS001045,0.050,SomaScan,Carbohydrate sulfotransferase 15,0.87 (0.85 0.89),9.43E-29
415,Pulmonary heart disease,circulatory system,OPGS001301,0.034,SomaScan,Glycosaminoglycan xylosylkinase,1.15 (1.12 1.17),6.31E-28
415,Pulmonary heart disease,circulatory system,OPGS000889,0.064,SomaScan,Hepatocyte growth factor receptor,0.87 (0.85 0.89),6.82E-28
415,Pulmonary heart disease,circulatory system,OPGS001127,0.044,SomaScan,Carbohydrate sulfotransferase 15,0.87 (0.85 0.89),9.13E-28
415,Pulmonary heart disease,circulatory system,OPGS001915,0.014,SomaScan,N-acetylglucosamine-6-sulfatase,0.88 (0.86 0.90),1.10E-27
415,Pulmonary heart disease,circulatory system,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.87 (0.85 0.90),1.08E-25
415,Pulmonary heart disease,circulatory system,OPGS000351,0.151,SomaScan,C1GALT1-specific chaperone 1,1.14 (1.11 1.16),2.26E-24
415,Pulmonary heart disease,circulatory system,OPGS000362,0.147,SomaScan,Golgi membrane protein 1,1.14 (1.11 1.16),5.58E-24
415,Pulmonary heart disease,circulatory system,OPGS000155,0.275,SomaScan,Interleukin-3 receptor subunit alpha,0.88 (0.86 0.90),8.85E-23
415,Pulmonary heart disease,circulatory system,OPGS000212,0.222,SomaScan,Tyrosine-protein kinase receptor Tie-1. soluble,1.13 (1.10 1.15),1.25E-22
415,Pulmonary heart disease,circulatory system,OPGS001626,0.021,SomaScan,Neural cell adhesion molecule L1,0.88 (0.86 0.90),3.73E-22
415,Pulmonary heart disease,circulatory system,OPGS000321,0.161,SomaScan,von Willebrand factor,1.15 (1.12 1.18),4.28E-22
415,Pulmonary heart disease,circulatory system,OPGS000146,0.291,SomaScan,Coagulation Factor XI,1.13 (1.10 1.16),1.32E-21
415,Pulmonary heart disease,circulatory system,OPGS000885,0.064,SomaScan,Dipeptidase 2,0.88 (0.86 0.91),2.64E-20
415,Pulmonary heart disease,circulatory system,OPGS000220,0.213,SomaScan,Vascular endothelial growth factor receptor 2,0.90 (0.88 0.92),9.83E-19
415,Pulmonary heart disease,circulatory system,OPGS000923,0.060,SomaScan,Thrombospondin type-1 domain-containing protein 1,0.89 (0.86 0.91),5.34E-17
415,Pulmonary heart disease,circulatory system,OPGS001083,0.047,SomaScan,Desmoglein-2,1.12 (1.09 1.14),1.07E-16
415,Pulmonary heart disease,circulatory system,OPGS000121,0.341,SomaScan,D-glucuronyl C5-epimerase,1.12 (1.09 1.14),4.87E-16
415,Pulmonary heart disease,circulatory system,OPGS001687,0.020,SomaScan,Acidic leucine-rich nuclear phosphoprotein 32 family member B,0.90 (0.88 0.92),1.07E-15
415,Pulmonary heart disease,circulatory system,OPGS000106,0.366,SomaScan,Protein FAM3D,1.10 (1.07 1.13),1.46E-12
415,Pulmonary heart disease,circulatory system,OPGS000671,0.088,SomaScan,Carbohydrate sulfotransferase 11,1.10 (1.07 1.13),3.91E-12
415,Pulmonary heart disease,circulatory system,OPGS000646,0.091,SomaScan,Protein-tyrosine sulfotransferase 2,1.10 (1.07 1.12),1.44E-11
415,Pulmonary heart disease,circulatory system,OPGS001191,0.039,SomaScan,Progonadoliberin-1,0.91 (0.89 0.93),1.98E-11
415,Pulmonary heart disease,circulatory system,OPGS002289,0.010,SomaScan,Inhibin beta C chain,0.91 (0.89 0.93),2.56E-11
415,Pulmonary heart disease,circulatory system,OPGS001779,0.018,SomaScan,Histatin-3,0.91 (0.89 0.94),6.39E-11
415,Pulmonary heart disease,circulatory system,OPGS002032,0.012,SomaScan,Transmembrane protein 132C,1.09 (1.07 1.12),1.17E-10
415,Pulmonary heart disease,circulatory system,OPGS002042,0.012,SomaScan,Cullin-3,0.91 (0.89 0.94),1.17E-10
415,Pulmonary heart disease,circulatory system,OPGS002095,0.012,SomaScan,Beta-defensin 113,1.09 (1.07 1.12),1.17E-10
415,Pulmonary heart disease,circulatory system,OPGS001993,0.013,SomaScan,Somatostatin-28,0.91 (0.89 0.94),1.17E-10
415,Pulmonary heart disease,circulatory system,OPGS000679,0.087,SomaScan,Mannosyl-oligosaccharide 1.2-alpha-mannosidase IB,1.09 (1.07 1.12),1.41E-10
415,Pulmonary heart disease,circulatory system,OPGS001754,0.018,SomaScan,Vascular endothelial growth factor D,1.09 (1.07 1.12),1.41E-10
415,Pulmonary heart disease,circulatory system,OPGS001721,0.019,SomaScan,Chromogranin-A,0.92 (0.89 0.94),3.21E-10
415,Pulmonary heart disease,circulatory system,OPGS000215,0.218,SomaScan,Immunoglobulin superfamily containing leucine-rich repeat protein 2,0.92 (0.90 0.94),8.81E-10
415,Pulmonary heart disease,circulatory system,OPGS000993,0.054,SomaScan,Protachykinin-1,0.92 (0.90 0.94),1.11E-09
415,Pulmonary heart disease,circulatory system,OPGS001824,0.016,SomaScan,ADM2,0.92 (0.90 0.94),1.13E-09
415,Pulmonary heart disease,circulatory system,OPGS000067,0.438,SomaScan,Adhesion G protein-coupled receptor F5,0.92 (0.90 0.94),1.37E-09
415,Pulmonary heart disease,circulatory system,OPGS001574,0.023,SomaScan,Keratin-associated protein 2-4,0.92 (0.90 0.94),1.46E-09
415,Pulmonary heart disease,circulatory system,OPGS000838,0.069,SomaScan,DNA/RNA-binding protein KIN17,0.92 (0.90 0.94),4.15E-09
415,Pulmonary heart disease,circulatory system,OPGS001327,0.032,SomaScan,Basal Cell Adhesion Molecule,1.08 (1.05 1.10),6.28E-09
415,Pulmonary heart disease,circulatory system,OPGS000960,0.057,SomaScan,Cadherin-15,0.92 (0.90 0.94),7.10E-09
415,Pulmonary heart disease,circulatory system,OPGS000378,0.143,SomaScan,Immunoglobulin superfamily containing leucine-rich repeat protein 2,0.92 (0.90 0.94),9.38E-09
415,Pulmonary heart disease,circulatory system,OPGS001436,0.028,SomaScan,Bone morphogenetic protein 7,1.08 (1.06 1.11),1.43E-08
415,Pulmonary heart disease,circulatory system,OPGS000166,0.267,SomaScan,P-selectin,0.93 (0.90 0.95),2.59E-08
415,Pulmonary heart disease,circulatory system,OPGS000844,0.068,SomaScan,Growth/differentiation factor 2,1.08 (1.06 1.11),2.59E-08
415,Pulmonary heart disease,circulatory system,OPGS001798,0.017,SomaScan,Bone sialoprotein 2,0.92 (0.90 0.95),2.81E-08
415,Pulmonary heart disease,circulatory system,OPGS000108,0.360,SomaScan,Intercellular adhesion molecule 5,0.93 (0.91 0.95),5.08E-08
415,Pulmonary heart disease,circulatory system,OPGS000914,0.061,SomaScan,Drebrin-like protein,1.08 (1.05 1.10),1.26E-07
415,Pulmonary heart disease,circulatory system,OPGS000463,0.125,SomaScan,Toll-like receptor 4:Lymphocyte antigen 96 complex,0.93 (0.91 0.95),2.55E-07
415,Pulmonary heart disease,circulatory system,OPGS001487,0.026,SomaScan,Interleukin-2,1.08 (1.05 1.10),3.64E-07
415,Pulmonary heart disease,circulatory system,OPGS000064,0.442,SomaScan,Calcium/calmodulin-dependent protein kinase type 1,1.08 (1.05 1.10),4.69E-07
415,Pulmonary heart disease,circulatory system,OPGS000606,0.098,SomaScan,Beta-1.4-galactosyltransferase 1,1.08 (1.05 1.10),4.69E-07
415,Pulmonary heart disease,circulatory system,OPGS001089,0.047,SomaScan,Tissue factor pathway inhibitor,0.93 (0.91 0.95),5.68E-07
415,Pulmonary heart disease,circulatory system,OPGS000888,0.064,SomaScan,Glucosidase 2 subunit beta,1.08 (1.05 1.10),5.77E-07
415,Pulmonary heart disease,circulatory system,OPGS000126,0.332,SomaScan,Vascular endothelial growth factor receptor 3,0.93 (0.91 0.95),6.16E-07
415,Pulmonary heart disease,circulatory system,OPGS000346,0.151,SomaScan,N-acetyllactosaminide beta-1.3-N-acetylglucosaminyltransferase 2,1.07 (1.05 1.10),7.88E-07
415,Pulmonary heart disease,circulatory system,OPGS001427,0.028,SomaScan,Alpha-2-macroglobulin,1.07 (1.05 1.10),9.69E-07
415,Pulmonary heart disease,circulatory system,OPGS000917,0.061,SomaScan,Interleukin-6 receptor subunit beta,0.93 (0.91 0.95),1.07E-06
415,Pulmonary heart disease,circulatory system,OPGS000925,0.060,SomaScan,Plexin domain-containing protein 1,0.93 (0.91 0.95),1.10E-06
415,Pulmonary heart disease,circulatory system,OPGS001060,0.049,SomaScan,Septin-11,1.07 (1.05 1.10),1.44E-06
415,Pulmonary heart disease,circulatory system,OPGS001049,0.049,SomaScan,Chloride intracellular channel protein 5,1.08 (1.05 1.11),1.47E-06
415,Pulmonary heart disease,circulatory system,OPGS001294,0.034,SomaScan,Peroxidasin homolog,0.93 (0.91 0.96),2.95E-06
415,Pulmonary heart disease,circulatory system,OPGS001476,0.026,SomaScan,Interleukin-13 receptor subunit alpha-1,1.07 (1.05 1.10),3.53E-06
415,Pulmonary heart disease,circulatory system,OPGS000643,0.092,SomaScan,CD27 antigen,1.07 (1.05 1.10),4.48E-06
415,Pulmonary heart disease,circulatory system,OPGS000736,0.080,SomaScan,Semaphorin-6A,0.93 (0.91 0.96),5.38E-06
415,Pulmonary heart disease,circulatory system,OPGS001257,0.036,SomaScan,Glucagon,0.93 (0.91 0.96),5.73E-06
415,Pulmonary heart disease,circulatory system,OPGS001174,0.040,SomaScan,Platelet glycoprotein 4,1.06 (1.04 1.09),6.97E-06
415,Pulmonary heart disease,circulatory system,OPGS001016,0.052,SomaScan,Protein jagged-1,0.94 (0.91 0.96),8.64E-06
415,Pulmonary heart disease,circulatory system,OPGS001059,0.049,SomaScan,Inter-alpha-trypsin inhibitor heavy chain H4,0.94 (0.91 0.96),9.72E-06
415,Pulmonary heart disease,circulatory system,OPGS001084,0.047,SomaScan,Activating signal cointegrator 1 complex subunit 1,1.07 (1.04 1.09),1.02E-05
415,Pulmonary heart disease,circulatory system,OPGS000150,0.284,SomaScan,Plasma kallikrein,1.07 (1.04 1.09),1.21E-05
415,Pulmonary heart disease,circulatory system,OPGS001273,0.035,SomaScan,Persulfide dioxygenase ETHE1. mitochondrial,0.94 (0.91 0.96),1.49E-05
415,Pulmonary heart disease,circulatory system,OPGS001832,0.016,SomaScan,Neurogenic locus notch homolog protein 1,1.06 (1.04 1.09),1.72E-05
415,Pulmonary heart disease,circulatory system,OPGS000663,0.089,SomaScan,Secreted and transmembrane protein 1,0.94 (0.92 0.96),1.98E-05
415,Pulmonary heart disease,circulatory system,OPGS001337,0.032,SomaScan,Cholecystokinin,0.94 (0.92 0.96),2.97E-05
415,Pulmonary heart disease,circulatory system,OPGS001700,0.019,SomaScan,Semaphorin-6B,1.06 (1.04 1.08),4.98E-05
415,Pulmonary heart disease,circulatory system,OPGS000710,0.082,SomaScan,Thrombin,1.06 (1.04 1.09),8.28E-05
415,Pulmonary heart disease,circulatory system,OPGS000214,0.221,SomaScan,Intercellular adhesion molecule 5,0.94 (0.92 0.96),8.34E-05
415,Pulmonary heart disease,circulatory system,OPGS000782,0.075,SomaScan,Beta-1.4-galactosyltransferase 2,1.06 (1.04 1.09),1.26E-04
415,Pulmonary heart disease,circulatory system,OPGS000910,0.062,SomaScan,Neurexin-1,0.94 (0.92 0.96),1.61E-04
415,Pulmonary heart disease,circulatory system,OPGS000766,0.077,SomaScan,Peptidyl-tRNA hydrolase ICT1. mitochondrial,0.94 (0.92 0.97),1.66E-04
415,Pulmonary heart disease,circulatory system,OPGS000284,0.177,SomaScan,Protein eva-1 homolog C,1.06 (1.04 1.09),2.11E-04
415,Pulmonary heart disease,circulatory system,OPGS000796,0.073,SomaScan,Transmembrane glycoprotein NMB,0.94 (0.92 0.96),2.11E-04
415,Pulmonary heart disease,circulatory system,OPGS000196,0.236,SomaScan,Protein FAM3B,1.06 (1.04 1.09),2.55E-04
415,Pulmonary heart disease,circulatory system,OPGS001496,0.026,SomaScan,Glycoprotein Xg,0.94 (0.92 0.97),3.11E-04
415,Pulmonary heart disease,circulatory system,OPGS001269,0.035,SomaScan,Histone-lysine N-methyltransferase EHMT2,1.06 (1.03 1.08),3.36E-04
415,Pulmonary heart disease,circulatory system,OPGS000795,0.074,SomaScan,Plasma serine protease inhibitor,0.94 (0.92 0.97),4.33E-04
415,Pulmonary heart disease,circulatory system,OPGS001485,0.026,SomaScan,Tolloid-like protein 1,1.05 (1.03 1.08),4.78E-04
415,Pulmonary heart disease,circulatory system,OPGS001743,0.018,SomaScan,14-3-3 protein sigma,0.95 (0.92 0.97),6.32E-04
415,Pulmonary heart disease,circulatory system,OPGS000308,0.164,SomaScan,Complement factor H-related protein 5,0.95 (0.93 0.97),6.32E-04
415,Pulmonary heart disease,circulatory system,OPGS001252,0.036,SomaScan,Neuronal pentraxin-2,0.95 (0.92 0.97),8.87E-04
415,Pulmonary heart disease,circulatory system,OPGS000383,0.142,SomaScan,Protein FAM3B,1.06 (1.03 1.08),9.12E-04
415,Pulmonary heart disease,circulatory system,OPGS000479,0.122,SomaScan,C-C motif chemokine 25,0.95 (0.92 0.97),1.12E-03
415,Pulmonary heart disease,circulatory system,OPGS000778,0.075,SomaScan,Tumor necrosis factor receptor superfamily member 16,0.95 (0.93 0.97),1.59E-03
415,Pulmonary heart disease,circulatory system,OPGS000750,0.078,SomaScan,Adrenomedullin,0.95 (0.93 0.97),1.95E-03
415,Pulmonary heart disease,circulatory system,OPGS001210,0.038,SomaScan,Neurensin-1,0.95 (0.93 0.97),1.96E-03
415,Pulmonary heart disease,circulatory system,OPGS000221,0.213,SomaScan,Protein FAM177A1,0.95 (0.92 0.97),2.14E-03
415,Pulmonary heart disease,circulatory system,OPGS000092,0.387,SomaScan,Hepatocyte growth factor activator,1.06 (1.03 1.08),2.33E-03
415,Pulmonary heart disease,circulatory system,OPGS001821,0.017,SomaScan,Plasminogen activator inhibitor 1,1.05 (1.03 1.08),2.47E-03
415,Pulmonary heart disease,circulatory system,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,1.05 (1.03 1.08),2.47E-03
415,Pulmonary heart disease,circulatory system,OPGS001234,0.037,SomaScan,CUB and sushi domain-containing protein 1,1.05 (1.03 1.08),2.66E-03
415,Pulmonary heart disease,circulatory system,OPGS000563,0.104,SomaScan,Liver-expressed antimicrobial peptide 2,0.95 (0.93 0.97),2.70E-03
415,Pulmonary heart disease,circulatory system,OPGS000682,0.087,SomaScan,Sulfotransferase family cytosolic 1B member 1,1.05 (1.03 1.08),3.03E-03
415,Pulmonary heart disease,circulatory system,OPGS001664,0.020,SomaScan,Thrombospondin-1,1.05 (1.03 1.08),3.03E-03
415,Pulmonary heart disease,circulatory system,OPGS000355,0.150,SomaScan,Platelet glycoprotein VI,1.05 (1.03 1.08),3.09E-03
415,Pulmonary heart disease,circulatory system,OPGS000828,0.070,SomaScan,Platelet endothelial aggregation receptor 1,0.95 (0.93 0.97),3.22E-03
415,Pulmonary heart disease,circulatory system,OPGS002004,0.013,SomaScan,Centromere protein W,1.05 (1.03 1.08),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS002193,0.011,SomaScan,MAGUK p55 subfamily member 7,1.05 (1.03 1.08),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS002084,0.012,SomaScan,Protein FAM210A,1.05 (1.03 1.08),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS002177,0.011,SomaScan,Synaptotagmin-17,1.05 (1.03 1.08),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS001974,0.013,SomaScan,Polyadenylate-binding protein-interacting protein 1,1.05 (1.03 1.08),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS001980,0.013,SomaScan,SPARC,1.05 (1.03 1.08),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS002082,0.012,SomaScan,Interleukin-7,1.05 (1.03 1.08),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS002077,0.012,SomaScan,Choriogonadotropin subunit beta variant 2,1.05 (1.03 1.08),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS002192,0.011,SomaScan,Beta-defensin 119,1.05 (1.03 1.08),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS001949,0.014,SomaScan,72 kDa inositol polyphosphate 5-phosphatase,1.05 (1.03 1.08),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS002214,0.011,SomaScan,DNA-binding protein SATB1,1.05 (1.03 1.08),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS001528,0.025,SomaScan,Histone H1.2,0.95 (0.93 0.97),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS000068,0.438,SomaScan,Hepatocyte growth factor activator,1.05 (1.03 1.08),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS001875,0.015,SomaScan,Synaptotagmin-11,1.05 (1.03 1.08),3.47E-03
415,Pulmonary heart disease,circulatory system,OPGS000790,0.074,SomaScan,Laminin subunit alpha-4,0.95 (0.93 0.97),3.49E-03
415,Pulmonary heart disease,circulatory system,OPGS001139,0.043,SomaScan,Protein SEC13 homolog,1.05 (1.03 1.08),3.51E-03
415,Pulmonary heart disease,circulatory system,OPGS001672,0.020,SomaScan,Angiopoietin-1,1.05 (1.03 1.08),3.63E-03
415,Pulmonary heart disease,circulatory system,OPGS001788,0.017,SomaScan,Platelet-derived growth factor subunit A,1.05 (1.03 1.08),4.44E-03
415,Pulmonary heart disease,circulatory system,OPGS001262,0.035,SomaScan,C-type lectin domain family 1 member B,1.05 (1.03 1.08),4.64E-03
415,Pulmonary heart disease,circulatory system,OPGS001942,0.014,SomaScan,Connective tissue-activating peptide III,1.05 (1.03 1.08),6.14E-03
415,Pulmonary heart disease,circulatory system,OPGS001104,0.046,SomaScan,Transmembrane protein C1orf162,0.95 (0.93 0.98),6.46E-03
415,Pulmonary heart disease,circulatory system,OPGS001827,0.016,SomaScan,UDP-glucuronosyltransferase 2A1,1.05 (1.02 1.08),8.90E-03
415,Pulmonary heart disease,circulatory system,OPGS000653,0.090,SomaScan,Neuropeptide W,0.95 (0.93 0.98),9.53E-03
415,Pulmonary heart disease,circulatory system,OPGS000244,0.195,SomaScan,C-C motif chemokine 25,0.96 (0.93 0.98),1.12E-02
415,Pulmonary heart disease,circulatory system,OPGS000719,0.081,SomaScan,Parathyroid hormone-related protein,0.96 (0.93 0.98),1.48E-02
415,Pulmonary heart disease,circulatory system,OPGS002068,0.012,SomaScan,Brain-derived neurotrophic factor,1.05 (1.02 1.07),1.58E-02
415,Pulmonary heart disease,circulatory system,OPGS001055,0.049,SomaScan,Aspartate aminotransferase. cytoplasmic,1.04 (1.02 1.07),1.69E-02
415,Pulmonary heart disease,circulatory system,OPGS001445,0.028,SomaScan,Endoplasmic reticulum resident protein 44,1.05 (1.02 1.07),1.70E-02
415,Pulmonary heart disease,circulatory system,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,0.96 (0.93 0.98),1.74E-02
415,Pulmonary heart disease,circulatory system,OPGS001553,0.024,SomaScan,Protein G6b,1.05 (1.02 1.07),1.80E-02
415,Pulmonary heart disease,circulatory system,OPGS001652,0.021,SomaScan,Galectin-7,1.05 (1.02 1.07),2.43E-02
415,Pulmonary heart disease,circulatory system,OPGS000911,0.062,SomaScan,Protein MENT,0.96 (0.93 0.98),2.68E-02
415,Pulmonary heart disease,circulatory system,OPGS000916,0.061,SomaScan,CD63 antigen,1.04 (1.02 1.07),3.13E-02
415,Pulmonary heart disease,circulatory system,OPGS000231,0.202,SomaScan,Glycosyltransferase 8 domain-containing protein 1,0.96 (0.93 0.98),3.13E-02
415,Pulmonary heart disease,circulatory system,OPGS000705,0.084,SomaScan,Growth arrest and DNA damage-inducible proteins-interacting protein 1,0.96 (0.94 0.98),3.63E-02
415,Pulmonary heart disease,circulatory system,OPGS002408,0.270,Olink,E-selectin,0.83 (0.82 0.85),6.03E-54
415,Pulmonary heart disease,circulatory system,OPGS002651,0.015,Olink,von Willebrand factor,1.20 (1.17 1.23),8.06E-50
415,Pulmonary heart disease,circulatory system,OPGS002500,0.098,Olink,Galectin-4,0.84 (0.82 0.86),2.66E-47
415,Pulmonary heart disease,circulatory system,OPGS002590,0.035,Olink,Platelet endothelial cell adhesion molecule,0.87 (0.85 0.90),4.89E-27
415,Pulmonary heart disease,circulatory system,OPGS002578,0.039,Olink,Leukemia inhibitory factor receptor,0.88 (0.86 0.90),8.33E-24
415,Pulmonary heart disease,circulatory system,OPGS002395,0.362,Olink,Intercellular adhesion molecule 2,0.89 (0.87 0.91),1.60E-19
415,Pulmonary heart disease,circulatory system,OPGS002638,0.019,Olink,Ephrin type-B receptor 4,0.90 (0.88 0.93),1.51E-13
415,Pulmonary heart disease,circulatory system,OPGS002554,0.053,Olink,P-selectin,0.92 (0.90 0.94),1.84E-10
415,Pulmonary heart disease,circulatory system,OPGS002510,0.085,Olink,Bone morphogenetic protein 6,0.92 (0.89 0.94),4.09E-10
415,Pulmonary heart disease,circulatory system,OPGS002540,0.062,Olink,Plexin-B1,1.09 (1.06 1.11),2.16E-09
415,Pulmonary heart disease,circulatory system,OPGS002592,0.035,Olink,Vascular endothelial growth factor D,1.09 (1.06 1.11),2.35E-09
415,Pulmonary heart disease,circulatory system,OPGS002479,0.127,Olink,Growth/differentiation factor 2,1.08 (1.05 1.10),3.79E-07
415,Pulmonary heart disease,circulatory system,OPGS002557,0.050,Olink,Epithelial cell adhesion molecule,0.94 (0.92 0.96),2.62E-05
415,Pulmonary heart disease,circulatory system,OPGS002531,0.066,Olink,Tissue factor,0.94 (0.92 0.96),3.49E-05
415,Pulmonary heart disease,circulatory system,OPGS002524,0.071,Olink,Sulfotransferase 1A1,1.06 (1.03 1.08),2.55E-04
415,Pulmonary heart disease,circulatory system,OPGS002629,0.023,Olink,Interleukin-18-binding protein,1.06 (1.03 1.08),2.87E-04
415,Pulmonary heart disease,circulatory system,OPGS002541,0.061,Olink,Thrombomodulin,1.05 (1.03 1.08),1.17E-03
415,Pulmonary heart disease,circulatory system,OPGS002605,0.030,Olink,Sortilin,1.06 (1.03 1.08),1.46E-03
415,Pulmonary heart disease,circulatory system,OPGS002454,0.157,Olink,Galectin-9,0.95 (0.93 0.97),2.17E-03
415,Pulmonary heart disease,circulatory system,OPGS002403,0.330,Olink,Sialic acid-binding Ig-like lectin 9,0.95 (0.93 0.97),4.52E-03
415,Pulmonary heart disease,circulatory system,OPGS002468,0.142,Olink,Galectin-8,0.95 (0.93 0.98),8.21E-03
415,Pulmonary heart disease,circulatory system,OPGS002475,0.133,Olink,UL16-binding protein 2,1.05 (1.02 1.07),1.27E-02
415,Pulmonary heart disease,circulatory system,OPGS002661,0.011,Olink,Platelet-derived growth factor subunit A,1.05 (1.02 1.07),1.76E-02
415,Pulmonary heart disease,circulatory system,OPGS002656,0.013,Olink,Angiotensin-converting enzyme 2,1.05 (1.02 1.07),2.27E-02
415,Pulmonary heart disease,circulatory system,OPGS002660,0.012,Olink,Angiopoietin-1,1.05 (1.02 1.07),2.30E-02
415,Pulmonary heart disease,circulatory system,OPGS002654,0.015,Olink,Thrombopoietin,1.04 (1.02 1.06),4.01E-02
415,Pulmonary heart disease,circulatory system,OPGS003149,0.015,Metabolon,sphingosine,1.17 (1.15 1.20),8.67E-42
415,Pulmonary heart disease,circulatory system,OPGS002894,0.054,Metabolon,bradykinin. hydroxy-pro(3),1.10 (1.07 1.13),5.98E-12
415,Pulmonary heart disease,circulatory system,OPGS002794,0.099,Metabolon,X - 14095,1.09 (1.06 1.11),2.16E-09
415,Pulmonary heart disease,circulatory system,OPGS002767,0.127,Metabolon,phenylalanylarginine,1.08 (1.06 1.11),9.36E-09
415,Pulmonary heart disease,circulatory system,OPGS002742,0.161,Metabolon,bradykinin,1.08 (1.06 1.11),1.64E-08
415,Pulmonary heart disease,circulatory system,OPGS002726,0.198,Metabolon,methionylalanine,1.08 (1.06 1.11),2.59E-08
415,Pulmonary heart disease,circulatory system,OPGS002825,0.081,Metabolon,bradykinin. des-arg(9),1.08 (1.06 1.11),3.50E-08
415,Pulmonary heart disease,circulatory system,OPGS002733,0.179,Metabolon,X - 21471,0.95 (0.93 0.98),4.64E-03
415,Pulmonary heart disease,circulatory system,OPGS002850,0.070,Metabolon,1-stearoyl-2-linoleoyl-GPE (18:0/18:2)*,0.95 (0.93 0.97),4.65E-03
415,Pulmonary heart disease,circulatory system,OPGS002921,0.047,Metabolon,1-oleoyl-2-linoleoyl-GPE (18:1/18:2)*,0.95 (0.93 0.98),8.32E-03
415,Pulmonary heart disease,circulatory system,OPGS002789,0.102,Metabolon,1-palmitoyl-2-linoleoyl-GPE (16:0/18:2),0.96 (0.93 0.98),1.50E-02
415,Pulmonary heart disease,circulatory system,OPGS002907,0.050,Metabolon,X - 18922,0.96 (0.93 0.98),1.67E-02
415,Pulmonary heart disease,circulatory system,OPGS002736,0.172,Metabolon,glycocholenate sulfate*,0.96 (0.93 0.98),2.97E-02
415,Pulmonary heart disease,circulatory system,OPGS002807,0.089,Metabolon,1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3)*,0.96 (0.94 0.98),4.29E-02
415,Pulmonary heart disease,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,0.95 (0.93 0.97),3.63E-03
415,Pulmonary heart disease,circulatory system,OPGS003497,0.072,Nightingale,Linoleic acid,0.95 (0.93 0.97),3.63E-03
415,Pulmonary heart disease,circulatory system,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,0.95 (0.93 0.97),4.03E-03
415,Pulmonary heart disease,circulatory system,OPGS003541,0.028,Nightingale,Histidine,1.05 (1.02 1.07),6.25E-03
415,Pulmonary heart disease,circulatory system,OPGS003450,0.092,Nightingale,Triglycerides in IDL,0.95 (0.93 0.98),7.11E-03
415,Pulmonary heart disease,circulatory system,OPGS003464,0.082,Nightingale,Triglycerides in LDL,0.96 (0.93 0.98),1.47E-02
415,Pulmonary heart disease,circulatory system,OPGS015054,0.015,RNAseq,H19,1.17 (1.15 1.20),6.71E-42
415,Pulmonary heart disease,circulatory system,OPGS003651,0.639,RNAseq,ABO,0.90 (0.88 0.92),9.47E-17
415,Pulmonary heart disease,circulatory system,OPGS012642,0.034,RNAseq,SLC19A2,1.08 (1.05 1.10),6.81E-08
415,Pulmonary heart disease,circulatory system,OPGS005968,0.205,RNAseq,TSPAN15,0.93 (0.91 0.96),3.43E-06
415,Pulmonary heart disease,circulatory system,OPGS008339,0.106,RNAseq,GBGT1,0.95 (0.93 0.97),1.41E-04
415,Pulmonary heart disease,circulatory system,OPGS014701,0.017,RNAseq,,0.95 (0.92 0.97),1.87E-03
415,Pulmonary heart disease,circulatory system,OPGS008089,0.113,RNAseq,AC012507.1,0.95 (0.93 0.97),1.91E-03
415,Pulmonary heart disease,circulatory system,OPGS010454,0.062,RNAseq,GP1BA,1.05 (1.03 1.08),2.06E-03
415,Pulmonary heart disease,circulatory system,OPGS010512,0.061,RNAseq,ITCH,1.05 (1.03 1.08),2.06E-03
415,Pulmonary heart disease,circulatory system,OPGS004049,0.450,RNAseq,JAM3,1.05 (1.03 1.08),2.47E-03
415,Pulmonary heart disease,circulatory system,OPGS013833,0.024,RNAseq,,0.95 (0.93 0.97),3.61E-03
415,Pulmonary heart disease,circulatory system,OPGS004135,0.427,RNAseq,AP1M2,1.05 (1.03 1.08),6.14E-03
415,Pulmonary heart disease,circulatory system,OPGS014440,0.019,RNAseq,C19orf38,1.05 (1.02 1.07),6.75E-03
415,Pulmonary heart disease,circulatory system,OPGS007797,0.122,RNAseq,SLC44A2,1.05 (1.02 1.07),8.23E-03
415,Pulmonary heart disease,circulatory system,OPGS014221,0.021,RNAseq,HIC1,0.95 (0.93 0.98),1.08E-02
415,Pulmonary heart disease,circulatory system,OPGS009107,0.087,RNAseq,SYNE2,0.96 (0.93 0.98),1.11E-02
415,Pulmonary heart disease,circulatory system,OPGS010019,0.069,RNAseq,STMN3,1.05 (1.02 1.08),1.11E-02
415,Pulmonary heart disease,circulatory system,OPGS010473,0.061,RNAseq,CTTN,1.05 (1.02 1.07),1.13E-02
415,Pulmonary heart disease,circulatory system,OPGS005508,0.237,RNAseq,SLC2A1-AS1,1.05 (1.02 1.07),1.24E-02
415,Pulmonary heart disease,circulatory system,OPGS007070,0.149,RNAseq,MED22,0.95 (0.93 0.98),1.36E-02
415,Pulmonary heart disease,circulatory system,OPGS004568,0.343,RNAseq,SURF6,0.96 (0.93 0.98),1.59E-02
415,Pulmonary heart disease,circulatory system,OPGS010302,0.064,RNAseq,AP000238.1,0.95 (0.93 0.98),1.63E-02
415,Pulmonary heart disease,circulatory system,OPGS006253,0.189,RNAseq,CABP5,0.96 (0.93 0.98),1.68E-02
415,Pulmonary heart disease,circulatory system,OPGS012130,0.040,RNAseq,SPSB1,1.05 (1.02 1.07),1.68E-02
415,Pulmonary heart disease,circulatory system,OPGS008053,0.114,RNAseq,EDEM2,0.96 (0.93 0.98),1.69E-02
415,Pulmonary heart disease,circulatory system,OPGS006007,0.203,RNAseq,SORBS2,0.96 (0.93 0.98),1.91E-02
415,Pulmonary heart disease,circulatory system,OPGS006025,0.201,RNAseq,ERCC3,0.96 (0.93 0.98),2.02E-02
415,Pulmonary heart disease,circulatory system,OPGS010692,0.058,RNAseq,IPO9,0.96 (0.93 0.98),2.09E-02
415,Pulmonary heart disease,circulatory system,OPGS011367,0.049,RNAseq,SLK,1.04 (1.02 1.07),2.43E-02
415,Pulmonary heart disease,circulatory system,OPGS008973,0.090,RNAseq,PLXDC2,1.04 (1.02 1.07),2.46E-02
415,Pulmonary heart disease,circulatory system,OPGS007851,0.120,RNAseq,TNFRSF13C,0.96 (0.94 0.98),2.67E-02
415,Pulmonary heart disease,circulatory system,OPGS012751,0.033,RNAseq,CRLS1,0.96 (0.93 0.98),2.90E-02
415,Pulmonary heart disease,circulatory system,OPGS006831,0.159,RNAseq,,0.96 (0.93 0.98),3.08E-02
415,Pulmonary heart disease,circulatory system,OPGS013350,0.028,RNAseq,ACSS2,0.96 (0.94 0.98),3.20E-02
415,Pulmonary heart disease,circulatory system,OPGS005419,0.245,RNAseq,,0.96 (0.94 0.98),3.69E-02
415,Pulmonary heart disease,circulatory system,OPGS010309,0.064,RNAseq,TGFA,0.96 (0.94 0.98),3.87E-02
415,Pulmonary heart disease,circulatory system,OPGS009539,0.078,RNAseq,,1.04 (1.02 1.07),4.48E-02
415,Pulmonary heart disease,circulatory system,OPGS007296,0.140,RNAseq,TLR3,0.96 (0.94 0.98),4.75E-02
415,Pulmonary heart disease,circulatory system,OPGS009279,0.084,RNAseq,PKN2-AS1,0.96 (0.94 0.98),4.89E-02
416,Cardiomegaly,circulatory system,OPGS001721,0.019,SomaScan,Chromogranin-A,0.95 (0.93 0.98),4.29E-02
416,Cardiomegaly,circulatory system,OPGS002900,0.053,Metabolon,X - 17357,0.95 (0.92 0.97),2.74E-02
416,Cardiomegaly,circulatory system,OPGS003204,0.012,Metabolon,X - 18886,1.05 (1.03 1.08),3.10E-02
416,Cardiomegaly,circulatory system,OPGS002825,0.081,Metabolon,bradykinin. des-arg(9),1.05 (1.03 1.08),4.06E-02
416,Cardiomegaly,circulatory system,OPGS002894,0.054,Metabolon,bradykinin. hydroxy-pro(3),1.05 (1.03 1.08),4.15E-02
416,Cardiomegaly,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.06 (1.04 1.09),1.10E-02
416,Cardiomegaly,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.06 (1.04 1.09),1.10E-02
416,Cardiomegaly,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.06 (1.04 1.09),1.10E-02
416,Cardiomegaly,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.06 (1.03 1.09),1.10E-02
416,Cardiomegaly,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.06 (1.03 1.08),2.35E-02
416,Cardiomegaly,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.06 (1.03 1.08),2.74E-02
416,Cardiomegaly,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.06 (1.03 1.08),2.87E-02
416,Cardiomegaly,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.06 (1.03 1.08),3.10E-02
416,Cardiomegaly,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.06 (1.03 1.08),3.10E-02
416,Cardiomegaly,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.05 (1.03 1.08),3.25E-02
416,Cardiomegaly,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.05 (1.03 1.08),3.25E-02
416,Cardiomegaly,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.05 (1.03 1.08),3.25E-02
416,Cardiomegaly,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.05 (1.03 1.08),3.56E-02
416,Cardiomegaly,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.05 (1.03 1.08),3.56E-02
416,Cardiomegaly,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.05 (1.03 1.08),3.56E-02
416,Cardiomegaly,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.05 (1.03 1.08),3.56E-02
416,Cardiomegaly,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.05 (1.03 1.08),3.56E-02
416,Cardiomegaly,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.05 (1.03 1.08),3.74E-02
416,Cardiomegaly,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.05 (1.03 1.08),4.02E-02
416,Cardiomegaly,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.05 (1.03 1.08),4.26E-02
416,Cardiomegaly,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.05 (1.03 1.08),4.29E-02
416,Cardiomegaly,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.05 (1.03 1.08),4.29E-02
416,Cardiomegaly,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.05 (1.03 1.08),4.63E-02
416,Cardiomegaly,circulatory system,OPGS003708,0.594,RNAseq,HSD17B12,0.95 (0.92 0.97),2.74E-02
416,Cardiomegaly,circulatory system,OPGS011110,0.052,RNAseq,CMTM2,1.05 (1.03 1.08),3.56E-02
416,Cardiomegaly,circulatory system,OPGS011138,0.052,RNAseq,SPATA6,0.95 (0.93 0.97),3.56E-02
418,Nonspecific chest pain,circulatory system,OPGS002010,0.013,SomaScan,Myc proto-oncogene protein,1.01 (1.01 1.02),2.41E-04
418,Nonspecific chest pain,circulatory system,OPGS001238,0.037,SomaScan,Dedicator of cytokinesis protein 9,1.02 (1.01 1.03),2.82E-03
418,Nonspecific chest pain,circulatory system,OPGS000698,0.085,SomaScan,Alcohol dehydrogenase 1B,1.02 (1.01 1.03),3.48E-03
418,Nonspecific chest pain,circulatory system,OPGS000204,0.233,SomaScan,PR domain zinc finger protein 1,1.02 (1.01 1.03),1.08E-02
418,Nonspecific chest pain,circulatory system,OPGS001626,0.021,SomaScan,Neural cell adhesion molecule L1,0.98 (0.97 0.99),1.20E-02
418,Nonspecific chest pain,circulatory system,OPGS000969,0.056,SomaScan,Transferrin receptor protein 1,1.02 (1.01 1.03),1.24E-02
418,Nonspecific chest pain,circulatory system,OPGS000155,0.275,SomaScan,Interleukin-3 receptor subunit alpha,0.98 (0.97 0.99),1.24E-02
418,Nonspecific chest pain,circulatory system,OPGS000671,0.088,SomaScan,Carbohydrate sulfotransferase 11,1.02 (1.01 1.03),1.26E-02
418,Nonspecific chest pain,circulatory system,OPGS000632,0.093,SomaScan,Erythrocyte band 7 integral membrane protein,1.02 (1.01 1.03),1.63E-02
418,Nonspecific chest pain,circulatory system,OPGS000521,0.113,SomaScan,Transmembrane protease serine 11D,1.02 (1.01 1.03),2.81E-02
418,Nonspecific chest pain,circulatory system,OPGS001658,0.020,SomaScan,Endoglin,0.98 (0.97 0.99),3.20E-02
418,Nonspecific chest pain,circulatory system,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.02 (1.01 1.03),4.48E-02
418,Nonspecific chest pain,circulatory system,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.98 (0.97 0.99),4.48E-02
418,Nonspecific chest pain,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.02 (1.01 1.03),1.24E-02
418,Nonspecific chest pain,circulatory system,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.02 (1.01 1.03),2.10E-02
418,Nonspecific chest pain,circulatory system,OPGS003228,0.010,Metabolon,adenine,1.02 (1.01 1.03),3.47E-02
418,Nonspecific chest pain,circulatory system,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.02 (1.01 1.03),4.84E-02
418,Nonspecific chest pain,circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.02 (1.01 1.03),4.99E-02
418,Nonspecific chest pain,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.03 (1.02 1.04),1.53E-04
418,Nonspecific chest pain,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.03 (1.02 1.04),1.53E-04
418,Nonspecific chest pain,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.03 (1.02 1.04),1.53E-04
418,Nonspecific chest pain,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.03 (1.02 1.04),1.53E-04
418,Nonspecific chest pain,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.03 (1.02 1.04),1.53E-04
418,Nonspecific chest pain,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.03 (1.02 1.04),1.58E-04
418,Nonspecific chest pain,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.03 (1.02 1.04),1.61E-04
418,Nonspecific chest pain,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.03 (1.02 1.04),1.76E-04
418,Nonspecific chest pain,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.03 (1.02 1.04),1.87E-04
418,Nonspecific chest pain,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.03 (1.02 1.04),1.95E-04
418,Nonspecific chest pain,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.03 (1.02 1.04),1.95E-04
418,Nonspecific chest pain,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.03 (1.02 1.04),1.99E-04
418,Nonspecific chest pain,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.03 (1.02 1.04),2.29E-04
418,Nonspecific chest pain,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.03 (1.02 1.04),2.41E-04
418,Nonspecific chest pain,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.03 (1.02 1.04),2.72E-04
418,Nonspecific chest pain,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.03 (1.02 1.04),3.27E-04
418,Nonspecific chest pain,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.03 (1.02 1.04),3.59E-04
418,Nonspecific chest pain,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.03 (1.02 1.04),5.35E-04
418,Nonspecific chest pain,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.03 (1.02 1.04),5.35E-04
418,Nonspecific chest pain,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.03 (1.02 1.04),6.15E-04
418,Nonspecific chest pain,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.02 (1.01 1.04),9.07E-04
418,Nonspecific chest pain,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.02 (1.01 1.03),2.82E-03
418,Nonspecific chest pain,circulatory system,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.02 (1.01 1.03),3.07E-03
418,Nonspecific chest pain,circulatory system,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.02 (1.01 1.03),3.29E-03
418,Nonspecific chest pain,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.02 (1.01 1.03),4.33E-03
418,Nonspecific chest pain,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.02 (1.01 1.03),7.81E-03
418,Nonspecific chest pain,circulatory system,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.02 (1.01 1.03),1.24E-02
418,Nonspecific chest pain,circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.02 (1.01 1.03),2.01E-02
418,Nonspecific chest pain,circulatory system,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.02 (1.01 1.03),2.81E-02
418,Nonspecific chest pain,circulatory system,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.02 (1.01 1.03),4.07E-02
418,Nonspecific chest pain,circulatory system,OPGS014718,0.017,RNAseq,MRC2,1.02 (1.01 1.03),4.67E-03
418,Nonspecific chest pain,circulatory system,OPGS006265,0.188,RNAseq,RBM6,0.98 (0.97 0.99),1.24E-02
418,Nonspecific chest pain,circulatory system,OPGS014044,0.022,RNAseq,KCND3,0.98 (0.97 0.99),1.24E-02
418,Nonspecific chest pain,circulatory system,OPGS010235,0.065,RNAseq,LRP3,1.02 (1.01 1.03),1.24E-02
418,Nonspecific chest pain,circulatory system,OPGS014992,0.016,RNAseq,KLF4,0.98 (0.97 0.99),1.26E-02
418,Nonspecific chest pain,circulatory system,OPGS012171,0.039,RNAseq,TRBV15,0.98 (0.97 0.99),1.36E-02
418,Nonspecific chest pain,circulatory system,OPGS008494,0.102,RNAseq,MIR9-3HG,1.02 (1.01 1.03),1.78E-02
418,Nonspecific chest pain,circulatory system,OPGS010780,0.057,RNAseq,GOLGA5,0.98 (0.97 0.99),1.96E-02
418,Nonspecific chest pain,circulatory system,OPGS009971,0.070,RNAseq,GOLGA1,0.98 (0.97 0.99),2.35E-02
418,Nonspecific chest pain,circulatory system,OPGS010692,0.058,RNAseq,IPO9,0.98 (0.97 0.99),2.35E-02
418,Nonspecific chest pain,circulatory system,OPGS014489,0.019,RNAseq,AP002381.2,1.02 (1.01 1.03),2.62E-02
418,Nonspecific chest pain,circulatory system,OPGS010211,0.066,RNAseq,TRBV27,0.98 (0.97 0.99),2.63E-02
418,Nonspecific chest pain,circulatory system,OPGS011979,0.041,RNAseq,AC104083.1,0.98 (0.97 0.99),3.05E-02
418,Nonspecific chest pain,circulatory system,OPGS004616,0.338,RNAseq,PITPNA,1.02 (1.01 1.03),3.18E-02
418,Nonspecific chest pain,circulatory system,OPGS006427,0.179,RNAseq,PDK1,0.98 (0.97 0.99),3.18E-02
418,Nonspecific chest pain,circulatory system,OPGS013416,0.027,RNAseq,ST3GAL2,1.02 (1.01 1.03),4.01E-02
418,Nonspecific chest pain,circulatory system,OPGS005983,0.204,RNAseq,AC118344.1,0.98 (0.97 0.99),4.48E-02
418,Nonspecific chest pain,circulatory system,OPGS014714,0.017,RNAseq,B3GAT3,0.98 (0.97 0.99),4.77E-02
418,Nonspecific chest pain,circulatory system,OPGS007764,0.123,RNAseq,HLA-E,1.02 (1.01 1.03),4.77E-02
418,Nonspecific chest pain,circulatory system,OPGS012178,0.039,RNAseq,PYROXD2,0.98 (0.97 0.99),4.84E-02
418,Nonspecific chest pain,circulatory system,OPGS009835,0.072,RNAseq,LRRC45,1.02 (1.01 1.03),4.84E-02
418.1,Precordial pain,circulatory system,OPGS001954,0.014,SomaScan,Tuftelin,0.94 (0.91 0.96),1.76E-03
418.1,Precordial pain,circulatory system,OPGS001658,0.020,SomaScan,Endoglin,0.94 (0.92 0.97),1.33E-02
418.1,Precordial pain,circulatory system,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.95 (0.92 0.97),2.98E-02
418.1,Precordial pain,circulatory system,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,0.95 (0.92 0.97),2.98E-02
418.1,Precordial pain,circulatory system,OPGS000088,0.392,SomaScan,E-selectin,0.95 (0.92 0.97),3.23E-02
418.1,Precordial pain,circulatory system,OPGS002590,0.035,Olink,Platelet endothelial cell adhesion molecule,0.95 (0.92 0.97),3.23E-02
418.1,Precordial pain,circulatory system,OPGS002408,0.270,Olink,E-selectin,0.95 (0.93 0.97),3.80E-02
418.1,Precordial pain,circulatory system,OPGS013780,0.024,RNAseq,ZSCAN16,1.06 (1.03 1.08),3.14E-02
420.22,Chronic pericarditis,circulatory system,OPGS014913,0.016,RNAseq,NAPEPLD,0.88 (0.87 0.88),0.00E+00
425.1,Primary/intrinsic cardiomyopathies,circulatory system,OPGS002030,0.012,SomaScan,BAG family molecular chaperone regulator 3,0.88 (0.84 0.92),1.25E-03
425.1,Primary/intrinsic cardiomyopathies,circulatory system,OPGS013667,0.025,RNAseq,AC092384.3,0.90 (0.86 0.94),1.25E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.08 (1.05 1.11),1.46E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.08 (1.05 1.11),1.46E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS000857,0.067,SomaScan,Moesin,1.07 (1.04 1.10),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.08 (1.05 1.11),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.07 (1.04 1.11),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.07 (1.04 1.10),1.66E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.07 (1.04 1.10),1.67E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.07 (1.04 1.10),1.67E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.07 (1.04 1.10),2.16E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.06 (1.03 1.09),5.50E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.06 (1.03 1.09),5.76E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.06 (1.03 1.09),8.99E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS001093,0.046,SomaScan,C-reactive protein,0.94 (0.92 0.97),1.30E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.06 (1.03 1.09),2.07E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.06 (1.03 1.09),3.27E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS000901,0.063,SomaScan,Ski-like protein,1.06 (1.03 1.09),3.47E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.95 (0.92 0.97),3.82E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.06 (1.03 1.09),4.41E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.07 (1.04 1.10),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.08 (1.05 1.11),1.40E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.07 (1.04 1.10),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.07 (1.04 1.10),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.07 (1.04 1.10),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.07 (1.04 1.10),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.07 (1.04 1.10),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.07 (1.04 1.10),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.07 (1.04 1.10),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.07 (1.04 1.10),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.07 (1.04 1.10),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.07 (1.04 1.11),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.07 (1.04 1.11),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.07 (1.04 1.11),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.07 (1.04 1.11),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.08 (1.04 1.11),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.07 (1.04 1.11),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.07 (1.04 1.11),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.07 (1.04 1.11),1.65E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.07 (1.04 1.10),1.66E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.07 (1.04 1.10),1.66E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.07 (1.04 1.10),1.66E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.07 (1.04 1.10),1.66E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.07 (1.04 1.10),1.66E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.07 (1.04 1.10),1.66E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.07 (1.04 1.10),1.67E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.07 (1.04 1.10),1.76E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.07 (1.04 1.10),1.97E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.07 (1.04 1.10),2.16E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.07 (1.04 1.10),2.23E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.07 (1.04 1.10),2.25E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.07 (1.04 1.10),2.37E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.07 (1.04 1.10),2.99E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.07 (1.04 1.10),3.47E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.06 (1.03 1.09),7.83E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.06 (1.03 1.09),9.78E-03
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.06 (1.03 1.09),1.20E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.06 (1.03 1.09),2.07E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.06 (1.03 1.09),3.05E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS004349,0.380,RNAseq,NRN1,1.06 (1.03 1.09),3.26E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS006758,0.163,RNAseq,LRRC58,1.05 (1.03 1.08),4.03E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS012082,0.040,RNAseq,OCM,0.95 (0.92 0.97),4.41E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS013151,0.029,RNAseq,ABCG1,1.06 (1.03 1.09),4.67E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS009992,0.069,RNAseq,CASP8,1.06 (1.03 1.09),4.87E-02
426.91,Cardiac pacemaker in situ,circulatory system,OPGS012980,0.031,RNAseq,ATP11A,0.95 (0.92 0.97),4.90E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS001376,0.030,SomaScan,NAD-dependent protein deacylase sirtuin-5. mitochondrial,1.05 (1.04 1.07),3.37E-08
427.2,Atrial fibrillation and flutter,circulatory system,OPGS000210,0.223,SomaScan,Dorsal root ganglia homeobox protein,0.96 (0.94 0.97),8.82E-06
427.2,Atrial fibrillation and flutter,circulatory system,OPGS000947,0.058,SomaScan,Lysosomal protective protein,1.04 (1.03 1.06),1.07E-05
427.2,Atrial fibrillation and flutter,circulatory system,OPGS001086,0.047,SomaScan,Dickkopf-related protein 1,1.04 (1.03 1.06),9.81E-05
427.2,Atrial fibrillation and flutter,circulatory system,OPGS000882,0.065,SomaScan,Dickkopf-related protein 4,1.04 (1.02 1.05),3.46E-04
427.2,Atrial fibrillation and flutter,circulatory system,OPGS000020,0.609,SomaScan,Interleukin-6 receptor subunit alpha,0.96 (0.95 0.98),7.05E-04
427.2,Atrial fibrillation and flutter,circulatory system,OPGS000022,0.602,SomaScan,Interleukin-6 receptor subunit alpha,0.96 (0.95 0.98),8.07E-04
427.2,Atrial fibrillation and flutter,circulatory system,OPGS001552,0.024,SomaScan,C-C motif chemokine 5,1.04 (1.02 1.05),1.81E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS000306,0.165,SomaScan,Beta-2-glycoprotein 1,0.97 (0.96 0.98),8.65E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS001479,0.026,SomaScan,C-C motif chemokine 5,1.03 (1.02 1.05),1.16E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS001672,0.020,SomaScan,Angiopoietin-1,1.03 (1.02 1.05),1.69E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS000825,0.070,SomaScan,Spondin-1,1.03 (1.01 1.04),1.82E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS001553,0.024,SomaScan,Protein G6b,1.03 (1.01 1.04),2.00E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS001664,0.020,SomaScan,Thrombospondin-1,1.03 (1.01 1.04),2.10E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS000656,0.090,SomaScan,Peptidyl-prolyl cis-trans isomerase FKBP7,1.03 (1.01 1.04),2.10E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS001652,0.021,SomaScan,Galectin-7,1.03 (1.01 1.04),2.43E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS002220,0.011,SomaScan,ATP-citrate synthase,0.97 (0.96 0.99),3.50E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS000671,0.088,SomaScan,Carbohydrate sulfotransferase 11,1.03 (1.01 1.04),3.50E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS001788,0.017,SomaScan,Platelet-derived growth factor subunit A,1.03 (1.01 1.04),3.53E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS000826,0.070,SomaScan,Tumor necrosis factor ligand superfamily member 12,0.97 (0.96 0.99),4.38E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS001821,0.017,SomaScan,Plasminogen activator inhibitor 1,1.03 (1.01 1.04),4.68E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS000670,0.088,SomaScan,Glutathione S-transferase A1,0.97 (0.96 0.99),4.75E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS002387,0.541,Olink,Interleukin-6 receptor subunit alpha,0.96 (0.95 0.98),1.49E-04
427.2,Atrial fibrillation and flutter,circulatory system,OPGS002613,0.027,Olink,Interleukin-6,0.96 (0.95 0.98),3.09E-04
427.2,Atrial fibrillation and flutter,circulatory system,OPGS002646,0.017,Olink,Proheparin-binding EGF-like growth factor,1.03 (1.02 1.05),5.46E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS002435,0.193,Olink,Fibroblast growth factor 5,1.03 (1.02 1.05),1.27E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS002653,0.015,Olink,CD40 ligand,1.03 (1.02 1.04),1.82E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS002660,0.012,Olink,Angiopoietin-1,1.03 (1.01 1.04),2.33E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS002661,0.011,Olink,Platelet-derived growth factor subunit A,1.03 (1.01 1.04),2.44E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS002663,0.011,Olink,C-type lectin domain family 1 member B,1.03 (1.01 1.04),2.86E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS002576,0.041,Olink,Spondin-1,1.03 (1.01 1.04),4.52E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.03 (1.01 1.04),2.41E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.03 (1.02 1.05),1.65E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.03 (1.01 1.04),2.52E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.03 (1.01 1.04),2.86E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.03 (1.01 1.04),3.46E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.03 (1.01 1.04),3.58E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.03 (1.01 1.04),3.63E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.03 (1.01 1.04),3.92E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.03 (1.01 1.04),3.92E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.03 (1.01 1.04),3.94E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.03 (1.01 1.04),4.10E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.03 (1.01 1.04),4.43E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.03 (1.01 1.04),4.52E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.03 (1.01 1.04),4.84E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS009272,0.084,RNAseq,KCNN3,0.95 (0.93 0.96),8.73E-09
427.2,Atrial fibrillation and flutter,circulatory system,OPGS010713,0.058,RNAseq,AL121929.3,0.95 (0.94 0.96),3.37E-08
427.2,Atrial fibrillation and flutter,circulatory system,OPGS011367,0.049,RNAseq,SLK,1.05 (1.04 1.07),3.37E-08
427.2,Atrial fibrillation and flutter,circulatory system,OPGS007376,0.137,RNAseq,ZBTB7B,0.95 (0.94 0.97),3.37E-08
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003721,0.587,RNAseq,PPFIA4,0.95 (0.94 0.97),1.42E-07
427.2,Atrial fibrillation and flutter,circulatory system,OPGS008513,0.101,RNAseq,CEP68,1.05 (1.03 1.06),1.27E-06
427.2,Atrial fibrillation and flutter,circulatory system,OPGS014953,0.016,RNAseq,AC010680.4,0.96 (0.94 0.97),4.71E-06
427.2,Atrial fibrillation and flutter,circulatory system,OPGS011451,0.048,RNAseq,PHLDB2,1.04 (1.03 1.06),6.69E-06
427.2,Atrial fibrillation and flutter,circulatory system,OPGS006215,0.191,RNAseq,PGAP3,1.04 (1.03 1.05),9.81E-05
427.2,Atrial fibrillation and flutter,circulatory system,OPGS011214,0.051,RNAseq,NEURL1,0.96 (0.95 0.98),1.16E-04
427.2,Atrial fibrillation and flutter,circulatory system,OPGS006688,0.166,RNAseq,PCM1,0.96 (0.95 0.98),3.93E-04
427.2,Atrial fibrillation and flutter,circulatory system,OPGS012852,0.032,RNAseq,ENO2,1.04 (1.02 1.05),4.92E-04
427.2,Atrial fibrillation and flutter,circulatory system,OPGS009703,0.075,RNAseq,HBP1,0.97 (0.95 0.98),1.48E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS010363,0.063,RNAseq,DEK,1.04 (1.02 1.05),1.72E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS005430,0.244,RNAseq,NCF1,1.03 (1.02 1.05),1.72E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS009107,0.087,RNAseq,SYNE2,0.97 (0.95 0.98),1.79E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003625,0.664,RNAseq,,0.97 (0.95 0.98),2.10E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS010972,0.054,RNAseq,FBXL20,1.03 (1.02 1.05),2.77E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS010014,0.069,RNAseq,LINC02245,1.03 (1.02 1.05),3.62E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS010844,0.056,RNAseq,R3HDM4,1.03 (1.02 1.05),3.85E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS004303,0.388,RNAseq,,0.97 (0.95 0.98),3.85E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS005263,0.259,RNAseq,NR3C1,0.97 (0.95 0.98),4.70E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS004282,0.392,RNAseq,CFL2,1.03 (1.02 1.05),4.75E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS005666,0.224,RNAseq,AOPEP,0.97 (0.95 0.98),5.17E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS013211,0.029,RNAseq,GNB4,0.97 (0.96 0.98),5.23E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS013148,0.029,RNAseq,CREBRF,0.97 (0.95 0.98),5.85E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS012875,0.032,RNAseq,KDM3B,1.03 (1.02 1.05),6.43E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS013402,0.027,RNAseq,NACC1,1.03 (1.02 1.05),7.15E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS012537,0.035,RNAseq,PLAG1,1.03 (1.02 1.05),8.06E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS007418,0.135,RNAseq,MTHFD1,1.03 (1.02 1.05),9.14E-03
427.2,Atrial fibrillation and flutter,circulatory system,OPGS012973,0.031,RNAseq,,1.03 (1.02 1.05),1.08E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS009380,0.082,RNAseq,LRIG1,1.03 (1.02 1.05),1.08E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS008593,0.099,RNAseq,SH3PXD2A,1.03 (1.02 1.05),1.23E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS010281,0.065,RNAseq,MED1,1.03 (1.02 1.04),1.27E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS014044,0.022,RNAseq,KCND3,0.97 (0.96 0.98),1.34E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS010272,0.065,RNAseq,OXSR1,1.03 (1.02 1.04),1.37E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS006637,0.169,RNAseq,PCCB,1.03 (1.02 1.04),1.48E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS014247,0.021,RNAseq,PTK2,0.97 (0.96 0.98),1.50E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003955,0.481,RNAseq,,1.03 (1.02 1.05),1.68E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS012768,0.033,RNAseq,HMGA1,1.03 (1.01 1.04),2.00E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS013530,0.026,RNAseq,CCT2,0.97 (0.96 0.99),2.34E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS004641,0.334,RNAseq,NRBF2,1.03 (1.01 1.04),2.49E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS006798,0.161,RNAseq,ANXA2,1.03 (1.01 1.04),2.57E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS006391,0.181,RNAseq,GTF2I,1.03 (1.01 1.04),2.57E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS008289,0.107,RNAseq,,1.03 (1.01 1.04),2.64E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS012283,0.038,RNAseq,RRBP1,1.03 (1.01 1.04),2.86E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS012376,0.037,RNAseq,ANO6,1.03 (1.01 1.04),3.50E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS012805,0.033,RNAseq,OSBPL7,1.03 (1.01 1.04),3.50E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS014843,0.017,RNAseq,SEPTIN7-AS1,0.97 (0.96 0.99),3.50E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003628,0.662,RNAseq,,0.97 (0.96 0.99),3.50E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003978,0.470,RNAseq,COG5,1.03 (1.01 1.04),3.89E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003678,0.611,RNAseq,,1.03 (1.01 1.04),3.94E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003698,0.599,RNAseq,,1.03 (1.01 1.04),3.94E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS004238,0.404,RNAseq,AP3B1,0.97 (0.96 0.99),4.02E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS013978,0.023,RNAseq,AKAP9,0.97 (0.96 0.99),4.07E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS004786,0.311,RNAseq,TKT,1.03 (1.01 1.04),4.10E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003830,0.538,RNAseq,DCAF4,0.97 (0.96 0.99),4.10E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS010473,0.061,RNAseq,CTTN,0.97 (0.96 0.99),4.15E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS006127,0.196,RNAseq,PLA2G4B,1.03 (1.01 1.04),4.20E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS012701,0.034,RNAseq,PEX2,1.03 (1.01 1.04),4.43E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS013355,0.028,RNAseq,FRS2,1.03 (1.01 1.04),4.52E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS007057,0.150,RNAseq,RPL3L,1.03 (1.01 1.04),4.52E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS014595,0.018,RNAseq,AF064858.1,1.03 (1.01 1.04),4.52E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS011149,0.052,RNAseq,HOMER2,0.97 (0.96 0.99),4.52E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS010340,0.064,RNAseq,CAMSAP2,0.97 (0.96 0.99),4.61E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS003644,0.643,RNAseq,KANSL1-AS1,1.03 (1.01 1.04),4.71E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS005186,0.267,RNAseq,NEIL2,0.97 (0.96 0.99),4.82E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS007202,0.143,RNAseq,FKBP1A,0.97 (0.96 0.99),4.82E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS012515,0.035,RNAseq,FANCD2,0.97 (0.96 0.99),4.99E-02
427.2,Atrial fibrillation and flutter,circulatory system,OPGS007982,0.116,RNAseq,AL137186.2,0.97 (0.96 0.99),5.00E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000857,0.067,SomaScan,Moesin,1.09 (1.06 1.11),1.41E-07
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000115,0.347,SomaScan,Protein CEI,1.09 (1.06 1.12),3.99E-07
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.08 (1.05 1.11),1.48E-06
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.08 (1.05 1.11),1.72E-06
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.08 (1.05 1.11),2.47E-06
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.08 (1.05 1.11),2.47E-06
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.08 (1.05 1.10),3.15E-06
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.08 (1.05 1.10),3.34E-06
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.08 (1.05 1.11),5.41E-06
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.07 (1.05 1.10),1.43E-05
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.08 (1.05 1.11),1.65E-05
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000613,0.096,SomaScan,Stromelysin-1,1.08 (1.05 1.10),2.94E-05
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000307,0.164,SomaScan,Apolipoprotein E,1.08 (1.05 1.10),2.94E-05
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000312,0.163,SomaScan,Selenoprotein S,1.07 (1.05 1.10),3.83E-05
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.07 (1.05 1.10),3.99E-05
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.07 (1.04 1.09),4.58E-05
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.07 (1.04 1.09),1.16E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.07 (1.04 1.10),1.57E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.07 (1.04 1.10),1.93E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.94 (0.92 0.96),2.61E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.07 (1.04 1.09),3.34E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.07 (1.04 1.09),6.53E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.06 (1.04 1.09),6.66E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.06 (1.03 1.09),1.11E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.06 (1.03 1.09),1.36E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001093,0.046,SomaScan,C-reactive protein,0.94 (0.92 0.97),1.93E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000672,0.088,SomaScan,RAC-beta serine/threonine-protein kinase,1.06 (1.03 1.09),2.08E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.06 (1.03 1.09),2.28E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000172,0.257,SomaScan,Dermokine,0.95 (0.92 0.97),3.11E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000083,0.401,SomaScan,Vacuolar protein sorting-associated protein 29,0.94 (0.92 0.97),3.36E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001159,0.041,SomaScan,Dual specificity protein phosphatase 26,1.06 (1.03 1.09),5.86E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.05 (1.03 1.08),6.62E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.95 (0.93 0.97),7.14E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.05 (1.03 1.08),7.14E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.95 (0.93 0.97),9.46E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000348,0.151,SomaScan,Quinone oxidoreductase-like protein 1,1.05 (1.02 1.08),2.37E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.05 (1.02 1.07),4.21E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001090,0.046,SomaScan,Histone-lysine N-methyltransferase 2C,0.95 (0.93 0.98),4.37E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS001472,0.027,SomaScan,Angiotensinogen,1.05 (1.02 1.07),4.63E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS000875,0.065,SomaScan,Pregnancy-specific beta-1-glycoprotein 5,1.05 (1.02 1.07),4.86E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS002598,0.031,Olink,Interleukin-10,0.95 (0.93 0.98),4.33E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.08 (1.05 1.10),3.34E-06
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.08 (1.05 1.10),1.60E-05
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.06 (1.04 1.09),3.91E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,1.06 (1.03 1.09),3.77E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.06 (1.03 1.08),5.69E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.05 (1.02 1.07),2.48E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.09 (1.07 1.12),4.82E-08
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.08 (1.06 1.11),1.54E-06
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.07 (1.04 1.10),1.16E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.07 (1.04 1.10),1.50E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.07 (1.04 1.10),1.50E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.07 (1.04 1.10),1.50E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.07 (1.04 1.10),1.55E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.07 (1.04 1.10),1.86E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.07 (1.04 1.10),1.96E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.07 (1.04 1.09),3.26E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.07 (1.04 1.09),3.26E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.07 (1.04 1.09),3.49E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.07 (1.04 1.09),3.91E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.06 (1.04 1.09),5.27E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.06 (1.04 1.09),5.27E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.06 (1.04 1.09),5.27E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.06 (1.04 1.09),6.53E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.06 (1.04 1.09),6.53E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.06 (1.04 1.09),6.53E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.06 (1.04 1.09),6.53E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.06 (1.04 1.09),6.53E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.06 (1.04 1.09),7.22E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.06 (1.04 1.09),7.22E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.06 (1.04 1.09),8.27E-04
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.06 (1.03 1.09),1.11E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.06 (1.03 1.09),1.42E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.06 (1.03 1.09),2.16E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.06 (1.03 1.09),2.28E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.06 (1.03 1.08),3.91E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.05 (1.03 1.08),6.46E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.05 (1.03 1.08),7.18E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.05 (1.03 1.08),9.33E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.05 (1.03 1.08),9.33E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003527,0.050,Nightingale,Sphingomyelins,1.05 (1.03 1.08),9.92E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003529,0.049,Nightingale,Average diameter for LDL particles,0.95 (0.93 0.97),1.21E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.05 (1.03 1.08),1.31E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.05 (1.03 1.08),1.31E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.05 (1.03 1.08),1.31E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.05 (1.02 1.07),4.27E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.05 (1.02 1.07),4.27E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.05 (1.02 1.07),4.69E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS010664,0.059,RNAseq,LINC01569,0.95 (0.92 0.97),1.93E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS011197,0.051,RNAseq,APC,0.95 (0.93 0.97),3.82E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS005398,0.247,RNAseq,RALGPS1,1.05 (1.03 1.08),5.69E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS014064,0.022,RNAseq,ZBTB34,1.05 (1.03 1.08),7.92E-03
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS010436,0.062,RNAseq,SLC2A3,0.95 (0.93 0.97),1.24E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS008540,0.101,RNAseq,COA6-AS1,0.95 (0.93 0.98),3.33E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS010505,0.061,RNAseq,PPP2R2B,0.95 (0.93 0.98),3.54E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS009703,0.075,RNAseq,HBP1,0.96 (0.93 0.98),4.30E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS014632,0.018,RNAseq,,1.05 (1.02 1.07),4.69E-02
427.3,Other specified cardiac dysrhythmias,circulatory system,OPGS011421,0.048,RNAseq,ITGAL,1.05 (1.02 1.07),4.70E-02
427.8,Sinoatrial node dysfunction (Bradycardia),circulatory system,OPGS006171,0.193,RNAseq,NOP10,1.16 (1.09 1.23),1.94E-02
428.2,Heart failure NOS,circulatory system,OPGS002030,0.012,SomaScan,BAG family molecular chaperone regulator 3,0.95 (0.93 0.97),3.83E-04
428.2,Heart failure NOS,circulatory system,OPGS000907,0.062,SomaScan,Glycerol-3-phosphate dehydrogenase 1-like protein,0.95 (0.93 0.97),4.50E-04
428.2,Heart failure NOS,circulatory system,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.05 (1.03 1.07),1.52E-03
428.2,Heart failure NOS,circulatory system,OPGS001626,0.021,SomaScan,Neural cell adhesion molecule L1,0.96 (0.94 0.98),3.33E-03
428.2,Heart failure NOS,circulatory system,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,0.96 (0.94 0.98),4.27E-03
428.2,Heart failure NOS,circulatory system,OPGS001443,0.028,SomaScan,Zona pellucida sperm-binding protein 4,0.96 (0.94 0.98),4.41E-03
428.2,Heart failure NOS,circulatory system,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.96 (0.94 0.98),4.43E-03
428.2,Heart failure NOS,circulatory system,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.05 (1.02 1.07),4.43E-03
428.2,Heart failure NOS,circulatory system,OPGS001954,0.014,SomaScan,Tuftelin,0.96 (0.94 0.98),6.30E-03
428.2,Heart failure NOS,circulatory system,OPGS001377,0.030,SomaScan,Vascular cell adhesion protein 1,1.04 (1.02 1.07),7.13E-03
428.2,Heart failure NOS,circulatory system,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,1.04 (1.02 1.06),7.32E-03
428.2,Heart failure NOS,circulatory system,OPGS000088,0.392,SomaScan,E-selectin,0.96 (0.94 0.98),7.60E-03
428.2,Heart failure NOS,circulatory system,OPGS000600,0.099,SomaScan,Insulin receptor,0.96 (0.94 0.98),1.05E-02
428.2,Heart failure NOS,circulatory system,OPGS001567,0.023,SomaScan,RecQ-mediated genome instability protein 1,0.96 (0.94 0.98),1.28E-02
428.2,Heart failure NOS,circulatory system,OPGS001045,0.050,SomaScan,Carbohydrate sulfotransferase 15,0.96 (0.94 0.98),1.53E-02
428.2,Heart failure NOS,circulatory system,OPGS001341,0.031,SomaScan,Augurin,0.96 (0.94 0.98),1.60E-02
428.2,Heart failure NOS,circulatory system,OPGS001658,0.020,SomaScan,Endoglin,0.96 (0.94 0.98),1.65E-02
428.2,Heart failure NOS,circulatory system,OPGS001268,0.035,SomaScan,Serine/threonine-protein kinase 16,0.96 (0.94 0.98),1.82E-02
428.2,Heart failure NOS,circulatory system,OPGS001127,0.044,SomaScan,Carbohydrate sulfotransferase 15,0.96 (0.94 0.98),1.93E-02
428.2,Heart failure NOS,circulatory system,OPGS000923,0.060,SomaScan,Thrombospondin type-1 domain-containing protein 1,0.96 (0.94 0.98),1.97E-02
428.2,Heart failure NOS,circulatory system,OPGS000666,0.088,SomaScan,Protein FAM171A2,0.96 (0.94 0.98),2.40E-02
428.2,Heart failure NOS,circulatory system,OPGS000463,0.125,SomaScan,Toll-like receptor 4:Lymphocyte antigen 96 complex,0.96 (0.94 0.98),2.80E-02
428.2,Heart failure NOS,circulatory system,OPGS000101,0.374,SomaScan,CD209 antigen,1.04 (1.02 1.06),2.88E-02
428.2,Heart failure NOS,circulatory system,OPGS001056,0.049,SomaScan,Insulin growth factor-like family member 3,0.96 (0.94 0.98),2.90E-02
428.2,Heart failure NOS,circulatory system,OPGS002181,0.011,SomaScan,DNA-binding protein inhibitor ID-1,0.96 (0.94 0.98),2.93E-02
428.2,Heart failure NOS,circulatory system,OPGS000893,0.064,SomaScan,t-SNARE domain-containing protein 1,0.96 (0.94 0.98),3.37E-02
428.2,Heart failure NOS,circulatory system,OPGS001900,0.015,SomaScan,Glucokinase,0.96 (0.94 0.98),3.50E-02
428.2,Heart failure NOS,circulatory system,OPGS001915,0.014,SomaScan,N-acetylglucosamine-6-sulfatase,0.96 (0.94 0.98),3.68E-02
428.2,Heart failure NOS,circulatory system,OPGS000695,0.085,SomaScan,SLAM family member 7,0.96 (0.94 0.98),3.75E-02
428.2,Heart failure NOS,circulatory system,OPGS000571,0.103,SomaScan,Cytoskeleton-associated protein 2,0.96 (0.94 0.98),4.06E-02
428.2,Heart failure NOS,circulatory system,OPGS001212,0.038,SomaScan,Regulator of G-protein signaling 19,0.96 (0.94 0.98),4.65E-02
428.2,Heart failure NOS,circulatory system,OPGS002651,0.015,Olink,von Willebrand factor,1.05 (1.03 1.07),4.50E-04
428.2,Heart failure NOS,circulatory system,OPGS002408,0.270,Olink,E-selectin,0.96 (0.94 0.98),4.46E-03
428.2,Heart failure NOS,circulatory system,OPGS002500,0.098,Olink,Galectin-4,0.96 (0.94 0.98),7.13E-03
428.2,Heart failure NOS,circulatory system,OPGS002656,0.013,Olink,Angiotensin-converting enzyme 2,0.96 (0.94 0.98),1.76E-02
428.2,Heart failure NOS,circulatory system,OPGS002395,0.362,Olink,Intercellular adhesion molecule 2,0.96 (0.94 0.98),4.28E-02
428.2,Heart failure NOS,circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.06 (1.03 1.08),1.16E-04
428.2,Heart failure NOS,circulatory system,OPGS003149,0.015,Metabolon,sphingosine,1.04 (1.02 1.07),4.41E-03
428.2,Heart failure NOS,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.04 (1.02 1.06),1.28E-02
428.2,Heart failure NOS,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.07 (1.05 1.10),7.84E-08
428.2,Heart failure NOS,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.07 (1.05 1.09),3.26E-07
428.2,Heart failure NOS,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.07 (1.05 1.09),3.26E-07
428.2,Heart failure NOS,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.07 (1.05 1.09),3.26E-07
428.2,Heart failure NOS,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.07 (1.05 1.09),3.26E-07
428.2,Heart failure NOS,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.07 (1.05 1.09),5.07E-07
428.2,Heart failure NOS,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.07 (1.05 1.09),5.30E-07
428.2,Heart failure NOS,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.07 (1.05 1.09),5.58E-07
428.2,Heart failure NOS,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.07 (1.05 1.09),5.58E-07
428.2,Heart failure NOS,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.07 (1.05 1.09),5.58E-07
428.2,Heart failure NOS,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.07 (1.05 1.09),5.58E-07
428.2,Heart failure NOS,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.07 (1.05 1.09),6.39E-07
428.2,Heart failure NOS,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.07 (1.04 1.09),8.27E-07
428.2,Heart failure NOS,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.07 (1.04 1.09),1.18E-06
428.2,Heart failure NOS,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.07 (1.04 1.09),1.22E-06
428.2,Heart failure NOS,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.07 (1.04 1.09),1.29E-06
428.2,Heart failure NOS,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.07 (1.04 1.09),1.29E-06
428.2,Heart failure NOS,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.07 (1.04 1.09),1.33E-06
428.2,Heart failure NOS,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.07 (1.04 1.09),1.33E-06
428.2,Heart failure NOS,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.07 (1.04 1.09),1.33E-06
428.2,Heart failure NOS,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.06 (1.04 1.09),1.84E-06
428.2,Heart failure NOS,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.06 (1.04 1.09),1.87E-06
428.2,Heart failure NOS,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.06 (1.04 1.09),1.92E-06
428.2,Heart failure NOS,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.06 (1.04 1.09),1.93E-06
428.2,Heart failure NOS,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.06 (1.04 1.09),2.04E-06
428.2,Heart failure NOS,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.06 (1.04 1.09),2.15E-06
428.2,Heart failure NOS,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.06 (1.04 1.09),2.59E-06
428.2,Heart failure NOS,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.06 (1.04 1.09),2.69E-06
428.2,Heart failure NOS,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.06 (1.04 1.09),3.26E-06
428.2,Heart failure NOS,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.06 (1.04 1.09),3.26E-06
428.2,Heart failure NOS,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.06 (1.04 1.09),3.36E-06
428.2,Heart failure NOS,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.06 (1.04 1.08),5.55E-06
428.2,Heart failure NOS,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.06 (1.04 1.08),8.01E-06
428.2,Heart failure NOS,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.06 (1.04 1.08),1.06E-05
428.2,Heart failure NOS,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.06 (1.04 1.08),1.55E-05
428.2,Heart failure NOS,circulatory system,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.06 (1.04 1.08),2.10E-05
428.2,Heart failure NOS,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.06 (1.04 1.08),2.12E-05
428.2,Heart failure NOS,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.06 (1.04 1.08),3.04E-05
428.2,Heart failure NOS,circulatory system,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.06 (1.03 1.08),5.09E-05
428.2,Heart failure NOS,circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.05 (1.03 1.08),1.25E-04
428.2,Heart failure NOS,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.05 (1.03 1.08),1.55E-04
428.2,Heart failure NOS,circulatory system,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.05 (1.03 1.07),3.99E-04
428.2,Heart failure NOS,circulatory system,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.05 (1.03 1.07),1.49E-03
428.2,Heart failure NOS,circulatory system,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.05 (1.03 1.07),1.70E-03
428.2,Heart failure NOS,circulatory system,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.05 (1.03 1.07),2.41E-03
428.2,Heart failure NOS,circulatory system,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.05 (1.03 1.07),2.70E-03
428.2,Heart failure NOS,circulatory system,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.05 (1.02 1.07),4.41E-03
428.2,Heart failure NOS,circulatory system,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.04 (1.02 1.07),5.01E-03
428.2,Heart failure NOS,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.04 (1.02 1.07),7.13E-03
428.2,Heart failure NOS,circulatory system,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.04 (1.02 1.07),7.13E-03
428.2,Heart failure NOS,circulatory system,OPGS003528,0.050,Nightingale,Total cholines,1.04 (1.02 1.06),7.94E-03
428.2,Heart failure NOS,circulatory system,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.04 (1.02 1.07),7.94E-03
428.2,Heart failure NOS,circulatory system,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.04 (1.02 1.06),8.08E-03
428.2,Heart failure NOS,circulatory system,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.04 (1.02 1.06),8.60E-03
428.2,Heart failure NOS,circulatory system,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.04 (1.02 1.06),1.68E-02
428.2,Heart failure NOS,circulatory system,OPGS003526,0.050,Nightingale,Phosphatidylcholines,1.04 (1.02 1.06),2.03E-02
428.2,Heart failure NOS,circulatory system,OPGS003527,0.050,Nightingale,Sphingomyelins,1.04 (1.02 1.06),2.81E-02
428.2,Heart failure NOS,circulatory system,OPGS003523,0.062,Nightingale,Total fatty acids,1.04 (1.02 1.06),2.88E-02
428.2,Heart failure NOS,circulatory system,OPGS003497,0.072,Nightingale,Linoleic acid,1.04 (1.02 1.06),2.88E-02
428.2,Heart failure NOS,circulatory system,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.04 (1.02 1.06),2.94E-02
428.2,Heart failure NOS,circulatory system,OPGS009492,0.079,RNAseq,LINC00189,0.95 (0.93 0.97),2.97E-04
428.2,Heart failure NOS,circulatory system,OPGS006454,0.178,RNAseq,,1.05 (1.03 1.07),4.24E-03
428.2,Heart failure NOS,circulatory system,OPGS004949,0.293,RNAseq,ILRUN,1.04 (1.02 1.06),4.41E-03
428.2,Heart failure NOS,circulatory system,OPGS011491,0.047,RNAseq,ZNF471,0.96 (0.94 0.98),1.12E-02
428.2,Heart failure NOS,circulatory system,OPGS006265,0.188,RNAseq,RBM6,0.96 (0.94 0.98),1.24E-02
428.2,Heart failure NOS,circulatory system,OPGS008946,0.091,RNAseq,SCAMP4,0.96 (0.94 0.98),1.25E-02
428.2,Heart failure NOS,circulatory system,OPGS013762,0.024,RNAseq,CFH,1.04 (1.02 1.06),1.28E-02
428.2,Heart failure NOS,circulatory system,OPGS012732,0.033,RNAseq,AF165147.1,0.96 (0.94 0.98),1.68E-02
428.2,Heart failure NOS,circulatory system,OPGS006215,0.191,RNAseq,PGAP3,1.04 (1.02 1.06),1.93E-02
428.2,Heart failure NOS,circulatory system,OPGS009218,0.085,RNAseq,EIF3CL,1.04 (1.02 1.06),1.94E-02
428.2,Heart failure NOS,circulatory system,OPGS013939,0.023,RNAseq,BATF2,1.04 (1.02 1.06),1.95E-02
428.2,Heart failure NOS,circulatory system,OPGS013653,0.025,RNAseq,KANSL1,0.96 (0.94 0.98),2.58E-02
428.2,Heart failure NOS,circulatory system,OPGS011108,0.052,RNAseq,LDLR,0.96 (0.94 0.98),3.03E-02
428.2,Heart failure NOS,circulatory system,OPGS006286,0.187,RNAseq,TMEM99,0.96 (0.94 0.98),3.22E-02
428.2,Heart failure NOS,circulatory system,OPGS014499,0.019,RNAseq,BAZ1A,0.96 (0.94 0.98),3.26E-02
428.2,Heart failure NOS,circulatory system,OPGS004303,0.388,RNAseq,,0.96 (0.94 0.98),3.79E-02
428.2,Heart failure NOS,circulatory system,OPGS013180,0.029,RNAseq,PRSS27,0.96 (0.94 0.98),3.93E-02
428.2,Heart failure NOS,circulatory system,OPGS007953,0.117,RNAseq,OASL,1.04 (1.02 1.06),4.09E-02
428.2,Heart failure NOS,circulatory system,OPGS006083,0.199,RNAseq,CCDC170,1.04 (1.02 1.06),4.52E-02
428.2,Heart failure NOS,circulatory system,OPGS005430,0.244,RNAseq,NCF1,1.04 (1.02 1.06),4.74E-02
428.2,Heart failure NOS,circulatory system,OPGS014320,0.020,RNAseq,MAPT,1.04 (1.02 1.06),4.90E-02
430.1,Subarachnoid hemorrhage,circulatory system,OPGS014251,0.021,RNAseq,PSPN,0.90 (0.86 0.94),3.54E-02
430.2,Intracerebral hemorrhage,circulatory system,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.18 (1.12 1.24),2.48E-07
430.2,Intracerebral hemorrhage,circulatory system,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.19 (1.13 1.25),1.11E-06
430.2,Intracerebral hemorrhage,circulatory system,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.19 (1.12 1.25),3.25E-06
430.2,Intracerebral hemorrhage,circulatory system,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.20 (1.13 1.27),4.41E-06
430.2,Intracerebral hemorrhage,circulatory system,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.18 (1.11 1.24),9.70E-06
430.2,Intracerebral hemorrhage,circulatory system,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.15 (1.10 1.21),9.70E-06
430.2,Intracerebral hemorrhage,circulatory system,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.15 (1.10 1.21),9.70E-06
430.2,Intracerebral hemorrhage,circulatory system,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.15 (1.10 1.21),1.20E-05
430.2,Intracerebral hemorrhage,circulatory system,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.15 (1.09 1.20),3.00E-05
430.2,Intracerebral hemorrhage,circulatory system,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.87 (0.83 0.91),3.15E-05
430.2,Intracerebral hemorrhage,circulatory system,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.16 (1.10 1.22),4.87E-05
430.2,Intracerebral hemorrhage,circulatory system,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.87 (0.83 0.92),6.06E-05
430.2,Intracerebral hemorrhage,circulatory system,OPGS000032,0.570,SomaScan,Protein S100-A13,0.88 (0.83 0.92),1.57E-04
430.2,Intracerebral hemorrhage,circulatory system,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.88 (0.83 0.92),1.57E-04
430.2,Intracerebral hemorrhage,circulatory system,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.14 (1.08 1.19),2.71E-04
430.2,Intracerebral hemorrhage,circulatory system,OPGS000857,0.067,SomaScan,Moesin,1.14 (1.08 1.19),2.71E-04
430.2,Intracerebral hemorrhage,circulatory system,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.14 (1.08 1.19),2.71E-04
430.2,Intracerebral hemorrhage,circulatory system,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.14 (1.08 1.19),3.29E-04
430.2,Intracerebral hemorrhage,circulatory system,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.88 (0.84 0.93),5.68E-04
430.2,Intracerebral hemorrhage,circulatory system,OPGS000911,0.062,SomaScan,Protein MENT,1.13 (1.08 1.19),9.44E-04
430.2,Intracerebral hemorrhage,circulatory system,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.13 (1.07 1.18),1.18E-03
430.2,Intracerebral hemorrhage,circulatory system,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.11 (1.06 1.17),3.46E-03
430.2,Intracerebral hemorrhage,circulatory system,OPGS000502,0.117,SomaScan,Neutrophil collagenase,1.13 (1.07 1.19),4.23E-03
430.2,Intracerebral hemorrhage,circulatory system,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.90 (0.85 0.94),2.60E-02
430.2,Intracerebral hemorrhage,circulatory system,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,0.91 (0.86 0.95),3.83E-02
430.2,Intracerebral hemorrhage,circulatory system,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.11 (1.05 1.16),3.83E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.10 (1.05 1.15),1.18E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.10 (1.05 1.15),1.61E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.10 (1.05 1.15),2.53E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS000857,0.067,SomaScan,Moesin,1.09 (1.04 1.14),3.19E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.09 (1.04 1.14),3.97E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.09 (1.04 1.14),4.26E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS001237,0.037,SomaScan,Granzyme M,0.93 (0.89 0.97),4.98E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.10 (1.05 1.16),1.55E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.10 (1.05 1.15),2.93E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003004,0.030,Metabolon,octadecanedioate,0.92 (0.88 0.96),4.98E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.16 (1.10 1.21),2.27E-05
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.15 (1.10 1.20),3.38E-05
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.14 (1.09 1.20),1.12E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.14 (1.09 1.19),1.39E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.14 (1.09 1.20),1.39E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.14 (1.09 1.20),1.39E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.14 (1.09 1.19),1.39E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.13 (1.08 1.19),1.39E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.13 (1.08 1.19),1.39E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.14 (1.09 1.19),1.39E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.14 (1.08 1.19),1.57E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.13 (1.08 1.19),2.05E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.13 (1.08 1.19),2.05E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.13 (1.08 1.19),2.05E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.13 (1.08 1.18),2.05E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.13 (1.08 1.19),2.05E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.13 (1.08 1.19),2.05E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.13 (1.08 1.19),2.05E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.13 (1.08 1.19),2.05E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.13 (1.08 1.19),2.05E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.13 (1.08 1.19),2.05E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.13 (1.08 1.19),2.14E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.13 (1.08 1.19),2.18E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.13 (1.08 1.19),2.30E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.13 (1.08 1.18),2.75E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.13 (1.08 1.18),2.75E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.13 (1.08 1.19),2.75E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.13 (1.08 1.18),2.75E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.13 (1.08 1.18),2.80E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.13 (1.08 1.18),3.57E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.89 (0.85 0.93),5.58E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.12 (1.07 1.18),6.99E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.12 (1.07 1.18),6.99E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.89 (0.85 0.94),7.26E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.12 (1.07 1.17),7.81E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003487,0.074,Nightingale,Phospholipids in chylomicrons and extremely large VLDL,0.90 (0.86 0.94),8.43E-04
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.90 (0.86 0.94),1.29E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.12 (1.07 1.17),1.29E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.90 (0.86 0.94),1.29E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.12 (1.07 1.17),1.29E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003491,0.073,Nightingale,Total lipids in chylomicrons and extremely large VLDL,0.90 (0.86 0.94),1.80E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003462,0.083,Nightingale,Average diameter for VLDL particles,0.90 (0.86 0.94),2.13E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003509,0.069,Nightingale,Free cholesterol in chylomicrons and extremely large VLDL,0.90 (0.86 0.94),2.13E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,0.90 (0.86 0.94),2.13E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.11 (1.06 1.16),2.22E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.90 (0.86 0.94),2.31E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003504,0.070,Nightingale,Triglycerides in very large VLDL,0.90 (0.86 0.94),2.33E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.11 (1.06 1.16),3.81E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.11 (1.06 1.16),4.07E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.90 (0.86 0.94),4.09E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,0.91 (0.87 0.95),1.31E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003500,0.071,Nightingale,Total lipids in very large VLDL,0.91 (0.87 0.95),1.37E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003502,0.070,Nightingale,Concentration of very large VLDL particles,0.91 (0.87 0.95),1.78E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003516,0.066,Nightingale,Phospholipids in very large VLDL,0.91 (0.87 0.96),2.06E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003513,0.067,Nightingale,Free cholesterol in very large VLDL,0.91 (0.87 0.96),2.59E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003510,0.068,Nightingale,Cholesterol in chylomicrons and extremely large VLDL,0.92 (0.87 0.96),2.93E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003506,0.070,Nightingale,Cholesterol in very large VLDL,0.92 (0.88 0.96),3.85E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.09 (1.04 1.14),3.86E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.09 (1.04 1.14),4.98E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003496,0.072,Nightingale,Cholesteryl esters in very large VLDL,0.92 (0.88 0.96),4.98E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS007364,0.137,RNAseq,NT5C2,0.90 (0.86 0.94),7.52E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003645,0.643,RNAseq,PYGB,1.10 (1.05 1.15),8.47E-03
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS003943,0.486,RNAseq,CLEC18A,0.91 (0.87 0.95),2.13E-02
433.1,Occlusion and stenosis of precerebral arteries,circulatory system,OPGS006632,0.169,RNAseq,SBF2-AS1,1.09 (1.05 1.14),2.41E-02
433.3,Cerebral ischemia,circulatory system,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.89 (0.86 0.92),3.34E-06
433.3,Cerebral ischemia,circulatory system,OPGS000032,0.570,SomaScan,Protein S100-A13,0.90 (0.87 0.93),2.30E-05
433.3,Cerebral ischemia,circulatory system,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.11 (1.07 1.15),2.30E-05
433.3,Cerebral ischemia,circulatory system,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.90 (0.87 0.93),3.46E-05
433.3,Cerebral ischemia,circulatory system,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.11 (1.07 1.15),6.54E-05
433.3,Cerebral ischemia,circulatory system,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.90 (0.87 0.94),6.54E-05
433.3,Cerebral ischemia,circulatory system,OPGS000911,0.062,SomaScan,Protein MENT,1.11 (1.07 1.15),6.54E-05
433.3,Cerebral ischemia,circulatory system,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.10 (1.07 1.14),6.83E-05
433.3,Cerebral ischemia,circulatory system,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.10 (1.06 1.14),1.13E-04
433.3,Cerebral ischemia,circulatory system,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.10 (1.06 1.14),4.17E-04
433.3,Cerebral ischemia,circulatory system,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.10 (1.06 1.14),5.01E-04
433.3,Cerebral ischemia,circulatory system,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.10 (1.06 1.15),5.01E-04
433.3,Cerebral ischemia,circulatory system,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.10 (1.06 1.15),5.54E-04
433.3,Cerebral ischemia,circulatory system,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.09 (1.05 1.13),1.28E-03
433.3,Cerebral ischemia,circulatory system,OPGS000502,0.117,SomaScan,Neutrophil collagenase,1.10 (1.06 1.14),1.65E-03
433.3,Cerebral ischemia,circulatory system,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.09 (1.05 1.13),1.65E-03
433.3,Cerebral ischemia,circulatory system,OPGS001343,0.031,SomaScan,Beta-1.3-N-acetylglucosaminyltransferase radical fringe,0.92 (0.88 0.95),1.83E-03
433.3,Cerebral ischemia,circulatory system,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.09 (1.05 1.13),1.83E-03
433.3,Cerebral ischemia,circulatory system,OPGS000857,0.067,SomaScan,Moesin,1.09 (1.05 1.13),3.16E-03
433.3,Cerebral ischemia,circulatory system,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,0.92 (0.89 0.95),3.46E-03
433.3,Cerebral ischemia,circulatory system,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.09 (1.05 1.13),5.73E-03
433.3,Cerebral ischemia,circulatory system,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.09 (1.05 1.13),1.46E-02
433.3,Cerebral ischemia,circulatory system,OPGS001092,0.046,SomaScan,TOM1-like protein 1,0.93 (0.89 0.96),2.26E-02
433.3,Cerebral ischemia,circulatory system,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.09 (1.04 1.13),2.65E-02
433.3,Cerebral ischemia,circulatory system,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.08 (1.04 1.12),3.32E-02
433.3,Cerebral ischemia,circulatory system,OPGS002275,0.010,SomaScan,Interferon-induced protein with tetratricopeptide repeats 2,0.93 (0.89 0.96),4.44E-02
433.3,Cerebral ischemia,circulatory system,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.11 (1.07 1.15),6.54E-05
433.3,Cerebral ischemia,circulatory system,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.93 (0.89 0.96),3.67E-02
433.3,Cerebral ischemia,circulatory system,OPGS006491,0.176,RNAseq,CCZ1B,1.08 (1.04 1.12),3.25E-02
433.3,Cerebral ischemia,circulatory system,OPGS012357,0.037,RNAseq,ATP6V1G1,0.92 (0.88 0.96),4.13E-02
433.5,Cerebral aneurysm,circulatory system,OPGS001590,0.022,SomaScan,Diacylglycerol kinase beta,0.89 (0.85 0.93),4.02E-03
440.9,Atherosclerosis of aorta,circulatory system,OPGS013744,0.024,RNAseq,RAB11FIP3,0.73 (0.65 0.83),1.13E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS000883,0.064,SomaScan,Group XIIB secretory phospholipase A2-like protein,1.11 (1.06 1.17),1.61E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS001279,0.035,SomaScan,Four-jointed box protein 1,1.10 (1.05 1.15),5.73E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS000154,0.277,SomaScan,Granulins,1.10 (1.05 1.15),9.60E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS000285,0.176,SomaScan,Complement C1q tumor necrosis factor-related protein 1,1.09 (1.04 1.15),2.64E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS000691,0.086,SomaScan,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,1.09 (1.04 1.14),3.29E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS001730,0.019,SomaScan,V-type immunoglobulin domain-containing suppressor of T-cell activation,1.08 (1.04 1.13),3.75E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS002436,0.191,Olink,Progranulin,1.09 (1.04 1.14),3.28E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.17 (1.11 1.22),1.07E-07
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.12 (1.07 1.17),1.12E-04
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003151,0.014,Metabolon,1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2)*,1.12 (1.07 1.17),1.16E-04
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003006,0.030,Metabolon,cholesterol,1.11 (1.06 1.17),9.63E-04
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003088,0.020,Metabolon,1-palmitoyl-2-linoleoyl-glycerol (16:0/18:2)*,1.10 (1.06 1.15),2.09E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.11 (1.06 1.16),4.30E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003116,0.018,Metabolon,1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1)*,0.91 (0.87 0.95),7.65E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.09 (1.05 1.14),1.51E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.09 (1.04 1.14),2.55E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003058,0.022,Metabolon,sphingomyelin (d18:1/17:0. d17:1/18:0. d19:1/16:0),1.09 (1.04 1.14),4.08E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.23 (1.18 1.29),2.02E-15
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.21 (1.16 1.27),3.81E-13
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.20 (1.15 1.26),4.95E-12
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.20 (1.14 1.25),5.57E-11
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.19 (1.14 1.24),2.18E-10
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.19 (1.14 1.24),2.77E-10
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.19 (1.13 1.24),6.00E-10
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.19 (1.13 1.24),1.07E-09
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.18 (1.13 1.24),5.85E-09
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.18 (1.13 1.24),5.85E-09
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.18 (1.13 1.24),6.00E-09
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.17 (1.12 1.23),1.35E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.18 (1.12 1.24),1.35E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.17 (1.12 1.23),1.35E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.17 (1.12 1.23),1.99E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.17 (1.12 1.23),1.99E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.17 (1.12 1.23),2.09E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.17 (1.12 1.23),2.49E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.17 (1.12 1.23),2.49E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.17 (1.12 1.23),2.55E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.17 (1.12 1.23),2.69E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.17 (1.12 1.23),2.78E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.17 (1.12 1.23),2.78E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.17 (1.12 1.23),2.78E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.17 (1.12 1.22),2.78E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.17 (1.12 1.23),2.78E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.16 (1.11 1.22),3.43E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.17 (1.11 1.22),4.03E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.17 (1.11 1.22),4.03E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.17 (1.12 1.23),4.03E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.17 (1.11 1.22),4.46E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.17 (1.11 1.22),4.98E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.17 (1.11 1.22),6.64E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.16 (1.11 1.21),8.35E-08
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.16 (1.11 1.22),1.40E-07
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.16 (1.11 1.22),1.44E-07
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.15 (1.10 1.20),3.53E-07
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.16 (1.10 1.21),3.58E-07
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.15 (1.10 1.21),3.92E-07
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.15 (1.10 1.20),5.61E-07
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.15 (1.10 1.20),9.58E-07
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,1.15 (1.10 1.20),9.93E-07
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003520,0.062,Nightingale,HDL cholesterol,0.87 (0.84 0.91),1.03E-06
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,1.14 (1.09 1.20),1.73E-06
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.14 (1.09 1.19),2.87E-06
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.14 (1.09 1.19),4.37E-06
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.13 (1.08 1.18),2.09E-05
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.89 (0.85 0.93),3.51E-05
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.89 (0.85 0.93),4.89E-05
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.13 (1.08 1.18),8.13E-05
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.12 (1.07 1.17),1.67E-04
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.89 (0.85 0.93),1.67E-04
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.89 (0.85 0.94),3.08E-04
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.90 (0.86 0.94),4.35E-04
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.11 (1.07 1.16),5.57E-04
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.90 (0.86 0.94),6.91E-04
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.11 (1.06 1.16),9.33E-04
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.90 (0.86 0.94),9.33E-04
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003534,0.038,Nightingale,Phospholipids in small HDL,0.90 (0.86 0.94),1.30E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.90 (0.86 0.94),1.57E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,1.11 (1.06 1.16),2.09E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003497,0.072,Nightingale,Linoleic acid,1.11 (1.06 1.16),2.09E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.90 (0.86 0.95),2.38E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.10 (1.06 1.15),3.07E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.10 (1.05 1.15),4.75E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003523,0.062,Nightingale,Total fatty acids,1.10 (1.05 1.15),5.52E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.10 (1.05 1.15),6.53E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.91 (0.87 0.95),1.21E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.10 (1.05 1.15),1.26E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003447,0.097,Nightingale,Average diameter for HDL particles,0.91 (0.87 0.96),1.48E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.09 (1.05 1.14),1.76E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003527,0.050,Nightingale,Sphingomyelins,1.09 (1.04 1.14),1.97E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003476,0.076,Nightingale,Phospholipids in medium VLDL,1.09 (1.04 1.14),2.55E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003532,0.045,Nightingale,Apolipoprotein A1,0.92 (0.88 0.96),3.22E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003465,0.081,Nightingale,Triglycerides in small VLDL,1.09 (1.04 1.14),3.44E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.92 (0.88 0.96),4.54E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS003525,0.052,Nightingale,Saturated fatty acids,1.09 (1.04 1.14),4.99E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS008550,0.100,RNAseq,LINC02280,1.09 (1.05 1.14),4.75E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS006535,0.174,RNAseq,PSRC1,0.91 (0.87 0.95),6.53E-03
442.11,Abdominal aortic aneurysm,circulatory system,OPGS008934,0.091,RNAseq,CFDP1,1.09 (1.04 1.14),2.64E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS013364,0.027,RNAseq,PHF19,0.93 (0.89 0.96),3.51E-02
442.11,Abdominal aortic aneurysm,circulatory system,OPGS009307,0.083,RNAseq,AXL,1.09 (1.04 1.14),4.88E-02
443.1,Raynaud's syndrome,circulatory system,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.91 (0.87 0.95),3.59E-02
443.1,Raynaud's syndrome,circulatory system,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.91 (0.87 0.95),3.59E-02
443.1,Raynaud's syndrome,circulatory system,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.91 (0.87 0.95),3.71E-02
443.1,Raynaud's syndrome,circulatory system,OPGS003732,0.582,RNAseq,AL513550.1,0.90 (0.86 0.94),2.84E-02
443.1,Raynaud's syndrome,circulatory system,OPGS013225,0.029,RNAseq,REG4,0.91 (0.87 0.95),3.59E-02
443.1,Raynaud's syndrome,circulatory system,OPGS011283,0.050,RNAseq,CD248,0.91 (0.87 0.95),3.59E-02
443.7,Peripheral angiopathy in diseases classified elsewhere,circulatory system,OPGS007094,0.148,RNAseq,UTP25,0.83 (0.76 0.90),4.02E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,1.07 (1.04 1.10),1.47E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.07 (1.04 1.10),3.30E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS000212,0.222,SomaScan,Tyrosine-protein kinase receptor Tie-1. soluble,1.06 (1.03 1.09),7.94E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS001086,0.047,SomaScan,Dickkopf-related protein 1,1.06 (1.03 1.09),3.03E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS000101,0.374,SomaScan,CD209 antigen,1.06 (1.03 1.09),3.61E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS000283,0.177,SomaScan,Cathelicidin antimicrobial peptide,1.06 (1.03 1.09),3.82E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.95 (0.92 0.97),3.89E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS001207,0.038,SomaScan,Apolipoprotein M,1.05 (1.02 1.09),5.00E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS002651,0.015,Olink,von Willebrand factor,1.07 (1.04 1.10),1.27E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS002500,0.098,Olink,Galectin-4,0.94 (0.92 0.97),1.70E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.07 (1.04 1.10),3.13E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003149,0.015,Metabolon,sphingosine,1.06 (1.03 1.09),3.52E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.11 (1.08 1.14),1.82E-07
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.10 (1.07 1.14),3.00E-07
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,0.92 (0.89 0.95),9.28E-05
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.09 (1.05 1.12),1.31E-04
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,0.92 (0.90 0.95),2.18E-04
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003487,0.074,Nightingale,Phospholipids in chylomicrons and extremely large VLDL,0.93 (0.90 0.95),2.63E-04
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003509,0.069,Nightingale,Free cholesterol in chylomicrons and extremely large VLDL,0.93 (0.90 0.95),2.63E-04
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.08 (1.05 1.11),2.84E-04
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003491,0.073,Nightingale,Total lipids in chylomicrons and extremely large VLDL,0.93 (0.90 0.95),2.84E-04
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.08 (1.05 1.11),2.84E-04
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.08 (1.05 1.11),6.85E-04
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003423,0.126,Nightingale,LDL cholesterol,1.08 (1.05 1.11),9.76E-04
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.08 (1.05 1.11),9.76E-04
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.08 (1.05 1.11),9.76E-04
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.08 (1.04 1.11),1.02E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.08 (1.05 1.11),1.02E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.08 (1.04 1.11),1.27E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003516,0.066,Nightingale,Phospholipids in very large VLDL,0.93 (0.91 0.96),1.27E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.07 (1.04 1.11),1.27E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.07 (1.04 1.11),1.27E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003504,0.070,Nightingale,Triglycerides in very large VLDL,0.93 (0.91 0.96),1.27E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.07 (1.04 1.11),1.27E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.07 (1.04 1.11),1.27E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.07 (1.04 1.11),1.27E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.07 (1.04 1.11),1.27E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003500,0.071,Nightingale,Total lipids in very large VLDL,0.93 (0.91 0.96),1.27E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.07 (1.04 1.11),1.28E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.07 (1.04 1.11),1.44E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.07 (1.04 1.10),1.47E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.07 (1.04 1.11),1.47E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.07 (1.04 1.10),1.47E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.07 (1.04 1.11),1.47E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003539,0.029,Nightingale,Cholesterol in medium HDL,0.93 (0.91 0.96),1.47E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.07 (1.04 1.10),1.47E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.07 (1.04 1.11),1.47E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.07 (1.04 1.10),1.47E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.93 (0.91 0.96),1.48E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.07 (1.04 1.10),1.50E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003455,0.087,Nightingale,Total free cholesterol,1.07 (1.04 1.10),1.50E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.07 (1.04 1.10),1.50E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003502,0.070,Nightingale,Concentration of very large VLDL particles,0.93 (0.91 0.96),1.52E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.07 (1.04 1.10),1.52E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.07 (1.04 1.10),1.52E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.07 (1.04 1.10),1.59E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003510,0.068,Nightingale,Cholesterol in chylomicrons and extremely large VLDL,0.94 (0.91 0.96),1.73E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.07 (1.04 1.10),1.73E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003538,0.030,Nightingale,Cholesteryl esters in medium HDL,0.93 (0.91 0.96),1.73E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.07 (1.04 1.10),1.99E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003513,0.067,Nightingale,Free cholesterol in very large VLDL,0.94 (0.91 0.96),3.21E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.94 (0.91 0.97),4.70E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.07 (1.03 1.10),5.39E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003520,0.062,Nightingale,HDL cholesterol,0.94 (0.91 0.97),6.21E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003545,0.026,Nightingale,Free cholesterol in medium HDL,0.94 (0.91 0.97),6.21E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003452,0.087,Nightingale,Total cholesterol,1.06 (1.03 1.10),7.07E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.94 (0.91 0.97),8.63E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.06 (1.03 1.09),8.78E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.06 (1.03 1.10),8.78E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003506,0.070,Nightingale,Cholesterol in very large VLDL,0.94 (0.92 0.97),1.66E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003462,0.083,Nightingale,Average diameter for VLDL particles,0.94 (0.92 0.97),2.45E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003543,0.028,Nightingale,Total lipids in medium HDL,0.95 (0.92 0.97),2.91E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003542,0.028,Nightingale,Phospholipids in medium HDL,0.95 (0.92 0.97),3.52E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003544,0.027,Nightingale,Concentration of medium HDL particles,0.95 (0.92 0.97),3.82E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.95 (0.92 0.97),3.98E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,0.95 (0.92 0.98),4.65E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS004694,0.324,RNAseq,IREB2,0.93 (0.91 0.96),1.50E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS005399,0.247,RNAseq,AP3M1,1.06 (1.04 1.09),2.89E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS012110,0.040,RNAseq,KCNQ1,0.94 (0.91 0.97),8.78E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS007675,0.126,RNAseq,TRAV12-2,1.06 (1.03 1.09),8.78E-03
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS013243,0.029,RNAseq,TRAV3,0.94 (0.92 0.97),1.13E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS005933,0.207,RNAseq,AC005332.7,1.06 (1.03 1.09),1.55E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS011132,0.052,RNAseq,HEATR5B,1.06 (1.03 1.09),2.91E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS007630,0.128,RNAseq,,1.06 (1.03 1.09),3.98E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS006716,0.164,RNAseq,IER3,1.06 (1.03 1.09),4.65E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS003843,0.532,RNAseq,BTN3A2,0.95 (0.92 0.98),4.71E-02
443.9,Peripheral vascular disease. unspecified,circulatory system,OPGS006381,0.182,RNAseq,AL391422.4,0.95 (0.92 0.98),4.71E-02
444,Arterial embolism and thrombosis,circulatory system,OPGS002452,0.162,Olink,Stromelysin-2,0.84 (0.79 0.91),3.85E-02
446.4,Wegener's granulomatosis,circulatory system,OPGS010607,0.059,RNAseq,TRAV8-1,0.72 (0.63 0.82),1.17E-02
446.5,Giant cell arteritis,circulatory system,OPGS001231,0.037,SomaScan,Osteocalcin,1.17 (1.09 1.26),1.58E-02
446.5,Giant cell arteritis,circulatory system,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.17 (1.09 1.26),2.14E-02
446.5,Giant cell arteritis,circulatory system,OPGS015030,0.016,RNAseq,PRRC2A,1.28 (1.19 1.37),2.20E-07
446.5,Giant cell arteritis,circulatory system,OPGS005389,0.248,RNAseq,TRAV23DV6,0.82 (0.77 0.87),2.20E-07
446.5,Giant cell arteritis,circulatory system,OPGS006038,0.201,RNAseq,HLA-DQA2,1.23 (1.15 1.31),4.01E-07
446.5,Giant cell arteritis,circulatory system,OPGS012171,0.039,RNAseq,TRBV15,0.80 (0.75 0.86),1.93E-06
446.5,Giant cell arteritis,circulatory system,OPGS010348,0.063,RNAseq,TRBV6-5,1.24 (1.16 1.33),3.82E-06
446.5,Giant cell arteritis,circulatory system,OPGS014758,0.017,RNAseq,TRAV10,1.25 (1.16 1.35),3.15E-05
446.5,Giant cell arteritis,circulatory system,OPGS008402,0.104,RNAseq,TNXB,1.21 (1.13 1.30),3.69E-05
446.5,Giant cell arteritis,circulatory system,OPGS012808,0.033,RNAseq,TRBV20-1,0.82 (0.77 0.88),2.40E-04
446.5,Giant cell arteritis,circulatory system,OPGS010624,0.059,RNAseq,TRBV18,1.18 (1.09 1.26),1.47E-02
446.5,Giant cell arteritis,circulatory system,OPGS007991,0.116,RNAseq,AC139720.1,0.86 (0.81 0.92),1.98E-02
447.1,Stricture of artery,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.15 (1.09 1.22),2.91E-03
447.1,Stricture of artery,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.14 (1.08 1.21),1.46E-02
447.1,Stricture of artery,circulatory system,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.14 (1.08 1.20),1.46E-02
450,Noninfectious disorders of lymphatic channels,circulatory system,OPGS014921,0.016,RNAseq,PPP1R15A,1.11 (1.06 1.15),1.50E-02
450,Noninfectious disorders of lymphatic channels,circulatory system,OPGS008183,0.110,RNAseq,AL118516.1,0.90 (0.85 0.94),4.07E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.27 (1.24 1.30),2.80E-77
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000101,0.374,SomaScan,CD209 antigen,1.26 (1.23 1.29),2.45E-71
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000088,0.392,SomaScan,E-selectin,0.81 (0.80 0.83),9.10E-61
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,1.24 (1.21 1.27),1.56E-60
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.82 (0.80 0.84),8.69E-54
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001658,0.020,SomaScan,Endoglin,0.83 (0.81 0.85),1.44E-51
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,0.83 (0.81 0.85),1.88E-49
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001954,0.014,SomaScan,Tuftelin,0.83 (0.81 0.85),3.86E-49
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000600,0.099,SomaScan,Insulin receptor,0.84 (0.82 0.86),3.16E-44
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000095,0.381,SomaScan,Sulfhydryl oxidase 2,1.20 (1.17 1.23),5.88E-43
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.83 (0.81 0.85),1.47E-42
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000212,0.222,SomaScan,Tyrosine-protein kinase receptor Tie-1. soluble,1.19 (1.16 1.21),1.70E-41
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001915,0.014,SomaScan,N-acetylglucosamine-6-sulfatase,0.84 (0.82 0.86),1.83E-41
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001127,0.044,SomaScan,Carbohydrate sulfotransferase 15,0.84 (0.82 0.86),7.30E-40
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001490,0.026,SomaScan,Intercellular adhesion molecule 2,0.84 (0.82 0.87),1.70E-39
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001045,0.050,SomaScan,Carbohydrate sulfotransferase 15,0.84 (0.82 0.87),3.53E-38
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000321,0.161,SomaScan,von Willebrand factor,1.22 (1.18 1.26),3.87E-37
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001626,0.021,SomaScan,Neural cell adhesion molecule L1,0.84 (0.82 0.87),2.45E-33
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000889,0.064,SomaScan,Hepatocyte growth factor receptor,0.85 (0.83 0.87),4.18E-33
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001301,0.034,SomaScan,Glycosaminoglycan xylosylkinase,1.17 (1.14 1.20),9.48E-33
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000351,0.151,SomaScan,C1GALT1-specific chaperone 1,1.17 (1.14 1.20),1.22E-30
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000362,0.147,SomaScan,Golgi membrane protein 1,1.16 (1.13 1.19),3.50E-28
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000220,0.213,SomaScan,Vascular endothelial growth factor receptor 2,0.87 (0.85 0.89),3.83E-27
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001083,0.047,SomaScan,Desmoglein-2,1.15 (1.12 1.18),1.71E-24
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000146,0.291,SomaScan,Coagulation Factor XI,1.14 (1.11 1.17),1.49E-21
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000121,0.341,SomaScan,D-glucuronyl C5-epimerase,1.15 (1.12 1.18),9.13E-21
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001327,0.032,SomaScan,Basal Cell Adhesion Molecule,1.12 (1.10 1.15),9.36E-21
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000155,0.275,SomaScan,Interleukin-3 receptor subunit alpha,0.88 (0.86 0.90),9.37E-20
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000885,0.064,SomaScan,Dipeptidase 2,0.88 (0.86 0.90),9.87E-19
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000671,0.088,SomaScan,Carbohydrate sulfotransferase 11,1.13 (1.10 1.16),1.45E-17
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000064,0.442,SomaScan,Calcium/calmodulin-dependent protein kinase type 1,1.13 (1.10 1.16),4.23E-17
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000646,0.091,SomaScan,Protein-tyrosine sulfotransferase 2,1.13 (1.10 1.16),1.00E-16
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001832,0.016,SomaScan,Neurogenic locus notch homolog protein 1,1.11 (1.09 1.14),1.60E-16
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000663,0.089,SomaScan,Secreted and transmembrane protein 1,0.89 (0.87 0.91),2.21E-16
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001049,0.049,SomaScan,Chloride intracellular channel protein 5,1.15 (1.11 1.19),5.90E-16
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001700,0.019,SomaScan,Semaphorin-6B,1.11 (1.08 1.13),5.99E-15
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001174,0.040,SomaScan,Platelet glycoprotein 4,1.11 (1.08 1.13),9.25E-15
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000923,0.060,SomaScan,Thrombospondin type-1 domain-containing protein 1,0.89 (0.86 0.91),1.37E-13
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000106,0.366,SomaScan,Protein FAM3D,1.11 (1.08 1.14),3.88E-13
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001089,0.047,SomaScan,Tissue factor pathway inhibitor,0.90 (0.88 0.93),1.54E-12
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001485,0.026,SomaScan,Tolloid-like protein 1,1.10 (1.07 1.12),3.57E-12
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000479,0.122,SomaScan,C-C motif chemokine 25,0.90 (0.88 0.93),6.67E-12
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000606,0.098,SomaScan,Beta-1.4-galactosyltransferase 1,1.10 (1.07 1.13),2.88E-11
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000463,0.125,SomaScan,Toll-like receptor 4:Lymphocyte antigen 96 complex,0.91 (0.89 0.94),1.59E-10
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001252,0.036,SomaScan,Neuronal pentraxin-2,0.91 (0.89 0.93),1.64E-10
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000244,0.195,SomaScan,C-C motif chemokine 25,0.91 (0.89 0.94),3.12E-10
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000067,0.438,SomaScan,Adhesion G protein-coupled receptor F5,0.91 (0.89 0.94),4.50E-10
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000838,0.069,SomaScan,DNA/RNA-binding protein KIN17,0.91 (0.89 0.93),6.45E-10
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001491,0.026,SomaScan,Platelet-derived growth factor subunit B,1.10 (1.07 1.12),1.77E-09
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000108,0.360,SomaScan,Intercellular adhesion molecule 5,0.92 (0.89 0.94),2.95E-09
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002289,0.010,SomaScan,Inhibin beta C chain,0.91 (0.89 0.94),3.63E-09
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001687,0.020,SomaScan,Acidic leucine-rich nuclear phosphoprotein 32 family member B,0.91 (0.89 0.94),5.41E-09
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001476,0.026,SomaScan,Interleukin-13 receptor subunit alpha-1,1.09 (1.06 1.12),2.09E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001191,0.039,SomaScan,Progonadoliberin-1,0.92 (0.89 0.94),2.30E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001779,0.018,SomaScan,Histatin-3,0.92 (0.89 0.94),2.76E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000221,0.213,SomaScan,Protein FAM177A1,0.92 (0.89 0.94),5.14E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002042,0.012,SomaScan,Cullin-3,0.92 (0.90 0.94),5.70E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002032,0.012,SomaScan,Transmembrane protein 132C,1.09 (1.06 1.12),5.70E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001993,0.013,SomaScan,Somatostatin-28,0.92 (0.90 0.94),5.70E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002095,0.012,SomaScan,Beta-defensin 113,1.09 (1.06 1.12),5.70E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001574,0.023,SomaScan,Keratin-associated protein 2-4,0.92 (0.90 0.94),8.58E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000679,0.087,SomaScan,Mannosyl-oligosaccharide 1.2-alpha-mannosidase IB,1.09 (1.06 1.12),8.96E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000215,0.218,SomaScan,Immunoglobulin superfamily containing leucine-rich repeat protein 2,0.92 (0.90 0.94),9.52E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000126,0.332,SomaScan,Vascular endothelial growth factor receptor 3,0.92 (0.90 0.95),9.77E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001821,0.017,SomaScan,Plasminogen activator inhibitor 1,1.09 (1.06 1.12),9.77E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001721,0.019,SomaScan,Chromogranin-A,0.92 (0.90 0.95),1.17E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001788,0.017,SomaScan,Platelet-derived growth factor subunit A,1.09 (1.06 1.12),1.26E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001664,0.020,SomaScan,Thrombospondin-1,1.09 (1.06 1.12),1.52E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001827,0.016,SomaScan,UDP-glucuronosyltransferase 2A1,1.09 (1.06 1.12),2.13E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001942,0.014,SomaScan,Connective tissue-activating peptide III,1.09 (1.06 1.12),2.59E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001672,0.020,SomaScan,Angiopoietin-1,1.09 (1.06 1.12),2.92E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002068,0.012,SomaScan,Brain-derived neurotrophic factor,1.09 (1.06 1.12),3.32E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000844,0.068,SomaScan,Growth/differentiation factor 2,1.08 (1.05 1.11),3.91E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001743,0.018,SomaScan,14-3-3 protein sigma,0.93 (0.90 0.95),4.21E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001139,0.043,SomaScan,Protein SEC13 homolog,1.08 (1.05 1.11),4.75E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001908,0.015,SomaScan,Neutrophil-activating peptide 2,1.08 (1.06 1.11),4.75E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001754,0.018,SomaScan,Vascular endothelial growth factor D,1.08 (1.05 1.11),4.91E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001652,0.021,SomaScan,Galectin-7,1.08 (1.05 1.11),9.12E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002084,0.012,SomaScan,Protein FAM210A,1.08 (1.05 1.11),1.15E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001980,0.013,SomaScan,SPARC,1.08 (1.05 1.11),1.15E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002177,0.011,SomaScan,Synaptotagmin-17,1.08 (1.05 1.11),1.15E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002193,0.011,SomaScan,MAGUK p55 subfamily member 7,1.08 (1.05 1.11),1.15E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002082,0.012,SomaScan,Interleukin-7,1.08 (1.05 1.11),1.15E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001974,0.013,SomaScan,Polyadenylate-binding protein-interacting protein 1,1.08 (1.05 1.11),1.15E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002004,0.013,SomaScan,Centromere protein W,1.08 (1.05 1.11),1.15E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002214,0.011,SomaScan,DNA-binding protein SATB1,1.08 (1.05 1.11),1.15E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002077,0.012,SomaScan,Choriogonadotropin subunit beta variant 2,1.08 (1.05 1.11),1.15E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001949,0.014,SomaScan,72 kDa inositol polyphosphate 5-phosphatase,1.08 (1.05 1.11),1.15E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002192,0.011,SomaScan,Beta-defensin 119,1.08 (1.05 1.11),1.15E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001875,0.015,SomaScan,Synaptotagmin-11,1.08 (1.05 1.11),1.15E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001436,0.028,SomaScan,Bone morphogenetic protein 7,1.08 (1.05 1.11),1.31E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000150,0.284,SomaScan,Plasma kallikrein,1.08 (1.05 1.11),1.98E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000960,0.057,SomaScan,Cadherin-15,0.93 (0.90 0.95),2.51E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001798,0.017,SomaScan,Bone sialoprotein 2,0.93 (0.90 0.95),2.54E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000166,0.267,SomaScan,P-selectin,0.93 (0.91 0.95),3.33E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000378,0.143,SomaScan,Immunoglobulin superfamily containing leucine-rich repeat protein 2,0.93 (0.90 0.95),3.80E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001445,0.028,SomaScan,Endoplasmic reticulum resident protein 44,1.08 (1.05 1.11),5.75E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000346,0.151,SomaScan,N-acetyllactosaminide beta-1.3-N-acetylglucosaminyltransferase 2,1.07 (1.05 1.10),6.14E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001487,0.026,SomaScan,Interleukin-2,1.08 (1.05 1.10),6.81E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001824,0.016,SomaScan,ADM2,0.93 (0.91 0.95),6.99E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000180,0.254,SomaScan,Sialic acid-binding Ig-like lectin 11,0.93 (0.91 0.95),9.05E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002204,0.011,SomaScan,Rho-related GTP-binding protein RhoG,1.07 (1.05 1.10),1.33E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001568,0.023,SomaScan,WAP four-disulfide core domain protein 13,1.07 (1.04 1.10),1.63E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001427,0.028,SomaScan,Alpha-2-macroglobulin,1.07 (1.05 1.10),1.73E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000214,0.221,SomaScan,Intercellular adhesion molecule 5,0.93 (0.91 0.96),1.74E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000993,0.054,SomaScan,Protachykinin-1,0.93 (0.91 0.96),2.75E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000196,0.236,SomaScan,Protein FAM3B,1.07 (1.04 1.10),3.88E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000383,0.142,SomaScan,Protein FAM3B,1.07 (1.04 1.10),4.18E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001262,0.035,SomaScan,C-type lectin domain family 1 member B,1.07 (1.04 1.10),4.94E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001269,0.035,SomaScan,Histone-lysine N-methyltransferase EHMT2,1.07 (1.04 1.09),8.46E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000888,0.064,SomaScan,Glucosidase 2 subunit beta,1.07 (1.04 1.10),1.01E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000104,0.372,SomaScan,Protein Z-dependent protease inhibitor,0.94 (0.91 0.96),1.05E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000917,0.061,SomaScan,Interleukin-6 receptor subunit beta,0.94 (0.91 0.96),1.15E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001812,0.017,SomaScan,Fibroblast growth factor 19,0.94 (0.91 0.96),1.17E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000225,0.210,SomaScan,Intercellular adhesion molecule 4,0.94 (0.91 0.96),1.54E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001496,0.026,SomaScan,Glycoprotein Xg,0.94 (0.91 0.96),1.85E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001084,0.047,SomaScan,Activating signal cointegrator 1 complex subunit 1,1.06 (1.04 1.09),2.53E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001376,0.030,SomaScan,NAD-dependent protein deacylase sirtuin-5. mitochondrial,1.06 (1.04 1.09),3.16E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000664,0.088,SomaScan,BPI fold-containing family A member 2,1.06 (1.04 1.09),3.20E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001273,0.035,SomaScan,Persulfide dioxygenase ETHE1. mitochondrial,0.94 (0.91 0.96),3.70E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001365,0.030,SomaScan,Leukocyte cell-derived chemotaxin 1,1.06 (1.03 1.09),4.28E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000736,0.080,SomaScan,Semaphorin-6A,0.94 (0.92 0.97),4.43E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000925,0.060,SomaScan,Plexin domain-containing protein 1,0.94 (0.92 0.97),4.66E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000710,0.082,SomaScan,Thrombin,1.06 (1.04 1.09),5.01E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001294,0.034,SomaScan,Peroxidasin homolog,0.94 (0.92 0.97),6.30E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000750,0.078,SomaScan,Adrenomedullin,0.94 (0.92 0.97),7.05E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001257,0.036,SomaScan,Glucagon,0.94 (0.92 0.97),9.79E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001553,0.024,SomaScan,Protein G6b,1.06 (1.03 1.09),1.09E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000782,0.075,SomaScan,Beta-1.4-galactosyltransferase 2,1.06 (1.03 1.09),1.70E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001059,0.049,SomaScan,Inter-alpha-trypsin inhibitor heavy chain H4,0.94 (0.92 0.97),1.74E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000682,0.087,SomaScan,Sulfotransferase family cytosolic 1B member 1,1.06 (1.03 1.09),1.74E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000355,0.150,SomaScan,Platelet glycoprotein VI,1.06 (1.03 1.09),1.91E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000778,0.075,SomaScan,Tumor necrosis factor receptor superfamily member 16,0.95 (0.92 0.97),2.05E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000914,0.061,SomaScan,Drebrin-like protein,1.06 (1.03 1.09),2.11E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001246,0.036,SomaScan,Endothelial cell-selective adhesion molecule,1.06 (1.03 1.09),2.16E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000327,0.159,SomaScan,Dihydrofolate reductase,1.06 (1.03 1.08),2.50E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000024,0.598,SomaScan,Mannose-binding protein C,1.06 (1.03 1.09),2.65E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001305,0.033,SomaScan,Endothelial cell-selective adhesion molecule,1.06 (1.03 1.09),2.79E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000910,0.062,SomaScan,Neurexin-1,0.95 (0.92 0.97),3.06E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000278,0.180,SomaScan,Cadherin-5,1.05 (1.03 1.08),3.10E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001060,0.049,SomaScan,Septin-11,1.06 (1.03 1.08),3.25E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001528,0.025,SomaScan,Histone H1.2,0.95 (0.93 0.97),3.28E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000228,0.207,SomaScan,Disintegrin and metalloproteinase domain-containing protein 23,1.06 (1.03 1.08),3.71E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000947,0.058,SomaScan,Lysosomal protective protein,1.06 (1.03 1.08),3.71E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001337,0.032,SomaScan,Cholecystokinin,0.95 (0.92 0.97),3.92E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001469,0.027,SomaScan,EH domain-binding protein 1,0.95 (0.93 0.97),4.07E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001104,0.046,SomaScan,Transmembrane protein C1orf162,0.95 (0.92 0.97),4.34E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000766,0.077,SomaScan,Peptidyl-tRNA hydrolase ICT1. mitochondrial,0.95 (0.92 0.97),5.41E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000093,0.383,SomaScan,Dual specificity mitogen-activated protein kinase kinase 2,0.95 (0.93 0.98),7.33E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000765,0.077,SomaScan,Angiopoietin-1 receptor. soluble,1.05 (1.02 1.08),1.09E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000563,0.104,SomaScan,Liver-expressed antimicrobial peptide 2,0.95 (0.93 0.98),1.11E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001442,0.028,SomaScan,Amyloid-like protein 2,1.05 (1.02 1.08),1.16E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000653,0.090,SomaScan,Neuropeptide W,0.95 (0.93 0.98),1.18E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000795,0.074,SomaScan,Plasma serine protease inhibitor,0.95 (0.93 0.98),1.53E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001086,0.047,SomaScan,Dickkopf-related protein 1,1.05 (1.02 1.08),1.58E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001027,0.051,SomaScan,GDNF family receptor alpha-like,1.05 (1.02 1.08),1.73E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,1.05 (1.02 1.08),1.96E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000962,0.057,SomaScan,Platelet-derived growth factor D,1.05 (1.02 1.08),2.02E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000796,0.073,SomaScan,Transmembrane glycoprotein NMB,0.95 (0.93 0.98),2.52E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001210,0.038,SomaScan,Neurensin-1,0.95 (0.93 0.98),2.71E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS001234,0.037,SomaScan,CUB and sushi domain-containing protein 1,1.05 (1.02 1.07),2.85E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000643,0.092,SomaScan,CD27 antigen,1.05 (1.02 1.07),3.58E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000161,0.270,SomaScan,Vascular endothelial growth factor A. isoform 121,1.05 (1.02 1.07),3.61E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000096,0.380,SomaScan,Protein Z-dependent protease inhibitor,0.96 (0.93 0.98),4.27E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS000916,0.061,SomaScan,CD63 antigen,1.05 (1.02 1.07),4.40E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002651,0.015,Olink,von Willebrand factor,1.28 (1.24 1.31),7.98E-78
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002500,0.098,Olink,Galectin-4,0.80 (0.78 0.82),2.85E-67
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002408,0.270,Olink,E-selectin,0.81 (0.79 0.83),6.80E-64
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002590,0.035,Olink,Platelet endothelial cell adhesion molecule,0.87 (0.84 0.89),3.24E-27
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002578,0.039,Olink,Leukemia inhibitory factor receptor,0.88 (0.86 0.90),1.88E-21
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002395,0.362,Olink,Intercellular adhesion molecule 2,0.88 (0.86 0.90),1.02E-19
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002554,0.053,Olink,P-selectin,0.90 (0.88 0.92),1.31E-13
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002557,0.050,Olink,Epithelial cell adhesion molecule,0.90 (0.88 0.93),3.36E-12
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002629,0.023,Olink,Interleukin-18-binding protein,1.10 (1.07 1.13),1.27E-11
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002638,0.019,Olink,Ephrin type-B receptor 4,0.91 (0.89 0.94),8.16E-10
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002510,0.085,Olink,Bone morphogenetic protein 6,0.91 (0.89 0.94),1.02E-09
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002541,0.061,Olink,Thrombomodulin,1.09 (1.06 1.12),3.26E-09
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002592,0.035,Olink,Vascular endothelial growth factor D,1.09 (1.06 1.12),7.04E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002479,0.127,Olink,Growth/differentiation factor 2,1.09 (1.06 1.11),1.12E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002660,0.012,Olink,Angiopoietin-1,1.09 (1.06 1.11),2.50E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002661,0.011,Olink,Platelet-derived growth factor subunit A,1.08 (1.06 1.11),3.55E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002540,0.062,Olink,Plexin-B1,1.08 (1.05 1.11),7.10E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002475,0.133,Olink,UL16-binding protein 2,1.08 (1.05 1.11),4.18E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002445,0.175,Olink,Chymotrypsin-C,1.07 (1.05 1.10),4.39E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002653,0.015,Olink,CD40 ligand,1.08 (1.05 1.10),5.73E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002605,0.030,Olink,Sortilin,1.07 (1.05 1.10),8.46E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002649,0.016,Olink,Platelet-derived growth factor subunit B,1.07 (1.05 1.10),8.88E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002652,0.015,Olink,Dickkopf-related protein 1,1.07 (1.04 1.10),2.33E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002655,0.014,Olink,Junctional adhesion molecule B,1.07 (1.04 1.09),3.04E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002394,0.405,Olink,C-C motif chemokine 25,0.93 (0.91 0.96),3.08E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002663,0.011,Olink,C-type lectin domain family 1 member B,1.07 (1.04 1.10),6.16E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002657,0.013,Olink,Fibroblast growth factor 19,0.94 (0.92 0.97),3.48E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002454,0.157,Olink,Galectin-9,0.94 (0.92 0.97),4.71E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002531,0.066,Olink,Tissue factor,0.94 (0.92 0.97),5.49E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002415,0.244,Olink,Programmed cell death 1 ligand 2,0.94 (0.92 0.97),1.52E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002437,0.187,Olink,Serine protease 27,1.06 (1.03 1.09),1.84E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002403,0.330,Olink,Sialic acid-binding Ig-like lectin 9,0.95 (0.93 0.97),7.08E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002534,0.063,Olink,Tyrosine-protein kinase Mer,0.95 (0.92 0.97),7.46E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002654,0.015,Olink,Thrombopoietin,1.05 (1.02 1.07),1.14E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002458,0.151,Olink,Cobalamin binding intrinsic factor,0.95 (0.93 0.98),1.87E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002468,0.142,Olink,Galectin-8,0.96 (0.93 0.98),2.35E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003149,0.015,Metabolon,sphingosine,1.21 (1.18 1.24),1.67E-53
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002825,0.081,Metabolon,bradykinin. des-arg(9),1.09 (1.06 1.12),8.38E-09
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002742,0.161,Metabolon,bradykinin,1.09 (1.06 1.12),2.07E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002794,0.099,Metabolon,X - 14095,1.09 (1.06 1.12),4.27E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002894,0.054,Metabolon,bradykinin. hydroxy-pro(3),1.09 (1.06 1.12),6.20E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002726,0.198,Metabolon,methionylalanine,1.08 (1.05 1.11),5.86E-07
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002767,0.127,Metabolon,phenylalanylarginine,1.08 (1.05 1.11),1.93E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002829,0.079,Metabolon,arachidonate (20:4n6),1.06 (1.03 1.09),1.39E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002997,0.032,Metabolon,1-palmitoyl-2-linoleoyl-GPC (16:0/18:2),0.94 (0.92 0.97),1.66E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002855,0.069,Metabolon,1-palmityl-2-arachidonoyl-GPC (O-16:0/20:4)*,1.06 (1.03 1.09),1.70E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002780,0.113,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)*,1.06 (1.03 1.09),1.73E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002791,0.100,Metabolon,2-arachidonoyl-GPC (20:4)*,1.06 (1.03 1.09),1.91E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003075,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*,1.06 (1.03 1.09),2.05E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002890,0.056,Metabolon,X - 23705,1.06 (1.03 1.09),2.05E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003125,0.017,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6),1.06 (1.03 1.09),2.39E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002949,0.041,Metabolon,1-stearoyl-2-meadoyl-GPC (18:0/20:3n9)*,1.06 (1.03 1.09),2.63E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002843,0.073,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4),1.06 (1.03 1.09),2.70E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002977,0.035,Metabolon,1.2-dilinoleoyl-GPC (18:2/18:2),0.95 (0.92 0.97),3.02E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002954,0.040,Metabolon,1-oleoyl-2-linoleoyl-GPC (18:1/18:2)*,0.95 (0.92 0.97),3.12E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002936,0.044,Metabolon,1-dihomo-linoleoyl-GPC (20:2)*,0.95 (0.92 0.97),3.62E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002972,0.036,Metabolon,1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9)*,1.06 (1.03 1.08),3.64E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003042,0.024,Metabolon,1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6),1.06 (1.03 1.08),3.64E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002764,0.129,Metabolon,1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4),1.06 (1.03 1.08),4.20E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003035,0.025,Metabolon,1-linoleoyl-GPI (18:2)*,0.95 (0.92 0.97),4.29E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002850,0.070,Metabolon,1-stearoyl-2-linoleoyl-GPE (18:0/18:2)*,0.95 (0.92 0.97),4.94E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002734,0.178,Metabolon,1-stearoyl-2-arachidonoyl-GPC (18:0/20:4),1.05 (1.03 1.08),5.18E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002931,0.045,Metabolon,eicosapentaenoate (EPA; 20:5n3),1.05 (1.03 1.08),5.20E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003189,0.012,Metabolon,2-linoleoyl-GPE (18:2)*,0.95 (0.92 0.97),5.35E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003016,0.029,Metabolon,1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)*,1.05 (1.03 1.08),6.37E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002921,0.047,Metabolon,1-oleoyl-2-linoleoyl-GPE (18:1/18:2)*,0.95 (0.92 0.97),6.37E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003100,0.019,Metabolon,1-arachidonylglycerol (20:4),1.05 (1.03 1.08),6.54E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002747,0.146,Metabolon,1-arachidonoyl-GPC (20:4n6)*,1.05 (1.03 1.08),6.62E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002980,0.034,Metabolon,1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2)*,0.95 (0.93 0.98),8.69E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003057,0.022,Metabolon,1-adrenoyl-GPC (22:4)*,1.05 (1.02 1.08),9.82E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003168,0.014,Metabolon,X - 24054,0.95 (0.93 0.98),9.85E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002872,0.061,Metabolon,1-eicosapentaenoyl-GPC (20:5)*,1.05 (1.02 1.08),1.04E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002941,0.043,Metabolon,1-palmitoyl-2-linolenoyl-GPC (16:0/18:3)*,0.95 (0.93 0.98),1.04E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003114,0.018,Metabolon,1-myristoyl-2-linoleoyl-GPC (14:0/18:2)*,0.95 (0.93 0.98),1.17E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003223,0.010,Metabolon,behenoyl sphingomyelin (d18:1/22:0)*,0.95 (0.93 0.98),1.21E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003109,0.018,Metabolon,1-linoleoyl-GPE (18:2)*,0.95 (0.93 0.98),1.26E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003073,0.021,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*,1.05 (1.02 1.08),1.44E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003159,0.014,Metabolon,docosapentaenoate (n3 DPA; 22:5n3),1.05 (1.02 1.08),1.61E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003152,0.014,Metabolon,1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2)*,0.95 (0.93 0.98),1.87E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002789,0.102,Metabolon,1-palmitoyl-2-linoleoyl-GPE (16:0/18:2),0.95 (0.93 0.98),2.08E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003120,0.017,Metabolon,2-docosahexaenoyl-GPC (22:6)*,1.05 (1.02 1.08),2.09E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003074,0.021,Metabolon,1-stearoyl-2-linoleoyl-GPC (18:0/18:2)*,0.95 (0.93 0.98),2.19E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002899,0.053,Metabolon,1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5)*,1.05 (1.02 1.08),2.27E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003077,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPC (P-16:0/22:6)*,1.05 (1.02 1.08),2.54E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003086,0.020,Metabolon,1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)*,0.95 (0.93 0.98),2.70E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003019,0.028,Metabolon,1-oleoyl-2-linoleoyl-GPI (18:1/18:2)*,0.95 (0.93 0.98),2.71E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003011,0.030,Metabolon,1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)*,0.95 (0.93 0.98),2.85E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003038,0.025,Metabolon,1-margaroyl-2-linoleoyl-GPC (17:0/18:2)*,0.95 (0.93 0.98),2.86E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002807,0.089,Metabolon,1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3)*,0.96 (0.93 0.98),3.06E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003118,0.017,Metabolon,1-(1-enyl-palmitoyl)-GPC (P-16:0)*,1.05 (1.02 1.07),3.11E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002834,0.075,Metabolon,phosphatidylcholine (18:0/20:5. 16:0/22:5n6)*,1.05 (1.02 1.07),4.38E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003121,0.017,Metabolon,1.2-dipalmitoyl-GPC (16:0/16:0),1.05 (1.02 1.07),4.71E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003043,0.024,Metabolon,1-docosahexaenoyl-GPC (22:6)*,1.05 (1.02 1.07),4.79E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS002982,0.033,Metabolon,X - 12681,1.04 (1.02 1.07),5.00E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003497,0.072,Nightingale,Linoleic acid,0.94 (0.92 0.96),2.12E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,0.95 (0.93 0.98),7.61E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,0.95 (0.93 0.98),8.69E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003522,0.062,Nightingale,Degree of unsaturation,1.05 (1.02 1.08),9.19E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,0.95 (0.93 0.98),9.92E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,0.95 (0.93 0.98),1.37E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,0.95 (0.93 0.98),1.37E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS012642,0.034,RNAseq,SLC19A2,1.21 (1.18 1.24),1.58E-52
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS015054,0.015,RNAseq,H19,1.21 (1.18 1.24),1.10E-50
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS003651,0.639,RNAseq,ABO,0.88 (0.86 0.90),4.28E-19
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS008339,0.106,RNAseq,GBGT1,0.91 (0.89 0.94),1.11E-11
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS005968,0.205,RNAseq,TSPAN15,0.92 (0.89 0.94),3.89E-08
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS014044,0.022,RNAseq,KCND3,0.93 (0.90 0.95),2.54E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS005386,0.248,RNAseq,METTL18,0.93 (0.91 0.96),2.59E-06
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS007070,0.149,RNAseq,MED22,0.93 (0.91 0.96),2.78E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS004332,0.383,RNAseq,ATP1B1,0.93 (0.91 0.96),6.23E-05
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS010454,0.062,RNAseq,GP1BA,1.06 (1.04 1.09),3.21E-04
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS009682,0.075,RNAseq,AL731557.1,1.06 (1.03 1.09),1.70E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS012680,0.034,RNAseq,P2RY12,1.06 (1.03 1.09),2.70E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS010512,0.061,RNAseq,ITCH,1.06 (1.03 1.08),3.24E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS006132,0.196,RNAseq,EIF6,1.05 (1.03 1.08),3.64E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS013350,0.028,RNAseq,ACSS2,0.95 (0.92 0.97),3.64E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS006611,0.170,RNAseq,C1orf112,1.05 (1.03 1.08),3.64E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS006381,0.182,RNAseq,AL391422.4,0.95 (0.92 0.97),3.68E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS009479,0.080,RNAseq,AL121753.2,0.95 (0.93 0.97),5.85E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS011942,0.042,RNAseq,FBXO46,0.95 (0.92 0.97),7.08E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS006025,0.201,RNAseq,ERCC3,0.95 (0.93 0.98),8.31E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS006789,0.161,RNAseq,CROCC,0.95 (0.92 0.97),8.50E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS014701,0.017,RNAseq,,0.95 (0.92 0.97),9.14E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS004049,0.450,RNAseq,JAM3,1.05 (1.02 1.08),9.19E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS004058,0.447,RNAseq,XCL2,0.95 (0.93 0.98),9.19E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS012415,0.037,RNAseq,BAG4,0.95 (0.93 0.98),9.85E-03
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS008202,0.109,RNAseq,TCF7L2,1.05 (1.02 1.08),1.11E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS007099,0.148,RNAseq,XXYLT1,0.95 (0.93 0.98),1.22E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS005667,0.223,RNAseq,DIP2A,1.05 (1.02 1.08),1.71E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS012729,0.033,RNAseq,SREBF2,0.95 (0.93 0.98),1.80E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS007493,0.132,RNAseq,TXN2,1.05 (1.02 1.08),1.80E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS004872,0.302,RNAseq,NFE2,0.96 (0.93 0.98),1.95E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS008975,0.090,RNAseq,LIME1,0.95 (0.92 0.98),1.98E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS007370,0.137,RNAseq,CHRNA5,1.05 (1.02 1.08),2.14E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS012175,0.039,RNAseq,LINC02848,0.95 (0.93 0.98),2.20E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS014984,0.016,RNAseq,LINC02086,0.96 (0.93 0.98),2.38E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS012997,0.031,RNAseq,AC022144.1,1.05 (1.02 1.08),2.83E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS008053,0.114,RNAseq,EDEM2,0.96 (0.93 0.98),2.84E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS014042,0.022,RNAseq,ZBTB8OS,0.96 (0.94 0.98),2.93E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS009399,0.081,RNAseq,MBOAT7,0.96 (0.93 0.98),3.05E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS007467,0.133,RNAseq,DNM1,0.95 (0.93 0.98),3.07E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS011108,0.052,RNAseq,LDLR,0.96 (0.93 0.98),3.12E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS011365,0.049,RNAseq,GGT7,0.96 (0.93 0.98),3.12E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS009200,0.085,RNAseq,OS9,1.05 (1.02 1.07),3.43E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS014727,0.017,RNAseq,BCL2L2,0.96 (0.93 0.98),4.03E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS004735,0.319,RNAseq,ADPRH,0.96 (0.93 0.98),4.10E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS015009,0.016,RNAseq,RASGEF1B,0.96 (0.93 0.98),4.14E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS008564,0.100,RNAseq,CLU,1.05 (1.02 1.07),4.27E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS011849,0.043,RNAseq,VRK3,1.05 (1.02 1.09),4.30E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS011614,0.046,RNAseq,H2BC7,1.05 (1.02 1.07),4.30E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS007538,0.131,RNAseq,AC245452.1,1.05 (1.02 1.07),4.34E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS013701,0.025,RNAseq,AC007216.3,1.05 (1.02 1.07),4.55E-02
451.2,Phlebitis and thrombophlebitis of lower extremities,circulatory system,OPGS006266,0.188,RNAseq,SMIM19,0.96 (0.93 0.98),5.00E-02
454,Varicose veins,circulatory system,OPGS015055,0.015,RNAseq,ZNF726,0.90 (0.87 0.94),1.75E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.95 (0.93 0.97),5.13E-06
454.1,Varicose veins of lower extremity,circulatory system,OPGS001136,0.043,SomaScan,R-spondin-3,0.95 (0.94 0.97),2.26E-05
454.1,Varicose veins of lower extremity,circulatory system,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.05 (1.03 1.06),1.43E-04
454.1,Varicose veins of lower extremity,circulatory system,OPGS000101,0.374,SomaScan,CD209 antigen,1.04 (1.02 1.06),9.74E-04
454.1,Varicose veins of lower extremity,circulatory system,OPGS001054,0.049,SomaScan,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,0.96 (0.94 0.98),1.47E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS000663,0.089,SomaScan,Secreted and transmembrane protein 1,0.96 (0.94 0.98),1.47E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS002139,0.011,SomaScan,Interleukin-27,0.96 (0.94 0.98),1.47E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS000649,0.091,SomaScan,Transcobalamin-1,1.04 (1.02 1.06),1.47E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS000088,0.392,SomaScan,E-selectin,0.96 (0.95 0.98),1.90E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS000664,0.088,SomaScan,BPI fold-containing family A member 2,1.04 (1.02 1.06),2.12E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS001812,0.017,SomaScan,Fibroblast growth factor 19,0.96 (0.94 0.98),2.12E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS000321,0.161,SomaScan,von Willebrand factor,1.04 (1.02 1.06),2.31E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS000969,0.056,SomaScan,Transferrin receptor protein 1,0.96 (0.95 0.98),4.35E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS000679,0.087,SomaScan,Mannosyl-oligosaccharide 1.2-alpha-mannosidase IB,1.04 (1.02 1.06),7.38E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS000367,0.145,SomaScan,Platelet-derived growth factor receptor alpha,1.03 (1.02 1.05),1.40E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.97 (0.95 0.98),1.53E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,1.03 (1.02 1.05),1.78E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,1.03 (1.02 1.05),1.78E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,1.03 (1.02 1.05),1.99E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,0.97 (0.95 0.98),2.07E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS001658,0.020,SomaScan,Endoglin,0.97 (0.95 0.98),2.16E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS000838,0.069,SomaScan,DNA/RNA-binding protein KIN17,0.97 (0.95 0.98),2.47E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS000028,0.585,SomaScan,Thioredoxin domain-containing protein 12,0.97 (0.95 0.98),2.51E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS001327,0.032,SomaScan,Basal Cell Adhesion Molecule,1.03 (1.01 1.05),2.51E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.97 (0.95 0.99),3.05E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS000606,0.098,SomaScan,Beta-1.4-galactosyltransferase 1,1.03 (1.01 1.05),3.12E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS000461,0.125,SomaScan,BPI fold-containing family B member 1,1.03 (1.01 1.05),3.37E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS000889,0.064,SomaScan,Hepatocyte growth factor receptor,0.97 (0.95 0.99),3.42E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS001954,0.014,SomaScan,Tuftelin,0.97 (0.95 0.99),3.78E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS002129,0.011,SomaScan,IgLON family member 5,0.97 (0.96 0.99),4.01E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS000351,0.151,SomaScan,C1GALT1-specific chaperone 1,1.03 (1.01 1.05),4.15E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.03 (1.01 1.05),4.16E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS000212,0.222,SomaScan,Tyrosine-protein kinase receptor Tie-1. soluble,1.03 (1.01 1.05),4.86E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS000798,0.073,SomaScan,N-acetylated-alpha-linked acidic dipeptidase 2,0.97 (0.95 0.99),4.87E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS002628,0.023,Olink,Pro-adrenomedullin,1.06 (1.04 1.08),3.06E-07
454.1,Varicose veins of lower extremity,circulatory system,OPGS002651,0.015,Olink,von Willebrand factor,1.05 (1.03 1.06),1.71E-04
454.1,Varicose veins of lower extremity,circulatory system,OPGS002657,0.013,Olink,Fibroblast growth factor 19,0.96 (0.94 0.97),3.40E-04
454.1,Varicose veins of lower extremity,circulatory system,OPGS002614,0.027,Olink,Carboxypeptidase B,1.04 (1.03 1.06),8.88E-04
454.1,Varicose veins of lower extremity,circulatory system,OPGS002408,0.270,Olink,E-selectin,0.96 (0.94 0.98),1.09E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS002500,0.098,Olink,Galectin-4,0.96 (0.95 0.98),2.55E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS002437,0.187,Olink,Serine protease 27,1.04 (1.02 1.06),6.99E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS002506,0.091,Olink,Cathepsin D,0.97 (0.95 0.98),1.48E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS002629,0.023,Olink,Interleukin-18-binding protein,1.03 (1.02 1.05),1.72E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS003090,0.020,Metabolon,X - 12714,1.04 (1.02 1.06),1.47E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS002724,0.200,Metabolon,imidazole lactate,0.96 (0.95 0.98),2.65E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS003170,0.014,Metabolon,X - 13846,1.04 (1.02 1.06),7.14E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS003149,0.015,Metabolon,sphingosine,1.03 (1.02 1.05),1.39E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS002944,0.043,Metabolon,X - 18249,0.97 (0.95 0.98),1.56E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS002840,0.074,Metabolon,X - 18914,0.97 (0.95 0.98),1.63E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS003160,0.014,Metabolon,X - 15469,1.04 (1.02 1.05),1.71E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS003023,0.027,Metabolon,5alpha-androstan-3beta.17alpha-diol disulfate,1.03 (1.02 1.05),2.19E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS002788,0.102,Metabolon,4-hydroxychlorothalonil,0.97 (0.95 0.98),2.90E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS003132,0.016,Metabolon,2-methylmalonyl carnitine,1.03 (1.01 1.05),4.22E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS003054,0.023,Metabolon,X - 21286,1.03 (1.01 1.05),4.87E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS004765,0.314,RNAseq,LINC01184,0.92 (0.91 0.94),3.77E-18
454.1,Varicose veins of lower extremity,circulatory system,OPGS013787,0.024,RNAseq,WDR92,0.93 (0.91 0.94),1.76E-15
454.1,Varicose veins of lower extremity,circulatory system,OPGS012744,0.033,RNAseq,AC138028.3,0.93 (0.92 0.95),9.97E-13
454.1,Varicose veins of lower extremity,circulatory system,OPGS004973,0.290,RNAseq,SNAI3-AS1,1.06 (1.04 1.08),1.09E-08
454.1,Varicose veins of lower extremity,circulatory system,OPGS004134,0.427,RNAseq,H2BC5,1.06 (1.04 1.07),5.86E-07
454.1,Varicose veins of lower extremity,circulatory system,OPGS010310,0.064,RNAseq,AC092384.1,0.95 (0.93 0.96),8.69E-07
454.1,Varicose veins of lower extremity,circulatory system,OPGS008605,0.099,RNAseq,PNO1,1.05 (1.04 1.07),1.55E-06
454.1,Varicose veins of lower extremity,circulatory system,OPGS011787,0.044,RNAseq,C2,0.95 (0.93 0.96),1.55E-06
454.1,Varicose veins of lower extremity,circulatory system,OPGS010555,0.060,RNAseq,C1D,1.05 (1.03 1.07),3.62E-05
454.1,Varicose veins of lower extremity,circulatory system,OPGS009865,0.072,RNAseq,TRAV17,1.05 (1.03 1.07),4.46E-05
454.1,Varicose veins of lower extremity,circulatory system,OPGS012562,0.035,RNAseq,H2BC17,0.95 (0.94 0.97),5.72E-05
454.1,Varicose veins of lower extremity,circulatory system,OPGS007612,0.128,RNAseq,AC074032.1,0.95 (0.94 0.97),6.45E-05
454.1,Varicose veins of lower extremity,circulatory system,OPGS007363,0.137,RNAseq,UCKL1,0.95 (0.94 0.97),7.42E-05
454.1,Varicose veins of lower extremity,circulatory system,OPGS013243,0.029,RNAseq,TRAV3,1.05 (1.03 1.07),1.17E-04
454.1,Varicose veins of lower extremity,circulatory system,OPGS009198,0.085,RNAseq,TRAV12-1,0.96 (0.94 0.97),2.37E-04
454.1,Varicose veins of lower extremity,circulatory system,OPGS007860,0.120,RNAseq,SBF2,1.05 (1.03 1.06),2.37E-04
454.1,Varicose veins of lower extremity,circulatory system,OPGS007764,0.123,RNAseq,HLA-E,0.96 (0.94 0.97),2.89E-04
454.1,Varicose veins of lower extremity,circulatory system,OPGS013068,0.030,RNAseq,AL021807.1,0.96 (0.94 0.98),1.12E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS008248,0.108,RNAseq,F11R,0.96 (0.94 0.98),1.46E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS006230,0.190,RNAseq,CHRNB1,0.96 (0.94 0.98),1.46E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS005055,0.281,RNAseq,KRTAP5-AS1,1.04 (1.02 1.06),1.47E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS013472,0.027,RNAseq,STAT1,1.04 (1.02 1.06),1.47E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS008370,0.105,RNAseq,AC138028.6,1.04 (1.02 1.06),2.12E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS010409,0.062,RNAseq,TBC1D5,1.04 (1.02 1.06),2.12E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS013437,0.027,RNAseq,TRAV29DV5,0.96 (0.94 0.98),2.31E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS006916,0.155,RNAseq,VAT1,0.96 (0.95 0.98),2.31E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS003975,0.471,RNAseq,CEP63,1.04 (1.02 1.06),2.35E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS003620,0.668,RNAseq,ZFP57,0.96 (0.94 0.98),2.35E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS005738,0.219,RNAseq,DENND3,0.96 (0.95 0.98),2.77E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS009171,0.086,RNAseq,NTN5,1.04 (1.02 1.06),3.04E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS008578,0.099,RNAseq,SUSD2,1.04 (1.02 1.06),3.19E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS014774,0.017,RNAseq,SMARCD1,1.04 (1.02 1.06),3.87E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS011796,0.044,RNAseq,AKAP13,0.96 (0.95 0.98),4.20E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS008467,0.102,RNAseq,PRKAR1B,0.96 (0.95 0.98),4.97E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS009875,0.071,RNAseq,DDX1,1.04 (1.02 1.06),5.57E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS013547,0.026,RNAseq,EPC1,0.96 (0.95 0.98),6.11E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS009357,0.082,RNAseq,GDAP1,1.04 (1.02 1.05),6.96E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS009687,0.075,RNAseq,ADO,1.04 (1.02 1.05),7.14E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS012855,0.032,RNAseq,TRBV9,1.04 (1.02 1.05),7.17E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS008369,0.105,RNAseq,ADM,1.04 (1.02 1.05),7.17E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS004325,0.384,RNAseq,LINC01948,1.04 (1.02 1.05),7.53E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS006499,0.176,RNAseq,C4A,1.04 (1.02 1.05),9.57E-03
454.1,Varicose veins of lower extremity,circulatory system,OPGS011674,0.045,RNAseq,PRSS23,1.04 (1.02 1.05),1.04E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS004720,0.321,RNAseq,AL590705.3,1.04 (1.02 1.05),1.29E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS015054,0.015,RNAseq,H19,1.03 (1.02 1.05),1.40E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS006881,0.156,RNAseq,RNF166,0.97 (0.95 0.98),1.56E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS003830,0.538,RNAseq,DCAF4,0.97 (0.95 0.98),1.56E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS014930,0.016,RNAseq,TXNL4A,1.04 (1.02 1.05),1.63E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS010434,0.062,RNAseq,RAPGEF6,1.03 (1.02 1.05),1.70E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS013310,0.028,RNAseq,BROX,0.97 (0.95 0.98),1.70E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS013571,0.026,RNAseq,ERMAP,0.97 (0.95 0.98),1.72E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS007282,0.140,RNAseq,CERCAM,1.03 (1.02 1.05),1.74E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS011095,0.052,RNAseq,CEBPA,1.03 (1.02 1.05),1.96E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS011948,0.042,RNAseq,ADGRG1,1.03 (1.02 1.05),1.97E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS009471,0.080,RNAseq,LIMA1,1.03 (1.02 1.05),1.97E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS005230,0.263,RNAseq,LINC00243,0.97 (0.95 0.98),1.99E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS011291,0.050,RNAseq,GMPPB,1.03 (1.02 1.05),1.99E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS008253,0.108,RNAseq,SPON2,1.03 (1.02 1.05),2.07E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS009688,0.075,RNAseq,H2BC12,0.97 (0.95 0.98),2.17E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS014355,0.020,RNAseq,VPS51,0.97 (0.95 0.98),2.32E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS014414,0.020,RNAseq,ZNF366,1.03 (1.02 1.05),2.47E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS013333,0.028,RNAseq,MNT,0.97 (0.95 0.98),2.49E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS014859,0.017,RNAseq,AC104452.1,0.97 (0.95 0.98),2.51E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS005763,0.217,RNAseq,FAM53A,1.03 (1.02 1.05),2.51E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS007034,0.151,RNAseq,LGR4,0.97 (0.95 0.98),2.52E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS008329,0.106,RNAseq,RELL2,1.03 (1.02 1.05),2.52E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS005266,0.259,RNAseq,MCMBP,0.97 (0.95 0.98),2.57E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS013667,0.025,RNAseq,AC092384.3,1.03 (1.02 1.05),2.66E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS014183,0.021,RNAseq,PAXBP1-AS1,1.03 (1.02 1.05),2.75E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS007800,0.122,RNAseq,CYBA,1.03 (1.02 1.05),2.78E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS010937,0.055,RNAseq,H4C3,0.97 (0.95 0.98),2.78E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS013305,0.028,RNAseq,TRBV14,1.03 (1.02 1.05),2.78E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS014193,0.021,RNAseq,AC116667.1,1.03 (1.02 1.05),2.83E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS006508,0.175,RNAseq,ASAH2B,1.03 (1.01 1.05),2.93E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS010191,0.066,RNAseq,MOB2,1.03 (1.02 1.05),2.95E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS012787,0.033,RNAseq,FURIN,0.97 (0.95 0.99),3.07E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS009279,0.084,RNAseq,PKN2-AS1,0.97 (0.95 0.99),3.11E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS013085,0.030,RNAseq,ROCK1,1.03 (1.01 1.05),3.13E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS010088,0.068,RNAseq,RHPN1,0.97 (0.95 0.99),3.15E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS011047,0.053,RNAseq,CTU2,0.97 (0.95 0.99),3.69E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS010781,0.057,RNAseq,ITGB8,1.03 (1.01 1.05),3.87E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS004313,0.387,RNAseq,,0.97 (0.95 0.99),4.01E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS004914,0.298,RNAseq,WDYHV1,0.97 (0.95 0.99),4.01E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS008160,0.110,RNAseq,SLC48A1,1.03 (1.01 1.05),4.12E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS010401,0.062,RNAseq,MVD,1.03 (1.01 1.05),4.16E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS007164,0.145,RNAseq,PGPEP1,1.03 (1.01 1.05),4.16E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS007649,0.127,RNAseq,LINC01505,1.03 (1.01 1.05),4.19E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS004353,0.380,RNAseq,KYAT3,1.03 (1.01 1.05),4.32E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS009986,0.070,RNAseq,CDC42SE2,1.03 (1.01 1.05),4.46E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS013471,0.027,RNAseq,BMI1,0.97 (0.95 0.99),4.48E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS012261,0.038,RNAseq,RUNDC1,1.03 (1.01 1.05),4.48E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS006133,0.196,RNAseq,LSM4,1.03 (1.01 1.05),4.48E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS006940,0.154,RNAseq,,0.97 (0.95 0.99),4.48E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS013882,0.023,RNAseq,AC138028.2,0.97 (0.95 0.99),4.63E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS007781,0.123,RNAseq,MAP3K13,1.03 (1.01 1.05),4.67E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS012130,0.040,RNAseq,SPSB1,1.03 (1.01 1.05),4.67E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS010883,0.055,RNAseq,ZNF664,0.97 (0.95 0.99),4.82E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS007199,0.143,RNAseq,PER3,1.03 (1.01 1.05),4.86E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS008432,0.103,RNAseq,GCNT4,0.97 (0.96 0.99),4.87E-02
454.1,Varicose veins of lower extremity,circulatory system,OPGS006158,0.194,RNAseq,ITLN1,1.03 (1.01 1.05),4.98E-02
455,Hemorrhoids,circulatory system,OPGS000212,0.222,SomaScan,Tyrosine-protein kinase receptor Tie-1. soluble,0.96 (0.94 0.97),6.23E-09
455,Hemorrhoids,circulatory system,OPGS000101,0.374,SomaScan,CD209 antigen,0.96 (0.95 0.97),5.91E-08
455,Hemorrhoids,circulatory system,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,0.96 (0.95 0.97),5.91E-08
455,Hemorrhoids,circulatory system,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,0.96 (0.95 0.97),5.91E-08
455,Hemorrhoids,circulatory system,OPGS000088,0.392,SomaScan,E-selectin,1.04 (1.02 1.05),9.17E-06
455,Hemorrhoids,circulatory system,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,1.04 (1.02 1.05),2.89E-05
455,Hemorrhoids,circulatory system,OPGS000362,0.147,SomaScan,Golgi membrane protein 1,0.97 (0.95 0.98),4.03E-05
455,Hemorrhoids,circulatory system,OPGS001083,0.047,SomaScan,Desmoglein-2,0.97 (0.96 0.98),6.44E-05
455,Hemorrhoids,circulatory system,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,1.03 (1.02 1.05),1.41E-04
455,Hemorrhoids,circulatory system,OPGS001915,0.014,SomaScan,N-acetylglucosamine-6-sulfatase,1.03 (1.02 1.05),1.41E-04
455,Hemorrhoids,circulatory system,OPGS001658,0.020,SomaScan,Endoglin,1.03 (1.02 1.05),1.96E-04
455,Hemorrhoids,circulatory system,OPGS000095,0.381,SomaScan,Sulfhydryl oxidase 2,0.97 (0.96 0.98),1.96E-04
455,Hemorrhoids,circulatory system,OPGS001490,0.026,SomaScan,Intercellular adhesion molecule 2,1.03 (1.02 1.05),1.96E-04
455,Hemorrhoids,circulatory system,OPGS001954,0.014,SomaScan,Tuftelin,1.03 (1.02 1.05),2.95E-04
455,Hemorrhoids,circulatory system,OPGS001127,0.044,SomaScan,Carbohydrate sulfotransferase 15,1.03 (1.02 1.04),8.27E-04
455,Hemorrhoids,circulatory system,OPGS000600,0.099,SomaScan,Insulin receptor,1.03 (1.02 1.04),9.83E-04
455,Hemorrhoids,circulatory system,OPGS000351,0.151,SomaScan,C1GALT1-specific chaperone 1,0.97 (0.96 0.98),1.18E-03
455,Hemorrhoids,circulatory system,OPGS000106,0.366,SomaScan,Protein FAM3D,0.97 (0.96 0.98),1.18E-03
455,Hemorrhoids,circulatory system,OPGS001832,0.016,SomaScan,Neurogenic locus notch homolog protein 1,0.97 (0.96 0.98),1.51E-03
455,Hemorrhoids,circulatory system,OPGS001700,0.019,SomaScan,Semaphorin-6B,0.97 (0.96 0.98),1.89E-03
455,Hemorrhoids,circulatory system,OPGS001174,0.040,SomaScan,Platelet glycoprotein 4,0.97 (0.96 0.98),1.89E-03
455,Hemorrhoids,circulatory system,OPGS001045,0.050,SomaScan,Carbohydrate sulfotransferase 15,1.03 (1.02 1.04),2.54E-03
455,Hemorrhoids,circulatory system,OPGS001327,0.032,SomaScan,Basal Cell Adhesion Molecule,0.97 (0.96 0.98),3.10E-03
455,Hemorrhoids,circulatory system,OPGS001301,0.034,SomaScan,Glycosaminoglycan xylosylkinase,0.97 (0.96 0.98),3.28E-03
455,Hemorrhoids,circulatory system,OPGS001626,0.021,SomaScan,Neural cell adhesion molecule L1,1.03 (1.01 1.04),7.18E-03
455,Hemorrhoids,circulatory system,OPGS000321,0.161,SomaScan,von Willebrand factor,0.97 (0.96 0.99),1.02E-02
455,Hemorrhoids,circulatory system,OPGS001049,0.049,SomaScan,Chloride intracellular channel protein 5,0.98 (0.96 0.99),1.14E-02
455,Hemorrhoids,circulatory system,OPGS002121,0.011,SomaScan,Tumor necrosis factor receptor superfamily member 27,1.03 (1.01 1.04),1.18E-02
455,Hemorrhoids,circulatory system,OPGS002076,0.012,SomaScan,Cytochrome c,1.03 (1.01 1.04),1.97E-02
455,Hemorrhoids,circulatory system,OPGS001485,0.026,SomaScan,Tolloid-like protein 1,0.97 (0.96 0.99),2.01E-02
455,Hemorrhoids,circulatory system,OPGS001910,0.014,SomaScan,Pappalysin-1,0.98 (0.96 0.99),2.45E-02
455,Hemorrhoids,circulatory system,OPGS000198,0.236,SomaScan,Peptidyl-glycine alpha-amidating monooxygenase,1.02 (1.01 1.04),2.49E-02
455,Hemorrhoids,circulatory system,OPGS000220,0.213,SomaScan,Vascular endothelial growth factor receptor 2,1.02 (1.01 1.04),3.35E-02
455,Hemorrhoids,circulatory system,OPGS000846,0.068,SomaScan,2-phosphoxylose phosphatase 1,1.02 (1.01 1.04),3.55E-02
455,Hemorrhoids,circulatory system,OPGS000815,0.071,SomaScan,Kelch-like protein 13,1.02 (1.01 1.04),4.54E-02
455,Hemorrhoids,circulatory system,OPGS000889,0.064,SomaScan,Hepatocyte growth factor receptor,1.02 (1.01 1.04),4.95E-02
455,Hemorrhoids,circulatory system,OPGS001889,0.015,SomaScan,Protein NOV homolog,0.98 (0.96 0.99),4.97E-02
455,Hemorrhoids,circulatory system,OPGS002651,0.015,Olink,von Willebrand factor,0.95 (0.94 0.96),1.58E-10
455,Hemorrhoids,circulatory system,OPGS002500,0.098,Olink,Galectin-4,1.04 (1.03 1.05),2.19E-07
455,Hemorrhoids,circulatory system,OPGS002408,0.270,Olink,E-selectin,1.04 (1.02 1.05),5.90E-05
455,Hemorrhoids,circulatory system,OPGS002468,0.142,Olink,Galectin-8,1.02 (1.01 1.04),2.63E-02
455,Hemorrhoids,circulatory system,OPGS002623,0.024,Olink,RGM domain family member B,0.98 (0.96 0.99),3.91E-02
455,Hemorrhoids,circulatory system,OPGS003149,0.015,Metabolon,sphingosine,0.96 (0.95 0.97),4.47E-08
455,Hemorrhoids,circulatory system,OPGS004154,0.422,RNAseq,CENPP,1.03 (1.02 1.04),4.97E-04
455,Hemorrhoids,circulatory system,OPGS015054,0.015,RNAseq,H19,0.97 (0.96 0.98),8.27E-04
455,Hemorrhoids,circulatory system,OPGS007876,0.119,RNAseq,MDM4,0.97 (0.96 0.98),1.52E-03
455,Hemorrhoids,circulatory system,OPGS014357,0.020,RNAseq,COX7A2,1.03 (1.02 1.04),2.31E-03
455,Hemorrhoids,circulatory system,OPGS003625,0.664,RNAseq,,0.97 (0.96 0.98),3.28E-03
455,Hemorrhoids,circulatory system,OPGS010348,0.063,RNAseq,TRBV6-5,1.03 (1.01 1.04),1.21E-02
455,Hemorrhoids,circulatory system,OPGS006593,0.171,RNAseq,SCRN1,0.98 (0.96 0.99),1.63E-02
455,Hemorrhoids,circulatory system,OPGS004696,0.324,RNAseq,NIPBL-DT,0.98 (0.96 0.99),1.87E-02
455,Hemorrhoids,circulatory system,OPGS011317,0.049,RNAseq,KNOP1,0.98 (0.96 0.99),2.45E-02
455,Hemorrhoids,circulatory system,OPGS003644,0.643,RNAseq,KANSL1-AS1,1.02 (1.01 1.04),3.55E-02
455,Hemorrhoids,circulatory system,OPGS007922,0.118,RNAseq,BYSL,1.02 (1.01 1.04),4.29E-02
455,Hemorrhoids,circulatory system,OPGS009040,0.089,RNAseq,NF1,0.98 (0.96 0.99),4.95E-02
459.1,Hemorrhage NOS,circulatory system,OPGS003099,0.019,Metabolon,glutamine,0.74 (0.66 0.84),2.62E-02
459.9,Circulatory disease NEC,circulatory system,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.09 (1.08 1.11),3.48E-51
459.9,Circulatory disease NEC,circulatory system,OPGS000088,0.392,SomaScan,E-selectin,0.92 (0.91 0.93),4.93E-49
459.9,Circulatory disease NEC,circulatory system,OPGS001658,0.020,SomaScan,Endoglin,0.92 (0.91 0.93),9.27E-47
459.9,Circulatory disease NEC,circulatory system,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.92 (0.91 0.93),4.60E-45
459.9,Circulatory disease NEC,circulatory system,OPGS001954,0.014,SomaScan,Tuftelin,0.92 (0.91 0.93),1.87E-43
459.9,Circulatory disease NEC,circulatory system,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,1.09 (1.07 1.10),1.87E-43
459.9,Circulatory disease NEC,circulatory system,OPGS000101,0.374,SomaScan,CD209 antigen,1.08 (1.07 1.10),6.81E-41
459.9,Circulatory disease NEC,circulatory system,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,0.92 (0.91 0.93),1.20E-40
459.9,Circulatory disease NEC,circulatory system,OPGS000600,0.099,SomaScan,Insulin receptor,0.93 (0.92 0.94),2.26E-39
459.9,Circulatory disease NEC,circulatory system,OPGS000095,0.381,SomaScan,Sulfhydryl oxidase 2,1.08 (1.06 1.09),6.38E-34
459.9,Circulatory disease NEC,circulatory system,OPGS001915,0.014,SomaScan,N-acetylglucosamine-6-sulfatase,0.93 (0.92 0.94),3.46E-32
459.9,Circulatory disease NEC,circulatory system,OPGS001045,0.050,SomaScan,Carbohydrate sulfotransferase 15,0.93 (0.92 0.94),1.16E-31
459.9,Circulatory disease NEC,circulatory system,OPGS001127,0.044,SomaScan,Carbohydrate sulfotransferase 15,0.93 (0.92 0.94),2.73E-31
459.9,Circulatory disease NEC,circulatory system,OPGS001301,0.034,SomaScan,Glycosaminoglycan xylosylkinase,1.07 (1.06 1.08),2.60E-30
459.9,Circulatory disease NEC,circulatory system,OPGS000351,0.151,SomaScan,C1GALT1-specific chaperone 1,1.07 (1.06 1.08),5.61E-30
459.9,Circulatory disease NEC,circulatory system,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.93 (0.92 0.94),4.99E-29
459.9,Circulatory disease NEC,circulatory system,OPGS001490,0.026,SomaScan,Intercellular adhesion molecule 2,0.94 (0.92 0.95),1.01E-28
459.9,Circulatory disease NEC,circulatory system,OPGS000362,0.147,SomaScan,Golgi membrane protein 1,1.07 (1.06 1.08),2.70E-26
459.9,Circulatory disease NEC,circulatory system,OPGS000155,0.275,SomaScan,Interleukin-3 receptor subunit alpha,0.94 (0.93 0.95),4.50E-26
459.9,Circulatory disease NEC,circulatory system,OPGS001626,0.021,SomaScan,Neural cell adhesion molecule L1,0.94 (0.93 0.95),2.41E-25
459.9,Circulatory disease NEC,circulatory system,OPGS000923,0.060,SomaScan,Thrombospondin type-1 domain-containing protein 1,0.94 (0.93 0.95),3.25E-22
459.9,Circulatory disease NEC,circulatory system,OPGS000212,0.222,SomaScan,Tyrosine-protein kinase receptor Tie-1. soluble,1.06 (1.05 1.07),4.31E-21
459.9,Circulatory disease NEC,circulatory system,OPGS000889,0.064,SomaScan,Hepatocyte growth factor receptor,0.94 (0.93 0.95),1.70E-20
459.9,Circulatory disease NEC,circulatory system,OPGS000321,0.161,SomaScan,von Willebrand factor,1.06 (1.05 1.07),7.26E-19
459.9,Circulatory disease NEC,circulatory system,OPGS001083,0.047,SomaScan,Desmoglein-2,1.06 (1.04 1.07),3.76E-18
459.9,Circulatory disease NEC,circulatory system,OPGS000838,0.069,SomaScan,DNA/RNA-binding protein KIN17,0.95 (0.94 0.96),2.36E-17
459.9,Circulatory disease NEC,circulatory system,OPGS000106,0.366,SomaScan,Protein FAM3D,1.05 (1.04 1.07),2.23E-16
459.9,Circulatory disease NEC,circulatory system,OPGS000885,0.064,SomaScan,Dipeptidase 2,0.95 (0.94 0.96),9.61E-16
459.9,Circulatory disease NEC,circulatory system,OPGS000146,0.291,SomaScan,Coagulation Factor XI,1.05 (1.04 1.06),1.30E-15
459.9,Circulatory disease NEC,circulatory system,OPGS000121,0.341,SomaScan,D-glucuronyl C5-epimerase,1.05 (1.04 1.06),3.14E-15
459.9,Circulatory disease NEC,circulatory system,OPGS000220,0.213,SomaScan,Vascular endothelial growth factor receptor 2,0.95 (0.94 0.96),3.19E-15
459.9,Circulatory disease NEC,circulatory system,OPGS000663,0.089,SomaScan,Secreted and transmembrane protein 1,0.95 (0.94 0.97),1.02E-12
459.9,Circulatory disease NEC,circulatory system,OPGS000671,0.088,SomaScan,Carbohydrate sulfotransferase 11,1.05 (1.03 1.06),5.72E-12
459.9,Circulatory disease NEC,circulatory system,OPGS000646,0.091,SomaScan,Protein-tyrosine sulfotransferase 2,1.05 (1.03 1.06),1.19E-11
459.9,Circulatory disease NEC,circulatory system,OPGS000463,0.125,SomaScan,Toll-like receptor 4:Lymphocyte antigen 96 complex,0.96 (0.95 0.97),1.56E-10
459.9,Circulatory disease NEC,circulatory system,OPGS000215,0.218,SomaScan,Immunoglobulin superfamily containing leucine-rich repeat protein 2,0.96 (0.95 0.97),1.72E-10
459.9,Circulatory disease NEC,circulatory system,OPGS000108,0.360,SomaScan,Intercellular adhesion molecule 5,0.96 (0.95 0.97),3.82E-09
459.9,Circulatory disease NEC,circulatory system,OPGS001049,0.049,SomaScan,Chloride intracellular channel protein 5,1.04 (1.03 1.06),4.23E-09
459.9,Circulatory disease NEC,circulatory system,OPGS000067,0.438,SomaScan,Adhesion G protein-coupled receptor F5,0.96 (0.95 0.97),5.79E-09
459.9,Circulatory disease NEC,circulatory system,OPGS000679,0.087,SomaScan,Mannosyl-oligosaccharide 1.2-alpha-mannosidase IB,1.04 (1.03 1.05),6.27E-09
459.9,Circulatory disease NEC,circulatory system,OPGS000378,0.143,SomaScan,Immunoglobulin superfamily containing leucine-rich repeat protein 2,0.96 (0.95 0.97),1.62E-08
459.9,Circulatory disease NEC,circulatory system,OPGS001327,0.032,SomaScan,Basal Cell Adhesion Molecule,1.04 (1.03 1.05),2.24E-08
459.9,Circulatory disease NEC,circulatory system,OPGS001687,0.020,SomaScan,Acidic leucine-rich nuclear phosphoprotein 32 family member B,0.96 (0.95 0.97),6.02E-08
459.9,Circulatory disease NEC,circulatory system,OPGS000346,0.151,SomaScan,N-acetyllactosaminide beta-1.3-N-acetylglucosaminyltransferase 2,1.04 (1.03 1.05),8.33E-08
459.9,Circulatory disease NEC,circulatory system,OPGS000196,0.236,SomaScan,Protein FAM3B,1.04 (1.02 1.05),2.48E-07
459.9,Circulatory disease NEC,circulatory system,OPGS002289,0.010,SomaScan,Inhibin beta C chain,0.96 (0.95 0.98),3.25E-07
459.9,Circulatory disease NEC,circulatory system,OPGS001269,0.035,SomaScan,Histone-lysine N-methyltransferase EHMT2,1.04 (1.02 1.05),7.23E-07
459.9,Circulatory disease NEC,circulatory system,OPGS001191,0.039,SomaScan,Progonadoliberin-1,0.97 (0.95 0.98),7.50E-07
459.9,Circulatory disease NEC,circulatory system,OPGS001779,0.018,SomaScan,Histatin-3,0.97 (0.95 0.98),7.50E-07
459.9,Circulatory disease NEC,circulatory system,OPGS000736,0.080,SomaScan,Semaphorin-6A,0.97 (0.95 0.98),7.81E-07
459.9,Circulatory disease NEC,circulatory system,OPGS000150,0.284,SomaScan,Plasma kallikrein,1.03 (1.02 1.05),1.66E-06
459.9,Circulatory disease NEC,circulatory system,OPGS000606,0.098,SomaScan,Beta-1.4-galactosyltransferase 1,1.03 (1.02 1.05),2.06E-06
459.9,Circulatory disease NEC,circulatory system,OPGS002032,0.012,SomaScan,Transmembrane protein 132C,1.03 (1.02 1.05),2.99E-06
459.9,Circulatory disease NEC,circulatory system,OPGS002042,0.012,SomaScan,Cullin-3,0.97 (0.96 0.98),2.99E-06
459.9,Circulatory disease NEC,circulatory system,OPGS001993,0.013,SomaScan,Somatostatin-28,0.97 (0.96 0.98),2.99E-06
459.9,Circulatory disease NEC,circulatory system,OPGS002095,0.012,SomaScan,Beta-defensin 113,1.03 (1.02 1.05),2.99E-06
459.9,Circulatory disease NEC,circulatory system,OPGS000844,0.068,SomaScan,Growth/differentiation factor 2,1.03 (1.02 1.05),4.04E-06
459.9,Circulatory disease NEC,circulatory system,OPGS000383,0.142,SomaScan,Protein FAM3B,1.03 (1.02 1.05),4.40E-06
459.9,Circulatory disease NEC,circulatory system,OPGS000126,0.332,SomaScan,Vascular endothelial growth factor receptor 3,0.97 (0.96 0.98),4.40E-06
459.9,Circulatory disease NEC,circulatory system,OPGS001721,0.019,SomaScan,Chromogranin-A,0.97 (0.96 0.98),4.97E-06
459.9,Circulatory disease NEC,circulatory system,OPGS001574,0.023,SomaScan,Keratin-associated protein 2-4,0.97 (0.96 0.98),5.36E-06
459.9,Circulatory disease NEC,circulatory system,OPGS000214,0.221,SomaScan,Intercellular adhesion molecule 5,0.97 (0.96 0.98),7.10E-06
459.9,Circulatory disease NEC,circulatory system,OPGS000166,0.267,SomaScan,P-selectin,0.97 (0.96 0.98),9.63E-06
459.9,Circulatory disease NEC,circulatory system,OPGS001754,0.018,SomaScan,Vascular endothelial growth factor D,1.03 (1.02 1.04),1.22E-05
459.9,Circulatory disease NEC,circulatory system,OPGS000917,0.061,SomaScan,Interleukin-6 receptor subunit beta,0.97 (0.96 0.98),1.31E-05
459.9,Circulatory disease NEC,circulatory system,OPGS001016,0.052,SomaScan,Protein jagged-1,0.97 (0.96 0.98),1.98E-05
459.9,Circulatory disease NEC,circulatory system,OPGS000960,0.057,SomaScan,Cadherin-15,0.97 (0.96 0.98),2.05E-05
459.9,Circulatory disease NEC,circulatory system,OPGS001824,0.016,SomaScan,ADM2,0.97 (0.96 0.98),3.13E-05
459.9,Circulatory disease NEC,circulatory system,OPGS001798,0.017,SomaScan,Bone sialoprotein 2,0.97 (0.96 0.98),4.54E-05
459.9,Circulatory disease NEC,circulatory system,OPGS001436,0.028,SomaScan,Bone morphogenetic protein 7,1.03 (1.02 1.04),5.68E-05
459.9,Circulatory disease NEC,circulatory system,OPGS001821,0.017,SomaScan,Plasminogen activator inhibitor 1,1.03 (1.02 1.04),7.08E-05
459.9,Circulatory disease NEC,circulatory system,OPGS001427,0.028,SomaScan,Alpha-2-macroglobulin,1.03 (1.02 1.04),7.30E-05
459.9,Circulatory disease NEC,circulatory system,OPGS000479,0.122,SomaScan,C-C motif chemokine 25,0.97 (0.96 0.98),7.82E-05
459.9,Circulatory disease NEC,circulatory system,OPGS000993,0.054,SomaScan,Protachykinin-1,0.97 (0.96 0.98),9.36E-05
459.9,Circulatory disease NEC,circulatory system,OPGS000064,0.442,SomaScan,Calcium/calmodulin-dependent protein kinase type 1,1.03 (1.02 1.04),1.06E-04
459.9,Circulatory disease NEC,circulatory system,OPGS000914,0.061,SomaScan,Drebrin-like protein,1.03 (1.02 1.04),1.23E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001788,0.017,SomaScan,Platelet-derived growth factor subunit A,1.03 (1.02 1.04),1.36E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001487,0.026,SomaScan,Interleukin-2,1.03 (1.02 1.04),2.16E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001476,0.026,SomaScan,Interleukin-13 receptor subunit alpha-1,1.03 (1.02 1.04),2.17E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001084,0.047,SomaScan,Activating signal cointegrator 1 complex subunit 1,1.03 (1.02 1.04),2.27E-04
459.9,Circulatory disease NEC,circulatory system,OPGS000355,0.150,SomaScan,Platelet glycoprotein VI,1.03 (1.02 1.04),2.27E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001672,0.020,SomaScan,Angiopoietin-1,1.03 (1.02 1.04),2.27E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001664,0.020,SomaScan,Thrombospondin-1,1.03 (1.02 1.04),2.67E-04
459.9,Circulatory disease NEC,circulatory system,OPGS002068,0.012,SomaScan,Brain-derived neurotrophic factor,1.03 (1.02 1.04),2.87E-04
459.9,Circulatory disease NEC,circulatory system,OPGS000888,0.064,SomaScan,Glucosidase 2 subunit beta,1.03 (1.02 1.04),2.90E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001974,0.013,SomaScan,Polyadenylate-binding protein-interacting protein 1,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS002084,0.012,SomaScan,Protein FAM210A,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS002193,0.011,SomaScan,MAGUK p55 subfamily member 7,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001980,0.013,SomaScan,SPARC,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001875,0.015,SomaScan,Synaptotagmin-11,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS002177,0.011,SomaScan,Synaptotagmin-17,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS002192,0.011,SomaScan,Beta-defensin 119,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS002004,0.013,SomaScan,Centromere protein W,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS002077,0.012,SomaScan,Choriogonadotropin subunit beta variant 2,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS002214,0.011,SomaScan,DNA-binding protein SATB1,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001949,0.014,SomaScan,72 kDa inositol polyphosphate 5-phosphatase,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001445,0.028,SomaScan,Endoplasmic reticulum resident protein 44,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS002082,0.012,SomaScan,Interleukin-7,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001942,0.014,SomaScan,Connective tissue-activating peptide III,1.03 (1.02 1.04),3.53E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001827,0.016,SomaScan,UDP-glucuronosyltransferase 2A1,1.03 (1.02 1.04),4.15E-04
459.9,Circulatory disease NEC,circulatory system,OPGS000782,0.075,SomaScan,Beta-1.4-galactosyltransferase 2,1.03 (1.02 1.04),4.27E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001528,0.025,SomaScan,Histone H1.2,0.97 (0.96 0.98),4.39E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001908,0.015,SomaScan,Neutrophil-activating peptide 2,1.03 (1.02 1.04),4.39E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001376,0.030,SomaScan,NAD-dependent protein deacylase sirtuin-5. mitochondrial,1.03 (1.02 1.04),4.43E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001491,0.026,SomaScan,Platelet-derived growth factor subunit B,1.03 (1.02 1.04),6.19E-04
459.9,Circulatory disease NEC,circulatory system,OPGS000750,0.078,SomaScan,Adrenomedullin,0.97 (0.96 0.99),6.35E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001652,0.021,SomaScan,Galectin-7,1.03 (1.02 1.04),6.56E-04
459.9,Circulatory disease NEC,circulatory system,OPGS001060,0.049,SomaScan,Septin-11,1.03 (1.01 1.04),9.15E-04
459.9,Circulatory disease NEC,circulatory system,OPGS000925,0.060,SomaScan,Plexin domain-containing protein 1,0.97 (0.96 0.99),1.26E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001273,0.035,SomaScan,Persulfide dioxygenase ETHE1. mitochondrial,0.97 (0.96 0.99),1.26E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001294,0.034,SomaScan,Peroxidasin homolog,0.97 (0.96 0.99),1.29E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001086,0.047,SomaScan,Dickkopf-related protein 1,1.03 (1.01 1.04),1.49E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000882,0.065,SomaScan,Dickkopf-related protein 4,1.03 (1.01 1.04),1.56E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001496,0.026,SomaScan,Glycoprotein Xg,0.97 (0.96 0.99),1.59E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000828,0.070,SomaScan,Platelet endothelial aggregation receptor 1,0.98 (0.96 0.99),1.63E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000221,0.213,SomaScan,Protein FAM177A1,0.97 (0.96 0.99),1.63E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001262,0.035,SomaScan,C-type lectin domain family 1 member B,1.03 (1.01 1.04),1.89E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001059,0.049,SomaScan,Inter-alpha-trypsin inhibitor heavy chain H4,0.98 (0.96 0.99),2.15E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000653,0.090,SomaScan,Neuropeptide W,0.98 (0.96 0.99),2.18E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000778,0.075,SomaScan,Tumor necrosis factor receptor superfamily member 16,0.98 (0.96 0.99),2.39E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000710,0.082,SomaScan,Thrombin,1.03 (1.01 1.04),2.49E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000244,0.195,SomaScan,C-C motif chemokine 25,0.98 (0.96 0.99),2.52E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000563,0.104,SomaScan,Liver-expressed antimicrobial peptide 2,0.98 (0.96 0.99),2.71E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001257,0.036,SomaScan,Glucagon,0.98 (0.96 0.99),2.76E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001089,0.047,SomaScan,Tissue factor pathway inhibitor,0.98 (0.96 0.99),3.47E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001743,0.018,SomaScan,14-3-3 protein sigma,0.98 (0.97 0.99),4.16E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.02 (1.01 1.04),4.28E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000375,0.143,SomaScan,Thrombospondin-2,0.98 (0.96 0.99),4.28E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001337,0.032,SomaScan,Cholecystokinin,0.98 (0.97 0.99),4.33E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001832,0.016,SomaScan,Neurogenic locus notch homolog protein 1,1.02 (1.01 1.03),4.79E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000749,0.078,SomaScan,Protein TMEPAI,1.02 (1.01 1.04),5.39E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001568,0.023,SomaScan,WAP four-disulfide core domain protein 13,1.02 (1.01 1.04),5.50E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002204,0.011,SomaScan,Rho-related GTP-binding protein RhoG,1.02 (1.01 1.04),5.69E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001104,0.046,SomaScan,Transmembrane protein C1orf162,0.98 (0.97 0.99),5.92E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000766,0.077,SomaScan,Peptidyl-tRNA hydrolase ICT1. mitochondrial,0.98 (0.97 0.99),6.38E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000910,0.062,SomaScan,Neurexin-1,0.98 (0.97 0.99),6.60E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001139,0.043,SomaScan,Protein SEC13 homolog,1.02 (1.01 1.04),7.97E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001757,0.018,SomaScan,Stromal cell-derived factor 1,1.02 (1.01 1.03),8.74E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000068,0.438,SomaScan,Hepatocyte growth factor activator,1.02 (1.01 1.04),9.12E-03
459.9,Circulatory disease NEC,circulatory system,OPGS000795,0.074,SomaScan,Plasma serine protease inhibitor,0.98 (0.97 0.99),9.64E-03
459.9,Circulatory disease NEC,circulatory system,OPGS001700,0.019,SomaScan,Semaphorin-6B,1.02 (1.01 1.03),1.15E-02
459.9,Circulatory disease NEC,circulatory system,OPGS001900,0.015,SomaScan,Glucokinase,0.98 (0.97 0.99),1.42E-02
459.9,Circulatory disease NEC,circulatory system,OPGS001826,0.016,SomaScan,Stromal cell-derived factor 1,1.02 (1.01 1.03),1.87E-02
459.9,Circulatory disease NEC,circulatory system,OPGS000092,0.387,SomaScan,Hepatocyte growth factor activator,1.02 (1.01 1.03),2.05E-02
459.9,Circulatory disease NEC,circulatory system,OPGS000990,0.054,SomaScan,Cadherin-3,1.02 (1.01 1.03),2.22E-02
459.9,Circulatory disease NEC,circulatory system,OPGS000562,0.104,SomaScan,Galectin-3-binding protein,1.02 (1.01 1.03),2.34E-02
459.9,Circulatory disease NEC,circulatory system,OPGS000916,0.061,SomaScan,CD63 antigen,1.02 (1.01 1.03),2.34E-02
459.9,Circulatory disease NEC,circulatory system,OPGS000863,0.066,SomaScan,Endothelin-2,0.98 (0.97 0.99),2.35E-02
459.9,Circulatory disease NEC,circulatory system,OPGS000719,0.081,SomaScan,Parathyroid hormone-related protein,0.98 (0.97 0.99),2.37E-02
459.9,Circulatory disease NEC,circulatory system,OPGS001553,0.024,SomaScan,Protein G6b,1.02 (1.01 1.03),2.41E-02
459.9,Circulatory disease NEC,circulatory system,OPGS001174,0.040,SomaScan,Platelet glycoprotein 4,1.02 (1.01 1.03),2.74E-02
459.9,Circulatory disease NEC,circulatory system,OPGS000664,0.088,SomaScan,BPI fold-containing family A member 2,1.02 (1.01 1.03),2.74E-02
459.9,Circulatory disease NEC,circulatory system,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.98 (0.97 0.99),2.74E-02
459.9,Circulatory disease NEC,circulatory system,OPGS000104,0.372,SomaScan,Protein Z-dependent protease inhibitor,0.98 (0.97 0.99),2.75E-02
459.9,Circulatory disease NEC,circulatory system,OPGS001207,0.038,SomaScan,Apolipoprotein M,1.02 (1.01 1.03),2.84E-02
459.9,Circulatory disease NEC,circulatory system,OPGS001055,0.049,SomaScan,Aspartate aminotransferase. cytoplasmic,1.02 (1.01 1.03),2.87E-02
459.9,Circulatory disease NEC,circulatory system,OPGS000284,0.177,SomaScan,Protein eva-1 homolog C,1.02 (1.01 1.03),2.97E-02
459.9,Circulatory disease NEC,circulatory system,OPGS001464,0.027,SomaScan,Platelet glycoprotein Ib alpha chain,1.02 (1.01 1.03),3.35E-02
459.9,Circulatory disease NEC,circulatory system,OPGS000796,0.073,SomaScan,Transmembrane glycoprotein NMB,0.98 (0.97 0.99),3.66E-02
459.9,Circulatory disease NEC,circulatory system,OPGS001377,0.030,SomaScan,Vascular cell adhesion protein 1,1.02 (1.01 1.03),3.84E-02
459.9,Circulatory disease NEC,circulatory system,OPGS001485,0.026,SomaScan,Tolloid-like protein 1,1.02 (1.01 1.03),4.02E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002181,0.011,SomaScan,DNA-binding protein inhibitor ID-1,0.98 (0.97 0.99),4.30E-02
459.9,Circulatory disease NEC,circulatory system,OPGS000595,0.099,SomaScan,Protein LDOC1,0.98 (0.97 0.99),4.33E-02
459.9,Circulatory disease NEC,circulatory system,OPGS000093,0.383,SomaScan,Dual specificity mitogen-activated protein kinase kinase 2,0.98 (0.97 0.99),4.95E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002408,0.270,Olink,E-selectin,0.92 (0.91 0.93),1.65E-50
459.9,Circulatory disease NEC,circulatory system,OPGS002500,0.098,Olink,Galectin-4,0.91 (0.90 0.93),4.25E-50
459.9,Circulatory disease NEC,circulatory system,OPGS002651,0.015,Olink,von Willebrand factor,1.09 (1.08 1.10),3.62E-45
459.9,Circulatory disease NEC,circulatory system,OPGS002590,0.035,Olink,Platelet endothelial cell adhesion molecule,0.93 (0.92 0.95),1.08E-28
459.9,Circulatory disease NEC,circulatory system,OPGS002578,0.039,Olink,Leukemia inhibitory factor receptor,0.94 (0.93 0.95),9.01E-26
459.9,Circulatory disease NEC,circulatory system,OPGS002395,0.362,Olink,Intercellular adhesion molecule 2,0.95 (0.94 0.96),6.19E-18
459.9,Circulatory disease NEC,circulatory system,OPGS002638,0.019,Olink,Ephrin type-B receptor 4,0.95 (0.94 0.96),3.52E-16
459.9,Circulatory disease NEC,circulatory system,OPGS002554,0.053,Olink,P-selectin,0.96 (0.95 0.97),1.42E-10
459.9,Circulatory disease NEC,circulatory system,OPGS002510,0.085,Olink,Bone morphogenetic protein 6,0.96 (0.95 0.97),9.25E-09
459.9,Circulatory disease NEC,circulatory system,OPGS002557,0.050,Olink,Epithelial cell adhesion molecule,0.96 (0.95 0.98),9.81E-08
459.9,Circulatory disease NEC,circulatory system,OPGS002479,0.127,Olink,Growth/differentiation factor 2,1.04 (1.03 1.05),9.81E-08
459.9,Circulatory disease NEC,circulatory system,OPGS002592,0.035,Olink,Vascular endothelial growth factor D,1.04 (1.03 1.05),1.11E-07
459.9,Circulatory disease NEC,circulatory system,OPGS002540,0.062,Olink,Plexin-B1,1.03 (1.02 1.05),4.96E-06
459.9,Circulatory disease NEC,circulatory system,OPGS002531,0.066,Olink,Tissue factor,0.97 (0.96 0.98),1.42E-05
459.9,Circulatory disease NEC,circulatory system,OPGS002475,0.133,Olink,UL16-binding protein 2,1.03 (1.02 1.04),7.13E-05
459.9,Circulatory disease NEC,circulatory system,OPGS002534,0.063,Olink,Tyrosine-protein kinase Mer,0.97 (0.96 0.98),9.36E-05
459.9,Circulatory disease NEC,circulatory system,OPGS002454,0.157,Olink,Galectin-9,0.97 (0.96 0.98),1.37E-04
459.9,Circulatory disease NEC,circulatory system,OPGS002653,0.015,Olink,CD40 ligand,1.03 (1.02 1.04),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS002660,0.012,Olink,Angiopoietin-1,1.03 (1.02 1.04),4.41E-04
459.9,Circulatory disease NEC,circulatory system,OPGS002661,0.011,Olink,Platelet-derived growth factor subunit A,1.03 (1.01 1.04),9.93E-04
459.9,Circulatory disease NEC,circulatory system,OPGS002629,0.023,Olink,Interleukin-18-binding protein,1.02 (1.01 1.04),2.06E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002458,0.151,Olink,Cobalamin binding intrinsic factor,0.98 (0.96 0.99),3.16E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002403,0.330,Olink,Sialic acid-binding Ig-like lectin 9,0.98 (0.97 0.99),3.75E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002464,0.144,Olink,Thrombospondin-2,0.98 (0.96 0.99),4.20E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002541,0.061,Olink,Thrombomodulin,1.02 (1.01 1.03),7.73E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002468,0.142,Olink,Galectin-8,0.98 (0.97 0.99),8.58E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002605,0.030,Olink,Sortilin,1.02 (1.01 1.03),8.74E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002663,0.011,Olink,C-type lectin domain family 1 member B,1.02 (1.01 1.03),8.96E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002633,0.021,Olink,C-X-C motif chemokine 11,1.02 (1.01 1.03),2.07E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002394,0.405,Olink,C-C motif chemokine 25,0.98 (0.97 0.99),3.16E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002585,0.037,Olink,T-cell surface glycoprotein CD5,1.02 (1.01 1.03),3.27E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002484,0.124,Olink,Vascular endothelial growth factor A,1.02 (1.01 1.03),4.88E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003149,0.015,Metabolon,sphingosine,1.08 (1.07 1.09),3.01E-38
459.9,Circulatory disease NEC,circulatory system,OPGS002825,0.081,Metabolon,bradykinin. des-arg(9),1.04 (1.02 1.05),9.20E-07
459.9,Circulatory disease NEC,circulatory system,OPGS002742,0.161,Metabolon,bradykinin,1.03 (1.02 1.05),1.93E-06
459.9,Circulatory disease NEC,circulatory system,OPGS002894,0.054,Metabolon,bradykinin. hydroxy-pro(3),1.03 (1.02 1.04),6.22E-06
459.9,Circulatory disease NEC,circulatory system,OPGS002794,0.099,Metabolon,X - 14095,1.03 (1.02 1.04),1.16E-05
459.9,Circulatory disease NEC,circulatory system,OPGS002726,0.198,Metabolon,methionylalanine,1.03 (1.02 1.04),1.22E-05
459.9,Circulatory disease NEC,circulatory system,OPGS002767,0.127,Metabolon,phenylalanylarginine,1.03 (1.02 1.04),3.13E-05
459.9,Circulatory disease NEC,circulatory system,OPGS002949,0.041,Metabolon,1-stearoyl-2-meadoyl-GPC (18:0/20:3n9)*,1.02 (1.01 1.04),4.18E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002981,0.034,Metabolon,1-docosapentaenoyl-GPC (22:5n3)*,1.02 (1.01 1.04),5.29E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002954,0.040,Metabolon,1-oleoyl-2-linoleoyl-GPC (18:1/18:2)*,0.98 (0.97 0.99),5.43E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002734,0.178,Metabolon,1-stearoyl-2-arachidonoyl-GPC (18:0/20:4),1.02 (1.01 1.04),6.60E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002941,0.043,Metabolon,1-palmitoyl-2-linolenoyl-GPC (16:0/18:3)*,0.98 (0.97 0.99),8.74E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002972,0.036,Metabolon,1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9)*,1.02 (1.01 1.03),9.12E-03
459.9,Circulatory disease NEC,circulatory system,OPGS002803,0.092,Metabolon,X - 11538,0.98 (0.97 0.99),1.00E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003038,0.025,Metabolon,1-margaroyl-2-linoleoyl-GPC (17:0/18:2)*,0.98 (0.97 0.99),1.01E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002977,0.035,Metabolon,1.2-dilinoleoyl-GPC (18:2/18:2),0.98 (0.97 0.99),1.02E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002893,0.054,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3)*,1.02 (1.01 1.03),1.06E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003057,0.022,Metabolon,1-adrenoyl-GPC (22:4)*,1.02 (1.01 1.03),1.09E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002936,0.044,Metabolon,1-dihomo-linoleoyl-GPC (20:2)*,0.98 (0.97 0.99),1.22E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002843,0.073,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4),1.02 (1.01 1.03),1.33E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003073,0.021,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*,1.02 (1.01 1.03),1.50E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003109,0.018,Metabolon,1-linoleoyl-GPE (18:2)*,0.98 (0.97 0.99),1.52E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002890,0.056,Metabolon,X - 23705,1.02 (1.01 1.03),1.59E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003159,0.014,Metabolon,docosapentaenoate (n3 DPA; 22:5n3),1.02 (1.01 1.03),1.61E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002761,0.132,Metabolon,X - 11905,0.98 (0.97 0.99),1.67E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003019,0.028,Metabolon,1-oleoyl-2-linoleoyl-GPI (18:1/18:2)*,0.98 (0.97 0.99),1.73E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002819,0.083,Metabolon,phosphatidylcholine (16:0/22:5n3. 18:1/20:4)*,1.02 (1.01 1.03),1.81E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002829,0.079,Metabolon,arachidonate (20:4n6),1.02 (1.01 1.03),1.87E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003016,0.029,Metabolon,1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)*,1.02 (1.01 1.03),2.02E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003060,0.022,Metabolon,stearidonate (18:4n3),1.02 (1.01 1.03),2.17E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002764,0.129,Metabolon,1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4),1.02 (1.01 1.03),2.22E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003074,0.021,Metabolon,1-stearoyl-2-linoleoyl-GPC (18:0/18:2)*,0.98 (0.97 0.99),2.31E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002736,0.172,Metabolon,glycocholenate sulfate*,0.98 (0.97 0.99),2.34E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003075,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*,1.02 (1.01 1.03),2.46E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002791,0.100,Metabolon,2-arachidonoyl-GPC (20:4)*,1.02 (1.01 1.03),2.47E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002899,0.053,Metabolon,1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5)*,1.02 (1.01 1.03),2.51E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003189,0.012,Metabolon,2-linoleoyl-GPE (18:2)*,0.98 (0.97 0.99),2.74E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002769,0.124,Metabolon,hexadecanedioate,0.98 (0.97 0.99),2.74E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003168,0.014,Metabolon,X - 24054,0.98 (0.97 0.99),2.97E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002997,0.032,Metabolon,1-palmitoyl-2-linoleoyl-GPC (16:0/18:2),0.98 (0.97 0.99),3.30E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002783,0.104,Metabolon,X - 21668,0.98 (0.97 0.99),3.34E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002926,0.046,Metabolon,X - 11549,0.98 (0.97 0.99),3.41E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003152,0.014,Metabolon,1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2)*,0.98 (0.97 0.99),3.53E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002948,0.042,Metabolon,1-dihomo-linolenoyl-GPE (20:3n3 or 6)*,0.98 (0.97 0.99),3.55E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003100,0.019,Metabolon,1-arachidonylglycerol (20:4),1.02 (1.01 1.03),3.83E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002882,0.058,Metabolon,1-methylxanthine,0.98 (0.97 0.99),4.02E-02
459.9,Circulatory disease NEC,circulatory system,OPGS002959,0.039,Metabolon,sphingomyelin (d18:1/18:1. d18:2/18:0),1.02 (1.01 1.03),4.62E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.03 (1.02 1.04),4.00E-04
459.9,Circulatory disease NEC,circulatory system,OPGS003541,0.028,Nightingale,Histidine,1.02 (1.01 1.04),1.92E-03
459.9,Circulatory disease NEC,circulatory system,OPGS003522,0.062,Nightingale,Degree of unsaturation,1.02 (1.01 1.04),2.64E-03
459.9,Circulatory disease NEC,circulatory system,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.02 (1.01 1.04),2.66E-03
459.9,Circulatory disease NEC,circulatory system,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.03 (1.01 1.04),2.66E-03
459.9,Circulatory disease NEC,circulatory system,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.02 (1.01 1.04),3.32E-03
459.9,Circulatory disease NEC,circulatory system,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.02 (1.01 1.03),9.12E-03
459.9,Circulatory disease NEC,circulatory system,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.02 (1.01 1.03),9.12E-03
459.9,Circulatory disease NEC,circulatory system,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.02 (1.01 1.03),9.70E-03
459.9,Circulatory disease NEC,circulatory system,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.02 (1.01 1.03),1.00E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.02 (1.01 1.03),1.02E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.02 (1.01 1.03),1.22E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.02 (1.01 1.03),1.61E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.02 (1.01 1.03),2.05E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.02 (1.01 1.03),2.58E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.02 (1.01 1.03),2.68E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.02 (1.01 1.03),3.27E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.02 (1.01 1.03),3.56E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.02 (1.01 1.03),4.30E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.02 (1.01 1.03),4.43E-02
459.9,Circulatory disease NEC,circulatory system,OPGS015054,0.015,RNAseq,H19,1.09 (1.07 1.10),1.11E-43
459.9,Circulatory disease NEC,circulatory system,OPGS003651,0.639,RNAseq,ABO,0.94 (0.93 0.95),2.62E-23
459.9,Circulatory disease NEC,circulatory system,OPGS012642,0.034,RNAseq,SLC19A2,1.05 (1.04 1.06),1.94E-14
459.9,Circulatory disease NEC,circulatory system,OPGS008339,0.106,RNAseq,GBGT1,0.97 (0.96 0.98),1.88E-06
459.9,Circulatory disease NEC,circulatory system,OPGS011108,0.052,RNAseq,LDLR,0.97 (0.96 0.98),2.13E-05
459.9,Circulatory disease NEC,circulatory system,OPGS007070,0.149,RNAseq,MED22,0.97 (0.96 0.98),3.38E-04
459.9,Circulatory disease NEC,circulatory system,OPGS014044,0.022,RNAseq,KCND3,0.97 (0.96 0.98),4.02E-04
459.9,Circulatory disease NEC,circulatory system,OPGS005386,0.248,RNAseq,METTL18,0.97 (0.96 0.99),8.44E-04
459.9,Circulatory disease NEC,circulatory system,OPGS007852,0.120,RNAseq,NOS3,1.03 (1.01 1.04),1.32E-03
459.9,Circulatory disease NEC,circulatory system,OPGS007404,0.136,RNAseq,APP,0.97 (0.96 0.99),1.42E-03
459.9,Circulatory disease NEC,circulatory system,OPGS010454,0.062,RNAseq,GP1BA,1.03 (1.01 1.04),1.44E-03
459.9,Circulatory disease NEC,circulatory system,OPGS004407,0.369,RNAseq,MAP3K2-DT,0.97 (0.96 0.99),1.63E-03
459.9,Circulatory disease NEC,circulatory system,OPGS004262,0.398,RNAseq,TRIM14,0.98 (0.96 0.99),3.28E-03
459.9,Circulatory disease NEC,circulatory system,OPGS008231,0.108,RNAseq,PUS3,1.02 (1.01 1.04),4.01E-03
459.9,Circulatory disease NEC,circulatory system,OPGS009107,0.087,RNAseq,SYNE2,0.98 (0.97 0.99),4.11E-03
459.9,Circulatory disease NEC,circulatory system,OPGS008564,0.100,RNAseq,CLU,1.02 (1.01 1.04),4.71E-03
459.9,Circulatory disease NEC,circulatory system,OPGS013939,0.023,RNAseq,BATF2,1.02 (1.01 1.04),5.23E-03
459.9,Circulatory disease NEC,circulatory system,OPGS006621,0.169,RNAseq,NME7,0.98 (0.97 0.99),5.38E-03
459.9,Circulatory disease NEC,circulatory system,OPGS005968,0.205,RNAseq,TSPAN15,0.98 (0.97 0.99),5.98E-03
459.9,Circulatory disease NEC,circulatory system,OPGS007160,0.145,RNAseq,IFI27L2,0.98 (0.97 0.99),6.31E-03
459.9,Circulatory disease NEC,circulatory system,OPGS007342,0.138,RNAseq,MAP3K7CL,0.98 (0.97 0.99),6.60E-03
459.9,Circulatory disease NEC,circulatory system,OPGS005651,0.225,RNAseq,PTGFR,0.98 (0.97 0.99),1.32E-02
459.9,Circulatory disease NEC,circulatory system,OPGS014183,0.021,RNAseq,PAXBP1-AS1,1.02 (1.01 1.03),1.34E-02
459.9,Circulatory disease NEC,circulatory system,OPGS006943,0.154,RNAseq,EVI5,1.02 (1.01 1.03),1.51E-02
459.9,Circulatory disease NEC,circulatory system,OPGS011614,0.046,RNAseq,H2BC7,1.02 (1.01 1.03),1.89E-02
459.9,Circulatory disease NEC,circulatory system,OPGS006320,0.185,RNAseq,CEP128,0.98 (0.97 0.99),1.90E-02
459.9,Circulatory disease NEC,circulatory system,OPGS006381,0.182,RNAseq,AL391422.4,0.98 (0.97 0.99),1.91E-02
459.9,Circulatory disease NEC,circulatory system,OPGS011731,0.044,RNAseq,ARPC4,1.02 (1.01 1.03),2.11E-02
459.9,Circulatory disease NEC,circulatory system,OPGS008846,0.093,RNAseq,ZFAND5,1.02 (1.01 1.03),2.16E-02
459.9,Circulatory disease NEC,circulatory system,OPGS004332,0.383,RNAseq,ATP1B1,0.98 (0.97 0.99),2.17E-02
459.9,Circulatory disease NEC,circulatory system,OPGS008614,0.098,RNAseq,SCAMP5,1.02 (1.01 1.03),2.34E-02
459.9,Circulatory disease NEC,circulatory system,OPGS011791,0.044,RNAseq,CROT,0.98 (0.97 0.99),2.34E-02
459.9,Circulatory disease NEC,circulatory system,OPGS010561,0.060,RNAseq,IL2RA,1.02 (1.01 1.03),2.34E-02
459.9,Circulatory disease NEC,circulatory system,OPGS009970,0.070,RNAseq,CLDN23,1.02 (1.01 1.03),2.34E-02
459.9,Circulatory disease NEC,circulatory system,OPGS003980,0.470,RNAseq,BAK1,1.02 (1.01 1.03),2.41E-02
459.9,Circulatory disease NEC,circulatory system,OPGS012751,0.033,RNAseq,CRLS1,0.98 (0.97 0.99),2.57E-02
459.9,Circulatory disease NEC,circulatory system,OPGS014049,0.022,RNAseq,CNTLN,0.98 (0.97 0.99),2.66E-02
459.9,Circulatory disease NEC,circulatory system,OPGS006200,0.192,RNAseq,AL157895.2,0.98 (0.97 0.99),2.68E-02
459.9,Circulatory disease NEC,circulatory system,OPGS009682,0.075,RNAseq,AL731557.1,1.02 (1.01 1.03),2.74E-02
459.9,Circulatory disease NEC,circulatory system,OPGS012729,0.033,RNAseq,SREBF2,0.98 (0.97 0.99),2.74E-02
459.9,Circulatory disease NEC,circulatory system,OPGS004456,0.362,RNAseq,RIN1,1.02 (1.01 1.03),2.94E-02
459.9,Circulatory disease NEC,circulatory system,OPGS009116,0.087,RNAseq,CALD1,1.02 (1.01 1.03),2.94E-02
459.9,Circulatory disease NEC,circulatory system,OPGS009296,0.083,RNAseq,RTP4,0.98 (0.97 0.99),3.04E-02
459.9,Circulatory disease NEC,circulatory system,OPGS008517,0.101,RNAseq,BAZ2B,1.02 (1.01 1.03),3.25E-02
459.9,Circulatory disease NEC,circulatory system,OPGS009483,0.080,RNAseq,DNAJC5,0.98 (0.97 0.99),3.27E-02
459.9,Circulatory disease NEC,circulatory system,OPGS014718,0.017,RNAseq,MRC2,1.02 (1.01 1.03),3.36E-02
459.9,Circulatory disease NEC,circulatory system,OPGS007551,0.130,RNAseq,UROD,1.02 (1.01 1.03),3.52E-02
459.9,Circulatory disease NEC,circulatory system,OPGS010489,0.061,RNAseq,PRDX3,0.98 (0.97 0.99),4.03E-02
459.9,Circulatory disease NEC,circulatory system,OPGS011093,0.052,RNAseq,FAIM,0.98 (0.97 0.99),4.29E-02
459.9,Circulatory disease NEC,circulatory system,OPGS010676,0.058,RNAseq,LRRC37A,1.02 (1.01 1.03),4.32E-02
465.4,Acute laryngitis and tracheitis,respiratory,OPGS008937,0.091,RNAseq,TGFB3,0.82 (0.75 0.89),4.53E-02
471,Nasal polyps,respiratory,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,1.12 (1.08 1.15),3.31E-08
471,Nasal polyps,respiratory,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.11 (1.08 1.15),1.37E-07
471,Nasal polyps,respiratory,OPGS000832,0.069,SomaScan,Complement C1q tumor necrosis factor-related protein 5,1.10 (1.07 1.14),1.64E-06
471,Nasal polyps,respiratory,OPGS002246,0.010,SomaScan,Sperm-associated antigen 11B,0.91 (0.88 0.94),4.11E-06
471,Nasal polyps,respiratory,OPGS001860,0.016,SomaScan,Immunoglobulin E,0.91 (0.88 0.94),1.49E-05
471,Nasal polyps,respiratory,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.92 (0.89 0.95),4.67E-05
471,Nasal polyps,respiratory,OPGS000137,0.312,SomaScan,Complement C4b,0.92 (0.89 0.95),9.18E-05
471,Nasal polyps,respiratory,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.92 (0.89 0.95),1.49E-04
471,Nasal polyps,respiratory,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.92 (0.89 0.95),3.23E-04
471,Nasal polyps,respiratory,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,0.92 (0.89 0.95),5.10E-04
471,Nasal polyps,respiratory,OPGS000576,0.102,SomaScan,Interleukin-21,0.93 (0.90 0.96),8.41E-04
471,Nasal polyps,respiratory,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.93 (0.90 0.96),7.41E-03
471,Nasal polyps,respiratory,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.07 (1.04 1.10),8.17E-03
471,Nasal polyps,respiratory,OPGS002143,0.011,SomaScan,Neurotrophin-3,1.06 (1.03 1.09),1.01E-02
471,Nasal polyps,respiratory,OPGS000191,0.247,SomaScan,Tenascin-X,0.94 (0.91 0.97),1.29E-02
471,Nasal polyps,respiratory,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.94 (0.91 0.97),1.44E-02
471,Nasal polyps,respiratory,OPGS000426,0.133,SomaScan,Sushi. von Willebrand factor type A. EGF and pentraxin domain-containing protein 1,1.06 (1.03 1.09),2.26E-02
471,Nasal polyps,respiratory,OPGS000334,0.156,SomaScan,Sushi. von Willebrand factor type A. EGF and pentraxin domain-containing protein 1,1.06 (1.03 1.09),2.82E-02
471,Nasal polyps,respiratory,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,1.06 (1.03 1.10),2.93E-02
471,Nasal polyps,respiratory,OPGS001231,0.037,SomaScan,Osteocalcin,1.06 (1.03 1.10),3.17E-02
471,Nasal polyps,respiratory,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.94 (0.91 0.97),4.15E-02
471,Nasal polyps,respiratory,OPGS001011,0.052,SomaScan,Transmembrane glycoprotein NMB,0.94 (0.91 0.97),4.16E-02
471,Nasal polyps,respiratory,OPGS001025,0.051,SomaScan,Transmembrane glycoprotein NMB,0.94 (0.91 0.97),4.17E-02
471,Nasal polyps,respiratory,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.93 (0.90 0.96),2.04E-03
471,Nasal polyps,respiratory,OPGS002401,0.336,Olink,Interleukin-1 receptor-like 1,0.94 (0.91 0.96),7.49E-03
471,Nasal polyps,respiratory,OPGS003189,0.012,Metabolon,2-linoleoyl-GPE (18:2)*,0.93 (0.90 0.96),6.88E-03
471,Nasal polyps,respiratory,OPGS003016,0.029,Metabolon,1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)*,1.07 (1.04 1.11),7.00E-03
471,Nasal polyps,respiratory,OPGS002972,0.036,Metabolon,1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9)*,1.07 (1.04 1.10),1.20E-02
471,Nasal polyps,respiratory,OPGS003057,0.022,Metabolon,1-adrenoyl-GPC (22:4)*,1.07 (1.04 1.10),1.20E-02
471,Nasal polyps,respiratory,OPGS003029,0.026,Metabolon,docosatrienoate (22:3n3),0.94 (0.91 0.97),1.21E-02
471,Nasal polyps,respiratory,OPGS002734,0.178,Metabolon,1-stearoyl-2-arachidonoyl-GPC (18:0/20:4),1.07 (1.03 1.10),1.26E-02
471,Nasal polyps,respiratory,OPGS002899,0.053,Metabolon,1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5)*,1.07 (1.03 1.10),1.28E-02
471,Nasal polyps,respiratory,OPGS002948,0.042,Metabolon,1-dihomo-linolenoyl-GPE (20:3n3 or 6)*,0.94 (0.91 0.97),1.29E-02
471,Nasal polyps,respiratory,OPGS002791,0.100,Metabolon,2-arachidonoyl-GPC (20:4)*,1.07 (1.03 1.10),1.60E-02
471,Nasal polyps,respiratory,OPGS002949,0.041,Metabolon,1-stearoyl-2-meadoyl-GPC (18:0/20:3n9)*,1.07 (1.03 1.10),1.63E-02
471,Nasal polyps,respiratory,OPGS002909,0.049,Metabolon,X - 24439,0.94 (0.91 0.97),1.65E-02
471,Nasal polyps,respiratory,OPGS002764,0.129,Metabolon,1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4),1.07 (1.03 1.10),1.65E-02
471,Nasal polyps,respiratory,OPGS003073,0.021,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*,1.07 (1.03 1.10),1.77E-02
471,Nasal polyps,respiratory,OPGS002819,0.083,Metabolon,phosphatidylcholine (16:0/22:5n3. 18:1/20:4)*,1.07 (1.03 1.10),1.88E-02
471,Nasal polyps,respiratory,OPGS003100,0.019,Metabolon,1-arachidonylglycerol (20:4),1.07 (1.03 1.10),2.04E-02
471,Nasal polyps,respiratory,OPGS002931,0.045,Metabolon,eicosapentaenoate (EPA; 20:5n3),1.06 (1.03 1.10),2.10E-02
471,Nasal polyps,respiratory,OPGS003159,0.014,Metabolon,docosapentaenoate (n3 DPA; 22:5n3),1.06 (1.03 1.10),2.26E-02
471,Nasal polyps,respiratory,OPGS003109,0.018,Metabolon,1-linoleoyl-GPE (18:2)*,0.94 (0.91 0.97),2.64E-02
471,Nasal polyps,respiratory,OPGS002747,0.146,Metabolon,1-arachidonoyl-GPC (20:4n6)*,1.06 (1.03 1.10),2.66E-02
471,Nasal polyps,respiratory,OPGS002843,0.073,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4),1.06 (1.03 1.10),2.93E-02
471,Nasal polyps,respiratory,OPGS002829,0.079,Metabolon,arachidonate (20:4n6),1.06 (1.03 1.10),3.17E-02
471,Nasal polyps,respiratory,OPGS002855,0.069,Metabolon,1-palmityl-2-arachidonoyl-GPC (O-16:0/20:4)*,1.06 (1.03 1.10),3.17E-02
471,Nasal polyps,respiratory,OPGS002780,0.113,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)*,1.06 (1.03 1.10),3.52E-02
471,Nasal polyps,respiratory,OPGS003038,0.025,Metabolon,1-margaroyl-2-linoleoyl-GPC (17:0/18:2)*,0.94 (0.91 0.97),4.17E-02
471,Nasal polyps,respiratory,OPGS003168,0.014,Metabolon,X - 24054,0.94 (0.91 0.97),4.26E-02
471,Nasal polyps,respiratory,OPGS002893,0.054,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3)*,1.06 (1.03 1.09),4.31E-02
471,Nasal polyps,respiratory,OPGS002890,0.056,Metabolon,X - 23705,1.06 (1.03 1.09),4.53E-02
471,Nasal polyps,respiratory,OPGS003462,0.083,Nightingale,Average diameter for VLDL particles,0.94 (0.91 0.97),2.28E-02
471,Nasal polyps,respiratory,OPGS006038,0.201,RNAseq,HLA-DQA2,1.14 (1.11 1.18),2.06E-15
471,Nasal polyps,respiratory,OPGS008889,0.092,RNAseq,TRAV20,1.14 (1.10 1.17),2.14E-12
471,Nasal polyps,respiratory,OPGS005389,0.248,RNAseq,TRAV23DV6,0.89 (0.86 0.92),4.42E-12
471,Nasal polyps,respiratory,OPGS012171,0.039,RNAseq,TRBV15,0.89 (0.86 0.91),8.01E-11
471,Nasal polyps,respiratory,OPGS004121,0.430,RNAseq,SLC22A5,1.12 (1.09 1.16),1.10E-09
471,Nasal polyps,respiratory,OPGS004213,0.410,RNAseq,,1.11 (1.07 1.14),7.19E-08
471,Nasal polyps,respiratory,OPGS008402,0.104,RNAseq,TNXB,1.10 (1.07 1.14),2.72E-07
471,Nasal polyps,respiratory,OPGS011536,0.047,RNAseq,TRAV2,0.90 (0.88 0.93),1.33E-06
471,Nasal polyps,respiratory,OPGS007018,0.151,RNAseq,TRBV10-3,1.11 (1.07 1.14),1.64E-06
471,Nasal polyps,respiratory,OPGS012761,0.033,RNAseq,TRAV12-3,1.11 (1.07 1.14),1.64E-06
471,Nasal polyps,respiratory,OPGS009711,0.075,RNAseq,TRAV21,0.91 (0.88 0.94),2.47E-06
471,Nasal polyps,respiratory,OPGS003748,0.571,RNAseq,ALOX15,1.09 (1.06 1.13),4.24E-05
471,Nasal polyps,respiratory,OPGS005280,0.258,RNAseq,DEXI,0.92 (0.89 0.95),5.42E-05
471,Nasal polyps,respiratory,OPGS013305,0.028,RNAseq,TRBV14,0.92 (0.89 0.95),1.04E-04
471,Nasal polyps,respiratory,OPGS011287,0.050,RNAseq,,0.92 (0.89 0.95),2.30E-04
471,Nasal polyps,respiratory,OPGS003711,0.593,RNAseq,,1.08 (1.05 1.12),2.58E-04
471,Nasal polyps,respiratory,OPGS006845,0.158,RNAseq,FLOT1,1.08 (1.05 1.12),2.83E-04
471,Nasal polyps,respiratory,OPGS012242,0.039,RNAseq,,1.08 (1.05 1.12),3.83E-04
471,Nasal polyps,respiratory,OPGS014611,0.018,RNAseq,GATA3,0.93 (0.90 0.96),4.29E-04
471,Nasal polyps,respiratory,OPGS014758,0.017,RNAseq,TRAV10,1.09 (1.05 1.12),4.29E-04
471,Nasal polyps,respiratory,OPGS006712,0.165,RNAseq,SLC22A4,1.08 (1.05 1.11),5.10E-04
471,Nasal polyps,respiratory,OPGS015035,0.016,RNAseq,PLAAT4,1.08 (1.05 1.12),8.24E-04
471,Nasal polyps,respiratory,OPGS013958,0.023,RNAseq,CSNK2B,0.93 (0.90 0.96),8.41E-04
471,Nasal polyps,respiratory,OPGS010348,0.063,RNAseq,TRBV6-5,1.08 (1.04 1.11),1.25E-03
471,Nasal polyps,respiratory,OPGS013045,0.030,RNAseq,NEU1,1.08 (1.04 1.11),1.41E-03
471,Nasal polyps,respiratory,OPGS006172,0.193,RNAseq,NDFIP1,0.93 (0.90 0.96),2.04E-03
471,Nasal polyps,respiratory,OPGS004111,0.433,RNAseq,IL18RAP,0.93 (0.90 0.96),2.72E-03
471,Nasal polyps,respiratory,OPGS010874,0.056,RNAseq,ALS2CL,0.93 (0.90 0.96),2.76E-03
471,Nasal polyps,respiratory,OPGS011321,0.049,RNAseq,GDF11,0.93 (0.90 0.96),3.05E-03
471,Nasal polyps,respiratory,OPGS013243,0.029,RNAseq,TRAV3,0.93 (0.90 0.96),3.97E-03
471,Nasal polyps,respiratory,OPGS015030,0.016,RNAseq,PRRC2A,1.07 (1.04 1.11),4.19E-03
471,Nasal polyps,respiratory,OPGS005518,0.236,RNAseq,POLR2E,1.07 (1.04 1.11),4.55E-03
471,Nasal polyps,respiratory,OPGS009438,0.081,RNAseq,DLEU1,1.07 (1.04 1.11),7.49E-03
471,Nasal polyps,respiratory,OPGS013073,0.030,RNAseq,BACH2,1.07 (1.04 1.11),9.75E-03
471,Nasal polyps,respiratory,OPGS004144,0.424,RNAseq,PSORS1C3,1.07 (1.03 1.10),1.01E-02
471,Nasal polyps,respiratory,OPGS011431,0.048,RNAseq,VWA7,1.07 (1.03 1.10),1.29E-02
471,Nasal polyps,respiratory,OPGS012772,0.033,RNAseq,GIGYF2,0.94 (0.91 0.97),1.99E-02
471,Nasal polyps,respiratory,OPGS013293,0.028,RNAseq,LINC01232,1.07 (1.03 1.11),2.02E-02
471,Nasal polyps,respiratory,OPGS014622,0.018,RNAseq,CACNA1I,1.07 (1.03 1.11),2.09E-02
471,Nasal polyps,respiratory,OPGS011079,0.053,RNAseq,UBAC2,0.94 (0.91 0.97),2.19E-02
471,Nasal polyps,respiratory,OPGS004406,0.369,RNAseq,,0.94 (0.91 0.97),2.26E-02
471,Nasal polyps,respiratory,OPGS012794,0.033,RNAseq,PRR14,0.94 (0.91 0.97),2.26E-02
471,Nasal polyps,respiratory,OPGS005230,0.263,RNAseq,LINC00243,1.06 (1.03 1.10),2.26E-02
471,Nasal polyps,respiratory,OPGS013320,0.028,RNAseq,SCIMP,0.94 (0.91 0.97),2.53E-02
471,Nasal polyps,respiratory,OPGS010693,0.058,RNAseq,TRBV5-1,0.94 (0.91 0.97),3.17E-02
471,Nasal polyps,respiratory,OPGS006129,0.196,RNAseq,TCEA3,0.94 (0.91 0.97),3.47E-02
471,Nasal polyps,respiratory,OPGS005519,0.236,RNAseq,AL645933.3,1.06 (1.03 1.10),3.68E-02
471,Nasal polyps,respiratory,OPGS014368,0.020,RNAseq,PTCH2,1.06 (1.03 1.09),3.69E-02
471,Nasal polyps,respiratory,OPGS009687,0.075,RNAseq,ADO,0.94 (0.91 0.97),4.03E-02
471,Nasal polyps,respiratory,OPGS008202,0.109,RNAseq,TCF7L2,0.94 (0.92 0.97),4.10E-02
471,Nasal polyps,respiratory,OPGS010904,0.055,RNAseq,EEFSEC,0.94 (0.92 0.97),4.10E-02
471,Nasal polyps,respiratory,OPGS008307,0.106,RNAseq,AC015813.6,0.94 (0.91 0.97),4.17E-02
471,Nasal polyps,respiratory,OPGS006436,0.179,RNAseq,KRT10,1.06 (1.03 1.09),4.26E-02
471,Nasal polyps,respiratory,OPGS013909,0.023,RNAseq,SDHAF1,1.06 (1.03 1.10),4.26E-02
471,Nasal polyps,respiratory,OPGS004662,0.329,RNAseq,NLRC5,0.94 (0.91 0.97),4.26E-02
471,Nasal polyps,respiratory,OPGS003946,0.486,RNAseq,TMEM273,0.94 (0.91 0.97),4.26E-02
471,Nasal polyps,respiratory,OPGS008023,0.115,RNAseq,ARNT,1.06 (1.03 1.09),4.26E-02
471,Nasal polyps,respiratory,OPGS007648,0.127,RNAseq,FNDC3B,0.95 (0.92 0.98),4.26E-02
471,Nasal polyps,respiratory,OPGS011645,0.045,RNAseq,DARS2,0.94 (0.91 0.97),4.31E-02
471,Nasal polyps,respiratory,OPGS003755,0.569,RNAseq,CASP7,1.06 (1.03 1.09),4.34E-02
475,Chronic sinusitis,respiratory,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,1.10 (1.06 1.13),7.05E-04
475,Chronic sinusitis,respiratory,OPGS008889,0.092,RNAseq,TRAV20,1.10 (1.06 1.13),5.68E-04
475,Chronic sinusitis,respiratory,OPGS006038,0.201,RNAseq,HLA-DQA2,1.09 (1.05 1.12),1.11E-03
475,Chronic sinusitis,respiratory,OPGS007018,0.151,RNAseq,TRBV10-3,1.08 (1.05 1.12),1.54E-02
477,Epistaxis or throat hemorrhage,respiratory,OPGS001860,0.016,SomaScan,Immunoglobulin E,0.92 (0.89 0.95),3.64E-03
477,Epistaxis or throat hemorrhage,respiratory,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,0.92 (0.89 0.95),3.99E-03
477,Epistaxis or throat hemorrhage,respiratory,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.08 (1.05 1.12),4.25E-03
477,Epistaxis or throat hemorrhage,respiratory,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.93 (0.90 0.96),1.52E-02
477,Epistaxis or throat hemorrhage,respiratory,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.07 (1.04 1.11),1.67E-02
477,Epistaxis or throat hemorrhage,respiratory,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,0.93 (0.90 0.96),2.27E-02
477,Epistaxis or throat hemorrhage,respiratory,OPGS000101,0.374,SomaScan,CD209 antigen,0.93 (0.90 0.97),3.93E-02
477,Epistaxis or throat hemorrhage,respiratory,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,1.07 (1.04 1.11),3.93E-02
477,Epistaxis or throat hemorrhage,respiratory,OPGS000034,0.558,SomaScan,Serum amyloid A-1 protein,0.93 (0.90 0.97),4.05E-02
477,Epistaxis or throat hemorrhage,respiratory,OPGS002651,0.015,Olink,von Willebrand factor,0.93 (0.90 0.96),2.27E-02
477,Epistaxis or throat hemorrhage,respiratory,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.07 (1.03 1.10),4.16E-02
477,Epistaxis or throat hemorrhage,respiratory,OPGS009371,0.082,RNAseq,TRBV19,1.08 (1.05 1.12),3.99E-03
477,Epistaxis or throat hemorrhage,respiratory,OPGS012093,0.040,RNAseq,TRIM26,0.92 (0.89 0.95),3.99E-03
477,Epistaxis or throat hemorrhage,respiratory,OPGS012006,0.041,RNAseq,VARS2,1.08 (1.05 1.12),4.25E-03
477,Epistaxis or throat hemorrhage,respiratory,OPGS013045,0.030,RNAseq,NEU1,1.08 (1.05 1.12),5.01E-03
477,Epistaxis or throat hemorrhage,respiratory,OPGS009222,0.085,RNAseq,,1.08 (1.05 1.12),5.44E-03
477,Epistaxis or throat hemorrhage,respiratory,OPGS014496,0.019,RNAseq,VARS1,0.92 (0.89 0.95),5.54E-03
477,Epistaxis or throat hemorrhage,respiratory,OPGS010826,0.056,RNAseq,TRIM10,1.08 (1.04 1.11),1.38E-02
477,Epistaxis or throat hemorrhage,respiratory,OPGS014580,0.018,RNAseq,DACT1,0.93 (0.90 0.96),1.48E-02
477,Epistaxis or throat hemorrhage,respiratory,OPGS010607,0.059,RNAseq,TRAV8-1,0.93 (0.90 0.97),3.93E-02
477,Epistaxis or throat hemorrhage,respiratory,OPGS010671,0.058,RNAseq,LINC02649,1.07 (1.04 1.11),3.93E-02
477,Epistaxis or throat hemorrhage,respiratory,OPGS005651,0.225,RNAseq,PTGFR,0.94 (0.91 0.97),4.91E-02
480.3,Pneumonia due to fungus (mycoses),respiratory,OPGS004394,0.372,RNAseq,SYK,0.74 (0.65 0.84),3.17E-02
495,Asthma,respiratory,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.06 (1.05 1.07),3.94E-26
495,Asthma,respiratory,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.95 (0.94 0.96),2.18E-19
495,Asthma,respiratory,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.95 (0.94 0.96),4.49E-18
495,Asthma,respiratory,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.05 (1.04 1.06),6.81E-16
495,Asthma,respiratory,OPGS000846,0.068,SomaScan,2-phosphoxylose phosphatase 1,1.04 (1.03 1.05),2.33E-11
495,Asthma,respiratory,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.96 (0.95 0.97),1.86E-10
495,Asthma,respiratory,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.04 (1.03 1.05),4.22E-10
495,Asthma,respiratory,OPGS000984,0.055,SomaScan,Complement C2,1.04 (1.03 1.05),9.38E-10
495,Asthma,respiratory,OPGS000879,0.065,SomaScan,Natural cytotoxicity triggering receptor 3,1.04 (1.03 1.05),1.33E-08
495,Asthma,respiratory,OPGS002114,0.012,SomaScan,Neutrophil gelatinase-associated lipocalin,1.03 (1.02 1.05),5.29E-08
495,Asthma,respiratory,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.03 (1.02 1.04),1.07E-07
495,Asthma,respiratory,OPGS000517,0.114,SomaScan,Advanced glycosylation end product-specific receptor. soluble,0.97 (0.96 0.98),1.28E-07
495,Asthma,respiratory,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.97 (0.96 0.98),2.87E-07
495,Asthma,respiratory,OPGS000137,0.312,SomaScan,Complement C4b,0.97 (0.96 0.98),3.63E-07
495,Asthma,respiratory,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.03 (1.02 1.04),1.20E-06
495,Asthma,respiratory,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.97 (0.96 0.98),2.30E-06
495,Asthma,respiratory,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,1.03 (1.02 1.04),2.97E-06
495,Asthma,respiratory,OPGS002246,0.010,SomaScan,Sperm-associated antigen 11B,0.97 (0.96 0.98),1.60E-05
495,Asthma,respiratory,OPGS001231,0.037,SomaScan,Osteocalcin,1.03 (1.02 1.04),3.68E-05
495,Asthma,respiratory,OPGS001598,0.022,SomaScan,SPARC,0.97 (0.96 0.98),1.08E-04
495,Asthma,respiratory,OPGS000129,0.329,SomaScan,Neutrophil collagenase,0.97 (0.96 0.98),1.80E-04
495,Asthma,respiratory,OPGS001200,0.039,SomaScan,DnaJ homolog subfamily B member 11,0.98 (0.97 0.99),3.06E-04
495,Asthma,respiratory,OPGS001883,0.015,SomaScan,UMP-CMP kinase,1.02 (1.01 1.03),8.73E-04
495,Asthma,respiratory,OPGS000832,0.069,SomaScan,Complement C1q tumor necrosis factor-related protein 5,1.02 (1.01 1.03),1.17E-03
495,Asthma,respiratory,OPGS000967,0.056,SomaScan,Interleukin-7 receptor subunit alpha,1.02 (1.01 1.03),1.31E-03
495,Asthma,respiratory,OPGS000935,0.059,SomaScan,Vitronectin,0.98 (0.97 0.99),1.47E-03
495,Asthma,respiratory,OPGS000642,0.092,SomaScan,Heparin cofactor 2,0.98 (0.97 0.99),1.94E-03
495,Asthma,respiratory,OPGS000061,0.457,SomaScan,Haptoglobin,0.98 (0.97 0.99),2.54E-03
495,Asthma,respiratory,OPGS001398,0.029,SomaScan,Nephronectin,0.98 (0.97 0.99),3.82E-03
495,Asthma,respiratory,OPGS000586,0.101,SomaScan,Interleukin-1 receptor type 2,0.98 (0.97 0.99),3.89E-03
495,Asthma,respiratory,OPGS000073,0.428,SomaScan,Interleukin-1 receptor-like 1,0.98 (0.97 0.99),4.39E-03
495,Asthma,respiratory,OPGS000270,0.184,SomaScan,Suppressor of cytokine signaling 3,1.02 (1.01 1.03),4.76E-03
495,Asthma,respiratory,OPGS000681,0.087,SomaScan,Protein-glutamine gamma-glutamyltransferase E,0.98 (0.97 0.99),5.26E-03
495,Asthma,respiratory,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.02 (1.01 1.03),5.51E-03
495,Asthma,respiratory,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,0.98 (0.97 0.99),6.64E-03
495,Asthma,respiratory,OPGS001893,0.015,SomaScan,Interleukin-17F,1.02 (1.01 1.03),6.78E-03
495,Asthma,respiratory,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,0.98 (0.97 0.99),8.16E-03
495,Asthma,respiratory,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,1.02 (1.01 1.03),1.21E-02
495,Asthma,respiratory,OPGS000040,0.535,SomaScan,Haptoglobin,0.98 (0.97 0.99),1.22E-02
495,Asthma,respiratory,OPGS001761,0.018,SomaScan,Sulfatase-modifying factor 2,0.98 (0.97 0.99),1.53E-02
495,Asthma,respiratory,OPGS000391,0.141,SomaScan,T-cell surface glycoprotein CD3 epsilon chain,0.98 (0.97 0.99),1.67E-02
495,Asthma,respiratory,OPGS001501,0.025,SomaScan,Hemoglobin,1.02 (1.01 1.03),1.72E-02
495,Asthma,respiratory,OPGS000156,0.272,SomaScan,alpha-2-macroglobulin receptor-associated protein,0.98 (0.97 0.99),2.03E-02
495,Asthma,respiratory,OPGS000274,0.182,SomaScan,NAD(P)H dehydrogenase [quinone] 1,0.98 (0.97 0.99),2.08E-02
495,Asthma,respiratory,OPGS000880,0.065,SomaScan,Procollagen galactosyltransferase 1,0.98 (0.97 0.99),2.63E-02
495,Asthma,respiratory,OPGS001911,0.014,SomaScan,Ectodysplasin-A. secreted form,1.02 (1.01 1.03),2.81E-02
495,Asthma,respiratory,OPGS000103,0.372,SomaScan,Lysophosphatidic acid phosphatase type 6,0.98 (0.97 0.99),2.93E-02
495,Asthma,respiratory,OPGS000970,0.056,SomaScan,Extracellular matrix protein 1,1.02 (1.01 1.03),2.94E-02
495,Asthma,respiratory,OPGS000022,0.602,SomaScan,Interleukin-6 receptor subunit alpha,1.02 (1.01 1.03),2.94E-02
495,Asthma,respiratory,OPGS000020,0.609,SomaScan,Interleukin-6 receptor subunit alpha,1.02 (1.01 1.03),2.96E-02
495,Asthma,respiratory,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,1.02 (1.01 1.03),3.05E-02
495,Asthma,respiratory,OPGS000118,0.344,SomaScan,Cation-independent mannose-6-phosphate receptor,1.02 (1.01 1.03),3.32E-02
495,Asthma,respiratory,OPGS000255,0.191,SomaScan,Ferritin,0.98 (0.97 0.99),3.54E-02
495,Asthma,respiratory,OPGS000216,0.217,SomaScan,Kallikrein-14,0.98 (0.97 0.99),3.85E-02
495,Asthma,respiratory,OPGS001541,0.024,SomaScan,Transmembrane protein 106B,0.98 (0.97 0.99),4.14E-02
495,Asthma,respiratory,OPGS001550,0.024,SomaScan,Trefoil factor 3,1.02 (1.01 1.03),4.37E-02
495,Asthma,respiratory,OPGS001288,0.034,SomaScan,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1.02 (1.01 1.03),4.53E-02
495,Asthma,respiratory,OPGS001617,0.022,SomaScan,Nutritionally-regulated adipose and cardiac enriched protein homolog,1.02 (1.01 1.03),4.93E-02
495,Asthma,respiratory,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.96 (0.95 0.97),7.53E-11
495,Asthma,respiratory,OPGS002401,0.336,Olink,Interleukin-1 receptor-like 1,0.96 (0.95 0.97),2.99E-09
495,Asthma,respiratory,OPGS002658,0.013,Olink,C-C motif chemokine 22,1.04 (1.03 1.05),6.72E-09
495,Asthma,respiratory,OPGS002594,0.033,Olink,Interleukin-4 receptor subunit alpha,0.97 (0.96 0.98),2.57E-07
495,Asthma,respiratory,OPGS002577,0.041,Olink,Interleukin-1 receptor type 1,1.03 (1.02 1.04),8.83E-06
495,Asthma,respiratory,OPGS002598,0.031,Olink,Interleukin-10,0.97 (0.96 0.98),2.78E-05
495,Asthma,respiratory,OPGS002530,0.067,Olink,Trefoil factor 3,1.03 (1.02 1.04),3.06E-05
495,Asthma,respiratory,OPGS002643,0.018,Olink,Neuroblastoma suppressor of tumorigenicity 1,1.02 (1.01 1.03),1.52E-03
495,Asthma,respiratory,OPGS002448,0.172,Olink,Interleukin-1 receptor-like 2,0.98 (0.97 0.99),1.75E-03
495,Asthma,respiratory,OPGS002646,0.017,Olink,Proheparin-binding EGF-like growth factor,1.02 (1.01 1.03),4.33E-03
495,Asthma,respiratory,OPGS002427,0.216,Olink,Alpha-2-macroglobulin receptor-associated protein,0.98 (0.97 0.99),4.49E-03
495,Asthma,respiratory,OPGS002647,0.017,Olink,Oncostatin-M,1.02 (1.01 1.03),6.23E-03
495,Asthma,respiratory,OPGS002614,0.027,Olink,Carboxypeptidase B,0.98 (0.97 0.99),1.50E-02
495,Asthma,respiratory,OPGS002387,0.541,Olink,Interleukin-6 receptor subunit alpha,1.02 (1.01 1.03),1.79E-02
495,Asthma,respiratory,OPGS002601,0.030,Olink,Peptidoglycan recognition protein 1,1.02 (1.01 1.03),2.20E-02
495,Asthma,respiratory,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.98 (0.97 0.99),2.61E-02
495,Asthma,respiratory,OPGS002629,0.023,Olink,Interleukin-18-binding protein,0.98 (0.97 0.99),2.92E-02
495,Asthma,respiratory,OPGS002623,0.024,Olink,RGM domain family member B,1.02 (1.01 1.03),4.32E-02
495,Asthma,respiratory,OPGS002579,0.039,Olink,Macrophage receptor MARCO,0.98 (0.97 0.99),4.53E-02
495,Asthma,respiratory,OPGS002613,0.027,Olink,Interleukin-6,1.02 (1.01 1.03),4.65E-02
495,Asthma,respiratory,OPGS003184,0.013,Metabolon,2-hydroxyglutarate,0.95 (0.94 0.96),1.39E-17
495,Asthma,respiratory,OPGS003121,0.017,Metabolon,1.2-dipalmitoyl-GPC (16:0/16:0),1.04 (1.03 1.05),9.25E-13
495,Asthma,respiratory,OPGS002893,0.054,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3)*,1.03 (1.02 1.04),3.96E-07
495,Asthma,respiratory,OPGS002819,0.083,Metabolon,phosphatidylcholine (16:0/22:5n3. 18:1/20:4)*,1.03 (1.02 1.04),2.16E-06
495,Asthma,respiratory,OPGS002734,0.178,Metabolon,1-stearoyl-2-arachidonoyl-GPC (18:0/20:4),1.03 (1.02 1.04),2.41E-06
495,Asthma,respiratory,OPGS002899,0.053,Metabolon,1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5)*,1.03 (1.02 1.04),2.64E-06
495,Asthma,respiratory,OPGS002909,0.049,Metabolon,X - 24439,0.97 (0.96 0.98),3.19E-06
495,Asthma,respiratory,OPGS003029,0.026,Metabolon,docosatrienoate (22:3n3),0.97 (0.96 0.98),4.38E-06
495,Asthma,respiratory,OPGS002949,0.041,Metabolon,1-stearoyl-2-meadoyl-GPC (18:0/20:3n9)*,1.03 (1.02 1.04),5.78E-06
495,Asthma,respiratory,OPGS002972,0.036,Metabolon,1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9)*,1.03 (1.02 1.04),7.50E-06
495,Asthma,respiratory,OPGS002857,0.067,Metabolon,1-arachidonoyl-GPA (20:4),1.03 (1.02 1.04),7.72E-06
495,Asthma,respiratory,OPGS003109,0.018,Metabolon,1-linoleoyl-GPE (18:2)*,0.97 (0.96 0.98),8.78E-06
495,Asthma,respiratory,OPGS003152,0.014,Metabolon,1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2)*,0.97 (0.96 0.98),9.57E-06
495,Asthma,respiratory,OPGS003189,0.012,Metabolon,2-linoleoyl-GPE (18:2)*,0.97 (0.96 0.98),1.09E-05
495,Asthma,respiratory,OPGS003159,0.014,Metabolon,docosapentaenoate (n3 DPA; 22:5n3),1.03 (1.02 1.04),1.26E-05
495,Asthma,respiratory,OPGS002747,0.146,Metabolon,1-arachidonoyl-GPC (20:4n6)*,1.03 (1.02 1.04),1.98E-05
495,Asthma,respiratory,OPGS002931,0.045,Metabolon,eicosapentaenoate (EPA; 20:5n3),1.03 (1.02 1.04),2.10E-05
495,Asthma,respiratory,OPGS002977,0.035,Metabolon,1.2-dilinoleoyl-GPC (18:2/18:2),0.97 (0.96 0.98),2.10E-05
495,Asthma,respiratory,OPGS002890,0.056,Metabolon,X - 23705,1.03 (1.02 1.04),2.51E-05
495,Asthma,respiratory,OPGS002791,0.100,Metabolon,2-arachidonoyl-GPC (20:4)*,1.03 (1.02 1.04),2.93E-05
495,Asthma,respiratory,OPGS002971,0.036,Metabolon,1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4)*,1.03 (1.02 1.04),3.06E-05
495,Asthma,respiratory,OPGS003100,0.019,Metabolon,1-arachidonylglycerol (20:4),1.03 (1.02 1.04),3.06E-05
495,Asthma,respiratory,OPGS002872,0.061,Metabolon,1-eicosapentaenoyl-GPC (20:5)*,1.03 (1.02 1.04),3.35E-05
495,Asthma,respiratory,OPGS003057,0.022,Metabolon,1-adrenoyl-GPC (22:4)*,1.03 (1.02 1.04),3.44E-05
495,Asthma,respiratory,OPGS003168,0.014,Metabolon,X - 24054,0.97 (0.96 0.98),3.44E-05
495,Asthma,respiratory,OPGS002764,0.129,Metabolon,1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4),1.03 (1.02 1.04),3.74E-05
495,Asthma,respiratory,OPGS003074,0.021,Metabolon,1-stearoyl-2-linoleoyl-GPC (18:0/18:2)*,0.97 (0.96 0.98),5.16E-05
495,Asthma,respiratory,OPGS002834,0.075,Metabolon,phosphatidylcholine (18:0/20:5. 16:0/22:5n6)*,1.03 (1.02 1.04),5.19E-05
495,Asthma,respiratory,OPGS002954,0.040,Metabolon,1-oleoyl-2-linoleoyl-GPC (18:1/18:2)*,0.97 (0.96 0.98),5.80E-05
495,Asthma,respiratory,OPGS003011,0.030,Metabolon,1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)*,0.97 (0.96 0.98),8.46E-05
495,Asthma,respiratory,OPGS003016,0.029,Metabolon,1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)*,1.03 (1.02 1.04),9.05E-05
495,Asthma,respiratory,OPGS002829,0.079,Metabolon,arachidonate (20:4n6),1.03 (1.02 1.04),9.35E-05
495,Asthma,respiratory,OPGS002981,0.034,Metabolon,1-docosapentaenoyl-GPC (22:5n3)*,1.03 (1.02 1.04),1.05E-04
495,Asthma,respiratory,OPGS002980,0.034,Metabolon,1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2)*,0.97 (0.96 0.98),1.23E-04
495,Asthma,respiratory,OPGS003086,0.020,Metabolon,1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)*,0.97 (0.96 0.98),1.23E-04
495,Asthma,respiratory,OPGS002843,0.073,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4),1.03 (1.02 1.04),1.51E-04
495,Asthma,respiratory,OPGS003038,0.025,Metabolon,1-margaroyl-2-linoleoyl-GPC (17:0/18:2)*,0.97 (0.96 0.98),1.71E-04
495,Asthma,respiratory,OPGS002941,0.043,Metabolon,1-palmitoyl-2-linolenoyl-GPC (16:0/18:3)*,0.97 (0.96 0.98),1.80E-04
495,Asthma,respiratory,OPGS002855,0.069,Metabolon,1-palmityl-2-arachidonoyl-GPC (O-16:0/20:4)*,1.03 (1.02 1.04),1.86E-04
495,Asthma,respiratory,OPGS003136,0.016,Metabolon,1-eicosapentaenoyl-GPE (20:5)*,1.03 (1.01 1.04),2.14E-04
495,Asthma,respiratory,OPGS002936,0.044,Metabolon,1-dihomo-linoleoyl-GPC (20:2)*,0.98 (0.97 0.99),3.09E-04
495,Asthma,respiratory,OPGS003075,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*,1.02 (1.01 1.04),4.19E-04
495,Asthma,respiratory,OPGS003060,0.022,Metabolon,stearidonate (18:4n3),1.02 (1.01 1.03),1.08E-03
495,Asthma,respiratory,OPGS002997,0.032,Metabolon,1-palmitoyl-2-linoleoyl-GPC (16:0/18:2),0.98 (0.97 0.99),1.46E-03
495,Asthma,respiratory,OPGS002859,0.067,Metabolon,1-arachidonoyl-GPE (20:4n6)*,1.02 (1.01 1.03),1.75E-03
495,Asthma,respiratory,OPGS003073,0.021,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*,1.02 (1.01 1.03),1.96E-03
495,Asthma,respiratory,OPGS002832,0.078,Metabolon,X - 24438,0.98 (0.97 0.99),2.60E-03
495,Asthma,respiratory,OPGS002969,0.036,Metabolon,tryptophan betaine,0.98 (0.97 0.99),2.99E-03
495,Asthma,respiratory,OPGS002780,0.113,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)*,1.02 (1.01 1.03),3.79E-03
495,Asthma,respiratory,OPGS002938,0.044,Metabolon,2-arachidonoyl-GPE (20:4)*,1.02 (1.01 1.03),3.84E-03
495,Asthma,respiratory,OPGS002934,0.044,Metabolon,1-oleoyl-2-dihomo-linolenoyl-GPC (18:1/20:3)*,0.98 (0.97 0.99),3.88E-03
495,Asthma,respiratory,OPGS002948,0.042,Metabolon,1-dihomo-linolenoyl-GPE (20:3n3 or 6)*,0.98 (0.97 0.99),5.49E-03
495,Asthma,respiratory,OPGS003132,0.016,Metabolon,2-methylmalonyl carnitine,1.02 (1.01 1.03),6.46E-03
495,Asthma,respiratory,OPGS003042,0.024,Metabolon,1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6),1.02 (1.01 1.03),9.50E-03
495,Asthma,respiratory,OPGS002904,0.051,Metabolon,1-arachidonoyl-GPI (20:4)*,1.02 (1.01 1.03),1.05E-02
495,Asthma,respiratory,OPGS003019,0.028,Metabolon,1-oleoyl-2-linoleoyl-GPI (18:1/18:2)*,0.98 (0.97 0.99),1.08E-02
495,Asthma,respiratory,OPGS003125,0.017,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6),1.02 (1.01 1.03),1.60E-02
495,Asthma,respiratory,OPGS002886,0.057,Metabolon,X - 12822,1.02 (1.01 1.03),1.86E-02
495,Asthma,respiratory,OPGS003014,0.029,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6)*,1.02 (1.01 1.03),2.22E-02
495,Asthma,respiratory,OPGS002837,0.075,Metabolon,1-stearoyl-2-arachidonoyl-GPI (18:0/20:4),1.02 (1.01 1.03),2.28E-02
495,Asthma,respiratory,OPGS002958,0.040,Metabolon,1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6)*,0.98 (0.97 0.99),3.10E-02
495,Asthma,respiratory,OPGS003120,0.017,Metabolon,2-docosahexaenoyl-GPC (22:6)*,1.02 (1.01 1.03),3.13E-02
495,Asthma,respiratory,OPGS003114,0.018,Metabolon,1-myristoyl-2-linoleoyl-GPC (14:0/18:2)*,0.98 (0.97 0.99),3.21E-02
495,Asthma,respiratory,OPGS002807,0.089,Metabolon,1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3)*,0.98 (0.97 0.99),3.92E-02
495,Asthma,respiratory,OPGS003035,0.025,Metabolon,1-linoleoyl-GPI (18:2)*,0.98 (0.97 0.99),4.53E-02
495,Asthma,respiratory,OPGS003522,0.062,Nightingale,Degree of unsaturation,1.03 (1.02 1.04),3.06E-05
495,Asthma,respiratory,OPGS003497,0.072,Nightingale,Linoleic acid,0.98 (0.97 0.99),1.71E-02
495,Asthma,respiratory,OPGS012171,0.039,RNAseq,TRBV15,0.93 (0.92 0.93),1.49E-45
495,Asthma,respiratory,OPGS006038,0.201,RNAseq,HLA-DQA2,1.07 (1.06 1.08),5.28E-38
495,Asthma,respiratory,OPGS004213,0.410,RNAseq,,1.07 (1.05 1.08),7.10E-31
495,Asthma,respiratory,OPGS010624,0.059,RNAseq,TRBV18,1.07 (1.06 1.08),2.61E-30
495,Asthma,respiratory,OPGS013305,0.028,RNAseq,TRBV14,0.94 (0.93 0.95),1.45E-28
495,Asthma,respiratory,OPGS005389,0.248,RNAseq,TRAV23DV6,0.95 (0.94 0.96),3.23E-20
495,Asthma,respiratory,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.05 (1.04 1.07),4.88E-18
495,Asthma,respiratory,OPGS010348,0.063,RNAseq,TRBV6-5,1.05 (1.04 1.06),4.88E-18
495,Asthma,respiratory,OPGS008402,0.104,RNAseq,TNXB,1.05 (1.04 1.06),3.56E-16
495,Asthma,respiratory,OPGS006001,0.203,RNAseq,HLA-DQA1,0.95 (0.94 0.96),4.50E-16
495,Asthma,respiratory,OPGS009865,0.072,RNAseq,TRAV17,0.96 (0.95 0.97),5.59E-15
495,Asthma,respiratory,OPGS013073,0.030,RNAseq,BACH2,1.05 (1.04 1.06),1.03E-14
495,Asthma,respiratory,OPGS011853,0.043,RNAseq,TRBV6-1,0.96 (0.95 0.97),2.70E-14
495,Asthma,respiratory,OPGS006499,0.176,RNAseq,C4A,0.96 (0.95 0.97),1.12E-13
495,Asthma,respiratory,OPGS013243,0.029,RNAseq,TRAV3,0.96 (0.95 0.97),1.59E-12
495,Asthma,respiratory,OPGS011431,0.048,RNAseq,VWA7,1.04 (1.03 1.05),2.20E-12
495,Asthma,respiratory,OPGS008867,0.093,RNAseq,TSBP1-AS1,1.04 (1.03 1.05),1.08E-11
495,Asthma,respiratory,OPGS007384,0.137,RNAseq,HLA-B,0.96 (0.95 0.97),1.79E-11
495,Asthma,respiratory,OPGS006967,0.153,RNAseq,ING5,0.96 (0.95 0.97),7.86E-11
495,Asthma,respiratory,OPGS014758,0.017,RNAseq,TRAV10,1.04 (1.03 1.05),1.76E-10
495,Asthma,respiratory,OPGS008274,0.107,RNAseq,NCR3,1.04 (1.03 1.05),1.97E-10
495,Asthma,respiratory,OPGS004100,0.438,RNAseq,GSDMB,1.04 (1.03 1.05),2.93E-10
495,Asthma,respiratory,OPGS004111,0.433,RNAseq,IL18RAP,0.96 (0.95 0.97),3.91E-10
495,Asthma,respiratory,OPGS011543,0.047,RNAseq,IKZF3,0.96 (0.95 0.97),4.41E-10
495,Asthma,respiratory,OPGS010097,0.068,RNAseq,BCL2L11,1.04 (1.03 1.05),6.28E-10
495,Asthma,respiratory,OPGS006301,0.186,RNAseq,AC007278.1,0.96 (0.95 0.97),1.18E-09
495,Asthma,respiratory,OPGS009198,0.085,RNAseq,TRAV12-1,1.04 (1.03 1.05),5.59E-09
495,Asthma,respiratory,OPGS010279,0.065,RNAseq,SMAD3,0.97 (0.96 0.98),1.05E-08
495,Asthma,respiratory,OPGS014380,0.020,RNAseq,BAG3,1.03 (1.02 1.05),8.16E-08
495,Asthma,respiratory,OPGS004121,0.430,RNAseq,SLC22A5,1.03 (1.02 1.04),1.18E-07
495,Asthma,respiratory,OPGS012808,0.033,RNAseq,TRBV20-1,0.97 (0.96 0.98),1.18E-07
495,Asthma,respiratory,OPGS012698,0.034,RNAseq,SNHG32,1.03 (1.02 1.04),1.26E-07
495,Asthma,respiratory,OPGS006716,0.164,RNAseq,IER3,1.03 (1.02 1.04),7.17E-07
495,Asthma,respiratory,OPGS012271,0.038,RNAseq,TRBV5-6,0.97 (0.96 0.98),8.34E-07
495,Asthma,respiratory,OPGS015030,0.016,RNAseq,PRRC2A,1.03 (1.02 1.04),8.96E-07
495,Asthma,respiratory,OPGS011536,0.047,RNAseq,TRAV2,0.97 (0.96 0.98),9.85E-07
495,Asthma,respiratory,OPGS006845,0.158,RNAseq,FLOT1,1.03 (1.02 1.04),2.13E-06
495,Asthma,respiratory,OPGS006215,0.191,RNAseq,PGAP3,1.03 (1.02 1.04),2.31E-06
495,Asthma,respiratory,OPGS010632,0.059,RNAseq,LRRN3,0.97 (0.96 0.98),2.64E-06
495,Asthma,respiratory,OPGS005264,0.259,RNAseq,TGFBR1,0.97 (0.96 0.98),5.38E-06
495,Asthma,respiratory,OPGS014496,0.019,RNAseq,VARS1,1.03 (1.02 1.04),5.60E-06
495,Asthma,respiratory,OPGS012942,0.031,RNAseq,NIBAN1,1.03 (1.02 1.04),5.85E-06
495,Asthma,respiratory,OPGS003711,0.593,RNAseq,,1.03 (1.02 1.04),7.72E-06
495,Asthma,respiratory,OPGS011988,0.041,RNAseq,ZBTB10,1.03 (1.02 1.04),1.23E-05
495,Asthma,respiratory,OPGS006172,0.193,RNAseq,NDFIP1,0.97 (0.96 0.98),1.56E-05
495,Asthma,respiratory,OPGS006787,0.161,RNAseq,IL1RL1,0.97 (0.96 0.98),1.73E-05
495,Asthma,respiratory,OPGS005230,0.263,RNAseq,LINC00243,1.03 (1.02 1.04),1.73E-05
495,Asthma,respiratory,OPGS007675,0.126,RNAseq,TRAV12-2,1.03 (1.02 1.04),1.75E-05
495,Asthma,respiratory,OPGS006034,0.201,RNAseq,,0.97 (0.96 0.98),2.57E-05
495,Asthma,respiratory,OPGS007691,0.126,RNAseq,HLA-DRB1,0.97 (0.96 0.98),3.27E-05
495,Asthma,respiratory,OPGS010874,0.056,RNAseq,ALS2CL,0.97 (0.96 0.98),3.43E-05
495,Asthma,respiratory,OPGS008383,0.104,RNAseq,CD160,0.97 (0.96 0.98),4.63E-05
495,Asthma,respiratory,OPGS008889,0.092,RNAseq,TRAV20,1.03 (1.02 1.04),5.39E-05
495,Asthma,respiratory,OPGS005519,0.236,RNAseq,AL645933.3,1.03 (1.02 1.04),6.39E-05
495,Asthma,respiratory,OPGS014622,0.018,RNAseq,CACNA1I,1.03 (1.02 1.04),8.25E-05
495,Asthma,respiratory,OPGS009401,0.081,RNAseq,EPHX1,1.03 (1.02 1.04),8.86E-05
495,Asthma,respiratory,OPGS011794,0.044,RNAseq,PRKCQ,0.97 (0.96 0.98),1.09E-04
495,Asthma,respiratory,OPGS012242,0.039,RNAseq,,1.03 (1.02 1.04),1.19E-04
495,Asthma,respiratory,OPGS006574,0.172,RNAseq,AC109449.1,0.97 (0.96 0.98),1.38E-04
495,Asthma,respiratory,OPGS011079,0.053,RNAseq,UBAC2,0.97 (0.96 0.98),1.60E-04
495,Asthma,respiratory,OPGS014611,0.018,RNAseq,GATA3,0.98 (0.97 0.99),1.85E-04
495,Asthma,respiratory,OPGS011482,0.047,RNAseq,TRAV8-4,1.03 (1.02 1.04),2.22E-04
495,Asthma,respiratory,OPGS015035,0.016,RNAseq,PLAAT4,1.03 (1.02 1.04),2.23E-04
495,Asthma,respiratory,OPGS010903,0.055,RNAseq,AL359962.1,0.98 (0.97 0.99),2.23E-04
495,Asthma,respiratory,OPGS010826,0.056,RNAseq,TRIM10,0.98 (0.97 0.99),2.30E-04
495,Asthma,respiratory,OPGS007393,0.136,RNAseq,SLC25A46,0.98 (0.97 0.99),2.99E-04
495,Asthma,respiratory,OPGS006360,0.183,RNAseq,ADAM19,1.02 (1.01 1.04),3.09E-04
495,Asthma,respiratory,OPGS006887,0.156,RNAseq,CD28,0.98 (0.97 0.99),3.70E-04
495,Asthma,respiratory,OPGS013165,0.029,RNAseq,B3GALT2,1.03 (1.01 1.04),3.82E-04
495,Asthma,respiratory,OPGS004498,0.354,RNAseq,TEF,1.02 (1.01 1.03),4.41E-04
495,Asthma,respiratory,OPGS005802,0.215,RNAseq,HOXB-AS1,1.02 (1.01 1.04),4.48E-04
495,Asthma,respiratory,OPGS005685,0.222,RNAseq,TLR1,1.02 (1.01 1.04),6.05E-04
495,Asthma,respiratory,OPGS009300,0.083,RNAseq,TRAV26-1,0.98 (0.97 0.99),6.70E-04
495,Asthma,respiratory,OPGS008479,0.102,RNAseq,NMT1,1.02 (1.01 1.03),7.30E-04
495,Asthma,respiratory,OPGS008485,0.102,RNAseq,GRIP1,1.02 (1.01 1.03),7.88E-04
495,Asthma,respiratory,OPGS011321,0.049,RNAseq,GDF11,0.98 (0.97 0.99),1.08E-03
495,Asthma,respiratory,OPGS012080,0.040,RNAseq,CD70,0.98 (0.97 0.99),1.21E-03
495,Asthma,respiratory,OPGS004567,0.343,RNAseq,HLA-C,0.98 (0.97 0.99),1.29E-03
495,Asthma,respiratory,OPGS011311,0.049,RNAseq,CYTH4,1.02 (1.01 1.03),1.29E-03
495,Asthma,respiratory,OPGS011106,0.052,RNAseq,CRYBG2,1.02 (1.01 1.03),1.30E-03
495,Asthma,respiratory,OPGS011496,0.047,RNAseq,SORCS3,0.98 (0.97 0.99),1.30E-03
495,Asthma,respiratory,OPGS011068,0.053,RNAseq,AC099811.1,0.98 (0.97 0.99),1.46E-03
495,Asthma,respiratory,OPGS005150,0.271,RNAseq,RERE,1.02 (1.01 1.03),1.69E-03
495,Asthma,respiratory,OPGS013293,0.028,RNAseq,LINC01232,1.02 (1.01 1.03),1.73E-03
495,Asthma,respiratory,OPGS004193,0.413,RNAseq,CBWD1,0.98 (0.97 0.99),1.94E-03
495,Asthma,respiratory,OPGS005122,0.274,RNAseq,OBI1,0.98 (0.97 0.99),2.02E-03
495,Asthma,respiratory,OPGS014902,0.016,RNAseq,STK32B,0.98 (0.97 0.99),2.05E-03
495,Asthma,respiratory,OPGS006439,0.178,RNAseq,HLA-DPB1,1.02 (1.01 1.03),2.05E-03
495,Asthma,respiratory,OPGS007900,0.118,RNAseq,AC073508.3,1.02 (1.01 1.03),2.32E-03
495,Asthma,respiratory,OPGS010672,0.058,RNAseq,SREK1IP1,1.02 (1.01 1.03),2.53E-03
495,Asthma,respiratory,OPGS005704,0.221,RNAseq,AF131215.5,1.02 (1.01 1.03),2.54E-03
495,Asthma,respiratory,OPGS005375,0.249,RNAseq,,1.02 (1.01 1.03),2.60E-03
495,Asthma,respiratory,OPGS014236,0.021,RNAseq,NPEPPS,0.98 (0.97 0.99),2.65E-03
495,Asthma,respiratory,OPGS010281,0.065,RNAseq,MED1,1.02 (1.01 1.03),2.93E-03
495,Asthma,respiratory,OPGS004956,0.291,RNAseq,,0.98 (0.97 0.99),3.03E-03
495,Asthma,respiratory,OPGS011776,0.044,RNAseq,LST1,0.98 (0.97 0.99),3.27E-03
495,Asthma,respiratory,OPGS007361,0.137,RNAseq,NDUFS2,1.02 (1.01 1.03),3.39E-03
495,Asthma,respiratory,OPGS010685,0.058,RNAseq,FAM89B,1.02 (1.01 1.03),3.43E-03
495,Asthma,respiratory,OPGS008201,0.109,RNAseq,ORMDL3,1.02 (1.01 1.03),3.71E-03
495,Asthma,respiratory,OPGS006712,0.165,RNAseq,SLC22A4,1.02 (1.01 1.03),3.76E-03
495,Asthma,respiratory,OPGS011585,0.046,RNAseq,CD8B,1.02 (1.01 1.03),3.90E-03
495,Asthma,respiratory,OPGS008005,0.115,RNAseq,GNGT2,1.02 (1.01 1.03),4.33E-03
495,Asthma,respiratory,OPGS005795,0.215,RNAseq,PASK,0.98 (0.97 0.99),4.76E-03
495,Asthma,respiratory,OPGS003641,0.645,RNAseq,EIF5AL1,0.98 (0.97 0.99),4.97E-03
495,Asthma,respiratory,OPGS012761,0.033,RNAseq,TRAV12-3,1.02 (1.01 1.03),5.13E-03
495,Asthma,respiratory,OPGS004763,0.314,RNAseq,ACP6,0.98 (0.97 0.99),5.15E-03
495,Asthma,respiratory,OPGS009271,0.084,RNAseq,AC087289.5,1.02 (1.01 1.03),5.82E-03
495,Asthma,respiratory,OPGS011626,0.046,RNAseq,ABCF1,1.02 (1.01 1.03),5.85E-03
495,Asthma,respiratory,OPGS014995,0.016,RNAseq,SNX32,1.02 (1.01 1.03),5.87E-03
495,Asthma,respiratory,OPGS004390,0.372,RNAseq,FZD1,1.02 (1.01 1.03),6.10E-03
495,Asthma,respiratory,OPGS007089,0.148,RNAseq,HLA-A,0.98 (0.97 0.99),6.18E-03
495,Asthma,respiratory,OPGS006596,0.171,RNAseq,SESN1,0.98 (0.97 0.99),6.18E-03
495,Asthma,respiratory,OPGS012927,0.032,RNAseq,THEMIS,1.02 (1.01 1.03),6.44E-03
495,Asthma,respiratory,OPGS011740,0.044,RNAseq,FBXO31,0.98 (0.97 0.99),6.56E-03
495,Asthma,respiratory,OPGS013634,0.025,RNAseq,PKN1,0.98 (0.97 0.99),6.97E-03
495,Asthma,respiratory,OPGS009970,0.070,RNAseq,CLDN23,1.02 (1.01 1.03),7.09E-03
495,Asthma,respiratory,OPGS008535,0.101,RNAseq,EVA1C,0.98 (0.97 0.99),7.25E-03
495,Asthma,respiratory,OPGS005723,0.220,RNAseq,ZMAT3,0.98 (0.97 0.99),7.35E-03
495,Asthma,respiratory,OPGS012057,0.041,RNAseq,POLG2,0.98 (0.97 0.99),7.52E-03
495,Asthma,respiratory,OPGS008369,0.105,RNAseq,ADM,1.02 (1.01 1.03),7.82E-03
495,Asthma,respiratory,OPGS014008,0.023,RNAseq,LINC01781,1.02 (1.01 1.03),8.03E-03
495,Asthma,respiratory,OPGS007394,0.136,RNAseq,AL662844.4,0.98 (0.97 0.99),8.16E-03
495,Asthma,respiratory,OPGS004163,0.418,RNAseq,LGSN,1.02 (1.01 1.03),8.67E-03
495,Asthma,respiratory,OPGS006321,0.185,RNAseq,IL18R1,0.98 (0.97 0.99),8.73E-03
495,Asthma,respiratory,OPGS005701,0.221,RNAseq,AXIN2,1.02 (1.01 1.03),8.76E-03
495,Asthma,respiratory,OPGS005337,0.253,RNAseq,AKIRIN1,0.98 (0.97 0.99),8.96E-03
495,Asthma,respiratory,OPGS014629,0.018,RNAseq,BCL6,1.02 (1.01 1.03),9.16E-03
495,Asthma,respiratory,OPGS012434,0.036,RNAseq,GRAP2,1.02 (1.01 1.03),9.43E-03
495,Asthma,respiratory,OPGS006615,0.170,RNAseq,TNFRSF14,0.98 (0.97 0.99),1.05E-02
495,Asthma,respiratory,OPGS010831,0.056,RNAseq,KLF2,0.98 (0.97 0.99),1.05E-02
495,Asthma,respiratory,OPGS012806,0.033,RNAseq,SERTAD2,0.98 (0.97 0.99),1.05E-02
495,Asthma,respiratory,OPGS009082,0.088,RNAseq,SERPING1,1.02 (1.01 1.03),1.07E-02
495,Asthma,respiratory,OPGS011671,0.045,RNAseq,MICA,1.02 (1.01 1.03),1.08E-02
495,Asthma,respiratory,OPGS011219,0.051,RNAseq,AAGAB,0.98 (0.97 0.99),1.08E-02
495,Asthma,respiratory,OPGS004169,0.417,RNAseq,RBM26-AS1,1.02 (1.01 1.03),1.12E-02
495,Asthma,respiratory,OPGS010091,0.068,RNAseq,TRANK1,1.02 (1.01 1.03),1.13E-02
495,Asthma,respiratory,OPGS007297,0.140,RNAseq,GPANK1,0.98 (0.97 0.99),1.14E-02
495,Asthma,respiratory,OPGS004973,0.290,RNAseq,SNAI3-AS1,0.98 (0.97 0.99),1.22E-02
495,Asthma,respiratory,OPGS008370,0.105,RNAseq,AC138028.6,0.98 (0.97 0.99),1.22E-02
495,Asthma,respiratory,OPGS008947,0.091,RNAseq,LBH,1.02 (1.01 1.03),1.22E-02
495,Asthma,respiratory,OPGS008456,0.103,RNAseq,GALK1,0.98 (0.97 0.99),1.22E-02
495,Asthma,respiratory,OPGS005721,0.220,RNAseq,AC024028.1,0.98 (0.97 0.99),1.22E-02
495,Asthma,respiratory,OPGS005300,0.257,RNAseq,AF131215.6,1.02 (1.01 1.03),1.24E-02
495,Asthma,respiratory,OPGS006153,0.194,RNAseq,ADORA1,0.98 (0.97 0.99),1.29E-02
495,Asthma,respiratory,OPGS010502,0.061,RNAseq,PPBP,1.02 (1.01 1.03),1.30E-02
495,Asthma,respiratory,OPGS006338,0.184,RNAseq,ENO1,0.98 (0.97 0.99),1.35E-02
495,Asthma,respiratory,OPGS014313,0.020,RNAseq,ZNF827,1.02 (1.01 1.03),1.39E-02
495,Asthma,respiratory,OPGS012458,0.036,RNAseq,PRAG1,1.02 (1.01 1.03),1.42E-02
495,Asthma,respiratory,OPGS006340,0.184,RNAseq,SIK2,0.98 (0.97 0.99),1.43E-02
495,Asthma,respiratory,OPGS015007,0.016,RNAseq,RMDN3,1.02 (1.01 1.03),1.44E-02
495,Asthma,respiratory,OPGS014489,0.019,RNAseq,AP002381.2,1.02 (1.01 1.03),1.46E-02
495,Asthma,respiratory,OPGS010244,0.065,RNAseq,NXN,1.02 (1.01 1.03),1.48E-02
495,Asthma,respiratory,OPGS010190,0.066,RNAseq,TAB2,0.98 (0.97 0.99),1.49E-02
495,Asthma,respiratory,OPGS011905,0.042,RNAseq,DYNC1I1,1.02 (1.01 1.03),1.51E-02
495,Asthma,respiratory,OPGS005605,0.230,RNAseq,NPIPA1,0.98 (0.97 0.99),1.56E-02
495,Asthma,respiratory,OPGS013087,0.030,RNAseq,ZNF229,1.02 (1.01 1.03),1.63E-02
495,Asthma,respiratory,OPGS005516,0.236,RNAseq,FCER1G,1.02 (1.01 1.03),1.63E-02
495,Asthma,respiratory,OPGS009118,0.087,RNAseq,LY6G5C,1.02 (1.01 1.03),1.64E-02
495,Asthma,respiratory,OPGS005059,0.281,RNAseq,STIM2,1.02 (1.01 1.03),1.64E-02
495,Asthma,respiratory,OPGS005919,0.208,RNAseq,COX6B1,1.02 (1.01 1.03),1.64E-02
495,Asthma,respiratory,OPGS006619,0.169,RNAseq,,1.02 (1.01 1.03),1.70E-02
495,Asthma,respiratory,OPGS008564,0.100,RNAseq,CLU,1.02 (1.01 1.03),1.71E-02
495,Asthma,respiratory,OPGS012903,0.032,RNAseq,XPR1,0.98 (0.97 0.99),1.73E-02
495,Asthma,respiratory,OPGS003856,0.526,RNAseq,RPS26,1.02 (1.01 1.03),1.87E-02
495,Asthma,respiratory,OPGS009764,0.074,RNAseq,AIF1,1.02 (1.01 1.03),1.88E-02
495,Asthma,respiratory,OPGS011382,0.048,RNAseq,LMAN2,1.02 (1.01 1.03),2.03E-02
495,Asthma,respiratory,OPGS009626,0.076,RNAseq,APBA2,0.98 (0.97 0.99),2.09E-02
495,Asthma,respiratory,OPGS009461,0.080,RNAseq,TG,0.98 (0.97 0.99),2.10E-02
495,Asthma,respiratory,OPGS010781,0.057,RNAseq,ITGB8,0.98 (0.97 0.99),2.11E-02
495,Asthma,respiratory,OPGS006401,0.181,RNAseq,HOXB2,1.02 (1.01 1.03),2.16E-02
495,Asthma,respiratory,OPGS009503,0.079,RNAseq,RIC1,0.98 (0.97 0.99),2.17E-02
495,Asthma,respiratory,OPGS008263,0.107,RNAseq,USP47,1.02 (1.01 1.03),2.19E-02
495,Asthma,respiratory,OPGS007773,0.123,RNAseq,KCNE1,0.98 (0.97 0.99),2.20E-02
495,Asthma,respiratory,OPGS006921,0.154,RNAseq,ARRDC1,1.02 (1.01 1.03),2.22E-02
495,Asthma,respiratory,OPGS006573,0.172,RNAseq,PCNX1,1.02 (1.01 1.03),2.22E-02
495,Asthma,respiratory,OPGS007199,0.143,RNAseq,PER3,1.02 (1.01 1.03),2.27E-02
495,Asthma,respiratory,OPGS012393,0.037,RNAseq,TUBA1B,0.98 (0.97 0.99),2.31E-02
495,Asthma,respiratory,OPGS009175,0.086,RNAseq,CEACAM19,0.98 (0.97 0.99),2.40E-02
495,Asthma,respiratory,OPGS004809,0.309,RNAseq,PRMT5,0.98 (0.97 0.99),2.44E-02
495,Asthma,respiratory,OPGS005900,0.209,RNAseq,NPIPA5,1.02 (1.01 1.03),2.47E-02
495,Asthma,respiratory,OPGS013950,0.023,RNAseq,CD247,0.98 (0.97 0.99),2.61E-02
495,Asthma,respiratory,OPGS007248,0.141,RNAseq,,0.98 (0.97 0.99),2.62E-02
495,Asthma,respiratory,OPGS012361,0.037,RNAseq,ADAMTSL2,1.02 (1.01 1.03),2.71E-02
495,Asthma,respiratory,OPGS014497,0.019,RNAseq,LAPTM4A,0.98 (0.97 0.99),2.76E-02
495,Asthma,respiratory,OPGS003628,0.662,RNAseq,,0.98 (0.97 0.99),2.79E-02
495,Asthma,respiratory,OPGS014549,0.019,RNAseq,AC004466.1,1.02 (1.01 1.03),2.79E-02
495,Asthma,respiratory,OPGS004310,0.387,RNAseq,AP003071.5,1.02 (1.01 1.03),2.81E-02
495,Asthma,respiratory,OPGS005353,0.251,RNAseq,WWP2,1.02 (1.01 1.03),2.86E-02
495,Asthma,respiratory,OPGS009728,0.074,RNAseq,NMB,1.02 (1.01 1.03),2.94E-02
495,Asthma,respiratory,OPGS010104,0.068,RNAseq,ABHD13,0.98 (0.97 0.99),2.98E-02
495,Asthma,respiratory,OPGS009106,0.087,RNAseq,SCAF8,0.98 (0.97 0.99),2.98E-02
495,Asthma,respiratory,OPGS008244,0.108,RNAseq,ICA1L,0.98 (0.97 0.99),2.98E-02
495,Asthma,respiratory,OPGS011287,0.050,RNAseq,,0.98 (0.97 0.99),2.98E-02
495,Asthma,respiratory,OPGS007983,0.116,RNAseq,CPEB2,0.98 (0.97 0.99),3.29E-02
495,Asthma,respiratory,OPGS004444,0.364,RNAseq,FADS2,0.98 (0.97 0.99),3.29E-02
495,Asthma,respiratory,OPGS011110,0.052,RNAseq,CMTM2,1.02 (1.01 1.03),3.36E-02
495,Asthma,respiratory,OPGS004421,0.367,RNAseq,WDFY4,0.98 (0.97 0.99),3.37E-02
495,Asthma,respiratory,OPGS007385,0.136,RNAseq,SP140L,1.02 (1.01 1.03),3.38E-02
495,Asthma,respiratory,OPGS004097,0.438,RNAseq,AC107223.1,0.98 (0.97 0.99),3.38E-02
495,Asthma,respiratory,OPGS004430,0.367,RNAseq,PPP1R17,0.98 (0.97 0.99),3.44E-02
495,Asthma,respiratory,OPGS014249,0.021,RNAseq,IFI6,0.98 (0.97 0.99),3.46E-02
495,Asthma,respiratory,OPGS012865,0.032,RNAseq,VIM-AS1,1.02 (1.01 1.03),3.46E-02
495,Asthma,respiratory,OPGS004212,0.410,RNAseq,INF2,1.02 (1.01 1.03),3.50E-02
495,Asthma,respiratory,OPGS009477,0.080,RNAseq,ADORA2B,0.98 (0.97 0.99),3.50E-02
495,Asthma,respiratory,OPGS005289,0.258,RNAseq,UBA7,0.98 (0.97 0.99),3.50E-02
495,Asthma,respiratory,OPGS004826,0.308,RNAseq,NRROS,0.98 (0.97 0.99),3.50E-02
495,Asthma,respiratory,OPGS009052,0.089,RNAseq,TOGARAM2,0.98 (0.97 0.99),3.54E-02
495,Asthma,respiratory,OPGS013726,0.025,RNAseq,H2AX,0.98 (0.97 0.99),3.54E-02
495,Asthma,respiratory,OPGS004406,0.369,RNAseq,,0.98 (0.97 0.99),3.54E-02
495,Asthma,respiratory,OPGS008976,0.090,RNAseq,EDEM3,0.98 (0.97 0.99),3.58E-02
495,Asthma,respiratory,OPGS006346,0.184,RNAseq,PLCG2,1.02 (1.01 1.03),3.59E-02
495,Asthma,respiratory,OPGS010263,0.065,RNAseq,CBX7,1.02 (1.01 1.03),3.59E-02
495,Asthma,respiratory,OPGS007138,0.146,RNAseq,HCG27,0.98 (0.97 0.99),3.59E-02
495,Asthma,respiratory,OPGS012028,0.041,RNAseq,HLA-DQB1-AS1,0.98 (0.97 0.99),3.60E-02
495,Asthma,respiratory,OPGS013903,0.023,RNAseq,UBE2W,1.02 (1.01 1.03),3.61E-02
495,Asthma,respiratory,OPGS009070,0.088,RNAseq,ITK,1.02 (1.01 1.03),3.66E-02
495,Asthma,respiratory,OPGS012030,0.041,RNAseq,STXBP2,0.98 (0.97 0.99),3.66E-02
495,Asthma,respiratory,OPGS012559,0.035,RNAseq,CORO1B,0.98 (0.97 0.99),3.75E-02
495,Asthma,respiratory,OPGS005135,0.273,RNAseq,CNN2,1.02 (1.01 1.03),3.82E-02
495,Asthma,respiratory,OPGS009998,0.069,RNAseq,PHKB,1.02 (1.01 1.03),3.82E-02
495,Asthma,respiratory,OPGS006679,0.166,RNAseq,,1.02 (1.01 1.03),3.84E-02
495,Asthma,respiratory,OPGS005502,0.238,RNAseq,CLIC4,0.98 (0.97 0.99),3.84E-02
495,Asthma,respiratory,OPGS005796,0.215,RNAseq,,1.02 (1.01 1.03),3.84E-02
495,Asthma,respiratory,OPGS013423,0.027,RNAseq,TANGO6,1.02 (1.01 1.03),3.85E-02
495,Asthma,respiratory,OPGS014188,0.021,RNAseq,AKT3,0.98 (0.97 0.99),3.85E-02
495,Asthma,respiratory,OPGS011064,0.053,RNAseq,NAT1,0.98 (0.97 0.99),3.87E-02
495,Asthma,respiratory,OPGS014579,0.018,RNAseq,AC016074.2,1.02 (1.01 1.03),3.87E-02
495,Asthma,respiratory,OPGS005882,0.210,RNAseq,SEC31B,0.98 (0.97 0.99),3.87E-02
495,Asthma,respiratory,OPGS007658,0.127,RNAseq,EFEMP2,0.98 (0.97 0.99),3.89E-02
495,Asthma,respiratory,OPGS010561,0.060,RNAseq,IL2RA,1.02 (1.01 1.03),3.90E-02
495,Asthma,respiratory,OPGS013059,0.030,RNAseq,NPM3,1.02 (1.01 1.03),3.92E-02
495,Asthma,respiratory,OPGS005523,0.236,RNAseq,RCN1,0.98 (0.97 0.99),4.02E-02
495,Asthma,respiratory,OPGS005280,0.258,RNAseq,DEXI,0.98 (0.97 0.99),4.05E-02
495,Asthma,respiratory,OPGS012328,0.038,RNAseq,SNU13,0.98 (0.97 0.99),4.09E-02
495,Asthma,respiratory,OPGS011616,0.046,RNAseq,RPP25L,0.98 (0.97 0.99),4.19E-02
495,Asthma,respiratory,OPGS008920,0.091,RNAseq,AP002360.2,0.98 (0.97 0.99),4.22E-02
495,Asthma,respiratory,OPGS013840,0.024,RNAseq,SLC16A4,0.98 (0.97 0.99),4.22E-02
495,Asthma,respiratory,OPGS009800,0.073,RNAseq,CD180,1.02 (1.01 1.03),4.30E-02
495,Asthma,respiratory,OPGS012130,0.040,RNAseq,SPSB1,1.02 (1.01 1.03),4.32E-02
495,Asthma,respiratory,OPGS007088,0.148,RNAseq,SMARCE1,1.02 (1.01 1.03),4.32E-02
495,Asthma,respiratory,OPGS005147,0.272,RNAseq,PODXL2,0.98 (0.97 0.99),4.32E-02
495,Asthma,respiratory,OPGS010462,0.062,RNAseq,GFAP,0.98 (0.97 0.99),4.32E-02
495,Asthma,respiratory,OPGS004108,0.434,RNAseq,GPD2,0.98 (0.97 0.99),4.32E-02
495,Asthma,respiratory,OPGS005419,0.245,RNAseq,,1.02 (1.01 1.03),4.33E-02
495,Asthma,respiratory,OPGS012716,0.033,RNAseq,PSPC1-AS2,1.02 (1.01 1.03),4.33E-02
495,Asthma,respiratory,OPGS006002,0.203,RNAseq,HSD17B4,1.02 (1.01 1.03),4.33E-02
495,Asthma,respiratory,OPGS005499,0.238,RNAseq,FARP2,1.02 (1.01 1.03),4.34E-02
495,Asthma,respiratory,OPGS014002,0.023,RNAseq,BAHD1,0.98 (0.97 0.99),4.36E-02
495,Asthma,respiratory,OPGS011735,0.044,RNAseq,STAT6,0.98 (0.97 0.99),4.37E-02
495,Asthma,respiratory,OPGS010934,0.055,RNAseq,SAMSN1,0.98 (0.97 0.99),4.37E-02
495,Asthma,respiratory,OPGS008417,0.103,RNAseq,GPR19,1.02 (1.01 1.03),4.49E-02
495,Asthma,respiratory,OPGS006296,0.186,RNAseq,AC060766.4,0.98 (0.97 0.99),4.49E-02
495,Asthma,respiratory,OPGS008185,0.110,RNAseq,TSEN54,1.02 (1.01 1.03),4.49E-02
495,Asthma,respiratory,OPGS013230,0.029,RNAseq,EP300,1.02 (1.01 1.03),4.56E-02
495,Asthma,respiratory,OPGS010608,0.059,RNAseq,BBS12,0.98 (0.97 0.99),4.61E-02
495,Asthma,respiratory,OPGS014319,0.020,RNAseq,RUVBL1,0.98 (0.97 0.99),4.61E-02
495,Asthma,respiratory,OPGS006941,0.154,RNAseq,RBMS1,1.02 (1.01 1.03),4.65E-02
495,Asthma,respiratory,OPGS006661,0.167,RNAseq,NUDT13,0.98 (0.97 0.99),4.78E-02
495,Asthma,respiratory,OPGS003576,0.728,RNAseq,DGKQ,1.02 (1.01 1.03),4.88E-02
496,Chronic airway obstruction,respiratory,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,0.96 (0.94 0.97),2.88E-03
496,Chronic airway obstruction,respiratory,OPGS001587,0.023,SomaScan,Carboxypeptidase E,0.96 (0.94 0.97),2.88E-03
496,Chronic airway obstruction,respiratory,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,0.96 (0.95 0.98),7.43E-03
496,Chronic airway obstruction,respiratory,OPGS000179,0.254,SomaScan,Cardiotrophin-1,0.96 (0.95 0.98),8.38E-03
496,Chronic airway obstruction,respiratory,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,0.96 (0.95 0.98),8.38E-03
496,Chronic airway obstruction,respiratory,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,0.96 (0.95 0.98),8.38E-03
496,Chronic airway obstruction,respiratory,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,0.96 (0.95 0.98),8.88E-03
496,Chronic airway obstruction,respiratory,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,0.96 (0.95 0.98),8.88E-03
496,Chronic airway obstruction,respiratory,OPGS000857,0.067,SomaScan,Moesin,0.96 (0.95 0.98),8.88E-03
496,Chronic airway obstruction,respiratory,OPGS002114,0.012,SomaScan,Neutrophil gelatinase-associated lipocalin,1.04 (1.02 1.05),8.88E-03
496,Chronic airway obstruction,respiratory,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,0.96 (0.95 0.98),1.42E-02
496,Chronic airway obstruction,respiratory,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,1.04 (1.02 1.05),1.82E-02
496,Chronic airway obstruction,respiratory,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,0.97 (0.95 0.98),2.79E-02
496,Chronic airway obstruction,respiratory,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,0.97 (0.95 0.98),3.24E-02
496,Chronic airway obstruction,respiratory,OPGS001354,0.031,SomaScan,M-phase inducer phosphatase 2,0.97 (0.95 0.98),3.43E-02
496,Chronic airway obstruction,respiratory,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,0.97 (0.95 0.99),4.74E-02
496,Chronic airway obstruction,respiratory,OPGS002617,0.026,Olink,C-X-C motif chemokine 9,1.04 (1.02 1.05),1.51E-02
496,Chronic airway obstruction,respiratory,OPGS003226,0.010,Metabolon,indolin-2-one,0.96 (0.95 0.98),1.29E-02
496,Chronic airway obstruction,respiratory,OPGS003190,0.012,Metabolon,3-methylxanthine,1.03 (1.02 1.05),2.79E-02
496,Chronic airway obstruction,respiratory,OPGS003106,0.018,Metabolon,X - 12126,1.03 (1.02 1.05),3.27E-02
496,Chronic airway obstruction,respiratory,OPGS003497,0.072,Nightingale,Linoleic acid,0.97 (0.95 0.98),2.40E-02
496,Chronic airway obstruction,respiratory,OPGS004694,0.324,RNAseq,IREB2,0.95 (0.93 0.96),3.75E-06
496,Chronic airway obstruction,respiratory,OPGS005704,0.221,RNAseq,AF131215.5,1.04 (1.02 1.06),2.88E-03
496,Chronic airway obstruction,respiratory,OPGS008702,0.097,RNAseq,,0.96 (0.95 0.98),8.38E-03
496,Chronic airway obstruction,respiratory,OPGS003645,0.643,RNAseq,PYGB,1.04 (1.02 1.05),8.88E-03
496,Chronic airway obstruction,respiratory,OPGS012942,0.031,RNAseq,NIBAN1,1.04 (1.02 1.05),8.88E-03
496,Chronic airway obstruction,respiratory,OPGS014376,0.020,RNAseq,PLEKHN1,0.97 (0.95 0.98),9.32E-03
496,Chronic airway obstruction,respiratory,OPGS010279,0.065,RNAseq,SMAD3,0.97 (0.95 0.98),1.42E-02
496,Chronic airway obstruction,respiratory,OPGS012458,0.036,RNAseq,PRAG1,1.04 (1.02 1.05),1.46E-02
496,Chronic airway obstruction,respiratory,OPGS013999,0.023,RNAseq,GUK1,1.03 (1.02 1.05),1.46E-02
496,Chronic airway obstruction,respiratory,OPGS011618,0.046,RNAseq,MED27,1.03 (1.02 1.05),1.85E-02
496,Chronic airway obstruction,respiratory,OPGS009111,0.087,RNAseq,KCNC3,1.03 (1.02 1.05),2.01E-02
496,Chronic airway obstruction,respiratory,OPGS012697,0.034,RNAseq,RNFT2,0.97 (0.95 0.98),2.26E-02
496,Chronic airway obstruction,respiratory,OPGS007516,0.132,RNAseq,HSPA6,0.97 (0.95 0.98),2.27E-02
496,Chronic airway obstruction,respiratory,OPGS006215,0.191,RNAseq,PGAP3,1.03 (1.02 1.05),2.27E-02
496,Chronic airway obstruction,respiratory,OPGS006034,0.201,RNAseq,,0.97 (0.95 0.98),2.43E-02
496,Chronic airway obstruction,respiratory,OPGS005117,0.275,RNAseq,NPIPB12,1.03 (1.02 1.05),2.50E-02
496,Chronic airway obstruction,respiratory,OPGS004638,0.335,RNAseq,MYO16-AS1,1.03 (1.02 1.05),2.50E-02
496,Chronic airway obstruction,respiratory,OPGS008976,0.090,RNAseq,EDEM3,0.97 (0.95 0.98),2.50E-02
496,Chronic airway obstruction,respiratory,OPGS010468,0.062,RNAseq,SCAI,1.03 (1.02 1.05),2.79E-02
496,Chronic airway obstruction,respiratory,OPGS007728,0.124,RNAseq,PRAM1,1.03 (1.02 1.05),2.79E-02
496,Chronic airway obstruction,respiratory,OPGS005815,0.214,RNAseq,LINC01089,0.97 (0.95 0.98),3.27E-02
496,Chronic airway obstruction,respiratory,OPGS004108,0.434,RNAseq,GPD2,0.97 (0.95 0.98),3.27E-02
496,Chronic airway obstruction,respiratory,OPGS012274,0.038,RNAseq,BCAS2,0.97 (0.95 0.98),3.43E-02
496,Chronic airway obstruction,respiratory,OPGS006038,0.201,RNAseq,HLA-DQA2,1.03 (1.02 1.05),3.43E-02
496,Chronic airway obstruction,respiratory,OPGS003831,0.538,RNAseq,,0.97 (0.95 0.98),3.43E-02
496,Chronic airway obstruction,respiratory,OPGS009978,0.070,RNAseq,C3orf38,1.03 (1.02 1.05),4.12E-02
496,Chronic airway obstruction,respiratory,OPGS006315,0.186,RNAseq,NPRL3,0.97 (0.95 0.98),4.25E-02
496,Chronic airway obstruction,respiratory,OPGS005796,0.215,RNAseq,,1.03 (1.02 1.05),4.39E-02
496,Chronic airway obstruction,respiratory,OPGS007619,0.128,RNAseq,KCNG2,1.03 (1.02 1.05),4.45E-02
496,Chronic airway obstruction,respiratory,OPGS005300,0.257,RNAseq,AF131215.6,1.03 (1.02 1.05),4.45E-02
496,Chronic airway obstruction,respiratory,OPGS009728,0.074,RNAseq,NMB,1.03 (1.02 1.05),4.62E-02
496.1,Emphysema,respiratory,OPGS002186,0.011,SomaScan,Suprabasin,1.13 (1.10 1.16),1.02E-18
496.1,Emphysema,respiratory,OPGS001879,0.015,SomaScan,Arfaptin-2,0.88 (0.86 0.91),1.02E-18
496.1,Emphysema,respiratory,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,1.13 (1.10 1.16),1.88E-16
496.1,Emphysema,respiratory,OPGS000717,0.082,SomaScan,Zinc finger protein 175,1.13 (1.10 1.16),3.32E-16
496.1,Emphysema,respiratory,OPGS001546,0.024,SomaScan,Glypican-6,1.13 (1.10 1.16),2.48E-14
496.1,Emphysema,respiratory,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,1.12 (1.09 1.15),1.92E-11
496.1,Emphysema,respiratory,OPGS000159,0.271,SomaScan,39S ribosomal protein L33. mitochondrial,1.12 (1.09 1.16),3.10E-10
496.1,Emphysema,respiratory,OPGS000272,0.183,SomaScan,Alpha-1-antitrypsin,0.89 (0.87 0.92),8.05E-10
496.1,Emphysema,respiratory,OPGS000518,0.114,SomaScan,Thioredoxin domain-containing protein 5,1.10 (1.07 1.14),2.60E-06
496.1,Emphysema,respiratory,OPGS000793,0.074,SomaScan,Lysosomal acid phosphatase,1.09 (1.06 1.13),4.24E-05
496.1,Emphysema,respiratory,OPGS000658,0.089,SomaScan,Ubiquitin carboxyl-terminal hydrolase isozyme L1,1.08 (1.05 1.12),2.07E-04
496.1,Emphysema,respiratory,OPGS000523,0.112,SomaScan,DnaJ homolog subfamily B member 9,1.09 (1.05 1.12),3.95E-04
496.1,Emphysema,respiratory,OPGS000500,0.118,SomaScan,Synaptosomal-associated protein 25,1.08 (1.05 1.11),9.47E-04
496.1,Emphysema,respiratory,OPGS000007,0.709,SomaScan,Paired immunoglobulin-like type 2 receptor alpha isoform FDF03-deltaTM,1.07 (1.04 1.10),2.92E-02
496.1,Emphysema,respiratory,OPGS000285,0.176,SomaScan,Complement C1q tumor necrosis factor-related protein 1,0.94 (0.91 0.97),3.50E-02
496.1,Emphysema,respiratory,OPGS000864,0.066,SomaScan,UDP-glucuronosyltransferase 1-6,1.07 (1.03 1.10),4.37E-02
496.1,Emphysema,respiratory,OPGS002654,0.015,Olink,Thrombopoietin,1.12 (1.09 1.16),1.32E-12
496.1,Emphysema,respiratory,OPGS002529,0.068,Olink,Tumor necrosis factor receptor superfamily member 3,1.12 (1.09 1.15),4.47E-10
496.1,Emphysema,respiratory,OPGS002482,0.125,Olink,Tumor necrosis factor ligand superfamily member 10,1.10 (1.06 1.13),5.15E-05
496.1,Emphysema,respiratory,OPGS003106,0.018,Metabolon,X - 12126,1.08 (1.05 1.12),2.39E-03
496.1,Emphysema,respiratory,OPGS003226,0.010,Metabolon,indolin-2-one,0.92 (0.89 0.96),3.14E-03
496.1,Emphysema,respiratory,OPGS003190,0.012,Metabolon,3-methylxanthine,1.08 (1.04 1.12),9.88E-03
496.1,Emphysema,respiratory,OPGS003097,0.019,Metabolon,X - 12216,1.07 (1.04 1.11),3.14E-02
496.1,Emphysema,respiratory,OPGS004694,0.324,RNAseq,IREB2,0.92 (0.89 0.95),9.47E-04
496.1,Emphysema,respiratory,OPGS006038,0.201,RNAseq,HLA-DQA2,1.07 (1.04 1.11),4.81E-03
496.1,Emphysema,respiratory,OPGS009512,0.079,RNAseq,NUMBL,0.93 (0.90 0.96),4.81E-03
496.1,Emphysema,respiratory,OPGS013657,0.025,RNAseq,TAF15,1.07 (1.03 1.10),2.02E-02
496.1,Emphysema,respiratory,OPGS008065,0.114,RNAseq,TOP3A,0.94 (0.90 0.97),4.37E-02
496.3,Bronchiectasis,respiratory,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,0.91 (0.88 0.94),3.55E-06
496.3,Bronchiectasis,respiratory,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.90 (0.87 0.93),3.55E-06
496.3,Bronchiectasis,respiratory,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,0.91 (0.88 0.94),3.73E-05
496.3,Bronchiectasis,respiratory,OPGS000645,0.091,SomaScan,Trypsin-3,0.92 (0.89 0.95),8.96E-05
496.3,Bronchiectasis,respiratory,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,1.08 (1.04 1.11),2.85E-03
496.3,Bronchiectasis,respiratory,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,0.93 (0.90 0.96),2.85E-03
496.3,Bronchiectasis,respiratory,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,0.92 (0.89 0.95),2.85E-03
496.3,Bronchiectasis,respiratory,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.93 (0.90 0.96),8.22E-03
496.3,Bronchiectasis,respiratory,OPGS001893,0.015,SomaScan,Interleukin-17F,0.93 (0.90 0.96),1.24E-02
496.3,Bronchiectasis,respiratory,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.93 (0.91 0.96),1.33E-02
496.3,Bronchiectasis,respiratory,OPGS001464,0.027,SomaScan,Platelet glycoprotein Ib alpha chain,1.06 (1.03 1.10),3.18E-02
496.3,Bronchiectasis,respiratory,OPGS002598,0.031,Olink,Interleukin-10,1.08 (1.05 1.11),1.46E-03
496.3,Bronchiectasis,respiratory,OPGS002422,0.223,Olink,Lymphotoxin-alpha,0.93 (0.91 0.96),5.70E-03
496.3,Bronchiectasis,respiratory,OPGS010624,0.059,RNAseq,TRBV18,0.91 (0.88 0.94),2.38E-05
496.3,Bronchiectasis,respiratory,OPGS011853,0.043,RNAseq,TRBV6-1,1.09 (1.06 1.12),1.19E-04
496.3,Bronchiectasis,respiratory,OPGS005519,0.236,RNAseq,AL645933.3,1.09 (1.05 1.12),6.07E-04
496.3,Bronchiectasis,respiratory,OPGS009711,0.075,RNAseq,TRAV21,0.92 (0.89 0.95),7.17E-04
496.3,Bronchiectasis,respiratory,OPGS006942,0.154,RNAseq,SKIV2L,0.93 (0.90 0.96),2.38E-03
496.3,Bronchiectasis,respiratory,OPGS009077,0.088,RNAseq,DDAH2,1.08 (1.04 1.11),2.85E-03
496.3,Bronchiectasis,respiratory,OPGS007018,0.151,RNAseq,TRBV10-3,1.08 (1.05 1.11),2.85E-03
496.3,Bronchiectasis,respiratory,OPGS004070,0.445,RNAseq,AC092683.1,1.07 (1.04 1.11),4.03E-03
496.3,Bronchiectasis,respiratory,OPGS010607,0.059,RNAseq,TRAV8-1,0.93 (0.90 0.96),9.91E-03
496.3,Bronchiectasis,respiratory,OPGS011010,0.054,RNAseq,TRBV5-4,1.07 (1.04 1.11),1.04E-02
496.3,Bronchiectasis,respiratory,OPGS003680,0.611,RNAseq,,0.93 (0.90 0.96),1.33E-02
496.3,Bronchiectasis,respiratory,OPGS007138,0.146,RNAseq,HCG27,0.93 (0.91 0.96),1.54E-02
496.3,Bronchiectasis,respiratory,OPGS005167,0.269,RNAseq,TCF19,1.06 (1.03 1.10),2.03E-02
496.3,Bronchiectasis,respiratory,OPGS010561,0.060,RNAseq,IL2RA,1.07 (1.03 1.10),2.10E-02
496.3,Bronchiectasis,respiratory,OPGS004122,0.430,RNAseq,HLA-DRB5,1.06 (1.03 1.10),3.94E-02
496.3,Bronchiectasis,respiratory,OPGS015068,0.015,RNAseq,ZBTB41,0.94 (0.92 0.97),4.63E-02
501,Pneumonitis due to inhalation of food or vomitus,respiratory,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.10 (1.06 1.15),3.46E-02
501,Pneumonitis due to inhalation of food or vomitus,respiratory,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.10 (1.05 1.15),3.46E-02
501,Pneumonitis due to inhalation of food or vomitus,respiratory,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.10 (1.05 1.14),3.46E-02
501,Pneumonitis due to inhalation of food or vomitus,respiratory,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.10 (1.05 1.14),3.46E-02
501,Pneumonitis due to inhalation of food or vomitus,respiratory,OPGS000857,0.067,SomaScan,Moesin,1.10 (1.05 1.14),3.80E-02
502,Postinflammatory pulmonary fibrosis,respiratory,OPGS003644,0.643,RNAseq,KANSL1-AS1,0.89 (0.85 0.93),1.69E-03
502,Postinflammatory pulmonary fibrosis,respiratory,OPGS003625,0.664,RNAseq,,1.13 (1.08 1.18),1.69E-03
502,Postinflammatory pulmonary fibrosis,respiratory,OPGS008327,0.106,RNAseq,PLEKHM1,0.90 (0.86 0.94),7.29E-03
502,Postinflammatory pulmonary fibrosis,respiratory,OPGS010026,0.069,RNAseq,HIF1A,1.11 (1.06 1.16),1.01E-02
502,Postinflammatory pulmonary fibrosis,respiratory,OPGS009893,0.071,RNAseq,HORMAD1,0.90 (0.86 0.94),1.03E-02
502,Postinflammatory pulmonary fibrosis,respiratory,OPGS012851,0.032,RNAseq,SUDS3,0.90 (0.86 0.94),1.62E-02
502,Postinflammatory pulmonary fibrosis,respiratory,OPGS005416,0.245,RNAseq,ARHGAP5,1.10 (1.05 1.15),4.69E-02
510,Other diseases of lung,respiratory,OPGS006176,0.193,RNAseq,ZBED4,1.11 (1.07 1.16),1.47E-03
510,Other diseases of lung,respiratory,OPGS014179,0.021,RNAseq,AFF4,0.90 (0.87 0.94),1.56E-03
510,Other diseases of lung,respiratory,OPGS006711,0.165,RNAseq,PAQR9,0.91 (0.87 0.94),1.27E-02
512.7,Shortness of breath,respiratory,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.96 (0.94 0.97),2.26E-02
512.7,Shortness of breath,respiratory,OPGS000351,0.151,SomaScan,C1GALT1-specific chaperone 1,1.05 (1.03 1.07),2.26E-02
512.7,Shortness of breath,respiratory,OPGS001658,0.020,SomaScan,Endoglin,0.96 (0.94 0.98),2.26E-02
512.7,Shortness of breath,respiratory,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,1.05 (1.03 1.07),2.26E-02
512.7,Shortness of breath,respiratory,OPGS001915,0.014,SomaScan,N-acetylglucosamine-6-sulfatase,0.96 (0.94 0.98),2.96E-02
512.7,Shortness of breath,respiratory,OPGS001127,0.044,SomaScan,Carbohydrate sulfotransferase 15,0.96 (0.94 0.98),3.05E-02
512.7,Shortness of breath,respiratory,OPGS001954,0.014,SomaScan,Tuftelin,0.96 (0.94 0.98),3.23E-02
512.7,Shortness of breath,respiratory,OPGS001045,0.050,SomaScan,Carbohydrate sulfotransferase 15,0.96 (0.94 0.98),3.23E-02
512.7,Shortness of breath,respiratory,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,0.96 (0.94 0.98),3.91E-02
512.7,Shortness of breath,respiratory,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.04 (1.02 1.06),3.91E-02
512.7,Shortness of breath,respiratory,OPGS000088,0.392,SomaScan,E-selectin,0.96 (0.94 0.98),3.91E-02
512.7,Shortness of breath,respiratory,OPGS000923,0.060,SomaScan,Thrombospondin type-1 domain-containing protein 1,0.96 (0.94 0.98),3.91E-02
512.7,Shortness of breath,respiratory,OPGS002500,0.098,Olink,Galectin-4,0.96 (0.94 0.98),2.26E-02
512.7,Shortness of breath,respiratory,OPGS002408,0.270,Olink,E-selectin,0.96 (0.94 0.98),2.63E-02
512.7,Shortness of breath,respiratory,OPGS002590,0.035,Olink,Platelet endothelial cell adhesion molecule,0.96 (0.94 0.98),3.23E-02
512.7,Shortness of breath,respiratory,OPGS015054,0.015,RNAseq,H19,1.04 (1.02 1.06),4.46E-02
512.9,Other dyspnea,respiratory,OPGS001659,0.020,SomaScan,Phosphoribosyl pyrophosphate synthase-associated protein 1,0.90 (0.86 0.94),1.44E-02
514,Abnormal findings examination of lungs,respiratory,OPGS002175,0.011,SomaScan,Chymase,0.99 (0.98 0.99),4.80E-04
519.8,Other diseases of respiratory system. NEC,respiratory,OPGS002010,0.013,SomaScan,Myc proto-oncogene protein,1.02 (1.01 1.02),2.95E-05
524.3,Anomalies of tooth position/malocclusion,digestive,OPGS008573,0.099,RNAseq,CACNB4,1.26 (1.15 1.39),2.53E-02
527.8,Other specified diseases of the salivary glands,digestive,OPGS009390,0.082,RNAseq,ZFAND1,0.73 (0.64 0.83),2.26E-02
530,Diseases of esophagus,digestive,OPGS002145,0.011,SomaScan,Radiation-inducible immediate-early gene IEX-1,1.09 (1.05 1.14),4.05E-02
530.11,GERD,digestive,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,1.03 (1.02 1.04),3.22E-02
530.11,GERD,digestive,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.03 (1.02 1.04),3.22E-02
530.11,GERD,digestive,OPGS001102,0.046,SomaScan,Granzyme A,1.03 (1.01 1.04),3.27E-02
530.11,GERD,digestive,OPGS002568,0.043,Olink,Granzyme A,1.03 (1.01 1.04),4.94E-02
530.11,GERD,digestive,OPGS014864,0.017,RNAseq,SUGCT,1.03 (1.01 1.04),3.27E-02
530.11,GERD,digestive,OPGS004134,0.427,RNAseq,H2BC5,1.03 (1.01 1.04),3.27E-02
530.14,Reflux esophagitis,digestive,OPGS000015,0.645,SomaScan,Endoplasmic reticulum aminopeptidase 2,1.04 (1.02 1.05),4.69E-02
530.14,Reflux esophagitis,digestive,OPGS005810,0.214,RNAseq,AC009318.4,0.96 (0.95 0.98),2.72E-02
530.14,Reflux esophagitis,digestive,OPGS004511,0.352,RNAseq,EXOC3,0.97 (0.95 0.98),4.69E-02
530.14,Reflux esophagitis,digestive,OPGS014226,0.021,RNAseq,ITGAM,1.04 (1.02 1.05),4.69E-02
530.14,Reflux esophagitis,digestive,OPGS011283,0.050,RNAseq,CD248,1.04 (1.02 1.05),4.69E-02
530.14,Reflux esophagitis,digestive,OPGS009371,0.082,RNAseq,TRBV19,1.04 (1.02 1.05),4.69E-02
530.14,Reflux esophagitis,digestive,OPGS004406,0.369,RNAseq,,1.04 (1.02 1.05),4.69E-02
531.3,Duodenal ulcer,digestive,OPGS000362,0.147,SomaScan,Golgi membrane protein 1,0.90 (0.88 0.93),8.18E-06
531.3,Duodenal ulcer,digestive,OPGS000106,0.366,SomaScan,Protein FAM3D,0.91 (0.88 0.94),2.26E-05
531.3,Duodenal ulcer,digestive,OPGS000885,0.064,SomaScan,Dipeptidase 2,1.09 (1.06 1.13),4.73E-05
531.3,Duodenal ulcer,digestive,OPGS000664,0.088,SomaScan,BPI fold-containing family A member 2,1.09 (1.05 1.12),7.13E-04
531.3,Duodenal ulcer,digestive,OPGS001812,0.017,SomaScan,Fibroblast growth factor 19,0.92 (0.89 0.95),1.03E-03
531.3,Duodenal ulcer,digestive,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,1.08 (1.05 1.12),2.50E-03
531.3,Duodenal ulcer,digestive,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,0.92 (0.90 0.95),2.50E-03
531.3,Duodenal ulcer,digestive,OPGS001954,0.014,SomaScan,Tuftelin,1.08 (1.05 1.12),2.89E-03
531.3,Duodenal ulcer,digestive,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,1.08 (1.05 1.12),3.02E-03
531.3,Duodenal ulcer,digestive,OPGS001658,0.020,SomaScan,Endoglin,1.08 (1.05 1.12),3.79E-03
531.3,Duodenal ulcer,digestive,OPGS000095,0.381,SomaScan,Sulfhydryl oxidase 2,0.93 (0.90 0.96),3.88E-03
531.3,Duodenal ulcer,digestive,OPGS000088,0.392,SomaScan,E-selectin,1.08 (1.04 1.11),3.88E-03
531.3,Duodenal ulcer,digestive,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,0.93 (0.90 0.96),4.03E-03
531.3,Duodenal ulcer,digestive,OPGS000600,0.099,SomaScan,Insulin receptor,1.08 (1.04 1.11),4.03E-03
531.3,Duodenal ulcer,digestive,OPGS001490,0.026,SomaScan,Intercellular adhesion molecule 2,1.07 (1.04 1.11),8.00E-03
531.3,Duodenal ulcer,digestive,OPGS000889,0.064,SomaScan,Hepatocyte growth factor receptor,1.07 (1.04 1.10),1.50E-02
531.3,Duodenal ulcer,digestive,OPGS001045,0.050,SomaScan,Carbohydrate sulfotransferase 15,1.07 (1.04 1.10),1.65E-02
531.3,Duodenal ulcer,digestive,OPGS001127,0.044,SomaScan,Carbohydrate sulfotransferase 15,1.07 (1.03 1.10),2.64E-02
531.3,Duodenal ulcer,digestive,OPGS001915,0.014,SomaScan,N-acetylglucosamine-6-sulfatase,1.07 (1.03 1.10),2.65E-02
531.3,Duodenal ulcer,digestive,OPGS001301,0.034,SomaScan,Glycosaminoglycan xylosylkinase,0.94 (0.91 0.97),2.96E-02
531.3,Duodenal ulcer,digestive,OPGS000150,0.284,SomaScan,Plasma kallikrein,0.94 (0.91 0.97),4.99E-02
531.3,Duodenal ulcer,digestive,OPGS002657,0.013,Olink,Fibroblast growth factor 19,0.92 (0.89 0.95),2.97E-04
531.3,Duodenal ulcer,digestive,OPGS002408,0.270,Olink,E-selectin,1.08 (1.04 1.11),3.88E-03
531.3,Duodenal ulcer,digestive,OPGS002651,0.015,Olink,von Willebrand factor,0.93 (0.90 0.96),8.00E-03
531.3,Duodenal ulcer,digestive,OPGS002437,0.187,Olink,Serine protease 27,1.07 (1.04 1.10),1.58E-02
531.3,Duodenal ulcer,digestive,OPGS002500,0.098,Olink,Galectin-4,1.07 (1.04 1.10),1.85E-02
531.3,Duodenal ulcer,digestive,OPGS002590,0.035,Olink,Platelet endothelial cell adhesion molecule,1.07 (1.04 1.10),1.85E-02
531.3,Duodenal ulcer,digestive,OPGS003149,0.015,Metabolon,sphingosine,0.93 (0.90 0.96),8.01E-03
531.3,Duodenal ulcer,digestive,OPGS002726,0.198,Metabolon,methionylalanine,0.94 (0.91 0.97),2.65E-02
531.3,Duodenal ulcer,digestive,OPGS002742,0.161,Metabolon,bradykinin,0.94 (0.91 0.97),4.09E-02
531.3,Duodenal ulcer,digestive,OPGS007421,0.135,RNAseq,ARMH1,0.93 (0.90 0.96),1.94E-03
531.3,Duodenal ulcer,digestive,OPGS006849,0.158,RNAseq,LYPD2,1.07 (1.04 1.10),1.24E-02
531.3,Duodenal ulcer,digestive,OPGS008595,0.099,RNAseq,TMPRSS5,1.06 (1.03 1.09),2.65E-02
531.3,Duodenal ulcer,digestive,OPGS011768,0.044,RNAseq,ZCCHC9,1.06 (1.03 1.09),4.96E-02
535.6,Duodenitis,digestive,OPGS000362,0.147,SomaScan,Golgi membrane protein 1,0.95 (0.93 0.97),1.19E-03
535.6,Duodenitis,digestive,OPGS000106,0.366,SomaScan,Protein FAM3D,0.95 (0.93 0.97),2.32E-03
535.6,Duodenitis,digestive,OPGS000645,0.091,SomaScan,Trypsin-3,1.05 (1.03 1.07),6.48E-03
535.6,Duodenitis,digestive,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.05 (1.03 1.07),8.58E-03
535.6,Duodenitis,digestive,OPGS001812,0.017,SomaScan,Fibroblast growth factor 19,0.96 (0.94 0.98),1.38E-02
535.6,Duodenitis,digestive,OPGS000664,0.088,SomaScan,BPI fold-containing family A member 2,1.04 (1.02 1.06),2.46E-02
535.6,Duodenitis,digestive,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.04 (1.02 1.06),3.52E-02
535.6,Duodenitis,digestive,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,0.96 (0.94 0.98),3.71E-02
535.6,Duodenitis,digestive,OPGS000088,0.392,SomaScan,E-selectin,1.04 (1.02 1.06),4.76E-02
535.6,Duodenitis,digestive,OPGS000101,0.374,SomaScan,CD209 antigen,0.96 (0.94 0.98),4.76E-02
535.6,Duodenitis,digestive,OPGS002657,0.013,Olink,Fibroblast growth factor 19,0.96 (0.94 0.98),2.40E-02
535.6,Duodenitis,digestive,OPGS012028,0.041,RNAseq,HLA-DQB1-AS1,0.95 (0.94 0.97),5.32E-03
535.6,Duodenitis,digestive,OPGS014496,0.019,RNAseq,VARS1,1.05 (1.03 1.07),6.61E-03
535.6,Duodenitis,digestive,OPGS006499,0.176,RNAseq,C4A,0.96 (0.94 0.98),1.80E-02
535.6,Duodenitis,digestive,OPGS012304,0.038,RNAseq,PBX2,0.96 (0.94 0.98),2.46E-02
535.6,Duodenitis,digestive,OPGS006262,0.188,RNAseq,GHRLOS,1.04 (1.02 1.06),3.71E-02
535.6,Duodenitis,digestive,OPGS003680,0.611,RNAseq,,1.04 (1.02 1.06),3.71E-02
535.6,Duodenitis,digestive,OPGS006849,0.158,RNAseq,LYPD2,1.04 (1.02 1.06),3.77E-02
535.6,Duodenitis,digestive,OPGS004256,0.400,RNAseq,RAB5A,1.04 (1.02 1.06),4.76E-02
536.8,Dyspepsia and other specified disorders of function of stomach,digestive,OPGS014762,0.017,RNAseq,ADSS1,0.90 (0.90 0.91),0.00E+00
537,Other disorders of stomach and duodenum,digestive,OPGS002437,0.187,Olink,Serine protease 27,1.07 (1.04 1.09),4.13E-02
550,Abdominal hernia,digestive,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.90 (0.88 0.93),3.81E-09
550,Abdominal hernia,digestive,OPGS013201,0.029,RNAseq,NRCAM,1.07 (1.04 1.10),2.01E-03
550.1,Inguinal hernia,digestive,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.88 (0.87 0.89),2.50E-66
550.1,Inguinal hernia,digestive,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,1.04 (1.02 1.05),2.88E-04
550.1,Inguinal hernia,digestive,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.03 (1.02 1.05),8.55E-04
550.1,Inguinal hernia,digestive,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,1.03 (1.02 1.05),1.41E-03
550.1,Inguinal hernia,digestive,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,1.03 (1.02 1.05),1.56E-03
550.1,Inguinal hernia,digestive,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,1.03 (1.02 1.05),1.58E-03
550.1,Inguinal hernia,digestive,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.97 (0.96 0.98),2.28E-03
550.1,Inguinal hernia,digestive,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.03 (1.02 1.05),2.92E-03
550.1,Inguinal hernia,digestive,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,1.03 (1.02 1.04),4.18E-03
550.1,Inguinal hernia,digestive,OPGS000163,0.269,SomaScan,Single Ig IL-1-related receptor,1.03 (1.02 1.04),5.38E-03
550.1,Inguinal hernia,digestive,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.03 (1.02 1.04),9.15E-03
550.1,Inguinal hernia,digestive,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,1.03 (1.02 1.04),9.60E-03
550.1,Inguinal hernia,digestive,OPGS000173,0.257,SomaScan,Janus kinase and microtubule-interacting protein 3,1.03 (1.01 1.04),1.05E-02
550.1,Inguinal hernia,digestive,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,1.03 (1.01 1.04),1.11E-02
550.1,Inguinal hernia,digestive,OPGS001831,0.016,SomaScan,SUN domain-containing protein 3,1.03 (1.01 1.04),1.11E-02
550.1,Inguinal hernia,digestive,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.03 (1.01 1.04),1.32E-02
550.1,Inguinal hernia,digestive,OPGS000115,0.347,SomaScan,Protein CEI,1.03 (1.01 1.04),1.32E-02
550.1,Inguinal hernia,digestive,OPGS000197,0.236,SomaScan,Inter-alpha-trypsin inhibitor heavy chain H1,0.97 (0.96 0.99),1.57E-02
550.1,Inguinal hernia,digestive,OPGS000576,0.102,SomaScan,Interleukin-21,1.03 (1.01 1.04),1.67E-02
550.1,Inguinal hernia,digestive,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.03 (1.01 1.04),1.67E-02
550.1,Inguinal hernia,digestive,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.03 (1.01 1.04),2.23E-02
550.1,Inguinal hernia,digestive,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,1.03 (1.01 1.04),2.26E-02
550.1,Inguinal hernia,digestive,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.03 (1.01 1.04),2.35E-02
550.1,Inguinal hernia,digestive,OPGS000572,0.102,SomaScan,Glutamate receptor 4,1.03 (1.01 1.04),2.50E-02
550.1,Inguinal hernia,digestive,OPGS000184,0.253,SomaScan,Granulysin,1.03 (1.01 1.04),2.56E-02
550.1,Inguinal hernia,digestive,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.03 (1.01 1.04),2.58E-02
550.1,Inguinal hernia,digestive,OPGS000613,0.096,SomaScan,Stromelysin-1,1.03 (1.01 1.04),2.69E-02
550.1,Inguinal hernia,digestive,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,1.03 (1.01 1.04),3.51E-02
550.1,Inguinal hernia,digestive,OPGS000857,0.067,SomaScan,Moesin,1.02 (1.01 1.04),3.55E-02
550.1,Inguinal hernia,digestive,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.02 (1.01 1.04),3.80E-02
550.1,Inguinal hernia,digestive,OPGS001906,0.015,SomaScan,Chondroitin sulfate N-acetylgalactosaminyltransferase 2,0.98 (0.96 0.99),3.96E-02
550.1,Inguinal hernia,digestive,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,0.98 (0.96 0.99),4.18E-02
550.1,Inguinal hernia,digestive,OPGS001581,0.023,SomaScan,SLAM family member 6,1.02 (1.01 1.04),4.38E-02
550.1,Inguinal hernia,digestive,OPGS000101,0.374,SomaScan,CD209 antigen,0.98 (0.96 0.99),4.45E-02
550.1,Inguinal hernia,digestive,OPGS000317,0.162,SomaScan,Ficolin-1,1.02 (1.01 1.04),4.49E-02
550.1,Inguinal hernia,digestive,OPGS001022,0.052,SomaScan,Carbohydrate sulfotransferase 9,1.02 (1.01 1.04),4.74E-02
550.1,Inguinal hernia,digestive,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,0.98 (0.96 0.99),4.86E-02
550.1,Inguinal hernia,digestive,OPGS001157,0.041,SomaScan,Transmembrane protein 106A,0.98 (0.96 0.99),4.89E-02
550.1,Inguinal hernia,digestive,OPGS003031,0.026,Metabolon,X - 21312,0.96 (0.95 0.98),9.42E-05
550.1,Inguinal hernia,digestive,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.03 (1.02 1.05),6.46E-04
550.1,Inguinal hernia,digestive,OPGS003220,0.011,Metabolon,3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF),1.03 (1.02 1.05),1.56E-03
550.1,Inguinal hernia,digestive,OPGS003113,0.018,Metabolon,1-docosapentaenoyl-GPC (22:5n6)*,1.03 (1.02 1.05),1.90E-03
550.1,Inguinal hernia,digestive,OPGS003006,0.030,Metabolon,cholesterol,1.03 (1.02 1.05),3.09E-03
550.1,Inguinal hernia,digestive,OPGS003089,0.020,Metabolon,X - 17690,0.97 (0.96 0.98),3.66E-03
550.1,Inguinal hernia,digestive,OPGS002930,0.046,Metabolon,X - 13866,0.97 (0.96 0.98),5.90E-03
550.1,Inguinal hernia,digestive,OPGS002931,0.045,Metabolon,eicosapentaenoate (EPA; 20:5n3),1.03 (1.02 1.04),8.79E-03
550.1,Inguinal hernia,digestive,OPGS003060,0.022,Metabolon,stearidonate (18:4n3),1.03 (1.02 1.04),9.20E-03
550.1,Inguinal hernia,digestive,OPGS003075,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*,1.03 (1.02 1.04),9.46E-03
550.1,Inguinal hernia,digestive,OPGS002884,0.058,Metabolon,ferulic acid 4-sulfate,0.97 (0.96 0.98),9.46E-03
550.1,Inguinal hernia,digestive,OPGS003111,0.018,Metabolon,X - 24542,1.03 (1.02 1.04),9.46E-03
550.1,Inguinal hernia,digestive,OPGS003109,0.018,Metabolon,1-linoleoyl-GPE (18:2)*,0.97 (0.96 0.98),9.60E-03
550.1,Inguinal hernia,digestive,OPGS003125,0.017,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6),1.03 (1.01 1.04),1.09E-02
550.1,Inguinal hernia,digestive,OPGS002909,0.049,Metabolon,X - 24439,0.97 (0.96 0.99),1.24E-02
550.1,Inguinal hernia,digestive,OPGS003042,0.024,Metabolon,1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6),1.03 (1.01 1.04),1.30E-02
550.1,Inguinal hernia,digestive,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.03 (1.01 1.04),1.32E-02
550.1,Inguinal hernia,digestive,OPGS002801,0.093,Metabolon,X - 12824,0.97 (0.96 0.99),1.33E-02
550.1,Inguinal hernia,digestive,OPGS002791,0.100,Metabolon,2-arachidonoyl-GPC (20:4)*,1.03 (1.01 1.04),1.38E-02
550.1,Inguinal hernia,digestive,OPGS003120,0.017,Metabolon,2-docosahexaenoyl-GPC (22:6)*,1.03 (1.01 1.04),1.49E-02
550.1,Inguinal hernia,digestive,OPGS003029,0.026,Metabolon,docosatrienoate (22:3n3),0.97 (0.96 0.99),1.59E-02
550.1,Inguinal hernia,digestive,OPGS003057,0.022,Metabolon,1-adrenoyl-GPC (22:4)*,1.03 (1.01 1.04),1.67E-02
550.1,Inguinal hernia,digestive,OPGS002843,0.073,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4),1.03 (1.01 1.04),1.67E-02
550.1,Inguinal hernia,digestive,OPGS002899,0.053,Metabolon,1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5)*,1.03 (1.01 1.04),1.68E-02
550.1,Inguinal hernia,digestive,OPGS002949,0.041,Metabolon,1-stearoyl-2-meadoyl-GPC (18:0/20:3n9)*,1.03 (1.01 1.04),1.73E-02
550.1,Inguinal hernia,digestive,OPGS002972,0.036,Metabolon,1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9)*,1.03 (1.01 1.04),1.80E-02
550.1,Inguinal hernia,digestive,OPGS002834,0.075,Metabolon,phosphatidylcholine (18:0/20:5. 16:0/22:5n6)*,1.03 (1.01 1.04),2.12E-02
550.1,Inguinal hernia,digestive,OPGS002829,0.079,Metabolon,arachidonate (20:4n6),1.03 (1.01 1.04),2.14E-02
550.1,Inguinal hernia,digestive,OPGS002890,0.056,Metabolon,X - 23705,1.03 (1.01 1.04),2.31E-02
550.1,Inguinal hernia,digestive,OPGS003159,0.014,Metabolon,docosapentaenoate (n3 DPA; 22:5n3),1.03 (1.01 1.04),2.35E-02
550.1,Inguinal hernia,digestive,OPGS003016,0.029,Metabolon,1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)*,1.03 (1.01 1.04),2.50E-02
550.1,Inguinal hernia,digestive,OPGS003100,0.019,Metabolon,1-arachidonylglycerol (20:4),1.03 (1.01 1.04),2.52E-02
550.1,Inguinal hernia,digestive,OPGS002980,0.034,Metabolon,1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2)*,0.97 (0.96 0.99),2.55E-02
550.1,Inguinal hernia,digestive,OPGS003077,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPC (P-16:0/22:6)*,1.03 (1.01 1.04),2.56E-02
550.1,Inguinal hernia,digestive,OPGS003189,0.012,Metabolon,2-linoleoyl-GPE (18:2)*,0.97 (0.96 0.99),2.58E-02
550.1,Inguinal hernia,digestive,OPGS002764,0.129,Metabolon,1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4),1.03 (1.01 1.04),2.62E-02
550.1,Inguinal hernia,digestive,OPGS002734,0.178,Metabolon,1-stearoyl-2-arachidonoyl-GPC (18:0/20:4),1.03 (1.01 1.04),2.65E-02
550.1,Inguinal hernia,digestive,OPGS003152,0.014,Metabolon,1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2)*,0.97 (0.96 0.99),2.65E-02
550.1,Inguinal hernia,digestive,OPGS002981,0.034,Metabolon,1-docosapentaenoyl-GPC (22:5n3)*,1.03 (1.01 1.04),2.65E-02
550.1,Inguinal hernia,digestive,OPGS002886,0.057,Metabolon,X - 12822,0.98 (0.96 0.99),3.28E-02
550.1,Inguinal hernia,digestive,OPGS003035,0.025,Metabolon,1-linoleoyl-GPI (18:2)*,0.98 (0.96 0.99),3.41E-02
550.1,Inguinal hernia,digestive,OPGS002855,0.069,Metabolon,1-palmityl-2-arachidonoyl-GPC (O-16:0/20:4)*,1.03 (1.01 1.04),3.80E-02
550.1,Inguinal hernia,digestive,OPGS003168,0.014,Metabolon,X - 24054,0.98 (0.96 0.99),3.85E-02
550.1,Inguinal hernia,digestive,OPGS002977,0.035,Metabolon,1.2-dilinoleoyl-GPC (18:2/18:2),0.98 (0.96 0.99),4.01E-02
550.1,Inguinal hernia,digestive,OPGS002872,0.061,Metabolon,1-eicosapentaenoyl-GPC (20:5)*,1.02 (1.01 1.04),4.03E-02
550.1,Inguinal hernia,digestive,OPGS003073,0.021,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*,1.02 (1.01 1.04),4.20E-02
550.1,Inguinal hernia,digestive,OPGS002747,0.146,Metabolon,1-arachidonoyl-GPC (20:4n6)*,1.02 (1.01 1.04),4.20E-02
550.1,Inguinal hernia,digestive,OPGS003014,0.029,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6)*,1.02 (1.01 1.04),4.33E-02
550.1,Inguinal hernia,digestive,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.03 (1.02 1.05),1.58E-03
550.1,Inguinal hernia,digestive,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.03 (1.02 1.04),6.86E-03
550.1,Inguinal hernia,digestive,OPGS006934,0.154,RNAseq,PRRG4,0.94 (0.93 0.96),1.26E-13
550.1,Inguinal hernia,digestive,OPGS013068,0.030,RNAseq,AL021807.1,0.95 (0.94 0.97),2.61E-08
550.1,Inguinal hernia,digestive,OPGS013243,0.029,RNAseq,TRAV3,1.04 (1.02 1.05),1.20E-04
550.1,Inguinal hernia,digestive,OPGS007041,0.151,RNAseq,SYT11,1.04 (1.02 1.05),1.90E-04
550.1,Inguinal hernia,digestive,OPGS010693,0.058,RNAseq,TRBV5-1,0.96 (0.95 0.98),2.88E-04
550.1,Inguinal hernia,digestive,OPGS009685,0.075,RNAseq,KCTD9,1.04 (1.02 1.05),2.88E-04
550.1,Inguinal hernia,digestive,OPGS009865,0.072,RNAseq,TRAV17,1.04 (1.02 1.05),2.88E-04
550.1,Inguinal hernia,digestive,OPGS009371,0.082,RNAseq,TRBV19,1.03 (1.02 1.05),6.46E-04
550.1,Inguinal hernia,digestive,OPGS010702,0.058,RNAseq,TASOR,1.03 (1.02 1.05),8.55E-04
550.1,Inguinal hernia,digestive,OPGS013225,0.029,RNAseq,REG4,1.03 (1.02 1.05),8.55E-04
550.1,Inguinal hernia,digestive,OPGS014283,0.021,RNAseq,MXRA8,1.03 (1.02 1.05),8.55E-04
550.1,Inguinal hernia,digestive,OPGS007675,0.126,RNAseq,TRAV12-2,0.97 (0.95 0.98),8.55E-04
550.1,Inguinal hernia,digestive,OPGS010142,0.067,RNAseq,PRSS16,0.97 (0.95 0.98),8.55E-04
550.1,Inguinal hernia,digestive,OPGS006248,0.189,RNAseq,MCCD1,1.03 (1.02 1.05),2.87E-03
550.1,Inguinal hernia,digestive,OPGS011283,0.050,RNAseq,CD248,1.03 (1.02 1.05),3.09E-03
550.1,Inguinal hernia,digestive,OPGS005230,0.263,RNAseq,LINC00243,0.97 (0.96 0.98),3.66E-03
550.1,Inguinal hernia,digestive,OPGS007642,0.127,RNAseq,CDK11B,0.97 (0.96 0.98),4.61E-03
550.1,Inguinal hernia,digestive,OPGS008069,0.114,RNAseq,PPP2R5E,0.97 (0.96 0.98),5.07E-03
550.1,Inguinal hernia,digestive,OPGS004107,0.435,RNAseq,TMEM204,0.97 (0.96 0.98),5.64E-03
550.1,Inguinal hernia,digestive,OPGS010826,0.056,RNAseq,TRIM10,1.03 (1.02 1.04),8.74E-03
550.1,Inguinal hernia,digestive,OPGS006845,0.158,RNAseq,FLOT1,0.97 (0.96 0.98),9.46E-03
550.1,Inguinal hernia,digestive,OPGS003644,0.643,RNAseq,KANSL1-AS1,1.03 (1.02 1.04),9.46E-03
550.1,Inguinal hernia,digestive,OPGS009917,0.071,RNAseq,TELO2,1.03 (1.02 1.04),9.46E-03
550.1,Inguinal hernia,digestive,OPGS006866,0.157,RNAseq,AL662795.2,0.97 (0.96 0.99),1.09E-02
550.1,Inguinal hernia,digestive,OPGS007018,0.151,RNAseq,TRBV10-3,0.97 (0.96 0.99),1.29E-02
550.1,Inguinal hernia,digestive,OPGS011438,0.048,RNAseq,H3C10,1.03 (1.01 1.04),1.30E-02
550.1,Inguinal hernia,digestive,OPGS008184,0.110,RNAseq,SEMA3A,1.03 (1.01 1.04),1.32E-02
550.1,Inguinal hernia,digestive,OPGS004956,0.291,RNAseq,,0.97 (0.96 0.99),1.38E-02
550.1,Inguinal hernia,digestive,OPGS008786,0.094,RNAseq,GABBR1,0.97 (0.96 0.99),1.38E-02
550.1,Inguinal hernia,digestive,OPGS009463,0.080,RNAseq,ZNHIT6,1.03 (1.01 1.04),1.67E-02
550.1,Inguinal hernia,digestive,OPGS013300,0.028,RNAseq,TBC1D23,0.97 (0.96 0.99),1.67E-02
550.1,Inguinal hernia,digestive,OPGS013324,0.028,RNAseq,PRF1,1.03 (1.01 1.04),1.67E-02
550.1,Inguinal hernia,digestive,OPGS006499,0.176,RNAseq,C4A,1.03 (1.01 1.04),1.73E-02
550.1,Inguinal hernia,digestive,OPGS013201,0.029,RNAseq,NRCAM,1.03 (1.01 1.04),1.77E-02
550.1,Inguinal hernia,digestive,OPGS012358,0.037,RNAseq,SFRP5,1.03 (1.01 1.04),1.83E-02
550.1,Inguinal hernia,digestive,OPGS006619,0.169,RNAseq,,0.97 (0.96 0.99),1.95E-02
550.1,Inguinal hernia,digestive,OPGS011574,0.046,RNAseq,AIG1,1.03 (1.01 1.04),2.11E-02
550.1,Inguinal hernia,digestive,OPGS009241,0.084,RNAseq,ZKSCAN4,0.97 (0.96 0.99),2.11E-02
550.1,Inguinal hernia,digestive,OPGS013045,0.030,RNAseq,NEU1,1.03 (1.01 1.04),2.14E-02
550.1,Inguinal hernia,digestive,OPGS009728,0.074,RNAseq,NMB,0.97 (0.96 0.99),2.18E-02
550.1,Inguinal hernia,digestive,OPGS003576,0.728,RNAseq,DGKQ,0.97 (0.96 0.99),2.33E-02
550.1,Inguinal hernia,digestive,OPGS005810,0.214,RNAseq,AC009318.4,0.97 (0.96 0.99),2.33E-02
550.1,Inguinal hernia,digestive,OPGS004109,0.434,RNAseq,CCDC146,0.97 (0.96 0.99),2.40E-02
550.1,Inguinal hernia,digestive,OPGS013780,0.024,RNAseq,ZSCAN16,0.97 (0.96 0.99),2.50E-02
550.1,Inguinal hernia,digestive,OPGS013101,0.030,RNAseq,MBNL1-AS1,1.03 (1.01 1.04),2.65E-02
550.1,Inguinal hernia,digestive,OPGS008652,0.097,RNAseq,AC006252.1,0.97 (0.96 0.99),2.65E-02
550.1,Inguinal hernia,digestive,OPGS010567,0.060,RNAseq,PNPT1,1.03 (1.01 1.04),2.65E-02
550.1,Inguinal hernia,digestive,OPGS003671,0.619,RNAseq,COL26A1,0.97 (0.96 0.99),2.65E-02
550.1,Inguinal hernia,digestive,OPGS009970,0.070,RNAseq,CLDN23,0.97 (0.96 0.99),2.65E-02
550.1,Inguinal hernia,digestive,OPGS009322,0.083,RNAseq,FAM126A,1.03 (1.01 1.04),2.65E-02
550.1,Inguinal hernia,digestive,OPGS013723,0.025,RNAseq,ARID3B,1.03 (1.01 1.04),2.65E-02
550.1,Inguinal hernia,digestive,OPGS014596,0.018,RNAseq,PLRG1,0.97 (0.96 0.99),2.67E-02
550.1,Inguinal hernia,digestive,OPGS010359,0.063,RNAseq,WDR5,1.03 (1.01 1.04),3.19E-02
550.1,Inguinal hernia,digestive,OPGS003694,0.603,RNAseq,SHKBP1,1.03 (1.01 1.04),3.26E-02
550.1,Inguinal hernia,digestive,OPGS006324,0.185,RNAseq,RPS23,0.98 (0.96 0.99),3.28E-02
550.1,Inguinal hernia,digestive,OPGS006052,0.200,RNAseq,RNASEH2B-AS1,0.98 (0.96 0.99),3.41E-02
550.1,Inguinal hernia,digestive,OPGS011346,0.049,RNAseq,CNIH1,1.02 (1.01 1.04),3.44E-02
550.1,Inguinal hernia,digestive,OPGS011784,0.044,RNAseq,TUBB,0.98 (0.96 0.99),3.56E-02
550.1,Inguinal hernia,digestive,OPGS004043,0.452,RNAseq,ESYT2,0.98 (0.96 0.99),3.80E-02
550.1,Inguinal hernia,digestive,OPGS010607,0.059,RNAseq,TRAV8-1,0.98 (0.96 0.99),3.87E-02
550.1,Inguinal hernia,digestive,OPGS011878,0.043,RNAseq,LYPLAL1-DT,1.03 (1.01 1.04),3.87E-02
550.1,Inguinal hernia,digestive,OPGS013267,0.028,RNAseq,CCDC84,1.02 (1.01 1.04),3.88E-02
550.1,Inguinal hernia,digestive,OPGS007764,0.123,RNAseq,HLA-E,0.98 (0.96 0.99),4.18E-02
550.1,Inguinal hernia,digestive,OPGS006276,0.188,RNAseq,CRACR2B,1.02 (1.01 1.04),4.18E-02
550.1,Inguinal hernia,digestive,OPGS003625,0.664,RNAseq,,0.98 (0.96 0.99),4.18E-02
550.1,Inguinal hernia,digestive,OPGS013390,0.027,RNAseq,STAU2,0.98 (0.96 0.99),4.18E-02
550.1,Inguinal hernia,digestive,OPGS008213,0.109,RNAseq,QSER1,0.98 (0.96 0.99),4.20E-02
550.1,Inguinal hernia,digestive,OPGS005936,0.207,RNAseq,YTHDC2,0.98 (0.96 0.99),4.20E-02
550.1,Inguinal hernia,digestive,OPGS005519,0.236,RNAseq,AL645933.3,1.02 (1.01 1.04),4.31E-02
550.1,Inguinal hernia,digestive,OPGS014459,0.019,RNAseq,ARID2,0.98 (0.96 0.99),4.33E-02
550.1,Inguinal hernia,digestive,OPGS004874,0.301,RNAseq,ST7L,1.02 (1.01 1.04),4.38E-02
550.1,Inguinal hernia,digestive,OPGS012040,0.041,RNAseq,ATRIP,1.02 (1.01 1.04),4.60E-02
550.1,Inguinal hernia,digestive,OPGS005689,0.222,RNAseq,SLC47A1,0.98 (0.96 0.99),4.83E-02
550.1,Inguinal hernia,digestive,OPGS008012,0.115,RNAseq,GNL3,0.98 (0.96 0.99),4.86E-02
550.1,Inguinal hernia,digestive,OPGS007056,0.150,RNAseq,LGALS8,1.02 (1.01 1.04),4.86E-02
550.1,Inguinal hernia,digestive,OPGS006085,0.199,RNAseq,ANKLE2,0.98 (0.96 0.99),4.89E-02
550.1,Inguinal hernia,digestive,OPGS004009,0.461,RNAseq,KCNN4,1.02 (1.01 1.04),4.94E-02
550.1,Inguinal hernia,digestive,OPGS006039,0.201,RNAseq,TRIP12,1.02 (1.01 1.04),4.94E-02
550.1,Inguinal hernia,digestive,OPGS006448,0.178,RNAseq,AL031123.5,1.02 (1.01 1.04),4.96E-02
550.1,Inguinal hernia,digestive,OPGS004056,0.447,RNAseq,PKIA,1.02 (1.01 1.04),4.96E-02
550.1,Inguinal hernia,digestive,OPGS003680,0.611,RNAseq,,0.98 (0.96 0.99),4.96E-02
550.2,Diaphragmatic hernia,digestive,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.96 (0.95 0.97),2.20E-10
550.2,Diaphragmatic hernia,digestive,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.02 (1.01 1.03),3.38E-03
550.2,Diaphragmatic hernia,digestive,OPGS001102,0.046,SomaScan,Granzyme A,1.02 (1.01 1.03),3.65E-03
550.2,Diaphragmatic hernia,digestive,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.98 (0.97 0.99),4.96E-03
550.2,Diaphragmatic hernia,digestive,OPGS000375,0.143,SomaScan,Thrombospondin-2,0.98 (0.97 0.99),1.22E-02
550.2,Diaphragmatic hernia,digestive,OPGS001547,0.024,SomaScan,Cytokine receptor-like factor 1,0.98 (0.97 0.99),1.23E-02
550.2,Diaphragmatic hernia,digestive,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,1.02 (1.01 1.03),1.62E-02
550.2,Diaphragmatic hernia,digestive,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,1.02 (1.01 1.03),1.94E-02
550.2,Diaphragmatic hernia,digestive,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,0.98 (0.97 0.99),2.16E-02
550.2,Diaphragmatic hernia,digestive,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.02 (1.01 1.03),2.83E-02
550.2,Diaphragmatic hernia,digestive,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,1.02 (1.01 1.03),2.84E-02
550.2,Diaphragmatic hernia,digestive,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,1.02 (1.01 1.03),3.77E-02
550.2,Diaphragmatic hernia,digestive,OPGS002568,0.043,Olink,Granzyme A,1.02 (1.01 1.03),2.35E-03
550.2,Diaphragmatic hernia,digestive,OPGS002464,0.144,Olink,Thrombospondin-2,0.98 (0.97 0.99),7.38E-03
550.2,Diaphragmatic hernia,digestive,OPGS002466,0.143,Olink,SLAM family member 7,1.02 (1.01 1.03),1.90E-02
550.2,Diaphragmatic hernia,digestive,OPGS002585,0.037,Olink,T-cell surface glycoprotein CD5,1.02 (1.01 1.03),3.76E-02
550.2,Diaphragmatic hernia,digestive,OPGS003031,0.026,Metabolon,X - 21312,0.97 (0.96 0.98),3.76E-04
550.2,Diaphragmatic hernia,digestive,OPGS002775,0.116,Metabolon,X - 21410,0.97 (0.96 0.98),7.39E-04
550.2,Diaphragmatic hernia,digestive,OPGS002753,0.142,Metabolon,andro steroid monosulfate (1)*,0.98 (0.97 0.99),3.88E-03
550.2,Diaphragmatic hernia,digestive,OPGS003126,0.017,Metabolon,X - 21829,0.98 (0.97 0.99),4.03E-03
550.2,Diaphragmatic hernia,digestive,OPGS003096,0.019,Metabolon,pyroglutamylglutamine,0.98 (0.97 0.99),8.31E-03
550.2,Diaphragmatic hernia,digestive,OPGS002729,0.194,Metabolon,16a-hydroxy DHEA 3-sulfate,0.98 (0.97 0.99),1.72E-02
550.2,Diaphragmatic hernia,digestive,OPGS003220,0.011,Metabolon,3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF),1.02 (1.01 1.03),3.16E-02
550.2,Diaphragmatic hernia,digestive,OPGS002957,0.040,Metabolon,cys-gly. oxidized,0.98 (0.97 0.99),3.34E-02
550.2,Diaphragmatic hernia,digestive,OPGS003067,0.022,Metabolon,X - 12339,1.02 (1.01 1.03),3.89E-02
550.2,Diaphragmatic hernia,digestive,OPGS003089,0.020,Metabolon,X - 17690,0.98 (0.97 0.99),4.79E-02
550.2,Diaphragmatic hernia,digestive,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,0.98 (0.97 0.99),4.54E-03
550.2,Diaphragmatic hernia,digestive,OPGS003452,0.087,Nightingale,Total cholesterol,0.98 (0.97 0.99),6.43E-03
550.2,Diaphragmatic hernia,digestive,OPGS003454,0.087,Nightingale,Total esterified cholesterol,0.98 (0.97 0.99),6.55E-03
550.2,Diaphragmatic hernia,digestive,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,0.98 (0.97 0.99),8.31E-03
550.2,Diaphragmatic hernia,digestive,OPGS003527,0.050,Nightingale,Sphingomyelins,0.98 (0.97 0.99),1.06E-02
550.2,Diaphragmatic hernia,digestive,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,0.98 (0.97 0.99),1.06E-02
550.2,Diaphragmatic hernia,digestive,OPGS003423,0.126,Nightingale,LDL cholesterol,0.98 (0.97 0.99),1.06E-02
550.2,Diaphragmatic hernia,digestive,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,0.98 (0.97 0.99),1.22E-02
550.2,Diaphragmatic hernia,digestive,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,0.98 (0.97 0.99),1.23E-02
550.2,Diaphragmatic hernia,digestive,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,0.98 (0.97 0.99),1.23E-02
550.2,Diaphragmatic hernia,digestive,OPGS003438,0.109,Nightingale,Total lipids in IDL,0.98 (0.97 0.99),1.50E-02
550.2,Diaphragmatic hernia,digestive,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,0.98 (0.97 0.99),1.50E-02
550.2,Diaphragmatic hernia,digestive,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,0.98 (0.97 0.99),1.59E-02
550.2,Diaphragmatic hernia,digestive,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,0.98 (0.97 0.99),1.62E-02
550.2,Diaphragmatic hernia,digestive,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,0.98 (0.97 0.99),1.63E-02
550.2,Diaphragmatic hernia,digestive,OPGS003431,0.118,Nightingale,Total lipids in large LDL,0.98 (0.97 0.99),1.81E-02
550.2,Diaphragmatic hernia,digestive,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,0.98 (0.97 0.99),1.84E-02
550.2,Diaphragmatic hernia,digestive,OPGS003497,0.072,Nightingale,Linoleic acid,0.98 (0.97 0.99),1.84E-02
550.2,Diaphragmatic hernia,digestive,OPGS003444,0.101,Nightingale,Apolipoprotein B,0.98 (0.97 0.99),1.84E-02
550.2,Diaphragmatic hernia,digestive,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,0.98 (0.97 0.99),1.84E-02
550.2,Diaphragmatic hernia,digestive,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,0.98 (0.97 0.99),1.84E-02
550.2,Diaphragmatic hernia,digestive,OPGS003428,0.121,Nightingale,Total lipids in small LDL,0.98 (0.97 0.99),1.85E-02
550.2,Diaphragmatic hernia,digestive,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,0.98 (0.97 0.99),1.85E-02
550.2,Diaphragmatic hernia,digestive,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,0.98 (0.97 0.99),1.90E-02
550.2,Diaphragmatic hernia,digestive,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,0.98 (0.97 0.99),2.04E-02
550.2,Diaphragmatic hernia,digestive,OPGS003434,0.113,Nightingale,Phospholipids in IDL,0.98 (0.97 0.99),2.04E-02
550.2,Diaphragmatic hernia,digestive,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,0.98 (0.97 0.99),2.07E-02
550.2,Diaphragmatic hernia,digestive,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,0.98 (0.97 0.99),2.07E-02
550.2,Diaphragmatic hernia,digestive,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,0.98 (0.97 0.99),2.09E-02
550.2,Diaphragmatic hernia,digestive,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,0.98 (0.97 0.99),2.09E-02
550.2,Diaphragmatic hernia,digestive,OPGS003440,0.106,Nightingale,Cholesterol in IDL,0.98 (0.97 0.99),2.09E-02
550.2,Diaphragmatic hernia,digestive,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,0.98 (0.97 0.99),2.09E-02
550.2,Diaphragmatic hernia,digestive,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,0.98 (0.97 0.99),2.16E-02
550.2,Diaphragmatic hernia,digestive,OPGS003439,0.107,Nightingale,Concentration of IDL particles,0.98 (0.97 0.99),2.23E-02
550.2,Diaphragmatic hernia,digestive,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,0.98 (0.97 0.99),2.23E-02
550.2,Diaphragmatic hernia,digestive,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,0.98 (0.97 0.99),2.25E-02
550.2,Diaphragmatic hernia,digestive,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,0.98 (0.97 0.99),2.26E-02
550.2,Diaphragmatic hernia,digestive,OPGS003455,0.087,Nightingale,Total free cholesterol,0.98 (0.97 0.99),2.82E-02
550.2,Diaphragmatic hernia,digestive,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,0.98 (0.97 0.99),3.32E-02
550.2,Diaphragmatic hernia,digestive,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,0.98 (0.97 0.99),4.00E-02
550.2,Diaphragmatic hernia,digestive,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,0.98 (0.97 0.99),4.37E-02
550.2,Diaphragmatic hernia,digestive,OPGS009371,0.082,RNAseq,TRBV19,1.03 (1.02 1.04),3.76E-04
550.2,Diaphragmatic hernia,digestive,OPGS013225,0.029,RNAseq,REG4,1.03 (1.02 1.04),7.39E-04
550.2,Diaphragmatic hernia,digestive,OPGS011283,0.050,RNAseq,CD248,1.02 (1.01 1.03),2.35E-03
550.2,Diaphragmatic hernia,digestive,OPGS003843,0.532,RNAseq,BTN3A2,1.02 (1.01 1.03),2.39E-03
550.2,Diaphragmatic hernia,digestive,OPGS013906,0.023,RNAseq,YPEL2,0.98 (0.97 0.99),3.65E-03
550.2,Diaphragmatic hernia,digestive,OPGS007511,0.132,RNAseq,FHOD1,0.98 (0.97 0.99),3.88E-03
550.2,Diaphragmatic hernia,digestive,OPGS004804,0.309,RNAseq,WFIKKN1,0.98 (0.97 0.99),7.14E-03
550.2,Diaphragmatic hernia,digestive,OPGS003699,0.599,RNAseq,AC009506.2,1.02 (1.01 1.03),7.38E-03
550.2,Diaphragmatic hernia,digestive,OPGS014580,0.018,RNAseq,DACT1,0.98 (0.97 0.99),8.31E-03
550.2,Diaphragmatic hernia,digestive,OPGS010142,0.067,RNAseq,PRSS16,0.98 (0.97 0.99),8.70E-03
550.2,Diaphragmatic hernia,digestive,OPGS013201,0.029,RNAseq,NRCAM,1.02 (1.01 1.03),8.70E-03
550.2,Diaphragmatic hernia,digestive,OPGS004195,0.413,RNAseq,TRIM27,1.02 (1.01 1.03),1.01E-02
550.2,Diaphragmatic hernia,digestive,OPGS003993,0.465,RNAseq,SRR,0.98 (0.97 0.99),1.01E-02
550.2,Diaphragmatic hernia,digestive,OPGS007604,0.128,RNAseq,U91328.1,0.98 (0.97 0.99),1.01E-02
550.2,Diaphragmatic hernia,digestive,OPGS003621,0.665,RNAseq,,1.02 (1.01 1.03),1.06E-02
550.2,Diaphragmatic hernia,digestive,OPGS014144,0.021,RNAseq,AC118549.1,1.02 (1.01 1.03),1.23E-02
550.2,Diaphragmatic hernia,digestive,OPGS010512,0.061,RNAseq,ITCH,0.98 (0.97 0.99),1.23E-02
550.2,Diaphragmatic hernia,digestive,OPGS014773,0.017,RNAseq,HEATR9,1.02 (1.01 1.03),1.23E-02
550.2,Diaphragmatic hernia,digestive,OPGS014283,0.021,RNAseq,MXRA8,1.02 (1.01 1.03),1.42E-02
550.2,Diaphragmatic hernia,digestive,OPGS010365,0.063,RNAseq,AC084036.1,1.02 (1.01 1.03),1.57E-02
550.2,Diaphragmatic hernia,digestive,OPGS005008,0.285,RNAseq,AL391807.1,1.02 (1.01 1.03),1.57E-02
550.2,Diaphragmatic hernia,digestive,OPGS003615,0.672,RNAseq,,0.98 (0.97 0.99),1.59E-02
550.2,Diaphragmatic hernia,digestive,OPGS004406,0.369,RNAseq,,1.02 (1.01 1.03),1.64E-02
550.2,Diaphragmatic hernia,digestive,OPGS014226,0.021,RNAseq,ITGAM,1.02 (1.01 1.03),1.71E-02
550.2,Diaphragmatic hernia,digestive,OPGS011874,0.043,RNAseq,DEPTOR,1.02 (1.01 1.03),1.72E-02
550.2,Diaphragmatic hernia,digestive,OPGS004278,0.393,RNAseq,QKI,0.98 (0.97 0.99),1.84E-02
550.2,Diaphragmatic hernia,digestive,OPGS013298,0.028,RNAseq,IL7R,1.02 (1.01 1.03),1.84E-02
550.2,Diaphragmatic hernia,digestive,OPGS010210,0.066,RNAseq,DCAF16,0.98 (0.97 0.99),1.84E-02
550.2,Diaphragmatic hernia,digestive,OPGS008042,0.115,RNAseq,ZNF169,1.02 (1.01 1.03),1.85E-02
550.2,Diaphragmatic hernia,digestive,OPGS005913,0.208,RNAseq,DELE1,0.98 (0.97 0.99),1.90E-02
550.2,Diaphragmatic hernia,digestive,OPGS005918,0.208,RNAseq,DDR1,1.02 (1.01 1.03),2.00E-02
550.2,Diaphragmatic hernia,digestive,OPGS004582,0.342,RNAseq,BCL2L14,0.98 (0.97 0.99),2.00E-02
550.2,Diaphragmatic hernia,digestive,OPGS008926,0.091,RNAseq,PKD2,0.98 (0.97 0.99),2.00E-02
550.2,Diaphragmatic hernia,digestive,OPGS005059,0.281,RNAseq,STIM2,1.02 (1.01 1.03),2.07E-02
550.2,Diaphragmatic hernia,digestive,OPGS014036,0.022,RNAseq,,0.98 (0.97 0.99),2.07E-02
550.2,Diaphragmatic hernia,digestive,OPGS012732,0.033,RNAseq,AF165147.1,0.98 (0.97 0.99),2.08E-02
550.2,Diaphragmatic hernia,digestive,OPGS014858,0.017,RNAseq,AC022893.1,1.02 (1.01 1.03),2.09E-02
550.2,Diaphragmatic hernia,digestive,OPGS013207,0.029,RNAseq,CASS4,1.02 (1.01 1.03),2.09E-02
550.2,Diaphragmatic hernia,digestive,OPGS004235,0.404,RNAseq,ABHD11,0.98 (0.97 0.99),2.09E-02
550.2,Diaphragmatic hernia,digestive,OPGS006866,0.157,RNAseq,AL662795.2,0.98 (0.97 0.99),2.09E-02
550.2,Diaphragmatic hernia,digestive,OPGS006249,0.189,RNAseq,PIAS2,0.98 (0.97 0.99),2.09E-02
550.2,Diaphragmatic hernia,digestive,OPGS005755,0.218,RNAseq,PRKD3,0.98 (0.97 0.99),2.16E-02
550.2,Diaphragmatic hernia,digestive,OPGS013514,0.026,RNAseq,GZMK,1.02 (1.01 1.03),2.21E-02
550.2,Diaphragmatic hernia,digestive,OPGS006484,0.176,RNAseq,SYCE1L,0.98 (0.97 0.99),2.25E-02
550.2,Diaphragmatic hernia,digestive,OPGS014443,0.019,RNAseq,ABCB1,1.02 (1.01 1.03),2.25E-02
550.2,Diaphragmatic hernia,digestive,OPGS008494,0.102,RNAseq,MIR9-3HG,1.02 (1.01 1.03),2.26E-02
550.2,Diaphragmatic hernia,digestive,OPGS014674,0.018,RNAseq,AC005519.1,1.02 (1.01 1.03),2.36E-02
550.2,Diaphragmatic hernia,digestive,OPGS004952,0.292,RNAseq,KLHL30,1.02 (1.01 1.03),2.36E-02
550.2,Diaphragmatic hernia,digestive,OPGS012093,0.040,RNAseq,TRIM26,0.98 (0.97 0.99),2.36E-02
550.2,Diaphragmatic hernia,digestive,OPGS011248,0.050,RNAseq,ILDR1,0.98 (0.97 0.99),2.42E-02
550.2,Diaphragmatic hernia,digestive,OPGS007200,0.143,RNAseq,ZNF239,1.02 (1.01 1.03),2.42E-02
550.2,Diaphragmatic hernia,digestive,OPGS013469,0.027,RNAseq,SDHA,1.02 (1.01 1.03),2.51E-02
550.2,Diaphragmatic hernia,digestive,OPGS012716,0.033,RNAseq,PSPC1-AS2,1.02 (1.01 1.03),2.56E-02
550.2,Diaphragmatic hernia,digestive,OPGS003983,0.469,RNAseq,TMOD2,0.98 (0.97 0.99),2.83E-02
550.2,Diaphragmatic hernia,digestive,OPGS014873,0.017,RNAseq,LLGL1,0.98 (0.97 0.99),2.83E-02
550.2,Diaphragmatic hernia,digestive,OPGS010527,0.060,RNAseq,SPG7,1.02 (1.01 1.03),2.87E-02
550.2,Diaphragmatic hernia,digestive,OPGS007859,0.120,RNAseq,RFXANK,1.02 (1.01 1.03),2.87E-02
550.2,Diaphragmatic hernia,digestive,OPGS011390,0.048,RNAseq,MAP3K1,0.98 (0.97 0.99),3.01E-02
550.2,Diaphragmatic hernia,digestive,OPGS011365,0.049,RNAseq,GGT7,1.02 (1.01 1.03),3.02E-02
550.2,Diaphragmatic hernia,digestive,OPGS014295,0.020,RNAseq,HID1,0.98 (0.97 0.99),3.32E-02
550.2,Diaphragmatic hernia,digestive,OPGS009315,0.083,RNAseq,,0.98 (0.97 0.99),3.41E-02
550.2,Diaphragmatic hernia,digestive,OPGS013382,0.027,RNAseq,ZNF44,0.98 (0.97 0.99),3.77E-02
550.2,Diaphragmatic hernia,digestive,OPGS012605,0.035,RNAseq,HSPA1A,0.98 (0.97 0.99),3.98E-02
550.2,Diaphragmatic hernia,digestive,OPGS012136,0.040,RNAseq,NFIL3,0.98 (0.97 0.99),4.00E-02
550.2,Diaphragmatic hernia,digestive,OPGS009291,0.084,RNAseq,CCDC12,0.98 (0.97 0.99),4.00E-02
550.2,Diaphragmatic hernia,digestive,OPGS013492,0.026,RNAseq,KNTC1,0.98 (0.97 0.99),4.09E-02
550.2,Diaphragmatic hernia,digestive,OPGS010826,0.056,RNAseq,TRIM10,1.02 (1.01 1.03),4.25E-02
550.2,Diaphragmatic hernia,digestive,OPGS011336,0.049,RNAseq,,0.98 (0.97 0.99),4.37E-02
550.2,Diaphragmatic hernia,digestive,OPGS010348,0.063,RNAseq,TRBV6-5,1.02 (1.01 1.03),4.38E-02
550.2,Diaphragmatic hernia,digestive,OPGS010578,0.060,RNAseq,MAP2K4,0.98 (0.97 0.99),4.45E-02
550.2,Diaphragmatic hernia,digestive,OPGS013939,0.023,RNAseq,BATF2,1.02 (1.01 1.03),4.57E-02
550.2,Diaphragmatic hernia,digestive,OPGS005778,0.217,RNAseq,SAMHD1,0.98 (0.97 0.99),4.57E-02
550.2,Diaphragmatic hernia,digestive,OPGS013472,0.027,RNAseq,STAT1,1.02 (1.01 1.03),4.57E-02
550.2,Diaphragmatic hernia,digestive,OPGS013776,0.024,RNAseq,QSOX2,1.02 (1.01 1.03),4.79E-02
550.2,Diaphragmatic hernia,digestive,OPGS012859,0.032,RNAseq,NBEAL2,1.02 (1.01 1.03),4.79E-02
550.2,Diaphragmatic hernia,digestive,OPGS012242,0.039,RNAseq,,0.98 (0.97 0.99),4.79E-02
550.2,Diaphragmatic hernia,digestive,OPGS003711,0.593,RNAseq,,0.98 (0.97 0.99),4.79E-02
550.2,Diaphragmatic hernia,digestive,OPGS012552,0.035,RNAseq,REV3L,1.02 (1.01 1.03),4.79E-02
550.2,Diaphragmatic hernia,digestive,OPGS007287,0.140,RNAseq,MAX,0.98 (0.97 0.99),4.95E-02
550.2,Diaphragmatic hernia,digestive,OPGS014859,0.017,RNAseq,AC104452.1,0.98 (0.97 0.99),4.95E-02
550.3,Femoral hernia,digestive,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.79 (0.74 0.84),4.16E-08
550.4,Umbilical hernia,digestive,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.91 (0.89 0.94),1.89E-06
550.4,Umbilical hernia,digestive,OPGS010097,0.068,RNAseq,BCL2L11,1.07 (1.04 1.09),7.55E-03
550.5,Ventral hernia,digestive,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.91 (0.88 0.94),4.20E-06
550.5,Ventral hernia,digestive,OPGS013201,0.029,RNAseq,NRCAM,1.07 (1.04 1.10),3.47E-02
555.1,Regional enteritis,digestive,OPGS001221,0.037,SomaScan,Interleukin-23 receptor,1.10 (1.05 1.14),2.93E-02
555.1,Regional enteritis,digestive,OPGS000546,0.107,SomaScan,Calcium/calmodulin-dependent protein kinase type II subunit beta,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000161,0.270,SomaScan,Vascular endothelial growth factor A. isoform 121,0.93 (0.89 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS000697,0.085,SomaScan,Mitogen-activated protein kinase 14,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001064,0.048,SomaScan,Differentially expressed in FDCP 6 homolog,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000943,0.058,SomaScan,Pyruvate kinase PKM,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000235,0.201,SomaScan,40S ribosomal protein S7,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000619,0.096,SomaScan,1-phosphatidylinositol 4.5-bisphosphate phosphodiesterase gamma-2,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000158,0.272,SomaScan,Copine-1,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000929,0.059,SomaScan,Adenosylhomocysteinase 2,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000495,0.119,SomaScan,Tyrosine-protein kinase Lck,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001108,0.046,SomaScan,Calcineurin,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000462,0.125,SomaScan,Signal transducer and activator of transcription 6,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000514,0.114,SomaScan,ADP-ribosylation factor GTPase-activating protein 2,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000731,0.080,SomaScan,Mitogen-activated protein kinase 1,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000333,0.156,SomaScan,Heterogeneous nuclear ribonucleoprotein D-like,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001585,0.023,SomaScan,Prefoldin subunit 5,1.07 (1.03 1.11),2.93E-02
555.1,Regional enteritis,digestive,OPGS000506,0.117,SomaScan,SHC-transforming protein 1,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000950,0.058,SomaScan,Signal transducer and activator of transcription 3,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000431,0.132,SomaScan,Tyrosine-protein phosphatase non-receptor type 6,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000868,0.066,SomaScan,Adenine phosphoribosyltransferase,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000644,0.091,SomaScan,Ribosomal protein S6 kinase alpha-6,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000708,0.083,SomaScan,Interleukin-21 receptor,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000488,0.120,SomaScan,Sorting nexin-1,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000551,0.106,SomaScan,Eukaryotic translation initiation factor 1A. X-chromosomal,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000638,0.092,SomaScan,Adenylosuccinate synthetase isozyme 2,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000490,0.120,SomaScan,Protein ABHD14A,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000199,0.235,SomaScan,Vascular endothelial growth factor A. isoform 121,0.93 (0.89 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS000258,0.190,SomaScan,Caspase recruitment domain-containing protein 19,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001373,0.030,SomaScan,Fructose-bisphosphate aldolase A,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000295,0.169,SomaScan,Protein S100-A12,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001507,0.025,SomaScan,Cytochrome c oxidase subunit 6C,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000503,0.117,SomaScan,Serine/arginine-rich splicing factor 7,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001220,0.038,SomaScan,Malate dehydrogenase. cytoplasmic,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000756,0.077,SomaScan,Proto-oncogene vav,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000637,0.093,SomaScan,Protein-tyrosine kinase 2-beta,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000539,0.109,SomaScan,SH3 domain-binding glutamic acid-rich-like protein,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000433,0.132,SomaScan,Allograft inflammatory factor 1,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001015,0.052,SomaScan,Transformer-2 protein homolog beta,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000824,0.070,SomaScan,GTP-binding nuclear protein Ran,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000455,0.126,SomaScan,Hexokinase-2,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000965,0.056,SomaScan,Prenylcysteine oxidase-like,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000548,0.106,SomaScan,Heterogeneous nuclear ribonucleoprotein A/B,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000770,0.076,SomaScan,Myotubularin-related protein 6,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000891,0.064,SomaScan,Glycogen synthase kinase-3 alpha/beta,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000385,0.142,SomaScan,Spliceosome RNA helicase DDX39B,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000867,0.066,SomaScan,Inorganic pyrophosphatase,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000722,0.081,SomaScan,ADP-ribosylation factor-binding protein GGA3,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000648,0.091,SomaScan,BRICHOS domain-containing protein 5,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000475,0.123,SomaScan,Diphosphoinositol polyphosphate phosphohydrolase 1,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000781,0.075,SomaScan,COMM domain-containing protein 7,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000561,0.104,SomaScan,Y-box-binding protein 2,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000687,0.086,SomaScan,cAMP-regulated phosphoprotein 19,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001333,0.032,SomaScan,Cyclin-dependent kinase 8:Cyclin-C complex,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000437,0.130,SomaScan,Mitogen-activated protein kinase kinase kinase 3,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000848,0.068,SomaScan,IST1 homolog,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000747,0.078,SomaScan,Selenide. water dikinase 1,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000746,0.078,SomaScan,L-lactate dehydrogenase B chain,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000759,0.077,SomaScan,14-3-3 protein family,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001103,0.046,SomaScan,Calcium uptake protein 2. mitochondrial,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001000,0.053,SomaScan,Beta-arrestin-1,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000906,0.062,SomaScan,Growth factor receptor-bound protein 2,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001005,0.053,SomaScan,Acid ceramidase,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000507,0.116,SomaScan,Eukaryotic translation initiation factor 3 subunit G,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000529,0.112,SomaScan,ADP-ribosylation factor-like protein 3,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000342,0.153,SomaScan,AP-1 complex subunit gamma-like 2,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS002131,0.011,SomaScan,Interleukin-4 receptor subunit alpha,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002227,0.011,SomaScan,Complement C1q-like protein 4,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002238,0.011,SomaScan,Ephrin-B3,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001877,0.015,SomaScan,Protocadherin-10,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS002055,0.012,SomaScan,C-type lectin domain family 10 member A,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001971,0.013,SomaScan,Olfactomedin-4,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001983,0.013,SomaScan,Enteropeptidase,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001940,0.014,SomaScan,Twisted gastrulation protein homolog 1,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002006,0.013,SomaScan,Ran-binding protein 3,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001996,0.013,SomaScan,Fibroblast growth factor receptor 3,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002045,0.012,SomaScan,Tumor necrosis factor receptor superfamily member 6,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001882,0.015,SomaScan,Cyclin-dependent kinase 2:Cyclin-A2 complex,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002104,0.012,SomaScan,Interleukin-1 receptor type 2,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002308,0.010,SomaScan,Alpha-2.8-sialyltransferase 8F,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001814,0.017,SomaScan,Thrombopoietin Receptor,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001999,0.013,SomaScan,Galectin-10,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS002105,0.012,SomaScan,Kallikrein-4,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002109,0.012,SomaScan,X-ray repair cross-complementing protein 6,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS002195,0.011,SomaScan,Fibroblast growth factor 8 isoform B,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002019,0.012,SomaScan,Zinc finger protein 264,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001881,0.015,SomaScan,YTH domain-containing protein 1,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001976,0.013,SomaScan,Alanine--tRNA ligase. cytoplasmic,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS002309,0.010,SomaScan,Interleukin-10 receptor subunit beta,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001962,0.013,SomaScan,Glucokinase regulatory protein,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002147,0.011,SomaScan,Serum paraoxonase/arylesterase 1,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001994,0.013,SomaScan,Fibroblast growth factor 17,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002151,0.011,SomaScan,Kin of IRRE-like protein 3,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001925,0.014,SomaScan,C-C motif chemokine 24,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001930,0.014,SomaScan,Homeobox protein NANOG,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002101,0.012,SomaScan,Immunoglobulin superfamily member 8,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002118,0.012,SomaScan,Group IIE secretory phospholipase A2,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002141,0.011,SomaScan,V-set and immunoglobulin domain-containing protein 1,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001032,0.051,SomaScan,Mineralocorticoid receptor,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000304,0.165,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000742,0.079,SomaScan,Ubiquitin-conjugating enzyme E2 N,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000678,0.087,SomaScan,Signal transducer and activator of transcription 1-alpha/beta,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001921,0.014,SomaScan,Immunoglobulin J chain,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS000627,0.094,SomaScan,Charged multivesicular body protein 3,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001290,0.034,SomaScan,Glypican-3,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000829,0.070,SomaScan,ADP-ribosylation factor-binding protein GGA1,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000714,0.082,SomaScan,Ubiquitin-like protein 4A,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001975,0.013,SomaScan,Interleukin-10,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002135,0.011,SomaScan,39S ribosomal protein L34. mitochondrial,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001960,0.013,SomaScan,Killer cell lectin-like receptor subfamily F member 1,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002200,0.011,SomaScan,Retinoblastoma-binding protein 5,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002047,0.012,SomaScan,Killer cell immunoglobulin-like receptor 2DL4,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002096,0.012,SomaScan,Interferon lambda-2,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001863,0.015,SomaScan,Syntaxin-3,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS002018,0.013,SomaScan,Prokineticin-1,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001849,0.016,SomaScan,Cysteine-rich secretory protein 3,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001957,0.014,SomaScan,Tumor-associated calcium signal transducer 2,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002157,0.011,SomaScan,LysM and putative peptidoglycan-binding domain-containing protein 3,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002221,0.011,SomaScan,Zinc finger protein 774,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002324,0.010,SomaScan,Granzyme H,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002166,0.011,SomaScan,Interleukin-7,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS001933,0.014,SomaScan,Activin receptor type-1B,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002122,0.011,SomaScan,Group 10 secretory phospholipase A2,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002199,0.011,SomaScan,Mitogen-activated protein kinase kinase kinase kinase 3,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002307,0.010,SomaScan,Calcineurin B homologous protein 1,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS002060,0.012,SomaScan,Oxidized low-density lipoprotein receptor 1,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001919,0.014,SomaScan,Uncharacterized protein C7orf69,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000651,0.090,SomaScan,Peptidyl-prolyl cis-trans isomerase H,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001023,0.051,SomaScan,Microtubule-associated proteins 1A/1B light chain 3B,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000724,0.081,SomaScan,Activator of 90 kDa heat shock protein ATPase homolog 1,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000776,0.075,SomaScan,Stromal membrane-associated protein 1,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000484,0.120,SomaScan,Poly(rC)-binding protein 1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000839,0.069,SomaScan,Eukaryotic translation initiation factor 4E type 2,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000338,0.154,SomaScan,High mobility group protein B1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000704,0.084,SomaScan,Probable dimethyladenosine transferase,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000753,0.078,SomaScan,Cryptic protein,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000865,0.066,SomaScan,RAC-alpha/beta/gamma serine/threonine-protein kinase,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000549,0.106,SomaScan,Tyrosine-protein kinase SYK,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000341,0.154,SomaScan,Endothelial differentiation-related factor 1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000467,0.125,SomaScan,Heterogeneous nuclear ribonucleoprotein M,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000485,0.120,SomaScan,RNA polymerase II subunit A C-terminal domain phosphatase SSU72,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000581,0.102,SomaScan,Low-density lipoprotein receptor class A domain-containing protein 4,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000344,0.152,SomaScan,Protein FEV,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000508,0.116,SomaScan,3-phosphoinositide-dependent protein kinase 1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000684,0.087,SomaScan,Triosephosphate isomerase,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000737,0.079,SomaScan,Eukaryotic translation initiation factor 1b,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000931,0.059,SomaScan,Chloride intracellular channel protein 1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000291,0.170,SomaScan,High mobility group protein B3,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000732,0.080,SomaScan,Bis(5'-adenosyl)-triphosphatase,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000339,0.154,SomaScan,RNA-binding protein 3,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000315,0.163,SomaScan,DNA-(apurinic or apyrimidinic site) lyase,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000596,0.099,SomaScan,Dual specificity mitogen-activated protein kinase kinase 1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000985,0.055,SomaScan,RAC-beta serine/threonine-protein kinase,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000328,0.158,SomaScan,Arf-GAP domain and FG repeat-containing protein 1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000454,0.126,SomaScan,Glia maturation factor gamma,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000309,0.164,SomaScan,NHP2-like protein 1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000420,0.135,SomaScan,Tumor necrosis factor alpha-induced protein 8,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000805,0.072,SomaScan,Protein DGCR14,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000256,0.191,SomaScan,Retinoid-binding protein 7,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000898,0.063,SomaScan,Transaldolase,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000693,0.086,SomaScan,Transketolase,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000662,0.089,SomaScan,Probable ATP-dependent RNA helicase DDX6,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000429,0.132,SomaScan,Death-associated protein kinase 2,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000930,0.059,SomaScan,Protein unc-93 homolog B1,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS001948,0.014,SomaScan,Tumor necrosis factor receptor superfamily member 11B,1.10 (1.05 1.14),2.93E-02
555.1,Regional enteritis,digestive,OPGS000318,0.161,SomaScan,Switch-associated protein 70,1.09 (1.05 1.14),2.93E-02
555.1,Regional enteritis,digestive,OPGS000364,0.146,SomaScan,Double C2-like domain-containing protein beta,1.09 (1.05 1.14),2.93E-02
555.1,Regional enteritis,digestive,OPGS000580,0.102,SomaScan,Ubiquitin-conjugating enzyme E2 D4,1.09 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000820,0.071,SomaScan,6-phosphogluconate dehydrogenase. decarboxylating,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000744,0.078,SomaScan,40S ribosomal protein SA,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000465,0.125,SomaScan,Peptidyl-prolyl cis-trans isomerase A,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000625,0.094,SomaScan,Breast cancer anti-estrogen resistance protein 3,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,0.92 (0.88 0.96),2.93E-02
555.1,Regional enteritis,digestive,OPGS000347,0.151,SomaScan,SH3 domain-binding protein 2,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000374,0.144,SomaScan,beta-adrenergic receptor kinase 1,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000264,0.185,SomaScan,Small ubiquitin-related modifier 3,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000509,0.115,SomaScan,Protein S100-A9,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000329,0.158,SomaScan,Heterogeneous nuclear ribonucleoproteins A2/B1,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000621,0.095,SomaScan,Protein S100-A6,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000316,0.162,SomaScan,Stathmin-2,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000294,0.169,SomaScan,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000279,0.178,SomaScan,Pulmonary surfactant-associated protein D,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000474,0.123,SomaScan,Immunoglobulin superfamily DCC subclass member 3,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS001063,0.049,SomaScan,Nischarin,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000253,0.192,SomaScan,Macrophage-capping protein,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000457,0.126,SomaScan,Glucose-6-phosphate isomerase,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000387,0.141,SomaScan,Structural maintenance of chromosomes protein 3,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000241,0.196,SomaScan,SUMO-conjugating enzyme UBC9,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000477,0.122,SomaScan,Probable RNA-binding protein 23,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000516,0.114,SomaScan,Ezrin,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000534,0.111,SomaScan,Fructose-2.6-bisphosphatase TIGAR,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000368,0.145,SomaScan,Inositol 1.4.5-trisphosphate receptor-interacting protein-like 1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000449,0.127,SomaScan,Interferon regulatory factor 2,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000813,0.071,SomaScan,Eukaryotic initiation factor 4A-III,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000945,0.058,SomaScan,Macrophage migration inhibitory factor,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000365,0.146,SomaScan,Rho GDP-dissociation inhibitor 2,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000486,0.120,SomaScan,Transforming protein RhoA,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000599,0.099,SomaScan,Protein kinase C beta type (splice variant beta-II),1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000735,0.080,SomaScan,Cyclin-dependent kinase inhibitor 1B,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000472,0.124,SomaScan,ATP-dependent RNA helicase DDX19B,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001168,0.041,SomaScan,Runt-related transcription factor 3,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001829,0.016,SomaScan,Ephrin type-A receptor 5,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000513,0.115,SomaScan,High mobility group protein B2,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000320,0.161,SomaScan,Adenylate kinase 2. mitochondrial,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000359,0.149,SomaScan,DnaJ homolog subfamily B member 14,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000696,0.085,SomaScan,LEM domain-containing protein 1,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000673,0.088,SomaScan,Translationally-controlled tumor protein,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000411,0.136,SomaScan,Heterogeneous nuclear ribonucleoprotein A/B,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000876,0.065,SomaScan,Cyclin-dependent kinase 4 inhibitor D,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000869,0.066,SomaScan,Mitotic checkpoint serine/threonine-protein kinase BUB1,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000777,0.075,SomaScan,Signal-regulatory protein beta-2,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000634,0.093,SomaScan,Aldehyde dehydrogenase family 3 member B1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000980,0.055,SomaScan,Apoptotic protease-activating factor 1,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000615,0.096,SomaScan,Protein NDRG4,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000928,0.059,SomaScan,Ubiquitin+1. truncated mutation for UbB,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000535,0.110,SomaScan,UPF0696 protein C11orf68,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000604,0.098,SomaScan,Protein S100-A11,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000726,0.081,SomaScan,Plasminogen,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS000751,0.078,SomaScan,Eukaryotic translation initiation factor 4H,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000611,0.097,SomaScan,Grancalcin,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000982,0.055,SomaScan,Glucosamine 6-phosphate N-acetyltransferase,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000497,0.118,SomaScan,Stathmin-3,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000494,0.119,SomaScan,Calcium/calmodulin-dependent protein kinase type II subunit delta,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000979,0.055,SomaScan,Deoxyuridine 5'-triphosphate nucleotidohydrolase. mitochondrial,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000823,0.070,SomaScan,Thioredoxin reductase 1. cytoplasmic,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000859,0.067,SomaScan,Mothers against decapentaplegic homolog 4,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000418,0.135,SomaScan,Death-associated protein kinase 1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000900,0.063,SomaScan,Nuclear migration protein nudC,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000733,0.080,SomaScan,DnaJ homolog subfamily B member 2,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000809,0.072,SomaScan,Nicotinamide phosphoribosyltransferase,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000894,0.063,SomaScan,Calcium/calmodulin-dependent protein kinase type II subunit alpha,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000363,0.147,SomaScan,Rho GTPase-activating protein 25,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000635,0.093,SomaScan,Prostaglandin G/H synthase 2,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000233,0.202,SomaScan,Small ubiquitin-related modifier 3,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000217,0.216,SomaScan,Neutrophil cytosol factor 2,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000519,0.114,SomaScan,Liprin-alpha-1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000542,0.108,SomaScan,Calcyclin-binding protein,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000436,0.131,SomaScan,Annexin A1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001293,0.034,SomaScan,Thymocyte nuclear protein 1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000612,0.096,SomaScan,B melanoma antigen 2,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000946,0.058,SomaScan,Vacuolar protein sorting-associated protein 4B,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000961,0.057,SomaScan,RAC-alpha/beta/gamma serine/threonine-protein kinase,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000425,0.133,SomaScan,Serine/threonine-protein kinase 17B,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000871,0.065,SomaScan,Eukaryotic translation initiation factor 5A-1,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000728,0.080,SomaScan,Enhancer of rudimentary homolog,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000788,0.074,SomaScan,Double-stranded RNA-binding protein Staufen homolog 2,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000424,0.133,SomaScan,Probable RNA-binding protein EIF1AD,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000441,0.130,SomaScan,Peptidyl-prolyl cis-trans isomerase A,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001176,0.040,SomaScan,Vesicle transport through interaction with t-SNAREs homolog 1B,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000623,0.094,SomaScan,Lymphocyte antigen 6 complex locus protein G6c,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000629,0.094,SomaScan,14-3-3 protein beta/alpha,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000443,0.129,SomaScan,Maspardin,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000856,0.067,SomaScan,RNA-binding protein 39,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000323,0.160,SomaScan,Gamma-aminobutyric acid receptor-associated protein-like 1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000428,0.132,SomaScan,RNA-binding protein EWS,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000616,0.096,SomaScan,Tyrosine-protein kinase CSK,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000739,0.079,SomaScan,Pyridoxal kinase,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000861,0.066,SomaScan,PolyUbiquitin K48-linked,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000850,0.067,SomaScan,Arginase-1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS000834,0.069,SomaScan,N-acetyltransferase 14,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001030,0.051,SomaScan,Ubiquitin-fold modifier 1,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001495,0.026,SomaScan,p53 and DNA damage-regulated protein 1,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001097,0.046,SomaScan,Ubiquilin-4,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001381,0.030,SomaScan,TBC1 domain family member 5,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001012,0.052,SomaScan,ETS domain-containing protein Elk-1,1.07 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS001704,0.019,SomaScan,Eukaryotic translation initiation factor 3 subunit J,1.07 (1.03 1.12),2.94E-02
555.1,Regional enteritis,digestive,OPGS001324,0.032,SomaScan,Rap1 GTPase-activating protein 1,1.07 (1.03 1.12),2.94E-02
555.1,Regional enteritis,digestive,OPGS000380,0.142,SomaScan,Cold-inducible RNA-binding protein,1.07 (1.03 1.12),2.94E-02
555.1,Regional enteritis,digestive,OPGS000470,0.125,SomaScan,U1 small nuclear ribonucleoprotein A,1.07 (1.03 1.12),2.95E-02
555.1,Regional enteritis,digestive,OPGS000602,0.098,SomaScan,RISC-loading complex subunit TARBP2,1.07 (1.03 1.12),2.96E-02
555.1,Regional enteritis,digestive,OPGS000555,0.105,SomaScan,Ribosomal protein S6 kinase alpha-3,1.07 (1.03 1.12),2.97E-02
555.1,Regional enteritis,digestive,OPGS000336,0.155,SomaScan,Clathrin interactor 1,1.07 (1.03 1.12),2.97E-02
555.1,Regional enteritis,digestive,OPGS001847,0.016,SomaScan,Lymphotactin,0.93 (0.90 0.97),2.98E-02
555.1,Regional enteritis,digestive,OPGS000448,0.128,SomaScan,Lamina-associated polypeptide 2. isoforms beta/gamma,1.07 (1.03 1.12),3.00E-02
555.1,Regional enteritis,digestive,OPGS001775,0.018,SomaScan,Purine nucleoside phosphorylase,1.07 (1.03 1.12),3.01E-02
555.1,Regional enteritis,digestive,OPGS000288,0.172,SomaScan,DNA-3-methyladenine glycosylase,1.07 (1.03 1.12),3.01E-02
555.1,Regional enteritis,digestive,OPGS000995,0.054,SomaScan,Acyl-CoA-binding domain-containing protein 6,1.07 (1.03 1.12),3.01E-02
555.1,Regional enteritis,digestive,OPGS000398,0.139,SomaScan,Toll/interleukin-1 receptor domain-containing adapter protein,1.07 (1.03 1.12),3.01E-02
555.1,Regional enteritis,digestive,OPGS001040,0.050,SomaScan,ETS domain-containing protein Elk-3,1.07 (1.03 1.12),3.06E-02
555.1,Regional enteritis,digestive,OPGS000583,0.101,SomaScan,N-terminal Xaa-Pro-Lys N-methyltransferase 1,1.07 (1.03 1.12),3.07E-02
555.1,Regional enteritis,digestive,OPGS000593,0.100,SomaScan,Uncharacterized protein KIAA0040,1.07 (1.03 1.12),3.09E-02
555.1,Regional enteritis,digestive,OPGS000314,0.163,SomaScan,Coiled-coil-helix-coiled-coil-helix domain-containing protein 10. mitochondrial,1.07 (1.03 1.12),3.12E-02
555.1,Regional enteritis,digestive,OPGS000791,0.074,SomaScan,Plastin-2,1.07 (1.03 1.12),3.12E-02
555.1,Regional enteritis,digestive,OPGS000543,0.108,SomaScan,Phosphatidylethanolamine-binding protein 1,1.08 (1.03 1.12),3.12E-02
555.1,Regional enteritis,digestive,OPGS001799,0.017,SomaScan,Interleukin-12 receptor subunit beta-1,0.93 (0.90 0.97),3.12E-02
555.1,Regional enteritis,digestive,OPGS001247,0.036,SomaScan,Interferon-induced protein with tetratricopeptide repeats 3,1.07 (1.03 1.12),3.12E-02
555.1,Regional enteritis,digestive,OPGS001926,0.014,SomaScan,UV excision repair protein RAD23 homolog A,1.07 (1.03 1.11),3.12E-02
555.1,Regional enteritis,digestive,OPGS001219,0.038,SomaScan,Docking protein 2,1.07 (1.03 1.12),3.19E-02
555.1,Regional enteritis,digestive,OPGS000757,0.077,SomaScan,Rab GDP dissociation inhibitor beta,1.07 (1.03 1.12),3.33E-02
555.1,Regional enteritis,digestive,OPGS000712,0.082,SomaScan,Ubiquitin-fold modifier-conjugating enzyme 1,1.07 (1.03 1.12),3.34E-02
555.1,Regional enteritis,digestive,OPGS000806,0.072,SomaScan,Chromobox protein homolog 7,1.07 (1.03 1.11),3.37E-02
555.1,Regional enteritis,digestive,OPGS000976,0.056,SomaScan,General transcription factor II-I,1.07 (1.03 1.11),3.41E-02
555.1,Regional enteritis,digestive,OPGS001017,0.052,SomaScan,CUB and sushi domain-containing protein 2,1.07 (1.03 1.11),3.41E-02
555.1,Regional enteritis,digestive,OPGS001008,0.053,SomaScan,Sorcin,1.07 (1.03 1.11),3.41E-02
555.1,Regional enteritis,digestive,OPGS000453,0.127,SomaScan,E3 ubiquitin-protein ligase CBL,1.07 (1.03 1.12),3.41E-02
555.1,Regional enteritis,digestive,OPGS001564,0.023,SomaScan,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,0.93 (0.90 0.97),3.41E-02
555.1,Regional enteritis,digestive,OPGS000559,0.105,SomaScan,Glutathione S-transferase P,1.07 (1.03 1.12),3.41E-02
555.1,Regional enteritis,digestive,OPGS001116,0.045,SomaScan,Tyrosine-protein phosphatase non-receptor type 9,1.07 (1.03 1.12),3.41E-02
555.1,Regional enteritis,digestive,OPGS001266,0.035,SomaScan,Polyadenylate-binding protein 3,1.07 (1.03 1.11),3.43E-02
555.1,Regional enteritis,digestive,OPGS000326,0.159,SomaScan,40S ribosomal protein S4. X isoform,1.07 (1.03 1.11),3.48E-02
555.1,Regional enteritis,digestive,OPGS001741,0.018,SomaScan,Delta-like protein 1,0.93 (0.89 0.97),3.50E-02
555.1,Regional enteritis,digestive,OPGS000178,0.255,SomaScan,Annexin A2,1.07 (1.03 1.11),3.50E-02
555.1,Regional enteritis,digestive,OPGS000959,0.057,SomaScan,ICOS ligand,1.07 (1.03 1.12),3.55E-02
555.1,Regional enteritis,digestive,OPGS001667,0.020,SomaScan,Fibroblast growth factor 1,0.94 (0.90 0.97),3.57E-02
555.1,Regional enteritis,digestive,OPGS000480,0.122,SomaScan,Nuclear RNA export factor 1,1.07 (1.03 1.11),3.58E-02
555.1,Regional enteritis,digestive,OPGS001109,0.045,SomaScan,Integrin alpha-I: beta-1 complex,1.07 (1.03 1.12),3.58E-02
555.1,Regional enteritis,digestive,OPGS001782,0.017,SomaScan,DNA/RNA-binding protein KIN17,1.07 (1.03 1.11),3.60E-02
555.1,Regional enteritis,digestive,OPGS000814,0.071,SomaScan,Ribonucleoside-diphosphate reductase subunit M2 B,1.07 (1.03 1.12),3.60E-02
555.1,Regional enteritis,digestive,OPGS001429,0.028,SomaScan,14-3-3 protein zeta/delta,1.07 (1.03 1.12),3.60E-02
555.1,Regional enteritis,digestive,OPGS001848,0.016,SomaScan,A disintegrin and metalloproteinase with thrombospondin motifs 4,0.93 (0.90 0.97),3.62E-02
555.1,Regional enteritis,digestive,OPGS000948,0.058,SomaScan,Signal transducer and activator of transcription 1-alpha/beta,1.07 (1.03 1.12),3.69E-02
555.1,Regional enteritis,digestive,OPGS001582,0.023,SomaScan,NKG2-F type II integral membrane protein,1.07 (1.03 1.11),3.71E-02
555.1,Regional enteritis,digestive,OPGS000709,0.082,SomaScan,ADP-ribosylation factor 6,1.07 (1.03 1.11),3.75E-02
555.1,Regional enteritis,digestive,OPGS001031,0.051,SomaScan,Serine/threonine-protein kinase Nek7,1.07 (1.03 1.11),3.79E-02
555.1,Regional enteritis,digestive,OPGS000526,0.112,SomaScan,Indoleamine 2.3-dioxygenase 1,1.07 (1.03 1.12),3.80E-02
555.1,Regional enteritis,digestive,OPGS002023,0.012,SomaScan,Rho GTPase-activating protein 1,1.07 (1.03 1.11),3.83E-02
555.1,Regional enteritis,digestive,OPGS001216,0.038,SomaScan,C-type mannose receptor 2,1.07 (1.03 1.12),3.85E-02
555.1,Regional enteritis,digestive,OPGS000554,0.105,SomaScan,Contactin-5,1.07 (1.03 1.11),3.89E-02
555.1,Regional enteritis,digestive,OPGS001179,0.040,SomaScan,NAD kinase,1.07 (1.03 1.11),3.95E-02
555.1,Regional enteritis,digestive,OPGS000974,0.056,SomaScan,E3 ubiquitin-protein ligase DTX3L,1.07 (1.03 1.11),4.02E-02
555.1,Regional enteritis,digestive,OPGS000924,0.060,SomaScan,Aldose reductase,1.07 (1.03 1.12),4.02E-02
555.1,Regional enteritis,digestive,OPGS000214,0.221,SomaScan,Intercellular adhesion molecule 5,1.07 (1.03 1.12),4.03E-02
555.1,Regional enteritis,digestive,OPGS000403,0.138,SomaScan,Vascular endothelial growth factor receptor 1,1.07 (1.03 1.12),4.10E-02
555.1,Regional enteritis,digestive,OPGS001178,0.040,SomaScan,Cartilage intermediate layer protein 1,1.07 (1.03 1.11),4.10E-02
555.1,Regional enteritis,digestive,OPGS000652,0.090,SomaScan,60S ribosomal protein L30,1.07 (1.03 1.11),4.16E-02
555.1,Regional enteritis,digestive,OPGS000901,0.063,SomaScan,Ski-like protein,1.07 (1.03 1.11),4.16E-02
555.1,Regional enteritis,digestive,OPGS000015,0.645,SomaScan,Endoplasmic reticulum aminopeptidase 2,1.07 (1.03 1.12),4.16E-02
555.1,Regional enteritis,digestive,OPGS000187,0.251,SomaScan,Annexin A2,1.07 (1.03 1.11),4.16E-02
555.1,Regional enteritis,digestive,OPGS001781,0.017,SomaScan,Phosphomevalonate kinase,1.07 (1.03 1.11),4.16E-02
555.1,Regional enteritis,digestive,OPGS000273,0.183,SomaScan,Gamma-interferon-inducible protein 16,1.07 (1.03 1.11),4.16E-02
555.1,Regional enteritis,digestive,OPGS000515,0.114,SomaScan,40S ribosomal protein S3a,1.07 (1.03 1.11),4.19E-02
555.1,Regional enteritis,digestive,OPGS001316,0.033,SomaScan,14-3-3 protein beta/alpha,1.07 (1.03 1.11),4.21E-02
555.1,Regional enteritis,digestive,OPGS000723,0.081,SomaScan,Vascular endothelial growth factor A,0.93 (0.90 0.97),4.22E-02
555.1,Regional enteritis,digestive,OPGS001434,0.028,SomaScan,Toll-interacting protein,1.07 (1.03 1.11),4.22E-02
555.1,Regional enteritis,digestive,OPGS000963,0.057,SomaScan,Proliferation-associated protein 2G4,1.07 (1.03 1.11),4.22E-02
555.1,Regional enteritis,digestive,OPGS001498,0.025,SomaScan,F-actin-capping protein subunit alpha-1,1.07 (1.03 1.11),4.22E-02
555.1,Regional enteritis,digestive,OPGS001166,0.041,SomaScan,Eukaryotic translation initiation factor 4B,1.07 (1.03 1.11),4.22E-02
555.1,Regional enteritis,digestive,OPGS000682,0.087,SomaScan,Sulfotransferase family cytosolic 1B member 1,1.07 (1.03 1.11),4.28E-02
555.1,Regional enteritis,digestive,OPGS001898,0.015,SomaScan,Serine/threonine-protein kinase PAK 4,1.07 (1.03 1.11),4.28E-02
555.1,Regional enteritis,digestive,OPGS001868,0.015,SomaScan,Fibroblast growth factor 16,0.94 (0.90 0.97),4.33E-02
555.1,Regional enteritis,digestive,OPGS001548,0.024,SomaScan,Glyceraldehyde-3-phosphate dehydrogenase,1.07 (1.03 1.11),4.33E-02
555.1,Regional enteritis,digestive,OPGS001946,0.014,SomaScan,Inosine-5'-monophosphate dehydrogenase 1,1.07 (1.03 1.11),4.33E-02
555.1,Regional enteritis,digestive,OPGS001034,0.051,SomaScan,Inhibitor of growth protein 1,1.07 (1.03 1.11),4.33E-02
555.1,Regional enteritis,digestive,OPGS000556,0.105,SomaScan,Protein MRVI1,1.07 (1.03 1.11),4.36E-02
555.1,Regional enteritis,digestive,OPGS000701,0.085,SomaScan,ELAV-like protein 1,1.07 (1.03 1.11),4.38E-02
555.1,Regional enteritis,digestive,OPGS000269,0.184,SomaScan,5-formyltetrahydrofolate cyclo-ligase,1.07 (1.03 1.11),4.38E-02
555.1,Regional enteritis,digestive,OPGS001873,0.015,SomaScan,Obg-like ATPase 1,1.07 (1.03 1.11),4.40E-02
555.1,Regional enteritis,digestive,OPGS000785,0.075,SomaScan,Tyrosine-protein phosphatase non-receptor type 7,1.07 (1.03 1.11),4.46E-02
555.1,Regional enteritis,digestive,OPGS001797,0.017,SomaScan,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,1.07 (1.03 1.11),4.50E-02
555.1,Regional enteritis,digestive,OPGS001857,0.016,SomaScan,Transforming growth factor beta-3,0.94 (0.90 0.97),4.50E-02
555.1,Regional enteritis,digestive,OPGS001484,0.026,SomaScan,Autophagy protein 5,1.07 (1.03 1.11),4.61E-02
555.1,Regional enteritis,digestive,OPGS001989,0.013,SomaScan,Serine/threonine-protein kinase PAK 5,0.94 (0.90 0.97),4.69E-02
555.1,Regional enteritis,digestive,OPGS001629,0.021,SomaScan,Regulatory factor X-associated protein,1.07 (1.03 1.11),4.70E-02
555.1,Regional enteritis,digestive,OPGS001405,0.029,SomaScan,Heterogeneous nuclear ribonucleoprotein Q,1.07 (1.03 1.12),4.81E-02
555.1,Regional enteritis,digestive,OPGS001408,0.029,SomaScan,Type II inositol 1.4.5-trisphosphate 5-phosphatase,1.07 (1.03 1.11),4.82E-02
555.1,Regional enteritis,digestive,OPGS001726,0.019,SomaScan,C-type lectin domain family 4 member K,0.94 (0.90 0.97),4.82E-02
555.1,Regional enteritis,digestive,OPGS001378,0.030,SomaScan,Cytoplasmic protein NCK2,1.07 (1.03 1.11),4.85E-02
555.1,Regional enteritis,digestive,OPGS001074,0.047,SomaScan,Core-binding factor subunit beta,1.07 (1.03 1.11),4.94E-02
555.1,Regional enteritis,digestive,OPGS002518,0.079,Olink,Serine/threonine-protein kinase 4,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS002593,0.034,Olink,Tumor necrosis factor receptor superfamily member 11B,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS002606,0.029,Olink,Matrix extracellular phosphoglycoprotein,0.93 (0.90 0.97),3.41E-02
555.1,Regional enteritis,digestive,OPGS002419,0.225,Olink,Poly,1.07 (1.03 1.11),3.41E-02
555.1,Regional enteritis,digestive,OPGS002501,0.098,Olink,Ezrin,1.07 (1.03 1.11),3.60E-02
555.1,Regional enteritis,digestive,OPGS002635,0.020,Olink,Caspase-3,1.07 (1.03 1.11),4.22E-02
555.1,Regional enteritis,digestive,OPGS002465,0.143,Olink,Interleukin-18,1.07 (1.03 1.11),4.38E-02
555.1,Regional enteritis,digestive,OPGS002484,0.124,Olink,Vascular endothelial growth factor A,0.93 (0.90 0.97),4.50E-02
555.1,Regional enteritis,digestive,OPGS002599,0.031,Olink,Basement membrane-specific heparan sulfate proteoglycan core protein,0.94 (0.90 0.97),4.70E-02
555.1,Regional enteritis,digestive,OPGS002969,0.036,Metabolon,tryptophan betaine,1.10 (1.05 1.14),2.93E-02
555.1,Regional enteritis,digestive,OPGS003198,0.012,Metabolon,gamma-glutamylthreonine*,0.93 (0.89 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS003200,0.012,Metabolon,threonine,0.93 (0.89 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS003208,0.011,Metabolon,phenylalanylalanine,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS002883,0.058,Metabolon,taurine,1.07 (1.03 1.12),3.01E-02
555.1,Regional enteritis,digestive,OPGS002762,0.131,Metabolon,maltose,1.07 (1.03 1.12),3.12E-02
555.1,Regional enteritis,digestive,OPGS002814,0.086,Metabolon,spermidine,1.07 (1.03 1.11),4.16E-02
555.1,Regional enteritis,digestive,OPGS002975,0.035,Metabolon,hypotaurine,1.07 (1.03 1.11),4.22E-02
555.1,Regional enteritis,digestive,OPGS002953,0.040,Metabolon,nicotinamide,1.07 (1.03 1.11),4.23E-02
555.1,Regional enteritis,digestive,OPGS011776,0.044,RNAseq,LST1,1.11 (1.07 1.16),5.20E-03
555.1,Regional enteritis,digestive,OPGS011626,0.046,RNAseq,ABCF1,0.93 (0.89 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS009865,0.072,RNAseq,TRAV17,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS004191,0.414,RNAseq,CARD9,1.08 (1.03 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS012603,0.035,RNAseq,DMAC2L,1.08 (1.03 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS008051,0.114,RNAseq,SLC27A3,0.92 (0.88 0.96),2.93E-02
555.1,Regional enteritis,digestive,OPGS013814,0.024,RNAseq,POLB,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS012162,0.040,RNAseq,RSAD2,0.93 (0.89 0.96),2.93E-02
555.1,Regional enteritis,digestive,OPGS006001,0.203,RNAseq,HLA-DQA1,1.08 (1.04 1.12),2.93E-02
555.1,Regional enteritis,digestive,OPGS004307,0.388,RNAseq,ITGA4,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS012518,0.035,RNAseq,IL23R,1.09 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS010384,0.063,RNAseq,FOCAD,0.92 (0.89 0.96),2.93E-02
555.1,Regional enteritis,digestive,OPGS011092,0.052,RNAseq,IFIT1,0.92 (0.88 0.96),2.93E-02
555.1,Regional enteritis,digestive,OPGS011698,0.045,RNAseq,JAK2,1.09 (1.05 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS012072,0.040,RNAseq,MBD5,0.92 (0.88 0.95),2.93E-02
555.1,Regional enteritis,digestive,OPGS009563,0.078,RNAseq,CUL2,0.92 (0.88 0.95),2.93E-02
555.1,Regional enteritis,digestive,OPGS005518,0.236,RNAseq,POLR2E,0.91 (0.87 0.95),2.93E-02
555.1,Regional enteritis,digestive,OPGS008169,0.110,RNAseq,AC104695.3,1.08 (1.04 1.13),2.93E-02
555.1,Regional enteritis,digestive,OPGS009764,0.074,RNAseq,AIF1,0.93 (0.90 0.97),2.93E-02
555.1,Regional enteritis,digestive,OPGS010434,0.062,RNAseq,RAPGEF6,0.93 (0.89 0.97),2.98E-02
555.1,Regional enteritis,digestive,OPGS010063,0.068,RNAseq,FAM120AOS,0.93 (0.90 0.97),3.06E-02
555.1,Regional enteritis,digestive,OPGS005427,0.244,RNAseq,SRBD1,1.07 (1.03 1.12),3.12E-02
555.1,Regional enteritis,digestive,OPGS004164,0.418,RNAseq,IRF5,1.07 (1.03 1.12),3.12E-02
555.1,Regional enteritis,digestive,OPGS008865,0.093,RNAseq,AC240565.4,1.07 (1.03 1.12),3.17E-02
555.1,Regional enteritis,digestive,OPGS006845,0.158,RNAseq,FLOT1,0.93 (0.89 0.97),3.17E-02
555.1,Regional enteritis,digestive,OPGS006403,0.180,RNAseq,AL356599.1,1.07 (1.03 1.12),3.33E-02
555.1,Regional enteritis,digestive,OPGS010615,0.059,RNAseq,SIGLEC1,0.93 (0.90 0.97),3.41E-02
555.1,Regional enteritis,digestive,OPGS006147,0.194,RNAseq,TMEM263,1.07 (1.03 1.12),3.46E-02
555.1,Regional enteritis,digestive,OPGS012062,0.041,RNAseq,ZFYVE1,1.07 (1.03 1.11),3.50E-02
555.1,Regional enteritis,digestive,OPGS009428,0.081,RNAseq,DCAF13,1.08 (1.03 1.12),3.55E-02
555.1,Regional enteritis,digestive,OPGS012163,0.040,RNAseq,TRAF2,0.93 (0.89 0.97),4.10E-02
555.1,Regional enteritis,digestive,OPGS004121,0.430,RNAseq,SLC22A5,0.93 (0.90 0.97),4.19E-02
555.1,Regional enteritis,digestive,OPGS013154,0.029,RNAseq,RBFA,1.07 (1.03 1.12),4.28E-02
555.1,Regional enteritis,digestive,OPGS014249,0.021,RNAseq,IFI6,0.93 (0.90 0.97),4.33E-02
555.1,Regional enteritis,digestive,OPGS007174,0.144,RNAseq,AGAP3,0.94 (0.90 0.97),4.36E-02
555.1,Regional enteritis,digestive,OPGS003883,0.515,RNAseq,IPMK,1.07 (1.03 1.12),4.38E-02
555.1,Regional enteritis,digestive,OPGS012904,0.032,RNAseq,ZMIZ1,0.93 (0.90 0.97),4.40E-02
555.1,Regional enteritis,digestive,OPGS004103,0.437,RNAseq,PHLDB3,0.93 (0.90 0.97),4.50E-02
555.1,Regional enteritis,digestive,OPGS013321,0.028,RNAseq,KPNA3,0.94 (0.90 0.97),4.70E-02
555.1,Regional enteritis,digestive,OPGS012021,0.041,RNAseq,ZNF25,0.93 (0.90 0.97),4.83E-02
555.1,Regional enteritis,digestive,OPGS012512,0.036,RNAseq,PEX1,1.06 (1.02 1.10),4.89E-02
555.2,Ulcerative colitis,digestive,OPGS000003,0.745,SomaScan,Low affinity immunoglobulin gamma Fc region receptor II-a,0.88 (0.86 0.91),1.05E-10
555.2,Ulcerative colitis,digestive,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,0.91 (0.88 0.94),1.16E-05
555.2,Ulcerative colitis,digestive,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,0.92 (0.89 0.95),2.25E-04
555.2,Ulcerative colitis,digestive,OPGS000005,0.727,SomaScan,Low affinity immunoglobulin gamma Fc region receptor II-b,0.92 (0.89 0.95),2.25E-04
555.2,Ulcerative colitis,digestive,OPGS002070,0.012,SomaScan,Gro-beta/gamma,1.08 (1.05 1.11),3.40E-04
555.2,Ulcerative colitis,digestive,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,0.92 (0.89 0.95),3.40E-04
555.2,Ulcerative colitis,digestive,OPGS001883,0.015,SomaScan,UMP-CMP kinase,0.92 (0.89 0.95),3.40E-04
555.2,Ulcerative colitis,digestive,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.93 (0.90 0.96),5.56E-03
555.2,Ulcerative colitis,digestive,OPGS001409,0.029,SomaScan,Gremlin-1,0.93 (0.90 0.96),5.68E-03
555.2,Ulcerative colitis,digestive,OPGS000204,0.233,SomaScan,PR domain zinc finger protein 1,0.94 (0.91 0.97),2.21E-02
555.2,Ulcerative colitis,digestive,OPGS001615,0.022,SomaScan,Cerebral cavernous malformations 2 protein,1.07 (1.03 1.10),2.46E-02
555.2,Ulcerative colitis,digestive,OPGS000984,0.055,SomaScan,Complement C2,0.94 (0.91 0.97),2.47E-02
555.2,Ulcerative colitis,digestive,OPGS002598,0.031,Olink,Interleukin-10,1.11 (1.08 1.15),9.36E-09
555.2,Ulcerative colitis,digestive,OPGS002385,0.615,Olink,Low affinity immunoglobulin gamma Fc region receptor II-b,0.90 (0.87 0.93),1.17E-06
555.2,Ulcerative colitis,digestive,OPGS002530,0.067,Olink,Trefoil factor 3,0.92 (0.89 0.95),1.14E-03
555.2,Ulcerative colitis,digestive,OPGS003170,0.014,Metabolon,X - 13846,1.07 (1.03 1.10),2.46E-02
555.2,Ulcerative colitis,digestive,OPGS003090,0.020,Metabolon,X - 12714,1.06 (1.03 1.10),3.10E-02
555.2,Ulcerative colitis,digestive,OPGS010624,0.059,RNAseq,TRBV18,0.90 (0.87 0.92),2.54E-08
555.2,Ulcerative colitis,digestive,OPGS004213,0.410,RNAseq,,0.89 (0.86 0.92),2.54E-08
555.2,Ulcerative colitis,digestive,OPGS011853,0.043,RNAseq,TRBV6-1,1.11 (1.08 1.15),3.23E-08
555.2,Ulcerative colitis,digestive,OPGS010561,0.060,RNAseq,IL2RA,1.11 (1.08 1.15),3.23E-08
555.2,Ulcerative colitis,digestive,OPGS005389,0.248,RNAseq,TRAV23DV6,1.12 (1.08 1.16),2.68E-07
555.2,Ulcerative colitis,digestive,OPGS010348,0.063,RNAseq,TRBV6-5,0.91 (0.88 0.94),5.16E-06
555.2,Ulcerative colitis,digestive,OPGS009865,0.072,RNAseq,TRAV17,1.10 (1.06 1.13),1.16E-05
555.2,Ulcerative colitis,digestive,OPGS015030,0.016,RNAseq,PRRC2A,0.92 (0.89 0.95),6.39E-05
555.2,Ulcerative colitis,digestive,OPGS009764,0.074,RNAseq,AIF1,0.92 (0.89 0.95),1.30E-04
555.2,Ulcerative colitis,digestive,OPGS014758,0.017,RNAseq,TRAV10,0.93 (0.90 0.95),2.25E-04
555.2,Ulcerative colitis,digestive,OPGS012171,0.039,RNAseq,TRBV15,1.09 (1.05 1.12),3.40E-04
555.2,Ulcerative colitis,digestive,OPGS007691,0.126,RNAseq,HLA-DRB1,1.08 (1.05 1.12),3.42E-04
555.2,Ulcerative colitis,digestive,OPGS011776,0.044,RNAseq,LST1,1.08 (1.05 1.12),3.68E-04
555.2,Ulcerative colitis,digestive,OPGS011092,0.052,RNAseq,IFIT1,0.92 (0.89 0.95),3.68E-04
555.2,Ulcerative colitis,digestive,OPGS012855,0.032,RNAseq,TRBV9,1.08 (1.05 1.12),4.30E-04
555.2,Ulcerative colitis,digestive,OPGS004263,0.397,RNAseq,TNFSF15,0.92 (0.89 0.95),5.75E-04
555.2,Ulcerative colitis,digestive,OPGS011010,0.054,RNAseq,TRBV5-4,1.08 (1.05 1.12),6.28E-04
555.2,Ulcerative colitis,digestive,OPGS003620,0.668,RNAseq,ZFP57,0.93 (0.90 0.96),2.05E-03
555.2,Ulcerative colitis,digestive,OPGS011232,0.050,RNAseq,AL589765.4,1.08 (1.04 1.11),4.05E-03
555.2,Ulcerative colitis,digestive,OPGS006499,0.176,RNAseq,C4A,1.08 (1.04 1.11),4.05E-03
555.2,Ulcerative colitis,digestive,OPGS004086,0.442,RNAseq,PRKCB,1.07 (1.04 1.11),5.68E-03
555.2,Ulcerative colitis,digestive,OPGS006038,0.201,RNAseq,HLA-DQA2,0.93 (0.90 0.96),6.04E-03
555.2,Ulcerative colitis,digestive,OPGS013243,0.029,RNAseq,TRAV3,1.07 (1.04 1.11),6.51E-03
555.2,Ulcerative colitis,digestive,OPGS011482,0.047,RNAseq,TRAV8-4,0.94 (0.91 0.96),7.97E-03
555.2,Ulcerative colitis,digestive,OPGS006942,0.154,RNAseq,SKIV2L,0.93 (0.90 0.96),7.97E-03
555.2,Ulcerative colitis,digestive,OPGS014076,0.022,RNAseq,PUSL1,1.07 (1.04 1.10),1.01E-02
555.2,Ulcerative colitis,digestive,OPGS013309,0.028,RNAseq,LINC00304,0.93 (0.90 0.96),1.21E-02
555.2,Ulcerative colitis,digestive,OPGS011065,0.053,RNAseq,INTS11,1.06 (1.03 1.09),1.51E-02
555.2,Ulcerative colitis,digestive,OPGS005168,0.269,RNAseq,,1.07 (1.03 1.10),2.06E-02
555.2,Ulcerative colitis,digestive,OPGS007675,0.126,RNAseq,TRAV12-2,0.94 (0.91 0.97),2.15E-02
555.2,Ulcerative colitis,digestive,OPGS007898,0.118,RNAseq,CPTP,1.06 (1.03 1.09),2.41E-02
555.2,Ulcerative colitis,digestive,OPGS008856,0.093,RNAseq,OAS3,0.95 (0.92 0.97),3.28E-02
555.2,Ulcerative colitis,digestive,OPGS011344,0.049,RNAseq,,1.06 (1.03 1.10),3.52E-02
555.2,Ulcerative colitis,digestive,OPGS008591,0.099,RNAseq,,0.94 (0.91 0.97),3.66E-02
555.2,Ulcerative colitis,digestive,OPGS009711,0.075,RNAseq,TRAV21,0.94 (0.91 0.97),3.85E-02
555.2,Ulcerative colitis,digestive,OPGS011585,0.046,RNAseq,CD8B,0.94 (0.91 0.97),4.09E-02
555.2,Ulcerative colitis,digestive,OPGS004422,0.367,RNAseq,VIPR1,0.94 (0.91 0.97),4.18E-02
555.2,Ulcerative colitis,digestive,OPGS006650,0.168,RNAseq,GORAB,0.94 (0.92 0.97),4.57E-02
557,Intestinal malabsorption (non-celiac),digestive,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.81 (0.75 0.88),7.32E-03
557,Intestinal malabsorption (non-celiac),digestive,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.82 (0.76 0.89),8.32E-03
557,Intestinal malabsorption (non-celiac),digestive,OPGS000645,0.091,SomaScan,Trypsin-3,1.25 (1.14 1.37),8.32E-03
557,Intestinal malabsorption (non-celiac),digestive,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.83 (0.77 0.90),2.09E-02
557,Intestinal malabsorption (non-celiac),digestive,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.83 (0.77 0.90),2.45E-02
557,Intestinal malabsorption (non-celiac),digestive,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.84 (0.77 0.91),3.48E-02
557,Intestinal malabsorption (non-celiac),digestive,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.20 (1.10 1.30),3.87E-02
557,Intestinal malabsorption (non-celiac),digestive,OPGS012006,0.041,RNAseq,VARS2,0.82 (0.75 0.89),8.32E-03
557,Intestinal malabsorption (non-celiac),digestive,OPGS010607,0.059,RNAseq,TRAV8-1,1.21 (1.11 1.31),2.45E-02
557,Intestinal malabsorption (non-celiac),digestive,OPGS013958,0.023,RNAseq,CSNK2B,1.22 (1.12 1.34),2.66E-02
557.1,Celiac disease,digestive,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.44 (0.42 0.45),0.00E+00
557.1,Celiac disease,digestive,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.44 (0.42 0.45),0.00E+00
557.1,Celiac disease,digestive,OPGS001860,0.016,SomaScan,Immunoglobulin E,2.83 (2.72 2.94),0.00E+00
557.1,Celiac disease,digestive,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.37 (0.35 0.39),0.00E+00
557.1,Celiac disease,digestive,OPGS000645,0.091,SomaScan,Trypsin-3,3.04 (2.88 3.21),0.00E+00
557.1,Celiac disease,digestive,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.48 (0.46 0.50),0.00E+00
557.1,Celiac disease,digestive,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.42 (0.40 0.44),0.00E+00
557.1,Celiac disease,digestive,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.47 (0.46 0.49),0.00E+00
557.1,Celiac disease,digestive,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.45 (0.43 0.46),0.00E+00
557.1,Celiac disease,digestive,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,2.53 (2.44 2.63),0.00E+00
557.1,Celiac disease,digestive,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.44 (0.42 0.45),0.00E+00
557.1,Celiac disease,digestive,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.93 (1.87 2.00),0.00E+00
557.1,Celiac disease,digestive,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,2.72 (2.58 2.85),0.00E+00
557.1,Celiac disease,digestive,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.45 (0.43 0.46),0.00E+00
557.1,Celiac disease,digestive,OPGS000984,0.055,SomaScan,Complement C2,2.37 (2.27 2.48),1.66E-306
557.1,Celiac disease,digestive,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,2.20 (2.11 2.29),2.05E-303
557.1,Celiac disease,digestive,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,2.06 (1.99 2.15),5.10E-301
557.1,Celiac disease,digestive,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.50 (0.48 0.52),1.04E-300
557.1,Celiac disease,digestive,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.92 (1.85 1.99),6.45E-270
557.1,Celiac disease,digestive,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,0.53 (0.51 0.55),2.06E-219
557.1,Celiac disease,digestive,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,2.06 (1.97 2.16),2.36E-218
557.1,Celiac disease,digestive,OPGS000290,0.171,SomaScan,Complement C4,0.52 (0.50 0.54),1.95E-215
557.1,Celiac disease,digestive,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,0.59 (0.57 0.61),5.36E-189
557.1,Celiac disease,digestive,OPGS000576,0.102,SomaScan,Interleukin-21,0.62 (0.60 0.64),3.37E-176
557.1,Celiac disease,digestive,OPGS002246,0.010,SomaScan,Sperm-associated antigen 11B,1.81 (1.72 1.90),1.24E-123
557.1,Celiac disease,digestive,OPGS001102,0.046,SomaScan,Granzyme A,0.64 (0.62 0.66),3.00E-122
557.1,Celiac disease,digestive,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,1.66 (1.59 1.73),2.04E-120
557.1,Celiac disease,digestive,OPGS000390,0.141,SomaScan,Palmitoyl-protein thioesterase 1,1.53 (1.47 1.60),5.58E-98
557.1,Celiac disease,digestive,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,0.68 (0.65 0.71),3.33E-85
557.1,Celiac disease,digestive,OPGS001755,0.018,SomaScan,N-acetyllactosaminide beta-1.6-N-acetylglucosaminyl-transferase. isoform C,0.59 (0.56 0.63),5.76E-83
557.1,Celiac disease,digestive,OPGS000879,0.065,SomaScan,Natural cytotoxicity triggering receptor 3,1.77 (1.67 1.87),9.56E-83
557.1,Celiac disease,digestive,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.69 (0.67 0.72),1.57E-78
557.1,Celiac disease,digestive,OPGS001598,0.022,SomaScan,SPARC,1.49 (1.43 1.56),2.56E-74
557.1,Celiac disease,digestive,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.65 (0.62 0.68),7.54E-73
557.1,Celiac disease,digestive,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,1.48 (1.42 1.55),3.13E-67
557.1,Celiac disease,digestive,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.70 (0.67 0.73),5.69E-64
557.1,Celiac disease,digestive,OPGS001883,0.015,SomaScan,UMP-CMP kinase,0.66 (0.63 0.69),3.85E-62
557.1,Celiac disease,digestive,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.68 (0.65 0.72),2.19E-53
557.1,Celiac disease,digestive,OPGS000391,0.141,SomaScan,T-cell surface glycoprotein CD3 epsilon chain,1.35 (1.30 1.41),2.60E-48
557.1,Celiac disease,digestive,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,0.67 (0.64 0.71),4.30E-46
557.1,Celiac disease,digestive,OPGS000469,0.125,SomaScan,Complement factor B,1.34 (1.28 1.40),4.20E-39
557.1,Celiac disease,digestive,OPGS000184,0.253,SomaScan,Granulysin,0.75 (0.72 0.78),1.95E-38
557.1,Celiac disease,digestive,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,0.78 (0.74 0.81),4.06E-31
557.1,Celiac disease,digestive,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,1.26 (1.21 1.30),2.08E-30
557.1,Celiac disease,digestive,OPGS000137,0.312,SomaScan,Complement C4b,1.25 (1.20 1.30),1.37E-27
557.1,Celiac disease,digestive,OPGS000846,0.068,SomaScan,2-phosphoxylose phosphatase 1,1.23 (1.19 1.28),8.92E-25
557.1,Celiac disease,digestive,OPGS001231,0.037,SomaScan,Osteocalcin,1.22 (1.18 1.27),6.18E-23
557.1,Celiac disease,digestive,OPGS000681,0.087,SomaScan,Protein-glutamine gamma-glutamyltransferase E,0.82 (0.79 0.85),1.47E-22
557.1,Celiac disease,digestive,OPGS001679,0.020,SomaScan,Metalloproteinase inhibitor 1,1.21 (1.17 1.26),2.20E-20
557.1,Celiac disease,digestive,OPGS000531,0.111,SomaScan,Cadherin-7,1.22 (1.17 1.27),4.15E-20
557.1,Celiac disease,digestive,OPGS000899,0.063,SomaScan,Collagen alpha-2(XI) chain,0.84 (0.81 0.88),6.67E-15
557.1,Celiac disease,digestive,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,0.86 (0.83 0.89),5.74E-14
557.1,Celiac disease,digestive,OPGS001286,0.034,SomaScan,Granzyme K,0.86 (0.83 0.89),1.08E-13
557.1,Celiac disease,digestive,OPGS001409,0.029,SomaScan,Gremlin-1,0.85 (0.81 0.89),2.23E-11
557.1,Celiac disease,digestive,OPGS000351,0.151,SomaScan,C1GALT1-specific chaperone 1,0.86 (0.83 0.90),2.63E-11
557.1,Celiac disease,digestive,OPGS000129,0.329,SomaScan,Neutrophil collagenase,0.88 (0.84 0.91),2.25E-08
557.1,Celiac disease,digestive,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,1.13 (1.08 1.17),1.01E-07
557.1,Celiac disease,digestive,OPGS000986,0.054,SomaScan,Solute carrier family 22 member 16,1.13 (1.08 1.17),1.73E-07
557.1,Celiac disease,digestive,OPGS000765,0.077,SomaScan,Angiopoietin-1 receptor. soluble,0.88 (0.85 0.92),2.55E-07
557.1,Celiac disease,digestive,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.12 (1.07 1.16),1.33E-06
557.1,Celiac disease,digestive,OPGS001893,0.015,SomaScan,Interleukin-17F,0.90 (0.86 0.94),1.29E-05
557.1,Celiac disease,digestive,OPGS001200,0.039,SomaScan,DnaJ homolog subfamily B member 11,0.90 (0.87 0.94),2.21E-05
557.1,Celiac disease,digestive,OPGS000356,0.149,SomaScan,Promotilin,1.10 (1.06 1.14),7.72E-05
557.1,Celiac disease,digestive,OPGS001377,0.030,SomaScan,Vascular cell adhesion protein 1,1.10 (1.06 1.14),8.79E-05
557.1,Celiac disease,digestive,OPGS000155,0.275,SomaScan,Interleukin-3 receptor subunit alpha,1.10 (1.06 1.14),9.19E-05
557.1,Celiac disease,digestive,OPGS001911,0.014,SomaScan,Ectodysplasin-A. secreted form,0.91 (0.87 0.94),1.64E-04
557.1,Celiac disease,digestive,OPGS000896,0.063,SomaScan,Interleukin-23,0.92 (0.88 0.95),3.57E-04
557.1,Celiac disease,digestive,OPGS002103,0.012,SomaScan,Trefoil factor 3,1.08 (1.04 1.12),9.49E-04
557.1,Celiac disease,digestive,OPGS000238,0.200,SomaScan,Mono [ADP-ribose] polymerase PARP16,0.92 (0.88 0.96),1.68E-03
557.1,Celiac disease,digestive,OPGS000538,0.109,SomaScan,Cyclic AMP-responsive element-binding protein 3-like protein 4,0.92 (0.88 0.96),1.82E-03
557.1,Celiac disease,digestive,OPGS000144,0.298,SomaScan,Interleukin-18 receptor 1,1.08 (1.04 1.12),1.86E-03
557.1,Celiac disease,digestive,OPGS001464,0.027,SomaScan,Platelet glycoprotein Ib alpha chain,1.08 (1.04 1.12),3.12E-03
557.1,Celiac disease,digestive,OPGS000010,0.691,SomaScan,Tapasin-related protein,1.08 (1.04 1.12),3.32E-03
557.1,Celiac disease,digestive,OPGS000517,0.114,SomaScan,Advanced glycosylation end product-specific receptor. soluble,0.93 (0.89 0.96),3.50E-03
557.1,Celiac disease,digestive,OPGS000107,0.362,SomaScan,Kininogen-1,1.09 (1.04 1.13),3.58E-03
557.1,Celiac disease,digestive,OPGS001151,0.042,SomaScan,APOBEC1 complementation factor,0.92 (0.89 0.96),4.91E-03
557.1,Celiac disease,digestive,OPGS000969,0.056,SomaScan,Transferrin receptor protein 1,1.08 (1.04 1.12),5.89E-03
557.1,Celiac disease,digestive,OPGS001977,0.013,SomaScan,C-C motif chemokine 4-like,0.92 (0.89 0.96),6.16E-03
557.1,Celiac disease,digestive,OPGS000665,0.088,SomaScan,Glutamate receptor ionotropic. delta-2,0.93 (0.89 0.96),6.16E-03
557.1,Celiac disease,digestive,OPGS000303,0.166,SomaScan,Interleukin-18 receptor 1,1.08 (1.04 1.12),6.66E-03
557.1,Celiac disease,digestive,OPGS000118,0.344,SomaScan,Cation-independent mannose-6-phosphate receptor,1.07 (1.03 1.12),1.17E-02
557.1,Celiac disease,digestive,OPGS000458,0.126,SomaScan,Fc receptor-like protein 6,0.94 (0.90 0.97),1.87E-02
557.1,Celiac disease,digestive,OPGS001047,0.049,SomaScan,Kininogen-1,1.07 (1.03 1.12),2.13E-02
557.1,Celiac disease,digestive,OPGS000501,0.117,SomaScan,GDNF family receptor alpha-2,1.07 (1.03 1.11),2.86E-02
557.1,Celiac disease,digestive,OPGS000049,0.490,SomaScan,MAP kinase-activated protein kinase 5,0.94 (0.90 0.97),3.26E-02
557.1,Celiac disease,digestive,OPGS001927,0.014,SomaScan,Peroxiredoxin-6,1.06 (1.02 1.10),4.83E-02
557.1,Celiac disease,digestive,OPGS002114,0.012,SomaScan,Neutrophil gelatinase-associated lipocalin,1.06 (1.02 1.11),4.88E-02
557.1,Celiac disease,digestive,OPGS002568,0.043,Olink,Granzyme A,0.48 (0.46 0.50),0.00E+00
557.1,Celiac disease,digestive,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.45 (0.43 0.47),0.00E+00
557.1,Celiac disease,digestive,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.46 (0.44 0.48),4.97E-301
557.1,Celiac disease,digestive,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.66 (0.64 0.69),5.59E-106
557.1,Celiac disease,digestive,OPGS002551,0.054,Olink,Gastrotropin,0.70 (0.67 0.73),1.33E-70
557.1,Celiac disease,digestive,OPGS002439,0.184,Olink,Interleukin-5 receptor subunit alpha,0.73 (0.71 0.76),1.57E-53
557.1,Celiac disease,digestive,OPGS002428,0.212,Olink,Secreted frizzled-related protein 3,0.77 (0.74 0.80),1.67E-35
557.1,Celiac disease,digestive,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,0.77 (0.74 0.81),2.95E-32
557.1,Celiac disease,digestive,OPGS002598,0.031,Olink,Interleukin-10,0.75 (0.72 0.79),4.87E-32
557.1,Celiac disease,digestive,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.80 (0.77 0.84),2.40E-24
557.1,Celiac disease,digestive,OPGS002581,0.038,Olink,Fractalkine,1.18 (1.14 1.23),1.04E-16
557.1,Celiac disease,digestive,OPGS002530,0.067,Olink,Trefoil factor 3,1.14 (1.10 1.18),1.04E-11
557.1,Celiac disease,digestive,OPGS002466,0.143,Olink,SLAM family member 7,0.88 (0.85 0.91),1.01E-09
557.1,Celiac disease,digestive,OPGS002522,0.073,Olink,CUB domain-containing protein 1,0.88 (0.85 0.92),5.13E-09
557.1,Celiac disease,digestive,OPGS002433,0.194,Olink,Interleukin-12 subunit alpha;beta,1.12 (1.08 1.16),9.21E-07
557.1,Celiac disease,digestive,OPGS002608,0.028,Olink,Integrin beta-2,1.11 (1.07 1.16),1.50E-06
557.1,Celiac disease,digestive,OPGS002422,0.223,Olink,Lymphotoxin-alpha,1.10 (1.06 1.15),2.05E-04
557.1,Celiac disease,digestive,OPGS002420,0.225,Olink,Interleukin-12 subunit beta,1.10 (1.05 1.14),2.37E-04
557.1,Celiac disease,digestive,OPGS002399,0.342,Olink,Pulmonary surfactant-associated protein D,0.92 (0.88 0.95),6.80E-04
557.1,Celiac disease,digestive,OPGS002643,0.018,Olink,Neuroblastoma suppressor of tumorigenicity 1,0.92 (0.88 0.96),7.95E-04
557.1,Celiac disease,digestive,OPGS002585,0.037,Olink,T-cell surface glycoprotein CD5,1.09 (1.05 1.13),8.26E-04
557.1,Celiac disease,digestive,OPGS002402,0.333,Olink,Interleukin-18 receptor 1,1.08 (1.04 1.13),1.58E-03
557.1,Celiac disease,digestive,OPGS002584,0.037,Olink,Fms-related tyrosine kinase 3 ligand,1.06 (1.02 1.09),3.71E-02
557.1,Celiac disease,digestive,OPGS002427,0.216,Olink,Alpha-2-macroglobulin receptor-associated protein,0.93 (0.89 0.97),4.48E-02
557.1,Celiac disease,digestive,OPGS002813,0.087,Metabolon,histidylalanine,0.69 (0.66 0.71),3.73E-69
557.1,Celiac disease,digestive,OPGS003031,0.026,Metabolon,X - 21312,1.34 (1.30 1.39),1.29E-57
557.1,Celiac disease,digestive,OPGS003220,0.011,Metabolon,3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF),0.76 (0.73 0.79),3.27E-37
557.1,Celiac disease,digestive,OPGS003121,0.017,Metabolon,1.2-dipalmitoyl-GPC (16:0/16:0),1.32 (1.26 1.37),4.27E-37
557.1,Celiac disease,digestive,OPGS002775,0.116,Metabolon,X - 21410,1.20 (1.16 1.25),6.81E-22
557.1,Celiac disease,digestive,OPGS002913,0.049,Metabolon,X - 21285,1.20 (1.16 1.25),3.79E-19
557.1,Celiac disease,digestive,OPGS003135,0.016,Metabolon,X - 15486,1.20 (1.15 1.24),3.87E-18
557.1,Celiac disease,digestive,OPGS002801,0.093,Metabolon,X - 12824,1.18 (1.14 1.23),9.39E-16
557.1,Celiac disease,digestive,OPGS003089,0.020,Metabolon,X - 17690,1.17 (1.13 1.22),6.55E-15
557.1,Celiac disease,digestive,OPGS002886,0.057,Metabolon,X - 12822,1.15 (1.11 1.20),7.41E-12
557.1,Celiac disease,digestive,OPGS003126,0.017,Metabolon,X - 21829,1.15 (1.11 1.19),1.98E-11
557.1,Celiac disease,digestive,OPGS003180,0.013,Metabolon,1-palmitoyl-GPA (16:0),1.21 (1.15 1.27),2.29E-11
557.1,Celiac disease,digestive,OPGS002857,0.067,Metabolon,1-arachidonoyl-GPA (20:4),1.16 (1.12 1.21),2.35E-11
557.1,Celiac disease,digestive,OPGS002884,0.058,Metabolon,ferulic acid 4-sulfate,1.15 (1.11 1.20),5.93E-11
557.1,Celiac disease,digestive,OPGS002930,0.046,Metabolon,X - 13866,1.13 (1.09 1.18),5.94E-09
557.1,Celiac disease,digestive,OPGS002753,0.142,Metabolon,andro steroid monosulfate (1)*,1.12 (1.08 1.16),1.13E-08
557.1,Celiac disease,digestive,OPGS003193,0.012,Metabolon,1-linoleoyl-GPA (18:2)*,1.15 (1.10 1.20),1.10E-07
557.1,Celiac disease,digestive,OPGS003177,0.013,Metabolon,X - 02269,0.90 (0.87 0.93),5.56E-07
557.1,Celiac disease,digestive,OPGS002864,0.066,Metabolon,21-hydroxypregnenolone disulfate,0.90 (0.87 0.94),1.61E-05
557.1,Celiac disease,digestive,OPGS002925,0.046,Metabolon,gamma-CEHC,0.91 (0.88 0.94),4.47E-05
557.1,Celiac disease,digestive,OPGS002787,0.102,Metabolon,X - 24544,1.09 (1.05 1.13),7.55E-04
557.1,Celiac disease,digestive,OPGS002750,0.146,Metabolon,5alpha-androstan-3alpha.17alpha-diol monosulfate,1.09 (1.05 1.13),1.44E-03
557.1,Celiac disease,digestive,OPGS002698,0.378,Metabolon,X - 19141,0.93 (0.89 0.96),6.25E-03
557.1,Celiac disease,digestive,OPGS002866,0.064,Metabolon,N-acetyltryptophan,1.08 (1.04 1.12),8.19E-03
557.1,Celiac disease,digestive,OPGS002711,0.257,Metabolon,X - 21792,0.93 (0.90 0.97),1.34E-02
557.1,Celiac disease,digestive,OPGS002746,0.149,Metabolon,5alpha-androstan-3beta.17beta-diol monosulfate (1),1.08 (1.03 1.12),1.52E-02
557.1,Celiac disease,digestive,OPGS003111,0.018,Metabolon,X - 24542,0.94 (0.90 0.97),3.02E-02
557.1,Celiac disease,digestive,OPGS003122,0.017,Metabolon,2-methylbutyrylcarnitine (C5),0.94 (0.90 0.97),3.48E-02
557.1,Celiac disease,digestive,OPGS002967,0.037,Metabolon,X - 11381,0.94 (0.90 0.97),3.48E-02
557.1,Celiac disease,digestive,OPGS003018,0.028,Metabolon,X - 18899,0.94 (0.91 0.98),4.15E-02
557.1,Celiac disease,digestive,OPGS003537,0.031,Nightingale,Glycoprotein acetyls,0.87 (0.84 0.91),9.44E-11
557.1,Celiac disease,digestive,OPGS003550,0.015,Nightingale,Phenylalanine,0.92 (0.89 0.96),3.25E-03
557.1,Celiac disease,digestive,OPGS003497,0.072,Nightingale,Linoleic acid,0.93 (0.89 0.97),7.02E-03
557.1,Celiac disease,digestive,OPGS003484,0.075,Nightingale,Triglycerides in HDL,0.94 (0.90 0.97),3.69E-02
557.1,Celiac disease,digestive,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.94 (0.90 0.97),3.92E-02
557.1,Celiac disease,digestive,OPGS013045,0.030,RNAseq,NEU1,0.38 (0.37 0.40),0.00E+00
557.1,Celiac disease,digestive,OPGS009865,0.072,RNAseq,TRAV17,0.49 (0.47 0.50),0.00E+00
557.1,Celiac disease,digestive,OPGS007675,0.126,RNAseq,TRAV12-2,2.36 (2.28 2.45),0.00E+00
557.1,Celiac disease,digestive,OPGS010607,0.059,RNAseq,TRAV8-1,2.36 (2.28 2.44),0.00E+00
557.1,Celiac disease,digestive,OPGS003680,0.611,RNAseq,,2.08 (2.01 2.14),0.00E+00
557.1,Celiac disease,digestive,OPGS013243,0.029,RNAseq,TRAV3,0.48 (0.46 0.50),0.00E+00
557.1,Celiac disease,digestive,OPGS010693,0.058,RNAseq,TRBV5-1,2.43 (2.34 2.51),0.00E+00
557.1,Celiac disease,digestive,OPGS006845,0.158,RNAseq,FLOT1,2.08 (2.01 2.15),0.00E+00
557.1,Celiac disease,digestive,OPGS011784,0.044,RNAseq,TUBB,2.30 (2.21 2.39),0.00E+00
557.1,Celiac disease,digestive,OPGS012093,0.040,RNAseq,TRIM26,2.28 (2.19 2.37),0.00E+00
557.1,Celiac disease,digestive,OPGS009371,0.082,RNAseq,TRBV19,0.42 (0.40 0.44),0.00E+00
557.1,Celiac disease,digestive,OPGS014496,0.019,RNAseq,VARS1,2.57 (2.49 2.65),0.00E+00
557.1,Celiac disease,digestive,OPGS010826,0.056,RNAseq,TRIM10,0.48 (0.47 0.50),0.00E+00
557.1,Celiac disease,digestive,OPGS012006,0.041,RNAseq,VARS2,0.40 (0.38 0.41),0.00E+00
557.1,Celiac disease,digestive,OPGS008402,0.104,RNAseq,TNXB,0.35 (0.33 0.37),0.00E+00
557.1,Celiac disease,digestive,OPGS006499,0.176,RNAseq,C4A,0.43 (0.42 0.44),0.00E+00
557.1,Celiac disease,digestive,OPGS006716,0.164,RNAseq,IER3,2.26 (2.18 2.35),0.00E+00
557.1,Celiac disease,digestive,OPGS005334,0.253,RNAseq,AL645933.4,0.48 (0.46 0.49),2.33E-301
557.1,Celiac disease,digestive,OPGS013958,0.023,RNAseq,CSNK2B,2.57 (2.44 2.70),8.01E-288
557.1,Celiac disease,digestive,OPGS013225,0.029,RNAseq,REG4,0.51 (0.49 0.53),7.60E-283
557.1,Celiac disease,digestive,OPGS005230,0.263,RNAseq,LINC00243,2.03 (1.95 2.11),7.40E-279
557.1,Celiac disease,digestive,OPGS009198,0.085,RNAseq,TRAV12-1,2.11 (2.03 2.20),7.61E-277
557.1,Celiac disease,digestive,OPGS007297,0.140,RNAseq,GPANK1,0.40 (0.38 0.42),7.72E-269
557.1,Celiac disease,digestive,OPGS004406,0.369,RNAseq,,0.48 (0.46 0.50),2.17E-264
557.1,Celiac disease,digestive,OPGS007248,0.141,RNAseq,,0.41 (0.39 0.43),1.59E-261
557.1,Celiac disease,digestive,OPGS006248,0.189,RNAseq,MCCD1,0.50 (0.48 0.52),2.70E-254
557.1,Celiac disease,digestive,OPGS013896,0.023,RNAseq,ATF6B,1.82 (1.76 1.88),2.89E-253
557.1,Celiac disease,digestive,OPGS007407,0.135,RNAseq,TRBV2,1.81 (1.75 1.88),7.08E-234
557.1,Celiac disease,digestive,OPGS015052,0.015,RNAseq,CISH,2.05 (1.97 2.15),7.54E-222
557.1,Celiac disease,digestive,OPGS014232,0.021,RNAseq,TRAV1-2,0.49 (0.46 0.51),2.60E-219
557.1,Celiac disease,digestive,OPGS013514,0.026,RNAseq,GZMK,0.52 (0.50 0.54),4.83E-213
557.1,Celiac disease,digestive,OPGS013699,0.025,RNAseq,TRAV5,0.52 (0.50 0.54),3.39E-204
557.1,Celiac disease,digestive,OPGS009222,0.085,RNAseq,,0.59 (0.57 0.61),1.85E-189
557.1,Celiac disease,digestive,OPGS013013,0.031,RNAseq,FOXJ1,0.64 (0.62 0.66),1.41E-187
557.1,Celiac disease,digestive,OPGS009711,0.075,RNAseq,TRAV21,1.69 (1.63 1.75),1.05E-181
557.1,Celiac disease,digestive,OPGS010799,0.057,RNAseq,SAPCD1-AS1,4.03 (3.66 4.43),1.10E-175
557.1,Celiac disease,digestive,OPGS011853,0.043,RNAseq,TRBV6-1,0.55 (0.53 0.58),1.35E-173
557.1,Celiac disease,digestive,OPGS015030,0.016,RNAseq,PRRC2A,0.55 (0.53 0.57),2.44E-171
557.1,Celiac disease,digestive,OPGS014443,0.019,RNAseq,ABCB1,0.54 (0.52 0.56),1.25E-168
557.1,Celiac disease,digestive,OPGS006866,0.157,RNAseq,AL662795.2,1.85 (1.77 1.93),1.63E-167
557.1,Celiac disease,digestive,OPGS007089,0.148,RNAseq,HLA-A,0.52 (0.49 0.54),8.33E-167
557.1,Celiac disease,digestive,OPGS004334,0.383,RNAseq,HLA-G,0.56 (0.53 0.58),2.43E-162
557.1,Celiac disease,digestive,OPGS003621,0.665,RNAseq,,0.57 (0.55 0.59),7.30E-154
557.1,Celiac disease,digestive,OPGS004939,0.294,RNAseq,,1.67 (1.60 1.73),2.85E-153
557.1,Celiac disease,digestive,OPGS006048,0.200,RNAseq,,0.53 (0.50 0.55),1.69E-149
557.1,Celiac disease,digestive,OPGS003843,0.532,RNAseq,BTN3A2,0.65 (0.63 0.67),1.13E-148
557.1,Celiac disease,digestive,OPGS011283,0.050,RNAseq,CD248,0.60 (0.58 0.62),8.97E-144
557.1,Celiac disease,digestive,OPGS010564,0.060,RNAseq,CEACAM6,0.60 (0.58 0.63),7.16E-142
557.1,Celiac disease,digestive,OPGS014580,0.018,RNAseq,DACT1,1.87 (1.78 1.97),4.43E-136
557.1,Celiac disease,digestive,OPGS012028,0.041,RNAseq,HLA-DQB1-AS1,0.64 (0.62 0.66),6.14E-133
557.1,Celiac disease,digestive,OPGS013780,0.024,RNAseq,ZSCAN16,1.53 (1.48 1.58),2.68E-126
557.1,Celiac disease,digestive,OPGS011073,0.053,RNAseq,TRBV7-3,1.89 (1.80 2.00),1.35E-123
557.1,Celiac disease,digestive,OPGS004489,0.357,RNAseq,,0.59 (0.56 0.62),6.39E-122
557.1,Celiac disease,digestive,OPGS008889,0.092,RNAseq,TRAV20,0.60 (0.58 0.63),6.66E-122
557.1,Celiac disease,digestive,OPGS005918,0.208,RNAseq,DDR1,0.56 (0.53 0.59),1.24E-121
557.1,Celiac disease,digestive,OPGS012304,0.038,RNAseq,PBX2,0.65 (0.63 0.67),5.32E-117
557.1,Celiac disease,digestive,OPGS011005,0.054,RNAseq,SLC1A5,1.43 (1.39 1.47),2.50E-112
557.1,Celiac disease,digestive,OPGS010142,0.067,RNAseq,PRSS16,1.40 (1.36 1.44),4.18E-104
557.1,Celiac disease,digestive,OPGS011787,0.044,RNAseq,C2,1.51 (1.46 1.57),3.19E-103
557.1,Celiac disease,digestive,OPGS010929,0.055,RNAseq,EOMES,0.63 (0.61 0.66),1.28E-99
557.1,Celiac disease,digestive,OPGS013298,0.028,RNAseq,IL7R,0.63 (0.60 0.65),4.31E-99
557.1,Celiac disease,digestive,OPGS010277,0.065,RNAseq,CXCR6,0.67 (0.65 0.70),4.73E-99
557.1,Celiac disease,digestive,OPGS010475,0.061,RNAseq,ZNRD1,0.67 (0.65 0.69),1.60E-97
557.1,Celiac disease,digestive,OPGS014283,0.021,RNAseq,MXRA8,0.64 (0.61 0.67),4.78E-93
557.1,Celiac disease,digestive,OPGS003620,0.668,RNAseq,ZFP57,1.45 (1.40 1.50),8.13E-92
557.1,Celiac disease,digestive,OPGS011472,0.047,RNAseq,FEZ1,0.68 (0.66 0.71),4.46E-90
557.1,Celiac disease,digestive,OPGS006942,0.154,RNAseq,SKIV2L,0.64 (0.61 0.67),4.12E-87
557.1,Celiac disease,digestive,OPGS012358,0.037,RNAseq,SFRP5,0.66 (0.63 0.69),4.78E-87
557.1,Celiac disease,digestive,OPGS004122,0.430,RNAseq,HLA-DRB5,0.65 (0.62 0.68),1.25E-85
557.1,Celiac disease,digestive,OPGS007394,0.136,RNAseq,AL662844.4,1.52 (1.46 1.58),1.11E-84
557.1,Celiac disease,digestive,OPGS012636,0.034,RNAseq,KIR2DL3,1.38 (1.33 1.42),1.24E-82
557.1,Celiac disease,digestive,OPGS012698,0.034,RNAseq,SNHG32,0.63 (0.60 0.66),2.13E-81
557.1,Celiac disease,digestive,OPGS006001,0.203,RNAseq,HLA-DQA1,0.65 (0.62 0.68),1.94E-79
557.1,Celiac disease,digestive,OPGS009241,0.084,RNAseq,ZKSCAN4,1.39 (1.34 1.43),7.66E-79
557.1,Celiac disease,digestive,OPGS013068,0.030,RNAseq,AL021807.1,1.40 (1.35 1.46),6.05E-72
557.1,Celiac disease,digestive,OPGS012271,0.038,RNAseq,TRBV5-6,0.81 (0.79 0.83),2.98E-66
557.1,Celiac disease,digestive,OPGS006634,0.169,RNAseq,,0.70 (0.68 0.73),1.47E-61
557.1,Celiac disease,digestive,OPGS009920,0.071,RNAseq,LINC02446,0.72 (0.69 0.75),5.59E-61
557.1,Celiac disease,digestive,OPGS009626,0.076,RNAseq,APBA2,0.67 (0.63 0.70),5.77E-61
557.1,Celiac disease,digestive,OPGS006038,0.201,RNAseq,HLA-DQA2,0.65 (0.62 0.69),9.98E-59
557.1,Celiac disease,digestive,OPGS009072,0.088,RNAseq,HLA-DQB1,0.75 (0.73 0.78),2.40E-58
557.1,Celiac disease,digestive,OPGS007604,0.128,RNAseq,U91328.1,1.37 (1.32 1.42),1.19E-57
557.1,Celiac disease,digestive,OPGS010624,0.059,RNAseq,TRBV18,1.38 (1.33 1.44),6.90E-57
557.1,Celiac disease,digestive,OPGS013406,0.027,RNAseq,AL353759.1,1.42 (1.36 1.49),8.41E-57
557.1,Celiac disease,digestive,OPGS014680,0.018,RNAseq,GALE,0.76 (0.73 0.79),8.25E-54
557.1,Celiac disease,digestive,OPGS013748,0.024,RNAseq,KLRB1,0.73 (0.71 0.76),1.72E-53
557.1,Celiac disease,digestive,OPGS010348,0.063,RNAseq,TRBV6-5,0.73 (0.70 0.76),3.58E-51
557.1,Celiac disease,digestive,OPGS007764,0.123,RNAseq,HLA-E,1.35 (1.30 1.41),2.29E-48
557.1,Celiac disease,digestive,OPGS010965,0.054,RNAseq,H4C12,0.58 (0.54 0.63),4.03E-47
557.1,Celiac disease,digestive,OPGS012587,0.035,RNAseq,COL5A1,0.77 (0.74 0.80),3.04E-46
557.1,Celiac disease,digestive,OPGS005245,0.261,RNAseq,ZNF391,1.38 (1.32 1.44),5.88E-44
557.1,Celiac disease,digestive,OPGS010561,0.060,RNAseq,IL2RA,1.31 (1.26 1.36),8.38E-44
557.1,Celiac disease,digestive,OPGS013155,0.029,RNAseq,MDS2,1.33 (1.28 1.39),9.88E-44
557.1,Celiac disease,digestive,OPGS009300,0.083,RNAseq,TRAV26-1,0.77 (0.75 0.80),1.61E-43
557.1,Celiac disease,digestive,OPGS010926,0.055,RNAseq,CACNA2D4,0.79 (0.76 0.81),3.22E-41
557.1,Celiac disease,digestive,OPGS008786,0.094,RNAseq,GABBR1,1.34 (1.29 1.40),1.72E-40
557.1,Celiac disease,digestive,OPGS011265,0.050,RNAseq,HSPA5,0.79 (0.76 0.82),1.90E-38
557.1,Celiac disease,digestive,OPGS011671,0.045,RNAseq,MICA,0.74 (0.70 0.77),7.36E-38
557.1,Celiac disease,digestive,OPGS004567,0.343,RNAseq,HLA-C,1.28 (1.23 1.33),9.32E-38
557.1,Celiac disease,digestive,OPGS008383,0.104,RNAseq,CD160,0.77 (0.74 0.80),1.64E-37
557.1,Celiac disease,digestive,OPGS005167,0.269,RNAseq,TCF19,0.70 (0.66 0.74),8.48E-37
557.1,Celiac disease,digestive,OPGS013437,0.027,RNAseq,TRAV29DV5,1.26 (1.21 1.30),2.39E-36
557.1,Celiac disease,digestive,OPGS005519,0.236,RNAseq,AL645933.3,0.80 (0.77 0.83),1.49E-34
557.1,Celiac disease,digestive,OPGS004956,0.291,RNAseq,,1.29 (1.24 1.35),5.16E-31
557.1,Celiac disease,digestive,OPGS011494,0.047,RNAseq,RNF26,1.26 (1.21 1.31),2.07E-30
557.1,Celiac disease,digestive,OPGS005433,0.244,RNAseq,MICB,1.29 (1.24 1.35),3.66E-30
557.1,Celiac disease,digestive,OPGS007145,0.146,RNAseq,BAG6,1.24 (1.20 1.29),2.14E-29
557.1,Celiac disease,digestive,OPGS004144,0.424,RNAseq,PSORS1C3,0.76 (0.73 0.80),4.54E-29
557.1,Celiac disease,digestive,OPGS011626,0.046,RNAseq,ABCF1,1.21 (1.17 1.25),7.35E-29
557.1,Celiac disease,digestive,OPGS008274,0.107,RNAseq,NCR3,1.37 (1.30 1.44),4.09E-28
557.1,Celiac disease,digestive,OPGS004134,0.427,RNAseq,H2BC5,0.80 (0.77 0.83),4.31E-28
557.1,Celiac disease,digestive,OPGS013959,0.023,RNAseq,TMEM131,0.79 (0.76 0.83),2.18E-25
557.1,Celiac disease,digestive,OPGS012171,0.039,RNAseq,TRBV15,1.24 (1.20 1.29),2.21E-25
557.1,Celiac disease,digestive,OPGS014758,0.017,RNAseq,TRAV10,0.84 (0.82 0.87),6.01E-23
557.1,Celiac disease,digestive,OPGS014075,0.022,RNAseq,AGER,1.20 (1.16 1.25),6.29E-23
557.1,Celiac disease,digestive,OPGS010041,0.069,RNAseq,GPRC5B,1.18 (1.14 1.22),1.29E-22
557.1,Celiac disease,digestive,OPGS010212,0.066,RNAseq,PSMB9,1.21 (1.16 1.25),1.42E-22
557.1,Celiac disease,digestive,OPGS013201,0.029,RNAseq,NRCAM,0.81 (0.77 0.84),6.65E-22
557.1,Celiac disease,digestive,OPGS006986,0.152,RNAseq,H4C8,1.20 (1.15 1.24),1.27E-20
557.1,Celiac disease,digestive,OPGS008869,0.093,RNAseq,,1.32 (1.25 1.39),1.68E-20
557.1,Celiac disease,digestive,OPGS004065,0.446,RNAseq,,0.78 (0.75 0.82),1.71E-20
557.1,Celiac disease,digestive,OPGS003980,0.470,RNAseq,BAK1,1.21 (1.17 1.26),5.19E-20
557.1,Celiac disease,digestive,OPGS008418,0.103,RNAseq,SESN3,1.21 (1.16 1.26),1.48E-19
557.1,Celiac disease,digestive,OPGS007691,0.126,RNAseq,HLA-DRB1,1.20 (1.16 1.25),1.99E-19
557.1,Celiac disease,digestive,OPGS013660,0.025,RNAseq,CD8A,1.20 (1.16 1.25),7.02E-19
557.1,Celiac disease,digestive,OPGS012808,0.033,RNAseq,TRBV20-1,1.19 (1.15 1.24),1.64E-18
557.1,Celiac disease,digestive,OPGS014270,0.021,RNAseq,AL121944.2,1.16 (1.12 1.19),1.65E-18
557.1,Celiac disease,digestive,OPGS008281,0.107,RNAseq,HLA-F-AS1,0.85 (0.82 0.88),6.97E-18
557.1,Celiac disease,digestive,OPGS009077,0.088,RNAseq,DDAH2,1.18 (1.14 1.22),4.57E-17
557.1,Celiac disease,digestive,OPGS012123,0.040,RNAseq,SLFN13,0.87 (0.84 0.90),1.39E-16
557.1,Celiac disease,digestive,OPGS007705,0.125,RNAseq,TRBV12-4,0.86 (0.83 0.89),1.07E-15
557.1,Celiac disease,digestive,OPGS008268,0.107,RNAseq,CD4,1.20 (1.15 1.25),2.01E-15
557.1,Celiac disease,digestive,OPGS008867,0.093,RNAseq,TSBP1-AS1,1.20 (1.15 1.25),5.59E-15
557.1,Celiac disease,digestive,OPGS012761,0.033,RNAseq,TRAV12-3,1.19 (1.14 1.24),5.72E-15
557.1,Celiac disease,digestive,OPGS012562,0.035,RNAseq,H2BC17,1.19 (1.14 1.24),1.52E-14
557.1,Celiac disease,digestive,OPGS011482,0.047,RNAseq,TRAV8-4,1.19 (1.14 1.24),1.69E-14
557.1,Celiac disease,digestive,OPGS011948,0.042,RNAseq,ADGRG1,0.85 (0.82 0.89),3.01E-14
557.1,Celiac disease,digestive,OPGS014985,0.016,RNAseq,PDLIM7,1.17 (1.12 1.21),9.75E-14
557.1,Celiac disease,digestive,OPGS006648,0.168,RNAseq,TRBV11-3,0.83 (0.79 0.87),5.40E-13
557.1,Celiac disease,digestive,OPGS008162,0.110,RNAseq,,1.20 (1.15 1.26),5.90E-13
557.1,Celiac disease,digestive,OPGS012984,0.031,RNAseq,POU5F1,1.22 (1.16 1.28),1.98E-12
557.1,Celiac disease,digestive,OPGS008073,0.114,RNAseq,,1.20 (1.15 1.26),2.42E-12
557.1,Celiac disease,digestive,OPGS006370,0.183,RNAseq,NELL2,0.87 (0.84 0.90),4.76E-12
557.1,Celiac disease,digestive,OPGS011288,0.050,RNAseq,AC104809.2,1.16 (1.12 1.21),5.70E-12
557.1,Celiac disease,digestive,OPGS011776,0.044,RNAseq,LST1,0.87 (0.84 0.90),1.00E-11
557.1,Celiac disease,digestive,OPGS009404,0.081,RNAseq,GCSAM,0.87 (0.84 0.90),1.00E-11
557.1,Celiac disease,digestive,OPGS004081,0.443,RNAseq,,1.15 (1.11 1.19),1.24E-11
557.1,Celiac disease,digestive,OPGS014059,0.022,RNAseq,BCL2,1.15 (1.11 1.19),3.39E-11
557.1,Celiac disease,digestive,OPGS008534,0.101,RNAseq,HLA-DRA,0.87 (0.84 0.91),9.69E-11
557.1,Celiac disease,digestive,OPGS014176,0.021,RNAseq,TRAV27,1.14 (1.10 1.18),1.02E-10
557.1,Celiac disease,digestive,OPGS009764,0.074,RNAseq,AIF1,1.16 (1.11 1.21),5.88E-10
557.1,Celiac disease,digestive,OPGS007730,0.124,RNAseq,CKB,1.14 (1.10 1.18),2.29E-09
557.1,Celiac disease,digestive,OPGS006439,0.178,RNAseq,HLA-DPB1,1.15 (1.10 1.20),3.16E-09
557.1,Celiac disease,digestive,OPGS011344,0.049,RNAseq,,1.13 (1.09 1.17),1.36E-08
557.1,Celiac disease,digestive,OPGS004213,0.410,RNAseq,,0.88 (0.84 0.92),2.19E-08
557.1,Celiac disease,digestive,OPGS010255,0.065,RNAseq,HLA-DPA1,1.14 (1.09 1.18),3.02E-08
557.1,Celiac disease,digestive,OPGS010739,0.057,RNAseq,CUTA,0.87 (0.83 0.91),4.27E-08
557.1,Celiac disease,digestive,OPGS008094,0.113,RNAseq,SCART1,0.88 (0.84 0.92),4.69E-08
557.1,Celiac disease,digestive,OPGS010779,0.057,RNAseq,ACE,1.13 (1.09 1.17),4.78E-08
557.1,Celiac disease,digestive,OPGS004716,0.322,RNAseq,RPS18,1.15 (1.10 1.20),7.18E-08
557.1,Celiac disease,digestive,OPGS009669,0.076,RNAseq,CRTAM,1.12 (1.08 1.17),7.83E-08
557.1,Celiac disease,digestive,OPGS006434,0.179,RNAseq,BTN2A1,0.88 (0.84 0.92),9.86E-08
557.1,Celiac disease,digestive,OPGS007138,0.146,RNAseq,HCG27,1.12 (1.07 1.16),6.22E-07
557.1,Celiac disease,digestive,OPGS004195,0.413,RNAseq,TRIM27,0.89 (0.86 0.93),1.34E-06
557.1,Celiac disease,digestive,OPGS013798,0.024,RNAseq,RNF5,0.90 (0.87 0.93),1.67E-06
557.1,Celiac disease,digestive,OPGS009118,0.087,RNAseq,LY6G5C,1.12 (1.08 1.17),3.70E-06
557.1,Celiac disease,digestive,OPGS007411,0.135,RNAseq,HOPX,0.90 (0.87 0.94),4.90E-06
557.1,Celiac disease,digestive,OPGS009810,0.073,RNAseq,,1.11 (1.07 1.16),2.26E-05
557.1,Celiac disease,digestive,OPGS013419,0.027,RNAseq,SLC4A10,0.91 (0.88 0.95),4.68E-05
557.1,Celiac disease,digestive,OPGS013324,0.028,RNAseq,PRF1,0.92 (0.89 0.95),6.29E-05
557.1,Celiac disease,digestive,OPGS007240,0.142,RNAseq,,1.09 (1.05 1.13),6.97E-05
557.1,Celiac disease,digestive,OPGS006940,0.154,RNAseq,,0.91 (0.87 0.94),9.17E-05
557.1,Celiac disease,digestive,OPGS003973,0.474,RNAseq,B3GNT2,1.10 (1.06 1.14),1.29E-04
557.1,Celiac disease,digestive,OPGS013383,0.027,RNAseq,PPP1R11,0.90 (0.86 0.94),1.53E-04
557.1,Celiac disease,digestive,OPGS013472,0.027,RNAseq,STAT1,1.09 (1.05 1.14),2.36E-04
557.1,Celiac disease,digestive,OPGS005168,0.269,RNAseq,,0.91 (0.88 0.95),3.66E-04
557.1,Celiac disease,digestive,OPGS008375,0.105,RNAseq,IFI27,0.92 (0.88 0.95),3.80E-04
557.1,Celiac disease,digestive,OPGS011496,0.047,RNAseq,SORCS3,1.09 (1.05 1.13),4.29E-04
557.1,Celiac disease,digestive,OPGS012286,0.038,RNAseq,GPR18,0.91 (0.87 0.95),5.50E-04
557.1,Celiac disease,digestive,OPGS009163,0.086,RNAseq,HCG11,0.92 (0.88 0.95),9.67E-04
557.1,Celiac disease,digestive,OPGS008066,0.114,RNAseq,PSMB8-AS1,1.09 (1.05 1.14),1.31E-03
557.1,Celiac disease,digestive,OPGS011585,0.046,RNAseq,CD8B,0.92 (0.89 0.96),1.33E-03
557.1,Celiac disease,digestive,OPGS007172,0.144,RNAseq,ALDH5A1,1.09 (1.04 1.13),1.51E-03
557.1,Celiac disease,digestive,OPGS014093,0.022,RNAseq,MYBL1,1.09 (1.05 1.14),1.62E-03
557.1,Celiac disease,digestive,OPGS006887,0.156,RNAseq,CD28,0.93 (0.89 0.96),1.64E-03
557.1,Celiac disease,digestive,OPGS010017,0.069,RNAseq,,0.92 (0.88 0.96),1.66E-03
557.1,Celiac disease,digestive,OPGS011959,0.042,RNAseq,SRC,0.92 (0.89 0.96),1.74E-03
557.1,Celiac disease,digestive,OPGS005952,0.206,RNAseq,EBF4,0.93 (0.89 0.96),2.23E-03
557.1,Celiac disease,digestive,OPGS011025,0.053,RNAseq,MDC1,0.91 (0.87 0.95),2.29E-03
557.1,Celiac disease,digestive,OPGS010874,0.056,RNAseq,ALS2CL,0.92 (0.89 0.96),2.63E-03
557.1,Celiac disease,digestive,OPGS006276,0.188,RNAseq,CRACR2B,0.93 (0.89 0.96),3.41E-03
557.1,Celiac disease,digestive,OPGS005389,0.248,RNAseq,TRAV23DV6,0.93 (0.90 0.96),3.95E-03
557.1,Celiac disease,digestive,OPGS014326,0.020,RNAseq,,1.09 (1.04 1.14),4.86E-03
557.1,Celiac disease,digestive,OPGS005009,0.285,RNAseq,DKK3,0.93 (0.89 0.96),5.22E-03
557.1,Celiac disease,digestive,OPGS004136,0.427,RNAseq,IFNAR2,0.93 (0.89 0.96),5.33E-03
557.1,Celiac disease,digestive,OPGS007167,0.145,RNAseq,ABT1,1.09 (1.04 1.14),5.49E-03
557.1,Celiac disease,digestive,OPGS011108,0.052,RNAseq,LDLR,0.93 (0.89 0.96),5.87E-03
557.1,Celiac disease,digestive,OPGS006336,0.184,RNAseq,PDE4A,1.07 (1.03 1.11),6.82E-03
557.1,Celiac disease,digestive,OPGS010917,0.055,RNAseq,LSM2,0.94 (0.90 0.97),7.92E-03
557.1,Celiac disease,digestive,OPGS005626,0.227,RNAseq,DUSP16,0.93 (0.90 0.97),8.08E-03
557.1,Celiac disease,digestive,OPGS009252,0.084,RNAseq,KIAA1109,0.92 (0.89 0.96),8.34E-03
557.1,Celiac disease,digestive,OPGS011431,0.048,RNAseq,VWA7,0.93 (0.90 0.97),9.04E-03
557.1,Celiac disease,digestive,OPGS014494,0.019,RNAseq,CLNK,0.93 (0.90 0.97),9.42E-03
557.1,Celiac disease,digestive,OPGS005775,0.217,RNAseq,REELD1,1.07 (1.03 1.12),9.54E-03
557.1,Celiac disease,digestive,OPGS008158,0.110,RNAseq,,1.08 (1.04 1.13),9.68E-03
557.1,Celiac disease,digestive,OPGS013526,0.026,RNAseq,H2BC11,0.93 (0.89 0.97),1.01E-02
557.1,Celiac disease,digestive,OPGS003776,0.560,RNAseq,CARMIL1,0.93 (0.89 0.97),1.19E-02
557.1,Celiac disease,digestive,OPGS010821,0.056,RNAseq,PAFAH1B2,1.07 (1.03 1.11),1.20E-02
557.1,Celiac disease,digestive,OPGS004176,0.416,RNAseq,ACOX1,0.93 (0.90 0.97),1.28E-02
557.1,Celiac disease,digestive,OPGS008571,0.099,RNAseq,TNFRSF1B,0.93 (0.90 0.97),1.34E-02
557.1,Celiac disease,digestive,OPGS012927,0.032,RNAseq,THEMIS,1.07 (1.03 1.12),1.39E-02
557.1,Celiac disease,digestive,OPGS010829,0.056,RNAseq,GPLD1,1.07 (1.03 1.11),1.47E-02
557.1,Celiac disease,digestive,OPGS014398,0.020,RNAseq,,1.08 (1.03 1.12),1.49E-02
557.1,Celiac disease,digestive,OPGS004826,0.308,RNAseq,NRROS,0.93 (0.90 0.97),1.53E-02
557.1,Celiac disease,digestive,OPGS012741,0.033,RNAseq,GIPR,0.93 (0.90 0.97),1.65E-02
557.1,Celiac disease,digestive,OPGS006096,0.198,RNAseq,PDCD5,0.93 (0.90 0.97),1.78E-02
557.1,Celiac disease,digestive,OPGS014337,0.020,RNAseq,CASTOR1,0.93 (0.90 0.97),1.78E-02
557.1,Celiac disease,digestive,OPGS005005,0.286,RNAseq,HLA-DOA,1.07 (1.03 1.11),2.04E-02
557.1,Celiac disease,digestive,OPGS003812,0.544,RNAseq,AP002954.1,1.07 (1.03 1.11),2.18E-02
557.1,Celiac disease,digestive,OPGS007865,0.119,RNAseq,MAL,1.07 (1.03 1.11),2.35E-02
557.1,Celiac disease,digestive,OPGS013257,0.029,RNAseq,TAPBP,1.08 (1.03 1.13),2.37E-02
557.1,Celiac disease,digestive,OPGS005589,0.231,RNAseq,GIMAP1,1.07 (1.03 1.12),2.38E-02
557.1,Celiac disease,digestive,OPGS009464,0.080,RNAseq,CTLA4,0.94 (0.90 0.97),2.49E-02
557.1,Celiac disease,digestive,OPGS013305,0.028,RNAseq,TRBV14,0.94 (0.90 0.97),2.50E-02
557.1,Celiac disease,digestive,OPGS012452,0.036,RNAseq,H2AC6,0.94 (0.91 0.97),2.69E-02
557.1,Celiac disease,digestive,OPGS010417,0.062,RNAseq,PHETA1,0.93 (0.90 0.97),2.83E-02
557.1,Celiac disease,digestive,OPGS005683,0.222,RNAseq,SOAT1,0.94 (0.90 0.97),2.86E-02
557.1,Celiac disease,digestive,OPGS011010,0.054,RNAseq,TRBV5-4,1.07 (1.03 1.11),2.95E-02
557.1,Celiac disease,digestive,OPGS011953,0.042,RNAseq,PWWP2B,1.07 (1.03 1.11),3.11E-02
557.1,Celiac disease,digestive,OPGS008988,0.090,RNAseq,MRPL55,1.07 (1.03 1.11),3.15E-02
557.1,Celiac disease,digestive,OPGS004727,0.320,RNAseq,CD226,0.94 (0.90 0.97),3.17E-02
557.1,Celiac disease,digestive,OPGS006675,0.166,RNAseq,,0.94 (0.90 0.97),3.45E-02
557.1,Celiac disease,digestive,OPGS013839,0.024,RNAseq,,1.06 (1.03 1.10),3.60E-02
557.1,Celiac disease,digestive,OPGS006518,0.174,RNAseq,KDELR2,1.07 (1.03 1.11),3.60E-02
557.1,Celiac disease,digestive,OPGS013939,0.023,RNAseq,BATF2,1.07 (1.03 1.11),3.63E-02
557.1,Celiac disease,digestive,OPGS004056,0.447,RNAseq,PKIA,0.94 (0.91 0.97),3.71E-02
557.1,Celiac disease,digestive,OPGS010789,0.057,RNAseq,TFRC,0.94 (0.90 0.97),3.78E-02
557.1,Celiac disease,digestive,OPGS004068,0.445,RNAseq,IMPA1,1.07 (1.03 1.11),3.87E-02
557.1,Celiac disease,digestive,OPGS012545,0.035,RNAseq,AC007032.1,0.94 (0.90 0.98),4.05E-02
557.1,Celiac disease,digestive,OPGS006097,0.198,RNAseq,GNAZ,1.07 (1.03 1.11),4.11E-02
557.1,Celiac disease,digestive,OPGS009962,0.070,RNAseq,CCHCR1,0.94 (0.90 0.98),4.21E-02
557.1,Celiac disease,digestive,OPGS009960,0.070,RNAseq,PSMB8,0.93 (0.89 0.97),4.22E-02
557.1,Celiac disease,digestive,OPGS005306,0.256,RNAseq,TMEM119,0.93 (0.90 0.97),4.23E-02
557.1,Celiac disease,digestive,OPGS010007,0.069,RNAseq,LINC02731,1.07 (1.03 1.11),4.31E-02
557.1,Celiac disease,digestive,OPGS013141,0.029,RNAseq,RPS10,1.06 (1.02 1.10),4.67E-02
557.1,Celiac disease,digestive,OPGS007018,0.151,RNAseq,TRBV10-3,0.94 (0.91 0.98),4.88E-02
557.1,Celiac disease,digestive,OPGS005015,0.285,RNAseq,TRAV26-2,1.07 (1.03 1.11),4.99E-02
558,Noninfectious gastroenteritis,digestive,OPGS011315,0.049,RNAseq,NR1D2,1.03 (1.02 1.05),4.89E-02
559,Ileostomy status,digestive,OPGS002103,0.012,SomaScan,Trefoil factor 3,0.88 (0.84 0.92),3.59E-04
559,Ileostomy status,digestive,OPGS001550,0.024,SomaScan,Trefoil factor 3,0.90 (0.86 0.94),7.24E-03
559,Ileostomy status,digestive,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.92 (0.88 0.95),3.12E-02
559,Ileostomy status,digestive,OPGS002598,0.031,Olink,Interleukin-10,1.12 (1.08 1.16),5.22E-05
559,Ileostomy status,digestive,OPGS002530,0.067,Olink,Trefoil factor 3,0.89 (0.85 0.93),3.59E-04
559,Ileostomy status,digestive,OPGS003115,0.018,Metabolon,sphingosine 1-phosphate,1.09 (1.05 1.14),2.87E-02
559,Ileostomy status,digestive,OPGS009764,0.074,RNAseq,AIF1,0.92 (0.88 0.95),1.96E-02
559,Ileostomy status,digestive,OPGS010561,0.060,RNAseq,IL2RA,1.09 (1.05 1.13),3.09E-02
559,Ileostomy status,digestive,OPGS014283,0.021,RNAseq,MXRA8,0.92 (0.88 0.95),3.12E-02
559,Ileostomy status,digestive,OPGS010348,0.063,RNAseq,TRBV6-5,0.92 (0.88 0.95),3.12E-02
561,Symptoms involving digestive system,digestive,OPGS004108,0.434,RNAseq,GPD2,0.97 (0.95 0.98),1.38E-02
561.1,Diarrhea,digestive,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.83 (0.78 0.88),4.56E-06
561.1,Diarrhea,digestive,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.83 (0.77 0.88),3.90E-05
561.1,Diarrhea,digestive,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.85 (0.80 0.90),1.07E-04
561.1,Diarrhea,digestive,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.85 (0.80 0.90),1.08E-04
561.1,Diarrhea,digestive,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.85 (0.80 0.91),1.58E-04
561.1,Diarrhea,digestive,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.17 (1.10 1.24),1.64E-04
561.1,Diarrhea,digestive,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.86 (0.81 0.91),2.22E-04
561.1,Diarrhea,digestive,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.86 (0.81 0.91),3.04E-04
561.1,Diarrhea,digestive,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.15 (1.08 1.22),4.23E-03
561.1,Diarrhea,digestive,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.15 (1.08 1.22),4.60E-03
561.1,Diarrhea,digestive,OPGS000576,0.102,SomaScan,Interleukin-21,0.88 (0.83 0.93),5.17E-03
561.1,Diarrhea,digestive,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.14 (1.08 1.21),6.56E-03
561.1,Diarrhea,digestive,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.87 (0.82 0.93),7.42E-03
561.1,Diarrhea,digestive,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.88 (0.83 0.93),8.04E-03
561.1,Diarrhea,digestive,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,1.14 (1.07 1.22),1.39E-02
561.1,Diarrhea,digestive,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,0.89 (0.84 0.95),4.71E-02
561.1,Diarrhea,digestive,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.87 (0.82 0.92),4.23E-03
561.1,Diarrhea,digestive,OPGS011784,0.044,RNAseq,TUBB,1.23 (1.16 1.32),3.83E-06
561.1,Diarrhea,digestive,OPGS010826,0.056,RNAseq,TRIM10,0.84 (0.79 0.89),4.71E-06
561.1,Diarrhea,digestive,OPGS012006,0.041,RNAseq,VARS2,0.84 (0.79 0.89),3.90E-05
561.1,Diarrhea,digestive,OPGS006716,0.164,RNAseq,IER3,1.19 (1.12 1.26),3.90E-05
561.1,Diarrhea,digestive,OPGS007675,0.126,RNAseq,TRAV12-2,1.18 (1.11 1.26),5.97E-05
561.1,Diarrhea,digestive,OPGS003680,0.611,RNAseq,,1.18 (1.11 1.25),5.97E-05
561.1,Diarrhea,digestive,OPGS013045,0.030,RNAseq,NEU1,0.85 (0.80 0.90),5.97E-05
561.1,Diarrhea,digestive,OPGS013896,0.023,RNAseq,ATF6B,1.19 (1.12 1.26),6.13E-05
561.1,Diarrhea,digestive,OPGS006845,0.158,RNAseq,FLOT1,1.18 (1.11 1.25),6.13E-05
561.1,Diarrhea,digestive,OPGS006499,0.176,RNAseq,C4A,0.85 (0.80 0.90),6.13E-05
561.1,Diarrhea,digestive,OPGS005334,0.253,RNAseq,AL645933.4,0.85 (0.79 0.90),9.90E-05
561.1,Diarrhea,digestive,OPGS014496,0.019,RNAseq,VARS1,1.17 (1.10 1.23),1.58E-04
561.1,Diarrhea,digestive,OPGS008402,0.104,RNAseq,TNXB,0.84 (0.79 0.90),1.59E-04
561.1,Diarrhea,digestive,OPGS012093,0.040,RNAseq,TRIM26,1.17 (1.10 1.24),4.67E-04
561.1,Diarrhea,digestive,OPGS013243,0.029,RNAseq,TRAV3,0.86 (0.81 0.91),6.69E-04
561.1,Diarrhea,digestive,OPGS010607,0.059,RNAseq,TRAV8-1,1.16 (1.09 1.23),7.71E-04
561.1,Diarrhea,digestive,OPGS012628,0.034,RNAseq,RMC1,0.86 (0.81 0.92),1.79E-03
561.1,Diarrhea,digestive,OPGS005230,0.263,RNAseq,LINC00243,1.16 (1.09 1.23),1.79E-03
561.1,Diarrhea,digestive,OPGS009222,0.085,RNAseq,,0.87 (0.82 0.93),5.02E-03
561.1,Diarrhea,digestive,OPGS013225,0.029,RNAseq,REG4,0.87 (0.82 0.93),5.08E-03
561.1,Diarrhea,digestive,OPGS014758,0.017,RNAseq,TRAV10,0.89 (0.84 0.94),8.22E-03
561.1,Diarrhea,digestive,OPGS007407,0.135,RNAseq,TRBV2,1.14 (1.07 1.21),9.55E-03
561.1,Diarrhea,digestive,OPGS009371,0.082,RNAseq,TRBV19,0.87 (0.82 0.93),9.55E-03
561.1,Diarrhea,digestive,OPGS009865,0.072,RNAseq,TRAV17,0.88 (0.83 0.94),1.68E-02
561.1,Diarrhea,digestive,OPGS015030,0.016,RNAseq,PRRC2A,0.88 (0.83 0.94),3.58E-02
561.1,Diarrhea,digestive,OPGS006866,0.157,RNAseq,AL662795.2,1.13 (1.06 1.21),3.64E-02
561.1,Diarrhea,digestive,OPGS010693,0.058,RNAseq,TRBV5-1,1.13 (1.06 1.20),3.67E-02
561.1,Diarrhea,digestive,OPGS008055,0.114,RNAseq,TJP3,1.14 (1.06 1.21),4.13E-02
562.1,Diverticulosis,digestive,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.95 (0.94 0.96),4.01E-22
562.1,Diverticulosis,digestive,OPGS000101,0.374,SomaScan,CD209 antigen,0.97 (0.96 0.98),9.66E-10
562.1,Diverticulosis,digestive,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,0.97 (0.96 0.98),2.19E-09
562.1,Diverticulosis,digestive,OPGS001889,0.015,SomaScan,Protein NOV homolog,0.97 (0.96 0.98),6.21E-09
562.1,Diverticulosis,digestive,OPGS000362,0.147,SomaScan,Golgi membrane protein 1,0.97 (0.96 0.98),2.85E-07
562.1,Diverticulosis,digestive,OPGS000004,0.743,SomaScan,Histo-blood group ABO system transferase,0.97 (0.96 0.98),2.98E-06
562.1,Diverticulosis,digestive,OPGS000088,0.392,SomaScan,E-selectin,1.03 (1.02 1.04),5.73E-06
562.1,Diverticulosis,digestive,OPGS000212,0.222,SomaScan,Tyrosine-protein kinase receptor Tie-1. soluble,0.97 (0.96 0.98),5.73E-06
562.1,Diverticulosis,digestive,OPGS000826,0.070,SomaScan,Tumor necrosis factor ligand superfamily member 12,1.03 (1.02 1.04),8.54E-06
562.1,Diverticulosis,digestive,OPGS001490,0.026,SomaScan,Intercellular adhesion molecule 2,1.03 (1.02 1.04),1.71E-05
562.1,Diverticulosis,digestive,OPGS000321,0.161,SomaScan,von Willebrand factor,0.98 (0.97 0.98),1.90E-05
562.1,Diverticulosis,digestive,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,1.03 (1.02 1.03),4.10E-05
562.1,Diverticulosis,digestive,OPGS001954,0.014,SomaScan,Tuftelin,1.02 (1.02 1.03),5.68E-05
562.1,Diverticulosis,digestive,OPGS001658,0.020,SomaScan,Endoglin,1.02 (1.02 1.03),9.42E-05
562.1,Diverticulosis,digestive,OPGS001327,0.032,SomaScan,Basal Cell Adhesion Molecule,0.98 (0.97 0.99),1.40E-04
562.1,Diverticulosis,digestive,OPGS000106,0.366,SomaScan,Protein FAM3D,0.98 (0.97 0.99),2.16E-04
562.1,Diverticulosis,digestive,OPGS001738,0.018,SomaScan,Ectonucleoside triphosphate diphosphohydrolase 1,1.02 (1.01 1.03),2.38E-04
562.1,Diverticulosis,digestive,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,1.02 (1.01 1.03),2.40E-04
562.1,Diverticulosis,digestive,OPGS000095,0.381,SomaScan,Sulfhydryl oxidase 2,0.98 (0.97 0.99),2.97E-04
562.1,Diverticulosis,digestive,OPGS001130,0.044,SomaScan,Chordin-like protein 2,1.02 (1.01 1.03),4.22E-04
562.1,Diverticulosis,digestive,OPGS000198,0.236,SomaScan,Peptidyl-glycine alpha-amidating monooxygenase,1.02 (1.01 1.03),1.06E-03
562.1,Diverticulosis,digestive,OPGS000600,0.099,SomaScan,Insulin receptor,1.02 (1.01 1.03),1.06E-03
562.1,Diverticulosis,digestive,OPGS001231,0.037,SomaScan,Osteocalcin,1.02 (1.01 1.03),1.18E-03
562.1,Diverticulosis,digestive,OPGS000517,0.114,SomaScan,Advanced glycosylation end product-specific receptor. soluble,0.98 (0.97 0.99),1.27E-03
562.1,Diverticulosis,digestive,OPGS001915,0.014,SomaScan,N-acetylglucosamine-6-sulfatase,1.02 (1.01 1.03),1.27E-03
562.1,Diverticulosis,digestive,OPGS000415,0.136,SomaScan,Protein delta homolog 1,0.98 (0.97 0.99),1.35E-03
562.1,Diverticulosis,digestive,OPGS000220,0.213,SomaScan,Vascular endothelial growth factor receptor 2,1.02 (1.01 1.03),1.99E-03
562.1,Diverticulosis,digestive,OPGS000366,0.146,SomaScan,Protein delta homolog 1,0.98 (0.97 0.99),2.97E-03
562.1,Diverticulosis,digestive,OPGS001367,0.030,SomaScan,Collagen alpha-1(VI) chain,0.98 (0.97 0.99),3.90E-03
562.1,Diverticulosis,digestive,OPGS001700,0.019,SomaScan,Semaphorin-6B,0.98 (0.97 0.99),4.24E-03
562.1,Diverticulosis,digestive,OPGS000263,0.187,SomaScan,Plexin-B2,1.02 (1.01 1.03),4.86E-03
562.1,Diverticulosis,digestive,OPGS001832,0.016,SomaScan,Neurogenic locus notch homolog protein 1,0.98 (0.97 0.99),5.17E-03
562.1,Diverticulosis,digestive,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.98 (0.97 0.99),5.71E-03
562.1,Diverticulosis,digestive,OPGS001485,0.026,SomaScan,Tolloid-like protein 1,0.98 (0.97 0.99),6.10E-03
562.1,Diverticulosis,digestive,OPGS001174,0.040,SomaScan,Platelet glycoprotein 4,0.98 (0.97 0.99),7.84E-03
562.1,Diverticulosis,digestive,OPGS001127,0.044,SomaScan,Carbohydrate sulfotransferase 15,1.02 (1.01 1.03),9.56E-03
562.1,Diverticulosis,digestive,OPGS000671,0.088,SomaScan,Carbohydrate sulfotransferase 11,0.98 (0.97 0.99),9.77E-03
562.1,Diverticulosis,digestive,OPGS000117,0.345,SomaScan,Galactoside 3(4)-L-fucosyltransferase,0.98 (0.97 0.99),1.14E-02
562.1,Diverticulosis,digestive,OPGS002027,0.012,SomaScan,Retroviral-like aspartic protease 1,1.02 (1.01 1.03),1.37E-02
562.1,Diverticulosis,digestive,OPGS000468,0.125,SomaScan,Dermatopontin,0.98 (0.97 0.99),1.61E-02
562.1,Diverticulosis,digestive,OPGS000679,0.087,SomaScan,Mannosyl-oligosaccharide 1.2-alpha-mannosidase IB,0.98 (0.97 0.99),1.95E-02
562.1,Diverticulosis,digestive,OPGS002207,0.011,SomaScan,Putative POTE ankyrin domain family member M,0.98 (0.97 0.99),2.12E-02
562.1,Diverticulosis,digestive,OPGS001965,0.013,SomaScan,Bone morphogenetic protein 6,1.02 (1.01 1.03),2.53E-02
562.1,Diverticulosis,digestive,OPGS000046,0.516,SomaScan,Endoplasmic reticulum aminopeptidase 1,1.02 (1.01 1.03),2.77E-02
562.1,Diverticulosis,digestive,OPGS001045,0.050,SomaScan,Carbohydrate sulfotransferase 15,1.02 (1.01 1.03),2.82E-02
562.1,Diverticulosis,digestive,OPGS000646,0.091,SomaScan,Protein-tyrosine sulfotransferase 2,0.98 (0.97 0.99),3.25E-02
562.1,Diverticulosis,digestive,OPGS000606,0.098,SomaScan,Beta-1.4-galactosyltransferase 1,0.98 (0.97 0.99),3.26E-02
562.1,Diverticulosis,digestive,OPGS001751,0.018,SomaScan,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+),1.02 (1.01 1.03),3.26E-02
562.1,Diverticulosis,digestive,OPGS001235,0.037,SomaScan,Collagen alpha-1(XV) chain,1.02 (1.01 1.03),3.26E-02
562.1,Diverticulosis,digestive,OPGS001083,0.047,SomaScan,Desmoglein-2,0.98 (0.98 0.99),3.36E-02
562.1,Diverticulosis,digestive,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,0.98 (0.98 0.99),3.45E-02
562.1,Diverticulosis,digestive,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,1.02 (1.01 1.03),3.78E-02
562.1,Diverticulosis,digestive,OPGS001840,0.016,SomaScan,Inactive pancreatic lipase-related protein 1,0.98 (0.98 0.99),3.81E-02
562.1,Diverticulosis,digestive,OPGS001626,0.021,SomaScan,Neural cell adhesion molecule L1,1.02 (1.01 1.03),3.99E-02
562.1,Diverticulosis,digestive,OPGS001458,0.027,SomaScan,Potassium-transporting ATPase subunit beta,0.98 (0.98 0.99),4.23E-02
562.1,Diverticulosis,digestive,OPGS000885,0.064,SomaScan,Dipeptidase 2,1.02 (1.01 1.03),4.28E-02
562.1,Diverticulosis,digestive,OPGS000570,0.103,SomaScan,Complement decay-accelerating factor,1.02 (1.01 1.03),4.43E-02
562.1,Diverticulosis,digestive,OPGS001300,0.034,SomaScan,Melanoma-associated antigen 10,0.98 (0.98 0.99),4.48E-02
562.1,Diverticulosis,digestive,OPGS001812,0.017,SomaScan,Fibroblast growth factor 19,0.98 (0.98 0.99),4.53E-02
562.1,Diverticulosis,digestive,OPGS002651,0.015,Olink,von Willebrand factor,0.97 (0.96 0.98),6.47E-09
562.1,Diverticulosis,digestive,OPGS002408,0.270,Olink,E-selectin,1.03 (1.02 1.04),4.91E-06
562.1,Diverticulosis,digestive,OPGS002500,0.098,Olink,Galectin-4,1.03 (1.02 1.04),5.73E-06
562.1,Diverticulosis,digestive,OPGS002615,0.026,Olink,Tumor necrosis factor ligand superfamily member 12,1.03 (1.02 1.04),7.68E-06
562.1,Diverticulosis,digestive,OPGS002614,0.027,Olink,Carboxypeptidase B,0.98 (0.97 0.99),4.88E-04
562.1,Diverticulosis,digestive,OPGS002629,0.023,Olink,Interleukin-18-binding protein,0.98 (0.97 0.99),6.55E-04
562.1,Diverticulosis,digestive,OPGS002395,0.362,Olink,Intercellular adhesion molecule 2,1.02 (1.01 1.03),2.10E-03
562.1,Diverticulosis,digestive,OPGS002483,0.125,Olink,Protein delta homolog 1,0.98 (0.97 0.99),5.39E-03
562.1,Diverticulosis,digestive,OPGS002645,0.017,Olink,Carboxypeptidase A1,0.98 (0.97 0.99),5.51E-03
562.1,Diverticulosis,digestive,OPGS002437,0.187,Olink,Serine protease 27,1.02 (1.01 1.03),1.23E-02
562.1,Diverticulosis,digestive,OPGS002458,0.151,Olink,Cobalamin binding intrinsic factor,1.02 (1.01 1.03),3.36E-02
562.1,Diverticulosis,digestive,OPGS002534,0.063,Olink,Tyrosine-protein kinase Mer,1.02 (1.01 1.03),3.65E-02
562.1,Diverticulosis,digestive,OPGS002587,0.036,Olink,Glial cell line-derived neurotrophic factor,0.98 (0.98 0.99),4.31E-02
562.1,Diverticulosis,digestive,OPGS002656,0.013,Olink,Angiotensin-converting enzyme 2,0.98 (0.98 0.99),4.43E-02
562.1,Diverticulosis,digestive,OPGS003117,0.018,Metabolon,3-hydroxydecanoate,1.03 (1.02 1.04),2.13E-06
562.1,Diverticulosis,digestive,OPGS002798,0.095,Metabolon,X - 18921,1.03 (1.02 1.04),7.64E-06
562.1,Diverticulosis,digestive,OPGS003048,0.023,Metabolon,X - 21353,1.03 (1.02 1.04),1.90E-05
562.1,Diverticulosis,digestive,OPGS003176,0.013,Metabolon,X - 12442,1.03 (1.02 1.03),3.68E-05
562.1,Diverticulosis,digestive,OPGS003149,0.015,Metabolon,sphingosine,0.98 (0.97 0.98),5.55E-05
562.1,Diverticulosis,digestive,OPGS003026,0.026,Metabolon,X - 23680,0.98 (0.97 0.99),1.92E-03
562.1,Diverticulosis,digestive,OPGS002732,0.184,Metabolon,escitalopram,1.02 (1.01 1.03),8.34E-03
562.1,Diverticulosis,digestive,OPGS002793,0.100,Metabolon,indoleacetylglutamine,0.98 (0.97 0.99),9.45E-03
562.1,Diverticulosis,digestive,OPGS002820,0.082,Metabolon,5alpha-androstan-3alpha. 17beta-diol-17-glucosiduronate,0.98 (0.97 0.99),9.97E-03
562.1,Diverticulosis,digestive,OPGS002817,0.085,Metabolon,X - 23293,1.02 (1.01 1.03),1.54E-02
562.1,Diverticulosis,digestive,OPGS003091,0.020,Metabolon,myo-inositol,0.98 (0.97 0.99),1.58E-02
562.1,Diverticulosis,digestive,OPGS002695,0.405,Metabolon,X - 11491,0.98 (0.97 0.99),2.17E-02
562.1,Diverticulosis,digestive,OPGS003210,0.011,Metabolon,1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (P-16:0/18:2)*,0.98 (0.98 0.99),3.81E-02
562.1,Diverticulosis,digestive,OPGS003101,0.019,Metabolon,1-palmityl-2-oleoyl-GPC (O-16:0/18:1)*,0.98 (0.98 0.99),4.28E-02
562.1,Diverticulosis,digestive,OPGS003103,0.018,Metabolon,X - 21849,1.02 (1.01 1.02),4.31E-02
562.1,Diverticulosis,digestive,OPGS003448,0.093,Nightingale,Phospholipids in very large HDL,0.98 (0.98 0.99),4.31E-02
562.1,Diverticulosis,digestive,OPGS009595,0.077,RNAseq,AC092652.2,1.04 (1.03 1.05),3.42E-13
562.1,Diverticulosis,digestive,OPGS006230,0.190,RNAseq,CHRNB1,0.97 (0.96 0.98),1.20E-06
562.1,Diverticulosis,digestive,OPGS006570,0.172,RNAseq,SCAPER,0.97 (0.96 0.98),2.25E-06
562.1,Diverticulosis,digestive,OPGS006108,0.197,RNAseq,P2RY14,1.03 (1.02 1.04),5.73E-06
562.1,Diverticulosis,digestive,OPGS011636,0.045,RNAseq,LIN7C,0.97 (0.97 0.98),7.68E-06
562.1,Diverticulosis,digestive,OPGS005843,0.212,RNAseq,AJ239328.1,1.03 (1.02 1.04),8.73E-06
562.1,Diverticulosis,digestive,OPGS013699,0.025,RNAseq,TRAV5,1.03 (1.02 1.03),1.90E-05
562.1,Diverticulosis,digestive,OPGS006038,0.201,RNAseq,HLA-DQA2,1.03 (1.02 1.03),2.61E-05
562.1,Diverticulosis,digestive,OPGS015030,0.016,RNAseq,PRRC2A,1.03 (1.02 1.03),3.68E-05
562.1,Diverticulosis,digestive,OPGS008780,0.094,RNAseq,ALDH18A1,1.02 (1.02 1.03),4.72E-05
562.1,Diverticulosis,digestive,OPGS008244,0.108,RNAseq,ICA1L,0.98 (0.97 0.98),5.22E-05
562.1,Diverticulosis,digestive,OPGS013164,0.029,RNAseq,FSIP1,1.02 (1.02 1.03),5.41E-05
562.1,Diverticulosis,digestive,OPGS015054,0.015,RNAseq,H19,0.98 (0.97 0.98),5.68E-05
562.1,Diverticulosis,digestive,OPGS011727,0.044,RNAseq,SH2B2,0.98 (0.97 0.99),6.45E-05
562.1,Diverticulosis,digestive,OPGS010624,0.059,RNAseq,TRBV18,1.02 (1.01 1.03),1.12E-04
562.1,Diverticulosis,digestive,OPGS004866,0.303,RNAseq,DISP2,1.02 (1.01 1.03),1.32E-04
562.1,Diverticulosis,digestive,OPGS009774,0.073,RNAseq,METTL6,1.02 (1.01 1.03),2.02E-04
562.1,Diverticulosis,digestive,OPGS010191,0.066,RNAseq,MOB2,1.02 (1.01 1.03),2.11E-04
562.1,Diverticulosis,digestive,OPGS010425,0.062,RNAseq,BTD,0.98 (0.97 0.99),2.16E-04
562.1,Diverticulosis,digestive,OPGS014215,0.021,RNAseq,TRPS1,1.02 (1.01 1.03),2.72E-04
562.1,Diverticulosis,digestive,OPGS009968,0.070,RNAseq,AC009065.3,1.02 (1.01 1.03),3.46E-04
562.1,Diverticulosis,digestive,OPGS014601,0.018,RNAseq,HLX-AS1,0.98 (0.97 0.99),4.27E-04
562.1,Diverticulosis,digestive,OPGS010103,0.068,RNAseq,RABGAP1L,0.98 (0.97 0.99),4.88E-04
562.1,Diverticulosis,digestive,OPGS010348,0.063,RNAseq,TRBV6-5,1.02 (1.01 1.03),6.41E-04
562.1,Diverticulosis,digestive,OPGS005021,0.284,RNAseq,RABGAP1L-DT,0.98 (0.97 0.99),6.51E-04
562.1,Diverticulosis,digestive,OPGS013305,0.028,RNAseq,TRBV14,0.98 (0.97 0.99),7.10E-04
562.1,Diverticulosis,digestive,OPGS011283,0.050,RNAseq,CD248,1.02 (1.01 1.03),8.64E-04
562.1,Diverticulosis,digestive,OPGS008114,0.112,RNAseq,FADD,0.98 (0.97 0.99),9.89E-04
562.1,Diverticulosis,digestive,OPGS004806,0.309,RNAseq,INAFM2,1.02 (1.01 1.03),1.01E-03
562.1,Diverticulosis,digestive,OPGS006119,0.196,RNAseq,LCMT2,0.98 (0.97 0.99),1.01E-03
562.1,Diverticulosis,digestive,OPGS010452,0.062,RNAseq,CCN3,0.98 (0.97 0.99),1.01E-03
562.1,Diverticulosis,digestive,OPGS010037,0.069,RNAseq,CTTNBP2,1.02 (1.01 1.03),1.06E-03
562.1,Diverticulosis,digestive,OPGS005752,0.218,RNAseq,SPINT2,1.02 (1.01 1.03),1.23E-03
562.1,Diverticulosis,digestive,OPGS009348,0.082,RNAseq,NSUN6,0.98 (0.97 0.99),2.10E-03
562.1,Diverticulosis,digestive,OPGS012171,0.039,RNAseq,TRBV15,0.98 (0.97 0.99),2.29E-03
562.1,Diverticulosis,digestive,OPGS014060,0.022,RNAseq,AC074117.1,1.02 (1.01 1.03),2.74E-03
562.1,Diverticulosis,digestive,OPGS009973,0.070,RNAseq,DDX17,1.02 (1.01 1.03),3.65E-03
562.1,Diverticulosis,digestive,OPGS005395,0.247,RNAseq,FAM160A1,0.98 (0.97 0.99),3.80E-03
562.1,Diverticulosis,digestive,OPGS012855,0.032,RNAseq,TRBV9,0.98 (0.97 0.99),3.81E-03
562.1,Diverticulosis,digestive,OPGS011316,0.049,RNAseq,MYOSLID,1.02 (1.01 1.03),3.81E-03
562.1,Diverticulosis,digestive,OPGS013781,0.024,RNAseq,RCBTB2,0.98 (0.97 0.99),3.83E-03
562.1,Diverticulosis,digestive,OPGS004660,0.330,RNAseq,LRWD1,1.02 (1.01 1.03),4.56E-03
562.1,Diverticulosis,digestive,OPGS008742,0.095,RNAseq,VEPH1,1.02 (1.01 1.03),4.59E-03
562.1,Diverticulosis,digestive,OPGS007261,0.141,RNAseq,INSC,1.02 (1.01 1.03),4.91E-03
562.1,Diverticulosis,digestive,OPGS005618,0.227,RNAseq,PPP1R14A,1.02 (1.01 1.03),4.92E-03
562.1,Diverticulosis,digestive,OPGS009759,0.074,RNAseq,ZNF512B,0.98 (0.97 0.99),5.08E-03
562.1,Diverticulosis,digestive,OPGS011445,0.048,RNAseq,ATG13,1.02 (1.01 1.03),5.27E-03
562.1,Diverticulosis,digestive,OPGS009040,0.089,RNAseq,NF1,0.98 (0.97 0.99),5.38E-03
562.1,Diverticulosis,digestive,OPGS003621,0.665,RNAseq,,1.02 (1.01 1.03),5.47E-03
562.1,Diverticulosis,digestive,OPGS007649,0.127,RNAseq,LINC01505,0.98 (0.97 0.99),5.71E-03
562.1,Diverticulosis,digestive,OPGS008529,0.101,RNAseq,CRIP3,1.02 (1.01 1.03),6.91E-03
562.1,Diverticulosis,digestive,OPGS003897,0.508,RNAseq,CASC8,1.02 (1.01 1.03),6.94E-03
562.1,Diverticulosis,digestive,OPGS004810,0.309,RNAseq,TRAM1,1.02 (1.01 1.03),7.15E-03
562.1,Diverticulosis,digestive,OPGS013811,0.024,RNAseq,ZRANB3,1.02 (1.01 1.03),7.49E-03
562.1,Diverticulosis,digestive,OPGS006324,0.185,RNAseq,RPS23,0.98 (0.97 0.99),7.82E-03
562.1,Diverticulosis,digestive,OPGS004846,0.305,RNAseq,CUBN,1.02 (1.01 1.03),9.86E-03
562.1,Diverticulosis,digestive,OPGS003695,0.603,RNAseq,LINC00339,1.02 (1.01 1.03),9.87E-03
562.1,Diverticulosis,digestive,OPGS004543,0.347,RNAseq,ITPA,0.98 (0.97 0.99),9.97E-03
562.1,Diverticulosis,digestive,OPGS009906,0.071,RNAseq,CHST15,0.98 (0.97 0.99),1.16E-02
562.1,Diverticulosis,digestive,OPGS006065,0.200,RNAseq,RRP15,1.02 (1.01 1.03),1.18E-02
562.1,Diverticulosis,digestive,OPGS007137,0.146,RNAseq,CD8B2,0.98 (0.97 0.99),1.18E-02
562.1,Diverticulosis,digestive,OPGS003702,0.597,RNAseq,AC008957.1,1.02 (1.01 1.03),1.24E-02
562.1,Diverticulosis,digestive,OPGS005287,0.258,RNAseq,RMDN1,0.98 (0.97 0.99),1.46E-02
562.1,Diverticulosis,digestive,OPGS015042,0.016,RNAseq,EAF1-AS1,0.98 (0.97 0.99),1.58E-02
562.1,Diverticulosis,digestive,OPGS011242,0.050,RNAseq,C1orf122,0.98 (0.97 0.99),1.58E-02
562.1,Diverticulosis,digestive,OPGS010946,0.055,RNAseq,HELZ2,0.98 (0.97 0.99),1.70E-02
562.1,Diverticulosis,digestive,OPGS014857,0.017,RNAseq,NFYB,0.98 (0.97 0.99),1.70E-02
562.1,Diverticulosis,digestive,OPGS005068,0.279,RNAseq,METTL27,1.02 (1.01 1.03),1.73E-02
562.1,Diverticulosis,digestive,OPGS008523,0.101,RNAseq,AC008937.3,1.02 (1.01 1.03),1.78E-02
562.1,Diverticulosis,digestive,OPGS012799,0.033,RNAseq,ETV6,1.02 (1.01 1.03),1.87E-02
562.1,Diverticulosis,digestive,OPGS003993,0.465,RNAseq,SRR,0.98 (0.97 0.99),2.01E-02
562.1,Diverticulosis,digestive,OPGS007485,0.133,RNAseq,NUDCD3,1.02 (1.01 1.03),2.01E-02
562.1,Diverticulosis,digestive,OPGS007329,0.138,RNAseq,PHLPP2,1.02 (1.01 1.03),2.04E-02
562.1,Diverticulosis,digestive,OPGS008024,0.115,RNAseq,FMNL3,1.02 (1.01 1.03),2.04E-02
562.1,Diverticulosis,digestive,OPGS009462,0.080,RNAseq,MRVI1,1.02 (1.01 1.03),2.13E-02
562.1,Diverticulosis,digestive,OPGS010241,0.065,RNAseq,ZNF226,0.98 (0.98 0.99),2.17E-02
562.1,Diverticulosis,digestive,OPGS008746,0.095,RNAseq,TUBGCP4,1.02 (1.01 1.03),2.17E-02
562.1,Diverticulosis,digestive,OPGS012173,0.039,RNAseq,ZNF200,0.98 (0.97 0.99),2.27E-02
562.1,Diverticulosis,digestive,OPGS009379,0.082,RNAseq,AC016876.2,0.98 (0.97 0.99),2.36E-02
562.1,Diverticulosis,digestive,OPGS009242,0.084,RNAseq,ELL,0.98 (0.97 0.99),2.65E-02
562.1,Diverticulosis,digestive,OPGS009607,0.077,RNAseq,SLC1A3,0.98 (0.97 0.99),2.82E-02
562.1,Diverticulosis,digestive,OPGS010776,0.057,RNAseq,GLYCTK,1.02 (1.01 1.03),2.82E-02
562.1,Diverticulosis,digestive,OPGS003628,0.662,RNAseq,,1.02 (1.01 1.03),2.82E-02
562.1,Diverticulosis,digestive,OPGS004201,0.411,RNAseq,IPO8,0.98 (0.97 0.99),3.05E-02
562.1,Diverticulosis,digestive,OPGS012813,0.033,RNAseq,SLC25A28,0.98 (0.97 0.99),3.11E-02
562.1,Diverticulosis,digestive,OPGS013435,0.027,RNAseq,DAB1,0.98 (0.97 0.99),3.18E-02
562.1,Diverticulosis,digestive,OPGS005328,0.254,RNAseq,AC007406.5,0.98 (0.97 0.99),3.18E-02
562.1,Diverticulosis,digestive,OPGS003812,0.544,RNAseq,AP002954.1,1.02 (1.01 1.03),3.18E-02
562.1,Diverticulosis,digestive,OPGS011853,0.043,RNAseq,TRBV6-1,0.98 (0.97 0.99),3.19E-02
562.1,Diverticulosis,digestive,OPGS005995,0.204,RNAseq,ADAMTS6,0.98 (0.97 0.99),3.19E-02
562.1,Diverticulosis,digestive,OPGS004943,0.293,RNAseq,,0.98 (0.97 0.99),3.22E-02
562.1,Diverticulosis,digestive,OPGS004949,0.293,RNAseq,ILRUN,1.02 (1.01 1.03),3.22E-02
562.1,Diverticulosis,digestive,OPGS003767,0.566,RNAseq,PAM,0.98 (0.97 0.99),3.22E-02
562.1,Diverticulosis,digestive,OPGS009672,0.076,RNAseq,CALR,0.98 (0.97 0.99),3.25E-02
562.1,Diverticulosis,digestive,OPGS006787,0.161,RNAseq,IL1RL1,0.98 (0.98 0.99),3.26E-02
562.1,Diverticulosis,digestive,OPGS008605,0.099,RNAseq,PNO1,0.98 (0.97 0.99),3.26E-02
562.1,Diverticulosis,digestive,OPGS005421,0.245,RNAseq,MUC20,0.98 (0.97 0.99),3.26E-02
562.1,Diverticulosis,digestive,OPGS011191,0.051,RNAseq,EIF2S1,0.98 (0.98 0.99),3.26E-02
562.1,Diverticulosis,digestive,OPGS009254,0.084,RNAseq,GNMT,1.02 (1.01 1.03),3.36E-02
562.1,Diverticulosis,digestive,OPGS004693,0.325,RNAseq,FEZ2,1.02 (1.01 1.03),3.45E-02
562.1,Diverticulosis,digestive,OPGS012086,0.040,RNAseq,FAM83D,0.98 (0.98 0.99),3.45E-02
562.1,Diverticulosis,digestive,OPGS006499,0.176,RNAseq,C4A,0.98 (0.98 0.99),3.46E-02
562.1,Diverticulosis,digestive,OPGS007585,0.129,RNAseq,SPATS2L,0.98 (0.98 0.99),3.46E-02
562.1,Diverticulosis,digestive,OPGS012513,0.036,RNAseq,AC112254.1,0.98 (0.98 0.99),3.65E-02
562.1,Diverticulosis,digestive,OPGS006132,0.196,RNAseq,EIF6,0.98 (0.97 0.99),3.76E-02
562.1,Diverticulosis,digestive,OPGS010918,0.055,RNAseq,,0.98 (0.98 0.99),3.77E-02
562.1,Diverticulosis,digestive,OPGS013631,0.025,RNAseq,AL135999.1,0.98 (0.98 0.99),3.81E-02
562.1,Diverticulosis,digestive,OPGS007739,0.124,RNAseq,CAPS2,0.98 (0.98 0.99),3.82E-02
562.1,Diverticulosis,digestive,OPGS007651,0.127,RNAseq,KMT5A,0.98 (0.98 0.99),3.83E-02
562.1,Diverticulosis,digestive,OPGS007041,0.151,RNAseq,SYT11,1.02 (1.01 1.03),3.83E-02
562.1,Diverticulosis,digestive,OPGS003652,0.639,RNAseq,PLAAT3,0.98 (0.98 0.99),3.83E-02
562.1,Diverticulosis,digestive,OPGS008940,0.091,RNAseq,GNPTG,1.02 (1.01 1.03),3.85E-02
562.1,Diverticulosis,digestive,OPGS006565,0.172,RNAseq,ANKRA2,1.02 (1.01 1.03),4.08E-02
562.1,Diverticulosis,digestive,OPGS004915,0.297,RNAseq,AC110285.2,0.98 (0.98 0.99),4.09E-02
562.1,Diverticulosis,digestive,OPGS003860,0.524,RNAseq,,0.98 (0.98 0.99),4.10E-02
562.1,Diverticulosis,digestive,OPGS010758,0.057,RNAseq,TOX2,0.98 (0.98 0.99),4.23E-02
562.1,Diverticulosis,digestive,OPGS006466,0.177,RNAseq,NR1H3,0.98 (0.98 0.99),4.23E-02
562.1,Diverticulosis,digestive,OPGS005204,0.265,RNAseq,HYAL3,1.02 (1.01 1.03),4.27E-02
562.1,Diverticulosis,digestive,OPGS007377,0.137,RNAseq,ANKRD28,0.98 (0.98 0.99),4.28E-02
562.1,Diverticulosis,digestive,OPGS005958,0.206,RNAseq,ZNF154,1.02 (1.01 1.02),4.31E-02
562.1,Diverticulosis,digestive,OPGS004319,0.386,RNAseq,ETFA,0.98 (0.98 0.99),4.31E-02
562.1,Diverticulosis,digestive,OPGS010379,0.063,RNAseq,THEM5,1.02 (1.01 1.03),4.37E-02
562.1,Diverticulosis,digestive,OPGS005189,0.267,RNAseq,LDAH,0.98 (0.98 0.99),4.43E-02
562.1,Diverticulosis,digestive,OPGS012837,0.032,RNAseq,INKA2,0.98 (0.98 0.99),4.43E-02
562.1,Diverticulosis,digestive,OPGS007753,0.124,RNAseq,,1.02 (1.01 1.02),4.43E-02
562.1,Diverticulosis,digestive,OPGS014197,0.021,RNAseq,GOSR2,0.98 (0.98 0.99),4.43E-02
562.1,Diverticulosis,digestive,OPGS013898,0.023,RNAseq,TSC2,0.98 (0.98 0.99),4.43E-02
562.1,Diverticulosis,digestive,OPGS005245,0.261,RNAseq,ZNF391,0.98 (0.98 0.99),4.43E-02
562.1,Diverticulosis,digestive,OPGS010004,0.069,RNAseq,PAM16,1.02 (1.01 1.03),4.48E-02
562.1,Diverticulosis,digestive,OPGS011183,0.051,RNAseq,DLK1,0.98 (0.98 0.99),4.48E-02
562.1,Diverticulosis,digestive,OPGS006273,0.188,RNAseq,AC137932.2,1.02 (1.01 1.02),4.48E-02
562.1,Diverticulosis,digestive,OPGS006687,0.166,RNAseq,C15orf40,0.98 (0.98 0.99),4.48E-02
562.1,Diverticulosis,digestive,OPGS010853,0.056,RNAseq,STN1,0.98 (0.98 0.99),4.56E-02
562.1,Diverticulosis,digestive,OPGS014567,0.018,RNAseq,ARMC9,0.98 (0.98 0.99),4.59E-02
562.1,Diverticulosis,digestive,OPGS008754,0.095,RNAseq,CPM,1.02 (1.01 1.02),4.66E-02
562.1,Diverticulosis,digestive,OPGS008537,0.101,RNAseq,CERS6,1.02 (1.01 1.02),4.66E-02
562.1,Diverticulosis,digestive,OPGS011469,0.047,RNAseq,DDX51,1.02 (1.01 1.02),4.66E-02
562.1,Diverticulosis,digestive,OPGS014112,0.022,RNAseq,SNRPA,0.98 (0.98 0.99),4.84E-02
562.1,Diverticulosis,digestive,OPGS003988,0.468,RNAseq,SIRT1,1.02 (1.01 1.02),4.84E-02
562.1,Diverticulosis,digestive,OPGS005557,0.234,RNAseq,SLC25A26,0.98 (0.98 0.99),4.88E-02
562.1,Diverticulosis,digestive,OPGS007715,0.125,RNAseq,CEP85L,0.98 (0.98 0.99),4.92E-02
562.1,Diverticulosis,digestive,OPGS007333,0.138,RNAseq,EFCAB13,1.02 (1.01 1.03),4.92E-02
563,Constipation,digestive,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.97 (0.96 0.98),3.37E-02
563,Constipation,digestive,OPGS008907,0.092,RNAseq,FXYD6,1.03 (1.02 1.05),3.37E-02
564.9,Personal history of diseases of digestive system,digestive,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.96 (0.95 0.98),3.96E-05
564.9,Personal history of diseases of digestive system,digestive,OPGS000212,0.222,SomaScan,Tyrosine-protein kinase receptor Tie-1. soluble,0.97 (0.96 0.98),3.40E-02
564.9,Personal history of diseases of digestive system,digestive,OPGS005188,0.267,RNAseq,FIGNL1,0.97 (0.96 0.98),3.40E-02
564.9,Personal history of diseases of digestive system,digestive,OPGS008478,0.102,RNAseq,MT1X,1.03 (1.01 1.04),3.40E-02
565.1,Anal and rectal polyp,digestive,OPGS000117,0.345,SomaScan,Galactoside 3(4)-L-fucosyltransferase,0.96 (0.94 0.97),3.67E-03
565.1,Anal and rectal polyp,digestive,OPGS002857,0.067,Metabolon,1-arachidonoyl-GPA (20:4),1.04 (1.02 1.06),3.00E-02
565.1,Anal and rectal polyp,digestive,OPGS002819,0.083,Metabolon,phosphatidylcholine (16:0/22:5n3. 18:1/20:4)*,1.04 (1.02 1.06),3.00E-02
565.1,Anal and rectal polyp,digestive,OPGS002893,0.054,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3)*,1.04 (1.02 1.06),3.16E-02
565.1,Anal and rectal polyp,digestive,OPGS010163,0.066,RNAseq,AL121832.2,1.10 (1.08 1.12),8.02E-20
565.1,Anal and rectal polyp,digestive,OPGS010719,0.058,RNAseq,LAMA5,1.05 (1.04 1.07),1.11E-04
565.1,Anal and rectal polyp,digestive,OPGS005738,0.219,RNAseq,DENND3,0.96 (0.94 0.98),3.00E-02
565.1,Anal and rectal polyp,digestive,OPGS009731,0.074,RNAseq,ETFDH,1.04 (1.02 1.06),3.16E-02
565.1,Anal and rectal polyp,digestive,OPGS010624,0.059,RNAseq,TRBV18,1.04 (1.02 1.06),3.24E-02
569.1,Toxic gastroenteritis and colitis,digestive,OPGS002175,0.011,SomaScan,Chymase,0.98 (0.97 0.99),3.42E-07
571,Chronic liver disease and cirrhosis,digestive,OPGS002186,0.011,SomaScan,Suprabasin,1.16 (1.11 1.21),3.66E-09
571,Chronic liver disease and cirrhosis,digestive,OPGS001879,0.015,SomaScan,Arfaptin-2,0.86 (0.83 0.90),3.66E-09
571,Chronic liver disease and cirrhosis,digestive,OPGS000717,0.082,SomaScan,Zinc finger protein 175,1.16 (1.11 1.21),6.09E-08
571,Chronic liver disease and cirrhosis,digestive,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,1.15 (1.11 1.20),7.00E-08
571,Chronic liver disease and cirrhosis,digestive,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,1.15 (1.10 1.21),3.98E-06
571,Chronic liver disease and cirrhosis,digestive,OPGS001546,0.024,SomaScan,Glypican-6,1.15 (1.10 1.20),1.18E-05
571,Chronic liver disease and cirrhosis,digestive,OPGS000272,0.183,SomaScan,Alpha-1-antitrypsin,0.87 (0.82 0.91),8.46E-05
571,Chronic liver disease and cirrhosis,digestive,OPGS000793,0.074,SomaScan,Lysosomal acid phosphatase,1.13 (1.07 1.19),3.85E-03
571,Chronic liver disease and cirrhosis,digestive,OPGS000500,0.118,SomaScan,Synaptosomal-associated protein 25,1.12 (1.07 1.18),6.66E-03
571,Chronic liver disease and cirrhosis,digestive,OPGS002654,0.015,Olink,Thrombopoietin,1.15 (1.09 1.20),2.69E-05
571,Chronic liver disease and cirrhosis,digestive,OPGS002529,0.068,Olink,Tumor necrosis factor receptor superfamily member 3,1.13 (1.08 1.19),1.83E-03
571,Chronic liver disease and cirrhosis,digestive,OPGS006705,0.165,RNAseq,MAU2,0.86 (0.82 0.91),4.23E-05
571,Chronic liver disease and cirrhosis,digestive,OPGS008831,0.093,RNAseq,ARHGEF37,0.88 (0.83 0.93),1.44E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001661,0.020,SomaScan,Stromal cell-derived factor 2-like protein 1,1.12 (1.09 1.16),4.06E-10
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,1.11 (1.07 1.14),1.06E-05
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,0.90 (0.87 0.93),1.71E-05
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,0.91 (0.88 0.94),3.49E-05
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,0.91 (0.88 0.94),4.25E-05
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,1.10 (1.06 1.13),5.59E-05
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,0.91 (0.88 0.94),5.59E-05
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000032,0.570,SomaScan,Protein S100-A13,1.10 (1.06 1.13),5.77E-05
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,0.91 (0.88 0.94),7.13E-05
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001587,0.023,SomaScan,Carboxypeptidase E,0.91 (0.88 0.94),1.02E-04
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,1.09 (1.06 1.13),1.06E-04
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,0.92 (0.89 0.95),1.06E-04
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000912,0.061,SomaScan,Ras-related protein Rab-14,1.09 (1.05 1.12),1.06E-04
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,1.09 (1.05 1.12),2.61E-04
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000911,0.062,SomaScan,Protein MENT,0.92 (0.89 0.95),3.07E-04
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,0.92 (0.90 0.95),1.18E-03
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000857,0.067,SomaScan,Moesin,0.93 (0.90 0.96),1.50E-03
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001343,0.031,SomaScan,Beta-1.3-N-acetylglucosaminyltransferase radical fringe,1.08 (1.05 1.12),1.65E-03
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,0.93 (0.90 0.96),4.26E-03
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001155,0.042,SomaScan,Zinc finger protein 276,0.93 (0.91 0.96),6.90E-03
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,0.93 (0.90 0.96),6.90E-03
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,1.07 (1.04 1.10),7.02E-03
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,0.94 (0.91 0.96),7.58E-03
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001323,0.032,SomaScan,Sorting nexin-7,0.94 (0.91 0.97),1.18E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000149,0.285,SomaScan,CUB and zona pellucida-like domain-containing protein 1,1.07 (1.04 1.11),1.24E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000179,0.254,SomaScan,Cardiotrophin-1,0.94 (0.91 0.97),2.38E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000821,0.071,SomaScan,Alcohol dehydrogenase class-3,1.06 (1.03 1.10),2.76E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS002225,0.011,SomaScan,Persephin,0.94 (0.92 0.97),2.76E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,0.94 (0.91 0.97),2.92E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,0.94 (0.91 0.97),3.29E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS000217,0.216,SomaScan,Neutrophil cytosol factor 2,1.06 (1.03 1.09),4.91E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS002665,0.011,Olink,Neurocan core protein,0.93 (0.90 0.95),2.61E-04
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS002626,0.023,Olink,Fibroblast growth factor 21,1.07 (1.03 1.10),2.09E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS002497,0.100,Olink,Scavenger receptor cysteine-rich type 1 protein M130,1.06 (1.03 1.09),4.71E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003034,0.025,Metabolon,1-palmitoleoyl-GPC (16:1)*,1.08 (1.05 1.12),3.08E-04
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003006,0.030,Metabolon,cholesterol,0.93 (0.90 0.95),4.26E-04
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003162,0.014,Metabolon,2-hydroxybutyrate/2-hydroxyisobutyrate,1.08 (1.05 1.11),1.41E-03
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003201,0.012,Metabolon,glycerophosphorylcholine (GPC),1.07 (1.04 1.11),6.88E-03
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),0.93 (0.90 0.96),8.52E-03
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),0.94 (0.91 0.97),3.22E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003217,0.011,Metabolon,X - 24024,1.06 (1.03 1.09),4.29E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003119,0.017,Metabolon,1-palmitoyl-GPC (16:0),1.06 (1.03 1.10),4.29E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003114,0.018,Metabolon,1-myristoyl-2-linoleoyl-GPC (14:0/18:2)*,1.06 (1.03 1.09),4.29E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003462,0.083,Nightingale,Average diameter for VLDL particles,1.09 (1.06 1.12),7.13E-05
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003455,0.087,Nightingale,Total free cholesterol,0.94 (0.91 0.96),9.96E-03
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003527,0.050,Nightingale,Sphingomyelins,0.94 (0.91 0.97),2.09E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003508,0.069,Nightingale,Triglycerides in small HDL,1.06 (1.03 1.10),2.90E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003481,0.075,Nightingale,Triglycerides in medium VLDL,1.06 (1.03 1.10),3.84E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003493,0.073,Nightingale,Total lipids in large VLDL,1.06 (1.03 1.10),3.84E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003509,0.069,Nightingale,Free cholesterol in chylomicrons and extremely large VLDL,1.06 (1.03 1.10),3.84E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,0.94 (0.91 0.97),4.16E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003479,0.075,Nightingale,Triglycerides in VLDL,1.06 (1.03 1.10),4.29E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,0.94 (0.91 0.97),4.29E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS003498,0.071,Nightingale,Triglycerides in large VLDL,1.06 (1.03 1.09),4.91E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS006705,0.165,RNAseq,MAU2,0.91 (0.88 0.93),8.69E-07
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS004293,0.390,RNAseq,CWF19L1,0.93 (0.90 0.96),2.37E-03
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS005991,0.204,RNAseq,POMC,0.93 (0.90 0.96),1.09E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS008655,0.097,RNAseq,AC006299.1,1.07 (1.03 1.10),2.36E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS004504,0.354,RNAseq,ADH5,1.06 (1.03 1.10),2.38E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS006626,0.169,RNAseq,MYO9A,1.07 (1.03 1.10),3.15E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS012263,0.038,RNAseq,GDPD3,1.05 (1.03 1.08),3.84E-02
571.5,Other chronic nonalcoholic liver disease,digestive,OPGS012768,0.033,RNAseq,HMGA1,1.06 (1.03 1.09),4.71E-02
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS002186,0.011,SomaScan,Suprabasin,1.15 (1.11 1.20),2.81E-09
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS001879,0.015,SomaScan,Arfaptin-2,0.87 (0.84 0.90),2.81E-09
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS000717,0.082,SomaScan,Zinc finger protein 175,1.15 (1.11 1.20),1.79E-08
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,1.15 (1.10 1.19),6.85E-08
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS001546,0.024,SomaScan,Glypican-6,1.14 (1.10 1.20),3.57E-06
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,1.14 (1.09 1.19),1.24E-05
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS000272,0.183,SomaScan,Alpha-1-antitrypsin,0.87 (0.83 0.92),7.32E-05
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS000793,0.074,SomaScan,Lysosomal acid phosphatase,1.13 (1.08 1.19),4.96E-04
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS000500,0.118,SomaScan,Synaptosomal-associated protein 25,1.11 (1.06 1.17),2.04E-02
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS002654,0.015,Olink,Thrombopoietin,1.14 (1.09 1.19),2.10E-05
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS002529,0.068,Olink,Tumor necrosis factor receptor superfamily member 3,1.13 (1.07 1.18),1.58E-03
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS006705,0.165,RNAseq,MAU2,0.87 (0.82 0.91),2.10E-05
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS014906,0.016,RNAseq,GEMIN2,0.92 (0.88 0.96),2.57E-02
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS008831,0.093,RNAseq,ARHGEF37,0.89 (0.85 0.94),2.57E-02
571.51,Cirrhosis of liver without mention of alcohol,digestive,OPGS011293,0.050,RNAseq,OTUD1,0.92 (0.88 0.96),3.19E-02
571.6,Primary biliary cirrhosis,digestive,OPGS013643,0.025,RNAseq,HLA-DQB2,1.23 (1.14 1.34),7.26E-03
571.8,Liver abscess and sequelae of chronic liver disease,digestive,OPGS011993,0.041,RNAseq,CD24,0.89 (0.84 0.93),4.76E-02
573.5,Jaundice (not of newborn),digestive,OPGS001707,0.019,SomaScan,Serine/threonine-protein kinase VRK1,1.13 (1.08 1.18),1.65E-03
573.5,Jaundice (not of newborn),digestive,OPGS002216,0.011,SomaScan,Interferon gamma,1.14 (1.08 1.20),1.69E-03
573.5,Jaundice (not of newborn),digestive,OPGS001556,0.023,SomaScan,Retinol dehydrogenase 16,1.12 (1.07 1.18),1.69E-03
573.5,Jaundice (not of newborn),digestive,OPGS000864,0.066,SomaScan,UDP-glucuronosyltransferase 1-6,0.88 (0.83 0.93),2.31E-03
573.5,Jaundice (not of newborn),digestive,OPGS000499,0.118,SomaScan,Angiopoietin-related protein 1,1.13 (1.07 1.19),2.31E-03
573.5,Jaundice (not of newborn),digestive,OPGS001903,0.015,SomaScan,Tissue Factor,1.12 (1.07 1.18),5.61E-03
573.5,Jaundice (not of newborn),digestive,OPGS001953,0.014,SomaScan,Nuclear receptor subfamily 1 group D member 2,1.12 (1.07 1.18),5.65E-03
573.5,Jaundice (not of newborn),digestive,OPGS001837,0.016,SomaScan,Testis-specific chromodomain protein Y 1,1.12 (1.07 1.18),6.39E-03
573.5,Jaundice (not of newborn),digestive,OPGS002003,0.013,SomaScan,Ectonucleoside triphosphate diphosphohydrolase 6,1.12 (1.06 1.18),1.43E-02
573.5,Jaundice (not of newborn),digestive,OPGS001683,0.020,SomaScan,Protein-tyrosine kinase 6,1.12 (1.06 1.17),1.91E-02
573.5,Jaundice (not of newborn),digestive,OPGS003157,0.014,Metabolon,X - 10458,0.85 (0.81 0.90),3.62E-05
573.5,Jaundice (not of newborn),digestive,OPGS002716,0.242,Metabolon,bilirubin (E.E)*,1.15 (1.09 1.21),4.66E-04
573.5,Jaundice (not of newborn),digestive,OPGS002722,0.209,Metabolon,X - 16946,1.14 (1.09 1.20),1.65E-03
573.5,Jaundice (not of newborn),digestive,OPGS002717,0.241,Metabolon,biliverdin,1.14 (1.08 1.20),1.69E-03
573.5,Jaundice (not of newborn),digestive,OPGS002718,0.234,Metabolon,bilirubin (Z.Z),1.14 (1.08 1.20),1.69E-03
573.5,Jaundice (not of newborn),digestive,OPGS002790,0.100,Metabolon,X - 11442,1.14 (1.08 1.20),1.69E-03
573.5,Jaundice (not of newborn),digestive,OPGS002719,0.216,Metabolon,X - 21448,1.14 (1.08 1.20),1.69E-03
573.5,Jaundice (not of newborn),digestive,OPGS002737,0.169,Metabolon,succinimide,1.14 (1.08 1.20),1.69E-03
573.5,Jaundice (not of newborn),digestive,OPGS002725,0.200,Metabolon,X - 11530,1.14 (1.08 1.20),1.69E-03
573.5,Jaundice (not of newborn),digestive,OPGS002723,0.204,Metabolon,X - 21458,1.13 (1.08 1.19),1.83E-03
573.5,Jaundice (not of newborn),digestive,OPGS002727,0.198,Metabolon,X - 11522,1.13 (1.08 1.19),1.83E-03
573.5,Jaundice (not of newborn),digestive,OPGS002808,0.089,Metabolon,X - 11441,1.13 (1.08 1.19),1.93E-03
573.5,Jaundice (not of newborn),digestive,OPGS003027,0.026,Metabolon,xanthurenate,1.13 (1.07 1.18),4.39E-03
573.5,Jaundice (not of newborn),digestive,OPGS003169,0.014,Metabolon,X - 21796,1.12 (1.07 1.18),8.53E-03
573.5,Jaundice (not of newborn),digestive,OPGS003527,0.050,Nightingale,Sphingomyelins,0.90 (0.85 0.95),3.21E-02
573.5,Jaundice (not of newborn),digestive,OPGS010622,0.059,RNAseq,ECM1,1.09 (1.05 1.14),3.86E-02
573.7,Abnormal results of function study of liver,digestive,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,1.07 (1.05 1.09),8.23E-06
573.7,Abnormal results of function study of liver,digestive,OPGS002216,0.011,SomaScan,Interferon gamma,1.07 (1.05 1.10),1.83E-05
573.7,Abnormal results of function study of liver,digestive,OPGS000500,0.118,SomaScan,Synaptosomal-associated protein 25,1.07 (1.04 1.09),3.19E-05
573.7,Abnormal results of function study of liver,digestive,OPGS000499,0.118,SomaScan,Angiopoietin-related protein 1,1.07 (1.04 1.10),5.01E-05
573.7,Abnormal results of function study of liver,digestive,OPGS001683,0.020,SomaScan,Protein-tyrosine kinase 6,1.07 (1.04 1.09),5.29E-05
573.7,Abnormal results of function study of liver,digestive,OPGS001837,0.016,SomaScan,Testis-specific chromodomain protein Y 1,1.07 (1.04 1.09),7.13E-05
573.7,Abnormal results of function study of liver,digestive,OPGS001556,0.023,SomaScan,Retinol dehydrogenase 16,1.06 (1.04 1.09),1.09E-04
573.7,Abnormal results of function study of liver,digestive,OPGS002186,0.011,SomaScan,Suprabasin,1.06 (1.04 1.08),1.36E-04
573.7,Abnormal results of function study of liver,digestive,OPGS001879,0.015,SomaScan,Arfaptin-2,0.94 (0.92 0.97),1.36E-04
573.7,Abnormal results of function study of liver,digestive,OPGS000717,0.082,SomaScan,Zinc finger protein 175,1.06 (1.04 1.08),1.74E-04
573.7,Abnormal results of function study of liver,digestive,OPGS000658,0.089,SomaScan,Ubiquitin carboxyl-terminal hydrolase isozyme L1,1.06 (1.04 1.09),1.74E-04
573.7,Abnormal results of function study of liver,digestive,OPGS001903,0.015,SomaScan,Tissue Factor,1.06 (1.04 1.09),3.51E-04
573.7,Abnormal results of function study of liver,digestive,OPGS001953,0.014,SomaScan,Nuclear receptor subfamily 1 group D member 2,1.06 (1.04 1.09),5.80E-04
573.7,Abnormal results of function study of liver,digestive,OPGS000272,0.183,SomaScan,Alpha-1-antitrypsin,0.94 (0.92 0.97),1.06E-03
573.7,Abnormal results of function study of liver,digestive,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,1.05 (1.03 1.08),2.31E-03
573.7,Abnormal results of function study of liver,digestive,OPGS001707,0.019,SomaScan,Serine/threonine-protein kinase VRK1,1.06 (1.03 1.08),2.85E-03
573.7,Abnormal results of function study of liver,digestive,OPGS002003,0.013,SomaScan,Ectonucleoside triphosphate diphosphohydrolase 6,1.06 (1.03 1.08),3.71E-03
573.7,Abnormal results of function study of liver,digestive,OPGS000522,0.113,SomaScan,Urea transporter 2,1.05 (1.03 1.08),1.16E-02
573.7,Abnormal results of function study of liver,digestive,OPGS001546,0.024,SomaScan,Glypican-6,1.05 (1.02 1.07),2.09E-02
573.7,Abnormal results of function study of liver,digestive,OPGS002654,0.015,Olink,Thrombopoietin,1.06 (1.03 1.08),5.96E-04
573.7,Abnormal results of function study of liver,digestive,OPGS002716,0.242,Metabolon,bilirubin (E.E)*,1.08 (1.05 1.11),3.97E-06
573.7,Abnormal results of function study of liver,digestive,OPGS002737,0.169,Metabolon,succinimide,1.08 (1.05 1.11),3.97E-06
573.7,Abnormal results of function study of liver,digestive,OPGS002717,0.241,Metabolon,biliverdin,1.08 (1.05 1.10),6.53E-06
573.7,Abnormal results of function study of liver,digestive,OPGS002722,0.209,Metabolon,X - 16946,1.08 (1.05 1.10),6.53E-06
573.7,Abnormal results of function study of liver,digestive,OPGS002719,0.216,Metabolon,X - 21448,1.08 (1.05 1.10),6.53E-06
573.7,Abnormal results of function study of liver,digestive,OPGS002725,0.200,Metabolon,X - 11530,1.08 (1.05 1.10),6.53E-06
573.7,Abnormal results of function study of liver,digestive,OPGS002790,0.100,Metabolon,X - 11442,1.07 (1.05 1.10),8.23E-06
573.7,Abnormal results of function study of liver,digestive,OPGS002808,0.089,Metabolon,X - 11441,1.07 (1.05 1.10),8.56E-06
573.7,Abnormal results of function study of liver,digestive,OPGS002718,0.234,Metabolon,bilirubin (Z.Z),1.07 (1.05 1.10),8.68E-06
573.7,Abnormal results of function study of liver,digestive,OPGS002727,0.198,Metabolon,X - 11522,1.07 (1.05 1.10),9.15E-06
573.7,Abnormal results of function study of liver,digestive,OPGS002723,0.204,Metabolon,X - 21458,1.07 (1.05 1.10),1.49E-05
573.7,Abnormal results of function study of liver,digestive,OPGS003157,0.014,Metabolon,X - 10458,0.94 (0.91 0.96),5.29E-05
573.7,Abnormal results of function study of liver,digestive,OPGS003169,0.014,Metabolon,X - 21796,1.07 (1.04 1.09),1.09E-04
573.7,Abnormal results of function study of liver,digestive,OPGS003166,0.014,Metabolon,thyroxine,0.95 (0.92 0.97),3.60E-03
573.7,Abnormal results of function study of liver,digestive,OPGS002874,0.060,Metabolon,campesterol,0.95 (0.93 0.97),1.59E-02
573.7,Abnormal results of function study of liver,digestive,OPGS005747,0.218,RNAseq,AP000350.6,0.94 (0.92 0.97),1.51E-03
573.7,Abnormal results of function study of liver,digestive,OPGS012605,0.035,RNAseq,HSPA1A,0.95 (0.93 0.97),3.47E-02
573.7,Abnormal results of function study of liver,digestive,OPGS010700,0.058,RNAseq,DCLRE1B,0.95 (0.93 0.98),4.14E-02
573.7,Abnormal results of function study of liver,digestive,OPGS012892,0.032,RNAseq,KLF10,0.95 (0.93 0.98),4.14E-02
573.9,Abnormal serum enzyme levels,digestive,OPGS004165,0.418,RNAseq,ARHGAP22,0.79 (0.71 0.87),3.43E-02
573.9,Abnormal serum enzyme levels,digestive,OPGS010743,0.057,RNAseq,BBS10,1.22 (1.12 1.33),3.43E-02
574,Cholelithiasis and cholecystitis,digestive,OPGS000500,0.118,SomaScan,Synaptosomal-associated protein 25,1.21 (1.11 1.32),4.08E-02
574,Cholelithiasis and cholecystitis,digestive,OPGS000658,0.089,SomaScan,Ubiquitin carboxyl-terminal hydrolase isozyme L1,1.20 (1.11 1.31),4.65E-02
574,Cholelithiasis and cholecystitis,digestive,OPGS002874,0.060,Metabolon,campesterol,0.70 (0.63 0.77),1.96E-08
574,Cholelithiasis and cholecystitis,digestive,OPGS013914,0.023,RNAseq,AP1AR,0.87 (0.82 0.93),4.08E-02
574.1,Cholelithiasis,digestive,OPGS002216,0.011,SomaScan,Interferon gamma,1.06 (1.04 1.08),2.79E-09
574.1,Cholelithiasis,digestive,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.94 (0.93 0.96),3.08E-09
574.1,Cholelithiasis,digestive,OPGS000499,0.118,SomaScan,Angiopoietin-related protein 1,1.06 (1.04 1.08),9.06E-09
574.1,Cholelithiasis,digestive,OPGS001837,0.016,SomaScan,Testis-specific chromodomain protein Y 1,1.06 (1.04 1.08),1.08E-08
574.1,Cholelithiasis,digestive,OPGS001903,0.015,SomaScan,Tissue Factor,1.06 (1.04 1.08),2.23E-08
574.1,Cholelithiasis,digestive,OPGS001683,0.020,SomaScan,Protein-tyrosine kinase 6,1.06 (1.04 1.08),3.34E-08
574.1,Cholelithiasis,digestive,OPGS001953,0.014,SomaScan,Nuclear receptor subfamily 1 group D member 2,1.06 (1.04 1.08),3.34E-08
574.1,Cholelithiasis,digestive,OPGS001707,0.019,SomaScan,Serine/threonine-protein kinase VRK1,1.06 (1.04 1.07),3.42E-08
574.1,Cholelithiasis,digestive,OPGS000664,0.088,SomaScan,BPI fold-containing family A member 2,1.06 (1.04 1.08),6.93E-08
574.1,Cholelithiasis,digestive,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,1.05 (1.04 1.07),1.17E-07
574.1,Cholelithiasis,digestive,OPGS002003,0.013,SomaScan,Ectonucleoside triphosphate diphosphohydrolase 6,1.05 (1.04 1.07),2.35E-07
574.1,Cholelithiasis,digestive,OPGS001812,0.017,SomaScan,Fibroblast growth factor 19,0.95 (0.93 0.96),2.68E-07
574.1,Cholelithiasis,digestive,OPGS000500,0.118,SomaScan,Synaptosomal-associated protein 25,1.05 (1.03 1.07),1.44E-06
574.1,Cholelithiasis,digestive,OPGS000658,0.089,SomaScan,Ubiquitin carboxyl-terminal hydrolase isozyme L1,1.05 (1.03 1.06),9.17E-06
574.1,Cholelithiasis,digestive,OPGS001556,0.023,SomaScan,Retinol dehydrogenase 16,1.05 (1.03 1.06),1.48E-05
574.1,Cholelithiasis,digestive,OPGS000272,0.183,SomaScan,Alpha-1-antitrypsin,0.95 (0.94 0.97),1.53E-05
574.1,Cholelithiasis,digestive,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,1.04 (1.03 1.06),3.79E-05
574.1,Cholelithiasis,digestive,OPGS001879,0.015,SomaScan,Arfaptin-2,0.96 (0.94 0.98),4.72E-05
574.1,Cholelithiasis,digestive,OPGS002186,0.011,SomaScan,Suprabasin,1.04 (1.03 1.06),4.72E-05
574.1,Cholelithiasis,digestive,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,0.96 (0.94 0.97),6.73E-05
574.1,Cholelithiasis,digestive,OPGS000717,0.082,SomaScan,Zinc finger protein 175,1.04 (1.02 1.06),8.94E-05
574.1,Cholelithiasis,digestive,OPGS001093,0.046,SomaScan,C-reactive protein,1.04 (1.03 1.06),9.92E-05
574.1,Cholelithiasis,digestive,OPGS000857,0.067,SomaScan,Moesin,0.96 (0.94 0.97),1.76E-04
574.1,Cholelithiasis,digestive,OPGS000117,0.345,SomaScan,Galactoside 3(4)-L-fucosyltransferase,0.96 (0.94 0.98),2.10E-04
574.1,Cholelithiasis,digestive,OPGS001546,0.024,SomaScan,Glypican-6,1.04 (1.02 1.06),2.45E-04
574.1,Cholelithiasis,digestive,OPGS000833,0.069,SomaScan,Protein LEG1 homolog,1.05 (1.03 1.07),2.60E-04
574.1,Cholelithiasis,digestive,OPGS000864,0.066,SomaScan,UDP-glucuronosyltransferase 1-6,0.96 (0.94 0.98),3.47E-04
574.1,Cholelithiasis,digestive,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,0.96 (0.94 0.98),5.71E-04
574.1,Cholelithiasis,digestive,OPGS000115,0.347,SomaScan,Protein CEI,0.96 (0.94 0.98),5.79E-04
574.1,Cholelithiasis,digestive,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,0.96 (0.94 0.98),8.92E-04
574.1,Cholelithiasis,digestive,OPGS000179,0.254,SomaScan,Cardiotrophin-1,0.96 (0.94 0.98),9.22E-04
574.1,Cholelithiasis,digestive,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,0.96 (0.95 0.98),1.63E-03
574.1,Cholelithiasis,digestive,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,0.96 (0.95 0.98),1.88E-03
574.1,Cholelithiasis,digestive,OPGS000797,0.073,SomaScan,Ras-related protein Rab-31,1.04 (1.02 1.05),2.72E-03
574.1,Cholelithiasis,digestive,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,0.96 (0.95 0.98),2.79E-03
574.1,Cholelithiasis,digestive,OPGS001587,0.023,SomaScan,Carboxypeptidase E,0.96 (0.95 0.98),2.82E-03
574.1,Cholelithiasis,digestive,OPGS000284,0.177,SomaScan,Protein eva-1 homolog C,1.04 (1.02 1.06),3.51E-03
574.1,Cholelithiasis,digestive,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,0.96 (0.95 0.98),6.08E-03
574.1,Cholelithiasis,digestive,OPGS000434,0.132,SomaScan,DNA repair protein RAD51 homolog 4,1.04 (1.02 1.06),6.08E-03
574.1,Cholelithiasis,digestive,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,0.97 (0.95 0.98),8.03E-03
574.1,Cholelithiasis,digestive,OPGS000663,0.089,SomaScan,Secreted and transmembrane protein 1,0.97 (0.95 0.98),1.22E-02
574.1,Cholelithiasis,digestive,OPGS000307,0.164,SomaScan,Apolipoprotein E,0.97 (0.95 0.99),1.55E-02
574.1,Cholelithiasis,digestive,OPGS000613,0.096,SomaScan,Stromelysin-1,0.97 (0.95 0.99),1.75E-02
574.1,Cholelithiasis,digestive,OPGS000972,0.056,SomaScan,Uncharacterized protein C14orf93,0.97 (0.95 0.99),2.02E-02
574.1,Cholelithiasis,digestive,OPGS000522,0.113,SomaScan,Urea transporter 2,1.03 (1.01 1.05),2.08E-02
574.1,Cholelithiasis,digestive,OPGS001954,0.014,SomaScan,Tuftelin,0.97 (0.95 0.99),2.08E-02
574.1,Cholelithiasis,digestive,OPGS000442,0.130,SomaScan,Angiopoietin-related protein 1,0.97 (0.95 0.99),2.12E-02
574.1,Cholelithiasis,digestive,OPGS000379,0.142,SomaScan,Kallikrein-7,1.03 (1.01 1.05),2.36E-02
574.1,Cholelithiasis,digestive,OPGS000088,0.392,SomaScan,E-selectin,0.97 (0.95 0.99),2.97E-02
574.1,Cholelithiasis,digestive,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,0.97 (0.95 0.99),2.98E-02
574.1,Cholelithiasis,digestive,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.03 (1.01 1.05),3.05E-02
574.1,Cholelithiasis,digestive,OPGS000312,0.163,SomaScan,Selenoprotein S,0.97 (0.95 0.99),3.37E-02
574.1,Cholelithiasis,digestive,OPGS000159,0.271,SomaScan,39S ribosomal protein L33. mitochondrial,1.03 (1.01 1.05),3.52E-02
574.1,Cholelithiasis,digestive,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,1.03 (1.01 1.05),3.73E-02
574.1,Cholelithiasis,digestive,OPGS001172,0.040,SomaScan,Apolipoprotein B,0.97 (0.95 0.99),4.29E-02
574.1,Cholelithiasis,digestive,OPGS002557,0.050,Olink,Epithelial cell adhesion molecule,0.93 (0.91 0.94),3.69E-15
574.1,Cholelithiasis,digestive,OPGS002437,0.187,Olink,Serine protease 27,1.07 (1.05 1.08),3.26E-10
574.1,Cholelithiasis,digestive,OPGS002657,0.013,Olink,Fibroblast growth factor 19,0.94 (0.93 0.96),3.60E-08
574.1,Cholelithiasis,digestive,OPGS002531,0.066,Olink,Tissue factor,0.96 (0.94 0.97),1.53E-04
574.1,Cholelithiasis,digestive,OPGS002656,0.013,Olink,Angiotensin-converting enzyme 2,1.04 (1.02 1.06),2.95E-04
574.1,Cholelithiasis,digestive,OPGS002654,0.015,Olink,Thrombopoietin,1.04 (1.02 1.05),4.28E-03
574.1,Cholelithiasis,digestive,OPGS002408,0.270,Olink,E-selectin,0.97 (0.95 0.98),6.08E-03
574.1,Cholelithiasis,digestive,OPGS002472,0.139,Olink,Bleomycin hydrolase,0.97 (0.95 0.98),1.21E-02
574.1,Cholelithiasis,digestive,OPGS002529,0.068,Olink,Tumor necrosis factor receptor superfamily member 3,1.03 (1.01 1.05),1.85E-02
574.1,Cholelithiasis,digestive,OPGS002564,0.046,Olink,Polymeric immunoglobulin receptor,1.03 (1.01 1.05),2.12E-02
574.1,Cholelithiasis,digestive,OPGS002874,0.060,Metabolon,campesterol,0.82 (0.81 0.84),9.75E-100
574.1,Cholelithiasis,digestive,OPGS002716,0.242,Metabolon,bilirubin (E.E)*,1.07 (1.05 1.09),5.42E-12
574.1,Cholelithiasis,digestive,OPGS002782,0.110,Metabolon,4-androsten-3beta.17beta-diol disulfate (1),1.07 (1.05 1.09),9.15E-12
574.1,Cholelithiasis,digestive,OPGS002719,0.216,Metabolon,X - 21448,1.07 (1.05 1.09),1.16E-11
574.1,Cholelithiasis,digestive,OPGS002722,0.209,Metabolon,X - 16946,1.07 (1.05 1.09),1.67E-11
574.1,Cholelithiasis,digestive,OPGS002737,0.169,Metabolon,succinimide,1.07 (1.05 1.09),2.06E-11
574.1,Cholelithiasis,digestive,OPGS002717,0.241,Metabolon,biliverdin,1.07 (1.05 1.09),3.65E-11
574.1,Cholelithiasis,digestive,OPGS002718,0.234,Metabolon,bilirubin (Z.Z),1.07 (1.05 1.09),4.36E-11
574.1,Cholelithiasis,digestive,OPGS003166,0.014,Metabolon,thyroxine,0.94 (0.92 0.95),4.54E-11
574.1,Cholelithiasis,digestive,OPGS003079,0.020,Metabolon,glycolithocholate,0.93 (0.92 0.95),5.76E-11
574.1,Cholelithiasis,digestive,OPGS002738,0.166,Metabolon,pregnen-diol disulfate*,1.07 (1.05 1.09),7.78E-11
574.1,Cholelithiasis,digestive,OPGS002725,0.200,Metabolon,X - 11530,1.07 (1.05 1.08),7.78E-11
574.1,Cholelithiasis,digestive,OPGS002790,0.100,Metabolon,X - 11442,1.07 (1.05 1.08),1.60E-10
574.1,Cholelithiasis,digestive,OPGS002862,0.066,Metabolon,4-androsten-3alpha.17alpha-diol monosulfate (2),0.94 (0.92 0.95),1.79E-10
574.1,Cholelithiasis,digestive,OPGS003113,0.018,Metabolon,1-docosapentaenoyl-GPC (22:5n6)*,0.94 (0.92 0.95),1.79E-10
574.1,Cholelithiasis,digestive,OPGS002743,0.159,Metabolon,X - 11440,1.07 (1.05 1.09),1.94E-10
574.1,Cholelithiasis,digestive,OPGS002808,0.089,Metabolon,X - 11441,1.06 (1.05 1.08),2.62E-10
574.1,Cholelithiasis,digestive,OPGS002727,0.198,Metabolon,X - 11522,1.06 (1.05 1.08),4.13E-10
574.1,Cholelithiasis,digestive,OPGS002723,0.204,Metabolon,X - 21458,1.06 (1.05 1.08),5.43E-10
574.1,Cholelithiasis,digestive,OPGS003060,0.022,Metabolon,stearidonate (18:4n3),0.94 (0.93 0.96),1.51E-09
574.1,Cholelithiasis,digestive,OPGS003157,0.014,Metabolon,X - 10458,0.94 (0.93 0.96),2.34E-09
574.1,Cholelithiasis,digestive,OPGS003086,0.020,Metabolon,1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2)*,1.06 (1.04 1.08),9.64E-09
574.1,Cholelithiasis,digestive,OPGS003169,0.014,Metabolon,X - 21796,1.06 (1.04 1.08),1.70E-08
574.1,Cholelithiasis,digestive,OPGS003014,0.029,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6)*,0.95 (0.93 0.96),3.34E-08
574.1,Cholelithiasis,digestive,OPGS002773,0.121,Metabolon,5alpha-androstan-3alpha.17beta-diol monosulfate (2),0.95 (0.93 0.96),8.08E-08
574.1,Cholelithiasis,digestive,OPGS003074,0.021,Metabolon,1-stearoyl-2-linoleoyl-GPC (18:0/18:2)*,1.06 (1.04 1.07),2.35E-07
574.1,Cholelithiasis,digestive,OPGS002834,0.075,Metabolon,phosphatidylcholine (18:0/20:5. 16:0/22:5n6)*,0.95 (0.93 0.97),3.55E-07
574.1,Cholelithiasis,digestive,OPGS002893,0.054,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3)*,0.95 (0.93 0.97),4.33E-07
574.1,Cholelithiasis,digestive,OPGS002779,0.113,Metabolon,X - 21470,1.05 (1.04 1.07),4.33E-07
574.1,Cholelithiasis,digestive,OPGS002954,0.040,Metabolon,1-oleoyl-2-linoleoyl-GPC (18:1/18:2)*,1.05 (1.04 1.07),5.53E-07
574.1,Cholelithiasis,digestive,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),0.95 (0.93 0.97),9.86E-07
574.1,Cholelithiasis,digestive,OPGS002977,0.035,Metabolon,1.2-dilinoleoyl-GPC (18:2/18:2),1.05 (1.03 1.07),1.46E-06
574.1,Cholelithiasis,digestive,OPGS002709,0.272,Metabolon,4-androsten-3alpha.17alpha-diol monosulfate (3),1.05 (1.03 1.07),2.22E-06
574.1,Cholelithiasis,digestive,OPGS003201,0.012,Metabolon,glycerophosphorylcholine (GPC),0.95 (0.93 0.97),2.26E-06
574.1,Cholelithiasis,digestive,OPGS003168,0.014,Metabolon,X - 24054,1.05 (1.03 1.07),2.87E-06
574.1,Cholelithiasis,digestive,OPGS002980,0.034,Metabolon,1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2)*,1.05 (1.03 1.07),4.74E-06
574.1,Cholelithiasis,digestive,OPGS003109,0.018,Metabolon,1-linoleoyl-GPE (18:2)*,1.05 (1.03 1.07),6.06E-06
574.1,Cholelithiasis,digestive,OPGS002941,0.043,Metabolon,1-palmitoyl-2-linolenoyl-GPC (16:0/18:3)*,1.05 (1.03 1.07),7.44E-06
574.1,Cholelithiasis,digestive,OPGS003011,0.030,Metabolon,1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)*,1.05 (1.03 1.07),7.88E-06
574.1,Cholelithiasis,digestive,OPGS002843,0.073,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4),0.95 (0.94 0.97),8.19E-06
574.1,Cholelithiasis,digestive,OPGS003075,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*,0.95 (0.94 0.97),9.17E-06
574.1,Cholelithiasis,digestive,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),0.95 (0.94 0.97),1.40E-05
574.1,Cholelithiasis,digestive,OPGS002981,0.034,Metabolon,1-docosapentaenoyl-GPC (22:5n3)*,0.95 (0.94 0.97),1.53E-05
574.1,Cholelithiasis,digestive,OPGS003189,0.012,Metabolon,2-linoleoyl-GPE (18:2)*,1.05 (1.03 1.07),1.75E-05
574.1,Cholelithiasis,digestive,OPGS002780,0.113,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)*,0.95 (0.94 0.97),1.77E-05
574.1,Cholelithiasis,digestive,OPGS002764,0.129,Metabolon,1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4),0.95 (0.94 0.97),1.77E-05
574.1,Cholelithiasis,digestive,OPGS002890,0.056,Metabolon,X - 23705,0.95 (0.94 0.97),2.08E-05
574.1,Cholelithiasis,digestive,OPGS003152,0.014,Metabolon,1-pentadecanoyl-2-linoleoyl-GPC (15:0/18:2)*,1.05 (1.03 1.07),2.08E-05
574.1,Cholelithiasis,digestive,OPGS003009,0.030,Metabolon,4-androsten-3beta.17beta-diol monosulfate (1),1.05 (1.03 1.07),2.13E-05
574.1,Cholelithiasis,digestive,OPGS002936,0.044,Metabolon,1-dihomo-linoleoyl-GPC (20:2)*,1.05 (1.03 1.07),2.13E-05
574.1,Cholelithiasis,digestive,OPGS002855,0.069,Metabolon,1-palmityl-2-arachidonoyl-GPC (O-16:0/20:4)*,0.96 (0.94 0.97),3.14E-05
574.1,Cholelithiasis,digestive,OPGS002829,0.079,Metabolon,arachidonate (20:4n6),0.96 (0.94 0.97),3.50E-05
574.1,Cholelithiasis,digestive,OPGS002791,0.100,Metabolon,2-arachidonoyl-GPC (20:4)*,0.96 (0.94 0.97),4.01E-05
574.1,Cholelithiasis,digestive,OPGS002997,0.032,Metabolon,1-palmitoyl-2-linoleoyl-GPC (16:0/18:2),1.05 (1.03 1.06),4.15E-05
574.1,Cholelithiasis,digestive,OPGS003159,0.014,Metabolon,docosapentaenoate (n3 DPA; 22:5n3),0.96 (0.94 0.97),4.26E-05
574.1,Cholelithiasis,digestive,OPGS002734,0.178,Metabolon,1-stearoyl-2-arachidonoyl-GPC (18:0/20:4),0.96 (0.94 0.97),4.34E-05
574.1,Cholelithiasis,digestive,OPGS002833,0.077,Metabolon,taurocholenate sulfate,1.05 (1.03 1.06),4.55E-05
574.1,Cholelithiasis,digestive,OPGS002873,0.061,Metabolon,X - 14658,1.05 (1.03 1.06),4.72E-05
574.1,Cholelithiasis,digestive,OPGS002972,0.036,Metabolon,1-palmitoyl-2-meadoyl-GPC (16:0/20:3n9)*,0.96 (0.94 0.97),5.31E-05
574.1,Cholelithiasis,digestive,OPGS002747,0.146,Metabolon,1-arachidonoyl-GPC (20:4n6)*,0.96 (0.94 0.97),6.35E-05
574.1,Cholelithiasis,digestive,OPGS003125,0.017,Metabolon,1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6),0.96 (0.94 0.97),6.56E-05
574.1,Cholelithiasis,digestive,OPGS002819,0.083,Metabolon,phosphatidylcholine (16:0/22:5n3. 18:1/20:4)*,0.96 (0.94 0.97),8.83E-05
574.1,Cholelithiasis,digestive,OPGS002949,0.041,Metabolon,1-stearoyl-2-meadoyl-GPC (18:0/20:3n9)*,0.96 (0.94 0.97),9.31E-05
574.1,Cholelithiasis,digestive,OPGS002935,0.044,Metabolon,dehydroisoandrosterone sulfate (DHEA-S),1.05 (1.03 1.07),1.13E-04
574.1,Cholelithiasis,digestive,OPGS002931,0.045,Metabolon,eicosapentaenoate (EPA; 20:5n3),0.96 (0.94 0.97),1.22E-04
574.1,Cholelithiasis,digestive,OPGS003024,0.027,Metabolon,X - 13529,0.96 (0.94 0.98),1.91E-04
574.1,Cholelithiasis,digestive,OPGS003057,0.022,Metabolon,1-adrenoyl-GPC (22:4)*,0.96 (0.94 0.98),2.14E-04
574.1,Cholelithiasis,digestive,OPGS002994,0.032,Metabolon,glycohyocholate,0.96 (0.94 0.98),2.21E-04
574.1,Cholelithiasis,digestive,OPGS003043,0.024,Metabolon,1-docosahexaenoyl-GPC (22:6)*,0.96 (0.94 0.98),2.40E-04
574.1,Cholelithiasis,digestive,OPGS003042,0.024,Metabolon,1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6),0.96 (0.94 0.98),2.44E-04
574.1,Cholelithiasis,digestive,OPGS002928,0.046,Metabolon,5alpha-pregnan-3beta.20alpha-diol disulfate,1.04 (1.02 1.06),2.60E-04
574.1,Cholelithiasis,digestive,OPGS003100,0.019,Metabolon,1-arachidonylglycerol (20:4),0.96 (0.94 0.98),2.60E-04
574.1,Cholelithiasis,digestive,OPGS003019,0.028,Metabolon,1-oleoyl-2-linoleoyl-GPI (18:1/18:2)*,1.04 (1.02 1.06),2.91E-04
574.1,Cholelithiasis,digestive,OPGS003077,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPC (P-16:0/22:6)*,0.96 (0.94 0.98),2.92E-04
574.1,Cholelithiasis,digestive,OPGS003016,0.029,Metabolon,1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)*,0.96 (0.94 0.98),3.34E-04
574.1,Cholelithiasis,digestive,OPGS002979,0.034,Metabolon,5alpha-pregnan-3(alpha or beta).20beta-diol disulfate,1.04 (1.02 1.06),3.67E-04
574.1,Cholelithiasis,digestive,OPGS002919,0.048,Metabolon,cysteine-glutathione disulfide,0.96 (0.94 0.98),4.98E-04
574.1,Cholelithiasis,digestive,OPGS003073,0.021,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*,0.96 (0.94 0.98),5.58E-04
574.1,Cholelithiasis,digestive,OPGS003120,0.017,Metabolon,2-docosahexaenoyl-GPC (22:6)*,0.96 (0.94 0.98),5.77E-04
574.1,Cholelithiasis,digestive,OPGS003027,0.026,Metabolon,xanthurenate,1.04 (1.02 1.06),5.77E-04
574.1,Cholelithiasis,digestive,OPGS003118,0.017,Metabolon,1-(1-enyl-palmitoyl)-GPC (P-16:0)*,0.96 (0.94 0.98),6.17E-04
574.1,Cholelithiasis,digestive,OPGS003142,0.016,Metabolon,5alpha-pregnan-3beta.20alpha-diol monosulfate (2),0.96 (0.94 0.98),7.34E-04
574.1,Cholelithiasis,digestive,OPGS002768,0.125,Metabolon,3-methylglutarylcarnitine (2),0.96 (0.95 0.98),1.06E-03
574.1,Cholelithiasis,digestive,OPGS002964,0.037,Metabolon,1-docosahexaenoyl-GPE (22:6)*,0.96 (0.95 0.98),1.14E-03
574.1,Cholelithiasis,digestive,OPGS003217,0.011,Metabolon,X - 24024,0.96 (0.95 0.98),1.47E-03
574.1,Cholelithiasis,digestive,OPGS002733,0.179,Metabolon,X - 21471,1.04 (1.02 1.06),1.55E-03
574.1,Cholelithiasis,digestive,OPGS002859,0.067,Metabolon,1-arachidonoyl-GPE (20:4n6)*,0.96 (0.95 0.98),2.10E-03
574.1,Cholelithiasis,digestive,OPGS003025,0.027,Metabolon,X - 17469,1.04 (1.02 1.06),2.67E-03
574.1,Cholelithiasis,digestive,OPGS002872,0.061,Metabolon,1-eicosapentaenoyl-GPC (20:5)*,0.96 (0.95 0.98),2.79E-03
574.1,Cholelithiasis,digestive,OPGS002909,0.049,Metabolon,X - 24439,1.04 (1.02 1.05),2.91E-03
574.1,Cholelithiasis,digestive,OPGS002899,0.053,Metabolon,1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5)*,0.96 (0.95 0.98),3.56E-03
574.1,Cholelithiasis,digestive,OPGS002947,0.043,Metabolon,pregn steroid monosulfate*,1.04 (1.02 1.05),4.36E-03
574.1,Cholelithiasis,digestive,OPGS002863,0.066,Metabolon,1-stearoyl-2-linoleoyl-GPI (18:0/18:2),1.04 (1.02 1.05),5.63E-03
574.1,Cholelithiasis,digestive,OPGS002804,0.092,Metabolon,glycochenodeoxycholate sulfate,1.04 (1.02 1.05),6.64E-03
574.1,Cholelithiasis,digestive,OPGS003006,0.030,Metabolon,cholesterol,0.97 (0.95 0.98),6.76E-03
574.1,Cholelithiasis,digestive,OPGS003198,0.012,Metabolon,gamma-glutamylthreonine*,1.04 (1.02 1.05),7.07E-03
574.1,Cholelithiasis,digestive,OPGS003038,0.025,Metabolon,1-margaroyl-2-linoleoyl-GPC (17:0/18:2)*,1.03 (1.02 1.05),7.89E-03
574.1,Cholelithiasis,digestive,OPGS003121,0.017,Metabolon,1.2-dipalmitoyl-GPC (16:0/16:0),0.97 (0.95 0.98),1.08E-02
574.1,Cholelithiasis,digestive,OPGS003196,0.012,Metabolon,1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)*,0.97 (0.95 0.98),1.09E-02
574.1,Cholelithiasis,digestive,OPGS003172,0.013,Metabolon,deoxycholate,0.97 (0.95 0.98),1.09E-02
574.1,Cholelithiasis,digestive,OPGS002938,0.044,Metabolon,2-arachidonoyl-GPE (20:4)*,0.97 (0.95 0.98),1.14E-02
574.1,Cholelithiasis,digestive,OPGS002783,0.104,Metabolon,X - 21668,0.97 (0.95 0.98),1.16E-02
574.1,Cholelithiasis,digestive,OPGS002809,0.089,Metabolon,X - 14626,1.03 (1.02 1.05),1.51E-02
574.1,Cholelithiasis,digestive,OPGS002959,0.039,Metabolon,sphingomyelin (d18:1/18:1. d18:2/18:0),0.97 (0.95 0.99),2.12E-02
574.1,Cholelithiasis,digestive,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),0.97 (0.95 0.99),2.18E-02
574.1,Cholelithiasis,digestive,OPGS003200,0.012,Metabolon,threonine,1.03 (1.01 1.05),2.39E-02
574.1,Cholelithiasis,digestive,OPGS002777,0.114,Metabolon,glycodeoxycholate sulfate,1.03 (1.01 1.05),2.48E-02
574.1,Cholelithiasis,digestive,OPGS003216,0.011,Metabolon,1-linolenoyl-GPC (18:3)*,0.97 (0.95 0.99),2.68E-02
574.1,Cholelithiasis,digestive,OPGS003136,0.016,Metabolon,1-eicosapentaenoyl-GPE (20:5)*,0.97 (0.95 0.99),2.86E-02
574.1,Cholelithiasis,digestive,OPGS002697,0.394,Metabolon,androsterone sulfate,1.03 (1.01 1.05),3.35E-02
574.1,Cholelithiasis,digestive,OPGS003029,0.026,Metabolon,docosatrienoate (22:3n3),1.03 (1.01 1.05),3.79E-02
574.1,Cholelithiasis,digestive,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,0.92 (0.90 0.93),1.67E-18
574.1,Cholelithiasis,digestive,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,0.92 (0.90 0.93),1.95E-18
574.1,Cholelithiasis,digestive,OPGS003452,0.087,Nightingale,Total cholesterol,0.92 (0.90 0.94),5.70E-18
574.1,Cholelithiasis,digestive,OPGS003454,0.087,Nightingale,Total esterified cholesterol,0.92 (0.90 0.94),7.21E-18
574.1,Cholelithiasis,digestive,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,0.92 (0.91 0.94),4.60E-17
574.1,Cholelithiasis,digestive,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,0.92 (0.91 0.94),1.02E-16
574.1,Cholelithiasis,digestive,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,0.92 (0.91 0.94),3.60E-16
574.1,Cholelithiasis,digestive,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,0.93 (0.91 0.94),7.01E-16
574.1,Cholelithiasis,digestive,OPGS003455,0.087,Nightingale,Total free cholesterol,0.92 (0.91 0.94),7.01E-16
574.1,Cholelithiasis,digestive,OPGS003439,0.107,Nightingale,Concentration of IDL particles,0.93 (0.91 0.94),8.74E-16
574.1,Cholelithiasis,digestive,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,0.93 (0.91 0.94),1.40E-15
574.1,Cholelithiasis,digestive,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,0.93 (0.91 0.94),1.94E-15
574.1,Cholelithiasis,digestive,OPGS003440,0.106,Nightingale,Cholesterol in IDL,0.93 (0.91 0.94),1.98E-15
574.1,Cholelithiasis,digestive,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,0.93 (0.91 0.94),2.14E-15
574.1,Cholelithiasis,digestive,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,0.93 (0.91 0.94),3.69E-15
574.1,Cholelithiasis,digestive,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,0.93 (0.91 0.94),3.69E-15
574.1,Cholelithiasis,digestive,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,0.93 (0.91 0.94),3.69E-15
574.1,Cholelithiasis,digestive,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,0.93 (0.91 0.94),4.07E-15
574.1,Cholelithiasis,digestive,OPGS003431,0.118,Nightingale,Total lipids in large LDL,0.93 (0.91 0.94),5.78E-15
574.1,Cholelithiasis,digestive,OPGS003444,0.101,Nightingale,Apolipoprotein B,0.93 (0.91 0.94),6.99E-15
574.1,Cholelithiasis,digestive,OPGS003438,0.109,Nightingale,Total lipids in IDL,0.93 (0.91 0.94),7.48E-15
574.1,Cholelithiasis,digestive,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,0.93 (0.91 0.94),1.02E-14
574.1,Cholelithiasis,digestive,OPGS003428,0.121,Nightingale,Total lipids in small LDL,0.93 (0.91 0.94),1.16E-14
574.1,Cholelithiasis,digestive,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,0.93 (0.91 0.94),1.70E-14
574.1,Cholelithiasis,digestive,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,0.93 (0.91 0.95),2.26E-14
574.1,Cholelithiasis,digestive,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,0.93 (0.91 0.95),2.38E-14
574.1,Cholelithiasis,digestive,OPGS003423,0.126,Nightingale,LDL cholesterol,0.93 (0.91 0.95),3.03E-14
574.1,Cholelithiasis,digestive,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,0.93 (0.91 0.95),3.11E-14
574.1,Cholelithiasis,digestive,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,0.93 (0.91 0.95),4.87E-14
574.1,Cholelithiasis,digestive,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,0.93 (0.91 0.95),5.30E-14
574.1,Cholelithiasis,digestive,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,0.93 (0.91 0.95),6.99E-14
574.1,Cholelithiasis,digestive,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,0.93 (0.91 0.95),6.99E-14
574.1,Cholelithiasis,digestive,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,0.93 (0.91 0.95),1.14E-13
574.1,Cholelithiasis,digestive,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,0.93 (0.92 0.95),1.17E-13
574.1,Cholelithiasis,digestive,OPGS003434,0.113,Nightingale,Phospholipids in IDL,0.93 (0.92 0.95),1.17E-13
574.1,Cholelithiasis,digestive,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,0.93 (0.92 0.95),1.17E-13
574.1,Cholelithiasis,digestive,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,0.93 (0.92 0.95),3.86E-13
574.1,Cholelithiasis,digestive,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,0.93 (0.92 0.95),9.54E-13
574.1,Cholelithiasis,digestive,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,0.93 (0.92 0.95),4.29E-12
574.1,Cholelithiasis,digestive,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,0.94 (0.92 0.95),2.62E-11
574.1,Cholelithiasis,digestive,OPGS003488,0.074,Nightingale,VLDL cholesterol,0.94 (0.92 0.95),3.70E-11
574.1,Cholelithiasis,digestive,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,0.94 (0.92 0.95),5.53E-11
574.1,Cholelithiasis,digestive,OPGS003497,0.072,Nightingale,Linoleic acid,0.94 (0.92 0.96),1.09E-09
574.1,Cholelithiasis,digestive,OPGS003525,0.052,Nightingale,Saturated fatty acids,0.95 (0.93 0.97),1.45E-06
574.1,Cholelithiasis,digestive,OPGS003527,0.050,Nightingale,Sphingomyelins,0.96 (0.94 0.97),3.15E-05
574.1,Cholelithiasis,digestive,OPGS003528,0.050,Nightingale,Total cholines,0.96 (0.94 0.97),4.99E-05
574.1,Cholelithiasis,digestive,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,0.96 (0.94 0.97),5.48E-05
574.1,Cholelithiasis,digestive,OPGS003523,0.062,Nightingale,Total fatty acids,0.96 (0.94 0.97),8.45E-05
574.1,Cholelithiasis,digestive,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,0.96 (0.94 0.97),1.64E-04
574.1,Cholelithiasis,digestive,OPGS003530,0.047,Nightingale,Phosphoglycerides,0.96 (0.94 0.98),1.92E-04
574.1,Cholelithiasis,digestive,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,0.96 (0.94 0.98),2.45E-04
574.1,Cholelithiasis,digestive,OPGS003522,0.062,Nightingale,Degree of unsaturation,0.96 (0.94 0.98),4.58E-04
574.1,Cholelithiasis,digestive,OPGS003464,0.082,Nightingale,Triglycerides in LDL,0.96 (0.94 0.98),5.12E-04
574.1,Cholelithiasis,digestive,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,0.96 (0.94 0.98),7.34E-04
574.1,Cholelithiasis,digestive,OPGS003526,0.050,Nightingale,Phosphatidylcholines,0.96 (0.94 0.98),7.36E-04
574.1,Cholelithiasis,digestive,OPGS003524,0.061,Nightingale,Monounsaturated fatty acids,0.96 (0.95 0.98),1.04E-03
574.1,Cholelithiasis,digestive,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,0.96 (0.95 0.98),1.09E-03
574.1,Cholelithiasis,digestive,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,0.96 (0.95 0.98),2.10E-03
574.1,Cholelithiasis,digestive,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,0.96 (0.95 0.98),2.12E-03
574.1,Cholelithiasis,digestive,OPGS003450,0.092,Nightingale,Triglycerides in IDL,0.97 (0.95 0.98),4.90E-03
574.1,Cholelithiasis,digestive,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,0.97 (0.95 0.98),6.08E-03
574.1,Cholelithiasis,digestive,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,0.97 (0.95 0.98),6.37E-03
574.1,Cholelithiasis,digestive,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,0.97 (0.95 0.98),1.46E-02
574.1,Cholelithiasis,digestive,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,0.97 (0.95 0.98),1.61E-02
574.1,Cholelithiasis,digestive,OPGS003537,0.031,Nightingale,Glycoprotein acetyls,0.97 (0.95 0.99),1.79E-02
574.1,Cholelithiasis,digestive,OPGS008216,0.109,RNAseq,NSMAF,1.05 (1.03 1.07),1.57E-05
574.1,Cholelithiasis,digestive,OPGS004360,0.378,RNAseq,WASHC2C,0.96 (0.94 0.97),2.30E-05
574.1,Cholelithiasis,digestive,OPGS007452,0.134,RNAseq,TMEM258,1.05 (1.03 1.06),4.43E-05
574.1,Cholelithiasis,digestive,OPGS007111,0.147,RNAseq,AC008403.3,1.05 (1.03 1.06),6.60E-05
574.1,Cholelithiasis,digestive,OPGS003912,0.502,RNAseq,TTC39B,0.96 (0.94 0.97),7.74E-05
574.1,Cholelithiasis,digestive,OPGS013619,0.025,RNAseq,LRBA,0.96 (0.94 0.98),1.34E-04
574.1,Cholelithiasis,digestive,OPGS011791,0.044,RNAseq,CROT,0.96 (0.94 0.98),1.10E-03
574.1,Cholelithiasis,digestive,OPGS010480,0.061,RNAseq,TMEM147,0.96 (0.95 0.98),1.32E-03
574.1,Cholelithiasis,digestive,OPGS013230,0.029,RNAseq,EP300,1.04 (1.02 1.06),2.31E-03
574.1,Cholelithiasis,digestive,OPGS009965,0.070,RNAseq,ZFAND4,0.97 (0.95 0.98),5.43E-03
574.1,Cholelithiasis,digestive,OPGS004105,0.436,RNAseq,HTR6,1.04 (1.02 1.05),7.59E-03
574.1,Cholelithiasis,digestive,OPGS009401,0.081,RNAseq,EPHX1,1.03 (1.02 1.05),7.91E-03
574.1,Cholelithiasis,digestive,OPGS009171,0.086,RNAseq,NTN5,1.03 (1.02 1.05),9.40E-03
574.1,Cholelithiasis,digestive,OPGS006677,0.166,RNAseq,AL109627.1,0.97 (0.95 0.98),1.12E-02
574.1,Cholelithiasis,digestive,OPGS007746,0.124,RNAseq,PLEKHA2,1.03 (1.02 1.05),1.22E-02
574.1,Cholelithiasis,digestive,OPGS009217,0.085,RNAseq,PDP1,1.03 (1.02 1.05),1.64E-02
574.1,Cholelithiasis,digestive,OPGS007426,0.135,RNAseq,SLC2A9,0.97 (0.95 0.99),1.87E-02
574.1,Cholelithiasis,digestive,OPGS011647,0.045,RNAseq,U2AF1L4,1.03 (1.02 1.05),2.01E-02
574.1,Cholelithiasis,digestive,OPGS011213,0.051,RNAseq,GOLIM4,0.97 (0.95 0.99),2.08E-02
574.1,Cholelithiasis,digestive,OPGS010305,0.064,RNAseq,KCNH2,0.97 (0.95 0.99),2.10E-02
574.1,Cholelithiasis,digestive,OPGS006249,0.189,RNAseq,PIAS2,0.97 (0.95 0.99),2.53E-02
574.1,Cholelithiasis,digestive,OPGS014695,0.017,RNAseq,QPCTL,0.97 (0.95 0.99),2.97E-02
574.1,Cholelithiasis,digestive,OPGS009973,0.070,RNAseq,DDX17,1.03 (1.01 1.05),3.01E-02
574.1,Cholelithiasis,digestive,OPGS009634,0.076,RNAseq,ADAR,0.97 (0.95 0.99),3.11E-02
574.1,Cholelithiasis,digestive,OPGS009904,0.071,RNAseq,NCOR2,0.97 (0.95 0.99),3.41E-02
574.1,Cholelithiasis,digestive,OPGS005391,0.247,RNAseq,CMTM7,1.03 (1.01 1.05),3.43E-02
574.1,Cholelithiasis,digestive,OPGS012056,0.041,RNAseq,DUSP8,1.03 (1.01 1.05),3.58E-02
574.1,Cholelithiasis,digestive,OPGS008309,0.106,RNAseq,SP1,1.03 (1.01 1.05),4.33E-02
574.1,Cholelithiasis,digestive,OPGS008008,0.115,RNAseq,EIF2B2,0.97 (0.95 0.99),4.61E-02
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS000404,0.137,SomaScan,Fetuin-B,0.91 (0.88 0.95),5.06E-04
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,1.08 (1.04 1.12),8.50E-03
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS001584,0.023,SomaScan,Mitochondrial import inner membrane translocase subunit TIM14,1.08 (1.04 1.13),2.69E-02
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS002294,0.010,SomaScan,Neuroepithelial cell-transforming gene 1 protein,1.07 (1.03 1.11),4.58E-02
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS002874,0.060,Metabolon,campesterol,0.78 (0.75 0.81),1.65E-30
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003200,0.012,Metabolon,threonine,1.08 (1.04 1.12),4.28E-02
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,0.88 (0.85 0.92),4.36E-06
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,0.89 (0.85 0.92),5.87E-06
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003454,0.087,Nightingale,Total esterified cholesterol,0.89 (0.86 0.92),5.92E-06
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003431,0.118,Nightingale,Total lipids in large LDL,0.89 (0.86 0.92),5.92E-06
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,0.89 (0.86 0.93),7.69E-06
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003444,0.101,Nightingale,Apolipoprotein B,0.89 (0.86 0.93),1.17E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,0.89 (0.86 0.93),1.17E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,0.89 (0.86 0.93),1.18E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,0.89 (0.86 0.93),1.18E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,0.89 (0.86 0.93),1.18E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003455,0.087,Nightingale,Total free cholesterol,0.89 (0.86 0.93),1.32E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,0.90 (0.86 0.93),1.51E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,0.90 (0.86 0.93),1.97E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003428,0.121,Nightingale,Total lipids in small LDL,0.90 (0.86 0.93),1.97E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,0.89 (0.86 0.93),2.04E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,0.90 (0.86 0.93),2.12E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003434,0.113,Nightingale,Phospholipids in IDL,0.90 (0.86 0.93),2.12E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,0.90 (0.86 0.93),2.12E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003452,0.087,Nightingale,Total cholesterol,0.90 (0.86 0.93),2.36E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,0.90 (0.87 0.93),2.73E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,0.90 (0.87 0.93),2.81E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,0.90 (0.87 0.93),2.81E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003439,0.107,Nightingale,Concentration of IDL particles,0.90 (0.87 0.93),3.50E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,0.90 (0.87 0.93),3.50E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,0.90 (0.87 0.94),3.50E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003423,0.126,Nightingale,LDL cholesterol,0.90 (0.87 0.94),3.50E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003438,0.109,Nightingale,Total lipids in IDL,0.90 (0.87 0.93),3.50E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,0.90 (0.86 0.93),3.52E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,0.90 (0.86 0.93),3.99E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,0.90 (0.87 0.94),4.16E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,0.90 (0.87 0.94),6.99E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003440,0.106,Nightingale,Cholesterol in IDL,0.90 (0.87 0.94),9.52E-05
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,0.90 (0.87 0.94),1.39E-04
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,0.91 (0.87 0.94),2.41E-04
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,0.91 (0.87 0.94),2.41E-04
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003488,0.074,Nightingale,VLDL cholesterol,0.91 (0.87 0.94),3.00E-04
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,0.91 (0.88 0.94),4.36E-04
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,0.91 (0.88 0.95),4.36E-04
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,0.91 (0.88 0.95),8.59E-04
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,0.91 (0.88 0.95),1.19E-03
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,0.91 (0.88 0.95),1.19E-03
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS003497,0.072,Nightingale,Linoleic acid,0.91 (0.88 0.95),1.66E-03
574.11,Cholelithiasis with acute cholecystitis,digestive,OPGS010624,0.059,RNAseq,TRBV18,1.08 (1.04 1.12),4.12E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS000664,0.088,SomaScan,BPI fold-containing family A member 2,1.07 (1.05 1.10),4.49E-07
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS001812,0.017,SomaScan,Fibroblast growth factor 19,0.94 (0.92 0.96),1.68E-06
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.94 (0.92 0.96),4.67E-06
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS000117,0.345,SomaScan,Galactoside 3(4)-L-fucosyltransferase,0.94 (0.92 0.96),8.68E-06
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS000434,0.132,SomaScan,DNA repair protein RAD51 homolog 4,1.05 (1.03 1.08),2.61E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS000855,0.067,SomaScan,Cathepsin B,1.04 (1.02 1.07),1.10E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS000857,0.067,SomaScan,Moesin,0.96 (0.94 0.98),1.95E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS001093,0.046,SomaScan,C-reactive protein,1.04 (1.02 1.07),2.01E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,0.96 (0.94 0.98),2.39E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,0.96 (0.94 0.98),2.64E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS001556,0.023,SomaScan,Retinol dehydrogenase 16,1.04 (1.02 1.06),2.66E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,0.96 (0.94 0.98),3.53E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS001376,0.030,SomaScan,NAD-dependent protein deacylase sirtuin-5. mitochondrial,1.04 (1.02 1.07),3.53E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS000179,0.254,SomaScan,Cardiotrophin-1,0.96 (0.94 0.98),3.55E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,0.96 (0.94 0.98),3.84E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS000833,0.069,SomaScan,Protein LEG1 homolog,1.04 (1.02 1.07),4.21E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS000115,0.347,SomaScan,Protein CEI,0.96 (0.94 0.98),4.84E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002437,0.187,Olink,Serine protease 27,1.09 (1.07 1.12),7.13E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002657,0.013,Olink,Fibroblast growth factor 19,0.93 (0.91 0.95),6.26E-08
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002557,0.050,Olink,Epithelial cell adhesion molecule,0.93 (0.91 0.95),3.97E-07
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002531,0.066,Olink,Tissue factor,0.94 (0.91 0.96),9.27E-07
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002564,0.046,Olink,Polymeric immunoglobulin receptor,1.06 (1.03 1.08),3.97E-04
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002529,0.068,Olink,Tumor necrosis factor receptor superfamily member 3,1.04 (1.02 1.06),2.39E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002420,0.225,Olink,Interleukin-12 subunit beta,1.04 (1.02 1.06),4.52E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002874,0.060,Metabolon,campesterol,0.77 (0.75 0.79),7.67E-108
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002743,0.159,Metabolon,X - 11440,1.10 (1.07 1.12),3.64E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002862,0.066,Metabolon,4-androsten-3alpha.17alpha-diol monosulfate (2),0.91 (0.89 0.93),6.24E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002782,0.110,Metabolon,4-androsten-3beta.17beta-diol disulfate (1),1.09 (1.07 1.12),2.73E-11
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002738,0.166,Metabolon,pregnen-diol disulfate*,1.09 (1.07 1.12),5.20E-11
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003079,0.020,Metabolon,glycolithocholate,0.92 (0.90 0.94),2.73E-10
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002779,0.113,Metabolon,X - 21470,1.08 (1.06 1.11),8.06E-10
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002773,0.121,Metabolon,5alpha-androstan-3alpha.17beta-diol monosulfate (2),0.93 (0.91 0.95),3.18E-08
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002733,0.179,Metabolon,X - 21471,1.08 (1.05 1.10),4.49E-08
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003025,0.027,Metabolon,X - 17469,1.07 (1.05 1.10),1.56E-07
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003009,0.030,Metabolon,4-androsten-3beta.17beta-diol monosulfate (1),1.08 (1.05 1.10),2.24E-07
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002833,0.077,Metabolon,taurocholenate sulfate,1.07 (1.05 1.09),2.50E-07
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002873,0.061,Metabolon,X - 14658,1.07 (1.05 1.09),9.27E-07
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002864,0.066,Metabolon,21-hydroxypregnenolone disulfate,1.06 (1.04 1.09),8.92E-06
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002709,0.272,Metabolon,4-androsten-3alpha.17alpha-diol monosulfate (3),1.06 (1.04 1.09),1.98E-05
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002928,0.046,Metabolon,5alpha-pregnan-3beta.20alpha-diol disulfate,1.06 (1.04 1.09),2.04E-05
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002893,0.054,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3)*,0.94 (0.92 0.96),3.91E-05
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002898,0.053,Metabolon,X - 16654,1.06 (1.04 1.08),3.99E-05
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003142,0.016,Metabolon,5alpha-pregnan-3beta.20alpha-diol monosulfate (2),0.94 (0.92 0.96),5.07E-05
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003060,0.022,Metabolon,stearidonate (18:4n3),0.94 (0.92 0.97),8.89E-05
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003113,0.018,Metabolon,1-docosapentaenoyl-GPC (22:5n6)*,0.95 (0.92 0.97),1.18E-04
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002809,0.089,Metabolon,X - 14626,1.06 (1.03 1.08),1.18E-04
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002777,0.114,Metabolon,glycodeoxycholate sulfate,1.06 (1.03 1.08),1.31E-04
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002804,0.092,Metabolon,glycochenodeoxycholate sulfate,1.06 (1.03 1.08),1.49E-04
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002935,0.044,Metabolon,dehydroisoandrosterone sulfate (DHEA-S),1.06 (1.03 1.08),6.64E-04
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003198,0.012,Metabolon,gamma-glutamylthreonine*,1.05 (1.03 1.08),6.91E-04
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003166,0.014,Metabolon,thyroxine,0.95 (0.93 0.97),7.32E-04
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),0.95 (0.93 0.97),7.73E-04
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),0.95 (0.93 0.97),1.18E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002981,0.034,Metabolon,1-docosapentaenoyl-GPC (22:5n3)*,0.95 (0.93 0.97),1.25E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002749,0.146,Metabolon,X - 21441,1.05 (1.03 1.07),1.97E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003006,0.030,Metabolon,cholesterol,0.95 (0.93 0.97),2.99E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003014,0.029,Metabolon,1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6)*,0.95 (0.93 0.97),3.06E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002708,0.275,Metabolon,X - 12063,1.05 (1.03 1.07),3.09E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),0.95 (0.93 0.97),3.49E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003153,0.014,Metabolon,retinol (Vitamin A),0.95 (0.93 0.97),3.49E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003217,0.011,Metabolon,X - 24024,0.95 (0.93 0.98),5.56E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002757,0.135,Metabolon,5alpha-androstan-3beta.17beta-diol disulfate,1.05 (1.02 1.07),6.31E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002768,0.125,Metabolon,3-methylglutarylcarnitine (2),0.95 (0.93 0.98),6.31E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003200,0.012,Metabolon,threonine,1.05 (1.02 1.07),1.21E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002783,0.104,Metabolon,X - 21668,0.95 (0.93 0.98),1.35E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002834,0.075,Metabolon,phosphatidylcholine (18:0/20:5. 16:0/22:5n6)*,0.96 (0.94 0.98),1.36E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002980,0.034,Metabolon,1-palmitoleoyl-2-linoleoyl-GPC (16:1/18:2)*,1.04 (1.02 1.07),1.95E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003216,0.011,Metabolon,1-linolenoyl-GPC (18:3)*,0.96 (0.94 0.98),1.99E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002819,0.083,Metabolon,phosphatidylcholine (16:0/22:5n3. 18:1/20:4)*,0.96 (0.94 0.98),2.03E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002736,0.172,Metabolon,glycocholenate sulfate*,1.04 (1.02 1.07),2.16E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002716,0.242,Metabolon,bilirubin (E.E)*,1.04 (1.02 1.07),2.46E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003119,0.017,Metabolon,1-palmitoyl-GPC (16:0),0.96 (0.94 0.98),2.64E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003201,0.012,Metabolon,glycerophosphorylcholine (GPC),0.96 (0.94 0.98),3.00E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002855,0.069,Metabolon,1-palmityl-2-arachidonoyl-GPC (O-16:0/20:4)*,0.96 (0.94 0.98),3.45E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003073,0.021,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*,0.96 (0.94 0.98),3.74E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003039,0.024,Metabolon,X - 14662,1.04 (1.02 1.06),3.79E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003157,0.014,Metabolon,X - 10458,0.96 (0.94 0.98),3.79E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002725,0.200,Metabolon,X - 11530,1.04 (1.02 1.06),3.99E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002987,0.033,Metabolon,glycolithocholate sulfate*,1.04 (1.02 1.06),3.99E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003075,0.021,Metabolon,1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*,0.96 (0.94 0.98),3.99E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002737,0.169,Metabolon,succinimide,1.04 (1.02 1.06),4.14E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003172,0.013,Metabolon,deoxycholate,0.96 (0.94 0.98),4.41E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS002719,0.216,Metabolon,X - 21448,1.04 (1.02 1.06),4.41E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003196,0.012,Metabolon,1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)*,0.96 (0.94 0.98),4.42E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,0.90 (0.88 0.92),5.15E-17
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,0.91 (0.89 0.93),8.34E-15
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003454,0.087,Nightingale,Total esterified cholesterol,0.91 (0.89 0.93),1.00E-14
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003452,0.087,Nightingale,Total cholesterol,0.91 (0.89 0.93),1.51E-13
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,0.91 (0.89 0.93),1.51E-13
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,0.91 (0.89 0.93),1.51E-13
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,0.91 (0.89 0.93),2.07E-13
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,0.91 (0.89 0.93),5.87E-13
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,0.91 (0.89 0.93),6.57E-13
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,0.91 (0.89 0.93),6.93E-13
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,0.91 (0.89 0.93),6.93E-13
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,0.91 (0.90 0.93),6.98E-13
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,0.92 (0.90 0.94),2.43E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003423,0.126,Nightingale,LDL cholesterol,0.92 (0.90 0.94),3.64E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003444,0.101,Nightingale,Apolipoprotein B,0.92 (0.90 0.94),3.64E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,0.92 (0.90 0.94),4.86E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,0.92 (0.90 0.94),6.95E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003431,0.118,Nightingale,Total lipids in large LDL,0.92 (0.90 0.94),6.99E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,0.92 (0.90 0.94),7.13E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,0.92 (0.90 0.94),8.83E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003428,0.121,Nightingale,Total lipids in small LDL,0.92 (0.90 0.94),8.88E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003439,0.107,Nightingale,Concentration of IDL particles,0.92 (0.90 0.94),8.88E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003440,0.106,Nightingale,Cholesterol in IDL,0.92 (0.90 0.94),9.29E-12
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,0.92 (0.90 0.94),1.13E-11
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003455,0.087,Nightingale,Total free cholesterol,0.92 (0.90 0.94),1.13E-11
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,0.92 (0.90 0.94),1.13E-11
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,0.92 (0.90 0.94),1.27E-11
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,0.92 (0.90 0.94),1.27E-11
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003438,0.109,Nightingale,Total lipids in IDL,0.92 (0.90 0.94),1.43E-11
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,0.92 (0.90 0.94),3.51E-11
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003434,0.113,Nightingale,Phospholipids in IDL,0.92 (0.90 0.94),3.73E-11
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,0.92 (0.90 0.94),1.17E-10
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,0.92 (0.90 0.94),1.19E-10
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,0.92 (0.90 0.94),1.19E-10
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,0.92 (0.90 0.94),1.32E-10
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003488,0.074,Nightingale,VLDL cholesterol,0.92 (0.90 0.94),2.40E-10
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,0.93 (0.91 0.95),6.92E-10
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,0.92 (0.90 0.94),8.31E-10
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,0.93 (0.91 0.95),1.00E-09
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,0.93 (0.91 0.95),1.93E-09
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003497,0.072,Nightingale,Linoleic acid,0.93 (0.91 0.95),1.79E-08
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,0.93 (0.91 0.95),1.66E-07
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003473,0.076,Nightingale,Cholesteryl esters in medium VLDL,0.94 (0.92 0.96),5.73E-05
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,0.95 (0.93 0.97),1.80E-04
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003528,0.050,Nightingale,Total cholines,0.95 (0.93 0.97),3.03E-04
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003492,0.073,Nightingale,Cholesterol in medium VLDL,0.95 (0.93 0.97),2.88E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,0.95 (0.93 0.98),6.26E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003526,0.050,Nightingale,Phosphatidylcholines,0.96 (0.94 0.98),1.21E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,0.96 (0.94 0.98),1.35E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003525,0.052,Nightingale,Saturated fatty acids,0.96 (0.94 0.98),1.43E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003530,0.047,Nightingale,Phosphoglycerides,0.96 (0.94 0.98),1.46E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,0.96 (0.94 0.98),1.92E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003523,0.062,Nightingale,Total fatty acids,0.96 (0.94 0.98),1.95E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003466,0.080,Nightingale,Concentration of small VLDL particles,0.96 (0.94 0.98),1.95E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,0.96 (0.94 0.98),2.80E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003527,0.050,Nightingale,Sphingomyelins,0.96 (0.94 0.98),3.74E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,0.96 (0.94 0.98),3.81E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,0.96 (0.94 0.98),3.89E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,0.96 (0.94 0.98),4.26E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS009171,0.086,RNAseq,NTN5,1.06 (1.04 1.08),7.52E-05
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS004232,0.404,RNAseq,DCLK2,1.06 (1.04 1.08),7.83E-05
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS005736,0.219,RNAseq,,1.06 (1.04 1.08),9.29E-05
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS008216,0.109,RNAseq,NSMAF,1.06 (1.03 1.08),1.48E-04
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003912,0.502,RNAseq,TTC39B,0.95 (0.93 0.97),3.08E-04
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS013619,0.025,RNAseq,LRBA,0.95 (0.93 0.97),1.44E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS004515,0.352,RNAseq,RAC1,1.05 (1.03 1.07),2.04E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS007647,0.127,RNAseq,FUCA1,0.95 (0.93 0.97),2.53E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS011791,0.044,RNAseq,CROT,0.95 (0.93 0.97),3.49E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS010944,0.055,RNAseq,NARS1,0.95 (0.93 0.98),4.29E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS009973,0.070,RNAseq,DDX17,1.05 (1.02 1.07),8.62E-03
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS013362,0.027,RNAseq,ZNF347,1.04 (1.02 1.07),2.01E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS010624,0.059,RNAseq,TRBV18,1.04 (1.02 1.07),2.39E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS006621,0.169,RNAseq,NME7,0.96 (0.94 0.98),2.52E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS008345,0.105,RNAseq,BCAT2,0.96 (0.94 0.98),2.55E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS005494,0.239,RNAseq,,1.04 (1.02 1.07),3.03E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS006269,0.188,RNAseq,RALY-AS1,0.96 (0.94 0.98),3.20E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS011770,0.044,RNAseq,ADIPOR2,0.96 (0.94 0.98),3.31E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS014333,0.020,RNAseq,,1.04 (1.02 1.07),3.32E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS007111,0.147,RNAseq,AC008403.3,1.04 (1.02 1.07),3.45E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS014424,0.020,RNAseq,ZNF10,0.96 (0.94 0.98),3.53E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS007452,0.134,RNAseq,TMEM258,1.04 (1.02 1.06),3.99E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS011806,0.043,RNAseq,NCF2,0.96 (0.94 0.98),4.14E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS014183,0.021,RNAseq,PAXBP1-AS1,1.04 (1.02 1.06),4.40E-02
574.12,Cholelithiasis with other cholecystitis,digestive,OPGS003701,0.597,RNAseq,AC040970.1,1.04 (1.02 1.06),4.90E-02
574.2,Calculus of bile duct,digestive,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,1.07 (1.05 1.10),1.21E-04
574.2,Calculus of bile duct,digestive,OPGS002186,0.011,SomaScan,Suprabasin,1.06 (1.04 1.09),2.71E-03
574.2,Calculus of bile duct,digestive,OPGS001879,0.015,SomaScan,Arfaptin-2,0.94 (0.91 0.97),2.71E-03
574.2,Calculus of bile duct,digestive,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,1.07 (1.04 1.10),5.12E-03
574.2,Calculus of bile duct,digestive,OPGS000272,0.183,SomaScan,Alpha-1-antitrypsin,0.94 (0.91 0.97),1.08E-02
574.2,Calculus of bile duct,digestive,OPGS000717,0.082,SomaScan,Zinc finger protein 175,1.06 (1.03 1.09),2.98E-02
574.2,Calculus of bile duct,digestive,OPGS002654,0.015,Olink,Thrombopoietin,1.08 (1.05 1.11),2.13E-04
574.2,Calculus of bile duct,digestive,OPGS002874,0.060,Metabolon,campesterol,0.80 (0.77 0.82),1.20E-39
574.2,Calculus of bile duct,digestive,OPGS002738,0.166,Metabolon,pregnen-diol disulfate*,1.06 (1.03 1.10),4.11E-02
574.2,Calculus of bile duct,digestive,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,0.91 (0.88 0.94),2.57E-05
574.2,Calculus of bile duct,digestive,OPGS003455,0.087,Nightingale,Total free cholesterol,0.91 (0.88 0.94),2.90E-05
574.2,Calculus of bile duct,digestive,OPGS003454,0.087,Nightingale,Total esterified cholesterol,0.92 (0.89 0.95),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003452,0.087,Nightingale,Total cholesterol,0.92 (0.89 0.95),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,0.92 (0.89 0.95),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,0.92 (0.89 0.95),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,0.92 (0.89 0.95),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,0.92 (0.89 0.95),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003438,0.109,Nightingale,Total lipids in IDL,0.92 (0.89 0.95),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,0.92 (0.89 0.95),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,0.92 (0.89 0.95),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003439,0.107,Nightingale,Concentration of IDL particles,0.92 (0.89 0.95),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,0.92 (0.89 0.94),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,0.91 (0.89 0.94),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003440,0.106,Nightingale,Cholesterol in IDL,0.92 (0.89 0.94),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,0.92 (0.89 0.95),6.04E-05
574.2,Calculus of bile duct,digestive,OPGS003431,0.118,Nightingale,Total lipids in large LDL,0.92 (0.89 0.95),6.10E-05
574.2,Calculus of bile duct,digestive,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,0.92 (0.89 0.95),6.10E-05
574.2,Calculus of bile duct,digestive,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,0.92 (0.89 0.95),6.10E-05
574.2,Calculus of bile duct,digestive,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,0.92 (0.89 0.95),6.10E-05
574.2,Calculus of bile duct,digestive,OPGS003423,0.126,Nightingale,LDL cholesterol,0.92 (0.89 0.95),7.60E-05
574.2,Calculus of bile duct,digestive,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,0.92 (0.89 0.95),7.68E-05
574.2,Calculus of bile duct,digestive,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,0.92 (0.89 0.95),7.68E-05
574.2,Calculus of bile duct,digestive,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,0.92 (0.89 0.95),8.34E-05
574.2,Calculus of bile duct,digestive,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,0.92 (0.89 0.95),8.76E-05
574.2,Calculus of bile duct,digestive,OPGS003434,0.113,Nightingale,Phospholipids in IDL,0.92 (0.89 0.95),8.76E-05
574.2,Calculus of bile duct,digestive,OPGS003428,0.121,Nightingale,Total lipids in small LDL,0.92 (0.89 0.95),9.07E-05
574.2,Calculus of bile duct,digestive,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,0.92 (0.89 0.95),9.11E-05
574.2,Calculus of bile duct,digestive,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,0.92 (0.89 0.95),1.08E-04
574.2,Calculus of bile duct,digestive,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,0.92 (0.89 0.95),1.22E-04
574.2,Calculus of bile duct,digestive,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,0.92 (0.90 0.95),2.55E-04
574.2,Calculus of bile duct,digestive,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,0.92 (0.90 0.95),2.68E-04
574.2,Calculus of bile duct,digestive,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,0.92 (0.90 0.95),2.69E-04
574.2,Calculus of bile duct,digestive,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,0.93 (0.90 0.95),2.99E-04
574.2,Calculus of bile duct,digestive,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,0.93 (0.90 0.96),4.05E-04
574.2,Calculus of bile duct,digestive,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,0.93 (0.90 0.96),8.08E-04
574.2,Calculus of bile duct,digestive,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,0.93 (0.90 0.96),1.16E-03
574.2,Calculus of bile duct,digestive,OPGS003444,0.101,Nightingale,Apolipoprotein B,0.93 (0.90 0.96),1.72E-03
574.2,Calculus of bile duct,digestive,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,0.93 (0.90 0.96),2.40E-03
574.2,Calculus of bile duct,digestive,OPGS003497,0.072,Nightingale,Linoleic acid,0.94 (0.91 0.97),1.75E-02
574.2,Calculus of bile duct,digestive,OPGS003488,0.074,Nightingale,VLDL cholesterol,0.94 (0.91 0.97),3.09E-02
574.2,Calculus of bile duct,digestive,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,0.94 (0.91 0.97),3.23E-02
574.2,Calculus of bile duct,digestive,OPGS012737,0.033,RNAseq,HEIH,0.94 (0.91 0.97),9.91E-03
574.2,Calculus of bile duct,digestive,OPGS015050,0.016,RNAseq,RAD51-AS1,1.06 (1.03 1.10),1.03E-02
574.2,Calculus of bile duct,digestive,OPGS009217,0.085,RNAseq,PDP1,1.06 (1.03 1.10),3.41E-02
574.2,Calculus of bile duct,digestive,OPGS009545,0.078,RNAseq,HAUS1,0.93 (0.90 0.97),4.55E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS002216,0.011,SomaScan,Interferon gamma,1.06 (1.03 1.09),4.59E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS002557,0.050,Olink,Epithelial cell adhesion molecule,0.93 (0.91 0.96),1.61E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS002874,0.060,Metabolon,campesterol,0.85 (0.82 0.87),6.51E-21
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003166,0.014,Metabolon,thyroxine,0.93 (0.91 0.96),1.60E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS002719,0.216,Metabolon,X - 21448,1.06 (1.03 1.10),3.58E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS002737,0.169,Metabolon,succinimide,1.06 (1.03 1.10),3.66E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS002725,0.200,Metabolon,X - 11530,1.06 (1.03 1.10),3.70E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS002722,0.209,Metabolon,X - 16946,1.06 (1.03 1.10),3.70E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS002727,0.198,Metabolon,X - 11522,1.06 (1.03 1.10),3.70E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS002717,0.241,Metabolon,biliverdin,1.06 (1.03 1.10),3.70E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS002790,0.100,Metabolon,X - 11442,1.06 (1.03 1.10),4.11E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS002709,0.272,Metabolon,4-androsten-3alpha.17alpha-diol monosulfate (3),1.06 (1.03 1.10),4.37E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS002716,0.242,Metabolon,bilirubin (E.E)*,1.06 (1.03 1.10),4.37E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003157,0.014,Metabolon,X - 10458,0.94 (0.91 0.97),4.59E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS002718,0.234,Metabolon,bilirubin (Z.Z),1.06 (1.03 1.09),4.63E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,0.92 (0.89 0.95),4.58E-04
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,0.92 (0.89 0.95),9.77E-04
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,0.92 (0.89 0.95),1.33E-03
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,0.92 (0.89 0.95),1.45E-03
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003454,0.087,Nightingale,Total esterified cholesterol,0.93 (0.90 0.96),3.05E-03
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,0.93 (0.90 0.96),3.30E-03
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,0.93 (0.90 0.96),4.27E-03
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,0.93 (0.90 0.96),4.94E-03
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003438,0.109,Nightingale,Total lipids in IDL,0.93 (0.90 0.96),5.18E-03
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003452,0.087,Nightingale,Total cholesterol,0.93 (0.90 0.96),5.62E-03
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003455,0.087,Nightingale,Total free cholesterol,0.93 (0.90 0.96),5.62E-03
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003439,0.107,Nightingale,Concentration of IDL particles,0.93 (0.90 0.96),7.89E-03
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,0.93 (0.90 0.96),8.65E-03
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003488,0.074,Nightingale,VLDL cholesterol,0.93 (0.90 0.96),1.01E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,0.93 (0.91 0.96),1.26E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,0.93 (0.91 0.96),1.36E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,0.93 (0.91 0.96),1.48E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,0.94 (0.91 0.96),1.61E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003440,0.106,Nightingale,Cholesterol in IDL,0.94 (0.91 0.96),1.61E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,0.94 (0.91 0.97),1.61E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003444,0.101,Nightingale,Apolipoprotein B,0.94 (0.91 0.96),1.61E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,0.94 (0.91 0.96),1.61E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003434,0.113,Nightingale,Phospholipids in IDL,0.94 (0.91 0.97),1.75E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,0.94 (0.91 0.97),2.20E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003497,0.072,Nightingale,Linoleic acid,0.94 (0.91 0.97),2.60E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,0.94 (0.91 0.97),2.66E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,0.94 (0.91 0.97),2.83E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003431,0.118,Nightingale,Total lipids in large LDL,0.94 (0.91 0.97),2.85E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,0.94 (0.91 0.97),2.85E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,0.94 (0.91 0.97),2.85E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003423,0.126,Nightingale,LDL cholesterol,0.94 (0.91 0.97),2.92E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,0.94 (0.91 0.97),2.92E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,0.94 (0.91 0.97),3.01E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,0.94 (0.91 0.97),3.58E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,0.94 (0.91 0.97),3.58E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,0.94 (0.91 0.97),3.66E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,0.94 (0.91 0.97),3.70E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,0.94 (0.91 0.97),4.11E-02
574.3,Cholecystitis without cholelithiasis,digestive,OPGS014090,0.022,RNAseq,NFKBIZ,0.94 (0.91 0.97),3.58E-02
575.2,Obstruction of bile duct,digestive,OPGS002874,0.060,Metabolon,campesterol,0.88 (0.84 0.93),4.17E-02
575.6,Cholesterolosis of gallbladder,digestive,OPGS002557,0.050,Olink,Epithelial cell adhesion molecule,0.84 (0.78 0.91),4.17E-02
575.6,Cholesterolosis of gallbladder,digestive,OPGS002874,0.060,Metabolon,campesterol,0.76 (0.70 0.82),1.16E-07
575.6,Cholesterolosis of gallbladder,digestive,OPGS012867,0.032,RNAseq,CCND2,0.84 (0.78 0.91),4.17E-02
575.7,Other disorders of gallbladder,digestive,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.91 (0.88 0.95),3.26E-02
575.7,Other disorders of gallbladder,digestive,OPGS002874,0.060,Metabolon,campesterol,0.86 (0.83 0.90),1.01E-07
575.7,Other disorders of gallbladder,digestive,OPGS002743,0.159,Metabolon,X - 11440,1.11 (1.06 1.16),1.87E-02
575.7,Other disorders of gallbladder,digestive,OPGS002862,0.066,Metabolon,4-androsten-3alpha.17alpha-diol monosulfate (2),0.90 (0.86 0.94),1.87E-02
575.7,Other disorders of gallbladder,digestive,OPGS002738,0.166,Metabolon,pregnen-diol disulfate*,1.10 (1.06 1.15),1.87E-02
575.7,Other disorders of gallbladder,digestive,OPGS003142,0.016,Metabolon,5alpha-pregnan-3beta.20alpha-diol monosulfate (2),0.91 (0.87 0.95),3.26E-02
575.7,Other disorders of gallbladder,digestive,OPGS003079,0.020,Metabolon,glycolithocholate,0.91 (0.87 0.95),4.15E-02
575.7,Other disorders of gallbladder,digestive,OPGS002779,0.113,Metabolon,X - 21470,1.09 (1.05 1.14),4.19E-02
575.8,Other disorders of biliary tract,digestive,OPGS002874,0.060,Metabolon,campesterol,0.88 (0.84 0.92),1.52E-03
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.75 (0.67 0.83),8.17E-04
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.35 (1.21 1.52),8.17E-04
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.74 (0.66 0.83),8.17E-04
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.75 (0.67 0.84),8.17E-04
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.75 (0.67 0.84),1.34E-03
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,0.76 (0.68 0.85),2.86E-03
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.77 (0.69 0.86),4.82E-03
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS000576,0.102,SomaScan,Interleukin-21,0.77 (0.69 0.87),9.25E-03
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.77 (0.69 0.87),1.39E-02
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.29 (1.15 1.45),1.47E-02
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS000645,0.091,SomaScan,Trypsin-3,1.33 (1.17 1.52),1.95E-02
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.31 (1.15 1.49),2.83E-02
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS000290,0.171,SomaScan,Complement C4,0.78 (0.69 0.88),4.06E-02
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.78 (0.69 0.88),4.31E-02
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.78 (0.69 0.87),1.94E-02
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS006499,0.176,RNAseq,C4A,0.74 (0.66 0.82),4.36E-04
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS012006,0.041,RNAseq,VARS2,0.74 (0.66 0.83),8.17E-04
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS007675,0.126,RNAseq,TRAV12-2,1.33 (1.18 1.49),2.41E-03
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS014496,0.019,RNAseq,VARS1,1.30 (1.17 1.45),2.47E-03
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS010607,0.059,RNAseq,TRAV8-1,1.30 (1.15 1.46),1.39E-02
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS013045,0.030,RNAseq,NEU1,0.78 (0.70 0.88),1.91E-02
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS007382,0.137,RNAseq,LRATD2,1.33 (1.16 1.52),2.52E-02
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS013744,0.024,RNAseq,RAB11FIP3,0.78 (0.69 0.88),2.83E-02
580,Nephritis; nephrosis; renal sclerosis,genitourinary,OPGS009865,0.072,RNAseq,TRAV17,0.79 (0.71 0.89),3.98E-02
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.66 (0.58 0.75),3.94E-07
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.52 (1.33 1.74),2.13E-06
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.67 (0.59 0.76),2.13E-06
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.66 (0.58 0.75),3.60E-06
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS000290,0.171,SomaScan,Complement C4,0.64 (0.56 0.74),6.04E-06
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.68 (0.60 0.77),6.53E-06
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.69 (0.60 0.78),6.53E-06
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.69 (0.61 0.78),7.33E-06
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS000984,0.055,SomaScan,Complement C2,1.58 (1.35 1.85),1.53E-05
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS000576,0.102,SomaScan,Interleukin-21,0.69 (0.61 0.79),1.53E-05
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.50 (1.30 1.72),1.96E-05
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.43 (1.25 1.63),1.65E-04
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.73 (0.64 0.84),6.34E-03
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,0.75 (0.65 0.85),6.34E-03
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS000438,0.130,SomaScan,ICOS ligand,0.75 (0.66 0.85),8.36E-03
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.31 (1.15 1.50),2.15E-02
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.69 (0.60 0.79),6.12E-05
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.71 (0.62 0.82),1.55E-03
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS007675,0.126,RNAseq,TRAV12-2,1.68 (1.48 1.91),3.94E-11
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS006716,0.164,RNAseq,IER3,1.45 (1.27 1.66),6.16E-05
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS006499,0.176,RNAseq,C4A,0.72 (0.63 0.81),1.40E-04
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS006845,0.158,RNAseq,FLOT1,1.41 (1.24 1.60),1.83E-04
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS013243,0.029,RNAseq,TRAV3,0.71 (0.62 0.81),2.29E-04
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS010693,0.058,RNAseq,TRBV5-1,1.41 (1.23 1.60),3.28E-04
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS014496,0.019,RNAseq,VARS1,1.37 (1.21 1.54),3.30E-04
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS013045,0.030,RNAseq,NEU1,0.72 (0.63 0.82),4.36E-04
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS012006,0.041,RNAseq,VARS2,0.72 (0.63 0.82),6.15E-04
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS003680,0.611,RNAseq,,1.34 (1.18 1.51),2.48E-03
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS005230,0.263,RNAseq,LINC00243,1.36 (1.18 1.56),8.46E-03
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS006248,0.189,RNAseq,MCCD1,0.74 (0.64 0.85),8.46E-03
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS015030,0.016,RNAseq,PRRC2A,0.74 (0.64 0.85),1.37E-02
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS010826,0.056,RNAseq,TRIM10,0.77 (0.68 0.87),1.82E-02
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS010607,0.059,RNAseq,TRAV8-1,1.32 (1.16 1.51),2.15E-02
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS005334,0.253,RNAseq,AL645933.4,0.76 (0.66 0.87),3.54E-02
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS014541,0.019,RNAseq,,0.76 (0.66 0.87),4.39E-02
580.12,Non-proliferative glomerulonephritis,genitourinary,OPGS013950,0.023,RNAseq,CD247,1.31 (1.14 1.50),4.61E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.22 (1.14 1.31),5.01E-05
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.83 (0.78 0.89),1.49E-04
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.83 (0.78 0.89),1.95E-04
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.83 (0.78 0.89),1.97E-04
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.84 (0.79 0.90),4.90E-04
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.85 (0.79 0.90),7.93E-04
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.85 (0.79 0.90),7.93E-04
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS000645,0.091,SomaScan,Trypsin-3,1.20 (1.11 1.29),1.70E-03
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.17 (1.09 1.25),3.98E-03
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,0.86 (0.80 0.92),7.40E-03
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.17 (1.09 1.26),9.33E-03
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.17 (1.09 1.25),1.13E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS000576,0.102,SomaScan,Interleukin-21,0.87 (0.81 0.93),1.44E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.86 (0.80 0.92),1.53E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,1.17 (1.09 1.25),1.53E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS000390,0.141,SomaScan,Palmitoyl-protein thioesterase 1,1.16 (1.08 1.25),1.89E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS000984,0.055,SomaScan,Complement C2,1.16 (1.08 1.25),3.81E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.87 (0.81 0.93),2.44E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS006499,0.176,RNAseq,C4A,0.82 (0.77 0.88),5.01E-05
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS012006,0.041,RNAseq,VARS2,0.82 (0.77 0.88),8.96E-05
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS007675,0.126,RNAseq,TRAV12-2,1.20 (1.12 1.28),1.97E-04
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS013243,0.029,RNAseq,TRAV3,0.83 (0.78 0.89),1.97E-04
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS009865,0.072,RNAseq,TRAV17,0.84 (0.78 0.89),3.05E-04
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS014496,0.019,RNAseq,VARS1,1.18 (1.10 1.26),7.93E-04
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS003680,0.611,RNAseq,,1.17 (1.10 1.25),1.55E-03
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS005389,0.248,RNAseq,TRAV23DV6,0.86 (0.81 0.92),1.70E-03
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS008786,0.094,RNAseq,GABBR1,1.19 (1.10 1.28),3.98E-03
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS005029,0.283,RNAseq,DHRS9,0.85 (0.79 0.91),3.98E-03
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS007407,0.135,RNAseq,TRBV2,1.16 (1.09 1.25),7.40E-03
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS010624,0.059,RNAseq,TRBV18,1.17 (1.09 1.25),1.03E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS006845,0.158,RNAseq,FLOT1,1.16 (1.08 1.24),1.28E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS015052,0.015,RNAseq,CISH,1.16 (1.08 1.25),1.92E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS006166,0.193,RNAseq,CCM2,1.14 (1.07 1.22),2.44E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS010607,0.059,RNAseq,TRAV8-1,1.15 (1.07 1.23),3.31E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS013326,0.028,RNAseq,H2AZ2,0.88 (0.83 0.94),3.52E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS003620,0.668,RNAseq,ZFP57,1.14 (1.07 1.22),3.79E-02
580.2,Nephrotic syndrome without mention of glomerulonephritis,genitourinary,OPGS006716,0.164,RNAseq,IER3,1.15 (1.07 1.23),3.81E-02
585.1,Acute renal failure,genitourinary,OPGS001157,0.041,SomaScan,Transmembrane protein 106A,0.96 (0.95 0.98),3.14E-02
585.1,Acute renal failure,genitourinary,OPGS009794,0.073,RNAseq,RN7SL473P,0.96 (0.95 0.98),3.14E-02
585.3,Chronic renal failure [CKD],genitourinary,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.95 (0.93 0.97),4.60E-02
585.3,Chronic renal failure [CKD],genitourinary,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.95 (0.93 0.97),4.60E-02
585.3,Chronic renal failure [CKD],genitourinary,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.95 (0.93 0.97),4.60E-02
585.3,Chronic renal failure [CKD],genitourinary,OPGS006216,0.191,RNAseq,RRAGD,1.06 (1.03 1.09),3.89E-02
585.3,Chronic renal failure [CKD],genitourinary,OPGS003680,0.611,RNAseq,,1.06 (1.03 1.08),4.60E-02
585.3,Chronic renal failure [CKD],genitourinary,OPGS010607,0.059,RNAseq,TRAV8-1,1.05 (1.03 1.08),4.60E-02
585.3,Chronic renal failure [CKD],genitourinary,OPGS006996,0.152,RNAseq,FBRSL1,0.95 (0.93 0.97),4.94E-02
592.12,Chronic cystitis,genitourinary,OPGS013250,0.029,RNAseq,AC004982.2,0.89 (0.85 0.94),3.65E-02
593,Hematuria,genitourinary,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,1.08 (1.06 1.09),1.01E-21
593,Hematuria,genitourinary,OPGS001102,0.046,SomaScan,Granzyme A,1.08 (1.06 1.09),3.91E-21
593,Hematuria,genitourinary,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.07 (1.05 1.08),2.12E-17
593,Hematuria,genitourinary,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,1.07 (1.05 1.08),6.74E-17
593,Hematuria,genitourinary,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.94 (0.93 0.95),5.97E-16
593,Hematuria,genitourinary,OPGS000572,0.102,SomaScan,Glutamate receptor 4,1.06 (1.05 1.08),1.48E-14
593,Hematuria,genitourinary,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,1.06 (1.05 1.08),9.41E-14
593,Hematuria,genitourinary,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.06 (1.05 1.08),9.83E-14
593,Hematuria,genitourinary,OPGS000645,0.091,SomaScan,Trypsin-3,0.95 (0.94 0.96),4.14E-11
593,Hematuria,genitourinary,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,0.95 (0.94 0.96),2.01E-10
593,Hematuria,genitourinary,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,1.05 (1.04 1.07),7.14E-10
593,Hematuria,genitourinary,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.05 (1.04 1.07),1.98E-09
593,Hematuria,genitourinary,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,1.05 (1.03 1.06),1.21E-08
593,Hematuria,genitourinary,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,0.95 (0.94 0.97),1.73E-08
593,Hematuria,genitourinary,OPGS001860,0.016,SomaScan,Immunoglobulin E,0.95 (0.94 0.97),2.56E-08
593,Hematuria,genitourinary,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,1.05 (1.03 1.06),3.19E-08
593,Hematuria,genitourinary,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,0.96 (0.94 0.97),5.66E-08
593,Hematuria,genitourinary,OPGS000879,0.065,SomaScan,Natural cytotoxicity triggering receptor 3,0.96 (0.95 0.97),1.52E-07
593,Hematuria,genitourinary,OPGS002246,0.010,SomaScan,Sperm-associated antigen 11B,0.96 (0.95 0.97),1.57E-06
593,Hematuria,genitourinary,OPGS000290,0.171,SomaScan,Complement C4,1.04 (1.03 1.05),4.61E-06
593,Hematuria,genitourinary,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,0.96 (0.95 0.98),2.95E-05
593,Hematuria,genitourinary,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.96 (0.95 0.98),4.12E-05
593,Hematuria,genitourinary,OPGS000255,0.191,SomaScan,Ferritin,0.96 (0.95 0.98),4.43E-05
593,Hematuria,genitourinary,OPGS001598,0.022,SomaScan,SPARC,0.96 (0.95 0.98),5.17E-05
593,Hematuria,genitourinary,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,0.96 (0.95 0.98),5.36E-05
593,Hematuria,genitourinary,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,0.97 (0.95 0.98),1.09E-04
593,Hematuria,genitourinary,OPGS000061,0.457,SomaScan,Haptoglobin,0.97 (0.95 0.98),1.63E-04
593,Hematuria,genitourinary,OPGS000040,0.535,SomaScan,Haptoglobin,0.97 (0.95 0.98),1.89E-04
593,Hematuria,genitourinary,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,1.04 (1.02 1.05),2.03E-04
593,Hematuria,genitourinary,OPGS000706,0.084,SomaScan,Low affinity immunoglobulin gamma Fc region receptor III-B,1.03 (1.02 1.05),3.82E-04
593,Hematuria,genitourinary,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,1.03 (1.02 1.05),6.15E-04
593,Hematuria,genitourinary,OPGS001286,0.034,SomaScan,Granzyme K,1.03 (1.02 1.05),1.35E-03
593,Hematuria,genitourinary,OPGS000691,0.086,SomaScan,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,0.97 (0.96 0.98),1.71E-03
593,Hematuria,genitourinary,OPGS000642,0.092,SomaScan,Heparin cofactor 2,0.97 (0.96 0.98),2.35E-03
593,Hematuria,genitourinary,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,0.97 (0.96 0.98),2.53E-03
593,Hematuria,genitourinary,OPGS000137,0.312,SomaScan,Complement C4b,0.97 (0.96 0.98),2.83E-03
593,Hematuria,genitourinary,OPGS000984,0.055,SomaScan,Complement C2,0.97 (0.96 0.99),4.62E-03
593,Hematuria,genitourinary,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,0.97 (0.96 0.99),6.41E-03
593,Hematuria,genitourinary,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,1.03 (1.01 1.04),1.91E-02
593,Hematuria,genitourinary,OPGS000798,0.073,SomaScan,N-acetylated-alpha-linked acidic dipeptidase 2,0.97 (0.96 0.99),2.21E-02
593,Hematuria,genitourinary,OPGS002568,0.043,Olink,Granzyme A,1.08 (1.06 1.09),3.02E-21
593,Hematuria,genitourinary,OPGS002581,0.038,Olink,Fractalkine,0.95 (0.94 0.96),2.19E-10
593,Hematuria,genitourinary,OPGS002422,0.223,Olink,Lymphotoxin-alpha,0.95 (0.94 0.97),2.03E-09
593,Hematuria,genitourinary,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,1.05 (1.04 1.06),2.53E-09
593,Hematuria,genitourinary,OPGS002619,0.025,Olink,Transforming growth factor beta-1 proprotein,0.95 (0.94 0.97),7.92E-09
593,Hematuria,genitourinary,OPGS002658,0.013,Olink,C-C motif chemokine 22,1.04 (1.02 1.05),2.90E-05
593,Hematuria,genitourinary,OPGS002433,0.194,Olink,Interleukin-12 subunit alpha;beta,0.97 (0.96 0.99),2.10E-02
593,Hematuria,genitourinary,OPGS002420,0.225,Olink,Interleukin-12 subunit beta,0.98 (0.96 0.99),4.85E-02
593,Hematuria,genitourinary,OPGS003031,0.026,Metabolon,X - 21312,0.97 (0.96 0.99),1.47E-02
593,Hematuria,genitourinary,OPGS002913,0.049,Metabolon,X - 21285,0.97 (0.96 0.99),1.78E-02
593,Hematuria,genitourinary,OPGS002866,0.064,Metabolon,N-acetyltryptophan,1.03 (1.01 1.04),3.88E-02
593,Hematuria,genitourinary,OPGS002957,0.040,Metabolon,cys-gly. oxidized,1.03 (1.01 1.04),4.35E-02
593,Hematuria,genitourinary,OPGS002816,0.086,Metabolon,X - 11470,0.98 (0.96 0.99),4.73E-02
593,Hematuria,genitourinary,OPGS002932,0.045,Metabolon,4-androsten-3beta.17beta-diol monosulfate (2),0.98 (0.96 0.99),4.73E-02
593,Hematuria,genitourinary,OPGS012006,0.041,RNAseq,VARS2,1.08 (1.06 1.09),1.01E-21
593,Hematuria,genitourinary,OPGS014232,0.021,RNAseq,TRAV1-2,1.07 (1.06 1.09),1.73E-20
593,Hematuria,genitourinary,OPGS010693,0.058,RNAseq,TRBV5-1,0.93 (0.92 0.95),7.21E-19
593,Hematuria,genitourinary,OPGS015052,0.015,RNAseq,CISH,0.93 (0.92 0.95),2.52E-18
593,Hematuria,genitourinary,OPGS004334,0.383,RNAseq,HLA-G,1.07 (1.05 1.08),5.92E-18
593,Hematuria,genitourinary,OPGS010826,0.056,RNAseq,TRIM10,1.07 (1.06 1.09),7.33E-18
593,Hematuria,genitourinary,OPGS013225,0.029,RNAseq,REG4,1.07 (1.05 1.08),1.29E-17
593,Hematuria,genitourinary,OPGS014580,0.018,RNAseq,DACT1,0.94 (0.93 0.95),1.76E-16
593,Hematuria,genitourinary,OPGS004489,0.357,RNAseq,,1.06 (1.05 1.08),2.53E-16
593,Hematuria,genitourinary,OPGS006048,0.200,RNAseq,,1.06 (1.05 1.08),7.23E-16
593,Hematuria,genitourinary,OPGS006866,0.157,RNAseq,AL662795.2,0.94 (0.93 0.95),2.82E-15
593,Hematuria,genitourinary,OPGS009371,0.082,RNAseq,TRBV19,1.06 (1.05 1.08),3.92E-15
593,Hematuria,genitourinary,OPGS013514,0.026,RNAseq,GZMK,1.06 (1.05 1.08),6.32E-14
593,Hematuria,genitourinary,OPGS014443,0.019,RNAseq,ABCB1,1.06 (1.04 1.07),1.64E-13
593,Hematuria,genitourinary,OPGS011283,0.050,RNAseq,CD248,1.06 (1.04 1.07),2.02E-13
593,Hematuria,genitourinary,OPGS008889,0.092,RNAseq,TRAV20,1.06 (1.04 1.07),1.13E-12
593,Hematuria,genitourinary,OPGS010607,0.059,RNAseq,TRAV8-1,0.94 (0.93 0.96),1.22E-12
593,Hematuria,genitourinary,OPGS013045,0.030,RNAseq,NEU1,1.06 (1.04 1.07),2.18E-12
593,Hematuria,genitourinary,OPGS003621,0.665,RNAseq,,1.06 (1.04 1.07),2.40E-12
593,Hematuria,genitourinary,OPGS003680,0.611,RNAseq,,0.95 (0.93 0.96),4.73E-12
593,Hematuria,genitourinary,OPGS014496,0.019,RNAseq,VARS1,0.95 (0.93 0.96),4.87E-12
593,Hematuria,genitourinary,OPGS013298,0.028,RNAseq,IL7R,1.05 (1.04 1.07),1.06E-11
593,Hematuria,genitourinary,OPGS011784,0.044,RNAseq,TUBB,0.95 (0.94 0.96),2.35E-11
593,Hematuria,genitourinary,OPGS013780,0.024,RNAseq,ZSCAN16,0.95 (0.93 0.96),4.14E-11
593,Hematuria,genitourinary,OPGS014283,0.021,RNAseq,MXRA8,1.05 (1.04 1.07),8.74E-11
593,Hematuria,genitourinary,OPGS013699,0.025,RNAseq,TRAV5,1.05 (1.04 1.07),1.95E-10
593,Hematuria,genitourinary,OPGS012358,0.037,RNAseq,SFRP5,1.05 (1.04 1.06),2.28E-09
593,Hematuria,genitourinary,OPGS006845,0.158,RNAseq,FLOT1,0.95 (0.94 0.97),5.07E-09
593,Hematuria,genitourinary,OPGS003843,0.532,RNAseq,BTN3A2,1.05 (1.04 1.07),5.20E-09
593,Hematuria,genitourinary,OPGS009222,0.085,RNAseq,,1.05 (1.03 1.06),5.34E-09
593,Hematuria,genitourinary,OPGS004406,0.369,RNAseq,,1.05 (1.03 1.06),6.46E-09
593,Hematuria,genitourinary,OPGS013068,0.030,RNAseq,AL021807.1,0.95 (0.94 0.97),7.92E-09
593,Hematuria,genitourinary,OPGS013958,0.023,RNAseq,CSNK2B,0.95 (0.94 0.97),8.17E-09
593,Hematuria,genitourinary,OPGS012636,0.034,RNAseq,KIR2DL3,0.95 (0.94 0.97),8.17E-09
593,Hematuria,genitourinary,OPGS009711,0.075,RNAseq,TRAV21,0.95 (0.94 0.97),9.88E-09
593,Hematuria,genitourinary,OPGS012093,0.040,RNAseq,TRIM26,0.95 (0.94 0.97),1.04E-08
593,Hematuria,genitourinary,OPGS009865,0.072,RNAseq,TRAV17,1.05 (1.03 1.06),1.09E-08
593,Hematuria,genitourinary,OPGS008402,0.104,RNAseq,TNXB,1.05 (1.03 1.06),1.27E-08
593,Hematuria,genitourinary,OPGS005918,0.208,RNAseq,DDR1,1.05 (1.03 1.06),3.69E-08
593,Hematuria,genitourinary,OPGS007297,0.140,RNAseq,GPANK1,1.04 (1.03 1.06),7.85E-08
593,Hematuria,genitourinary,OPGS006716,0.164,RNAseq,IER3,0.96 (0.94 0.97),9.11E-08
593,Hematuria,genitourinary,OPGS003620,0.668,RNAseq,ZFP57,0.96 (0.94 0.97),2.84E-07
593,Hematuria,genitourinary,OPGS007089,0.148,RNAseq,HLA-A,1.04 (1.03 1.06),3.42E-07
593,Hematuria,genitourinary,OPGS010929,0.055,RNAseq,EOMES,1.04 (1.03 1.06),3.84E-07
593,Hematuria,genitourinary,OPGS007394,0.136,RNAseq,AL662844.4,0.96 (0.95 0.97),1.34E-06
593,Hematuria,genitourinary,OPGS005230,0.263,RNAseq,LINC00243,0.96 (0.95 0.97),1.40E-06
593,Hematuria,genitourinary,OPGS013243,0.029,RNAseq,TRAV3,1.04 (1.03 1.06),1.71E-06
593,Hematuria,genitourinary,OPGS010142,0.067,RNAseq,PRSS16,0.96 (0.95 0.97),2.94E-06
593,Hematuria,genitourinary,OPGS006248,0.189,RNAseq,MCCD1,1.04 (1.03 1.06),4.61E-06
593,Hematuria,genitourinary,OPGS009241,0.084,RNAseq,ZKSCAN4,0.96 (0.95 0.97),4.85E-06
593,Hematuria,genitourinary,OPGS012587,0.035,RNAseq,COL5A1,1.04 (1.03 1.06),5.12E-06
593,Hematuria,genitourinary,OPGS005245,0.261,RNAseq,ZNF391,0.96 (0.95 0.98),5.92E-06
593,Hematuria,genitourinary,OPGS005167,0.269,RNAseq,TCF19,1.04 (1.02 1.05),1.01E-05
593,Hematuria,genitourinary,OPGS006499,0.176,RNAseq,C4A,1.04 (1.02 1.05),5.50E-05
593,Hematuria,genitourinary,OPGS006807,0.160,RNAseq,BNC2,0.97 (0.95 0.98),8.07E-05
593,Hematuria,genitourinary,OPGS013013,0.031,RNAseq,FOXJ1,1.04 (1.02 1.05),9.26E-05
593,Hematuria,genitourinary,OPGS006940,0.154,RNAseq,,1.04 (1.02 1.05),1.09E-04
593,Hematuria,genitourinary,OPGS009198,0.085,RNAseq,TRAV12-1,0.97 (0.95 0.98),1.17E-04
593,Hematuria,genitourinary,OPGS004065,0.446,RNAseq,,1.03 (1.02 1.05),1.51E-04
593,Hematuria,genitourinary,OPGS009626,0.076,RNAseq,APBA2,1.03 (1.02 1.05),1.66E-04
593,Hematuria,genitourinary,OPGS004144,0.424,RNAseq,PSORS1C3,1.03 (1.02 1.05),3.53E-04
593,Hematuria,genitourinary,OPGS010564,0.060,RNAseq,CEACAM6,1.03 (1.02 1.05),3.56E-04
593,Hematuria,genitourinary,OPGS015030,0.016,RNAseq,PRRC2A,1.03 (1.02 1.05),4.16E-04
593,Hematuria,genitourinary,OPGS007604,0.128,RNAseq,U91328.1,0.97 (0.95 0.98),5.27E-04
593,Hematuria,genitourinary,OPGS011005,0.054,RNAseq,SLC1A5,0.97 (0.95 0.98),7.44E-04
593,Hematuria,genitourinary,OPGS006634,0.169,RNAseq,,1.03 (1.02 1.05),1.05E-03
593,Hematuria,genitourinary,OPGS007675,0.126,RNAseq,TRAV12-2,0.97 (0.96 0.98),1.05E-03
593,Hematuria,genitourinary,OPGS009920,0.071,RNAseq,LINC02446,1.03 (1.02 1.05),1.05E-03
593,Hematuria,genitourinary,OPGS010277,0.065,RNAseq,CXCR6,1.03 (1.02 1.05),1.10E-03
593,Hematuria,genitourinary,OPGS014680,0.018,RNAseq,GALE,1.03 (1.02 1.05),1.13E-03
593,Hematuria,genitourinary,OPGS009841,0.072,RNAseq,PDGFRB,0.97 (0.96 0.98),1.43E-03
593,Hematuria,genitourinary,OPGS007809,0.122,RNAseq,,1.03 (1.02 1.05),1.48E-03
593,Hematuria,genitourinary,OPGS004727,0.320,RNAseq,CD226,0.97 (0.96 0.98),1.59E-03
593,Hematuria,genitourinary,OPGS010926,0.055,RNAseq,CACNA2D4,1.03 (1.02 1.05),1.63E-03
593,Hematuria,genitourinary,OPGS010475,0.061,RNAseq,ZNRD1,1.03 (1.02 1.05),1.84E-03
593,Hematuria,genitourinary,OPGS013201,0.029,RNAseq,NRCAM,1.03 (1.02 1.04),2.56E-03
593,Hematuria,genitourinary,OPGS007384,0.137,RNAseq,HLA-B,0.97 (0.96 0.98),2.65E-03
593,Hematuria,genitourinary,OPGS011372,0.049,RNAseq,TIFAB,1.03 (1.02 1.04),3.02E-03
593,Hematuria,genitourinary,OPGS008268,0.107,RNAseq,CD4,0.97 (0.96 0.98),3.22E-03
593,Hematuria,genitourinary,OPGS013383,0.027,RNAseq,PPP1R11,1.03 (1.02 1.04),3.44E-03
593,Hematuria,genitourinary,OPGS012363,0.037,RNAseq,AC004593.2,0.97 (0.96 0.98),3.88E-03
593,Hematuria,genitourinary,OPGS007248,0.141,RNAseq,,1.03 (1.02 1.04),4.29E-03
593,Hematuria,genitourinary,OPGS011379,0.048,RNAseq,AHNAK,1.03 (1.02 1.04),4.65E-03
593,Hematuria,genitourinary,OPGS012707,0.033,RNAseq,CCDC97,1.03 (1.02 1.04),5.37E-03
593,Hematuria,genitourinary,OPGS012171,0.039,RNAseq,TRBV15,0.97 (0.96 0.99),5.40E-03
593,Hematuria,genitourinary,OPGS007282,0.140,RNAseq,CERCAM,0.97 (0.96 0.99),5.67E-03
593,Hematuria,genitourinary,OPGS012510,0.036,RNAseq,KLRF1,0.97 (0.96 0.99),6.30E-03
593,Hematuria,genitourinary,OPGS012562,0.035,RNAseq,H2BC17,0.97 (0.96 0.99),6.76E-03
593,Hematuria,genitourinary,OPGS006395,0.181,RNAseq,CDC42BPB,1.03 (1.01 1.04),7.82E-03
593,Hematuria,genitourinary,OPGS008534,0.101,RNAseq,HLA-DRA,1.03 (1.01 1.04),8.28E-03
593,Hematuria,genitourinary,OPGS004499,0.354,RNAseq,EML3,1.03 (1.01 1.04),9.63E-03
593,Hematuria,genitourinary,OPGS011787,0.044,RNAseq,C2,0.97 (0.96 0.99),9.65E-03
593,Hematuria,genitourinary,OPGS008253,0.108,RNAseq,SPON2,0.97 (0.96 0.99),1.05E-02
593,Hematuria,genitourinary,OPGS011671,0.045,RNAseq,MICA,1.03 (1.01 1.04),1.47E-02
593,Hematuria,genitourinary,OPGS009462,0.080,RNAseq,MRVI1,1.03 (1.01 1.04),1.55E-02
593,Hematuria,genitourinary,OPGS011073,0.053,RNAseq,TRBV7-3,0.97 (0.96 0.99),1.58E-02
593,Hematuria,genitourinary,OPGS010418,0.062,RNAseq,,0.97 (0.96 0.99),1.58E-02
593,Hematuria,genitourinary,OPGS007407,0.135,RNAseq,TRBV2,0.97 (0.96 0.99),1.75E-02
593,Hematuria,genitourinary,OPGS005334,0.253,RNAseq,AL645933.4,1.03 (1.01 1.04),1.82E-02
593,Hematuria,genitourinary,OPGS009112,0.087,RNAseq,SMG9,1.03 (1.01 1.04),1.91E-02
593,Hematuria,genitourinary,OPGS013472,0.027,RNAseq,STAT1,0.97 (0.96 0.99),2.05E-02
593,Hematuria,genitourinary,OPGS011425,0.048,RNAseq,DNMT3A,1.03 (1.01 1.04),2.07E-02
593,Hematuria,genitourinary,OPGS010041,0.069,RNAseq,GPRC5B,0.97 (0.96 0.99),2.08E-02
593,Hematuria,genitourinary,OPGS011316,0.049,RNAseq,MYOSLID,1.03 (1.01 1.04),2.09E-02
593,Hematuria,genitourinary,OPGS009077,0.088,RNAseq,DDAH2,0.97 (0.96 0.99),2.14E-02
593,Hematuria,genitourinary,OPGS004134,0.427,RNAseq,H2BC5,1.03 (1.01 1.04),2.17E-02
593,Hematuria,genitourinary,OPGS004939,0.294,RNAseq,,0.97 (0.96 0.99),2.21E-02
593,Hematuria,genitourinary,OPGS008786,0.094,RNAseq,GABBR1,0.97 (0.96 0.99),2.39E-02
593,Hematuria,genitourinary,OPGS012761,0.033,RNAseq,TRAV12-3,1.03 (1.01 1.04),2.42E-02
593,Hematuria,genitourinary,OPGS013931,0.023,RNAseq,FAM210A,0.97 (0.96 0.99),2.47E-02
593,Hematuria,genitourinary,OPGS011585,0.046,RNAseq,CD8B,1.03 (1.01 1.04),2.57E-02
593,Hematuria,genitourinary,OPGS011265,0.050,RNAseq,HSPA5,1.03 (1.01 1.04),2.72E-02
593,Hematuria,genitourinary,OPGS011262,0.050,RNAseq,GNAL,0.97 (0.96 0.99),2.97E-02
593,Hematuria,genitourinary,OPGS009231,0.085,RNAseq,DAB2,0.98 (0.96 0.99),3.05E-02
593,Hematuria,genitourinary,OPGS013155,0.029,RNAseq,MDS2,0.98 (0.96 0.99),3.63E-02
593,Hematuria,genitourinary,OPGS011288,0.050,RNAseq,AC104809.2,0.98 (0.96 0.99),3.72E-02
593,Hematuria,genitourinary,OPGS007330,0.138,RNAseq,YWHAH,1.02 (1.01 1.04),4.24E-02
593,Hematuria,genitourinary,OPGS014366,0.020,RNAseq,FSD1,0.98 (0.96 0.99),4.47E-02
593,Hematuria,genitourinary,OPGS008274,0.107,RNAseq,NCR3,0.98 (0.96 0.99),4.55E-02
593,Hematuria,genitourinary,OPGS014234,0.021,RNAseq,GFOD1,0.98 (0.96 0.99),4.58E-02
594.1,Calculus of kidney,genitourinary,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,1.08 (1.05 1.11),2.94E-04
594.1,Calculus of kidney,genitourinary,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,1.08 (1.05 1.12),2.94E-04
594.1,Calculus of kidney,genitourinary,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,1.07 (1.04 1.10),4.27E-02
594.1,Calculus of kidney,genitourinary,OPGS000572,0.102,SomaScan,Glutamate receptor 4,1.06 (1.03 1.10),4.43E-02
594.1,Calculus of kidney,genitourinary,OPGS002840,0.074,Metabolon,X - 18914,1.06 (1.03 1.09),4.38E-02
594.1,Calculus of kidney,genitourinary,OPGS003188,0.012,Metabolon,2-palmitoleoyl-GPC (16:1)*,1.06 (1.03 1.10),4.43E-02
594.1,Calculus of kidney,genitourinary,OPGS007373,0.137,RNAseq,HIBADH,0.92 (0.89 0.95),2.94E-04
594.1,Calculus of kidney,genitourinary,OPGS011382,0.048,RNAseq,LMAN2,1.07 (1.04 1.10),7.19E-03
594.1,Calculus of kidney,genitourinary,OPGS005504,0.238,RNAseq,MRTO4,1.07 (1.04 1.11),1.08E-02
594.1,Calculus of kidney,genitourinary,OPGS007675,0.126,RNAseq,TRAV12-2,0.94 (0.91 0.96),1.99E-02
594.1,Calculus of kidney,genitourinary,OPGS004406,0.369,RNAseq,,1.07 (1.04 1.10),1.99E-02
594.1,Calculus of kidney,genitourinary,OPGS006340,0.184,RNAseq,SIK2,0.94 (0.91 0.97),4.43E-02
594.1,Calculus of kidney,genitourinary,OPGS011287,0.050,RNAseq,,1.06 (1.03 1.09),4.43E-02
596,Other disorders of bladder,genitourinary,OPGS003834,0.535,RNAseq,AC026748.3,1.05 (1.03 1.07),9.01E-03
596.1,Bladder neck obstruction,genitourinary,OPGS003834,0.535,RNAseq,AC026748.3,1.10 (1.06 1.14),3.41E-02
596.1,Bladder neck obstruction,genitourinary,OPGS012654,0.034,RNAseq,CLPTM1L,0.91 (0.87 0.95),3.41E-02
600,Hyperplasia of prostate,genitourinary,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.95 (0.94 0.97),3.90E-08
600,Hyperplasia of prostate,genitourinary,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,0.97 (0.95 0.98),1.57E-03
600,Hyperplasia of prostate,genitourinary,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,0.97 (0.95 0.98),1.57E-03
600,Hyperplasia of prostate,genitourinary,OPGS001860,0.016,SomaScan,Immunoglobulin E,0.97 (0.95 0.98),3.52E-03
600,Hyperplasia of prostate,genitourinary,OPGS000608,0.097,SomaScan,Interleukin-17 receptor D,0.97 (0.95 0.98),4.24E-03
600,Hyperplasia of prostate,genitourinary,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,1.03 (1.02 1.05),4.32E-03
600,Hyperplasia of prostate,genitourinary,OPGS000984,0.055,SomaScan,Complement C2,0.97 (0.96 0.98),4.75E-03
600,Hyperplasia of prostate,genitourinary,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.03 (1.02 1.05),1.47E-02
600,Hyperplasia of prostate,genitourinary,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,1.03 (1.01 1.04),1.69E-02
600,Hyperplasia of prostate,genitourinary,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,1.03 (1.01 1.04),2.53E-02
600,Hyperplasia of prostate,genitourinary,OPGS000400,0.139,SomaScan,Agouti-signaling protein,1.03 (1.01 1.04),4.77E-02
600,Hyperplasia of prostate,genitourinary,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,1.03 (1.02 1.05),9.69E-03
600,Hyperplasia of prostate,genitourinary,OPGS003220,0.011,Metabolon,3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF),1.04 (1.02 1.05),1.77E-04
600,Hyperplasia of prostate,genitourinary,OPGS003031,0.026,Metabolon,X - 21312,0.97 (0.95 0.98),1.17E-03
600,Hyperplasia of prostate,genitourinary,OPGS003126,0.017,Metabolon,X - 21829,0.97 (0.96 0.98),1.55E-02
600,Hyperplasia of prostate,genitourinary,OPGS003135,0.016,Metabolon,X - 15486,0.97 (0.96 0.99),3.84E-02
600,Hyperplasia of prostate,genitourinary,OPGS003834,0.535,RNAseq,AC026748.3,1.07 (1.06 1.09),8.00E-18
600,Hyperplasia of prostate,genitourinary,OPGS012654,0.034,RNAseq,CLPTM1L,0.94 (0.92 0.95),4.81E-15
600,Hyperplasia of prostate,genitourinary,OPGS013826,0.024,RNAseq,MLLT10,1.05 (1.04 1.06),8.13E-11
600,Hyperplasia of prostate,genitourinary,OPGS003843,0.532,RNAseq,BTN3A2,1.05 (1.04 1.07),3.22E-08
600,Hyperplasia of prostate,genitourinary,OPGS010142,0.067,RNAseq,PRSS16,0.95 (0.94 0.97),1.65E-06
600,Hyperplasia of prostate,genitourinary,OPGS009371,0.082,RNAseq,TRBV19,1.04 (1.03 1.06),4.66E-06
600,Hyperplasia of prostate,genitourinary,OPGS014496,0.019,RNAseq,VARS1,0.96 (0.94 0.97),4.66E-06
600,Hyperplasia of prostate,genitourinary,OPGS005580,0.232,RNAseq,ZBTB38,1.04 (1.03 1.06),4.95E-05
600,Hyperplasia of prostate,genitourinary,OPGS009865,0.072,RNAseq,TRAV17,1.04 (1.03 1.06),9.46E-05
600,Hyperplasia of prostate,genitourinary,OPGS009198,0.085,RNAseq,TRAV12-1,0.96 (0.95 0.98),1.91E-04
600,Hyperplasia of prostate,genitourinary,OPGS007604,0.128,RNAseq,U91328.1,0.96 (0.95 0.98),2.42E-04
600,Hyperplasia of prostate,genitourinary,OPGS010826,0.056,RNAseq,TRIM10,1.04 (1.02 1.05),3.65E-04
600,Hyperplasia of prostate,genitourinary,OPGS013780,0.024,RNAseq,ZSCAN16,0.96 (0.95 0.98),3.82E-04
600,Hyperplasia of prostate,genitourinary,OPGS012819,0.033,RNAseq,DNAJC1,0.97 (0.95 0.98),9.47E-04
600,Hyperplasia of prostate,genitourinary,OPGS013068,0.030,RNAseq,AL021807.1,0.97 (0.95 0.98),1.14E-03
600,Hyperplasia of prostate,genitourinary,OPGS013013,0.031,RNAseq,FOXJ1,1.04 (1.02 1.05),1.48E-03
600,Hyperplasia of prostate,genitourinary,OPGS003680,0.611,RNAseq,,0.97 (0.95 0.98),1.57E-03
600,Hyperplasia of prostate,genitourinary,OPGS004134,0.427,RNAseq,H2BC5,1.03 (1.02 1.05),1.60E-03
600,Hyperplasia of prostate,genitourinary,OPGS010171,0.066,RNAseq,CABLES2,0.97 (0.95 0.98),1.87E-03
600,Hyperplasia of prostate,genitourinary,OPGS013045,0.030,RNAseq,NEU1,1.03 (1.02 1.05),2.70E-03
600,Hyperplasia of prostate,genitourinary,OPGS010693,0.058,RNAseq,TRBV5-1,0.97 (0.95 0.98),3.11E-03
600,Hyperplasia of prostate,genitourinary,OPGS009241,0.084,RNAseq,ZKSCAN4,0.97 (0.95 0.98),3.39E-03
600,Hyperplasia of prostate,genitourinary,OPGS006499,0.176,RNAseq,C4A,1.03 (1.02 1.05),4.32E-03
600,Hyperplasia of prostate,genitourinary,OPGS006517,0.174,RNAseq,,0.97 (0.95 0.98),4.86E-03
600,Hyperplasia of prostate,genitourinary,OPGS010607,0.059,RNAseq,TRAV8-1,0.97 (0.96 0.98),6.50E-03
600,Hyperplasia of prostate,genitourinary,OPGS004144,0.424,RNAseq,PSORS1C3,1.03 (1.02 1.05),6.50E-03
600,Hyperplasia of prostate,genitourinary,OPGS011784,0.044,RNAseq,TUBB,0.97 (0.96 0.98),8.94E-03
600,Hyperplasia of prostate,genitourinary,OPGS012712,0.033,RNAseq,APPL1,0.97 (0.96 0.98),9.69E-03
600,Hyperplasia of prostate,genitourinary,OPGS011283,0.050,RNAseq,CD248,1.03 (1.02 1.05),1.07E-02
600,Hyperplasia of prostate,genitourinary,OPGS012006,0.041,RNAseq,VARS2,1.03 (1.02 1.05),1.15E-02
600,Hyperplasia of prostate,genitourinary,OPGS014680,0.018,RNAseq,GALE,1.03 (1.02 1.05),1.16E-02
600,Hyperplasia of prostate,genitourinary,OPGS013406,0.027,RNAseq,AL353759.1,0.97 (0.96 0.98),1.37E-02
600,Hyperplasia of prostate,genitourinary,OPGS007407,0.135,RNAseq,TRBV2,0.97 (0.96 0.98),1.37E-02
600,Hyperplasia of prostate,genitourinary,OPGS005763,0.217,RNAseq,FAM53A,0.97 (0.96 0.98),1.55E-02
600,Hyperplasia of prostate,genitourinary,OPGS010926,0.055,RNAseq,CACNA2D4,1.03 (1.02 1.05),1.55E-02
600,Hyperplasia of prostate,genitourinary,OPGS005065,0.280,RNAseq,SLC25A37,1.03 (1.02 1.05),1.55E-02
600,Hyperplasia of prostate,genitourinary,OPGS011367,0.049,RNAseq,SLK,1.03 (1.02 1.04),1.57E-02
600,Hyperplasia of prostate,genitourinary,OPGS003620,0.668,RNAseq,ZFP57,0.97 (0.96 0.98),1.60E-02
600,Hyperplasia of prostate,genitourinary,OPGS006052,0.200,RNAseq,RNASEH2B-AS1,0.97 (0.96 0.99),1.68E-02
600,Hyperplasia of prostate,genitourinary,OPGS004334,0.383,RNAseq,HLA-G,1.03 (1.01 1.04),1.69E-02
600,Hyperplasia of prostate,genitourinary,OPGS012768,0.033,RNAseq,HMGA1,1.03 (1.01 1.04),1.69E-02
600,Hyperplasia of prostate,genitourinary,OPGS006638,0.168,RNAseq,AL118506.1,0.97 (0.96 0.99),2.06E-02
600,Hyperplasia of prostate,genitourinary,OPGS007675,0.126,RNAseq,TRAV12-2,0.97 (0.96 0.99),2.14E-02
600,Hyperplasia of prostate,genitourinary,OPGS008889,0.092,RNAseq,TRAV20,1.03 (1.01 1.04),2.36E-02
600,Hyperplasia of prostate,genitourinary,OPGS014716,0.017,RNAseq,AC114778.2,1.03 (1.01 1.04),2.53E-02
600,Hyperplasia of prostate,genitourinary,OPGS011997,0.041,RNAseq,GATA6,0.97 (0.96 0.99),2.62E-02
600,Hyperplasia of prostate,genitourinary,OPGS009222,0.085,RNAseq,,1.03 (1.01 1.04),2.67E-02
600,Hyperplasia of prostate,genitourinary,OPGS005110,0.275,RNAseq,PLPBP,0.97 (0.96 0.99),3.13E-02
600,Hyperplasia of prostate,genitourinary,OPGS010664,0.059,RNAseq,LINC01569,0.97 (0.96 0.99),4.69E-02
602,Other disorders of prostate,genitourinary,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.89 (0.85 0.93),2.95E-03
602,Other disorders of prostate,genitourinary,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.11 (1.06 1.17),1.98E-02
602,Other disorders of prostate,genitourinary,OPGS011283,0.050,RNAseq,CD248,1.14 (1.09 1.19),4.98E-04
602,Other disorders of prostate,genitourinary,OPGS003843,0.532,RNAseq,BTN3A2,1.14 (1.09 1.20),9.49E-04
602,Other disorders of prostate,genitourinary,OPGS009371,0.082,RNAseq,TRBV19,1.12 (1.07 1.17),2.95E-03
602,Other disorders of prostate,genitourinary,OPGS014283,0.021,RNAseq,MXRA8,1.10 (1.06 1.15),4.02E-02
602,Other disorders of prostate,genitourinary,OPGS010693,0.058,RNAseq,TRBV5-1,0.90 (0.86 0.95),4.60E-02
602,Other disorders of prostate,genitourinary,OPGS004334,0.383,RNAseq,HLA-G,1.10 (1.05 1.15),4.73E-02
602,Other disorders of prostate,genitourinary,OPGS013225,0.029,RNAseq,REG4,1.10 (1.05 1.16),4.96E-02
602,Other disorders of prostate,genitourinary,OPGS010142,0.067,RNAseq,PRSS16,0.90 (0.86 0.95),4.96E-02
603.1,Hydrocele,genitourinary,OPGS008309,0.106,RNAseq,SP1,1.14 (1.09 1.19),2.04E-05
603.1,Hydrocele,genitourinary,OPGS011303,0.050,RNAseq,,1.14 (1.09 1.19),3.32E-05
603.1,Hydrocele,genitourinary,OPGS005053,0.281,RNAseq,PSD4,1.12 (1.07 1.17),6.32E-03
603.1,Hydrocele,genitourinary,OPGS005234,0.263,RNAseq,UBE2F,0.90 (0.86 0.94),1.53E-02
604.1,Redundant prepuce and phimosis/BXO,genitourinary,OPGS001911,0.014,SomaScan,Ectodysplasin-A. secreted form,1.08 (1.05 1.12),4.46E-03
604.1,Redundant prepuce and phimosis/BXO,genitourinary,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,1.08 (1.05 1.12),4.46E-03
604.1,Redundant prepuce and phimosis/BXO,genitourinary,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,1.08 (1.05 1.12),4.86E-03
604.1,Redundant prepuce and phimosis/BXO,genitourinary,OPGS001893,0.015,SomaScan,Interleukin-17F,1.07 (1.04 1.11),4.45E-02
604.1,Redundant prepuce and phimosis/BXO,genitourinary,OPGS002658,0.013,Olink,C-C motif chemokine 22,1.08 (1.05 1.12),5.61E-03
604.1,Redundant prepuce and phimosis/BXO,genitourinary,OPGS012171,0.039,RNAseq,TRBV15,0.91 (0.88 0.93),1.75E-05
604.1,Redundant prepuce and phimosis/BXO,genitourinary,OPGS004956,0.291,RNAseq,,0.93 (0.90 0.96),3.99E-02
604.1,Redundant prepuce and phimosis/BXO,genitourinary,OPGS010624,0.059,RNAseq,TRBV18,1.07 (1.04 1.11),4.55E-02
610.4,Benign neoplasm of breast,genitourinary,OPGS007002,0.152,RNAseq,,0.88 (0.84 0.93),3.46E-03
610.8,Other specified benign mammary dysplasias,genitourinary,OPGS002130,0.011,SomaScan,Interferon gamma receptor 2,0.85 (0.79 0.91),4.30E-02
613,Other nonmalignant breast conditions,genitourinary,OPGS001062,0.049,SomaScan,ER membrane protein complex subunit 1,1.28 (1.16 1.41),1.16E-02
613,Other nonmalignant breast conditions,genitourinary,OPGS002314,0.010,SomaScan,Ras-related protein Rab-39B,1.27 (1.15 1.40),1.16E-02
613,Other nonmalignant breast conditions,genitourinary,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.25 (1.14 1.38),2.67E-02
613,Other nonmalignant breast conditions,genitourinary,OPGS005126,0.274,RNAseq,GOLGA6L10,0.79 (0.71 0.87),2.67E-02
613,Other nonmalignant breast conditions,genitourinary,OPGS011356,0.049,RNAseq,CA13,0.82 (0.75 0.90),4.18E-02
615,Endometriosis,genitourinary,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.93 (0.90 0.95),3.82E-03
615,Endometriosis,genitourinary,OPGS002557,0.050,Olink,Epithelial cell adhesion molecule,0.93 (0.90 0.96),6.09E-03
618.1,Prolapse of vaginal walls,genitourinary,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.95 (0.93 0.97),1.51E-03
618.1,Prolapse of vaginal walls,genitourinary,OPGS004765,0.314,RNAseq,LINC01184,1.06 (1.03 1.08),1.51E-03
618.1,Prolapse of vaginal walls,genitourinary,OPGS014487,0.019,RNAseq,FAM71F2,0.95 (0.93 0.97),6.57E-03
618.1,Prolapse of vaginal walls,genitourinary,OPGS008924,0.091,RNAseq,SWAP70,1.05 (1.03 1.07),1.74E-02
618.1,Prolapse of vaginal walls,genitourinary,OPGS007860,0.120,RNAseq,SBF2,1.05 (1.03 1.07),2.25E-02
618.2,Uterine/Uterovaginal prolapse,genitourinary,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.91 (0.89 0.93),1.83E-09
618.2,Uterine/Uterovaginal prolapse,genitourinary,OPGS005189,0.267,RNAseq,LDAH,0.94 (0.92 0.97),9.32E-03
618.2,Uterine/Uterovaginal prolapse,genitourinary,OPGS012058,0.041,RNAseq,SLC35B3,1.06 (1.03 1.08),1.72E-02
618.2,Uterine/Uterovaginal prolapse,genitourinary,OPGS010142,0.067,RNAseq,PRSS16,0.94 (0.92 0.97),1.72E-02
619.3,Noninflammatory disorders of cervix,genitourinary,OPGS004352,0.380,RNAseq,MSR1,1.11 (1.07 1.15),6.36E-05
619.3,Noninflammatory disorders of cervix,genitourinary,OPGS007228,0.142,RNAseq,SMG7,0.92 (0.89 0.95),2.63E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS001490,0.026,SomaScan,Intercellular adhesion molecule 2,0.95 (0.93 0.97),7.70E-03
622.1,Polyp of corpus uteri,genitourinary,OPGS001557,0.023,SomaScan,Leukemia inhibitory factor receptor,0.95 (0.94 0.97),1.24E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS001954,0.014,SomaScan,Tuftelin,0.96 (0.94 0.97),1.60E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS000600,0.099,SomaScan,Insulin receptor,0.96 (0.94 0.97),1.70E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS000923,0.060,SomaScan,Thrombospondin type-1 domain-containing protein 1,0.95 (0.93 0.97),1.70E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS000088,0.392,SomaScan,E-selectin,0.96 (0.94 0.98),2.24E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS001658,0.020,SomaScan,Endoglin,0.96 (0.94 0.98),2.29E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS000215,0.218,SomaScan,Immunoglobulin superfamily containing leucine-rich repeat protein 2,0.96 (0.94 0.98),2.81E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS001987,0.013,SomaScan,Insulin-like growth factor 1 receptor,0.96 (0.94 0.98),2.98E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS000351,0.151,SomaScan,C1GALT1-specific chaperone 1,1.04 (1.02 1.06),3.38E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS000378,0.143,SomaScan,Immunoglobulin superfamily containing leucine-rich repeat protein 2,0.96 (0.94 0.98),3.38E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS000828,0.070,SomaScan,Platelet endothelial aggregation receptor 1,0.96 (0.94 0.98),4.09E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS000121,0.341,SomaScan,D-glucuronyl C5-epimerase,1.04 (1.02 1.07),4.09E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS002408,0.270,Olink,E-selectin,0.95 (0.93 0.97),9.27E-03
622.1,Polyp of corpus uteri,genitourinary,OPGS002500,0.098,Olink,Galectin-4,0.96 (0.94 0.98),4.98E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS003171,0.014,Metabolon,cyclo(leu-pro),0.96 (0.94 0.98),4.86E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS010904,0.055,RNAseq,EEFSEC,0.93 (0.91 0.95),1.72E-08
622.1,Polyp of corpus uteri,genitourinary,OPGS014319,0.020,RNAseq,RUVBL1,1.05 (1.03 1.08),6.61E-04
622.1,Polyp of corpus uteri,genitourinary,OPGS009143,0.087,RNAseq,DCK,1.04 (1.02 1.06),2.98E-02
622.1,Polyp of corpus uteri,genitourinary,OPGS008253,0.108,RNAseq,SPON2,1.04 (1.02 1.06),4.86E-02
626,Disorders of menstruation and other abnormal bleeding from female genital tract,genitourinary,OPGS007419,0.135,RNAseq,JRK,1.08 (1.05 1.11),1.10E-02
626.12,Excessive or frequent menstruation,genitourinary,OPGS013531,0.026,RNAseq,FAT4,0.95 (0.93 0.97),1.12E-02
626.12,Excessive or frequent menstruation,genitourinary,OPGS009685,0.075,RNAseq,KCTD9,1.05 (1.03 1.07),1.19E-02
642.1,Preeclampsia and eclampsia,pregnancy complications,OPGS013107,0.030,RNAseq,PSD,0.79 (0.71 0.87),3.01E-02
647.1,Infections of genitourinary tract during pregnancy,pregnancy complications,OPGS001840,0.016,SomaScan,Inactive pancreatic lipase-related protein 1,0.80 (0.72 0.88),2.81E-02
647.1,Infections of genitourinary tract during pregnancy,pregnancy complications,OPGS002645,0.017,Olink,Carboxypeptidase A1,0.81 (0.74 0.88),2.81E-02
654.1,Abnormality of organs and soft tissues of pelvis complicating pregnancy. childbirth. or the puerperium,pregnancy complications,OPGS013499,0.026,RNAseq,SLC10A7,1.16 (1.09 1.23),2.36E-02
654.2,Rhesus isoimmunization in pregnancy,pregnancy complications,OPGS000225,0.210,SomaScan,Intercellular adhesion molecule 4,0.19 (0.16 0.22),3.17E-93
654.2,Rhesus isoimmunization in pregnancy,pregnancy complications,OPGS001066,0.048,SomaScan,Transmembrane protein 2,1.76 (1.55 1.99),1.89E-15
654.2,Rhesus isoimmunization in pregnancy,pregnancy complications,OPGS003225,0.010,Metabolon,pyruvate,2.62 (2.34 2.93),3.91E-60
654.2,Rhesus isoimmunization in pregnancy,pregnancy complications,OPGS003799,0.548,RNAseq,,0.21 (0.18 0.24),8.99E-86
654.2,Rhesus isoimmunization in pregnancy,pregnancy complications,OPGS007911,0.118,RNAseq,RHD,0.63 (0.56 0.69),1.61E-15
654.2,Rhesus isoimmunization in pregnancy,pregnancy complications,OPGS008585,0.099,RNAseq,TMEM50A,0.66 (0.57 0.76),1.49E-05
654.2,Rhesus isoimmunization in pregnancy,pregnancy complications,OPGS012454,0.036,RNAseq,,0.73 (0.65 0.82),2.65E-04
654.2,Rhesus isoimmunization in pregnancy,pregnancy complications,OPGS014676,0.018,RNAseq,ICE2,0.78 (0.70 0.88),3.65E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS001485,0.026,SomaScan,Tolloid-like protein 1,1.04 (1.02 1.07),3.21E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS000022,0.602,SomaScan,Interleukin-6 receptor subunit alpha,1.05 (1.03 1.07),3.21E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS000020,0.609,SomaScan,Interleukin-6 receptor subunit alpha,1.05 (1.02 1.07),3.21E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS001174,0.040,SomaScan,Platelet glycoprotein 4,1.04 (1.02 1.06),3.99E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS001700,0.019,SomaScan,Semaphorin-6B,1.04 (1.02 1.06),3.99E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS002139,0.011,SomaScan,Interleukin-27,0.96 (0.94 0.98),4.74E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.04 (1.02 1.07),4.74E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS001832,0.016,SomaScan,Neurogenic locus notch homolog protein 1,1.04 (1.02 1.06),4.85E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS002651,0.015,Olink,von Willebrand factor,1.05 (1.03 1.07),1.10E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS002387,0.541,Olink,Interleukin-6 receptor subunit alpha,1.05 (1.03 1.07),3.21E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS002613,0.027,Olink,Interleukin-6,1.05 (1.02 1.07),3.99E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS002568,0.043,Olink,Granzyme A,0.96 (0.94 0.98),3.99E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS003149,0.015,Metabolon,sphingosine,1.05 (1.02 1.07),3.21E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS004765,0.314,RNAseq,LINC01184,0.92 (0.90 0.94),4.08E-12
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS006919,0.155,RNAseq,AC105233.5,0.95 (0.93 0.97),1.56E-02
681.3,Cellulitis and abscess of arm/hand,dermatologic,OPGS012562,0.035,RNAseq,H2BC17,0.95 (0.93 0.97),1.56E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS001485,0.026,SomaScan,Tolloid-like protein 1,1.04 (1.02 1.07),3.35E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS000022,0.602,SomaScan,Interleukin-6 receptor subunit alpha,1.05 (1.02 1.07),3.35E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS000020,0.609,SomaScan,Interleukin-6 receptor subunit alpha,1.05 (1.02 1.07),3.35E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS002139,0.011,SomaScan,Interleukin-27,0.96 (0.94 0.98),4.27E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS001700,0.019,SomaScan,Semaphorin-6B,1.04 (1.02 1.06),4.27E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS001174,0.040,SomaScan,Platelet glycoprotein 4,1.04 (1.02 1.06),4.27E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.04 (1.02 1.07),4.27E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS001832,0.016,SomaScan,Neurogenic locus notch homolog protein 1,1.04 (1.02 1.06),4.96E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS002651,0.015,Olink,von Willebrand factor,1.05 (1.03 1.07),1.27E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS002387,0.541,Olink,Interleukin-6 receptor subunit alpha,1.05 (1.02 1.07),3.35E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS002613,0.027,Olink,Interleukin-6,1.05 (1.02 1.07),3.99E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS002568,0.043,Olink,Granzyme A,0.96 (0.94 0.98),4.90E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS003149,0.015,Metabolon,sphingosine,1.05 (1.02 1.07),3.35E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS004765,0.314,RNAseq,LINC01184,0.92 (0.90 0.94),7.33E-12
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS012562,0.035,RNAseq,H2BC17,0.95 (0.93 0.97),1.47E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS006919,0.155,RNAseq,AC105233.5,0.95 (0.93 0.97),1.77E-02
681.5,Cellulitis and abscess of leg. except foot,dermatologic,OPGS014283,0.021,RNAseq,MXRA8,0.96 (0.94 0.98),4.90E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS001485,0.026,SomaScan,Tolloid-like protein 1,1.04 (1.02 1.07),3.40E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS000022,0.602,SomaScan,Interleukin-6 receptor subunit alpha,1.05 (1.03 1.07),3.40E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS000020,0.609,SomaScan,Interleukin-6 receptor subunit alpha,1.05 (1.02 1.07),3.40E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS001700,0.019,SomaScan,Semaphorin-6B,1.04 (1.02 1.06),4.19E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS002139,0.011,SomaScan,Interleukin-27,0.96 (0.94 0.98),4.19E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS001174,0.040,SomaScan,Platelet glycoprotein 4,1.04 (1.02 1.06),4.19E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS001832,0.016,SomaScan,Neurogenic locus notch homolog protein 1,1.04 (1.02 1.06),4.86E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS000456,0.126,SomaScan,Coagulation Factor VIII,1.04 (1.02 1.07),4.91E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS002651,0.015,Olink,von Willebrand factor,1.05 (1.03 1.07),1.22E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS002387,0.541,Olink,Interleukin-6 receptor subunit alpha,1.05 (1.03 1.07),3.40E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS002613,0.027,Olink,Interleukin-6,1.05 (1.02 1.07),3.70E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS002568,0.043,Olink,Granzyme A,0.96 (0.94 0.98),3.70E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS003149,0.015,Metabolon,sphingosine,1.05 (1.02 1.07),3.40E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS004765,0.314,RNAseq,LINC01184,0.92 (0.90 0.94),6.74E-12
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS012562,0.035,RNAseq,H2BC17,0.95 (0.93 0.97),1.32E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS006919,0.155,RNAseq,AC105233.5,0.95 (0.93 0.97),1.32E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS014283,0.021,RNAseq,MXRA8,0.96 (0.94 0.98),4.38E-02
681.6,Cellulitis and abscess of foot. toe,dermatologic,OPGS012358,0.037,RNAseq,SFRP5,0.96 (0.94 0.98),4.91E-02
686,Other local infections of skin and subcutaneous tissue,dermatologic,OPGS000810,0.072,SomaScan,Cystatin-C,0.91 (0.87 0.94),3.72E-03
686,Other local infections of skin and subcutaneous tissue,dermatologic,OPGS000389,0.141,SomaScan,Transmembrane emp24 domain-containing protein 10,0.91 (0.87 0.94),7.36E-03
686,Other local infections of skin and subcutaneous tissue,dermatologic,OPGS004603,0.339,RNAseq,CST3,0.90 (0.87 0.94),2.17E-03
686,Other local infections of skin and subcutaneous tissue,dermatologic,OPGS011211,0.051,RNAseq,THAP12,1.09 (1.05 1.13),1.84E-02
694.2,Other dyschromia,dermatologic,OPGS000400,0.139,SomaScan,Agouti-signaling protein,1.15 (1.09 1.21),8.36E-04
695.42,Systemic lupus erythematosus,dermatologic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.70 (0.64 0.76),7.11E-15
695.42,Systemic lupus erythematosus,dermatologic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.70 (0.64 0.76),7.11E-15
695.42,Systemic lupus erythematosus,dermatologic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.70 (0.65 0.76),2.03E-14
695.42,Systemic lupus erythematosus,dermatologic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.71 (0.65 0.77),3.82E-13
695.42,Systemic lupus erythematosus,dermatologic,OPGS000290,0.171,SomaScan,Complement C4,0.69 (0.63 0.76),5.70E-12
695.42,Systemic lupus erythematosus,dermatologic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.72 (0.67 0.78),2.62E-11
695.42,Systemic lupus erythematosus,dermatologic,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.75 (0.68 0.81),8.04E-08
695.42,Systemic lupus erythematosus,dermatologic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.76 (0.69 0.82),1.87E-07
695.42,Systemic lupus erythematosus,dermatologic,OPGS000576,0.102,SomaScan,Interleukin-21,0.77 (0.71 0.83),2.34E-07
695.42,Systemic lupus erythematosus,dermatologic,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,1.32 (1.21 1.45),7.65E-07
695.42,Systemic lupus erythematosus,dermatologic,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.77 (0.71 0.84),1.59E-06
695.42,Systemic lupus erythematosus,dermatologic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.77 (0.71 0.84),4.79E-06
695.42,Systemic lupus erythematosus,dermatologic,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,0.79 (0.72 0.86),9.39E-06
695.42,Systemic lupus erythematosus,dermatologic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.28 (1.18 1.40),1.46E-05
695.42,Systemic lupus erythematosus,dermatologic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.27 (1.16 1.38),1.88E-05
695.42,Systemic lupus erythematosus,dermatologic,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.79 (0.72 0.86),2.66E-05
695.42,Systemic lupus erythematosus,dermatologic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.77 (0.70 0.85),3.49E-05
695.42,Systemic lupus erythematosus,dermatologic,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,0.81 (0.74 0.89),1.05E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS000984,0.055,SomaScan,Complement C2,1.25 (1.13 1.37),1.41E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.21 (1.11 1.32),2.87E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,0.83 (0.76 0.91),1.05E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.19 (1.09 1.30),1.51E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.83 (0.76 0.91),1.62E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.18 (1.08 1.29),2.56E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS001883,0.015,SomaScan,UMP-CMP kinase,0.83 (0.75 0.91),2.68E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS000691,0.086,SomaScan,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,1.20 (1.09 1.31),2.69E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.82 (0.75 0.91),2.95E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS001550,0.024,SomaScan,Trefoil factor 3,0.82 (0.74 0.91),3.93E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.19 (1.08 1.30),4.48E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS000645,0.091,SomaScan,Trypsin-3,1.19 (1.08 1.30),4.55E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS002568,0.043,Olink,Granzyme A,0.80 (0.73 0.87),9.69E-05
695.42,Systemic lupus erythematosus,dermatologic,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.81 (0.74 0.88),7.22E-04
695.42,Systemic lupus erythematosus,dermatologic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.83 (0.76 0.90),5.51E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS002428,0.212,Olink,Secreted frizzled-related protein 3,0.84 (0.76 0.92),2.30E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS003031,0.026,Metabolon,X - 21312,1.19 (1.09 1.29),1.60E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS002813,0.087,Metabolon,histidylalanine,0.83 (0.76 0.92),2.20E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS011784,0.044,RNAseq,TUBB,1.40 (1.28 1.54),3.57E-09
695.42,Systemic lupus erythematosus,dermatologic,OPGS010826,0.056,RNAseq,TRIM10,0.76 (0.70 0.82),2.26E-08
695.42,Systemic lupus erythematosus,dermatologic,OPGS010693,0.058,RNAseq,TRBV5-1,1.34 (1.23 1.46),2.26E-08
695.42,Systemic lupus erythematosus,dermatologic,OPGS007675,0.126,RNAseq,TRAV12-2,1.33 (1.22 1.44),4.96E-08
695.42,Systemic lupus erythematosus,dermatologic,OPGS013225,0.029,RNAseq,REG4,0.75 (0.69 0.82),5.57E-08
695.42,Systemic lupus erythematosus,dermatologic,OPGS006845,0.158,RNAseq,FLOT1,1.32 (1.22 1.44),5.57E-08
695.42,Systemic lupus erythematosus,dermatologic,OPGS013243,0.029,RNAseq,TRAV3,0.76 (0.70 0.83),1.87E-07
695.42,Systemic lupus erythematosus,dermatologic,OPGS012006,0.041,RNAseq,VARS2,0.76 (0.70 0.83),1.87E-07
695.42,Systemic lupus erythematosus,dermatologic,OPGS005230,0.263,RNAseq,LINC00243,1.33 (1.22 1.45),2.47E-07
695.42,Systemic lupus erythematosus,dermatologic,OPGS010607,0.059,RNAseq,TRAV8-1,1.31 (1.20 1.43),5.41E-07
695.42,Systemic lupus erythematosus,dermatologic,OPGS006716,0.164,RNAseq,IER3,1.31 (1.20 1.43),7.37E-07
695.42,Systemic lupus erythematosus,dermatologic,OPGS011283,0.050,RNAseq,CD248,0.76 (0.70 0.83),1.23E-06
695.42,Systemic lupus erythematosus,dermatologic,OPGS006866,0.157,RNAseq,AL662795.2,1.33 (1.21 1.46),1.26E-06
695.42,Systemic lupus erythematosus,dermatologic,OPGS013045,0.030,RNAseq,NEU1,0.78 (0.71 0.84),1.31E-06
695.42,Systemic lupus erythematosus,dermatologic,OPGS006248,0.189,RNAseq,MCCD1,0.76 (0.70 0.83),1.31E-06
695.42,Systemic lupus erythematosus,dermatologic,OPGS003843,0.532,RNAseq,BTN3A2,0.79 (0.73 0.85),1.31E-06
695.42,Systemic lupus erythematosus,dermatologic,OPGS014496,0.019,RNAseq,VARS1,1.27 (1.17 1.37),1.70E-06
695.42,Systemic lupus erythematosus,dermatologic,OPGS009371,0.082,RNAseq,TRBV19,0.76 (0.69 0.83),2.22E-06
695.42,Systemic lupus erythematosus,dermatologic,OPGS003680,0.611,RNAseq,,1.26 (1.16 1.36),9.39E-06
695.42,Systemic lupus erythematosus,dermatologic,OPGS012093,0.040,RNAseq,TRIM26,1.29 (1.18 1.41),9.39E-06
695.42,Systemic lupus erythematosus,dermatologic,OPGS013699,0.025,RNAseq,TRAV5,0.77 (0.71 0.85),1.60E-05
695.42,Systemic lupus erythematosus,dermatologic,OPGS014283,0.021,RNAseq,MXRA8,0.77 (0.70 0.85),1.82E-05
695.42,Systemic lupus erythematosus,dermatologic,OPGS015030,0.016,RNAseq,PRRC2A,0.78 (0.71 0.85),2.26E-05
695.42,Systemic lupus erythematosus,dermatologic,OPGS007297,0.140,RNAseq,GPANK1,0.75 (0.67 0.83),2.26E-05
695.42,Systemic lupus erythematosus,dermatologic,OPGS006942,0.154,RNAseq,SKIV2L,0.77 (0.70 0.84),2.26E-05
695.42,Systemic lupus erythematosus,dermatologic,OPGS012358,0.037,RNAseq,SFRP5,0.78 (0.71 0.85),3.31E-05
695.42,Systemic lupus erythematosus,dermatologic,OPGS004406,0.369,RNAseq,,0.78 (0.72 0.86),5.18E-05
695.42,Systemic lupus erythematosus,dermatologic,OPGS008402,0.104,RNAseq,TNXB,0.78 (0.71 0.86),1.13E-04
695.42,Systemic lupus erythematosus,dermatologic,OPGS009865,0.072,RNAseq,TRAV17,0.81 (0.74 0.88),2.46E-04
695.42,Systemic lupus erythematosus,dermatologic,OPGS007248,0.141,RNAseq,,0.77 (0.69 0.86),3.66E-04
695.42,Systemic lupus erythematosus,dermatologic,OPGS003620,0.668,RNAseq,ZFP57,1.23 (1.13 1.33),4.98E-04
695.42,Systemic lupus erythematosus,dermatologic,OPGS014232,0.021,RNAseq,TRAV1-2,0.80 (0.73 0.88),6.88E-04
695.42,Systemic lupus erythematosus,dermatologic,OPGS010564,0.060,RNAseq,CEACAM6,0.81 (0.74 0.89),1.18E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS010475,0.061,RNAseq,ZNRD1,0.81 (0.74 0.89),1.58E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS006499,0.176,RNAseq,C4A,0.83 (0.76 0.90),1.59E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS005334,0.253,RNAseq,AL645933.4,0.82 (0.75 0.89),1.60E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS013013,0.031,RNAseq,FOXJ1,0.83 (0.77 0.90),2.79E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS004334,0.383,RNAseq,HLA-G,0.81 (0.74 0.89),2.79E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS003621,0.665,RNAseq,,0.82 (0.75 0.90),5.31E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS009222,0.085,RNAseq,,0.83 (0.77 0.91),6.21E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS015052,0.015,RNAseq,CISH,1.21 (1.10 1.33),9.62E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS009920,0.071,RNAseq,LINC02446,0.83 (0.76 0.91),9.62E-03
695.42,Systemic lupus erythematosus,dermatologic,OPGS013958,0.023,RNAseq,CSNK2B,1.21 (1.11 1.33),1.09E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS012636,0.034,RNAseq,KIR2DL3,1.18 (1.09 1.28),1.39E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS011472,0.047,RNAseq,FEZ1,0.84 (0.77 0.91),1.41E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS004489,0.357,RNAseq,,0.83 (0.75 0.91),1.49E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS010561,0.060,RNAseq,IL2RA,1.19 (1.09 1.30),1.49E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS010929,0.055,RNAseq,EOMES,0.83 (0.76 0.91),1.69E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS010142,0.067,RNAseq,PRSS16,1.17 (1.08 1.27),1.81E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS004164,0.418,RNAseq,IRF5,1.20 (1.09 1.31),1.82E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS013406,0.027,RNAseq,AL353759.1,1.21 (1.10 1.32),2.16E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS009198,0.085,RNAseq,TRAV12-1,1.19 (1.09 1.30),2.16E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS011944,0.042,RNAseq,LINC01578,1.17 (1.08 1.27),2.20E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS007439,0.134,RNAseq,SKAP1,1.18 (1.09 1.29),2.45E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS008268,0.107,RNAseq,CD4,1.20 (1.09 1.32),2.47E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS013780,0.024,RNAseq,ZSCAN16,1.18 (1.08 1.28),2.61E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS010615,0.059,RNAseq,SIGLEC1,1.20 (1.09 1.31),2.62E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS011151,0.052,RNAseq,HADH,1.16 (1.07 1.25),2.90E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS009024,0.089,RNAseq,MYO1C,0.86 (0.79 0.93),2.93E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS014443,0.019,RNAseq,ABCB1,0.84 (0.77 0.92),3.61E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS011787,0.044,RNAseq,C2,1.18 (1.08 1.29),3.61E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS007407,0.135,RNAseq,TRBV2,1.17 (1.07 1.28),4.72E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS013429,0.027,RNAseq,AC004492.1,1.15 (1.07 1.24),4.72E-02
695.42,Systemic lupus erythematosus,dermatologic,OPGS013201,0.029,RNAseq,NRCAM,0.84 (0.76 0.92),4.72E-02
695.7,Prurigo and Lichen,dermatologic,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.81 (0.76 0.86),1.27E-06
695.7,Prurigo and Lichen,dermatologic,OPGS000984,0.055,SomaScan,Complement C2,1.20 (1.13 1.27),2.69E-05
695.7,Prurigo and Lichen,dermatologic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.88 (0.83 0.93),1.31E-02
695.7,Prurigo and Lichen,dermatologic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.13 (1.07 1.19),1.66E-02
695.7,Prurigo and Lichen,dermatologic,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.12 (1.06 1.18),3.96E-02
695.7,Prurigo and Lichen,dermatologic,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.87 (0.82 0.92),6.11E-03
695.7,Prurigo and Lichen,dermatologic,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.88 (0.83 0.93),8.25E-03
695.7,Prurigo and Lichen,dermatologic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.88 (0.84 0.93),1.51E-02
695.7,Prurigo and Lichen,dermatologic,OPGS010385,0.063,RNAseq,DNAJC10,0.86 (0.82 0.91),1.02E-03
695.7,Prurigo and Lichen,dermatologic,OPGS006911,0.155,RNAseq,RPS6KA2,0.86 (0.81 0.91),1.83E-03
695.7,Prurigo and Lichen,dermatologic,OPGS006499,0.176,RNAseq,C4A,0.88 (0.83 0.92),3.95E-03
695.7,Prurigo and Lichen,dermatologic,OPGS014496,0.019,RNAseq,VARS1,1.13 (1.07 1.19),8.25E-03
695.7,Prurigo and Lichen,dermatologic,OPGS013243,0.029,RNAseq,TRAV3,0.88 (0.83 0.93),8.25E-03
695.7,Prurigo and Lichen,dermatologic,OPGS003928,0.495,RNAseq,RNASET2,0.88 (0.83 0.93),1.10E-02
695.7,Prurigo and Lichen,dermatologic,OPGS009865,0.072,RNAseq,TRAV17,0.88 (0.84 0.93),1.31E-02
695.7,Prurigo and Lichen,dermatologic,OPGS009300,0.083,RNAseq,TRAV26-1,0.89 (0.84 0.94),1.51E-02
695.7,Prurigo and Lichen,dermatologic,OPGS013648,0.025,RNAseq,RN7SL491P,1.12 (1.06 1.18),1.79E-02
695.7,Prurigo and Lichen,dermatologic,OPGS004122,0.430,RNAseq,HLA-DRB5,0.88 (0.83 0.93),2.01E-02
695.7,Prurigo and Lichen,dermatologic,OPGS007675,0.126,RNAseq,TRAV12-2,1.13 (1.07 1.19),2.04E-02
695.7,Prurigo and Lichen,dermatologic,OPGS009198,0.085,RNAseq,TRAV12-1,1.13 (1.07 1.19),2.12E-02
696.4,Psoriasis,dermatologic,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,1.38 (1.35 1.42),4.20E-127
696.4,Psoriasis,dermatologic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,1.41 (1.37 1.45),1.41E-103
696.4,Psoriasis,dermatologic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,1.36 (1.32 1.41),1.10E-61
696.4,Psoriasis,dermatologic,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,0.73 (0.70 0.75),1.89E-61
696.4,Psoriasis,dermatologic,OPGS001883,0.015,SomaScan,UMP-CMP kinase,1.31 (1.27 1.35),9.85E-58
696.4,Psoriasis,dermatologic,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,1.20 (1.16 1.25),2.81E-21
696.4,Psoriasis,dermatologic,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,1.18 (1.14 1.22),3.44E-20
696.4,Psoriasis,dermatologic,OPGS000576,0.102,SomaScan,Interleukin-21,1.20 (1.15 1.24),5.68E-18
696.4,Psoriasis,dermatologic,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,0.84 (0.81 0.87),1.15E-17
696.4,Psoriasis,dermatologic,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.16 (1.12 1.20),2.30E-12
696.4,Psoriasis,dermatologic,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.15 (1.11 1.19),8.40E-11
696.4,Psoriasis,dermatologic,OPGS001102,0.046,SomaScan,Granzyme A,1.15 (1.11 1.19),1.39E-10
696.4,Psoriasis,dermatologic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,1.15 (1.11 1.20),1.39E-10
696.4,Psoriasis,dermatologic,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.88 (0.85 0.91),4.46E-10
696.4,Psoriasis,dermatologic,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,1.13 (1.09 1.17),1.45E-08
696.4,Psoriasis,dermatologic,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.12 (1.08 1.16),5.20E-07
696.4,Psoriasis,dermatologic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,1.12 (1.08 1.16),6.44E-07
696.4,Psoriasis,dermatologic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,1.11 (1.07 1.16),4.16E-06
696.4,Psoriasis,dermatologic,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.11 (1.07 1.15),5.52E-06
696.4,Psoriasis,dermatologic,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,0.90 (0.87 0.94),7.81E-06
696.4,Psoriasis,dermatologic,OPGS000645,0.091,SomaScan,Trypsin-3,1.11 (1.07 1.15),9.80E-06
696.4,Psoriasis,dermatologic,OPGS002103,0.012,SomaScan,Trefoil factor 3,0.90 (0.86 0.93),2.25E-05
696.4,Psoriasis,dermatologic,OPGS000531,0.111,SomaScan,Cadherin-7,1.10 (1.06 1.14),4.50E-05
696.4,Psoriasis,dermatologic,OPGS000986,0.054,SomaScan,Solute carrier family 22 member 16,1.09 (1.05 1.13),3.49E-04
696.4,Psoriasis,dermatologic,OPGS001550,0.024,SomaScan,Trefoil factor 3,0.91 (0.87 0.95),4.14E-04
696.4,Psoriasis,dermatologic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,0.92 (0.89 0.96),2.26E-03
696.4,Psoriasis,dermatologic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,0.92 (0.89 0.96),2.86E-03
696.4,Psoriasis,dermatologic,OPGS000538,0.109,SomaScan,Cyclic AMP-responsive element-binding protein 3-like protein 4,0.92 (0.89 0.96),5.47E-03
696.4,Psoriasis,dermatologic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,1.08 (1.04 1.12),8.84E-03
696.4,Psoriasis,dermatologic,OPGS000290,0.171,SomaScan,Complement C4,1.08 (1.04 1.12),9.16E-03
696.4,Psoriasis,dermatologic,OPGS000763,0.077,SomaScan,Trypsin-2,0.93 (0.90 0.97),1.29E-02
696.4,Psoriasis,dermatologic,OPGS001200,0.039,SomaScan,DnaJ homolog subfamily B member 11,1.07 (1.03 1.11),1.92E-02
696.4,Psoriasis,dermatologic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,1.07 (1.03 1.11),2.32E-02
696.4,Psoriasis,dermatologic,OPGS001598,0.022,SomaScan,SPARC,1.07 (1.03 1.11),2.34E-02
696.4,Psoriasis,dermatologic,OPGS000391,0.141,SomaScan,T-cell surface glycoprotein CD3 epsilon chain,1.07 (1.03 1.11),2.65E-02
696.4,Psoriasis,dermatologic,OPGS000184,0.253,SomaScan,Granulysin,0.93 (0.90 0.97),2.75E-02
696.4,Psoriasis,dermatologic,OPGS001727,0.019,SomaScan,Apolipoprotein F,1.08 (1.03 1.12),3.38E-02
696.4,Psoriasis,dermatologic,OPGS002299,0.010,SomaScan,Cytochrome P450 3A4,0.95 (0.92 0.98),3.96E-02
696.4,Psoriasis,dermatologic,OPGS000046,0.516,SomaScan,Endoplasmic reticulum aminopeptidase 1,1.07 (1.03 1.11),4.98E-02
696.4,Psoriasis,dermatologic,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,1.25 (1.21 1.30),3.90E-35
696.4,Psoriasis,dermatologic,OPGS002658,0.013,Olink,C-C motif chemokine 22,1.18 (1.14 1.23),1.95E-16
696.4,Psoriasis,dermatologic,OPGS002568,0.043,Olink,Granzyme A,1.14 (1.10 1.19),3.80E-10
696.4,Psoriasis,dermatologic,OPGS002530,0.067,Olink,Trefoil factor 3,0.89 (0.86 0.93),4.06E-06
696.4,Psoriasis,dermatologic,OPGS002643,0.018,Olink,Neuroblastoma suppressor of tumorigenicity 1,1.11 (1.07 1.15),1.75E-05
696.4,Psoriasis,dermatologic,OPGS002581,0.038,Olink,Fractalkine,0.92 (0.89 0.96),1.78E-03
696.4,Psoriasis,dermatologic,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,1.08 (1.04 1.12),4.62E-03
696.4,Psoriasis,dermatologic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.93 (0.90 0.96),1.09E-02
696.4,Psoriasis,dermatologic,OPGS002559,0.048,Olink,C-C motif chemokine 19,1.07 (1.03 1.11),2.54E-02
696.4,Psoriasis,dermatologic,OPGS011287,0.050,RNAseq,,1.42 (1.37 1.46),3.72E-106
696.4,Psoriasis,dermatologic,OPGS005433,0.244,RNAseq,MICB,0.75 (0.73 0.77),1.68E-81
696.4,Psoriasis,dermatologic,OPGS010624,0.059,RNAseq,TRBV18,1.39 (1.34 1.44),7.64E-64
696.4,Psoriasis,dermatologic,OPGS004567,0.343,RNAseq,HLA-C,1.32 (1.28 1.37),1.48E-54
696.4,Psoriasis,dermatologic,OPGS012761,0.033,RNAseq,TRAV12-3,0.79 (0.76 0.81),6.43E-47
696.4,Psoriasis,dermatologic,OPGS009711,0.075,RNAseq,TRAV21,1.28 (1.24 1.33),1.26E-41
696.4,Psoriasis,dermatologic,OPGS007764,0.123,RNAseq,HLA-E,1.30 (1.25 1.35),2.03E-39
696.4,Psoriasis,dermatologic,OPGS012855,0.032,RNAseq,TRBV9,0.78 (0.75 0.81),5.78E-38
696.4,Psoriasis,dermatologic,OPGS007446,0.134,RNAseq,AL645939.6,1.28 (1.23 1.33),1.53E-31
696.4,Psoriasis,dermatologic,OPGS005918,0.208,RNAseq,DDR1,1.23 (1.19 1.27),2.11E-31
696.4,Psoriasis,dermatologic,OPGS006845,0.158,RNAseq,FLOT1,0.79 (0.76 0.82),7.08E-31
696.4,Psoriasis,dermatologic,OPGS003680,0.611,RNAseq,,1.23 (1.19 1.27),7.57E-31
696.4,Psoriasis,dermatologic,OPGS004406,0.369,RNAseq,,1.24 (1.20 1.29),7.07E-30
696.4,Psoriasis,dermatologic,OPGS007018,0.151,RNAseq,TRBV10-3,0.82 (0.79 0.85),1.61E-27
696.4,Psoriasis,dermatologic,OPGS013201,0.029,RNAseq,NRCAM,1.22 (1.18 1.26),1.61E-27
696.4,Psoriasis,dermatologic,OPGS013896,0.023,RNAseq,ATF6B,0.82 (0.79 0.85),5.70E-27
696.4,Psoriasis,dermatologic,OPGS003621,0.665,RNAseq,,1.23 (1.18 1.27),2.46E-26
696.4,Psoriasis,dermatologic,OPGS011283,0.050,RNAseq,CD248,1.23 (1.19 1.28),3.67E-26
696.4,Psoriasis,dermatologic,OPGS011536,0.047,RNAseq,TRAV2,1.20 (1.16 1.25),7.45E-22
696.4,Psoriasis,dermatologic,OPGS012012,0.041,RNAseq,STK19,0.87 (0.85 0.89),8.30E-21
696.4,Psoriasis,dermatologic,OPGS013225,0.029,RNAseq,REG4,1.20 (1.16 1.25),2.00E-19
696.4,Psoriasis,dermatologic,OPGS013045,0.030,RNAseq,NEU1,1.20 (1.16 1.25),1.34E-18
696.4,Psoriasis,dermatologic,OPGS010348,0.063,RNAseq,TRBV6-5,1.19 (1.14 1.23),3.68E-18
696.4,Psoriasis,dermatologic,OPGS010492,0.061,RNAseq,HCG18,0.83 (0.80 0.86),5.07E-18
696.4,Psoriasis,dermatologic,OPGS004956,0.291,RNAseq,,0.85 (0.82 0.88),1.29E-17
696.4,Psoriasis,dermatologic,OPGS009176,0.086,RNAseq,,1.19 (1.14 1.23),2.54E-17
696.4,Psoriasis,dermatologic,OPGS005519,0.236,RNAseq,AL645933.3,0.86 (0.83 0.89),9.98E-16
696.4,Psoriasis,dermatologic,OPGS015030,0.016,RNAseq,PRRC2A,1.17 (1.13 1.22),2.09E-15
696.4,Psoriasis,dermatologic,OPGS014758,0.017,RNAseq,TRAV10,1.19 (1.14 1.23),8.47E-15
696.4,Psoriasis,dermatologic,OPGS011853,0.043,RNAseq,TRBV6-1,0.85 (0.82 0.89),1.74E-14
696.4,Psoriasis,dermatologic,OPGS007248,0.141,RNAseq,,1.14 (1.10 1.18),4.72E-13
696.4,Psoriasis,dermatologic,OPGS006716,0.164,RNAseq,IER3,0.87 (0.83 0.90),1.18E-11
696.4,Psoriasis,dermatologic,OPGS010929,0.055,RNAseq,EOMES,1.14 (1.10 1.18),4.75E-11
696.4,Psoriasis,dermatologic,OPGS010561,0.060,RNAseq,IL2RA,0.87 (0.84 0.90),1.31E-10
696.4,Psoriasis,dermatologic,OPGS014059,0.022,RNAseq,BCL2,0.89 (0.86 0.92),6.96E-09
696.4,Psoriasis,dermatologic,OPGS012698,0.034,RNAseq,SNHG32,1.12 (1.08 1.16),1.90E-08
696.4,Psoriasis,dermatologic,OPGS009920,0.071,RNAseq,LINC02446,1.12 (1.08 1.16),1.34E-07
696.4,Psoriasis,dermatologic,OPGS010475,0.061,RNAseq,ZNRD1,1.12 (1.08 1.16),1.63E-07
696.4,Psoriasis,dermatologic,OPGS006248,0.189,RNAseq,MCCD1,1.12 (1.08 1.16),2.55E-07
696.4,Psoriasis,dermatologic,OPGS013305,0.028,RNAseq,TRBV14,1.12 (1.08 1.17),3.98E-07
696.4,Psoriasis,dermatologic,OPGS007675,0.126,RNAseq,TRAV12-2,0.89 (0.86 0.93),4.03E-07
696.4,Psoriasis,dermatologic,OPGS013437,0.027,RNAseq,TRAV29DV5,1.11 (1.07 1.15),5.73E-07
696.4,Psoriasis,dermatologic,OPGS007691,0.126,RNAseq,HLA-DRB1,0.90 (0.87 0.93),9.02E-07
696.4,Psoriasis,dermatologic,OPGS007138,0.146,RNAseq,HCG27,1.11 (1.07 1.15),9.44E-07
696.4,Psoriasis,dermatologic,OPGS007384,0.137,RNAseq,HLA-B,1.12 (1.08 1.16),1.24E-06
696.4,Psoriasis,dermatologic,OPGS011585,0.046,RNAseq,CD8B,1.11 (1.07 1.15),3.94E-06
696.4,Psoriasis,dermatologic,OPGS011716,0.045,RNAseq,FBLN7,0.90 (0.87 0.94),6.28E-06
696.4,Psoriasis,dermatologic,OPGS010965,0.054,RNAseq,H4C12,1.09 (1.06 1.13),9.62E-06
696.4,Psoriasis,dermatologic,OPGS014443,0.019,RNAseq,ABCB1,1.10 (1.06 1.14),9.80E-06
696.4,Psoriasis,dermatologic,OPGS005230,0.263,RNAseq,LINC00243,0.90 (0.87 0.94),1.00E-05
696.4,Psoriasis,dermatologic,OPGS013383,0.027,RNAseq,PPP1R11,0.89 (0.86 0.93),1.07E-05
696.4,Psoriasis,dermatologic,OPGS009222,0.085,RNAseq,,0.91 (0.88 0.94),1.78E-05
696.4,Psoriasis,dermatologic,OPGS006940,0.154,RNAseq,,1.10 (1.06 1.14),1.89E-05
696.4,Psoriasis,dermatologic,OPGS013959,0.023,RNAseq,TMEM131,0.90 (0.87 0.94),1.98E-05
696.4,Psoriasis,dermatologic,OPGS010693,0.058,RNAseq,TRBV5-1,0.91 (0.87 0.94),2.97E-05
696.4,Psoriasis,dermatologic,OPGS011787,0.044,RNAseq,C2,0.91 (0.88 0.94),4.06E-05
696.4,Psoriasis,dermatologic,OPGS007407,0.135,RNAseq,TRBV2,0.91 (0.87 0.94),4.41E-05
696.4,Psoriasis,dermatologic,OPGS003620,0.668,RNAseq,ZFP57,1.10 (1.06 1.13),8.19E-05
696.4,Psoriasis,dermatologic,OPGS009672,0.076,RNAseq,CALR,0.91 (0.88 0.95),1.08E-04
696.4,Psoriasis,dermatologic,OPGS004716,0.322,RNAseq,RPS18,0.92 (0.89 0.95),1.92E-04
696.4,Psoriasis,dermatologic,OPGS013660,0.025,RNAseq,CD8A,1.09 (1.06 1.13),2.17E-04
696.4,Psoriasis,dermatologic,OPGS004334,0.383,RNAseq,HLA-G,0.92 (0.88 0.95),4.12E-04
696.4,Psoriasis,dermatologic,OPGS008162,0.110,RNAseq,,0.92 (0.89 0.96),7.28E-04
696.4,Psoriasis,dermatologic,OPGS011671,0.045,RNAseq,MICA,1.08 (1.05 1.12),7.59E-04
696.4,Psoriasis,dermatologic,OPGS012521,0.035,RNAseq,HERC5,1.09 (1.05 1.13),8.30E-04
696.4,Psoriasis,dermatologic,OPGS009841,0.072,RNAseq,PDGFRB,1.09 (1.05 1.13),9.00E-04
696.4,Psoriasis,dermatologic,OPGS013699,0.025,RNAseq,TRAV5,1.08 (1.05 1.12),1.58E-03
696.4,Psoriasis,dermatologic,OPGS009300,0.083,RNAseq,TRAV26-1,0.92 (0.89 0.96),2.13E-03
696.4,Psoriasis,dermatologic,OPGS013595,0.026,RNAseq,NINJ2,1.09 (1.05 1.13),2.21E-03
696.4,Psoriasis,dermatologic,OPGS010151,0.066,RNAseq,TAGAP,0.93 (0.90 0.96),2.43E-03
696.4,Psoriasis,dermatologic,OPGS011010,0.054,RNAseq,TRBV5-4,0.92 (0.89 0.96),2.46E-03
696.4,Psoriasis,dermatologic,OPGS004195,0.413,RNAseq,TRIM27,1.08 (1.04 1.12),4.56E-03
696.4,Psoriasis,dermatologic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.93 (0.90 0.96),4.62E-03
696.4,Psoriasis,dermatologic,OPGS008073,0.114,RNAseq,,1.09 (1.04 1.13),7.14E-03
696.4,Psoriasis,dermatologic,OPGS010779,0.057,RNAseq,ACE,0.93 (0.89 0.96),7.41E-03
696.4,Psoriasis,dermatologic,OPGS008402,0.104,RNAseq,TNXB,1.08 (1.04 1.11),7.41E-03
696.4,Psoriasis,dermatologic,OPGS009669,0.076,RNAseq,CRTAM,1.08 (1.04 1.12),7.57E-03
696.4,Psoriasis,dermatologic,OPGS011948,0.042,RNAseq,ADGRG1,1.08 (1.04 1.12),8.06E-03
696.4,Psoriasis,dermatologic,OPGS007711,0.125,RNAseq,HMOX1,0.93 (0.90 0.96),8.62E-03
696.4,Psoriasis,dermatologic,OPGS008786,0.094,RNAseq,GABBR1,1.08 (1.04 1.12),8.88E-03
696.4,Psoriasis,dermatologic,OPGS014249,0.021,RNAseq,IFI6,1.08 (1.04 1.12),9.12E-03
696.4,Psoriasis,dermatologic,OPGS010533,0.060,RNAseq,STXBP1,1.08 (1.04 1.11),1.15E-02
696.4,Psoriasis,dermatologic,OPGS011732,0.044,RNAseq,LRRC43,1.07 (1.03 1.11),2.14E-02
696.4,Psoriasis,dermatologic,OPGS010564,0.060,RNAseq,CEACAM6,1.07 (1.03 1.11),2.23E-02
696.4,Psoriasis,dermatologic,OPGS005198,0.266,RNAseq,RBCK1,1.07 (1.03 1.11),2.45E-02
696.4,Psoriasis,dermatologic,OPGS008699,0.097,RNAseq,DUSP4,0.94 (0.90 0.97),3.09E-02
696.4,Psoriasis,dermatologic,OPGS014158,0.021,RNAseq,DNAJC4,1.07 (1.03 1.10),3.09E-02
696.4,Psoriasis,dermatologic,OPGS007337,0.138,RNAseq,MED21,1.07 (1.03 1.11),3.40E-02
696.4,Psoriasis,dermatologic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.07 (1.03 1.12),3.66E-02
696.4,Psoriasis,dermatologic,OPGS012951,0.031,RNAseq,MRPL4,0.93 (0.90 0.97),3.83E-02
696.4,Psoriasis,dermatologic,OPGS009962,0.070,RNAseq,CCHCR1,0.94 (0.90 0.97),3.83E-02
696.4,Psoriasis,dermatologic,OPGS004489,0.357,RNAseq,,1.07 (1.03 1.11),3.83E-02
696.4,Psoriasis,dermatologic,OPGS012162,0.040,RNAseq,RSAD2,1.07 (1.03 1.11),4.50E-02
696.4,Psoriasis,dermatologic,OPGS010926,0.055,RNAseq,CACNA2D4,0.94 (0.91 0.97),4.71E-02
696.4,Psoriasis,dermatologic,OPGS004501,0.354,RNAseq,TBKBP1,0.94 (0.90 0.97),4.72E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,1.37 (1.33 1.40),1.17E-123
696.41,Psoriasis vulgaris,dermatologic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,1.39 (1.35 1.44),4.34E-101
696.41,Psoriasis vulgaris,dermatologic,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,0.73 (0.71 0.76),7.85E-62
696.41,Psoriasis vulgaris,dermatologic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,1.35 (1.30 1.40),3.43E-61
696.41,Psoriasis vulgaris,dermatologic,OPGS001883,0.015,SomaScan,UMP-CMP kinase,1.29 (1.25 1.33),1.22E-54
696.41,Psoriasis vulgaris,dermatologic,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,1.19 (1.15 1.23),5.15E-20
696.41,Psoriasis vulgaris,dermatologic,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,1.17 (1.13 1.20),1.65E-18
696.41,Psoriasis vulgaris,dermatologic,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,0.85 (0.82 0.88),3.24E-16
696.41,Psoriasis vulgaris,dermatologic,OPGS000576,0.102,SomaScan,Interleukin-21,1.17 (1.13 1.22),2.74E-15
696.41,Psoriasis vulgaris,dermatologic,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.15 (1.11 1.19),4.48E-12
696.41,Psoriasis vulgaris,dermatologic,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.88 (0.85 0.91),1.21E-10
696.41,Psoriasis vulgaris,dermatologic,OPGS001102,0.046,SomaScan,Granzyme A,1.14 (1.10 1.18),2.06E-10
696.41,Psoriasis vulgaris,dermatologic,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.14 (1.10 1.18),3.90E-10
696.41,Psoriasis vulgaris,dermatologic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,1.14 (1.10 1.18),2.39E-09
696.41,Psoriasis vulgaris,dermatologic,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.12 (1.08 1.17),6.02E-08
696.41,Psoriasis vulgaris,dermatologic,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,1.11 (1.08 1.15),2.34E-07
696.41,Psoriasis vulgaris,dermatologic,OPGS000645,0.091,SomaScan,Trypsin-3,1.12 (1.08 1.16),3.71E-07
696.41,Psoriasis vulgaris,dermatologic,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,0.90 (0.87 0.94),2.53E-06
696.41,Psoriasis vulgaris,dermatologic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,1.11 (1.07 1.15),5.60E-06
696.41,Psoriasis vulgaris,dermatologic,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.10 (1.06 1.14),3.77E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS002103,0.012,SomaScan,Trefoil factor 3,0.90 (0.87 0.94),5.30E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,1.10 (1.06 1.14),9.09E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS000531,0.111,SomaScan,Cadherin-7,1.10 (1.06 1.14),9.37E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS001550,0.024,SomaScan,Trefoil factor 3,0.91 (0.88 0.95),4.15E-04
696.41,Psoriasis vulgaris,dermatologic,OPGS000986,0.054,SomaScan,Solute carrier family 22 member 16,1.08 (1.05 1.12),1.59E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS000538,0.109,SomaScan,Cyclic AMP-responsive element-binding protein 3-like protein 4,0.92 (0.89 0.96),4.19E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,0.93 (0.90 0.96),9.37E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS000391,0.141,SomaScan,T-cell surface glycoprotein CD3 epsilon chain,1.07 (1.03 1.11),2.02E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS002299,0.010,SomaScan,Cytochrome P450 3A4,0.95 (0.92 0.97),2.16E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS001200,0.039,SomaScan,DnaJ homolog subfamily B member 11,1.07 (1.03 1.10),2.19E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS000290,0.171,SomaScan,Complement C4,1.07 (1.03 1.11),2.24E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,0.94 (0.90 0.97),2.57E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS000763,0.077,SomaScan,Trypsin-2,0.94 (0.90 0.97),2.92E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,1.07 (1.03 1.11),3.29E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS000665,0.088,SomaScan,Glutamate receptor ionotropic. delta-2,0.94 (0.90 0.97),3.39E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,0.94 (0.91 0.97),3.59E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS001598,0.022,SomaScan,SPARC,1.07 (1.03 1.11),3.96E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS000184,0.253,SomaScan,Granulysin,0.94 (0.90 0.97),4.20E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,1.24 (1.20 1.29),5.99E-35
696.41,Psoriasis vulgaris,dermatologic,OPGS002658,0.013,Olink,C-C motif chemokine 22,1.17 (1.13 1.21),1.86E-15
696.41,Psoriasis vulgaris,dermatologic,OPGS002568,0.043,Olink,Granzyme A,1.13 (1.09 1.17),3.14E-09
696.41,Psoriasis vulgaris,dermatologic,OPGS002530,0.067,Olink,Trefoil factor 3,0.90 (0.87 0.94),1.59E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS002643,0.018,Olink,Neuroblastoma suppressor of tumorigenicity 1,1.10 (1.06 1.14),4.17E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS002581,0.038,Olink,Fractalkine,0.92 (0.89 0.95),8.53E-04
696.41,Psoriasis vulgaris,dermatologic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.93 (0.90 0.97),1.24E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,1.07 (1.04 1.11),1.26E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS002559,0.048,Olink,C-C motif chemokine 19,1.07 (1.03 1.10),3.60E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS002454,0.157,Olink,Galectin-9,0.94 (0.91 0.97),4.09E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS002648,0.017,Olink,Collagen alpha-1,1.07 (1.03 1.11),4.68E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS002598,0.031,Olink,Interleukin-10,0.94 (0.90 0.97),4.95E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS011287,0.050,RNAseq,,1.40 (1.36 1.44),2.79E-103
696.41,Psoriasis vulgaris,dermatologic,OPGS005433,0.244,RNAseq,MICB,0.76 (0.74 0.78),1.71E-79
696.41,Psoriasis vulgaris,dermatologic,OPGS010624,0.059,RNAseq,TRBV18,1.37 (1.33 1.42),1.47E-63
696.41,Psoriasis vulgaris,dermatologic,OPGS004567,0.343,RNAseq,HLA-C,1.32 (1.28 1.36),1.82E-56
696.41,Psoriasis vulgaris,dermatologic,OPGS012761,0.033,RNAseq,TRAV12-3,0.79 (0.77 0.82),6.46E-47
696.41,Psoriasis vulgaris,dermatologic,OPGS009711,0.075,RNAseq,TRAV21,1.27 (1.23 1.32),5.48E-41
696.41,Psoriasis vulgaris,dermatologic,OPGS012855,0.032,RNAseq,TRBV9,0.79 (0.76 0.81),1.65E-38
696.41,Psoriasis vulgaris,dermatologic,OPGS007764,0.123,RNAseq,HLA-E,1.27 (1.22 1.32),1.16E-35
696.41,Psoriasis vulgaris,dermatologic,OPGS007446,0.134,RNAseq,AL645939.6,1.27 (1.22 1.32),4.62E-32
696.41,Psoriasis vulgaris,dermatologic,OPGS003680,0.611,RNAseq,,1.22 (1.19 1.26),5.85E-32
696.41,Psoriasis vulgaris,dermatologic,OPGS005918,0.208,RNAseq,DDR1,1.22 (1.18 1.26),1.60E-30
696.41,Psoriasis vulgaris,dermatologic,OPGS006845,0.158,RNAseq,FLOT1,0.80 (0.77 0.83),5.60E-30
696.41,Psoriasis vulgaris,dermatologic,OPGS004406,0.369,RNAseq,,1.23 (1.19 1.27),8.60E-29
696.41,Psoriasis vulgaris,dermatologic,OPGS013201,0.029,RNAseq,NRCAM,1.21 (1.17 1.25),4.18E-27
696.41,Psoriasis vulgaris,dermatologic,OPGS007018,0.151,RNAseq,TRBV10-3,0.83 (0.80 0.86),9.32E-27
696.41,Psoriasis vulgaris,dermatologic,OPGS011283,0.050,RNAseq,CD248,1.22 (1.18 1.27),9.85E-26
696.41,Psoriasis vulgaris,dermatologic,OPGS013896,0.023,RNAseq,ATF6B,0.83 (0.80 0.86),9.95E-25
696.41,Psoriasis vulgaris,dermatologic,OPGS003621,0.665,RNAseq,,1.21 (1.17 1.25),3.36E-24
696.41,Psoriasis vulgaris,dermatologic,OPGS011536,0.047,RNAseq,TRAV2,1.19 (1.15 1.23),1.60E-20
696.41,Psoriasis vulgaris,dermatologic,OPGS012012,0.041,RNAseq,STK19,0.87 (0.85 0.90),5.00E-20
696.41,Psoriasis vulgaris,dermatologic,OPGS010492,0.061,RNAseq,HCG18,0.83 (0.80 0.87),5.25E-18
696.41,Psoriasis vulgaris,dermatologic,OPGS013225,0.029,RNAseq,REG4,1.19 (1.14 1.23),9.54E-18
696.41,Psoriasis vulgaris,dermatologic,OPGS013045,0.030,RNAseq,NEU1,1.19 (1.14 1.23),2.36E-17
696.41,Psoriasis vulgaris,dermatologic,OPGS010348,0.063,RNAseq,TRBV6-5,1.17 (1.13 1.21),9.78E-17
696.41,Psoriasis vulgaris,dermatologic,OPGS004956,0.291,RNAseq,,0.86 (0.83 0.89),1.13E-16
696.41,Psoriasis vulgaris,dermatologic,OPGS005519,0.236,RNAseq,AL645933.3,0.86 (0.83 0.89),1.32E-16
696.41,Psoriasis vulgaris,dermatologic,OPGS009176,0.086,RNAseq,,1.17 (1.13 1.22),3.02E-16
696.41,Psoriasis vulgaris,dermatologic,OPGS011853,0.043,RNAseq,TRBV6-1,0.86 (0.83 0.89),6.50E-15
696.41,Psoriasis vulgaris,dermatologic,OPGS014758,0.017,RNAseq,TRAV10,1.18 (1.13 1.22),1.04E-14
696.41,Psoriasis vulgaris,dermatologic,OPGS015030,0.016,RNAseq,PRRC2A,1.16 (1.12 1.20),3.75E-14
696.41,Psoriasis vulgaris,dermatologic,OPGS007248,0.141,RNAseq,,1.14 (1.10 1.17),9.30E-13
696.41,Psoriasis vulgaris,dermatologic,OPGS010561,0.060,RNAseq,IL2RA,0.87 (0.84 0.90),1.67E-11
696.41,Psoriasis vulgaris,dermatologic,OPGS006716,0.164,RNAseq,IER3,0.87 (0.84 0.91),4.52E-11
696.41,Psoriasis vulgaris,dermatologic,OPGS010929,0.055,RNAseq,EOMES,1.14 (1.10 1.18),6.43E-11
696.41,Psoriasis vulgaris,dermatologic,OPGS014059,0.022,RNAseq,BCL2,0.89 (0.86 0.92),2.52E-09
696.41,Psoriasis vulgaris,dermatologic,OPGS012698,0.034,RNAseq,SNHG32,1.12 (1.08 1.16),1.65E-08
696.41,Psoriasis vulgaris,dermatologic,OPGS013437,0.027,RNAseq,TRAV29DV5,1.12 (1.08 1.15),4.05E-08
696.41,Psoriasis vulgaris,dermatologic,OPGS009920,0.071,RNAseq,LINC02446,1.12 (1.08 1.16),8.87E-08
696.41,Psoriasis vulgaris,dermatologic,OPGS010475,0.061,RNAseq,ZNRD1,1.11 (1.08 1.15),9.90E-08
696.41,Psoriasis vulgaris,dermatologic,OPGS013305,0.028,RNAseq,TRBV14,1.12 (1.08 1.16),1.81E-07
696.41,Psoriasis vulgaris,dermatologic,OPGS007138,0.146,RNAseq,HCG27,1.11 (1.08 1.15),3.34E-07
696.41,Psoriasis vulgaris,dermatologic,OPGS006248,0.189,RNAseq,MCCD1,1.11 (1.07 1.15),2.02E-06
696.41,Psoriasis vulgaris,dermatologic,OPGS014443,0.019,RNAseq,ABCB1,1.10 (1.07 1.14),3.12E-06
696.41,Psoriasis vulgaris,dermatologic,OPGS007675,0.126,RNAseq,TRAV12-2,0.90 (0.87 0.94),4.65E-06
696.41,Psoriasis vulgaris,dermatologic,OPGS007384,0.137,RNAseq,HLA-B,1.11 (1.07 1.15),5.49E-06
696.41,Psoriasis vulgaris,dermatologic,OPGS011716,0.045,RNAseq,FBLN7,0.91 (0.88 0.94),8.82E-06
696.41,Psoriasis vulgaris,dermatologic,OPGS003620,0.668,RNAseq,ZFP57,1.10 (1.06 1.14),8.82E-06
696.41,Psoriasis vulgaris,dermatologic,OPGS007691,0.126,RNAseq,HLA-DRB1,0.91 (0.88 0.94),1.27E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS010965,0.054,RNAseq,H4C12,1.09 (1.06 1.12),1.39E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS006940,0.154,RNAseq,,1.10 (1.06 1.13),1.43E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS011585,0.046,RNAseq,CD8B,1.10 (1.06 1.14),1.59E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS005230,0.263,RNAseq,LINC00243,0.91 (0.88 0.94),2.69E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS009672,0.076,RNAseq,CALR,0.91 (0.88 0.94),3.49E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS009222,0.085,RNAseq,,0.91 (0.88 0.94),3.56E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS013959,0.023,RNAseq,TMEM131,0.91 (0.88 0.94),4.27E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS007407,0.135,RNAseq,TRBV2,0.91 (0.88 0.95),9.09E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS013383,0.027,RNAseq,PPP1R11,0.90 (0.87 0.94),9.37E-05
696.41,Psoriasis vulgaris,dermatologic,OPGS011787,0.044,RNAseq,C2,0.91 (0.88 0.95),1.34E-04
696.41,Psoriasis vulgaris,dermatologic,OPGS010693,0.058,RNAseq,TRBV5-1,0.92 (0.89 0.95),4.27E-04
696.41,Psoriasis vulgaris,dermatologic,OPGS011671,0.045,RNAseq,MICA,1.08 (1.05 1.12),6.99E-04
696.41,Psoriasis vulgaris,dermatologic,OPGS009841,0.072,RNAseq,PDGFRB,1.09 (1.05 1.13),7.95E-04
696.41,Psoriasis vulgaris,dermatologic,OPGS004716,0.322,RNAseq,RPS18,0.93 (0.90 0.96),7.98E-04
696.41,Psoriasis vulgaris,dermatologic,OPGS013660,0.025,RNAseq,CD8A,1.08 (1.05 1.12),1.22E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS011948,0.042,RNAseq,ADGRG1,1.08 (1.04 1.12),1.90E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS004334,0.383,RNAseq,HLA-G,0.92 (0.89 0.96),1.95E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS009300,0.083,RNAseq,TRAV26-1,0.93 (0.90 0.96),3.14E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS013595,0.026,RNAseq,NINJ2,1.08 (1.04 1.12),4.19E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS008162,0.110,RNAseq,,0.93 (0.90 0.96),4.24E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS004195,0.413,RNAseq,TRIM27,1.08 (1.04 1.11),4.74E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS012521,0.035,RNAseq,HERC5,1.08 (1.04 1.12),4.94E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS011010,0.054,RNAseq,TRBV5-4,0.93 (0.90 0.96),5.72E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS005389,0.248,RNAseq,TRAV23DV6,0.93 (0.90 0.96),5.87E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS007337,0.138,RNAseq,MED21,1.08 (1.04 1.12),5.87E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS013699,0.025,RNAseq,TRAV5,1.08 (1.04 1.11),6.49E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS008402,0.104,RNAseq,TNXB,1.07 (1.04 1.11),8.16E-03
696.41,Psoriasis vulgaris,dermatologic,OPGS008786,0.094,RNAseq,GABBR1,1.08 (1.04 1.12),1.00E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS009669,0.076,RNAseq,CRTAM,1.07 (1.04 1.11),1.18E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS009962,0.070,RNAseq,CCHCR1,0.93 (0.90 0.97),1.33E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.08 (1.04 1.12),1.40E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS009855,0.072,RNAseq,LEXM,0.93 (0.90 0.97),1.54E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS010779,0.057,RNAseq,ACE,0.93 (0.90 0.97),1.55E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS004489,0.357,RNAseq,,1.07 (1.03 1.11),1.73E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS010564,0.060,RNAseq,CEACAM6,1.07 (1.03 1.11),1.76E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS003626,0.663,RNAseq,SLC22A18,1.07 (1.03 1.11),1.87E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS007711,0.125,RNAseq,HMOX1,0.94 (0.90 0.97),1.95E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS008073,0.114,RNAseq,,1.08 (1.04 1.12),2.02E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS008889,0.092,RNAseq,TRAV20,0.93 (0.90 0.97),2.34E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS008051,0.114,RNAseq,SLC27A3,1.06 (1.03 1.10),3.19E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS008699,0.097,RNAseq,DUSP4,0.94 (0.91 0.97),3.29E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS005198,0.266,RNAseq,RBCK1,1.06 (1.03 1.10),3.39E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS010926,0.055,RNAseq,CACNA2D4,0.94 (0.91 0.97),3.46E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS014398,0.020,RNAseq,,0.94 (0.91 0.97),3.70E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS010151,0.066,RNAseq,TAGAP,0.94 (0.91 0.97),3.71E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS011732,0.044,RNAseq,LRRC43,1.07 (1.03 1.10),3.94E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS014249,0.021,RNAseq,IFI6,1.07 (1.03 1.10),4.05E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS004452,0.363,RNAseq,LRRC25,0.94 (0.91 0.97),4.51E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS009083,0.088,RNAseq,ZBTB11-AS1,0.94 (0.91 0.97),4.77E-02
696.41,Psoriasis vulgaris,dermatologic,OPGS010845,0.056,RNAseq,RNF145,1.07 (1.03 1.10),4.95E-02
696.42,Psoriatic arthropathy,dermatologic,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,1.36 (1.31 1.42),1.74E-41
696.42,Psoriatic arthropathy,dermatologic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,1.34 (1.27 1.41),3.38E-25
696.42,Psoriatic arthropathy,dermatologic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,1.29 (1.22 1.37),6.12E-15
696.42,Psoriatic arthropathy,dermatologic,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,0.77 (0.72 0.82),9.06E-15
696.42,Psoriatic arthropathy,dermatologic,OPGS001883,0.015,SomaScan,UMP-CMP kinase,1.23 (1.16 1.30),6.24E-11
696.42,Psoriatic arthropathy,dermatologic,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,0.82 (0.78 0.87),3.80E-08
696.42,Psoriatic arthropathy,dermatologic,OPGS001550,0.024,SomaScan,Trefoil factor 3,0.80 (0.75 0.86),1.15E-06
696.42,Psoriatic arthropathy,dermatologic,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,1.20 (1.13 1.28),3.30E-06
696.42,Psoriatic arthropathy,dermatologic,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,0.84 (0.80 0.90),1.93E-05
696.42,Psoriatic arthropathy,dermatologic,OPGS002103,0.012,SomaScan,Trefoil factor 3,0.83 (0.78 0.90),3.08E-04
696.42,Psoriatic arthropathy,dermatologic,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.87 (0.82 0.92),1.10E-03
696.42,Psoriatic arthropathy,dermatologic,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.13 (1.06 1.20),2.08E-02
696.42,Psoriatic arthropathy,dermatologic,OPGS002530,0.067,Olink,Trefoil factor 3,0.84 (0.78 0.89),1.40E-04
696.42,Psoriatic arthropathy,dermatologic,OPGS003537,0.031,Nightingale,Glycoprotein acetyls,1.13 (1.07 1.20),1.85E-02
696.42,Psoriatic arthropathy,dermatologic,OPGS011287,0.050,RNAseq,,1.38 (1.32 1.46),4.27E-33
696.42,Psoriatic arthropathy,dermatologic,OPGS005433,0.244,RNAseq,MICB,0.75 (0.71 0.78),8.03E-32
696.42,Psoriatic arthropathy,dermatologic,OPGS012855,0.032,RNAseq,TRBV9,0.74 (0.70 0.79),2.33E-20
696.42,Psoriatic arthropathy,dermatologic,OPGS005519,0.236,RNAseq,AL645933.3,0.78 (0.74 0.82),5.76E-17
696.42,Psoriatic arthropathy,dermatologic,OPGS012761,0.033,RNAseq,TRAV12-3,0.79 (0.75 0.83),3.26E-15
696.42,Psoriatic arthropathy,dermatologic,OPGS003680,0.611,RNAseq,,1.26 (1.20 1.33),1.15E-14
696.42,Psoriatic arthropathy,dermatologic,OPGS007764,0.123,RNAseq,HLA-E,1.27 (1.19 1.35),1.46E-11
696.42,Psoriatic arthropathy,dermatologic,OPGS004567,0.343,RNAseq,HLA-C,1.24 (1.18 1.32),4.85E-11
696.42,Psoriatic arthropathy,dermatologic,OPGS009711,0.075,RNAseq,TRAV21,1.23 (1.16 1.31),6.35E-10
696.42,Psoriatic arthropathy,dermatologic,OPGS013896,0.023,RNAseq,ATF6B,0.83 (0.78 0.87),1.12E-08
696.42,Psoriatic arthropathy,dermatologic,OPGS010624,0.059,RNAseq,TRBV18,1.22 (1.15 1.30),3.80E-08
696.42,Psoriatic arthropathy,dermatologic,OPGS005918,0.208,RNAseq,DDR1,1.19 (1.13 1.26),2.37E-07
696.42,Psoriatic arthropathy,dermatologic,OPGS013201,0.029,RNAseq,NRCAM,1.18 (1.12 1.25),2.60E-06
696.42,Psoriatic arthropathy,dermatologic,OPGS013437,0.027,RNAseq,TRAV29DV5,1.18 (1.11 1.24),6.09E-06
696.42,Psoriatic arthropathy,dermatologic,OPGS004406,0.369,RNAseq,,1.18 (1.11 1.25),1.27E-05
696.42,Psoriatic arthropathy,dermatologic,OPGS007446,0.134,RNAseq,AL645939.6,1.19 (1.12 1.27),2.47E-05
696.42,Psoriatic arthropathy,dermatologic,OPGS006940,0.154,RNAseq,,1.16 (1.10 1.23),3.72E-05
696.42,Psoriatic arthropathy,dermatologic,OPGS009176,0.086,RNAseq,,1.17 (1.11 1.25),6.16E-05
696.42,Psoriatic arthropathy,dermatologic,OPGS011536,0.047,RNAseq,TRAV2,1.17 (1.10 1.24),7.65E-05
696.42,Psoriatic arthropathy,dermatologic,OPGS010492,0.061,RNAseq,HCG18,0.85 (0.79 0.90),1.40E-04
696.42,Psoriatic arthropathy,dermatologic,OPGS011283,0.050,RNAseq,CD248,1.17 (1.10 1.24),1.40E-04
696.42,Psoriatic arthropathy,dermatologic,OPGS003620,0.668,RNAseq,ZFP57,1.16 (1.09 1.22),2.05E-04
696.42,Psoriatic arthropathy,dermatologic,OPGS007248,0.141,RNAseq,,1.14 (1.08 1.20),2.89E-04
696.42,Psoriatic arthropathy,dermatologic,OPGS012521,0.035,RNAseq,HERC5,1.15 (1.08 1.22),1.30E-03
696.42,Psoriatic arthropathy,dermatologic,OPGS010929,0.055,RNAseq,EOMES,1.15 (1.08 1.21),1.46E-03
696.42,Psoriatic arthropathy,dermatologic,OPGS006248,0.189,RNAseq,MCCD1,1.15 (1.08 1.22),1.48E-03
696.42,Psoriatic arthropathy,dermatologic,OPGS012012,0.041,RNAseq,STK19,0.89 (0.85 0.94),1.61E-03
696.42,Psoriatic arthropathy,dermatologic,OPGS013243,0.029,RNAseq,TRAV3,0.88 (0.83 0.93),2.31E-03
696.42,Psoriatic arthropathy,dermatologic,OPGS013045,0.030,RNAseq,NEU1,1.14 (1.08 1.22),5.45E-03
696.42,Psoriatic arthropathy,dermatologic,OPGS008786,0.094,RNAseq,GABBR1,1.14 (1.07 1.22),8.13E-03
696.42,Psoriatic arthropathy,dermatologic,OPGS006845,0.158,RNAseq,FLOT1,0.88 (0.83 0.94),2.31E-02
696.42,Psoriatic arthropathy,dermatologic,OPGS007138,0.146,RNAseq,HCG27,1.12 (1.06 1.19),2.74E-02
696.42,Psoriatic arthropathy,dermatologic,OPGS006634,0.169,RNAseq,,0.89 (0.83 0.94),2.90E-02
696.42,Psoriatic arthropathy,dermatologic,OPGS005653,0.225,RNAseq,STARD3NL,1.13 (1.06 1.20),3.02E-02
696.42,Psoriatic arthropathy,dermatologic,OPGS015030,0.016,RNAseq,PRRC2A,1.12 (1.06 1.19),3.03E-02
696.42,Psoriatic arthropathy,dermatologic,OPGS014249,0.021,RNAseq,IFI6,1.13 (1.06 1.19),3.57E-02
696.42,Psoriatic arthropathy,dermatologic,OPGS011431,0.048,RNAseq,VWA7,0.89 (0.84 0.95),3.67E-02
696.42,Psoriatic arthropathy,dermatologic,OPGS008169,0.110,RNAseq,AC104695.3,1.12 (1.06 1.19),4.67E-02
696.42,Psoriatic arthropathy,dermatologic,OPGS013958,0.023,RNAseq,CSNK2B,0.90 (0.85 0.95),4.69E-02
697,Sarcoidosis,dermatologic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.81 (0.76 0.86),2.81E-07
697,Sarcoidosis,dermatologic,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,0.80 (0.75 0.86),3.35E-07
697,Sarcoidosis,dermatologic,OPGS000645,0.091,SomaScan,Trypsin-3,1.27 (1.18 1.37),3.67E-07
697,Sarcoidosis,dermatologic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.82 (0.77 0.88),2.38E-06
697,Sarcoidosis,dermatologic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.83 (0.78 0.89),2.87E-05
697,Sarcoidosis,dermatologic,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.22 (1.14 1.32),2.87E-05
697,Sarcoidosis,dermatologic,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.84 (0.78 0.89),1.13E-04
697,Sarcoidosis,dermatologic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.84 (0.79 0.90),1.40E-04
697,Sarcoidosis,dermatologic,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.85 (0.79 0.91),9.15E-04
697,Sarcoidosis,dermatologic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.17 (1.10 1.26),9.15E-04
697,Sarcoidosis,dermatologic,OPGS001221,0.037,SomaScan,Interleukin-23 receptor,1.17 (1.10 1.26),2.63E-03
697,Sarcoidosis,dermatologic,OPGS000290,0.171,SomaScan,Complement C4,0.85 (0.80 0.91),2.69E-03
697,Sarcoidosis,dermatologic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.86 (0.81 0.92),3.52E-03
697,Sarcoidosis,dermatologic,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.16 (1.08 1.24),4.72E-03
697,Sarcoidosis,dermatologic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.86 (0.81 0.92),5.39E-03
697,Sarcoidosis,dermatologic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.15 (1.07 1.23),1.41E-02
697,Sarcoidosis,dermatologic,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,1.14 (1.07 1.22),2.91E-02
697,Sarcoidosis,dermatologic,OPGS000538,0.109,SomaScan,Cyclic AMP-responsive element-binding protein 3-like protein 4,0.86 (0.80 0.93),3.18E-02
697,Sarcoidosis,dermatologic,OPGS002598,0.031,Olink,Interleukin-10,0.79 (0.73 0.86),1.21E-05
697,Sarcoidosis,dermatologic,OPGS002568,0.043,Olink,Granzyme A,0.84 (0.78 0.89),9.49E-05
697,Sarcoidosis,dermatologic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.87 (0.81 0.93),6.44E-03
697,Sarcoidosis,dermatologic,OPGS002529,0.068,Olink,Tumor necrosis factor receptor superfamily member 3,1.14 (1.07 1.21),7.09E-03
697,Sarcoidosis,dermatologic,OPGS003031,0.026,Metabolon,X - 21312,1.13 (1.06 1.21),4.90E-02
697,Sarcoidosis,dermatologic,OPGS014232,0.021,RNAseq,TRAV1-2,0.77 (0.72 0.83),1.04E-08
697,Sarcoidosis,dermatologic,OPGS008889,0.092,RNAseq,TRAV20,0.78 (0.73 0.84),5.59E-08
697,Sarcoidosis,dermatologic,OPGS010826,0.056,RNAseq,TRIM10,0.81 (0.76 0.86),2.06E-07
697,Sarcoidosis,dermatologic,OPGS012093,0.040,RNAseq,TRIM26,1.25 (1.17 1.34),3.63E-07
697,Sarcoidosis,dermatologic,OPGS014580,0.018,RNAseq,DACT1,1.27 (1.18 1.37),8.62E-07
697,Sarcoidosis,dermatologic,OPGS015052,0.015,RNAseq,CISH,1.25 (1.17 1.34),9.02E-07
697,Sarcoidosis,dermatologic,OPGS012358,0.037,RNAseq,SFRP5,0.81 (0.75 0.87),2.48E-06
697,Sarcoidosis,dermatologic,OPGS013958,0.023,RNAseq,CSNK2B,1.25 (1.16 1.34),2.48E-06
697,Sarcoidosis,dermatologic,OPGS010693,0.058,RNAseq,TRBV5-1,1.22 (1.14 1.30),4.16E-06
697,Sarcoidosis,dermatologic,OPGS010607,0.059,RNAseq,TRAV8-1,1.20 (1.13 1.29),4.81E-05
697,Sarcoidosis,dermatologic,OPGS013514,0.026,RNAseq,GZMK,0.83 (0.77 0.89),5.98E-05
697,Sarcoidosis,dermatologic,OPGS013699,0.025,RNAseq,TRAV5,0.83 (0.77 0.89),5.98E-05
697,Sarcoidosis,dermatologic,OPGS012006,0.041,RNAseq,VARS2,0.84 (0.78 0.89),8.27E-05
697,Sarcoidosis,dermatologic,OPGS013045,0.030,RNAseq,NEU1,0.84 (0.79 0.90),1.03E-04
697,Sarcoidosis,dermatologic,OPGS006845,0.158,RNAseq,FLOT1,1.19 (1.12 1.27),1.13E-04
697,Sarcoidosis,dermatologic,OPGS006248,0.189,RNAseq,MCCD1,0.84 (0.78 0.89),1.31E-04
697,Sarcoidosis,dermatologic,OPGS009222,0.085,RNAseq,,0.84 (0.79 0.90),1.80E-04
697,Sarcoidosis,dermatologic,OPGS009118,0.087,RNAseq,LY6G5C,1.23 (1.14 1.34),1.87E-04
697,Sarcoidosis,dermatologic,OPGS009865,0.072,RNAseq,TRAV17,0.85 (0.79 0.90),2.87E-04
697,Sarcoidosis,dermatologic,OPGS011784,0.044,RNAseq,TUBB,1.20 (1.11 1.29),4.47E-04
697,Sarcoidosis,dermatologic,OPGS005167,0.269,RNAseq,TCF19,0.81 (0.75 0.88),5.76E-04
697,Sarcoidosis,dermatologic,OPGS006499,0.176,RNAseq,C4A,0.85 (0.80 0.91),7.66E-04
697,Sarcoidosis,dermatologic,OPGS013225,0.029,RNAseq,REG4,0.85 (0.80 0.91),1.41E-03
697,Sarcoidosis,dermatologic,OPGS014496,0.019,RNAseq,VARS1,1.16 (1.09 1.24),1.67E-03
697,Sarcoidosis,dermatologic,OPGS006866,0.157,RNAseq,AL662795.2,1.18 (1.10 1.27),1.67E-03
697,Sarcoidosis,dermatologic,OPGS009371,0.082,RNAseq,TRBV19,0.85 (0.80 0.92),3.52E-03
697,Sarcoidosis,dermatologic,OPGS005230,0.263,RNAseq,LINC00243,1.17 (1.09 1.25),3.71E-03
697,Sarcoidosis,dermatologic,OPGS007297,0.140,RNAseq,GPANK1,0.84 (0.78 0.91),3.72E-03
697,Sarcoidosis,dermatologic,OPGS011853,0.043,RNAseq,TRBV6-1,0.86 (0.80 0.92),4.03E-03
697,Sarcoidosis,dermatologic,OPGS003843,0.532,RNAseq,BTN3A2,0.87 (0.81 0.93),4.21E-03
697,Sarcoidosis,dermatologic,OPGS010799,0.057,RNAseq,SAPCD1-AS1,1.20 (1.11 1.30),4.21E-03
697,Sarcoidosis,dermatologic,OPGS004334,0.383,RNAseq,HLA-G,0.86 (0.80 0.92),4.94E-03
697,Sarcoidosis,dermatologic,OPGS003680,0.611,RNAseq,,1.15 (1.08 1.23),5.31E-03
697,Sarcoidosis,dermatologic,OPGS011283,0.050,RNAseq,CD248,0.86 (0.81 0.92),6.49E-03
697,Sarcoidosis,dermatologic,OPGS013959,0.023,RNAseq,TMEM131,0.86 (0.80 0.92),7.84E-03
697,Sarcoidosis,dermatologic,OPGS004956,0.291,RNAseq,,1.16 (1.08 1.25),9.56E-03
697,Sarcoidosis,dermatologic,OPGS011698,0.045,RNAseq,JAK2,1.15 (1.08 1.23),1.04E-02
697,Sarcoidosis,dermatologic,OPGS006048,0.200,RNAseq,,0.86 (0.80 0.92),1.04E-02
697,Sarcoidosis,dermatologic,OPGS012271,0.038,RNAseq,TRBV5-6,0.89 (0.85 0.94),1.24E-02
697,Sarcoidosis,dermatologic,OPGS006942,0.154,RNAseq,SKIV2L,0.86 (0.80 0.93),1.29E-02
697,Sarcoidosis,dermatologic,OPGS007384,0.137,RNAseq,HLA-B,1.16 (1.08 1.25),1.29E-02
697,Sarcoidosis,dermatologic,OPGS014443,0.019,RNAseq,ABCB1,0.87 (0.81 0.93),1.51E-02
697,Sarcoidosis,dermatologic,OPGS004406,0.369,RNAseq,,0.87 (0.81 0.93),2.20E-02
697,Sarcoidosis,dermatologic,OPGS013919,0.023,RNAseq,PDE8A,0.87 (0.81 0.93),2.20E-02
697,Sarcoidosis,dermatologic,OPGS010142,0.067,RNAseq,PRSS16,1.13 (1.06 1.20),2.32E-02
697,Sarcoidosis,dermatologic,OPGS015030,0.016,RNAseq,PRRC2A,0.87 (0.82 0.94),2.45E-02
697,Sarcoidosis,dermatologic,OPGS011787,0.044,RNAseq,C2,1.14 (1.07 1.22),2.57E-02
697,Sarcoidosis,dermatologic,OPGS013298,0.028,RNAseq,IL7R,0.87 (0.81 0.93),2.76E-02
697,Sarcoidosis,dermatologic,OPGS010929,0.055,RNAseq,EOMES,0.87 (0.81 0.94),2.83E-02
697,Sarcoidosis,dermatologic,OPGS010277,0.065,RNAseq,CXCR6,0.88 (0.82 0.94),3.15E-02
697,Sarcoidosis,dermatologic,OPGS011747,0.044,RNAseq,LINC01814,0.88 (0.82 0.94),3.30E-02
702.1,Actinic keratosis,dermatologic,OPGS001634,0.021,SomaScan,Melanocyte protein PMEL,0.88 (0.86 0.91),3.16E-15
702.1,Actinic keratosis,dermatologic,OPGS000400,0.139,SomaScan,Agouti-signaling protein,1.11 (1.08 1.14),1.40E-11
702.1,Actinic keratosis,dermatologic,OPGS001025,0.051,SomaScan,Transmembrane glycoprotein NMB,0.91 (0.88 0.93),1.96E-06
702.1,Actinic keratosis,dermatologic,OPGS001011,0.052,SomaScan,Transmembrane glycoprotein NMB,0.91 (0.89 0.94),9.07E-05
702.1,Actinic keratosis,dermatologic,OPGS004322,0.386,RNAseq,CDK10,0.91 (0.89 0.94),3.07E-07
702.1,Actinic keratosis,dermatologic,OPGS010527,0.060,RNAseq,SPG7,0.91 (0.89 0.94),6.79E-07
702.1,Actinic keratosis,dermatologic,OPGS005895,0.209,RNAseq,MAP1LC3A,0.93 (0.91 0.96),2.34E-03
702.1,Actinic keratosis,dermatologic,OPGS013073,0.030,RNAseq,BACH2,1.07 (1.04 1.11),3.12E-03
702.1,Actinic keratosis,dermatologic,OPGS008718,0.096,RNAseq,,1.06 (1.03 1.09),2.24E-02
702.1,Actinic keratosis,dermatologic,OPGS007528,0.131,RNAseq,SPIRE2,0.94 (0.91 0.96),2.27E-02
704,Diseases of hair and hair follicles,dermatologic,OPGS002191,0.011,SomaScan,Interferon regulatory factor 6,1.06 (1.03 1.08),1.73E-02
704,Diseases of hair and hair follicles,dermatologic,OPGS002039,0.012,SomaScan,EKC/KEOPS complex subunit TPRKB,1.06 (1.03 1.08),1.73E-02
704,Diseases of hair and hair follicles,dermatologic,OPGS011240,0.050,RNAseq,VILL,1.24 (1.22 1.27),2.80E-81
704,Diseases of hair and hair follicles,dermatologic,OPGS009257,0.084,RNAseq,PLCD1,1.19 (1.16 1.22),8.83E-45
704,Diseases of hair and hair follicles,dermatologic,OPGS003834,0.535,RNAseq,AC026748.3,1.08 (1.05 1.11),2.29E-05
704,Diseases of hair and hair follicles,dermatologic,OPGS006267,0.188,RNAseq,,0.93 (0.91 0.96),2.50E-04
704,Diseases of hair and hair follicles,dermatologic,OPGS007294,0.140,RNAseq,RPS6KL1,0.94 (0.92 0.96),3.51E-03
704,Diseases of hair and hair follicles,dermatologic,OPGS005439,0.243,RNAseq,CDKL1,0.94 (0.92 0.97),5.58E-03
704,Diseases of hair and hair follicles,dermatologic,OPGS006735,0.164,RNAseq,TPCN2,1.06 (1.03 1.09),1.81E-02
704,Diseases of hair and hair follicles,dermatologic,OPGS007170,0.145,RNAseq,AC105749.1,1.06 (1.03 1.08),2.36E-02
706,Diseases of sebaceous glands,dermatologic,OPGS000797,0.073,SomaScan,Ras-related protein Rab-31,1.16 (1.09 1.24),4.71E-02
706,Diseases of sebaceous glands,dermatologic,OPGS000407,0.137,SomaScan,Out at first protein homolog,1.18 (1.10 1.28),4.71E-02
706,Diseases of sebaceous glands,dermatologic,OPGS011240,0.050,RNAseq,VILL,1.33 (1.24 1.42),1.95E-12
706,Diseases of sebaceous glands,dermatologic,OPGS009257,0.084,RNAseq,PLCD1,1.25 (1.17 1.34),2.98E-06
706.2,Sebaceous cyst,dermatologic,OPGS002039,0.012,SomaScan,EKC/KEOPS complex subunit TPRKB,1.04 (1.02 1.06),2.61E-02
706.2,Sebaceous cyst,dermatologic,OPGS002191,0.011,SomaScan,Interferon regulatory factor 6,1.04 (1.02 1.06),2.61E-02
706.2,Sebaceous cyst,dermatologic,OPGS002933,0.044,Metabolon,1-palmitoyl-2-linoleoyl-GPI (16:0/18:2),0.96 (0.94 0.98),2.71E-02
706.2,Sebaceous cyst,dermatologic,OPGS003043,0.024,Metabolon,1-docosahexaenoyl-GPC (22:6)*,1.04 (1.02 1.06),3.71E-02
706.2,Sebaceous cyst,dermatologic,OPGS003038,0.025,Metabolon,1-margaroyl-2-linoleoyl-GPC (17:0/18:2)*,0.96 (0.94 0.98),3.71E-02
706.2,Sebaceous cyst,dermatologic,OPGS002904,0.051,Metabolon,1-arachidonoyl-GPI (20:4)*,1.04 (1.02 1.06),3.71E-02
706.2,Sebaceous cyst,dermatologic,OPGS003073,0.021,Metabolon,1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)*,1.04 (1.02 1.06),4.58E-02
706.2,Sebaceous cyst,dermatologic,OPGS011240,0.050,RNAseq,VILL,1.18 (1.16 1.20),1.14E-75
706.2,Sebaceous cyst,dermatologic,OPGS009257,0.084,RNAseq,PLCD1,1.14 (1.12 1.16),1.19E-42
706.2,Sebaceous cyst,dermatologic,OPGS003834,0.535,RNAseq,AC026748.3,1.07 (1.05 1.09),3.65E-08
706.2,Sebaceous cyst,dermatologic,OPGS007294,0.140,RNAseq,RPS6KL1,0.94 (0.93 0.96),2.03E-05
706.2,Sebaceous cyst,dermatologic,OPGS007170,0.145,RNAseq,AC105749.1,1.05 (1.03 1.07),1.61E-04
706.2,Sebaceous cyst,dermatologic,OPGS012654,0.034,RNAseq,CLPTM1L,0.95 (0.93 0.97),4.11E-04
706.2,Sebaceous cyst,dermatologic,OPGS008008,0.115,RNAseq,EIF2B2,0.95 (0.93 0.97),6.03E-04
706.2,Sebaceous cyst,dermatologic,OPGS006267,0.188,RNAseq,,0.95 (0.93 0.97),6.62E-04
706.2,Sebaceous cyst,dermatologic,OPGS005579,0.232,RNAseq,MLH3,0.95 (0.94 0.97),3.27E-03
706.2,Sebaceous cyst,dermatologic,OPGS004184,0.415,RNAseq,TECPR1,1.05 (1.03 1.07),6.41E-03
706.2,Sebaceous cyst,dermatologic,OPGS005928,0.207,RNAseq,LSP1,1.04 (1.02 1.06),8.96E-03
706.2,Sebaceous cyst,dermatologic,OPGS010826,0.056,RNAseq,TRIM10,1.04 (1.02 1.06),2.71E-02
706.2,Sebaceous cyst,dermatologic,OPGS013243,0.029,RNAseq,TRAV3,1.04 (1.02 1.06),2.71E-02
706.2,Sebaceous cyst,dermatologic,OPGS008506,0.101,RNAseq,CSTA,0.96 (0.94 0.98),3.49E-02
706.2,Sebaceous cyst,dermatologic,OPGS012214,0.039,RNAseq,GORASP1,0.96 (0.94 0.98),3.71E-02
709.2,Sicca syndrome,dermatologic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.70 (0.65 0.75),2.90E-18
709.2,Sicca syndrome,dermatologic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.73 (0.68 0.78),8.08E-18
709.2,Sicca syndrome,dermatologic,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.74 (0.70 0.79),1.80E-17
709.2,Sicca syndrome,dermatologic,OPGS001302,0.033,SomaScan,Immunoglobulin D,0.74 (0.69 0.79),1.46E-16
709.2,Sicca syndrome,dermatologic,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.76 (0.71 0.81),1.64E-15
709.2,Sicca syndrome,dermatologic,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.76 (0.71 0.81),1.64E-15
709.2,Sicca syndrome,dermatologic,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.76 (0.71 0.81),3.79E-15
709.2,Sicca syndrome,dermatologic,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,1.32 (1.23 1.41),1.35E-12
709.2,Sicca syndrome,dermatologic,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,0.78 (0.73 0.83),2.58E-12
709.2,Sicca syndrome,dermatologic,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,0.77 (0.72 0.82),5.48E-12
709.2,Sicca syndrome,dermatologic,OPGS000290,0.171,SomaScan,Complement C4,0.77 (0.72 0.83),7.51E-11
709.2,Sicca syndrome,dermatologic,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.78 (0.73 0.83),9.22E-11
709.2,Sicca syndrome,dermatologic,OPGS001102,0.046,SomaScan,Granzyme A,0.80 (0.75 0.86),1.13E-08
709.2,Sicca syndrome,dermatologic,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.80 (0.75 0.86),2.73E-08
709.2,Sicca syndrome,dermatologic,OPGS000576,0.102,SomaScan,Interleukin-21,0.82 (0.77 0.87),8.81E-08
709.2,Sicca syndrome,dermatologic,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.24 (1.15 1.32),2.28E-07
709.2,Sicca syndrome,dermatologic,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,0.81 (0.76 0.87),4.31E-07
709.2,Sicca syndrome,dermatologic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.21 (1.14 1.30),7.79E-07
709.2,Sicca syndrome,dermatologic,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.81 (0.76 0.87),1.37E-06
709.2,Sicca syndrome,dermatologic,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.81 (0.75 0.87),1.84E-05
709.2,Sicca syndrome,dermatologic,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.19 (1.11 1.27),6.69E-05
709.2,Sicca syndrome,dermatologic,OPGS001883,0.015,SomaScan,UMP-CMP kinase,0.82 (0.77 0.89),6.85E-05
709.2,Sicca syndrome,dermatologic,OPGS001146,0.042,SomaScan,Spermatogenesis-associated protein 20,0.85 (0.80 0.91),1.29E-04
709.2,Sicca syndrome,dermatologic,OPGS001550,0.024,SomaScan,Trefoil factor 3,0.82 (0.76 0.89),3.48E-04
709.2,Sicca syndrome,dermatologic,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,0.82 (0.76 0.89),3.90E-04
709.2,Sicca syndrome,dermatologic,OPGS001488,0.026,SomaScan,Ubiquitin-conjugating enzyme E2 G2,0.86 (0.80 0.91),5.03E-04
709.2,Sicca syndrome,dermatologic,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,1.17 (1.09 1.25),8.95E-04
709.2,Sicca syndrome,dermatologic,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,0.86 (0.80 0.92),1.13E-03
709.2,Sicca syndrome,dermatologic,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,1.17 (1.09 1.25),1.33E-03
709.2,Sicca syndrome,dermatologic,OPGS001386,0.030,SomaScan,Coiled-coil domain-containing protein 134,1.16 (1.08 1.23),2.67E-03
709.2,Sicca syndrome,dermatologic,OPGS001860,0.016,SomaScan,Immunoglobulin E,1.15 (1.07 1.22),7.43E-03
709.2,Sicca syndrome,dermatologic,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.13 (1.06 1.21),3.78E-02
709.2,Sicca syndrome,dermatologic,OPGS002568,0.043,Olink,Granzyme A,0.75 (0.70 0.80),2.52E-15
709.2,Sicca syndrome,dermatologic,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.80 (0.75 0.86),2.01E-08
709.2,Sicca syndrome,dermatologic,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.81 (0.76 0.87),4.94E-07
709.2,Sicca syndrome,dermatologic,OPGS002581,0.038,Olink,Fractalkine,1.14 (1.07 1.22),9.38E-03
709.2,Sicca syndrome,dermatologic,OPGS002530,0.067,Olink,Trefoil factor 3,0.87 (0.81 0.94),2.90E-02
709.2,Sicca syndrome,dermatologic,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,0.88 (0.82 0.94),3.44E-02
709.2,Sicca syndrome,dermatologic,OPGS003031,0.026,Metabolon,X - 21312,1.16 (1.09 1.24),8.81E-04
709.2,Sicca syndrome,dermatologic,OPGS003220,0.011,Metabolon,3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF),0.87 (0.81 0.93),7.66E-03
709.2,Sicca syndrome,dermatologic,OPGS003089,0.020,Metabolon,X - 17690,1.14 (1.07 1.22),7.86E-03
709.2,Sicca syndrome,dermatologic,OPGS013225,0.029,RNAseq,REG4,0.70 (0.66 0.75),2.28E-22
709.2,Sicca syndrome,dermatologic,OPGS006845,0.158,RNAseq,FLOT1,1.39 (1.31 1.48),3.15E-21
709.2,Sicca syndrome,dermatologic,OPGS011283,0.050,RNAseq,CD248,0.71 (0.66 0.75),1.49E-20
709.2,Sicca syndrome,dermatologic,OPGS012358,0.037,RNAseq,SFRP5,0.73 (0.68 0.78),2.52E-15
709.2,Sicca syndrome,dermatologic,OPGS004406,0.369,RNAseq,,0.74 (0.69 0.79),6.38E-15
709.2,Sicca syndrome,dermatologic,OPGS014283,0.021,RNAseq,MXRA8,0.73 (0.68 0.79),2.64E-14
709.2,Sicca syndrome,dermatologic,OPGS010826,0.056,RNAseq,TRIM10,0.77 (0.73 0.82),3.06E-14
709.2,Sicca syndrome,dermatologic,OPGS010693,0.058,RNAseq,TRBV5-1,1.32 (1.23 1.40),4.33E-14
709.2,Sicca syndrome,dermatologic,OPGS006248,0.189,RNAseq,MCCD1,0.75 (0.70 0.80),4.60E-14
709.2,Sicca syndrome,dermatologic,OPGS006716,0.164,RNAseq,IER3,1.31 (1.23 1.40),1.69E-13
709.2,Sicca syndrome,dermatologic,OPGS009371,0.082,RNAseq,TRBV19,0.75 (0.70 0.80),2.00E-13
709.2,Sicca syndrome,dermatologic,OPGS011784,0.044,RNAseq,TUBB,1.34 (1.25 1.44),4.06E-13
709.2,Sicca syndrome,dermatologic,OPGS012093,0.040,RNAseq,TRIM26,1.32 (1.23 1.41),8.18E-13
709.2,Sicca syndrome,dermatologic,OPGS003621,0.665,RNAseq,,0.76 (0.71 0.81),4.50E-12
709.2,Sicca syndrome,dermatologic,OPGS012006,0.041,RNAseq,VARS2,0.78 (0.73 0.83),2.02E-11
709.2,Sicca syndrome,dermatologic,OPGS014443,0.019,RNAseq,ABCB1,0.76 (0.71 0.82),6.22E-11
709.2,Sicca syndrome,dermatologic,OPGS005230,0.263,RNAseq,LINC00243,1.29 (1.21 1.38),6.29E-11
709.2,Sicca syndrome,dermatologic,OPGS007675,0.126,RNAseq,TRAV12-2,1.27 (1.19 1.36),8.26E-11
709.2,Sicca syndrome,dermatologic,OPGS013045,0.030,RNAseq,NEU1,0.79 (0.74 0.84),1.03E-10
709.2,Sicca syndrome,dermatologic,OPGS015030,0.016,RNAseq,PRRC2A,0.78 (0.73 0.83),1.79E-10
709.2,Sicca syndrome,dermatologic,OPGS013699,0.025,RNAseq,TRAV5,0.78 (0.73 0.84),1.16E-09
709.2,Sicca syndrome,dermatologic,OPGS007297,0.140,RNAseq,GPANK1,0.76 (0.70 0.82),1.48E-09
709.2,Sicca syndrome,dermatologic,OPGS006866,0.157,RNAseq,AL662795.2,1.28 (1.19 1.37),3.30E-09
709.2,Sicca syndrome,dermatologic,OPGS013243,0.029,RNAseq,TRAV3,0.80 (0.75 0.85),3.30E-09
709.2,Sicca syndrome,dermatologic,OPGS006942,0.154,RNAseq,SKIV2L,0.78 (0.73 0.84),6.05E-09
709.2,Sicca syndrome,dermatologic,OPGS009920,0.071,RNAseq,LINC02446,0.79 (0.74 0.85),6.68E-09
709.2,Sicca syndrome,dermatologic,OPGS014232,0.021,RNAseq,TRAV1-2,0.79 (0.74 0.85),7.94E-09
709.2,Sicca syndrome,dermatologic,OPGS009222,0.085,RNAseq,,0.81 (0.76 0.86),2.28E-08
709.2,Sicca syndrome,dermatologic,OPGS015052,0.015,RNAseq,CISH,1.26 (1.17 1.35),4.89E-08
709.2,Sicca syndrome,dermatologic,OPGS012271,0.038,RNAseq,TRBV5-6,0.86 (0.82 0.90),7.82E-08
709.2,Sicca syndrome,dermatologic,OPGS003843,0.532,RNAseq,BTN3A2,0.82 (0.77 0.88),1.29E-07
709.2,Sicca syndrome,dermatologic,OPGS005918,0.208,RNAseq,DDR1,0.79 (0.73 0.85),1.47E-07
709.2,Sicca syndrome,dermatologic,OPGS014496,0.019,RNAseq,VARS1,1.21 (1.14 1.29),1.71E-07
709.2,Sicca syndrome,dermatologic,OPGS010348,0.063,RNAseq,TRBV6-5,0.81 (0.75 0.86),1.86E-07
709.2,Sicca syndrome,dermatologic,OPGS004489,0.357,RNAseq,,0.80 (0.75 0.86),2.37E-07
709.2,Sicca syndrome,dermatologic,OPGS009865,0.072,RNAseq,TRAV17,0.82 (0.77 0.88),4.96E-07
709.2,Sicca syndrome,dermatologic,OPGS007018,0.151,RNAseq,TRBV10-3,1.24 (1.16 1.34),1.02E-06
709.2,Sicca syndrome,dermatologic,OPGS010607,0.059,RNAseq,TRAV8-1,1.22 (1.14 1.30),1.10E-06
709.2,Sicca syndrome,dermatologic,OPGS013514,0.026,RNAseq,GZMK,0.82 (0.76 0.87),1.37E-06
709.2,Sicca syndrome,dermatologic,OPGS011787,0.044,RNAseq,C2,1.21 (1.13 1.29),4.40E-06
709.2,Sicca syndrome,dermatologic,OPGS006499,0.176,RNAseq,C4A,0.84 (0.78 0.89),4.49E-06
709.2,Sicca syndrome,dermatologic,OPGS006048,0.200,RNAseq,,0.82 (0.76 0.88),7.81E-06
709.2,Sicca syndrome,dermatologic,OPGS013013,0.031,RNAseq,FOXJ1,0.84 (0.79 0.90),1.27E-05
709.2,Sicca syndrome,dermatologic,OPGS014580,0.018,RNAseq,DACT1,1.21 (1.13 1.31),3.39E-05
709.2,Sicca syndrome,dermatologic,OPGS003680,0.611,RNAseq,,1.17 (1.10 1.25),8.20E-05
709.2,Sicca syndrome,dermatologic,OPGS007089,0.148,RNAseq,HLA-A,0.83 (0.78 0.90),1.40E-04
709.2,Sicca syndrome,dermatologic,OPGS010561,0.060,RNAseq,IL2RA,1.18 (1.11 1.26),1.46E-04
709.2,Sicca syndrome,dermatologic,OPGS004956,0.291,RNAseq,,1.20 (1.11 1.28),1.69E-04
709.2,Sicca syndrome,dermatologic,OPGS008402,0.104,RNAseq,TNXB,0.84 (0.78 0.90),2.06E-04
709.2,Sicca syndrome,dermatologic,OPGS013201,0.029,RNAseq,NRCAM,0.84 (0.78 0.90),2.33E-04
709.2,Sicca syndrome,dermatologic,OPGS011585,0.046,RNAseq,CD8B,0.85 (0.80 0.91),2.61E-04
709.2,Sicca syndrome,dermatologic,OPGS009198,0.085,RNAseq,TRAV12-1,1.18 (1.10 1.26),2.61E-04
709.2,Sicca syndrome,dermatologic,OPGS010564,0.060,RNAseq,CEACAM6,0.85 (0.79 0.91),2.61E-04
709.2,Sicca syndrome,dermatologic,OPGS014680,0.018,RNAseq,GALE,0.86 (0.81 0.91),3.11E-04
709.2,Sicca syndrome,dermatologic,OPGS013406,0.027,RNAseq,AL353759.1,1.19 (1.11 1.28),3.22E-04
709.2,Sicca syndrome,dermatologic,OPGS012636,0.034,RNAseq,KIR2DL3,1.16 (1.09 1.24),3.83E-04
709.2,Sicca syndrome,dermatologic,OPGS003620,0.668,RNAseq,ZFP57,1.17 (1.10 1.25),3.83E-04
709.2,Sicca syndrome,dermatologic,OPGS009579,0.077,RNAseq,MTOR,1.16 (1.09 1.23),6.29E-04
709.2,Sicca syndrome,dermatologic,OPGS009077,0.088,RNAseq,DDAH2,1.16 (1.09 1.24),9.77E-04
709.2,Sicca syndrome,dermatologic,OPGS013068,0.030,RNAseq,AL021807.1,1.16 (1.09 1.24),9.87E-04
709.2,Sicca syndrome,dermatologic,OPGS007248,0.141,RNAseq,,0.84 (0.78 0.91),1.33E-03
709.2,Sicca syndrome,dermatologic,OPGS013958,0.023,RNAseq,CSNK2B,1.17 (1.09 1.26),1.53E-03
709.2,Sicca syndrome,dermatologic,OPGS013896,0.023,RNAseq,ATF6B,1.16 (1.09 1.24),2.12E-03
709.2,Sicca syndrome,dermatologic,OPGS011010,0.054,RNAseq,TRBV5-4,1.17 (1.09 1.25),2.26E-03
709.2,Sicca syndrome,dermatologic,OPGS004334,0.383,RNAseq,HLA-G,0.86 (0.80 0.92),2.48E-03
709.2,Sicca syndrome,dermatologic,OPGS011073,0.053,RNAseq,TRBV7-3,1.17 (1.08 1.26),6.22E-03
709.2,Sicca syndrome,dermatologic,OPGS005334,0.253,RNAseq,AL645933.4,0.87 (0.81 0.93),6.24E-03
709.2,Sicca syndrome,dermatologic,OPGS010142,0.067,RNAseq,PRSS16,1.13 (1.07 1.21),7.43E-03
709.2,Sicca syndrome,dermatologic,OPGS009176,0.086,RNAseq,,0.87 (0.82 0.93),8.30E-03
709.2,Sicca syndrome,dermatologic,OPGS004217,0.408,RNAseq,PNPLA7,0.87 (0.81 0.93),9.55E-03
709.2,Sicca syndrome,dermatologic,OPGS013748,0.024,RNAseq,KLRB1,0.87 (0.82 0.93),1.01E-02
709.2,Sicca syndrome,dermatologic,OPGS013383,0.027,RNAseq,PPP1R11,0.85 (0.79 0.92),1.10E-02
709.2,Sicca syndrome,dermatologic,OPGS012855,0.032,RNAseq,TRBV9,1.14 (1.07 1.22),1.14E-02
709.2,Sicca syndrome,dermatologic,OPGS010475,0.061,RNAseq,ZNRD1,0.87 (0.82 0.93),1.17E-02
709.2,Sicca syndrome,dermatologic,OPGS010929,0.055,RNAseq,EOMES,0.87 (0.82 0.94),1.52E-02
709.2,Sicca syndrome,dermatologic,OPGS013959,0.023,RNAseq,TMEM131,0.87 (0.81 0.94),1.85E-02
709.2,Sicca syndrome,dermatologic,OPGS004879,0.301,RNAseq,CELSR1,1.13 (1.06 1.20),1.85E-02
709.2,Sicca syndrome,dermatologic,OPGS011948,0.042,RNAseq,ADGRG1,0.88 (0.82 0.94),2.42E-02
709.2,Sicca syndrome,dermatologic,OPGS008281,0.107,RNAseq,HLA-F-AS1,0.89 (0.83 0.95),2.42E-02
709.2,Sicca syndrome,dermatologic,OPGS006634,0.169,RNAseq,,0.88 (0.82 0.94),2.47E-02
709.2,Sicca syndrome,dermatologic,OPGS013824,0.024,RNAseq,RNU6-892P,0.89 (0.84 0.95),2.66E-02
709.2,Sicca syndrome,dermatologic,OPGS008268,0.107,RNAseq,CD4,1.14 (1.06 1.23),2.82E-02
709.2,Sicca syndrome,dermatologic,OPGS010277,0.065,RNAseq,CXCR6,0.88 (0.83 0.94),2.89E-02
709.2,Sicca syndrome,dermatologic,OPGS004144,0.424,RNAseq,PSORS1C3,0.87 (0.81 0.94),2.98E-02
709.2,Sicca syndrome,dermatologic,OPGS011005,0.054,RNAseq,SLC1A5,1.12 (1.06 1.20),3.04E-02
709.2,Sicca syndrome,dermatologic,OPGS003644,0.643,RNAseq,KANSL1-AS1,0.88 (0.82 0.94),3.08E-02
709.2,Sicca syndrome,dermatologic,OPGS011325,0.049,RNAseq,MLF2,0.89 (0.83 0.95),3.52E-02
709.2,Sicca syndrome,dermatologic,OPGS011716,0.045,RNAseq,FBLN7,1.13 (1.05 1.21),4.84E-02
709.3,Systemic sclerosis,dermatologic,OPGS000576,0.102,SomaScan,Interleukin-21,0.74 (0.66 0.83),1.24E-03
709.3,Systemic sclerosis,dermatologic,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.75 (0.66 0.84),9.25E-03
709.3,Systemic sclerosis,dermatologic,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,0.68 (0.58 0.80),1.72E-02
709.3,Systemic sclerosis,dermatologic,OPGS002249,0.010,SomaScan,Tumor necrosis factor receptor superfamily member 4,1.14 (1.08 1.21),1.72E-02
709.3,Systemic sclerosis,dermatologic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.75 (0.66 0.85),2.39E-02
709.3,Systemic sclerosis,dermatologic,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.71 (0.61 0.83),2.39E-02
709.3,Systemic sclerosis,dermatologic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.77 (0.68 0.87),3.30E-02
709.3,Systemic sclerosis,dermatologic,OPGS013243,0.029,RNAseq,TRAV3,0.77 (0.68 0.86),1.72E-02
709.3,Systemic sclerosis,dermatologic,OPGS007018,0.151,RNAseq,TRBV10-3,1.36 (1.19 1.55),1.72E-02
709.3,Systemic sclerosis,dermatologic,OPGS003843,0.532,RNAseq,BTN3A2,0.79 (0.71 0.88),3.30E-02
709.3,Systemic sclerosis,dermatologic,OPGS008190,0.109,RNAseq,TM2D3,1.29 (1.14 1.46),4.89E-02
709.7,Unspecified diffuse connective tissue disease,dermatologic,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.91 (0.88 0.95),6.55E-03
709.7,Unspecified diffuse connective tissue disease,dermatologic,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.92 (0.88 0.95),3.24E-02
709.7,Unspecified diffuse connective tissue disease,dermatologic,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.08 (1.04 1.12),3.24E-02
709.7,Unspecified diffuse connective tissue disease,dermatologic,OPGS009222,0.085,RNAseq,,0.91 (0.88 0.95),6.55E-03
709.7,Unspecified diffuse connective tissue disease,dermatologic,OPGS006716,0.164,RNAseq,IER3,1.09 (1.05 1.13),1.18E-02
709.7,Unspecified diffuse connective tissue disease,dermatologic,OPGS010826,0.056,RNAseq,TRIM10,0.92 (0.89 0.96),3.24E-02
709.7,Unspecified diffuse connective tissue disease,dermatologic,OPGS003843,0.532,RNAseq,BTN3A2,0.93 (0.89 0.96),3.24E-02
709.7,Unspecified diffuse connective tissue disease,dermatologic,OPGS013068,0.030,RNAseq,AL021807.1,1.08 (1.04 1.12),3.24E-02
709.7,Unspecified diffuse connective tissue disease,dermatologic,OPGS013243,0.029,RNAseq,TRAV3,0.92 (0.89 0.96),3.24E-02
709.7,Unspecified diffuse connective tissue disease,dermatologic,OPGS009865,0.072,RNAseq,TRAV17,0.92 (0.89 0.96),3.28E-02
709.7,Unspecified diffuse connective tissue disease,dermatologic,OPGS006845,0.158,RNAseq,FLOT1,1.08 (1.04 1.12),4.04E-02
709.7,Unspecified diffuse connective tissue disease,dermatologic,OPGS010758,0.057,RNAseq,TOX2,0.92 (0.89 0.96),4.09E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001860,0.016,SomaScan,Immunoglobulin E,0.82 (0.79 0.84),2.75E-37
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,1.21 (1.17 1.24),2.75E-35
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.20 (1.16 1.23),3.64E-32
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000645,0.091,SomaScan,Trypsin-3,0.86 (0.83 0.88),4.12E-26
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.84 (0.82 0.87),1.12E-24
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.17 (1.14 1.20),2.74E-24
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000137,0.312,SomaScan,Complement C4b,0.86 (0.84 0.89),5.29E-23
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.87 (0.84 0.89),5.71E-22
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002246,0.010,SomaScan,Sperm-associated antigen 11B,0.88 (0.85 0.90),6.52E-19
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,0.88 (0.86 0.91),2.71E-16
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001893,0.015,SomaScan,Interleukin-17F,0.88 (0.85 0.90),5.52E-15
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001911,0.014,SomaScan,Ectodysplasin-A. secreted form,0.87 (0.85 0.90),7.45E-15
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,0.89 (0.86 0.91),1.03E-14
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.88 (0.85 0.91),2.03E-13
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001231,0.037,SomaScan,Osteocalcin,1.11 (1.08 1.15),2.18E-11
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001598,0.022,SomaScan,SPARC,0.90 (0.88 0.93),2.32E-10
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001550,0.024,SomaScan,Trefoil factor 3,0.90 (0.87 0.92),8.72E-10
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000517,0.114,SomaScan,Advanced glycosylation end product-specific receptor. soluble,0.91 (0.88 0.93),9.35E-10
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002103,0.012,SomaScan,Trefoil factor 3,0.90 (0.87 0.92),1.73E-09
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001553,0.024,SomaScan,Protein G6b,1.09 (1.06 1.12),3.40E-06
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000191,0.247,SomaScan,Tenascin-X,0.92 (0.90 0.95),3.79E-06
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000576,0.102,SomaScan,Interleukin-21,0.93 (0.90 0.95),2.47E-05
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.92 (0.90 0.95),2.78E-05
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.93 (0.91 0.96),1.50E-04
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,1.07 (1.04 1.11),2.34E-04
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,1.07 (1.04 1.10),4.29E-04
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000572,0.102,SomaScan,Glutamate receptor 4,1.07 (1.04 1.10),1.91E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.94 (0.91 0.97),3.52E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000214,0.221,SomaScan,Intercellular adhesion molecule 5,1.06 (1.03 1.09),5.00E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.94 (0.92 0.97),5.09E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000213,0.222,SomaScan,ER membrane protein complex subunit 4,1.06 (1.03 1.09),6.95E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000681,0.087,SomaScan,Protein-glutamine gamma-glutamyltransferase E,0.94 (0.92 0.97),7.61E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000108,0.360,SomaScan,Intercellular adhesion molecule 5,1.06 (1.03 1.09),8.01E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001883,0.015,SomaScan,UMP-CMP kinase,1.06 (1.03 1.09),1.10E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002220,0.011,SomaScan,ATP-citrate synthase,0.95 (0.93 0.98),1.81E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000156,0.272,SomaScan,alpha-2-macroglobulin receptor-associated protein,0.94 (0.91 0.97),2.39E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002205,0.011,SomaScan,Apolipoprotein D,0.95 (0.93 0.98),2.79E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001865,0.015,SomaScan,Alpha-2-antiplasmin,1.06 (1.03 1.09),3.36E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS001457,0.027,SomaScan,Lutropin subunit beta,0.95 (0.93 0.98),4.54E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS000287,0.174,SomaScan,Human Chorionic Gonadotropin,1.05 (1.02 1.08),4.54E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.86 (0.83 0.88),1.14E-22
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002530,0.067,Olink,Trefoil factor 3,0.93 (0.90 0.96),1.53E-04
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002399,0.342,Olink,Pulmonary surfactant-associated protein D,1.07 (1.04 1.10),9.17E-04
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.94 (0.92 0.97),3.80E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,0.94 (0.91 0.97),3.91E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002598,0.031,Olink,Interleukin-10,1.06 (1.03 1.09),5.56E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002427,0.216,Olink,Alpha-2-macroglobulin receptor-associated protein,0.94 (0.91 0.97),1.81E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002568,0.043,Olink,Granzyme A,1.06 (1.03 1.09),2.79E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS002886,0.057,Metabolon,X - 12822,1.06 (1.03 1.09),1.33E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS006038,0.201,RNAseq,HLA-DQA2,1.26 (1.23 1.29),2.91E-72
714.1,Rheumatoid arthritis,musculoskeletal,OPGS008889,0.092,RNAseq,TRAV20,1.27 (1.24 1.31),2.96E-62
714.1,Rheumatoid arthritis,musculoskeletal,OPGS013958,0.023,RNAseq,CSNK2B,0.80 (0.78 0.82),6.26E-62
714.1,Rheumatoid arthritis,musculoskeletal,OPGS012171,0.039,RNAseq,TRBV15,0.81 (0.79 0.84),5.93E-45
714.1,Rheumatoid arthritis,musculoskeletal,OPGS008402,0.104,RNAseq,TNXB,1.19 (1.16 1.22),5.67E-35
714.1,Rheumatoid arthritis,musculoskeletal,OPGS005389,0.248,RNAseq,TRAV23DV6,0.85 (0.83 0.88),8.54E-33
714.1,Rheumatoid arthritis,musculoskeletal,OPGS009711,0.075,RNAseq,TRAV21,0.83 (0.81 0.86),3.84E-31
714.1,Rheumatoid arthritis,musculoskeletal,OPGS013305,0.028,RNAseq,TRBV14,0.85 (0.82 0.87),8.43E-31
714.1,Rheumatoid arthritis,musculoskeletal,OPGS007018,0.151,RNAseq,TRBV10-3,1.20 (1.16 1.23),2.44E-28
714.1,Rheumatoid arthritis,musculoskeletal,OPGS015030,0.016,RNAseq,PRRC2A,1.17 (1.14 1.21),9.84E-26
714.1,Rheumatoid arthritis,musculoskeletal,OPGS012698,0.034,RNAseq,SNHG32,1.16 (1.13 1.19),4.19E-24
714.1,Rheumatoid arthritis,musculoskeletal,OPGS013699,0.025,RNAseq,TRAV5,1.16 (1.13 1.19),2.06E-22
714.1,Rheumatoid arthritis,musculoskeletal,OPGS013243,0.029,RNAseq,TRAV3,0.87 (0.85 0.89),1.37E-20
714.1,Rheumatoid arthritis,musculoskeletal,OPGS013045,0.030,RNAseq,NEU1,1.15 (1.12 1.19),1.34E-18
714.1,Rheumatoid arthritis,musculoskeletal,OPGS011536,0.047,RNAseq,TRAV2,0.87 (0.85 0.90),1.41E-17
714.1,Rheumatoid arthritis,musculoskeletal,OPGS010607,0.059,RNAseq,TRAV8-1,0.87 (0.85 0.90),1.42E-17
714.1,Rheumatoid arthritis,musculoskeletal,OPGS011671,0.045,RNAseq,MICA,1.12 (1.10 1.15),8.88E-17
714.1,Rheumatoid arthritis,musculoskeletal,OPGS004213,0.410,RNAseq,,1.11 (1.08 1.14),1.35E-12
714.1,Rheumatoid arthritis,musculoskeletal,OPGS010348,0.063,RNAseq,TRBV6-5,1.11 (1.08 1.14),1.89E-11
714.1,Rheumatoid arthritis,musculoskeletal,OPGS012808,0.033,RNAseq,TRBV20-1,0.90 (0.87 0.92),8.95E-11
714.1,Rheumatoid arthritis,musculoskeletal,OPGS013660,0.025,RNAseq,CD8A,1.11 (1.08 1.14),2.62E-10
714.1,Rheumatoid arthritis,musculoskeletal,OPGS010693,0.058,RNAseq,TRBV5-1,0.90 (0.88 0.93),4.13E-10
714.1,Rheumatoid arthritis,musculoskeletal,OPGS006248,0.189,RNAseq,MCCD1,1.11 (1.08 1.14),8.72E-10
714.1,Rheumatoid arthritis,musculoskeletal,OPGS006845,0.158,RNAseq,FLOT1,1.10 (1.07 1.13),9.69E-10
714.1,Rheumatoid arthritis,musculoskeletal,OPGS007394,0.136,RNAseq,AL662844.4,0.91 (0.88 0.93),1.89E-09
714.1,Rheumatoid arthritis,musculoskeletal,OPGS014496,0.019,RNAseq,VARS1,0.90 (0.87 0.93),2.36E-09
714.1,Rheumatoid arthritis,musculoskeletal,OPGS013514,0.026,RNAseq,GZMK,1.10 (1.07 1.13),4.30E-09
714.1,Rheumatoid arthritis,musculoskeletal,OPGS011344,0.049,RNAseq,,1.10 (1.07 1.13),8.75E-09
714.1,Rheumatoid arthritis,musculoskeletal,OPGS009198,0.085,RNAseq,TRAV12-1,1.10 (1.07 1.13),2.24E-08
714.1,Rheumatoid arthritis,musculoskeletal,OPGS005230,0.263,RNAseq,LINC00243,1.10 (1.07 1.13),2.60E-08
714.1,Rheumatoid arthritis,musculoskeletal,OPGS010917,0.055,RNAseq,LSM2,1.11 (1.08 1.15),3.07E-08
714.1,Rheumatoid arthritis,musculoskeletal,OPGS010700,0.058,RNAseq,DCLRE1B,0.92 (0.90 0.94),9.92E-08
714.1,Rheumatoid arthritis,musculoskeletal,OPGS014075,0.022,RNAseq,AGER,0.92 (0.89 0.94),4.57E-07
714.1,Rheumatoid arthritis,musculoskeletal,OPGS011626,0.046,RNAseq,ABCF1,1.08 (1.05 1.11),1.20E-05
714.1,Rheumatoid arthritis,musculoskeletal,OPGS008356,0.105,RNAseq,IL6ST,1.08 (1.05 1.11),1.20E-05
714.1,Rheumatoid arthritis,musculoskeletal,OPGS004567,0.343,RNAseq,HLA-C,0.92 (0.90 0.95),1.40E-05
714.1,Rheumatoid arthritis,musculoskeletal,OPGS009865,0.072,RNAseq,TRAV17,0.93 (0.90 0.96),7.38E-05
714.1,Rheumatoid arthritis,musculoskeletal,OPGS005262,0.259,RNAseq,ANKRD55,1.08 (1.05 1.11),8.07E-05
714.1,Rheumatoid arthritis,musculoskeletal,OPGS004144,0.424,RNAseq,PSORS1C3,1.07 (1.04 1.10),8.48E-05
714.1,Rheumatoid arthritis,musculoskeletal,OPGS012006,0.041,RNAseq,VARS2,1.08 (1.05 1.11),8.48E-05
714.1,Rheumatoid arthritis,musculoskeletal,OPGS007240,0.142,RNAseq,,0.93 (0.90 0.95),1.18E-04
714.1,Rheumatoid arthritis,musculoskeletal,OPGS005918,0.208,RNAseq,DDR1,1.07 (1.04 1.10),2.01E-04
714.1,Rheumatoid arthritis,musculoskeletal,OPGS006695,0.166,RNAseq,DLL1,1.07 (1.04 1.10),6.52E-04
714.1,Rheumatoid arthritis,musculoskeletal,OPGS013639,0.025,RNAseq,H2BC15,0.94 (0.92 0.97),6.54E-04
714.1,Rheumatoid arthritis,musculoskeletal,OPGS007384,0.137,RNAseq,HLA-B,0.94 (0.91 0.96),9.89E-04
714.1,Rheumatoid arthritis,musculoskeletal,OPGS014758,0.017,RNAseq,TRAV10,1.07 (1.04 1.10),1.21E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS010661,0.059,RNAseq,PTPN22,1.06 (1.04 1.09),1.77E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS011787,0.044,RNAseq,C2,1.07 (1.04 1.10),1.82E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS013201,0.029,RNAseq,NRCAM,0.94 (0.91 0.97),3.52E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS008699,0.097,RNAseq,DUSP4,1.06 (1.03 1.10),3.80E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS006866,0.157,RNAseq,AL662795.2,1.06 (1.03 1.09),5.90E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS010929,0.055,RNAseq,EOMES,1.06 (1.03 1.09),6.51E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS004164,0.418,RNAseq,IRF5,1.06 (1.03 1.09),7.93E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS014232,0.021,RNAseq,TRAV1-2,1.06 (1.03 1.09),8.01E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS010492,0.061,RNAseq,HCG18,0.94 (0.92 0.97),8.01E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS005411,0.245,RNAseq,REEP1,1.06 (1.03 1.09),8.62E-03
714.1,Rheumatoid arthritis,musculoskeletal,OPGS013798,0.024,RNAseq,RNF5,1.06 (1.03 1.09),1.08E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS006942,0.154,RNAseq,SKIV2L,0.94 (0.92 0.97),1.12E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS014860,0.017,RNAseq,,0.95 (0.92 0.97),1.17E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS009077,0.088,RNAseq,DDAH2,0.95 (0.92 0.97),1.50E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS013286,0.028,RNAseq,AC137932.1,0.94 (0.91 0.97),1.61E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS009278,0.084,RNAseq,,0.95 (0.92 0.98),2.91E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS012739,0.033,RNAseq,CNOT4,1.05 (1.02 1.08),2.91E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS011324,0.049,RNAseq,ARL2,0.95 (0.92 0.98),3.36E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS007277,0.140,RNAseq,VPS28,0.95 (0.92 0.98),3.46E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS008891,0.092,RNAseq,NAALADL1,1.05 (1.02 1.08),4.08E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS008786,0.094,RNAseq,GABBR1,1.05 (1.02 1.08),4.54E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS008841,0.093,RNAseq,HSD17B8,1.05 (1.02 1.08),4.68E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS014283,0.021,RNAseq,MXRA8,0.95 (0.92 0.98),4.76E-02
714.1,Rheumatoid arthritis,musculoskeletal,OPGS014736,0.017,RNAseq,WDR75,1.05 (1.02 1.09),4.95E-02
715,Other inflammatory spondylopathies,musculoskeletal,OPGS006943,0.154,RNAseq,EVI5,1.16 (1.09 1.23),4.65E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000082,0.401,SomaScan,MHC class I polypeptide-related sequence A,0.58 (0.54 0.63),1.54E-39
715.2,Ankylosing spondylitis,musculoskeletal,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,0.67 (0.62 0.72),2.09E-20
715.2,Ankylosing spondylitis,musculoskeletal,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,0.70 (0.65 0.75),7.53E-18
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,1.55 (1.41 1.70),1.46E-17
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,1.50 (1.37 1.65),7.13E-16
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000879,0.065,SomaScan,Natural cytotoxicity triggering receptor 3,0.76 (0.71 0.81),9.92E-14
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000572,0.102,SomaScan,Glutamate receptor 4,1.44 (1.32 1.57),4.23E-13
715.2,Ankylosing spondylitis,musculoskeletal,OPGS001302,0.033,SomaScan,Immunoglobulin D,1.35 (1.24 1.46),3.10E-10
715.2,Ankylosing spondylitis,musculoskeletal,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.34 (1.24 1.45),3.10E-10
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000878,0.065,SomaScan,Beta-2-microglobulin,0.76 (0.70 0.82),3.98E-10
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000175,0.256,SomaScan,Killer cell immunoglobulin-like receptor 2DS2,0.77 (0.71 0.83),3.54E-08
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000783,0.075,SomaScan,Interleukin-36 alpha,1.31 (1.21 1.43),5.84E-08
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000290,0.171,SomaScan,Complement C4,1.27 (1.18 1.37),2.39E-07
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,0.80 (0.74 0.86),4.87E-07
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,1.29 (1.19 1.41),1.06E-06
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000137,0.312,SomaScan,Complement C4b,0.79 (0.73 0.86),1.31E-06
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000984,0.055,SomaScan,Complement C2,0.82 (0.77 0.88),8.18E-06
715.2,Ankylosing spondylitis,musculoskeletal,OPGS001860,0.016,SomaScan,Immunoglobulin E,0.81 (0.75 0.88),1.02E-04
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,1.23 (1.13 1.33),1.18E-04
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000538,0.109,SomaScan,Cyclic AMP-responsive element-binding protein 3-like protein 4,0.79 (0.72 0.87),2.11E-04
715.2,Ankylosing spondylitis,musculoskeletal,OPGS001550,0.024,SomaScan,Trefoil factor 3,0.80 (0.72 0.88),5.88E-04
715.2,Ankylosing spondylitis,musculoskeletal,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,0.83 (0.77 0.90),1.64E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS000046,0.516,SomaScan,Endoplasmic reticulum aminopeptidase 1,1.19 (1.10 1.28),2.86E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.19 (1.10 1.28),4.22E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.83 (0.76 0.91),5.07E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.83 (0.76 0.91),6.50E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS001102,0.046,SomaScan,Granzyme A,1.17 (1.08 1.27),1.39E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS002103,0.012,SomaScan,Trefoil factor 3,0.83 (0.75 0.91),1.61E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS002246,0.010,SomaScan,Sperm-associated antigen 11B,0.87 (0.80 0.93),2.63E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS001966,0.013,SomaScan,DnaJ homolog subfamily C member 10,0.86 (0.79 0.93),3.90E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS002441,0.181,Olink,Angiopoietin-1 receptor,0.57 (0.51 0.63),1.73E-24
715.2,Ankylosing spondylitis,musculoskeletal,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,0.73 (0.67 0.80),3.98E-10
715.2,Ankylosing spondylitis,musculoskeletal,OPGS002598,0.031,Olink,Interleukin-10,1.20 (1.12 1.29),3.66E-05
715.2,Ankylosing spondylitis,musculoskeletal,OPGS002643,0.018,Olink,Neuroblastoma suppressor of tumorigenicity 1,0.82 (0.76 0.88),7.61E-05
715.2,Ankylosing spondylitis,musculoskeletal,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,1.22 (1.13 1.33),1.59E-04
715.2,Ankylosing spondylitis,musculoskeletal,OPGS002568,0.043,Olink,Granzyme A,1.17 (1.08 1.27),1.53E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS003550,0.015,Nightingale,Phenylalanine,1.23 (1.13 1.33),7.66E-05
715.2,Ankylosing spondylitis,musculoskeletal,OPGS007394,0.136,RNAseq,AL662844.4,0.52 (0.49 0.56),1.10E-79
715.2,Ankylosing spondylitis,musculoskeletal,OPGS004489,0.357,RNAseq,,1.60 (1.50 1.72),3.19E-37
715.2,Ankylosing spondylitis,musculoskeletal,OPGS012271,0.038,RNAseq,TRBV5-6,2.00 (1.80 2.23),1.30E-32
715.2,Ankylosing spondylitis,musculoskeletal,OPGS012984,0.031,RNAseq,POU5F1,0.73 (0.70 0.77),3.87E-30
715.2,Ankylosing spondylitis,musculoskeletal,OPGS011025,0.053,RNAseq,MDC1,0.39 (0.33 0.46),1.76E-28
715.2,Ankylosing spondylitis,musculoskeletal,OPGS013958,0.023,RNAseq,CSNK2B,0.69 (0.64 0.74),1.38E-22
715.2,Ankylosing spondylitis,musculoskeletal,OPGS012006,0.041,RNAseq,VARS2,1.55 (1.42 1.69),7.02E-21
715.2,Ankylosing spondylitis,musculoskeletal,OPGS007089,0.148,RNAseq,HLA-A,1.40 (1.30 1.49),4.85E-19
715.2,Ankylosing spondylitis,musculoskeletal,OPGS008889,0.092,RNAseq,TRAV20,1.44 (1.34 1.56),1.06E-18
715.2,Ankylosing spondylitis,musculoskeletal,OPGS013324,0.028,RNAseq,PRF1,1.89 (1.65 2.16),5.11E-17
715.2,Ankylosing spondylitis,musculoskeletal,OPGS008274,0.107,RNAseq,NCR3,0.77 (0.73 0.82),4.11E-15
715.2,Ankylosing spondylitis,musculoskeletal,OPGS013437,0.027,RNAseq,TRAV29DV5,0.69 (0.63 0.75),3.92E-14
715.2,Ankylosing spondylitis,musculoskeletal,OPGS010693,0.058,RNAseq,TRBV5-1,0.70 (0.65 0.76),1.38E-13
715.2,Ankylosing spondylitis,musculoskeletal,OPGS013748,0.024,RNAseq,KLRB1,0.72 (0.67 0.78),3.16E-13
715.2,Ankylosing spondylitis,musculoskeletal,OPGS011784,0.044,RNAseq,TUBB,0.78 (0.73 0.83),6.92E-12
715.2,Ankylosing spondylitis,musculoskeletal,OPGS009962,0.070,RNAseq,CCHCR1,0.77 (0.71 0.82),6.24E-11
715.2,Ankylosing spondylitis,musculoskeletal,OPGS007675,0.126,RNAseq,TRAV12-2,0.73 (0.67 0.79),6.79E-11
715.2,Ankylosing spondylitis,musculoskeletal,OPGS011626,0.046,RNAseq,ABCF1,1.27 (1.19 1.35),9.40E-11
715.2,Ankylosing spondylitis,musculoskeletal,OPGS009711,0.075,RNAseq,TRAV21,0.73 (0.67 0.80),1.14E-10
715.2,Ankylosing spondylitis,musculoskeletal,OPGS007730,0.124,RNAseq,CKB,0.75 (0.70 0.81),1.59E-10
715.2,Ankylosing spondylitis,musculoskeletal,OPGS004567,0.343,RNAseq,HLA-C,0.75 (0.69 0.81),1.39E-09
715.2,Ankylosing spondylitis,musculoskeletal,OPGS005167,0.269,RNAseq,TCF19,0.67 (0.59 0.75),1.95E-09
715.2,Ankylosing spondylitis,musculoskeletal,OPGS005519,0.236,RNAseq,AL645933.3,0.78 (0.73 0.84),3.75E-09
715.2,Ankylosing spondylitis,musculoskeletal,OPGS003680,0.611,RNAseq,,0.74 (0.68 0.81),6.20E-08
715.2,Ankylosing spondylitis,musculoskeletal,OPGS011776,0.044,RNAseq,LST1,1.29 (1.19 1.39),6.20E-08
715.2,Ankylosing spondylitis,musculoskeletal,OPGS014580,0.018,RNAseq,DACT1,1.33 (1.22 1.45),6.20E-08
715.2,Ankylosing spondylitis,musculoskeletal,OPGS013503,0.026,RNAseq,NOTCH4,0.81 (0.76 0.86),8.85E-08
715.2,Ankylosing spondylitis,musculoskeletal,OPGS007248,0.141,RNAseq,,1.22 (1.15 1.31),3.25E-07
715.2,Ankylosing spondylitis,musculoskeletal,OPGS013514,0.026,RNAseq,GZMK,1.27 (1.17 1.37),8.12E-07
715.2,Ankylosing spondylitis,musculoskeletal,OPGS010041,0.069,RNAseq,GPRC5B,1.21 (1.14 1.29),9.05E-07
715.2,Ankylosing spondylitis,musculoskeletal,OPGS013699,0.025,RNAseq,TRAV5,1.26 (1.17 1.36),1.08E-06
715.2,Ankylosing spondylitis,musculoskeletal,OPGS008402,0.104,RNAseq,TNXB,1.24 (1.16 1.34),1.26E-06
715.2,Ankylosing spondylitis,musculoskeletal,OPGS009764,0.074,RNAseq,AIF1,0.82 (0.76 0.87),2.10E-06
715.2,Ankylosing spondylitis,musculoskeletal,OPGS010607,0.059,RNAseq,TRAV8-1,0.80 (0.74 0.86),1.01E-05
715.2,Ankylosing spondylitis,musculoskeletal,OPGS010492,0.061,RNAseq,HCG18,1.21 (1.13 1.29),1.74E-05
715.2,Ankylosing spondylitis,musculoskeletal,OPGS009198,0.085,RNAseq,TRAV12-1,0.81 (0.75 0.87),2.32E-05
715.2,Ankylosing spondylitis,musculoskeletal,OPGS008281,0.107,RNAseq,HLA-F-AS1,1.26 (1.16 1.38),3.12E-05
715.2,Ankylosing spondylitis,musculoskeletal,OPGS013225,0.029,RNAseq,REG4,1.24 (1.14 1.34),6.34E-05
715.2,Ankylosing spondylitis,musculoskeletal,OPGS011010,0.054,RNAseq,TRBV5-4,0.82 (0.77 0.89),7.49E-05
715.2,Ankylosing spondylitis,musculoskeletal,OPGS006248,0.189,RNAseq,MCCD1,1.23 (1.14 1.33),8.71E-05
715.2,Ankylosing spondylitis,musculoskeletal,OPGS014496,0.019,RNAseq,VARS1,0.80 (0.73 0.87),1.22E-04
715.2,Ankylosing spondylitis,musculoskeletal,OPGS014059,0.022,RNAseq,BCL2,1.21 (1.12 1.30),1.51E-04
715.2,Ankylosing spondylitis,musculoskeletal,OPGS007711,0.125,RNAseq,HMOX1,1.24 (1.14 1.35),1.68E-04
715.2,Ankylosing spondylitis,musculoskeletal,OPGS006716,0.164,RNAseq,IER3,0.83 (0.76 0.90),7.14E-04
715.2,Ankylosing spondylitis,musculoskeletal,OPGS009077,0.088,RNAseq,DDAH2,0.82 (0.76 0.89),7.41E-04
715.2,Ankylosing spondylitis,musculoskeletal,OPGS009684,0.075,RNAseq,TRAF5,0.84 (0.79 0.91),8.20E-04
715.2,Ankylosing spondylitis,musculoskeletal,OPGS009371,0.082,RNAseq,TRBV19,1.19 (1.10 1.28),1.26E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS011585,0.046,RNAseq,CD8B,1.20 (1.11 1.30),1.43E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS004334,0.383,RNAseq,HLA-G,1.19 (1.10 1.28),1.73E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS013959,0.023,RNAseq,TMEM131,0.83 (0.76 0.90),2.24E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS011288,0.050,RNAseq,AC104809.2,0.84 (0.78 0.91),2.24E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS012171,0.039,RNAseq,TRBV15,0.84 (0.78 0.91),2.24E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS013045,0.030,RNAseq,NEU1,1.20 (1.10 1.30),3.18E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS011512,0.047,RNAseq,NRM,1.12 (1.06 1.18),6.11E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS013924,0.023,RNAseq,,1.14 (1.07 1.21),6.59E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS003642,0.644,RNAseq,ERAP1,1.18 (1.09 1.27),8.18E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS013424,0.027,RNAseq,AL162586.1,1.16 (1.08 1.24),9.52E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS011671,0.045,RNAseq,MICA,0.84 (0.77 0.91),9.95E-03
715.2,Ankylosing spondylitis,musculoskeletal,OPGS011853,0.043,RNAseq,TRBV6-1,1.17 (1.08 1.26),1.12E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS011536,0.047,RNAseq,TRAV2,0.86 (0.79 0.93),2.35E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS011612,0.046,RNAseq,LINC02694,1.15 (1.07 1.25),3.27E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS007018,0.151,RNAseq,TRBV10-3,1.17 (1.08 1.27),3.34E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS012808,0.033,RNAseq,TRBV20-1,0.86 (0.80 0.93),3.55E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS013383,0.027,RNAseq,PPP1R11,1.13 (1.06 1.21),4.25E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS006282,0.187,RNAseq,CSNK1D,0.88 (0.82 0.94),4.50E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS014232,0.021,RNAseq,TRAV1-2,0.86 (0.80 0.94),4.50E-02
715.2,Ankylosing spondylitis,musculoskeletal,OPGS015030,0.016,RNAseq,PRRC2A,1.15 (1.07 1.25),4.52E-02
716.1,Unspecified polyarthropathy or polyarthritis,musculoskeletal,OPGS010783,0.057,RNAseq,YKT6,1.06 (1.03 1.08),3.71E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS000400,0.139,SomaScan,Agouti-signaling protein,1.03 (1.01 1.04),1.21E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS000172,0.257,SomaScan,Dermokine,1.03 (1.01 1.04),2.11E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS001130,0.044,SomaScan,Chordin-like protein 2,1.02 (1.01 1.04),3.15E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS001238,0.037,SomaScan,Dedicator of cytokinesis protein 9,1.02 (1.01 1.04),3.17E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS001879,0.015,SomaScan,Arfaptin-2,1.03 (1.01 1.04),3.29E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS002186,0.011,SomaScan,Suprabasin,0.98 (0.96 0.99),3.29E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS000120,0.344,SomaScan,Anaphase-promoting complex subunit 7,1.02 (1.01 1.04),3.30E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS000936,0.059,SomaScan,Membrane-associated progesterone receptor component 2,1.02 (1.01 1.04),3.30E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,1.02 (1.01 1.04),3.30E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS000715,0.082,SomaScan,Surfeit locus protein 1,0.98 (0.96 0.99),3.41E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS000158,0.272,SomaScan,Copine-1,1.02 (1.01 1.04),3.51E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS000185,0.252,SomaScan,Histone-lysine N-methyltransferase 2D,1.02 (1.01 1.04),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS000231,0.202,SomaScan,Glycosyltransferase 8 domain-containing protein 1,0.98 (0.97 0.99),4.01E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS000113,0.350,SomaScan,NADH dehydrogenase [ubiquinone] iron-sulfur protein 4. mitochondrial,1.02 (1.01 1.04),4.01E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS000521,0.113,SomaScan,Transmembrane protease serine 11D,1.02 (1.01 1.03),4.64E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS000356,0.149,SomaScan,Promotilin,1.02 (1.01 1.03),4.85E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS000056,0.473,SomaScan,Glycoprotein endo-alpha-1.2-mannosidase,1.02 (1.01 1.04),4.85E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS000705,0.084,SomaScan,Growth arrest and DNA damage-inducible proteins-interacting protein 1,0.98 (0.97 0.99),4.85E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS002648,0.017,Olink,Collagen alpha-1,0.97 (0.96 0.98),1.89E-03
716.2,Unspecified monoarthritis,musculoskeletal,OPGS002628,0.023,Olink,Pro-adrenomedullin,1.03 (1.02 1.04),2.73E-03
716.2,Unspecified monoarthritis,musculoskeletal,OPGS002629,0.023,Olink,Interleukin-18-binding protein,0.98 (0.97 0.99),4.03E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003054,0.023,Metabolon,X - 21286,0.97 (0.96 0.98),3.65E-03
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003096,0.019,Metabolon,pyroglutamylglutamine,0.97 (0.96 0.99),1.21E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003031,0.026,Metabolon,X - 21312,1.03 (1.01 1.04),2.51E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS002713,0.250,Metabolon,N-acetyltyrosine,1.02 (1.01 1.04),2.60E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS002721,0.209,Metabolon,N-acetylphenylalanine,1.02 (1.01 1.04),3.41E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS002869,0.063,Metabolon,X - 11334,0.98 (0.97 0.99),3.51E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS002886,0.057,Metabolon,X - 12822,1.02 (1.01 1.04),3.51E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS002730,0.193,Metabolon,N-acetylkynurenine (2),1.02 (1.01 1.04),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003225,0.010,Metabolon,pyruvate,0.98 (0.97 0.99),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS002696,0.399,Metabolon,N-acetylarginine,1.02 (1.01 1.04),3.83E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003143,0.015,Metabolon,3-(4-hydroxyphenyl)lactate,1.02 (1.01 1.04),3.89E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003044,0.024,Metabolon,X - 21795,1.02 (1.01 1.04),4.01E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003089,0.020,Metabolon,X - 17690,1.02 (1.01 1.04),4.01E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS002766,0.128,Metabolon,N-acetylleucine,1.02 (1.01 1.03),4.64E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS002957,0.040,Metabolon,cys-gly. oxidized,0.98 (0.97 0.99),4.64E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,0.97 (0.96 0.99),1.18E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,0.98 (0.96 0.99),2.51E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,0.98 (0.96 0.99),3.04E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003444,0.101,Nightingale,Apolipoprotein B,0.98 (0.96 0.99),3.04E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,0.98 (0.96 0.99),3.25E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,0.98 (0.96 0.99),3.29E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,0.98 (0.96 0.99),3.29E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003428,0.121,Nightingale,Total lipids in small LDL,0.98 (0.96 0.99),3.29E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,0.98 (0.97 0.99),3.42E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,0.98 (0.97 0.99),3.51E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003431,0.118,Nightingale,Total lipids in large LDL,0.98 (0.97 0.99),3.51E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003423,0.126,Nightingale,LDL cholesterol,0.98 (0.97 0.99),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,0.98 (0.97 0.99),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,0.98 (0.97 0.99),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,0.98 (0.97 0.99),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,0.98 (0.97 0.99),3.81E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,0.98 (0.97 0.99),4.03E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003452,0.087,Nightingale,Total cholesterol,0.98 (0.97 0.99),4.06E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,0.98 (0.97 0.99),4.06E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003434,0.113,Nightingale,Phospholipids in IDL,0.98 (0.97 0.99),4.06E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,0.98 (0.97 0.99),4.09E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,0.98 (0.97 0.99),4.39E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,0.98 (0.97 0.99),4.56E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS009479,0.080,RNAseq,AL121753.2,1.04 (1.02 1.05),6.14E-05
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003943,0.486,RNAseq,CLEC18A,0.97 (0.95 0.98),2.42E-04
716.2,Unspecified monoarthritis,musculoskeletal,OPGS012484,0.036,RNAseq,ABCB9,0.97 (0.95 0.98),2.42E-04
716.2,Unspecified monoarthritis,musculoskeletal,OPGS011365,0.049,RNAseq,GGT7,1.03 (1.02 1.05),9.81E-04
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003843,0.532,RNAseq,BTN3A2,0.97 (0.96 0.98),1.77E-03
716.2,Unspecified monoarthritis,musculoskeletal,OPGS012019,0.041,RNAseq,SEMA7A,1.03 (1.02 1.04),1.89E-03
716.2,Unspecified monoarthritis,musculoskeletal,OPGS006132,0.196,RNAseq,EIF6,0.97 (0.96 0.98),3.65E-03
716.2,Unspecified monoarthritis,musculoskeletal,OPGS007313,0.139,RNAseq,MMP24OS,1.03 (1.02 1.04),3.65E-03
716.2,Unspecified monoarthritis,musculoskeletal,OPGS005829,0.213,RNAseq,MACF1,1.03 (1.02 1.04),3.65E-03
716.2,Unspecified monoarthritis,musculoskeletal,OPGS010066,0.068,RNAseq,PSMG1,0.97 (0.96 0.98),4.26E-03
716.2,Unspecified monoarthritis,musculoskeletal,OPGS011291,0.050,RNAseq,GMPPB,1.03 (1.02 1.04),8.10E-03
716.2,Unspecified monoarthritis,musculoskeletal,OPGS004014,0.460,RNAseq,PRMT6,0.97 (0.96 0.98),8.44E-03
716.2,Unspecified monoarthritis,musculoskeletal,OPGS013780,0.024,RNAseq,ZSCAN16,1.03 (1.01 1.04),1.21E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS006942,0.154,RNAseq,SKIV2L,0.97 (0.96 0.99),1.32E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS011286,0.050,RNAseq,USP8,0.97 (0.96 0.99),1.40E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS005059,0.281,RNAseq,STIM2,1.03 (1.01 1.04),1.62E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS012734,0.033,RNAseq,ERLEC1,0.98 (0.96 0.99),1.81E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS005356,0.251,RNAseq,TTC37,1.03 (1.01 1.04),1.87E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS014739,0.017,RNAseq,MPHOSPH9,0.97 (0.96 0.99),1.87E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS013788,0.024,RNAseq,SUMO1,1.03 (1.01 1.04),1.87E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS014341,0.020,RNAseq,NFAT5,1.03 (1.01 1.04),2.22E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS008628,0.098,RNAseq,DYM,0.98 (0.96 0.99),2.26E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS010103,0.068,RNAseq,RABGAP1L,0.98 (0.96 0.99),2.26E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS009849,0.072,RNAseq,SOCS2,0.98 (0.96 0.99),2.26E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS010215,0.066,RNAseq,CLEC18B,1.03 (1.01 1.04),2.26E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS013243,0.029,RNAseq,TRAV3,0.98 (0.96 0.99),2.26E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS013925,0.023,RNAseq,SPOPL,1.03 (1.01 1.04),2.34E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS014898,0.016,RNAseq,AC010245.2,1.03 (1.01 1.04),2.51E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS008702,0.097,RNAseq,,0.98 (0.96 0.99),2.60E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS014006,0.023,RNAseq,AC126544.1,0.98 (0.96 0.99),2.60E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS009865,0.072,RNAseq,TRAV17,0.98 (0.96 0.99),2.83E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS013286,0.028,RNAseq,AC137932.1,0.98 (0.96 0.99),2.85E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS005037,0.283,RNAseq,RWDD2B,0.98 (0.96 0.99),3.04E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS012257,0.038,RNAseq,NMD3,0.98 (0.96 0.99),3.04E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS007975,0.116,RNAseq,LTBP3,1.02 (1.01 1.04),3.04E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS005660,0.224,RNAseq,TFG,0.98 (0.96 0.99),3.04E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS008226,0.108,RNAseq,DPH1,1.02 (1.01 1.04),3.16E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS007604,0.128,RNAseq,U91328.1,1.02 (1.01 1.04),3.16E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS008896,0.092,RNAseq,COL27A1,0.98 (0.96 0.99),3.25E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS009633,0.076,RNAseq,CAPZB,1.02 (1.01 1.04),3.29E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS007663,0.127,RNAseq,NFE4,1.02 (1.01 1.04),3.29E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS007988,0.116,RNAseq,AC010632.2,1.02 (1.01 1.04),3.30E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS007354,0.137,RNAseq,ACOT4,1.02 (1.01 1.04),3.41E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS012964,0.031,RNAseq,SLC33A1,1.02 (1.01 1.04),3.42E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS009371,0.082,RNAseq,TRBV19,0.98 (0.96 0.99),3.42E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS013711,0.025,RNAseq,AL008727.1,1.02 (1.01 1.04),3.45E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS009150,0.086,RNAseq,UQCC1,1.02 (1.01 1.04),3.51E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS011036,0.053,RNAseq,GABARAPL1,1.02 (1.01 1.04),3.57E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS010512,0.061,RNAseq,ITCH,0.98 (0.97 0.99),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS009260,0.084,RNAseq,CSK,0.98 (0.97 0.99),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS005117,0.275,RNAseq,NPIPB12,1.02 (1.01 1.04),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS007954,0.117,RNAseq,LINC00910,0.98 (0.96 0.99),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS013349,0.028,RNAseq,UNC119,1.02 (1.01 1.04),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS012897,0.032,RNAseq,MROH8,0.98 (0.96 0.99),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS009241,0.084,RNAseq,ZKSCAN4,1.02 (1.01 1.04),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003790,0.552,RNAseq,,0.98 (0.97 0.99),3.58E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS008537,0.101,RNAseq,CERS6,1.02 (1.01 1.04),4.01E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS012027,0.041,RNAseq,HS2ST1,0.98 (0.97 0.99),4.01E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS013217,0.029,RNAseq,HMOX2,0.98 (0.97 0.99),4.03E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS004943,0.293,RNAseq,,0.98 (0.97 0.99),4.06E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS008694,0.097,RNAseq,LTBP1,0.98 (0.97 0.99),4.06E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS007321,0.139,RNAseq,BTN2A2,1.02 (1.01 1.04),4.39E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS013141,0.029,RNAseq,RPS10,1.02 (1.01 1.03),4.39E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS008286,0.107,RNAseq,NUDT4,0.98 (0.97 0.99),4.41E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS007152,0.146,RNAseq,ASAP1,1.02 (1.01 1.03),4.46E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS012640,0.034,RNAseq,WBP1L,1.02 (1.01 1.03),4.60E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS013350,0.028,RNAseq,ACSS2,1.02 (1.01 1.03),4.60E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS004125,0.429,RNAseq,UHRF1BP1,1.02 (1.01 1.03),4.64E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS005353,0.251,RNAseq,WWP2,1.02 (1.01 1.03),4.85E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS009228,0.085,RNAseq,SNRPC,0.98 (0.97 0.99),4.85E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS005879,0.210,RNAseq,EPS8L2,1.02 (1.01 1.03),4.85E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS003732,0.582,RNAseq,AL513550.1,0.98 (0.97 0.99),4.85E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS008151,0.110,RNAseq,FASN,0.98 (0.97 0.99),4.86E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS009868,0.072,RNAseq,SND1,1.02 (1.01 1.03),4.86E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS014093,0.022,RNAseq,MYBL1,0.98 (0.97 0.99),4.86E-02
716.2,Unspecified monoarthritis,musculoskeletal,OPGS009446,0.081,RNAseq,TRAF3,1.02 (1.01 1.03),4.98E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS001238,0.037,SomaScan,Dedicator of cytokinesis protein 9,1.02 (1.01 1.03),1.11E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS000521,0.113,SomaScan,Transmembrane protease serine 11D,1.02 (1.01 1.03),3.08E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS000011,0.683,SomaScan,Hepatocyte growth factor-like protein,1.02 (1.01 1.03),3.42E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS000636,0.093,SomaScan,Galectin-3,1.02 (1.01 1.03),4.59E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS000632,0.093,SomaScan,Erythrocyte band 7 integral membrane protein,1.02 (1.01 1.03),6.40E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS000172,0.257,SomaScan,Dermokine,1.02 (1.01 1.03),7.02E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS000204,0.233,SomaScan,PR domain zinc finger protein 1,1.02 (1.01 1.03),7.65E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS002046,0.012,SomaScan,Set1/Ash2 histone methyltransferase complex subunit ASH2,1.02 (1.01 1.03),1.01E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.98 (0.97 0.99),1.15E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS000698,0.085,SomaScan,Alcohol dehydrogenase 1B,1.02 (1.01 1.03),1.44E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,1.02 (1.01 1.03),2.08E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS001130,0.044,SomaScan,Chordin-like protein 2,1.02 (1.01 1.03),2.21E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS001542,0.024,SomaScan,Prostate-associated microseminoprotein,1.02 (1.01 1.03),2.44E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS000356,0.149,SomaScan,Promotilin,1.02 (1.01 1.03),2.65E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS000715,0.082,SomaScan,Surfeit locus protein 1,0.98 (0.97 0.99),2.77E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS001145,0.042,SomaScan,Amyloid beta A4 precursor protein-binding family B member 2,1.02 (1.01 1.03),2.88E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS000984,0.055,SomaScan,Complement C2,1.02 (1.01 1.03),2.88E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS001928,0.014,SomaScan,Sorting nexin-1,1.02 (1.01 1.03),3.02E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS000375,0.143,SomaScan,Thrombospondin-2,0.98 (0.97 0.99),3.06E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS001207,0.038,SomaScan,Apolipoprotein M,1.02 (1.01 1.03),3.14E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS000873,0.065,SomaScan,Tensin-2,1.02 (1.01 1.03),3.64E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS002464,0.144,Olink,Thrombospondin-2,0.98 (0.97 0.99),9.72E-04
716.9,Arthropathy NOS,musculoskeletal,OPGS002628,0.023,Olink,Pro-adrenomedullin,1.02 (1.01 1.03),3.08E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS002648,0.017,Olink,Collagen alpha-1,0.98 (0.97 0.99),1.01E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS002451,0.164,Olink,Galectin-3,1.02 (1.01 1.03),1.95E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS003054,0.023,Metabolon,X - 21286,0.98 (0.97 0.99),1.11E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS003096,0.019,Metabolon,pyroglutamylglutamine,0.98 (0.97 0.99),1.79E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS002698,0.378,Metabolon,X - 19141,0.98 (0.97 0.99),2.13E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS003225,0.010,Metabolon,pyruvate,0.98 (0.97 0.99),2.65E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS003089,0.020,Metabolon,X - 17690,1.02 (1.01 1.03),3.06E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS002886,0.057,Metabolon,X - 12822,1.02 (1.01 1.03),4.27E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,0.98 (0.97 0.99),3.04E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS006132,0.196,RNAseq,EIF6,0.97 (0.96 0.98),2.72E-05
716.9,Arthropathy NOS,musculoskeletal,OPGS012484,0.036,RNAseq,ABCB9,0.97 (0.96 0.98),8.37E-05
716.9,Arthropathy NOS,musculoskeletal,OPGS011291,0.050,RNAseq,GMPPB,1.03 (1.02 1.04),8.37E-05
716.9,Arthropathy NOS,musculoskeletal,OPGS009479,0.080,RNAseq,AL121753.2,1.03 (1.02 1.04),8.37E-05
716.9,Arthropathy NOS,musculoskeletal,OPGS011365,0.049,RNAseq,GGT7,1.02 (1.01 1.03),9.72E-04
716.9,Arthropathy NOS,musculoskeletal,OPGS005059,0.281,RNAseq,STIM2,1.02 (1.01 1.03),9.72E-04
716.9,Arthropathy NOS,musculoskeletal,OPGS007313,0.139,RNAseq,MMP24OS,1.02 (1.01 1.03),9.72E-04
716.9,Arthropathy NOS,musculoskeletal,OPGS014739,0.017,RNAseq,MPHOSPH9,0.98 (0.97 0.99),1.11E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS005829,0.213,RNAseq,MACF1,1.02 (1.01 1.03),1.93E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS005825,0.213,RNAseq,TMEM30A,1.02 (1.01 1.03),3.08E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS014859,0.017,RNAseq,AC104452.1,0.98 (0.97 0.99),3.08E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS003843,0.532,RNAseq,BTN3A2,0.98 (0.97 0.99),3.08E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS003943,0.486,RNAseq,CLEC18A,0.98 (0.97 0.99),3.36E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS013243,0.029,RNAseq,TRAV3,0.98 (0.97 0.99),3.37E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS012019,0.041,RNAseq,SEMA7A,1.02 (1.01 1.03),4.23E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS008896,0.092,RNAseq,COL27A1,0.98 (0.97 0.99),6.40E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS013788,0.024,RNAseq,SUMO1,1.02 (1.01 1.03),9.63E-03
716.9,Arthropathy NOS,musculoskeletal,OPGS009865,0.072,RNAseq,TRAV17,0.98 (0.97 0.99),1.01E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS011286,0.050,RNAseq,USP8,0.98 (0.97 0.99),1.01E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS005356,0.251,RNAseq,TTC37,1.02 (1.01 1.03),1.33E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS014542,0.019,RNAseq,AC011676.1,1.02 (1.01 1.03),1.44E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS013780,0.024,RNAseq,ZSCAN16,1.02 (1.01 1.03),1.44E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS014093,0.022,RNAseq,MYBL1,0.98 (0.97 0.99),1.60E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS006193,0.192,RNAseq,AC091230.1,0.98 (0.97 0.99),1.79E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS005289,0.258,RNAseq,UBA7,0.98 (0.97 0.99),1.79E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS004014,0.460,RNAseq,PRMT6,0.98 (0.97 0.99),1.95E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS009551,0.078,RNAseq,PCED1B-AS1,1.02 (1.01 1.03),1.96E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS003732,0.582,RNAseq,AL513550.1,0.98 (0.97 0.99),2.00E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS004534,0.349,RNAseq,BX322234.1,0.98 (0.97 0.99),2.64E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS013350,0.028,RNAseq,ACSS2,1.02 (1.01 1.03),2.65E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS007152,0.146,RNAseq,ASAP1,1.02 (1.01 1.03),2.65E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS006283,0.187,RNAseq,SCAMP2,1.02 (1.01 1.03),2.65E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS012593,0.035,RNAseq,BMP2K,1.02 (1.01 1.03),2.70E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS010636,0.059,RNAseq,ARHGAP32,1.02 (1.01 1.03),2.70E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS012628,0.034,RNAseq,RMC1,0.98 (0.97 0.99),2.77E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS005944,0.207,RNAseq,SSR1,0.98 (0.97 0.99),2.77E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS007238,0.142,RNAseq,FAM13A,1.02 (1.01 1.03),2.77E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS012964,0.031,RNAseq,SLC33A1,1.02 (1.01 1.03),2.88E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS013853,0.024,RNAseq,,1.02 (1.01 1.03),2.88E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS005254,0.260,RNAseq,MAN2C1,0.98 (0.97 0.99),2.88E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS010103,0.068,RNAseq,RABGAP1L,0.98 (0.97 0.99),2.88E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS011036,0.053,RNAseq,GABARAPL1,1.02 (1.01 1.03),2.88E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS014362,0.020,RNAseq,G6PC3,1.02 (1.01 1.03),2.88E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS008244,0.108,RNAseq,ICA1L,0.98 (0.97 0.99),2.88E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS009260,0.084,RNAseq,CSK,0.98 (0.97 0.99),3.02E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS003620,0.668,RNAseq,ZFP57,1.02 (1.01 1.03),3.02E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS005142,0.272,RNAseq,ZDHHC20,0.98 (0.97 0.99),3.04E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS014600,0.018,RNAseq,KXD1,1.02 (1.01 1.03),3.14E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS008310,0.106,RNAseq,HTRA1,1.02 (1.01 1.03),3.24E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS010512,0.061,RNAseq,ITCH,0.98 (0.97 0.99),3.25E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS007354,0.137,RNAseq,ACOT4,1.02 (1.01 1.03),3.48E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS012973,0.031,RNAseq,,1.02 (1.01 1.03),3.65E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS007321,0.139,RNAseq,BTN2A2,1.02 (1.01 1.03),3.74E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS007287,0.140,RNAseq,MAX,0.98 (0.97 0.99),3.76E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS004612,0.338,RNAseq,,0.98 (0.97 0.99),4.15E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS004949,0.293,RNAseq,ILRUN,1.02 (1.01 1.03),4.40E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS005117,0.275,RNAseq,NPIPB12,1.02 (1.01 1.03),4.42E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS014341,0.020,RNAseq,NFAT5,1.02 (1.01 1.03),4.50E-02
716.9,Arthropathy NOS,musculoskeletal,OPGS011832,0.043,RNAseq,HDAC11,1.02 (1.01 1.03),4.64E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001860,0.016,SomaScan,Immunoglobulin E,0.81 (0.78 0.84),7.30E-23
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002246,0.010,SomaScan,Sperm-associated antigen 11B,0.86 (0.83 0.89),5.10E-14
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001454,0.027,SomaScan,Tuberoinfundibular peptide of 39 residues,1.17 (1.13 1.22),5.93E-14
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001603,0.022,SomaScan,Zinc fingers and homeoboxes protein 3,0.84 (0.81 0.88),2.64E-12
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000645,0.091,SomaScan,Trypsin-3,0.87 (0.84 0.90),8.63E-12
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000137,0.312,SomaScan,Complement C4b,0.87 (0.84 0.90),1.23E-10
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001693,0.020,SomaScan,Cyclic AMP-dependent transcription factor ATF-6 alpha,0.87 (0.84 0.91),1.43E-10
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,1.15 (1.11 1.19),2.94E-10
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002070,0.012,SomaScan,Gro-beta/gamma,0.86 (0.83 0.90),7.80E-10
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001598,0.022,SomaScan,SPARC,0.89 (0.85 0.92),2.55E-08
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,0.89 (0.86 0.92),1.92E-07
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001416,0.029,SomaScan,Vesicle-fusing ATPase,1.13 (1.08 1.17),3.32E-07
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001893,0.015,SomaScan,Interleukin-17F,0.88 (0.85 0.92),4.19E-07
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,0.90 (0.86 0.93),1.42E-06
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001911,0.014,SomaScan,Ectodysplasin-A. secreted form,0.89 (0.85 0.92),1.65E-06
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002103,0.012,SomaScan,Trefoil factor 3,0.89 (0.85 0.93),1.69E-05
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001053,0.049,SomaScan,C-C motif chemokine 19,0.90 (0.86 0.93),3.92E-05
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001553,0.024,SomaScan,Protein G6b,1.11 (1.07 1.15),8.57E-05
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001281,0.035,SomaScan,PAX-interacting protein 1,0.91 (0.87 0.94),1.30E-04
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001550,0.024,SomaScan,Trefoil factor 3,0.90 (0.87 0.94),1.65E-04
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.91 (0.88 0.94),1.88E-04
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001231,0.037,SomaScan,Osteocalcin,1.10 (1.06 1.14),2.16E-04
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000576,0.102,SomaScan,Interleukin-21,0.91 (0.88 0.95),3.44E-04
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002012,0.013,SomaScan,Apolipoprotein M,1.12 (1.07 1.17),1.06E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000517,0.114,SomaScan,Advanced glycosylation end product-specific receptor. soluble,0.92 (0.88 0.95),1.15E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000397,0.139,SomaScan,TLR4 interactor with leucine rich repeats,0.92 (0.89 0.95),2.16E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001595,0.022,SomaScan,Thioredoxin domain-containing protein 15,1.09 (1.05 1.13),2.99E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.92 (0.89 0.96),5.05E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,0.92 (0.88 0.95),5.73E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001135,0.043,SomaScan,Hepatocyte nuclear factor 4-alpha,0.92 (0.89 0.96),6.03E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000311,0.164,SomaScan,Tyrosine-protein kinase JAK2,0.93 (0.89 0.96),8.82E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000213,0.222,SomaScan,ER membrane protein complex subunit 4,1.08 (1.04 1.12),1.52E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000042,0.526,SomaScan,Inactive peptidyl-prolyl cis-trans isomerase FKBP6,0.93 (0.89 0.96),1.91E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001210,0.038,SomaScan,Neurensin-1,0.93 (0.90 0.96),1.96E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000688,0.086,SomaScan,Dual specificity protein kinase CLK2,0.93 (0.90 0.96),1.96E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000750,0.078,SomaScan,Adrenomedullin,0.93 (0.90 0.97),2.15E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.93 (0.90 0.97),3.02E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000647,0.091,SomaScan,Mucin-1,0.93 (0.90 0.97),3.21E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001432,0.028,SomaScan,Synaptotagmin-like protein 4,0.93 (0.90 0.97),3.40E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000633,0.093,SomaScan,Interleukin-10 receptor subunit alpha,0.93 (0.90 0.97),3.96E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001410,0.029,SomaScan,Dipeptidyl peptidase 2,0.93 (0.90 0.97),3.97E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000257,0.191,SomaScan,Arf-GAP with SH3 domain. ANK repeat and PH domain-containing protein 2,0.93 (0.90 0.97),4.05E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001770,0.018,SomaScan,Myelin regulatory factor,0.93 (0.89 0.97),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002230,0.011,SomaScan,Protein delta homolog 1,0.93 (0.90 0.97),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002115,0.012,SomaScan,Uncharacterized protein C1orf115,0.93 (0.90 0.97),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002059,0.012,SomaScan,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11. mitochondrial,0.93 (0.90 0.97),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001886,0.015,SomaScan,Peptidyl-prolyl cis-trans isomerase FKBP2,1.07 (1.03 1.11),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002094,0.012,SomaScan,HEPACAM family member 2,0.93 (0.90 0.97),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002322,0.010,SomaScan,E3 ubiquitin-protein ligase RNF43,0.93 (0.90 0.97),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002251,0.010,SomaScan,Calcineurin B homologous protein 3,0.93 (0.90 0.97),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002119,0.012,SomaScan,Oxytocin-neurophysin 1,0.93 (0.90 0.97),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002325,0.010,SomaScan,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1,0.93 (0.90 0.97),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002262,0.010,SomaScan,EMILIN-3,1.07 (1.03 1.11),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002203,0.011,SomaScan,Leucine-rich repeat-containing protein 37A2,1.07 (1.03 1.11),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000051,0.488,SomaScan,Vitronectin,0.93 (0.90 0.97),4.43E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001577,0.023,SomaScan,Opalin,1.07 (1.03 1.11),4.52E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001850,0.016,SomaScan,Uncharacterized protein C4orf32,0.93 (0.90 0.97),4.61E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001194,0.039,SomaScan,Ras-related protein Rab-35,0.93 (0.90 0.97),4.62E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS001632,0.021,SomaScan,Rhophilin-2,0.93 (0.90 0.97),4.67E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS000260,0.190,SomaScan,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,0.93 (0.90 0.97),4.73E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002026,0.012,SomaScan,UBX domain-containing protein 4,1.07 (1.03 1.11),4.78E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002559,0.048,Olink,C-C motif chemokine 19,0.87 (0.84 0.90),1.21E-09
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002399,0.342,Olink,Pulmonary surfactant-associated protein D,1.08 (1.04 1.12),4.97E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.92 (0.89 0.96),5.28E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002560,0.048,Olink,Epithelial discoidin domain-containing receptor 1,0.92 (0.89 0.96),7.06E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS002530,0.067,Olink,Trefoil factor 3,0.93 (0.89 0.97),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS003216,0.011,Metabolon,1-linolenoyl-GPC (18:3)*,1.07 (1.03 1.11),2.45E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS003188,0.012,Metabolon,2-palmitoleoyl-GPC (16:1)*,1.07 (1.03 1.11),4.52E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS006038,0.201,RNAseq,HLA-DQA2,1.23 (1.19 1.27),2.30E-30
717,Polymyalgia Rheumatica,musculoskeletal,OPGS008889,0.092,RNAseq,TRAV20,1.22 (1.17 1.26),7.30E-23
717,Polymyalgia Rheumatica,musculoskeletal,OPGS012171,0.039,RNAseq,TRBV15,0.83 (0.80 0.86),4.25E-21
717,Polymyalgia Rheumatica,musculoskeletal,OPGS005389,0.248,RNAseq,TRAV23DV6,0.85 (0.82 0.88),4.63E-20
717,Polymyalgia Rheumatica,musculoskeletal,OPGS007018,0.151,RNAseq,TRBV10-3,1.22 (1.17 1.27),2.92E-19
717,Polymyalgia Rheumatica,musculoskeletal,OPGS013958,0.023,RNAseq,CSNK2B,0.84 (0.81 0.87),6.59E-19
717,Polymyalgia Rheumatica,musculoskeletal,OPGS008402,0.104,RNAseq,TNXB,1.18 (1.14 1.22),3.38E-17
717,Polymyalgia Rheumatica,musculoskeletal,OPGS009711,0.075,RNAseq,TRAV21,0.83 (0.80 0.87),4.90E-17
717,Polymyalgia Rheumatica,musculoskeletal,OPGS012808,0.033,RNAseq,TRBV20-1,0.84 (0.81 0.87),1.35E-16
717,Polymyalgia Rheumatica,musculoskeletal,OPGS011536,0.047,RNAseq,TRAV2,0.85 (0.81 0.88),1.46E-14
717,Polymyalgia Rheumatica,musculoskeletal,OPGS013305,0.028,RNAseq,TRBV14,0.86 (0.83 0.89),3.54E-13
717,Polymyalgia Rheumatica,musculoskeletal,OPGS013243,0.029,RNAseq,TRAV3,0.86 (0.83 0.90),2.64E-12
717,Polymyalgia Rheumatica,musculoskeletal,OPGS004213,0.410,RNAseq,,1.14 (1.10 1.18),1.36E-10
717,Polymyalgia Rheumatica,musculoskeletal,OPGS015030,0.016,RNAseq,PRRC2A,1.13 (1.09 1.17),1.80E-07
717,Polymyalgia Rheumatica,musculoskeletal,OPGS004567,0.343,RNAseq,HLA-C,0.89 (0.86 0.92),3.13E-07
717,Polymyalgia Rheumatica,musculoskeletal,OPGS008356,0.105,RNAseq,IL6ST,1.12 (1.08 1.17),9.18E-07
717,Polymyalgia Rheumatica,musculoskeletal,OPGS013045,0.030,RNAseq,NEU1,1.12 (1.08 1.17),1.25E-06
717,Polymyalgia Rheumatica,musculoskeletal,OPGS010348,0.063,RNAseq,TRBV6-5,1.12 (1.07 1.16),2.66E-06
717,Polymyalgia Rheumatica,musculoskeletal,OPGS006845,0.158,RNAseq,FLOT1,1.11 (1.07 1.15),2.66E-06
717,Polymyalgia Rheumatica,musculoskeletal,OPGS013201,0.029,RNAseq,NRCAM,0.89 (0.86 0.93),4.25E-06
717,Polymyalgia Rheumatica,musculoskeletal,OPGS010607,0.059,RNAseq,TRAV8-1,0.90 (0.86 0.93),4.32E-06
717,Polymyalgia Rheumatica,musculoskeletal,OPGS005230,0.263,RNAseq,LINC00243,1.10 (1.06 1.15),6.63E-05
717,Polymyalgia Rheumatica,musculoskeletal,OPGS013699,0.025,RNAseq,TRAV5,1.10 (1.06 1.14),1.02E-04
717,Polymyalgia Rheumatica,musculoskeletal,OPGS006942,0.154,RNAseq,SKIV2L,0.91 (0.87 0.94),1.48E-04
717,Polymyalgia Rheumatica,musculoskeletal,OPGS014496,0.019,RNAseq,VARS1,0.91 (0.87 0.94),3.65E-04
717,Polymyalgia Rheumatica,musculoskeletal,OPGS009198,0.085,RNAseq,TRAV12-1,1.10 (1.06 1.14),4.24E-04
717,Polymyalgia Rheumatica,musculoskeletal,OPGS004144,0.424,RNAseq,PSORS1C3,1.09 (1.05 1.13),4.80E-04
717,Polymyalgia Rheumatica,musculoskeletal,OPGS011344,0.049,RNAseq,,1.09 (1.05 1.13),5.85E-04
717,Polymyalgia Rheumatica,musculoskeletal,OPGS006866,0.157,RNAseq,AL662795.2,1.10 (1.05 1.14),6.39E-04
717,Polymyalgia Rheumatica,musculoskeletal,OPGS009300,0.083,RNAseq,TRAV26-1,1.09 (1.05 1.14),9.42E-04
717,Polymyalgia Rheumatica,musculoskeletal,OPGS012006,0.041,RNAseq,VARS2,1.09 (1.05 1.13),1.14E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS005262,0.259,RNAseq,ANKRD55,1.09 (1.05 1.13),1.48E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS012698,0.034,RNAseq,SNHG32,1.09 (1.05 1.12),1.88E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS007240,0.142,RNAseq,,0.91 (0.88 0.95),2.39E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS004237,0.404,RNAseq,ADCY9,0.92 (0.89 0.96),3.09E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS011671,0.045,RNAseq,MICA,1.08 (1.04 1.12),4.43E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS004537,0.348,RNAseq,VWF,0.92 (0.89 0.96),5.77E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS010917,0.055,RNAseq,LSM2,1.09 (1.05 1.14),6.76E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS008281,0.107,RNAseq,HLA-F-AS1,1.08 (1.04 1.13),7.75E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS011382,0.048,RNAseq,LMAN2,1.08 (1.04 1.12),9.50E-03
717,Polymyalgia Rheumatica,musculoskeletal,OPGS014283,0.021,RNAseq,MXRA8,0.93 (0.89 0.96),1.24E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS014232,0.021,RNAseq,TRAV1-2,1.08 (1.04 1.12),1.26E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS011787,0.044,RNAseq,C2,1.08 (1.04 1.12),1.48E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS014075,0.022,RNAseq,AGER,0.93 (0.89 0.96),1.96E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS010277,0.065,RNAseq,CXCR6,1.08 (1.04 1.12),1.96E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS013999,0.023,RNAseq,GUK1,1.07 (1.03 1.10),2.48E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS011948,0.042,RNAseq,ADGRG1,0.93 (0.90 0.97),3.20E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS013324,0.028,RNAseq,PRF1,0.94 (0.91 0.97),3.26E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS013968,0.023,RNAseq,AGBL3,1.07 (1.03 1.11),3.54E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS009865,0.072,RNAseq,TRAV17,0.93 (0.90 0.97),3.94E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS007546,0.131,RNAseq,ZBP1,1.07 (1.03 1.12),4.33E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS008867,0.093,RNAseq,TSBP1-AS1,1.07 (1.03 1.12),4.39E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS005011,0.285,RNAseq,,1.07 (1.03 1.11),4.62E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS008714,0.096,RNAseq,,1.07 (1.03 1.11),4.62E-02
717,Polymyalgia Rheumatica,musculoskeletal,OPGS013514,0.026,RNAseq,GZMK,1.07 (1.03 1.11),4.80E-02
722,Intervertebral disc disorders,musculoskeletal,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,0.95 (0.93 0.97),1.64E-02
722,Intervertebral disc disorders,musculoskeletal,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.05 (1.03 1.07),2.25E-02
722,Intervertebral disc disorders,musculoskeletal,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,1.05 (1.02 1.07),3.48E-02
722,Intervertebral disc disorders,musculoskeletal,OPGS000106,0.366,SomaScan,Protein FAM3D,1.05 (1.02 1.07),3.48E-02
722,Intervertebral disc disorders,musculoskeletal,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,0.96 (0.94 0.98),3.66E-02
722,Intervertebral disc disorders,musculoskeletal,OPGS000572,0.102,SomaScan,Glutamate receptor 4,0.96 (0.94 0.98),4.01E-02
722,Intervertebral disc disorders,musculoskeletal,OPGS004949,0.293,RNAseq,ILRUN,1.06 (1.04 1.08),3.75E-04
722,Intervertebral disc disorders,musculoskeletal,OPGS012006,0.041,RNAseq,VARS2,0.94 (0.93 0.96),3.75E-04
722,Intervertebral disc disorders,musculoskeletal,OPGS003680,0.611,RNAseq,,1.05 (1.03 1.07),9.10E-03
722,Intervertebral disc disorders,musculoskeletal,OPGS014496,0.019,RNAseq,VARS1,1.05 (1.03 1.07),9.10E-03
722,Intervertebral disc disorders,musculoskeletal,OPGS014232,0.021,RNAseq,TRAV1-2,0.96 (0.94 0.98),3.48E-02
722.7,Intervertebral disc disorder with myelopathy,musculoskeletal,OPGS013759,0.024,RNAseq,ATG16L1,1.17 (1.10 1.25),2.16E-02
722.9,Other and unspecified disc disorder,musculoskeletal,OPGS000521,0.113,SomaScan,Transmembrane protease serine 11D,1.06 (1.03 1.09),3.31E-02
722.9,Other and unspecified disc disorder,musculoskeletal,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,1.06 (1.03 1.08),3.45E-02
722.9,Other and unspecified disc disorder,musculoskeletal,OPGS000645,0.091,SomaScan,Trypsin-3,1.06 (1.03 1.08),3.68E-02
722.9,Other and unspecified disc disorder,musculoskeletal,OPGS005289,0.258,RNAseq,UBA7,0.94 (0.92 0.96),1.68E-02
722.9,Other and unspecified disc disorder,musculoskeletal,OPGS012628,0.034,RNAseq,RMC1,0.94 (0.92 0.97),1.68E-02
722.9,Other and unspecified disc disorder,musculoskeletal,OPGS012006,0.041,RNAseq,VARS2,0.94 (0.92 0.97),1.99E-02
722.9,Other and unspecified disc disorder,musculoskeletal,OPGS014232,0.021,RNAseq,TRAV1-2,0.94 (0.92 0.97),2.02E-02
722.9,Other and unspecified disc disorder,musculoskeletal,OPGS008889,0.092,RNAseq,TRAV20,0.95 (0.92 0.97),3.68E-02
726.1,Enthesopathy,musculoskeletal,OPGS000521,0.113,SomaScan,Transmembrane protease serine 11D,1.05 (1.03 1.07),2.98E-02
726.1,Enthesopathy,musculoskeletal,OPGS001238,0.037,SomaScan,Dedicator of cytokinesis protein 9,1.05 (1.03 1.07),2.98E-02
726.1,Enthesopathy,musculoskeletal,OPGS000632,0.093,SomaScan,Erythrocyte band 7 integral membrane protein,1.05 (1.03 1.07),3.08E-02
726.1,Enthesopathy,musculoskeletal,OPGS000698,0.085,SomaScan,Alcohol dehydrogenase 1B,1.05 (1.02 1.07),3.17E-02
726.1,Enthesopathy,musculoskeletal,OPGS010361,0.063,RNAseq,CEP112,0.96 (0.94 0.97),2.98E-02
726.1,Enthesopathy,musculoskeletal,OPGS005289,0.258,RNAseq,UBA7,0.96 (0.94 0.98),3.08E-02
727.1,Synovitis and tenosynovitis,musculoskeletal,OPGS001037,0.051,SomaScan,Polypeptide N-acetylgalactosaminyltransferase 1,1.08 (1.05 1.12),3.06E-02
727.1,Synovitis and tenosynovitis,musculoskeletal,OPGS009222,0.085,RNAseq,,0.92 (0.89 0.95),2.84E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.94 (0.91 0.97),2.52E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS000984,0.055,SomaScan,Complement C2,1.07 (1.03 1.10),3.48E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS000284,0.177,SomaScan,Protein eva-1 homolog C,1.07 (1.03 1.10),3.67E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.94 (0.91 0.97),3.48E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS014889,0.016,RNAseq,BX537318.1,1.36 (1.32 1.40),4.16E-91
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS008965,0.090,RNAseq,MIRLET7BHG,0.85 (0.83 0.88),3.33E-21
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS005768,0.217,RNAseq,EPDR1,0.86 (0.83 0.89),1.07E-18
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS014581,0.018,RNAseq,PRR34-AS1,1.15 (1.11 1.18),2.42E-14
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS006225,0.191,RNAseq,NME8,1.10 (1.07 1.14),8.06E-07
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS004753,0.316,RNAseq,AC008467.1,0.92 (0.89 0.95),1.93E-04
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS014496,0.019,RNAseq,VARS1,1.08 (1.05 1.11),1.38E-03
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS012553,0.035,RNAseq,TMCC2,1.08 (1.05 1.11),1.38E-03
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS009511,0.079,RNAseq,AFAP1-AS1,0.93 (0.90 0.95),1.51E-03
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS003656,0.631,RNAseq,AFAP1,0.93 (0.90 0.96),1.65E-03
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS012006,0.041,RNAseq,VARS2,0.93 (0.90 0.96),2.39E-03
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS010826,0.056,RNAseq,TRIM10,0.93 (0.90 0.96),2.68E-03
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS014050,0.022,RNAseq,AGO2,1.08 (1.04 1.11),3.32E-03
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS012943,0.031,RNAseq,RPLP0,1.07 (1.04 1.10),8.22E-03
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS006048,0.200,RNAseq,,0.93 (0.90 0.96),8.22E-03
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS012093,0.040,RNAseq,TRIM26,1.07 (1.04 1.10),1.69E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS004122,0.430,RNAseq,HLA-DRB5,0.93 (0.90 0.96),1.70E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS014548,0.019,RNAseq,,1.07 (1.04 1.11),2.07E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS006666,0.167,RNAseq,HDLBP,0.94 (0.91 0.97),2.14E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS015102,0.015,RNAseq,BOP1,1.07 (1.04 1.10),2.15E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS011919,0.042,RNAseq,SOS2,0.94 (0.91 0.97),2.30E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS008126,0.111,RNAseq,BET1L,1.06 (1.03 1.10),3.31E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS006499,0.176,RNAseq,C4A,0.94 (0.91 0.97),3.48E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS006726,0.164,RNAseq,PAQR4,1.06 (1.03 1.09),3.48E-02
728.71,Contracture of palmar fascia [Dupuytren's disease],musculoskeletal,OPGS008667,0.097,RNAseq,LACTB2-AS1,1.06 (1.03 1.10),4.43E-02
732.1,Juvenile osteochondrosis,musculoskeletal,OPGS013863,0.024,RNAseq,AHCYL1,0.82 (0.75 0.89),3.34E-02
735.21,Hammer toe (acquired),musculoskeletal,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.91 (0.87 0.94),1.30E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS001701,0.019,SomaScan,UDP-N-acetylhexosamine pyrophosphorylase,0.94 (0.92 0.96),2.90E-04
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS000147,0.288,SomaScan,Ferritin. mitochondrial,1.06 (1.03 1.08),2.47E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS000400,0.139,SomaScan,Agouti-signaling protein,1.05 (1.03 1.07),3.01E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS001409,0.029,SomaScan,Gremlin-1,1.05 (1.03 1.07),3.71E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS001860,0.016,SomaScan,Immunoglobulin E,0.95 (0.93 0.97),3.79E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS000645,0.091,SomaScan,Trypsin-3,0.95 (0.93 0.97),3.95E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS000690,0.086,SomaScan,Rac GTPase-activating protein 1,0.95 (0.93 0.97),4.42E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,1.05 (1.03 1.08),4.42E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS000129,0.329,SomaScan,Neutrophil collagenase,1.05 (1.03 1.07),5.59E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS000402,0.138,SomaScan,HLA class II histocompatibility antigen. DQ alpha 2 chain,1.05 (1.03 1.07),1.15E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,1.05 (1.03 1.07),1.26E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS001492,0.026,SomaScan,EGF-containing fibulin-like extracellular matrix protein 1,0.96 (0.93 0.98),1.98E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,1.05 (1.02 1.07),1.98E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS001130,0.044,SomaScan,Chordin-like protein 2,1.05 (1.02 1.07),1.98E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS000920,0.061,SomaScan,T-cell surface protein tactile,1.05 (1.02 1.07),1.98E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS000290,0.171,SomaScan,Complement C4,1.04 (1.02 1.07),3.22E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS000572,0.102,SomaScan,Glutamate receptor 4,1.04 (1.02 1.07),3.51E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS001067,0.048,SomaScan,Ubiquitin-like protein ISG15,0.96 (0.94 0.98),3.51E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS000905,0.063,SomaScan,Torsin-1A-interacting protein 1,0.96 (0.94 0.98),3.61E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS003132,0.016,Metabolon,2-methylmalonyl carnitine,1.05 (1.02 1.07),2.01E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS009479,0.080,RNAseq,AL121753.2,1.06 (1.04 1.09),5.94E-04
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS011365,0.049,RNAseq,GGT7,1.06 (1.04 1.08),1.01E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS009150,0.086,RNAseq,UQCC1,1.06 (1.04 1.08),1.01E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS010512,0.061,RNAseq,ITCH,0.95 (0.93 0.97),2.47E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS006716,0.164,RNAseq,IER3,0.95 (0.93 0.97),2.47E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS010826,0.056,RNAseq,TRIM10,1.06 (1.03 1.08),2.47E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS003680,0.611,RNAseq,,0.95 (0.93 0.97),3.01E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS008889,0.092,RNAseq,TRAV20,1.05 (1.03 1.07),3.71E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS014496,0.019,RNAseq,VARS1,0.95 (0.93 0.97),4.42E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS014870,0.017,RNAseq,ST20,0.95 (0.93 0.97),4.55E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS010142,0.067,RNAseq,PRSS16,0.95 (0.93 0.97),5.42E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS010181,0.066,RNAseq,KCTD21,1.05 (1.03 1.07),7.96E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS006499,0.176,RNAseq,C4A,1.05 (1.03 1.07),7.96E-03
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS004014,0.460,RNAseq,PRMT6,0.95 (0.93 0.98),1.26E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS003644,0.643,RNAseq,KANSL1-AS1,1.05 (1.02 1.07),1.72E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS015028,0.016,RNAseq,JUNB,1.05 (1.02 1.07),2.02E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS012404,0.037,RNAseq,BCKDHB,0.96 (0.93 0.98),2.05E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS013792,0.024,RNAseq,YIPF2,0.96 (0.94 0.98),2.32E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS004636,0.335,RNAseq,PTPA,1.05 (1.02 1.07),2.79E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS006845,0.158,RNAseq,FLOT1,0.96 (0.94 0.98),3.24E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS007313,0.139,RNAseq,MMP24OS,1.05 (1.02 1.07),3.24E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS007536,0.131,RNAseq,LDLRAP1,0.96 (0.94 0.98),3.51E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS004117,0.431,RNAseq,DDX58,1.04 (1.02 1.07),3.61E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS010277,0.065,RNAseq,CXCR6,1.04 (1.02 1.07),4.08E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS015083,0.015,RNAseq,AC020934.2,1.04 (1.02 1.07),4.13E-02
735.3,Hallux valgus (Bunion),musculoskeletal,OPGS004300,0.389,RNAseq,PLCL1,0.96 (0.94 0.98),4.67E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS000970,0.056,SomaScan,Extracellular matrix protein 1,1.04 (1.03 1.06),7.17E-05
740.1,Osteoarthritis; localized,musculoskeletal,OPGS000642,0.092,SomaScan,Heparin cofactor 2,0.97 (0.95 0.98),1.50E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS001415,0.029,SomaScan,WNT1-inducible-signaling pathway protein 3,0.97 (0.95 0.98),1.50E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS000040,0.535,SomaScan,Haptoglobin,0.97 (0.95 0.98),1.75E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS001018,0.052,SomaScan,Serine/threonine-protein kinase pim-1,0.97 (0.95 0.98),1.75E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS002186,0.011,SomaScan,Suprabasin,0.97 (0.95 0.98),2.09E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS001879,0.015,SomaScan,Arfaptin-2,1.04 (1.02 1.05),2.09E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS000061,0.457,SomaScan,Haptoglobin,0.97 (0.95 0.98),2.09E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS001187,0.039,SomaScan,Intestinal-type alkaline phosphatase,1.03 (1.02 1.05),2.31E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS001911,0.014,SomaScan,Ectodysplasin-A. secreted form,0.97 (0.95 0.98),3.74E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS001460,0.027,SomaScan,Gap junction alpha-1 protein,1.03 (1.02 1.05),4.08E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS002483,0.125,Olink,Protein delta homolog 1,0.97 (0.96 0.99),4.49E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS003625,0.664,RNAseq,,0.95 (0.94 0.97),6.92E-06
740.1,Osteoarthritis; localized,musculoskeletal,OPGS003744,0.573,RNAseq,COLGALT2,1.05 (1.03 1.06),6.92E-06
740.1,Osteoarthritis; localized,musculoskeletal,OPGS003644,0.643,RNAseq,KANSL1-AS1,1.05 (1.03 1.06),1.47E-05
740.1,Osteoarthritis; localized,musculoskeletal,OPGS006042,0.201,RNAseq,SUPT3H,1.04 (1.03 1.06),4.48E-04
740.1,Osteoarthritis; localized,musculoskeletal,OPGS005624,0.227,RNAseq,ZBED5-AS1,0.97 (0.95 0.98),1.06E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS008320,0.106,RNAseq,PELI3,0.97 (0.95 0.98),1.25E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS013201,0.029,RNAseq,NRCAM,0.97 (0.95 0.98),1.75E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS010691,0.058,RNAseq,RPRD2,1.03 (1.02 1.05),1.75E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS009078,0.088,RNAseq,MAPRE3,0.97 (0.95 0.98),1.95E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS009970,0.070,RNAseq,CLDN23,1.03 (1.02 1.05),1.95E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS012898,0.032,RNAseq,COA8,1.03 (1.02 1.05),2.09E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS008845,0.093,RNAseq,MLXIP,0.97 (0.95 0.98),2.34E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS005312,0.255,RNAseq,AC009971.1,0.97 (0.95 0.98),2.98E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS005763,0.217,RNAseq,FAM53A,0.97 (0.95 0.98),3.74E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS009357,0.082,RNAseq,GDAP1,0.97 (0.96 0.98),3.74E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS006048,0.200,RNAseq,,0.97 (0.96 0.98),4.49E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS006001,0.203,RNAseq,HLA-DQA1,1.03 (1.01 1.05),4.49E-02
740.1,Osteoarthritis; localized,musculoskeletal,OPGS008327,0.106,RNAseq,PLEKHM1,1.03 (1.01 1.05),4.49E-02
740.11,Osteoarthrosis. localized. primary,musculoskeletal,OPGS000163,0.269,SomaScan,Single Ig IL-1-related receptor,1.04 (1.03 1.06),1.68E-02
740.11,Osteoarthrosis. localized. primary,musculoskeletal,OPGS001162,0.041,SomaScan,Beta-defensin 119,0.96 (0.94 0.98),2.47E-02
740.11,Osteoarthrosis. localized. primary,musculoskeletal,OPGS001831,0.016,SomaScan,SUN domain-containing protein 3,1.04 (1.02 1.06),4.79E-02
740.11,Osteoarthrosis. localized. primary,musculoskeletal,OPGS010746,0.057,RNAseq,AC025857.2,1.04 (1.03 1.06),1.68E-02
740.11,Osteoarthrosis. localized. primary,musculoskeletal,OPGS012424,0.036,RNAseq,TSPAN18,0.96 (0.94 0.98),1.68E-02
740.11,Osteoarthrosis. localized. primary,musculoskeletal,OPGS011099,0.052,RNAseq,AC073332.1,0.96 (0.94 0.97),1.68E-02
740.11,Osteoarthrosis. localized. primary,musculoskeletal,OPGS005300,0.257,RNAseq,AF131215.6,1.04 (1.02 1.06),3.45E-02
740.11,Osteoarthrosis. localized. primary,musculoskeletal,OPGS005258,0.260,RNAseq,PISD,1.04 (1.02 1.06),3.45E-02
740.9,Osteoarthrosis NOS,musculoskeletal,OPGS009970,0.070,RNAseq,CLDN23,1.04 (1.02 1.06),3.71E-02
740.9,Osteoarthrosis NOS,musculoskeletal,OPGS008010,0.115,RNAseq,CHMP2B,1.04 (1.02 1.06),3.71E-02
743.11,Osteoporosis NOS,musculoskeletal,OPGS001136,0.043,SomaScan,R-spondin-3,0.95 (0.93 0.97),1.21E-03
743.11,Osteoporosis NOS,musculoskeletal,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.96 (0.94 0.98),4.80E-02
743.11,Osteoporosis NOS,musculoskeletal,OPGS002648,0.017,Olink,Collagen alpha-1,1.06 (1.04 1.08),1.21E-03
743.11,Osteoporosis NOS,musculoskeletal,OPGS003029,0.026,Metabolon,docosatrienoate (22:3n3),0.95 (0.93 0.97),1.32E-02
743.11,Osteoporosis NOS,musculoskeletal,OPGS003074,0.021,Metabolon,1-stearoyl-2-linoleoyl-GPC (18:0/18:2)*,0.96 (0.94 0.98),3.61E-02
743.11,Osteoporosis NOS,musculoskeletal,OPGS002909,0.049,Metabolon,X - 24439,0.96 (0.94 0.98),4.80E-02
743.11,Osteoporosis NOS,musculoskeletal,OPGS006176,0.193,RNAseq,ZBED4,1.05 (1.03 1.07),1.32E-02
743.11,Osteoporosis NOS,musculoskeletal,OPGS013850,0.024,RNAseq,ESR1,1.05 (1.03 1.07),1.32E-02
743.11,Osteoporosis NOS,musculoskeletal,OPGS014179,0.021,RNAseq,AFF4,0.95 (0.94 0.97),1.32E-02
743.11,Osteoporosis NOS,musculoskeletal,OPGS014695,0.017,RNAseq,QPCTL,0.95 (0.93 0.97),1.32E-02
743.11,Osteoporosis NOS,musculoskeletal,OPGS006042,0.201,RNAseq,SUPT3H,1.05 (1.03 1.07),2.28E-02
743.11,Osteoporosis NOS,musculoskeletal,OPGS013939,0.023,RNAseq,BATF2,1.05 (1.02 1.07),3.61E-02
743.11,Osteoporosis NOS,musculoskeletal,OPGS012070,0.040,RNAseq,P4HTM,0.96 (0.94 0.98),4.80E-02
743.11,Osteoporosis NOS,musculoskeletal,OPGS011858,0.043,RNAseq,CEMIP,1.04 (1.02 1.06),4.80E-02
743.11,Osteoporosis NOS,musculoskeletal,OPGS004444,0.364,RNAseq,FADS2,0.96 (0.94 0.98),4.80E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS001084,0.047,SomaScan,Activating signal cointegrator 1 complex subunit 1,1.18 (1.11 1.27),7.62E-03
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS001427,0.028,SomaScan,Alpha-2-macroglobulin,1.19 (1.11 1.27),7.62E-03
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS001294,0.034,SomaScan,Peroxidasin homolog,0.85 (0.79 0.91),7.62E-03
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS000844,0.068,SomaScan,Growth/differentiation factor 2,1.18 (1.10 1.26),7.62E-03
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS000916,0.061,SomaScan,CD63 antigen,1.18 (1.10 1.26),7.62E-03
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS001059,0.049,SomaScan,Inter-alpha-trypsin inhibitor heavy chain H4,0.85 (0.79 0.91),7.62E-03
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS000710,0.082,SomaScan,Thrombin,1.18 (1.10 1.26),7.62E-03
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS000795,0.074,SomaScan,Plasma serine protease inhibitor,0.85 (0.79 0.91),7.76E-03
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS001487,0.026,SomaScan,Interleukin-2,1.17 (1.09 1.26),9.16E-03
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS000888,0.064,SomaScan,Glucosidase 2 subunit beta,1.17 (1.09 1.26),9.16E-03
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS000925,0.060,SomaScan,Plexin domain-containing protein 1,0.85 (0.80 0.92),1.08E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS000910,0.062,SomaScan,Neurexin-1,0.86 (0.80 0.92),1.10E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS001191,0.039,SomaScan,Progonadoliberin-1,0.86 (0.80 0.92),1.10E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS001257,0.036,SomaScan,Glucagon,0.86 (0.80 0.92),1.10E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS000960,0.057,SomaScan,Cadherin-15,0.86 (0.80 0.92),1.22E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS001574,0.023,SomaScan,Keratin-associated protein 2-4,0.86 (0.80 0.92),1.38E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS001337,0.032,SomaScan,Cholecystokinin,0.86 (0.80 0.92),1.43E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS000766,0.077,SomaScan,Peptidyl-tRNA hydrolase ICT1. mitochondrial,0.86 (0.80 0.92),1.44E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS001273,0.035,SomaScan,Persulfide dioxygenase ETHE1. mitochondrial,0.86 (0.80 0.92),1.46E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS001436,0.028,SomaScan,Bone morphogenetic protein 7,1.16 (1.08 1.24),2.20E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS001060,0.049,SomaScan,Septin-11,1.15 (1.08 1.24),2.20E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS000563,0.104,SomaScan,Liver-expressed antimicrobial peptide 2,0.87 (0.81 0.93),3.38E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS000993,0.054,SomaScan,Protachykinin-1,0.87 (0.81 0.93),3.79E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS000394,0.140,SomaScan,Superoxide dismutase [Mn]. mitochondrial,1.15 (1.07 1.24),4.83E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS002510,0.085,Olink,Bone morphogenetic protein 6,0.87 (0.81 0.93),3.00E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS002742,0.161,Metabolon,bradykinin,1.18 (1.10 1.26),7.62E-03
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS002726,0.198,Metabolon,methionylalanine,1.17 (1.10 1.26),8.25E-03
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS002794,0.099,Metabolon,X - 14095,1.16 (1.08 1.24),2.28E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS002767,0.127,Metabolon,phenylalanylarginine,1.15 (1.08 1.24),2.79E-02
747.11,Cardiac shunt/ heart septal defect,congenital anomalies,OPGS009082,0.088,RNAseq,SERPING1,1.14 (1.07 1.22),3.18E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS001297,0.034,SomaScan,Neogenin,0.93 (0.90 0.96),8.71E-04
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS000883,0.064,SomaScan,Group XIIB secretory phospholipase A2-like protein,1.08 (1.04 1.11),1.42E-03
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS001279,0.035,SomaScan,Four-jointed box protein 1,1.07 (1.04 1.11),3.33E-03
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS000285,0.176,SomaScan,Complement C1q tumor necrosis factor-related protein 1,1.06 (1.03 1.10),2.46E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS000154,0.277,SomaScan,Granulins,1.06 (1.03 1.10),3.98E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS002605,0.030,Olink,Sortilin,0.94 (0.91 0.97),8.42E-03
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003001,0.031,Metabolon,palmitoyl sphingomyelin (d18:1/16:0),1.10 (1.07 1.14),1.16E-06
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003006,0.030,Metabolon,cholesterol,1.09 (1.05 1.12),1.24E-04
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003119,0.017,Metabolon,1-palmitoyl-GPC (16:0),1.08 (1.04 1.11),1.54E-03
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.07 (1.04 1.11),3.06E-03
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.07 (1.04 1.10),3.36E-03
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003069,0.021,Metabolon,1-oleoyl-3-linoleoyl-glycerol (18:1/18:2),1.07 (1.04 1.10),4.99E-03
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003041,0.024,Metabolon,1-oleoyl-2-linoleoyl-glycerol (18:1/18:2),1.07 (1.03 1.10),9.91E-03
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003217,0.011,Metabolon,X - 24024,1.06 (1.03 1.10),2.28E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003124,0.017,Metabolon,1-palmitoyl-2-stearoyl-GPC (16:0/18:0),1.06 (1.03 1.09),3.75E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.15 (1.12 1.19),2.79E-13
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.15 (1.11 1.18),3.26E-13
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.15 (1.11 1.18),4.00E-13
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.14 (1.10 1.18),8.91E-12
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.13 (1.10 1.17),3.56E-11
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.13 (1.09 1.17),1.93E-10
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.12 (1.09 1.16),6.22E-10
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.13 (1.09 1.16),1.01E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.13 (1.09 1.16),1.05E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.13 (1.09 1.16),1.16E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.12 (1.09 1.16),2.06E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.12 (1.09 1.16),2.41E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.12 (1.09 1.16),2.41E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.12 (1.09 1.16),2.77E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003455,0.087,Nightingale,Total free cholesterol,1.12 (1.09 1.16),2.77E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.12 (1.09 1.16),3.04E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.12 (1.09 1.16),3.06E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.12 (1.09 1.16),3.27E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.12 (1.09 1.16),4.11E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.12 (1.08 1.16),5.50E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.12 (1.08 1.16),5.50E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.12 (1.08 1.15),5.50E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.12 (1.08 1.16),5.50E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.12 (1.08 1.16),5.50E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.12 (1.08 1.16),7.90E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.12 (1.08 1.16),7.90E-09
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003452,0.087,Nightingale,Total cholesterol,1.12 (1.08 1.15),1.08E-08
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.12 (1.08 1.16),1.18E-08
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.12 (1.08 1.16),1.31E-08
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.12 (1.08 1.15),1.32E-08
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.12 (1.08 1.15),1.70E-08
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.12 (1.08 1.15),1.86E-08
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.12 (1.08 1.15),2.08E-08
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003423,0.126,Nightingale,LDL cholesterol,1.12 (1.08 1.15),2.23E-08
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.11 (1.08 1.15),5.36E-08
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.11 (1.08 1.15),9.05E-08
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.11 (1.08 1.15),1.28E-07
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003509,0.069,Nightingale,Free cholesterol in chylomicrons and extremely large VLDL,0.91 (0.88 0.93),1.63E-07
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003536,0.034,Nightingale,Docosahexaenoic acid,1.11 (1.07 1.14),1.63E-07
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.11 (1.07 1.14),1.81E-07
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.11 (1.07 1.14),3.84E-07
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.10 (1.07 1.14),4.50E-07
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.11 (1.07 1.14),4.57E-07
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003482,0.075,Nightingale,Triglycerides in chylomicrons and extremely large VLDL,0.91 (0.88 0.94),5.18E-07
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003462,0.083,Nightingale,Average diameter for VLDL particles,0.91 (0.88 0.94),9.09E-07
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003487,0.074,Nightingale,Phospholipids in chylomicrons and extremely large VLDL,0.91 (0.88 0.94),1.13E-06
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.10 (1.07 1.14),1.67E-06
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003489,0.074,Nightingale,Concentration of chylomicrons and extremely large VLDL particles,0.91 (0.88 0.94),1.67E-06
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.10 (1.06 1.14),1.78E-06
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003491,0.073,Nightingale,Total lipids in chylomicrons and extremely large VLDL,0.91 (0.88 0.94),2.59E-06
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.10 (1.06 1.13),3.30E-06
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003511,0.068,Nightingale,Polyunsaturated fatty acids,1.10 (1.06 1.13),5.17E-06
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003504,0.070,Nightingale,Triglycerides in very large VLDL,0.92 (0.89 0.95),1.70E-05
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003500,0.071,Nightingale,Total lipids in very large VLDL,0.92 (0.89 0.95),3.25E-05
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003505,0.070,Nightingale,Omega-6 fatty acids,1.09 (1.05 1.12),3.93E-05
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003502,0.070,Nightingale,Concentration of very large VLDL particles,0.92 (0.89 0.95),7.04E-05
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003513,0.067,Nightingale,Free cholesterol in very large VLDL,0.92 (0.89 0.95),7.78E-05
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003506,0.070,Nightingale,Cholesterol in very large VLDL,0.92 (0.89 0.95),9.33E-05
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003516,0.066,Nightingale,Phospholipids in very large VLDL,0.92 (0.89 0.95),1.29E-04
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003510,0.068,Nightingale,Cholesterol in chylomicrons and extremely large VLDL,0.92 (0.90 0.95),2.17E-04
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003528,0.050,Nightingale,Total cholines,1.08 (1.05 1.12),3.05E-04
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003496,0.072,Nightingale,Cholesteryl esters in very large VLDL,0.93 (0.90 0.96),4.82E-04
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003527,0.050,Nightingale,Sphingomyelins,1.07 (1.04 1.11),2.95E-03
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.07 (1.04 1.10),6.06E-03
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003480,0.075,Nightingale,Triglycerides in small LDL,1.07 (1.03 1.10),1.00E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003530,0.047,Nightingale,Phosphoglycerides,1.06 (1.03 1.10),1.82E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003453,0.087,Nightingale,Triglycerides in very small VLDL,1.06 (1.03 1.10),2.91E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003467,0.080,Nightingale,Total lipids in small VLDL,1.06 (1.03 1.10),3.55E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003498,0.071,Nightingale,Triglycerides in large VLDL,0.94 (0.91 0.97),3.92E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003526,0.050,Nightingale,Phosphatidylcholines,1.06 (1.03 1.09),4.18E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003514,0.067,Nightingale,Cholesteryl esters in chylomicrons and extremely large VLDL,0.94 (0.91 0.97),4.40E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS003494,0.072,Nightingale,Concentration of large VLDL particles,0.94 (0.91 0.97),4.66E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS011444,0.048,RNAseq,STEAP1B,1.10 (1.06 1.13),5.10E-06
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS007943,0.117,RNAseq,SLC22A1,0.93 (0.90 0.96),4.37E-04
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS008253,0.108,RNAseq,SPON2,0.93 (0.90 0.96),1.52E-03
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS011483,0.047,RNAseq,AC004865.2,0.94 (0.92 0.97),3.29E-03
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS004014,0.460,RNAseq,PRMT6,0.93 (0.91 0.96),3.33E-03
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS012510,0.036,RNAseq,KLRF1,0.94 (0.91 0.97),1.65E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS009826,0.072,RNAseq,CNN1,1.06 (1.03 1.10),2.15E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS011470,0.047,RNAseq,MAT2B,1.06 (1.03 1.10),2.38E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS013658,0.025,RNAseq,CXXC5,0.94 (0.91 0.97),2.63E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS005216,0.264,RNAseq,TMEM87B,0.94 (0.91 0.97),2.68E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS010653,0.059,RNAseq,CELSR2,1.06 (1.03 1.10),2.98E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS009320,0.083,RNAseq,ARG2,1.06 (1.03 1.09),3.44E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS010132,0.067,RNAseq,FAM216A,1.07 (1.03 1.10),3.46E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS006506,0.175,RNAseq,ATF1,1.06 (1.03 1.09),3.58E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS009151,0.086,RNAseq,AC064836.3,1.06 (1.03 1.09),3.92E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS006659,0.167,RNAseq,ADD1,0.94 (0.91 0.97),4.12E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS005600,0.230,RNAseq,AC022784.1,1.06 (1.03 1.09),4.41E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS006608,0.170,RNAseq,MFHAS1,1.06 (1.03 1.09),4.46E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS010274,0.065,RNAseq,ARPC3,1.06 (1.03 1.10),4.47E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS005800,0.215,RNAseq,ACTR2,1.06 (1.03 1.10),4.54E-02
747.13,Congenital anomalies of great vessels,congenital anomalies,OPGS011898,0.042,RNAseq,LINC02453,1.06 (1.03 1.09),4.57E-02
751.22,Other specified congenital anomalies of kidney,congenital anomalies,OPGS002106,0.012,SomaScan,Tyrosine-protein kinase receptor TYRO3,1.07 (1.04 1.09),2.18E-02
759,Other and unspecified congenital anomalies,congenital anomalies,OPGS001742,0.018,SomaScan,Protein G6b,0.81 (0.75 0.88),2.47E-02
782.3,Edema,symptoms,OPGS001658,0.020,SomaScan,Endoglin,0.93 (0.90 0.96),1.88E-02
785,Abdominal pain,symptoms,OPGS002874,0.060,Metabolon,campesterol,0.98 (0.97 0.99),9.31E-04
785,Abdominal pain,symptoms,OPGS003043,0.024,Metabolon,1-docosahexaenoyl-GPC (22:6)*,0.98 (0.97 0.99),3.67E-02
785,Abdominal pain,symptoms,OPGS005698,0.221,RNAseq,XPNPEP1,0.98 (0.97 0.99),3.45E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003052,0.023,Metabolon,X - 11880,0.96 (0.94 0.98),1.61E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003455,0.087,Nightingale,Total free cholesterol,1.05 (1.03 1.07),5.80E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.05 (1.03 1.07),5.80E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.04 (1.03 1.06),5.80E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.04 (1.03 1.06),5.80E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.04 (1.03 1.06),5.80E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.04 (1.03 1.06),5.80E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.04 (1.03 1.06),5.80E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.04 (1.03 1.06),5.80E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.04 (1.03 1.06),5.80E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.04 (1.02 1.06),5.80E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003423,0.126,Nightingale,LDL cholesterol,1.04 (1.02 1.06),5.80E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.04 (1.02 1.06),6.80E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.04 (1.02 1.06),6.87E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.04 (1.02 1.06),6.87E-03
790.6,Other abnormal blood chemistry,symptoms,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.04 (1.02 1.06),1.27E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.04 (1.02 1.06),1.27E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.04 (1.02 1.06),1.27E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.04 (1.02 1.06),1.27E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.04 (1.02 1.06),1.61E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.04 (1.02 1.06),2.18E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.04 (1.02 1.06),2.18E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.04 (1.02 1.06),2.43E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.04 (1.02 1.06),2.61E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003452,0.087,Nightingale,Total cholesterol,1.04 (1.02 1.06),2.71E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.04 (1.02 1.06),3.05E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003533,0.041,Nightingale,Omega-3 fatty acids,1.04 (1.02 1.06),3.07E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.04 (1.02 1.06),3.66E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.04 (1.02 1.06),3.84E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.04 (1.02 1.06),3.84E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.04 (1.02 1.06),3.91E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.04 (1.02 1.06),4.50E-02
790.6,Other abnormal blood chemistry,symptoms,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.04 (1.02 1.06),4.50E-02
793,Nonspecific abnormal findings on radiological and other examination of musculoskeletal system,symptoms,OPGS006314,0.186,RNAseq,,1.38 (1.21 1.57),1.81E-02
798.1,Chronic fatigue syndrome,symptoms,OPGS012877,0.032,RNAseq,UTP6,1.12 (1.07 1.16),4.33E-03
836,Traumatic arthropathy,injuries & poisonings,OPGS011267,0.050,RNAseq,C19orf54,0.75 (0.67 0.85),4.22E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS001377,0.030,SomaScan,Vascular cell adhesion protein 1,1.08 (1.04 1.11),1.78E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS002173,0.011,SomaScan,Interleukin-2 receptor subunit beta,1.07 (1.04 1.11),2.26E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS002585,0.037,Olink,T-cell surface glycoprotein CD5,1.07 (1.03 1.10),1.97E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS002973,0.035,Metabolon,palmitoyl dihydrosphingomyelin (d18:0/16:0)*,1.06 (1.03 1.10),3.86E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003451,0.092,Nightingale,Concentration of very small VLDL particles,1.11 (1.07 1.14),2.39E-06
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003449,0.092,Nightingale,Total lipids in very small VLDL,1.10 (1.07 1.14),3.14E-06
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003517,0.066,Nightingale,Cholesteryl esters in small VLDL,1.10 (1.07 1.14),5.78E-06
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003485,0.074,Nightingale,Cholesterol in very small VLDL,1.10 (1.06 1.13),3.25E-05
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003515,0.066,Nightingale,Cholesteryl esters in very small VLDL,1.09 (1.06 1.12),2.01E-04
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003501,0.070,Nightingale,Cholesterol in small VLDL,1.09 (1.05 1.12),2.21E-04
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003444,0.101,Nightingale,Apolipoprotein B,1.09 (1.05 1.12),2.27E-04
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003437,0.110,Nightingale,Phospholipids in very small VLDL,1.09 (1.05 1.12),3.12E-04
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003434,0.113,Nightingale,Phospholipids in IDL,1.09 (1.05 1.12),3.54E-04
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003456,0.086,Nightingale,Free cholesterol in very small VLDL,1.09 (1.05 1.12),3.54E-04
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003531,0.046,Nightingale,Cholesteryl esters in small HDL,1.08 (1.05 1.12),9.18E-04
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003443,0.102,Nightingale,Cholesteryl esters in IDL,1.08 (1.05 1.11),1.22E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003450,0.092,Nightingale,Triglycerides in IDL,1.08 (1.05 1.11),1.22E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003433,0.115,Nightingale,Concentration of large LDL particles,1.08 (1.05 1.11),1.22E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003441,0.104,Nightingale,Phospholipids in medium LDL,1.08 (1.05 1.11),1.22E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003425,0.122,Nightingale,Cholesterol in large LDL,1.08 (1.05 1.12),1.22E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003438,0.109,Nightingale,Total lipids in IDL,1.08 (1.05 1.12),1.22E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003431,0.118,Nightingale,Total lipids in large LDL,1.08 (1.05 1.12),1.22E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003432,0.116,Nightingale,Free cholesterol in IDL,1.08 (1.05 1.12),1.22E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003460,0.084,Nightingale,Triglycerides in large LDL,1.08 (1.05 1.11),1.22E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003470,0.078,Nightingale,Triglycerides in medium LDL,1.08 (1.05 1.11),1.22E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003464,0.082,Nightingale,Triglycerides in LDL,1.08 (1.04 1.11),1.47E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003440,0.106,Nightingale,Cholesterol in IDL,1.08 (1.05 1.11),1.60E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003439,0.107,Nightingale,Concentration of IDL particles,1.08 (1.04 1.11),1.64E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003429,0.121,Nightingale,Cholesteryl esters in large LDL,1.08 (1.04 1.11),2.26E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003427,0.121,Nightingale,Concentration of medium LDL particles,1.08 (1.04 1.11),2.82E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003426,0.121,Nightingale,Free cholesterol in large LDL,1.08 (1.04 1.11),3.77E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003436,0.111,Nightingale,Phospholipids in large LDL,1.07 (1.04 1.11),3.90E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003455,0.087,Nightingale,Total free cholesterol,1.07 (1.04 1.11),6.01E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003423,0.126,Nightingale,LDL cholesterol,1.07 (1.04 1.11),6.44E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003424,0.122,Nightingale,Total lipids in medium LDL,1.07 (1.04 1.11),8.10E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003435,0.113,Nightingale,Free cholesterol in medium LDL,1.07 (1.04 1.10),1.10E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003446,0.097,Nightingale,Phospholipids in small LDL,1.07 (1.04 1.10),1.10E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003419,0.134,Nightingale,Cholesteryl esters in small LDL,1.07 (1.04 1.10),1.11E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003428,0.121,Nightingale,Total lipids in small LDL,1.07 (1.04 1.10),1.31E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003442,0.103,Nightingale,Free cholesterol in small LDL,1.07 (1.04 1.10),1.40E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003421,0.128,Nightingale,Cholesteryl esters in medium LDL,1.07 (1.03 1.10),1.57E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003420,0.129,Nightingale,Cholesterol in small LDL,1.07 (1.03 1.10),1.75E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003452,0.087,Nightingale,Total cholesterol,1.07 (1.03 1.10),1.83E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003422,0.126,Nightingale,Cholesterol in medium LDL,1.07 (1.03 1.10),1.83E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003430,0.121,Nightingale,Concentration of small LDL particles,1.07 (1.03 1.10),1.83E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003474,0.076,Nightingale,Free cholesterol in small VLDL,1.07 (1.03 1.10),1.87E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003535,0.035,Nightingale,Cholesterol in small HDL,1.07 (1.03 1.10),1.99E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003454,0.087,Nightingale,Total esterified cholesterol,1.06 (1.03 1.10),2.47E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003463,0.082,Nightingale,Phospholipids in small VLDL,1.06 (1.03 1.09),3.87E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.94 (0.91 0.97),4.93E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS003488,0.074,Nightingale,VLDL cholesterol,1.06 (1.03 1.09),5.00E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS013939,0.023,RNAseq,BATF2,1.07 (1.04 1.10),5.69E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS014029,0.022,RNAseq,IGHV4-59,1.06 (1.03 1.09),9.41E-03
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS008932,0.091,RNAseq,IGF2BP2,0.94 (0.92 0.97),1.99E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS009423,0.081,RNAseq,PSTPIP2,1.06 (1.03 1.10),2.39E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS004224,0.407,RNAseq,SVBP,1.06 (1.03 1.09),2.59E-02
854,Complications of cardiac/vascular device. implant. and graft,injuries & poisonings,OPGS011641,0.045,RNAseq,DOK2,0.94 (0.92 0.97),2.84E-02
857,Mechanical complication of unspecified genitourinary device. implant. and graft,injuries & poisonings,OPGS004732,0.319,RNAseq,RALB,0.91 (0.87 0.95),3.46E-02
870.6,Open wound of neck,injuries & poisonings,OPGS015022,0.016,RNAseq,AC010491.1,1.31 (1.17 1.47),4.83E-02
907,Injuries to the nervous system,injuries & poisonings,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,1.10 (1.06 1.15),2.27E-02
939,Atopic/contact dermatitis due to other or unspecified,dermatologic,OPGS002175,0.011,SomaScan,Chymase,0.99 (0.98 0.99),4.91E-03
939,Atopic/contact dermatitis due to other or unspecified,dermatologic,OPGS000020,0.609,SomaScan,Interleukin-6 receptor subunit alpha,1.07 (1.04 1.10),4.52E-02
939,Atopic/contact dermatitis due to other or unspecified,dermatologic,OPGS000129,0.329,SomaScan,Neutrophil collagenase,0.93 (0.91 0.96),4.52E-02
939,Atopic/contact dermatitis due to other or unspecified,dermatologic,OPGS012096,0.040,RNAseq,CCR7,1.06 (1.03 1.09),4.16E-02
939,Atopic/contact dermatitis due to other or unspecified,dermatologic,OPGS013572,0.026,RNAseq,RTN4RL1,1.07 (1.04 1.10),4.37E-02
957,Injury to other and unspecified nerves,injuries & poisonings,OPGS000408,0.137,SomaScan,Ubiquitin carboxyl-terminal hydrolase 25,1.22 (1.14 1.30),1.56E-04
957,Injury to other and unspecified nerves,injuries & poisonings,OPGS012761,0.033,RNAseq,TRAV12-3,0.84 (0.78 0.90),2.42E-02
960.2,Allergy/adverse effect of penicillin,injuries & poisonings,OPGS000879,0.065,SomaScan,Natural cytotoxicity triggering receptor 3,0.97 (0.96 0.99),2.64E-02
960.2,Allergy/adverse effect of penicillin,injuries & poisonings,OPGS002614,0.027,Olink,Carboxypeptidase B,0.97 (0.96 0.98),2.64E-02
960.2,Allergy/adverse effect of penicillin,injuries & poisonings,OPGS010475,0.061,RNAseq,ZNRD1,1.03 (1.02 1.05),5.26E-03
960.2,Allergy/adverse effect of penicillin,injuries & poisonings,OPGS003621,0.665,RNAseq,,1.03 (1.02 1.04),8.31E-03
960.2,Allergy/adverse effect of penicillin,injuries & poisonings,OPGS005280,0.258,RNAseq,DEXI,0.97 (0.96 0.98),8.62E-03
960.2,Allergy/adverse effect of penicillin,injuries & poisonings,OPGS010700,0.058,RNAseq,DCLRE1B,0.97 (0.96 0.98),9.52E-03
960.2,Allergy/adverse effect of penicillin,injuries & poisonings,OPGS008128,0.111,RNAseq,LITAF,1.03 (1.02 1.04),2.64E-02
960.2,Allergy/adverse effect of penicillin,injuries & poisonings,OPGS011465,0.047,RNAseq,ACOT13,0.97 (0.96 0.98),2.97E-02
967,Adverse effects of sedatives or other central nervous system depressants and anesthetics,injuries & poisonings,OPGS004318,0.386,RNAseq,ATP9A,1.18 (1.10 1.27),3.44E-02
989,Toxic effect of other substances. chiefly nonmedicinal as to source,injuries & poisonings,OPGS012660,0.034,RNAseq,PHF1,0.78 (0.71 0.85),1.02E-03
1001,Foreign body injury,others,OPGS008913,0.091,RNAseq,MS4A6A,0.88 (0.84 0.93),1.64E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS000110,0.357,SomaScan,Leucine-rich repeat neuronal protein 1,1.06 (1.04 1.08),1.53E-06
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS000138,0.311,SomaScan,14-3-3 protein epsilon,1.06 (1.04 1.08),1.53E-06
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS002036,0.012,SomaScan,Tight junction protein ZO-1,1.06 (1.04 1.08),1.53E-06
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001529,0.024,SomaScan,Deoxycytidine kinase,1.06 (1.04 1.08),6.87E-06
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001587,0.023,SomaScan,Carboxypeptidase E,1.06 (1.04 1.08),6.87E-06
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001280,0.035,SomaScan,Killer cell immunoglobulin-like receptor 2DL5A,1.06 (1.04 1.08),3.58E-05
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001665,0.020,SomaScan,Trem-like transcript 1 protein,1.05 (1.03 1.07),4.67E-05
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS000857,0.067,SomaScan,Moesin,1.06 (1.04 1.08),5.58E-05
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS000037,0.550,SomaScan,Tubulin-specific chaperone A,0.95 (0.93 0.97),7.42E-05
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS000179,0.254,SomaScan,Cardiotrophin-1,1.06 (1.03 1.08),8.34E-05
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001314,0.033,SomaScan,ADP-ribosylation factor-like protein 1,0.95 (0.93 0.97),1.02E-04
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001513,0.025,SomaScan,TOMM20-like protein 1,1.05 (1.03 1.07),1.96E-04
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001466,0.027,SomaScan,DNA-directed RNA polymerases I and III subunit RPAC1,1.05 (1.03 1.08),1.96E-04
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS000305,0.165,SomaScan,Small nuclear ribonucleoprotein F,0.95 (0.93 0.97),3.67E-04
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS000032,0.570,SomaScan,Protein S100-A13,0.95 (0.94 0.97),1.13E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001140,0.043,SomaScan,Beta-soluble NSF attachment protein,1.05 (1.03 1.07),1.22E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001155,0.042,SomaScan,Zinc finger protein 276,1.05 (1.03 1.07),1.41E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS002172,0.011,SomaScan,Casein kinase I isoform delta,0.95 (0.94 0.97),1.51E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001128,0.044,SomaScan,Epididymal-specific lipocalin-10,1.05 (1.03 1.07),1.51E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS000590,0.100,SomaScan,Estrogen sulfotransferase,0.95 (0.94 0.97),2.46E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS000325,0.159,SomaScan,PH and SEC7 domain-containing protein 1,1.05 (1.03 1.07),2.46E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001162,0.041,SomaScan,Beta-defensin 119,1.05 (1.03 1.07),3.10E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS000994,0.054,SomaScan,Nuclear receptor-binding protein,1.05 (1.03 1.07),3.62E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001118,0.044,SomaScan,Glutathione S-transferase Mu 1,1.04 (1.02 1.06),3.74E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS000911,0.062,SomaScan,Protein MENT,1.04 (1.02 1.06),3.77E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001532,0.024,SomaScan,Interleukin-22 receptor subunit alpha-1,1.05 (1.03 1.07),3.86E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001214,0.038,SomaScan,Low-density lipoprotein receptor-related protein 1B,1.05 (1.03 1.07),3.86E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS000115,0.347,SomaScan,Protein CEI,1.05 (1.02 1.07),4.84E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001773,0.018,SomaScan,17-beta-hydroxysteroid dehydrogenase 14,0.96 (0.94 0.98),7.72E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001093,0.046,SomaScan,C-reactive protein,0.96 (0.94 0.98),1.97E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001229,0.037,SomaScan,Stromal interaction molecule 1,1.04 (1.02 1.06),2.35E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001323,0.032,SomaScan,Sorting nexin-7,1.04 (1.02 1.06),2.35E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001172,0.040,SomaScan,Apolipoprotein B,1.04 (1.02 1.06),2.35E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS001520,0.025,SomaScan,Cold shock domain-containing protein C2,1.04 (1.02 1.06),2.84E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS000912,0.061,SomaScan,Ras-related protein Rab-14,0.96 (0.95 0.98),4.65E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS002658,0.013,Olink,C-C motif chemokine 22,0.96 (0.94 0.97),2.66E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS002511,0.083,Olink,T-cell surface glycoprotein CD4,0.96 (0.94 0.98),1.37E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS003146,0.015,Metabolon,N-palmitoyl-sphingosine (d18:1/16:0),1.04 (1.02 1.06),3.04E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS003459,0.084,Nightingale,Cholesterol in large HDL,0.96 (0.94 0.97),3.30E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS003458,0.085,Nightingale,Cholesteryl esters in large HDL,0.96 (0.94 0.97),3.30E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS003472,0.077,Nightingale,Concentration of large HDL particles,0.96 (0.94 0.98),5.76E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS003469,0.078,Nightingale,Total lipids in large HDL,0.96 (0.94 0.98),7.33E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS003468,0.079,Nightingale,Free cholesterol in large HDL,0.96 (0.94 0.98),2.68E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS003503,0.070,Nightingale,Phospholipids in large HDL,0.96 (0.94 0.98),2.68E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS007675,0.126,RNAseq,TRAV12-2,1.05 (1.03 1.07),3.03E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS006709,0.165,RNAseq,LRP12,1.05 (1.03 1.07),3.10E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS006499,0.176,RNAseq,C4A,0.96 (0.94 0.98),4.22E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS013243,0.029,RNAseq,TRAV3,0.96 (0.94 0.98),4.84E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS006845,0.158,RNAseq,FLOT1,1.04 (1.02 1.06),5.00E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS011273,0.050,RNAseq,SLC25A4,1.04 (1.02 1.07),5.00E-03
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS014496,0.019,RNAseq,VARS1,1.04 (1.02 1.06),1.24E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS008662,0.097,RNAseq,HDAC4-AS1,0.96 (0.94 0.98),1.37E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS013045,0.030,RNAseq,NEU1,0.96 (0.94 0.98),2.37E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS010826,0.056,RNAseq,TRIM10,0.96 (0.95 0.98),3.42E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS005230,0.263,RNAseq,LINC00243,1.04 (1.02 1.06),4.70E-02
1002,Symptoms concerning nutrition. metabolism. and development,others,OPGS006866,0.157,RNAseq,AL662795.2,1.04 (1.02 1.06),4.84E-02
1010,Other tests,others,OPGS000569,0.103,SomaScan,cAMP-specific 3'.5'-cyclic phosphodiesterase 4D,0.95 (0.92 0.97),2.51E-02
1010,Other tests,others,OPGS000240,0.198,SomaScan,MHC class I polypeptide-related sequence B,0.95 (0.93 0.97),3.49E-02
1010,Other tests,others,OPGS000618,0.096,SomaScan,MHC class I polypeptide-related sequence B,0.95 (0.93 0.97),4.61E-02
1010,Other tests,others,OPGS002632,0.022,Olink,Advanced glycosylation end product-specific receptor,0.95 (0.93 0.97),4.11E-02
1010,Other tests,others,OPGS010826,0.056,RNAseq,TRIM10,0.94 (0.92 0.96),1.13E-02
1010,Other tests,others,OPGS010693,0.058,RNAseq,TRBV5-1,1.06 (1.03 1.09),1.45E-02
1010,Other tests,others,OPGS008728,0.096,RNAseq,RIOX2,1.06 (1.03 1.08),1.85E-02
1010,Other tests,others,OPGS012006,0.041,RNAseq,VARS2,0.95 (0.92 0.97),2.51E-02
1010,Other tests,others,OPGS009865,0.072,RNAseq,TRAV17,0.95 (0.93 0.97),3.33E-02
1010,Other tests,others,OPGS004406,0.369,RNAseq,,0.95 (0.93 0.97),3.33E-02
1010,Other tests,others,OPGS009222,0.085,RNAseq,,0.95 (0.93 0.97),3.74E-02
1010,Other tests,others,OPGS013780,0.024,RNAseq,ZSCAN16,1.05 (1.03 1.08),4.11E-02
1010,Other tests,others,OPGS003680,0.611,RNAseq,,1.05 (1.03 1.08),4.11E-02
1010,Other tests,others,OPGS014711,0.017,RNAseq,NIT1,0.94 (0.92 0.97),4.27E-02
1010,Other tests,others,OPGS003936,0.490,RNAseq,CTSH,1.05 (1.03 1.08),4.27E-02
1010,Other tests,others,OPGS013045,0.030,RNAseq,NEU1,0.95 (0.93 0.97),4.41E-02
1010,Other tests,others,OPGS014496,0.019,RNAseq,VARS1,1.05 (1.03 1.07),4.72E-02
1010,Other tests,others,OPGS012093,0.040,RNAseq,TRIM26,1.05 (1.03 1.08),4.72E-02
1010,Other tests,others,OPGS003843,0.532,RNAseq,BTN3A2,0.95 (0.93 0.98),4.72E-02